Citrus Sinensis ID: 042314
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 370 | 2.2.26 [Sep-21-2011] | |||||||
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.659 | 0.266 | 0.384 | 4e-41 | |
| Q02779 | 954 | Mitogen-activated protein | yes | no | 0.670 | 0.259 | 0.372 | 2e-38 | |
| Q54TA1 | 749 | Probable serine/threonine | no | no | 0.656 | 0.324 | 0.364 | 3e-38 | |
| P18160 | 2410 | Dual specificity protein | no | no | 0.681 | 0.104 | 0.346 | 7e-38 | |
| Q66L42 | 940 | Mitogen-activated protein | yes | no | 0.670 | 0.263 | 0.376 | 1e-37 | |
| Q54N73 | 691 | Seven transmembrane domai | no | no | 0.667 | 0.357 | 0.372 | 2e-37 | |
| Q86HG9 | 1024 | Probable serine/threonine | no | no | 0.654 | 0.236 | 0.371 | 1e-36 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.675 | 0.194 | 0.359 | 2e-36 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.675 | 0.389 | 0.356 | 3e-36 | |
| Q54I36 | 1338 | Dual specificity protein | no | no | 0.670 | 0.185 | 0.328 | 6e-36 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 169 bits (427), Expect = 4e-41, Method: Compositional matrix adjust.
Identities = 97/252 (38%), Positives = 143/252 (56%), Gaps = 8/252 (3%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
G +G VY WRG+ +A K I+ + N +V F KEL + +LRHPNIV +
Sbjct: 671 GTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAP 730
Query: 162 ERLIFLTEYLRNGSLHDIL-KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTP 220
L F+TEYL GSL+D L KK K++ A+ IA+GMNYLH +IHRD+
Sbjct: 731 PNLCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYLHL---SGVIHRDIKS 787
Query: 221 SNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFS 280
N+L DE ++K+ DFGLSK+ S S +MT GS +M+PE+ E Y + VDV++
Sbjct: 788 LNLLLDEHMNVKICDFGLSKL----KSKSTEMTKSIGSPIWMSPELLMGEDYTEKVDVYA 843
Query: 281 FALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRP 340
F +I+ E+ G +VQ+A + RP + + +P + L++ CWH++P +RP
Sbjct: 844 FGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRP 903
Query: 341 TFEEIIFRLEAI 352
+F EI+ L I
Sbjct: 904 SFTEILNLLNEI 915
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q02779|M3K10_HUMAN Mitogen-activated protein kinase kinase kinase 10 OS=Homo sapiens GN=MAP3K10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 160 bits (404), Expect = 2e-38, Method: Compositional matrix adjust.
Identities = 98/263 (37%), Positives = 137/263 (52%), Gaps = 15/263 (5%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVR-NSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +G+VY WRG E+A K R +P V +E L+ L+HPNI+ G +
Sbjct: 107 GGFGKVYRALWRGEEVAVKAARLDPEKDPAVTAEQVCQEARLFGALQHPNIIALRGACLN 166
Query: 161 SERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTP 220
L + EY R G+L +L + ++ P V +A+ +ARGMNYLH+ P IIHRDL
Sbjct: 167 PPHLCLVMEYARGGALSRVLAGR-RVPPHVLVNWAVQVARGMNYLHNDAPVPIIHRDLKS 225
Query: 221 SNVLQDEA--GH------LKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
N+L EA H LK+TDFGL++ + + G+Y +MAPEV R +
Sbjct: 226 INILILEAIENHNLADTVLKITDFGLAR-----EWHKTTKMSAAGTYAWMAPEVIRLSLF 280
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332
KS DV+SF +++ E+ G R A+ VA A + S PEP LL ECW
Sbjct: 281 SKSSDVWSFGVLLWELLTGEVPYREIDALAVAYGVAMNKLTLPIPSTCPEPFARLLEECW 340
Query: 333 HKNPDRRPTFEEIIFRLEAIQES 355
+P RP F I+ RLE I++S
Sbjct: 341 DPDPHGRPDFGSILKRLEVIEQS 363
|
Activates the JUN N-terminal pathway. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 159 bits (402), Expect = 3e-38, Method: Compositional matrix adjust.
Identities = 94/258 (36%), Positives = 137/258 (53%), Gaps = 15/258 (5%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
G+ EV+ WRG +A K + + N +E + +LRHPNI QFLG +
Sbjct: 500 GSCAEVFTGTWRGIIVAIKKAKLLNEDDEDFLNELAQEATIMSQLRHPNICQFLGTCNNP 559
Query: 162 ERLIFLTEYLRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTP 220
++ + EY+ GSL+ IL LD P + ALDIA+GMNYLH P +IHRDL
Sbjct: 560 PEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMALDIAKGMNYLHCCDP-IVIHRDLKS 618
Query: 221 SNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFS 280
N+L DE +K++DFGLS ++ MT G+ + APEV R + Y + DVFS
Sbjct: 619 HNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMT-PVGTPCWTAPEVLRNDPYTEKADVFS 677
Query: 281 FALIVHEM------FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
FA+++ E+ +QG P+ Q+ RP + P L+ ECW +
Sbjct: 678 FAIVLWEIVTREDPYQGMPT------FQIVISVGQHKLRPIVPPQVSAPFTRLITECWSE 731
Query: 335 NPDRRPTFEEIIFRLEAI 352
+P +RP+F+EI+ RLEA+
Sbjct: 732 DPQQRPSFQEIVKRLEAM 749
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 158 bits (399), Expect = 7e-38, Method: Composition-based stats.
Identities = 95/274 (34%), Positives = 141/274 (51%), Gaps = 22/274 (8%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
I G +GEV WR T++A K I F E+G+ KLRHPN+VQFLG
Sbjct: 2121 IGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVMFQNEVGILSKLRHPNVVQFLGAC 2180
Query: 159 KH--SERLIFLTEYLRNGSLHDILKKKGKL---DPPTAVAYALDIARGMNYLHHHRPHAI 213
+ +TE++ GSL L L +P + ALDIA+GMNYLH P I
Sbjct: 2181 TAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALDIAKGMNYLHGWTP-PI 2239
Query: 214 IHRDLTPSNVLQD-------------EAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYR 260
+HRDL+ N+L D + K++DFGLS++ E+ S +MT G
Sbjct: 2240 LHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKMEQAS---QMTQSVGCIP 2296
Query: 261 YMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLY 320
YMAPEV++ +S + DV+S+ +++ E+ + +++A AYE RP +
Sbjct: 2297 YMAPEVFKGDSNSEKSDVYSYGMVLFELLTSDEPQQDMKPMKMAHLAAYESYRPPIPLTT 2356
Query: 321 PEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQE 354
K +L +CW NPD RPTF++II L+ +++
Sbjct: 2357 SSKWKEILTQCWDSNPDSRPTFKQIIVHLKEMED 2390
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q66L42|M3K10_MOUSE Mitogen-activated protein kinase kinase kinase 10 OS=Mus musculus GN=Map3k10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 157 bits (397), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 99/263 (37%), Positives = 139/263 (52%), Gaps = 15/263 (5%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVR-NSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +G+VY WRG E+A K R +P V +E L+ L+HPNI+ G
Sbjct: 107 GGFGKVYRAVWRGEEVAVKAARLDPERDPAVTAEQVRQEARLFGALQHPNIIALRGACLS 166
Query: 161 SERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTP 220
L + EY R G+L +L + ++ P V +A+ +ARGMNYLH+ P IIHRDL
Sbjct: 167 PPNLCLVMEYARGGALSRVLAGR-RVPPHVLVNWAVQVARGMNYLHNDAPVPIIHRDLKS 225
Query: 221 SNVLQDEA--GH------LKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
N+L EA H LK+TDFGL++ + + KM+ G+Y +MAPEV R +
Sbjct: 226 INILILEAIENHNLADTVLKITDFGLAREWHK----TTKMSAA-GTYAWMAPEVIRLSLF 280
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332
KS DV+SF +++ E+ G R A+ VA A + S PEP LL ECW
Sbjct: 281 SKSSDVWSFGVLLWELLTGEVPYREIDALAVAYGVAMNKLTLPIPSTCPEPFARLLEECW 340
Query: 333 HKNPDRRPTFEEIIFRLEAIQES 355
+P RP F I+ +LE I++S
Sbjct: 341 DPDPHGRPDFGSILKQLEVIEQS 363
|
Activates the JUN N-terminal pathway. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54N73|7TMK1_DICDI Seven transmembrane domain-containing tyrosine-protein kinase 1 OS=Dictyostelium discoideum GN=7tmk1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 157 bits (396), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 98/263 (37%), Positives = 141/263 (53%), Gaps = 16/263 (6%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNP---RVRNSFMKELGLWQKLRHPNIVQFL 155
I G +GEV W+G +A K + + N + N F+KE+ + LRHPN++QFL
Sbjct: 369 IGEGYFGEVRKAVWKGAVVAVKILHRNSFRNTDGNKEENVFLKEVAILSILRHPNVLQFL 428
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKL---DPPTAVAYALDIARGMNYLHHHRPHA 212
GV + +TEY+ GSL +L + L +P A A+ IARGM YLH +P+
Sbjct: 429 GVCSETNLNGIVTEYMGGGSLDRLLTDRYFLIKQNPILAWNMAISIARGMFYLHDWKPNP 488
Query: 213 IIHRDLTPSNVLQDEAGHL-KVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES 271
I+HRDL+ N+L DE+ + KV DFGLSK ++MT G Y APEV+ E
Sbjct: 489 ILHRDLSTKNILLDESLTIAKVADFGLSK------EQGFEMTSTVGHLCYQAPEVFIGEL 542
Query: 272 YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYP---EPIKALL 328
Y DV+SF L+V + G N+ +++A AYE+ RP + E + L+
Sbjct: 543 YTPKADVYSFGLLVWCIITGEQPNQNLQPLKMAHLAAYENYRPPMPQPMDPMWENLGKLI 602
Query: 329 RECWHKNPDRRPTFEEIIFRLEA 351
CW K+P+ RP+F I+ LEA
Sbjct: 603 EMCWKKSPEERPSFSFILDFLEA 625
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q86HG9|Y9871_DICDI Probable serine/threonine-protein kinase DDB_G0271682 OS=Dictyostelium discoideum GN=DDB_G0271682 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 154 bits (389), Expect = 1e-36, Method: Compositional matrix adjust.
Identities = 95/256 (37%), Positives = 140/256 (54%), Gaps = 14/256 (5%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
I GA GEV +W+GT +A KTI S+ + F KE+ + + LRHPN+V F+G
Sbjct: 366 IGSGACGEVCQYEWKGTPVAVKTIFKSLLRKDKKE-EFEKEVSILKCLRHPNVVLFMGTC 424
Query: 159 KHSERLIFLTEYLRNGSLHDILK--KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ L +TEYL GSL D+L K +L V +D+A+GMNYLH + P IIHR
Sbjct: 425 LLNGNLAIITEYLNRGSLRDVLTTMNKSELSLSVKVKMLIDVAQGMNYLHTYSP-PIIHR 483
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
DL N+L D ++KV+DFGLS+ S K GT S ++APEV+ Y V
Sbjct: 484 DLKSLNLLVDNNFNVKVSDFGLSRFISGGIGSSAKTFCGTLS--WIAPEVFNGSGYTTKV 541
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336
DV+SF +++ E+ + +A + P L S P+ L++EC ++NP
Sbjct: 542 DVYSFGIVLWEILTHKQPSGNISATSLG--------HPELPSNCPQSFSDLIKECCNRNP 593
Query: 337 DRRPTFEEIIFRLEAI 352
D+RP F +I+ +L+ +
Sbjct: 594 DQRPNFSQILLKLKLM 609
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 153 bits (387), Expect = 2e-36, Method: Compositional matrix adjust.
Identities = 93/259 (35%), Positives = 138/259 (53%), Gaps = 9/259 (3%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
G YG+V+ WRGTE+A K + + N ++ + KE+ L KLRHPNIV F+G
Sbjct: 860 GGYGQVFRGSWRGTEVAVKMLFNDNV-NLKLISDLRKEVDLLCKLRHPNIVLFMGACTEP 918
Query: 162 ERLIFLTEYLRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTP 220
+TEYL GSL +IL + ++D + D ARGM YLH P IIHRDL
Sbjct: 919 SSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYLHSRNP-IIIHRDLKT 977
Query: 221 SNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFS 280
N+L D++ +KV DFGL+ + + +++ M G TG ++APEV E Y + DV+S
Sbjct: 978 DNLLVDDSWQVKVADFGLATV--KSHTFAKTMCGTTG---WVAPEVLAEEGYTEKADVYS 1032
Query: 281 FALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRP 340
+A+++ E+ +QV R R + + P AL+ CW +P RP
Sbjct: 1033 YAIVLWELLTRLIPYAGKNTMQVV-RSIDRGERLPMPAWCPPKYAALMNRCWETDPTHRP 1091
Query: 341 TFEEIIFRLEAIQESFQKK 359
+F EI+ +E + FQK+
Sbjct: 1092 SFPEILPIMEGMISEFQKE 1110
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (385), Expect = 3e-36, Method: Compositional matrix adjust.
Identities = 92/258 (35%), Positives = 134/258 (51%), Gaps = 8/258 (3%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
I G YGEVYL WRG+++A K + + N + F +E+ L + LRHPN++QFLG
Sbjct: 380 IGKGNYGEVYLGTWRGSQVAVKKLPAH-NINENILKEFHREINLMKNLRHPNVIQFLGSC 438
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+ TEY+ GSL+ IL + +L + +D A+G+ YLH+ P I+HRD
Sbjct: 439 LIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVIYLHNSTP-VILHRD 497
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVD 277
L N+L DE +KV DFGLS I Q+ + + G+ + +PEV R + Y + D
Sbjct: 498 LKSHNLLVDENWKVKVADFGLSTIEQQGATMT-----ACGTPCWTSPEVLRSQRYTEKAD 552
Query: 278 VFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPD 337
V+SF +I+ E QV E RP + P LL +C ++NP
Sbjct: 553 VYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPKYIQLLIDCLNENPS 612
Query: 338 RRPTFEEIIFRLEAIQES 355
RPT E+ + RLE+I S
Sbjct: 613 HRPTMEQCLERLESIDSS 630
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54I36|PYK3_DICDI Dual specificity protein kinase pyk3 OS=Dictyostelium discoideum GN=pyk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 152 bits (383), Expect = 6e-36, Method: Composition-based stats.
Identities = 86/262 (32%), Positives = 143/262 (54%), Gaps = 14/262 (5%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
+ G++ V+L W G ++A K +++ SN F+KE+ K HPN+V F+G
Sbjct: 1063 VGAGSFANVFLGIWNGYKVAIKILKNESISNDE---KFIKEVSSLIKSHHPNVVTFMGAC 1119
Query: 159 KHSERLIFLTEYLRNGSLHDILK-KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
TEYL+ GSL+D+L +K KL+P D++ GM +LH + ++HRD
Sbjct: 1120 IDPP--CIFTEYLQGGSLYDVLHIQKIKLNPLMMYKMIHDLSLGMEHLHSIQ---MLHRD 1174
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVD 277
LT N+L DE ++K+ DFGL+ + + S G + R+ +PE+ + Y + VD
Sbjct: 1175 LTSKNILLDEFKNIKIADFGLATTLSDDMTLS-----GITNPRWRSPELTKGLVYNEKVD 1229
Query: 278 VFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPD 337
V+SF L+V+E++ G A + A+E+ RPA+ P ++ L+ +CW +P
Sbjct: 1230 VYSFGLVVYEIYTGKIPFEGLDGTASAAKAAFENYRPAIPPDCPVSLRKLITKCWASDPS 1289
Query: 338 RRPTFEEIIFRLEAIQESFQKK 359
+RP+F EI+ LE ++ F K+
Sbjct: 1290 QRPSFTEILTELETMKSKFIKQ 1311
|
Involved in the development. Negatively regulates tyrosine phosphorylation and activation state of dstC/STATc, probably by activating a dstC/STATc phosphatase. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 370 | ||||||
| 297745272 | 583 | unnamed protein product [Vitis vinifera] | 0.991 | 0.629 | 0.753 | 1e-175 | |
| 297745273 | 304 | unnamed protein product [Vitis vinifera] | 0.694 | 0.845 | 0.682 | 1e-109 | |
| 302790345 | 395 | hypothetical protein SELMODRAFT_105905 [ | 0.932 | 0.873 | 0.493 | 2e-96 | |
| 168025436 | 419 | predicted protein [Physcomitrella patens | 0.962 | 0.849 | 0.473 | 2e-96 | |
| 224067888 | 352 | predicted protein [Populus trichocarpa] | 0.6 | 0.630 | 0.637 | 4e-96 | |
| 168011131 | 380 | predicted protein [Physcomitrella patens | 0.921 | 0.897 | 0.485 | 2e-94 | |
| 168037612 | 425 | predicted protein [Physcomitrella patens | 0.945 | 0.823 | 0.458 | 4e-88 | |
| 356499380 | 454 | PREDICTED: dual specificity protein kina | 0.951 | 0.775 | 0.434 | 1e-79 | |
| 225443668 | 462 | PREDICTED: dual specificity protein kina | 0.943 | 0.755 | 0.418 | 5e-79 | |
| 356549162 | 455 | PREDICTED: probable serine/threonine-pro | 0.956 | 0.778 | 0.430 | 6e-79 |
| >gi|297745272|emb|CBI40352.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 619 bits (1596), Expect = e-175, Method: Compositional matrix adjust.
Identities = 308/409 (75%), Positives = 335/409 (81%), Gaps = 42/409 (10%)
Query: 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLL 61
Q +DSEGPY+LL+CSSKGD+ GV+QELEKGV+ NLADYDKRTALHLA+ EG EIV+LLL
Sbjct: 177 QTMDSEGPYQLLHCSSKGDKEGVIQELEKGVDANLADYDKRTALHLAACEGCEEIVVLLL 236
Query: 62 EKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGG----------------------- 98
EKGADVNS+DRWGRTPLSDARSFGH ICKILE +G
Sbjct: 237 EKGADVNSIDRWGRTPLSDARSFGHEKICKILEAQGFHVLQTYKTHISEASFHYMQRTPC 296
Query: 99 ---------------IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLW 143
I GAYGEVYLVKWRGTE+AAKTIRSSIAS+PRV+N+F++ELGLW
Sbjct: 297 YEIDHTEVDMDEATLIGEGAYGEVYLVKWRGTEVAAKTIRSSIASDPRVKNTFLRELGLW 356
Query: 144 QKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMN 203
QKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL+DIL+KKG+LDPP AVAYALDIARGMN
Sbjct: 357 QKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLYDILRKKGRLDPPVAVAYALDIARGMN 416
Query: 204 YLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMA 263
YLH H+PHAIIHRDLTP NVLQDEAG LKVTDFGLSKIAQEKD+ YKMTGGTGSYRYMA
Sbjct: 417 YLHQHKPHAIIHRDLTPRNVLQDEAGRLKVTDFGLSKIAQEKDAVGYKMTGGTGSYRYMA 476
Query: 264 PEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSS-LYPE 322
PEVYRRESYGKS+DVFSFALIVHEMFQGGPSNRA+ A VAD+RAYEDSRP LSS +YPE
Sbjct: 477 PEVYRRESYGKSIDVFSFALIVHEMFQGGPSNRAENAEYVADKRAYEDSRPPLSSFVYPE 536
Query: 323 PIKALLRECWHKNPDRRPTFEEIIFRLEAIQESF-QKKTVPSCCDCMIL 370
PIK LLR CWHKNP+ RPTFE II LE IQES KKT +CCDC IL
Sbjct: 537 PIKTLLRNCWHKNPESRPTFEAIILELEKIQESMISKKT--ACCDCAIL 583
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745273|emb|CBI40353.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 402 bits (1033), Expect = e-109, Method: Compositional matrix adjust.
Identities = 200/293 (68%), Positives = 226/293 (77%), Gaps = 36/293 (12%)
Query: 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK 63
+DSEGPYRLL+CSSK D+AGV+QELEKGVE NLADYDKRTALHLA+ EG EIV+LLLEK
Sbjct: 1 MDSEGPYRLLHCSSKCDKAGVIQELEKGVEANLADYDKRTALHLAACEGCEEIVVLLLEK 60
Query: 64 GADVNSLDRWGRTPLSDARSFGHVVICKILEDRGGIDP---------------------- 101
GAD N +DRWGRTPLSDA SFGH IC+ILE +GGIDP
Sbjct: 61 GADANPIDRWGRTPLSDAHSFGHEKICEILEAQGGIDPVYTFLTCNNVGLDSKIPCYEID 120
Query: 102 --------------GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR 147
GAYGEVYLV+WR TE+AA I SSI+S+PRV+N+F++ELGLWQKL
Sbjct: 121 YAEVDMDEATLIGEGAYGEVYLVRWRETEVAANIIYSSISSDPRVKNTFLRELGLWQKLC 180
Query: 148 HPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHH 207
HPNIVQFLG KHS+RLIF+TEYLRNGSL+DIL KKG+LDPP VAYALDIARGMN+LH
Sbjct: 181 HPNIVQFLGFTKHSDRLIFVTEYLRNGSLYDILSKKGRLDPPVVVAYALDIARGMNHLHQ 240
Query: 208 HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYR 260
+PH+IIHRDLTP NVLQDEAGHLKVT L KIAQEKD+ YKMTGGTGS +
Sbjct: 241 LKPHSIIHRDLTPRNVLQDEAGHLKVTVSSLCKIAQEKDAVGYKMTGGTGSCK 293
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302790345|ref|XP_002976940.1| hypothetical protein SELMODRAFT_105905 [Selaginella moellendorffii] gi|302797847|ref|XP_002980684.1| hypothetical protein SELMODRAFT_113254 [Selaginella moellendorffii] gi|300151690|gb|EFJ18335.1| hypothetical protein SELMODRAFT_113254 [Selaginella moellendorffii] gi|300155418|gb|EFJ22050.1| hypothetical protein SELMODRAFT_105905 [Selaginella moellendorffii] | Back alignment and taxonomy information |
|---|
Score = 358 bits (920), Expect = 2e-96, Method: Compositional matrix adjust.
Identities = 190/385 (49%), Positives = 251/385 (65%), Gaps = 40/385 (10%)
Query: 11 RLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSL 70
+LLYC+S+GD G+ Q L +GV ++ADYDKRTALHLA+SEG A+ VLLL++ G D++
Sbjct: 3 KLLYCASRGDVEGLRQALREGVNKDVADYDKRTALHLAASEGHADCVLLLIQHGVDLSPR 62
Query: 71 DRWGRTPLSDARSFGHVVICKILE-------------------------DRGGI------ 99
DRWGRTPL+DAR +GH+ ICK+LE D G I
Sbjct: 63 DRWGRTPLADARRYGHMRICKLLEAHEAMDYVMILISFVKESVVPEYEIDPGEIERIGNN 122
Query: 100 DP---GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
DP GA+GE+ +VKWRGT++AAKTI +S+ + +V F++EL L QKL HPNIVQFLG
Sbjct: 123 DPIGRGAFGEIRVVKWRGTKVAAKTILTSLLQDKQVVREFVRELVLLQKLHHPNIVQFLG 182
Query: 157 VLKHSERLIFLTEYLRNGSLHDIL--KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ E LI +TEYL G L +L K KG L + +ALDIARGMN+LH H+P +I
Sbjct: 183 AVTKQENLIIITEYLPKGDLQALLRRKSKGSLGGKQVLHFALDIARGMNFLHEHKPEPVI 242
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY---SYKMTGGTGSY-RYMAPEVYRRE 270
HRDL P+N+L D+AGHLKV DFGLS++ + + YKMTG TGS RYMAPEV++ +
Sbjct: 243 HRDLKPTNILLDDAGHLKVGDFGLSRLVKASGATVDEVYKMTGETGSSDRYMAPEVFKHQ 302
Query: 271 SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330
SY KSVDV+SFALIV+EMF+G NR + + + RA +PA ++ YP +K LL
Sbjct: 303 SYDKSVDVYSFALIVYEMFEGHVGNRYENPIHAVEDRARHGYKPAFTAKYPTNMKQLLTR 362
Query: 331 CWHKNPDRRPTFEEIIFRLEAIQES 355
C + +RP+F EII LE ++ S
Sbjct: 363 CLDFDAKKRPSFREIIAELEDMERS 387
|
Source: Selaginella moellendorffii Species: Selaginella moellendorffii Genus: Selaginella Family: Selaginellaceae Order: Selaginellales Class: Isoetopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|168025436|ref|XP_001765240.1| predicted protein [Physcomitrella patens subsp. patens] gi|162683559|gb|EDQ69968.1| predicted protein [Physcomitrella patens subsp. patens] | Back alignment and taxonomy information |
|---|
Score = 358 bits (920), Expect = 2e-96, Method: Compositional matrix adjust.
Identities = 193/408 (47%), Positives = 252/408 (61%), Gaps = 52/408 (12%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
LL+ +SKG+ AGV + L++G+ + DYD RTALHLA+SEG +IV LLLE ADVN +D
Sbjct: 13 LLFYASKGNAAGVKKLLDQGMPVDATDYDGRTALHLAASEGHTDIVKLLLEYNADVNPID 72
Query: 72 RWGRTPLSDARSFGHVVICKILEDRGG--------------------------------- 98
R G TPL++A+ + H ICKILE R G
Sbjct: 73 RNGDTPLANAKEYDHKEICKILEARRGYVKVRSKSHVSHRAIHGLDEFEISIAELNLDQG 132
Query: 99 --IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I GA+GE+ +VKWRGT +AAKTI + ++ +P++ F+ EL L L HPNIVQFLG
Sbjct: 133 KFIGKGAFGEIRVVKWRGTVVAAKTITAELSKDPQIVKEFVDELALLANLSHPNIVQFLG 192
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ ++ +TEYL G LHD+++K+GKLD TA+ +ALDIARGMNYLH H+P+AI+HR
Sbjct: 193 AVTTQRPMVMVTEYLPKGDLHDLMQKRGKLDAETAIRFALDIARGMNYLHEHKPNAIVHR 252
Query: 217 DLTPS-NVLQDEAGHLKVTDFGLSKIAQEKDSYS---YKMTGGTGSYRYMAPEVYRRESY 272
DL PS N+LQ +AGHLKV DFGL K+ + + Y+MTG TGSYRYMAPEV+ + Y
Sbjct: 253 DLKPSRNLLQHDAGHLKVADFGLGKLLDPLTADANALYEMTGETGSYRYMAPEVFMHKHY 312
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSS-LYPEPIKALLREC 331
KSVDVFSF++IV EMF+G + +A RA RP ++ YP +K L+ EC
Sbjct: 313 DKSVDVFSFSIIVQEMFEGQNEQKYQLPKSIAIARAKNQERPVFNAQTYPPGMKKLICEC 372
Query: 332 WHKNPDRRPTFEEIIFRLEAIQ-----------ESFQKKTVPSCCDCM 368
W NP +RPTF +I RLE IQ E F+KK VP C M
Sbjct: 373 WDMNPRKRPTFSVVIQRLEKIQLEGGFLNSDVNEKFEKK-VPQRCTMM 419
|
Source: Physcomitrella patens subsp. patens Species: Physcomitrella patens Genus: Physcomitrella Family: Funariaceae Order: Funariales Class: Bryopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224067888|ref|XP_002302583.1| predicted protein [Populus trichocarpa] gi|222844309|gb|EEE81856.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 357 bits (917), Expect = 4e-96, Method: Compositional matrix adjust.
Identities = 192/301 (63%), Positives = 208/301 (69%), Gaps = 79/301 (26%)
Query: 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLL 61
Q IDSEGPYRLL CSSKGD+AGVLQELEKGVEPNLADYDKRTALHLAS EG E+V+LLL
Sbjct: 17 QAIDSEGPYRLLSCSSKGDKAGVLQELEKGVEPNLADYDKRTALHLASCEGCTEVVILLL 76
Query: 62 EKGADVNSLDRWGRT---------------------------------PLSDARSFGHVV 88
EKGADVNS+DRWGRT PLSDARSFGH
Sbjct: 77 EKGADVNSIDRWGRTGFPKFLSDCYYYHIRRVVVRFLEFCHLTLENLQPLSDARSFGHEG 136
Query: 89 ICKILEDRGGIDP---------------------------------GAYGEVYLVKWRGT 115
ICKILE RGGIDP G+YGEVYLVKWRGT
Sbjct: 137 ICKILEARGGIDPVGLDSQTACYEIDYSEVGMDDAILIGEIKKALQGSYGEVYLVKWRGT 196
Query: 116 EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN-- 173
E+AAKTIRSSIAS+PRVRN+F+KELGLWQKLRHPNIVQFLGVLKHS+RLIFLTEYLR+
Sbjct: 197 EVAAKTIRSSIASDPRVRNTFLKELGLWQKLRHPNIVQFLGVLKHSDRLIFLTEYLRDVG 256
Query: 174 -----------GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSN 222
GSL+DILK+KG+LD TAV+YALDIARGMNYLH H+P AIIHRDLTP
Sbjct: 257 YPIFNHDWTFLGSLYDILKRKGRLDQETAVSYALDIARGMNYLHQHKPRAIIHRDLTPRY 316
Query: 223 V 223
V
Sbjct: 317 V 317
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|168011131|ref|XP_001758257.1| predicted protein [Physcomitrella patens subsp. patens] gi|162690713|gb|EDQ77079.1| predicted protein [Physcomitrella patens subsp. patens] | Back alignment and taxonomy information |
|---|
Score = 352 bits (902), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 183/377 (48%), Positives = 240/377 (63%), Gaps = 36/377 (9%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
LLY +SKG+ + L+ G + DYD RTALHLA+SEG V LLLE G+ VN D
Sbjct: 4 LLYYASKGNVPILKHMLDNGTSVDAVDYDGRTALHLAASEGHTAAVKLLLEYGSSVNPCD 63
Query: 72 RWGRTPLSDARSFGHVVICKILEDRGG---------------------IDP--------- 101
R+ TPL++AR +G+ IC +L GG IDP
Sbjct: 64 RFNETPLANARRYGYEEICDLLVASGGFVKVRNSLAVVLPISTLSEYEIDPAELSLEKAR 123
Query: 102 ----GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
GA+GE+ +VKWRGT +AAKTI S + S+ ++ F+ EL L +LRHPNI+QFLG
Sbjct: 124 SVGKGAFGEIKIVKWRGTVVAAKTILSHLTSDQKIVKEFVDELALLSRLRHPNIMQFLGA 183
Query: 158 LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+ ++ I +TEYL G LHD L +KGKLD TAV +ALDIA+GMNYLH H+P I+HRD
Sbjct: 184 VTKTQPFIIVTEYLPKGDLHDYLDRKGKLDALTAVKFALDIAKGMNYLHEHKPDPIVHRD 243
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY-SYKMTGGTGSYRYMAPEVYRRESYGKSV 276
L P N+L EAG+LKV DFGL K+ ++ Y MTG TGSYRYMAPEV+ ++Y KSV
Sbjct: 244 LKPRNLLLHEAGYLKVADFGLGKLLDASEATKQYLMTGETGSYRYMAPEVFLHKAYDKSV 303
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPA-LSSLYPEPIKALLRECWHKN 335
DVFSFA+IVHE+F+GGP ++ A +A RA E RP+ + + YP +K LL++CWH++
Sbjct: 304 DVFSFAIIVHELFEGGPHSKFQGAKDIAHFRAKEGKRPSFVVNTYPSRMKDLLKQCWHQD 363
Query: 336 PDRRPTFEEIIFRLEAI 352
P +RP+F II LE I
Sbjct: 364 PTKRPSFATIIVHLEGI 380
|
Source: Physcomitrella patens subsp. patens Species: Physcomitrella patens Genus: Physcomitrella Family: Funariaceae Order: Funariales Class: Bryopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|168037612|ref|XP_001771297.1| predicted protein [Physcomitrella patens subsp. patens] gi|162677386|gb|EDQ63857.1| predicted protein [Physcomitrella patens subsp. patens] | Back alignment and taxonomy information |
|---|
Score = 331 bits (848), Expect = 4e-88, Method: Compositional matrix adjust.
Identities = 178/388 (45%), Positives = 236/388 (60%), Gaps = 38/388 (9%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
LLY +SK + + + L+ G + ADYD RTALHLA+SEG V LLLE G VN
Sbjct: 1 LLYYASKVNVSILKHMLDNGTPVDAADYDGRTALHLAASEGHTAAVKLLLEYGPSVNPCG 60
Query: 72 RWGRTPLSDARSFGHVVICKILEDRGG----------------------IDP-------- 101
R+ TPL++A+ + H IC +LE GG IDP
Sbjct: 61 RFNETPLANAQRYRHKDICDLLEVNGGFTKAHNPVTLDLGWHDTLSTYEIDPAELCMEKG 120
Query: 102 -----GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
GA+GE+ + KWRGT +AAK++ S + S+ ++ F+ EL L +LRHPN++QFLG
Sbjct: 121 RSIGKGAFGEIKIFKWRGTAVAAKSLLSHLTSDQKIVKEFVDELALLSRLRHPNVMQFLG 180
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ S+ + +TEYL G LHD L + GKLD TAV +ALDIA+GMNYLH H+P I+HR
Sbjct: 181 AVSKSQPFVIVTEYLPKGDLHDYLDRNGKLDALTAVKFALDIAKGMNYLHKHKPDPIVHR 240
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKD-SYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
DL P N+L EAG+LKV DFGL K+ + + Y MTG TGSYRYMAPEV+ ++Y KS
Sbjct: 241 DLKPRNLLVHEAGYLKVADFGLGKLLDVSEATQQYLMTGETGSYRYMAPEVFLHKAYDKS 300
Query: 276 VDVFSFALIVHEMF-QGGPSNRADTAVQVADRRAYEDSRPALSS-LYPEPIKALLRECWH 333
VDVFSFA+IVHE+ + GP ++ + +A RA E RP S+ YP +K LL ECWH
Sbjct: 301 VDVFSFAVIVHEVIVRSGPYSKFQGSKDIAHFRAKEGKRPTFSANTYPPKMKDLLNECWH 360
Query: 334 KNPDRRPTFEEIIFRLEAIQESFQKKTV 361
++P +RP+F +I LE I Q K V
Sbjct: 361 QDPTKRPSFSTLIVHLEDILHQIQHKKV 388
|
Source: Physcomitrella patens subsp. patens Species: Physcomitrella patens Genus: Physcomitrella Family: Funariaceae Order: Funariales Class: Bryopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356499380|ref|XP_003518519.1| PREDICTED: dual specificity protein kinase pyk1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 303 bits (775), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 171/394 (43%), Positives = 230/394 (58%), Gaps = 42/394 (10%)
Query: 11 RLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSL 70
RL+Y +++GD G+ + L+ G + N D D RTALH+A+ +GR ++V LLL +GADV+
Sbjct: 38 RLMYLANEGDSDGIKELLDAGSDVNFTDIDGRTALHVAACQGRTDVVGLLLRRGADVDPQ 97
Query: 71 DRWGRTPLSDARSFGHVVICKILEDRGG-------------------IDPG--------- 102
DRWG TPL DA + + + K+LE G IDP
Sbjct: 98 DRWGSTPLVDAMYYKNHDVVKLLEKHGARPPMAPMHVQNAREVPEYEIDPSELDFTNSVC 157
Query: 103 -AYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
G + WRGT++A KT+ + ++ +F EL L +K+RHPN+VQFLG + S
Sbjct: 158 ITKGTFRIALWRGTQVAVKTLGEELFTDDDKVKAFHDELTLLEKIRHPNVVQFLGAVTQS 217
Query: 162 ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPS 221
++ +TEYL G L LK+KG L P TAV +ALDIARGMNYLH H+P AIIHRDL PS
Sbjct: 218 TPMMIVTEYLPQGDLRAYLKRKGALKPVTAVKFALDIARGMNYLHEHKPEAIIHRDLEPS 277
Query: 222 NVLQDEAGHLKVTDFGLSKIAQEKDSY--SYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
N+L+D++GHLKV DFG+SK+ + + +T S+RY+APEVY+ E Y VDVF
Sbjct: 278 NILRDDSGHLKVADFGVSKLLKVAKTVKEDKPVTSLDTSWRYVAPEVYKNEEYDTKVDVF 337
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAY-EDSRP---ALSSLYPEPIKALLRECWHKN 335
SFALI+ EM +G P +V +AY E+ RP A LY +K L+ ECW +
Sbjct: 338 SFALILQEMIEGCPPFYEKPENEVP--KAYVENERPPFRASPKLYAYGLKQLIEECWDEK 395
Query: 336 PDRRPTFEEIIFRLEAI-----QESFQKKTVPSC 364
P RRPTF +II RLE I Q+ K P C
Sbjct: 396 PYRRPTFRQIIGRLEDIYYHLAQKRRWKVRAPGC 429
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225443668|ref|XP_002263226.1| PREDICTED: dual specificity protein kinase shkB [Vitis vinifera] gi|297740576|emb|CBI30758.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 301 bits (770), Expect = 5e-79, Method: Compositional matrix adjust.
Identities = 160/382 (41%), Positives = 227/382 (59%), Gaps = 33/382 (8%)
Query: 11 RLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSL 70
RL+Y +++GD G+ + L+ G++ N D D RTALH+A+ +G +++V LL+ GA+++
Sbjct: 45 RLMYLANEGDLEGLRELLDSGMDVNFRDIDNRTALHVAACQGFSDVVEFLLKNGAEIDLE 104
Query: 71 DRWGRTPLSDARSFGHVVICKILEDRGG-------------------IDPG--------- 102
DRWG TPL+DA + + + K+LE G IDP
Sbjct: 105 DRWGSTPLADAIHYKNHDVIKLLEKHGAQHLMAPMHVNNAREVPEYEIDPKELDFTNSVD 164
Query: 103 -AYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
G + WRG ++A K + + + +F EL L QK+RHPN+VQFLG + S
Sbjct: 165 ITKGTYRIASWRGIQVAVKRLGDEVIIDEDKVKAFRDELALLQKIRHPNVVQFLGAVTQS 224
Query: 162 ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPS 221
++ +TEYL G LH LK+KG L TAV +ALDIARGMNYLH HRP AIIHRDL PS
Sbjct: 225 SPMMIVTEYLPKGDLHAFLKRKGALKTATAVKFALDIARGMNYLHEHRPEAIIHRDLEPS 284
Query: 222 NVLQDEAGHLKVTDFGLSKIAQEKDSY--SYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
N+L+D++GHLKV DFG+SK+ + ++ Y + S RY+APEV++ E+Y VDVF
Sbjct: 285 NILRDDSGHLKVADFGVSKLLKVANTVKEDYPLICQETSCRYLAPEVFKNEAYDTKVDVF 344
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP--ALSSLYPEPIKALLRECWHKNPD 337
SFALI+ EM +G P A +V A ++ P A S LY +K L+ ECW++NP
Sbjct: 345 SFALILQEMIEGCPPFSAKPENEVPKVYAAQERPPFRAPSKLYSHGLKELIEECWNENPT 404
Query: 338 RRPTFEEIIFRLEAIQESFQKK 359
+RPTF +I+ RL+ I +K
Sbjct: 405 KRPTFGQILTRLDRIYNHLGQK 426
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549162|ref|XP_003542966.1| PREDICTED: probable serine/threonine-protein kinase drkA-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 300 bits (769), Expect = 6e-79, Method: Compositional matrix adjust.
Identities = 168/390 (43%), Positives = 230/390 (58%), Gaps = 36/390 (9%)
Query: 1 GQIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLL 60
G+++D RL+Y + +GD G+ + LE GV N D D RTALH+A EG ++V LL
Sbjct: 32 GEVVDQG--VRLMYSAFEGDVDGICEALEFGVSVNYKDIDNRTALHVAVCEGFTDVVDLL 89
Query: 61 LEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGG-------------------IDP 101
L+KGA+V+ DRWG TPL+DA + + K+LE G I+P
Sbjct: 90 LQKGAEVDPKDRWGSTPLADAIFYKKNDVIKLLEKHGAKLLMAPMHVNHAREVPEYEINP 149
Query: 102 G----------AYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNI 151
G + WRGTE+A K + + S+ +F EL L+QK+RHPN+
Sbjct: 150 KELDFTNSVEITKGTFCIALWRGTEVAVKKLGEDVISDEEKVKAFRDELALFQKIRHPNV 209
Query: 152 VQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPH 211
VQFLG + S ++ +TEYL G L D LK+KG L P TAV +ALDIARG+ YLH ++P
Sbjct: 210 VQFLGAVTQSSPMMIVTEYLPKGDLRDFLKRKGALKPSTAVRFALDIARGVGYLHENKPS 269
Query: 212 AIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES 271
IIHRDL PSN+L+D++GHLKV DFG+SK+ K+ +T S RY+APEV+R+E
Sbjct: 270 PIIHRDLEPSNILRDDSGHLKVADFGVSKLLAVKEDKP--LTCHDTSCRYVAPEVFRQE- 326
Query: 272 YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP--ALSSLYPEPIKALLR 329
Y VDVFSFALI+ EM +G P A +V A ++ P A + Y I+ L+
Sbjct: 327 YDTKVDVFSFALILQEMIEGCPPFSAKQDNEVPKVYAAKERPPFRAPAKHYSYGIRELIE 386
Query: 330 ECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359
ECW++NP +RPTF +II RLE+I + K
Sbjct: 387 ECWNENPAKRPTFRQIITRLESIYNTISHK 416
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 370 | ||||||
| TAIR|locus:2117129 | 459 | AT4G18950 [Arabidopsis thalian | 0.664 | 0.535 | 0.48 | 3.6e-76 | |
| TAIR|locus:2014849 | 438 | VIK "VH1-interacting kinase" [ | 0.689 | 0.582 | 0.486 | 3.2e-75 | |
| TAIR|locus:2098999 | 471 | AT3G58760 [Arabidopsis thalian | 0.656 | 0.515 | 0.465 | 3.2e-73 | |
| TAIR|locus:2044034 | 479 | AT2G43850 [Arabidopsis thalian | 0.948 | 0.732 | 0.357 | 2e-49 | |
| TAIR|locus:2080517 | 477 | AT3G59830 [Arabidopsis thalian | 0.943 | 0.731 | 0.345 | 1.6e-45 | |
| TAIR|locus:2045258 | 476 | AT2G31800 [Arabidopsis thalian | 0.927 | 0.720 | 0.338 | 7.1e-45 | |
| ZFIN|ZDB-GENE-081104-399 | 835 | tnni3k "TNNI3 interacting kina | 0.670 | 0.297 | 0.355 | 1e-44 | |
| UNIPROTKB|F1P6V7 | 835 | TNNI3K "Uncharacterized protei | 0.670 | 0.297 | 0.363 | 7.5e-43 | |
| UNIPROTKB|A0JNG5 | 835 | TNNI3K "TNNI3 interacting kina | 0.670 | 0.297 | 0.363 | 1.2e-42 | |
| UNIPROTKB|Q59H18 | 835 | TNNI3K "Serine/threonine-prote | 0.670 | 0.297 | 0.359 | 1.2e-42 |
| TAIR|locus:2117129 AT4G18950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 579 (208.9 bits), Expect = 3.6e-76, Sum P(2) = 3.6e-76
Identities = 120/250 (48%), Positives = 157/250 (62%)
Query: 105 GEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERL 164
G + WRG ++A K + + S+ F EL L Q+LRHPNIVQFLG + S +
Sbjct: 169 GTYCMAMWRGIQVAVKKLDDEVLSDDDQVRKFHDELALLQRLRHPNIVQFLGAVTQSNPM 228
Query: 165 IFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVL 224
+ +TEYL G L ++LK+KG+L P TAV YALDIARGM+YLH + IIHRDL PSN+L
Sbjct: 229 MIVTEYLPRGDLRELLKRKGQLKPATAVRYALDIARGMSYLHEIKGDPIIHRDLEPSNIL 288
Query: 225 QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALI 284
+D++GHLKV DFG+SK+ K+ + T S RY+APEV+ E Y DVFSFALI
Sbjct: 289 RDDSGHLKVADFGVSKLVTVKEDKPF--TCQDISCRYIAPEVFTSEEYDTKADVFSFALI 346
Query: 285 VHEMFQGG-P-SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTF 342
V EM +G P + + D+ A + A S YP +K L+ ECWH+ P +RPTF
Sbjct: 347 VQEMIEGRMPFAEKEDSEASEAYAGKHRPLFKAPSKNYPHGLKTLIEECWHEKPAKRPTF 406
Query: 343 EEIIFRLEAI 352
EII RLE+I
Sbjct: 407 REIIKRLESI 416
|
|
| TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 602 (217.0 bits), Expect = 3.2e-75, Sum P(2) = 3.2e-75
Identities = 127/261 (48%), Positives = 169/261 (64%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
I G++GE+ WRGT +A K I S++ + V F E+ L KLRHPNIVQFLG +
Sbjct: 168 IGKGSFGEIVKAYWRGTPVAVKRILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAV 227
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ L+ +TEYLR G LH LK+KG L P TAV +ALDIARGM YLH+ P+ IIHRDL
Sbjct: 228 TERKPLMLITEYLRGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLHNE-PNVIIHRDL 286
Query: 219 TPSNVL--QDEAGHLKVTDFGLSKIAQEKDSYS-YKMTGGTGSYRYMAPEVYRRESYGKS 275
P NVL A HLKV DFGLSK+ + ++S+ YKMTG TGSYRYMAPEV++ Y K
Sbjct: 287 KPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPEVFKHRRYDKK 346
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEP-IKALLRECWHK 334
VDVFSFA+I++EM +G P + A + + RP S P ++ L+ +CW
Sbjct: 347 VDVFSFAMILYEMLEGEPPFANHEPYEAA-KHVSDGHRPTFRSKGCTPDLRELIVKCWDA 405
Query: 335 NPDRRPTFEEIIFRLEAIQES 355
+ ++RP+F +I+ RLE I+E+
Sbjct: 406 DMNQRPSFLDILKRLEKIKET 426
|
|
| TAIR|locus:2098999 AT3G58760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 562 (202.9 bits), Expect = 3.2e-73, Sum P(2) = 3.2e-73
Identities = 120/258 (46%), Positives = 160/258 (62%)
Query: 112 WRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171
WRG ++A KT + ++ N+F EL L QK+RHPN+VQFLG + S ++ +TEYL
Sbjct: 182 WRGIDVAVKTFGEEMFTDEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYL 241
Query: 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHL 231
G L L +KG L P AV +AL+IARGMNYLH H+P AIIH DL P N+L+D++GHL
Sbjct: 242 PKGDLRQYLDRKGPLMPAHAVKFALEIARGMNYLHEHKPEAIIHCDLEPPNILRDDSGHL 301
Query: 232 KVTDFGLSKIAQEKDSYSYK---MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEM 288
KV DFG+SK+ K + +T S+RYMAPEVYR E Y VDVFSFALI+ EM
Sbjct: 302 KVADFGVSKLLVVKKTVKKDRPVVTCLDSSWRYMAPEVYRNEEYDTKVDVFSFALILQEM 361
Query: 289 FQGGPSNRADTAVQVADR---RAY-EDSRP---ALSSLYPEPIKALLRECWHKNPDRRPT 341
+G + ++ DR +AY ED RP A + YP ++ L+++CW K +RPT
Sbjct: 362 IEG-----CEPFHEIEDREVPKAYIEDERPPFNAPTKSYPFGLQELIQDCWDKEASKRPT 416
Query: 342 FEEIIFRLEAIQESFQKK 359
F II LE I + +K
Sbjct: 417 FRVIISTLELISDRIARK 434
|
|
| TAIR|locus:2044034 AT2G43850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 515 (186.3 bits), Expect = 2.0e-49, P = 2.0e-49
Identities = 131/366 (35%), Positives = 188/366 (51%)
Query: 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK 63
ID +G L + +G V L + + D TA A G ++ LL +
Sbjct: 107 IDLDGRTALHIAACEGHLGVVKALLSRRANIDARDRWGSTAAADAKYYGNLDVYNLLKAR 166
Query: 64 GADVNSLDRWGRTPLSDARSFGHVVICKI---LEDRGGIDPGAYGEVYLVKWRGTEIAAK 120
GA V + T +S+ R + + + GI GAY + KW GT ++ K
Sbjct: 167 GAKVPKTRKTPMT-VSNPREVPEYELNPLEVQVRKSDGISKGAY---QVAKWNGTRVSVK 222
Query: 121 TIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDIL 180
+ S+P N+F EL L +K+RHPN++QF+G + + ++ + EY G L L
Sbjct: 223 ILDKDSYSDPERINAFRHELTLLEKVRHPNVIQFVGAVTQNIPMMIVVEYNPKGDLSVYL 282
Query: 181 KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFG--- 237
+KKG+L P A+ +ALDIARGMNYLH +P IIH DL P N+L D G LK++ FG
Sbjct: 283 QKKGRLSPSKALRFALDIARGMNYLHECKPDPIIHCDLKPKNILLDRGGQLKISGFGMIR 342
Query: 238 LSKIAQEKDSYS-YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNR 296
LSKI+Q+K + +K +Y Y+APEVY+ E + VD SF +I++E+ +G P
Sbjct: 343 LSKISQDKAKVANHKAHIDLSNY-YIAPEVYKDEIFDLRVDAHSFGVILYEITEGVPVFH 401
Query: 297 ADTAVQVADRRAYEDSRPAL---SSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQ 353
+VA E RP S YP IK L+ +CWH RPTF EII RL+ I
Sbjct: 402 PRPPEEVARMMCLEGKRPVFKTKSRSYPPDIKELIEKCWHPEAGIRPTFSEIIIRLDKIV 461
Query: 354 ESFQKK 359
+ K+
Sbjct: 462 ANCSKQ 467
|
|
| TAIR|locus:2080517 AT3G59830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 478 (173.3 bits), Expect = 1.6e-45, P = 1.6e-45
Identities = 127/368 (34%), Positives = 187/368 (50%)
Query: 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK 63
ID +G L S +G V L + + D TA A G E+ LL +
Sbjct: 105 IDLDGRTALHIASCEGHYDVVKVLLSRRANIDARDRWGSTAAVDAKYYGNVEVYNLLKAR 164
Query: 64 GADVNSLDRWGRTPLS--DARSFGHVVICKI-LEDR--GGIDPGAYGEVYLVKWRGTEIA 118
GA + +TP++ + + + + L+ R GI G Y + KW GT ++
Sbjct: 165 GAKA---PKTRKTPMTVGNPKEVPEYELNPLELQVRKVDGISKGTY---QVAKWNGTRVS 218
Query: 119 AKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHD 178
K S+P N+F EL L K RHPNIVQF+G + + ++ + E G L
Sbjct: 219 VKIFDKDSYSDPERVNAFTNELTLLAKARHPNIVQFVGAVTQNLPMMIVVECNPKGDLSV 278
Query: 179 ILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGL 238
L+KKG+L P A+ +ALDIARGMNYLH +P IIH +L P N+L D G LK++ FGL
Sbjct: 279 YLQKKGRLSPSKALRFALDIARGMNYLHECKPDPIIHCELMPKNILLDRGGQLKISGFGL 338
Query: 239 SKIAQ-EKDS---YSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPS 294
K+++ +DS +++ +Y Y+APE+Y+ E + K DV SF +I++E+ +G
Sbjct: 339 IKLSKIGEDSAKVVNHEAQIDKSNY-YIAPEIYKDEVFDKRADVHSFGVILYELTEGVSL 397
Query: 295 NRADTAVQVADRRAYEDSRPAL---SSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEA 351
+VA+ E RP + S YP +K L+ ECWH RP F EII RL+
Sbjct: 398 FHPKPPEEVAESICIEGKRPTIRTKSKSYPPELKELIEECWHPEISVRPIFSEIIIRLDK 457
Query: 352 IQESFQKK 359
I + K+
Sbjct: 458 IVTNCSKQ 465
|
|
| TAIR|locus:2045258 AT2G31800 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 472 (171.2 bits), Expect = 7.1e-45, P = 7.1e-45
Identities = 122/360 (33%), Positives = 182/360 (50%)
Query: 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK 63
ID +G L + +G V L + + D TA A G ++ +L +
Sbjct: 104 IDLDGRTALHIAACEGHVDVVKLLLTRKANIDARDRWGSTAAADAKYYGNMDVFNILKAR 163
Query: 64 GADVNSLDRWGRTPL--SDARSFGHVVIC-KILEDR--GGIDPGAYGEVYLVKWRGTEIA 118
GA V + RTP+ ++ R + + L+ R GI G Y + KW GT+++
Sbjct: 164 GAKV---PKTKRTPMVVANPREVPEYELNPQELQVRKADGISKGIY---QVAKWNGTKVS 217
Query: 119 AKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHD 178
K + + + N+F EL L++K+RHPN+VQF+G + + ++ ++EY G L
Sbjct: 218 VKILDKDLYKDSDTINAFKHELTLFEKVRHPNVVQFVGAVTQNVPMMIVSEYHPKGDLGS 277
Query: 179 ILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGL 238
L+KKG+L P + +ALDIARGMNYLH +P +IH DL P N++ D GHLKV FGL
Sbjct: 278 YLQKKGRLSPAKVLRFALDIARGMNYLHECKPEPVIHCDLKPKNIMLDSGGHLKVAGFGL 337
Query: 239 SKIAQEKDSYSYKMTGGTG---SYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSN 295
A+ S + G S MAPEVY+ E + +SVD +SF ++++EM +G
Sbjct: 338 ISFAKLSSDKSKILNHGAHIDPSNYCMAPEVYKDEIFDRSVDSYSFGVVLYEMIEGVQPF 397
Query: 296 RADTAVQVADRRAYEDSRP---ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
+ E RP A S P+ ++ L+ ECW RPTF EII RL+ I
Sbjct: 398 HPKPPEEAVKLMCLEGRRPSFKAKSKSCPQEMRELIEECWDTETFVRPTFSEIIVRLDKI 457
|
|
| ZFIN|ZDB-GENE-081104-399 tnni3k "TNNI3 interacting kinase" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 375 (137.1 bits), Expect = 1.0e-44, Sum P(2) = 1.0e-44
Identities = 91/256 (35%), Positives = 137/256 (53%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV- 157
I G++G+VY K R +A K R + + + F +E+ + +L HP ++QF+G
Sbjct: 469 IGSGSFGKVYKGKCRNKIVAIKRYRPNTYCSKSDTDMFCREVSILCRLNHPCVIQFVGAC 528
Query: 158 LKHSERLIFLTEYLRNGSLHDIL-KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
L + +T+Y+ GSL +L ++K +D + + A+D+A+GM YLH+ IIHR
Sbjct: 529 LDDPSQFAIVTQYVSGGSLFSLLHEQKRIIDLQSKLIIAIDVAKGMEYLHN-LTQPIIHR 587
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR-ESYGKS 275
DL N+L E GH V DFG S+ D + MT G+ R+MAPEV+ + Y
Sbjct: 588 DLNSHNILLYEDGHAVVADFGESRFLLSVDEDN--MTKQPGNLRWMAPEVFTQCTRYTVK 645
Query: 276 VDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
D+FS+AL + E+ G P A AD AY RP + P+PI ALL W+
Sbjct: 646 ADMFSYALCLWELLTGEIPFAHLKPAAAAADM-AYHHVRPPIGYSIPKPISALLMRGWNV 704
Query: 335 NPDRRPTFEEIIFRLE 350
P+ RP F E++ +LE
Sbjct: 705 CPEERPEFSEVVAKLE 720
|
|
| UNIPROTKB|F1P6V7 TNNI3K "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 381 (139.2 bits), Expect = 7.5e-43, Sum P(2) = 7.5e-43
Identities = 93/256 (36%), Positives = 139/256 (54%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV- 157
I G++G+VY + R +A K R++ + + F +E+ + +L HP I+QF+G
Sbjct: 469 IGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMFCREVSILCRLNHPCIIQFVGAC 528
Query: 158 LKHSERLIFLTEYLRNGSLHDIL-KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
L + +T+Y+ GSL +L ++K LD + + A+D+A+GM YLH+ IIHR
Sbjct: 529 LNDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLIIAVDVAKGMEYLHN-LTQPIIHR 587
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR-ESYGKS 275
DL N+L E GH V DFG S+ Q D + MT G+ R+MAPEV+ + Y
Sbjct: 588 DLNSHNILLCEDGHAVVADFGESRFLQSLDEDN--MTKQPGNLRWMAPEVFTQCTRYTIK 645
Query: 276 VDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
DVFS+AL + E+ G P A AD AY RP + P+PI +LL W+
Sbjct: 646 ADVFSYALCLWELLTGEIPFAHLKPAAAAADM-AYHHLRPPIGYSIPKPISSLLMRGWNA 704
Query: 335 NPDRRPTFEEIIFRLE 350
P+ RP F E++ +LE
Sbjct: 705 CPEGRPEFSEVVTKLE 720
|
|
| UNIPROTKB|A0JNG5 TNNI3K "TNNI3 interacting kinase" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 380 (138.8 bits), Expect = 1.2e-42, Sum P(2) = 1.2e-42
Identities = 93/256 (36%), Positives = 139/256 (54%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV- 157
I G++G+VY + R +A K R++ + + F +E+ + +L HP I+QF+G
Sbjct: 469 IGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMFCREVSILCRLNHPCIIQFVGAC 528
Query: 158 LKHSERLIFLTEYLRNGSLHDIL-KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
L + +T+Y+ GSL +L ++K LD + + A+D+A+GM YLH+ IIHR
Sbjct: 529 LNDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLIIAVDVAKGMEYLHN-LTQPIIHR 587
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR-ESYGKS 275
DL N+L E GH V DFG S+ Q D + MT G+ R+MAPEV+ + Y
Sbjct: 588 DLNSHNILLYEDGHAVVADFGESRFLQSLDEDN--MTKQPGNLRWMAPEVFTQCTRYTIK 645
Query: 276 VDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
DVFS+AL + E+ G P A AD AY RP + P+PI +LL W+
Sbjct: 646 ADVFSYALCLWELLTGEIPFAHLKPAAAAADM-AYHHIRPPIGYSIPKPIASLLMRGWNA 704
Query: 335 NPDRRPTFEEIIFRLE 350
P+ RP F E++ +LE
Sbjct: 705 CPEGRPEFSEVVTKLE 720
|
|
| UNIPROTKB|Q59H18 TNNI3K "Serine/threonine-protein kinase TNNI3K" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 378 (138.1 bits), Expect = 1.2e-42, Sum P(2) = 1.2e-42
Identities = 92/256 (35%), Positives = 139/256 (54%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV- 157
I G++G+VY + R +A K R++ + + F +E+ + +L HP ++QF+G
Sbjct: 469 IGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMFCREVSILCQLNHPCVIQFVGAC 528
Query: 158 LKHSERLIFLTEYLRNGSLHDIL-KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
L + +T+Y+ GSL +L ++K LD + + A+D+A+GM YLH+ IIHR
Sbjct: 529 LNDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLIIAVDVAKGMEYLHN-LTQPIIHR 587
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR-ESYGKS 275
DL N+L E GH V DFG S+ Q D + MT G+ R+MAPEV+ + Y
Sbjct: 588 DLNSHNILLYEDGHAVVADFGESRFLQSLDEDN--MTKQPGNLRWMAPEVFTQCTRYTIK 645
Query: 276 VDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
DVFS+AL + E+ G P A AD AY RP + P+PI +LL W+
Sbjct: 646 ADVFSYALCLWEILTGEIPFAHLKPAAAAADM-AYHHIRPPIGYSIPKPISSLLIRGWNA 704
Query: 335 NPDRRPTFEEIIFRLE 350
P+ RP F E++ +LE
Sbjct: 705 CPEGRPEFSEVVMKLE 720
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.10 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 370 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-67 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-65 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-65 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-63 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-61 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-60 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-57 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-54 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-44 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-43 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-40 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-39 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-39 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-39 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-38 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-38 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-38 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-37 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-37 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-36 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-36 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-35 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-35 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-34 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-34 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-34 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-34 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-33 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-32 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-32 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-32 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-31 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-31 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-31 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-30 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-30 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-30 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-30 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-30 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-30 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-30 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-30 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-29 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-29 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-29 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-29 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-29 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-29 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-29 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-29 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-29 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-28 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-28 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-28 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-28 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-28 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-28 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-28 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-28 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-27 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-27 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-27 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-27 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-27 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-27 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-27 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-27 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-26 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-26 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-26 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-26 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-26 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-26 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-26 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-26 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-26 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-25 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-25 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-25 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-24 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-24 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-24 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-24 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-24 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-24 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-24 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-24 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-24 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-24 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-24 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-23 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-23 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-23 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-22 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-22 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-22 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-22 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-22 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-21 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-21 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-21 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-21 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-20 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-20 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 3e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-20 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-20 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-19 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-19 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-19 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-19 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-19 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-19 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-19 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-19 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-19 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-18 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-18 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-18 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-17 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-17 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-17 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 1e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-16 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-16 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-16 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-16 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 1e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-15 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-14 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-13 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-13 | |
| PTZ00322 | 664 | PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fruct | 8e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-13 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 1e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-12 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-12 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-11 | |
| pfam12796 | 91 | pfam12796, Ank_2, Ankyrin repeats (3 copies) | 3e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-10 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 1e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-09 | |
| PLN03192 | 823 | PLN03192, PLN03192, Voltage-dependent potassium ch | 3e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-09 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 9e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-08 | |
| pfam00023 | 33 | pfam00023, Ank, Ankyrin repeat | 3e-08 | |
| PHA02946 | 446 | PHA02946, PHA02946, ankyin-like protein; Provision | 4e-08 | |
| pfam13857 | 56 | pfam13857, Ank_5, Ankyrin repeats (many copies) | 6e-08 | |
| PHA02875 | 413 | PHA02875, PHA02875, ankyrin repeat protein; Provis | 7e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-06 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 5e-06 | |
| smart00248 | 30 | smart00248, ANK, ankyrin repeats | 1e-05 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 2e-05 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 3e-05 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 4e-05 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 6e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-05 | |
| PHA03095 | 471 | PHA03095, PHA03095, ankyrin-like protein; Provisio | 8e-05 | |
| pfam13606 | 30 | pfam13606, Ank_3, Ankyrin repeat | 8e-05 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 8e-05 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 9e-05 | |
| PHA02874 | 434 | PHA02874, PHA02874, ankyrin repeat protein; Provis | 1e-04 | |
| PHA03100 | 422 | PHA03100, PHA03100, ankyrin repeat protein; Provis | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-04 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 1e-04 | |
| cd00204 | 126 | cd00204, ANK, ankyrin repeats; ankyrin repeats med | 2e-04 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 3e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-04 | |
| pfam13637 | 54 | pfam13637, Ank_4, Ankyrin repeats (many copies) | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-04 | |
| PHA02878 | 477 | PHA02878, PHA02878, ankyrin repeat protein; Provis | 6e-04 | |
| PHA02876 | 682 | PHA02876, PHA02876, ankyrin repeat protein; Provis | 8e-04 | |
| PTZ00322 | 664 | PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fruct | 0.001 | |
| COG0666 | 235 | COG0666, Arp, FOG: Ankyrin repeat [General functio | 0.002 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 8e-67
Identities = 82/250 (32%), Positives = 131/250 (52%), Gaps = 17/250 (6%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++G+VYL + + T +A K I+ + R ++E+ + +KL+HPNIV+ V +
Sbjct: 10 GSFGKVYLARDKKTGKLVAIKVIKKK--KIKKDRERILREIKILKKLKHPNIVRLYDVFE 67
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
++L + EY G L D+LKK+G+L A Y I + YLH I+HRDL
Sbjct: 68 DEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IVHRDLK 124
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
P N+L DE GH+K+ DFGL++ + K+T G+ YMAPEV + YGK+VD++
Sbjct: 125 PENILLDEDGHVKLADFGLARQLDPGE----KLTTFVGTPEYMAPEVLLGKGYGKAVDIW 180
Query: 280 SFALIVHEMFQGGP----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335
S +I++E+ G P ++ + + P K L+R+ K+
Sbjct: 181 SLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP--EWDISPEAKDLIRKLLVKD 238
Query: 336 PDRRPTFEEI 345
P++R T EE
Sbjct: 239 PEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 4e-65
Identities = 87/253 (34%), Positives = 130/253 (51%), Gaps = 17/253 (6%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++G VY K +GT +A K ++ + + + +E+ + ++L HPNIV+ + +
Sbjct: 10 GSFGTVYKAKHKGTGKIVAVKILKKR-SEKSKKDQTARREIRILRRLSHPNIVRLIDAFE 68
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ L + EY G L D L + G L A AL I RG+ YLH + IIHRDL
Sbjct: 69 DKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG---IIHRDLK 125
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES-YGKSVDV 278
P N+L DE G +K+ DFGL+K + S +T G+ YMAPEV + YG VDV
Sbjct: 126 PENILLDENGVVKIADFGLAKKLLKSSS---SLTTFVGTPWYMAPEVLLGGNGYGPKVDV 182
Query: 279 FSFALIVHEM------FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332
+S +I++E+ F G ++ E P SS E K L+++C
Sbjct: 183 WSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSG-SEEAKDLIKKCL 241
Query: 333 HKNPDRRPTFEEI 345
+K+P +RPT EEI
Sbjct: 242 NKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 8e-65
Identities = 86/256 (33%), Positives = 130/256 (50%), Gaps = 16/256 (6%)
Query: 102 GAYGEVYLVKWRGT------EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
GA+GEVY K +G E+A KT++ ++ + F++E + +KL HPN+V+ L
Sbjct: 10 GAFGEVYKGKLKGKGGKKKVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNVVKLL 67
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
GV E L + EY+ G L L+K + KL +++AL IARGM YL I
Sbjct: 68 GVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN---FI 124
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
HRDL N L E +K++DFGLS+ D Y Y+ GG R+MAPE + +
Sbjct: 125 HRDLAARNCLVGENLVVKISDFGLSR-DLYDDDY-YRKRGGKLPIRWMAPESLKEGKFTS 182
Query: 275 SVDVFSFALIVHEMF-QGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333
DV+SF +++ E+F G + +V R P + L+ +CW
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL-EYLKNGYRLPQPPNCPPELYDLMLQCWA 241
Query: 334 KNPDRRPTFEEIIFRL 349
++P+ RPTF E++ L
Sbjct: 242 EDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 4e-63
Identities = 86/256 (33%), Positives = 129/256 (50%), Gaps = 15/256 (5%)
Query: 102 GAYGEVYLVKWRG------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
GA+GEVY +G E+A KT++ ++ + F++E + +KL HPNIV+ L
Sbjct: 10 GAFGEVYKGTLKGKGDGKEVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNIVKLL 67
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAI 213
GV E L+ + EY+ G L D L+K L +++AL IARGM YL
Sbjct: 68 GVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---F 124
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG 273
IHRDL N L E +K++DFGLS+ D Y YK+ GG R+MAPE + +
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDY-YKVKGGKLPIRWMAPESLKEGKFT 182
Query: 274 KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333
DV+SF +++ E+F G + + R P + L+ +CW
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWA 242
Query: 334 KNPDRRPTFEEIIFRL 349
++P+ RPTF E++ L
Sbjct: 243 EDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 2e-61
Identities = 92/263 (34%), Positives = 134/263 (50%), Gaps = 29/263 (11%)
Query: 102 GAYGEVYLVKWRG------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
GA+GEVY +G T++A KT++ ++ R F++E + +KL HPNIV+ L
Sbjct: 10 GAFGEVYKGTLKGDGEGTETKVAVKTLKEG--ASEEEREEFLEEASIMKKLSHPNIVRLL 67
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAII 214
GV E L +TEY+ G L D L+K G KL + AL IA+GM YL +
Sbjct: 68 GVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN---FV 124
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESY 272
HRDL N L E +K++DFGLS+ E D Y K GG ++MAPE + +
Sbjct: 125 HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-RKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 273 GKSVDVFSFALIVHEMFQGG------PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKA 326
KS DV+SF +++ E+F G SN + + D R P+ +
Sbjct: 184 -KS-DVWSFGVLLWEIFTLGEQPYPGMSN-EEVLELLEDGY-----RLPRPENCPDELYE 235
Query: 327 LLRECWHKNPDRRPTFEEIIFRL 349
L+ +CW +P+ RPTF E++ L
Sbjct: 236 LMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 1e-60
Identities = 76/253 (30%), Positives = 122/253 (48%), Gaps = 46/253 (18%)
Query: 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
+ G +G VYL + + G ++A K I+ + + ++E+ + +KL HPNIV+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE--DSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
V + L + EY GSL D+LK+ GKL + L I G+ YLH + IIH
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIH 115
Query: 216 RDLTPSNVL-QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYR-RESYG 273
RDL P N+L + G +K+ DFGLSK+ S + G+ YMAPEV + Y
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 274 KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333
+ D++S +I++E+ +K L+R+
Sbjct: 173 EKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQ 199
Query: 334 KNPDRRPTFEEII 346
K+P++RP+ +EI+
Sbjct: 200 KDPEKRPSAKEIL 212
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 5e-57
Identities = 93/268 (34%), Positives = 138/268 (51%), Gaps = 30/268 (11%)
Query: 102 GAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
GA+GEVY K +G TE+A KT++ ++ R F+KE + +KL HPN+V+ LG
Sbjct: 6 GAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLGHPNVVRLLG 63
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKK---------KGKLDPPTAVAYALDIARGMNYLHH 207
V E L + EY+ G L D L+K K L +++A+ IA+GM YL
Sbjct: 64 VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS 123
Query: 208 HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVY 267
+ +HRDL N L E +K++DFGLS+ + D Y K TGG R+MAPE
Sbjct: 124 KK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-RKKTGGKLPIRWMAPESL 179
Query: 268 RRESYG-KSVDVFSFALIVHEMFQGG--PSNRADTAVQVADRRAY--EDSRPALSSLYPE 322
+ + KS DV+SF +++ E+F G P + + Y + R P+
Sbjct: 180 KDGIFTSKS-DVWSFGVLLWEIFTLGATPYP----GLSNEEVLEYLRKGYRLPKPEYCPD 234
Query: 323 PIKALLRECWHKNPDRRPTFEEIIFRLE 350
+ L+ CW +P+ RPTF E++ RLE
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 7e-54
Identities = 82/249 (32%), Positives = 125/249 (50%), Gaps = 12/249 (4%)
Query: 102 GAYGEVYL--VKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++G VYL K G +A K++ S S + + +E+ + L+HPNIV++ G +
Sbjct: 11 GSFGSVYLALDKDTGELMAVKSVELSGDSEEELE-ALEREIRILSSLQHPNIVRYYGSER 69
Query: 160 HSER---LIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
E+ IFL EY+ GSL +LKK GKL P Y I G+ YLH + I+HR
Sbjct: 70 DEEKNTLNIFL-EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHR 125
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
D+ +N+L D G +K+ DFG +K + + G+ +MAPEV R E YG++
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIE-TGEGTGSVRGTPYWMAPEVIRGEEYGRAA 184
Query: 277 DVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335
D++S V EM G P + + + P + E K LR+C ++
Sbjct: 185 DIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRD 244
Query: 336 PDRRPTFEE 344
P +RPT +E
Sbjct: 245 PKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 3e-44
Identities = 75/250 (30%), Positives = 125/250 (50%), Gaps = 20/250 (8%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG-VL 158
G +GEVY + + G E+A K I+ + + E+ + +K +HPNIV++ G L
Sbjct: 11 GGFGEVYKARHKRTGKEVAIKVIKLESKEK---KEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAY-ALDIARGMNYLHHHRPHAIIHRD 217
K E I + E+ GSL D+LK + + +AY ++ +G+ YLH + IIHRD
Sbjct: 68 KKDELWIVM-EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRD 123
Query: 218 LTPSNVLQDEAGHLKVTDFGLSK-IAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
+ +N+L G +K+ DFGLS ++ K + G+ +MAPEV + Y
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM-----VGTPYWMAPEVINGKPYDYKA 178
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPAL--SSLYPEPIKALLRECWHK 334
D++S + E+ +G P ++ + A P L + + K L++C K
Sbjct: 179 DIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-PGLRNPEKWSDEFKDFLKKCLQK 237
Query: 335 NPDRRPTFEE 344
NP++RPT E+
Sbjct: 238 NPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 8e-43
Identities = 78/258 (30%), Positives = 127/258 (49%), Gaps = 31/258 (12%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++G+V LV+ + T A K ++ I V ++ E + ++ HP IV+ L
Sbjct: 4 GSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPFIVK----L 58
Query: 159 KHS----ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
++ E+L + EY G L L K+G+ A YA +I + YLH II
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---II 115
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
+RDL P N+L D GH+K+TDFGL+K + S + G+ Y+APEV + YGK
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF---CGTPEYLAPEVLLGKGYGK 172
Query: 275 SVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI----KALLRE 330
+VD +S ++++EM G P A+ ++ ++ + R +PE + + L+
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR------FPEFLSPEARDLISG 226
Query: 331 CWHKNPDRRPT---FEEI 345
K+P +R EEI
Sbjct: 227 LLQKDPTKRLGSGGAEEI 244
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 2e-41
Identities = 92/261 (35%), Positives = 130/261 (49%), Gaps = 26/261 (9%)
Query: 102 GAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +GEV++ W G T++A KT++ S +F++E + +KLRH +VQ V
Sbjct: 17 GQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 161 SERLIFLTEYLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
E + +TEY+ GSL D LK KL P V A IA GM YL IHRDL
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDL 129
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESYGKSV 276
N+L E K+ DFGL+++ E D Y+ + G ++ APE Y R + KS
Sbjct: 130 AARNILVGENLVCKIADFGLARLI-EDDEYTARE-GAKFPIKWTAPEAANYGRFTI-KS- 185
Query: 277 DVFSFALIVHEMFQGG----PS-NRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331
DV+SF +++ E+ G P + QV R Y RP PE + L+ +C
Sbjct: 186 DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE--RGYRMPRPPNC---PEELYDLMLQC 240
Query: 332 WHKNPDRRPTFEEIIFRLEAI 352
W K+P+ RPTFE + LE
Sbjct: 241 WDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 8e-40
Identities = 66/256 (25%), Positives = 124/256 (48%), Gaps = 26/256 (10%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++G+VYLV+ + G K I S + + R + E+ + +KL HPNI+++ +
Sbjct: 11 GSFGKVYLVRRKSDGKLYVLKEIDLS-NMSEKEREDALNEVKILKKLNHPNIIKYYESFE 69
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPP----TAVAYALDIARGMNYLHHHRPHAIIH 215
+L + EY G L +KK+ K P + + + + + YLH + I+H
Sbjct: 70 EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILH 126
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RD+ P N+ G +K+ DFG+SK+ + + GT Y Y++PE+ + + Y
Sbjct: 127 RDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GT-PY-YLSPELCQNKPYNYK 183
Query: 276 VDVFSFALIVHEM------FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329
D++S +++E+ F+G N + A+++ P + S Y ++ L+
Sbjct: 184 SDIWSLGCVLYELCTLKHPFEG--ENLLELALKILKG-----QYPPIPSQYSSELRNLVS 236
Query: 330 ECWHKNPDRRPTFEEI 345
K+P+ RP+ +I
Sbjct: 237 SLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-39
Identities = 72/275 (26%), Positives = 133/275 (48%), Gaps = 30/275 (10%)
Query: 102 GAYGEVYLVKW------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G +G+V L ++ G ++A K++ S + R+ F +E+ + + L H NIV++
Sbjct: 15 GHFGKVELCRYDPLGDNTGEQVAVKSLNHS--GEEQHRSDFEREIEILRTLDHENIVKYK 72
Query: 156 GVL--KHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
GV L + EYL +GSL D L++ + +++ + ++ I +GM+YL R
Sbjct: 73 GVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--- 129
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
IHRDL N+L + +K++DFGL+K+ E Y Y G + APE R +
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKF 189
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLY------------ 320
+ DV+SF + ++E+F G +++ A + + ++ L
Sbjct: 190 SSASDVWSFGVTLYELFTYGDPSQSPPA-EFLRMIGIAQGQMIVTRLLELLKEGERLPRP 248
Query: 321 ---PEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
P+ + L++ CW P RP+F ++I ++ +
Sbjct: 249 PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-39
Identities = 77/264 (29%), Positives = 123/264 (46%), Gaps = 23/264 (8%)
Query: 93 LEDRGGIDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN 150
LE G + G G V V R T +A KTIR I N ++ ++EL + K P
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPY 60
Query: 151 IVQFLGVLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHR 209
IV F G ++ + EY+ GSL ILK+ +G++ A+ + +G+ YLH
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK- 119
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK--IAQEKDSYSYKMTGGTGSYRYMAPEVY 267
H IIHRD+ PSN+L + G +K+ DFG+S + ++ G+ YMAPE
Sbjct: 120 -HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF-------VGTSSYMAPERI 171
Query: 268 RRESYGKSVDVFSFALIVHEMFQG-----GPSNRADTAVQVADRRAYEDSRPAL-SSLYP 321
+ Y D++S L + E+ G ++ D ++ E P L S +
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-PRLPSGKFS 230
Query: 322 EPIKALLRECWHKNPDRRPTFEEI 345
+ + C K+P RP+++E+
Sbjct: 231 PDFQDFVNLCLIKDPRERPSYKEL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 4e-39
Identities = 84/250 (33%), Positives = 123/250 (49%), Gaps = 9/250 (3%)
Query: 102 GAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVR---NSFMKELGLWQKLRHPNIVQFLG 156
GA+G VYL G E+A K + +P + N+ E+ L + L+H IVQ+ G
Sbjct: 13 GAFGRVYLCYDVDTGRELAVKQVPFD-PDSPETKKEVNALECEIQLLKNLQHERIVQYYG 71
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
L+ E L EY+ GS+ D LK G L Y I G+ YLH + I+HR
Sbjct: 72 CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHR 128
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
D+ +N+L+D AG++K+ DFG SK Q S M TG+ +M+PEV E YG+
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKA 188
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336
DV+S V EM P A+ + A + + P L S + LR + +N
Sbjct: 189 DVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENA 248
Query: 337 DRRPTFEEII 346
+RP+ EE++
Sbjct: 249 KKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 6e-39
Identities = 81/258 (31%), Positives = 120/258 (46%), Gaps = 20/258 (7%)
Query: 98 GIDPGAYGEVY--LVKWRGTEIAAKTIRSSIASNPRVRNSFMKELG----LWQKLRHPNI 151
+ G++G VY L G A K S+A + + +K+L L KL+HPNI
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVK--EVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 152 VQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPH 211
VQ+LG + + L E + GSL +LKK G P Y I G+ YLH
Sbjct: 65 VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN-- 122
Query: 212 AIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD-SYSYKMTGGTGSYRYMAPEVYRRE 270
+HRD+ +N+L D G +K+ DFG++K E + S+K GS +MAPEV ++
Sbjct: 123 -TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK-----GSPYWMAPEVIAQQ 176
Query: 271 -SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPAL-SSLYPEPIKALL 328
YG + D++S V EM G P V + P + L E K +
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDE-AKDFI 235
Query: 329 RECWHKNPDRRPTFEEII 346
+C ++P RPT E++
Sbjct: 236 LKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 81/264 (30%), Positives = 129/264 (48%), Gaps = 31/264 (11%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
I G +G+V L +RG ++A K ++ + +F+ E + LRHPN+VQ LGV+
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKD----DSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
L +TEY+ GSL D L+ +G+ + + +ALD+ GM YL +HR
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHR 126
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
DL NVL E KV+DFGL+K A S G ++ APE R + +
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEA------SQGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLY--------PEPIKALL 328
DV+SF +++ E++ G R R +D P + Y P + ++
Sbjct: 181 DVWSFGILLWEIYSFG---RVPYP-----RIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232
Query: 329 RECWHKNPDRRPTFEEIIFRLEAI 352
++CW +P +RPTF+++ +L I
Sbjct: 233 KDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-38
Identities = 76/258 (29%), Positives = 119/258 (46%), Gaps = 15/258 (5%)
Query: 99 IDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I GAYG V+L K + T A K I+ + + + E + + + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ + L + EYL G L +L+ G LD A Y +I + YLH + IIHR
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHR 117
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKI-----AQEKDSYSYKMTGGTGSYRYMAPEVYRRES 271
DL P N+L D GHLK+TDFGLSK+ + + G+ Y+APEV +
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177
Query: 272 YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADR-RAYEDSRPALSSLYPEPIKALLRE 330
+ K+VD +S I++E G P +T ++ + P + E I L+ +
Sbjct: 178 HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAID-LISK 236
Query: 331 CWHKNPDRRP---TFEEI 345
+P++R + EEI
Sbjct: 237 LLVPDPEKRLGAKSIEEI 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 9e-38
Identities = 80/253 (31%), Positives = 127/253 (50%), Gaps = 23/253 (9%)
Query: 102 GAYGEVYLVKWRGT-EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +G V+L KWRG ++A K IR S + F++E + KL HPN+VQ GV
Sbjct: 15 GQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 161 SERLIFLTEYLRNGSLHDILK-KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ +TEY+ NG L + L+ +KGKL + D+ M YL + IHRDL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLA 127
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS---YRYMAPEVYRRESYGKSV 276
N L E +KV+DFGL++ + D Y T G+ ++ PEV+ +
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVLD-DQY----TSSQGTKFPVKWAPPEVFDYSRFSSKS 182
Query: 277 DVFSFALIVHEMFQGGP---SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333
DV+SF +++ E+F G +++ V + Y RP L+ P + ++ CWH
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLA---PTEVYTIMYSCWH 239
Query: 334 KNPDRRPTFEEII 346
+ P+ RP F++++
Sbjct: 240 EKPEDRPAFKKLL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 81/256 (31%), Positives = 127/256 (49%), Gaps = 22/256 (8%)
Query: 99 IDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
I G +G+VY + TE+A KT RS++ P ++ F++E + ++ HPNIV+ +GV
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 158 LKHSERLIFLTEYLRNGSLHDIL-KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ + + E + GSL L KKK +L + +LD A GM YL IHR
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS--YRYMAPEVYRRESYGK 274
DL N L E LK++DFG+S+ E++ Y ++ G ++ APE Y
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 275 SVDVFSFALIVHEMFQGGPS-----NRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329
DV+S+ +++ E F G + + T ++ Y P L PE I L+
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI--ESGYRMPAPQLC---PEEIYRLML 229
Query: 330 ECWHKNPDRRPTFEEI 345
+CW +P+ RP+F EI
Sbjct: 230 QCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 77/247 (31%), Positives = 120/247 (48%), Gaps = 14/247 (5%)
Query: 102 GAYGEVY--LVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+G VY L G +A K I + S M+E+ L + L+HPNIV+++G ++
Sbjct: 11 GAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL-KSIMQEIDLLKNLKHPNIVKYIGSIE 69
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
S+ L + EY NGSL I+KK G Y + +G+ YLH +IHRD+
Sbjct: 70 TSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIK 126
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
+N+L + G +K+ DFG+ A + + S G+ +MAPEV + D++
Sbjct: 127 AANILTTKDGVVKLADFGV---ATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIW 183
Query: 280 SFALIVHEMFQGGP--SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPD 337
S V E+ G P + A A R +D P L +K L +C+ K+P+
Sbjct: 184 SLGCTVIELLTGNPPYYDLNPMA---ALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPN 240
Query: 338 RRPTFEE 344
RPT ++
Sbjct: 241 LRPTAKQ 247
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 77/262 (29%), Positives = 121/262 (46%), Gaps = 22/262 (8%)
Query: 93 LEDRGGIDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN 150
LE + G+ G VY V K G A K I + + R ++EL + P
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 151 IVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAY-ALDIARGMNYLHHHR 209
+V+ G + + EY+ GSL D+LKK GK+ P +AY A I +G++YLH R
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKI-PEPVLAYIARQILKGLDYLHTKR 119
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI----AQEKDSYSYKMTGGTGSYRYMAPE 265
H IIHRD+ PSN+L + G +K+ DFG+SK+ + +++ G+ YM+PE
Sbjct: 120 -H-IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-------VGTVTYMSPE 170
Query: 266 VYRRESYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADRRA--YEDSRPALSSLYPE 322
+ ESY + D++S L + E G P +A + +
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSP 230
Query: 323 PIKALLRECWHKNPDRRPTFEE 344
+ + C K+P +RP+ E
Sbjct: 231 EFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 6e-37
Identities = 82/257 (31%), Positives = 131/257 (50%), Gaps = 23/257 (8%)
Query: 102 GAYGEVYLVKWRGT-EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +G V KWRG ++A K I+ S + F++E + KL H +VQ GV
Sbjct: 15 GQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 161 SERLIFLTEYLRNGSLHDILKKKGK-LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ +TEY+ NG L + L++ GK P + D+ GM YL + IHRDL
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLA 127
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
N L D+ G +KV+DFGLS+ + D Y+ + G R+ PEV + DV+
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLD-DEYTSSV-GSKFPVRWSPPEVLLYSKFSSKSDVW 185
Query: 280 SFALIVHEMFQGGPS-----NRADTAVQVAD-RRAYEDSRPALSSLYPEPIKALLRECWH 333
+F +++ E++ G N ++T +V+ R Y RP L+S E + A++ CWH
Sbjct: 186 AFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY---RPHLAS---EKVYAIMYSCWH 239
Query: 334 KNPDRRPTFEEIIFRLE 350
+ + RPTF++++ +E
Sbjct: 240 EKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 4e-36
Identities = 73/260 (28%), Positives = 121/260 (46%), Gaps = 22/260 (8%)
Query: 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G +G+VY G +A K IR ++P+ E+ + + L+HPN+V++ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQ-DNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
V H E++ EY G+L ++L+ LD Y L + G+ YLH H I+HR
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHR 123
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQE-KDSYSYKMTGGTGSYRYMAPEVYRRES---Y 272
D+ P+N+ D G +K+ DFG + + + ++ G+ YMAPEV +
Sbjct: 124 DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183
Query: 273 GKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKA----- 326
G++ D++S +V EM G P + D Q+ +P P+ ++
Sbjct: 184 GRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPP----IPDSLQLSPEGK 238
Query: 327 -LLRECWHKNPDRRPTFEEI 345
L C +P +RPT E+
Sbjct: 239 DFLDRCLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 5e-36
Identities = 78/250 (31%), Positives = 128/250 (51%), Gaps = 17/250 (6%)
Query: 102 GAYGEVYLVKWRGT-EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +G V+L KWR ++A K I S F++E + KL HP +VQ GV
Sbjct: 15 GQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 161 SERLIFLTEYLRNGSLHDILK-KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ L +TE++ NG L + L+ ++GKL ++ D+ GM YL ++ IHRDL
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLA 127
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
N L G +KV+DFG+++ + D Y+ +G ++ PEV+ Y DV+
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVLD-DEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185
Query: 280 SFALIVHEMFQGGP---SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336
SF +++ E+F G +++ V R + RP L+S+ + ++ CWH+ P
Sbjct: 186 SFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMT---VYEVMYSCWHEKP 242
Query: 337 DRRPTFEEII 346
+ RPTF E++
Sbjct: 243 EGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 78/256 (30%), Positives = 121/256 (47%), Gaps = 20/256 (7%)
Query: 102 GAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +GEV+ W T +A KT++ F+ E + +KLRHP ++Q V
Sbjct: 17 GQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 161 SERLIFLTEYLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
E + +TE ++ GSL + L+ L P + A +A GM YL IHRDL
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDL 129
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
NVL E KV DFGL+++ +E D Y + G ++ APE + DV
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKE-DIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 279 FSFALIVHEMFQGG----PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
+SF +++ E+ G P +Q D + Y P P+ + ++ +CW +
Sbjct: 188 WSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGC---PKELYDIMLDCWKE 243
Query: 335 NPDRRPTFEEIIFRLE 350
+PD RPTFE + ++LE
Sbjct: 244 DPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 4e-35
Identities = 92/286 (32%), Positives = 135/286 (47%), Gaps = 55/286 (19%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA+G+VY + G T +A KT++ + + P+V+ F +E L L+HPNIV
Sbjct: 16 GAFGKVYKGELTGPNERLSATSVAIKTLKEN--AEPKVQQEFRQEAELMSDLQHPNIVCL 73
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDIL----------------KKKGKLDPPTAVAYALDI 198
LGV + L EYL +G LH+ L K LD + A+ I
Sbjct: 74 LGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQI 133
Query: 199 ARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS---YKMTGG 255
A GM YL H +HRDL N L E +K++DFGLS +D YS Y++
Sbjct: 134 AAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLS-----RDIYSADYYRVQSK 185
Query: 256 TG-SYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVADR-R 307
+ R+M PE + D++SF +++ E+F G P SN+ +V + R
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-----EVIEMIR 240
Query: 308 AYEDSRPALSSLY--PEPIKALLRECWHKNPDRRPTFEEIIFRLEA 351
SR L P + AL+ ECW++ P RRP F++I RL +
Sbjct: 241 ----SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 73/264 (27%), Positives = 127/264 (48%), Gaps = 20/264 (7%)
Query: 93 LEDRGGIDPGAYGEVYLVKWR------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL 146
LE + GA+G VY W +A K +R ++P+ + E + +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAYVMASV 66
Query: 147 RHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYL 205
HP++V+ LG+ S ++ +T+ + G L D ++ K + + + + IA+GM+YL
Sbjct: 67 DHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 206 HHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPE 265
R ++HRDL NVL H+K+TDFGL+K+ + D Y GG ++MA E
Sbjct: 126 EEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL-DVDEKEYHAEGGKVPIKWMALE 181
Query: 266 VYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT-AVQVAD--RRAYEDSRPALSSLYPE 322
Y DV+S+ + V E+ G AV++ D + +P + ++
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTI--- 238
Query: 323 PIKALLRECWHKNPDRRPTFEEII 346
+ +L +CW + + RPTF+E+I
Sbjct: 239 DVYMVLVKCWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 75/259 (28%), Positives = 122/259 (47%), Gaps = 22/259 (8%)
Query: 102 GAYGEVYLVKWRGT-EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +GEV+ W+ +A K ++S + + F KE+ ++LRH +++ V
Sbjct: 17 GYFGEVWEGLWKNRVRVAIKILKSD---DLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 161 SERLIFLTEYLRNGSLHDILKK-KGK-LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
E + +TE + GSL L+ +G+ L + + A +A GM YL IHRDL
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDL 130
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
N+L E KV DFGL+++ +E D Y Y++ APE ++ DV
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIKE-DVYLSSDK--KIPYKWTAPEAASHGTFSTKSDV 187
Query: 279 FSFALIVHEMFQGGP-----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333
+SF ++++EMF G N + Q+ Y PA P+ I ++ ECW
Sbjct: 188 WSFGILLYEMFTYGQVPYPGMNNHEVYDQIT--AGYRMPCPAKC---PQEIYKIMLECWA 242
Query: 334 KNPDRRPTFEEIIFRLEAI 352
P+ RP+F+ + L+ I
Sbjct: 243 AEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-34
Identities = 77/256 (30%), Positives = 128/256 (50%), Gaps = 17/256 (6%)
Query: 99 IDPGAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
I G +G V+L W ++A KTIR S F++E + KL HP +VQ GV
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 158 LKHSERLIFLTEYLRNGSLHDILK-KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ + E++ +G L D L+ ++GK T + LD+ GM YL +IHR
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHR 124
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
DL N L E +KV+DFG+++ + D Y+ TG ++ +PEV+ Y
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLD-DQYT-SSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 277 DVFSFALIVHEMFQGGP---SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333
DV+SF +++ E+F G NR+++ V + +P L+ + + L++ CW
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLA---SQSVYELMQHCWK 239
Query: 334 KNPDRRPTFEEIIFRL 349
+ P+ RP+F ++ +L
Sbjct: 240 ERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 6e-34
Identities = 78/272 (28%), Positives = 127/272 (46%), Gaps = 38/272 (13%)
Query: 99 IDPGAYGEVYLVKWRGT-----EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQ 153
I G +GEV + + ++A KT+++ S+ + R F+ E + + HPNI++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG--SSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 154 FLGVLKHSERLIFLTEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHA 212
GV+ S ++ +TEY+ NGSL L++ GK V IA GM YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MN 126
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
+HRDL N+L + KV+DFGLS+ ++ ++ +Y GG R+ APE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA-TYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR-----PALSSLY------- 320
+ DV+SF +++ E+ G R Y D A+ Y
Sbjct: 186 TSASDVWSFGIVMWEVMSYG-------------ERPYWDMSNQDVIKAVEDGYRLPPPMD 232
Query: 321 -PEPIKALLRECWHKNPDRRPTFEEIIFRLEA 351
P + L+ +CW K+ + RPTF +I+ L+
Sbjct: 233 CPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 81/265 (30%), Positives = 119/265 (44%), Gaps = 23/265 (8%)
Query: 99 IDPGAYGEVYLV--KWRGTEIAAKTI---RSSIASNPRVRNSFMK----ELGLWQKLRHP 149
I G YG VYL G +A K + + + + +K E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 150 NIVQFLGVLKHSERL-IFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH 208
NIVQ+LG E L IFL EY+ GS+ L+ G+ + + + G+ YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFL-EYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS- 126
Query: 209 RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY-SYKMTGGTGSYRYMAPEVY 267
I+HRDL N+L D G K++DFG+SK + D Y + + GS +MAPEV
Sbjct: 127 --KGILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSVFWMAPEVI 182
Query: 268 --RRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPAL----SSLYP 321
+ Y VD++S +V EMF G + A+ + + S P + S
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242
Query: 322 EPIKALLRECWHKNPDRRPTFEEII 346
L C+ NPD RPT E++
Sbjct: 243 PVALDFLNACFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 77/257 (29%), Positives = 127/257 (49%), Gaps = 17/257 (6%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
I G +G+V L +RG ++A K I+ N +F+ E + +LRH N+VQ LGV+
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIK-----NDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 159 -KHSERLIFLTEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ L +TEY+ GSL D L+ +G+ L + ++LD+ M YL + +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EANNFVH 125
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RDL NVL E KV+DFGL+K A S G ++ APE R + +
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335
DV+SF +++ E++ G ++ R + + P + ++++CWH +
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLD 239
Query: 336 PDRRPTFEEIIFRLEAI 352
RP+F ++ +LE I
Sbjct: 240 AATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 71/266 (26%), Positives = 108/266 (40%), Gaps = 31/266 (11%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVL 158
G++ V L K + E A K + + E + +L HP I++
Sbjct: 12 GSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ E L F+ EY NG L ++K G LD YA +I + YLH IIHRDL
Sbjct: 72 QDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDL 128
Query: 219 TPSNVLQDEAGHLKVTDFGLSKI-------------AQEKDSYSYKMTGGTGSY----RY 261
P N+L D+ H+K+TDFG +K+ A DS K S+ Y
Sbjct: 129 KPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEY 188
Query: 262 MAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADR---RAYEDSRPALSS 318
++PE+ + GKS D+++ I+++M G P R + Y
Sbjct: 189 VSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS-----FPP 243
Query: 319 LYPEPIKALLRECWHKNPDRRPTFEE 344
+P K L+ + +P R E
Sbjct: 244 NFPPDAKDLIEKLLVLDPQDRLGVNE 269
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 26/267 (9%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHP-NIVQFLGVLKH 160
G++GEVYL + +A K + + S + F++E+ + L HP NIV+ +
Sbjct: 11 GSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69
Query: 161 SERLIFLTEYLRNGSLHDILKK---KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
L + EY+ GSL D+LKK KG L A+ I + YLH IIHRD
Sbjct: 70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRD 126
Query: 218 LTPSNVLQDEAGH-LKVTDFGLSKIAQEKDSYS---YKMTGGTGSYRYMAPEVYR---RE 270
+ P N+L D G +K+ DFGL+K+ + S S + G+ YMAPEV
Sbjct: 127 IKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLA 186
Query: 271 SYGKSVDVFSFALIVHEMFQG---GPSNRADTAVQVADRRAYEDSRPALSSLYPEP---- 323
S D++S + ++E+ G + +A + E P+L+S
Sbjct: 187 YASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPEL 246
Query: 324 ----IKALLRECWHKNPDRRPTFEEII 346
LL++ K+P R + +
Sbjct: 247 ISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 79/257 (30%), Positives = 121/257 (47%), Gaps = 21/257 (8%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G YGEVY W+ +A KT++ V F+KE + ++++HPN+VQ LGV
Sbjct: 17 GQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEE-FLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+TE++ G+L D L++ + ++ + A I+ M YL IHRD
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRD 129
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVD 277
L N L E +KV DFGLS++ D+Y+ G ++ APE + D
Sbjct: 130 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAH-AGAKFPIKWTAPESLAYNKFSIKSD 187
Query: 278 VFSFALIVHEMFQGG--PSNRADTAVQVADR--RAYEDSRPALSSLYPEPIKALLRECWH 333
V++F +++ E+ G P D + QV + + Y RP P + L+R CW
Sbjct: 188 VWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKGYRMERPEGC---PPKVYELMRACWQ 243
Query: 334 KNPDRRPTFEEIIFRLE 350
NP RP+F EI E
Sbjct: 244 WNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 9/195 (4%)
Query: 99 IDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I GA+G+V +V+ R T+ A K + + + E + Q+L HP +V
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ E + + + L G L L +K K + +I + YLH IIHR
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHR 124
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
D+ P N+L DE GH+ +TDF ++ + T +G+ YMAPEV R+ Y +V
Sbjct: 125 DIKPDNILLDEQGHVHITDFNIATKV----TPDTLTTSTSGTPGYMAPEVLCRQGYSVAV 180
Query: 277 DVFSFALIVHEMFQG 291
D +S + +E +G
Sbjct: 181 DWWSLGVTAYECLRG 195
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 79/294 (26%), Positives = 135/294 (45%), Gaps = 50/294 (17%)
Query: 91 KILEDRGGIDPGAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH 148
++ ++ I GA GEVY R T E+A K +R + + + E+ + + +H
Sbjct: 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR--LRKQ--NKELIINEILIMKDCKH 74
Query: 149 PNIVQFLGVLKHSERLIFLTEYLRNGSLHDIL-KKKGKLDPPTAVAYALDIARGMNYLHH 207
PNIV + + L + EY+ GSL DI+ + +++ P ++ +G+ YLH
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 208 HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLS-KIAQEKDSYSYKMTGGTGSYRYMAPEV 266
+IHRD+ N+L + G +K+ DFG + ++ +EK K G+ +MAPEV
Sbjct: 135 QN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS----KRNSVVGTPYWMAPEV 187
Query: 267 YRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPA-----LSSLYP 321
+R+ YG VD++S ++ EM +G P Y P +++
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPP--------------YLREPPLRALFLITTKGI 233
Query: 322 EPIKA----------LLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKTVPSCC 365
P+K L +C K+P++RP+ EE+ +Q F KK P
Sbjct: 234 PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEEL------LQHPFLKKACPKEE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 73/250 (29%), Positives = 128/250 (51%), Gaps = 18/250 (7%)
Query: 102 GAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +GEV++ + T++A KT++ S +F++E L + L+H +V+ V+
Sbjct: 17 GQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 161 SERLIFLTEYLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
E + +TEY+ GSL D LK GK+ P + ++ IA GM Y+ IHRDL
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDL 129
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
+NVL E+ K+ DFGL+++ E + Y+ + G ++ APE S+ DV
Sbjct: 130 RAANVLVSESLMCKIADFGLARVI-EDNEYTAR-EGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 279 FSFALIVHEMFQGGP---SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335
+SF ++++E+ G +++ V A +R Y R P+ + +++ CW +
Sbjct: 188 WSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENC---PDELYDIMKTCWKEK 244
Query: 336 PDRRPTFEEI 345
+ RPTF+ +
Sbjct: 245 AEERPTFDYL 254
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 70/261 (26%), Positives = 107/261 (40%), Gaps = 17/261 (6%)
Query: 102 GAYGEVYLVKWR---GTEI--AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G +G V + G E+ A KT++ + F++E + +L HP IV+ +G
Sbjct: 6 GNFGSVVKGVYLMKSGKEVEVAVKTLKQE--HIAAGKKEFLREASVMAQLDHPCIVRLIG 63
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
V K E L+ + E G L LKK+ ++ A +A GM YL +HR
Sbjct: 64 VCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHR 119
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
DL NVL K++DFG+S+ Y T G ++ APE +
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKS 179
Query: 277 DVFSFALIVHEMFQ-GGPSNRADTAVQVAD--RRAYEDSRPALSSLYPEPIKALLRECWH 333
DV+S+ + + E F G +V RP P+ I +++ CW
Sbjct: 180 DVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEEC---PQEIYSIMLSCWK 236
Query: 334 KNPDRRPTFEEIIFRLEAIQE 354
P+ RPTF E+ E
Sbjct: 237 YRPEDRPTFSELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 83/251 (33%), Positives = 126/251 (50%), Gaps = 10/251 (3%)
Query: 102 GAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVR--NSFMKELGLWQKLRHPNIVQFLGV 157
GA+GEVYL G E+A K + S + N+ E+ L + LRH IVQ+ G
Sbjct: 13 GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72
Query: 158 LKHSE--RLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
L+ E +L EY+ GS+ D LK G L Y I +G++YLH + I+H
Sbjct: 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH---SNMIVH 129
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RD+ +N+L+D AG++K+ DFG SK Q + TG+ +M+PEV E YG+
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRK 189
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335
DV+S A V EM P A+ + A + ++P L + + L++ + +
Sbjct: 190 ADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVEE 249
Query: 336 PDRRPTFEEII 346
RRPT E ++
Sbjct: 250 -KRRPTAEFLL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 78/285 (27%), Positives = 129/285 (45%), Gaps = 44/285 (15%)
Query: 99 IDPGAYGEVYLVKWRGTE-------IAAKTIRSSIASNPRVRN-----SFMKELGLWQKL 146
+ GA+G+V + G + +A K ++ A+ + + MK +G
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIG----- 73
Query: 147 RHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKK----------------GKLDPPT 190
+H NI+ LGV L + EY +G+L D L+ + L
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 191 AVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250
V++A +ARGM +L + IHRDL NVL E +K+ DFGL++ D Y
Sbjct: 134 LVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR- 189
Query: 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAV-QVAD--RR 307
K T G ++MAPE Y DV+SF +++ E+F G S V ++ +
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 249
Query: 308 AYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
Y +P + + L+R+CWH+ P +RPTF++++ L+ +
Sbjct: 250 GYRMEKPQNC---TQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 74/256 (28%), Positives = 122/256 (47%), Gaps = 15/256 (5%)
Query: 102 GAYGEVYLVK--WRGTEIAAKTI---RSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
GA+ Y + GT +A K + R++ + V + KE+ L +L HP+I++ LG
Sbjct: 11 GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG 70
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
E++ GS+ +L K G + Y + RG++YLH ++ IIHR
Sbjct: 71 ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHR 127
Query: 217 DLTPSNVLQDEAGH-LKVTDFGLSKIAQEKDSYSYKMTGG-TGSYRYMAPEVYRRESYGK 274
D+ +N+L D G L++ DFG + K + + + G G+ +MAPEV R E YG+
Sbjct: 128 DVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGR 187
Query: 275 SVDVFSFALIVHEMFQGGPSNRAD---TAVQVADRRAYEDSRPAL-SSLYPEPIKALLRE 330
S DV+S ++ EM P A+ + + + A + P++ L P LR
Sbjct: 188 SCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLR- 246
Query: 331 CWHKNPDRRPTFEEII 346
C P+ RP E++
Sbjct: 247 CLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 67/254 (26%), Positives = 125/254 (49%), Gaps = 17/254 (6%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
I G +G V ++ G ++A K I+ + + +F++E + KL H N+V+ LGV+
Sbjct: 14 IGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQ-----AFLEETAVMTKLHHKNLVRLLGVI 68
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTA--VAYALDIARGMNYLHHHRPHAIIHR 216
H L + E + G+L + L+ +G+ + ++LD+A GM YL + ++HR
Sbjct: 69 LH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHR 124
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
DL N+L E G KV+DFGL++ + K+ ++ APE + + +
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKL-----PVKWTAPEALKHKKFSSKS 178
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336
DV+S+ +++ E+F G + +++ + R P + L+ CW P
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEP 238
Query: 337 DRRPTFEEIIFRLE 350
+RP+F ++ +LE
Sbjct: 239 KKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 83/279 (29%), Positives = 141/279 (50%), Gaps = 36/279 (12%)
Query: 102 GAYGEVYLVKW------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G +G V L ++ G +A K ++ S A + R F +E+ + + L+H NIV++
Sbjct: 15 GNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR---DFEREIEILKSLQHDNIVKYK 71
Query: 156 GVLKHSER--LIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
GV + R L + EYL GSL D L+K + +LD + YA I +GM YL R
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--- 128
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKI-AQEKDSYSYKMTGGTGSYRYMAPEVYRRES 271
+HRDL N+L + +K+ DFGL+K+ Q+K+ Y + G + + Y APE
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESK 187
Query: 272 YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLY----------- 320
+ + DV+SF ++++E+F + + A + R D + + +
Sbjct: 188 FSVASDVWSFGVVLYELFTYSDKSCSPPAEFM--RMMGNDKQGQMIVYHLIELLKNNGRL 245
Query: 321 ------PEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQ 353
P I A+++ECW+ +P +RP+F E+ ++EAI+
Sbjct: 246 PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 83/251 (33%), Positives = 123/251 (49%), Gaps = 10/251 (3%)
Query: 102 GAYGEVYLVKW--RGTEIAAKTIRSSIAS--NPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
GA+G VYL G E+AAK ++ S + ++ E+ L + L+H IVQ+ G
Sbjct: 13 GAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72
Query: 158 LK-HSER-LIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
L+ +E+ L EY+ GS+ D LK G L Y I GM+YLH + I+H
Sbjct: 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH---SNMIVH 129
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RD+ +N+L+D AG++K+ DFG SK Q + TG+ +M+PEV E YG+
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRK 189
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335
DV+S V EM P A+ + A + + P L S E + L C
Sbjct: 190 ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLG-CIFVE 248
Query: 336 PDRRPTFEEII 346
RP+ EE++
Sbjct: 249 ARHRPSAEELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 81/260 (31%), Positives = 133/260 (51%), Gaps = 17/260 (6%)
Query: 99 IDPGAYGEVYLV--KWRGTEIAAKTIR-SSIASNPRVRNSFM-----KELGLWQKLRHPN 150
I G++G VYL G +A K + S++++ + R M +E+ L ++L+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 151 IVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRP 210
IVQ+LG ++ L EY+ GS+ +L G + + I +G+NYLH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG- 126
Query: 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG----TGSYRYMAPEV 266
IIHRD+ +N+L D G +K++DFG+SK E +S S K G GS +MAPEV
Sbjct: 127 --IIHRDIKGANILVDNKGGIKISDFGISK-KLEANSLSTKTNGARPSLQGSVFWMAPEV 183
Query: 267 YRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKA 326
++ SY + D++S +V EM G T +Q A + E++ P + S
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFKIGENASPEIPSNISSEAID 242
Query: 327 LLRECWHKNPDRRPTFEEII 346
L + + + ++RPT E++
Sbjct: 243 FLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 6e-30
Identities = 71/260 (27%), Positives = 122/260 (46%), Gaps = 11/260 (4%)
Query: 99 IDPGAYGEVY--LVKWRG---TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQ 153
I G +GEV+ ++K G +A KT++ + R F+ E + + H NI++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE--KQRQDFLSEASIMGQFSHHNIIR 70
Query: 154 FLGVLKHSERLIFLTEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHA 212
GV+ + + +TEY+ NG+L L+ G+ V IA GM YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--- 127
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
+HRDL N+L + KV+DFGLS++ ++ +Y +GG R+ APE +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332
+ DV+SF +++ E+ G D + + + R P + L+ +CW
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCW 247
Query: 333 HKNPDRRPTFEEIIFRLEAI 352
++ RRP F +I+ L+ +
Sbjct: 248 QQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 80/275 (29%), Positives = 128/275 (46%), Gaps = 39/275 (14%)
Query: 102 GAYGEVY--LVKW-----RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
G++G VY L K T +A KT+ + ++ R R F+ E + ++ ++V+
Sbjct: 17 GSFGMVYEGLAKGVVKGEPETRVAIKTV--NENASMRERIEFLNEASVMKEFNCHHVVRL 74
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKK-------GKLDPPTA---VAYALDIARGMNY 204
LGV+ + + + E + G L L+ + L PPT + A +IA GM Y
Sbjct: 75 LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAY 134
Query: 205 LHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAP 264
L + +HRDL N + E +K+ DFG+++ E D Y K G R+MAP
Sbjct: 135 LAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAP 190
Query: 265 EVYRRESYGKSVDVFSFALIVHEM-------FQGGPSNRADTAVQ-VADRRAYEDSRPAL 316
E + + DV+SF +++ EM +Q G SN + ++ V D + P
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ-GLSN--EEVLKFVIDGGHLD--LPEN 245
Query: 317 SSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEA 351
P+ + L+R CW NP RPTF EI+ L+
Sbjct: 246 C---PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 80/288 (27%), Positives = 119/288 (41%), Gaps = 41/288 (14%)
Query: 84 FGHVVICK------ILEDRGGIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFM 137
FG V +C+ E + A V LV A K +R + N R F+
Sbjct: 18 FGEVHLCEADGLQDFSEKAFAENDNADAPV-LV-------AVKVLRPDASDN--AREDFL 67
Query: 138 KELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKK-----------KGKL 186
KE+ + +L PNI + LGV L + EY+ NG L+ L+K L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 187 DPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD 246
T + A IA GM YL +HRDL N L + +K+ DFG+S+ D
Sbjct: 128 SFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 247 SYSYKMTGGTG-SYRYMAPEVYRRESYGKSVDVFSFALIVHEMF---QGGPSNRADT--A 300
Y Y++ G R+MA E + DV++F + + E+ + P
Sbjct: 185 -Y-YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242
Query: 301 VQVADRRAYEDSRP---ALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345
++ A +D R P+ I L+ ECW ++ + RPTF EI
Sbjct: 243 IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-29
Identities = 62/195 (31%), Positives = 97/195 (49%), Gaps = 9/195 (4%)
Query: 102 GAYGEVYLVKWRGT-EIAA-KTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GAYG V + + T EI A K + S + V+ + ++E+ + ++LRH NIV +
Sbjct: 12 GAYGVVLKCRNKATGEIVAIKKFKES-EDDEDVKKTALREVKVLRQLRHENIVNLKEAFR 70
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
RL + EY+ L + G L P +Y + + + Y H H IIHRD+
Sbjct: 71 RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIK 127
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVY-RRESYGKSVDV 278
P N+L E+G LK+ DFG ++ + + + T YR APE+ +YGK VDV
Sbjct: 128 PENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYR--APELLVGDTNYGKPVDV 185
Query: 279 FSFALIVHEMFQGGP 293
++ I+ E+ G P
Sbjct: 186 WAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 13/211 (6%)
Query: 99 IDPGAYGEVYLVKWR--GTEIAAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
I GA+G VYL K R G A K ++ S + + +V N + + + P + +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ + L + EYL G ++K G L A Y ++ G+ LH IIH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIH 120
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RD+ P N+L D+ GHLK+TDFGLS+ E + G+ Y+APE K
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-------GTPDYLAPETILGVGDDKM 173
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADR 306
D +S ++ E G P A+T V D
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDN 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-29
Identities = 73/237 (30%), Positives = 111/237 (46%), Gaps = 19/237 (8%)
Query: 117 IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG-VLKHSERLIFLTEYLRNGS 175
+A K ++S S+ + + F+KE + L H N+++ G VL H ++ TE GS
Sbjct: 26 VAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMV--TELAPLGS 81
Query: 176 LHDILKK--KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKV 233
L D L+K G T YA+ IA GM YL R IHRDL N+L +K+
Sbjct: 82 LLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKI 138
Query: 234 TDFGLSKIAQEKDSYSYKMTGGTG-SYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGG 292
DFGL + + + + Y M + + APE R ++ + DV+ F + + EMF G
Sbjct: 139 GDFGLMRALPQNEDH-YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYG 197
Query: 293 PSNRAD-TAVQV---ADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345
A + Q+ D+ RP P+ I ++ +CW NP RPTF +
Sbjct: 198 EEPWAGLSGSQILKKIDKEGERLERPEAC---PQDIYNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-29
Identities = 78/277 (28%), Positives = 130/277 (46%), Gaps = 28/277 (10%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFLGVL 158
G++G+V L + +GT+ A K ++ + M E L +HP + Q
Sbjct: 6 GSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF 65
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ +RL F+ EY+ G L +++ G+ D P A YA +I G+ +LH II+RDL
Sbjct: 66 QTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDL 122
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
NVL D GH+K+ DFG+ K E + G+ Y+APE+ + YG +VD
Sbjct: 123 KLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDW 179
Query: 279 FSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYP----EPIKALLRECWHK 334
++ ++++EM G D ++ ++ R YP + K++L+ K
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR------YPRWLSKEAKSILKSFLTK 233
Query: 335 NPDRR----PTFEEII-----FRLEAIQESFQKKTVP 362
NP++R PT E+ I FR + +K+ P
Sbjct: 234 NPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKP 270
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-29
Identities = 63/199 (31%), Positives = 104/199 (52%), Gaps = 21/199 (10%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTI-RSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++G V LV+ +G+ A K + ++ I +V + + E + Q +RHP +V G
Sbjct: 12 GSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHV-LNEKRILQSIRHPFLVNLYGSF 70
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ L + EY+ G L L+K G+ P A YA + + YLH I++RDL
Sbjct: 71 QDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDL 127
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT----GSYRYMAPEVYRRESYGK 274
P N+L D G++K+TDFG +K ++ G T G+ Y+APE+ + YGK
Sbjct: 128 KPENLLLDSDGYIKITDFGFAK----------RVKGRTYTLCGTPEYLAPEIILSKGYGK 177
Query: 275 SVDVFSFALIVHEMFQGGP 293
+VD ++ ++++EM G P
Sbjct: 178 AVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-29
Identities = 73/252 (28%), Positives = 121/252 (48%), Gaps = 13/252 (5%)
Query: 99 IDPGAYGEVYLVKWRG--TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G +GEV+ + R T +A K+ R ++ P ++ F++E + ++ HPNIV+ +G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
V + + + E ++ G L+ +G +L + + A GM YL IH
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIH 117
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS--YRYMAPEVYRRESYG 273
RDL N L E LK++DFG+S+ +E+D Y TGG ++ APE Y
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSR--EEEDGV-YASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 274 KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333
DV+SF +++ E F G A+ + Q + R L P+ + L+ CW
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWE 234
Query: 334 KNPDRRPTFEEI 345
+P +RP+F +
Sbjct: 235 YDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 78/249 (31%), Positives = 125/249 (50%), Gaps = 21/249 (8%)
Query: 102 GAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +GEV++ + G T++A K+++ S +F+ E L ++L+HP +V+ V+
Sbjct: 17 GQFGEVWMGYYNGHTKVAIKSLKQGSMSP----EAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 161 SERLIFLTEYLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
E + +TEY+ NGSL D LK KL + A IA GM ++ IHRDL
Sbjct: 73 -EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDL 128
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
+N+L E K+ DFGL+++ E + Y+ + G ++ APE ++ DV
Sbjct: 129 RAANILVSETLCCKIADFGLARLI-EDNEYTAR-EGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 279 FSFALIVHEMFQGG----PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
+SF +++ E+ G P +Q + R Y RP PE + L+R CW +
Sbjct: 187 WSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNC---PEELYELMRLCWKE 242
Query: 335 NPDRRPTFE 343
P+ RPTFE
Sbjct: 243 KPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 62/255 (24%), Positives = 123/255 (48%), Gaps = 15/255 (5%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG--V 157
G++G V V+ + G + K I + + + + E+ + ++L+HPNIV++ +
Sbjct: 11 GSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYYDRII 69
Query: 158 LKHSERLIFLTEYLRNGSLHDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRP--H 211
+ ++ L + EY G L +++K + ++ + + H+ +
Sbjct: 70 DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN 129
Query: 212 AIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES 271
++HRDL P+N+ D ++K+ DFGL+KI DS K GT Y YM+PE S
Sbjct: 130 TVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-DSSFAKTYVGT-PY-YMSPEQLNHMS 186
Query: 272 YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331
Y + D++S +++E+ P A +Q+A + R + Y + +++
Sbjct: 187 YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR-IPYRYSSELNEVIKSM 245
Query: 332 WHKNPDRRPTFEEII 346
+ +PD+RP+ EE++
Sbjct: 246 LNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 11/195 (5%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +G V LVK + A K ++ + E + ++ HP IV+ K
Sbjct: 4 GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK 63
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ + L EY G L IL+ +G D TA Y + YLH+ II+RDL
Sbjct: 64 DKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLK 120
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKD-SYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
P N+L D G++K+ DFG +K + ++++ G+ Y+APE+ + Y SVD
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF-----CGTPEYVAPEIILNKGYDFSVDY 175
Query: 279 FSFALIVHEMFQGGP 293
+S ++++E+ G P
Sbjct: 176 WSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 78/284 (27%), Positives = 128/284 (45%), Gaps = 29/284 (10%)
Query: 91 KILEDRGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH 148
+ + D G G G V VK GT +A K + I + VR ++EL + + R
Sbjct: 8 ETISDLGA---GNGGSVSKVKHIPTGTVMAKKVVH--IGAKSSVRKQILRELQIMHECRS 62
Query: 149 PNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH 208
P IV F G + + E++ GSL I KK G + A+ + G+ YL++
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122
Query: 209 RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK--IAQEKDSYSYKMTGGTGSYRYMAPEV 266
H I+HRD+ PSN+L + G +K+ DFG+S I D++ G+ YM+PE
Sbjct: 123 --HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF-------VGTSTYMSPER 173
Query: 267 YRRESYGKSVDVFSFALIVHEMFQG--------GPSNRADTAVQVAD--RRAYEDSRPAL 316
+ Y DV+S + + E+ G + D + + D ++ ++ P L
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL 233
Query: 317 -SSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359
SS +PE ++ + C K+P RPT +++ IQ
Sbjct: 234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASN 277
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 2e-28
Identities = 76/260 (29%), Positives = 124/260 (47%), Gaps = 11/260 (4%)
Query: 99 IDPGAYGEV-----YLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQ 153
I G +GEV L R +A KT+++ + R F+ E + + HPNI+
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIH 69
Query: 154 FLGVLKHSERLIFLTEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHA 212
GV+ S+ ++ +TEY+ NGSL L+K G+ V IA GM YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---G 126
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
+HRDL N+L + KV+DFGLS++ ++ +Y GG R+ APE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332
+ DV+S+ +++ E+ G + + Q + E R P + L+ +CW
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCW 246
Query: 333 HKNPDRRPTFEEIIFRLEAI 352
K+ + RP FE+I+ L+ +
Sbjct: 247 QKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 75/283 (26%), Positives = 126/283 (44%), Gaps = 43/283 (15%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIA-------SNPRVRNSFMKELGLWQKLRHPNIVQF 154
G +G+V VK + + +++A ++ + E L +++ HP++++
Sbjct: 11 GEFGKV--VKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKL 68
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPP------------------------T 190
G L+ + EY + GSL L++ K+ P
Sbjct: 69 YGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGD 128
Query: 191 AVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250
+++A I+RGM YL + ++HRDL NVL E +K++DFGLS+ E+DSY
Sbjct: 129 LISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY-V 184
Query: 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ---VADRR 307
K + G ++MA E Y DV+SF +++ E+ G + A + +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT 244
Query: 308 AYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350
Y RP S E + L+ CW + PD+RPTF +I LE
Sbjct: 245 GYRMERPENCS---EEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-28
Identities = 63/259 (24%), Positives = 117/259 (45%), Gaps = 22/259 (8%)
Query: 99 IDPGAYGEVY--LVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G + VY + G +A K ++ + + R +KE+ L ++L HPN++++L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 157 VLKHSERLIFLTEYLRNGSLHDILK---KKGKLDP-PTAVAYALDIARGMNYLHHHRPHA 212
+ L + E G L ++K K+ +L P T Y + + + ++H R
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--- 126
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
I+HRD+ P+NV G +K+ D GL + K + ++ + G+ YM+PE Y
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPERIHENGY 183
Query: 273 GKSVDVFSFALIVHEM------FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKA 326
D++S +++EM F G N + + D P + Y E ++
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS----LCKKIEKCDYPPLPADHYSEELRD 239
Query: 327 LLRECWHKNPDRRPTFEEI 345
L+ C + +P++RP +
Sbjct: 240 LVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-28
Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 11/247 (4%)
Query: 102 GAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +GEV+ + T +A KT + + +++ F+ E + ++ HPNIV+ +GV
Sbjct: 6 GNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK--FLSEARILKQYDHPNIVKLIGVCTQ 63
Query: 161 SERLIFLTEYLRNGSLHDIL-KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ + + E + G L KKK +L V +ALD A GM YL IHRDL
Sbjct: 64 RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLA 120
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG-GTGSYRYMAPEVYRRESYGKSVDV 278
N L E LK++DFG+S+ QE D Y +G ++ APE Y DV
Sbjct: 121 ARNCLVGENNVLKISDFGMSR--QEDDGI-YSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 279 FSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDR 338
+S+ +++ E F G Q A + + R + P+ + +++ CW P+
Sbjct: 178 WSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPEN 237
Query: 339 RPTFEEI 345
RP F E+
Sbjct: 238 RPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 6e-28
Identities = 82/256 (32%), Positives = 127/256 (49%), Gaps = 21/256 (8%)
Query: 102 GAYGEVYLVKWRGT-EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +GEV++ W GT ++A KT++ +F++E + +KLRH +V V+
Sbjct: 17 GCFGEVWMGTWNGTTKVAIKTLKPGTMMP----EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 161 SERLIFLTEYLRNGSLHDILKK-KGK-LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
E + +TE++ GSL D LK+ GK L P V A IA GM Y+ IHRDL
Sbjct: 73 -EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDL 128
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
+N+L + K+ DFGL+++ E + Y+ + G ++ APE + DV
Sbjct: 129 RAANILVGDNLVCKIADFGLARLI-EDNEYTARQ-GAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 279 FSFALIVHEMFQGG----PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
+SF +++ E+ G P ++ +R Y P PE + L++ CW K
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMPCPQGC---PESLHELMKLCWKK 242
Query: 335 NPDRRPTFEEIIFRLE 350
+PD RPTFE I LE
Sbjct: 243 DPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 81/252 (32%), Positives = 127/252 (50%), Gaps = 32/252 (12%)
Query: 102 GAYGEVYLVKW-----RGTEIAAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G++G+V+LV+ G A K ++ +++ RVR E + ++ HP IV+
Sbjct: 7 GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT--KMERDILAEVNHPFIVKLH 64
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ +L + ++LR G L L K+ Y ++A +++LH II+
Sbjct: 65 YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIY 121
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSK--IAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG 273
RDL P N+L DE GH+K+TDFGLSK I EK +YS+ G+ YMAPEV R +
Sbjct: 122 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-----CGTVEYMAPEVVNRRGHT 176
Query: 274 KSVDVFSFALIVHEM------FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKAL 327
+S D +SF +++ EM FQG +R +T + + P L PE ++L
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQG--KDRKETMTMILKAKL---GMPQF--LSPEA-QSL 228
Query: 328 LRECWHKNPDRR 339
LR + +NP R
Sbjct: 229 LRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 84/251 (33%), Positives = 128/251 (50%), Gaps = 25/251 (9%)
Query: 102 GAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +GEV++ W G T++A KT++ S SF++E + +KLRH +VQ V+
Sbjct: 17 GQFGEVWMGTWNGNTKVAVKTLKPGTMSP----ESFLEEAQIMKKLRHDKLVQLYAVV-- 70
Query: 161 SERLIFL-TEYLRNGSLHDILKK-KGK-LDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
SE I++ TEY+ GSL D LK +G+ L P V A +A GM Y+ IHRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVD 277
L +N+L + K+ DFGL+++ E + Y+ + G ++ APE + D
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI-EDNEYTARQ-GAKFPIKWTAPEAALYGRFTIKSD 185
Query: 278 VFSFALIVHEMFQGG----PS-NRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332
V+SF +++ E+ G P N + QV R Y P P + L+ +CW
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNNREVLEQV--ERGYRMPCPQDC---PISLHELMLQCW 240
Query: 333 HKNPDRRPTFE 343
K+P+ RPTFE
Sbjct: 241 KKDPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 75/261 (28%), Positives = 122/261 (46%), Gaps = 15/261 (5%)
Query: 99 IDPGAYGEVY-----LVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQ 153
I G +GEV L R +A KT++S + R F+ E + + HPNI+
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNIIH 69
Query: 154 FLGVLKHSERLIFLTEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHA 212
GV+ S ++ +TE++ NG+L L++ G+ V IA GM YL
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MN 126
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS---YSYKMTGGTGSYRYMAPEVYRR 269
+HRDL N+L + KV+DFGLS+ ++ S Y+ + GG R+ APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSL-GGKIPIRWTAPEAIAY 185
Query: 270 ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329
+ + DV+S+ +++ E+ G D + Q +D R P + L+
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLML 245
Query: 330 ECWHKNPDRRPTFEEIIFRLE 350
+CW K+ + RP F +I+ L+
Sbjct: 246 DCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-27
Identities = 86/291 (29%), Positives = 127/291 (43%), Gaps = 62/291 (21%)
Query: 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR---HPNIVQ 153
I GAYG VY + G +A K +R ++ + S ++E+ L ++L HPNIV+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG-IPLSTLREIALLKQLESFEHPNIVR 65
Query: 154 FLGVL--KHSER-----LIF------LTEYLRNGSLHDILKKKGKLDPPTAVAYALDIAR 200
L V ++R L+F L YL K G L P T + R
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP------KPG-LPPETIKDLMRQLLR 118
Query: 201 GMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM--TGGTGS 258
G+++LH HR I+HRDL P N+L G +K+ DFGL++I YS++M T +
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI------YSFEMALTSVVVT 169
Query: 259 YRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADR------RAYEDS 312
Y APEV + SY VD++S I E+F+ P R + D+ E+
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 313 RPALSSL--------YPEPIKA-----------LLRECWHKNPDRRPTFEE 344
P SL P K+ LL++ NP +R + E
Sbjct: 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 4e-27
Identities = 75/252 (29%), Positives = 113/252 (44%), Gaps = 23/252 (9%)
Query: 117 IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176
+A KT++ +NP+ F +E L +L HPNIV LGV+ + + L EYL G L
Sbjct: 37 VAIKTLKD--INNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94
Query: 177 HDIL-----------------KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
H+ L K LD + A+ IA GM YL H +H+DL
Sbjct: 95 HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLA 151
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
N+L E H+K++D GLS+ D Y + R+M PE + D++
Sbjct: 152 ARNILIGEQLHVKISDLGLSREIYSADYYRVQ-PKSLLPIRWMPPEAIMYGKFSSDSDIW 210
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRR 339
SF +++ E+F G + Q + S P + +L+ ECW + P RR
Sbjct: 211 SFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRR 270
Query: 340 PTFEEIIFRLEA 351
P F++I RL +
Sbjct: 271 PRFKDIHTRLRS 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-27
Identities = 70/203 (34%), Positives = 105/203 (51%), Gaps = 20/203 (9%)
Query: 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASN--PRVRNSFMKELGLWQKLRHPNIVQF 154
+ G YG VY + + G +A K IR P + ++E+ L ++L+HPNIV+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPS---TALREISLLKELKHPNIVKL 63
Query: 155 LGVLKHSERLIFLT-EYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHA 212
L V+ H+ER ++L EY L L K+ G L P + + RG+ Y H HR
Sbjct: 64 LDVI-HTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--- 118
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQ-EKDSYSYKMTGGTGSYRYMAPEVYRRES 271
I+HRDL P N+L + G LK+ DFGL++ +Y++++ T YR APE+
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYR--APEILLGSK 174
Query: 272 -YGKSVDVFSFALIVHEMFQGGP 293
Y +VD++S I EM G P
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 69/222 (31%), Positives = 103/222 (46%), Gaps = 20/222 (9%)
Query: 147 RHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKK----------------GKLDPPT 190
+H NI+ LGV L + EY G+L + L+ + +L
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 191 AVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250
V+ A +ARGM YL R IHRDL NVL E +K+ DFGL++ + D Y
Sbjct: 136 LVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK- 191
Query: 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE 310
K + G ++MAPE Y DV+SF +++ E+F G S V+ + E
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE 251
Query: 311 DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
R S + L+RECWH P +RPTF++++ L+ +
Sbjct: 252 GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-27
Identities = 69/257 (26%), Positives = 119/257 (46%), Gaps = 24/257 (9%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
GA+G+VY + + T + A I S + + FM E+ + + +HPNIV +
Sbjct: 16 GAFGKVYKAQHKETGLFAAAKIIQIESEEELED-FMVEIDILSECKHPNIVGLYEAYFYE 74
Query: 162 ERLIFLTEYLRNGSLHDILKKKGK-LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTP 220
+L L E+ G+L I+ + + L P + +N+LH H+ +IHRDL
Sbjct: 75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKA 131
Query: 221 SNVLQDEAGHLKVTDFGLS----KIAQEKDSYSYKMTGGTGSYRYMAPEV-----YRRES 271
N+L G +K+ DFG+S Q++D++ G+ +MAPEV ++
Sbjct: 132 GNILLTLDGDVKLADFGVSAKNKSTLQKRDTF-------IGTPYWMAPEVVACETFKDNP 184
Query: 272 YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPAL--SSLYPEPIKALLR 329
Y D++S + + E+ Q P + ++V + + P L S + L+
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEP-PTLDQPSKWSSSFNDFLK 243
Query: 330 ECWHKNPDRRPTFEEII 346
C K+PD RPT E++
Sbjct: 244 SCLVKDPDDRPTAAELL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 7e-27
Identities = 86/253 (33%), Positives = 127/253 (50%), Gaps = 29/253 (11%)
Query: 102 GAYGEVYLVKWRGT-EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +GEV++ W GT +A KT++ S +F++E + +KLRH +VQ V+
Sbjct: 17 GCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 161 SERLIFLTEYLRNGSLHDILK-KKGK-LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
E + +TEY+ GSL D LK + GK L P V A IA GM Y+ +HRDL
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 128
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
+N+L E KV DFGL+++ E + Y+ + G ++ APE + DV
Sbjct: 129 RAANILVGENLVCKVADFGLARLI-EDNEYTARQ-GAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 279 FSFALIVHEMFQGG----PS--NRADTAVQVADR--RAYEDSRPALSSLYPEPIKALLRE 330
+SF +++ E+ G P NR +V D+ R Y R PE + L+ +
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNR-----EVLDQVERGY---RMPCPPECPESLHDLMCQ 238
Query: 331 CWHKNPDRRPTFE 343
CW K P+ RPTFE
Sbjct: 239 CWRKEPEERPTFE 251
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 79/271 (29%), Positives = 134/271 (49%), Gaps = 31/271 (11%)
Query: 99 IDPGAYGEVYLVKWRGTEI--AAKTIRSSIASNPRVRN-----SFMKELGLWQKLRHPNI 151
I G +G VY GT I + I ++ S R+ + F+KE + + HPN+
Sbjct: 3 IGKGHFGCVY----HGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 152 VQFLGVLKHSERL-IFLTEYLRNGSLHDILKKKGKLDPPTA---VAYALDIARGMNYLHH 207
+ LG+ SE + + Y+++G L + ++ + PT + + L +A+GM YL
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLAS 116
Query: 208 HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS-YKMTGGTGSYRYMAPEV 266
+ +HRDL N + DE+ +KV DFGL++ +K+ YS + TG ++MA E
Sbjct: 117 KK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 267 YRRESYGKSVDVFSFALIVHE-MFQGGPS----NRADTAVQVADRRAYEDSRPALSSLYP 321
+ + + DV+SF +++ E M +G P + D V + R R P
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR-----RLLQPEYCP 228
Query: 322 EPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
+P+ ++ CWH P+ RPTF E++ R+E I
Sbjct: 229 DPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 37/232 (15%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIRSS-IASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
GA+GEV+LV+ + T A K +R S + ++ + E + P IV+
Sbjct: 12 GAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADADSPWIVKLYYSF 70
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ E L + EY+ G L ++L +K TA Y ++ ++ +H IHRD+
Sbjct: 71 QDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDI 127
Query: 219 TPSNVLQDEAGHLKVTDFGLS-KIAQEKDSYSY--------KMTGGT------------- 256
P N+L D GH+K+ DFGL K+ + KD Y
Sbjct: 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRA 187
Query: 257 ----GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGP----SNRADTA 300
G+ Y+APEV R YG D +S +I++EM G P +T
Sbjct: 188 NSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 75/260 (28%), Positives = 118/260 (45%), Gaps = 32/260 (12%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG--V 157
GA G V + + T A KTI + NP ++ ++EL + + + P IV++ G +
Sbjct: 12 GAGGSVTKCRLKNTGMIFALKTI--TTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 158 LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIA----RGMNYLHHHRPHAI 213
+ S + EY GSL I KK K IA +G++YLH + I
Sbjct: 70 DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---I 126
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG 273
IHRD+ PSN+L G +K+ DFG+S + ++ TG+ YMAPE + + Y
Sbjct: 127 IHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF-----TGTSFYMAPERIQGKPYS 181
Query: 274 KSVDVFSFALIVHEMFQG------------GPSNRADTAVQVADRRAYEDSRPALSSLYP 321
+ DV+S L + E+ Q GP V + + ++ P +
Sbjct: 182 ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE--PGNGIKWS 239
Query: 322 EPIKALLRECWHKNPDRRPT 341
E K +++C K+P RRPT
Sbjct: 240 EEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 90 CKILEDRGGIDPGAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLR 147
KIL G I GA+G V+ K R T +A K + + N ++E+ Q +
Sbjct: 2 YKIL---GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQ 57
Query: 148 HPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGK-LDPPTAVAYALDIARGMNYLH 206
HP +V+ L V H + + EY+ L ++L+ + + L +Y + +G+ Y+H
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 207 HHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV 266
+ I+HRDL P+N+L G LK+ DFGL+++ E++ Y + + Y APE+
Sbjct: 117 ANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY--SHQVATRWYRAPEL 171
Query: 267 -YRRESYGKSVDVFSFALIVHEMFQGGP 293
Y Y VD+++ I E+ G P
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 76/271 (28%), Positives = 130/271 (47%), Gaps = 32/271 (11%)
Query: 99 IDPGAYGEVY---LVKWRGTEI--AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQ 153
I G +G+VY + +I A KT + ++P VR F++E + ++ HP+IV+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCK--NCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 154 FLGVLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
+GV+ + I + E G L L+ K LD + + Y+ ++ + YL R
Sbjct: 72 LIGVITENPVWIVM-ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--- 127
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRE 270
+HRD+ NVL +K+ DFGLS+ E +SY YK + G ++MAPE +RR
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESY-YKASKGKLPIKWMAPESINFRR- 184
Query: 271 SYGKSVDVFSFALIVHEM-------FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEP 323
+ + DV+ F + + E+ FQG +N ++ R + P
Sbjct: 185 -FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-------NGERLPMPPNCPPT 236
Query: 324 IKALLRECWHKNPDRRPTFEEIIFRLEAIQE 354
+ +L+ +CW +P +RP F E+ +L I +
Sbjct: 237 LYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-26
Identities = 72/264 (27%), Positives = 120/264 (45%), Gaps = 28/264 (10%)
Query: 102 GAYGEVYLVKWRGTE-------IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
G +GEV+L K +G E + K ++ + N +++ F +EL +++KL H N+V+
Sbjct: 16 GEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDEN--LQSEFRRELDMFRKLSHKNVVRL 73
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILK---------KKGKLDPPTAVAYALDIARGMNYL 205
LG+ + +E + EY G L L+ K L VA IA GM++L
Sbjct: 74 LGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL 133
Query: 206 HHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPE 265
+ R +HRDL N L +KV+ LSK + Y + R++APE
Sbjct: 134 SNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA--LIPLRWLAPE 188
Query: 266 VYRRESYGKSVDVFSFALIVHEMFQGGP---SNRADTAVQVADRRAYEDSRPALSSLYPE 322
+ + + DV+SF +++ E+F G +D +V +R + P
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQAGKLELPVPEGCPS 246
Query: 323 PIKALLRECWHKNPDRRPTFEEII 346
+ L+ CW NP RP+F E++
Sbjct: 247 RLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 76/253 (30%), Positives = 117/253 (46%), Gaps = 24/253 (9%)
Query: 99 IDPGAYGEVYLVKWRGT--EIAAKTI-RSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
I GAYG VYLV+ + T A K I + ++ +++ F+ E + +P +V
Sbjct: 9 ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVSMF 67
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ L + EY+ G +LK G L A Y + + YLH++ I+H
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVH 124
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIA------------QEKDSYSYKMTGGTGSYRYMA 263
RDL P N+L GH+K+TDFGLSKI EKD+ + G+ Y+A
Sbjct: 125 RDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIA 184
Query: 264 PEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT-----AVQVADRRAYEDSRPALSS 318
PEV R+ YGK VD ++ +I++E G DT ++D + + AL +
Sbjct: 185 PEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPA 244
Query: 319 LYPEPIKALLREC 331
+ I LLR+
Sbjct: 245 DAQDLISRLLRQN 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-26
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 11/203 (5%)
Query: 93 LEDRGGIDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN 150
E + G++G V + K +GT A K ++ + +E + +L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 151 IVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRP 210
IV + + R+ FL E++ G L L+K G+ A Y ++ YLH
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK-- 137
Query: 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE 270
II+RDL P N+L D GH+KVTDFG +K ++ ++ + G+ Y+APEV + +
Sbjct: 138 -DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---TFTL---CGTPEYLAPEVIQSK 190
Query: 271 SYGKSVDVFSFALIVHEMFQGGP 293
+GK+VD ++ ++++E G P
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-26
Identities = 73/246 (29%), Positives = 124/246 (50%), Gaps = 18/246 (7%)
Query: 102 GAYGEVYLVKW-----RGTEIAAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G YG+V+ V+ G A K ++ ++I N + E + + ++HP IV +
Sbjct: 7 GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLI 66
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ +L + EYL G L L+++G TA Y +I+ + +LH II+
Sbjct: 67 YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIY 123
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RDL P N+L D GH+K+TDFGL K + + + ++ G+ YMAPE+ R +GK+
Sbjct: 124 RDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF---CGTIEYMAPEILMRSGHGKA 180
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADR--RAYEDSRPALSSLYPEPIKALLRECWH 333
VD +S ++++M G P A+ + D+ + + P L+ PE + LL++
Sbjct: 181 VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLT---PEA-RDLLKKLLK 236
Query: 334 KNPDRR 339
+NP R
Sbjct: 237 RNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFL 155
I G++G+V L K + G+ A K ++ + +N M E L + L+HP +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ +E+L F+ +Y+ G L L+++ P A YA ++A + YLH II+
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIY 119
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RDL P N+L D GH+ +TDFGL K E + + G+ Y+APEV R+E Y ++
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF---CGTPEYLAPEVLRKEPYDRT 176
Query: 276 VDVFSFALIVHEMFQGGP 293
VD + +++EM G P
Sbjct: 177 VDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 99 IDPGAYGEVYLVKWRGTEI--AAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFL 155
I G++G+V L K + A K ++ + + M E L + ++HP +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ +++L F+ +Y+ G L L+++ P A YA +IA + YLH II+
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIY 119
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSK--IAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG 273
RDL P N+L D GH+ +TDFGL K I K + ++ G+ Y+APEV R++ Y
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF-----CGTPEYLAPEVLRKQPYD 174
Query: 274 KSVDVFSFALIVHEMFQGGP 293
++VD + +++EM G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 75/251 (29%), Positives = 122/251 (48%), Gaps = 15/251 (5%)
Query: 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFL 155
I G++G+V L K + G A K ++ I N + + M E L + ++HP +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ +E+L F+ +++ G L L+++ P A YA +IA + YLH I++
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVY 119
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RDL P N+L D GH+ +TDFGL K E + S T G+ Y+APEV R++ Y +
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED--SRPALSSLYPEPIKALLRECWH 333
VD + +++EM G P ++ D ++ RP S ++L E
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASL----TAWSILEELLE 232
Query: 334 KNPDRRPTFEE 344
K+ RR +E
Sbjct: 233 KDRQRRLGAKE 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 74/276 (26%), Positives = 123/276 (44%), Gaps = 41/276 (14%)
Query: 102 GAYGEVYLVKWRGT-------EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA+GEVY +RG ++A KT+ S + + + F+ E + K H NIV+
Sbjct: 17 GAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRL 74
Query: 155 LGV-LKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAY------ALDIARGMNYLH 206
+GV + R I L E + G L L++ + + + P+++ A D+A+G YL
Sbjct: 75 IGVSFERLPRFILL-ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 207 HHRPHAIIHRDLTPSNVLQDEAGH---LKVTDFGLSKIAQEKDSY--SYKMTGGTG--SY 259
+ IHRD+ N L G K+ DFG+++ D Y SY GG
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGGRAMLPI 185
Query: 260 RYMAPEVYRRESYGKSVDVFSFALIVHEMFQGG----PSNRADTAVQVADRRAYEDSRPA 315
++M PE + + DV+SF +++ E+F G P ++ D
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKG 245
Query: 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEA 351
P P+ ++ +CW P+ RP F I+ R++
Sbjct: 246 C----PGPVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 78/285 (27%), Positives = 128/285 (44%), Gaps = 55/285 (19%)
Query: 102 GAYGEVYLVKWRGTE-------IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA+G+V+L + E +A KT++ + ++ R F +E L +H NIV+F
Sbjct: 16 GAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQHENIVKF 73
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKG-------KLDPPTA-------VAYALDIAR 200
GV + I + EY+ +G L+ L+ G D P + A+ IA
Sbjct: 74 YGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIAS 133
Query: 201 GMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS---YKMTGGTG 257
GM YL +HRDL N L +K+ DFG+S +D Y+ Y++ G T
Sbjct: 134 GMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMS-----RDVYTTDYYRVGGHTM 185
Query: 258 -SYRYMAPE--VYRR---ESYGKSVDVFSFALIVHEMFQGGPS-----NRADTAVQVADR 306
R+M PE +YR+ ES DV+SF +++ E+F G + + +
Sbjct: 186 LPIRWMPPESIMYRKFTTES-----DVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240
Query: 307 RAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEA 351
R + R S +Y ++ CW ++P +R ++I RL+
Sbjct: 241 RLLQRPRTCPSEVY-----DIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 6e-25
Identities = 75/251 (29%), Positives = 118/251 (47%), Gaps = 10/251 (3%)
Query: 102 GAYGEVYLV--KWRGTEIAAKTIRSSIAS--NPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
GA+G VYL G E+A K ++ S + N+ E+ L + L H IVQ+ G
Sbjct: 13 GAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72
Query: 158 LKHSER--LIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
L+ L E++ GS+ D LK G L Y I G++YLH + I+H
Sbjct: 73 LRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH---SNMIVH 129
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RD+ +N+L+D G++K+ DFG SK Q M TG+ +M+PEV E YG+
Sbjct: 130 RDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRK 189
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335
D++S V EM P A+ + A + + P L + + L+ + +
Sbjct: 190 ADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFVE- 248
Query: 336 PDRRPTFEEII 346
RP+ +E++
Sbjct: 249 AKLRPSADELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-25
Identities = 68/258 (26%), Positives = 122/258 (47%), Gaps = 17/258 (6%)
Query: 102 GAYGEVYLVKW-RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +GEV++ + + T++A KT++ S +F+ E + + L+H +V+ V+
Sbjct: 17 GQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT- 71
Query: 161 SERLIFLTEYLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
E + +TE++ GSL D LK K P + ++ IA GM ++ IHRDL
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDL 128
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
+N+L + K+ DFGL+++ E + Y+ + G ++ APE S+ DV
Sbjct: 129 RAANILVSASLVCKIADFGLARVI-EDNEYTAR-EGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 279 FSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDR 338
+SF +++ E+ G + R R PE + ++ CW P+
Sbjct: 187 WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEE 246
Query: 339 RPTFEEIIFRLEAIQESF 356
RPTFE ++++ + F
Sbjct: 247 RPTFE----YIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-25
Identities = 78/285 (27%), Positives = 126/285 (44%), Gaps = 52/285 (18%)
Query: 102 GAYGEVYLVKWRGTE----------------IAAKTIRSSIASNPRVRNSFMKELGLWQK 145
G +GEV+L + G +A K +R+ + RN F+KE+ + +
Sbjct: 16 GQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKT--ARNDFLKEIKIMSR 73
Query: 146 LRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKK------GKLDPPTAVAY----- 194
L++PNI++ LGV + L +TEY+ NG L+ L ++ + +V+
Sbjct: 74 LKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLY 133
Query: 195 -ALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253
A+ IA GM YL +HRDL N L +K+ DFG+S+ D Y++
Sbjct: 134 MAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD--YYRIQ 188
Query: 254 G-GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMF----QGGPSNRADTAV------- 301
G R+MA E + + DV++F + + EMF + S +D V
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEF 248
Query: 302 -QVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345
+ R+ Y P L P P+ L+ CW ++ RPTF +I
Sbjct: 249 FRNQGRQIYLSQTP----LCPSPVFKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 68/263 (25%), Positives = 122/263 (46%), Gaps = 39/263 (14%)
Query: 102 GAYGEVYLVKWR---GTEIAAKTI--------RSSIASNPRVRN-----SFMKELGLWQK 145
GA+G VY V+ + +A K I + + + + + +KE +
Sbjct: 11 GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE-----Q 65
Query: 146 LRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDI---LKKKGKLDPPTAV-AYALDIARG 201
LRHPNIV++ ++RL + + + L + LK+K + + + +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 202 MNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRY 261
+ YLH + I+HRDLTP+N++ E + +TDFGL+K Q + K+T G+ Y
Sbjct: 126 LRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES----KLTSVVGTILY 179
Query: 262 MAPEVYRRESYGKSVDVFSFALIVHEMFQGGP----SNRADTAVQVADRRAYEDSRPALS 317
PE+ + E YG+ DV++F I+++M P +N A ++ + YE P
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV-YE---PLPE 235
Query: 318 SLYPEPIKALLRECWHKNPDRRP 340
+Y E + ++ C + + RP
Sbjct: 236 GMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 71/235 (30%), Positives = 105/235 (44%), Gaps = 31/235 (13%)
Query: 137 MKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTA----- 191
MK +G +H NI+ LG L L EY G+L + L+ + PP
Sbjct: 71 MKMIG-----KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRAR---RPPGMDYSFD 122
Query: 192 --------------VAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFG 237
V+ A +ARGM YL + IHRDL NVL E +K+ DFG
Sbjct: 123 TCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFG 179
Query: 238 LSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRA 297
L++ D Y K T G ++MAPE Y DV+SF +++ E+F G S
Sbjct: 180 LARDVHNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238
Query: 298 DTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
V+ + E R + + ++RECWH P +RPTF++++ L+ +
Sbjct: 239 GIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 66/252 (26%), Positives = 112/252 (44%), Gaps = 18/252 (7%)
Query: 102 GAYGEVYLVKWR---GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G+YG VY VK R A K + S R + E+ + + HPNI+ +
Sbjct: 11 GSYGSVYKVK-RLSDNQFYALKEVDLGSMSQKE-REDAVNEIRILASVNHPNIISYKEAF 68
Query: 159 KHSERLIFLTEYLRNGSLHDIL---KKKGKLDPPTAV-AYALDIARGMNYLHHHRPHAII 214
+L + EY G L + KKK KL P + + + RG+ LH + I+
Sbjct: 69 LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---IL 125
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
HRDL +N+L +K+ D G+SK+ ++ + + G+ YMAPEV++ Y
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-----IGTPHYMAPEVWKGRPYSY 180
Query: 275 SVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
D++S +++EM P A + Q + P + +Y + ++ +R
Sbjct: 181 KSDIWSLGCLLYEMATFAPPFEARSM-QDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQV 239
Query: 335 NPDRRPTFEEII 346
P RP ++I+
Sbjct: 240 KPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 62/197 (31%), Positives = 108/197 (54%), Gaps = 13/197 (6%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSSIA-SNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++G+V L + +GT+ A K ++ + + V + +++ L + + P + Q
Sbjct: 11 GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF 70
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ +RL F+ EY+ G L +++ GK P AV YA +I+ G+ +LH II+RDL
Sbjct: 71 QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDL 127
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT--GSYRYMAPEVYRRESYGKSV 276
NV+ D GH+K+ DFG+ K+ +T T G+ Y+APE+ + YGKSV
Sbjct: 128 KLDNVMLDSEGHIKIADFGMC-----KEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 277 DVFSFALIVHEMFQGGP 293
D +++ ++++EM G P
Sbjct: 183 DWWAYGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 70/250 (28%), Positives = 123/250 (49%), Gaps = 29/250 (11%)
Query: 102 GAYGEVYLVKWRGT-EIAAKTI--RSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++G+V L + +GT E+ A + + I + V + ++ L +HP +
Sbjct: 6 GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF 65
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ +RL F+ EY+ G L +++ K D P + YA ++ + +LH H +I+RDL
Sbjct: 66 QTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDL 122
Query: 219 TPSNVLQDEAGHLKVTDFGLSK--IAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
N+L D GH K+ DFG+ K I + ++ G+ Y+APE+ + YG SV
Sbjct: 123 KLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF-----CGTPDYIAPEILQELEYGPSV 177
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED-------SRPALSSLYPEPIKALLR 329
D ++ ++++EM G P AD + + ++D S+ A+S L KA +
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSIL-----KAFMT 232
Query: 330 ECWHKNPDRR 339
KNP++R
Sbjct: 233 ----KNPNKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 73/249 (29%), Positives = 121/249 (48%), Gaps = 10/249 (4%)
Query: 99 IDPGAYGEVYL-VKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
I G++GEVY + R E+ A I + + + +E+ + + P I ++ G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYITRYYGS 70
Query: 158 LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+L + EYL GS D+LK G L+ +I +G++YLH R IHRD
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERK---IHRD 126
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVD 277
+ +NVL E G +K+ DFG +A + K G+ +MAPEV ++ +Y D
Sbjct: 127 IKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183
Query: 278 VFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPD 337
++S + E+ +G P N ++V ++S P L Y +P K + C +K+P
Sbjct: 184 IWSLGITAIELAKGEPPNSDLHPMRVL-FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPR 242
Query: 338 RRPTFEEII 346
RPT +E++
Sbjct: 243 FRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 77/273 (28%), Positives = 115/273 (42%), Gaps = 26/273 (9%)
Query: 99 IDPGAYGEVYL-----VKWRGTE---IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN 150
+ GA+GEVY + G+ +A KT+R + + + F+KE L HPN
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK--GATDQEKKEFLKEAHLMSNFNHPN 60
Query: 151 IVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTA-------VAYALDIARGMN 203
IV+ LGV +E + E + G L L+ + LD+A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 204 YLHHHRPHAIIHRDLTPSNVLQDEAGH-----LKVTDFGLSKIAQEKDSYSYKMTGGTGS 258
YL IHRDL N L E G+ +K+ DFGL++ + D Y K G
Sbjct: 121 YLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR-KEGEGLLP 176
Query: 259 YRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSS 318
R+MAPE + DV+SF +++ E+ G Q + R
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPE 236
Query: 319 LYPEPIKALLRECWHKNPDRRPTFEEIIFRLEA 351
P+ I L+ CW ++P RPTF+ I L+
Sbjct: 237 NCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 32/276 (11%)
Query: 102 GAYGEVYLVKW------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G +G+V L ++ G ++A K+++ N KE+ + + L H NIV++
Sbjct: 15 GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHENIVKYK 72
Query: 156 GVLKHS--ERLIFLTEYLRNGSLHDIL-KKKGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
G+ + + E+L +GSL + L + K K++ + YA+ I +GM+YL +
Sbjct: 73 GICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--- 129
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSK-IAQEKDSYSYKMTGGTGSYRYMAPEVYRRES 271
+HRDL NVL + +K+ DFGL+K I +K+ Y+ K + + Y APE +
Sbjct: 130 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSK 188
Query: 272 YGKSVDVFSFALIVHEMFQG---------------GPSNRADTAVQVADRRAYEDSRPAL 316
+ + DV+SF + ++E+ GP++ T ++ R E R
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVLEEGKRLPR 247
Query: 317 SSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
PE + L+R+CW P +R TF+ +I EAI
Sbjct: 248 PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 68/253 (26%), Positives = 115/253 (45%), Gaps = 11/253 (4%)
Query: 102 GAYGEVYL-VKWRGTEIAAKTIR---SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
GAYG VY + +G IA K + S++ + + +E+ L + L+H NIVQ+LG
Sbjct: 11 GAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70
Query: 158 LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+ E++ GS+ IL + G L P Y I G+ YLH+ + ++HRD
Sbjct: 71 CLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRD 127
Query: 218 LTPSNVLQDEAGHLKVTDFGLSK---IAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
+ +NV+ G +K+ DFG ++ ++S + G+ +MAPEV YG+
Sbjct: 128 IKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGR 187
Query: 275 SVDVFSFALIVHEMFQGGPS-NRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333
D++S V EM G P D + A+ P L + + C
Sbjct: 188 KSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLT 247
Query: 334 KNPDRRPTFEEII 346
++ RP+ +++
Sbjct: 248 RDQHERPSALQLL 260
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 67/199 (33%), Positives = 105/199 (52%), Gaps = 17/199 (8%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKE---LGLWQKLRHPNIVQFLG 156
G++G+V L + +GT+ A K ++ + M E L L K P + Q
Sbjct: 11 GSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK--PPFLTQLHS 68
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ +RL F+ EY+ G L +++ GK P AV YA +IA G+ +LH II+R
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYR 125
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSK--IAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
DL NV+ D GH+K+ DFG+ K I K + ++ G+ Y+APE+ + YGK
Sbjct: 126 DLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF-----CGTPDYIAPEIIAYQPYGK 180
Query: 275 SVDVFSFALIVHEMFQGGP 293
SVD ++F ++++EM G P
Sbjct: 181 SVDWWAFGVLLYEMLAGQP 199
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-24
Identities = 66/261 (25%), Positives = 125/261 (47%), Gaps = 30/261 (11%)
Query: 102 GAYGEVYLVKWRGTE----IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
GA+GE L +R TE + K + + S + R + E+ + L+HPNI+ +
Sbjct: 11 GAFGEATL--YRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 158 LKHSERLIFLTEYLRNGSLHD-ILKKKGKL-DPPTAVAYALDIARGMNYLHHHRPHAIIH 215
L+ EY G+L+D I+++KG+L + + Y I ++Y+H I+H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILH 124
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RD+ N+ +AG +K+ DFG+SKI + S + + G+ YM+PE+ + Y
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV---VGTPYYMSPELCQGVKYNFK 181
Query: 276 VDVFSFALIVHEM------FQGGPSNRADTAVQ-VADRRAYEDSRPALSSLYPEPIKALL 328
D+++ +++E+ F +N + V+ V S Y + +L+
Sbjct: 182 SDIWALGCVLYELLTLKRTFDA--TNPLNLVVKIVQGNYTPVVSV------YSSELISLV 233
Query: 329 RECWHKNPDRRPTFEEIIFRL 349
++P++RPT +E++ +
Sbjct: 234 HSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 14/195 (7%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G+YG VY + G +A K + +KE+ + ++ P IV++ G
Sbjct: 14 GSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-----EIIKEISILKQCDSPYIVKYYGSYF 68
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGK-LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ L + EY GS+ DI+K K L A +G+ YLH ++ IHRD+
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDI 125
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
N+L +E G K+ DFG+S Q D+ + + T G+ +MAPEV + Y D+
Sbjct: 126 KAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYNNKADI 182
Query: 279 FSFALIVHEMFQGGP 293
+S + EM +G P
Sbjct: 183 WSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 10/200 (5%)
Query: 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
G I G YG VY + + G +A K I+ S + + ++E+ L ++L HPNI++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKL 63
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
L V +H L + E++ I ++ L +Y + +G+ + H H I+
Sbjct: 64 LDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---IL 120
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV-YRRESYG 273
HRDL P N+L + G LK+ DFGL++ S T + Y APE+ + Y
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSF---GSPVRPYTHYVVTRWYRAPELLLGDKGYS 177
Query: 274 KSVDVFSFALIVHEMFQGGP 293
VD++S I E+ P
Sbjct: 178 TPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 77/280 (27%), Positives = 126/280 (45%), Gaps = 38/280 (13%)
Query: 102 GAYGEVYLVKWRG---------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNI 151
G +G+V + + G T++A K ++S + + + + E+ + + + +H NI
Sbjct: 29 GCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNI 86
Query: 152 VQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTA-------------------V 192
+ LG L + EY G+L + L+ + PP V
Sbjct: 87 INLLGACTQDGPLYVIVEYASKGNLREYLRAR---RPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 193 AYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252
+ A +ARGM YL + IHRDL NVL E +K+ DFGL++ D Y K
Sbjct: 144 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK-KT 199
Query: 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS 312
T G ++MAPE Y DV+SF +++ E+F G S V+ + E
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 259
Query: 313 RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
R S + ++R+CWH P +RPTF++++ L+ I
Sbjct: 260 RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 99 IDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
+ G +G V+LV+ R +E A K + + E + +++ HP I++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
L L EY+ G L L+ G+ T + YA +I + YLH I++R
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYR 125
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
DL P N+L D+ GH+K+TDFG +K +++ ++ + G+ Y+APEV + + + K+V
Sbjct: 126 DLKPENILLDKEGHIKLTDFGFAKKLRDR---TWTL---CGTPEYLAPEVIQSKGHNKAV 179
Query: 277 DVFSFALIVHEMFQGGPSNRADT 299
D ++ ++++EM G P D
Sbjct: 180 DWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 6e-24
Identities = 76/288 (26%), Positives = 127/288 (44%), Gaps = 57/288 (19%)
Query: 102 GAYGEVYLVKWRGTE------------------IAAKTIRSSIASNPRVRNSFMKELGLW 143
G +GEV+L + G E +A K +R +N RN F+KE+ +
Sbjct: 16 GQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--ANKNARNDFLKEIKIM 73
Query: 144 QKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPP-----TAVAY---- 194
+L+ PNI++ L V S+ L +TEY+ NG L+ L + + ++Y
Sbjct: 74 SRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLI 133
Query: 195 --ALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252
A IA GM YL +HRDL N L + +K+ DFG+S+ D Y++
Sbjct: 134 FMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGD--YYRI 188
Query: 253 TG-GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED 311
G R+M+ E + + DV++F + + E+ + Q++D + E+
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT---LCKEQPYSQLSDEQVIEN 245
Query: 312 S--------------RPALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345
+ +PAL P+ + L+ CW +N RP+F+EI
Sbjct: 246 TGEFFRDQGRQVYLPKPALC---PDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 75/256 (29%), Positives = 112/256 (43%), Gaps = 25/256 (9%)
Query: 102 GAYGEVYLVKWRGT-EIAA-KTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G YG+V+L K + T EI A K ++ S+ + E + + +V+ L +
Sbjct: 12 GGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
E L EY+ G +L G L A Y ++ ++ LH IHRDL
Sbjct: 72 DDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLK 128
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
P N L D +GH+K+TDFGLSK +Y+ + GS YMAPEV R + Y +VD +
Sbjct: 129 PENFLIDASGHIKLTDFGLSK---GIVTYANSV---VGSPDYMAPEVLRGKGYDFTVDYW 182
Query: 280 SFALIVHEMFQGGPSNRADTAVQV----------ADRRAYEDSRPALSSLYPEPIKALLR 329
S +++E G P T + R Y+D R LS + I L+
Sbjct: 183 SLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLIN 242
Query: 330 ECWHKNPDRRPTFEEI 345
+ R + E+I
Sbjct: 243 D----PSRRFGSLEDI 254
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 7e-24
Identities = 75/267 (28%), Positives = 118/267 (44%), Gaps = 35/267 (13%)
Query: 102 GAYGEVYLVKWRGT-EIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLK 159
G YG+VY + + T ++ A I I +E + +K HPNI F G
Sbjct: 17 GTYGKVYKARHKKTGQLVAIKIMDIIEDE---EEEIKEEYNILRKYSNHPNIATFYGAFI 73
Query: 160 ------HSERLIFLTEYLRNGSLHDI---LKKKGKLDPPTAVAYAL-DIARGMNYLHHHR 209
+ ++L + E GS+ D+ L+KKGK +AY L + RG+ YLH ++
Sbjct: 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK 133
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--- 266
+IHRD+ N+L + +K+ DFG+S + DS + G+ +MAPEV
Sbjct: 134 ---VIHRDIKGQNILLTKNAEVKLVDFGVSA---QLDSTLGRRNTFIGTPYWMAPEVIAC 187
Query: 267 --YRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR---PALSS--L 319
SY DV+S + E+ G P R ++ R P L S
Sbjct: 188 DEQPDASYDARSDVWSLGITAIELADGKPP----LCDMHPMRALFKIPRNPPPTLKSPEN 243
Query: 320 YPEPIKALLRECWHKNPDRRPTFEEII 346
+ + + EC KN ++RP EE++
Sbjct: 244 WSKKFNDFISECLIKNYEQRPFMEELL 270
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 9e-24
Identities = 63/195 (32%), Positives = 105/195 (53%), Gaps = 9/195 (4%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSSIA-SNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++G+V L + +GT+ A K ++ + + V + +++ L + P + Q
Sbjct: 11 GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF 70
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ +RL F+ EY+ G L +++ G+ P AV YA +IA G+ +LH II+RDL
Sbjct: 71 QTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDL 127
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
NV+ D GH+K+ DFG+ K D + K GT Y +APE+ + YGKSVD
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDY--IAPEIIAYQPYGKSVDW 184
Query: 279 FSFALIVHEMFQGGP 293
++F ++++EM G
Sbjct: 185 WAFGVLLYEMLAGQA 199
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-23
Identities = 70/236 (29%), Positives = 104/236 (44%), Gaps = 33/236 (13%)
Query: 137 MKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYAL 196
MK +G +H NI+ LG L + EY G+L + L+ + P + Y+
Sbjct: 74 MKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR----RPPGMEYSY 124
Query: 197 DI--------------------ARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDF 236
DI ARGM YL + IHRDL NVL E +K+ DF
Sbjct: 125 DIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADF 181
Query: 237 GLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNR 296
GL++ D Y K T G ++MAPE Y DV+SF +++ E+F G S
Sbjct: 182 GLARDVNNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240
Query: 297 ADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
V+ + E R + + ++R+CWH P RPTF++++ L+ I
Sbjct: 241 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-23
Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 35/209 (16%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSF----MKELGLWQKLRHPNIVQFL 155
G YG+VY + + T +A K IR + F ++E+ L QKLRHPNIV+
Sbjct: 10 GTYGQVYKARNKKTGELVALKKIRME-----NEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 156 GVLKHSER----LIFLTEYLRNGSLHD----ILKKKGKLDPPTAVAYALDIARGMNYLHH 207
++ + ++F EY+ HD + + K Y + G+ YLH
Sbjct: 65 EIVTSKGKGSIYMVF--EYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 208 HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI--AQEKDSYSYKMTGGTGSYRYMAPE 265
+ I+HRD+ SN+L + G LK+ DFGL++ + Y+ ++ T YR PE
Sbjct: 119 NG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYR--PPE 171
Query: 266 VYRRE-SYGKSVDVFSFALIVHEMFQGGP 293
+ YG VD++S I+ E+F G P
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-23
Identities = 74/262 (28%), Positives = 131/262 (50%), Gaps = 34/262 (12%)
Query: 102 GAYGEVYLVKW--RGTEI----AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
GA+G VY W G ++ A K +R A++P+ + E + + +P++ + L
Sbjct: 18 GAFGTVYKGLWIPEGEKVKIPVAIKELRE--ATSPKANKEILDEAYVMASVDNPHVCRLL 75
Query: 156 GV-LKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
G+ L + +LI T+ + G L D +++ K + + + + IA+GMNYL R +
Sbjct: 76 GICLTSTVQLI--TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---L 130
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKI--AQEKDSYSYKMTGGTGSYRYMAPEVYRRES 271
+HRDL NVL H+K+TDFGL+K+ A EK+ Y GG ++MA E
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE---YHAEGGKVPIKWMALESILHRI 187
Query: 272 YGKSVDVFSFALIVHEM-------FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI 324
Y DV+S+ + V E+ + G P++ + ++ +R +P + ++ +
Sbjct: 188 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----PQPPICTI---DV 240
Query: 325 KALLRECWHKNPDRRPTFEEII 346
++ +CW + D RP F E+I
Sbjct: 241 YMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 6e-23
Identities = 63/196 (32%), Positives = 99/196 (50%), Gaps = 16/196 (8%)
Query: 102 GAYGEVYLVK--WRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV-L 158
GA+G V + G +A K I ++ + ++ +EL L + LRH NI+ + +
Sbjct: 21 GAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSDIFI 79
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
E + F+TE L LH +L + L+ + I RG+ Y+H ++HRDL
Sbjct: 80 SPLEDIYFVTE-LLGTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDL 134
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR-ESYGKSVD 277
PSN+L +E LK+ DFGL++I +D +MTG + Y APE+ + Y VD
Sbjct: 135 KPSNILINENCDLKICDFGLARI---QDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVD 188
Query: 278 VFSFALIVHEMFQGGP 293
++S I EM +G P
Sbjct: 189 IWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 7e-23
Identities = 86/284 (30%), Positives = 132/284 (46%), Gaps = 34/284 (11%)
Query: 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFL 155
I G +G+V + + G + A R ++ F EL + KL HPNI+ L
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKL--DPPTAVA--------------YALDIA 199
G +H L EY +G+L D L+K L DP A+A +A D+A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 200 RGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSY 259
RGM+YL + IHRDL N+L E K+ DFGLS+ QE K T G
Sbjct: 135 RGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR-GQE---VYVKKTMGRLPV 187
Query: 260 RYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADR--RAYEDSRPAL 316
R+MA E Y + DV+S+ +++ E+ GG T ++ ++ + Y +P
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLN 247
Query: 317 SSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKT 360
+ + L+R+CW + P RP+F +I+ L + E ++KT
Sbjct: 248 CD---DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE--ERKT 286
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 8e-23
Identities = 79/268 (29%), Positives = 123/268 (45%), Gaps = 32/268 (11%)
Query: 95 DRGGIDPGAYGEVYLVKWRGTE--IAAKTI--RSSIASNPRVRNSFMKELGLWQKLRHPN 150
+R + G YG VY + T+ IA K I R S P +E+ L L+H N
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-----LHEEIALHSYLKHRN 66
Query: 151 IVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKG---KLDPPTAVAYALDIARGMNYLHH 207
IVQ+LG + E + GSL +L+ K K + T + Y I G+ YLH
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 208 HRPHAIIHRDLTPSNVLQDE-AGHLKVTDFGLSK----IAQEKDSYSYKMTGGTGSYRYM 262
++ I+HRD+ NVL + +G +K++DFG SK I +++ TG+ +YM
Sbjct: 127 NQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF-------TGTLQYM 176
Query: 263 APEVYRR--ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRA--YEDSRPALSS 318
APEV + YG D++S + EM G P Q A + ++ S
Sbjct: 177 APEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES 236
Query: 319 LYPEPIKALLRECWHKNPDRRPTFEEII 346
L E K + C+ +PD+R + +++
Sbjct: 237 LSAEA-KNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 9e-23
Identities = 71/253 (28%), Positives = 116/253 (45%), Gaps = 34/253 (13%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSS-IASNPRVRNSFMKELGLWQ---KLRHPNIVQFL 155
G +G+V L +++ T A K ++ I + V S M E +++ RHP +V
Sbjct: 10 GHFGKVLLAEYKKTGELYAIKALKKGDIIARDEV-ESLMCEKRIFETANSERHPFLVNLF 68
Query: 156 GVLKHSERLIFLTEYLRNGSL--HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
+ + + F+ EY G L H P AV YA + G+ YLH ++ I
Sbjct: 69 ACFQTEDHVCFVMEYAAGGDLMMH---IHTDVFSEPRAVFYAACVVLGLQYLHENK---I 122
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT--GSYRYMAPEVYRRES 271
++RDL N+L D G +K+ DFGL K+ + T G+ ++APEV S
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLC-----KEGMGFGDRTSTFCGTPEFLAPEVLTETS 177
Query: 272 YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYP-----EPIKA 326
Y ++VD + ++++EM G D +V D ++ R YP E I +
Sbjct: 178 YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR------YPRFLSREAI-S 230
Query: 327 LLRECWHKNPDRR 339
++R +NP+RR
Sbjct: 231 IMRRLLRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-22
Identities = 67/249 (26%), Positives = 121/249 (48%), Gaps = 10/249 (4%)
Query: 99 IDPGAYGEVYL-VKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
I G++GEV+ + R ++ A I + + + +E+ + + P + ++ G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYVTKYYGS 70
Query: 158 LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+L + EYL GS D+L+ G LD +I +G++YLH + IHRD
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK---IHRD 126
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVD 277
+ +NVL E G +K+ DFG +A + K G+ +MAPEV ++ +Y D
Sbjct: 127 IKAANVLLSEHGEVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 278 VFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPD 337
++S + E+ +G P + ++V +++ P L Y +P+K + C +K P
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKVL-FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS 242
Query: 338 RRPTFEEII 346
RPT +E++
Sbjct: 243 FRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-22
Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 9/198 (4%)
Query: 99 IDPGAYGEVYLVKWRGTEI--AAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFL 155
I G++G+V L + + E A K ++ + M E L + ++HP +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ +++L F+ +Y+ G L L+++ P A YA +IA + YLH I++
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVY 119
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RDL P N+L D GH+ +TDFGL K E + + G+ Y+APEV ++ Y ++
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF---CGTPEYLAPEVLHKQPYDRT 176
Query: 276 VDVFSFALIVHEMFQGGP 293
VD + +++EM G P
Sbjct: 177 VDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-22
Identities = 76/279 (27%), Positives = 125/279 (44%), Gaps = 43/279 (15%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA+G+V+L + +A K ++ + + R F +E L L+H +IV+F
Sbjct: 16 GAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRF 72
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKK---------------GKLDPPTAVAYALDIA 199
GV L+ + EY+R+G L+ L+ G+L +A A IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 200 RGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS---YKMTGGT 256
GM YL +HRDL N L + +K+ DFG+S +D YS Y++ G T
Sbjct: 133 SGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMS-----RDIYSTDYYRVGGRT 184
Query: 257 G-SYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPS---NRADTAVQVADRRAYEDS 312
R+M PE + D++SF +++ E+F G ++T + E
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELE 244
Query: 313 RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEA 351
RP P + A+++ CW + P +R ++I RL+A
Sbjct: 245 RPRTC---PPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-22
Identities = 74/276 (26%), Positives = 117/276 (42%), Gaps = 30/276 (10%)
Query: 102 GAYGEVYLVKW------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G +G+V L + G +A KT++ + + + KE+ + + L H NIV++
Sbjct: 15 GHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIVKYK 72
Query: 156 GVLKHS--ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
G + L + EY+ GSL D L K KL+ + +A I GM YLH
Sbjct: 73 GCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---Y 128
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG 273
IHRDL NVL D +K+ DFGL+K E Y G + A E + +
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFS 188
Query: 274 KSVDVFSFALIVHEMFQG---------------GPSNRADTAVQVADRRAYEDSRPALSS 318
+ DV+SF + ++E+ GP T V++ + P +
Sbjct: 189 YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKN 248
Query: 319 LYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQE 354
P+ + L++ CW RPTF +I L+ +
Sbjct: 249 C-PQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-22
Identities = 60/193 (31%), Positives = 98/193 (50%), Gaps = 9/193 (4%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSSIA-SNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++G+V+L + +GT A K ++ + + V + +++ L HP +
Sbjct: 6 GSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF 65
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ E L F+ EYL G L ++ K D P A YA +I G+ +LH I++RDL
Sbjct: 66 QTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDL 122
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
N+L D GH+K+ DFG+ K D+ K G+ Y+APE+ + Y SVD
Sbjct: 123 KLDNILLDTDGHIKIADFGMCKENMLGDA---KTCTFCGTPDYIAPEILLGQKYNTSVDW 179
Query: 279 FSFALIVHEMFQG 291
+SF ++++EM G
Sbjct: 180 WSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 19/198 (9%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKE---LGL-WQKLRHPNIVQFL 155
G++G+V L + +GT A K ++ + M E L L W+ HP +
Sbjct: 6 GSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWE---HPFLTHLF 62
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ E L F+ EYL G L ++ G+ D A YA +I G+ +LH II+
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGIIY 119
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSK--IAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG 273
RDL NVL D+ GH+K+ DFG+ K + E + ++ G+ Y+APE+ + + Y
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF-----CGTPDYIAPEILKGQKYN 174
Query: 274 KSVDVFSFALIVHEMFQG 291
+SVD +SF ++++EM G
Sbjct: 175 ESVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-22
Identities = 75/296 (25%), Positives = 122/296 (41%), Gaps = 65/296 (21%)
Query: 102 GAYGEVYLV------------------KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLW 143
G +GEV+L K R +A K +R N RN F+KE+ +
Sbjct: 16 GQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKN--ARNDFLKEVKIL 73
Query: 144 QKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL------HDILKKKGKLDP--------- 188
+L+ PNI++ LGV + L +TEY+ NG L H + K+ +
Sbjct: 74 SRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLP 133
Query: 189 ----PTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQE 244
+ + AL IA GM YL +HRDL N L E +K+ DFG+S+
Sbjct: 134 AISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 245 KDSYSYKMTG-GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQV 303
D Y++ G R+MA E + + DV++F + + E+ + ++
Sbjct: 191 GD--YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM---LCKEQPYGEL 245
Query: 304 ADRRAYED--------------SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345
D + E+ RP P+ + L+ +CW ++ RP+F +I
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYLFRPPPC---PQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-22
Identities = 63/248 (25%), Positives = 116/248 (46%), Gaps = 11/248 (4%)
Query: 107 VYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIF 166
VY ++ + ++A K +++ + VR+ M+E + +L +P IV+ +GV + +E L+
Sbjct: 15 VYKMRKKQIDVAIKVLKNENEKS--VRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALML 71
Query: 167 LTEYLRNGSLHDILKKKGKLDPPTAVAYAL-DIARGMNYLHHHRPHAIIHRDLTPSNVLQ 225
+ E G L+ L K + V + ++ GM YL +HRDL NVL
Sbjct: 72 VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLL 128
Query: 226 DEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIV 285
+ K++DFGLSK DSY + G ++ APE + DV+S+ + +
Sbjct: 129 VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITM 188
Query: 286 HEMFQGGPSNRADTAVQVADRRAY--EDSRPALSSLYPEPIKALLRECWHKNPDRRPTFE 343
E F G + ++ + ++ + R + P + AL+++CW + RP F
Sbjct: 189 WEAFSYG--QKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFA 246
Query: 344 EIIFRLEA 351
++ R+
Sbjct: 247 KVEERMRT 254
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-22
Identities = 62/260 (23%), Positives = 111/260 (42%), Gaps = 15/260 (5%)
Query: 97 GGIDPGAYGEV---YLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQ 153
G + G +G V + + A I + ++P +++ ++E + Q+L +P IV+
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 154 FLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
+G+ + +E + + E G L+ L+K + ++ GM YL
Sbjct: 61 MIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---F 116
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG 273
+HRDL NVL + K++DFGLSK ++Y T G ++ APE +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 274 KSVDVFSFALIVHEMFQGGPSN----RADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329
DV+SF +++ E F G + + Q+ + + P + L++
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRC----PPEMYDLMK 232
Query: 330 ECWHKNPDRRPTFEEIIFRL 349
CW D RP F + RL
Sbjct: 233 LCWTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 6e-22
Identities = 64/205 (31%), Positives = 108/205 (52%), Gaps = 14/205 (6%)
Query: 94 EDRGGIDPGAYGEVYLVKWRGT-EIAAKTIRSSIAS--NPRVRNSFMKELGLWQKLRHPN 150
E+ G + G+YG V K + T +I A I+ + S + V+ M+E+ + ++LRH N
Sbjct: 4 ENLGLVGEGSYGMVMKCKHKETGQIVA--IKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 151 IVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRP 210
+V + V + +RL + E++ + L D+ K LD Y I RG+ + H H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN- 120
Query: 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSK-IAQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
IIHRD+ P N+L ++G +K+ DFG ++ +A + Y T + Y APE+
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY----TDYVATRWYRAPELLVG 174
Query: 270 E-SYGKSVDVFSFALIVHEMFQGGP 293
+ YG++VD+++ +V EM G P
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 64/197 (32%), Positives = 99/197 (50%), Gaps = 18/197 (9%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSS-IASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G +G+V LV+ + T A K ++ I + V ++ + E + Q RHP FL L
Sbjct: 6 GTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT-LTESRVLQNTRHP----FLTAL 60
Query: 159 KHS----ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
K+S +RL F+ EY G L L ++ A Y +I + YLH ++
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VV 117
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
+RDL N++ D+ GH+K+TDFGL K E S M G+ Y+APEV YG+
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 275 SVDVFSFALIVHEMFQG 291
+VD + ++++EM G
Sbjct: 175 AVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 6e-22
Identities = 71/274 (25%), Positives = 113/274 (41%), Gaps = 46/274 (16%)
Query: 99 IDPGAYGEVY--LVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I GA VY + ++A K I V + KE+ + HPN+V++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLE-KCQTSV-DELRKEVQAMSQCNHPNVVKYYT 66
Query: 157 VLKHSERLIFLTEYLRNGSLHDILK---KKGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
+ L + YL GSL DI+K +G LD ++ +G+ YLH +
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---Q 123
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSK-IAQEKDSYSYKMTGGTGSYRYMAPEVY-RRES 271
IHRD+ N+L E G +K+ DFG+S +A D G+ +MAPEV +
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 272 YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSL------------ 319
Y D++SF + TA+++A A P + L
Sbjct: 184 YDFKADIWSFGI---------------TAIELATGAAPYSKYPPMKVLMLTLQNDPPSLE 228
Query: 320 -------YPEPIKALLRECWHKNPDRRPTFEEII 346
Y + + ++ C K+P +RPT EE++
Sbjct: 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELL 262
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 7e-22
Identities = 68/246 (27%), Positives = 117/246 (47%), Gaps = 24/246 (9%)
Query: 116 EIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNG 174
++A K ++ + S+ R + M EL + L H NIV LG ++ +TEY G
Sbjct: 67 KVAVKMLKPTAHSSER--EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYG 124
Query: 175 SLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLK 232
L + L++K + L ++++ +A+GM +L IHRDL NVL +K
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVK 181
Query: 233 VTDFGLSKIAQEKDSYSYKMTGGTGSYR----YMAPEVYRRESYGKSVDVFSFALIVHEM 288
+ DFGL++ +Y K G+ R +MAPE Y DV+S+ +++ E+
Sbjct: 182 ICDFGLARDIMNDSNYVVK-----GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
Query: 289 FQGG----PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEE 344
F G P D+ + Y ++P + P I +++ CW +P +RPTF++
Sbjct: 237 FSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA---PAEIYDIMKTCWDADPLKRPTFKQ 293
Query: 345 IIFRLE 350
I+ +
Sbjct: 294 IVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 9e-22
Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 9/196 (4%)
Query: 99 IDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLW-QKLRHPNIVQFL 155
I G+Y +V LV+ + TE A K ++ + ++ + E ++ Q HP +V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ RL F+ EY+ G L ++++ KL A Y+ +I+ +NYLH II+
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIY 119
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RDL NVL D GH+K+TD+G+ K + G+ Y+APE+ R E YG S
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF---CGTPNYIAPEILRGEDYGFS 176
Query: 276 VDVFSFALIVHEMFQG 291
VD ++ +++ EM G
Sbjct: 177 VDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-21
Identities = 72/255 (28%), Positives = 129/255 (50%), Gaps = 21/255 (8%)
Query: 99 IDPGAYGEVYLVK--WRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I GA G V+ G E+A K I ++ P+ + + E+ + ++L++PNIV FL
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI--NLQKQPK-KELIINEILVMKELKNPNIVNFLD 83
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ L + EYL GSL D++ + +D A + + + +LH ++ +IHR
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQALEFLHANQ---VIHR 139
Query: 217 DLTPSNVLQDEAGHLKVTDFGL-SKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
D+ NVL G +K+TDFG ++I E+ K + G+ +MAPEV R++YG
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE----C 331
VD++S ++ EM +G P + ++ A + P L + PE + + R+ C
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN--PEKLSPIFRDFLNRC 252
Query: 332 WHKNPDRRPTFEEII 346
+ ++R + +E++
Sbjct: 253 LEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-21
Identities = 59/246 (23%), Positives = 112/246 (45%), Gaps = 12/246 (4%)
Query: 99 IDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G++G V+ V K A K I S N R R + E + KL I+++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLS-KMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYAL--DIARGMNYLHHHRPHAII 214
+L + EY NG LH +LK + P + I G+ +LH + I+
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---IL 123
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
HRD+ N+ D ++K+ D G++K+ + +++ + G+ Y++PE+ + Y +
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI---VGTPYYLSPELCEDKPYNE 180
Query: 275 SVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
DV++ ++++E G A+ + + P +S +Y + + L+ +C K
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGALI-LKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239
Query: 335 NPDRRP 340
+ +RP
Sbjct: 240 DYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 1e-21
Identities = 76/279 (27%), Positives = 121/279 (43%), Gaps = 45/279 (16%)
Query: 104 YGEVYLVKWRGTE-------IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
+G+VY GT +A KT++ +R F E + +L+HPNIV LG
Sbjct: 18 FGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP--LREEFKHEAMMRSRLQHPNIVCLLG 75
Query: 157 VLKHSERLIFLTEYLRNGSLHDIL----------------KKKGKLDPPTAVAYALDIAR 200
V+ + L + Y + LH+ L K L+P V IA
Sbjct: 76 VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAA 135
Query: 201 GMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYR 260
GM +L H ++H+DL NVL + ++K++D GL + D Y M R
Sbjct: 136 GMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL-MGNSLLPIR 191
Query: 261 YMAPEVYRRESYGKSVDVFSFALIVHEMFQ------GGPSNRADTAVQVADRRAY--EDS 312
+M+PE + D++S+ +++ E+F G SN+ D + +R+ D
Sbjct: 192 WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-DVIEMIRNRQVLPCPDD 250
Query: 313 RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEA 351
PA + L+ ECW++ P RRP F++I RL
Sbjct: 251 CPAW-------VYTLMLECWNEFPSRRPRFKDIHSRLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 65/201 (32%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 93 LEDRGGIDPGAYGEVYLVKWRGTEI--AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN 150
E G + G G V V R + + A K I I P +RN ++EL + + P
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPY 60
Query: 151 IVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRP 210
IV F G + E++ GSL +LKK G++ ++ + RG+ YL
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK-- 118
Query: 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE 270
H I+HRD+ PSN+L + G +K+ DFG+S Q DS + GT S YM+PE +
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV-GTRS--YMSPERLQGT 173
Query: 271 SYGKSVDVFSFALIVHEMFQG 291
Y D++S L + EM G
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-21
Identities = 70/256 (27%), Positives = 124/256 (48%), Gaps = 24/256 (9%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIA-------SNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA+G VY W +T++ +A + P+ FM E + + HP++V+
Sbjct: 18 GAFGTVYKGIWVPE---GETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 155 LGVLKHSERLIFLTEYLRNGSLHD-ILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
LGV S + +T+ + +G L D + + K + + + + IA+GM YL R +
Sbjct: 75 LGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---L 130
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG 273
+HRDL NVL H+K+TDFGL+++ E D Y GG ++MA E +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 274 KSVDVFSFALIVHEM--FQGGPSNRADTAVQVAD--RRAYEDSRPALSSLYPEPIKALLR 329
DV+S+ + + E+ F G P + T ++ D + +P + ++ + ++
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDGIPTR-EIPDLLEKGERLPQPPICTI---DVYMVMV 245
Query: 330 ECWHKNPDRRPTFEEI 345
+CW + D RP F+E+
Sbjct: 246 KCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 70/248 (28%), Positives = 117/248 (47%), Gaps = 13/248 (5%)
Query: 102 GAYGEVYL--VKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++GEVY K +A K I A + +E+ + R P I ++ G
Sbjct: 12 GSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI--EDIQQEIQFLSQCRSPYITKYYGSFL 69
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+L + EY GS D+LK GKLD ++ G+ YLH IHRD+
Sbjct: 70 KGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEGK---IHRDIK 125
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
+N+L E G +K+ DFG+S Q + S K G+ +MAPEV ++ Y + D++
Sbjct: 126 AANILLSEEGDVKLADFGVS--GQLTSTMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIW 182
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALS-SLYPEPIKALLRECWHKNPDR 338
S + E+ +G P +D +++ P+L + + +P K + C +K+P
Sbjct: 183 SLGITAIELAKGEPPL-SDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKE 241
Query: 339 RPTFEEII 346
RP+ +E++
Sbjct: 242 RPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-21
Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 14/198 (7%)
Query: 99 IDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I GA G VY G E+A K + ++ P+ + + E+ + ++ +HPNIV +L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM--NLQQQPK-KELIINEILVMRENKHPNIVNYLD 83
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ L + EYL GSL D++ + +D A + + + +LH ++ +IHR
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHR 139
Query: 217 DLTPSNVLQDEAGHLKVTDFGL-SKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
D+ N+L G +K+TDFG ++I E+ K + G+ +MAPEV R++YG
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 276 VDVFSFALIVHEMFQGGP 293
VD++S ++ EM +G P
Sbjct: 196 VDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 3e-21
Identities = 72/255 (28%), Positives = 131/255 (51%), Gaps = 21/255 (8%)
Query: 99 IDPGAYGEVY--LVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I GA G VY + G E+A K + ++ P+ + + E+ + ++ ++PNIV +L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM--NLQQQPK-KELIINEILVMRENKNPNIVNYLD 83
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ L + EYL GSL D++ + +D A + + +++LH ++ +IHR
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQ---VIHR 139
Query: 217 DLTPSNVLQDEAGHLKVTDFGL-SKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
D+ N+L G +K+TDFG ++I E+ K + G+ +MAPEV R++YG
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE----C 331
VD++S ++ EM +G P + ++ A + P L + PE + A+ R+ C
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPELQN--PERLSAVFRDFLNRC 252
Query: 332 WHKNPDRRPTFEEII 346
+ DRR + +E++
Sbjct: 253 LEMDVDRRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-21
Identities = 84/280 (30%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 99 IDPGAYGEVY--LVKWRGTEI-AAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQF 154
I G +G+V ++K G ++ AA + AS R+ F EL + KL HPNI+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD-FAGELEVLCKLGHHPNIINL 68
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVA----------------YALDI 198
LG ++ L EY G+L D L+K L+ A A +A D+
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 199 ARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS 258
A GM YL + IHRDL NVL E K+ DFGLS+ + K T G
Sbjct: 129 ATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGRLP 181
Query: 259 YRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADR--RAYEDSRPA 315
R+MA E Y DV+SF +++ E+ GG T ++ ++ + Y +P
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPR 241
Query: 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
+ + L+R+CW P RP F +I +L + E+
Sbjct: 242 NCD---DEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-21
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 25/201 (12%)
Query: 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G YG VY + + G +A K IR + V ++ ++E+ L ++L HPNIV+ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG-VPSTAIREISLLKELNHPNIVKLLD 66
Query: 157 VLKHSERLIFLT-EYLRNGSLHDILKKKGKLDPPTAVA------YALDIARGMNYLHHHR 209
V+ H+E ++L E+L H LKK P + + Y + +G+ + H HR
Sbjct: 67 VI-HTENKLYLVFEFL-----HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK-IAQEKDSYSYKMTGGTGSYRYMAPEVYR 268
++HRDL P N+L + G +K+ DFGL++ +Y++++ + Y APE+
Sbjct: 121 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEILL 173
Query: 269 -RESYGKSVDVFSFALIVHEM 288
+ Y +VD++S I EM
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-21
Identities = 70/259 (27%), Positives = 117/259 (45%), Gaps = 30/259 (11%)
Query: 102 GAYGEVYLVKWRGT-EIAA-KTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G YG+VY + T E+ A K I+ + +E+ + ++ RHPNIV + G
Sbjct: 14 GTYGDVYKARDIATGELVAIKVIKLEPGDD---FEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAY----ALDIARGMNYLHHHRPHAIIH 215
++L + EY GSL DI + +AY L +G+ YLH IH
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL---KGLAYLHETG---KIH 124
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVY---RRESY 272
RD+ +N+L E G +K+ DFG+S AQ + + K G+ +MAPEV R+ Y
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVS--AQLTATIA-KRKSFIGTPYWMAPEVAAVERKGGY 181
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADT----AVQVADRRAYEDSRPALS--SLYPEPIKA 326
D+++ + E+ + P D A+ + + + P L +
Sbjct: 182 DGKCDIWALGITAIELAELQPP-MFDLHPMRALFLISKSNFPP--PKLKDKEKWSPVFHD 238
Query: 327 LLRECWHKNPDRRPTFEEI 345
+++C K+P +RPT ++
Sbjct: 239 FIKKCLTKDPKKRPTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-21
Identities = 82/285 (28%), Positives = 135/285 (47%), Gaps = 44/285 (15%)
Query: 102 GAYGEVY------LVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
G++G VY ++K T +A KT+ S ++ R R F+ E + + ++V+
Sbjct: 17 GSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHVVRL 74
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILK--------KKGKLDPPT---AVAYALDIARGMN 203
LGV+ + + + E + +G L L+ G+ PPT + A +IA GM
Sbjct: 75 LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP-PPTLQEMIQMAAEIADGMA 133
Query: 204 YLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTG--SYRY 261
YL+ + +HRDL N + +K+ DFG+++ E D Y GG G R+
Sbjct: 134 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR---KGGKGLLPVRW 187
Query: 262 MAPEVYRRESYGKSVDVFSFALIVHEM-------FQGGPSNRADTAVQVADRRAYEDSRP 314
MAPE + + S D++SF +++ E+ +QG SN + ++ Y D +P
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSN--EQVLKFVMDGGYLD-QP 243
Query: 315 ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRL-EAIQESFQK 358
PE + L+R CW NP RPTF EI+ L + + SF +
Sbjct: 244 DNC---PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 5e-21
Identities = 69/256 (26%), Positives = 117/256 (45%), Gaps = 27/256 (10%)
Query: 114 GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE---RL---IFL 167
++A K +++ I S+ + F++E ++ HPN+++ +GV S RL + +
Sbjct: 27 FQKVAVKMLKADIFSSSDIE-EFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85
Query: 168 TEYLRNGSLHDILKKKGKLDPP------TAVAYALDIARGMNYLHHHRPHAIIHRDLTPS 221
++++G LH L + P T V + +DIA GM YL IHRDL
Sbjct: 86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAAR 142
Query: 222 NVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS---YRYMAPEVYRRESYGKSVDV 278
N + +E + V DFGLSK D Y G S +++A E Y DV
Sbjct: 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQ----GCASKLPVKWLALESLADNVYTTHSDV 198
Query: 279 FSFALIVHEMFQGGPSNRADTAVQVADRRAY--EDSRPALSSLYPEPIKALLRECWHKNP 336
++F + + E+ G + A V+ ++ Y + +R E + L+ +CW P
Sbjct: 199 WAFGVTMWEIMTRGQTPYA--GVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEP 256
Query: 337 DRRPTFEEIIFRLEAI 352
RP+F+ + +LE I
Sbjct: 257 KCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 72/295 (24%)
Query: 102 GAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSF---------MKELGLWQKLRHPN 150
GAYG V K G ++A K ++ N F ++E+ L + LRH N
Sbjct: 11 GAYGVVCSAVDKRTGRKVAIK----------KISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 151 IVQFLGVLKHSERLIF-----LTEYLRNGSLHDILKKKGKLDPPTAVAYAL-DIARGMNY 204
I+ L +L+ F +TE + LH ++K L + Y L I RG+ Y
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTD-DHIQYFLYQILRGLKY 118
Query: 205 LHHHRPHA-IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG--TGSYRY 261
LH A +IHRDL PSN+L + LK+ DFGL++ + +T T YR
Sbjct: 119 LHS----ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR- 173
Query: 262 MAPEV---YRRESYGKSVDVFSFALIVHEMF-------------Q--------GGPSNRA 297
APE+ R Y K++D++S I E+ Q G PS
Sbjct: 174 -APELLLSSSR--YTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230
Query: 298 DTAVQVADRRAYEDSRP-----ALSSLYPE-PIKA--LLRECWHKNPDRRPTFEE 344
+ R Y S P LS L+P +A LL + +P +R T +E
Sbjct: 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE 285
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-20
Identities = 72/269 (26%), Positives = 116/269 (43%), Gaps = 30/269 (11%)
Query: 92 ILEDRGGIDPGAYGEVYLVK----WRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR 147
IL+ R G G++G VYLVK + NP +E L KL
Sbjct: 3 ILQQRLG--KGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 148 HPNIVQFLGVLKHSERLIFLTEYLRNGSLHDIL---KKKGKLDP-PTAVAYALDIARGMN 203
HP IV+F + +TEY L L K GK + + + G++
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 204 YLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMA 263
Y+H R I+HRDL N+ + LK+ DFG+S++ + T TG+ YM+
Sbjct: 121 YMHQRR---ILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLA---TTFTGTPYYMS 173
Query: 264 PEVYRRESYGKSVDVFSFALIVHEM------FQGGPSNRADTAVQVADRRAYEDSRPALS 317
PE + + Y D++S I++EM F+G N +++ E P+L
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG--QNFLSVVLRIV-----EGPTPSLP 226
Query: 318 SLYPEPIKALLRECWHKNPDRRPTFEEII 346
Y + ++++ +K+P RP+ EI+
Sbjct: 227 ETYSRQLNSIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 67/253 (26%), Positives = 118/253 (46%), Gaps = 24/253 (9%)
Query: 102 GAYGEVYLVKWR-----GTEIAAKTIR-SSIASNPRVRNSFMKELGLWQKLRH-PNIVQF 154
GAYG+V+LV+ G A K ++ ++I + E + + +R P +V
Sbjct: 11 GAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTL 70
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ +L + +Y+ G L L ++ Y +I +++LH II
Sbjct: 71 HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GII 127
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKI--AQEKD-SYSYKMTGGTGSYRYMAPEVYRRES 271
+RD+ N+L D GH+ +TDFGLSK A+E++ +YS+ G+ YMAPEV R S
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSF-----CGTIEYMAPEVIRGGS 182
Query: 272 --YGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVAD--RRAYEDSRPALSSLYPEPIKA 326
+ K+VD +S ++ E+ G P ++ RR + P ++ E +
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE-ARD 241
Query: 327 LLRECWHKNPDRR 339
+++ K+P +R
Sbjct: 242 FIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 2e-20
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVL 158
G +G VYL + + G +A K ++ S N ++E+ +KL HPNIV+ V
Sbjct: 10 GTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKLKEVF 67
Query: 159 KHSERLIFLTEYLRNGSLHDILK--KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ ++ L F+ EY+ G+L+ ++K K + I +G+ ++H H HR
Sbjct: 68 RENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHR 123
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY-SYKMTGGTGSYR-YMAPEVY-RRESYG 273
DL P N+L +K+ DFGL++ + + Y Y T R Y APE+ R SY
Sbjct: 124 DLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST------RWYRAPEILLRSTSYS 177
Query: 274 KSVDVFSFALIVHEMFQGGP 293
VD+++ I+ E++ P
Sbjct: 178 SPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 76/271 (28%), Positives = 123/271 (45%), Gaps = 19/271 (7%)
Query: 91 KILEDRGGIDPGAYGEVYLVK-WRGTEIAA--KTIRSSIASNPRVRNSFMKELGLWQKLR 147
K+ D I G++G VY + R E+ A K S SN + ++ +KE+ Q+++
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVKFLQRIK 83
Query: 148 HPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILK-KKGKLDPPTAVAYALDIARGMNYLH 206
HPN +++ G + EY GS D+L+ K L A +G+ YLH
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 207 HHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV 266
H +IHRD+ N+L E G +K+ DFG + IA +S+ G+ +MAPEV
Sbjct: 143 ---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF-------VGTPYWMAPEV 192
Query: 267 ---YRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEP 323
Y VDV+S + E+ + P A+ A +S S+ + +
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY 252
Query: 324 IKALLRECWHKNPDRRPTFEEIIFRLEAIQE 354
+ + C K P RPT EE++ + ++E
Sbjct: 253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 3e-20
Identities = 60/237 (25%), Positives = 112/237 (47%), Gaps = 20/237 (8%)
Query: 133 RNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAV 192
R E+ + + +HPNIV+ + L + E+L G+L DI+ +++
Sbjct: 60 RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIA 118
Query: 193 AYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGL-SKIAQEKDSYSYK 251
L + + +++LH +IHRD+ ++L G +K++DFG +++++E +
Sbjct: 119 TVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP----R 171
Query: 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED 311
G+ +MAPEV R YG VD++S ++V EM G P + +Q A +R ++
Sbjct: 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-AMKRIRDN 230
Query: 312 SRPALSSLY---PEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKTVPSCC 365
P L +L+ P +++ L ++P +R T E+ + F K P
Sbjct: 231 LPPKLKNLHKVSPR-LRSFLDRMLVRDPAQRATAAEL------LNHPFLAKAGPPSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-20
Identities = 42/95 (44%), Positives = 52/95 (54%)
Query: 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLE 62
D +G L +S G V LE G + N D D RT LHLA+ G EIV LLLE
Sbjct: 2 ARDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLE 61
Query: 63 KGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
KGADVN+ D+ G TPL A G++ + K+L G
Sbjct: 62 KGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHG 96
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 4e-20
Identities = 61/193 (31%), Positives = 95/193 (49%), Gaps = 15/193 (7%)
Query: 102 GAYGEVYL--VKWRGTEIAAKTIRSSIASNPR--VRNSFMKELGLWQKLRHPNIVQFLGV 157
G Y VY K G +A K I+ + + + ++E+ L Q+L+HPNI+ L V
Sbjct: 11 GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDV 70
Query: 158 LKHSERLIFLTEYLRNGSLHDILK-KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
H + + E++ L ++K K L P +Y L RG+ YLH + I+HR
Sbjct: 71 FGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHR 126
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKI-AQEKDSYSYKMTGGTGSYRYMAPEV-YRRESYGK 274
DL P+N+L G LK+ DFGL++ ++++ T YR APE+ + YG
Sbjct: 127 DLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYR--APELLFGARHYGV 182
Query: 275 SVDVFSFALIVHE 287
VD++S I E
Sbjct: 183 GVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-20
Identities = 70/264 (26%), Positives = 119/264 (45%), Gaps = 27/264 (10%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
G++G VY +G T +A KT+ + ++ R R F+ E + ++ ++V+
Sbjct: 17 GSFGMVYEGIAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRL 74
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKK-------KGKLDPPT---AVAYALDIARGMNY 204
LGV+ + + + E + G L L+ PP+ + A +IA GM Y
Sbjct: 75 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAY 134
Query: 205 LHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTG--SYRYM 262
L+ ++ +HRDL N + E +K+ DFG+++ E D Y GG G R+M
Sbjct: 135 LNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR---KGGKGLLPVRWM 188
Query: 263 APEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPE 322
+PE + + DV+SF +++ E+ + + R E P+
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPD 248
Query: 323 PIKALLRECWHKNPDRRPTFEEII 346
+ L+R CW NP RP+F EII
Sbjct: 249 MLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 5e-20
Identities = 63/264 (23%), Positives = 121/264 (45%), Gaps = 42/264 (15%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRV---RNSFMKELGLWQKLRHPNIVQFLGVL 158
GA+G V+L + + + I I R + E + + L HPNI+++
Sbjct: 11 GAFGIVHLCRRKADQ--KLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF 68
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ L+ + EY G+L + ++K+ LD T + + + I ++++H I+HR
Sbjct: 69 LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHR 125
Query: 217 DLTPSNVLQDEAGH-LKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
DL N+L D+ +K+ DFG+SKI K S +Y + G+ Y++PE+ + Y +
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKILSSK-SKAYTV---VGTPCYISPELCEGKPYNQK 181
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR-PAL------------SSLYPE 322
D+++ +++E+ +RA+E + PAL S Y
Sbjct: 182 SDIWALGCVLYELAS--------------LKRAFEAANLPALVLKIMSGTFAPISDRYSP 227
Query: 323 PIKALLRECWHKNPDRRPTFEEII 346
++ L+ + +P +RP +I+
Sbjct: 228 DLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 5e-20
Identities = 68/250 (27%), Positives = 120/250 (48%), Gaps = 12/250 (4%)
Query: 99 IDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G++GEV+ T+ +A K I A + +E+ + + P + ++ G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDSPYVTKYYG 69
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+L + EYL GS D+L+ G D +I +G++YLH + IHR
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKK---IHR 125
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
D+ +NVL E G +K+ DFG +A + K G+ +MAPEV ++ +Y
Sbjct: 126 DIKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336
D++S + E+ +G P N ++V +++ P L+ + +P K + C +K+P
Sbjct: 183 DIWSLGITAIELAKGEPPNSDMHPMRVL-FLIPKNNPPTLTGEFSKPFKEFIDACLNKDP 241
Query: 337 DRRPTFEEII 346
RPT +E++
Sbjct: 242 SFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-20
Identities = 73/251 (29%), Positives = 120/251 (47%), Gaps = 15/251 (5%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G+YGEV LV+ R G + K + AS R R + +E L +L+HPNIV + +
Sbjct: 11 GSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWE 69
Query: 160 HSERLIFLTE-YLRNGSLHDILK-KKGKLDPPTAVA-YALDIARGMNYLHHHRPHAIIHR 216
+ L+++ + G L+ LK +KGKL P V + + IA + YLH I+HR
Sbjct: 70 GEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHR 126
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
DL NV +KV D G++++ + + + + G+ YM+PE++ + Y
Sbjct: 127 DLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL---IGTPYYMSPELFSNKPYNYKS 183
Query: 277 DVFSFALIVHEMFQGGPS-NRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335
DV++ V+EM + N D V R E P + Y + L+ K
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKDMNSLV--YRIIEGKLPPMPKDYSPELGELIATMLSKR 241
Query: 336 PDRRPTFEEII 346
P++RP+ + I+
Sbjct: 242 PEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 6e-20
Identities = 64/196 (32%), Positives = 98/196 (50%), Gaps = 15/196 (7%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +G+V LVK + T A K ++ + + E + Q RHP FL LK
Sbjct: 6 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP----FLTALK 61
Query: 160 HS----ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+S +RL F+ EY G L L ++ A Y +I ++YLH + +++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK--NVVY 119
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RDL N++ D+ GH+K+TDFGL K KD + K GT Y+APEV YG++
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGI-KDGATMKTFCGTP--EYLAPEVLEDNDYGRA 176
Query: 276 VDVFSFALIVHEMFQG 291
VD + ++++EM G
Sbjct: 177 VDWWGLGVVMYEMMCG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 8e-20
Identities = 69/245 (28%), Positives = 117/245 (47%), Gaps = 19/245 (7%)
Query: 102 GAYGEVYL--VKWRGTEIAAKTIRSSIA-SNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++G+V L +K +G A K ++ + + V + +++ L +P +
Sbjct: 6 GSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF 65
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ E L F+ E+L G L ++ KG+ D A YA +I G+ +LH II+RDL
Sbjct: 66 QTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDL 122
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
NV+ D GH+K+ DFG+ K D+ + + G+ Y+APE+ + Y SVD
Sbjct: 123 KLDNVMLDRDGHIKIADFGMCKENVFGDN---RASTFCGTPDYIAPEILQGLKYTFSVDW 179
Query: 279 FSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI----KALLRECWHK 334
+SF ++++EM G D D +S + YP I K +L + + +
Sbjct: 180 WSFGVLLYEMLIGQSPFHGD------DEDELFESIRVDTPHYPRWITKESKDILEKLFER 233
Query: 335 NPDRR 339
+P RR
Sbjct: 234 DPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 9e-20
Identities = 72/270 (26%), Positives = 129/270 (47%), Gaps = 25/270 (9%)
Query: 99 IDPGAYGEVYLVK--WRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I GA G VY G E+A + + ++ P+ + + E+ + ++ ++PNIV +L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPK-KELIINEILVMRENKNPNIVNYLD 84
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ L + EYL GSL D++ + +D A + + + +LH ++ +IHR
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQ---VIHR 140
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
D+ N+L G +K+TDFG + S M G + +MAPEV R++YG V
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG---TPYWMAPEVVTRKAYGPKV 197
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE----CW 332
D++S ++ EM +G P + ++ A + P L + PE + A+ R+ C
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPELQN--PEKLSAIFRDFLNRCL 254
Query: 333 HKNPDRRPTFEEIIFRLEAIQESFQKKTVP 362
+ ++R + +E+ +Q F K P
Sbjct: 255 DMDVEKRGSAKEL------LQHQFLKIAKP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-19
Identities = 72/281 (25%), Positives = 113/281 (40%), Gaps = 41/281 (14%)
Query: 97 GGIDPGAYGEVY------LVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN 150
I GA+G V+ L+ + + A + AS ++ F +E L + HPN
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAEFDHPN 69
Query: 151 IVQFLGVLKHSERLIFLTEYLRNGSLHDILKK----------------------KGKLDP 188
IV+ LGV + + L EY+ G L++ L+ L
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 189 PTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248
+ A +A GM YL + +HRDL N L E +K+ DFGLS ++ Y
Sbjct: 130 TEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLS-----RNIY 181
Query: 249 S---YKMTGGTG-SYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVA 304
S YK + R+M PE Y DV+++ +++ E+F G A +
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241
Query: 305 DRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345
+ + + P + L+R CW K P RP+F I
Sbjct: 242 IYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-19
Identities = 73/264 (27%), Positives = 120/264 (45%), Gaps = 28/264 (10%)
Query: 97 GGIDPGAYGEVYLVKWRGTEI--AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
G + GA+G+VY K + T AAK I + + +M E+ + HP IV+
Sbjct: 18 GELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKL 74
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGK-LDPPTAVAYALDIARGMNYLHHHRPHAI 213
LG +L + E+ G++ I+ + + L P + + YLH + I
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---I 131
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLS----KIAQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
IHRDL NVL G +K+ DFG+S K Q +DS+ G+ +MAPEV
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSF-------IGTPYWMAPEVVMC 184
Query: 270 ES-----YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALS--SLYPE 322
E+ Y D++S + + EM Q P + ++V + A + P LS S +
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-PTLSQPSKWSM 243
Query: 323 PIKALLRECWHKNPDRRPTFEEII 346
+ L+ K+P+ RP+ +++
Sbjct: 244 EFRDFLKTALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 72/206 (34%), Positives = 106/206 (51%), Gaps = 25/206 (12%)
Query: 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G YG VY + + G +A K IR + V ++ ++E+ L ++L HPNIV+ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLE-TEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 157 VLKHSERLIFLT-EYLRNGSLHDILKK------KGKLDPPTAVAYALDIARGMNYLHHHR 209
V+ HSE ++L E+L D LKK LDPP +Y + +G+ Y H HR
Sbjct: 66 VV-HSENKLYLVFEFLD----LD-LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI-AQEKDSYSYKMTGGTGSYRYMAPEVYR 268
++HRDL P N+L D G LK+ DFGL++ +Y++++ T YR APE+
Sbjct: 120 ---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYR--APEILL 172
Query: 269 -RESYGKSVDVFSFALIVHEMFQGGP 293
Y VD++S I EM P
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 99 IDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLW-QKLRHPNIVQFL 155
I G+Y +V LV+ + T A K I+ + ++ + E ++ HP +V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ RL F+ E++ G L ++++ KL A Y+ +I+ +N+LH II+
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIY 119
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RDL NVL D GH+K+TD+G+ K + G+ Y+APE+ R E YG S
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF---CGTPNYIAPEILRGEDYGFS 176
Query: 276 VDVFSFALIVHEMFQG 291
VD ++ +++ EM G
Sbjct: 177 VDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 63/254 (24%), Positives = 114/254 (44%), Gaps = 22/254 (8%)
Query: 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G + EVY G +A K ++ + + R +KE+ L ++L HPN++++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 157 VLKHSERLIFLTEYLRNGSLHDIL---KKKGKLDPPTAV-AYALDIARGMNYLHHHRPHA 212
L + E G L ++ KK+ +L P V Y + + + ++H R
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--- 126
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
++HRD+ P+NV G +K+ D GL + K + ++ + G+ YM+PE Y
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPERIHENGY 183
Query: 273 GKSVDVFSFALIVHEM------FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKA 326
D++S +++EM F G N ++ D P S Y E ++
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC----DYPPLPSDHYSEELRQ 239
Query: 327 LLRECWHKNPDRRP 340
L+ C + +P++RP
Sbjct: 240 LVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 99 IDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G YG VY + + T +A K IR + V ++ ++E+ L ++L+HPNIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLE-SEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 157 VLKHSERLIFLTEYLRNG--SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
VL RL + E+L D L K +D +Y I +G+ + H R ++
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VL 123
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSK-IAQEKDSYSYKMTGGTGSYRYMAPEVYRRES-Y 272
HRDL P N+L D G +K+ DFGL++ Y++++ T YR APEV Y
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYR--APEVLLGSPRY 179
Query: 273 GKSVDVFSFALIVHEM------FQG 291
VD++S I EM F G
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLFHG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 77/286 (26%), Positives = 121/286 (42%), Gaps = 54/286 (18%)
Query: 102 GAYGEVYLVKWRGTE-------IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA+G+V+L + +A K ++ R F +E L L+H +IV+F
Sbjct: 16 GAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKF 72
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILK----------------KKGKLDPPTAVAYALDI 198
GV + LI + EY+++G L+ L+ KG+L + A I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 199 ARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS---YKMTGG 255
A GM YL +HRDL N L +K+ DFG+S +D YS Y++ G
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMS-----RDVYSTDYYRVGGH 184
Query: 256 TG-SYRYMAPEVYRRESYGKSVDVFSFALIVHEM--------FQGGPSNRADTAVQVADR 306
T R+M PE + DV+SF +I+ E+ FQ + + Q
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ---G 241
Query: 307 RAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
R E R + P+ + ++ CW + P +R +EI L A+
Sbjct: 242 RVLERPR-----VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 2e-19
Identities = 84/279 (30%), Positives = 126/279 (45%), Gaps = 34/279 (12%)
Query: 99 IDPGAYGEVY--LVKWRGTEI-AAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQF 154
I G +G+V +K G + AA AS R+ F EL + KL HPNI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIINL 61
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVA----------------YALDI 198
LG +H L EY +G+L D L+K L+ A A +A D+
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 199 ARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS 258
ARGM+YL + IHRDL N+L E K+ DFGLS+ K T G
Sbjct: 122 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRLP 174
Query: 259 YRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADR--RAYEDSRPA 315
R+MA E Y + DV+S+ +++ E+ GG T ++ ++ + Y +P
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234
Query: 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQE 354
+ + L+R+CW + P RP+F +I+ L + E
Sbjct: 235 NCD---DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 19/200 (9%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GAYG+V T ++A K + S + ++ +EL L + + H N++ L V
Sbjct: 26 GAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGLLDVFT 84
Query: 160 HSERL-----IFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ L ++L +L L++I+K + KL I RG+ Y+H II
Sbjct: 85 PASSLEDFQDVYLVTHLMGADLNNIVKCQ-KLSDDHIQFLVYQILRGLKYIHSAG---II 140
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV-YRRESYG 273
HRDL PSN+ +E LK+ DFGL++ + +MTG + Y APE+ Y
Sbjct: 141 HRDLKPSNIAVNEDCELKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYN 194
Query: 274 KSVDVFSFALIVHEMFQGGP 293
++VD++S I+ E+ G
Sbjct: 195 QTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-19
Identities = 60/198 (30%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 99 IDPGAYGEVYLVKWRGTE--IAAKTIRSS-IASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
I G++G+V V+ R T+ A KTIR + I S V ++ + E + ++ P IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHT-LAERTVLAQVNCPFIVPLK 59
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ E+L + ++ G L L+++G+ D A Y ++ + LH +I+
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIY 116
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RDL P N+L D GH+ + DFGL K+ + D K G+ Y+APE+ Y K+
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 276 VDVFSFALIVHEMFQGGP 293
VD ++ ++++EM G P
Sbjct: 174 VDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-19
Identities = 72/259 (27%), Positives = 116/259 (44%), Gaps = 37/259 (14%)
Query: 116 EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV-LKHSERL-----IFLTE 169
++A KT++ +I + + + F+ E ++ HPN+++ +GV L+ E + +
Sbjct: 28 KVAVKTMKIAICTRSEMED-FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILP 86
Query: 170 YLRNGSLHDILKKKGKLDPP------TAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNV 223
++++G LH L D P V + DIA GM YL IHRDL N
Sbjct: 87 FMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNC 143
Query: 224 LQDEAGHLKVTDFGLSKIAQEKDSYSY----KMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
+ +E ++ V DFGLSK D Y KM +++A E Y DV+
Sbjct: 144 MLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM-----PVKWIAIESLADRVYTTKSDVW 198
Query: 280 SFALIVHEMFQGG--PSNRADTAVQVAD--RRAYEDSRPA--LSSLYPEPIKALLRECWH 333
SF + + E+ G P + + ++ D R+ +P L LY +L+ CW
Sbjct: 199 SFGVTMWEIATRGQTPYPGVENS-EIYDYLRQGNRLKQPPDCLDGLY-----SLMSSCWL 252
Query: 334 KNPDRRPTFEEIIFRLEAI 352
NP RP+FE + LE
Sbjct: 253 LNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 65/275 (23%), Positives = 127/275 (46%), Gaps = 30/275 (10%)
Query: 102 GAYGEVYLVKWR------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
GA+G VY W +A K +R + ++P+ + E + + P + + L
Sbjct: 18 GAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPYVCRLL 75
Query: 156 GV-LKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
G+ L + +L+ T+ + G L D +++ K ++ + + + IA+GM+YL R +
Sbjct: 76 GICLTSTVQLV--TQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---L 130
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG 273
+HRDL NVL H+K+TDFGL+++ + D Y GG ++MA E +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLL-DIDETEYHADGGKVPIKWMALESILHRRFT 189
Query: 274 KSVDVFSFALIVHEM-------FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKA 326
DV+S+ + V E+ + G P+ ++ +R +P + ++ +
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL----PQPPICTI---DVYM 242
Query: 327 LLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKTV 361
++ +CW + + RP F E++ + + V
Sbjct: 243 IMVKCWMIDSECRPRFRELVDEFSRMARDPSRFVV 277
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 73/244 (29%), Positives = 108/244 (44%), Gaps = 17/244 (6%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G G V+ V + G +A K I I P +RN ++EL + + P IV F G
Sbjct: 16 GNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 73
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ E++ GSL +LKK G++ ++ + +G+ YL H I+HRD+
Sbjct: 74 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVK 131
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
PSN+L + G +K+ DFG+S Q DS + G+ YM+PE + Y D++
Sbjct: 132 PSNILVNSRGEIKLCDFGVS--GQLIDSMANSF---VGTRSYMSPERLQGTHYSVQSDIW 186
Query: 280 SFALIVHEMFQGG---PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336
S L + EM G P A + D PA S P P + R P
Sbjct: 187 SMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD--PAESETSPRP-RPPGRPLSSYGP 243
Query: 337 DRRP 340
D RP
Sbjct: 244 DSRP 247
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 80/283 (28%), Positives = 125/283 (44%), Gaps = 51/283 (18%)
Query: 99 IDPGAYGEVYL---VKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR---HPNIV 152
I GAYG+V+ +K G +A K +R + S ++E+ + + L HPN+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQ-TGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 153 QFLGVLKHSE-----RLIFLTEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYL 205
+ V S +L + E++ + L L K + + T + RG+++L
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 206 HHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM--TGGTGSYRYMA 263
H HR ++HRDL P N+L +G +K+ DFGL++I YS++M T + Y A
Sbjct: 127 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI------YSFQMALTSVVVTLWYRA 177
Query: 264 PEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAV--------------------QV 303
PEV + SY VD++S I EMF+ P R + V V
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237
Query: 304 ADRRAYEDSRPA--LSSLYP---EPIKALLRECWHKNPDRRPT 341
A R S+ A + E K LL +C NP +R +
Sbjct: 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-19
Identities = 63/197 (31%), Positives = 98/197 (49%), Gaps = 18/197 (9%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIRSS-IASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G +G+V LV+ + T A K +R I + V ++ + E + Q RHP FL L
Sbjct: 6 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHP----FLTAL 60
Query: 159 KH----SERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
K+ +RL F+ EY G L L ++ A Y +I + YLH ++
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VV 117
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
+RD+ N++ D+ GH+K+TDFGL K E S M G+ Y+APEV YG+
Sbjct: 118 YRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 275 SVDVFSFALIVHEMFQG 291
+VD + ++++EM G
Sbjct: 175 AVDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-19
Identities = 66/245 (26%), Positives = 106/245 (43%), Gaps = 15/245 (6%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +GEV + + T A K + + + E + +K+ IV +
Sbjct: 4 GGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE 63
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+ L + + G L + G+ A+ YA I G+ +LH R I++RD
Sbjct: 64 TKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRD 120
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVD 277
L P NVL D+ G+++++D GL+ + K+ G G+ YMAPEV + E Y SVD
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGK----KIKGRAGTPGYMAPEVLQGEVYDFSVD 176
Query: 278 VFSFALIVHEMFQG-GPSNRADTAV--QVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
F+ ++EM G P + V + RR E + PE K L K
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPE-AKDLCEALLQK 235
Query: 335 NPDRR 339
+P++R
Sbjct: 236 DPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 70/276 (25%), Positives = 118/276 (42%), Gaps = 49/276 (17%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTI--RSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
G G V+LV+ +GT A K + + I N R E + L HP +
Sbjct: 12 GDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT--EQEILATLDHPFLPTLYAS 69
Query: 158 LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVA--YALDIARGMNYLHHHRPHAIIH 215
+ L + +Y G L +L+++ VA YA ++ + YLH I++
Sbjct: 70 FQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVY 126
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD---SYSYKMTGGT---------------- 256
RDL P N+L E+GH+ ++DF LSK + + S + +
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 257 -------GSYRYMAPEVYRRESYGKSVDVFSFALIVHEM------FQGGPSNRADTAVQV 303
G+ Y+APEV + +G +VD ++ ++++EM F+G SNR +T +
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG--SNRDETFSNI 244
Query: 304 ADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRR 339
+ P +SS + I+ LL K+P +R
Sbjct: 245 LKKEVTFPGSPPVSSSARDLIRKLLV----KDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-19
Identities = 60/184 (32%), Positives = 87/184 (47%), Gaps = 26/184 (14%)
Query: 186 LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEK 245
D A+ YA ++ G+ L R I++RDL P N+L D+ GH++++D GL+ E
Sbjct: 99 FDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155
Query: 246 DSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG-GPSNRADTAVQ-- 302
++ + G G+ YMAPEV E Y S D + +++EM QG P + V+
Sbjct: 156 ET----VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE 211
Query: 303 VADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRR--------------PTFEEIIF- 347
DRR ED S + E K++ R KNP R P F+ I F
Sbjct: 212 EVDRRVKEDQE-EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270
Query: 348 RLEA 351
RLEA
Sbjct: 271 RLEA 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-19
Identities = 63/254 (24%), Positives = 114/254 (44%), Gaps = 22/254 (8%)
Query: 99 IDPGAYGEVY--LVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G + EVY +A K ++ + + R +KE+ L ++L HPN++++L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 157 VLKHSERLIFLTEYLRNGSLHDIL---KKKGKLDPPTAV-AYALDIARGMNYLHHHRPHA 212
L + E G L ++ KK+ +L P V Y + + + ++H R
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--- 126
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
++HRD+ P+NV G +K+ D GL + K + ++ + G+ YM+PE Y
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL---VGTPYYMSPERIHENGY 183
Query: 273 GKSVDVFSFALIVHEM------FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKA 326
D++S +++EM F G N + + D P + Y E ++
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKIEQCDYPPLPTEHYSEKLRE 239
Query: 327 LLRECWHKNPDRRP 340
L+ C + +PD+RP
Sbjct: 240 LVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 5e-19
Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 11/234 (4%)
Query: 114 GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIF-LTEYLR 172
G E+A K +R+ R F +E L +L HPNIV L + L+F + EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG--- 229
+L ++L G L L + + H+ I+HRDL P N++ + G
Sbjct: 63 GRTLREVLAADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRP 119
Query: 230 HLKVTDFGLSKI---AQEKDSYSYKMTGGT-GSYRYMAPEVYRRESYGKSVDVFSFALIV 285
H KV DFG+ + ++ D + T G+ Y APE R E + D++++ LI
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 286 HEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRR 339
E G + + ++ ++ + P+ +LR+ +K+P +R
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-19
Identities = 65/251 (25%), Positives = 110/251 (43%), Gaps = 15/251 (5%)
Query: 102 GAYGEV-----YLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G +GE+ L R +A T+R+ + + R F+ E + H NIV+ G
Sbjct: 16 GRFGELCRGCLKLPSKRELPVAIHTLRAGCSD--KQRRGFLAEALTLGQFDHSNIVRLEG 73
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
V+ ++ +TEY+ NG+L L+K +G+L + +A GM YL +H
Sbjct: 74 VITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVH 130
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
+ L VL + K++ F ++ ++K Y G + APE + + +
Sbjct: 131 KGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA 188
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS-RPALSSLYPEPIKALLRECWHK 334
DV+SF +++ E+ G D + Q +A ED R P + L+ +CW K
Sbjct: 189 SDVWSFGIVMWEVMSYGERPYWDMSGQDV-IKAVEDGFRLPAPRNCPNLLHQLMLDCWQK 247
Query: 335 NPDRRPTFEEI 345
RP F +I
Sbjct: 248 ERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 5e-19
Identities = 76/258 (29%), Positives = 113/258 (43%), Gaps = 19/258 (7%)
Query: 91 KILEDRGGIDPGAYGEVYLVK-WRGTEIAA--KTIRSSIASNPRVRNSFMKELGLWQKLR 147
K+ D I G++G VY + R +E+ A K S SN + ++ +KE+ QKLR
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLR 73
Query: 148 HPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILK-KKGKLDPPTAVAYALDIARGMNYLH 206
HPN +Q+ G + EY GS D+L+ K L A +G+ YLH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 207 HHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV 266
H +IHRD+ N+L E G +K+ DFG + I + + G+ +MAPEV
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-------VGTPYWMAPEV 182
Query: 267 ---YRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEP 323
Y VDV+S + E+ + P A+ A +S S + E
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242
Query: 324 IKALLRECWHKNPDRRPT 341
+ + C K P RPT
Sbjct: 243 FRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 6e-19
Identities = 60/196 (30%), Positives = 98/196 (50%), Gaps = 16/196 (8%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +G+V LV+ + G A K ++ + + E + + RHP FL LK
Sbjct: 6 GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP----FLTSLK 61
Query: 160 HS----ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+S +RL F+ EY+ G L L ++ Y +I ++YLH + I++
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVY 118
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RDL N++ D+ GH+K+TDFGL K E + + M G+ Y+APEV YG++
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175
Query: 276 VDVFSFALIVHEMFQG 291
VD + ++++EM G
Sbjct: 176 VDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-19
Identities = 73/273 (26%), Positives = 119/273 (43%), Gaps = 45/273 (16%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA+G+V+L + +A KT++ + + R F +E L L+H +IV+F
Sbjct: 16 GAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKF 72
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKG-------KLDPPTAVA------YALDIARG 201
GV + LI + EY+++G L+ L+ G + + P + A IA G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 202 MNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS---YKMTGGTG- 257
M YL +HRDL N L E +K+ DFG+S +D YS Y++ G T
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMS-----RDVYSTDYYRVGGHTML 184
Query: 258 SYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPS-----NRADTAVQVADRRAYEDS 312
R+M PE + DV+S +++ E+F G + + + R +
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 244
Query: 313 RPALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345
R P+ + L+ CW + P R +EI
Sbjct: 245 RTC-----PKEVYDLMLGCWQREPHMRLNIKEI 272
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 7e-19
Identities = 57/195 (29%), Positives = 97/195 (49%), Gaps = 13/195 (6%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSS-IASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++G+V L + + + A K ++ I + V + ++ L HP + Q
Sbjct: 6 GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF 65
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ +RL F+ E++ G L ++K + D A YA +I + +LH II+RDL
Sbjct: 66 QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDL 122
Query: 219 TPSNVLQDEAGHLKVTDFGLSK--IAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
NVL D GH K+ DFG+ K I K + ++ G+ Y+APE+ + YG SV
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF-----CGTPDYIAPEILQEMLYGPSV 177
Query: 277 DVFSFALIVHEMFQG 291
D ++ ++++EM G
Sbjct: 178 DWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 7e-19
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 9/196 (4%)
Query: 99 IDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLW-QKLRHPNIVQFL 155
I G+Y +V LV+ + + A K ++ + + + E ++ Q +P +V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ + RL + EY+ G L ++++ KL A YA +I +N+LH II+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIY 119
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RDL NVL D GH+K+TD+G+ K E + G+ Y+APE+ R E YG S
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 176
Query: 276 VDVFSFALIVHEMFQG 291
VD ++ +++ EM G
Sbjct: 177 VDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 8e-19
Identities = 70/251 (27%), Positives = 112/251 (44%), Gaps = 21/251 (8%)
Query: 99 IDPGAYGEVYLVKWRGTE-------IAAKTI--RSSIASNPRVRNSFMKELGLWQKLRHP 149
I G +G+VY V+ + T ++ K I + +A RN ++ L P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL----LDESP 56
Query: 150 NIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHR 209
IV + L +T+Y+ G L L+K+G+ A Y ++ + +LH +
Sbjct: 57 FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD 116
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
I++RDL P N+L D GH+ + DFGLSK + + G T Y+APEV
Sbjct: 117 ---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT---EYLAPEVLLD 170
Query: 270 ES-YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328
E Y K VD +S ++V EM G A+ Q+ A+ R + L E + +
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEG-RQFV 229
Query: 329 RECWHKNPDRR 339
+ ++NP R
Sbjct: 230 KGLLNRNPQHR 240
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 8e-19
Identities = 63/212 (29%), Positives = 111/212 (52%), Gaps = 19/212 (8%)
Query: 102 GAYGEVYLVKWRGT-EIAA-KTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G Y VY + R T EI A K I + + ++ ++E+ L ++L+H NIV+ V+
Sbjct: 11 GTYATVYKGRNRTTGEIVALKEIH--LDAEEGTPSTAIREISLMKELKHENIVRLHDVIH 68
Query: 160 HSERLIFLTEYLRNG--SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+L+ + EY+ D +G LDP T ++ + +G+ + H +R ++HRD
Sbjct: 69 TENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRD 125
Query: 218 LTPSNVLQDEAGHLKVTDFGLSK-IAQEKDSYSYKMTGGTGSYRYMAPEVYR-RESYGKS 275
L P N+L ++ G LK+ DFGL++ +++S ++ T YR AP+V +Y S
Sbjct: 126 LKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYR--APDVLLGSRTYSTS 181
Query: 276 VDVFSFALIVHEMFQGGP----SNRADTAVQV 303
+D++S I+ EM G P +N D +++
Sbjct: 182 IDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 73/265 (27%), Positives = 119/265 (44%), Gaps = 26/265 (9%)
Query: 102 GAYGEVY--LVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G+Y VY + + G +A K I S+ + V + ++E L + L+H NIV ++
Sbjct: 16 GSYATVYKGISRINGQLVALKVI--SMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH 73
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
E L F+ EY+ +++ G L P + + RG+ Y+H I+HRDL
Sbjct: 74 TKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLK 130
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES-YGKSVDV 278
P N+L G LK+ DFGL++ A+ S +Y T YR P+V + Y ++D+
Sbjct: 131 PQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYR--PPDVLLGATDYSSALDI 187
Query: 279 FSFALIVHEMFQGGPSNRADTAVQVADRRAY-------EDSRPALSSL-------YPEPI 324
+ I EM QG P+ + V + + ED+ P +S L +
Sbjct: 188 WGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCK 247
Query: 325 KALLRECWHKNPDRRPTFEEIIFRL 349
LR W K R P E++ ++
Sbjct: 248 PQQLRVVW-KRLSRPPKAEDLASQM 271
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 73/237 (30%), Positives = 115/237 (48%), Gaps = 29/237 (12%)
Query: 99 IDPGAYGEVYLVKWRGT-EIAA-KTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G YG V+ K R T EI A K +R + V +S ++E+ L ++L+H NIV+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKK-----KGKLDPPTAVAYALDIARGMNYLHHHRPH 211
VL ++L + EY LKK G +DP ++ + +G+ + H H
Sbjct: 67 VLHSDKKLTLVFEYCDQD-----LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN-- 119
Query: 212 AIIHRDLTPSNVLQDEAGHLKVTDFGLSK-IAQEKDSYSYKMTGGTGSYRYMAPEV-YRR 269
++HRDL P N+L ++ G LK+ DFGL++ YS ++ T YR P+V +
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYR--PPDVLFGA 174
Query: 270 ESYGKSVDVFSFALIVHEMFQGG----PSNRADTAVQVADR---RAYEDSRPALSSL 319
+ Y S+D++S I E+ G P N D ++ R E+S P +S L
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 56/179 (31%), Positives = 85/179 (47%), Gaps = 26/179 (14%)
Query: 191 AVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250
AV YA +I G+ LH R I++RDL P N+L D+ GH++++D GL+ E ++
Sbjct: 104 AVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--- 157
Query: 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRA---DTAVQVADRR 307
+ G G+ YMAPEV + E Y S D + +++EM +G R + +RR
Sbjct: 158 -IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR 216
Query: 308 AYEDSRPALSSLYPEPIKALLRECWHKNPDRR--------------PTFEEIIF-RLEA 351
ED S + E +++ R+ K+P R P F F RLEA
Sbjct: 217 VKEDQE-EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEA 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 68/260 (26%), Positives = 122/260 (46%), Gaps = 25/260 (9%)
Query: 99 IDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
+ G++G LV+ ++ A K IR +S+ V +S KE L K++HPNIV F
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS-AVEDS-RKEAVLLAKMKHPNIVAFKE 65
Query: 157 VLKHSERLIFLTEYLRNGSL-HDILKKKGKLDPP-TAVAYALDIARGMNYLHHHRPHAII 214
+ L + EY G L I ++GKL P T + + + + G+ ++H R ++
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VL 122
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
HRD+ N+ + G +K+ DFG +++ +Y+ G+ Y+ PE++ Y
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY---VGTPYYVPPEIWENMPYNN 179
Query: 275 SVDVFSFALIVHEM------FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328
D++S I++E+ FQ V + S L S Y +++L+
Sbjct: 180 KSDIWSLGCILYELCTLKHPFQANSWKNLILKV-------CQGSYKPLPSHYSYELRSLI 232
Query: 329 RECWHKNPDRRPTFEEIIFR 348
++ + +NP RP+ I+ R
Sbjct: 233 KQMFKRNPRSRPSATTILSR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 76/264 (28%), Positives = 124/264 (46%), Gaps = 28/264 (10%)
Query: 97 GGIDPGAYGEVYLVKWRGTEI--AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
G + GA+G+VY + + T + AAK I + S + + +M E+ + HPNIV+
Sbjct: 11 GELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELED-YMVEIDILASCDHPNIVKL 67
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDI-LKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
L + L L E+ G++ + L+ + L P +NYLH ++ I
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---I 124
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLS----KIAQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
IHRDL N+L G +K+ DFG+S + Q +DS+ G+ +MAPEV
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-------IGTPYWMAPEVVMC 177
Query: 270 ES-----YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALS--SLYPE 322
E+ Y DV+S + + EM Q P + ++V + A + P L+ S +
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSS 236
Query: 323 PIKALLRECWHKNPDRRPTFEEII 346
K L++C KN D R T +++
Sbjct: 237 EFKDFLKKCLEKNVDARWTTTQLL 260
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-18
Identities = 75/260 (28%), Positives = 113/260 (43%), Gaps = 26/260 (10%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G YG VY V R T + A K IR + + N + EL + K P IV F G
Sbjct: 12 GNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFF 69
Query: 160 HSERLIFLTEYLRNGSLHDIL---KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ EY+ GSL + + + +G+ +L H IIHR
Sbjct: 70 IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHR 127
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYR------RE 270
D+ P+NVL + G +K+ DFG+S S + K G S YMAPE +
Sbjct: 128 DVKPTNVLVNGNGQVKLCDFGVS--GNLVASLA-KTNIGCQS--YMAPERIKSGGPNQNP 182
Query: 271 SYGKSVDVFSFALIVHEMFQGG----PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKA 326
+Y DV+S L + EM G P A+ Q++ + P L S Y + +
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS--AIVDGDPPTLPSGYSDDAQD 240
Query: 327 LLRECWHKNPDRRPTFEEII 346
+ +C +K P+RRPT+ +++
Sbjct: 241 FVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 10/162 (6%)
Query: 186 LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEK 245
P A Y I G+ +LH R II+RDL P NVL D G+++++D GL+ ++
Sbjct: 94 FPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150
Query: 246 DSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG-GPSNRADTAVQVA 304
S K G G+ +MAPE+ + E Y SVD F+ + ++EM GP V+
Sbjct: 151 QS---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK 207
Query: 305 D--RRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEE 344
+ +R DS + K+ K+P++R F +
Sbjct: 208 ELKQRILNDS-VTYPDKFSPASKSFCEALLAKDPEKRLGFRD 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 50/150 (33%), Positives = 74/150 (49%), Gaps = 5/150 (3%)
Query: 99 IDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I GA+G+VYL K A K ++ + N + + E + P IV
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
L+ + + + EYL G + +L G D AV Y ++A ++YLH H IIHR
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHR 128
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKD 246
DL P N+L GH+K+TDFGLSK+ ++
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 68/254 (26%), Positives = 107/254 (42%), Gaps = 17/254 (6%)
Query: 99 IDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G++G VY T +A K + S +KE+ Q+L+HPN +++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 157 VLKHSERLIFLTEYLRNGSLHDILK-KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ EY GS D+L+ K L A +G+ YLH H +IH
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIH 144
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV---YRRESY 272
RD+ N+L E G +K+ DFG + + +S+ G+ +MAPEV Y
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSASKSSPANSF-------VGTPYWMAPEVILAMDEGQY 197
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332
VDV+S + E+ + P A+ A DS S+ + + + + C
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCL 257
Query: 333 HKNPDRRPTFEEII 346
K P RP E++
Sbjct: 258 QKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-18
Identities = 74/257 (28%), Positives = 118/257 (45%), Gaps = 23/257 (8%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH-PNIVQFLGVL 158
GAYG V ++ GT +A K IR+++ N + + + +L + + P V F G L
Sbjct: 12 GAYGVVDKMRHVPTGTIMAVKRIRATV--NSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69
Query: 159 KHSERLIFLTEYLRNGSLHDILKK---KGKLDPPTAVA-YALDIARGMNYLHHHRPHAII 214
E +++ + + SL KK KG P + A+ I + + YLH ++I
Sbjct: 70 -FREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVI 126
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE---- 270
HRD+ PSNVL + G +K+ DFG+S DS + T G YMAPE E
Sbjct: 127 HRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSVA--KTIDAGCKPYMAPERINPELNQK 182
Query: 271 SYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPAL-SSLYPEPIKALL 328
Y DV+S + + E+ G P + T Q ++ E+ P L + + + +
Sbjct: 183 GYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL-KQVVEEPSPQLPAEKFSPEFQDFV 241
Query: 329 RECWHKNPDRRPTFEEI 345
+C KN RP + E+
Sbjct: 242 NKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 6e-18
Identities = 68/259 (26%), Positives = 108/259 (41%), Gaps = 39/259 (15%)
Query: 117 IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERL------IFLTEY 170
+A KT++ I + + F+ E + HPN+++ +GV + L + + +
Sbjct: 30 VAVKTMKLDIHTYSEIEE-FLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPF 88
Query: 171 LRNGSLHDILKKKGKLDPP------TAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVL 224
+++G LH L P T + + +DIA GM YL + IHRDL N +
Sbjct: 89 MKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCM 145
Query: 225 QDEAGHLKVTDFGLSKIAQEKDSYSY----KMTGGTGSYRYMAPEVYRRESYGKSVDVFS 280
E + V DFGLSK D Y KM +++A E Y DV++
Sbjct: 146 LREDMTVCVADFGLSKKIYSGDYYRQGRIAKM-----PVKWIAIESLADRVYTSKSDVWA 200
Query: 281 FALIVHEMFQGGPSNRADTAVQVAD-----RRAYEDSRPA--LSSLYPEPIKALLRECWH 333
F + + E+ G + V+ + R +P L LY L+ CW
Sbjct: 201 FGVTMWEIATRGQTPYP--GVENHEIYDYLRHGNRLKQPEDCLDELY-----DLMYSCWR 253
Query: 334 KNPDRRPTFEEIIFRLEAI 352
+P RPTF ++ LE I
Sbjct: 254 ADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 6e-18
Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 33/216 (15%)
Query: 89 ICKILEDRGGIDPGAYGEVYLVKWRGT-EIAAKTIRSSIAS--NPRVRNSFMKELGLWQK 145
+ KI E G+YG V+ + R T +I A I+ + S +P ++ ++E+ + ++
Sbjct: 6 LSKIGE-------GSYGVVFKCRNRETGQIVA--IKKFVESEDDPVIKKIALREIRMLKQ 56
Query: 146 LRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYL 205
L+HPN+V + V + +L + EY + L+++ K + + +N+
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 206 HHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYR----- 260
H H IHRD+ P N+L + G +K+ DFG ++I +TG Y
Sbjct: 117 HKHN---CIHRDVKPENILITKQGQIKLCDFGFARI----------LTGPGDDYTDYVAT 163
Query: 261 --YMAPEVYRRES-YGKSVDVFSFALIVHEMFQGGP 293
Y APE+ ++ YG VDV++ + E+ G P
Sbjct: 164 RWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 8e-18
Identities = 67/217 (30%), Positives = 104/217 (47%), Gaps = 34/217 (15%)
Query: 93 LEDRGGIDPGAYGEVY--LVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH-P 149
L+D G I GA+G V L K GT +A K IRS+ + + + + +L + + P
Sbjct: 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRST--VDEKEQKRLLMDLDVVMRSSDCP 63
Query: 150 NIVQFLGVLKHSERLIFLTEYLRNGSL-------HDILKKKGKLDPPTAVAYALDIARGM 202
IV+F G L E ++ L + SL +++LK + +A A + +
Sbjct: 64 YIVKFYGALFR-EGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA--TVKAL 120
Query: 203 NYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLS-----KIAQEKDSYSYKMTGGTG 257
NYL IIHRD+ PSN+L D G++K+ DFG+S IA+ +D+ G
Sbjct: 121 NYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA---------G 169
Query: 258 SYRYMAPE---VYRRESYGKSVDVFSFALIVHEMFQG 291
YMAPE R+ Y DV+S + ++E+ G
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 14/205 (6%)
Query: 91 KILEDRGGIDPGAYGEV--YLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH 148
K +E+ I GAYG V + G ++A K I P + ++EL + + +H
Sbjct: 8 KPIEN---IGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLRELKILRHFKH 63
Query: 149 PNIVQFLGVLKHSERL---IFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYL 205
NI+ +L+ +++ L LH I+ L + + RG+ Y+
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 206 HHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK-IAQEKDSYSYKMTGGTGSYRYMAP 264
H +IHRDL PSN+L +E L++ DFG+++ ++ + Y MT + Y AP
Sbjct: 124 H---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 265 EV-YRRESYGKSVDVFSFALIVHEM 288
E+ Y ++D++S I EM
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 67/256 (26%), Positives = 109/256 (42%), Gaps = 27/256 (10%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRS----SIASNPRVRNSFMKELGLWQKLRH---PNIVQF 154
GAYG VY RG + + + ++ + + +E+ L +LR PNI ++
Sbjct: 12 GAYGAVY----RGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
G RL + EY GS+ L K G + ++ + Y+H +I
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHKV---GVI 123
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR-ESYG 273
HRD+ +N+L G++K+ DFG +A + S K + G+ +MAPEV + Y
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFG---VAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYD 180
Query: 274 KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE--- 330
D++S + ++EM G P A + S+P L LLRE
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP--KSKP--PRLEDNGYSKLLREFVA 236
Query: 331 -CWHKNPDRRPTFEEI 345
C + P R + EE+
Sbjct: 237 ACLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 63/258 (24%), Positives = 123/258 (47%), Gaps = 24/258 (9%)
Query: 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G++G+ LVK + G + K I S S P+ R KE+ + ++HPNIVQ+
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 157 VLKHSERLIFLTEYLRNGSLHD-ILKKKGKLDPPTAV-AYALDIARGMNYLHHHRPHAII 214
+ + L + +Y G L+ I ++G L P + + + I + ++H + I+
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---IL 123
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
HRD+ N+ + G +K+ DFG++++ + G+ Y++PE+ Y
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC---IGTPYYLSPEICENRPYNN 180
Query: 275 SVDVFSFALIVHEM------FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328
D+++ +++EM F+ G N + +++ S P +SS Y ++ L+
Sbjct: 181 KSDIWALGCVLYEMCTLKHAFEAG--NMKNLVLKII-----RGSYPPVSSHYSYDLRNLV 233
Query: 329 RECWHKNPDRRPTFEEII 346
+ + +NP RP+ I+
Sbjct: 234 SQLFKRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 30/209 (14%)
Query: 99 IDPGAYGEVYLVKWRGT-EIAA-KTIRSSIASNPRVRN----SFMKELGLWQKLRHPNIV 152
I G YG VY + + EI A K +R R+ S ++E+ L LRHPNIV
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMD-----NERDGIPISSLREITLLLNLRHPNIV 69
Query: 153 QFLGVL--KHSERLIFLTEYLRN--GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH 208
+ V+ KH + + + EY SL D + L + RG+ YLH +
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHEN 127
Query: 209 RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY---KMTGGTGSYRYMAPE 265
IIHRDL SN+L + G LK+ DFGL++ +Y MT + Y APE
Sbjct: 128 ---FIIHRDLKVSNLLLTDKGCLKIADFGLAR------TYGLPAKPMTPKVVTLWYRAPE 178
Query: 266 V-YRRESYGKSVDVFSFALIVHEMFQGGP 293
+ +Y ++D+++ I+ E+ P
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 72/261 (27%), Positives = 117/261 (44%), Gaps = 39/261 (14%)
Query: 99 IDPGAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I GA G VY V R T A K I + VR +E+ + + + HPN+V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGN--HEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 157 VLKHSERLIFLTEYLRNGSL--HDILKKKGKLDPPTAVAYALDIAR----GMNYLHHHRP 210
+ H+ + L E++ GSL I + + D+AR G+ YLH R
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADE----------QFLADVARQILSGIAYLH--RR 187
Query: 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI-AQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
H I+HRD+ PSN+L + A ++K+ DFG+S+I AQ D G+ YM+PE
Sbjct: 188 H-IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP----CNSSVGTIAYMSPERINT 242
Query: 270 E----SY-GKSVDVFSFALIVHEMFQG----GPSNRADTAVQVADRRAYEDSRPALSSLY 320
+ +Y G + D++S + + E + G G + D A + A ++
Sbjct: 243 DLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC-AICMSQPPEAPATAS 301
Query: 321 PEPIKALLRECWHKNPDRRPT 341
E + + C + P +R +
Sbjct: 302 RE-FRHFISCCLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 52/196 (26%), Positives = 90/196 (45%), Gaps = 14/196 (7%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIR----SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
G++G V L ++ + I+ S I +V + F E + + HP V G
Sbjct: 41 GSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNLYGS 99
Query: 158 LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
K L + E++ G L++ + YA I YL I++RD
Sbjct: 100 FKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRD 156
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVD 277
L P N+L D+ G +K+TDFG +K+ D+ +Y + G+ Y+APE+ +GK+ D
Sbjct: 157 LKPENLLLDKDGFIKMTDFGFAKVV---DTRTYTL---CGTPEYIAPEILLNVGHGKAAD 210
Query: 278 VFSFALIVHEMFQGGP 293
++ + ++E+ G P
Sbjct: 211 WWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-17
Identities = 61/236 (25%), Positives = 108/236 (45%), Gaps = 18/236 (7%)
Query: 133 RNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAV 192
R E+ + + H N+V + L + E+L G+L DI+ +++
Sbjct: 63 RELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIA 121
Query: 193 AYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGL-SKIAQEKDSYSYK 251
L + R ++YLH+ +IHRD+ ++L G +K++DFG +++++E K
Sbjct: 122 TVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP----K 174
Query: 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED 311
G+ +MAPEV R YG VD++S ++V EM G P + +Q A RR ++
Sbjct: 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMRRIRDN 233
Query: 312 SRPALSSLY--PEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKTVPSCC 365
P + + ++ L + P +R T +E+ +Q F K P C
Sbjct: 234 LPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQEL------LQHPFLKLAGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 5e-17
Identities = 78/276 (28%), Positives = 128/276 (46%), Gaps = 17/276 (6%)
Query: 92 ILEDRGGIDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHP 149
+LE+ I G+ G V + K G ++A K + + R R E+ + + +H
Sbjct: 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMM--DLRKQQR-RELLFNEVVIMRDYQHQ 78
Query: 150 NIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHR 209
N+V+ E L L E+L+ G+L DI+ + +L+ + + + YLH
Sbjct: 79 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLH--- 134
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQ-EKDSYSYKMTGGTGSYRYMAPEVYR 268
+IHRD+ ++L G +K++DFG AQ KD K GT + MAPEV
Sbjct: 135 SQGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYW--MAPEVIS 190
Query: 269 RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYP-EPI-KA 326
R YG VD++S ++V EM G P +D+ VQ A +R + P L + + P+ +
Sbjct: 191 RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-AMKRLRDSPPPKLKNAHKISPVLRD 249
Query: 327 LLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKTVP 362
L + P R T +E++ +Q + VP
Sbjct: 250 FLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 77/264 (29%), Positives = 116/264 (43%), Gaps = 21/264 (7%)
Query: 91 KILEDRGGIDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRH 148
K+ D I G++G VY + T +A K + S + +KE+ Q+LRH
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 149 PNIVQFLGVLKHSERLIFLTEYLRNGSLHDILK--KKGKLDPPTAVAYALDIARGMNYLH 206
PN +++ G + EY GS DIL+ KK L A +G+ YLH
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKP-LQEVEIAAICHGALQGLAYLH 132
Query: 207 HHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV 266
H IHRD+ N+L E G +K+ DFG + + +S+ G+ +MAPEV
Sbjct: 133 SHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-------VGTPYWMAPEV 182
Query: 267 ---YRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSL-YPE 322
Y VDV+S + E+ + P A+ A DS P LSS + +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS-PTLSSNDWSD 241
Query: 323 PIKALLRECWHKNPDRRPTFEEII 346
+ + C K P RP+ EE++
Sbjct: 242 YFRNFVDSCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 5e-17
Identities = 61/245 (24%), Positives = 106/245 (43%), Gaps = 15/245 (6%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +GEV + R G A K + + + + E + +K+ +V +
Sbjct: 11 GGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE 70
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+ L + + G L + G + A+ YA +I G+ LH ++RD
Sbjct: 71 TKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRD 127
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVD 277
L P N+L D+ GH++++D GL+ E +S + G G+ YMAPEV + Y S D
Sbjct: 128 LKPENILLDDYGHIRISDLGLAVKIPEGES----IRGRVGTVGYMAPEVLNNQRYTLSPD 183
Query: 278 VFSFALIVHEMFQGGPSNRA---DTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
+ +++EM +G R + DRR E S+ + E K++ + K
Sbjct: 184 YWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE-VYSAKFSEEAKSICKMLLTK 242
Query: 335 NPDRR 339
+P +R
Sbjct: 243 DPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 6e-17
Identities = 58/192 (30%), Positives = 92/192 (47%), Gaps = 11/192 (5%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G G V V+ + G +A K I I P +RN ++EL + + P IV F G
Sbjct: 16 GNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 73
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ E++ GSL +LK+ ++ ++ + RG+ YL H I+HRD+
Sbjct: 74 SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVK 131
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
PSN+L + G +K+ DFG+S Q DS + G+ YM+PE + Y D++
Sbjct: 132 PSNILVNSRGEIKLCDFGVS--GQLIDSMANSF---VGTRSYMSPERLQGTHYSVQSDIW 186
Query: 280 SFALIVHEMFQG 291
S L + E+ G
Sbjct: 187 SMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 6e-17
Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 10/200 (5%)
Query: 97 GGIDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
G + GAYG V + + T+ +A K + S N V+ + ++EL + + L+ NIV+
Sbjct: 7 GVVGEGAYGVVLKCRHKETKEIVAIKKFKDS-EENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAV-AYALDIARGMNYLHHHRPHAI 213
+ +L + EY+ L ++L++ PP V +Y + + +++ H + I
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---I 121
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG 273
+HRD+ P N+L LK+ DFG ++ E + +Y T YR +PE+ YG
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYR--SPELLLGAPYG 179
Query: 274 KSVDVFSFALIVHEMFQGGP 293
K+VD++S I+ E+ G P
Sbjct: 180 KAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 6e-17
Identities = 64/237 (27%), Positives = 101/237 (42%), Gaps = 21/237 (8%)
Query: 117 IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176
+A K I I ++ M EL + K P I+ F G R+ TE++ GSL
Sbjct: 29 LAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL 86
Query: 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDF 236
D+ K+ A+ + +G+ YL + I+HRD+ PSN+L + G +K+ DF
Sbjct: 87 -DVY---RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDF 139
Query: 237 GLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGG---P 293
G+S + +Y G+ YMAPE E YG DV+S + E+ G P
Sbjct: 140 GVSTQLVNSIAKTY-----VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYP 194
Query: 294 SNRADTA----VQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346
+ + +Q+ ED + E + +C K P RP E ++
Sbjct: 195 QIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 8e-17
Identities = 73/286 (25%), Positives = 126/286 (44%), Gaps = 56/286 (19%)
Query: 102 GAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSF----MKELGLWQKLRHPNIVQFL 155
GAYG V K G ++A K I +P +F ++E+ + ++ +H NI+ L
Sbjct: 16 GAYGMVCSATHKPTGVKVAIKKI------SPFEHQTFCQRTLREIKILRRFKHENIIGIL 69
Query: 156 GVLK----HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPH 211
+++ S +++ + L L+ ++K + L + I RG+ Y+H
Sbjct: 70 DIIRPPSFESFNDVYIVQELMETDLYKLIKTQ-HLSNDHIQYFLYQILRGLKYIHSAN-- 126
Query: 212 AIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVY-RRE 270
++HRDL PSN+L + LK+ DFGL++IA + ++ +T + Y APE+ +
Sbjct: 127 -VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSK 185
Query: 271 SYGKSVDVFSFALIVHEMFQGGP--------------------SNRADTAVQVADR-RAY 309
Y K++D++S I+ EM P ++ D ++ R R Y
Sbjct: 186 GYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNY 245
Query: 310 EDSRP-----ALSSLYPEPIKA------LLRECWHKNPDRRPTFEE 344
S P + L+P A LL + NP +R T EE
Sbjct: 246 IKSLPFKPKVPWNKLFP---NADPKALDLLDKMLTFNPHKRITVEE 288
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-16
Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 2/92 (2%)
Query: 3 IIDSEGPYRLLYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLL 61
D++G L+ ++K +++ L EKG + N D D T LHLA+ G ++V LLL
Sbjct: 35 AKDNDG-RTPLHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLL 93
Query: 62 EKGADVNSLDRWGRTPLSDARSFGHVVICKIL 93
+ GADVN+ D+ GRTPL A GH+ + K+L
Sbjct: 94 KHGADVNARDKDGRTPLHLAAKNGHLEVVKLL 125
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 1e-16
Identities = 72/250 (28%), Positives = 112/250 (44%), Gaps = 25/250 (10%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G+Y VY K + G +A K IR + + ++E L + L+H NIV ++
Sbjct: 16 GSYATVYKGKSKVNGKLVALKVIR--LQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH 73
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
E L + EY+ + K G L P + + RG++Y+H I+HRDL
Sbjct: 74 TKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLK 130
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES-YGKSVDV 278
P N+L + G LK+ DFGL++ A+ S++Y T YR P+V + Y +D+
Sbjct: 131 PQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYR--PPDVLLGSTEYSTCLDM 187
Query: 279 FSFALIVHEMFQGGPSNRADTAVQVADRRAY-------EDSRPALSSL---YPEPIKAL- 327
+ I EM QG + +Q R + ED+ P + SL PE
Sbjct: 188 WGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYS 247
Query: 328 ---LRECWHK 334
LR+ W+K
Sbjct: 248 PKNLRQAWNK 257
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR---HPNIVQ 153
I GAYG VY + G +A K++R + + S ++E+ L ++L HPNIV+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVR 66
Query: 154 FLGVLK--HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYAL-----DIARGMNYLH 206
+ V ++R +T + D+ K+ PP A + RG+++LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 207 HHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM--TGGTGSYRYMAP 264
+ I+HRDL P N+L G +K+ DFGL++I YS +M T + Y AP
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARI------YSCQMALTPVVVTLWYRAP 176
Query: 265 EVYRRESYGKSVDVFSFALIVHEMFQGGP 293
EV + +Y VD++S I EMF+ P
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 30/213 (14%)
Query: 97 GGIDPGAYGEVYLVKW----RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIV 152
G I G YG VY K G E A K + + S +E+ L ++L+H N+V
Sbjct: 6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 153 QFLGV-LKHSERLIFLT-EYLRNGSLHDIL-------KKKGKLDPPTAVAYAL-DIARGM 202
+ V L+H+++ ++L +Y + HD+ + K PP+ V L I G+
Sbjct: 66 SLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 203 NYLHHHRPHAIIHRDLTPSNVL----QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS 258
+YLH + ++HRDL P+N+L E G +K+ D GL+++ + +
Sbjct: 122 HYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178
Query: 259 YRYMAPEVY---RRESYGKSVDVFSFALIVHEM 288
Y APE+ R Y K++D+++ I E+
Sbjct: 179 IWYRAPELLLGARH--YTKAIDIWAIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 6/201 (2%)
Query: 146 LRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNY 204
L H IV+ LG+ + L +T+ GSL D +++ + LDP + + + IA+GM Y
Sbjct: 66 LDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124
Query: 205 LHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAP 264
L HR ++HR+L N+L +++ DFG++ + D Y + ++MA
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK-KYFYSEHKTPIKWMAL 180
Query: 265 EVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI 324
E Y DV+S+ + V EM G A + R A + +
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240
Query: 325 KALLRECWHKNPDRRPTFEEI 345
++ +CW + + RPTF+E+
Sbjct: 241 YMVMVKCWMIDENVRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 3e-16
Identities = 61/260 (23%), Positives = 111/260 (42%), Gaps = 29/260 (11%)
Query: 105 GEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERL 164
GE + + K +R+S + P + F++E+ +++L HPN++Q LG S
Sbjct: 14 GEAHRGM-SKARVVVKELRAS--ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPY 70
Query: 165 IFLTEYLRNGSLHDILKK-----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ + E+ G L + L+ A ++A G+ L H+ IH DL
Sbjct: 71 LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGL--LWLHQAD-FIHSDLA 127
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG------ 273
N +K+ D+GL+ + Q + Y R++APE+ E G
Sbjct: 128 LRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELV--EIRGQDLLPK 184
Query: 274 ---KSVDVFSFALIVHEMFQGGP---SNRADTAV--QVADRRAYEDSRPALSSLYPEPIK 325
K +++S + + E+F + +D V QV + + +P L Y +
Sbjct: 185 DQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWY 244
Query: 326 ALLRECWHKNPDRRPTFEEI 345
+++ CW +P+ RPT EE+
Sbjct: 245 EVMQFCW-LDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 51/162 (31%), Positives = 81/162 (50%), Gaps = 11/162 (6%)
Query: 192 VAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251
+ Y+ +A+GM +L + IHRDL N+L E +K+ DFGL++ + Y K
Sbjct: 182 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 238
Query: 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAV-QVADRRAYE 310
++MAPE Y DV+SF +++ E+F G S + + RR E
Sbjct: 239 GDARL-PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 297
Query: 311 DSR---PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRL 349
+R P ++ PE + +L +CWH P +RPTF E++ L
Sbjct: 298 GTRMRAPDYTT--PEMYQTML-DCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 4e-16
Identities = 70/251 (27%), Positives = 114/251 (45%), Gaps = 60/251 (23%)
Query: 136 FMKELGLWQKLRHPNIVQFLGVLK-HSERLIFLT-EYL--------RNGSLHDILKKKGK 185
F++ELG HPNIV+ L V+K +++ I+L EY+ R L D+ K+
Sbjct: 59 FLQELG-----DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKR--- 110
Query: 186 LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK-IAQE 244
+ Y L + + Y+H +IHRDL PSN+L + +K+ DFGL++ +++
Sbjct: 111 -----YIMYQL--LKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160
Query: 245 KDSYSYK-MTGGTGSYRYMAPEV-YRRESYGKSVDVFSFALIVHEMFQGGP-------SN 295
+++ +T + Y APE+ Y K VD++S I+ EM G P N
Sbjct: 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN 220
Query: 296 RADTAVQVADRRAYED--------SRPALSSLYPEPIKA--------------LLRECWH 333
+ + ++V + ED + L SL P K LL++
Sbjct: 221 QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLV 280
Query: 334 KNPDRRPTFEE 344
NP++R T EE
Sbjct: 281 FNPNKRLTAEE 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 66/256 (25%), Positives = 117/256 (45%), Gaps = 17/256 (6%)
Query: 99 IDPGAYGEVYLVKWRGT-EIAA-KTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G YG+VY + T E+AA K I+ + V +E+ + + +H NIV + G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV---VQQEIIMMKDCKHSNIVAYFG 73
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
++L E+ GSL DI G L + + +G+ YLH +HR
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS---KGKMHR 130
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVY---RRESYG 273
D+ +N+L + GH+K+ DFG+S AQ + + K G+ +MAPEV R+ Y
Sbjct: 131 DIKGANILLTDNGHVKLADFGVS--AQITATIA-KRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 274 KSVDVFSFALIVHEMFQGGPSN---RADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330
+ D+++ + E+ + P A+ + + ++ + + ++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKM 247
Query: 331 CWHKNPDRRPTFEEII 346
KNP +RPT E+++
Sbjct: 248 ALTKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 5e-16
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 21/199 (10%)
Query: 102 GAYGEV---YLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
GAYG V Y + R ++A K + S R ++ +EL L + ++H N++ L V
Sbjct: 26 GAYGSVCSAYDTRLR-QKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGLLDVF 83
Query: 159 KHSERL-----IFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
+ + ++L L L++I+K + KL + RG+ Y+H I
Sbjct: 84 TPATSIENFNEVYLVTNLMGADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIH---SAGI 139
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR-ESY 272
IHRDL PSNV +E L++ DFGL++ A + +MTG + Y APE+ Y
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLARQADD------EMTGYVATRWYRAPEIMLNWMHY 193
Query: 273 GKSVDVFSFALIVHEMFQG 291
++VD++S I+ E+ +G
Sbjct: 194 NQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 68/271 (25%), Positives = 118/271 (43%), Gaps = 28/271 (10%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +GEV + R G A K + + + + E + +K+ +V +
Sbjct: 11 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE 70
Query: 160 HSERLIFLTEYLRNGSL--HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+ L + + G L H + + AV YA +I G+ LH R I++RD
Sbjct: 71 TKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRD 127
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVD 277
L P N+L D+ GH++++D GL+ E + + G G+ YMAPEV + E Y S D
Sbjct: 128 LKPENILLDDHGHIRISDLGLAVHVPEGQT----IKGRVGTVGYMAPEVVKNERYTFSPD 183
Query: 278 VFSFALIVHEMFQG-GPSNRADTAVQVAD-RRAYEDSRPALSSLYPEPIKALLRECWHKN 335
++ +++EM G P + ++ + R ++ + S + ++L + K+
Sbjct: 184 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKD 243
Query: 336 PDRR--------------PTFEEIIF-RLEA 351
P R P F++I F RLEA
Sbjct: 244 PKERLGCQGGGAREVKEHPLFKQINFKRLEA 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 5e-16
Identities = 68/253 (26%), Positives = 124/253 (49%), Gaps = 25/253 (9%)
Query: 102 GAYGEVYLVKW-----RGTEIAAKTIR-SSIASNPRVRNSFMKELGLWQKLRH-PNIVQF 154
GAYG+V+LV+ G A K ++ +++ + E + + +R P +V
Sbjct: 11 GAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTL 70
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ +L + +Y+ G + L ++ Y+ +I + +LH I+
Sbjct: 71 HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIV 127
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSK--IAQEKD-SYSYKMTGGTGSYRYMAPEVYRRES 271
+RD+ N+L D GH+ +TDFGLSK +++EK+ +YS+ G+ YMAPE+ R +
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF-----CGTIEYMAPEIIRGKG 182
Query: 272 -YGKSVDVFSFALIVHEMFQGGP----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKA 326
+GK+VD +S +++ E+ G +T +V+ RR + P S + PE +
Sbjct: 183 GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS-RRILKCDPPFPSFIGPEA-QD 240
Query: 327 LLRECWHKNPDRR 339
LL + K+P +R
Sbjct: 241 LLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 17/162 (10%)
Query: 192 VAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251
+ Y+ +ARGM +L + IHRDL N+L E +K+ DFGL++ + Y K
Sbjct: 177 ICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 233
Query: 252 MTGGTGSYR----YMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVAD-- 305
GS R +MAPE + Y DV+SF +++ E+F G S VQ+ +
Sbjct: 234 -----GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP--GVQINEEF 286
Query: 306 -RRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346
+R + +R I ++ CW +P RPTF ++
Sbjct: 287 CQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-15
Identities = 39/86 (45%), Positives = 49/86 (56%), Gaps = 2/86 (2%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L + G+ V LEKG + NL D TALHLA+ G EIV LLLE GADVN+ D
Sbjct: 1 LHLAAKNGNLELVKLLLEKGADVNL--GDTDTALHLAARNGNLEIVKLLLEHGADVNAKD 58
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
+ G T L A G++ I K+L + G
Sbjct: 59 KDGNTALHLAARNGNLEIVKLLLEHG 84
|
Length = 91 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 67/253 (26%), Positives = 115/253 (45%), Gaps = 30/253 (11%)
Query: 109 LVKWRGTEIAAKTIRSSIASNPRVRNSFMK-ELGLWQKLRHPNIVQFLGVLKHSERLIFL 167
V RG++ K + + N + ++ + EL H IV+ K ++L+ +
Sbjct: 84 FVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143
Query: 168 TEYLRNGSLHDILKKKGKLDPP----TAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNV 223
EY G L+ +K++ K P I ++ +H + ++HRDL +N+
Sbjct: 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANI 200
Query: 224 LQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG-TGSYRYMAPEVYRRESYGKSVDVFSFA 282
G +K+ DFG SK Q DS S + G+ Y+APE++ R+ Y K D++S
Sbjct: 201 FLMPTGIIKLGDFGFSK--QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLG 258
Query: 283 LIVHEMFQ-----GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI----KALLRECWH 333
+I++E+ GPS R ++ + Y P +P P+ KALL
Sbjct: 259 VILYELLTLHRPFKGPSQR-----EIMQQVLYGKYDP-----FPCPVSSGMKALLDPLLS 308
Query: 334 KNPDRRPTFEEII 346
KNP RPT ++++
Sbjct: 309 KNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 99 IDPGAYGEV--YLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
+ GAYG V G +A K + S + ++ +EL L + ++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 157 VLKHSERL-----IFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPH 211
V + L ++L +L L++I+K + KL I RG+ Y+H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIH---SA 139
Query: 212 AIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR-E 270
IIHRDL PSN+ +E LK+ DFGL++ + +MTG + Y APE+
Sbjct: 140 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWM 193
Query: 271 SYGKSVDVFSFALIVHEMFQG 291
Y ++VD++S I+ E+ G
Sbjct: 194 HYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 56/172 (32%), Positives = 88/172 (51%), Gaps = 18/172 (10%)
Query: 192 VAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251
++Y+ +ARGM +L + IHRDL N+L E +K+ DFGL++ + Y K
Sbjct: 176 ISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 232
Query: 252 MTGGTGSYR----YMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVAD-- 305
G R +MAPE + Y DV+SF +++ E+F G S VQ+ +
Sbjct: 233 -----GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP--GVQIDEEF 285
Query: 306 -RRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRL-EAIQES 355
RR E +R I +++ +CWH NP+ RPTF E++ L + +QE+
Sbjct: 286 CRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 99 IDPGAYGEVYLVKWRGT-EIAA-KTIRSSIASNPRVRNSF----MKELGLWQKLRHPNIV 152
I+ G YG VY + + T EI A K ++ + + F ++E+ + KL+HPNIV
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLK-----MEKEKEGFPITSLREINILLKLQHPNIV 67
Query: 153 QFLGVL--KHSERLIFLTEYLRNGSLHDILK-KKGKLDPPTAVAYALDIARGMNYLHHHR 209
V+ + +++ + EY+ + L +++ K L + G+ +LH +
Sbjct: 68 TVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW 126
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
I+HRDL SN+L + G LK+ DFGL A+E S T + Y APE+
Sbjct: 127 ---ILHRDLKTSNLLLNNRGILKICDFGL---AREYGSPLKPYTQLVVTLWYRAPELLLG 180
Query: 270 ES-YGKSVDVFSFALIVHEMFQGGP 293
Y ++D++S I E+ P
Sbjct: 181 AKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 16/211 (7%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +GEV +V+ + T A K ++ S+ + F +E + P I Q +
Sbjct: 12 GHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71
Query: 160 HSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ L + EY G L +L + + + D A Y ++ ++ +H +HRD+
Sbjct: 72 DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDI 128
Query: 219 TPSNVLQDEAGHLKVTDFGLS-KIAQEKDSYSYKMTGGTGSYRYMAPEV------YRRES 271
P NVL D GH+K+ DFG + ++ K S K+ GT Y+APEV + +
Sbjct: 129 KPENVLIDRTGHIKLADFGSAARLTANKMVNS-KLPVGTPD--YIAPEVLTTMNGDGKGT 185
Query: 272 YGKSVDVFSFALIVHEMFQGGPSNRADTAVQ 302
YG D +S +I +EM G T+ +
Sbjct: 186 YGVECDWWSLGVIAYEMIYGRSPFHEGTSAK 216
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 102 GAYGEV-YLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GAYG V + R G ++A K + S + ++ +EL L + ++H N++ L V
Sbjct: 26 GAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIGLLDVFT 84
Query: 160 HSERL-----IFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
L +L L ++K + KL + +G+ Y+H II
Sbjct: 85 PDLSLDRFHDFYLVMPFMGTDLGKLMKHE-KLSEDRIQFLVYQMLKGLKYIH---AAGII 140
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR-ESYG 273
HRDL P N+ +E LK+ DFGL A++ DS +MTG + Y APEV Y
Sbjct: 141 HRDLKPGNLAVNEDCELKILDFGL---ARQTDS---EMTGYVVTRWYRAPEVILNWMHYT 194
Query: 274 KSVDVFSFALIVHEMFQGGP 293
++VD++S I+ EM G P
Sbjct: 195 QTVDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 97 GGIDPGAYGEVYLVKWRGTE----IAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNI 151
+ GAYG V + T +A K I +++ S + ++EL L + R H NI
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKI-TNVFSKKILAKRALRELKLLRHFRGHKNI 64
Query: 152 VQFLG---VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH 208
V + ++L E L LH I++ L ++ I G+ Y+H
Sbjct: 65 TCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA 124
Query: 209 RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK-IAQEKDSYSYKMTGGTGSYRYMAPEVY 267
++HRDL P N+L + LK+ DFGL++ ++ + MT + Y APE+
Sbjct: 125 N---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181
Query: 268 -RRESYGKSVDVFSFALIVHEMFQGGP 293
+SY K++DV+S I+ E+ P
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 5e-15
Identities = 51/193 (26%), Positives = 92/193 (47%), Gaps = 10/193 (5%)
Query: 149 PNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH 208
P IV ++L F+ + + G LH L + G YA +I G+ ++H+
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 209 RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYR 268
+++RDL P+N+L DE GH++++D GL+ +K K G++ YMAPEV +
Sbjct: 117 ---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQ 168
Query: 269 R-ESYGKSVDVFSFALIVHEMFQG-GPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKA 326
+ +Y S D FS ++ ++ +G P + T + R L + +++
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 228
Query: 327 LLRECWHKNPDRR 339
LL ++ +RR
Sbjct: 229 LLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 74/268 (27%), Positives = 124/268 (46%), Gaps = 32/268 (11%)
Query: 99 IDPGAYGEVYLV--KWRGTEIAAKTIRS--SIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
I G YG+V+ V K G++ A K + I + +K L HPN+V+F
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPNVVKF 80
Query: 155 LGV-----LKHSERLIFLTEYLRNGSLHDILK---KKGKLDPPTAVAYALDIA-RGMNYL 205
G+ +K+ ++L + E GS+ D++K K+G+ +AY L A G+ +L
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140
Query: 206 HHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPE 265
H ++ IHRD+ +N+L G +K+ DFG+S + S + G+ +MAPE
Sbjct: 141 HVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSA---QLTSTRLRRNTSVGTPFWMAPE 194
Query: 266 VYRRE-----SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSS-- 318
V E +Y DV+S + E+ G P AD A + + P L
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPP-LADLHPMRALFKIPRNPPPTLHQPE 253
Query: 319 LYPEPIKALLRECWHKNPDRRPTFEEII 346
L+ +R+C K+ ++RPT +++
Sbjct: 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLL 281
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 99 IDPGAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I GAYG V K T ++A K I ++ + + + ++E+ L + L H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIKD 71
Query: 157 VLKHSERLIFLTEY----LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
++ R F Y L + LH I++ L + + RG+ Y+H
Sbjct: 72 IMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--- 128
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES- 271
++HRDL PSN+L + LK+ DFGL++ EK + MT + Y APE+ S
Sbjct: 129 VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDF---MTEYVVTRWYRAPELLLNCSE 185
Query: 272 YGKSVDVFSFALIVHEMFQGGP 293
Y ++DV+S I E+ P
Sbjct: 186 YTTAIDVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 5e-15
Identities = 68/208 (32%), Positives = 104/208 (50%), Gaps = 28/208 (13%)
Query: 99 IDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G YG VY + R T IA K IR + V ++ ++E+ L ++++H NIV+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLE-QEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 157 VLKHSERLIFLT-EYLRNGSLHDI-LKKKGKLDP-----PTAV-AYALDIARGMNYLHHH 208
V+ HSE+ ++L EYL D+ LKK P P + Y I RG+ Y H H
Sbjct: 69 VV-HSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 209 RPHAIIHRDLTPSNVLQDEAGH-LKVTDFGLSK-IAQEKDSYSYKMTGGTGSYRYMAPEV 266
R ++HRDL P N+L D + LK+ DFGL++ ++++++ + Y APE+
Sbjct: 122 R---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPEI 174
Query: 267 YR-RESYGKSVDVFSFALIVHEMFQGGP 293
Y VD++S I EM P
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 7e-15
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 90 CKILEDRGGIDPGAYGEVYLVKWRGT--EIAAKTIRSSI--ASNPRVRNSFMKELGLWQK 145
C+I++ ID G +G+V ++K + T K I++ A P V + MK+
Sbjct: 16 CEIVKKLKLID-GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMV-HQLMKD------ 67
Query: 146 LRHPNIVQ---FLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGM 202
+PN ++ + LK + + +Y+++G L D+LKK+GKL + +
Sbjct: 68 --NPNFIKLYYSVTTLKGH---VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEAL 122
Query: 203 NYLHHHRPHAIIHRDLTPSNVLQDEA-GHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRY 261
N LH H IIH D+ NVL D A + + D+GL KI Y G+ Y
Sbjct: 123 NDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD-------GTLDY 172
Query: 262 MAPEVYRRESYGKSVDVFSFALIVHEMFQGG 292
+PE + +Y S D ++ ++ +E+ G
Sbjct: 173 FSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-15
Identities = 58/260 (22%), Positives = 123/260 (47%), Gaps = 23/260 (8%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNP-RVRNSFMKELGLWQKLRHPNIVQFLGV 157
I G++G++YL K + + P + + + KE+ L K++HPNIV F
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 158 LKHSERLIFLTEYLRNGSL-HDILKKKGKL-DPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ + RL + EY G L I +++G L +++ + I+ G+ ++H + I+H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILH 124
Query: 216 RDLTPSNVLQDEAGHL-KVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
RD+ N+ + G + K+ DFG+++ + +Y G+ Y++PE+ + Y
Sbjct: 125 RDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC---VGTPYYLSPEICQNRPYNN 181
Query: 275 SVDVFSFALIVHEM------FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328
D++S +++E+ F+G +N +++ +S + +++L+
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFEG--NNLHQLVLKICQGYFA-----PISPNFSRDLRSLI 234
Query: 329 RECWHKNPDRRPTFEEIIFR 348
+ + +P RP+ I+ R
Sbjct: 235 SQLFKVSPRDRPSITSILKR 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 9e-15
Identities = 70/265 (26%), Positives = 121/265 (45%), Gaps = 31/265 (11%)
Query: 102 GAYGEVYLVKWRGT------EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G +G ++ E+ KT++ AS +V ++E L L H NI+ L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQV-TLLLQESCLLYGLSHQNILPIL 74
Query: 156 GV-LKHSERLIFLTEYLRNGSLHDILK--KKGKLDPPTA------VAYALDIARGMNYLH 206
V ++ E L Y+ G+L L+ + G+ + P A V A+ IA GM+YLH
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 207 HHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYR---YMA 263
+IH+D+ N + DE +K+TD LS+ D + G R +MA
Sbjct: 135 KRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL----GDNENRPVKWMA 187
Query: 264 PEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY--EDSRPALSSLYP 321
E + Y + DV+SF +++ E+ G + + + + AY + R A P
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE--IDPFEMAAYLKDGYRLAQPINCP 245
Query: 322 EPIKALLRECWHKNPDRRPTFEEII 346
+ + A++ CW +P+ RP+F +++
Sbjct: 246 DELFAVMACCWALDPEERPSFSQLV 270
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 47/223 (21%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSF----MKELGLWQKLRHPNIVQFL 155
G +GEVY + G +A K I + N + + F ++E+ + +KL+HPN+V +
Sbjct: 19 GTFGEVYKARQIKTGRVVALKKI---LMHNEK--DGFPITALREIKILKKLKHPNVVPLI 73
Query: 156 GVL------KHSERLIF----------LTEYLRNGSLHDILKKKGKLDPPTAVAYALDIA 199
+ +R L+ L N S+ L Y L +
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--------LTESQIKCYMLQLL 125
Query: 200 RGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQE-KDSYSYKMTGGTGS 258
G+NYLH + I+HRD+ +N+L D G LK+ DFGL++ + GGT
Sbjct: 126 EGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 259 YR-------YMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGP 293
Y Y PE+ E Y +VD++ + EMF P
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 42/144 (29%), Positives = 76/144 (52%), Gaps = 9/144 (6%)
Query: 149 PNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH 208
P IV ++L F+ + + G LH L + G YA +I G+ ++H+
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 209 RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYR 268
+++RDL P+N+L DE GH++++D GL+ +K ++ G++ YMAPEV +
Sbjct: 117 ---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-----SVGTHGYMAPEVLQ 168
Query: 269 R-ESYGKSVDVFSFALIVHEMFQG 291
+ +Y S D FS ++ ++ +G
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 62/240 (25%), Positives = 97/240 (40%), Gaps = 45/240 (18%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+GEV LV+ T A KT+R + E + + + +V+ +
Sbjct: 12 GAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ L F+ +Y+ G + +L + G + A Y ++ + +H IHRD+
Sbjct: 72 DKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIK 128
Query: 220 PSNVLQDEAGHLKVTDFGL---------SKIAQE-----KDSYSYKMTGG---------- 255
P N+L D GH+K+TDFGL SK Q+ +DS
Sbjct: 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPL 188
Query: 256 ----------------TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT 299
G+ Y+APEV R Y + D +S +I++EM G P ADT
Sbjct: 189 ERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADT 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 59/239 (24%), Positives = 108/239 (45%), Gaps = 24/239 (10%)
Query: 133 RNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAV 192
R E+ + + +H N+V+ + L + E+L G+L DI+ +++
Sbjct: 61 RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIA 119
Query: 193 AYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFG----LSKIAQEKDSY 248
A L + + ++ LH +IHRD+ ++L G +K++DFG +SK + S
Sbjct: 120 AVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176
Query: 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRA 308
G+ +MAPE+ R YG VD++S ++V EM G P + ++ A +
Sbjct: 177 -------VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMI 228
Query: 309 YEDSRPALSSLY--PEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKTVPSCC 365
++ P L +L+ +K L ++P +R T E+ ++ F K P C
Sbjct: 229 RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL------LKHPFLAKAGPPSC 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 31/218 (14%)
Query: 99 IDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G GEVYL +A K IR ++ NP ++ F++E + L HP IV
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKK-------KGKLDPPTAVAYALDI----ARGMNYL 205
+ + + + Y+ +L +LK +L T+V L I + Y+
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129
Query: 206 HHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFG--LSKIAQEKD--SYSYKMTGG------ 255
H ++HRDL P N+L G + + D+G + K +E+D
Sbjct: 130 H---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 256 -----TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEM 288
G+ YMAPE +S D+++ +I+++M
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224
|
Length = 932 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 16/211 (7%)
Query: 99 IDPGAYGEVYLVKWRGTE-IAAKTIRSSIASNPRVRNSFM-KELGLWQKLRHPNIVQFLG 156
I GA+GEV LV+ + ++ + A + S R ++F +E + P +VQ
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVA--YALDIARGMNYLHHHRPHAII 214
+ + L + EY+ G L +++ D P A Y ++ ++ +H +I
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIH---SMGLI 164
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES--- 271
HRD+ P N+L D+ GHLK+ DFG E GT Y++PEV + +
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD--YISPEVLKSQGGDG 222
Query: 272 -YGKSVDVFSFALIVHEMFQGGPSNRADTAV 301
YG+ D +S + + EM G AD+ V
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 32/257 (12%)
Query: 102 GAYGEVYLVKW-----RGTEIAAKTIR-SSIASNPRVRNSFMKELGLWQKLRH-PNIVQF 154
GAYG+V+LV+ G A K ++ ++I + E + + +R P +V
Sbjct: 11 GAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 70
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ +L + +Y+ G L L ++ + Y+ +I + +LH II
Sbjct: 71 HYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GII 127
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSK--IAQEKD-SYSYKMTGGTGSYRYMAPEVYRRES 271
+RD+ N+L D GH+ +TDFGLSK E + +YS+ G+ YMAP++ R
Sbjct: 128 YRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSF-----CGTIEYMAPDIVRGGD 182
Query: 272 YG--KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED-SRPALSSLYPEP----- 323
G K+VD +S ++++E+ G D ++ + + SR L S P P
Sbjct: 183 GGHDKAVDWWSMGVLMYELLTGASPFTVD-----GEKNSQAEISRRILKSEPPYPQEMSA 237
Query: 324 -IKALLRECWHKNPDRR 339
K +++ K+P +R
Sbjct: 238 LAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 99 IDPGAYGEVYLVKWRGT-EIAAKTIRSSIASNPRVRNSFM-KELGLWQKLRHPNIVQFLG 156
I GA+GEV LV+ + T ++ A + S R ++F +E + P +VQ
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVA--YALDIARGMNYLHHHRPHAII 214
+ L + EY+ G L +++ D P A Y ++ ++ +H I
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIH---SMGFI 164
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES--- 271
HRD+ P N+L D++GHLK+ DFG + + K+ + G+ Y++PEV + +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFG-TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 272 -YGKSVDVFSFALIVHEMFQGGPSNRADTAV 301
YG+ D +S + ++EM G AD+ V
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 6e-14
Identities = 66/246 (26%), Positives = 103/246 (41%), Gaps = 16/246 (6%)
Query: 102 GAYGEV--YLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +GEV VK G A K + + E + +K+ P IV +
Sbjct: 4 GGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE 63
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
L + + G L + G+ L+ + Y+ I G+ +LH I++RD
Sbjct: 64 SKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRD 120
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVD 277
+ P NVL D+ G+ +++D GL+ + KD + GT Y MAPE+ + E Y VD
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGY--MAPEILKEEPYSYPVD 176
Query: 278 VFSFALIVHEMFQGGPSNRADTAVQVAD----RRAYEDSRPALSSLYPEPIKALLRECWH 333
F+ ++EM G + D +VA RR ED + E K + R
Sbjct: 177 WFAMGCSIYEMVAGRTPFK-DHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA 235
Query: 334 KNPDRR 339
K P+ R
Sbjct: 236 KKPEDR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-14
Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 97 GGIDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
+ G Y V+ + + TE +A K IR + + ++E+ L + L+H NIV
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 155 LGVLKHSER-LIFLTEYLRNGSLHDILKKKGKLDPPTAVA-YALDIARGMNYLHHHRPHA 212
++ H+ER L + EYL + L L G L V + + RG++Y H +
Sbjct: 69 HDII-HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--- 123
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES- 271
I+HRDL P N+L +E G LK+ DFGL++ A+ + +Y T YR P+V +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYR--PPDVLLGSTE 180
Query: 272 YGKSVDVFSFALIVHEMFQGGP 293
Y +D++ I++EM G P
Sbjct: 181 YSTPIDMWGVGCILYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 41/223 (18%)
Query: 102 GAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRN-----------SFMKELGLWQKLRH 148
G YG+V G +A K ++ SN ++ + ++EL + +++H
Sbjct: 20 GTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH 79
Query: 149 PNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH 208
NI+ + V + + + + + L ++ +K +L L I G+N LH
Sbjct: 80 ENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW 138
Query: 209 RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSY-------RY 261
+HRDL+P+N+ + G K+ DFGL++ Y Y T S
Sbjct: 139 ---YFMHRDLSPANIFINSKGICKIADFGLAR------RYGYPPYSDTLSKDETMQRREE 189
Query: 262 MAPEV----YR-------RESYGKSVDVFSFALIVHEMFQGGP 293
M +V YR E Y +VD++S I E+ G P
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 102 GAYGEVYLVK--WRGTEIAAK---TIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
GA+G V+ V G +A K + ++ S RV +EL + +H N++ L
Sbjct: 11 GAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRV----FRELKMLCFFKHDNVLSALD 66
Query: 157 VLKHS-----ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPH 211
+L+ E + +TE L LH I+ L + I RG+ YLH
Sbjct: 67 ILQPPHIDPFEEIYVVTE-LMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG-- 123
Query: 212 AIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYR-RE 270
I+HRD+ P N+L + LK+ DFGL+++ +E D S MT + Y APE+
Sbjct: 124 -ILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDE-SKHMTQEVVTQYYRAPEILMGSR 180
Query: 271 SYGKSVDVFSFALIVHEMFQG 291
Y +VD++S I E+
Sbjct: 181 HYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 21/200 (10%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G+Y VY + + T +A K IR + + ++E L + L+H NIV ++
Sbjct: 16 GSYATVYKGRSKLTGQLVALKEIR--LEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH 73
Query: 160 HSERLIFLTEYLRNGSLHDILKK-----KGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ L + EYL LK+ G L + + RG+ Y H R ++
Sbjct: 74 TKKTLTLVFEYL-----DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VL 125
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES-YG 273
HRDL P N+L E G LK+ DFGL++ A+ S +Y T YR P+V + Y
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYR--PPDVLLGSTEYS 182
Query: 274 KSVDVFSFALIVHEMFQGGP 293
S+D++ I +EM G P
Sbjct: 183 TSLDMWGVGCIFYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 75/269 (27%), Positives = 122/269 (45%), Gaps = 34/269 (12%)
Query: 99 IDPGAYGEVYLV-KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLG 156
I G YG+VY V + +AA I I+ V E + Q L HPN+V+F G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYG 86
Query: 157 VLKHSERLI-----FLTEYLRNGSLHDILK---KKG-KLDPPTAVAYALDIAR-GMNYLH 206
+ +++L+ + E GS+ +++K G +LD ++Y L A G+ +LH
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM-ISYILYGALLGLQHLH 145
Query: 207 HHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV 266
++R IIHRD+ +N+L G +K+ DFG+S + S + G+ +MAPEV
Sbjct: 146 NNR---IIHRDVKGNNILLTTEGGVKLVDFGVSA---QLTSTRLRRNTSVGTPFWMAPEV 199
Query: 267 YRRE-----SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYP 321
E SY DV+S + E+ G P D + + P L L+P
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPP-LFDMHPVKTLFKIPRNPPPTL--LHP 256
Query: 322 EP----IKALLRECWHKNPDRRPTFEEII 346
E + +C K+ + RP+ ++
Sbjct: 257 EKWCRSFNHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 29/170 (17%)
Query: 194 YALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253
++ +A+GM++L IHRD+ NVL + K+ DFGL++ +Y K
Sbjct: 217 FSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK-- 271
Query: 254 GGTGSYR----YMAPE-----VYRRESYGKSVDVFSFALIVHEMFQGG----PSNRADTA 300
G+ R +MAPE VY +S DV+S+ +++ E+F G P ++
Sbjct: 272 ---GNARLPVKWMAPESIFDCVYTVQS-----DVWSYGILLWEIFSLGKSPYPGILVNSK 323
Query: 301 VQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350
+R Y+ SRP + P I ++++ CW+ P RPTF +I ++
Sbjct: 324 FYKMVKRGYQMSRPDFA---PPEIYSIMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 65/256 (25%), Positives = 113/256 (44%), Gaps = 17/256 (6%)
Query: 99 IDPGAYGEVYLVKWRGT-EIAAKTIRSSIASNPRVRNSFMK-ELGLWQKLRHPNIVQFLG 156
+ G YG+VY + T E+AA I I P S ++ E+ + ++ +H NIV + G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKI---IKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
E+L EY GSL DI G L + +G+ YLH +HR
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHR 130
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES---YG 273
D+ +N+L + G +K+ DFG +A + + K G+ +MAPEV E Y
Sbjct: 131 DIKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 274 KSVDVFSFALIVHEMFQGGPSN---RADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330
+ D+++ + E+ + P A+ + + ++ + + + ++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKI 247
Query: 331 CWHKNPDRRPTFEEII 346
KNP +RPT E ++
Sbjct: 248 SLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 29/178 (16%)
Query: 186 LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEK 245
LD ++++ +A+GM++L IHRDL N+L K+ DFGL++ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 246 DSYSYKMTGGTGSYR----YMAPE-----VYRRESYGKSVDVFSFALIVHEMFQGGPSNR 296
+Y K G+ R +MAPE VY ES DV+S+ +++ E+F G S
Sbjct: 268 SNYVVK-----GNARLPVKWMAPESIFNCVYTFES-----DVWSYGILLWEIFSLGSSPY 317
Query: 297 ADTAVQVADRRAYEDSRPALSSLYPE----PIKALLRECWHKNPDRRPTFEEIIFRLE 350
V D + Y+ + L PE + +++ CW +P +RPTF++I+ +E
Sbjct: 318 PGMPV---DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 68/266 (25%), Positives = 117/266 (43%), Gaps = 23/266 (8%)
Query: 93 LEDRGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH-- 148
LE+ G I G G+VY ++++ G +A K +R + N + +L + K H
Sbjct: 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT--GNKEENKRILMDLDVVLK-SHDC 73
Query: 149 PNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVA--YALDIARGMNYLH 206
P IV+ G + E + + D L K+ + P + + I + ++YL
Sbjct: 74 PYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 207 HHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV 266
H +IHRD+ PSN+L D +G++K+ DFG+S + DS + T G YMAPE
Sbjct: 132 EK--HGVIHRDVKPSNILLDASGNVKLCDFGIS--GRLVDSKAK--TRSAGCAAYMAPER 185
Query: 267 Y----RRESYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDS-RPALSSLY 320
Y DV+S + + E+ G P T +V + E+ + +
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGF 245
Query: 321 PEPIKALLRECWHKNPDRRPTFEEII 346
+ + C K+ +RP + E++
Sbjct: 246 SPDFCSFVDLCLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 7e-13
Identities = 69/261 (26%), Positives = 117/261 (44%), Gaps = 26/261 (9%)
Query: 102 GAYGEVYLVKWRGT-EIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVL- 158
G YG+VY + T ++AA + +E+ + +K H NI + G
Sbjct: 17 GTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 159 -----KHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAY-ALDIARGMNYLHHHRPH 211
++L + E+ GS+ D++K KG +AY +I RG+++LH H+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK-- 131
Query: 212 AIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE- 270
+IHRD+ NVL E +K+ DFG+S + D + G+ +MAPEV +
Sbjct: 132 -VIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 271 ----SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPAL-SSLYPEPIK 325
+Y D++S + EM +G P D A + P L S + + +
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPP-LCDMHPMRALFLIPRNPAPRLKSKKWSKKFQ 246
Query: 326 ALLRECWHKNPDRRPTFEEII 346
+ + C KN +RPT E+++
Sbjct: 247 SFIESCLVKNHSQRPTTEQLM 267
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|140343 PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 34/79 (43%), Positives = 44/79 (55%), Gaps = 2/79 (2%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L ++ GD G L G +PN DYD RT LH+A + G ++V +LLE GAD LD
Sbjct: 86 LCQLAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLD 145
Query: 72 RWGRTPLSDA--RSFGHVV 88
+ G+TPL A F VV
Sbjct: 146 KDGKTPLELAEENGFREVV 164
|
Length = 664 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 8e-13
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 25/220 (11%)
Query: 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH-PNIVQFL 155
I G YG+VY + + G +A K R + + + ++E+ L Q L IV+ L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 156 GVL----KHSERLIFLT-EYLRNGSLHDILKKKGK-----LDPPTAVAYALDIARGMNYL 205
V K+ + ++L EYL + L + G+ L T ++ + +G+ +
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 206 HHHRPHAIIHRDLTPSNVLQDEA-GHLKVTDFGLSK-IAQEKDSYSYKMTGGTGSYRYMA 263
H H ++HRDL P N+L D+ G LK+ D GL + + SY++++ T YR A
Sbjct: 127 HKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYR--A 179
Query: 264 PEVYRRES-YGKSVDVFSFALIVHEMFQGGPSNRADTAVQ 302
PEV + Y VD++S I EM + P D+ +Q
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 99 IDPGAYGEVYLVKWR--GTEIAAKTIRS---SIASNPRVRNSFMKELGLWQKLRHPNIVQ 153
I G+YG V G ++A K I ++ R+ ++E+ L + LRHP+IV+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRI----LREIKLLRLLRHPDIVE 63
Query: 154 FLGVLKHSERLIFLTEY----LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHR 209
++ R F Y L LH ++K L P + + R + Y+H
Sbjct: 64 IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH--- 120
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--- 266
+ HRDL P N+L + LK+ DFGL+++A + T + Y APE+
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 267 -YRRESYGKSVDVFSFALIVHEMFQGGP 293
+ + Y ++D++S I E+ G P
Sbjct: 181 FFSK--YTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 1e-12
Identities = 35/63 (55%), Positives = 42/63 (66%)
Query: 35 NLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILE 94
N D D RT LHLA+S G E+V LLLE GADVN+ D GRTPL A GH+ I K+L
Sbjct: 1 NARDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLL 60
Query: 95 DRG 97
++G
Sbjct: 61 EKG 63
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 30/220 (13%)
Query: 99 IDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSF----MKELGLWQKLRHPNIV 152
I G +GEV+ + + T+ +A K + + F ++E+ + Q L+H N+V
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLME-----NEKEGFPITALREIKILQLLKHENVV 74
Query: 153 QFLGV----------LKHSERLIF-LTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARG 201
+ + K S L+F E+ G L + K K + G
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNG 131
Query: 202 MNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK-IAQEKDSYSYKMTGGTGSYR 260
+ Y+H ++ I+HRD+ +N+L + G LK+ DFGL++ + K+S + T +
Sbjct: 132 LYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 261 YMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADT 299
Y PE+ E YG +D++ I+ EM+ P + +T
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 13/196 (6%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G Y VY + + T+ +A K IR + + ++E+ L + L+H NIV ++
Sbjct: 17 GTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH 74
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVA-YALDIARGMNYLHHHRPHAIIHRDL 218
+ L + EYL + L L G V + + RG+NY H + ++HRDL
Sbjct: 75 TEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDL 130
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES-YGKSVD 277
P N+L +E G LK+ DFGL++ A+ + +Y T YR P++ + Y +D
Sbjct: 131 KPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYR--PPDILLGSTDYSTQID 187
Query: 278 VFSFALIVHEMFQGGP 293
++ I +EM G P
Sbjct: 188 MWGVGCIFYEMSTGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 70/290 (24%), Positives = 116/290 (40%), Gaps = 60/290 (20%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIRSSIASNPRVRNSFMK---ELGLWQKLRHPNIVQFLG 156
GA+GEV L + T+ A KT+R + +RN E + + + +V+
Sbjct: 12 GAFGEVCLARKVDTKALYAMKTLRKK---DVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ + L F+ +Y+ G + +L + G A Y ++ + +H IHR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHR 125
Query: 217 DLTPSNVLQDEAGHLKVTDFGL---------SKIAQ-----EKDSYSYKMTGG------- 255
D+ P N+L D GH+K+TDFGL SK Q +DS + G
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC 185
Query: 256 -----------------------TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGG 292
G+ Y+APEV R Y + D +S +I++EM G
Sbjct: 186 GDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245
Query: 293 PSNRADTAVQVADRRAYEDSR---PALSSLYPEPIKALLRECWHKNPDRR 339
P A T ++ + + P + L PE +++ C + P+ R
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC--RGPEDR 293
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 64/254 (25%), Positives = 98/254 (38%), Gaps = 66/254 (25%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR----------H 148
I GA+GEV LV+ + T I + ++R S M E +R +
Sbjct: 9 IGRGAFGEVRLVQKKDT--------GHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 149 PNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH 208
P +V+ + L + EYL G + +L KK Y + ++ +H
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 209 RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK-------------------------IAQ 243
IHRD+ P N+L D GH+K++DFGL I++
Sbjct: 121 ---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK 177
Query: 244 EKDS---------------YSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEM 288
S YS T GT Y+APEV+ + Y K D +S +I++EM
Sbjct: 178 PMSSKRKAETWKRNRRALAYS---TVGTPD--YIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 289 FQGGPSNRADTAVQ 302
G P +D +
Sbjct: 233 LVGYPPFCSDNPQE 246
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 13/196 (6%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G Y V+ + + TE +A K IR + + ++E+ L + L+H NIV ++
Sbjct: 17 GTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH 74
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVA-YALDIARGMNYLHHHRPHAIIHRDL 218
+ L + EYL + L + G + V + I RG+ Y H + ++HRDL
Sbjct: 75 TDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDL 130
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES-YGKSVD 277
P N+L +E G LK+ DFGL++ A+ + +Y T YR P+V S Y +D
Sbjct: 131 KPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYR--PPDVLLGSSEYSTQID 187
Query: 278 VFSFALIVHEMFQGGP 293
++ I EM G P
Sbjct: 188 MWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 61/236 (25%), Positives = 97/236 (41%), Gaps = 51/236 (21%)
Query: 99 IDPGAYGEVYLVKWRGTE--IAAKTIRSS-------IASNPRVRNSFMKELGLWQKLRHP 149
I GA+GEV LV+ + T A K +R + +A R+ ++ G W
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW------ 62
Query: 150 NIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHR 209
+V+ + L + E+L G + +L KK L Y + ++ +H
Sbjct: 63 -VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL- 120
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLS---KIAQEKDSY------------------ 248
IHRD+ P N+L D GH+K++DFGL K A + Y
Sbjct: 121 --GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 249 -----SYKMT------GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGP 293
++K G+ Y+APEV+ + Y K D +S +I++EM G P
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 53/243 (21%), Positives = 98/243 (40%), Gaps = 45/243 (18%)
Query: 128 SNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLD 187
S+ R +F + L +L H ++V+ GV E I + EY++ G L L ++ +
Sbjct: 40 SDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREK--N 96
Query: 188 PPTA-----VAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH-------LKVTD 235
+ VA L A ++YL + ++H ++ N+L G +K++D
Sbjct: 97 NVSLHWKLDVAKQL--ASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSD 151
Query: 236 FGLSKIAQEKDSYSYKMTGGTGSYR-----YMAPEVYRRESYGKSV--DVFSFALIVHEM 288
G +T + R ++APE R ++ D +SF + E+
Sbjct: 152 PG------------IPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
Query: 289 FQGGPSNRADTAVQVADRRAYEDSR--PALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346
G + + +R Y+D P + L+ +CW +P +RP+F I+
Sbjct: 200 CSNGEEPLSTLSSSEKERF-YQDQHRLPMPDC---AELANLINQCWTYDPTKRPSFRAIL 255
Query: 347 FRL 349
L
Sbjct: 256 RDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 13/164 (7%)
Query: 192 VAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251
V ++ +A GM +L +HRDL NVL E +K+ DFGL++ +Y K
Sbjct: 242 VGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK 298
Query: 252 MTGGTG-SYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGG----PSNRADTAVQVADR 306
G T ++MAPE Y DV+SF +++ E+F G P + A +
Sbjct: 299 --GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK 356
Query: 307 RAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350
R Y ++PA +S + I ++++CW + + RP F +++ +
Sbjct: 357 RGYRMAKPAHAS---DEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 13/156 (8%)
Query: 192 VAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251
+++ +ARGM +L +HRDL NVL + +K+ DFGL++ +Y K
Sbjct: 240 LSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296
Query: 252 MTGGTG-SYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGG----PSNRADTAVQVADR 306
G T ++MAPE Y DV+S+ +++ E+F G P D+ +
Sbjct: 297 --GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK 354
Query: 307 RAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTF 342
Y ++P + + + ++ +CW+ P++RP+F
Sbjct: 355 SGYRMAKPDHA---TQEVYDIMVKCWNSEPEKRPSF 387
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVL-- 158
G YG+VY K R + + E+ + +K H NI + G
Sbjct: 27 GTYGQVY--KGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84
Query: 159 ----KHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAY-ALDIARGMNYLHHHRPHA 212
H ++L + E+ GS+ D++K KG +AY +I RG+ +LH H+
Sbjct: 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--- 141
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE-- 270
+IHRD+ NVL E +K+ DFG+S AQ + + T G+ +MAPEV +
Sbjct: 142 VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNT-FIGTPYWMAPEVIACDEN 198
Query: 271 ---SYGKSVDVFSFALIVHEMFQGGP 293
+Y D++S + EM +G P
Sbjct: 199 PDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 50/183 (27%), Positives = 86/183 (46%), Gaps = 15/183 (8%)
Query: 114 GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERL-----IFLT 168
G +A K + + + ++ +EL L + + H NI+ L V + L ++L
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104
Query: 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA 228
L + +L ++ + LD + G+ +LH IIHRDL PSN++
Sbjct: 105 MELMDANLCQVIHME--LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSD 159
Query: 229 GHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEM 288
LK+ DFGL++ A ++ MT + Y APEV Y ++VD++S I+ E+
Sbjct: 160 CTLKILDFGLARTA----CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
Query: 289 FQG 291
+G
Sbjct: 216 VKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-12
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 99 IDPGAYGEVYLVKWRGT-EIAAKTIRSSIASNPRVRNSFMKELGLWQK---LRHPN---I 151
I GA+GEV LV+ + + ++ A + S R ++F W++ + H N I
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF-----FWEERDIMAHANSEWI 105
Query: 152 VQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPT--AVAYALDIARGMNYLHHHR 209
VQ + + L + EY+ G D++ D P A Y ++ ++ +H
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGG---DLVNLMSNYDIPEKWARFYTAEVVLALDAIHSM- 161
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
IHRD+ P N+L D++GHLK+ DFG + + + + T G+ Y++PEV +
Sbjct: 162 --GFIHRDVKPDNMLLDKSGHLKLADFG-TCMKMDANGMVRCDT-AVGTPDYISPEVLKS 217
Query: 270 ES----YGKSVDVFSFALIVHEMFQGGPSNRADTAV 301
+ YG+ D +S + ++EM G AD+ V
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 61/236 (25%), Positives = 98/236 (41%), Gaps = 51/236 (21%)
Query: 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSS-IASNPRV------RNSFMKELGLWQKLRHP 149
I GA+GEV LV+ + G A K +R + + +V R+ ++ LW
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW------ 62
Query: 150 NIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHR 209
+V+ + L + E+L G + +L KK L Y + ++ +H
Sbjct: 63 -VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL- 120
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLS---KIAQEKDSY------------------ 248
IHRD+ P N+L D GH+K++DFGL K A + Y
Sbjct: 121 --GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 249 -----SYKMT------GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGP 293
++K G+ Y+APEV+ + Y K D +S +I++EM G P
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 99 IDPGAYGEV--YLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
+ GAYG V + K G ++A K + S + ++ +EL L + ++H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGLLD 81
Query: 157 V------LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYAL-DIARGMNYLHHHR 209
V + + Y++ D+ K G V Y + + G+ Y+H
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQT----DLQKIMGHPLSEDKVQYLVYQMLCGLKYIH--- 134
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
IIHRDL P N+ +E LK+ DFGL++ A +MTG + Y APEV
Sbjct: 135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA------EMTGYVVTRWYRAPEVILN 188
Query: 270 -ESYGKSVDVFSFALIVHEMFQG 291
Y ++VD++S I+ EM G
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies) | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-11
Identities = 26/60 (43%), Positives = 36/60 (60%), Gaps = 1/60 (1%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L+ +++ +++ L E G + N D D TALHLA+ G EIV LLLE GAD+N D
Sbjct: 32 LHLAARNGNLEIVKLLLEHGADVNAKDKDGNTALHLAARNGNLEIVKLLLEHGADINLKD 91
|
Length = 91 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 49/192 (25%), Positives = 91/192 (47%), Gaps = 22/192 (11%)
Query: 117 IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE-------------R 163
+A K I + ++P+ ++E+ + ++L H NIV+ VL S
Sbjct: 33 VAVKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 164 LIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNV 223
+++ + L ++L++ G L A + + RG+ Y+H ++HRDL P+NV
Sbjct: 90 SVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANV 145
Query: 224 L-QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPE-VYRRESYGKSVDVFSF 281
E LK+ DFGL++I S+ ++ G + Y +P + +Y K++D+++
Sbjct: 146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 205
Query: 282 ALIVHEMFQGGP 293
I EM G P
Sbjct: 206 GCIFAEMLTGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 27/211 (12%)
Query: 81 ARSFGHVVICKILEDRGGIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKEL 140
S G+ VI K L PG+ G V++ G + I + + E
Sbjct: 63 VASLGYTVI-KTLT------PGSEGRVFVATKPGQP---DPVVLKIGQKG----TTLIEA 108
Query: 141 GLWQKLRHPNIVQFLGVLKHSE-RLIFLTEYLRNGSLHDILKKK-GKLDPPTAVAYALDI 198
L Q + HP++++ L + L Y + L+ L K+ L A+ I
Sbjct: 109 MLLQNVNHPSVIRMKDTLVSGAITCMVLPHY--SSDLYTYLTKRSRPLPIDQALIIEKQI 166
Query: 199 ARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI-AQEKDSYSYKMTGGTG 257
G+ YLH R IIHRD+ N+ ++ + + D G ++ G G
Sbjct: 167 LEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL-----GLAG 218
Query: 258 SYRYMAPEVYRRESYGKSVDVFSFALIVHEM 288
+ APEV R+ Y D++S +++ EM
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 51/181 (28%), Positives = 87/181 (48%), Gaps = 15/181 (8%)
Query: 117 IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERL-----IFLTEYL 171
+A K + + + ++ +EL L + + H NI+ L V + L +++ L
Sbjct: 52 VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHL 231
+ +L +++ + LD + G+ +LH IIHRDL PSN++ L
Sbjct: 111 MDANLCQVIQME--LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 165
Query: 232 KVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG 291
K+ DFGL++ A S+ MT + Y APEV Y ++VD++S I+ EM +G
Sbjct: 166 KILDFGLARTA----GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
Query: 292 G 292
G
Sbjct: 222 G 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-11
Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 15/179 (8%)
Query: 117 IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERL-----IFLTEYL 171
+A K + + + ++ +EL L + + H NI+ L V + L ++L L
Sbjct: 45 VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 103
Query: 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHL 231
+ +L +++ + LD + G+ +LH IIHRDL PSN++ L
Sbjct: 104 MDANLCQVIQME--LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 158
Query: 232 KVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ 290
K+ DFGL++ A S+ MT + Y APEV Y ++VD++S I+ EM +
Sbjct: 159 KILDFGLARTA----GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 59/224 (26%), Positives = 107/224 (47%), Gaps = 33/224 (14%)
Query: 88 VICKILEDRGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQK 145
++ KI E G + EV + R G A K ++ S +V N +E+ ++
Sbjct: 3 ILGKIGE-------GTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL--REIQALRR 53
Query: 146 LR-HPNIVQFLGVL--KHSERLIFLTEYLRNGSLHDILK-KKGKLDPPTAVAYALDIARG 201
L HPNI++ + VL + + RL + E L + +L++++K +K L +Y + +
Sbjct: 54 LSPHPNILRLIEVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 202 MNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRY 261
++++H + I HRD+ P N+L + LK+ DFG + K Y+ ++ T YR
Sbjct: 113 LDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYIS--TRWYR- 165
Query: 262 MAPEVYRRE-SYGKSVDVFSFALIVHEM------FQGGPSNRAD 298
APE + YG +D+++ + E+ F G +N D
Sbjct: 166 -APECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG--TNELD 206
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 14/159 (8%)
Query: 138 KELGLWQKLRHPNIVQFLGVLKHSERL-----IFLTEYLRNGSLHDILKKKGKLDPPTAV 192
+EL L + + H NI+ L V + L ++L L + +L +++ LD
Sbjct: 64 RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMS 121
Query: 193 AYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252
+ G+ +LH IIHRDL PSN++ LK+ DFGL++ A S+ M
Sbjct: 122 YLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA----GTSFMM 174
Query: 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG 291
T + Y APEV Y ++VD++S I+ EM +G
Sbjct: 175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 62/260 (23%), Positives = 107/260 (41%), Gaps = 50/260 (19%)
Query: 99 IDPGAYGEVYLVKWRGTE-IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL-- 155
I GA+GEV +VK + T + A MK L W+ L+ F
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYA-----------------MKILNKWEMLKRAETACFREE 51
Query: 156 -GVLKHSER---------------LIFLTEYLRNGSLHDILKKKG-KLDPPTAVAYALDI 198
VL + +R L + +Y G L +L K +L A Y ++
Sbjct: 52 RDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEM 111
Query: 199 ARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS 258
++ +H +HRD+ P NVL D+ GH+++ DFG S + D + + G+
Sbjct: 112 VLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADG-TVQSNVAVGT 166
Query: 259 YRYMAPEVYR-----RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADR-RAYED- 311
Y++PE+ + + YG D +S + ++EM G A++ V+ + +++
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH 226
Query: 312 -SRPALSSLYPEPIKALLRE 330
P + E K L+R
Sbjct: 227 FQFPPDVTDVSEEAKDLIRR 246
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 64/265 (24%), Positives = 118/265 (44%), Gaps = 23/265 (8%)
Query: 99 IDPGAYGEVYLVK-WRGTEIAAKTIRSSIAS-NPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G +G+V L + + T +A ++ A+ + + +N F+++ ++ L+HPNI+Q LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 157 VLKHSERLIFLTEYLRNGSLHDILK----KKGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
+ + + EY G L L + A +IA G+ ++H H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--- 119
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
+H DL N +KV D+G+ ++ K+ Y R++APE+
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 273 G-------KSVDVFSFALIVHEMFQGGP---SNRADTAV--QVADRRAYEDSRPALSSLY 320
G K +V++ + + E+F+ S+ +D V V + + +P L Y
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238
Query: 321 PEPIKALLRECWHKNPDRRPTFEEI 345
E +L+ CW +P++R T EE+
Sbjct: 239 SERWYEVLQFCW-LSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 66/276 (23%), Positives = 122/276 (44%), Gaps = 35/276 (12%)
Query: 83 SFGHVVICKILEDRGGI--DPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKEL 140
S G KI + GI + G YGE++ TE+ K + S + SF +
Sbjct: 2 SLGQGTFTKIFK---GIRREVGDYGELHK-----TEVLLKVLDKS---HRNYSESFFEAA 50
Query: 141 GLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIAR 200
+ +L H ++V GV + I + EY++ GSL LKK L +++ L++A+
Sbjct: 51 SMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLIN---ISWKLEVAK 107
Query: 201 GMNY-LHHHRPHAIIHRDLTPSNVL-----QDEAGH---LKVTDFGLSKIAQEKDSYSYK 251
+ + LH + H ++ NVL + G+ +K++D G+S K+ +
Sbjct: 108 QLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLER 167
Query: 252 MTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE 310
+ ++ PE ++ + D +SF + E+F GG ++ +A+ + +
Sbjct: 168 IP-------WVPPECIENPQNLSLAADKWSFGTTLWEIFSGG--DKPLSALDSQKKLQFY 218
Query: 311 DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346
+ R L + + L+ +C PD RP+F II
Sbjct: 219 EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAII 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 67/272 (24%), Positives = 123/272 (45%), Gaps = 36/272 (13%)
Query: 99 IDPGAYGEVYL----VKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
I G +G+V L + ++ K +R S ++ + + F++E ++ L+H N++Q
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVS--ASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGKL-----DPPTAVAYALDIARGMNYLHHHR 209
LG + + E+ G L L+ K DP T A +IA G+ +LH +
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTG--SYRYMAPEVY 267
IH DL N L +K+ D+GLS ++D Y +T R++APE+
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED---YYVTPDQLWVPLRWIAPELV 174
Query: 268 RRESYG--------KSVDVFSFALIVHEMFQGGP------SNRADTAVQVADRRAYEDSR 313
E +G K +V+S + + E+F+ G S+ V +++ + +
Sbjct: 175 -DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ-LKLPK 232
Query: 314 PALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345
P L + +++ CW + P++RP+ EE+
Sbjct: 233 PRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-10
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 102 GAYGEVYLVKWRG----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
G YG VY K + E A K I + + S +E+ L ++L+HPN++ V
Sbjct: 12 GTYGHVYKAKRKDGKDEKEYALKQIEGT-----GISMSACREIALLRELKHPNVIALQKV 66
Query: 158 -LKHSERLIFLTEYLRNGSLHDILK-------KKGKLDPPTAVAYAL--DIARGMNYLHH 207
L HS+R ++L L I+K K + P ++ +L I G++YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH- 125
Query: 208 HRPHAIIHRDLTPSNVL----QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMA 263
+ ++HRDL P+N+L E G +K+ D G +++ + ++ Y A
Sbjct: 126 --ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 264 PEVYR-RESYGKSVDVFSFALIVHEMFQGGP 293
PE+ Y K++D+++ I E+ P
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 99 IDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSF----MKELGLWQKLRHPNIV 152
I G YG+VY K G +A K +R + F ++E+ + ++L H NIV
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLD-----NEKEGFPITAIREIKILRQLNHRNIV 69
Query: 153 QFLGVL----------KHSERLIFLTEYLRNGSLHDI--LKKKGKLD--PPTAVAYALDI 198
++ K + EY+ HD+ L + G + ++ +
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMD----HDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 199 ARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS 258
G+NY H +HRD+ SN+L + G +K+ DFGL+++ ++S Y T +
Sbjct: 126 LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY--TNKVIT 180
Query: 259 YRYMAPEVYR-RESYGKSVDVFSFALIVHEMFQGGPSNRAD 298
Y PE+ E YG ++DV+S I+ E+F P +A+
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 60/244 (24%), Positives = 102/244 (41%), Gaps = 28/244 (11%)
Query: 62 EKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGGID-----------PGAYGEVYLV 110
+K D++ D + SDA + + +C E R GI+ PGA G +
Sbjct: 56 DKHMDIDIFDIFADEDESDADA--SLALCA--EARAGIEKAGFSILETFTPGAEGFAFAC 111
Query: 111 KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170
I KT + R E + + + HP+I+Q G +++ +
Sbjct: 112 ------IDNKT-CEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164
Query: 171 LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH 230
+ L+ L K + +A + R + YLH +R IIHRD+ N+ + G
Sbjct: 165 YKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGD 220
Query: 231 LKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ 290
+ + DFG + D + K G G+ APE+ R+ YG +VD++S +++ EM
Sbjct: 221 VCLGDFGAA--CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
Query: 291 GGPS 294
S
Sbjct: 279 CHDS 282
|
Length = 391 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 66/279 (23%), Positives = 104/279 (37%), Gaps = 52/279 (18%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+GEV L T A KT+R N E + + + +V+ +
Sbjct: 12 GAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ 71
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ L F+ +Y+ G + +L + A Y ++ + +H IHRD+
Sbjct: 72 DKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIK 128
Query: 220 PSNVLQDEAGHLKVTDFGL----------------SKIAQEK-------DSYSYKMTGG- 255
P N+L D GH+K+TDFGL S I Q+ D S G
Sbjct: 129 PDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDR 188
Query: 256 --------------------TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSN 295
G+ Y+APEV R+ Y + D +S +I+ EM G P
Sbjct: 189 LKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
Query: 296 RADTAVQVADRRAYEDSR---PALSSLYPEPIKALLREC 331
A T + + ++ P L PE + + + C
Sbjct: 249 LAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLC 287
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 102 GAYGEVYLVKWRG----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
G YG VY K + + A K I + + S +E+ L ++L+HPN++ V
Sbjct: 12 GTYGHVYKAKRKDGKDDRDYALKQIEGT-----GISMSACREIALLRELKHPNVISLQKV 66
Query: 158 -LKHSERLIFLTEYLRNGSLHDILK-------KKGKLDPPTAVAYAL--DIARGMNYLHH 207
L H++R ++L L I+K K + P + +L I G++YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH- 125
Query: 208 HRPHAIIHRDLTPSNVL----QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMA 263
+ ++HRDL P+N+L E G +K+ D G +++ + ++ Y A
Sbjct: 126 --ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 264 PEVYR-RESYGKSVDVFSFALIVHEMFQGGP 293
PE+ Y K++D+++ I E+ P
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 57.9 bits (139), Expect = 1e-09
Identities = 30/66 (45%), Positives = 38/66 (57%)
Query: 34 PNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKIL 93
NL D D T LH A+ G A+IV LLLE GAD NS + +G T L A G + + K+L
Sbjct: 140 NNLRDEDGNTPLHWAALNGDADIVELLLEAGADPNSRNSYGVTALDPAAKNGRIELVKLL 199
Query: 94 EDRGGI 99
D+G
Sbjct: 200 LDKGLH 205
|
Length = 235 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 29/89 (32%), Positives = 51/89 (57%), Gaps = 11/89 (12%)
Query: 205 LHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTG-----SY 259
+HH +IHRD+ +N+L G +K+ DFG SK+ Y+ ++ G +
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM------YAATVSDDVGRTFCGTP 209
Query: 260 RYMAPEVYRRESYGKSVDVFSFALIVHEM 288
Y+APE++RR+ Y K D+FS ++++E+
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYEL 238
|
Length = 496 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 45/228 (19%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIV------ 152
I GA+GEV +VK + TE R MK L W+ L+
Sbjct: 9 IGRGAFGEVAVVKMKHTE----------------RIYAMKILNKWEMLKRAETACFREER 52
Query: 153 --------QFLGVLKHS----ERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIA 199
Q++ L ++ L + +Y G L +L K + +L A Y ++
Sbjct: 53 NVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMV 112
Query: 200 RGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSY 259
++ +H +HRD+ P NVL D GH+++ DFG S + +D + + + G+
Sbjct: 113 LAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDG-TVQSSVAVGTP 167
Query: 260 RYMAPEVYRRES-----YGKSVDVFSFALIVHEMFQGGPSNRADTAVQ 302
Y++PE+ + YG D +S + ++EM G A++ V+
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 55/256 (21%), Positives = 109/256 (42%), Gaps = 26/256 (10%)
Query: 107 VYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG----VLKHSE 162
+Y + E+ +T + + + + E+ +++ NI++ G ++
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 163 RLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH--RPHAIIHRDLTP 220
RL + EY G L ++L K+ L T + A+D +G+ L+ + +P +++LT
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP----YKNLTS 151
Query: 221 SNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR-----ESYGKS 275
+ L E LK+ GL KI S +K + +M Y+ Y
Sbjct: 152 VSFLVTENYKLKIICHGLEKILS---SPPFK------NVNFMVYFSYKMLNDIFSEYTIK 202
Query: 276 VDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
D++S +++ E+F G P T ++ D +++ L P IK ++ C
Sbjct: 203 DDIYSLGVVLWEIFTGKIPFENLTTK-EIYDLIINKNNSLKLPLDCPLEIKCIVEACTSH 261
Query: 335 NPDRRPTFEEIIFRLE 350
+ +RP +EI++ L
Sbjct: 262 DSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 39/215 (18%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIV-----Q 153
I G++G VY T + K + +P+ +N +EL + + L H NI+
Sbjct: 74 IGNGSFGVVYEAICIDT--SEKVAIKKVLQDPQYKN---RELLIMKNLNHINIIFLKDYY 128
Query: 154 FLGVLKHSERLIFLT---EYLRNGSLHDILKKKGKLD---PPTAVA-YALDIARGMNYLH 206
+ K +E+ IFL E++ ++H +K + + P V Y+ + R + Y+H
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 207 HHRPHAIIHRDLTPSNVLQDEAGH-LKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPE 265
I HRDL P N+L D H LK+ DFG +K + G S Y+
Sbjct: 188 ---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK----------NLLAGQRSVSYICSR 234
Query: 266 VYR-------RESYGKSVDVFSFALIVHEMFQGGP 293
YR +Y +D++S I+ EM G P
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 40/109 (36%), Positives = 61/109 (55%), Gaps = 3/109 (2%)
Query: 1 GQIIDSEGPYRLLYCSSKGDRAGVLQELEK-GVEPNLADYDKRTALHLASSEGRAEIVLL 59
G+ D LL +S G+ A +L+EL K ++P++ D RT LH+A+S+G + VL+
Sbjct: 518 GEHDDPNMASNLLTVASTGN-AALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLV 576
Query: 60 LLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGGI-DPGAYGEV 107
LL+ +V+ D G T L +A S H I +IL I DP A G++
Sbjct: 577 LLKHACNVHIRDANGNTALWNAISAKHHKIFRILYHFASISDPHAAGDL 625
|
Length = 823 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-09
Identities = 60/241 (24%), Positives = 91/241 (37%), Gaps = 49/241 (20%)
Query: 99 IDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I GA+GEV LV K G A KT+ S E + + P +V
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYY 68
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ ++ L + E+L G L +L K Y + + +H IHR
Sbjct: 69 SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHR 125
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSK-IAQEKDSYSYK------------------------ 251
D+ P N+L D GH+K++DFGLS ++ DS Y+
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSIN 185
Query: 252 ------------------MTGGT-GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGG 292
M T G+ Y+APE++ ++ YG+ D +S I+ E G
Sbjct: 186 LTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGW 245
Query: 293 P 293
P
Sbjct: 246 P 246
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 9e-09
Identities = 25/52 (48%), Positives = 32/52 (61%)
Query: 42 RTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKIL 93
RTALH A+ GR E+V LLEKG D+N D G T L A G++ + K+L
Sbjct: 2 RTALHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLL 53
|
Length = 54 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 58/242 (23%), Positives = 102/242 (42%), Gaps = 16/242 (6%)
Query: 99 IDPGAYGEVYLVKWRGTE-IAAKTIRSSIASNPRVRNS-FMKELGLWQKLRHPNIVQFLG 156
I GA+GEV +VK + + + A I + R + F +E + + I
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ L + +Y G L +L K + +L A Y ++ ++ +H +H
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVH 125
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYR-----RE 270
RD+ P N+L D GH+++ DFG E + + GT Y++PE+ + +
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD--YISPEILQAMEDGKG 183
Query: 271 SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR---PALSSLYPEPIKAL 327
YG D +S + ++EM G A++ V+ + R PA + E K L
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDL 243
Query: 328 LR 329
+R
Sbjct: 244 IR 245
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 64/238 (26%), Positives = 114/238 (47%), Gaps = 39/238 (16%)
Query: 99 IDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
I G +GEV+LVK + T+ K I S R ++ + E+ + ++L+H NIV+++
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAI-SYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79
Query: 157 VL--KHSERLIFLTEYLRNGSLHDILKKK----GKLDPPTAVAYALDIARGMNYLHHHR- 209
K +++L L E+ G L ++K GK++ V + + Y H+ +
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139
Query: 210 -PHA--IIHRDLTPSNV-----------LQDEAGHL------KVTDFGLSK-IAQEKDSY 248
P+ ++HRDL P N+ + +A +L K+ DFGLSK I E ++
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH 199
Query: 249 SYKMTGGTGSYRYMAPEVYRRE--SYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQV 303
S G+ Y +PE+ E SY D+++ I++E+ G P ++A+ Q+
Sbjct: 200 SC-----VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 3e-08
Identities = 19/33 (57%), Positives = 23/33 (69%)
Query: 40 DKRTALHLASSEGRAEIVLLLLEKGADVNSLDR 72
D T LHLA+ G E+V LLLE GADVN+ D+
Sbjct: 1 DGNTPLHLAARNGHLEVVKLLLEAGADVNARDK 33
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33 |
| >gnl|CDD|165256 PHA02946, PHA02946, ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 33/80 (41%), Positives = 42/80 (52%), Gaps = 3/80 (3%)
Query: 2 QIIDSEGPYRLL--YCSSKG-DRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVL 58
Q I+ G Y +L YC KG D V + L +G PN D D LH+AS IV
Sbjct: 30 QAIEPSGNYHILHAYCGIKGLDERFVEELLHRGYSPNETDDDGNYPLHIASKINNNRIVA 89
Query: 59 LLLEKGADVNSLDRWGRTPL 78
+LL GAD N+ D+ +TPL
Sbjct: 90 MLLTHGADPNACDKQHKTPL 109
|
Length = 446 |
| >gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 6e-08
Identities = 22/52 (42%), Positives = 27/52 (51%), Gaps = 1/52 (1%)
Query: 28 LEKGVE-PNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPL 78
LE G N D + T LHLA+ G E+V LL+ G D+N D G T L
Sbjct: 2 LEHGPIDLNATDGNGNTPLHLAAKYGALELVQWLLKPGVDLNLRDSDGLTAL 53
|
Length = 56 |
| >gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 27/86 (31%), Positives = 49/86 (56%), Gaps = 1/86 (1%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L+ ++ + +++ L +G +P++ + DK + LHLA G + + LL++ A ++ D
Sbjct: 106 LHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIED 165
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
G TPL A + G + ICK+L D G
Sbjct: 166 CCGCTPLIIAMAKGDIAICKMLLDSG 191
|
Length = 413 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 40/164 (24%), Positives = 79/164 (48%), Gaps = 19/164 (11%)
Query: 135 SFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAY 194
S + ++G KL+HPNIV+ +G+ + + + EY+ +L ++L+ L
Sbjct: 732 SEIADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKI 785
Query: 195 ALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD--EAGHLKVTDFGLSKIAQEKDSYSYKM 252
A+ IA+ + +LH A++ +L+P ++ D + HL+++ GL + S
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS--- 842
Query: 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG-GPSN 295
Y+APE + + D++ F LI+ E+ G P++
Sbjct: 843 -------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 33/144 (22%), Positives = 62/144 (43%), Gaps = 11/144 (7%)
Query: 149 PNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH 208
PN+V + + + + ++ G L + K + +A ++ ++ LH
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 209 RPHAIIHRDLTPSNVLQDEAGHLKVTDFG-LSKIAQEKDSYSYKMTGGTGSYRYMAPEVY 267
I+ RDL P+N+L D+ GH+++T F S++ D + Y APEV
Sbjct: 105 ---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV-------ENMYCAPEVG 154
Query: 268 RRESYGKSVDVFSFALIVHEMFQG 291
++ D +S I+ E+ G
Sbjct: 155 GISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 33/95 (34%), Positives = 46/95 (48%)
Query: 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLE 62
I D+E L Y KGD + E G + N+ D + +H+A +I+ LLLE
Sbjct: 119 IKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLE 178
Query: 63 KGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
KGA N D G +PL +A +G K+L D G
Sbjct: 179 KGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHG 213
|
Length = 434 |
| >gnl|CDD|197603 smart00248, ANK, ankyrin repeats | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 1e-05
Identities = 18/29 (62%), Positives = 22/29 (75%)
Query: 40 DKRTALHLASSEGRAEIVLLLLEKGADVN 68
D RT LHLA+ G E+V LLL+KGAD+N
Sbjct: 1 DGRTPLHLAAENGNLEVVKLLLDKGADIN 29
|
Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure. Length = 30 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 44.8 bits (105), Expect = 2e-05
Identities = 37/103 (35%), Positives = 45/103 (43%), Gaps = 8/103 (7%)
Query: 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGR-----AEIVL 58
D +G L +SKGD V L G + N D D T LHLA+ G E+
Sbjct: 69 RDLDGRLPLHSAASKGDDKIVKLLLASGADVNAKDADGDTPLHLAALNGNPPEGNIEVAK 128
Query: 59 LLLEKGA---DVNSLDRWGRTPLSDARSFGHVVICKILEDRGG 98
LLLE GA N D G TPL A G I ++L + G
Sbjct: 129 LLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGA 171
|
Length = 235 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 22/62 (35%), Positives = 34/62 (54%), Gaps = 3/62 (4%)
Query: 20 DRAGVLQEL-EKGVEPNLADYDKRTALHLAS--SEGRAEIVLLLLEKGADVNSLDRWGRT 76
RA +++EL G +P D T LH + S + +VL LL G +N+ +R+G+T
Sbjct: 200 PRARIVRELIRAGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQT 259
Query: 77 PL 78
PL
Sbjct: 260 PL 261
|
Length = 471 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 25/69 (36%), Positives = 38/69 (55%), Gaps = 1/69 (1%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHL-ASSEGRAEIVLLLLEKGADVNSL 70
L+ SS+ + V LE G + N + T LHL + +++ LL++ GADVN+
Sbjct: 54 YLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAK 113
Query: 71 DRWGRTPLS 79
D+ GRTPL
Sbjct: 114 DKVGRTPLH 122
|
Length = 471 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 26/54 (48%), Positives = 31/54 (57%), Gaps = 3/54 (5%)
Query: 28 LEKGVEPNLADYDKRTALHL---ASSEGRAEIVLLLLEKGADVNSLDRWGRTPL 78
L G + N +T LHL SSE +IV LLLE GADVN+ +R G TPL
Sbjct: 34 LAAGADVNFRGEYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPL 87
|
Length = 471 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 32/139 (23%), Positives = 61/139 (43%), Gaps = 10/139 (7%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
+ K T +A K I S ++ +E+ ++L+HPNI+ ++
Sbjct: 13 LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQ-QEIITSRQLQHPNILPYVTSFIVD 71
Query: 162 ERLIFLTEYLRNGSLHDILK---KKGKLDPPTAVAYAL-DIARGMNYLHHHRPHAIIHRD 217
L ++ + GS D+LK +G P A+A+ L D+ ++Y+H IHR
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTHFPEGL--PELAIAFILKDVLNALDYIHS---KGFIHRS 126
Query: 218 LTPSNVLQDEAGHLKVTDF 236
+ S++L G + ++
Sbjct: 127 VKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 23/53 (43%), Positives = 32/53 (60%), Gaps = 2/53 (3%)
Query: 28 LEKGVEPNLADYDKRTALH--LASSEGRAEIVLLLLEKGADVNSLDRWGRTPL 78
++ G + N D RT LH L+ +++ LLL KGADVN+LD +G TPL
Sbjct: 104 IKAGADVNAKDKVGRTPLHVYLSGFNINPKVIRLLLRKGADVNALDLYGMTPL 156
|
Length = 471 |
| >gnl|CDD|205784 pfam13606, Ank_3, Ankyrin repeat | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 8e-05
Identities = 17/29 (58%), Positives = 20/29 (68%)
Query: 40 DKRTALHLASSEGRAEIVLLLLEKGADVN 68
D T LHLA+ G E+V LLLE GAD+N
Sbjct: 1 DGNTPLHLAARNGNLELVKLLLEHGADIN 29
|
Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Length = 30 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 21/54 (38%), Positives = 28/54 (51%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81
L GV N+ D T LH A E V LL+ GA+ N ++++G TPL A
Sbjct: 179 LSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIA 232
|
Length = 422 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 36/98 (36%), Positives = 48/98 (48%), Gaps = 6/98 (6%)
Query: 4 IDSEGPYRLLYCSSKG--DRAGVLQELEKGVEPNLADYDKRTALHLASSEGR-AEIVLLL 60
I E P LY +K D + + G + N AD T LH AS+ R +IV+ L
Sbjct: 305 IKGETP---LYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLDRNKDIVITL 361
Query: 61 LEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGG 98
LE GA+VN+ D +TP+ A +VVI L D G
Sbjct: 362 LELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGA 399
|
Length = 682 |
| >gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 28/80 (35%), Positives = 41/80 (51%), Gaps = 5/80 (6%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ G++ N+ D + +T LH A +G E + +L E GADVN D G P+ A
Sbjct: 111 LDCGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFF 170
Query: 88 VICKILEDRGGIDPGAYGEV 107
I K+L ++ GAY V
Sbjct: 171 DIIKLL-----LEKGAYANV 185
|
Length = 434 |
| >gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 28/77 (36%), Positives = 37/77 (48%), Gaps = 7/77 (9%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRA-----EIVLLLLEKGADVNSLDRWGRTPLSDA- 81
L+ G + N + + T LH S+ EIV LLLE GA+VN+ D G TPL A
Sbjct: 55 LDNGADINSSTKNNSTPLHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAI 114
Query: 82 -RSFGHVVICKILEDRG 97
+ I + L D G
Sbjct: 115 SKKSNSYSIVEYLLDNG 131
|
Length = 422 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 46/192 (23%), Positives = 83/192 (43%), Gaps = 24/192 (12%)
Query: 114 GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173
GT + + + + + E+ L RHPNI+ V L ++ ++
Sbjct: 25 GTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83
Query: 174 GSLHDILKKKGKLDPPTAVAYAL------DIARGMNYLHHHRPHAIIHRDLTPSNVLQDE 227
GS + +LK P ++ AL RG+NYLH + IHR++ S++L
Sbjct: 84 GSANSLLKTYF----PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISG 136
Query: 228 AGHLKVTDFGLSKIAQ-----EKDSYSYKMTG-GTGSYRYMAPEVYRRESYGKSV--DVF 279
G + ++ GLS + +K Y T +++PE+ R++ YG +V D++
Sbjct: 137 DGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIY 194
Query: 280 SFALIVHEMFQG 291
S + E+ G
Sbjct: 195 SVGITACELATG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 46/200 (23%), Positives = 79/200 (39%), Gaps = 33/200 (16%)
Query: 101 PGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
PG+ GEV++ G E K I ++ + +E+ + + + H I+
Sbjct: 102 PGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIIN------- 150
Query: 161 SERLIFLTEYLRNGSLHDILKKKGKLD--------PPTAVAYALDIARGM----NYLHHH 208
L R S ++ K K D P + A+ I R + YLH
Sbjct: 151 ------LIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR 204
Query: 209 RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYR 268
IIHRD+ N+ DE + + DFG + + + G +G+ +PE+
Sbjct: 205 ---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP-DTPQCYGWSGTLETNSPELLA 260
Query: 269 RESYGKSVDVFSFALIVHEM 288
+ Y D++S L++ EM
Sbjct: 261 LDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 25/71 (35%), Positives = 34/71 (47%), Gaps = 1/71 (1%)
Query: 28 LEKGVEPNLADYDK-RTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
L G + N+ D K TALH A+ + LLL GA+VN D+ +PL A +
Sbjct: 154 LSYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYN 213
Query: 87 VVICKILEDRG 97
I IL + G
Sbjct: 214 KPIVHILLENG 224
|
Length = 477 |
| >gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 2e-04
Identities = 22/60 (36%), Positives = 31/60 (51%), Gaps = 2/60 (3%)
Query: 3 IIDSEGPYRLLYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLL 61
D +G L + G+ V++ L + G + N D D RT LHLA+ G E+V LLL
Sbjct: 68 ARDKDGNTPLHLAARNGNLD-VVKLLLKHGADVNARDKDGRTPLHLAAKNGHLEVVKLLL 126
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 25/73 (34%), Positives = 34/73 (46%), Gaps = 5/73 (6%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L G N+ D + LH A IV +LLE GA ++ D+ G TPL S G+
Sbjct: 188 LSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLH--ISVGYC 245
Query: 88 V---ICKILEDRG 97
I K+L + G
Sbjct: 246 KDYDILKLLLEHG 258
|
Length = 477 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 3e-04
Identities = 24/83 (28%), Positives = 41/83 (49%), Gaps = 8/83 (9%)
Query: 162 ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPS 221
E I + EY+ L D++ G + + +I R + LH IIH DLT S
Sbjct: 72 ENFIIVMEYIEGEPLKDLINSNG----MEELELSREIGRLVGKLHSAG---IIHGDLTTS 124
Query: 222 NVLQDEAGHLKVTDFGLSKIAQE 244
N++ G + + DFGL++ +++
Sbjct: 125 NMILSG-GKIYLIDFGLAEFSKD 146
|
Length = 211 |
| >gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies) | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 4e-04
Identities = 18/34 (52%), Positives = 23/34 (67%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLL 61
LEKGV+ N D D TALH+A+ G E++ LLL
Sbjct: 21 LEKGVDINRTDEDGNTALHIAAENGNLEVLKLLL 54
|
Length = 54 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 8/155 (5%)
Query: 135 SFMKELGLWQKLRHPNIVQFLGVLKHSE-RLIFLTEYLRNGSLHDILKKKGK-LDPPTAV 192
S + E L ++L HP ++ L V + L +Y L+ L + + L
Sbjct: 206 SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY--RSDLYTYLGARLRPLGLAQVT 263
Query: 193 AYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252
A A + ++Y+H IIHRD+ NVL + + + DFG + A+ S +
Sbjct: 264 AVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320
Query: 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHE 287
G G+ APEV + Y SVD++S L++ E
Sbjct: 321 -GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 43/213 (20%), Positives = 90/213 (42%), Gaps = 36/213 (16%)
Query: 102 GAYGEVYLVKWR---GTEIAAKTIRSSIASNPR--------VRNS------FMKELGLWQ 144
GA+G++++ R A + + S+ P+ V+ E+
Sbjct: 159 GAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALG 218
Query: 145 KLRHPNIVQFLGVLKHSERLIFLTE--------YLRNGSLHDILKKKGKLDPPTAVAYAL 196
+L H NI++ +L+ +T+ ++ + + K + L A+ L
Sbjct: 219 RLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD--WKDRPLLKQTRAIMKQL 276
Query: 197 DIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFG-LSKIAQEKDSYSYKMTGG 255
A + Y+H + +IHRD+ N+ + G + + DFG +E++++ Y G
Sbjct: 277 LCA--VEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY---GW 328
Query: 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEM 288
G+ +PE+ + Y + D++S LI+ +M
Sbjct: 329 VGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 28/90 (31%), Positives = 44/90 (48%), Gaps = 10/90 (11%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQ 153
GA+G+V G +A K +++S ++ R + M EL + L +H NIV
Sbjct: 49 GAFGKVVEATAFGLGKEDNVLRVAVKMLKAS--AHTDEREALMSELKILSHLGQHKNIVN 106
Query: 154 FLGVLKHSERLIFLTEYLRNGSLHDILKKK 183
LG H ++ +TEY G L + L+KK
Sbjct: 107 LLGACTHGGPVLVITEYCCYGDLLNFLRKK 136
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 30/69 (43%), Positives = 41/69 (59%), Gaps = 6/69 (8%)
Query: 28 LEKGVEPNLADYDKR-TALHLASSEGRAEIVL-LLLEKGADVNSLDRWGRTPLSDA-RSF 84
LE GV+ N Y TALH + ++E L LLLE GAD+NSL+ + TPLS A + +
Sbjct: 255 LEHGVDVNAKSYILGLTALHSSI---KSERKLKLLLEYGADINSLNSYKLTPLSSAVKQY 311
Query: 85 GHVVICKIL 93
+ I +IL
Sbjct: 312 LCINIGRIL 320
|
Length = 477 |
| >gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 25/74 (33%), Positives = 38/74 (51%), Gaps = 1/74 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
LE G + N D T +H A+ G A++V LLL GADVN + + L A ++
Sbjct: 165 LEGGADVNAKDIYCITPIHYAAERGNAKMVNLLLSYGADVNIIALDDLSVLECAVDSKNI 224
Query: 88 -VICKILEDRGGID 100
I I+++R I+
Sbjct: 225 DTIKAIIDNRSNIN 238
|
Length = 682 |
| >gnl|CDD|140343 PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 25/58 (43%), Positives = 32/58 (55%), Gaps = 2/58 (3%)
Query: 46 HLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGGIDPGA 103
LA+S G A +LL GAD N D GRTPL A + GHV + ++L + G DP
Sbjct: 88 QLAAS-GDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGA-DPTL 143
|
Length = 664 |
| >gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only] | Back alignment and domain information |
|---|
Score = 38.7 bits (89), Expect = 0.002
Identities = 28/73 (38%), Positives = 38/73 (52%), Gaps = 2/73 (2%)
Query: 16 SSKGDRAGVLQELEKGVEPNLADYDK--RTALHLASSEGRAEIVLLLLEKGADVNSLDRW 73
+ + L+ V+ +LA D R LH A+S+G +IV LLL GADVN+ D
Sbjct: 46 ALLPAASLSELLLKLIVDRHLAARDLDGRLPLHSAASKGDDKIVKLLLASGADVNAKDAD 105
Query: 74 GRTPLSDARSFGH 86
G TPL A G+
Sbjct: 106 GDTPLHLAALNGN 118
|
Length = 235 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 370 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG4412 | 226 | consensus 26S proteasome regulatory complex, subun | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.76 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.75 | |
| PHA02736 | 154 | Viral ankyrin protein; Provisional | 99.75 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 99.75 | |
| KOG0509 | 600 | consensus Ankyrin repeat and DHHC-type Zn-finger d | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| PHA02791 | 284 | ankyrin-like protein; Provisional | 99.73 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 99.73 | |
| KOG0502 | 296 | consensus Integral membrane ankyrin-repeat protein | 99.72 | |
| KOG4177 | 1143 | consensus Ankyrin [Cell wall/membrane/envelope bio | 99.71 | |
| PHA02741 | 169 | hypothetical protein; Provisional | 99.71 | |
| PF12796 | 89 | Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02 | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.7 | |
| PF12796 | 89 | Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02 | 99.7 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 99.7 | |
| PF13637 | 54 | Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A | 99.7 | |
| KOG0508 | 615 | consensus Ankyrin repeat protein [General function | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.69 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.69 | |
| KOG4214 | 117 | consensus Myotrophin and similar proteins [Transcr | 99.68 | |
| KOG0510 | 929 | consensus Ankyrin repeat protein [General function | 99.68 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 99.68 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 99.68 | |
| PHA02884 | 300 | ankyrin repeat protein; Provisional | 99.68 | |
| KOG0512 | 228 | consensus Fetal globin-inducing factor (contains a | 99.67 | |
| PHA02795 | 437 | ankyrin-like protein; Provisional | 99.67 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 99.67 | |
| KOG0514 | 452 | consensus Ankyrin repeat protein [General function | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.66 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.66 | |
| PF13857 | 56 | Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A | 99.65 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 99.65 | |
| PHA02859 | 209 | ankyrin repeat protein; Provisional | 99.65 | |
| PHA02875 | 413 | ankyrin repeat protein; Provisional | 99.64 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 99.63 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.62 | |
| PHA02743 | 166 | Viral ankyrin protein; Provisional | 99.61 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 99.61 | |
| PHA03095 | 471 | ankyrin-like protein; Provisional | 99.61 | |
| PHA02878 | 477 | ankyrin repeat protein; Provisional | 99.61 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 99.6 | |
| PHA02874 | 434 | ankyrin repeat protein; Provisional | 99.6 | |
| PHA02716 | 764 | CPXV016; CPX019; EVM010; Provisional | 99.59 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 99.59 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.59 | |
| PF13857 | 56 | Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A | 99.59 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 99.58 | |
| PHA03100 | 480 | ankyrin repeat protein; Provisional | 99.57 | |
| KOG4214 | 117 | consensus Myotrophin and similar proteins [Transcr | 99.57 | |
| PHA02946 | 446 | ankyin-like protein; Provisional | 99.56 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 99.55 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 99.55 | |
| KOG1710 | 396 | consensus MYND Zn-finger and ankyrin repeat protei | 99.55 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.54 | |
| PHA02917 | 661 | ankyrin-like protein; Provisional | 99.53 | |
| PHA02730 | 672 | ankyrin-like protein; Provisional | 99.52 | |
| PHA02798 | 489 | ankyrin-like protein; Provisional | 99.52 | |
| PHA02989 | 494 | ankyrin repeat protein; Provisional | 99.52 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| PTZ00322 | 664 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatas | 99.51 | |
| cd00204 | 126 | ANK ankyrin repeats; ankyrin repeats mediate prote | 99.5 | |
| KOG0502 | 296 | consensus Integral membrane ankyrin-repeat protein | 99.49 | |
| PHA02876 | 682 | ankyrin repeat protein; Provisional | 99.48 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-54 Score=370.29 Aligned_cols=245 Identities=30% Similarity=0.530 Sum_probs=219.1
Q ss_pred eecccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCc-eEEEEe
Q 042314 93 LEDRGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSER-LIFLTE 169 (370)
Q Consensus 93 L~~~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~-~~~v~e 169 (370)
|...+.+|.|..|+||++..+ +..+|+|++.. ..++...+++.+|+++++.++||+||.+++.|..... ++|+||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 445566999999999999876 78899999843 3567889999999999999999999999999999884 999999
Q ss_pred ecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhh-cCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 170 YLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHH-HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
||+||||+.++...+++++...-+++.++++||.|||+ .+ ||||||||+||||...|.+||||||.|..+...
T Consensus 159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999999999999999999999999999999996 66 999999999999999999999999999877654
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHhhccCCCCCCCCC-CcH
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRAD-----TAVQVADRRAYEDSRPALSSL-YPE 322 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~-~~~ 322 (370)
...+..||..|||||++.+..|+.++||||||++++|+.+|+.||... ...++...+. ..+.|.+|.. +|+
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGEFSP 309 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCcccCCH
Confidence 234457999999999999999999999999999999999999998774 4455555555 5566677775 999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 323 PIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 323 ~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+|++||..||++||.+|||+.+|++|
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 99999999999999999999999876
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=376.34 Aligned_cols=257 Identities=41% Similarity=0.698 Sum_probs=233.5
Q ss_pred CCCCCCcccEEEEEEcCce-eEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC-ceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWRGTE-IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE-RLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~~-vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~-~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++.|+|.. +|+|.+......... .+.|.+|+.++.+++|||||+++|++.... .+++||||+++|+
T Consensus 48 ~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 48 VLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 3899999999999999999 999999876544433 889999999999999999999999999887 7999999999999
Q ss_pred HHHHHHh--CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC-cEEEeccccceeccccCccceec
Q 042314 176 LHDILKK--KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG-HLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 176 L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|.+++.. +..++...++.++.||+.||.|||++++ ||||||||+|||++.++ ++||+|||+++...... ..+
T Consensus 127 L~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~---~~~ 201 (362)
T KOG0192|consen 127 LSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK---TSM 201 (362)
T ss_pred HHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc---ccc
Confidence 9999987 5789999999999999999999999884 99999999999999998 99999999998776543 123
Q ss_pred cCCCCCccccCccccc--ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 253 TGGTGSYRYMAPEVYR--RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
....||+.|||||++. +..|+.++||||||+++|||+||+.||.................++.++..+|+.+..+|.+
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~ 281 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMER 281 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHH
Confidence 3457999999999999 66999999999999999999999999999998777777777899999999999999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHHhccCC
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAIQESFQKKT 360 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~ 360 (370)
||..||+.||++.+++..|+.+...+....
T Consensus 282 CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~ 311 (362)
T KOG0192|consen 282 CWLVDPSRRPSFLEIVSRLESIMSHISSAG 311 (362)
T ss_pred hCCCCCCcCCCHHHHHHHHHHHHHhhcccC
Confidence 999999999999999999999988777543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-54 Score=351.03 Aligned_cols=341 Identities=28% Similarity=0.472 Sum_probs=298.7
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.-|..|.+||||||..||..+|+.||++||.||..|....||||+||..||.++|+.|++..+|+|+.+..|.||||+|+
T Consensus 29 ~gddhgfsplhwaakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgntplhyac 108 (448)
T KOG0195|consen 29 VGDDHGFSPLHWAAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTPLHYAC 108 (448)
T ss_pred cccccCcchhhhhhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCchhhhh
Confidence 45788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecccC----------------------------------------------------------------
Q 042314 83 SFGHVVICKILEDRGG---------------------------------------------------------------- 98 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~---------------------------------------------------------------- 98 (370)
.+|...+++.|...++
T Consensus 109 fwgydqiaedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdatlsr~~gid 188 (448)
T KOG0195|consen 109 FWGYDQIAEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDATLSRYTGID 188 (448)
T ss_pred hhcHHHHHHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCcccccccccccccccccccccccccCcc
Confidence 9998776665554432
Q ss_pred ---------CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEe
Q 042314 99 ---------IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 99 ---------l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
+.....|..|+++|.|..+++|++..... .......|..|.-.++-+.||||+.+++.+.....+.++..
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 55667889999999999999999987643 34556778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCC--CChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 170 YLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
|++.|||+.++.+... .+..++.+++.+++.|++|||+..+ -|..--|.+..++||++-+.+|+ .+ ...
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltaris-ma-------d~k 338 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARIS-MA-------DTK 338 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhhee-cc-------cce
Confidence 9999999999987653 5778999999999999999999873 34445789999999998877764 11 122
Q ss_pred cceeccCCCCCccccCcccccccCCC---chhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHH
Q 042314 248 YSYKMTGGTGSYRYMAPEVYRRESYG---KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI 324 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~~~~~~---~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 324 (370)
++++..+..-.|.|++||.+...+-+ .+.|+|||++++|||-|...||...++.+.--++..++.+..+|+.++...
T Consensus 339 fsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm 418 (448)
T KOG0195|consen 339 FSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHM 418 (448)
T ss_pred eeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHH
Confidence 34455555678999999999876543 689999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042314 325 KALLRECWHKNPDRRPTFEEIIFRLEAIQ 353 (370)
Q Consensus 325 ~~li~~~l~~~p~~Rp~~~~ll~~l~~~~ 353 (370)
..++.-|+..||.+||.++.++-.|++++
T Consensus 419 ~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 419 NKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999999999999999999999998874
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=373.34 Aligned_cols=247 Identities=26% Similarity=0.478 Sum_probs=226.5
Q ss_pred ecccCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 94 EDRGGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 94 ~~~~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
.....+|+|+|+.+|.+.. .|..+|+|++.+.....+..++.+.+|+++.+.++|||||+++++|++.+.+|+|+|+|
T Consensus 21 ~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC 100 (592)
T KOG0575|consen 21 KRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELC 100 (592)
T ss_pred eeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEec
Confidence 3345589999999999987 58999999999887778889999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
..++|..++++++.+++.+++.+++||+.||.|||+++ |+|||||..|+|++++.++||+|||+|..+..... .
T Consensus 101 ~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E---r 174 (592)
T KOG0575|consen 101 HRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE---R 174 (592)
T ss_pred CCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccc---c
Confidence 99999999999999999999999999999999999999 99999999999999999999999999998875533 2
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
..+.+|||.|.|||++.+...+..+||||+||+||-|+.|+|||......+.+.++. ......|..++.+.++||.++
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik--~~~Y~~P~~ls~~A~dLI~~l 252 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK--LNEYSMPSHLSAEAKDLIRKL 252 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH--hcCcccccccCHHHHHHHHHH
Confidence 234589999999999999999999999999999999999999999999988888876 344455668899999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~ 348 (370)
|++||.+|||+++++.+
T Consensus 253 L~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 253 LRPNPSERPSLDEVLDH 269 (592)
T ss_pred hcCCcccCCCHHHHhcC
Confidence 99999999999999876
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=355.17 Aligned_cols=245 Identities=25% Similarity=0.387 Sum_probs=208.5
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCC----hHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASN----PRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~----~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
..+|.|+||.|.+|..+ |+.+|+|++.+..... ........+|+++|++++|||||+++++|...+..||||||
T Consensus 178 ~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~ 257 (475)
T KOG0615|consen 178 KTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEY 257 (475)
T ss_pred eeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEE
Confidence 44899999999999664 8999999997654322 11223357999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC---CcEEEeccccceeccccCc
Q 042314 171 LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA---GHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 171 ~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~---~~~kl~Dfg~~~~~~~~~~ 247 (370)
++||.|.+.+-.++.+.+.....++.|++.|+.|||++| |+||||||+|||+..+ -.+||+|||+|+..+...
T Consensus 258 v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~s- 333 (475)
T KOG0615|consen 258 VEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGS- 333 (475)
T ss_pred ecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhccccce-
Confidence 999999999999999999999999999999999999999 9999999999999876 579999999999887443
Q ss_pred cceeccCCCCCccccCcccccccCCC---chhhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhc--cCCCCCCCCCCc
Q 042314 248 YSYKMTGGTGSYRYMAPEVYRRESYG---KSVDVFSFALIVHEMFQGGPSNRADTAVQ-VADRRAY--EDSRPALSSLYP 321 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~~~~~~---~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~--~~~~~~~~~~~~ 321 (370)
.+.+.+|||.|.|||++.+..+. .++|+||+||++|-+++|.+||....... ..+++.. ....|..+..++
T Consensus 334 ---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Is 410 (475)
T KOG0615|consen 334 ---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRIS 410 (475)
T ss_pred ---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhh
Confidence 35667999999999999876543 47899999999999999999998765444 3333331 233455677899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
++..+||.+||..||++|||+.|+|++
T Consensus 411 eea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 411 EEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 999999999999999999999999876
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-50 Score=343.16 Aligned_cols=236 Identities=30% Similarity=0.515 Sum_probs=214.1
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.|+.++.+ ++.+|+|++++.........+....|..++..++||.||++...|++...+|+|+||+.||.
T Consensus 32 viGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGe 111 (357)
T KOG0598|consen 32 VIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGE 111 (357)
T ss_pred eeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCcc
Confidence 4899999999999765 78899999988766555677889999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|...+++.+.+++..++.++.+|+.||.|||++| ||||||||+|||++.+|+++|+|||+++..-.... ...+.
T Consensus 112 Lf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~---~t~tf 185 (357)
T KOG0598|consen 112 LFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD---ATRTF 185 (357)
T ss_pred HHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCC---ccccc
Confidence 9999999999999999999999999999999999 99999999999999999999999999985544332 23346
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
+||+.|||||++.+..|+..+|.||||+++|||++|.+||...+......++. ....+..+..++...+++++++|..|
T Consensus 186 cGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~-~~k~~~~p~~ls~~ardll~~LL~rd 264 (357)
T KOG0598|consen 186 CGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL-KGKLPLPPGYLSEEARDLLKKLLKRD 264 (357)
T ss_pred cCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh-cCcCCCCCccCCHHHHHHHHHHhccC
Confidence 89999999999999999999999999999999999999999999888888877 33446666778999999999999999
Q ss_pred CCCCC
Q 042314 336 PDRRP 340 (370)
Q Consensus 336 p~~Rp 340 (370)
|++|.
T Consensus 265 p~~RL 269 (357)
T KOG0598|consen 265 PRQRL 269 (357)
T ss_pred HHHhc
Confidence 99996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=356.45 Aligned_cols=248 Identities=33% Similarity=0.609 Sum_probs=221.9
Q ss_pred CCCCCCcccEEEEEEcCc-eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWRGT-EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~-~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|.||.||.+.+++. .+++|.++... .....|.+|+.+|++++|++||++++++..++.++|||||++.|+|
T Consensus 213 ~LG~G~FG~V~~g~~~~~~~vavk~ik~~~----m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 213 ELGSGQFGEVWLGKWNGSTKVAVKTIKEGS----MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HhcCCccceEEEEEEcCCCcccceEEeccc----cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 399999999999999987 89999997652 3346678999999999999999999999998899999999999999
Q ss_pred HHHHHh--CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKK--KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.++++. ...+...+.+.++.||++||+||++++ +|||||..+||||+++..+||+|||+++...+. ......+
T Consensus 289 l~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~--~Y~~~~~ 363 (468)
T KOG0197|consen 289 LDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD--EYTASEG 363 (468)
T ss_pred HHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC--ceeecCC
Confidence 999997 457899999999999999999999999 999999999999999999999999999944433 2223444
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..-+..|.|||.+....|+.+|||||||++||||+| |+.|+...+..+....+. .+.+.+-|..+|+.+.++|..||.
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP~~vY~lM~~CW~ 442 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCPDEVYELMKSCWH 442 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCCHHHHHHHHHHhh
Confidence 456889999999999999999999999999999997 788888888888777766 788889999999999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
.+|++|||++.+...|+++...
T Consensus 443 ~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 443 EDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCcccCCCHHHHHHHHHHhhhc
Confidence 9999999999999998887654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=333.25 Aligned_cols=249 Identities=26% Similarity=0.493 Sum_probs=213.9
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeee-eEeeCC-ceEEEEeecC
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG-VLKHSE-RLIFLTEYLR 172 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~-~~~~~~-~~~~v~e~~~ 172 (370)
..+|.|.||.||++.. .|..+|.|.+.... -+...++....|+.++++++|||||++++ .|..++ .++||||+|+
T Consensus 25 ~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~ 103 (375)
T KOG0591|consen 25 KKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCD 103 (375)
T ss_pred HHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhc
Confidence 3489999999999865 58899999988443 45677889999999999999999999998 444444 4899999999
Q ss_pred CCCHHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcCCC-ceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 173 NGSLHDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRPH-AIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 173 g~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~-~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
+|+|.++++. ++.+++..+|+++.|++.||.++|+.-++ -|+||||||.||+++.+|.+||+|||+++.......
T Consensus 104 ~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t 183 (375)
T KOG0591|consen 104 AGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT 183 (375)
T ss_pred ccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhH
Confidence 9999998863 45799999999999999999999994322 289999999999999999999999999998876543
Q ss_pred cceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCC-CCCcHHHHH
Q 042314 248 YSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALS-SLYPEPIKA 326 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~ 326 (370)
. ..+.+|||-||+||.+.+.+|+++|||||+||++|||..-++||.+.+...+..++. .+..+++| ..+|..+..
T Consensus 184 f---A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~-qgd~~~~p~~~YS~~l~~ 259 (375)
T KOG0591|consen 184 F---AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIE-QGDYPPLPDEHYSTDLRE 259 (375)
T ss_pred H---HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHH-cCCCCCCcHHHhhhHHHH
Confidence 2 344579999999999999999999999999999999999999999998888888776 45666666 678999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 042314 327 LLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 327 li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
+|..|+..||+.||+...++..+.
T Consensus 260 li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 260 LINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HHHHHccCCcccCCCcchHHHHHH
Confidence 999999999999999655554443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=340.64 Aligned_cols=241 Identities=30% Similarity=0.536 Sum_probs=211.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+|++||+++.+ +..||+|.+.... -+....+.+..|+++++.++|||||++++++..++.+|+|||||+||+|
T Consensus 18 iG~GsfavVykg~h~~~~~~VAIK~i~~~~-l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDL 96 (429)
T KOG0595|consen 18 IGSGSFAVVYKGRHKKSGTEVAIKCIAKKK-LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDL 96 (429)
T ss_pred ccCcceEEEEEeEeccCCceEEeeeehhhc-cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCH
Confidence 899999999999775 7889999987653 2567788899999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC------CcEEEeccccceeccccCccce
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA------GHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~------~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
.+++++++++++..++.++.||+.||++||+++ ||||||||.|||++.. -.+||+|||+|+......
T Consensus 97 s~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~---- 169 (429)
T KOG0595|consen 97 SDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS---- 169 (429)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh----
Confidence 999999999999999999999999999999999 9999999999999865 358999999999888553
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC-CCCCCCCCCcHHHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED-SRPALSSLYPEPIKALLR 329 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 329 (370)
.....+|+|-|||||++....|+.|+|+||+|+++|++++|++||...+..++...+.... ..+.++...+....+++-
T Consensus 170 ~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~ 249 (429)
T KOG0595|consen 170 MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLI 249 (429)
T ss_pred HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhh
Confidence 2344589999999999999999999999999999999999999999999988877554332 234455566777788888
Q ss_pred HhcccCCCCCCCHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIF 347 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~ 347 (370)
..+..+|.+|-++.+...
T Consensus 250 ~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 250 SLLQRNPKDRISFEDFFD 267 (429)
T ss_pred HHHhcCccccCchHHhhh
Confidence 889999888887776543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=350.48 Aligned_cols=246 Identities=30% Similarity=0.496 Sum_probs=222.1
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|+|++|++|... ++.+|+|++.+.....+.-.+....|-.+|.+| +||.|++++..|.++..+|+|+||+++|
T Consensus 80 ~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nG 159 (604)
T KOG0592|consen 80 ILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNG 159 (604)
T ss_pred eeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCC
Confidence 3899999999999775 889999999887666666677889999999999 7999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc------
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY------ 248 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------ 248 (370)
+|.++|.+.+.|++..++.++.+|+.||+|||++| ||||||||+|||++++|++||+|||.++.+.+....
T Consensus 160 dll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~ 236 (604)
T KOG0592|consen 160 DLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVD 236 (604)
T ss_pred cHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccC
Confidence 99999999999999999999999999999999999 999999999999999999999999999987654221
Q ss_pred ----ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHH
Q 042314 249 ----SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI 324 (370)
Q Consensus 249 ----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 324 (370)
.......+||..|.+||++.....++.+|+|+|||++|+|+.|.+||...+.....+++. .....++..+|+.+
T Consensus 237 ~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--~l~y~fp~~fp~~a 314 (604)
T KOG0592|consen 237 PNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--ALDYEFPEGFPEDA 314 (604)
T ss_pred cccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH--HhcccCCCCCCHHH
Confidence 111134679999999999999999999999999999999999999999999988888776 45567788899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 042314 325 KALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 325 ~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+||+++|..||.+|++.++|-+|
T Consensus 315 ~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 315 RDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHHHHccCccccccHHHHhhC
Confidence 999999999999999999888765
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=321.45 Aligned_cols=232 Identities=29% Similarity=0.529 Sum_probs=215.2
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|+||.|.+++.+ |..+|+|++.+...-.-.+.+...+|..+++.+.||.++++.+.+.+.+.+++||||++||
T Consensus 50 ~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GG 129 (355)
T KOG0616|consen 50 KTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGG 129 (355)
T ss_pred eeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCc
Confidence 34799999999999875 7889999998876666777888999999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.|.+++++.+++++..++.++.|++.|++|||+++ |++|||||+|||+|.+|.+||+|||.|+.+... ...
T Consensus 130 ElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r------T~T 200 (355)
T KOG0616|consen 130 ELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR------TWT 200 (355)
T ss_pred cHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc------EEE
Confidence 99999999999999999999999999999999999 999999999999999999999999999887654 234
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.+|||.|+|||.+...++..++|.||||+++|||+.|.+||...++.....++. ......|..+++.+++|++++|+.
T Consensus 201 lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~--~~~v~fP~~fs~~~kdLl~~LL~v 278 (355)
T KOG0616|consen 201 LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL--EGKVKFPSYFSSDAKDLLKKLLQV 278 (355)
T ss_pred ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH--hCcccCCcccCHHHHHHHHHHHhh
Confidence 589999999999999999999999999999999999999999999999998887 455667788999999999999999
Q ss_pred CCCCC
Q 042314 335 NPDRR 339 (370)
Q Consensus 335 ~p~~R 339 (370)
|-.+|
T Consensus 279 D~t~R 283 (355)
T KOG0616|consen 279 DLTKR 283 (355)
T ss_pred hhHhh
Confidence 99999
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=336.93 Aligned_cols=254 Identities=33% Similarity=0.551 Sum_probs=214.0
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC--ceEEEEeecC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE--RLIFLTEYLR 172 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~--~~~~v~e~~~ 172 (370)
..+|.|+||.||++... |...|+|...... ... .+.+.+|+.++++++|||||++++...... .+++.|||++
T Consensus 23 ~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 23 KLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred ccccCccceEEEEEEecCCCcceeeeeeeccc--chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence 44899999999999875 6889999887652 122 677899999999999999999999754444 6899999999
Q ss_pred CCCHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC-CCcEEEeccccceeccccCccce
Q 042314 173 NGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE-AGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 173 g~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+|+|.+++.+.+ ++++..++.+.+|+++||.|||++| |+|+||||+|||++. ++.+||+|||++...........
T Consensus 100 ~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~ 176 (313)
T KOG0198|consen 100 GGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSD 176 (313)
T ss_pred CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccccccc
Confidence 999999999887 7999999999999999999999998 999999999999999 79999999999987764222222
Q ss_pred eccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRA-DTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
......||+.|||||++..+ ...+++|||||||++.||+||.+||.. .........+......|.+|..+|+..++|+
T Consensus 177 ~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl 256 (313)
T KOG0198|consen 177 SELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFL 256 (313)
T ss_pred ccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHH
Confidence 23345799999999999853 334599999999999999999999987 4445555555555666788999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 329 RECWHKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
++|+..+|++|||++++|++--..+...
T Consensus 257 ~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 257 RKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 9999999999999999999876655443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=332.58 Aligned_cols=247 Identities=21% Similarity=0.314 Sum_probs=217.3
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee----CCceEEEEeecCCC
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH----SERLIFLTEYLRNG 174 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~----~~~~~~v~e~~~g~ 174 (370)
+++|+++.||++.++|+.+++|.++..........+.+.+|+.++++++||||+++++++.+ ...+++||||+++|
T Consensus 28 i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g 107 (283)
T PHA02988 28 IKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRG 107 (283)
T ss_pred EeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCC
Confidence 78899999999999999999999987655555566888999999999999999999999876 35789999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhc-CCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH-RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+|.+++.+.+.++......++.+++.|+.|||+. + ++||||||+||+++.++.+||+|||++....... .
T Consensus 108 ~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~------~ 178 (283)
T PHA02988 108 YLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP------F 178 (283)
T ss_pred cHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc------c
Confidence 9999999888899999999999999999999985 6 8899999999999999999999999987654322 1
Q ss_pred CCCCCccccCcccccc--cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 254 GGTGSYRYMAPEVYRR--ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
...+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.....++..+..+|+.+.+++.+|
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 258 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHH
Confidence 2357889999999976 67899999999999999999999999988777766665545556666667899999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFRLEAIQE 354 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~l~~~~~ 354 (370)
|+.||++|||++++++.|+.++.
T Consensus 259 l~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 259 TSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred hcCCcccCcCHHHHHHHHHHHHh
Confidence 99999999999999999998864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=321.65 Aligned_cols=249 Identities=24% Similarity=0.469 Sum_probs=206.8
Q ss_pred eecccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 93 LEDRGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 93 L~~~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
++..+.+|+|+||.|++++.+ |+.||+|.+..+. +++...+-..+|++++++++|||+|.++++|.....+++|+||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 344567999999999999765 8899999997664 5678888899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 171 LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 171 ~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
|+..-|.++-.....++...+.+++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||.|+.+..++..
T Consensus 83 ~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~-- 157 (396)
T KOG0593|consen 83 CDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN-- 157 (396)
T ss_pred cchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcch--
Confidence 988445554444457899999999999999999999999 999999999999999999999999999988854332
Q ss_pred eccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-------------------
Q 042314 251 KMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE------------------- 310 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~------------------- 310 (370)
.+..+.|.+|.|||.+.+ .+|...+|||++||++.||++|.+.|.+.++.+....+...
T Consensus 158 -YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 158 -YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred -hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 233467999999999998 67999999999999999999999999988776644322210
Q ss_pred CC---CCC----CC---CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 311 DS---RPA----LS---SLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 311 ~~---~~~----~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+. .+. +. ..++..+.+|+++||..||++|++.++++.+
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 00 010 11 1244568899999999999999999999865
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=341.00 Aligned_cols=242 Identities=30% Similarity=0.488 Sum_probs=218.5
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|+|.||.||+++.+ .+.||+|.+.+.. ..+...+.+.+|+++++.++||||+.++++|+...++|+|+||+.|
T Consensus 8 e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g- 85 (808)
T KOG0597|consen 8 EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG- 85 (808)
T ss_pred HHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence 34899999999999776 5678999887764 4456678899999999999999999999999999999999999988
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|..+++..+.++++.+..++.++++||.|||+++ |+|||+||.||+++..|.+|+||||+++.++.... ..+.
T Consensus 86 ~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~---vlts 159 (808)
T KOG0597|consen 86 DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS---VLTS 159 (808)
T ss_pred hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCce---eeee
Confidence 99999999999999999999999999999999998 99999999999999999999999999998876543 2344
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
..|||-|||||...+..|+..+|+||+||++||++.|+|||...+...+...+.. .+..+|...+..+..|+..+|.+
T Consensus 160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~--d~v~~p~~~S~~f~nfl~gLL~k 237 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK--DPVKPPSTASSSFVNFLQGLLIK 237 (808)
T ss_pred ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc--CCCCCcccccHHHHHHHHHHhhc
Confidence 5699999999999999999999999999999999999999999998888888774 33444557899999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042314 335 NPDRRPTFEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~ 348 (370)
||..|.++.+++.|
T Consensus 238 dP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 238 DPAQRLTWTDLLGH 251 (808)
T ss_pred ChhhcccHHHHhcC
Confidence 99999999999876
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=342.34 Aligned_cols=242 Identities=27% Similarity=0.425 Sum_probs=220.7
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+.|.|.+|.. +|+.+|||++.+...-.......+.+|+-+|+.+.||||++++++++...++|+|.||++||.|
T Consensus 20 LG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGEL 99 (786)
T KOG0588|consen 20 LGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGEL 99 (786)
T ss_pred ccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchh
Confidence 79999999999976 4999999999876444455667889999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
++++-+++++++.++.++++||+.|+.|+|..+ |+||||||+|+|++..+++||+|||+|....++.. ..+.+
T Consensus 100 Fdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl----LeTSC 172 (786)
T KOG0588|consen 100 FDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL----LETSC 172 (786)
T ss_pred HHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCcc----ccccC
Confidence 999999999999999999999999999999998 99999999999999999999999999987655432 34568
Q ss_pred CCccccCcccccccCCC-chhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 257 GSYRYMAPEVYRRESYG-KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
|+|.|.+||++.+.+|+ .++||||+|||||.|++|+.||+.++...+..++. .....+|.++|.+.++|+++|+..|
T Consensus 173 GSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~--~G~f~MPs~Is~eaQdLLr~ml~VD 250 (786)
T KOG0588|consen 173 GSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQ--RGVFEMPSNISSEAQDLLRRMLDVD 250 (786)
T ss_pred CCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHH--cCcccCCCcCCHHHHHHHHHHhccC
Confidence 99999999999999996 79999999999999999999999999999888876 4445667899999999999999999
Q ss_pred CCCCCCHHHHHHHH
Q 042314 336 PDRRPTFEEIIFRL 349 (370)
Q Consensus 336 p~~Rp~~~~ll~~l 349 (370)
|++|.|.+++++|-
T Consensus 251 p~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 251 PSTRITTEEILKHP 264 (786)
T ss_pred ccccccHHHHhhCc
Confidence 99999999999884
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=325.23 Aligned_cols=246 Identities=25% Similarity=0.408 Sum_probs=209.8
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|..+.||+|++. +..||+|.+.-....+. .+.+.+|+..++.++||||++++..|..+..+|+||.||.+||
T Consensus 33 ~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS 110 (516)
T KOG0582|consen 33 VIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGS 110 (516)
T ss_pred EEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCc
Confidence 3889999999999875 78899999977654432 6889999999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc-eec
Q 042314 176 LHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS-YKM 252 (370)
Q Consensus 176 L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~ 252 (370)
+.+++... ..+++..+..|++++++||.|||.+| .||||||+.||||+.+|.|||+|||.+..+...+... ...
T Consensus 111 ~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf 187 (516)
T KOG0582|consen 111 LLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRF 187 (516)
T ss_pred HHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEee
Confidence 99999864 46899999999999999999999999 9999999999999999999999999876665544222 222
Q ss_pred cCCCCCccccCccccc--ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--------CCCCCCCcH
Q 042314 253 TGGTGSYRYMAPEVYR--RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--------PALSSLYPE 322 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 322 (370)
....||+.|||||++. ...|+.|+||||||++..||.+|..||....+...........+. ......++.
T Consensus 188 ~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~k 267 (516)
T KOG0582|consen 188 NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSK 267 (516)
T ss_pred ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcH
Confidence 5568999999999964 357999999999999999999999999999888766554422221 112234778
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 323 PIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 323 ~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.|+.+|..||++||++|||+++++++
T Consensus 268 sf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 268 SFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 89999999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=335.43 Aligned_cols=241 Identities=29% Similarity=0.510 Sum_probs=211.2
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCC-C-hHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIAS-N-PRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~-~-~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|+||.|+.+.. .+..+|+|++...... . ....+.+.+|+.+++.++ ||||+++++++.....+++||||+.
T Consensus 24 ~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~ 103 (370)
T KOG0583|consen 24 TLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCS 103 (370)
T ss_pred eecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecC
Confidence 379999999999976 4789999977654221 1 235566779999999999 9999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC-CcEEEeccccceecc-ccCccce
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA-GHLKVTDFGLSKIAQ-EKDSYSY 250 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~-~~~kl~Dfg~~~~~~-~~~~~~~ 250 (370)
||+|.+++.+.+++.+..+..+++|+++|++|+|++| |+||||||+||+++.+ +++||+|||++.... ...
T Consensus 104 gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~---- 176 (370)
T KOG0583|consen 104 GGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDG---- 176 (370)
T ss_pred CccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccCCCCC----
Confidence 9999999999999999999999999999999999999 9999999999999999 999999999998774 221
Q ss_pred eccCCCCCccccCcccccccC-CC-chhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCC-cHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRES-YG-KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLY-PEPIKAL 327 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~-~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l 327 (370)
.....+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||..........++. ......|..+ ++.+..|
T Consensus 177 ~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~--~~~~~~p~~~~S~~~~~L 254 (370)
T KOG0583|consen 177 LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR--KGEFKIPSYLLSPEARSL 254 (370)
T ss_pred cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh--cCCccCCCCcCCHHHHHH
Confidence 344568999999999999987 86 78999999999999999999999988777777644 4455566666 9999999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 042314 328 LRECWHKNPDRRPTFEEIIF 347 (370)
Q Consensus 328 i~~~l~~~p~~Rp~~~~ll~ 347 (370)
+++||..||.+|+++.+++.
T Consensus 255 i~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 255 IEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred HHHHcCCCcccCCCHHHHhh
Confidence 99999999999999999993
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=338.11 Aligned_cols=244 Identities=29% Similarity=0.484 Sum_probs=213.0
Q ss_pred cccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 95 DRGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 95 ~~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
....+|+|+.|.||.|... +..||+|.+...... ..+-+.+|+.+|+..+|+|||.+++.|...+.+|+||||++
T Consensus 277 ~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 277 DFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP---KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred chhhhccccccceeeeeeccCCceEEEEEEEeccCC---chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 3345999999999999775 667888887654322 24567899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
||+|.+++... .+++.++..|.+++++||+|||.+| |+|||||.+|||++.+|.+||+|||++..+..... ..
T Consensus 354 ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~---KR 426 (550)
T KOG0578|consen 354 GGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS---KR 426 (550)
T ss_pred CCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC---cc
Confidence 99999999886 6999999999999999999999999 99999999999999999999999999877765443 34
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-cCCCCCCCCCCcHHHHHHHHHh
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY-EDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~ 331 (370)
....|||.|||||+.....|+++.||||||++++||+.|++||-..++......+.. ..+....+..+|+.|++|+.+|
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~c 506 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRC 506 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHH
Confidence 556899999999999999999999999999999999999999998777665555442 2334455678999999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~ 348 (370)
|..||++|+++.|||+|
T Consensus 507 L~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 507 LVVDVEQRASAKELLEH 523 (550)
T ss_pred hhcchhcCCCHHHHhcC
Confidence 99999999999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=324.40 Aligned_cols=249 Identities=28% Similarity=0.481 Sum_probs=211.2
Q ss_pred eecccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC--CceEEEE
Q 042314 93 LEDRGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS--ERLIFLT 168 (370)
Q Consensus 93 L~~~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~--~~~~~v~ 168 (370)
++....||+|.||.||+|+.. |+.||+|.++... ..+.......+|+.+|++++||||+++.+..... ..+|+|+
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 333445999999999999875 8889999998764 3456677789999999999999999999998776 6899999
Q ss_pred eecCCCCHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 169 EYLRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
|||+. +|.-++...+ .|++.++..++.||+.||+|+|++| |+|||||..||||+.+|.+||+|||+|+++.....
T Consensus 198 eYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred ecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99988 9998888753 7999999999999999999999999 99999999999999999999999999998876554
Q ss_pred cceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC--------CCC-
Q 042314 248 YSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP--------ALS- 317 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~- 317 (370)
. ..+..+-|.+|.|||.+.+. .|+.++|+||+||||.||++|++.|.+.+..+...++......| .+|
T Consensus 274 ~--~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 274 A--PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred c--ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 3 24556789999999999886 58999999999999999999999999998877666654321111 111
Q ss_pred ------------------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 318 ------------------SLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 318 ------------------~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
..+|....+|+..+|..||.+|.|+.+.|..
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 2356788899999999999999999998653
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=329.86 Aligned_cols=243 Identities=27% Similarity=0.466 Sum_probs=216.3
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|.||.||++.+. ++.+|+|++..... ......+.+|+.++.+++++||.++++.+..+..+|++|||+.||
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gG 96 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGG 96 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCc
Confidence 45899999999999875 78899999976543 345677889999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
++.+.++..+.+++..+..++++++.|+.|||+.+ .+|||||+.||++...|.+||+|||.+........ ....
T Consensus 97 sv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~---rr~t 170 (467)
T KOG0201|consen 97 SVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK---RRKT 170 (467)
T ss_pred chhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh---cccc
Confidence 99999999877799999999999999999999999 99999999999999999999999999977765433 2245
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.+|||.|||||++.+..|+.++||||||++.+||.+|.+|+....+......+ .+...|.+...+++.|++||+.||.+
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-pk~~PP~L~~~~S~~~kEFV~~CL~k 249 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-PKSAPPRLDGDFSPPFKEFVEACLDK 249 (467)
T ss_pred ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-cCCCCCccccccCHHHHHHHHHHhhc
Confidence 68999999999999999999999999999999999999999988875443333 35666777778999999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042314 335 NPDRRPTFEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~ 348 (370)
||+.||++.+|+++
T Consensus 250 ~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 250 NPEFRPSAKELLKH 263 (467)
T ss_pred CcccCcCHHHHhhh
Confidence 99999999999876
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=335.37 Aligned_cols=244 Identities=32% Similarity=0.558 Sum_probs=216.9
Q ss_pred cCCCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 97 GGIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.-+|.|+.|+||.++..+..||||.++.. -..++.-|++|+||||+.+.|+|.....+|||||||..|-|
T Consensus 130 eWlGSGaQGAVF~Grl~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLHNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhccCcccceeeeeccCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 34899999999999999999999987542 23568889999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
..+++....++......|..+|+.|+.|||.++ |||||||+-||||+.+..|||+|||-++...... ......
T Consensus 200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S----TkMSFa 272 (904)
T KOG4721|consen 200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS----TKMSFA 272 (904)
T ss_pred HHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh----hhhhhh
Confidence 999999999999999999999999999999999 9999999999999999999999999998776542 233457
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
||..|||||++...+.+.|+|||||||+||||+||..||.......++--+.......+.|..+|+.|+-||+.||+..|
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKp 352 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKP 352 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCC
Confidence 99999999999999999999999999999999999999987766655544444445567788999999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHhc
Q 042314 337 DRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 337 ~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
.+||++.+++.||+-....+-
T Consensus 353 RNRPSFrqil~HldIa~pell 373 (904)
T KOG4721|consen 353 RNRPSFRQILLHLDIASPELL 373 (904)
T ss_pred CCCccHHHHHHHHhhcCHHHh
Confidence 999999999999987654443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=327.12 Aligned_cols=247 Identities=27% Similarity=0.389 Sum_probs=211.8
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..||+|+||.||+|+.+ |..+|+|+++++.-....+.+....|-.+|....+|.||+++..|++.+.+|+||||++||
T Consensus 147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGG 226 (550)
T KOG0605|consen 147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGG 226 (550)
T ss_pred eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCc
Confidence 34899999999999765 8999999999876666667788899999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccC--------
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD-------- 246 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-------- 246 (370)
++..+|.+.+.+++..++.++.+++.|++.+|+.| +|||||||+|+|||..|++||+|||++..+....
T Consensus 227 D~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~ 303 (550)
T KOG0605|consen 227 DMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLD 303 (550)
T ss_pred cHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcch
Confidence 99999999999999999999999999999999999 9999999999999999999999999985432100
Q ss_pred -----------cccee-----c--------------------cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh
Q 042314 247 -----------SYSYK-----M--------------------TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ 290 (370)
Q Consensus 247 -----------~~~~~-----~--------------------~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 290 (370)
..... . ...+|||.|+|||++.+..|+..+|.||||||||||+.
T Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLv 383 (550)
T KOG0605|consen 304 EQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLV 383 (550)
T ss_pred hhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHh
Confidence 00000 0 01259999999999999999999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHhhccCCCCC--CCCCCcHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 042314 291 GGPSNRADTAVQVADRRAYEDSRPA--LSSLYPEPIKALLRECWHKNPDRRPT---FEEIIF 347 (370)
Q Consensus 291 g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~ll~ 347 (370)
|.|||...++.+...++........ ....++++.++||.+|+. ||++|.. ++||-.
T Consensus 384 GyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 384 GYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred CCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 9999999999998888765442222 233467899999999999 9999975 555543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=328.74 Aligned_cols=251 Identities=25% Similarity=0.478 Sum_probs=204.5
Q ss_pred CCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeC-CceEEEE
Q 042314 98 GIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHS-ERLIFLT 168 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~-~~~~~v~ 168 (370)
.+|.|+||.||++... +..+|+|.++.. ........+.+|+.+++.+ +||||+++++++... ..++++|
T Consensus 14 ~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (338)
T cd05102 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG--ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIV 91 (338)
T ss_pred EeccCCcceEEEEEEeccCCcccchhhheeccccc--cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEE
Confidence 3799999999999742 457999998753 2234456789999999999 899999999987654 4689999
Q ss_pred eecCCCCHHHHHHhC--------------------------------------------------------------CCC
Q 042314 169 EYLRNGSLHDILKKK--------------------------------------------------------------GKL 186 (370)
Q Consensus 169 e~~~g~~L~~~l~~~--------------------------------------------------------------~~~ 186 (370)
||+++|+|.+++... .++
T Consensus 92 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 171 (338)
T cd05102 92 EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPL 171 (338)
T ss_pred ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCC
Confidence 999999999998753 236
Q ss_pred ChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCCCCccccCccc
Q 042314 187 DPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV 266 (370)
Q Consensus 187 ~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 266 (370)
+...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......... ......+++.|+|||+
T Consensus 172 ~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~~~~~y~aPE~ 247 (338)
T cd05102 172 TMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKGSARLPLKWMAPES 247 (338)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchh-cccCCCCCccccCcHH
Confidence 77788999999999999999998 9999999999999999999999999997654332211 1122245678999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 042314 267 YRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345 (370)
Q Consensus 267 ~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~l 345 (370)
+.+..++.++||||||+++|||++ |..||...............+.....+..+++.+.+++.+||+.||++|||+.++
T Consensus 248 ~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el 327 (338)
T cd05102 248 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSAL 327 (338)
T ss_pred hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 998889999999999999999997 9999987554333333333344455567788999999999999999999999999
Q ss_pred HHHHHHHHH
Q 042314 346 IFRLEAIQE 354 (370)
Q Consensus 346 l~~l~~~~~ 354 (370)
++.|+++..
T Consensus 328 ~~~l~~~~~ 336 (338)
T cd05102 328 VEILGDLLQ 336 (338)
T ss_pred HHHHHHHHh
Confidence 999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=344.47 Aligned_cols=253 Identities=32% Similarity=0.558 Sum_probs=222.7
Q ss_pred CCCCCCcccEEEEEEcC-------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 98 GIDPGAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g-------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
.+|+|+||.||++...| ..||||.++.. .+...+.+|.+|++++..++|||||+++|.+..++.+++|+||
T Consensus 493 eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY 570 (774)
T KOG1026|consen 493 ELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY 570 (774)
T ss_pred hhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence 38999999999997653 34899999875 4556889999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC--------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 042314 171 LRNGSLHDILKKK--------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDF 236 (370)
Q Consensus 171 ~~g~~L~~~l~~~--------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Df 236 (370)
|..|+|.+++..+ ++++..+.+.|+.||+.||.||-++. +|||||-.+|+||.+.-.|||+||
T Consensus 571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDf 647 (774)
T KOG1026|consen 571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDF 647 (774)
T ss_pred cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEeccc
Confidence 9999999999743 13788899999999999999999998 999999999999999999999999
Q ss_pred ccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCC
Q 042314 237 GLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPA 315 (370)
Q Consensus 237 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 315 (370)
|+++.+-..+.+.... ...-+++|||||.+..++||.+|||||+||+|||+++ |+.||.+.+..+.+..+.. +....
T Consensus 648 GLsRdiYssDYYk~~~-~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~-g~lL~ 725 (774)
T KOG1026|consen 648 GLSRDIYSSDYYKVRG-NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA-GQLLS 725 (774)
T ss_pred ccchhhhhhhhhcccC-CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc-CCccc
Confidence 9999877665443221 2234789999999999999999999999999999996 8899999999888887774 44477
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 316 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
-|..+|.++++||..||+.+|++||+++||-..|++....-+
T Consensus 726 ~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 726 CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 788999999999999999999999999999999998876544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=325.27 Aligned_cols=242 Identities=26% Similarity=0.440 Sum_probs=204.6
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCC-ceEEEEeecC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSE-RLIFLTEYLR 172 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~-~~~~v~e~~~ 172 (370)
..+|.|.||.||+|... |..||+|.++.....-+ ...-.+|+..+++++ ||||+++.+++.+.+ .+++|||||+
T Consensus 16 ~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e--e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md 93 (538)
T KOG0661|consen 16 RKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD 93 (538)
T ss_pred HHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH--HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh
Confidence 44899999999999764 88899999988754432 334479999999998 999999999998877 8999999998
Q ss_pred CCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 173 NGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 173 g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
. +|+++++.+ ..|++..++.|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+|+.+.....+
T Consensus 94 ~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY--- 166 (538)
T KOG0661|consen 94 C-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY--- 166 (538)
T ss_pred h-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCCCc---
Confidence 7 999999866 46899999999999999999999999 999999999999999899999999999988876543
Q ss_pred ccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCC---------------
Q 042314 252 MTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPA--------------- 315 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------- 315 (370)
+..+.|.+|+|||++.. +.|+.+.|+|++||+++|+++-++.|.+.+..+...++...-..|.
T Consensus 167 -TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn 245 (538)
T KOG0661|consen 167 -TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN 245 (538)
T ss_pred -chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence 33467999999999865 5689999999999999999999999998877765555432211110
Q ss_pred -------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 316 -------------LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 316 -------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+-...+.+..++|.+|+..||++|||+++++++
T Consensus 246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 112366889999999999999999999999876
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=329.89 Aligned_cols=242 Identities=26% Similarity=0.423 Sum_probs=209.0
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... |+.+|+|+++............+.+|+.+++.++||||+++++.+...+..++||||+.+++|
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L 82 (323)
T cd05571 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL 82 (323)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcH
Confidence 789999999999764 788999998765433444556778999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.+.+.+++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+|||+++....... ......
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~~~~~ 156 (323)
T cd05571 83 FFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFC 156 (323)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC---ccccee
Confidence 999998889999999999999999999999998 99999999999999999999999999875432211 122346
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
||+.|+|||.+.+..++.++||||+||++|||++|+.||...........+.. .....+..+++.+.++|++||..||
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP 234 (323)
T cd05571 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EEIRFPRTLSPEAKSLLAGLLKKDP 234 (323)
T ss_pred cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccCCH
Confidence 89999999999999999999999999999999999999988776665554432 2345567789999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 042314 337 DRRP-----TFEEIIFR 348 (370)
Q Consensus 337 ~~Rp-----~~~~ll~~ 348 (370)
++|| ++.+++++
T Consensus 235 ~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 235 KQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHcCCCCCCCHHHHHcC
Confidence 9999 79999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=296.46 Aligned_cols=245 Identities=28% Similarity=0.464 Sum_probs=206.1
Q ss_pred ccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 96 RGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
...+|+|.||.||+|.+. |+.||+|.++..... +.......+|+..++.++|+||+.++++|.+.+.+.+|+||++.
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc
Confidence 445899999999999874 889999999876433 23456678999999999999999999999999999999999977
Q ss_pred CCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 174 GSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 174 ~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
+|+.+++.+ -.++..++..++.++++|++|+|++. |+||||||+|+|++++|.+||+|||+++....+....
T Consensus 86 -dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~--- 158 (318)
T KOG0659|consen 86 -DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ--- 158 (318)
T ss_pred -cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCccc---
Confidence 999999866 46899999999999999999999998 9999999999999999999999999999888765432
Q ss_pred cCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc--CCCCC--------------
Q 042314 253 TGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE--DSRPA-------------- 315 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~-------------- 315 (370)
...+-|.+|.|||.+.|. .|+..+|+||.||++.||+.|.+.|.+.++.+....+... .+.+.
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 122568999999999875 5899999999999999999999999988877655443221 11111
Q ss_pred ----------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 316 ----------LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 316 ----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+....+....+|+.++|..||.+|.+++|++++
T Consensus 239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 112244678999999999999999999999876
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=313.73 Aligned_cols=244 Identities=27% Similarity=0.456 Sum_probs=220.5
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|.||.|.+|.. .|+.||+|.+++....+....-.+.+|+++|..++||||+.++++|+..+.+.|||||..+|
T Consensus 59 etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~G 138 (668)
T KOG0611|consen 59 ETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGG 138 (668)
T ss_pred HHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCc
Confidence 3489999999999966 49999999999988888888888999999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.|++++.+++.+++.+++.+++||++|+.|+|.++ ++|||||.+|||+|.++++||+|||++..+..... ...
T Consensus 139 eLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf----LqT 211 (668)
T KOG0611|consen 139 ELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF----LQT 211 (668)
T ss_pred cHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccccH----HHH
Confidence 99999999999999999999999999999999998 99999999999999999999999999988876643 345
Q ss_pred CCCCccccCcccccccCCC-chhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYG-KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
.+|+|-|.+||++++.+|. +.+|-||||++||.|..|.+||++.....+..++.....+.+ .-|.....||+.||-
T Consensus 212 FCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP---~~PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 212 FCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP---ETPSDASGLIRWMLM 288 (668)
T ss_pred hcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC---CCCchHHHHHHHHHh
Confidence 6899999999999999985 789999999999999999999999988888877764333322 235678999999999
Q ss_pred cCCCCCCCHHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~ 350 (370)
.||++|.|..++..+..
T Consensus 289 VNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 289 VNPERRATIEDIASHWW 305 (668)
T ss_pred cCcccchhHHHHhhhhe
Confidence 99999999999988753
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=324.64 Aligned_cols=242 Identities=26% Similarity=0.423 Sum_probs=207.8
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+|+|.+.............+..|+.++++++||||+++++.+...+..++||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 588999999999875 678999998764333445567788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.+.+++++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~ 154 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFC 154 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---cccccc
Confidence 999998889999999999999999999999998 99999999999999999999999999875432221 122346
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
||+.|+|||.+.+..++.++||||+||++|+|++|+.||............. ......+..+++.+.+++.+||..||
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp 232 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--QEPLRFPDGFDRDAKDLLIGLLSRDP 232 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHcCCCH
Confidence 8999999999999999999999999999999999999998877766555544 23445567789999999999999999
Q ss_pred CCCCC---HHHHHHH
Q 042314 337 DRRPT---FEEIIFR 348 (370)
Q Consensus 337 ~~Rp~---~~~ll~~ 348 (370)
++||+ +.+++.+
T Consensus 233 ~~R~~~~~~~e~l~h 247 (312)
T cd05585 233 TRRLGYNGAQEIKNH 247 (312)
T ss_pred HHcCCCCCHHHHHcC
Confidence 99975 6777654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=322.81 Aligned_cols=240 Identities=25% Similarity=0.424 Sum_probs=209.5
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... ++.+++|.+.............+.+|+.+++.++||||+++++++.+.+..++||||+.+++
T Consensus 8 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 87 (291)
T cd05612 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGE 87 (291)
T ss_pred eeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCC
Confidence 3789999999999876 78899999875433334456678899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 88 L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~------~~~ 158 (291)
T cd05612 88 LFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT------WTL 158 (291)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCc------ccc
Confidence 9999998889999999999999999999999998 9999999999999999999999999987654321 123
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.|++.|+|||.+.+..++.++|||||||++|+|++|+.||...........+.. .....+..++..+.++|++||+.|
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~d 236 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA--GKLEFPRHLDLYAKDLIKKLLVVD 236 (291)
T ss_pred cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCcCCCccCCHHHHHHHHHHcCCC
Confidence 589999999999998899999999999999999999999998877666555542 234556667899999999999999
Q ss_pred CCCCCC-----HHHHHHH
Q 042314 336 PDRRPT-----FEEIIFR 348 (370)
Q Consensus 336 p~~Rp~-----~~~ll~~ 348 (370)
|.+||+ +++++++
T Consensus 237 p~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 237 RTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHccCCccCCHHHHhcC
Confidence 999995 9998877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=327.17 Aligned_cols=239 Identities=26% Similarity=0.474 Sum_probs=209.2
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+++|.+.............+.+|+.++++++||||+++++.+...+..++||||+.|++|
T Consensus 26 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 105 (329)
T PTZ00263 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL 105 (329)
T ss_pred EEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChH
Confidence 788999999999875 778999998765433344567789999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ...
T Consensus 106 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~------~~~ 176 (329)
T PTZ00263 106 FTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF------TLC 176 (329)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc------eec
Confidence 999998889999999999999999999999998 99999999999999999999999999876643221 235
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+. ......+..++..+.+||++||+.||
T Consensus 177 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~L~~dP 254 (329)
T PTZ00263 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--AGRLKFPNWFDGRARDLVKGLLQTDH 254 (329)
T ss_pred CChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCcCCCCCCCHHHHHHHHHHhhcCH
Confidence 8999999999999989999999999999999999999998887766555544 23345566788999999999999999
Q ss_pred CCCCC-----HHHHHHH
Q 042314 337 DRRPT-----FEEIIFR 348 (370)
Q Consensus 337 ~~Rp~-----~~~ll~~ 348 (370)
.+||+ +++++.+
T Consensus 255 ~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 255 TKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHcCCCCCCCHHHHhcC
Confidence 99986 6888866
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=324.27 Aligned_cols=242 Identities=26% Similarity=0.425 Sum_probs=208.1
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... |..+|+|.++............+.+|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L 82 (323)
T cd05595 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL 82 (323)
T ss_pred eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcH
Confidence 789999999999764 788999999765433444566778899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
..++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........ ......
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~ 156 (323)
T cd05595 83 FFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFC 156 (323)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---cccccc
Confidence 999988888999999999999999999999998 99999999999999999999999998865322211 122346
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
||+.|+|||.+.+..++.++|+|||||++|+|++|+.||.............. .....+..+++.+.++|.+||..||
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~dP 234 (323)
T cd05595 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSLLAGLLKKDP 234 (323)
T ss_pred CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHccCCH
Confidence 89999999999998999999999999999999999999987776665554432 2334566789999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 042314 337 DRRP-----TFEEIIFR 348 (370)
Q Consensus 337 ~~Rp-----~~~~ll~~ 348 (370)
++|| ++.+++++
T Consensus 235 ~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 235 KQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHhCCCCCCCHHHHHcC
Confidence 9998 89988875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=326.09 Aligned_cols=256 Identities=31% Similarity=0.537 Sum_probs=226.5
Q ss_pred cCCCCCCcccEEEEEEcC-----ce-eEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 97 GGIDPGAYGEVYLVKWRG-----TE-IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g-----~~-vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
..+|+|+||.||++...- .. ||+|..+.......+....+++|++++++++|||||+++|+......+++|||+
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl 242 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL 242 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence 458999999999997651 23 788888765546678899999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 171 LRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 171 ~~g~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
|.||+|.+++++.+ .++..+...++.+.+.||+|||+++ +|||||-.+|+|++..+.+||+|||+++....- .
T Consensus 243 ~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~---~ 316 (474)
T KOG0194|consen 243 CNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY---V 316 (474)
T ss_pred cCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcce---e
Confidence 99999999999987 4999999999999999999999999 999999999999999999999999998654311 1
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.......-+.+|+|||.+....|+.++|||||||++||+++ |..||.+....+...++...+.+...+...|..+..++
T Consensus 317 ~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~ 396 (474)
T KOG0194|consen 317 MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVM 396 (474)
T ss_pred eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHH
Confidence 11111234789999999999999999999999999999998 78899999999888888777888888889999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHhcc
Q 042314 329 RECWHKNPDRRPTFEEIIFRLEAIQESFQK 358 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~ 358 (370)
.+||..+|++||++.++.+.++.+......
T Consensus 397 ~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 397 KQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 999999999999999999999999777664
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=324.36 Aligned_cols=242 Identities=26% Similarity=0.428 Sum_probs=209.1
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+|+|++.............+.+|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L 82 (328)
T cd05593 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL 82 (328)
T ss_pred eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCH
Confidence 689999999999764 788999999765444445567788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
..++...+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........ ......
T Consensus 83 ~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~~~~~ 156 (328)
T cd05593 83 FFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TMKTFC 156 (328)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc---cccccc
Confidence 999988888999999999999999999999998 99999999999999999999999999875332211 122346
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+. .....++..+++.+.++|++||..||
T Consensus 157 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~--~~~~~~p~~~~~~~~~li~~~L~~dP 234 (328)
T cd05593 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKFPRTLSADAKSLLSGLLIKDP 234 (328)
T ss_pred CCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc--cCCccCCCCCCHHHHHHHHHHcCCCH
Confidence 8999999999999889999999999999999999999998776665554443 23345667789999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 042314 337 DRRP-----TFEEIIFR 348 (370)
Q Consensus 337 ~~Rp-----~~~~ll~~ 348 (370)
++|| ++.+++++
T Consensus 235 ~~R~~~~~~~~~~il~h 251 (328)
T cd05593 235 NKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHcCCCCCCCHHHHhcC
Confidence 9997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=293.09 Aligned_cols=243 Identities=28% Similarity=0.446 Sum_probs=218.3
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|-||.||.++.+ +..+|+|++-++.........++.+|+++.+.++||||++++++|.++...|+++||...|
T Consensus 28 r~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~g 107 (281)
T KOG0580|consen 28 RPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRG 107 (281)
T ss_pred ccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCc
Confidence 34788999999999876 6679999987765566677888999999999999999999999999999999999999999
Q ss_pred CHHHHHH--hCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 175 SLHDILK--KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 175 ~L~~~l~--~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
+|...++ ...++++..+..++.|++.|+.|+|.++ +|||||||+|+|++..|.+|++|||-+...... ..
T Consensus 108 el~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~-----kR 179 (281)
T KOG0580|consen 108 ELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSN-----KR 179 (281)
T ss_pred hHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCCC-----Cc
Confidence 9999999 5578999999999999999999999998 999999999999999999999999988655422 23
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
...+||..|.+||...+...+..+|+|++|++.||++.|.+||...+..+.+.++. ..+..+|..++...+++|++|+
T Consensus 180 ~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~--k~~~~~p~~is~~a~dlI~~ll 257 (281)
T KOG0580|consen 180 KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR--KVDLKFPSTISGGAADLISRLL 257 (281)
T ss_pred eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH--HccccCCcccChhHHHHHHHHh
Confidence 44589999999999999999999999999999999999999999998877777775 4455566889999999999999
Q ss_pred ccCCCCCCCHHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~l 349 (370)
..+|.+|.+..+++.+-
T Consensus 258 ~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 258 VKNPIERLALTEVMDHP 274 (281)
T ss_pred ccCccccccHHHHhhhH
Confidence 99999999999998764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=323.70 Aligned_cols=240 Identities=22% Similarity=0.401 Sum_probs=208.0
Q ss_pred CCCCCCcccEEEEEEcC---ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWRG---TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g---~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|+||.||++.+.+ ..+++|.+.............+.+|+.+++.++||||+++++++...+.+++||||+.+|
T Consensus 37 ~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g 116 (340)
T PTZ00426 37 TLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG 116 (340)
T ss_pred EEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCC
Confidence 37899999999997642 579999886544334445667889999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 117 ~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~------~~ 187 (340)
T PTZ00426 117 EFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT------YT 187 (340)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCCc------ce
Confidence 99999998889999999999999999999999998 9999999999999999999999999987654321 22
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
..||+.|+|||++.+..++.++|+||+||++|||++|.+||...........+.. .....+..+++.+.++|++||+.
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~l~~ 265 (340)
T PTZ00426 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE--GIIYFPKFLDNNCKHLMKKLLSH 265 (340)
T ss_pred ecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHccc
Confidence 3689999999999988899999999999999999999999998877665555442 23345667889999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 042314 335 NPDRRP-----TFEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp-----~~~~ll~~ 348 (370)
||++|+ ++++++++
T Consensus 266 dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 266 DLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CHHHcCCCCCCCHHHHHcC
Confidence 999995 89999876
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=304.39 Aligned_cols=247 Identities=25% Similarity=0.477 Sum_probs=209.5
Q ss_pred CCCCCcccEEEEEE----cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 99 IDPGAYGEVYLVKW----RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 99 l~~g~~~~v~~a~~----~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
+|.|+||.||++.+ .+..+++|+++... .+....+.+..|+.+++.++||||+++++++. .+..++||||+.++
T Consensus 3 lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred CCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 78999999999865 36779999886543 34566788999999999999999999999875 45678999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|.+++.....+++..+..++.|++.|+.|||+++ ++||||||.||+++.++.+||+|||++...............
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 99999988778999999999999999999999998 999999999999999999999999999876544322212222
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..++..|+|||.+....++.++|+||||+++|||++ |..||...........+. ....+..+..+|+.+.++|++||+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~~~ 236 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-SGERMECPQRCPPEMYDLMKLCWT 236 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHhc
Confidence 345679999999988888999999999999999998 999998877666555544 334456677889999999999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~ 351 (370)
.||++||+++++.+.|+.
T Consensus 237 ~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 237 YGVDERPGFAVVELRLRN 254 (257)
T ss_pred cCchhCcCHHHHHHHHhc
Confidence 999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=325.02 Aligned_cols=252 Identities=30% Similarity=0.525 Sum_probs=213.6
Q ss_pred CCCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 98 GIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
.||.|.||+||++.|-|. ||||++.... ..++..+.|++|+.++++-+|.||+-++|++..... .||+.+|+|.+|+
T Consensus 399 rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~-pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY 475 (678)
T KOG0193|consen 399 RIGSGSFGTVYRGRWHGD-VAVKLLNVDD-PTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLY 475 (678)
T ss_pred eeccccccceeecccccc-eEEEEEecCC-CCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhh
Confidence 499999999999998864 7999998875 445688999999999999999999999999988776 9999999999999
Q ss_pred HHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 178 DILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 178 ~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.++... .+|...+.+.|++|+++||.|||.++ |||||||..||++.++++|||+|||++.....- ..........
T Consensus 476 ~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w-~g~~q~~qp~ 551 (678)
T KOG0193|consen 476 THLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW-SGEQQLEQPH 551 (678)
T ss_pred hhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeee-ccccccCCCc
Confidence 998743 57899999999999999999999999 999999999999999999999999998755432 1111223345
Q ss_pred CCccccCcccccc---cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc---CCCCCCCCCCcHHHHHHHHH
Q 042314 257 GSYRYMAPEVYRR---ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE---DSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 257 g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~ 330 (370)
|...|||||++.. .+|++.+||||||+++|||++|..||.....+.++-.+... .........+|.++++|+..
T Consensus 552 gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~ 631 (678)
T KOG0193|consen 552 GSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSD 631 (678)
T ss_pred cchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHH
Confidence 7889999999864 46899999999999999999999999966666555444422 12233455688899999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
||..++++||.+.+|+..|+.+..+.
T Consensus 632 C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 632 CWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred HHhcCcccCccHHHHHHHHHHhhhcc
Confidence 99999999999999999998887753
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=320.04 Aligned_cols=242 Identities=26% Similarity=0.429 Sum_probs=205.8
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... +..+|+|.+.............+..|..++..+ +||||+++++++...+.+++||||++|++
T Consensus 3 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~ 82 (320)
T cd05590 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGD 82 (320)
T ss_pred eeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCch
Confidence 789999999999875 678999998764333334556677888888776 69999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 83 L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---~~~~~ 156 (320)
T cd05590 83 LMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---TTSTF 156 (320)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---ccccc
Confidence 9999998889999999999999999999999998 99999999999999999999999999875432211 12234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||.+.+..++.++|+|||||++|+|++|+.||...........+. ......+..++..+.+++++||+.|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~d 234 (320)
T cd05590 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL--NDEVVYPTWLSQDAVDILKAFMTKN 234 (320)
T ss_pred ccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHcccC
Confidence 68999999999999889999999999999999999999999887776665554 2334456678899999999999999
Q ss_pred CCCCCCH------HHHHHH
Q 042314 336 PDRRPTF------EEIIFR 348 (370)
Q Consensus 336 p~~Rp~~------~~ll~~ 348 (370)
|++||++ ++++.+
T Consensus 235 P~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 235 PTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred HHHCCCCCCCCCHHHHHcC
Confidence 9999998 555554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=322.52 Aligned_cols=241 Identities=28% Similarity=0.426 Sum_probs=207.1
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+|+|+++............+..|+.+++.++||||+++++++...+..++||||++|++|
T Consensus 9 ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L 88 (333)
T cd05600 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF 88 (333)
T ss_pred EeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCH
Confidence 788999999999875 788999999765433344567788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... .....
T Consensus 89 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~------~~~~~ 159 (333)
T cd05600 89 RTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY------ANSVV 159 (333)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccccc------cCCcc
Confidence 999998888999999999999999999999998 999999999999999999999999998765431 22346
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC---CCCCC---CCCCcHHHHHHHHH
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED---SRPAL---SSLYPEPIKALLRE 330 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~~---~~~~~~~l~~li~~ 330 (370)
||+.|+|||.+.+..++.++|||||||++|||++|..||...+.......+.... ..+.. ...+++.+.+++.+
T Consensus 160 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 239 (333)
T cd05600 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITK 239 (333)
T ss_pred cCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHH
Confidence 8999999999999999999999999999999999999998877665544333211 11111 12568899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~ 348 (370)
||..+|++||++.+++++
T Consensus 240 ~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 240 LINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HhhChhhhcCCHHHHHhC
Confidence 999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=305.96 Aligned_cols=246 Identities=24% Similarity=0.446 Sum_probs=207.8
Q ss_pred CCCCCcccEEEEEEc-----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWR-----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|+|+||.||++.+. +..+++|.++... .......+.+|+..+++++||||+++++++...+..++||||+++
T Consensus 13 ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 90 (266)
T cd05064 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSN 90 (266)
T ss_pred ecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCC
Confidence 789999999998653 4578899887642 334556789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 174 GSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 174 ~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
++|.+++... ..+++..++.++.|++.||+|||+++ ++||||||+||+++.++.++++|||.+........ ...
T Consensus 91 ~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 165 (266)
T cd05064 91 GALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI--YTT 165 (266)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccch--hcc
Confidence 9999999874 57899999999999999999999998 99999999999999999999999998765432211 111
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
....++..|+|||.+.+..++.++|||||||++||+++ |..||............. .....+.+..+|..+.+++.+|
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~c 244 (266)
T cd05064 166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-DGFRLPAPRNCPNLLHQLMLDC 244 (266)
T ss_pred cCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHH
Confidence 22345678999999999999999999999999999875 999998887766555443 3344456777899999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
|+.+|++||+++++++.|+++
T Consensus 245 ~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 245 WQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred cCCCchhCCCHHHHHHHHHhh
Confidence 999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=309.12 Aligned_cols=248 Identities=33% Similarity=0.566 Sum_probs=209.6
Q ss_pred cCCCCCCcccEEEEEEcC-------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEe
Q 042314 97 GGIDPGAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g-------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
..+|.|++|.||++...+ ..+++|.+... ........+.+|+..++.++||||+++++++......+++||
T Consensus 11 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e 88 (283)
T cd05048 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN--AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFE 88 (283)
T ss_pred hcccCccCCcEEEEEEecCCCCcceeeEEEEecccC--CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEe
Confidence 348999999999997653 35888887643 334566778999999999999999999999998889999999
Q ss_pred ecCCCCHHHHHHhC----------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEE
Q 042314 170 YLRNGSLHDILKKK----------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKV 233 (370)
Q Consensus 170 ~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl 233 (370)
|+++++|.+++... ..++...++.++.|++.||.|||+++ ++|+||||+||++++++.++|
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L 165 (283)
T cd05048 89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEE
Confidence 99999999999764 35778889999999999999999998 999999999999999999999
Q ss_pred eccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCC
Q 042314 234 TDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDS 312 (370)
Q Consensus 234 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 312 (370)
+|||++.......... ......+++.|+|||.+....++.++|+|||||++|||++ |..||......+....+. ...
T Consensus 166 ~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~-~~~ 243 (283)
T cd05048 166 SDFGLSRDIYSADYYR-VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR-SRQ 243 (283)
T ss_pred CCCcceeecccccccc-ccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCC
Confidence 9999987654332211 1223356789999999988889999999999999999998 999998877766555544 334
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042314 313 RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 313 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~ 351 (370)
.+..+..+|..+.+++++||+.||.+||++++++++|++
T Consensus 244 ~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 244 LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 445667889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=304.59 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=213.9
Q ss_pred CCCCCCcccEEEEEEcC--ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWRG--TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g--~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|.-|.||++..++ ..+|+|++.+..........+...|.++|+.+.||.++.++..|+.+...|+|||||.||+
T Consensus 84 ~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGd 163 (459)
T KOG0610|consen 84 RLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGD 163 (459)
T ss_pred HcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCcc
Confidence 38999999999999886 6799999987765556677888999999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccC-------
Q 042314 176 LHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD------- 246 (370)
Q Consensus 176 L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~------- 246 (370)
|..+++++ +.+++..++.++.+++.||+|||..| ||+|||||+||||.++|++.|+||.++.......
T Consensus 164 L~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~ 240 (459)
T KOG0610|consen 164 LHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSS 240 (459)
T ss_pred HHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCC
Confidence 99999876 47999999999999999999999999 9999999999999999999999999875432100
Q ss_pred --------------------------c--------------------cceeccCCCCCccccCcccccccCCCchhhHHH
Q 042314 247 --------------------------S--------------------YSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFS 280 (370)
Q Consensus 247 --------------------------~--------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~s 280 (370)
. ........+||-.|.|||++.+..-+.++|.|+
T Consensus 241 ~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWt 320 (459)
T KOG0610|consen 241 PRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWT 320 (459)
T ss_pred CCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHH
Confidence 0 001112235899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 042314 281 FALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPT----FEEIIFR 348 (370)
Q Consensus 281 lG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~----~~~ll~~ 348 (370)
||+++|||+.|..||.+.+..+....+......-+.....+...++||+++|.+||++|.. ++||-+|
T Consensus 321 fGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 321 FGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 9999999999999999999988888777555544444467889999999999999999988 7776543
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=317.97 Aligned_cols=241 Identities=27% Similarity=0.493 Sum_probs=203.5
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... +..+|+|.++............+..|..++... +||||+++++++...+..++||||+.||+
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~ 82 (316)
T cd05592 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGD 82 (316)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCc
Confidence 789999999999875 667999998765433333444556677776654 79999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 83 L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~---~~~~~ 156 (316)
T cd05592 83 LMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG---KASTF 156 (316)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC---ccccc
Confidence 9999998889999999999999999999999998 99999999999999999999999999876433221 12234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+. ...+..+..++..+.+++++||+.|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~ll~~~l~~~ 234 (316)
T cd05592 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL--NDRPHFPRWISKEAKDCLSKLFERD 234 (316)
T ss_pred cCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHccCC
Confidence 68999999999999889999999999999999999999999887766655543 3445566778999999999999999
Q ss_pred CCCCCCHH-HHHH
Q 042314 336 PDRRPTFE-EIIF 347 (370)
Q Consensus 336 p~~Rp~~~-~ll~ 347 (370)
|++||+.. ++++
T Consensus 235 P~~R~~~~~~l~~ 247 (316)
T cd05592 235 PTKRLGVDGDIRQ 247 (316)
T ss_pred HHHcCCChHHHHc
Confidence 99999865 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=322.15 Aligned_cols=242 Identities=26% Similarity=0.424 Sum_probs=207.8
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++.. .+..+++|+++............+..|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L 82 (325)
T cd05594 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL 82 (325)
T ss_pred eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcH
Confidence 68999999999976 4788999999765444444556778899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhh-cCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHH-HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
..++.+.+.+++..+..++.|++.||.|||+ .+ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 83 ~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~~~~ 156 (325)
T cd05594 83 FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTF 156 (325)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---ccccc
Confidence 9999888889999999999999999999997 67 99999999999999999999999999875432211 12234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. ......+..+++.+.+++++||+.|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~L~~d 234 (325)
T cd05594 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEEIRFPRTLSPEAKSLLSGLLKKD 234 (325)
T ss_pred cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 68999999999999899999999999999999999999998877665555443 2334456678999999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 042314 336 PDRRP-----TFEEIIFR 348 (370)
Q Consensus 336 p~~Rp-----~~~~ll~~ 348 (370)
|++|+ ++.+++++
T Consensus 235 P~~R~~~~~~~~~~il~h 252 (325)
T cd05594 235 PKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHhCCCCCCCHHHHhcC
Confidence 99996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=325.65 Aligned_cols=238 Identities=26% Similarity=0.456 Sum_probs=212.9
Q ss_pred ccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecC
Q 042314 96 RGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
..++|.|+||.|+++..+ +..+|+|++++...-..+..+..+.|.+++...+ ||.++.++.+|+..+++++||||+.
T Consensus 373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~ 452 (694)
T KOG0694|consen 373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA 452 (694)
T ss_pred EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence 345899999999999876 5679999999987666677788999999988875 9999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
||++. .++..+.+++..++.++..++.||.|||++| ||+||||.+|||+|.+|.+||+|||+++..-..+. ..
T Consensus 453 Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~---~T 525 (694)
T KOG0694|consen 453 GGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD---RT 525 (694)
T ss_pred CCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCCC---cc
Confidence 99944 3445569999999999999999999999999 99999999999999999999999999986543322 34
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
.+.+|||.|+|||++.+..|+.++|.|||||+||||+.|..||.+++..+....+. ...+.+|..+|.+..++++++|
T Consensus 526 sTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--~d~~~yP~~ls~ea~~il~~ll 603 (694)
T KOG0694|consen 526 STFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--NDEVRYPRFLSKEAIAIMRRLL 603 (694)
T ss_pred ccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCCCCCCcccHHHHHHHHHHh
Confidence 56789999999999999999999999999999999999999999999999988886 5667778889999999999999
Q ss_pred ccCCCCCCCH
Q 042314 333 HKNPDRRPTF 342 (370)
Q Consensus 333 ~~~p~~Rp~~ 342 (370)
.++|++|..+
T Consensus 604 ~k~p~kRLG~ 613 (694)
T KOG0694|consen 604 RKNPEKRLGS 613 (694)
T ss_pred ccCcccccCC
Confidence 9999999765
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=318.83 Aligned_cols=243 Identities=29% Similarity=0.481 Sum_probs=207.2
Q ss_pred CCCCCCcccEEEEEE-----cCceeEEEEeccccC-CChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKW-----RGTEIAAKTIRSSIA-SNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~-----~g~~vavK~l~~~~~-~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
.+|.|+||.||++.. .++.+|+|+++.... ........+..|+.+++.++||||+++++.+...+..++||||+
T Consensus 3 ~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 82 (323)
T cd05584 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYL 82 (323)
T ss_pred eeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCC
Confidence 378999999999875 367899999875422 22334556789999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
.+++|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 156 (323)
T cd05584 83 SGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT---V 156 (323)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC---c
Confidence 99999999998888999999999999999999999998 99999999999999999999999999875432221 1
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...........+. ......+..+++.+.++|++|
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~ 234 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL--KGKLNLPPYLTPEARDLLKKL 234 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHH
Confidence 223468999999999999889999999999999999999999998877766555443 233456677889999999999
Q ss_pred cccCCCCCC-----CHHHHHHH
Q 042314 332 WHKNPDRRP-----TFEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp-----~~~~ll~~ 348 (370)
|+.||++|| ++.+++.+
T Consensus 235 l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 235 LKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred cccCHhHcCCCCCCCHHHHhcC
Confidence 999999999 88888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=321.22 Aligned_cols=249 Identities=27% Similarity=0.459 Sum_probs=204.8
Q ss_pred CCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEe
Q 042314 98 GIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
.+|.|+||.||++.+. +..+++|.++... .......+.+|+.+++.+ +||||+++++++...+..++|||
T Consensus 45 ~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~e 122 (374)
T cd05106 45 TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITE 122 (374)
T ss_pred eecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHh
Confidence 4799999999998753 2469999987543 234466788999999999 89999999999999999999999
Q ss_pred ecCCCCHHHHHHhC------------------------------------------------------------------
Q 042314 170 YLRNGSLHDILKKK------------------------------------------------------------------ 183 (370)
Q Consensus 170 ~~~g~~L~~~l~~~------------------------------------------------------------------ 183 (370)
|+.+|+|.+++...
T Consensus 123 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (374)
T cd05106 123 YCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEED 202 (374)
T ss_pred hccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhc
Confidence 99999999988642
Q ss_pred ----CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCCCCc
Q 042314 184 ----GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSY 259 (370)
Q Consensus 184 ----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~ 259 (370)
.+++...+++++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......... ......+++
T Consensus 203 ~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~ 278 (374)
T cd05106 203 TEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV-VKGNARLPV 278 (374)
T ss_pred cCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee-eccCCCCcc
Confidence 13677889999999999999999998 9999999999999999999999999987654332211 111223567
Q ss_pred cccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCCCC
Q 042314 260 RYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDR 338 (370)
Q Consensus 260 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 338 (370)
.|+|||++.+..++.++||||||+++|+|++ |+.||..................+..+...|+.+.+++.+||+.||++
T Consensus 279 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 358 (374)
T cd05106 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTE 358 (374)
T ss_pred ceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhh
Confidence 8999999988889999999999999999997 999997765443333333333445556667899999999999999999
Q ss_pred CCCHHHHHHHHHHH
Q 042314 339 RPTFEEIIFRLEAI 352 (370)
Q Consensus 339 Rp~~~~ll~~l~~~ 352 (370)
|||+.++++.|+++
T Consensus 359 RPs~~~l~~~l~~~ 372 (374)
T cd05106 359 RPTFSQISQLIQRQ 372 (374)
T ss_pred CcCHHHHHHHHHHH
Confidence 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=318.35 Aligned_cols=242 Identities=26% Similarity=0.439 Sum_probs=207.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... +..+++|.++............+..|.++++.+ +||+|+++++++...+..++||||+++++
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 82 (321)
T cd05591 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGD 82 (321)
T ss_pred cccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCc
Confidence 789999999999875 678999998765433444556677888888866 79999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|...+...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 83 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~~~~ 156 (321)
T cd05591 83 LMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---TTTTF 156 (321)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc---ccccc
Confidence 9999988888999999999999999999999998 99999999999999999999999999875432221 12234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||.+.+..++.++|+|||||++|+|++|+.||...........+.. .....+..+++.+.+++.+||..|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~ll~~~L~~d 234 (321)
T cd05591 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH--DDVLYPVWLSKEAVSILKAFMTKN 234 (321)
T ss_pred ccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHhccC
Confidence 689999999999998999999999999999999999999998887776665542 233445568899999999999999
Q ss_pred CCCCC-------CHHHHHHH
Q 042314 336 PDRRP-------TFEEIIFR 348 (370)
Q Consensus 336 p~~Rp-------~~~~ll~~ 348 (370)
|++|| ++.+++++
T Consensus 235 p~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 235 PNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHcCCCCCCCCCHHHHhcC
Confidence 99999 88888766
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=308.73 Aligned_cols=246 Identities=35% Similarity=0.668 Sum_probs=205.4
Q ss_pred cCCCCCCcccEEEEEEc------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 97 GGIDPGAYGEVYLVKWR------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
..+|.|.||.||+|.+. +..|+||.++.. ...+....+.+|+..+++++||||+++++++...+..++|+||
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccccc
Confidence 34889999999999988 677999999552 4455678899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 171 LRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 171 ~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
+.+|+|.+++... ..++...+..++.|++.||.|||+++ ++|++|+++||+++.++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999986 68999999999999999999999998 999999999999999999999999999877332221
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHH
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKAL 327 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 327 (370)
...........|+|||.+....++.++||||||+++||+++ |+.||............ ....+...+..+|..+.++
T Consensus 160 -~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 237 (259)
T PF07714_consen 160 -KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSL 237 (259)
T ss_dssp -EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHH
T ss_pred -ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHH
Confidence 12222346789999999999889999999999999999999 67999888777766655 3555566677889999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHH
Q 042314 328 LRECWHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 328 i~~~l~~~p~~Rp~~~~ll~~l 349 (370)
|.+||..+|++|||+.++++.|
T Consensus 238 i~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 238 IQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHhcC
Confidence 9999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=292.90 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=209.3
Q ss_pred ccCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 96 RGGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
...+|+|.|+.|++... .|+.+++|++....... ...+.+.+|+++.+.++||||+++.+.+.+....++|+|+++|
T Consensus 16 ~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 16 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccc
Confidence 34589999999998755 48888888875432222 2456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC---CcEEEeccccceeccccCccce
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA---GHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
++|..-+-.+.-+++..+..+++||+.+|.|+|.++ |||||+||+|+++-+. .-+||+|||++..++.+.
T Consensus 95 ~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~---- 167 (355)
T KOG0033|consen 95 GELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE---- 167 (355)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCCcc----
Confidence 999765555457899999999999999999999999 9999999999999643 358999999999888332
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC--CCCCCCCCCcHHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED--SRPALSSLYPEPIKALL 328 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li 328 (370)
.-.+..|||.|+|||++...+|+..+|||+.|+++|-|+.|.+||.+.+...+.+.+.... ..++.++.++++.++||
T Consensus 168 ~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lv 247 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLI 247 (355)
T ss_pred ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHH
Confidence 2245679999999999999999999999999999999999999999988888887776433 34456778999999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~ 348 (370)
++||..||.+|.|+.|.|++
T Consensus 248 rrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 248 RRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HHHhccChhhhccHHHHhCC
Confidence 99999999999999998765
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=320.36 Aligned_cols=250 Identities=27% Similarity=0.462 Sum_probs=204.0
Q ss_pred cCCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEE
Q 042314 97 GGIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~ 168 (370)
..+|.|+||.||++.+. +..+|+|+++... .......+.+|+.+++.+ +||||+++++++...+..++||
T Consensus 41 ~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 41 KTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred heecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence 45899999999998642 4579999987542 233456788999999999 7999999999999999999999
Q ss_pred eecCCCCHHHHHHhCC----------------------------------------------------------------
Q 042314 169 EYLRNGSLHDILKKKG---------------------------------------------------------------- 184 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~---------------------------------------------------------------- 184 (370)
||+++|+|.+++....
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 9999999999886432
Q ss_pred -----------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 185 -----------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 185 -----------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
.++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......... ...
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~ 274 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV-VKG 274 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc-ccC
Confidence 3677788999999999999999998 9999999999999999999999999998665432211 111
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
...++..|+|||.+.+..++.++||||||+++|||++ |..||..................+..+...|..+.+++.+||
T Consensus 275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 354 (375)
T cd05104 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCW 354 (375)
T ss_pred CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHc
Confidence 2234678999999999999999999999999999998 888987665433333333333444455667889999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~l~~~ 352 (370)
+.||++||++.++++.|++.
T Consensus 355 ~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 355 DADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred cCChhHCcCHHHHHHHHHhh
Confidence 99999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=310.81 Aligned_cols=242 Identities=26% Similarity=0.426 Sum_probs=202.2
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+|+|.+.............+.+|+.+++.++|++|+++++.+...+..++|+||+.+|+|
T Consensus 8 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L 87 (285)
T cd05631 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDL 87 (285)
T ss_pred EecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcH
Confidence 789999999999764 889999998764433334455678999999999999999999999999999999999999999
Q ss_pred HHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++........ ...
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~----~~~ 160 (285)
T cd05631 88 KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET----VRG 160 (285)
T ss_pred HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe----ecC
Confidence 9887643 36889999999999999999999998 99999999999999999999999999876543221 123
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH---HHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQV---ADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
..||+.|+|||.+.+..++.++||||+||++|+|++|+.||........ ..... .......+..+++.+.+|+++|
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~ 239 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV-KEDQEEYSEKFSEDAKSICRML 239 (285)
T ss_pred CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh-hcccccCCccCCHHHHHHHHHH
Confidence 4689999999999999999999999999999999999999986543221 11111 2233445667889999999999
Q ss_pred cccCCCCCCC-----HHHHHHH
Q 042314 332 WHKNPDRRPT-----FEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp~-----~~~ll~~ 348 (370)
|+.||++||+ +++++++
T Consensus 240 l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 240 LTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred hhcCHHHhcCCCCCCHHHHhcC
Confidence 9999999997 8898876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=301.96 Aligned_cols=247 Identities=29% Similarity=0.412 Sum_probs=205.8
Q ss_pred ccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee-----CCceEEEE
Q 042314 96 RGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH-----SERLIFLT 168 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~-----~~~~~~v~ 168 (370)
...+|.|+||.|+.+..+ |..||+|.+.... .+.-..++..+|+.+++.++|+||+.+++++.. -+.+|+|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence 455999999999998775 8889999987443 445667889999999999999999999998865 35689999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
|+|+. +|.++++.++.+++..+..++.|++.||.|+|+.+ |+||||||.|++++.+..+||+|||+|+..... ..
T Consensus 106 elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~-~~ 180 (359)
T KOG0660|consen 106 ELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF-FE 180 (359)
T ss_pred hHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecccc-Cc
Confidence 99954 99999999888999999999999999999999999 999999999999999999999999999988654 33
Q ss_pred ceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc------------------
Q 042314 249 SYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY------------------ 309 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~------------------ 309 (370)
...++....|.+|.|||.+.. ..|+.+.||||+|||+.||++|++-|.+.........+..
T Consensus 181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a 260 (359)
T KOG0660|consen 181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA 260 (359)
T ss_pred ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence 335566778999999998754 5799999999999999999999999987654432222211
Q ss_pred ------cCCCCC-----CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 310 ------EDSRPA-----LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 310 ------~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+..+. ..+..++...+|+.+||..||.+|+|++|.|.|
T Consensus 261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 111111 113456788999999999999999999999876
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=316.48 Aligned_cols=243 Identities=28% Similarity=0.488 Sum_probs=217.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCc-eEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSER-LIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~-~~~v~e~~~g~ 174 (370)
.+|.|+||.+++++.+ ++.+++|.+...... ...+....+|+.+++++.|||||.+.+.|..++. ++|||+|++||
T Consensus 11 ~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t-~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg 89 (426)
T KOG0589|consen 11 QVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT-EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGG 89 (426)
T ss_pred hcCccccchhhhhhhccCCceEEEEEEeccccC-chhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCC
Confidence 4899999999988665 677999998765433 3445578899999999999999999999998888 99999999999
Q ss_pred CHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 175 SLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 175 ~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
+|.+.+.+.+ -++++.+..|+.|++.|+.|||++. |+|||||+.|||++.++.|||.|||+|+........ .
T Consensus 90 ~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~---a 163 (426)
T KOG0589|consen 90 DLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL---A 163 (426)
T ss_pred CHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCchhh---h
Confidence 9999997653 6899999999999999999999888 999999999999999999999999999988876522 2
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
....||+.|++||.+.+.+|..++|||||||++|||.+-+++|...+...+..++. .....+++..++.+++.+|+.||
T Consensus 164 ~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~-~~~~~Plp~~ys~el~~lv~~~l 242 (426)
T KOG0589|consen 164 STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN-RGLYSPLPSMYSSELRSLVKSML 242 (426)
T ss_pred heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-hccCCCCCccccHHHHHHHHHHh
Confidence 34479999999999999999999999999999999999999999999988888877 34467788889999999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFR 348 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~ 348 (370)
..+|..||++.+||.+
T Consensus 243 ~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 243 RKNPEHRPSALELLRR 258 (426)
T ss_pred hcCCccCCCHHHHhhC
Confidence 9999999999999987
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=315.90 Aligned_cols=242 Identities=26% Similarity=0.472 Sum_probs=206.8
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... +..+|+|.++............+..|..+++.+ +||||+++++++...+.+++||||+.|++
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 82 (318)
T cd05570 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGD 82 (318)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCC
Confidence 789999999999875 678999999865433344556678888888887 69999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|..++.+.+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 83 L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 156 (318)
T cd05570 83 LMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---TTSTF 156 (318)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---cccce
Confidence 9999998889999999999999999999999998 99999999999999999999999999865322221 11223
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...........+. ......+..+++.+.++|++||..|
T Consensus 157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~d 234 (318)
T cd05570 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL--EDEVRYPRWLSKEAKSILKSFLTKN 234 (318)
T ss_pred ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH--cCCCCCCCcCCHHHHHHHHHHccCC
Confidence 58999999999999999999999999999999999999998877666555443 2334456678999999999999999
Q ss_pred CCCCCCH-----HHHHHH
Q 042314 336 PDRRPTF-----EEIIFR 348 (370)
Q Consensus 336 p~~Rp~~-----~~ll~~ 348 (370)
|++||++ .+++++
T Consensus 235 P~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 235 PEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHcCCCCCCCHHHHhcC
Confidence 9999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=312.77 Aligned_cols=243 Identities=25% Similarity=0.438 Sum_probs=202.8
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|.+... ..+.....+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (331)
T cd06649 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (331)
T ss_pred eecCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCc
Confidence 3789999999999876 677889988654 234567789999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.....+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 90 L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~ 162 (331)
T cd06649 90 LDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSF 162 (331)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc-----cccC
Confidence 9999998888999999999999999999999853 39999999999999999999999999987654322 1233
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--------------------------
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY-------------------------- 309 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-------------------------- 309 (370)
.|++.|+|||.+.+..++.++|||||||++|+|++|+.||......+.......
T Consensus 163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (331)
T cd06649 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSG 242 (331)
T ss_pred CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccc
Confidence 689999999999998999999999999999999999999976544332211100
Q ss_pred -------------------cCCCCC-CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042314 310 -------------------EDSRPA-LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 310 -------------------~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l 349 (370)
....+. ....+++.+.+||.+||+.||++|||+.+++++-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 243 HGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 001111 1224678999999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=315.55 Aligned_cols=240 Identities=27% Similarity=0.452 Sum_probs=202.2
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... |..+|+|.++...............|..++... +||+|+++++++...+.+++||||+.|++
T Consensus 3 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~ 82 (316)
T cd05620 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGD 82 (316)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCc
Confidence 789999999999875 678999998764322223345567777777654 89999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|..++...+.++...+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 83 L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 156 (316)
T cd05620 83 LMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN---RASTF 156 (316)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---ceecc
Confidence 9999998888999999999999999999999998 99999999999999999999999999864322211 12234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||.+.+..++.++||||+||++|+|++|+.||............. ...+..+..++..+.+++++||+.|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~d 234 (316)
T cd05620 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR--VDTPHYPRWITKESKDILEKLFERD 234 (316)
T ss_pred CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCCCCCCCCCHHHHHHHHHHccCC
Confidence 68999999999999999999999999999999999999998877766555443 2345556678899999999999999
Q ss_pred CCCCCCHH-HHH
Q 042314 336 PDRRPTFE-EII 346 (370)
Q Consensus 336 p~~Rp~~~-~ll 346 (370)
|++||++. +++
T Consensus 235 P~~R~~~~~~~~ 246 (316)
T cd05620 235 PTRRLGVVGNIR 246 (316)
T ss_pred HHHcCCChHHHH
Confidence 99999974 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=338.88 Aligned_cols=255 Identities=32% Similarity=0.571 Sum_probs=221.2
Q ss_pred CCCCCCcccEEEEEEc---Cc--e--eEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 98 GIDPGAYGEVYLVKWR---GT--E--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~---g~--~--vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
.+|.|+||.||.+... |. + |++|.++.. .+.+...+|.+|..+|+.++|||||+++|++.+....+|++||
T Consensus 699 ~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ley 776 (1025)
T KOG1095|consen 699 VLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEY 776 (1025)
T ss_pred eeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehh
Confidence 4899999999999775 33 2 667766553 5567788999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC-------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceecc
Q 042314 171 LRNGSLHDILKKK-------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQ 243 (370)
Q Consensus 171 ~~g~~L~~~l~~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 243 (370)
|+||+|..++++. ..++..+.+.++.|+++|+.||++++ +|||||..+|+|++....+||+|||+|+.+-
T Consensus 777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy 853 (1025)
T KOG1095|consen 777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIY 853 (1025)
T ss_pred cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhh
Confidence 9999999999976 25788999999999999999999999 9999999999999999999999999999665
Q ss_pred ccCccceeccCC-CCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCc
Q 042314 244 EKDSYSYKMTGG-TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYP 321 (370)
Q Consensus 244 ~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (370)
....+ ...+. .-+.+|||||.+....|+.++|||||||++||++| |..||......+........+ +...|..+|
T Consensus 854 ~~~yy--r~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P~~CP 930 (1025)
T KOG1095|consen 854 DKDYY--RKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPPSYCP 930 (1025)
T ss_pred hchhe--eccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCCCCCC
Confidence 44332 22222 44679999999999999999999999999999998 678888888877777565444 888999999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccCC
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKT 360 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~ 360 (370)
+.++++|..||+.+|++||++..|++.+.++........
T Consensus 931 ~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 931 EKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred hHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 999999999999999999999999999999877665444
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=299.68 Aligned_cols=247 Identities=26% Similarity=0.485 Sum_probs=206.5
Q ss_pred CCCCCcccEEEEEEc----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 99 IDPGAYGEVYLVKWR----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 99 l~~g~~~~v~~a~~~----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
+|.|+||.||++.+. +..+++|++... ......+.+.+|+.++++++||||+++++++. ....++||||++++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccc--cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 789999999998764 345888888654 23455677999999999999999999999875 45789999999999
Q ss_pred CHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+|.+++.. ...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++..............
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999875 457899999999999999999999998 99999999999999999999999999876544332222222
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
...+++.|+|||.+....++.++|+||||+++|++++ |..||............. ....+..+...++++.+++.+||
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c~ 235 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-QGKRLDCPAECPPEMYALMKDCW 235 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHc
Confidence 2334678999999988889999999999999999996 999998877665554443 34455666778999999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~l~~~ 352 (370)
..+|++||++.++.+.|+.+
T Consensus 236 ~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 236 IYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCChhhCcCHHHHHHHHhhh
Confidence 99999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=317.12 Aligned_cols=242 Identities=26% Similarity=0.438 Sum_probs=202.8
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... +..+|+|+++............+..|..+++.+ +||||+++++++...+.+++||||++|++
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~ 82 (329)
T cd05588 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGD 82 (329)
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCC
Confidence 689999999999874 778999999876544555667788999999888 69999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.+.+++++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 83 L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~~~~~ 156 (329)
T cd05588 83 LMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---TTSTF 156 (329)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC---ccccc
Confidence 9999988889999999999999999999999998 99999999999999999999999999864322111 12234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc--------HHH-HHHHhhccCCCCCCCCCCcHHHHH
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT--------AVQ-VADRRAYEDSRPALSSLYPEPIKA 326 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~--------~~~-~~~~~~~~~~~~~~~~~~~~~l~~ 326 (370)
.||+.|+|||++.+..++.++|+|||||++|+|++|+.||.... ... ..... .......+..++..+.+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~p~~~~~~~~~ 234 (329)
T cd05588 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKASS 234 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--HcCCCCCCCCCCHHHHH
Confidence 68999999999999999999999999999999999999996321 111 11212 23344566778999999
Q ss_pred HHHHhcccCCCCCCC------HHHHHHH
Q 042314 327 LLRECWHKNPDRRPT------FEEIIFR 348 (370)
Q Consensus 327 li~~~l~~~p~~Rp~------~~~ll~~ 348 (370)
++++||..||.+||+ +++++++
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 235 VLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 999999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=309.31 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=211.4
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCC-----------hHHHHHHHHHHHHHHhcCCCceeeeeeeEee--C
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASN-----------PRVRNSFMKELGLWQKLRHPNIVQFLGVLKH--S 161 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~-----------~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~--~ 161 (370)
..+|.|.||.|.+|... ++.+|+|++.+..... ..-.+...+|+.+|++|.|||||+++++..+ .
T Consensus 103 ~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s 182 (576)
T KOG0585|consen 103 KEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPES 182 (576)
T ss_pred hhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCccc
Confidence 34999999999999875 7889999996542111 1123578999999999999999999999865 4
Q ss_pred CceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecccccee
Q 042314 162 ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI 241 (370)
Q Consensus 162 ~~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~ 241 (370)
+.+|+|+|||+.|.+...-.....+++.+++.++++++.||+|||.+| ||||||||.|+|++++|++||+|||.+..
T Consensus 183 ~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs~~ 259 (576)
T KOG0585|consen 183 DKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFGVSNE 259 (576)
T ss_pred CceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeeccceeee
Confidence 689999999999888765555444899999999999999999999999 99999999999999999999999999886
Q ss_pred ccccCccc--eeccCCCCCccccCcccccccC---C-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCC
Q 042314 242 AQEKDSYS--YKMTGGTGSYRYMAPEVYRRES---Y-GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPA 315 (370)
Q Consensus 242 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~---~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 315 (370)
...+.... .......|||.|+|||...++. + +.+.||||+|++||-|+.|+.||..+...+...++.......+
T Consensus 260 ~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP 339 (576)
T KOG0585|consen 260 FPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFP 339 (576)
T ss_pred cccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCC
Confidence 64332111 1223357999999999998733 3 4789999999999999999999999999999999986666555
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042314 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQ 353 (370)
Q Consensus 316 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~ 353 (370)
..+.+.+.+++||.++|++||+.|.+..++..|.....
T Consensus 340 ~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 340 ENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred CcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 55567899999999999999999999999987765443
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=313.56 Aligned_cols=241 Identities=27% Similarity=0.459 Sum_probs=202.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHh-cCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQK-LRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~-l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... +..+|+|.++...............|..+++. ++||||+++++++...+.+++||||++||+
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~ 82 (316)
T cd05619 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGD 82 (316)
T ss_pred eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCc
Confidence 789999999999875 67899999876532222334556677777776 489999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.....++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 83 L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 156 (316)
T cd05619 83 LMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---KTCTF 156 (316)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---ceeee
Confidence 9999998888999999999999999999999998 99999999999999999999999999875432221 11233
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||.+.+..++.++|+||+||++|+|++|+.||.............. ..+..+..++..+.+++.+||+.|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~ 234 (316)
T cd05619 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM--DNPCYPRWLTREAKDILVKLFVRE 234 (316)
T ss_pred cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHhccC
Confidence 589999999999998899999999999999999999999988777665555442 234455668899999999999999
Q ss_pred CCCCCCHH-HHHH
Q 042314 336 PDRRPTFE-EIIF 347 (370)
Q Consensus 336 p~~Rp~~~-~ll~ 347 (370)
|++||++. +++.
T Consensus 235 P~~R~~~~~~l~~ 247 (316)
T cd05619 235 PERRLGVKGDIRQ 247 (316)
T ss_pred HhhcCCChHHHHc
Confidence 99999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=313.00 Aligned_cols=253 Identities=34% Similarity=0.555 Sum_probs=202.7
Q ss_pred ccCCCCCCcccEEEEEEcC-ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC-ceEEEEeecCC
Q 042314 96 RGGIDPGAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE-RLIFLTEYLRN 173 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~g-~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~-~~~~v~e~~~g 173 (370)
...+|+|+||.||++...+ ..+|||.+....... ..+|.+|+.++.+++|||+|+++|+|.+.+ ..++|+||+..
T Consensus 80 ~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~n 156 (361)
T KOG1187|consen 80 SNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPN 156 (361)
T ss_pred hcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCC
Confidence 3459999999999998875 889999776643322 455999999999999999999999999988 59999999999
Q ss_pred CCHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccc-cCccce
Q 042314 174 GSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQE-KDSYSY 250 (370)
Q Consensus 174 ~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~ 250 (370)
|+|.+.+.... .+++..+++|+.++++||+|||+..+++||||||||.|||+|++.+.||+|||+++.... ......
T Consensus 157 GsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~ 236 (361)
T KOG1187|consen 157 GSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVST 236 (361)
T ss_pred CCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceee
Confidence 99999998764 889999999999999999999997767899999999999999999999999999965543 221111
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc------HHHHHHH-----hhccCCCCCCC-C
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT------AVQVADR-----RAYEDSRPALS-S 318 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~------~~~~~~~-----~~~~~~~~~~~-~ 318 (370)
. ..||.+|+|||.+..+..+.++||||||+++.|++||+.+..... ....... ...+-.++.+. .
T Consensus 237 ~---~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~ 313 (361)
T KOG1187|consen 237 T---VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEG 313 (361)
T ss_pred e---cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCC
Confidence 1 068999999999999999999999999999999999998776432 1111111 11122233333 3
Q ss_pred CCc--HH---HHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042314 319 LYP--EP---IKALLRECWHKNPDRRPTFEEIIFRLEAIQE 354 (370)
Q Consensus 319 ~~~--~~---l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~ 354 (370)
.++ .. +..+..+|++.+|.+||++.++++.|+.+..
T Consensus 314 ~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 314 EYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 344 23 5567779999999999999999998865543
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=321.50 Aligned_cols=248 Identities=23% Similarity=0.307 Sum_probs=204.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+|+|.+.............+.+|+.+++.++||||+++++.+...+.+++||||++||+
T Consensus 8 ~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~ 87 (381)
T cd05626 8 TLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGD 87 (381)
T ss_pred EEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCc
Confidence 3799999999999774 67899999976544445566788999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc-------
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY------- 248 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------- 248 (370)
|.+++.+.+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 88 L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~ 164 (381)
T cd05626 88 MMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGS 164 (381)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccc
Confidence 9999998888999999999999999999999998 999999999999999999999999987533110000
Q ss_pred -------------------------------------ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhC
Q 042314 249 -------------------------------------SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG 291 (370)
Q Consensus 249 -------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g 291 (370)
........||+.|+|||.+.+..++.++|||||||++|||++|
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG 244 (381)
T cd05626 165 HIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG 244 (381)
T ss_pred cccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhC
Confidence 0001123689999999999998899999999999999999999
Q ss_pred CCCCCCCcHHHHHHHhhccCCCCC--CCCCCcHHHHHHHHHhc--ccCCCCCCCHHHHHHH
Q 042314 292 GPSNRADTAVQVADRRAYEDSRPA--LSSLYPEPIKALLRECW--HKNPDRRPTFEEIIFR 348 (370)
Q Consensus 292 ~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l--~~~p~~Rp~~~~ll~~ 348 (370)
.+||...........+........ ....+++++.++|.+|+ ..+|..||++.+++.+
T Consensus 245 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 245 QPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred CCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999988776555444432222222 23357899999999944 5666679999999886
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-43 Score=315.82 Aligned_cols=237 Identities=29% Similarity=0.478 Sum_probs=198.8
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHH-HHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~-~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... |..+++|.+.............+..|.. +++.++||||+++++.+...+..++||||+.+++
T Consensus 3 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~ 82 (323)
T cd05575 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGE 82 (323)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCC
Confidence 789999999999874 7889999987543322333344555554 4678899999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|..++++.+.+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 83 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 156 (323)
T cd05575 83 LFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---TTSTF 156 (323)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---ccccc
Confidence 9999998889999999999999999999999998 99999999999999999999999999865332211 12234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.. .....+..++..+.++|++||+.|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~ 234 (323)
T cd05575 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN--KPLRLKPNISVSARHLLEGLLQKD 234 (323)
T ss_pred cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHhhcC
Confidence 689999999999999999999999999999999999999988776665555442 233445567899999999999999
Q ss_pred CCCCCCHH
Q 042314 336 PDRRPTFE 343 (370)
Q Consensus 336 p~~Rp~~~ 343 (370)
|.+||++.
T Consensus 235 p~~R~~~~ 242 (323)
T cd05575 235 RTKRLGAK 242 (323)
T ss_pred HHhCCCCC
Confidence 99999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=298.68 Aligned_cols=248 Identities=27% Similarity=0.464 Sum_probs=207.9
Q ss_pred CCCCCCcccEEEEEEcC-----ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g-----~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|+||.||++.+.. ..+++|.+...... .....+.+|+.+++.++||||+++++++. .+..++||||+.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 37899999999997642 56889988755322 45567899999999999999999999875 456899999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
+++|.+++.+.+.+++..+..++.|++.++.|||..+ ++|+||||+||+++.++.+||+|||+++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999998888999999999999999999999998 9999999999999999999999999988765443222112
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
....++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...........+. .......+..+|..+++++.+|
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c 234 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLSC 234 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHH
Confidence 22234568999999998899999999999999999998 999998776655544443 3334455667889999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
|..+|++||++.++++.|+.+
T Consensus 235 l~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 235 WKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred hcCChhhCcCHHHHHHHHHhc
Confidence 999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=307.37 Aligned_cols=247 Identities=29% Similarity=0.473 Sum_probs=199.6
Q ss_pred CCCCCCcccEEEEEEc------------------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEe
Q 042314 98 GIDPGAYGEVYLVKWR------------------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~------------------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~ 159 (370)
.+|.|+||.||++.+. +..+++|.+... ........+.+|+.++++++||||+++++++.
T Consensus 12 ~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 89 (304)
T cd05096 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD--ANKNARNDFLKEVKILSRLKDPNIIRLLGVCV 89 (304)
T ss_pred EecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC--CCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence 3799999999999753 235899988654 23455678999999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHHhCC-------------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCC
Q 042314 160 HSERLIFLTEYLRNGSLHDILKKKG-------------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTP 220 (370)
Q Consensus 160 ~~~~~~~v~e~~~g~~L~~~l~~~~-------------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~ 220 (370)
..+..++||||+.+++|.+++.... .++...++.++.|++.||.|||+.+ |+||||||
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp 166 (304)
T cd05096 90 DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLAT 166 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcch
Confidence 9999999999999999999986532 3566788999999999999999998 99999999
Q ss_pred CCeeeCCCCcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh--CCCCCCCC
Q 042314 221 SNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ--GGPSNRAD 298 (370)
Q Consensus 221 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~--g~~p~~~~ 298 (370)
+||+++.++.+||+|||++.......... ......++..|+|||.+....++.++||||||+++|+|++ +..||...
T Consensus 167 ~Nill~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 245 (304)
T cd05096 167 RNCLVGENLTIKIADFGMSRNLYAGDYYR-IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245 (304)
T ss_pred hheEEcCCccEEECCCccceecccCceeE-ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence 99999999999999999997664433211 1122345788999999988889999999999999999986 56788766
Q ss_pred cHHHHHHHhhc------cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 299 TAVQVADRRAY------EDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 299 ~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
........... .......+..+|..+.+++.+||+.||++|||+.++.+.|+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 246 TDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 55443332211 11122234567899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=321.89 Aligned_cols=247 Identities=29% Similarity=0.425 Sum_probs=209.7
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+|+|+++............+..|+.++..++||||+++++++...+..++||||+.+++
T Consensus 8 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (350)
T cd05573 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGD 87 (350)
T ss_pred EEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCC
Confidence 3789999999999886 88999999976543333556778899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc--------
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS-------- 247 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-------- 247 (370)
|.+++.+.+.+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++........
T Consensus 88 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 164 (350)
T cd05573 88 LMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164 (350)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccc
Confidence 9999998888999999999999999999999988 99999999999999999999999999876654320
Q ss_pred ------------------cceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Q 042314 248 ------------------YSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY 309 (370)
Q Consensus 248 ------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~ 309 (370)
.........||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~ 244 (350)
T cd05573 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIIN 244 (350)
T ss_pred ccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhc
Confidence 00112234589999999999999999999999999999999999999988876665555543
Q ss_pred c--CCCCCCCCCCcHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 042314 310 E--DSRPALSSLYPEPIKALLRECWHKNPDRRPT-FEEIIFR 348 (370)
Q Consensus 310 ~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~-~~~ll~~ 348 (370)
. ....+....+|+.+.++|.+||. ||.+||+ +++++++
T Consensus 245 ~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 245 WKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred cCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 22222223368999999999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=313.43 Aligned_cols=242 Identities=26% Similarity=0.434 Sum_probs=204.9
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCC-ceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHP-NIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp-~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... ++.+|+|++.............+..|..++..++|+ +|+++++++...+.+++||||++||+
T Consensus 8 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~ 87 (324)
T cd05587 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 87 (324)
T ss_pred EeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCc
Confidence 789999999999875 568999998765433344556778899999999765 58889999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........ .....
T Consensus 88 L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~~~~ 161 (324)
T cd05587 88 LMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTF 161 (324)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC---ceeee
Confidence 9999998888999999999999999999999998 99999999999999999999999999865322211 12234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||++.+..++.++|+||+||++|+|++|+.||...........+. ......+..+++.+.+++++||..|
T Consensus 162 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~ 239 (324)
T cd05587 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM--EHNVSYPKSLSKEAVSICKGLLTKH 239 (324)
T ss_pred cCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 68999999999999999999999999999999999999998887766665554 2344566778999999999999999
Q ss_pred CCCCCCH-----HHHHHH
Q 042314 336 PDRRPTF-----EEIIFR 348 (370)
Q Consensus 336 p~~Rp~~-----~~ll~~ 348 (370)
|.+|++. ++++++
T Consensus 240 P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 240 PAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHHcCCCCCCCHHHHhcC
Confidence 9999976 666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=306.15 Aligned_cols=243 Identities=25% Similarity=0.391 Sum_probs=200.7
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... ++.+++|.+.............+..|+.+++.++||+|+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 588999999998764 788999998765433333446678899999999999999999999999999999999999999
Q ss_pred HHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 177 HDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 177 ~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
...+.. ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~---~~ 154 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS---KT 154 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc---cc
Confidence 887743 346899999999999999999999998 99999999999999999999999999876654322 12
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ---VADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
....||+.|+|||.+.+..++.++|+||+|+++|+|++|+.||....... ...... .......+..+|+.+.+++.
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 233 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI-LNDSVTYPDKFSPASKSFCE 233 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh-cccCCCCcccCCHHHHHHHH
Confidence 23468999999999999999999999999999999999999997653221 111111 12233445678999999999
Q ss_pred HhcccCCCCCC-----CHHHHHHH
Q 042314 330 ECWHKNPDRRP-----TFEEIIFR 348 (370)
Q Consensus 330 ~~l~~~p~~Rp-----~~~~ll~~ 348 (370)
+||+.||++|| ++++++++
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 234 ALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHhcCCHHHhcCCCCCCHHHHhcC
Confidence 99999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=290.20 Aligned_cols=245 Identities=22% Similarity=0.369 Sum_probs=210.0
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccC-----CChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEE
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIA-----SNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~-----~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~ 168 (370)
..+|.|..+.|.++.. .|+..++|++..... ...+.++...+|+.+++++ +||+|+.+.++++.+..+++|+
T Consensus 23 eilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVF 102 (411)
T KOG0599|consen 23 EILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVF 102 (411)
T ss_pred HHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhh
Confidence 3477788888876643 478888888754321 1234567788999999998 6999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
|.++-|.|++++.+.-.++++..++|++|++.|++|||.++ ||||||||+|||++++.++||+|||.++.+.++..
T Consensus 103 dl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek- 178 (411)
T KOG0599|consen 103 DLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK- 178 (411)
T ss_pred hhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCCchh-
Confidence 99999999999999989999999999999999999999998 99999999999999999999999999998877653
Q ss_pred ceeccCCCCCccccCccccc------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc--CCCCCCCCCC
Q 042314 249 SYKMTGGTGSYRYMAPEVYR------RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE--DSRPALSSLY 320 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~ 320 (370)
....+|||+|.|||.+. ...|+..+|+|++|++||.|+.|-+||+.....-+...+... ....+.+..+
T Consensus 179 ---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadi 255 (411)
T KOG0599|consen 179 ---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADI 255 (411)
T ss_pred ---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhc
Confidence 33458999999999985 346788999999999999999999999988776666555432 2345566778
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 321 PEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 321 ~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+...++||++||+.||++|.|++|.|.|
T Consensus 256 s~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 256 SATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 9999999999999999999999999876
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=313.69 Aligned_cols=242 Identities=26% Similarity=0.458 Sum_probs=202.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHH---HhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLW---QKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l---~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|++|.||++... +..+++|+++............+.+|.+++ +.++||||+++++++...+..++||||++
T Consensus 6 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 85 (324)
T cd05589 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAA 85 (324)
T ss_pred EEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCC
Confidence 3789999999999775 788999999765333334455667776655 45679999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|++|...+.. +.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ..
T Consensus 86 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~~ 158 (324)
T cd05589 86 GGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD---RT 158 (324)
T ss_pred CCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC---cc
Confidence 9999988865 47999999999999999999999998 99999999999999999999999999865332211 12
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...........+.. .....+..+|+.+.++|++||
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN--DEVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHh
Confidence 334689999999999999999999999999999999999999998877666555442 234456678999999999999
Q ss_pred ccCCCCCC-----CHHHHHHH
Q 042314 333 HKNPDRRP-----TFEEIIFR 348 (370)
Q Consensus 333 ~~~p~~Rp-----~~~~ll~~ 348 (370)
..||++|| ++.+++++
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhC
Confidence 99999999 57777765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=317.99 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=204.6
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... ++.+|+|++.............+..|..++..++||+|+++++.+.....+++||||++||+
T Consensus 8 ~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~ 87 (363)
T cd05628 8 VIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGD 87 (363)
T ss_pred EEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCc
Confidence 3789999999999764 78899999976433334556778899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc------
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS------ 249 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~------ 249 (370)
|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 88 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 164 (363)
T cd05628 88 MMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLN 164 (363)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccc
Confidence 9999998889999999999999999999999998 9999999999999999999999999987543211000
Q ss_pred --------------------------eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q 042314 250 --------------------------YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQV 303 (370)
Q Consensus 250 --------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~ 303 (370)
.......||+.|+|||++.+..++.++|+|||||++|||++|+.||........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~ 244 (363)
T cd05628 165 HSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244 (363)
T ss_pred ccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 001234689999999999999999999999999999999999999998877766
Q ss_pred HHHhhccCCCCCCC--CCCcHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 042314 304 ADRRAYEDSRPALS--SLYPEPIKALLRECWH--KNPDRRPTFEEIIFR 348 (370)
Q Consensus 304 ~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~--~~p~~Rp~~~~ll~~ 348 (370)
...+.........+ ..+++.+.+++.+++. .++..||++++++++
T Consensus 245 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 245 YKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 66554322222222 2367889999998664 233456899999987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=324.00 Aligned_cols=244 Identities=22% Similarity=0.348 Sum_probs=204.6
Q ss_pred cCCCCCCcccEEEEEEc---CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 97 GGIDPGAYGEVYLVKWR---GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~---g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
..+|.|++|.||++... +..+++|.+.. ........+.+|+.+++.++||||+++++.+...+..++||||++|
T Consensus 73 ~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~---~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~g 149 (478)
T PTZ00267 73 TLVGRNPTTAAFVATRGSDPKEKVVAKFVML---NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149 (478)
T ss_pred EEEEeCCCcEEEEEEEcCCCCeEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCC
Confidence 34788999999999764 45677776543 2344556778899999999999999999999999999999999999
Q ss_pred CCHHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 174 GSLHDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 174 ~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
|+|.+++.. ..++++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..........
T Consensus 150 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 150 GDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 999987753 346889999999999999999999998 9999999999999999999999999998765432211
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............. +.....+..++..+.++|.
T Consensus 227 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~ 304 (478)
T PTZ00267 227 -VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY-GKYDPFPCPVSSGMKALLD 304 (478)
T ss_pred -cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCCCCccCCHHHHHHHH
Confidence 12334689999999999999999999999999999999999999988777666555542 3333455678899999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~ 348 (370)
+||..||++||++.+++.+
T Consensus 305 ~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 305 PLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHhccChhhCcCHHHHHhC
Confidence 9999999999999998754
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=314.63 Aligned_cols=242 Identities=27% Similarity=0.441 Sum_probs=201.8
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... +..+++|+++............+..|..++.++ +||||+++++++...+..++||||+++++
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~ 82 (329)
T cd05618 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD 82 (329)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCC
Confidence 789999999999875 678999999876544555667788899888776 79999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|..++.+.+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 83 L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~~~~~ 156 (329)
T cd05618 83 LMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTF 156 (329)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---ccccc
Confidence 9999988889999999999999999999999998 99999999999999999999999999865322211 11234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc---------HHHHHHHhhccCCCCCCCCCCcHHHHH
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT---------AVQVADRRAYEDSRPALSSLYPEPIKA 326 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~ 326 (370)
.||+.|+|||.+.+..++.++|+||||+++|+|++|+.||.... ........ .......+..++..+.+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--~~~~~~~p~~~~~~~~~ 234 (329)
T cd05618 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLSVKAAS 234 (329)
T ss_pred cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--hcCCCCCCCCCCHHHHH
Confidence 68999999999999999999999999999999999999995211 11111212 23344566778899999
Q ss_pred HHHHhcccCCCCCCC------HHHHHHH
Q 042314 327 LLRECWHKNPDRRPT------FEEIIFR 348 (370)
Q Consensus 327 li~~~l~~~p~~Rp~------~~~ll~~ 348 (370)
++++||..||++||+ +.+++++
T Consensus 235 ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 235 VLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred HHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 999999999999998 4676655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=296.93 Aligned_cols=245 Identities=27% Similarity=0.508 Sum_probs=204.4
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++.. .++.+++|..... ...+....+.+|+++++.++||||+++++++...+..++||||+.+++|
T Consensus 3 lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 3 IGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred cCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 78999999999977 4788999987643 2345667899999999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 177 HDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 177 ~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
.+++... ..+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++.......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~ 156 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS-TGGMK 156 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccc-cCCCC
Confidence 9999764 36899999999999999999999998 9999999999999999999999999987554321111 11111
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
..+..|+|||.+.+..++.++|+||||+++|+|++ |..||............. .......+..+|..+.+++.+||..
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 235 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-QGVRLPCPELCPDAVYRLMERCWEY 235 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCcccCCHHHHHHHHHHcCC
Confidence 23567999999998889999999999999999997 888887766554433333 2334455667889999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 042314 335 NPDRRPTFEEIIFRLE 350 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~l~ 350 (370)
+|++|||+.++++.|+
T Consensus 236 ~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 236 DPGQRPSFSTVHQELQ 251 (252)
T ss_pred ChhhCcCHHHHHHHHh
Confidence 9999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=320.31 Aligned_cols=247 Identities=26% Similarity=0.380 Sum_probs=206.1
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... ++.+|+|++.............+.+|+.+++.++||||+++++++...+..++||||+.||+
T Consensus 8 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~ 87 (364)
T cd05599 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGD 87 (364)
T ss_pred EEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcH
Confidence 3789999999999874 78899999976533334556778899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc------
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS------ 249 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~------ 249 (370)
|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++..........
T Consensus 88 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 164 (364)
T cd05599 88 MMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164 (364)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccccccccc
Confidence 9999998888999999999999999999999998 9999999999999999999999999987543221100
Q ss_pred -----------------------------eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH
Q 042314 250 -----------------------------YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA 300 (370)
Q Consensus 250 -----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~ 300 (370)
.......||+.|+|||++.+..++.++|||||||++|+|++|.+||.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~ 244 (364)
T cd05599 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244 (364)
T ss_pred ccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCH
Confidence 001123589999999999999999999999999999999999999998877
Q ss_pred HHHHHHhhccCCCCCC--CCCCcHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 042314 301 VQVADRRAYEDSRPAL--SSLYPEPIKALLRECWHKNPDRRPT---FEEIIFR 348 (370)
Q Consensus 301 ~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~---~~~ll~~ 348 (370)
......+......... ...+++.+.++|++|+. +|.+|++ +.+++.+
T Consensus 245 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 245 QETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred HHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 6655544322222222 22468899999999996 9999998 9998875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=298.65 Aligned_cols=249 Identities=34% Similarity=0.511 Sum_probs=210.8
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCC--ChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIAS--NPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~--~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
..+|.|++|.||.+.. .+..+++|.+...... .......+.+|+.++++++||||+++++++...+..++|+||++
T Consensus 8 ~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 87 (263)
T cd06625 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMP 87 (263)
T ss_pred ceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECC
Confidence 4488999999999975 4789999998654322 12234678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
+++|.+++...+.++...+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.............
T Consensus 88 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 164 (263)
T cd06625 88 GGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM 164 (263)
T ss_pred CCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccccccccc
Confidence 9999999998888999999999999999999999998 9999999999999999999999999987654322111111
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||..................+..+..++..+.+++++||
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 244 (263)
T cd06625 165 KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTF 244 (263)
T ss_pred cCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHh
Confidence 22356789999999999889999999999999999999999998766655555544444556677788999999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFR 348 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~ 348 (370)
..+|++|||+.+++.+
T Consensus 245 ~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 245 VENAKKRPSAEELLRH 260 (263)
T ss_pred hcCcccCCCHHHHhhC
Confidence 9999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=307.10 Aligned_cols=244 Identities=23% Similarity=0.400 Sum_probs=199.2
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+++|.+.... ........+.+|+.+++.++||||+++++++...+..++||||+.++.+
T Consensus 9 lg~g~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 87 (287)
T cd07848 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSE-ENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNML 87 (287)
T ss_pred ecccCCEEEEEEEECCCCcEEEEEEEeccc-ccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHH
Confidence 688999999999885 6789999987643 2334556788999999999999999999999999999999999999877
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
..+......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......... ......
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~ 162 (287)
T cd07848 88 ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA--NYTEYV 162 (287)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc--cccccc
Confidence 766665567999999999999999999999998 999999999999999999999999998876433221 112335
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-C------------------C-CC--
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-D------------------S-RP-- 314 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~------------------~-~~-- 314 (370)
+++.|+|||.+.+..++.++|+||+||++|+|++|++||............... + . .+
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (287)
T cd07848 163 ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAV 242 (287)
T ss_pred cccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcc
Confidence 789999999999888999999999999999999999999876543322211100 0 0 00
Q ss_pred --------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 315 --------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 315 --------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.....+|..+.+|+++||+.||++|||+++++++
T Consensus 243 ~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 243 NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0112367889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=314.64 Aligned_cols=238 Identities=27% Similarity=0.463 Sum_probs=198.0
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHH-HHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~-~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... +..+++|++.............+..|.. +++.++||||+++++++...+..++||||+.|++
T Consensus 3 lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~ 82 (325)
T cd05602 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGE 82 (325)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCc
Confidence 789999999999875 6679999987543222222334444443 5678899999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++...+.+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++........ .....
T Consensus 83 L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~~~~~ 156 (325)
T cd05602 83 LFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---TTSTF 156 (325)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---Ccccc
Confidence 9999998888999999999999999999999998 99999999999999999999999999875432221 12234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+.. .....+..+++.+.+++++||+.|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~~ 234 (325)
T cd05602 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSARHLLEGLLQKD 234 (325)
T ss_pred cCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCcCCCCCCCHHHHHHHHHHcccC
Confidence 689999999999999999999999999999999999999988777665555432 223345568899999999999999
Q ss_pred CCCCCCHHH
Q 042314 336 PDRRPTFEE 344 (370)
Q Consensus 336 p~~Rp~~~~ 344 (370)
|.+||++.+
T Consensus 235 p~~R~~~~~ 243 (325)
T cd05602 235 RTKRLGAKD 243 (325)
T ss_pred HHHCCCCCC
Confidence 999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=298.85 Aligned_cols=250 Identities=24% Similarity=0.427 Sum_probs=208.3
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++.. .+..+++|.+......+......+.+|+.+++.++||||+++++.+...+..++++||+++++
T Consensus 9 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 88 (267)
T cd08228 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGD 88 (267)
T ss_pred eeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCc
Confidence 378899999999976 478899998876544556667788999999999999999999999999999999999999999
Q ss_pred HHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 176 LHDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 176 L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........ .
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~---~ 162 (267)
T cd08228 89 LSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---A 162 (267)
T ss_pred HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhH---H
Confidence 9988853 345788999999999999999999998 99999999999999999999999999876653321 1
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA--VQVADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
.....+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||..... .............+.....++..+.++++
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 242 (267)
T cd08228 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVS 242 (267)
T ss_pred HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHH
Confidence 1233578899999999888899999999999999999999999865532 23333332222233334467889999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIFRLEAIQ 353 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~l~~~~ 353 (370)
+||..+|++||++.++++.++.++
T Consensus 243 ~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 243 MCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHCCCCcccCcCHHHHHHHHHHhc
Confidence 999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.14 Aligned_cols=252 Identities=26% Similarity=0.451 Sum_probs=206.0
Q ss_pred cCCCCCCcccEEEEEEcC-------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEE
Q 042314 97 GGIDPGAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g-------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~ 168 (370)
..+|.|+||.||++...+ ..+|+|.+... ........+.+|+.++++++ ||||+++++++...+..++||
T Consensus 43 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (400)
T cd05105 43 RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT--ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT 120 (400)
T ss_pred heecCCCCceEEEEEEcccCCCCCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence 348999999999987632 35899988654 23345577899999999996 999999999999999999999
Q ss_pred eecCCCCHHHHHHhC-----------------------------------------------------------------
Q 042314 169 EYLRNGSLHDILKKK----------------------------------------------------------------- 183 (370)
Q Consensus 169 e~~~g~~L~~~l~~~----------------------------------------------------------------- 183 (370)
||+++|+|.+++.++
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (400)
T cd05105 121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY 200 (400)
T ss_pred EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence 999999999987642
Q ss_pred -------------------------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEE
Q 042314 184 -------------------------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLK 232 (370)
Q Consensus 184 -------------------------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~k 232 (370)
..++...+..++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~k 277 (400)
T cd05105 201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVK 277 (400)
T ss_pred hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEE
Confidence 13667778899999999999999998 99999999999999999999
Q ss_pred EeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccC
Q 042314 233 VTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYED 311 (370)
Q Consensus 233 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 311 (370)
|+|||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||................
T Consensus 278 L~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~ 356 (400)
T cd05105 278 ICDFGLARDIMHDSNYV-SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG 356 (400)
T ss_pred EEeCCcceecccccccc-ccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcC
Confidence 99999987654332211 1122346788999999998889999999999999999997 889987655433333333334
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042314 312 SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQE 354 (370)
Q Consensus 312 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~ 354 (370)
..+..+..+|..+.+++.+||..||++||++.++.+.|+++.+
T Consensus 357 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 357 YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 4455566789999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=300.61 Aligned_cols=252 Identities=27% Similarity=0.473 Sum_probs=209.9
Q ss_pred cCCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEe
Q 042314 97 GGIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
..+|.|+||.||++... +..+++|.+... .......+.+|+.++++++||||+++++++...+..++|+|
T Consensus 11 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (288)
T cd05093 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE 87 (288)
T ss_pred cccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 34899999999998742 344777877542 34456778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCC-------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 042314 170 YLRNGSLHDILKKKG-------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDF 236 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~-------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Df 236 (370)
|+.+++|.+++...+ .+++..++.++.|++.||.|||+++ ++||||||+||++++++.++|+||
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccC
Confidence 999999999987543 4899999999999999999999998 999999999999999999999999
Q ss_pred ccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCC
Q 042314 237 GLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPA 315 (370)
Q Consensus 237 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 315 (370)
|++......... .......+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...........+. .+....
T Consensus 165 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~-~~~~~~ 242 (288)
T cd05093 165 GMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-QGRVLQ 242 (288)
T ss_pred CccccccCCcee-ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCcCC
Confidence 998765433211 11122235778999999998889999999999999999998 899998777666555544 333344
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 316 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
.+..+|..+.+++.+||+.||.+|||+.+++..|+++....
T Consensus 243 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 243 RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 55678899999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=320.89 Aligned_cols=247 Identities=24% Similarity=0.355 Sum_probs=202.9
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++.. .+..+|+|.+.............+.+|+.+++.++||||+++++++...+..++||||+.||+
T Consensus 8 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~ 87 (377)
T cd05629 8 VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGD 87 (377)
T ss_pred EEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCc
Confidence 378999999999976 478899999866433334556778899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc-------
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY------- 248 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------- 248 (370)
|.+++...+.+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~ 164 (377)
T cd05629 88 LMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164 (377)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccccccccc
Confidence 9999988888999999999999999999999998 999999999999999999999999998633211000
Q ss_pred -----c--------------------------------eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhC
Q 042314 249 -----S--------------------------------YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG 291 (370)
Q Consensus 249 -----~--------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g 291 (370)
. .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG 244 (377)
T cd05629 165 QGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244 (377)
T ss_pred cccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcC
Confidence 0 000123589999999999998999999999999999999999
Q ss_pred CCCCCCCcHHHHHHHhhccCCCCCCCC--CCcHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 042314 292 GPSNRADTAVQVADRRAYEDSRPALSS--LYPEPIKALLRECWHKNPDRR---PTFEEIIFR 348 (370)
Q Consensus 292 ~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~R---p~~~~ll~~ 348 (370)
.+||...........+.........+. .++..+.+||++||. +|.+| +++.+++.+
T Consensus 245 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 245 WPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999988776555544432222222222 478899999999997 66665 699999887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=297.34 Aligned_cols=248 Identities=30% Similarity=0.557 Sum_probs=209.1
Q ss_pred CCCCCCcccEEEEEEc-----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWR-----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|+||.||++.+. ...+++|.++.. ........+.+|+.+++.++||||+++++++...+..+++|||+.
T Consensus 11 ~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 88 (266)
T cd05033 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG--SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME 88 (266)
T ss_pred EecCCccceEEEEEEccCCCCcceEEEEEcCCC--CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence 3789999999999874 246888887653 334556778899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 173 NGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 173 g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
+++|.+++... +.++...++.++.|++.|+.|||+++ |+|+||||+||++++++.++|+|||++......... ..
T Consensus 89 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 164 (266)
T cd05033 89 NGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT-YT 164 (266)
T ss_pred CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccccc-ee
Confidence 99999998764 47899999999999999999999988 999999999999999999999999999877522211 12
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
.....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||............. .....+.+..+|+.+.+++.+
T Consensus 165 ~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~ 243 (266)
T cd05033 165 TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPSALYQLMLD 243 (266)
T ss_pred ccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHH
Confidence 223345678999999998889999999999999999998 999998777665555443 233444556789999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
||+.+|++||++.+++++|+++
T Consensus 244 cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 244 CWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=301.83 Aligned_cols=253 Identities=27% Similarity=0.478 Sum_probs=209.8
Q ss_pred cCCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEe
Q 042314 97 GGIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
..+|.|++|.||.+... +..+++|.+.. ........+.+|+..+++++||||+++++++...+..++|||
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (291)
T cd05094 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD---PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE 87 (291)
T ss_pred eeecccCCCeEEEeEeeccCCCCcceeeEEEecCC---ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEe
Confidence 34788999999999753 23477777654 223445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCC----------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEE
Q 042314 170 YLRNGSLHDILKKKG----------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKV 233 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl 233 (370)
|+++++|.+++...+ .+++..++.++.|++.|+.|||+++ ++||||||+||+++.++.++|
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l 164 (291)
T cd05094 88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKI 164 (291)
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEE
Confidence 999999999997542 3788899999999999999999998 999999999999999999999
Q ss_pred eccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCC
Q 042314 234 TDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDS 312 (370)
Q Consensus 234 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 312 (370)
+|||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||............. ...
T Consensus 165 ~dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~ 242 (291)
T cd05094 165 GDFGMSRDVYSTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT-QGR 242 (291)
T ss_pred CCCCcccccCCCceee-cCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-CCC
Confidence 9999987654432111 1122346788999999999999999999999999999998 999998777665554443 344
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 313 RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 313 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
.+..+..+|..+.+++.+||+.+|++||++.++++.|+++....+
T Consensus 243 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 243 VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 445566788999999999999999999999999999999977543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=292.22 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=204.7
Q ss_pred ecccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEe--eCCceEEEEe
Q 042314 94 EDRGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK--HSERLIFLTE 169 (370)
Q Consensus 94 ~~~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~--~~~~~~~v~e 169 (370)
.....+++|.||.||+++++ +..||+|.++... ......-...+|+.++.+++|||||.+-.+.. +-+.+|+|||
T Consensus 79 e~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 79 EKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 33445899999999999875 7789999998764 22334445679999999999999999998764 3467999999
Q ss_pred ecCCCCHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 170 YLRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
||+. +|..++..-+ +|...++..++.|+++|+.|||.+. |+|||||++|+|++..|.+||+|||+|+.++.+..
T Consensus 158 ~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k- 232 (419)
T KOG0663|consen 158 YVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK- 232 (419)
T ss_pred HHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCcc-
Confidence 9987 9999998764 8999999999999999999999998 99999999999999999999999999999887633
Q ss_pred ceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC--C----------
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP--A---------- 315 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~---------- 315 (370)
.++..+-|.+|.|||.+.+. .|+.+.|+||+|||+.||+++++.|.+.+..+...++...-..| .
T Consensus 233 --~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 233 --PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred --cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 23444679999999999875 58999999999999999999999999988777666554211111 0
Q ss_pred -----------------CCC-CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 316 -----------------LSS-LYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 316 -----------------~~~-~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
++. .+++.-.+|+..+|..||.+|.|+++.|++
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 001 144778899999999999999999999876
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=311.13 Aligned_cols=243 Identities=26% Similarity=0.421 Sum_probs=204.9
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|+||.||++... +..+|+|++.............+..|..++..+ .|++|+++++++...+.+++||||+++|
T Consensus 7 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 86 (323)
T cd05616 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 86 (323)
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCC
Confidence 3789999999999775 568999998765433344455677788888777 4889999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........ ....
T Consensus 87 ~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~---~~~~ 160 (323)
T cd05616 87 DLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV---TTKT 160 (323)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC---cccc
Confidence 99999988888999999999999999999999998 99999999999999999999999999875432221 1223
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
..||+.|+|||.+.+..++.++|+|||||++|+|++|+.||...........+.. .....+..++..+.+++.+||+.
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~~l~~ 238 (323)
T cd05616 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAVAICKGLMTK 238 (323)
T ss_pred CCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCcCCHHHHHHHHHHccc
Confidence 4689999999999999999999999999999999999999998877766665542 33445667899999999999999
Q ss_pred CCCCCCCH-----HHHHHH
Q 042314 335 NPDRRPTF-----EEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~-----~~ll~~ 348 (370)
||++|++. .+++++
T Consensus 239 ~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 239 HPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CHHhcCCCCCCCHHHHhcC
Confidence 99999984 566543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=315.17 Aligned_cols=238 Identities=29% Similarity=0.460 Sum_probs=202.3
Q ss_pred CCCCCCcccEEEEEE-----cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKW-----RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~-----~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|+||.||++.. .|..+++|++...... ......+..|+.++++++||||+++++++...+..++||||+.
T Consensus 3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 378999999998864 4788999998764322 2234567789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
+++|.+++.+...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ..
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~ 155 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KA 155 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC---ce
Confidence 9999999988888999999999999999999999998 99999999999999999999999999876543321 12
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+. ......+..+++.+.+++++||
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~--~~~~~~p~~~~~~~~~li~~~l 233 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--KAKLGMPQFLSPEAQSLLRALF 233 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCHHHHHHHHHHh
Confidence 23468999999999998889999999999999999999999998877665555443 2234456678899999999999
Q ss_pred ccCCCCCCCHHH
Q 042314 333 HKNPDRRPTFEE 344 (370)
Q Consensus 333 ~~~p~~Rp~~~~ 344 (370)
+.||++||++.+
T Consensus 234 ~~~P~~R~~a~~ 245 (318)
T cd05582 234 KRNPANRLGAGP 245 (318)
T ss_pred hcCHhHcCCCCC
Confidence 999999999443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=312.68 Aligned_cols=249 Identities=25% Similarity=0.488 Sum_probs=217.5
Q ss_pred cCCCCCCcccEEEEEEcC----c--eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 97 GGIDPGAYGEVYLVKWRG----T--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g----~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
..+|.|.||.||.+.+.. . .||||..+... .++..+.|..|..+++.++||||++++|++.. ...|||||+
T Consensus 395 r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL 471 (974)
T KOG4257|consen 395 RLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMEL 471 (974)
T ss_pred HhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEec
Confidence 449999999999998753 2 37888887653 34558899999999999999999999999875 468999999
Q ss_pred cCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 171 LRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 171 ~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+.-|.|..+++.+ ..++......+..||+.||.|||+.+ +|||||..+||||.+...+||+|||+++.+.+...+.
T Consensus 472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 9999999999865 57889999999999999999999998 9999999999999999999999999999988765433
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMF-QGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.....-++.|||||.++..+|+.+||||.||++|||++ .|..||.+-...+....+. .+.+.+.|..+|+.++.++
T Consensus 549 --aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-nGeRlP~P~nCPp~LYslm 625 (974)
T KOG4257|consen 549 --ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-NGERLPCPPNCPPALYSLM 625 (974)
T ss_pred --ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-CCCCCCCCCCCChHHHHHH
Confidence 33344578999999999999999999999999999976 5889998877666555444 6889999999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFRLEAIQE 354 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l~~~~~ 354 (370)
++||..+|.+||++.++...|..+..
T Consensus 626 skcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 626 SKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred HHHhccCcccCCcHHHHHHHHHHHHH
Confidence 99999999999999999999988754
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=301.26 Aligned_cols=242 Identities=25% Similarity=0.390 Sum_probs=196.0
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... |+.+++|.+.............+..|+.++++++||||+++++.+......++||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 588999999999765 788999998654333323344566799999999999999999999999999999999999999
Q ss_pred HHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++...+ .++...+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~----~~~ 153 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT----ITQ 153 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----eec
Confidence 98886543 5788889999999999999999998 99999999999999999999999999876654321 122
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAV---QVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
..++..|+|||.+.+..++.++|+||+||++|+|++|+.||...... ..................+++.+.+++++|
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 233 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLF 233 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHH
Confidence 35789999999999888999999999999999999999999754321 111111111222222346789999999999
Q ss_pred cccCCCCCCCHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIF 347 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~ 347 (370)
|+.||++||++.|+++
T Consensus 234 L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 234 LAKKPEDRLGSREKND 249 (277)
T ss_pred hccCHhhCCCCccchh
Confidence 9999999999966553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=308.13 Aligned_cols=244 Identities=28% Similarity=0.460 Sum_probs=216.4
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
..+|.|.||.||.+... |..+|+|.+.+...........+.+|+.+++++. ||||+.+.++|+....+++|||+++|
T Consensus 41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~G 120 (382)
T KOG0032|consen 41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEG 120 (382)
T ss_pred hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCC
Confidence 55899999999999775 7889999998876555556788999999999998 99999999999999999999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC----CcEEEeccccceeccccCccc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA----GHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~----~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
|.|.+.+... .+++..+..++.|++.++.|||+.| |+||||||+|+|+... +.+|++|||++.......
T Consensus 121 GeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~--- 193 (382)
T KOG0032|consen 121 GELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE--- 193 (382)
T ss_pred chHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc---
Confidence 9999999876 4999999999999999999999998 9999999999998743 479999999999887622
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC--CCCCCCCCCcHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED--SRPALSSLYPEPIKAL 327 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l 327 (370)
.....+||+.|+|||++....|+..+|+||+|+++|.|++|.+||...+.......+.... .....+..++..++++
T Consensus 194 -~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~ 272 (382)
T KOG0032|consen 194 -RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDF 272 (382)
T ss_pred -eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHH
Confidence 3455689999999999999999999999999999999999999999998777666555332 2344566789999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 042314 328 LRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 328 i~~~l~~~p~~Rp~~~~ll~~ 348 (370)
|++++..||..|+|+.++++|
T Consensus 273 i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 273 IRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHhcccCcccCCCHHHHhcC
Confidence 999999999999999999996
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=299.27 Aligned_cols=247 Identities=27% Similarity=0.480 Sum_probs=206.9
Q ss_pred cCCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEe
Q 042314 97 GGIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
..+|.|+||.||++... +..+++|.++.. ...+....+.+|+.+++.++||||+++++++......++|||
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 88 (280)
T cd05049 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFE 88 (280)
T ss_pred hhccccCCceEeeeeeccccCcCCcceEEEEeeccc--CCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEe
Confidence 34899999999999753 357899988654 233456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCC--------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEec
Q 042314 170 YLRNGSLHDILKKKG--------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTD 235 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~--------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~D 235 (370)
|+.+++|.+++...+ .+++..+..++.|++.|+.|||+++ ++||||||+||+++.++.++|+|
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d 165 (280)
T cd05049 89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGD 165 (280)
T ss_pred cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECC
Confidence 999999999997542 4678889999999999999999998 99999999999999999999999
Q ss_pred cccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCC
Q 042314 236 FGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRP 314 (370)
Q Consensus 236 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 314 (370)
||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||............. .+...
T Consensus 166 ~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-~~~~~ 243 (280)
T cd05049 166 FGMSRDVYTTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-QGRLL 243 (280)
T ss_pred cccceecccCccee-cCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCcC
Confidence 99987653322111 1112235788999999999999999999999999999998 999998777666555544 33344
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 315 ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 315 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
..+..+|..+.+++.+||..||++||++.|+++.|+
T Consensus 244 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 244 QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 455678999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=311.51 Aligned_cols=246 Identities=25% Similarity=0.406 Sum_probs=195.0
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC-----CceEEEEee
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS-----ERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~-----~~~~~v~e~ 170 (370)
.+|.|+||.||++... +..+++|.+...... ......+.+|+.+++.++||||+++++++... ...++||||
T Consensus 7 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~ 85 (338)
T cd07859 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 85 (338)
T ss_pred EEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEec
Confidence 3788999999999764 788999988653222 23345688999999999999999999987543 247999999
Q ss_pred cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 171 LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 171 ~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+. ++|.+++...+.+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 86 ~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 161 (338)
T cd07859 86 ME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI 161 (338)
T ss_pred CC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccccCccc
Confidence 95 599999998888999999999999999999999998 99999999999999999999999999876543222111
Q ss_pred eccCCCCCccccCcccccc--cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-------------------
Q 042314 251 KMTGGTGSYRYMAPEVYRR--ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY------------------- 309 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~------------------- 309 (370)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||..............
T Consensus 162 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 241 (338)
T cd07859 162 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKAR 241 (338)
T ss_pred cccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHH
Confidence 2233468999999999866 5788999999999999999999999976554322111000
Q ss_pred ------cCCC-C---CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 310 ------EDSR-P---ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 310 ------~~~~-~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.... . ......++.+.+++.+||+.||++|||+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 242 RYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 0 0112467789999999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=306.74 Aligned_cols=242 Identities=26% Similarity=0.479 Sum_probs=199.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|.+... ........+.+|+++++.++||||+++++++...+..++||||+.+++
T Consensus 12 ~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (333)
T cd06650 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (333)
T ss_pred cccCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCc
Confidence 4799999999999875 667888887654 234556778999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++...+.+++..+..++.|++.||.|||+.+ +++|+||||+||+++.++.+||+|||++....... ....
T Consensus 90 L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-----~~~~ 162 (333)
T cd06650 90 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSF 162 (333)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-----cccC
Confidence 9999998888999999999999999999999752 29999999999999999999999999987553321 1223
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh---------------------------
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRA--------------------------- 308 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~--------------------------- 308 (370)
.++..|+|||.+.+..++.++|+|||||++|+|++|+.||.............
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (333)
T cd06650 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYG 242 (333)
T ss_pred CCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhc
Confidence 57899999999998889999999999999999999999997654432211100
Q ss_pred ----------------ccCCCCCC-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 309 ----------------YEDSRPAL-SSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 309 ----------------~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.....+.. ...++.++++|+.+||+.||++|||+.+++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 243 PDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00111111 12367889999999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=299.05 Aligned_cols=247 Identities=31% Similarity=0.547 Sum_probs=205.4
Q ss_pred CCCCCCcccEEEEEE------cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKW------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~------~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
.+|+|+||.||++.. .+..+++|.+... ........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 12 ~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 89 (283)
T cd05090 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89 (283)
T ss_pred eccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence 378999999999875 3467888888653 33445577889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC-----------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEe
Q 042314 172 RNGSLHDILKKK-----------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVT 234 (370)
Q Consensus 172 ~g~~L~~~l~~~-----------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~ 234 (370)
.+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (283)
T cd05090 90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKIS 166 (283)
T ss_pred CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEec
Confidence 999999998532 23678889999999999999999998 9999999999999999999999
Q ss_pred ccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCC
Q 042314 235 DFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSR 313 (370)
Q Consensus 235 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 313 (370)
|||++.......... ......++..|+|||.+.+..++.++|+||||+++|||++ |.+||............. ....
T Consensus 167 dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~ 244 (283)
T cd05090 167 DLGLSREIYSADYYR-VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR-KRQL 244 (283)
T ss_pred cccccccccCCccee-cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCc
Confidence 999997664432211 1222345678999999988889999999999999999998 899998776655544444 2334
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042314 314 PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 314 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~ 351 (370)
...+..+|+.+.+++.+||+.||++||++.+++++|+.
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 245 LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 45567789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=311.80 Aligned_cols=237 Identities=31% Similarity=0.480 Sum_probs=198.5
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHH-HHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~-~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... +..+++|++.............+..|.. +++.++||||+++++.+...+..++||||++|++
T Consensus 3 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 82 (321)
T cd05603 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGE 82 (321)
T ss_pred eeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCC
Confidence 789999999999874 7789999987543323333445555554 5788899999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|...+.+...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 83 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 156 (321)
T cd05603 83 LFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---TTSTF 156 (321)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---ccccc
Confidence 9999988888999999999999999999999998 99999999999999999999999999875322211 12234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||.+.+..++.++|||||||++|+|++|.+||...........+. ......+...+..+.+++.+||+.|
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~l~~~ 234 (321)
T cd05603 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKPLQLPGGKTVAACDLLVGLLHKD 234 (321)
T ss_pred cCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCHHHHHHHHHHccCC
Confidence 68999999999999889999999999999999999999998877665555443 2234455677889999999999999
Q ss_pred CCCCCCHH
Q 042314 336 PDRRPTFE 343 (370)
Q Consensus 336 p~~Rp~~~ 343 (370)
|.+||++.
T Consensus 235 p~~R~~~~ 242 (321)
T cd05603 235 QRRRLGAK 242 (321)
T ss_pred HhhcCCCC
Confidence 99999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=310.91 Aligned_cols=243 Identities=26% Similarity=0.417 Sum_probs=202.1
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... +..+++|+++............+..|..++.++ +||+|+++++++...+.+++||||++|++
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 82 (327)
T cd05617 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGD 82 (327)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCc
Confidence 789999999999764 678999999876544555667788999998888 59999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|..++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 83 L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 156 (327)
T cd05617 83 LMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---TTSTF 156 (327)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---ceecc
Confidence 9999988888999999999999999999999998 99999999999999999999999999875322211 12234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT------AVQVADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
.||+.|+|||.+.+..++.++|+||||+++|+|++|+.||.... ......... .......+..+|..+.++++
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~li~ 235 (327)
T cd05617 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI-LEKPIRIPRFLSVKASHVLK 235 (327)
T ss_pred cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH-HhCCCCCCCCCCHHHHHHHH
Confidence 68999999999999999999999999999999999999995321 111122222 22334466778899999999
Q ss_pred HhcccCCCCCCCH------HHHHHH
Q 042314 330 ECWHKNPDRRPTF------EEIIFR 348 (370)
Q Consensus 330 ~~l~~~p~~Rp~~------~~ll~~ 348 (370)
+||..||++|+++ .+++.+
T Consensus 236 ~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 236 GFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred HHhccCHHHcCCCCCCCCHHHHHcC
Confidence 9999999999984 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=295.62 Aligned_cols=246 Identities=29% Similarity=0.506 Sum_probs=208.3
Q ss_pred CCCCCcccEEEEEEcC---c--eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWRG---T--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g---~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|.|++|.||++.+.. . .+++|.+...... ...+.+.+|+..+++++||||+++++.+.. ...++|+||+++
T Consensus 3 ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 7899999999997642 2 5889988765432 667889999999999999999999999887 889999999999
Q ss_pred CCHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 174 GSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 174 ~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
++|.+++.+.. .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++............
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999998764 6889999999999999999999998 999999999999999999999999999876543322112
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......+..............+...|..+.+++.+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 223346788999999998889999999999999999998 9999987776665555543444444556788999999999
Q ss_pred hcccCCCCCCCHHHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~ 350 (370)
||..+|++||++.++++.|.
T Consensus 237 ~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 237 CWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HCCCCcccCCCHHHHHHHhc
Confidence 99999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=298.53 Aligned_cols=247 Identities=28% Similarity=0.468 Sum_probs=203.3
Q ss_pred cCCCCCCcccEEEEEEcC-------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEe
Q 042314 97 GGIDPGAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g-------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
..+|.|++|.||.+...+ ..+++|.+... ........+.+|+.+++.++||||+++++++......++|||
T Consensus 12 ~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e 89 (277)
T cd05062 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 89 (277)
T ss_pred eeeccccCCeEEEEEeccCCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEe
Confidence 347899999999987643 46888887543 223445678899999999999999999999998899999999
Q ss_pred ecCCCCHHHHHHhCC----------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccc
Q 042314 170 YLRNGSLHDILKKKG----------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLS 239 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~----------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~ 239 (370)
|+.+++|.+++.+.. .++...+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~ 166 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCc
Confidence 999999999987532 2466788999999999999999988 999999999999999999999999998
Q ss_pred eeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCC
Q 042314 240 KIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSS 318 (370)
Q Consensus 240 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 318 (370)
.......... ......+++.|+|||.+.+..++.++|+||||+++|||++ |..||............. ....+..+.
T Consensus 167 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~ 244 (277)
T cd05062 167 RDIYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM-EGGLLDKPD 244 (277)
T ss_pred cccCCcceee-cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcCCCCC
Confidence 7654332211 1112345778999999998889999999999999999999 688998777665554443 333445566
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 319 LYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 319 ~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
..|+.+.+++.+||+.+|++|||+.++++.|+
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 245 NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 78899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=292.35 Aligned_cols=249 Identities=28% Similarity=0.436 Sum_probs=204.3
Q ss_pred ccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCc-eeeeeeeEeeCC------ceEE
Q 042314 96 RGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN-IVQFLGVLKHSE------RLIF 166 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~-Iv~~~~~~~~~~------~~~~ 166 (370)
...+|+|.||.||+|+.. |+.||+|.++-.... +.......+|+.+++.++|+| |+.+++++...+ .+++
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~l 94 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYL 94 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEE
Confidence 344899999999999775 888999998765432 234556789999999999999 999999988776 7899
Q ss_pred EEeecCCCCHHHHHHhCC----CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceec
Q 042314 167 LTEYLRNGSLHDILKKKG----KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIA 242 (370)
Q Consensus 167 v~e~~~g~~L~~~l~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~ 242 (370)
|+||++. +|..++...+ .++...+..+++||+.||+|||+++ |+||||||.||+|++.|.+||+|||+|+..
T Consensus 95 vfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 95 VFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred EEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHh
Confidence 9999966 9999998765 5777899999999999999999999 999999999999999999999999999966
Q ss_pred cccCccceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC-------
Q 042314 243 QEKDSYSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP------- 314 (370)
Q Consensus 243 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~------- 314 (370)
..+... .+..++|.+|+|||++.+. .|+...||||+|||++||+++++.|.+.+..+....+...-..|
T Consensus 171 ~ip~~~---yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 171 SIPMRT---YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred cCCccc---ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 644321 3345689999999999887 68999999999999999999999999988866555443211111
Q ss_pred ------------CC--C-------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHH
Q 042314 315 ------------AL--S-------SLYPEPIKALLRECWHKNPDRRPTFEEIIFR--LEAI 352 (370)
Q Consensus 315 ------------~~--~-------~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~--l~~~ 352 (370)
.. + +...+...+++++||+.+|.+|.|++..+++ +..+
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 00 0 0112478899999999999999999999987 4444
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=315.53 Aligned_cols=244 Identities=24% Similarity=0.372 Sum_probs=203.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+|+|.+.............+..|+.+++.++||||+++++++...+..++||||++||+|
T Consensus 51 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L 130 (370)
T cd05596 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL 130 (370)
T ss_pred EeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcH
Confidence 688999999999774 778999998654323333445678899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......... ......
T Consensus 131 ~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~--~~~~~~ 204 (370)
T cd05596 131 VNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV--RCDTAV 204 (370)
T ss_pred HHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc--cCCCCC
Confidence 9998764 6889999999999999999999998 999999999999999999999999998765433211 123346
Q ss_pred CCccccCccccccc----CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCC--CCcHHHHHHHHH
Q 042314 257 GSYRYMAPEVYRRE----SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSS--LYPEPIKALLRE 330 (370)
Q Consensus 257 g~~~y~aPE~~~~~----~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~ 330 (370)
||+.|+|||.+.+. .++.++|+|||||++|||++|++||...........+.........+. .+|..+.++|++
T Consensus 205 gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 284 (370)
T cd05596 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICA 284 (370)
T ss_pred CCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHH
Confidence 89999999998653 378899999999999999999999998877666555543222222332 578999999999
Q ss_pred hcccCCCC--CCCHHHHHHH
Q 042314 331 CWHKNPDR--RPTFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~--Rp~~~~ll~~ 348 (370)
||..+|++ ||++.+++++
T Consensus 285 ~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 285 FLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HccChhhccCCCCHHHHhcC
Confidence 99999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=296.20 Aligned_cols=246 Identities=36% Similarity=0.640 Sum_probs=212.6
Q ss_pred CCCCCCcccEEEEEEc-----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWR-----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|+||.||++... +..+++|.+...... .....+.+|+..++.++|+||+++++++......+++|||++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 3789999999999876 678999998765332 256788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC---------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceecc
Q 042314 173 NGSLHDILKKK---------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQ 243 (370)
Q Consensus 173 g~~L~~~l~~~---------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 243 (370)
+++|.+++... ..+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999875 68899999999999999999999998 9999999999999999999999999998766
Q ss_pred ccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcH
Q 042314 244 EKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPE 322 (370)
Q Consensus 244 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (370)
..... .......+++.|+|||.+....++.++|+||+|+++|+|++ |..||............. .......+..+|.
T Consensus 157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (262)
T cd00192 157 DDDYY-RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLPKPEYCPD 234 (262)
T ss_pred ccccc-ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCh
Confidence 54321 12233457889999999988889999999999999999999 599998887766665555 3455566777899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 323 PIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 323 ~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
.+.+++.+||..+|++|||+.+++++|+
T Consensus 235 ~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 235 ELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 9999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=303.33 Aligned_cols=242 Identities=24% Similarity=0.371 Sum_probs=195.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|.++.... ......+.+|+.+++.++||||+++++++...+..++||||+++ +
T Consensus 12 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~ 88 (288)
T cd07871 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-D 88 (288)
T ss_pred EEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-C
Confidence 4789999999999764 77899999865422 22334667899999999999999999999999999999999976 9
Q ss_pred HHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++...+ .++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 89 l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~---~~~~ 162 (288)
T cd07871 89 LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK---TYSN 162 (288)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc---cccC
Confidence 999887654 5788999999999999999999998 99999999999999999999999999876543221 1123
Q ss_pred CCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC--------------------C
Q 042314 255 GTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS--------------------R 313 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--------------------~ 313 (370)
..+++.|+|||.+.+ ..++.++|+||+||++|+|++|++||......+.......... .
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence 357899999999875 4688999999999999999999999987765443322211000 0
Q ss_pred C--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 P--------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 ~--------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+ ......++.+.+|+++||..||.+|||+++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 0112356789999999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=294.66 Aligned_cols=246 Identities=29% Similarity=0.515 Sum_probs=207.0
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|++|.||++.+. +..+++|.+... ......+.+|+.+++.++||||+++++++...+..+++|||++++
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (263)
T cd05052 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 87 (263)
T ss_pred eecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence 34789999999999775 778999987643 223467889999999999999999999999999999999999999
Q ss_pred CHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 175 SLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 175 ~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
+|.+++... ..++...++.++.|++.+|.|||+++ ++||||||+||++++++.+||+|||++......... ..
T Consensus 88 ~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~--~~ 162 (263)
T cd05052 88 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT--AH 162 (263)
T ss_pred cHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee--cc
Confidence 999999764 35888999999999999999999998 999999999999999999999999998766543211 11
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
.....++.|+|||.+.+..++.++||||||+++|||++ |..||............. ....+..+..+|..+.+++.+|
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~c 241 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVYELMRAC 241 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHH
Confidence 12234668999999998889999999999999999998 899998766655544443 3345566677899999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
|..+|++||++.++++.|+.+
T Consensus 242 l~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 242 WQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ccCCcccCCCHHHHHHHHHhh
Confidence 999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=319.43 Aligned_cols=247 Identities=25% Similarity=0.351 Sum_probs=203.7
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+|+|.+.............+.+|+.+++.++||||+++++.+...+.+++||||++||+
T Consensus 8 ~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~ 87 (376)
T cd05598 8 TIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGD 87 (376)
T ss_pred EEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCc
Confidence 3789999999999765 78899999865433333445678899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc--------
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS-------- 247 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-------- 247 (370)
|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 88 L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~ 164 (376)
T cd05598 88 MMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164 (376)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccc
Confidence 9999998888999999999999999999999998 99999999999999999999999999753210000
Q ss_pred --------------------------------cceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCC
Q 042314 248 --------------------------------YSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSN 295 (370)
Q Consensus 248 --------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~ 295 (370)
.........||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf 244 (376)
T cd05598 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244 (376)
T ss_pred ccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCC
Confidence 000011236899999999999999999999999999999999999999
Q ss_pred CCCcHHHHHHHhhccCCC--CCCCCCCcHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 042314 296 RADTAVQVADRRAYEDSR--PALSSLYPEPIKALLRECWHKNPDRRP---TFEEIIFR 348 (370)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp---~~~~ll~~ 348 (370)
...........+...... .+....+++.+.++|.+|+ .+|.+|+ ++.+++.+
T Consensus 245 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 245 LADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 888766554443322222 2223457889999999976 5999999 89999877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=314.15 Aligned_cols=245 Identities=23% Similarity=0.354 Sum_probs=205.8
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|.++............+..|+.+++.++||+|+++++.+...+..++||||+++++
T Consensus 8 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (330)
T cd05601 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGD 87 (330)
T ss_pred EEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCC
Confidence 3789999999999764 78899999986544444566778899999999999999999999999999999999999999
Q ss_pred HHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++.+. +.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......... ....
T Consensus 88 L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~--~~~~ 162 (330)
T cd05601 88 LLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV--NSKL 162 (330)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce--eeec
Confidence 99999876 68999999999999999999999998 999999999999999999999999999876543221 1223
Q ss_pred CCCCccccCccccc------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCC--CCCCCcHHHHH
Q 042314 255 GTGSYRYMAPEVYR------RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPA--LSSLYPEPIKA 326 (370)
Q Consensus 255 ~~g~~~y~aPE~~~------~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~ 326 (370)
..||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+........ ....+++.+.+
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 242 (330)
T cd05601 163 PVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLD 242 (330)
T ss_pred ccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHH
Confidence 36899999999986 45678899999999999999999999988776655554432222122 22357889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 042314 327 LLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 327 li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
|+++||. +|.+||++++++.+
T Consensus 243 li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 243 LIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHHcc-ChhhCCCHHHHhCC
Confidence 9999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=312.38 Aligned_cols=237 Identities=30% Similarity=0.475 Sum_probs=199.2
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHH-HHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~-~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... |..+++|++.............+..|.. +++.++||||+++++.+...+..++||||+.|++
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 82 (325)
T cd05604 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGE 82 (325)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCC
Confidence 789999999999764 7889999987654333344455556655 4677899999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|..++...+.+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|||++........ .....
T Consensus 83 L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~~~~ 156 (325)
T cd05604 83 LFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---TTTTF 156 (325)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---Ccccc
Confidence 9999988889999999999999999999999998 99999999999999999999999999865322211 12234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||.+.+..++.++|||||||++|+|++|.+||.............. .....+...+..+.+++++||..+
T Consensus 157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ll~~ll~~~ 234 (325)
T cd05604 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH--KPLVLRPGASLTAWSILEELLEKD 234 (325)
T ss_pred cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--CCccCCCCCCHHHHHHHHHHhccC
Confidence 689999999999999999999999999999999999999988777665555442 223344567889999999999999
Q ss_pred CCCCCCHH
Q 042314 336 PDRRPTFE 343 (370)
Q Consensus 336 p~~Rp~~~ 343 (370)
|.+||++.
T Consensus 235 p~~R~~~~ 242 (325)
T cd05604 235 RQRRLGAK 242 (325)
T ss_pred HHhcCCCC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=318.09 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=203.6
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+|+|.+.............+.+|+.++++++||||+++++.+...+.+++||||+++|+
T Consensus 8 ~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~ 87 (382)
T cd05625 8 TLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGD 87 (382)
T ss_pred EEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCc
Confidence 3789999999999874 67899999876543344566788999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc--------
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS-------- 247 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-------- 247 (370)
|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.+|.+||+|||++........
T Consensus 88 L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~ 164 (382)
T cd05625 88 MMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGD 164 (382)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccc
Confidence 9999988888999999999999999999999998 99999999999999999999999999753211000
Q ss_pred ------------------------------------cceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhC
Q 042314 248 ------------------------------------YSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG 291 (370)
Q Consensus 248 ------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g 291 (370)
.........||+.|+|||++.+..++.++||||+||++|||++|
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG 244 (382)
T cd05625 165 HVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 244 (382)
T ss_pred ccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhC
Confidence 00001123589999999999999999999999999999999999
Q ss_pred CCCCCCCcHHHHHHHhhccCCCC--CCCCCCcHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 042314 292 GPSNRADTAVQVADRRAYEDSRP--ALSSLYPEPIKALLRECWHKNPDRRPT---FEEIIFR 348 (370)
Q Consensus 292 ~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~ll~~ 348 (370)
++||...........+....... +....+++.+.++|.+|+ .+|++|++ +.+++++
T Consensus 245 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 245 QPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred CCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 99998877665555444222222 223457889999999976 59999987 8888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=300.65 Aligned_cols=254 Identities=30% Similarity=0.546 Sum_probs=209.3
Q ss_pred CCCCCCcccEEEEEEcC---------ceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEE
Q 042314 98 GIDPGAYGEVYLVKWRG---------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFL 167 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g---------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v 167 (370)
.+|+|+||.||++...+ ..+++|.+.... .......+..|+.+++.+ +||||+++++++...+..++|
T Consensus 25 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 102 (307)
T cd05098 25 PLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 102 (307)
T ss_pred eeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 37899999999997632 458889887542 234456788899999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHHhCC----------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcE
Q 042314 168 TEYLRNGSLHDILKKKG----------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHL 231 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~ 231 (370)
|||+.+++|.+++...+ .++..+++.++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~ 179 (307)
T cd05098 103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM 179 (307)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcE
Confidence 99999999999997642 3778889999999999999999998 9999999999999999999
Q ss_pred EEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcc
Q 042314 232 KVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYE 310 (370)
Q Consensus 232 kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 310 (370)
||+|||++.......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||............. .
T Consensus 180 kL~dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-~ 257 (307)
T cd05098 180 KIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-E 257 (307)
T ss_pred EECCCcccccccccchhh-ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-c
Confidence 999999987654322111 1122234578999999998889999999999999999998 888988776655444433 3
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhcc
Q 042314 311 DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQK 358 (370)
Q Consensus 311 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~ 358 (370)
......+..++..+.+++.+||..+|++||++.++++.|+++......
T Consensus 258 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~ 305 (307)
T cd05098 258 GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305 (307)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence 334455667889999999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=299.38 Aligned_cols=247 Identities=28% Similarity=0.490 Sum_probs=206.9
Q ss_pred CCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 98 GIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
.+|.|+||.||++... +..+++|.+... ........+..|..+++.++||||+++++++......++++||
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05091 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK--AEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSY 89 (283)
T ss_pred HhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEc
Confidence 4799999999999764 367899998754 2344567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC----------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEe
Q 042314 171 LRNGSLHDILKKK----------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVT 234 (370)
Q Consensus 171 ~~g~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~ 234 (370)
+.+++|.+++... ..++...+..++.|++.||.|||+++ ++||||||+||++++++.+||+
T Consensus 90 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~ 166 (283)
T cd05091 90 CSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKIS 166 (283)
T ss_pred CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEec
Confidence 9999999998532 24778889999999999999999998 9999999999999999999999
Q ss_pred ccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCC
Q 042314 235 DFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSR 313 (370)
Q Consensus 235 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 313 (370)
|||+++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...........+. ....
T Consensus 167 Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~-~~~~ 244 (283)
T cd05091 167 DLGLFREVYAADYYK-LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR-NRQV 244 (283)
T ss_pred ccccccccccchhee-eccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCc
Confidence 999987664432211 1222345789999999988889999999999999999998 888888777766555544 3334
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042314 314 PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 314 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~ 351 (370)
...+..+|..+.+++.+||+.+|++||++++++..|+.
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 245 LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 45567799999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=303.68 Aligned_cols=253 Identities=26% Similarity=0.535 Sum_probs=208.7
Q ss_pred cCCCCCCcccEEEEEEc--Cc----eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 97 GGIDPGAYGEVYLVKWR--GT----EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
..+|+|+||.||++.+. +. .+++|.++.. ........+..|+.+++.++||||+++++++... ..++++||
T Consensus 13 ~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~ 89 (316)
T cd05108 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 89 (316)
T ss_pred eeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeeec
Confidence 34899999999999763 33 3788888643 3345567788999999999999999999988764 56799999
Q ss_pred cCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 171 LRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 171 ~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+.+|+|.+++... ..++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 90 ~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~- 165 (316)
T cd05108 90 MPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE- 165 (316)
T ss_pred CCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCCcc-
Confidence 9999999999875 46888999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||............. .......+..++..+.+++
T Consensus 166 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 244 (316)
T cd05108 166 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDVYMIM 244 (316)
T ss_pred eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHH
Confidence 12223345678999999999999999999999999999997 999998776655443332 3444455567888999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 329 RECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
.+||..+|++||++.+++..+.++.....
T Consensus 245 ~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 245 VKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 99999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=323.44 Aligned_cols=258 Identities=28% Similarity=0.520 Sum_probs=231.7
Q ss_pred ccCCCCCCcccEEEEEEc-----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 96 RGGIDPGAYGEVYLVKWR-----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~-----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
...||.|.||.|+.++.+ ...||+|.++.. ..+.++..|..|+.+|-++.||||+++-|+......++||+||
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 445899999999998765 346999999875 4567889999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 171 LRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 171 ~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
|+.|+|+.+++++ +.|+..+...+++.|+.||.||-.++ +|||||..+||||+.+-..|++|||+++.+.+.....
T Consensus 712 MENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 712 MENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 9999999999876 67999999999999999999999999 9999999999999999999999999999887665444
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMF-QGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
+...+.--+.+|.|||.+...+++.+|||||+|++|||.+ .|..||...+..+....+. ++.+.+.|..+|..|.+|+
T Consensus 789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmDCP~aL~qLM 867 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMDCPAALYQLM 867 (996)
T ss_pred ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCCCcHHHHHHH
Confidence 4555555678999999999999999999999999999966 5899999999888777766 7888888999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHhccC
Q 042314 329 RECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~ 359 (370)
..||++|-.+||.+.+|+..|+++.+...+-
T Consensus 868 ldCWqkdR~~RP~F~qiV~~lDklIrnP~SL 898 (996)
T KOG0196|consen 868 LDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL 898 (996)
T ss_pred HHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence 9999999999999999999999997665543
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=293.12 Aligned_cols=242 Identities=30% Similarity=0.584 Sum_probs=203.6
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|+||.||++.+. +..+++|.+.... .....+.+|+.+++.++||||+++++++...+..++||||+++|+|
T Consensus 11 ~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L 86 (256)
T cd05114 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL 86 (256)
T ss_pred EecCCcCceEEEEEeccCceEEEEecccCC----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcH
Confidence 3899999999999876 4578888876432 1235678899999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 177 HDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 177 ~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
.+++... +.++...+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||.+......... .....
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~--~~~~~ 161 (256)
T cd05114 87 LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT--SSSGA 161 (256)
T ss_pred HHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee--ccCCC
Confidence 9998753 56889999999999999999999998 999999999999999999999999998765432211 11222
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.++..|+|||.+.+..++.++|+||||+++|+|++ |++||...........+. ....+..+...+..+.+++.+||..
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~c~~~ 240 (256)
T cd05114 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRLYRPKLASMTVYEVMYSCWHE 240 (256)
T ss_pred CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHccC
Confidence 45678999999988889999999999999999999 899998877766655554 2334444566788999999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 042314 335 NPDRRPTFEEIIFRL 349 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~l 349 (370)
+|++||+++++++.|
T Consensus 241 ~p~~Rps~~~l~~~l 255 (256)
T cd05114 241 KPEGRPTFAELLRAI 255 (256)
T ss_pred CcccCcCHHHHHHhh
Confidence 999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=322.88 Aligned_cols=249 Identities=21% Similarity=0.364 Sum_probs=204.3
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeee-Eee------CCceEEEE
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGV-LKH------SERLIFLT 168 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~-~~~------~~~~~~v~ 168 (370)
|.+|||+.||.|... |..+|+|.+-. .++...+...+|+.+|++|+ |+|||.++|. ... .-.+++.|
T Consensus 45 LAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm 121 (738)
T KOG1989|consen 45 LAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM 121 (738)
T ss_pred EccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence 678999999999886 37899998765 36778899999999999996 9999999993 221 13578999
Q ss_pred eecCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccC
Q 042314 169 EYLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD 246 (370)
Q Consensus 169 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 246 (370)
|||.||+|-+++..+ .+|++.++++|+.++++|+.+||... .+|||||||-+|||++.+|+.||||||.++......
T Consensus 122 EyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~ 200 (738)
T KOG1989|consen 122 EYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSP 200 (738)
T ss_pred hhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccccCCC
Confidence 999999999999854 57999999999999999999999998 689999999999999999999999999987543322
Q ss_pred cccee------ccCCCCCccccCccccc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCC
Q 042314 247 SYSYK------MTGGTGSYRYMAPEVYR---RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALS 317 (370)
Q Consensus 247 ~~~~~------~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 317 (370)
..... .-....|+.|+|||++. +...+.|+|||+|||+||-|+....||+......+... ....+..
T Consensus 201 ~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng----~Y~~P~~ 276 (738)
T KOG1989|consen 201 TSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNG----NYSFPPF 276 (738)
T ss_pred ccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEec----cccCCCC
Confidence 11100 01124799999999884 56789999999999999999999999998755443321 2222333
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042314 318 SLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 318 ~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
..++..+.+||+.||++||++||++-+++..+-.++..
T Consensus 277 p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 277 PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 56889999999999999999999999999999888653
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=293.43 Aligned_cols=243 Identities=29% Similarity=0.577 Sum_probs=204.3
Q ss_pred CCCCCCcccEEEEEEcCc-eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWRGT-EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~-~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|++|.||.+.+.+. .+++|.+..... ....+.+|+.++++++||||+++++++...+..+++|||+.+++|
T Consensus 11 ~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 86 (256)
T cd05113 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86 (256)
T ss_pred EecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcH
Confidence 378999999999987654 589998764321 235688999999999999999999999988899999999999999
Q ss_pred HHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 177 HDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 177 ~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
.+++... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 87 ~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~ 161 (256)
T cd05113 87 LNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT--SSVGS 161 (256)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee--ecCCC
Confidence 9999764 46899999999999999999999998 999999999999999999999999998765443211 12223
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.++..|+|||.+.+..++.++|+||||+++|+|++ |..||............. ...+...+...++.+.+++.+||+.
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~ 240 (256)
T cd05113 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYAIMYSCWHE 240 (256)
T ss_pred ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 45678999999988889999999999999999998 999998777655555443 3344445566789999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 042314 335 NPDRRPTFEEIIFRLE 350 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~l~ 350 (370)
+|++||++.++++.|+
T Consensus 241 ~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 241 KAEERPTFQQLLSSIE 256 (256)
T ss_pred CcccCCCHHHHHHhhC
Confidence 9999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=294.22 Aligned_cols=249 Identities=30% Similarity=0.554 Sum_probs=207.6
Q ss_pred CCCCCCcccEEEEEEc-----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWR-----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|+||.||++... +..+++|.++... .......+.+|+.++++++||||+++++++...+..++||||++
T Consensus 11 ~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (267)
T cd05066 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 88 (267)
T ss_pred eecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 4789999999999763 2368888876532 23456788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 173 NGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 173 g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
+++|.+++.+. +.++..++..++.|++.|+.|||+++ ++||||||+||+++.++.++|+|||++............
T Consensus 89 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (267)
T cd05066 89 NGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165 (267)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccceeee
Confidence 99999999765 46899999999999999999999998 999999999999999999999999998876543322222
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
.....++..|+|||.+.+..++.++|+||||+++|++++ |..||............. ...+.+.+..+|+.+.+++.+
T Consensus 166 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 244 (267)
T cd05066 166 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCPAALHQLMLD 244 (267)
T ss_pred cCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-CCCcCCCCCCCCHHHHHHHHH
Confidence 222334668999999998889999999999999999886 999998776655444443 233444556688999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
||+.+|.+||++.++++.|+++
T Consensus 245 ~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 245 CWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HcccCchhCCCHHHHHHHHHhh
Confidence 9999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=320.14 Aligned_cols=245 Identities=21% Similarity=0.326 Sum_probs=205.9
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC--------ceEEE
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE--------RLIFL 167 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~--------~~~~v 167 (370)
.+|.|+||.||++.. .+..+|+|.+..... .......+.+|+..+..++|+|++++.+.+...+ .+++|
T Consensus 39 ~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV 117 (496)
T PTZ00283 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALV 117 (496)
T ss_pred EEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEE
Confidence 378999999999976 488999999876532 3455677889999999999999999988765432 36899
Q ss_pred EeecCCCCHHHHHHhC----CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceecc
Q 042314 168 TEYLRNGSLHDILKKK----GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQ 243 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 243 (370)
|||+.+|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~ 194 (496)
T PTZ00283 118 LDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYA 194 (496)
T ss_pred EeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeecc
Confidence 9999999999988653 46889999999999999999999998 9999999999999999999999999998665
Q ss_pred ccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHH
Q 042314 244 EKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEP 323 (370)
Q Consensus 244 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (370)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............. .......+..+++.
T Consensus 195 ~~~~~~-~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 272 (496)
T PTZ00283 195 ATVSDD-VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL-AGRYDPLPPSISPE 272 (496)
T ss_pred cccccc-ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHH
Confidence 432111 1233468999999999999999999999999999999999999999887766655544 23344566778999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 324 IKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 324 l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+.+++.+||..||++||++.+++++
T Consensus 273 l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 273 MQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHHHcccChhhCcCHHHHHhC
Confidence 9999999999999999999999875
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=296.16 Aligned_cols=246 Identities=28% Similarity=0.508 Sum_probs=202.9
Q ss_pred CCCCCCcccEEEEEEcC-------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 98 GIDPGAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g-------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
.+|.|++|.||++...+ ..+++|..... ........+..|+.+++.++|+||+++++++...+..++||||
T Consensus 13 ~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05036 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL 90 (277)
T ss_pred ECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence 37899999999998754 45777766543 2334456788999999999999999999999888899999999
Q ss_pred cCCCCHHHHHHhCC-------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC---cEEEeccccce
Q 042314 171 LRNGSLHDILKKKG-------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG---HLKVTDFGLSK 240 (370)
Q Consensus 171 ~~g~~L~~~l~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~---~~kl~Dfg~~~ 240 (370)
+.|++|.+++...+ .+++..++.++.|++.|+.|||+++ ++|+||||+||+++.++ .+||+|||+++
T Consensus 91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~ 167 (277)
T cd05036 91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167 (277)
T ss_pred CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCcccc
Confidence 99999999997653 4788999999999999999999998 99999999999998765 58999999988
Q ss_pred eccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCC
Q 042314 241 IAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSL 319 (370)
Q Consensus 241 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (370)
......... .......+..|+|||.+.+..++.++|||||||++|+|++ |..||............. .......+..
T Consensus 168 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~ 245 (277)
T cd05036 168 DIYRASYYR-KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GGGRLDPPKG 245 (277)
T ss_pred ccCCcccee-cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcCCCCCC
Confidence 663322111 1112233568999999998889999999999999999997 999998877666555443 3344555677
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 320 YPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 320 ~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
+|..+.+++.+||+.+|++||++.+++++|+
T Consensus 246 ~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 246 CPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 8999999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=312.93 Aligned_cols=243 Identities=26% Similarity=0.406 Sum_probs=198.9
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc---CCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL---RHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l---~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|.|+||.||++... +..+|+|++................|..++... +||+|+++++.+...+..++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 588999999999774 788999998654322333344455666666655 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
++|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~~~ 154 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---TTN 154 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---Ccc
Confidence 999999998889999999999999999999999998 99999999999999999999999999875432221 122
Q ss_pred CCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 254 GGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
...||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+...... .....+++.+.+++++||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~~L 233 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR-FPKNVLSDEGRQFVKGLL 233 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHc
Confidence 34689999999998764 4789999999999999999999999887776665555432222 122357899999999999
Q ss_pred ccCCCCCC----CHHHHHHH
Q 042314 333 HKNPDRRP----TFEEIIFR 348 (370)
Q Consensus 333 ~~~p~~Rp----~~~~ll~~ 348 (370)
..||.+|| ++.+++++
T Consensus 234 ~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 234 NRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CCCHHHCCCCCCCHHHHhcC
Confidence 99999998 57777664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=304.33 Aligned_cols=242 Identities=26% Similarity=0.435 Sum_probs=191.0
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+|+|.+..... ......+.+|+.+++.++||||+++++++......++||||+.+ +
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~ 88 (303)
T cd07869 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-D 88 (303)
T ss_pred eEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCCc-C
Confidence 3788999999999874 78899999875432 12234567899999999999999999999999999999999965 7
Q ss_pred HHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++.+. +.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 162 (303)
T cd07869 89 LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH---TYSN 162 (303)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc---cCCC
Confidence 87777654 57899999999999999999999998 99999999999999999999999999875433221 1233
Q ss_pred CCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHhhcc--CC--------------CCC-
Q 042314 255 GTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQV-ADRRAYE--DS--------------RPA- 315 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~~~~~--~~--------------~~~- 315 (370)
..+++.|+|||++.+. .++.++|+||+||++|+|++|.+||........ ....... .. .+.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPER 242 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccccc
Confidence 4678999999998654 578899999999999999999999986533221 1111000 00 000
Q ss_pred -------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 316 -------------LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 316 -------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
....+++.+.+|+++||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 001245678999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=297.26 Aligned_cols=251 Identities=28% Similarity=0.516 Sum_probs=207.5
Q ss_pred cCCCCCCcccEEEEEEcC-------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEe
Q 042314 97 GGIDPGAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g-------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
..+|.|+||.||++.... ..+++|.+.... .......+.+|+.+++.++||||+++++.+...+..++++|
T Consensus 6 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 347999999999997642 457777776432 23345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhC------------------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee
Q 042314 170 YLRNGSLHDILKKK------------------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ 225 (370)
Q Consensus 170 ~~~g~~L~~~l~~~------------------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~ 225 (370)
|+.+++|.+++... ..++...++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEE
Confidence 99999999998642 24678889999999999999999998 9999999999999
Q ss_pred CCCCcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHH
Q 042314 226 DEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVA 304 (370)
Q Consensus 226 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~ 304 (370)
++++.+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred cCCCcEEeccccccccccCccchh-cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999987654332211 1222345678999999988889999999999999999998 99999877766655
Q ss_pred HHhhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042314 305 DRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQE 354 (370)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~ 354 (370)
.... .......+..++..+.+++.+||+.+|++||++.++++.|+++..
T Consensus 240 ~~~~-~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 240 NLLK-TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHh-CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 4433 333445567788999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=307.34 Aligned_cols=237 Identities=26% Similarity=0.433 Sum_probs=200.7
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|+||.||++... ++.+|+|++.............+..|..+++.+. |++|+++++++...+.+++||||++||
T Consensus 7 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g 86 (323)
T cd05615 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGG 86 (323)
T ss_pred EEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCC
Confidence 3789999999999774 7889999987643333344566778888888886 577888999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 87 ~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~---~~~~ 160 (323)
T cd05615 87 DLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV---TTRT 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc---cccC
Confidence 99999998889999999999999999999999998 99999999999999999999999999875432221 1223
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
..||+.|+|||.+.+..++.++|+||+|+++|+|++|++||...........+.. .....+..++..+.+++.+||+.
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~l~~ 238 (323)
T cd05615 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAVSICKGLMTK 238 (323)
T ss_pred ccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHccc
Confidence 3589999999999988899999999999999999999999998877666555542 33445667889999999999999
Q ss_pred CCCCCCCH
Q 042314 335 NPDRRPTF 342 (370)
Q Consensus 335 ~p~~Rp~~ 342 (370)
+|.+|++.
T Consensus 239 ~p~~R~~~ 246 (323)
T cd05615 239 HPSKRLGC 246 (323)
T ss_pred CHhhCCCC
Confidence 99999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=292.83 Aligned_cols=240 Identities=32% Similarity=0.607 Sum_probs=208.5
Q ss_pred CCCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 98 GIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
.+|.|++|.||++...|+.+++|.+..... ....+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus 13 ~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 88 (256)
T cd05039 13 TIGKGEFGDVMLGDYRGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88 (256)
T ss_pred eeecCCCceEEEEEecCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence 378899999999999999999999875422 4677899999999999999999999999889999999999999999
Q ss_pred HHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 178 DILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 178 ~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
+++.... .+++..+..++.|++.|+.|||+++ ++|+||||+||+++.++.++|+|||.+........ ..
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~------~~ 159 (256)
T cd05039 89 DYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD------SG 159 (256)
T ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc------cC
Confidence 9998765 6899999999999999999999998 99999999999999999999999999876633211 22
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
..+..|+|||.+....++.++|+||||+++|++++ |..||............. .......+..+|+.+.+++++||..
T Consensus 160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 238 (256)
T cd05039 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE-KGYRMEAPEGCPPEVYKVMKDCWEL 238 (256)
T ss_pred CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-cCCCCCCccCCCHHHHHHHHHHhcc
Confidence 34668999999988889999999999999999997 999998887666555443 2334455667899999999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 042314 335 NPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~l~~ 351 (370)
+|++||++.+++..|+.
T Consensus 239 ~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 239 DPAKRPTFKQLREQLAL 255 (256)
T ss_pred ChhhCcCHHHHHHHHhc
Confidence 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=293.20 Aligned_cols=244 Identities=30% Similarity=0.541 Sum_probs=205.5
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|++|.||++... +..+++|.++.... ..+.+.+|+.++++++||||+++++++...+..+++|||+.+++|
T Consensus 13 ~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (261)
T cd05068 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSL 88 (261)
T ss_pred EecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcH
Confidence 3789999999998764 56789998865321 245688899999999999999999999999999999999999999
Q ss_pred HHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++.... .++...+..++.|++.|+.+||+++ ++|+||||+||+++.++.++|+|||++......... ...+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 163 (261)
T cd05068 89 LEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE--AREG 163 (261)
T ss_pred HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc--ccCC
Confidence 99997654 6899999999999999999999998 999999999999999999999999999876533211 1112
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
...+..|+|||.+.+..++.++|+||||+++|+|++ |+.||............. .......+...+..+.+++.+||+
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 242 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPKELYDIMLDCWK 242 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHhh
Confidence 223468999999998889999999999999999999 999998877666555443 233344556688999999999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~ 351 (370)
.+|++||++.++++.|+.
T Consensus 243 ~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 243 EDPDDRPTFETLQWKLED 260 (261)
T ss_pred cCcccCCCHHHHHHHHhc
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=309.82 Aligned_cols=244 Identities=25% Similarity=0.430 Sum_probs=201.4
Q ss_pred CCCCCCcccEEEEEE-----cCceeEEEEecccc-CCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEee
Q 042314 98 GIDPGAYGEVYLVKW-----RGTEIAAKTIRSSI-ASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~-----~g~~vavK~l~~~~-~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
.+|.|+||.||++.. .+..+++|++.... .........+..|+.+++.++ ||+|+++++++...+..++||||
T Consensus 7 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (332)
T cd05614 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDY 86 (332)
T ss_pred EEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeC
Confidence 378999999999875 46789999986532 223344567889999999994 89999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 171 LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 171 ~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+.+|+|.+++.+++.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-- 161 (332)
T cd05614 87 VSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-- 161 (332)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC--
Confidence 999999999988888999999999999999999999998 999999999999999999999999998765332211
Q ss_pred eccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHhhccCCCCCCCCCCcHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADT----AVQVADRRAYEDSRPALSSLYPEPIK 325 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~ 325 (370)
......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.... ........ ....+..+..+++.+.
T Consensus 162 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI--LKCDPPFPSFIGPEAQ 239 (332)
T ss_pred ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--hcCCCCCCCCCCHHHH
Confidence 11234689999999999865 47889999999999999999999996432 22222222 2344556677899999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHHHH
Q 042314 326 ALLRECWHKNPDRRP-----TFEEIIFR 348 (370)
Q Consensus 326 ~li~~~l~~~p~~Rp-----~~~~ll~~ 348 (370)
+++.+||..||++|| ++++++++
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 999999999999999 77888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=297.71 Aligned_cols=251 Identities=28% Similarity=0.473 Sum_probs=200.8
Q ss_pred cCCCCCCcccEEEEEE------cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC--CceEEEE
Q 042314 97 GGIDPGAYGEVYLVKW------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS--ERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~------~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~--~~~~~v~ 168 (370)
..+|.|+||.||.+.. .+..+++|.++... .......+.+|+.+++.++||||+++++++... ...+++|
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred eecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEe
Confidence 4488999999988653 36679999987542 234556788999999999999999999987653 4589999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
||+++++|.+++... .+++..++.++.|++.|+.|||+++ |+||||||+||+++.++.++|+|||++.........
T Consensus 88 e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 88 EYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred cCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 999999999999775 6999999999999999999999998 999999999999999999999999998766543221
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH--------------HHHHhhccCCCC
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ--------------VADRRAYEDSRP 314 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--------------~~~~~~~~~~~~ 314 (370)
........++..|+|||.+.+..++.++||||||+++|+|++|..||....... ............
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRL 243 (283)
T ss_pred hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCC
Confidence 111122235667999999988889999999999999999999999886432210 000111112233
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042314 315 ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQ 353 (370)
Q Consensus 315 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~ 353 (370)
..+..+|..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 244 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 244 PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 345668899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=305.18 Aligned_cols=252 Identities=28% Similarity=0.504 Sum_probs=203.4
Q ss_pred cCCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEee-CCceEEE
Q 042314 97 GGIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKH-SERLIFL 167 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~-~~~~~~v 167 (370)
..+|.|+||.||++... ++.+++|.++... .......+..|+.+++++ +||||+++++++.. ...++++
T Consensus 13 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v 90 (337)
T cd05054 13 KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (337)
T ss_pred cccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEE
Confidence 34899999999998643 3679999886532 233446678899999999 79999999998764 4578899
Q ss_pred EeecCCCCHHHHHHhC-------------------------------------------------------------CCC
Q 042314 168 TEYLRNGSLHDILKKK-------------------------------------------------------------GKL 186 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~-------------------------------------------------------------~~~ 186 (370)
+||+.+++|.+++... ..+
T Consensus 91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (337)
T cd05054 91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL 170 (337)
T ss_pred EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence 9999999999988642 257
Q ss_pred ChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCCCCccccCccc
Q 042314 187 DPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV 266 (370)
Q Consensus 187 ~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 266 (370)
+...+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++.......... ......++..|+|||.
T Consensus 171 ~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~-~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 171 TLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKGDARLPLKWMAPES 246 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchh-hccCCCCCccccCcHH
Confidence 88889999999999999999998 9999999999999999999999999998764332111 1222345678999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 042314 267 YRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345 (370)
Q Consensus 267 ~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~l 345 (370)
+.+..++.++|||||||++|+|++ |..||......+...........+..+...++.+.+++.+||+.+|++||++.++
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~el 326 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSEL 326 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999999999999999999998 9999976443333222222334444556678899999999999999999999999
Q ss_pred HHHHHHHHH
Q 042314 346 IFRLEAIQE 354 (370)
Q Consensus 346 l~~l~~~~~ 354 (370)
+++|+++..
T Consensus 327 l~~l~~~~~ 335 (337)
T cd05054 327 VEILGDLLQ 335 (337)
T ss_pred HHHHHHHHh
Confidence 999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=308.69 Aligned_cols=251 Identities=27% Similarity=0.461 Sum_probs=206.5
Q ss_pred cCCCCCCcccEEEEEEcC-------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEE
Q 042314 97 GGIDPGAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g-------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~ 168 (370)
..+|.|+||.||++.+.+ ..+++|.++... .......+.+|+.++.++. ||||+++++++...+..++|+
T Consensus 43 ~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~ 120 (401)
T cd05107 43 RTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT 120 (401)
T ss_pred hhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence 458999999999998643 579999997642 2334457889999999997 999999999999989999999
Q ss_pred eecCCCCHHHHHHhCC----------------------------------------------------------------
Q 042314 169 EYLRNGSLHDILKKKG---------------------------------------------------------------- 184 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~---------------------------------------------------------------- 184 (370)
||+.+|+|.+++.+.+
T Consensus 121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (401)
T cd05107 121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK 200 (401)
T ss_pred eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence 9999999999986532
Q ss_pred ----------------------------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc
Q 042314 185 ----------------------------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH 230 (370)
Q Consensus 185 ----------------------------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~ 230 (370)
.++...++.++.|++.||.|||+.+ ++||||||+||+++..+.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~ 277 (401)
T cd05107 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKL 277 (401)
T ss_pred hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCE
Confidence 2455677889999999999999988 999999999999999999
Q ss_pred EEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhc
Q 042314 231 LKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAY 309 (370)
Q Consensus 231 ~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 309 (370)
+||+|||+++......... ......+++.|+|||.+.+..++.++|+||||+++|||++ |+.||......+.......
T Consensus 278 ~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~ 356 (401)
T cd05107 278 VKICDFGLARDIMRDSNYI-SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK 356 (401)
T ss_pred EEEEecCcceecccccccc-cCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHH
Confidence 9999999997654322111 1112246788999999998889999999999999999998 8899877655444444333
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042314 310 EDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQ 353 (370)
Q Consensus 310 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~ 353 (370)
.+.++..+..++..+.+++.+||..+|.+||+++++++.|+.+.
T Consensus 357 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 357 RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 44455566678899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=298.82 Aligned_cols=250 Identities=27% Similarity=0.458 Sum_probs=206.6
Q ss_pred cCCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEE
Q 042314 97 GGIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~ 168 (370)
..+|.|+||.||++... +..+++|.++... .......+.+|+.+++++ +||||+++++.+...+..+++|
T Consensus 41 ~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 118 (302)
T cd05055 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVIT 118 (302)
T ss_pred ceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEE
Confidence 34789999999998652 3468888876542 234567789999999999 7999999999999999999999
Q ss_pred eecCCCCHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccC
Q 042314 169 EYLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD 246 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 246 (370)
||+.+++|.++++... .++..++..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.......
T Consensus 119 e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 195 (302)
T cd05055 119 EYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS 195 (302)
T ss_pred EcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccCCC
Confidence 9999999999997643 3899999999999999999999998 9999999999999999999999999987654432
Q ss_pred ccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHH
Q 042314 247 SYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIK 325 (370)
Q Consensus 247 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 325 (370)
... ......++..|+|||.+.+..++.++||||+|+++|+|++ |..||..................+..+...++.+.
T Consensus 196 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (302)
T cd05055 196 NYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIY 274 (302)
T ss_pred cee-ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 211 1122245778999999999889999999999999999998 99999876655444333333344445556789999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042314 326 ALLRECWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 326 ~li~~~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
+++.+||..+|++||++.+++..|.++
T Consensus 275 ~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 275 DIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=312.71 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=202.3
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... ++.+|+|++.............+..|+.+++.++||||+++++++...+.+++||||++||+|
T Consensus 51 lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L 130 (370)
T cd05621 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL 130 (370)
T ss_pred EEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcH
Confidence 688999999999875 678999998654333334456678899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......... ......
T Consensus 131 ~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~--~~~~~~ 204 (370)
T cd05621 131 VNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV--RCDTAV 204 (370)
T ss_pred HHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCce--ecccCC
Confidence 9999765 6899999999999999999999998 999999999999999999999999999876433221 223446
Q ss_pred CCccccCcccccccC----CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCC--CCcHHHHHHHHH
Q 042314 257 GSYRYMAPEVYRRES----YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSS--LYPEPIKALLRE 330 (370)
Q Consensus 257 g~~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~ 330 (370)
||+.|+|||++.+.. ++.++|+||+||++|+|++|++||...+.......+.........+. .++..+++++.+
T Consensus 205 gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~ 284 (370)
T cd05621 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICA 284 (370)
T ss_pred CCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHH
Confidence 899999999987643 67899999999999999999999998877665555543322233333 468899999999
Q ss_pred hcccCCCC--CCCHHHHHHH
Q 042314 331 CWHKNPDR--RPTFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~--Rp~~~~ll~~ 348 (370)
||..++.+ |+++.+++++
T Consensus 285 ~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 285 FLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HccCchhccCCCCHHHHhcC
Confidence 99865544 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=301.26 Aligned_cols=244 Identities=25% Similarity=0.415 Sum_probs=203.5
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+|+|.+.............+.+|+.+++.++||||+++++.+...+.+++||||+.+++
T Consensus 7 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 86 (285)
T cd05605 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD 86 (285)
T ss_pred EEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCc
Confidence 3789999999999864 78899999876543334445667889999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 176 LHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 176 L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++........ ..
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~----~~ 159 (285)
T cd05605 87 LKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET----IR 159 (285)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc----cc
Confidence 99887653 46899999999999999999999998 99999999999999999999999999876543221 12
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh--hccCCCCCCCCCCcHHHHHHHHHh
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRR--AYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
...|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||............ .........+..+++.+.+++.+|
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05605 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239 (285)
T ss_pred cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence 346899999999999888999999999999999999999999876543222111 112233445566889999999999
Q ss_pred cccCCCCCC-----CHHHHHHH
Q 042314 332 WHKNPDRRP-----TFEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp-----~~~~ll~~ 348 (370)
|..||++|| ++++++++
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 240 LTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCCHHHhcCCCCCCHHHHhcC
Confidence 999999999 89999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=292.12 Aligned_cols=249 Identities=28% Similarity=0.533 Sum_probs=207.3
Q ss_pred CCCCCCcccEEEEEEc--Cc---eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWR--GT---EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~---~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|++|.||++... +. .+++|.+... ........+..|+.+++.++|||++++.+++...+..++||||++
T Consensus 12 ~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (268)
T cd05063 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME 89 (268)
T ss_pred EecCCCCccEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence 4889999999999764 32 5788887653 234456778999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 173 NGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 173 g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
+++|.+++... +.++...+..++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||++............
T Consensus 90 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 166 (268)
T cd05063 90 NGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT 166 (268)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccccccccee
Confidence 99999999764 57899999999999999999999998 999999999999999999999999998766543322222
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
......++.|+|||.+....++.++|+||||+++|||++ |+.||...........+. .....+.+..+|..+.+++.+
T Consensus 167 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~ 245 (268)
T cd05063 167 TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMDCPSAVYQLMLQ 245 (268)
T ss_pred ccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHH
Confidence 222234567999999988889999999999999999997 999998776665555544 233444455678999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
||..+|++||++.++++.|+++
T Consensus 246 c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 246 CWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HcCCCcccCcCHHHHHHHHHhh
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=293.82 Aligned_cols=249 Identities=26% Similarity=0.442 Sum_probs=202.6
Q ss_pred CCCCCCcccEEEEEEcCc----eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC------CceEEE
Q 042314 98 GIDPGAYGEVYLVKWRGT----EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS------ERLIFL 167 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~------~~~~~v 167 (370)
.+|.|+||.||++.+... .+++|.++... ........+..|+.+++.++||||+++++.+... ...+++
T Consensus 6 ~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v 84 (272)
T cd05075 6 TLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVI 84 (272)
T ss_pred ccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEE
Confidence 489999999999987532 47888876543 2344567889999999999999999999976432 356899
Q ss_pred EeecCCCCHHHHHHh------CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecccccee
Q 042314 168 TEYLRNGSLHDILKK------KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI 241 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~ 241 (370)
+||+.+++|.+++.. ...++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 85 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 85 LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccc
Confidence 999999999988742 234788999999999999999999988 99999999999999999999999999886
Q ss_pred ccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCC
Q 042314 242 AQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLY 320 (370)
Q Consensus 242 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (370)
........ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||............. .......+..+
T Consensus 162 ~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 239 (272)
T cd05075 162 IYNGDYYR-QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-QGNRLKQPPDC 239 (272)
T ss_pred cCccccee-cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence 65432211 1122245778999999999889999999999999999999 789998776655555443 33334455678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042314 321 PEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 321 ~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 240 LDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 89999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=293.65 Aligned_cols=249 Identities=26% Similarity=0.428 Sum_probs=205.9
Q ss_pred CCCCCCcccEEEEEEc-----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCc------eEE
Q 042314 98 GIDPGAYGEVYLVKWR-----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSER------LIF 166 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~------~~~ 166 (370)
.+|.|+||.||.+... +..+++|.++.... .......+.+|+..++.++||||+++++++..... .++
T Consensus 6 ~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05035 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMV 84 (273)
T ss_pred ccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEE
Confidence 4799999999999764 25699999875432 33445678999999999999999999998765443 799
Q ss_pred EEeecCCCCHHHHHHhC------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccce
Q 042314 167 LTEYLRNGSLHDILKKK------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK 240 (370)
Q Consensus 167 v~e~~~g~~L~~~l~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~ 240 (370)
++||+.+++|..++... ..++...+..++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++
T Consensus 85 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 161 (273)
T cd05035 85 ILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSK 161 (273)
T ss_pred EEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCcccee
Confidence 99999999999988542 35788999999999999999999998 9999999999999999999999999988
Q ss_pred eccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCC
Q 042314 241 IAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSL 319 (370)
Q Consensus 241 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (370)
......... .......+..|+|||.+.+..++.++||||||+++|||++ |.+||......+...... .+.....+..
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (273)
T cd05035 162 KIYSGDYYR-QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-HGNRLKQPED 239 (273)
T ss_pred ecccccccc-ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcC
Confidence 665433211 1112234678999999988889999999999999999999 889998777665554443 3445556777
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042314 320 YPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 320 ~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
++..+.+++.+||+.||++||++.++++.|+++
T Consensus 240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 240 CLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=298.96 Aligned_cols=258 Identities=29% Similarity=0.534 Sum_probs=212.1
Q ss_pred cCCCCCCcccEEEEEEc---------CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEE
Q 042314 97 GGIDPGAYGEVYLVKWR---------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIF 166 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~---------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~ 166 (370)
..+|.|+||.||++... ...+++|.++... .......+.+|+.+++.+ +||||+++++++...+..++
T Consensus 18 ~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 95 (314)
T cd05099 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV 95 (314)
T ss_pred eeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence 34899999999999752 3458888876532 234456788999999999 59999999999998889999
Q ss_pred EEeecCCCCHHHHHHhC----------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc
Q 042314 167 LTEYLRNGSLHDILKKK----------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH 230 (370)
Q Consensus 167 v~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~ 230 (370)
++||+.+++|.+++... ..++...+..++.|++.||.|||++| ++||||||+||+++.++.
T Consensus 96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~ 172 (314)
T cd05099 96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNV 172 (314)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCc
Confidence 99999999999999763 24788889999999999999999998 999999999999999999
Q ss_pred EEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhc
Q 042314 231 LKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAY 309 (370)
Q Consensus 231 ~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 309 (370)
+||+|||+++......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.............
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~- 250 (314)
T cd05099 173 MKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR- 250 (314)
T ss_pred EEEcccccccccccccccc-ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 9999999997664332211 1112234568999999988889999999999999999999 889998777665555443
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccCCC
Q 042314 310 EDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKTV 361 (370)
Q Consensus 310 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~~ 361 (370)
.......+..++..+.+++.+||..+|++||++.++++.|+++........+
T Consensus 251 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 302 (314)
T cd05099 251 EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYL 302 (314)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCce
Confidence 3334455667889999999999999999999999999999999887765543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=315.22 Aligned_cols=248 Identities=28% Similarity=0.437 Sum_probs=216.3
Q ss_pred EEeeecccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEE
Q 042314 90 CKILEDRGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFL 167 (370)
Q Consensus 90 ~~~L~~~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v 167 (370)
.+++....-||-|+||+||.|.+. ...||+|.+..+.....+--..+..|+.++++++|||++.+-++|......|+|
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 333444445999999999999875 667999999888777778889999999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccC
Q 042314 168 TEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD 246 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 246 (370)
||||-| |-.+++.-. +++.+.++..|..+.+.||+|||+.+ .||||||..|||+++.|.|||+|||.+....+..
T Consensus 105 MEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred HHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 999966 888888643 57889999999999999999999998 9999999999999999999999999988776544
Q ss_pred ccceeccCCCCCccccCccccc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHH
Q 042314 247 SYSYKMTGGTGSYRYMAPEVYR---RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEP 323 (370)
Q Consensus 247 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (370)
. .+|||.|||||++. .+.|+-++||||||++-.||...+||..+.+.......+.....+.-..+.++..
T Consensus 181 s-------FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~ 253 (948)
T KOG0577|consen 181 S-------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY 253 (948)
T ss_pred c-------ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHH
Confidence 3 47999999999984 5789999999999999999999999999998888777776443333334568899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 324 IKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 324 l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
|.+||..||++-|.+|||.++++++
T Consensus 254 F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 254 FRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHHHHHhhCcccCCcHHHHhhc
Confidence 9999999999999999999999876
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=308.32 Aligned_cols=240 Identities=25% Similarity=0.433 Sum_probs=195.7
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|+||.||++... ++.+++|.+... ........+.+|+.+++.++|+||+++++++...+.+++||||++++
T Consensus 80 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGN--HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhccCCCCeEEEEEEECCCCCEEEEEEEecC--CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 45899999999999875 789999998653 23456678899999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|... ...++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++........ ....
T Consensus 158 ~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~~~ 227 (353)
T PLN00034 158 SLEGT----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD---PCNS 227 (353)
T ss_pred ccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc---cccc
Confidence 98653 24567788899999999999999998 99999999999999999999999999886643321 1123
Q ss_pred CCCCccccCccccccc-----CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHhhccCCCCCCCCCCcHHHHHH
Q 042314 255 GTGSYRYMAPEVYRRE-----SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ--VADRRAYEDSRPALSSLYPEPIKAL 327 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~l 327 (370)
..||..|+|||.+... ..+.++|||||||++|||++|+.||....... ...........+..+..++..+.+|
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 307 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHF 307 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHH
Confidence 4689999999988532 23468999999999999999999997433211 1111111233445566788999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 042314 328 LRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 328 i~~~l~~~p~~Rp~~~~ll~~ 348 (370)
|.+||..||++||++.|++++
T Consensus 308 i~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 308 ISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999886
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=292.31 Aligned_cols=239 Identities=31% Similarity=0.586 Sum_probs=202.9
Q ss_pred CCCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEe-eCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK-HSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~-~~~~~~~v~e~~~g~~L 176 (370)
.+|.|++|.||++...|..+++|..+.. ...+.+.+|+.++++++|++++++++++. ..+..++++||+++++|
T Consensus 13 ~lg~g~~~~v~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L 87 (256)
T cd05082 13 TIGKGEFGDVMLGDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87 (256)
T ss_pred eecccCCCeEEEEEEcCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence 3788999999999999999999988543 23457889999999999999999999754 45678999999999999
Q ss_pred HHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++.+.+ .+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........ .
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~------~ 158 (256)
T cd05082 88 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------T 158 (256)
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCC------C
Confidence 99998653 4788999999999999999999998 99999999999999999999999999875543221 1
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
...+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...........+. ....+..+..+|+.+.+++.+||+
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 237 (256)
T cd05082 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPVVYDVMKQCWH 237 (256)
T ss_pred CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHhc
Confidence 234568999999998889999999999999999997 999998776655544443 234445567789999999999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~ 351 (370)
.+|++|||+.++++.|+.
T Consensus 238 ~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 238 LDAATRPSFLQLREQLEH 255 (256)
T ss_pred CChhhCcCHHHHHHHHhc
Confidence 999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=294.11 Aligned_cols=252 Identities=24% Similarity=0.512 Sum_probs=207.6
Q ss_pred cCCCCCCcccEEEEEEc--Cc----eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 97 GGIDPGAYGEVYLVKWR--GT----EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
..+|.|+||.||++.+. +. .+++|.++.. ........+.+|..+++.++||||+++++++.. ...++++||
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~ 89 (279)
T cd05109 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQL 89 (279)
T ss_pred eecCCCCCceEEEEEEecCCCccceEEEEEEecCC--CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEc
Confidence 34789999999999763 44 3788888653 334556778899999999999999999998865 457899999
Q ss_pred cCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 171 LRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 171 ~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+++|+|.+++... +.++...++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++........
T Consensus 90 ~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~- 165 (279)
T cd05109 90 MPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE- 165 (279)
T ss_pred CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccccce-
Confidence 9999999999764 56899999999999999999999998 999999999999999999999999998876533221
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.......+++.|+|||.+.+..++.++|||||||++|||++ |..||............. ....+..+..++..+.+++
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 244 (279)
T cd05109 166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGERLPQPPICTIDVYMIM 244 (279)
T ss_pred eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCcCCCCccCCHHHHHHH
Confidence 12222345678999999998889999999999999999998 899998766655444333 3334445567889999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 329 RECWHKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
.+||..||++||++.++++.|..+....
T Consensus 245 ~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 245 VKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 9999999999999999999998886654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=292.74 Aligned_cols=244 Identities=28% Similarity=0.531 Sum_probs=204.9
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|++|.||++... +..+++|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..++++||+.+++|
T Consensus 13 ~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 88 (261)
T cd05072 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSL 88 (261)
T ss_pred ecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcH
Confidence 3789999999999765 5668888875432 2356788999999999999999999999999999999999999999
Q ss_pred HHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++.+. ..++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......... ....
T Consensus 89 ~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 163 (261)
T cd05072 89 LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT--AREG 163 (261)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee--ccCC
Confidence 9998753 46788899999999999999999988 999999999999999999999999999876543211 1122
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..++..|+|||.+.+..++.++|+||||+++|+|++ |..||............. .....+....+|..+.+++.+||.
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 242 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENCPDELYDIMKTCWK 242 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcc
Confidence 345678999999988889999999999999999998 999998776665555443 233344445688999999999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~ 351 (370)
.+|++||+++++++.|++
T Consensus 243 ~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 243 EKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCcccCcCHHHHHHHHhc
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=294.46 Aligned_cols=251 Identities=24% Similarity=0.430 Sum_probs=208.0
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|++|.||++.. .+..+++|.+......+......+.+|+.+++.++||||+++++++...+..++++||+.++
T Consensus 8 ~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 87 (267)
T cd08229 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 87 (267)
T ss_pred hhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCC
Confidence 3488999999999985 58899999887654444556678899999999999999999999999999999999999999
Q ss_pred CHHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 175 SLHDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 175 ~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+|.+++.. ...+++..++.++.|++.|+.|||+++ ++|+||||+||+++.++.++|+|||++.........
T Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-- 162 (267)
T cd08229 88 DLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-- 162 (267)
T ss_pred CHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--
Confidence 99998864 346889999999999999999999998 999999999999999999999999998765443221
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAV--QVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ............+..+..+++.+.+++
T Consensus 163 -~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 241 (267)
T cd08229 163 -AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 241 (267)
T ss_pred -cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHH
Confidence 12235788999999998888999999999999999999999999755432 222222212222233445788999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFRLEAIQ 353 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l~~~~ 353 (370)
.+||..+|++|||+.++++.++++.
T Consensus 242 ~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 242 NMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHhcCCCcccCCCHHHHHHHHhhhc
Confidence 9999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=297.60 Aligned_cols=253 Identities=27% Similarity=0.525 Sum_probs=209.1
Q ss_pred cCCCCCCcccEEEEEEc---------CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEE
Q 042314 97 GGIDPGAYGEVYLVKWR---------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIF 166 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~---------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~ 166 (370)
..+|.|+||.||++... +..+++|.+... ........+.+|+.+++.+ +||||+++++.+......++
T Consensus 21 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 98 (304)
T cd05101 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 98 (304)
T ss_pred ceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEE
Confidence 34889999999999752 235888887643 2234456789999999999 79999999999999999999
Q ss_pred EEeecCCCCHHHHHHhCC----------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc
Q 042314 167 LTEYLRNGSLHDILKKKG----------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH 230 (370)
Q Consensus 167 v~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~ 230 (370)
+|||+.+++|.+++.+.. .++...+..++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~ 175 (304)
T cd05101 99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNV 175 (304)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCc
Confidence 999999999999997642 3677788999999999999999998 999999999999999999
Q ss_pred EEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhc
Q 042314 231 LKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAY 309 (370)
Q Consensus 231 ~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 309 (370)
+||+|||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+.........
T Consensus 176 ~kl~D~g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~- 253 (304)
T cd05101 176 MKIADFGLARDVNNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK- 253 (304)
T ss_pred EEECCCccceecccccccc-cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-
Confidence 9999999988665432211 1222345678999999988889999999999999999998 788888777666555543
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 310 EDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 310 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
.......+..++..+.+++.+||..+|++|||+.++++.|+++...-
T Consensus 254 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 254 EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 33344455678899999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=294.97 Aligned_cols=246 Identities=27% Similarity=0.494 Sum_probs=204.3
Q ss_pred cCCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEe
Q 042314 97 GGIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
..+|.|+||.||++... +..+++|.+... .......+.+|+++++.++|+||+++++++...+..++++|
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 11 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred cccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 44899999999998642 446777876542 34556789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCC---------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEe
Q 042314 170 YLRNGSLHDILKKKG---------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVT 234 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~---------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~ 234 (370)
|+.+++|.+++...+ .++...+..++.|++.|+.|||+.+ ++||||||+||++++++.+||+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEEC
Confidence 999999999987643 4788999999999999999999998 9999999999999999999999
Q ss_pred ccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCC
Q 042314 235 DFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSR 313 (370)
Q Consensus 235 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~ 313 (370)
|||++.......... ......+++.|+|||.+.+..++.++|+|||||++|+|++ |.+||............. ....
T Consensus 165 dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~ 242 (280)
T cd05092 165 DFGMSRDIYSTDYYR-VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT-QGRE 242 (280)
T ss_pred CCCceeEcCCCceee-cCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH-cCcc
Confidence 999987654332111 1112234678999999999999999999999999999998 899998776665554443 3334
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 314 PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 314 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
...+..+|+.+.+++.+||+.||.+||++.++++.|+
T Consensus 243 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 243 LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 4555678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=299.49 Aligned_cols=251 Identities=31% Similarity=0.523 Sum_probs=203.7
Q ss_pred cCCCCCCcccEEEEEEc--Cce--eEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeec
Q 042314 97 GGIDPGAYGEVYLVKWR--GTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~--vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
..+|.|+||.||++.+. +.. +++|.++.. ........+.+|+.++.++ +||||+++++++...+..++|+||+
T Consensus 13 ~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (303)
T cd05088 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 90 (303)
T ss_pred eeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeC
Confidence 34899999999999864 443 455555432 2344567788999999999 8999999999999999999999999
Q ss_pred CCCCHHHHHHhCC----------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEec
Q 042314 172 RNGSLHDILKKKG----------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTD 235 (370)
Q Consensus 172 ~g~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~D 235 (370)
++++|.+++.+.+ .++...++.++.|++.|+.|||+++ ++||||||+||+++.++.+||+|
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~d 167 (303)
T cd05088 91 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIAD 167 (303)
T ss_pred CCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCc
Confidence 9999999997542 4688899999999999999999998 99999999999999999999999
Q ss_pred cccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCC
Q 042314 236 FGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRP 314 (370)
Q Consensus 236 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 314 (370)
||++....... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||......+...... .....
T Consensus 168 fg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~ 242 (303)
T cd05088 168 FGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRL 242 (303)
T ss_pred cccCcccchhh----hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCcC
Confidence 99986332111 1111234668999999988888999999999999999998 999998776655544433 23334
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 315 ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 315 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
..+...++.+.+++.+||+.+|++||++++++..|..+...-.
T Consensus 243 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 243 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 4455678999999999999999999999999999988755443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=292.46 Aligned_cols=252 Identities=26% Similarity=0.448 Sum_probs=204.5
Q ss_pred cCCCCCCcccEEEEEEc--Cc----eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 97 GGIDPGAYGEVYLVKWR--GT----EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
..+|.|+||.||++.+. +. .+++|.+... ........+..|+..++.++||||+++++++. ....++++||
T Consensus 13 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~ 89 (279)
T cd05111 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQL 89 (279)
T ss_pred cccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEe
Confidence 45899999999999873 44 3566665432 22334467788888999999999999999875 4557889999
Q ss_pred cCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 171 LRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 171 ~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+.+|+|.+++... +.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++....... .
T Consensus 90 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~-~ 165 (279)
T cd05111 90 SPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK-K 165 (279)
T ss_pred CCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCc-c
Confidence 9999999999764 57899999999999999999999998 99999999999999999999999999986643321 1
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.......++..|+|||.+.+..++.++|+||||+++||+++ |..||............ .....+..+..++..+..++
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li 244 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERLAQPQICTIDVYMVM 244 (279)
T ss_pred cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcCCCCCCCCHHHHHHH
Confidence 12223346778999999998889999999999999999998 99999877655433333 23445555666788999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 329 RECWHKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
.+||..+|++|||+.++++.|..+.+..
T Consensus 245 ~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 245 VKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred HHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 9999999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=291.17 Aligned_cols=243 Identities=23% Similarity=0.429 Sum_probs=208.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.++.|++|.+|++... +..+++|.+...... ......+.+|+.+++.++||||+++++.+...+..++|+||+++++
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08529 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGD 85 (256)
T ss_pred EecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCc
Confidence 3788999999999774 788999988654322 4456778999999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 176 LHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 176 L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|.+++... ..++...++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......... ..
T Consensus 86 L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~---~~ 159 (256)
T cd08529 86 LHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF---AN 159 (256)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch---hh
Confidence 99999764 57889999999999999999999988 999999999999999999999999998766543221 12
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
...+++.|+|||.+.+..++.++|+||||+++|+|++|+.||............. ....+..+..++..+.+++.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLIDQCLT 238 (256)
T ss_pred ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHHHHcc
Confidence 3357889999999999889999999999999999999999998887655555443 344455566788999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~ 348 (370)
.+|++||++.+++++
T Consensus 239 ~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 239 KDYRQRPDTFQLLRN 253 (256)
T ss_pred CCcccCcCHHHHhhC
Confidence 999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=313.03 Aligned_cols=247 Identities=25% Similarity=0.369 Sum_probs=204.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+|+|++.............+..|..++..++||+|+++++.+...+.+++||||++||+
T Consensus 8 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~ 87 (360)
T cd05627 8 VIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGD 87 (360)
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCcc
Confidence 3789999999999774 78899999876433344556778899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc-------
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY------- 248 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------- 248 (370)
|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 88 L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~ 164 (360)
T cd05627 88 MMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT 164 (360)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccc
Confidence 9999998889999999999999999999999998 999999999999999999999999998654321100
Q ss_pred -------------------------ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH
Q 042314 249 -------------------------SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQV 303 (370)
Q Consensus 249 -------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~ 303 (370)
........||+.|+|||++.+..++.++|+|||||++|||++|++||........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~ 244 (360)
T cd05627 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244 (360)
T ss_pred cCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHH
Confidence 0001123689999999999999999999999999999999999999988877666
Q ss_pred HHHhhccCCCCCCC--CCCcHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 042314 304 ADRRAYEDSRPALS--SLYPEPIKALLRECWHKNPDRRPT---FEEIIFR 348 (370)
Q Consensus 304 ~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp~---~~~ll~~ 348 (370)
...+.........+ ..+++.+.++|.+++ .||.+|++ +.+++.+
T Consensus 245 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 245 YRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred HHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 55544322222222 236789999999977 49999985 6777766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=292.51 Aligned_cols=244 Identities=28% Similarity=0.504 Sum_probs=208.3
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|++|.||++... +..+++|.+.... ......+..|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 13 ~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (261)
T cd05148 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSL 89 (261)
T ss_pred hhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCH
Confidence 4799999999999875 5778888876542 23456788999999999999999999999999999999999999999
Q ss_pred HHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++.+. ..++...++.++.|++.|+.|||+++ ++|+||||+||+++.++.+||+|||.+........ ....
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~---~~~~ 163 (261)
T cd05148 90 LAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY---LSSD 163 (261)
T ss_pred HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc---cccC
Confidence 9999863 46889999999999999999999998 99999999999999999999999999876643321 1123
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..++..|+|||.+....++.++|+||||+++|+|++ |+.||............. .......+..+|+.+.+++.+||.
T Consensus 164 ~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~ 242 (261)
T cd05148 164 KKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIMLECWA 242 (261)
T ss_pred CCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHHHHHcC
Confidence 345778999999988889999999999999999998 899998777665555444 344555567889999999999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~ 351 (370)
.||++|||+.++++.|+.
T Consensus 243 ~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 243 AEPEDRPSFKALREELDN 260 (261)
T ss_pred CCchhCcCHHHHHHHHhc
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=290.31 Aligned_cols=243 Identities=30% Similarity=0.579 Sum_probs=203.2
Q ss_pred cCCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 97 GGIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
..+|.|++|.||++.+. +..+++|.+..... ....+.+|+.+++.++||||+++++++...+..++|+||++|++
T Consensus 10 ~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 10 KELGSGQFGVVHLGKWRGKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred hhhccCCCceEEEeEecCCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 34889999999999876 44789998764322 23457789999999999999999999999999999999999999
Q ss_pred HHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++..+ ..+++..++.++.|++.|+.|||+++ ++||||||+||+++.++.+||+|||+++........ ....
T Consensus 86 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~--~~~~ 160 (256)
T cd05059 86 LLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT--SSQG 160 (256)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc--ccCC
Confidence 99998764 46889999999999999999999998 999999999999999999999999998765432211 1111
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..++..|+|||.+.+..++.++|+||||+++|+|++ |+.||............. .......+..+|..+.+++.+||.
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~ 239 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMYSCWH 239 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhc
Confidence 224568999999998889999999999999999999 899998776665555443 344455566789999999999999
Q ss_pred cCCCCCCCHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRL 349 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l 349 (370)
.+|++|||+.++++.|
T Consensus 240 ~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 240 EKPEDRPAFKKLLSQL 255 (256)
T ss_pred CChhhCcCHHHHHHHh
Confidence 9999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=295.66 Aligned_cols=251 Identities=31% Similarity=0.492 Sum_probs=206.8
Q ss_pred CCCCCCcccEEEEEEc--Cc--eeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWR--GT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|+||.||++... +. .+++|.++.. ......+.+.+|+.+++++ +||||+++++++...+..++++||++
T Consensus 9 ~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 4799999999999764 22 3577776532 2334456789999999999 79999999999999899999999999
Q ss_pred CCCHHHHHHhCC----------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 042314 173 NGSLHDILKKKG----------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDF 236 (370)
Q Consensus 173 g~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Df 236 (370)
+++|.+++.+.. .++...++.++.|++.||.|||+++ ++||||||+||+++.++.+||+||
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~df 163 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADF 163 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCc
Confidence 999999997542 4778899999999999999999988 999999999999999999999999
Q ss_pred ccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCC
Q 042314 237 GLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPA 315 (370)
Q Consensus 237 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 315 (370)
|++....... .......+..|+|||.+.+..++.++||||||+++|+|++ |..||............. ......
T Consensus 164 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~-~~~~~~ 238 (297)
T cd05089 164 GLSRGEEVYV----KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRME 238 (297)
T ss_pred CCCcccccee----ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCC
Confidence 9986332111 1111123567999999988889999999999999999997 999998877766555443 334445
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhcc
Q 042314 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQK 358 (370)
Q Consensus 316 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~ 358 (370)
.+..+|..+.+++.+||+.+|.+|||++++++.|..+......
T Consensus 239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 5667899999999999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=294.61 Aligned_cols=247 Identities=28% Similarity=0.492 Sum_probs=206.8
Q ss_pred cCCCCCCcccEEEEEEcC-------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEe
Q 042314 97 GGIDPGAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g-------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
..+|.|+||.||++...+ ..+++|.+... ........+.+|+.+++.++||||+++++++......++|||
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 89 (277)
T cd05032 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVME 89 (277)
T ss_pred eEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc--cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEe
Confidence 347899999999987653 56899987643 233445678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCC----------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccc
Q 042314 170 YLRNGSLHDILKKKG----------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLS 239 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~----------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~ 239 (370)
|+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~ 166 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccc
Confidence 999999999987532 3577889999999999999999998 999999999999999999999999998
Q ss_pred eeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCC
Q 042314 240 KIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSS 318 (370)
Q Consensus 240 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 318 (370)
+......... ......++..|+|||.+.+..++.++||||||+++||+++ |..||............. .......+.
T Consensus 167 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 244 (277)
T cd05032 167 RDIYETDYYR-KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGGHLDLPE 244 (277)
T ss_pred hhhccCcccc-cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCCCCCCCC
Confidence 7654432211 1222346788999999988889999999999999999998 899998777666555544 444556677
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 319 LYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 319 ~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
.+|..+.+++.+||..+|++|||+.+++..|+
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 245 NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 78999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=297.07 Aligned_cols=249 Identities=30% Similarity=0.563 Sum_probs=207.2
Q ss_pred CCCCCCcccEEEEEEcC-------ceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEe
Q 042314 98 GIDPGAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g-------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
.+|.|++|.||++...+ ..+++|.+... ........+.+|+.+++++ +||||+++++++...+..+++||
T Consensus 19 ~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e 96 (293)
T cd05053 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE 96 (293)
T ss_pred EecccccccEEEEEEecCCCCCCceeEEEEEccCC--CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence 37899999999997642 46888888654 2234456788999999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHHhC----------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEE
Q 042314 170 YLRNGSLHDILKKK----------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKV 233 (370)
Q Consensus 170 ~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl 233 (370)
|+.+++|..+++.. +.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL 173 (293)
T cd05053 97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKI 173 (293)
T ss_pred eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEe
Confidence 99999999999642 35788899999999999999999998 999999999999999999999
Q ss_pred eccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCC
Q 042314 234 TDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDS 312 (370)
Q Consensus 234 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 312 (370)
+|||+++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+...... ...
T Consensus 174 ~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~ 251 (293)
T cd05053 174 ADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK-EGY 251 (293)
T ss_pred Ccccccccccccccee-ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH-cCC
Confidence 9999988665432211 1122235678999999988889999999999999999997 899998777665554443 334
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042314 313 RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQ 353 (370)
Q Consensus 313 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~ 353 (370)
.+..+...+..+.+++.+||..||++|||+.++++.|+.+.
T Consensus 252 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 252 RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 44556677899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=309.26 Aligned_cols=245 Identities=25% Similarity=0.381 Sum_probs=202.0
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+|+|++.............+..|..+++.++||||+++++.+...+..++||||++||+|
T Consensus 51 lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L 130 (371)
T cd05622 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL 130 (371)
T ss_pred EeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcH
Confidence 788999999999875 678999998654333334456678899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ......
T Consensus 131 ~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~--~~~~~~ 204 (371)
T cd05622 131 VNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV--RCDTAV 204 (371)
T ss_pred HHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc--cccCcc
Confidence 9998765 6899999999999999999999998 999999999999999999999999999866433211 223446
Q ss_pred CCccccCcccccccC----CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC--CCCCCCcHHHHHHHHH
Q 042314 257 GSYRYMAPEVYRRES----YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP--ALSSLYPEPIKALLRE 330 (370)
Q Consensus 257 g~~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~ 330 (370)
||+.|+|||++.+.. ++.++|||||||++|||++|.+||...........+....... +....++..+.++|.+
T Consensus 205 gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 284 (371)
T cd05622 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA 284 (371)
T ss_pred cCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHH
Confidence 899999999987543 7889999999999999999999999887766655554322222 2234688999999999
Q ss_pred hcccCCCC--CCCHHHHHHHH
Q 042314 331 CWHKNPDR--RPTFEEIIFRL 349 (370)
Q Consensus 331 ~l~~~p~~--Rp~~~~ll~~l 349 (370)
||..++.+ |+++.+++++.
T Consensus 285 ~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 285 FLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HcCChhhhcCCCCHHHHhcCc
Confidence 99844433 78999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=292.38 Aligned_cols=243 Identities=26% Similarity=0.451 Sum_probs=209.1
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|++|.||++... +..+++|.+...........+.+.+|+.+++.++||||+++++.+...+..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 578999999999887 889999998766545555668899999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.+...++...+..++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~----~~~~~ 153 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK----TWTFC 153 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc----ccccc
Confidence 999998878999999999999999999999988 99999999999999999999999999876654321 12235
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT--AVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.... .................+...++.+.++|.+||..
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR 233 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence 7889999999988889999999999999999999999998776 44444444322344555666689999999999999
Q ss_pred CCCCCCC-----HHHHHHH
Q 042314 335 NPDRRPT-----FEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~-----~~~ll~~ 348 (370)
+|++||+ +.|++++
T Consensus 234 ~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 234 NPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred ChhhCcCCcccCHHHHhcC
Confidence 9999999 7887763
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=292.48 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=208.7
Q ss_pred cCCCCCCcccEEEEEEcC------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee-CCceEEEEe
Q 042314 97 GGIDPGAYGEVYLVKWRG------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH-SERLIFLTE 169 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~-~~~~~~v~e 169 (370)
..+++|+||.||++.... ..+++|.+... ........+.+|+.+++.++||||+++++++.. ....++++|
T Consensus 12 ~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred eeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEE
Confidence 347899999999998753 66888887643 345566778999999999999999999998765 567899999
Q ss_pred ecCCCCHHHHHHhC--------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecccccee
Q 042314 170 YLRNGSLHDILKKK--------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI 241 (370)
Q Consensus 170 ~~~g~~L~~~l~~~--------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~ 241 (370)
|+.+++|.+++... ..++...+..++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++.
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~ 166 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRD 166 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCccc
Confidence 99999999998763 35789999999999999999999998 99999999999999999999999999976
Q ss_pred ccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCC
Q 042314 242 AQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLY 320 (370)
Q Consensus 242 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (370)
........ ......++..|+|||.+.+..++.++||||||+++|++++ |++||............. .......+..+
T Consensus 167 ~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 244 (280)
T cd05043 167 LFPMDYHC-LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-DGYRLAQPINC 244 (280)
T ss_pred ccCCceEE-eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-cCCCCCCCCcC
Confidence 54332211 1122245678999999988889999999999999999998 999998877666554433 23344445567
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042314 321 PEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 321 ~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
|+.+.+++.+||..+|++|||+.+++..|+.+.+.
T Consensus 245 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 245 PDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 89999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=323.37 Aligned_cols=254 Identities=22% Similarity=0.351 Sum_probs=206.0
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... ++.+|+|.+...........+++.+|+.+++.++||||+++++++...+..++||||++|++|
T Consensus 10 LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL 89 (932)
T PRK13184 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTL 89 (932)
T ss_pred EecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCH
Confidence 688999999999774 788999999876555666778899999999999999999999999999999999999999999
Q ss_pred HHHHHhC-----------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceecccc
Q 042314 177 HDILKKK-----------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEK 245 (370)
Q Consensus 177 ~~~l~~~-----------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 245 (370)
.+++... ...+...++.++.|+++||.|||+++ |+||||||+||+++.++.++|+|||++......
T Consensus 90 ~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~ 166 (932)
T PRK13184 90 KSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLE 166 (932)
T ss_pred HHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceecccc
Confidence 9988642 23455678899999999999999998 999999999999999999999999999866211
Q ss_pred Ccc---------------ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc
Q 042314 246 DSY---------------SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE 310 (370)
Q Consensus 246 ~~~---------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 310 (370)
... ........||+.|+|||.+.+..++.++||||+||++|||++|+.||...............
T Consensus 167 ~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~ 246 (932)
T PRK13184 167 EEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVIL 246 (932)
T ss_pred cccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhcc
Confidence 100 00111235899999999999999999999999999999999999999875544333222111
Q ss_pred CC-CCCCCCCCcHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHHH
Q 042314 311 DS-RPALSSLYPEPIKALLRECWHKNPDRRP-TFEEIIFRLEAIQES 355 (370)
Q Consensus 311 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rp-~~~~ll~~l~~~~~~ 355 (370)
.. .......+|+.+.+++.+||..||++|| +++++++.|+.....
T Consensus 247 ~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 247 SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 1112246789999999999999999996 577788888877554
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=291.76 Aligned_cols=247 Identities=30% Similarity=0.498 Sum_probs=207.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCC------hHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEe
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASN------PRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~------~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
.+|.|++|.||.+... +..+++|.+....... ....+.+.+|+.++++++||||+++++++...+..++++|
T Consensus 7 ~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (267)
T cd06628 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLE 86 (267)
T ss_pred eeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEE
Confidence 4788999999999764 6789999886543222 1344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 170 YLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
|+++++|.+++.+.+.++...+..++.|++.||.|||+++ ++||||+|+||++++++.++|+|||+++.........
T Consensus 87 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06628 87 YVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST 163 (267)
T ss_pred ecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccccccccC
Confidence 9999999999998888999999999999999999999998 9999999999999999999999999987665321111
Q ss_pred ---eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHH
Q 042314 250 ---YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKA 326 (370)
Q Consensus 250 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 326 (370)
.......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||............. ....+..+..++..+.+
T Consensus 164 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 242 (267)
T cd06628 164 KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG-ENASPEIPSNISSEAID 242 (267)
T ss_pred CccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh-ccCCCcCCcccCHHHHH
Confidence 01122347889999999998889999999999999999999999998766544433332 24455666778999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 042314 327 LLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 327 li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+|++||+.||.+||++.+++++
T Consensus 243 li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 243 FLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHHHHccCCchhCcCHHHHhhC
Confidence 9999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=289.62 Aligned_cols=250 Identities=26% Similarity=0.523 Sum_probs=201.0
Q ss_pred CCCCCcccEEEEEEc-----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEe-eCCceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKWR-----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK-HSERLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~-~~~~~~~v~e~~~ 172 (370)
+|.|+||.||++.+. ...+++|.+... ........+.+|+.+++.++||||+++++++. .++..++++||+.
T Consensus 3 lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred ccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 789999999999753 245888877532 33445677889999999999999999999765 4556899999999
Q ss_pred CCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce-
Q 042314 173 NGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY- 250 (370)
Q Consensus 173 g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~- 250 (370)
+++|.+++.+. ...+...+..++.|+++|+.|||+.+ ++||||||+||++++++.+||+|||+++..........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999764 35677788899999999999999998 99999999999999999999999999875543221111
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG-GPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
......++..|+|||.+.+..++.++||||||+++|||++| .+||............. ....+..+..+|+.+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 236 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL-QGRRLLQPEYCPDPLYEVML 236 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHHHH
Confidence 11122457789999999888899999999999999999995 66676666555444332 33444455667899999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIFRLEAIQE 354 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~l~~~~~ 354 (370)
+||..+|++||++.+++..|+++..
T Consensus 237 ~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 237 SCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHcCCChhhCCCHHHHHHHHHHHhc
Confidence 9999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=290.09 Aligned_cols=249 Identities=24% Similarity=0.450 Sum_probs=207.8
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|++|.||++... |..+++|.++............+.+|+.++++++|++++++++.+...+..++||||+++++
T Consensus 9 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (267)
T cd08224 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGD 88 (267)
T ss_pred eeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCC
Confidence 3789999999999875 88899999876544555567789999999999999999999999999999999999999999
Q ss_pred HHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 176 LHDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 176 L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
|.+++.. ...++...+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 89 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--- 162 (267)
T cd08224 89 LSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--- 162 (267)
T ss_pred HHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCcc---
Confidence 9998864 245789999999999999999999998 999999999999999999999999998765433211
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHhhccCCCCCCCC-CCcHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA--VQVADRRAYEDSRPALSS-LYPEPIKALL 328 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~l~~li 328 (370)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ........ ....++.+. .++..+.+++
T Consensus 163 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i 241 (267)
T cd08224 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPLPADHYSEELRDLV 241 (267)
T ss_pred cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cCCCCCCChhhcCHHHHHHH
Confidence 1223578899999999988899999999999999999999999865432 22222222 222333333 6788999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFRLEAIQ 353 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l~~~~ 353 (370)
.+||..+|++|||+.++++.|+++.
T Consensus 242 ~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 242 SRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHcCCCcccCCCHHHHHHHHHHhc
Confidence 9999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=290.04 Aligned_cols=246 Identities=30% Similarity=0.524 Sum_probs=201.0
Q ss_pred CCCCCCcccEEEEEEcC--c--eeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWRG--T--EIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g--~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|+||.||++...+ . .+++|.++.. ........+.+|+.+++++ +||||+++++++...+..++||||+.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 37899999999998753 3 3567776532 2334556788999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHhCC----------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 042314 173 NGSLHDILKKKG----------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDF 236 (370)
Q Consensus 173 g~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Df 236 (370)
+++|.+++.+.. .++...++.++.|++.|++|||+.+ ++||||||+||+++.++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence 999999997643 4678899999999999999999988 999999999999999999999999
Q ss_pred ccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCC
Q 042314 237 GLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPA 315 (370)
Q Consensus 237 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 315 (370)
|++....... .......+..|+|||.+....++.++|+||||+++|+|++ |..||............. ......
T Consensus 157 gl~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~ 231 (270)
T cd05047 157 GLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLE 231 (270)
T ss_pred CCccccchhh----hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-CCCCCC
Confidence 9975322111 1111234567999999988889999999999999999997 999998766655444433 233444
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042314 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQ 353 (370)
Q Consensus 316 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~ 353 (370)
.+...+..+.+++.+||..+|.+|||+.+++..|+.+.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 55567889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=285.90 Aligned_cols=245 Identities=28% Similarity=0.501 Sum_probs=204.4
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|++|.||++... +..+++|.+.... .......+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3789999999999764 6678999876542 334556788999999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 177 HDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 177 ~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
.+++... ..+++..+..++.|++.+|.|+|+++ ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~ 154 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS--SSGLK 154 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc--cCCCC
Confidence 9998754 46789999999999999999999998 999999999999999999999999998754332111 11112
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.+++.|+|||.+.+..++.++|+||||+++|++++ |..||............. ...+...+..+|..+.+++.+||..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 233 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDY 233 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccc
Confidence 34668999999998889999999999999999998 999998776655544443 3444455667889999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 042314 335 NPDRRPTFEEIIFRLE 350 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~l~ 350 (370)
+|++||++.++++.|.
T Consensus 234 ~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 234 KPENRPKFSELQKELA 249 (250)
T ss_pred CcccCCCHHHHHHHhc
Confidence 9999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=290.52 Aligned_cols=242 Identities=29% Similarity=0.429 Sum_probs=196.2
Q ss_pred eeecccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC-----ce
Q 042314 92 ILEDRGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE-----RL 164 (370)
Q Consensus 92 ~L~~~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~-----~~ 164 (370)
.+.....+|.|+||.||.+... +..+|+|....... .-.+|+.+|+.++|||||++.-+|.... ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 3445566999999999999765 67899998765422 2247999999999999999999886432 45
Q ss_pred EEEEeecCCCCHHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC-CcEEEeccccc
Q 042314 165 IFLTEYLRNGSLHDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA-GHLKVTDFGLS 239 (370)
Q Consensus 165 ~~v~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~-~~~kl~Dfg~~ 239 (370)
.+||||++. +|.++++. +.+++...+.-++.||++||.|||+.| |+||||||.|+|||.+ |.+||||||.|
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcc
Confidence 789999977 99999884 568999999999999999999999988 9999999999999965 89999999999
Q ss_pred eeccccCccceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC-----
Q 042314 240 KIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR----- 313 (370)
Q Consensus 240 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~----- 313 (370)
+.+..+.... ..+-|.-|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+.+..+....+......
T Consensus 174 K~L~~~epni----SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 174 KVLVKGEPNI----SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred eeeccCCCce----eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9887654322 12347789999999875 5899999999999999999999999988766544333211000
Q ss_pred -------------C---------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 -------------P---------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 -------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+ ......+++..+|+.++|..+|.+|.++.+++.+
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1 0234578899999999999999999999999865
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=297.88 Aligned_cols=242 Identities=29% Similarity=0.457 Sum_probs=191.8
Q ss_pred CCCCCCcccEEEEEEc---CceeEEEEeccccCCChHHHHHHHHHHHHHHhc---CCCceeeeeeeEe-----eCCceEE
Q 042314 98 GIDPGAYGEVYLVKWR---GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL---RHPNIVQFLGVLK-----HSERLIF 166 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~---g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l---~hp~Iv~~~~~~~-----~~~~~~~ 166 (370)
.+|.|+||.||++... +..+|+|.++...... .....+.+|+.+++.+ +||||+++++++. ....+++
T Consensus 8 ~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~l 86 (290)
T cd07862 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 86 (290)
T ss_pred EeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEE
Confidence 3789999999999763 5679999887643222 2234455677766665 6999999999875 2456899
Q ss_pred EEeecCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccc
Q 042314 167 LTEYLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQE 244 (370)
Q Consensus 167 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 244 (370)
|+||+.+ +|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 87 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T cd07862 87 VFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF 162 (290)
T ss_pred EEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccC
Confidence 9999964 999988764 35889999999999999999999998 99999999999999999999999999876543
Q ss_pred cCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC---C--------
Q 042314 245 KDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS---R-------- 313 (370)
Q Consensus 245 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~-------- 313 (370)
.. ......+|+.|+|||.+.+..++.++|||||||++|||++|++||...........+..... .
T Consensus 163 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (290)
T cd07862 163 QM----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238 (290)
T ss_pred Cc----ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence 31 12334589999999999888899999999999999999999999988766554433321100 0
Q ss_pred --------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 --------------PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 --------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
......+++.+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00112467789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=296.37 Aligned_cols=243 Identities=24% Similarity=0.405 Sum_probs=201.9
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... ++.+++|.+.............+..|+.+++.++|++|+.+++.+...+..++||||+.|++
T Consensus 7 ~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 86 (285)
T cd05630 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD 86 (285)
T ss_pred EeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCc
Confidence 3789999999998875 77899999876544444455667889999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 176 LHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 176 L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........ ..
T Consensus 87 L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~----~~ 159 (285)
T cd05630 87 LKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT----IK 159 (285)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc----cc
Confidence 99988644 35889999999999999999999998 99999999999999999999999999876543221 12
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAV---QVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
...|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...... ...... ........+..+++.+.+|+.+
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ 238 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL-VKEVQEEYSEKFSPDARSLCKM 238 (285)
T ss_pred CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh-hhhhhhhcCccCCHHHHHHHHH
Confidence 336899999999999989999999999999999999999999865321 111111 1122234456688999999999
Q ss_pred hcccCCCCCCC-----HHHHHHH
Q 042314 331 CWHKNPDRRPT-----FEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~Rp~-----~~~ll~~ 348 (370)
||+.||++||| +.+++++
T Consensus 239 ~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 239 LLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HhhcCHHHccCCCCCchHHHHcC
Confidence 99999999999 8899884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=293.01 Aligned_cols=243 Identities=24% Similarity=0.381 Sum_probs=198.7
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++.. .+..+++|++..... .....+.+|+.++++++||||+++++.+...+..++|+||+++++
T Consensus 16 ~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~ 92 (267)
T cd06646 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGS 92 (267)
T ss_pred eeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCc
Confidence 378899999999986 477899999865422 233467889999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++...+.+++..+..++.|++.|+.|||+.+ |+||||+|+||+++.++.++|+|||++........ .....
T Consensus 93 L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~---~~~~~ 166 (267)
T cd06646 93 LQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA---KRKSF 166 (267)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc---ccCcc
Confidence 9999988888999999999999999999999998 99999999999999999999999999876643211 11223
Q ss_pred CCCccccCccccc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC---CCCCCCCcHHHHHHHH
Q 042314 256 TGSYRYMAPEVYR---RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR---PALSSLYPEPIKALLR 329 (370)
Q Consensus 256 ~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~ 329 (370)
.+++.|+|||.+. ...++.++|+||+|+++|+|++|+.||.................. ......++..+.++++
T Consensus 167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (267)
T cd06646 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVK 246 (267)
T ss_pred ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHH
Confidence 5788999999884 345778999999999999999999998765543332222111111 1223357889999999
Q ss_pred HhcccCCCCCCCHHHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~l 349 (370)
+||..+|++||+++++++++
T Consensus 247 ~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 247 ISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHhhCChhhCcCHHHHhcCC
Confidence 99999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=290.95 Aligned_cols=248 Identities=26% Similarity=0.446 Sum_probs=206.2
Q ss_pred CCCCCCcccEEEEEE-cCceeEEEEeccccCC---ChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKW-RGTEIAAKTIRSSIAS---NPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~-~g~~vavK~l~~~~~~---~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
.+|.|+||.||++.. .+..+++|.+...... .......+.+|+++++.++|+||+++++++...+..++++||+++
T Consensus 7 ~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (265)
T cd06631 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPG 86 (265)
T ss_pred eEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCC
Confidence 378899999999876 4777999988654321 233456789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccC---ccce
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD---SYSY 250 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~ 250 (370)
++|.+++.+.+.+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 87 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (265)
T cd06631 87 GSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSN 163 (265)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccc
Confidence 999999988888999999999999999999999998 9999999999999999999999999887553211 1111
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-cCCCCCCCCCCcHHHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY-EDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~ 329 (370)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.............. ....+..+..++..+.++++
T Consensus 164 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 243 (265)
T cd06631 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVT 243 (265)
T ss_pred cccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHH
Confidence 12234578899999999988899999999999999999999999987655443332221 23445567778999999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~ 348 (370)
+||..+|++||++.+++.+
T Consensus 244 ~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 244 SCLTRDQHERPSALQLLRH 262 (265)
T ss_pred HHhcCCcccCCCHHHHhcC
Confidence 9999999999999999763
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=286.55 Aligned_cols=246 Identities=32% Similarity=0.551 Sum_probs=206.0
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|++|.||++... ++.+++|.+..... ......+.+|+.++++++||||+++++++......++|+||+.+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 3789999999999876 78899998865432 24567889999999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 177 HDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 177 ~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
.+++... ..++...+..++.+++.++.|||+++ ++||||+|+||+++.++.++|+|||++........ .......
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 155 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-TVSDGLK 155 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc-eeccccC
Confidence 9999764 46788999999999999999999998 99999999999999999999999999876542211 1111112
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
..+..|+|||.+.+..++.++|+||||+++|+|++ |..||............. .......+...|..+.+++.+||..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 234 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-SGYRMPAPQLCPEEIYRLMLQCWAY 234 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHhcc
Confidence 23567999999988889999999999999999999 888887776655544443 2334445667889999999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 042314 335 NPDRRPTFEEIIFRLE 350 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~l~ 350 (370)
+|++||++.++++.|+
T Consensus 235 ~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 235 DPENRPSFSEIYNELQ 250 (251)
T ss_pred ChhhCcCHHHHHHHhh
Confidence 9999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=288.99 Aligned_cols=249 Identities=27% Similarity=0.535 Sum_probs=206.9
Q ss_pred CCCCCCcccEEEEEEcC-----ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g-----~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|++|.||++.... ..+++|..... ......+.+.+|+.+++.++||||+++++++.. +..++||||++
T Consensus 13 ~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~ 89 (270)
T cd05056 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAP 89 (270)
T ss_pred eeCCccceeEEEEEEecCCCCCcceEEEecCCc--CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCC
Confidence 37899999999997643 35788877543 224566789999999999999999999998865 45789999999
Q ss_pred CCCHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 173 NGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 173 g~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
+++|.+++.+.. .++...++.++.|++.||.|||+.+ ++|+||||+||+++..+.++|+|||++......... .
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~ 164 (270)
T cd05056 90 LGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY--K 164 (270)
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccccce--e
Confidence 999999998753 5899999999999999999999998 999999999999999999999999998766543221 1
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
.....++..|+|||.+....++.++|+||||+++|++++ |..||............. .......+..+|..+.+++.+
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 243 (270)
T cd05056 165 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLMTK 243 (270)
T ss_pred cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHH
Confidence 222234568999999988889999999999999999986 999998777655544433 334455667789999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
||..+|++|||+.+++..|+.+..+
T Consensus 244 ~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 244 CWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HcCCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=289.04 Aligned_cols=249 Identities=29% Similarity=0.537 Sum_probs=206.6
Q ss_pred CCCCCCcccEEEEEEc--C---ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWR--G---TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g---~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|+||.||++... + ..+++|.+... ........+..|+.+++.++||||+++++++......++||||+.
T Consensus 11 ~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T cd05065 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME 88 (269)
T ss_pred EecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence 3789999999999875 2 35899988654 235566789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce-
Q 042314 173 NGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY- 250 (370)
Q Consensus 173 g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~- 250 (370)
+++|.+++... +.++...++.++.|++.|+.|||+++ ++|+||||+||+++.++.++|+|||++...........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 165 (269)
T cd05065 89 NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 165 (269)
T ss_pred CCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCcccccc
Confidence 99999998764 56899999999999999999999998 99999999999999999999999999876543322111
Q ss_pred -eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 251 -KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 251 -~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
...+...+..|+|||.+.+..++.++|+||+|+++||+++ |..||...........+. .....+.+..+|..+.+++
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li 244 (269)
T cd05065 166 TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTALHQLM 244 (269)
T ss_pred ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCHHHHHHH
Confidence 1111122457999999998889999999999999999886 999998777665555443 2334444566889999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
.+||..+|++||++.+++..|+++
T Consensus 245 ~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 245 LDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHcCCChhhCcCHHHHHHHHHhh
Confidence 999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=294.23 Aligned_cols=248 Identities=30% Similarity=0.475 Sum_probs=202.8
Q ss_pred cCCCCCCcccEEEEEEcC------------------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeE
Q 042314 97 GGIDPGAYGEVYLVKWRG------------------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g------------------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~ 158 (370)
..+|.|+||.||++.... ..+++|.+.... .......+.+|+.++++++||||+++++++
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 88 (296)
T cd05051 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNIARLLGVC 88 (296)
T ss_pred ccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 348999999999987642 347888876542 235667889999999999999999999999
Q ss_pred eeCCceEEEEeecCCCCHHHHHHhCC-----------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC
Q 042314 159 KHSERLIFLTEYLRNGSLHDILKKKG-----------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE 227 (370)
Q Consensus 159 ~~~~~~~~v~e~~~g~~L~~~l~~~~-----------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~ 227 (370)
...+..++++|++.+++|.+++.+.. .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~ 165 (296)
T cd05051 89 TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGK 165 (296)
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecC
Confidence 99999999999999999999998765 6899999999999999999999998 999999999999999
Q ss_pred CCcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh--CCCCCCCCcHHHHHH
Q 042314 228 AGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ--GGPSNRADTAVQVAD 305 (370)
Q Consensus 228 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~--g~~p~~~~~~~~~~~ 305 (370)
++.++|+|||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++ +..||..........
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~ 244 (296)
T cd05051 166 NYTIKIADFGMSRNLYSSDYYR-VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIE 244 (296)
T ss_pred CCceEEccccceeecccCccee-ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHH
Confidence 9999999999987654332211 1122345778999999988889999999999999999998 678887665554433
Q ss_pred Hhhcc------CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 306 RRAYE------DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 306 ~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
..... ......+..+|.++.+++.+||+.||++|||+.++++.|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 245 NAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 33211 1112234457789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=292.26 Aligned_cols=251 Identities=28% Similarity=0.512 Sum_probs=201.6
Q ss_pred cCCCCCCcccEEEEEE------cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC--CceEEEE
Q 042314 97 GGIDPGAYGEVYLVKW------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS--ERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~------~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~--~~~~~v~ 168 (370)
..+|+|+||.||.+.. .+..+++|.++.. ........+.+|+.+++.++||||+++++++... ...++||
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05079 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 87 (284)
T ss_pred eecCCCCceeEEEEEEccCCCCccceEEEEEcCcc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEE
Confidence 3489999999999874 3677999998653 2345567799999999999999999999988765 5689999
Q ss_pred eecCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 169 EYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 169 e~~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
||++|++|.+++.+. ..++...+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++........
T Consensus 88 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05079 88 EFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 164 (284)
T ss_pred EccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccccCcc
Confidence 999999999999765 35899999999999999999999998 99999999999999999999999999887654332
Q ss_pred cceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH--------------HHHHHHhhccCCC
Q 042314 248 YSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA--------------VQVADRRAYEDSR 313 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--------------~~~~~~~~~~~~~ 313 (370)
.........++..|+|||.+.+..++.++||||||+++|+|+++..|+..... .............
T Consensus 165 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
T cd05079 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244 (284)
T ss_pred ceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCcc
Confidence 21112233467789999999888899999999999999999998766432111 0111111112333
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042314 314 PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 314 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
.+.+..+|..+.+|+.+||+.+|++||++.++++.++.+
T Consensus 245 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 245 LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 445567889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=306.23 Aligned_cols=244 Identities=27% Similarity=0.423 Sum_probs=199.2
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC-----ceEEEEee
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE-----RLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~-----~~~~v~e~ 170 (370)
.+|.|+||.||++.. .++.+|+|.+.... .+......+.+|+.+++.++||||+++++++...+ ..++|+||
T Consensus 7 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 85 (372)
T cd07853 7 PIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTEL 85 (372)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeec
Confidence 489999999999985 48899999886543 23344567889999999999999999999988766 78999999
Q ss_pred cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 171 LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 171 ~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+. ++|.+++...+.++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-- 159 (372)
T cd07853 86 MQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-- 159 (372)
T ss_pred cc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCccc--
Confidence 96 489998888788999999999999999999999998 999999999999999999999999999765433221
Q ss_pred eccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--------------------
Q 042314 251 KMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY-------------------- 309 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-------------------- 309 (370)
......+++.|+|||.+.+. .++.++||||+||++|||++|++||...........+..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 22334578899999998874 478999999999999999999999987665443322211
Q ss_pred ---cCCCC-------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 310 ---EDSRP-------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 310 ---~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
....+ ......++.+.+||.+||+.||++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00111 1223457889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=290.22 Aligned_cols=247 Identities=33% Similarity=0.517 Sum_probs=204.3
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCC--ChHHHHHHHHHHHHHHhcCCCceeeeeeeEee--CCceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIAS--NPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH--SERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~--~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~--~~~~~~v~e~~ 171 (370)
.+|+|++|.||++.. .+..+++|.+...... .......+.+|+.+++.++||||+++++++.. ....++++||+
T Consensus 9 ~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~ 88 (266)
T cd06651 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYM 88 (266)
T ss_pred eecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCC
Confidence 478999999999976 4788999988654322 23445678999999999999999999998865 35788999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
.+++|.+++...+.++....+.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++............
T Consensus 89 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (266)
T cd06651 89 PGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG 165 (266)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCc
Confidence 99999999988878999999999999999999999988 999999999999999999999999998765432211111
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||..................+..+..+++.+++++ +|
T Consensus 166 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~ 244 (266)
T cd06651 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GC 244 (266)
T ss_pred cccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HH
Confidence 12234788999999999888999999999999999999999999877655555444444445666677888999999 67
Q ss_pred cccCCCCCCCHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~ 348 (370)
|..+|++||++++++++
T Consensus 245 ~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 245 IFVEARHRPSAEELLRH 261 (266)
T ss_pred hcCChhhCcCHHHHhcC
Confidence 77899999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=298.09 Aligned_cols=250 Identities=26% Similarity=0.452 Sum_probs=217.5
Q ss_pred eEEeeecccCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEE
Q 042314 89 ICKILEDRGGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIF 166 (370)
Q Consensus 89 ~~~~L~~~~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~ 166 (370)
++-++.....+|.|.|+.|.+|+. .|..||||++.+..- +......+.+|++.|+.+.|||||++|++......+|+
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 444444455699999999999864 699999999987643 33456678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC-CCCcEEEeccccceeccc
Q 042314 167 LTEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD-EAGHLKVTDFGLSKIAQE 244 (370)
Q Consensus 167 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~ 244 (370)
|+|+-++|+|+++|.+. ..+.+..+.+++.||+.|+.|+|+.. +|||||||+|+.+- .-|-+||.|||++..+.+
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999999876 46899999999999999999999998 99999999999865 678999999999876665
Q ss_pred cCccceeccCCCCCccccCcccccccCCC-chhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHH
Q 042314 245 KDSYSYKMTGGTGSYRYMAPEVYRRESYG-KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEP 323 (370)
Q Consensus 245 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (370)
+. .....+|+..|.|||++.+..|+ +++||||||+|||.|.+|++||...++.+..-++. .-....|..++.+
T Consensus 172 G~----kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm--DCKYtvPshvS~e 245 (864)
T KOG4717|consen 172 GK----KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM--DCKYTVPSHVSKE 245 (864)
T ss_pred cc----hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh--cccccCchhhhHH
Confidence 54 33456899999999999999998 68999999999999999999999988887777664 4455677888999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 324 IKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 324 l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.++||..||..||++|.+.++|...
T Consensus 246 CrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 246 CRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred HHHHHHHHHhcCchhhccHHHHhcc
Confidence 9999999999999999999998754
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=307.13 Aligned_cols=235 Identities=23% Similarity=0.339 Sum_probs=188.8
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... ++.+|+|... ...+.+|+.++++++||||+++++++......++|+|++. ++|
T Consensus 100 lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 100 FTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDL 169 (391)
T ss_pred EcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence 789999999999774 7788998643 2346789999999999999999999999999999999995 599
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
..++.....++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ......
T Consensus 170 ~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~--~~~~~~ 244 (391)
T PHA03212 170 YCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN--KYYGWA 244 (391)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccc--cccccc
Confidence 999988888999999999999999999999998 999999999999999999999999998654322111 223346
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHh----------------------
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA-------VQVADRR---------------------- 307 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-------~~~~~~~---------------------- 307 (370)
||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+
T Consensus 245 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~ 324 (391)
T PHA03212 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEI 324 (391)
T ss_pred CccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHH
Confidence 89999999999998999999999999999999999987643210 0000000
Q ss_pred ----hcc-CCCCCC------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 308 ----AYE-DSRPAL------SSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 308 ----~~~-~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
... ...+.. ....|..+.+||.+||+.||.+|||+.|++++
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 325 YIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 000000 01246789999999999999999999999875
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=292.53 Aligned_cols=241 Identities=24% Similarity=0.393 Sum_probs=208.6
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
+.+|+|+||.||+|.. .|+.+|+|.+... ...+.+..|+.++++++.|+||++++.+.....+|+|||||..|
T Consensus 39 ~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 39 GKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 4589999999999865 4889999988654 34677899999999999999999999999999999999999999
Q ss_pred CHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+..++++- ++++++.++..+++..++||+|||... -||||||..|||+..+|..||+|||.+..+.+.- ....
T Consensus 114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM---AKRN 187 (502)
T KOG0574|consen 114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM---AKRN 187 (502)
T ss_pred cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH---HhhC
Confidence 99999874 468999999999999999999999988 8999999999999999999999999987665432 2334
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC-CCCCCCCcHHHHHHHHHhc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR-PALSSLYPEPIKALLRECW 332 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l 332 (370)
..+|||.|||||++..-.|+.++||||||++..||..|++||....+......+...++. ..-|..++.+|.+|+++||
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL 267 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL 267 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence 558999999999999999999999999999999999999999988776655554422221 1234567889999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFR 348 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~ 348 (370)
.++|++|.|+.+|+++
T Consensus 268 iK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 268 IKKPEERKTALRLCEH 283 (502)
T ss_pred cCCHHHHHHHHHHhhh
Confidence 9999999999998876
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=277.72 Aligned_cols=247 Identities=26% Similarity=0.487 Sum_probs=203.4
Q ss_pred eeecccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEE
Q 042314 92 ILEDRGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLT 168 (370)
Q Consensus 92 ~L~~~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~ 168 (370)
-|...+.+|.|..|.|+++..+ |+..|||.+... .+.+..+++...++++.... +|+||+++|+|..+..+++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3455566999999999999876 588999998775 55677788888888876664 899999999999999999999
Q ss_pred eecCCCCHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 169 EYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 169 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
|.|.- -++.++.+ ++++++..+-++...+.+||.||.++. +|+|||+||+|||+|..|++||||||++.++-+...
T Consensus 171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 99844 66666654 367899888899999999999999875 699999999999999999999999999987766543
Q ss_pred cceeccCCCCCccccCcccccc---cCCCchhhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhccCCCCCCC--CCCc
Q 042314 248 YSYKMTGGTGSYRYMAPEVYRR---ESYGKSVDVFSFALIVHEMFQGGPSNRADTA-VQVADRRAYEDSRPALS--SLYP 321 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~--~~~~ 321 (370)
.+ ...|-+.|||||.+.- ..|+.++||||||++++||.||..||..... .+...++.. ...|.++ ..++
T Consensus 248 ht----rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFS 322 (391)
T KOG0983|consen 248 HT----RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFS 322 (391)
T ss_pred cc----cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcC
Confidence 22 2257789999999964 4688999999999999999999999988644 444444442 3334443 3489
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+.|.+|+..||.+|+.+||.+.+|+++
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 999999999999999999999999875
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=293.52 Aligned_cols=244 Identities=23% Similarity=0.387 Sum_probs=203.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... ++.+++|.+.............+.+|+.+++.++|++|+.+.+.+...+..+++|||+.+++
T Consensus 7 ~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (285)
T cd05632 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGD 86 (285)
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCcc
Confidence 3789999999999875 77899999876543444445667889999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 176 LHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 176 L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........ ..
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~----~~ 159 (285)
T cd05632 87 LKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES----IR 159 (285)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc----cc
Confidence 99888653 36899999999999999999999998 99999999999999999999999999876543221 12
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh--ccCCCCCCCCCCcHHHHHHHHHh
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRA--YEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
...|+..|+|||.+.+..++.++|+||+|+++|+|++|..||............. ........+..+++.+.+|+.+|
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 3468999999999998889999999999999999999999998765543222221 12223345566889999999999
Q ss_pred cccCCCCCCC-----HHHHHHH
Q 042314 332 WHKNPDRRPT-----FEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp~-----~~~ll~~ 348 (370)
|+.||++||+ +.+++.+
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcC
Confidence 9999999999 7788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=287.83 Aligned_cols=242 Identities=24% Similarity=0.446 Sum_probs=205.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|++|.||++... +..+++|.++... .....+.+..|+.+++.++||||+++++.+...+.+++++||+++++
T Consensus 7 ~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 84 (255)
T cd08219 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD 84 (255)
T ss_pred EeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence 3788999999999764 7789999886432 23455678899999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 176 LHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 176 L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|.+++... ..+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++++|||++......... ..
T Consensus 85 l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~---~~ 158 (255)
T cd08219 85 LMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY---AC 158 (255)
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc---cc
Confidence 99988653 45789999999999999999999998 999999999999999999999999998766443221 12
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
...+++.|+|||.+.+..++.++|+||+|+++|+|++|..||............. .......+..++..+.+++++||+
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 237 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIKQMFK 237 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHHh
Confidence 2357889999999988889999999999999999999999998877655554443 333444566788999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~ 348 (370)
.||++||++.+++..
T Consensus 238 ~~P~~Rp~~~~il~~ 252 (255)
T cd08219 238 RNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCCCHHHHhhc
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=296.44 Aligned_cols=253 Identities=29% Similarity=0.542 Sum_probs=208.8
Q ss_pred cCCCCCCcccEEEEEEcC---------ceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEE
Q 042314 97 GGIDPGAYGEVYLVKWRG---------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIF 166 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g---------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~ 166 (370)
..+|.|+||.||++.+.+ ..+++|.++.. ........+.+|+.+++++ +||||+++++++...+..++
T Consensus 18 ~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 95 (334)
T cd05100 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 95 (334)
T ss_pred ceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEE
Confidence 348999999999997532 25788877643 2334567889999999999 79999999999999999999
Q ss_pred EEeecCCCCHHHHHHhCC----------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc
Q 042314 167 LTEYLRNGSLHDILKKKG----------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH 230 (370)
Q Consensus 167 v~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~ 230 (370)
++||+.+++|.+++.+.. .++...+..++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 96 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~ 172 (334)
T cd05100 96 LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNV 172 (334)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCc
Confidence 999999999999997532 3677888999999999999999998 999999999999999999
Q ss_pred EEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhc
Q 042314 231 LKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAY 309 (370)
Q Consensus 231 ~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~ 309 (370)
+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.............
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~- 250 (334)
T cd05100 173 MKIADFGLARDVHNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK- 250 (334)
T ss_pred EEECCcccceecccccccc-cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-
Confidence 9999999987664432211 1122234568999999999889999999999999999998 889998877666555443
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 310 EDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 310 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
.......+..++..+.+++.+||+.+|++||++.++++.|+++...-
T Consensus 251 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 251 EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 33444556678899999999999999999999999999999997433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=290.56 Aligned_cols=249 Identities=28% Similarity=0.461 Sum_probs=202.6
Q ss_pred cCCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEe
Q 042314 97 GGIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
..+|.|+||.||++..+ +..+++|.+... ........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 12 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (288)
T cd05061 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVME 89 (288)
T ss_pred eeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 34789999999998643 346888887643 223344567889999999999999999999998899999999
Q ss_pred ecCCCCHHHHHHhC----------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccc
Q 042314 170 YLRNGSLHDILKKK----------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLS 239 (370)
Q Consensus 170 ~~~g~~L~~~l~~~----------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~ 239 (370)
|+.+|+|.+++.+. ...+...+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++
T Consensus 90 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~ 166 (288)
T cd05061 90 LMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMT 166 (288)
T ss_pred CCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCcc
Confidence 99999999999753 23456678899999999999999998 999999999999999999999999998
Q ss_pred eeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCC
Q 042314 240 KIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSS 318 (370)
Q Consensus 240 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 318 (370)
+......... ......++..|+|||.+.+..++.++|+|||||++|||++ |..||......+...... .......+.
T Consensus 167 ~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~ 244 (288)
T cd05061 167 RDIYETDYYR-KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-DGGYLDQPD 244 (288)
T ss_pred cccccccccc-ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence 7654332211 1122245678999999998889999999999999999998 788998776655444433 333444556
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042314 319 LYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 319 ~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
..++.+.+++.+||+.+|++|||+.++++.|++.
T Consensus 245 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 245 NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 6789999999999999999999999999887765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=294.28 Aligned_cols=240 Identities=28% Similarity=0.523 Sum_probs=208.0
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|++|.||++... +..+++|.+.............+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 8 ~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 87 (290)
T cd05580 8 TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGE 87 (290)
T ss_pred EeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCC
Confidence 4788999999999874 78899999876544444566788999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++...+.++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 88 L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~------~~~ 158 (290)
T cd05580 88 LFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT------YTL 158 (290)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCCC------CCC
Confidence 9999998889999999999999999999999998 9999999999999999999999999987664431 223
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.+++.|+|||.+.+...+.++|+||||+++|+|++|..||............. ......+..++..+++++++||..|
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~ 236 (290)
T cd05580 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIRNLLQVD 236 (290)
T ss_pred CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHHHHccCC
Confidence 57899999999988888999999999999999999999998777555444433 3344566677899999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 042314 336 PDRRP-----TFEEIIFR 348 (370)
Q Consensus 336 p~~Rp-----~~~~ll~~ 348 (370)
|.+|+ ++++++++
T Consensus 237 p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 237 LTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HHHccCcccCCHHHHHcC
Confidence 99998 78888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=289.30 Aligned_cols=242 Identities=25% Similarity=0.414 Sum_probs=198.7
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|.++... ......+.+|+.+++.++||||+++++.+...+..++|+||+++++
T Consensus 16 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 92 (267)
T cd06645 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGS 92 (267)
T ss_pred HhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCc
Confidence 3799999999999774 7889999886542 2234567889999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++...+.+++.++..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++........ .....
T Consensus 93 L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~ 166 (267)
T cd06645 93 LQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA---KRKSF 166 (267)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc---ccccc
Confidence 9999998889999999999999999999999998 99999999999999999999999999876543221 12234
Q ss_pred CCCccccCccccc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC-CC--CCCCcHHHHHHHH
Q 042314 256 TGSYRYMAPEVYR---RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP-AL--SSLYPEPIKALLR 329 (370)
Q Consensus 256 ~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~l~~li~ 329 (370)
.|++.|+|||.+. ...++.++|+|||||++|+|++|.+||..................+ .. ...+|..+.+++.
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246 (267)
T ss_pred cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHH
Confidence 6889999999974 4457889999999999999999999987654433222221111111 11 2246788999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~ 348 (370)
+||..+|++||++++++++
T Consensus 247 ~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 247 MALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred HHccCCchhCcCHHHHhcC
Confidence 9999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=299.54 Aligned_cols=252 Identities=26% Similarity=0.485 Sum_probs=201.7
Q ss_pred cCCCCCCcccEEEEEE-------cCceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEee-CCceEEE
Q 042314 97 GGIDPGAYGEVYLVKW-------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKH-SERLIFL 167 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~-------~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~-~~~~~~v 167 (370)
..+|.|+||.||++.+ .++.+|+|.++... .......+.+|+.++.++ +||||+++++++.. ....+++
T Consensus 13 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (343)
T cd05103 13 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (343)
T ss_pred ccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEE
Confidence 3489999999999974 35789999987542 233456788999999999 68999999998765 4567999
Q ss_pred EeecCCCCHHHHHHhC----------------------------------------------------------------
Q 042314 168 TEYLRNGSLHDILKKK---------------------------------------------------------------- 183 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~---------------------------------------------------------------- 183 (370)
|||+++|+|.+++...
T Consensus 91 ~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (343)
T cd05103 91 VEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQED 170 (343)
T ss_pred EeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhh
Confidence 9999999999998643
Q ss_pred ---CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCCCCcc
Q 042314 184 ---GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYR 260 (370)
Q Consensus 184 ---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~ 260 (370)
..++...+..++.|+++||.|||+++ |+||||||+||+++.++.+||+|||++.......... ......+++.
T Consensus 171 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~ 246 (343)
T cd05103 171 LYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKGDARLPLK 246 (343)
T ss_pred hhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchh-hcCCCCCCcc
Confidence 13567788899999999999999998 9999999999999999999999999987654322111 1112235678
Q ss_pred ccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCCCCC
Q 042314 261 YMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRR 339 (370)
Q Consensus 261 y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 339 (370)
|+|||.+.+..++.++|+||||+++|+|++ |..||.....................+...++.+.+++.+||+.||++|
T Consensus 247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~R 326 (343)
T cd05103 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 326 (343)
T ss_pred eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999988889999999999999999997 8899876543332222222344445556678899999999999999999
Q ss_pred CCHHHHHHHHHHHHH
Q 042314 340 PTFEEIIFRLEAIQE 354 (370)
Q Consensus 340 p~~~~ll~~l~~~~~ 354 (370)
||+.+++++|+.+.+
T Consensus 327 ps~~eil~~l~~~~~ 341 (343)
T cd05103 327 PTFSELVEHLGNLLQ 341 (343)
T ss_pred cCHHHHHHHHHHHHh
Confidence 999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=288.31 Aligned_cols=246 Identities=30% Similarity=0.479 Sum_probs=203.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccC--CChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC--CceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIA--SNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS--ERLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~--~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~--~~~~~v~e~~~ 172 (370)
++.|+||.||.+... +..+++|.+..... ........+.+|+.++++++||||+++++++... ..+++++||++
T Consensus 10 l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~ 89 (265)
T cd06652 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMP 89 (265)
T ss_pred EecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecC
Confidence 788999999999764 78899998764322 2234567889999999999999999999988663 46889999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
+++|.+++.+.+.+++..+..++.|++.+|.|||+++ ++|+||||+||+++.++.++|+|||++.............
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 166 (265)
T cd06652 90 GGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM 166 (265)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccccccccccccc
Confidence 9999999988778899999999999999999999998 9999999999999999999999999987654322111112
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..................+..+..++..+.+++++||
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 246 (265)
T cd06652 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF 246 (265)
T ss_pred ccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHh
Confidence 23357889999999988889999999999999999999999998765555444444344455566677888999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFR 348 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~ 348 (370)
. +|++||++++++++
T Consensus 247 ~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 247 V-EAKLRPSADELLRH 261 (265)
T ss_pred c-ChhhCCCHHHHhcC
Confidence 5 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=285.76 Aligned_cols=243 Identities=30% Similarity=0.551 Sum_probs=202.4
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|++|.||++... +..+++|.+..... ....+.+|+.++++++|++++++++++. .+..+++|||+.+++|
T Consensus 13 ~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L 87 (260)
T cd05070 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSL 87 (260)
T ss_pred eeccccCceEEEEEecCCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcH
Confidence 4889999999999865 56788888865432 1346889999999999999999999875 4568899999999999
Q ss_pred HHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++... ..++...+..++.|++.||.|||+++ ++|+||||+||++++++.++|+|||++......... ....
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 162 (260)
T cd05070 88 LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT--ARQG 162 (260)
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc--cccC
Confidence 9999764 35889999999999999999999998 999999999999999999999999999766443211 1122
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..++..|+|||.+.+..++.++|+||||+++|+|++ |.+||......+...... .....+.+...|..+.+++.+||.
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 241 (260)
T cd05070 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLHELMLQCWK 241 (260)
T ss_pred CCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcc
Confidence 235678999999988889999999999999999999 899998777665555443 234445566788999999999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~ 351 (370)
.+|++|||++++++.|+.
T Consensus 242 ~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 242 KDPEERPTFEYLQSFLED 259 (260)
T ss_pred cCcccCcCHHHHHHHHhc
Confidence 999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=285.51 Aligned_cols=244 Identities=32% Similarity=0.558 Sum_probs=201.8
Q ss_pred CCCCCCcccEEEEEEcC-ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g-~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|++|.||++.+.+ ..+++|.++.... ....+.+|+.+++.++||||+++++.+. .+..++||||+.+++|
T Consensus 13 ~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L 87 (262)
T cd05071 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 87 (262)
T ss_pred ecCCCCCCcEEEEEecCCceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcH
Confidence 37899999999997753 4688888865322 2356889999999999999999999874 4568999999999999
Q ss_pred HHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++.+. ..++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+......... ....
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~--~~~~ 162 (262)
T cd05071 88 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQG 162 (262)
T ss_pred HHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc--cccC
Confidence 9999763 35788999999999999999999998 999999999999999999999999999766543221 1122
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..++..|+|||...+..++.++|+||||+++|+|++ |..||............. .......+..+|..+.+++.+||+
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~ 241 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWR 241 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCccccCHHHHHHHHHHcc
Confidence 345678999999988889999999999999999999 888998776665554443 223334456688999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~~ 352 (370)
.+|++||++.++++.|+..
T Consensus 242 ~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 242 KEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCcccCCCHHHHHHHHHHh
Confidence 9999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=285.07 Aligned_cols=243 Identities=31% Similarity=0.563 Sum_probs=201.5
Q ss_pred CCCCCCcccEEEEEEcC-ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g-~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|++|.||++...+ ..+++|.+.... .....+.+|+.+++.++||+++++++++. .+..+++|||+.+++|
T Consensus 13 ~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L 87 (260)
T cd05069 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSL 87 (260)
T ss_pred eecCcCCCeEEEEEEcCCceEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCH
Confidence 47899999999998764 468888875432 23456788999999999999999999875 4568999999999999
Q ss_pred HHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++... ..++...+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++......... ....
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 162 (260)
T cd05069 88 LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT--ARQG 162 (260)
T ss_pred HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc--ccCC
Confidence 9999764 24788899999999999999999998 999999999999999999999999999766433211 1122
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..++..|+|||.+.+..++.++|+||||+++|+|++ |..||............. ....+..+...|..+.+++++||.
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 241 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHELMKLCWK 241 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHHHHcc
Confidence 245678999999988889999999999999999999 899998877665554443 233444556788999999999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~ 351 (370)
.||++||+++++++.|++
T Consensus 242 ~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 242 KDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCcCHHHHHHHHhc
Confidence 999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=289.72 Aligned_cols=249 Identities=31% Similarity=0.565 Sum_probs=198.3
Q ss_pred CCCCCCcccEEEEEE------cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee--CCceEEEEe
Q 042314 98 GIDPGAYGEVYLVKW------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH--SERLIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~------~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~--~~~~~~v~e 169 (370)
.+|.|+||.||.+.. .+..+++|.+... .......+.+|+.+++.++||||+++++++.. ...+++|+|
T Consensus 11 ~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 87 (284)
T cd05081 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87 (284)
T ss_pred eccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEE
Confidence 379999999999874 3678999987653 34456778999999999999999999997643 346899999
Q ss_pred ecCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 170 YLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 170 ~~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
|+++++|.+++.+. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.........
T Consensus 88 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 164 (284)
T cd05081 88 YLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY 164 (284)
T ss_pred ecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCCcc
Confidence 99999999999764 46899999999999999999999998 999999999999999999999999999876543321
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH---------------HHHhhccCCC
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQV---------------ADRRAYEDSR 313 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---------------~~~~~~~~~~ 313 (370)
........++..|+|||.+.+..++.++|+||||+++|||++|..++........ ..........
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
T cd05081 165 YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGR 244 (284)
T ss_pred eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCc
Confidence 1111122345569999999988899999999999999999998766543321110 0011112223
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042314 314 PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 314 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
.+.+..+|..+.+++.+||..+|++|||+.+++..|+++
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 245 LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 344556889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=287.04 Aligned_cols=252 Identities=28% Similarity=0.553 Sum_probs=209.8
Q ss_pred CCCCCCcccEEEEEEc--Cc----eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKWR--GT----EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
.+|.|+||.||++.+. |. .+++|.+.... .......+.+|+..++.++||||+++++++.. ...++|+||+
T Consensus 14 ~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 90 (279)
T cd05057 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLM 90 (279)
T ss_pred eecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecC
Confidence 4789999999999764 32 47888776542 24556778899999999999999999999877 7889999999
Q ss_pred CCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 172 RNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 172 ~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
.+++|.+++.+. ..+++..+..++.|++.|+.|||+++ ++|+||||+||+++.++.+||+|||+++....... ..
T Consensus 91 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~-~~ 166 (279)
T cd05057 91 PLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK-EY 166 (279)
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCccc-ce
Confidence 999999998864 46899999999999999999999988 99999999999999999999999999987654322 11
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
......++..|+|||.+....++.++|+||||+++||+++ |+.||............. .......+..++..+.+++.
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 245 (279)
T cd05057 167 HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDVYMVLV 245 (279)
T ss_pred ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHH
Confidence 2222334678999999988889999999999999999998 999998877766555444 33344455667889999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 330 ECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
+||..+|.+||++.++++.|+++.+...
T Consensus 246 ~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 246 KCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred HHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 9999999999999999999999866443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=300.36 Aligned_cols=246 Identities=23% Similarity=0.344 Sum_probs=200.8
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+|+|++.............+..|..+++.++|++|+++++++...+.+++||||+.|++
T Consensus 8 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 87 (331)
T cd05597 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGD 87 (331)
T ss_pred EEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCc
Confidence 3789999999999874 78899999875433333455668899999999999999999999999999999999999999
Q ss_pred HHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++.+ ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......... ....
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~ 162 (331)
T cd05597 88 LLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV--QSNV 162 (331)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc--cccc
Confidence 9999976 457899999999999999999999998 999999999999999999999999998765433221 1122
Q ss_pred CCCCccccCcccccc-----cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC---CCCCCCCCcHHHHH
Q 042314 255 GTGSYRYMAPEVYRR-----ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS---RPALSSLYPEPIKA 326 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~ 326 (370)
..||+.|+|||++.. ..++.++||||+||++|+|++|+.||......+....+..... .+.....+|+.+++
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 242 (331)
T cd05597 163 AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKD 242 (331)
T ss_pred eeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHH
Confidence 358999999999863 4567899999999999999999999988776655544432222 12223347899999
Q ss_pred HHHHhcccCCC--CCCCHHHHHHH
Q 042314 327 LLRECWHKNPD--RRPTFEEIIFR 348 (370)
Q Consensus 327 li~~~l~~~p~--~Rp~~~~ll~~ 348 (370)
++++||..++. .||++.+++++
T Consensus 243 li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 243 LIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred HHHHHccCcccccCCCCHHHHhcC
Confidence 99998865443 47899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=290.31 Aligned_cols=247 Identities=28% Similarity=0.490 Sum_probs=203.3
Q ss_pred cCCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEe
Q 042314 97 GGIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
..+|.|+||.||++... +..+++|.+... ........+.+|+.+++.++||||+++++++...+..++++|
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (288)
T cd05050 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFE 88 (288)
T ss_pred ccccccccccEEEEEEcccCCCCcceeEEEEecCCC--cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEe
Confidence 34789999999999763 467889988653 234556778999999999999999999999999899999999
Q ss_pred ecCCCCHHHHHHhCC----------------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC
Q 042314 170 YLRNGSLHDILKKKG----------------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE 227 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~----------------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~ 227 (370)
|+.+++|.+++.... .++...++.++.|++.||.|||+++ ++||||||+||+++.
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~ 165 (288)
T cd05050 89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGE 165 (288)
T ss_pred cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecC
Confidence 999999999997532 3677888999999999999999998 999999999999999
Q ss_pred CCcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 042314 228 AGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADR 306 (370)
Q Consensus 228 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~ 306 (370)
++.++|+|||++.......... .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~ 244 (288)
T cd05050 166 NMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY 244 (288)
T ss_pred CCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999987554332111 1112234678999999988889999999999999999997 8888877666555444
Q ss_pred hhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 307 RAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 307 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
.. .......+..+|..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 245 ~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 245 VR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred Hh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 33 23333445678899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=287.25 Aligned_cols=245 Identities=25% Similarity=0.427 Sum_probs=193.1
Q ss_pred CCCCCcccEEEEEEc----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 99 IDPGAYGEVYLVKWR----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 99 l~~g~~~~v~~a~~~----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
+|.|+||.||++... ...+++|.+... ........+.+|+..++.++||||+++++.+......++||||+++|
T Consensus 3 lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CCccCCceEEEEEEecCCCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 789999999998643 234666765432 23445567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhCC-----CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 175 SLHDILKKKG-----KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 175 ~L~~~l~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+|.+++.... ..+...+..++.|++.|+.|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999997643 2456778899999999999999998 9999999999999999999999999986543322111
Q ss_pred eeccCCCCCccccCcccccc-------cCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccC----CCCCCC
Q 042314 250 YKMTGGTGSYRYMAPEVYRR-------ESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYED----SRPALS 317 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~----~~~~~~ 317 (370)
......+++.|+|||.+.. ..++.++||||||+++|||++ |..||................ ..+..+
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05042 158 -TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD 236 (269)
T ss_pred -ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence 1122345778999998743 346789999999999999999 788887766554433332221 233445
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 318 SLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 318 ~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
..+++.+.+++..|| .||++|||++++++.|.
T Consensus 237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 568899999999999 59999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=301.34 Aligned_cols=243 Identities=26% Similarity=0.367 Sum_probs=192.8
Q ss_pred ccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC------ceEEE
Q 042314 96 RGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE------RLIFL 167 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~------~~~~v 167 (370)
...+|.|+||.||++... |..+++|.+.... ........+.+|+.+++.++||||+++++++.... ..++|
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 104 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104 (359)
T ss_pred EEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEE
Confidence 345899999999999764 7889999987543 23344567789999999999999999999886543 47999
Q ss_pred EeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 168 TEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
|||+++ +|.+.+.. .++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......
T Consensus 105 ~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 177 (359)
T cd07876 105 MELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF- 177 (359)
T ss_pred EeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccCc-
Confidence 999976 67766643 5788999999999999999999998 9999999999999999999999999987543321
Q ss_pred cceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc------------------
Q 042314 248 YSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY------------------ 309 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~------------------ 309 (370)
......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||..............
T Consensus 178 ---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (359)
T cd07876 178 ---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254 (359)
T ss_pred ---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 12234679999999999999999999999999999999999999986644322111000
Q ss_pred --cCCCC--------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042314 310 --EDSRP--------------------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 310 --~~~~~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l 349 (370)
....+ ......++.+.+|+.+||..||++|||+.|++.+-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00000 01122457799999999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=291.47 Aligned_cols=248 Identities=29% Similarity=0.507 Sum_probs=199.9
Q ss_pred cCCCCCCcccEEEEEEcC----------------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee
Q 042314 97 GGIDPGAYGEVYLVKWRG----------------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g----------------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~ 160 (370)
..+|+|+||.||++...+ ..+++|.+... ........+.+|++++++++|||++++++++..
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 88 (295)
T cd05097 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS 88 (295)
T ss_pred hccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcC
Confidence 348999999999986542 23788887653 234556779999999999999999999999999
Q ss_pred CCceEEEEeecCCCCHHHHHHhCC------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC
Q 042314 161 SERLIFLTEYLRNGSLHDILKKKG------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA 228 (370)
Q Consensus 161 ~~~~~~v~e~~~g~~L~~~l~~~~------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~ 228 (370)
.+..++||||+.+++|.+++.... .++...+..++.|++.||.|||+++ ++|+||||+||+++.+
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~ 165 (295)
T cd05097 89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNH 165 (295)
T ss_pred CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCC
Confidence 999999999999999999986532 3677889999999999999999998 9999999999999999
Q ss_pred CcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh--CCCCCCCCcHHHHHHH
Q 042314 229 GHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ--GGPSNRADTAVQVADR 306 (370)
Q Consensus 229 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~--g~~p~~~~~~~~~~~~ 306 (370)
+.+||+|||++......... .......++..|+|||.+.+..++.++|+||||+++|+|++ +..||...........
T Consensus 166 ~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~ 244 (295)
T cd05097 166 YTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244 (295)
T ss_pred CcEEecccccccccccCcce-eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHH
Confidence 99999999998765433211 11122235678999999988889999999999999999988 6678877665444332
Q ss_pred hhc------cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 307 RAY------EDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 307 ~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
... .......+..+|+.+.+++.+||+.+|++||+++++++.|+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 245 TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 211 11122334567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=288.99 Aligned_cols=246 Identities=28% Similarity=0.518 Sum_probs=204.6
Q ss_pred CCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 98 GIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
.+|.|+||.||++... ...+++|.+... ........+.+|+.++++++||||+++++++...+..++||||
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 3789999999999864 345888877543 2334667899999999999999999999999988899999999
Q ss_pred cCCCCHHHHHHhCC---------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecccccee
Q 042314 171 LRNGSLHDILKKKG---------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI 241 (370)
Q Consensus 171 ~~g~~L~~~l~~~~---------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~ 241 (370)
+++++|.+++.... .++...+..++.|++.||.|||+++ |+||||||+||+++.++.++++|||++..
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccccc
Confidence 99999999998765 6899999999999999999999998 99999999999999999999999998865
Q ss_pred ccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCC
Q 042314 242 AQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLY 320 (370)
Q Consensus 242 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (370)
....... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....................+..+
T Consensus 167 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (275)
T cd05046 167 VYNSEYY--KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGC 244 (275)
T ss_pred cCccccc--ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCC
Confidence 4332211 2222345778999999988888999999999999999998 788887666655555444333333445678
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 321 PEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 321 ~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
|..+.+++.+||+.+|++||++.+++..|+
T Consensus 245 ~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 245 PSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=286.54 Aligned_cols=245 Identities=27% Similarity=0.422 Sum_probs=193.2
Q ss_pred CCCCCcccEEEEEEc----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 99 IDPGAYGEVYLVKWR----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 99 l~~g~~~~v~~a~~~----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
+|.|+||.||++.+. +..+++|.++.... ......+.+|+.+++.++||||+++++.+......++||||++++
T Consensus 3 lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred ccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 789999999999764 34578888765432 234457888999999999999999999999888999999999999
Q ss_pred CHHHHHHhCC-----CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 175 SLHDILKKKG-----KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 175 ~L~~~l~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+|.+++.... ..+...+..++.|++.|+.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~- 156 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY- 156 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee-
Confidence 9999987532 3456778889999999999999998 999999999999999999999999998654332211
Q ss_pred eeccCCCCCccccCccccccc-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcc----CCCCCCC
Q 042314 250 YKMTGGTGSYRYMAPEVYRRE-------SYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYE----DSRPALS 317 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~-------~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~----~~~~~~~ 317 (370)
.......++..|+|||.+.+. .++.++|+||||+++|||++ |+.||......+........ ...+...
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK 236 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence 112233467889999998642 35789999999999999996 99999776655443322211 1223333
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 318 SLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 318 ~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
...++.+.+++++|| .+|++|||+++++..|+
T Consensus 237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 457788999999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=299.47 Aligned_cols=252 Identities=29% Similarity=0.505 Sum_probs=215.3
Q ss_pred ccCCCCCCcccEEEEEEcC-ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 96 RGGIDPGAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~g-~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
...+|+|.||.|.++...+ ..||||.++.. .....++.|.+|+++|.+++||||++++++|..++.+++++||++.|
T Consensus 543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~--a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPD--ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred hhhhcCcccceeEEEEecCceEEEEeecCcc--cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 3459999999999998876 88999999875 34456889999999999999999999999999999999999999999
Q ss_pred CHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 175 SLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 175 ~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
+|.+++.++ +........+|+.||++||+||.+.+ +|||||.++|+|++.++++||+|||+++-+-..+.+..+
T Consensus 621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq- 696 (807)
T KOG1094|consen 621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ- 696 (807)
T ss_pred cHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceeee-
Confidence 999999987 34456678889999999999999999 999999999999999999999999999866555433221
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHH--hCCCCCCCCcHHHHHHHhhccCC------CCCCCCCCcHHH
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMF--QGGPSNRADTAVQVADRRAYEDS------RPALSSLYPEPI 324 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~--~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l 324 (370)
....-+++|||||.+.-++++.+||+|+||+++||++ +...||...+..+.......... .+..|..+|..+
T Consensus 697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~l 776 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGL 776 (807)
T ss_pred cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHH
Confidence 1123578999999999999999999999999999975 57899998888777665543221 123466789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042314 325 KALLRECWHKNPDRRPTFEEIIFRLEAIQ 353 (370)
Q Consensus 325 ~~li~~~l~~~p~~Rp~~~~ll~~l~~~~ 353 (370)
+++|.+||..+.++||+++++...|.+..
T Consensus 777 yelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 777 YELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred HHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 99999999999999999999999987653
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.37 Aligned_cols=243 Identities=28% Similarity=0.469 Sum_probs=199.8
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|.+... ........+.+|++++++++||||+++++.+...+.+++|+||+++++
T Consensus 8 ~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~ 85 (308)
T cd06615 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 85 (308)
T ss_pred eccCCCCeEEEEEEEcCCCeEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence 3789999999999875 667788887643 234566778899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhh-cCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHH-HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++.+.+.+++..+..++.|+++||.|||+ .+ ++|+||||+||+++.++.++|+|||++....... ...
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~ 157 (308)
T cd06615 86 LDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANS 157 (308)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc-----ccc
Confidence 99999988889999999999999999999997 46 9999999999999999999999999986553321 123
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc------------------------
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE------------------------ 310 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~------------------------ 310 (370)
..+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...............
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchh
Confidence 36789999999998888899999999999999999999998655433322111100
Q ss_pred -----------CCCCCCC-CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 311 -----------DSRPALS-SLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 311 -----------~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
...+..+ ..++..+.+++.+||..+|++||++.+++++--
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred hHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0011111 136778999999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=285.76 Aligned_cols=243 Identities=30% Similarity=0.538 Sum_probs=203.1
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|+||.||++... +..+++|.+..... ....+.+|+.++++++||||+++++++. .+..++++||+.+++|
T Consensus 13 ~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L 87 (260)
T cd05067 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSL 87 (260)
T ss_pred eeccCccceEEeeecCCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCH
Confidence 3889999999999764 68899998865432 2356889999999999999999999864 4578999999999999
Q ss_pred HHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++... ..++..++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......... ....
T Consensus 88 ~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 162 (260)
T cd05067 88 VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT--AREG 162 (260)
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc--cccC
Confidence 9998753 36788999999999999999999988 999999999999999999999999998766532211 1122
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..++..|+|||.+....++.++|+||||+++|++++ |++||............. .......+...|..+.+++++||.
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 241 (260)
T cd05067 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-RGYRMPRPDNCPEELYELMRLCWK 241 (260)
T ss_pred CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcc
Confidence 245678999999998889999999999999999998 999998777665555443 333445566788999999999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~ 351 (370)
.+|++||++++++..|+.
T Consensus 242 ~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 242 EKPEERPTFEYLRSVLED 259 (260)
T ss_pred CChhhCCCHHHHHHHhhc
Confidence 999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=307.07 Aligned_cols=243 Identities=26% Similarity=0.437 Sum_probs=207.1
Q ss_pred cCCCCCCcccEEEEEEcCc--eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
|-+|.|+||.||+|..+.. -.|.|++.. ...+....+.-|++++..|.||+||++++.|...+.+||+.|||.||
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 4489999999999987633 244555533 45677889999999999999999999999999999999999999999
Q ss_pred CHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
-.+.++-+ ...+++.++..+.+|++.||.|||+++ |||||||..|||++-+|.++|+|||.+...... .....
T Consensus 115 AVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t---~qkRD 188 (1187)
T KOG0579|consen 115 AVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST---RQKRD 188 (1187)
T ss_pred hHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH---Hhhhc
Confidence 99887654 457999999999999999999999999 999999999999999999999999987544322 12345
Q ss_pred CCCCCccccCccccc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC-CCCCCCCCcHHHHHH
Q 042314 254 GGTGSYRYMAPEVYR-----RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS-RPALSSLYPEPIKAL 327 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 327 (370)
..+|||.|||||+.. ..+|++++||||||++|.||..+.||....++.....++....+ ...-|..++..|.+|
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~Df 268 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDF 268 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHH
Confidence 568999999999864 56799999999999999999999999999998888877763322 233466788999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 042314 328 LRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 328 i~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+.+||.+||..||++++|++|
T Consensus 269 Lk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 269 LKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHhcCCccCCCHHHHhhC
Confidence 999999999999999999875
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=284.22 Aligned_cols=244 Identities=35% Similarity=0.632 Sum_probs=206.9
Q ss_pred CCCCCCcccEEEEEEcC------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKWRG------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
.+|.|+||.||++.+.. ..+++|.+... ........+..|+..++.++|+||+++++.+...+..+++|||+
T Consensus 6 ~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 6 KLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED--ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred eeccCCCcceEEEEecCCCCCCCceEEEEEccCC--CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 47899999999998864 77999998654 22235678899999999999999999999999989999999999
Q ss_pred CCCCHHHHHHhCCC--CChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 172 RNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 172 ~g~~L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
++++|.+++..... +++..+..++.|++.|+.+||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 84 ~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 84 EGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred CCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 99999999986544 899999999999999999999998 9999999999999999999999999987766542221
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.....+++.|+|||.+.+..++.++|+||+|+++++|++ |.+||............. .......+...|..+.+++
T Consensus 161 --~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i 237 (258)
T smart00219 161 --KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK-KGYRLPKPENCPPEIYKLM 237 (258)
T ss_pred --cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHHHHH
Confidence 112236789999999988889999999999999999998 788888766665555444 2334455666899999999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l 349 (370)
.+||..+|++|||+.++++.|
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 238 LQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHCcCChhhCcCHHHHHhhC
Confidence 999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=285.27 Aligned_cols=244 Identities=32% Similarity=0.558 Sum_probs=204.8
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|++|.||++... +..+++|.+.... ...+.+.+|+.++++++||||+++++++......++||||+++++|
T Consensus 13 ~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 88 (261)
T cd05034 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSL 88 (261)
T ss_pred eeccCcceEEEEEEEcCCceEEEEEecCCc----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCH
Confidence 4789999999999765 4678888876532 2245688999999999999999999999988899999999999999
Q ss_pred HHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++... ..++...+..++.+++.|+.|||+++ ++|+||||+||+++.++.++|+|||++......... ....
T Consensus 89 ~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~ 163 (261)
T cd05034 89 LDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT--AREG 163 (261)
T ss_pred HHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh--hhhc
Confidence 9999765 36899999999999999999999998 999999999999999999999999998766532111 1112
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
...+..|+|||.+.+..++.++|+||+|+++|+|++ |+.||............. .......+...|..+.+++.+||.
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~ 242 (261)
T cd05034 164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELYDLMLQCWD 242 (261)
T ss_pred cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcc
Confidence 234678999999998889999999999999999998 999998777665555543 233444556678999999999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~ 351 (370)
.+|++||++++++..|+.
T Consensus 243 ~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 243 KDPEERPTFEYLQSFLED 260 (261)
T ss_pred cCcccCCCHHHHHHHHhc
Confidence 999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=284.40 Aligned_cols=238 Identities=28% Similarity=0.572 Sum_probs=201.4
Q ss_pred CCCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 98 GIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
.+|.|+||.||.+...++.+++|..+.. .....+.+|+.+++.++|||++++++++... ..+++|||+.+++|.
T Consensus 13 ~lg~g~~g~v~~~~~~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~ 86 (254)
T cd05083 13 IIGEGEFGAVLQGEYTGQKVAVKNIKCD-----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLV 86 (254)
T ss_pred eeccCCCCceEecccCCCceEEEeecCc-----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHH
Confidence 3789999999999989999999988643 2345788999999999999999999998654 479999999999999
Q ss_pred HHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 178 DILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 178 ~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
+++.... .++...+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~------~~~ 157 (254)
T cd05083 87 NFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV------DNS 157 (254)
T ss_pred HHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC------CCC
Confidence 9997653 5788999999999999999999988 9999999999999999999999999987543221 112
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
..+..|+|||.+.+..++.++|+||||+++|+|++ |++||............. ....+..+..+|+.+.+++++||+.
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 236 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-KGYRMEPPEGCPADVYVLMTSCWET 236 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHHHHcCC
Confidence 34568999999988889999999999999999997 999998777655544433 3344455667899999999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 042314 335 NPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~l~~ 351 (370)
+|++||+++++++.|++
T Consensus 237 ~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 237 EPKKRPSFHKLREKLEK 253 (254)
T ss_pred ChhhCcCHHHHHHHHcc
Confidence 99999999999988753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=283.39 Aligned_cols=243 Identities=23% Similarity=0.431 Sum_probs=206.7
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|++|.++.+.. .+..+++|.+..... .......+.+|+.++++++|+||+++++++...+.++++|||+++++
T Consensus 7 ~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (256)
T cd08221 7 VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85 (256)
T ss_pred EecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCc
Confidence 378899998888765 478899998765432 23455678899999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 176 LHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 176 L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|.+++.+. ..++...+..++.|++.++.|||+.+ ++|+||+|+||+++.++.+||+|||++........ ...
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~---~~~ 159 (256)
T cd08221 86 LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS---MAE 159 (256)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc---ccc
Confidence 99999865 46899999999999999999999998 99999999999999999999999999876644331 122
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
...+++.|.|||.+.+..++.++|+||+|+++|+|++|..||......+....... ......+..++..+.+++.+||.
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ-GNYTPVVSVYSSELISLVHSLLQ 238 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-CCCCCCccccCHHHHHHHHHHcc
Confidence 34578999999999888889999999999999999999999988777665555542 33334456688999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~ 348 (370)
.+|++||++.+++++
T Consensus 239 ~~p~~R~s~~~ll~~ 253 (256)
T cd08221 239 QDPEKRPTADEVLDQ 253 (256)
T ss_pred cCcccCCCHHHHhhC
Confidence 999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=289.94 Aligned_cols=253 Identities=26% Similarity=0.542 Sum_probs=205.6
Q ss_pred cCCCCCCcccEEEEEEc--Cc----eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 97 GGIDPGAYGEVYLVKWR--GT----EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
..+|.|+||.||++.+. +. .+++|.+... ........+.+|+.+++.++||||+++++++... ..++++||
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET--TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred cccccCCCccEEEEEEecCCCcceeeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 45899999999999763 43 4677777543 2234445688999999999999999999988654 46789999
Q ss_pred cCCCCHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 171 LRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 171 ~~g~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+.+|+|.+++.... .++...+..++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+++........
T Consensus 90 ~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~- 165 (303)
T cd05110 90 MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE- 165 (303)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCcccc-
Confidence 99999999987654 6889999999999999999999998 999999999999999999999999999866433221
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||............. .......+..++..+.+++
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 244 (303)
T cd05110 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGERLPQPPICTIDVYMVM 244 (303)
T ss_pred cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHH
Confidence 12223345778999999998889999999999999999997 889997765544333332 3334444566788999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 329 RECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
.+||..+|++||++.++++.|+++.+.-.
T Consensus 245 ~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 245 VKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 99999999999999999999999876654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=282.94 Aligned_cols=243 Identities=30% Similarity=0.585 Sum_probs=203.7
Q ss_pred cCCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 97 GGIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
..+|.|++|.||++.+. +..+++|.+...... ...+.+|+.++++++||+++++++++......++|+||+.+++
T Consensus 10 ~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 10 QEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred eeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 34789999999999775 778999988654322 3467889999999999999999999999899999999999999
Q ss_pred HHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++... +.+++..++.++.|++.++.+||+.+ ++|+||||+||+++.++.++|+|||++......... ....
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--~~~~ 160 (256)
T cd05112 86 LSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT--SSTG 160 (256)
T ss_pred HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc--ccCC
Confidence 99998764 46889999999999999999999998 999999999999999999999999998765433211 1122
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..++..|+|||.+.+..++.++|+||||+++|+|++ |..||............. .......+...+..+.+++.+||.
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~l~ 239 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPRLASQSVYELMQHCWK 239 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHcc
Confidence 235678999999998889999999999999999998 999998777665555443 233334455678999999999999
Q ss_pred cCCCCCCCHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRL 349 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l 349 (370)
.+|++||++.++++.|
T Consensus 240 ~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 240 ERPEDRPSFSLLLHQL 255 (256)
T ss_pred cChhhCCCHHHHHHhh
Confidence 9999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=299.99 Aligned_cols=246 Identities=24% Similarity=0.375 Sum_probs=201.8
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|++.............+..|..++..++|++|+++++.+...+.+++||||+.+|+
T Consensus 8 ~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~ 87 (332)
T cd05623 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGD 87 (332)
T ss_pred EEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCc
Confidence 3799999999999875 56789999865332333445568889999999999999999999999999999999999999
Q ss_pred HHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++.+ ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ....
T Consensus 88 L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~--~~~~ 162 (332)
T cd05623 88 LLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV--QSSV 162 (332)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcc--eecc
Confidence 9999987 467899999999999999999999998 999999999999999999999999998755432211 1223
Q ss_pred CCCCccccCccccc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC---CCCCCCCcHHHHH
Q 042314 255 GTGSYRYMAPEVYR-----RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR---PALSSLYPEPIKA 326 (370)
Q Consensus 255 ~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~ 326 (370)
..||+.|+|||++. ...++.++|+|||||++|||++|+.||...........+.....+ +.....+++.+.+
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~ 242 (332)
T cd05623 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKD 242 (332)
T ss_pred cccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHH
Confidence 46899999999986 345788999999999999999999999988776666655433322 2223457899999
Q ss_pred HHHHhcccCCCC--CCCHHHHHHH
Q 042314 327 LLRECWHKNPDR--RPTFEEIIFR 348 (370)
Q Consensus 327 li~~~l~~~p~~--Rp~~~~ll~~ 348 (370)
++++|+..++.+ |+++.+++++
T Consensus 243 li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 243 LIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHHHHccChhhhcCCCCHHHHhCC
Confidence 999999665544 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=287.65 Aligned_cols=243 Identities=28% Similarity=0.450 Sum_probs=200.0
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|+||.||++... +..+++|.+... .......+.+|+.+++.++||||+++++.+...+..++|+||+.++
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 11 GELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred hhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 34899999999999876 556777776442 3445677889999999999999999999999999999999999999
Q ss_pred CHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+|..++.+ ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ...
T Consensus 88 ~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~---~~~ 161 (282)
T cd06643 88 AVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ---RRD 161 (282)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc---ccc
Confidence 99988765 457899999999999999999999998 99999999999999999999999999865533211 122
Q ss_pred CCCCCccccCccccc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-CCCCCCCCCCcHHHHHH
Q 042314 254 GGTGSYRYMAPEVYR-----RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-DSRPALSSLYPEPIKAL 327 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~l 327 (370)
...+++.|+|||.+. +..++.++|+||+||++|+|++|++||............... ......+..+|..+.++
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 335788999999984 345778999999999999999999999877665544443321 22233455688999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 042314 328 LRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 328 i~~~l~~~p~~Rp~~~~ll~~ 348 (370)
|.+||+.||.+||++.+++++
T Consensus 242 i~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 242 LKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999998765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=300.40 Aligned_cols=246 Identities=22% Similarity=0.345 Sum_probs=201.9
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... ++.+|+|.+.............+..|..++..++|++|+++++++...+..++||||+.||+
T Consensus 8 ~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~ 87 (331)
T cd05624 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGD 87 (331)
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCc
Confidence 3789999999999875 67799999865432333445567889999999999999999999999999999999999999
Q ss_pred HHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++.+ ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ....
T Consensus 88 L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~ 162 (331)
T cd05624 88 LLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV--QSSV 162 (331)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce--eecc
Confidence 9999987 467899999999999999999999998 999999999999999999999999998766543221 1223
Q ss_pred CCCCccccCcccccc-----cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCC---CCCcHHHHH
Q 042314 255 GTGSYRYMAPEVYRR-----ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALS---SLYPEPIKA 326 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~ 326 (370)
..||+.|+|||++.+ ..++.++|+||+|+++|+|++|+.||...........+.....+...+ ..+++.+.+
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~ 242 (331)
T cd05624 163 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKD 242 (331)
T ss_pred ccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHH
Confidence 468999999999875 457889999999999999999999998877766555554333322222 346889999
Q ss_pred HHHHhcccCCCC--CCCHHHHHHH
Q 042314 327 LLRECWHKNPDR--RPTFEEIIFR 348 (370)
Q Consensus 327 li~~~l~~~p~~--Rp~~~~ll~~ 348 (370)
++.+||..++.+ |+++++++++
T Consensus 243 li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 243 LIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHHHccCchhhcCCCCHHHHhcC
Confidence 999999876544 4688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=288.45 Aligned_cols=245 Identities=32% Similarity=0.530 Sum_probs=202.1
Q ss_pred CCCCCcccEEEEEEcC--------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 99 IDPGAYGEVYLVKWRG--------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g--------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
+|.|++|.||++.... ..+++|.+.... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 3 lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred cccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 7899999999987642 457888775432 223456788999999999999999999999998999999999
Q ss_pred cCCCCHHHHHHhC-------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC-----cEEEecccc
Q 042314 171 LRNGSLHDILKKK-------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG-----HLKVTDFGL 238 (370)
Q Consensus 171 ~~g~~L~~~l~~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~-----~~kl~Dfg~ 238 (370)
+++++|.+++... ..++...+..++.|++.|+.|||+.+ ++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998743 24678899999999999999999988 99999999999999877 899999999
Q ss_pred ceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCC
Q 042314 239 SKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALS 317 (370)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 317 (370)
+.......... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||............. .......+
T Consensus 158 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 235 (269)
T cd05044 158 ARDIYKSDYYR-KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT-AGGRLQKP 235 (269)
T ss_pred ccccccccccc-cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh-cCCccCCc
Confidence 87654332111 1112245678999999998889999999999999999998 999998776655544433 23344556
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 318 SLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 318 ~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
..+|..+.+++.+||..+|++||++.++++.|+
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 236 ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 678999999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=304.72 Aligned_cols=243 Identities=26% Similarity=0.501 Sum_probs=203.5
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEec-cccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC--ceEEEEeec
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE--RLIFLTEYL 171 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~-~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~--~~~~v~e~~ 171 (370)
..+|.|+|.+||+|.+. |-.||=-.++ ......+....+|..|+.+|+.|+||||+++++++.+.. .+.+|+|++
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 34899999999999775 4444311111 122356778899999999999999999999999987754 488999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC-CCCcEEEeccccceeccccCccce
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD-EAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
..|+|..|+++.++.+.+.+..|++||++||.|||++. +||||||||.+||||+ ..|.|||+|+|+|........
T Consensus 126 TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a--- 201 (632)
T KOG0584|consen 126 TSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA--- 201 (632)
T ss_pred cCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcccc---
Confidence 99999999999999999999999999999999999998 5899999999999998 568999999999988765532
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhccCCCC-CCCCCCcHHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA-VQVADRRAYEDSRP-ALSSLYPEPIKALL 328 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~l~~li 328 (370)
...+|||.|||||+.. ..|+..+||||||++|+||.|+..||..... .+++.++. .+..| .+...-.+++++||
T Consensus 202 --ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~-SGiKP~sl~kV~dPevr~fI 277 (632)
T KOG0584|consen 202 --KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT-SGIKPAALSKVKDPEVREFI 277 (632)
T ss_pred --ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH-cCCCHHHhhccCCHHHHHHH
Confidence 2358999999999987 7799999999999999999999999987655 44555555 44444 44555567899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+|+.. .++|||+.|||.+
T Consensus 278 ekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 278 EKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHhcC-chhccCHHHHhhC
Confidence 999999 8999999999864
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=286.06 Aligned_cols=242 Identities=27% Similarity=0.485 Sum_probs=205.2
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|++|.||.+.+. +..+++|.+.... .......+.+|+.+++.++||||+++++.+...+..++||||++|+
T Consensus 10 ~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06640 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred hhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence 34899999999999764 6789999886542 2345578899999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|.+++.. ++++...+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 88 ~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~ 160 (277)
T cd06640 88 SALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNT 160 (277)
T ss_pred cHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc---cccc
Confidence 99999875 47899999999999999999999998 99999999999999999999999999876644321 1122
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||............. ....+..+..+|..+.+++.+||+.
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 239 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDACLNK 239 (277)
T ss_pred ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHHHHHHHccc
Confidence 356888999999988889999999999999999999999998766554443322 2334455566888999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042314 335 NPDRRPTFEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~ 348 (370)
+|++||++.+++.+
T Consensus 240 ~p~~Rp~~~~il~~ 253 (277)
T cd06640 240 DPSFRPTAKELLKH 253 (277)
T ss_pred CcccCcCHHHHHhC
Confidence 99999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=290.89 Aligned_cols=240 Identities=25% Similarity=0.451 Sum_probs=200.3
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|++|.||++.. .+..+++|.+..... .....+.+|+.+++.++||||+++++.+......++||||+.+++|
T Consensus 28 lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L 104 (296)
T cd06654 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (296)
T ss_pred ecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence 78999999999976 478899998865432 2346688999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.+. .++..++..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......... .....
T Consensus 105 ~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~ 177 (296)
T cd06654 105 TDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMV 177 (296)
T ss_pred HHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc---cCccc
Confidence 9998754 6889999999999999999999998 999999999999999999999999988755432211 12235
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC-CCCCCCCCCcHHHHHHHHHhcccC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED-SRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
+++.|+|||.+.+..++.++|+||||+++|+|++|+.||................ .....+..++..+.+++.+||..+
T Consensus 178 ~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (296)
T cd06654 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257 (296)
T ss_pred CCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCC
Confidence 7889999999998888999999999999999999999998776543332222111 122334567889999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042314 336 PDRRPTFEEIIFR 348 (370)
Q Consensus 336 p~~Rp~~~~ll~~ 348 (370)
|++||++.+++.+
T Consensus 258 p~~Rpt~~eil~~ 270 (296)
T cd06654 258 VEKRGSAKELLQH 270 (296)
T ss_pred cccCcCHHHHhhC
Confidence 9999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=285.25 Aligned_cols=236 Identities=19% Similarity=0.353 Sum_probs=189.6
Q ss_pred CCCCCcccEEEEEEcC--------------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCce
Q 042314 99 IDPGAYGEVYLVKWRG--------------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERL 164 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g--------------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~ 164 (370)
+|.|+||.||++.... ..+++|.+... .......+..|+.+++.++||||+++++++......
T Consensus 3 lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred cccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 7899999999997532 24677776543 234456788899999999999999999999988899
Q ss_pred EEEEeecCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc-------EEEecc
Q 042314 165 IFLTEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH-------LKVTDF 236 (370)
Q Consensus 165 ~~v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~-------~kl~Df 236 (370)
+++|||+++++|..++.+. ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++. ++++||
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999988754 56899999999999999999999998 999999999999987664 899999
Q ss_pred ccceeccccCccceeccCCCCCccccCccccc-ccCCCchhhHHHHHHHHHHHH-hCCCCCCCCcHHHHHHHhhccCCCC
Q 042314 237 GLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYR-RESYGKSVDVFSFALIVHEMF-QGGPSNRADTAVQVADRRAYEDSRP 314 (370)
Q Consensus 237 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~-~g~~p~~~~~~~~~~~~~~~~~~~~ 314 (370)
|++...... ....++..|+|||.+. +..++.++||||||+++|+|+ +|..||......+...... ...
T Consensus 157 g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~---~~~ 226 (262)
T cd05077 157 GIPITVLSR-------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE---GQC 226 (262)
T ss_pred CCCccccCc-------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh---cCc
Confidence 988654322 1234678899999886 466889999999999999997 5888887655433322111 111
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 315 ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 315 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
......++.+.+++++||+.||++||++.++++.|+
T Consensus 227 ~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 227 MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 222334678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=307.80 Aligned_cols=236 Identities=24% Similarity=0.315 Sum_probs=186.5
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC--------CceEEE
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS--------ERLIFL 167 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~--------~~~~~v 167 (370)
.+|.|+||.||++.. .+..+|+|.+.... ....+|+.+++.++||||+++++++... ..+++|
T Consensus 73 ~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred EEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEE
Confidence 378999999999987 47889999875431 2234799999999999999998876432 246799
Q ss_pred EeecCCCCHHHHHH----hCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC-cEEEeccccceec
Q 042314 168 TEYLRNGSLHDILK----KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG-HLKVTDFGLSKIA 242 (370)
Q Consensus 168 ~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~ 242 (370)
|||+.+ +|.+++. ....++...++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 146 mE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 999976 7777664 3457899999999999999999999998 99999999999999665 6999999999866
Q ss_pred cccCccceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC---------
Q 042314 243 QEKDSYSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS--------- 312 (370)
Q Consensus 243 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--------- 312 (370)
..... .....+|+.|+|||++.+. .++.++|||||||++|||++|.+||...........+.....
T Consensus 222 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 222 LAGQR----SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred cCCCC----cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 43321 1234679999999998764 689999999999999999999999987765443322211000
Q ss_pred ------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 313 ------------------RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 313 ------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
...++...|+++.+||++||..||.+|||+.+++.+
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 011233467889999999999999999999999866
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=292.09 Aligned_cols=249 Identities=29% Similarity=0.414 Sum_probs=202.7
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.++.|+||.||++... ++.+++|.+.............+.+|+.+++.++||||+++++.+...+..++||||++|++
T Consensus 8 ~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 87 (305)
T cd05609 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGD 87 (305)
T ss_pred EeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCc
Confidence 3788999999999775 67899998876543334456678899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc--------
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS-------- 247 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-------- 247 (370)
|.+++...+.+++..+..++.|++.|+.|||+++ ++||||||+||+++.++.++|+|||+++.......
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 164 (305)
T cd05609 88 CATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164 (305)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccccccc
Confidence 9999988888999999999999999999999998 99999999999999999999999998864211100
Q ss_pred ----cceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC-CCCCCCCCCcH
Q 042314 248 ----YSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED-SRPALSSLYPE 322 (370)
Q Consensus 248 ----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 322 (370)
.........++..|+|||.+.+..++.++|+||||+++|+|++|..||................ ..+.....+|.
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (305)
T cd05609 165 EKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPA 244 (305)
T ss_pred ccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCH
Confidence 0001112346788999999988889999999999999999999999998777665555443222 22333346789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042314 323 PIKALLRECWHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 323 ~l~~li~~~l~~~p~~Rp~~~~ll~~l 349 (370)
.+.++|++||+.+|++||+..++.+.|
T Consensus 245 ~~~~li~~~l~~~P~~R~~~~~~~~ll 271 (305)
T cd05609 245 DAQDLISRLLRQNPLERLGTGGAFEVK 271 (305)
T ss_pred HHHHHHHHHhccChhhccCccCHHHHH
Confidence 999999999999999999854444333
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=282.63 Aligned_cols=242 Identities=27% Similarity=0.451 Sum_probs=202.0
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee-CCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH-SERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~-~~~~~~v~e~~~g~~ 175 (370)
+|.|++|.||.+... ++.+++|.+.... ......+.+.+|+.++++++|||++++++.+.. ...+++++||+++++
T Consensus 8 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 86 (257)
T cd08223 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGD 86 (257)
T ss_pred ecCCCCeEEEEEEEcCCCcEEEEEEEehhh-cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCc
Confidence 688999999998764 6789999986543 223445678899999999999999999998764 446899999999999
Q ss_pred HHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 176 LHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 176 L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|.+++... ..+++.++..++.+++.++.+||+++ ++|+||||+||+++.++.++|+|||++........ ...
T Consensus 87 l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~ 160 (257)
T cd08223 87 LYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD---MAS 160 (257)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC---ccc
Confidence 99998763 45899999999999999999999998 99999999999999999999999999876643322 122
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
...+++.|+|||.+.+..++.++|+||+|+++++|++|+.||............. ....+..+..+++.+.+++.+||+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 239 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPPMPKDYSPELGELIATMLS 239 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHHHhc
Confidence 3457889999999999889999999999999999999999998776655444333 233345566788999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~ 348 (370)
.+|++||++.+++++
T Consensus 240 ~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 240 KRPEKRPSVKSILRQ 254 (257)
T ss_pred cCcccCCCHHHHhcC
Confidence 999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=284.01 Aligned_cols=244 Identities=30% Similarity=0.495 Sum_probs=208.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccC--CChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIA--SNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~--~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
.+|.|++|.||++... +..+++|.+..... ...+....+.+|+.+++.++||||+++++++......++++||+++
T Consensus 7 ~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (258)
T cd06632 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPG 86 (258)
T ss_pred eeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCC
Confidence 4789999999999874 78899998865432 2244567889999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
++|.+++.+.+.+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~----~~~ 159 (258)
T cd06632 87 GSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS----FAK 159 (258)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc----ccc
Confidence 999999998878999999999999999999999998 9999999999999999999999999987654332 122
Q ss_pred CCCCCccccCcccccccC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 254 GGTGSYRYMAPEVYRRES-YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
...+++.|+|||.+.... ++.++|+||||+++|+|++|+.||..................+..+..+++.+.+++++||
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 239 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence 345788999999987766 8999999999999999999999998776555444444334455566778899999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFR 348 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~ 348 (370)
..+|++||++.+++.+
T Consensus 240 ~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 240 QRDPSLRPTAAELLEH 255 (258)
T ss_pred hcCcccCcCHHHHhcC
Confidence 9999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=286.74 Aligned_cols=241 Identities=28% Similarity=0.473 Sum_probs=204.6
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|++|.||++... +..+++|.+.... .......+.+|+.+++.++||||+++++.+.....+++|+||+.+++
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (274)
T cd06609 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS 85 (274)
T ss_pred hhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCc
Confidence 4789999999999874 7789999886542 23345668899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++... ++++..+..++.|++.++.|||+.+ ++|+||+|+||++++++.++|+|||++........ .....
T Consensus 86 L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---~~~~~ 158 (274)
T cd06609 86 CLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS---KRNTF 158 (274)
T ss_pred HHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc---ccccc
Confidence 99999876 8899999999999999999999998 99999999999999999999999999987764421 12233
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCC-CcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSL-YPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~ 334 (370)
.+++.|+|||.+.+..++.++|+||||+++|+|++|.+||............. ....+..+.. +|..+.+++.+||..
T Consensus 159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~l~~ 237 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNPPSLEGNKFSKPFKDFVSLCLNK 237 (274)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-hcCCCCCcccccCHHHHHHHHHHhhC
Confidence 57889999999998889999999999999999999999998766554443333 2233333333 889999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042314 335 NPDRRPTFEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~ 348 (370)
+|++||++++++++
T Consensus 238 ~p~~Rpt~~~il~~ 251 (274)
T cd06609 238 DPKERPSAKELLKH 251 (274)
T ss_pred ChhhCcCHHHHhhC
Confidence 99999999999774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=287.26 Aligned_cols=236 Identities=21% Similarity=0.380 Sum_probs=189.4
Q ss_pred CCCCCcccEEEEEEc--------------------------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCcee
Q 042314 99 IDPGAYGEVYLVKWR--------------------------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIV 152 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--------------------------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv 152 (370)
+|+|+||.||++... ...+++|.+... .......+..|+.+++.++||||+
T Consensus 3 lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred cCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCee
Confidence 799999999988642 123677777543 234456788899999999999999
Q ss_pred eeeeeEeeCCceEEEEeecCCCCHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC--
Q 042314 153 QFLGVLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG-- 229 (370)
Q Consensus 153 ~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~-- 229 (370)
++++++......++||||+++++|..++.+ .+.++...+..++.|++.||.|||+++ |+||||||+||+++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999999875 467899999999999999999999998 99999999999998644
Q ss_pred -----cEEEeccccceeccccCccceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHH-hCCCCCCCCcHHH
Q 042314 230 -----HLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMF-QGGPSNRADTAVQ 302 (370)
Q Consensus 230 -----~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~-~g~~p~~~~~~~~ 302 (370)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|+||||+++|||+ +|..||.......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cCccceeeecCCccccccccc-------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3899999987543221 11246788999998865 55789999999999999984 7899997765544
Q ss_pred HHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 303 VADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
...... .....+...++.+.+++.+||+.+|++|||+.++++.|+
T Consensus 230 ~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERFYE---KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHH---hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 322211 122233345678999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=293.14 Aligned_cols=242 Identities=23% Similarity=0.373 Sum_probs=193.9
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|.++.... ......+.+|+.++++++||||+++++++...+..++||||+++ +
T Consensus 13 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 89 (309)
T cd07872 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D 89 (309)
T ss_pred EecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence 4799999999999764 67799998875432 22334567899999999999999999999999999999999976 8
Q ss_pred HHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++... ..++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 90 l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 163 (309)
T cd07872 90 LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK---TYSN 163 (309)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc---cccc
Confidence 88887654 45788999999999999999999998 99999999999999999999999999876543321 1122
Q ss_pred CCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC--------------------CC
Q 042314 255 GTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED--------------------SR 313 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--------------------~~ 313 (370)
..+++.|+|||.+.+ ..++.++||||+|+++|+|++|++||...+..+......... ..
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 357889999999865 457899999999999999999999998766543322211000 00
Q ss_pred C--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 P--------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 ~--------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+ .....+++.+.++|.+||..||.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0 0112467889999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=293.39 Aligned_cols=248 Identities=24% Similarity=0.387 Sum_probs=205.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|++|.||++... +..+++|.+.............+..|+.+++.++||+|+++++.+......++||||+.|++
T Consensus 8 ~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (316)
T cd05574 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGE 87 (316)
T ss_pred eecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCC
Confidence 4789999999999875 68899999876544444566778999999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc----
Q 042314 176 LHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS---- 249 (370)
Q Consensus 176 L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---- 249 (370)
|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 88 L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (316)
T cd05574 88 LFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL 164 (316)
T ss_pred HHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccccccccc
Confidence 99998764 46899999999999999999999998 9999999999999999999999999886543221110
Q ss_pred ----------------------eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Q 042314 250 ----------------------YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRR 307 (370)
Q Consensus 250 ----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~ 307 (370)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~ 244 (316)
T cd05574 165 RKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNI 244 (316)
T ss_pred ccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHH
Confidence 0111235788999999999888999999999999999999999999877665544444
Q ss_pred hccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 042314 308 AYEDSRPALSSLYPEPIKALLRECWHKNPDRRPT----FEEIIFR 348 (370)
Q Consensus 308 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~----~~~ll~~ 348 (370)
.............|..+.+++.+||..||++||+ +.+++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 245 LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 3222222222337899999999999999999999 8888775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=303.76 Aligned_cols=245 Identities=28% Similarity=0.510 Sum_probs=216.8
Q ss_pred CCCCCCcccEEEEEEc---Cc--eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWR---GT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~---g~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|+|.||.|+.+.|+ |+ .||||.++... .......|.+|+.+|.+|.|||++++||+..+ ....+|+|++.
T Consensus 117 ~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~--l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 117 LLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDS--LNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HhcCcceeeEeeccccCCCCcEEeEEEEeccCCc--cchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 4899999999999996 33 48999987653 22367889999999999999999999999887 67889999999
Q ss_pred CCCHHHHHHh--CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 173 NGSLHDILKK--KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 173 g~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
.|+|.+.+.+ +..|.......++.||+.||.||.+++ +|||||..+|+++-....|||+|||+++.++.......
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 9999999986 356788889999999999999999998 99999999999999999999999999999988766553
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
.....--...|+|||.+....|+.++|+|++|+++||||+ |+.||.+.....+...+. .+.+.+-++.+|+.+++++.
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csedIY~imk 349 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSEDIYQIMK 349 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHHHHHHHH
Confidence 4334445779999999999999999999999999999997 679999999988888887 77888888999999999999
Q ss_pred HhcccCCCCCCCHHHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~l 349 (370)
.||..+|.+||++..|.+.+
T Consensus 350 ~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 350 NCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HhccCCccccccHHHHHHhH
Confidence 99999999999999997543
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=288.76 Aligned_cols=251 Identities=29% Similarity=0.576 Sum_probs=204.3
Q ss_pred cCCCCCCcccEEEEEEc------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee--CCceEEEE
Q 042314 97 GGIDPGAYGEVYLVKWR------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH--SERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~--~~~~~~v~ 168 (370)
..+|.|+||.||++.+. +..+++|.+...... .....+.+|+..++.++||||+++++++.. ....+++|
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIM 87 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEE
Confidence 44789999999999764 568999998765322 456789999999999999999999998877 55789999
Q ss_pred eecCCCCHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 169 EYLRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
||+++++|.+++.... .++...+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........
T Consensus 88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05038 88 EYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD 164 (284)
T ss_pred ecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCc
Confidence 9999999999998754 6899999999999999999999998 99999999999999999999999999987763322
Q ss_pred cceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH--------------HHHHhhccCCC
Q 042314 248 YSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ--------------VADRRAYEDSR 313 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--------------~~~~~~~~~~~ 313 (370)
.........++..|+|||.+.+..++.++|+||||+++|+|++|..|+....... ...........
T Consensus 165 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
T cd05038 165 YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER 244 (284)
T ss_pred ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCc
Confidence 2111122234667999999988889999999999999999999999876543221 11111112233
Q ss_pred CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042314 314 PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 314 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
...+..+|..+.+++.+||..+|++||++.++++.|+++
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 245 LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 344556788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=285.15 Aligned_cols=242 Identities=26% Similarity=0.425 Sum_probs=201.7
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.++.|++|.||++... +..+++|.+.... ......+.+|+.++++++||||+++++.+...+.++++|||+.+++
T Consensus 10 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~ 86 (262)
T cd06613 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGS 86 (262)
T ss_pred EecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence 3788999999999864 6789999987543 2356788999999999999999999999999999999999999999
Q ss_pred HHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 87 l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---~~~~ 160 (262)
T cd06613 87 LQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA---KRKS 160 (262)
T ss_pred HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh---cccc
Confidence 99999876 78999999999999999999999998 99999999999999999999999999876543221 1122
Q ss_pred CCCCccccCccccccc---CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC---CCCCCCCcHHHHHHH
Q 042314 255 GTGSYRYMAPEVYRRE---SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR---PALSSLYPEPIKALL 328 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~---~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li 328 (370)
..++..|+|||.+... .++.++|+||+|+++|+|++|++||.................. ...+..+|..+.+++
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI 240 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHH
Confidence 3578889999999776 7889999999999999999999999877655444333222111 122334678899999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+||..+|.+|||+.+++.+
T Consensus 241 ~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 241 KKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHHcCCChhhCCCHHHHhcC
Confidence 99999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=289.23 Aligned_cols=247 Identities=29% Similarity=0.493 Sum_probs=198.6
Q ss_pred CCCCCCcccEEEEEEc------------------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEe
Q 042314 98 GIDPGAYGEVYLVKWR------------------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~------------------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~ 159 (370)
.+|.|+||.||++.+. +..+++|.+... ........+.+|+.+++.++|+||+++++++.
T Consensus 12 ~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05095 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI 89 (296)
T ss_pred eccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 3899999999998543 234788887653 23455678899999999999999999999999
Q ss_pred eCCceEEEEeecCCCCHHHHHHhCC-----------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC
Q 042314 160 HSERLIFLTEYLRNGSLHDILKKKG-----------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA 228 (370)
Q Consensus 160 ~~~~~~~v~e~~~g~~L~~~l~~~~-----------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~ 228 (370)
..+..+++|||+.+++|.+++.... .++...+..++.|++.|+.|||+++ ++|+||||+||+++.+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~ 166 (296)
T cd05095 90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKN 166 (296)
T ss_pred cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCC
Confidence 9999999999999999999987642 3566789999999999999999998 9999999999999999
Q ss_pred CcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh--CCCCCCCCcHHHHHHH
Q 042314 229 GHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ--GGPSNRADTAVQVADR 306 (370)
Q Consensus 229 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~--g~~p~~~~~~~~~~~~ 306 (370)
+.++|+|||++.......... ......+++.|++||...+..++.++|+|||||++|||++ |..||......+....
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~ 245 (296)
T cd05095 167 YTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN 245 (296)
T ss_pred CCEEeccCcccccccCCccee-ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 999999999987654332111 1111234678999999888889999999999999999998 7788876655443332
Q ss_pred hhc------cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 307 RAY------EDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 307 ~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
... .....+.+..+|+.+.+++.+||+.||++||++.++++.|+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 246 TGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 210 11122334567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=284.08 Aligned_cols=246 Identities=29% Similarity=0.521 Sum_probs=205.0
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+++.||++.. .+..+++|.++..... ......+..|+.+++.++|+||+++++.+...+..++|+||+.+++
T Consensus 7 ~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06626 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT 85 (264)
T ss_pred EeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCc
Confidence 378899999999976 4788999998765433 4567889999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee-ccC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK-MTG 254 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~ 254 (370)
|.+++.+.+.+++..+..++.+++.|+.|||+.+ ++|+||+|+||+++.++.+||+|||++............ ...
T Consensus 86 L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~ 162 (264)
T cd06626 86 LEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162 (264)
T ss_pred HHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccC
Confidence 9999998877899999999999999999999998 999999999999999999999999998876554332211 123
Q ss_pred CCCCccccCcccccccC---CCchhhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhccCCCCCCCCC--CcHHHHHHH
Q 042314 255 GTGSYRYMAPEVYRRES---YGKSVDVFSFALIVHEMFQGGPSNRADTA-VQVADRRAYEDSRPALSSL--YPEPIKALL 328 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~--~~~~l~~li 328 (370)
..+++.|+|||.+.+.. ++.++|+||||+++|++++|+.||..... ........ ....+..+.. ++..+.+++
T Consensus 163 ~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li 241 (264)
T cd06626 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQLSPEGKDFL 241 (264)
T ss_pred CcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh-cCCCCCCCcccccCHHHHHHH
Confidence 45788999999998766 78999999999999999999999976532 22222222 2333344443 488999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+||+.+|++||++.+++.+
T Consensus 242 ~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 242 DRCLESDPKKRPTASELLQH 261 (264)
T ss_pred HHHccCCcccCCCHHHHhcC
Confidence 99999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=286.45 Aligned_cols=242 Identities=26% Similarity=0.445 Sum_probs=199.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|++|.||++... +..+++|.+... .......+.+|+.+++.++||||+++++.+...+..++||||+++++
T Consensus 19 ~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (292)
T cd06644 19 ELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGA 95 (292)
T ss_pred eecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence 3789999999999875 678888888643 44566778899999999999999999999999999999999999999
Q ss_pred HHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|..++.+ ...+++..+..++.|++.++.|||+.+ ++||||||+||+++.++.++|+|||++........ ....
T Consensus 96 l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~ 169 (292)
T cd06644 96 VDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ---RRDS 169 (292)
T ss_pred HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc---ccce
Confidence 9988764 457899999999999999999999998 99999999999999999999999998765432211 1123
Q ss_pred CCCCccccCccccc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-CCCCCCCCCCcHHHHHHH
Q 042314 255 GTGSYRYMAPEVYR-----RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-DSRPALSSLYPEPIKALL 328 (370)
Q Consensus 255 ~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 328 (370)
..+++.|+|||.+. ...++.++|+||||+++|+|++|.+||............... ......+..++..+.+++
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (292)
T cd06644 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFL 249 (292)
T ss_pred ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHH
Confidence 35788999999985 344678999999999999999999999876654443333211 112233456788999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+||..+|++||++.+++++
T Consensus 250 ~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 250 KTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHhcCCcccCcCHHHHhcC
Confidence 99999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=308.11 Aligned_cols=241 Identities=31% Similarity=0.526 Sum_probs=207.7
Q ss_pred CCCCCcccEEEEEEcC--ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWRG--TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g--~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|+|.||+||.+++.. ..+|+|.+... +....+.+..|+...++++|.|||+++|.+..++.+-|.||-++||+|
T Consensus 583 LGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 583 LGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred eecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 8999999999998864 45788877654 334567788999999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCC--ChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC-CCCcEEEeccccceeccccCccceec
Q 042314 177 HDILKKK-GKL--DPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD-EAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 177 ~~~l~~~-~~~--~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
.++++.+ +++ .+.+.-.+..||++||.|||.+. |||||||-+|+||. -.|.+||+|||-++++..-++. .
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~---T 733 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC---T 733 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCcc---c
Confidence 9999865 677 78889999999999999999999 99999999999997 4688999999999887654432 2
Q ss_pred cCCCCCccccCccccccc--CCCchhhHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 253 TGGTGSYRYMAPEVYRRE--SYGKSVDVFSFALIVHEMFQGGPSNRAD-TAVQVADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
....||..|||||++..+ .|..++|||||||++.||.||+|||... ++.....+......-|++|..++.+.+.||.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fil 813 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFIL 813 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHH
Confidence 345799999999999765 5889999999999999999999999765 3444445555566678889999999999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~ 348 (370)
+|+.++|.+||++.++|..
T Consensus 814 rcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 814 RCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHcCCCcccCccHHHhccC
Confidence 9999999999999999764
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=299.45 Aligned_cols=243 Identities=26% Similarity=0.353 Sum_probs=194.4
Q ss_pred cccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC------CceEE
Q 042314 95 DRGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS------ERLIF 166 (370)
Q Consensus 95 ~~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~------~~~~~ 166 (370)
....+|.|+||.||++... ++.+++|.+.... ........+.+|+.+++.++||||+++++++... ...++
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~l 106 (364)
T cd07875 28 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI 106 (364)
T ss_pred EEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEE
Confidence 3345899999999999764 7889999987543 2334456778999999999999999999987543 35799
Q ss_pred EEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccC
Q 042314 167 LTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD 246 (370)
Q Consensus 167 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 246 (370)
||||+++ +|.+.+.. .++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 107 v~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 180 (364)
T cd07875 107 VMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 180 (364)
T ss_pred EEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCCC
Confidence 9999976 78877764 5788899999999999999999998 9999999999999999999999999997654322
Q ss_pred ccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC---------------
Q 042314 247 SYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED--------------- 311 (370)
Q Consensus 247 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--------------- 311 (370)
......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...........+....
T Consensus 181 ----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 181 ----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred ----cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 1223468999999999999999999999999999999999999998765544332221100
Q ss_pred -----CCC--------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 -----SRP--------------------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 -----~~~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.++ ......+..+.+||.+||..||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 0111234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=293.28 Aligned_cols=247 Identities=17% Similarity=0.319 Sum_probs=193.3
Q ss_pred CCCCC--CcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 98 GIDPG--AYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g--~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
.+|.| +++.||++... |..+|+|.+..... .......+..|+.+++.++||||+++++++..++..++|+||+++
T Consensus 5 ~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 36667 77899998764 78899999876532 334566788899999999999999999999999999999999999
Q ss_pred CCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc--
Q 042314 174 GSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS-- 249 (370)
Q Consensus 174 ~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-- 249 (370)
++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++++||+............
T Consensus 84 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 84 GSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred CcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999753 45899999999999999999999998 9999999999999999999999998654332211100
Q ss_pred --eeccCCCCCccccCcccccc--cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC-------------
Q 042314 250 --YKMTGGTGSYRYMAPEVYRR--ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS------------- 312 (370)
Q Consensus 250 --~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~------------- 312 (370)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 00112246778999999976 4588999999999999999999999976544332211110000
Q ss_pred -------------------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 313 -------------------------------RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 313 -------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.......+++.+.+|+.+||+.||++|||+++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 001112356789999999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=287.94 Aligned_cols=242 Identities=26% Similarity=0.421 Sum_probs=200.0
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... |+.+++|.+.............+..|+.+++.++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 578999999998764 788999998764333334455677899999999999999999999999999999999999999
Q ss_pred HHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++.+.+ .+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~ 153 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----KIKG 153 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC----cccc
Confidence 99998765 7899999999999999999999998 9999999999999999999999999887654321 1122
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAV---QVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
..++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... ....... .......+..+++.+.++|++|
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT-LEMAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc-ccccccCCccCCHHHHHHHHHH
Confidence 35688999999998888999999999999999999999999765431 1111111 1233445566889999999999
Q ss_pred cccCCCCCC-----CHHHHHHH
Q 042314 332 WHKNPDRRP-----TFEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp-----~~~~ll~~ 348 (370)
|+.+|++|| ++.+++.+
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred ccCChhHccCCCcccHHHHHhC
Confidence 999999999 77778764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=290.23 Aligned_cols=244 Identities=31% Similarity=0.545 Sum_probs=197.9
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|.+...... ........+|+.++++++||||+++++++......++|||++.+++
T Consensus 6 ~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~ 84 (260)
T PF00069_consen 6 KLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGS 84 (260)
T ss_dssp EEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEB
T ss_pred EEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhcccccccccccccccccccccccccccccccccc
Confidence 3788999999999887 456999999775322 2223344569999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++...+.++...+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||.+....... ......
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~ 158 (260)
T PF00069_consen 85 LQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENN---ENFNPF 158 (260)
T ss_dssp HHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTT---SEBSSS
T ss_pred cccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc---cccccc
Confidence 9999997779999999999999999999999998 9999999999999999999999999987642111 123344
Q ss_pred CCCccccCccccc-ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhhccCC--CCCCCCCCcHHHHHHHH
Q 042314 256 TGSYRYMAPEVYR-RESYGKSVDVFSFALIVHEMFQGGPSNRADTA---VQVADRRAYEDS--RPALSSLYPEPIKALLR 329 (370)
Q Consensus 256 ~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~l~~li~ 329 (370)
.+++.|+|||.+. +..++.++|+||+|+++|+|++|..||..... ............ ........++.+.+++.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 238 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIK 238 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHH
Confidence 6799999999998 78889999999999999999999999988732 222221111000 01111122478999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~ 348 (370)
+||+.||++||++.+++++
T Consensus 239 ~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 239 KMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HHSSSSGGGSTTHHHHHTS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=286.98 Aligned_cols=241 Identities=29% Similarity=0.498 Sum_probs=202.9
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.++.|++|.||++... +..+++|.+.... .......+.+|+.+++.++||||+++++.+...+..++|+||+++++
T Consensus 11 ~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06642 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS 88 (277)
T ss_pred HhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCc
Confidence 4789999999999764 6789999876442 23455778999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.. +.+++..+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 89 L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~---~~~~~ 161 (277)
T cd06642 89 ALDLLKP-GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---KRNTF 161 (277)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch---hhhcc
Confidence 9998875 47899999999999999999999988 99999999999999999999999999876543321 11223
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.++..|+|||.+.+..++.++|+||||+++|+|++|+.||............. ....+.....++..+.+++.+||..+
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~ 240 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTLEGQYSKPFKEFVEACLNKD 240 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh-cCCCCCCCcccCHHHHHHHHHHccCC
Confidence 57889999999998889999999999999999999999997665544333222 23344455667889999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042314 336 PDRRPTFEEIIFR 348 (370)
Q Consensus 336 p~~Rp~~~~ll~~ 348 (370)
|++||++.+++.+
T Consensus 241 p~~Rp~~~~il~~ 253 (277)
T cd06642 241 PRFRPTAKELLKH 253 (277)
T ss_pred cccCcCHHHHHHh
Confidence 9999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=287.45 Aligned_cols=242 Identities=29% Similarity=0.481 Sum_probs=202.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|+|++|.||++... +..+++|.+... ........+.+|+++++.++||||+++++.+...+..++|+||+++++
T Consensus 12 ~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (284)
T cd06620 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIG--AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGS 89 (284)
T ss_pred HcCCCCCeEEEEEEEcCCCcEEEEEEEEec--CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCC
Confidence 4899999999999875 788999987653 234566788999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhh-cCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHH-HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++.+.+.++...+..++.+++.++.|||+ .+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 90 L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-----~~~ 161 (284)
T cd06620 90 LDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-----ADT 161 (284)
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc-----cCc
Confidence 99999988889999999999999999999997 46 9999999999999999999999999876543221 122
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH-----------HHHHHhhccCCCCCCCC-CCcH
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAV-----------QVADRRAYEDSRPALSS-LYPE 322 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-----------~~~~~~~~~~~~~~~~~-~~~~ 322 (370)
..++..|+|||.+.+..++.++|+||+||++|+|++|+.||...... ....... ....+..+. .+|.
T Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 240 (284)
T cd06620 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-QEPPPRLPSSDFPE 240 (284)
T ss_pred cccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-hccCCCCCchhcCH
Confidence 35789999999998888999999999999999999999999865432 1122221 122222222 3788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 323 PIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 323 ~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
.+.+|+++||+.||++|||+.+++++..
T Consensus 241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 241 DLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 9999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=284.97 Aligned_cols=241 Identities=25% Similarity=0.421 Sum_probs=196.6
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeC------CceEEEE
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHS------ERLIFLT 168 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~------~~~~~v~ 168 (370)
.+|.|+||.||++... +..+++|.+.... .....+.+|+.+++++ +||||+++++.+... ...+++|
T Consensus 13 ~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 88 (272)
T cd06637 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 88 (272)
T ss_pred heeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEE
Confidence 3788999999999774 6788999886542 2235678899999988 699999999998653 4589999
Q ss_pred eecCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccC
Q 042314 169 EYLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD 246 (370)
Q Consensus 169 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 246 (370)
||+.+++|.+++... ..+++..+..++.|++.|+.|||+++ |+|+||||+||+++.++.++|+|||++.......
T Consensus 89 e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~ 165 (272)
T cd06637 89 EFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 165 (272)
T ss_pred EcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence 999999999998864 36889999999999999999999998 9999999999999999999999999987654322
Q ss_pred ccceeccCCCCCccccCccccc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCc
Q 042314 247 SYSYKMTGGTGSYRYMAPEVYR-----RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYP 321 (370)
Q Consensus 247 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (370)
. ......|++.|+|||.+. ...++.++|+||+||++|+|++|..||........................+|
T Consensus 166 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (272)
T cd06637 166 G---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 242 (272)
T ss_pred c---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcC
Confidence 1 122345788999999986 33578899999999999999999999976655444443333333334445678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
..+.+|+.+||..+|.+|||+.+++++
T Consensus 243 ~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 243 KKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 999999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=299.10 Aligned_cols=241 Identities=24% Similarity=0.335 Sum_probs=192.7
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC------CceEEEE
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS------ERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~------~~~~~v~ 168 (370)
..+|.|+||.||++... +..+++|.+.... ........+.+|+.+++.++||||+++++++... ...++||
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 101 (355)
T cd07874 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 101 (355)
T ss_pred EEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence 34799999999999764 7889999987543 2334556788999999999999999999987643 3579999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
||+++ +|.+.+.. .++...+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||+++......
T Consensus 102 e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 173 (355)
T cd07874 102 ELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-- 173 (355)
T ss_pred hhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCcc--
Confidence 99976 77777754 5888999999999999999999998 9999999999999999999999999997654332
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc------------------
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE------------------ 310 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~------------------ 310 (370)
......+|+.|+|||.+.+..++.++|+|||||++|+|++|+.||...............
T Consensus 174 --~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T cd07874 174 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_pred --ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHH
Confidence 122346899999999999989999999999999999999999999766543322111000
Q ss_pred --CC--------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 311 --DS--------------------RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 311 --~~--------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.. ....+...+..+.+||.+||..||++|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 001112245678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=285.62 Aligned_cols=236 Identities=27% Similarity=0.419 Sum_probs=194.9
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|++|.||++.. .+..+++|.+... ........+.+|+.++++++||||+++++.+...+..++|+||+++++
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 85 (279)
T cd06619 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85 (279)
T ss_pred eeccCCCeEEEEEEEcCCCcEEEEEEEecC--CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence 478999999999976 4788999988654 234455678999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|..+ ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....... ....
T Consensus 86 l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-----~~~~ 153 (279)
T cd06619 86 LDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-----AKTY 153 (279)
T ss_pred hHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-----ccCC
Confidence 9755 35788899999999999999999998 9999999999999999999999999987654322 1234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhccCCCCC-CCCCCcHHHHHH
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAV-------QVADRRAYEDSRPA-LSSLYPEPIKAL 327 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~l~~l 327 (370)
.++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ....... ....+. .....++.+.++
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-ccCCCCCCCCcCCHHHHHH
Confidence 6889999999999888999999999999999999999999653211 1111111 111222 234577899999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 042314 328 LRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 328 i~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+.+||+.+|++||++++++++
T Consensus 233 i~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 233 ITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHhhCChhhCCCHHHHhcC
Confidence 999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=285.60 Aligned_cols=242 Identities=28% Similarity=0.461 Sum_probs=201.9
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.++.|++|.||++... +..+++|..... .......+..|+.++++++||||+++++.+......++||||+++++
T Consensus 12 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (280)
T cd06611 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGA 88 (280)
T ss_pred HhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCc
Confidence 4789999999999874 778999988643 34455778899999999999999999999999999999999999999
Q ss_pred HHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++.+. ..+++..+..++.|++.+|.|||+++ |+|+||+|+||+++.++.++|+|||++........ ....
T Consensus 89 L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---~~~~ 162 (280)
T cd06611 89 LDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ---KRDT 162 (280)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc---ccce
Confidence 99998764 46899999999999999999999998 99999999999999999999999998765543221 1123
Q ss_pred CCCCccccCccccc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC-CCCCCCCCCcHHHHHHH
Q 042314 255 GTGSYRYMAPEVYR-----RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED-SRPALSSLYPEPIKALL 328 (370)
Q Consensus 255 ~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li 328 (370)
..+++.|+|||.+. ...++.++|+||||+++|+|++|++||................ .....+..++..+.+++
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFL 242 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHH
Confidence 35788999999875 3446789999999999999999999998776655444443211 12223456889999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+||..+|++||++.+++++
T Consensus 243 ~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 243 KSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHhccChhhCcCHHHHhcC
Confidence 99999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=281.37 Aligned_cols=243 Identities=27% Similarity=0.521 Sum_probs=201.8
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|+||.||++... +..+++|.+... ......+.+|+.+++.++|+||+++++.+.. ...+++|||+++++|
T Consensus 13 ~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L 87 (260)
T cd05073 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSL 87 (260)
T ss_pred EecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcH
Confidence 3788999999999764 566888877642 2345678899999999999999999999877 778999999999999
Q ss_pred HHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++.+. ..++...+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+......... ....
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~ 162 (260)
T cd05073 88 LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT--AREG 162 (260)
T ss_pred HHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc--cccC
Confidence 9999764 35788889999999999999999988 999999999999999999999999998765432211 1122
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..++..|+|||.+....++.++|+||||+++|++++ |+.||............. .......+...|..+.+++.+||+
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~ 241 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELYNIMMRCWK 241 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-CCCCCCCcccCCHHHHHHHHHHcc
Confidence 235678999999988889999999999999999998 899998776655554433 233334456788999999999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~ 351 (370)
.+|++||++.++++.|+.
T Consensus 242 ~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 242 NRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cCcccCcCHHHHHHHHhc
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=286.65 Aligned_cols=241 Identities=25% Similarity=0.414 Sum_probs=194.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHH---hcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQ---KLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~---~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|+|+||.||++... +..+++|.+.............+..|..+++ ..+||+|+.+++.+...+..++||||+.+
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG 81 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence 689999999998774 7889999887654333333333444544433 34799999999999999999999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
++|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++........ .
T Consensus 82 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-----~ 153 (279)
T cd05633 82 GDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----H 153 (279)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-----c
Confidence 999999988888999999999999999999999998 99999999999999999999999999875543221 2
Q ss_pred CCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 254 GGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTA--VQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
...+++.|+|||.+.. ..++.++|+||+||++|+|++|..||..... ........ .......+..++..+.+++++
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHH
Confidence 2358999999999864 5678999999999999999999999975432 11111111 223345566788999999999
Q ss_pred hcccCCCCCC-----CHHHHHHH
Q 042314 331 CWHKNPDRRP-----TFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~Rp-----~~~~ll~~ 348 (370)
||..||++|| ++++++++
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhC
Confidence 9999999999 59999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=299.47 Aligned_cols=239 Identities=26% Similarity=0.350 Sum_probs=198.2
Q ss_pred ccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-C-----CceeeeeeeEeeCCceEEE
Q 042314 96 RGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-H-----PNIVQFLGVLKHSERLIFL 167 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-h-----p~Iv~~~~~~~~~~~~~~v 167 (370)
...+|.|.||.|.+|.+. +..||+|+++.. .....+...|+.+|..++ | -|+|+++++|...+++|||
T Consensus 191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 345899999999999775 788999999754 466778889999999997 4 3899999999999999999
Q ss_pred EeecCCCCHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC--cEEEeccccceecc
Q 042314 168 TEYLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG--HLKVTDFGLSKIAQ 243 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~--~~kl~Dfg~~~~~~ 243 (370)
+|.++- +|+++++.+. .++...++.++.||+.+|.+||+.+ |||.||||+|||+...+ .+||+|||+|+...
T Consensus 267 fELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred ehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccC
Confidence 999955 9999999763 6889999999999999999999998 99999999999998544 79999999999887
Q ss_pred ccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC------------
Q 042314 244 EKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED------------ 311 (370)
Q Consensus 244 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~------------ 311 (370)
.... ..+.+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+.+..+....+....
T Consensus 343 q~vy------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 343 QRVY------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred Ccce------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 6543 2356888999999999999999999999999999999999998887665332221100
Q ss_pred --------------------------------------CCCCCC-------C----CCcHHHHHHHHHhcccCCCCCCCH
Q 042314 312 --------------------------------------SRPALS-------S----LYPEPIKALLRECWHKNPDRRPTF 342 (370)
Q Consensus 312 --------------------------------------~~~~~~-------~----~~~~~l~~li~~~l~~~p~~Rp~~ 342 (370)
.....| . .-...|.+|+++||..||.+|+|+
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 000001 0 011458999999999999999999
Q ss_pred HHHHHH
Q 042314 343 EEIIFR 348 (370)
Q Consensus 343 ~~ll~~ 348 (370)
.+.++|
T Consensus 497 ~qal~H 502 (586)
T KOG0667|consen 497 AQALNH 502 (586)
T ss_pred HHHhcC
Confidence 999887
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=292.74 Aligned_cols=242 Identities=24% Similarity=0.391 Sum_probs=184.3
Q ss_pred CCCCCCcccEEEEEEc----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee--CCceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKWR----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH--SERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~--~~~~~~v~e~~ 171 (370)
.+|.|+||.||++... +..+++|.+.... ....+.+|+.++++++||||+++++.+.. ....++++||+
T Consensus 8 ~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 4899999999999753 4678999886532 22446789999999999999999998854 45689999999
Q ss_pred CCCCHHHHHHhC---------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee----CCCCcEEEecccc
Q 042314 172 RNGSLHDILKKK---------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ----DEAGHLKVTDFGL 238 (370)
Q Consensus 172 ~g~~L~~~l~~~---------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~----~~~~~~kl~Dfg~ 238 (370)
.+ +|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||+ +..+.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 65 898887632 25888999999999999999999998 9999999999999 4567899999999
Q ss_pred ceeccccCccceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHH---------HHHHHhh
Q 042314 239 SKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAV---------QVADRRA 308 (370)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---------~~~~~~~ 308 (370)
++................+|+.|+|||.+.+. .++.++|+||+||++|+|++|++||...... .....+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 98765432222223345689999999998774 5789999999999999999999999643210 0000000
Q ss_pred c-cC--------------CC---------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 309 Y-ED--------------SR---------------------PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 309 ~-~~--------------~~---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
. .+ .. .......+..+.++|++||+.||.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 00 00 00001124568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=281.83 Aligned_cols=247 Identities=33% Similarity=0.511 Sum_probs=206.7
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccC--CChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC--CceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIA--SNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS--ERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~--~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~--~~~~~v~e~~ 171 (370)
.+++|++|.||++.. .+..+++|.+..... ........+.+|+.++++++||||+++++++... ..+++++||+
T Consensus 9 ~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~ 88 (264)
T cd06653 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYM 88 (264)
T ss_pred eEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeC
Confidence 378899999999976 478899998754321 2344567889999999999999999999998664 4588999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
.+++|.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++............
T Consensus 89 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 165 (264)
T cd06653 89 PGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG 165 (264)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccccccCcc
Confidence 99999999988778999999999999999999999998 999999999999999999999999998765432111111
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
.....++..|+|||.+.+..++.++|+||||+++|+|++|++||..................+..+..+++.+.+++.+|
T Consensus 166 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~ 245 (264)
T cd06653 166 IKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQI 245 (264)
T ss_pred ccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHH
Confidence 22345788999999999888899999999999999999999999877666655555544556667888999999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~ 348 (370)
|. +|..||++.+++.+
T Consensus 246 l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 246 FV-EEKRRPTAEFLLRH 261 (264)
T ss_pred hc-CcccCccHHHHhcC
Confidence 99 57999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=285.54 Aligned_cols=237 Identities=24% Similarity=0.372 Sum_probs=191.5
Q ss_pred CCCCCCcccEEEEEEcC---------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEE
Q 042314 98 GIDPGAYGEVYLVKWRG---------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLT 168 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g---------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~ 168 (370)
.+|.|+||.||++.... ..+++|.+... .....+.+..|..+++.++||||+++++++......++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 37899999999997642 23666666432 2344567888999999999999999999999988999999
Q ss_pred eecCCCCHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc--------EEEeccccc
Q 042314 169 EYLRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH--------LKVTDFGLS 239 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~--------~kl~Dfg~~ 239 (370)
||+++|+|.+++..++ .+++..+..++.|++.||.|||+++ |+||||||+||+++.++. ++++|||.+
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999998654 5889999999999999999999998 999999999999987664 699999987
Q ss_pred eeccccCccceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCC-CCCCCCcHHHHHHHhhccCCCCCCC
Q 042314 240 KIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALS 317 (370)
Q Consensus 240 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~ 317 (370)
....... ...+++.|+|||.+.+. .++.++|+||||+++|+|++|. +||............ ......+
T Consensus 156 ~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~---~~~~~~~ 225 (258)
T cd05078 156 ITVLPKE-------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY---EDRHQLP 225 (258)
T ss_pred cccCCch-------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH---HccccCC
Confidence 6543321 12467889999999864 5789999999999999999995 666555444332221 2234455
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 318 SLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 318 ~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
...+..+.+++++||+.||++|||++++++.|+
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 226 APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 556788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=280.22 Aligned_cols=243 Identities=26% Similarity=0.399 Sum_probs=214.1
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|+|.||.|.+++.+ ++-+|+|++++...-..+....-..|-++++.++||.+..+--.|+..+++|+||||..||.
T Consensus 175 vLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGe 254 (516)
T KOG0690|consen 175 VLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGE 254 (516)
T ss_pred HhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCce
Confidence 4899999999998765 88999999998766666666777889999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.-.+++...+++..++.+..+|++||.|||+++ ||.||||.+|+|+|.+|++||.|||+.+..-... ..+...
T Consensus 255 Lf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g---~t~kTF 328 (516)
T KOG0690|consen 255 LFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG---DTTKTF 328 (516)
T ss_pred EeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccccc---ceeccc
Confidence 9999999889999999999999999999999998 9999999999999999999999999987543322 245667
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
+|||.|.|||++....|..++|.|.+|++||||++|+.||.......+...+.. .....|..++++.+.|++.+|.+|
T Consensus 329 CGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~--ed~kFPr~ls~eAktLLsGLL~kd 406 (516)
T KOG0690|consen 329 CGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM--EDLKFPRTLSPEAKTLLSGLLKKD 406 (516)
T ss_pred cCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh--hhccCCccCCHHHHHHHHHHhhcC
Confidence 899999999999999999999999999999999999999998887777666553 345567889999999999999999
Q ss_pred CCCCC-----CHHHHHHH
Q 042314 336 PDRRP-----TFEEIIFR 348 (370)
Q Consensus 336 p~~Rp-----~~~~ll~~ 348 (370)
|.+|. ++.|+.++
T Consensus 407 P~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 407 PKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred hHhhcCCCchhHHHHHhh
Confidence 99994 35555443
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=268.89 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=197.6
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee-----CCceEEEEeec
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH-----SERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~-----~~~~~~v~e~~ 171 (370)
+|+|||+-|+++.. +++.+|+|.+.... .+..+..++|++..++++||||++++++... ....|+++.|.
T Consensus 29 LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy 105 (302)
T KOG2345|consen 29 LGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYY 105 (302)
T ss_pred ecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehh
Confidence 79999999999873 57889999987643 4567788999999999999999999987543 33589999999
Q ss_pred CCCCHHHHHHhC----CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 172 RNGSLHDILKKK----GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 172 ~g~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
..|+|.+.++.. ..+++.++++|+.++++||.+||+.. .++.||||||.||++++.+.+++.|||.++...-.-.
T Consensus 106 ~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~ 184 (302)
T KOG2345|consen 106 KRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIE 184 (302)
T ss_pred ccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEee
Confidence 999999988753 36899999999999999999999998 4799999999999999999999999999876543211
Q ss_pred ccee------ccCCCCCccccCccccccc---CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--CCC
Q 042314 248 YSYK------MTGGTGSYRYMAPEVYRRE---SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PAL 316 (370)
Q Consensus 248 ~~~~------~~~~~g~~~y~aPE~~~~~---~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~ 316 (370)
.... -....-|..|.|||.+.-. ..+.++|||||||++|.|+.|..||...-..-........... .+-
T Consensus 185 ~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~ 264 (302)
T KOG2345|consen 185 GSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPN 264 (302)
T ss_pred chHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCC
Confidence 1100 0112358899999999644 4678999999999999999999999754321110011111111 111
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042314 317 SSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQ 353 (370)
Q Consensus 317 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~ 353 (370)
...+|+.+.++|+.||+.||.+||+..+++..++.+.
T Consensus 265 ~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 265 SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 2238999999999999999999999999999988763
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=288.82 Aligned_cols=241 Identities=28% Similarity=0.417 Sum_probs=189.5
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc---CCCceeeeeeeEee-----CCceEEEE
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL---RHPNIVQFLGVLKH-----SERLIFLT 168 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l---~hp~Iv~~~~~~~~-----~~~~~~v~ 168 (370)
+|.|++|.||++... ++.+++|.++...... .....+.+|+.+++.+ +||||+++++++.. ....++++
T Consensus 8 lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~ 86 (288)
T cd07863 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVF 86 (288)
T ss_pred EeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEE
Confidence 789999999999775 7789999887543222 2223345666666554 79999999998764 24579999
Q ss_pred eecCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccC
Q 042314 169 EYLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD 246 (370)
Q Consensus 169 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 246 (370)
||+.+ +|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 87 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd07863 87 EHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM 162 (288)
T ss_pred ccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccCcc
Confidence 99975 898888764 35899999999999999999999998 9999999999999999999999999987664332
Q ss_pred ccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC---C-----------
Q 042314 247 SYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED---S----------- 312 (370)
Q Consensus 247 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~----------- 312 (370)
. .....+|+.|+|||.+.+..++.++||||+||++|+|++|++||..........+..... .
T Consensus 163 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07863 163 A----LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238 (288)
T ss_pred c----CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence 1 122357889999999998889999999999999999999999998766544332221100 0
Q ss_pred ----C-------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 313 ----R-------PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 313 ----~-------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
. ......++..+.+++.+||+.||++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 01113467789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=287.12 Aligned_cols=240 Identities=27% Similarity=0.467 Sum_probs=201.5
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
++.|++|.||++.. .+..+++|.+.... ......+.+|+..++.++||||+++++.+...+..++|+||+.+++|
T Consensus 27 lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 27 IGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 68899999999875 47889999886532 22346678999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++... .+++.++..++.+++.++.|||+.+ ++|+||||+||+++.++.++|+|||++......... .....
T Consensus 104 ~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~---~~~~~ 176 (296)
T cd06655 104 TDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMV 176 (296)
T ss_pred HHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc---CCCcC
Confidence 9988765 6899999999999999999999998 999999999999999999999999988765433221 12235
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-CCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-DSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
+++.|+|||.+.+..++.++|+||||+++|+|++|+.||............... ......+..+++.+.++|++||..|
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 256 (296)
T cd06655 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMD 256 (296)
T ss_pred CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcC
Confidence 788999999999888999999999999999999999999887665443332211 1222345568889999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042314 336 PDRRPTFEEIIFR 348 (370)
Q Consensus 336 p~~Rp~~~~ll~~ 348 (370)
|++||++.+++.+
T Consensus 257 p~~Rpt~~~il~~ 269 (296)
T cd06655 257 VEKRGSAKELLQH 269 (296)
T ss_pred hhhCCCHHHHhhC
Confidence 9999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=286.95 Aligned_cols=241 Identities=25% Similarity=0.420 Sum_probs=206.6
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|.+...........+.+.+|+.++++++||||+++++.+...+..++|+||+.|++
T Consensus 7 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (258)
T cd05578 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGD 86 (258)
T ss_pred EeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCC
Confidence 3788999999999875 78899999976554444567789999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.....+++..+..++.|++++|.|||+++ ++|+||+|+||++++++.++|+|||++........ ....
T Consensus 87 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~ 159 (258)
T cd05578 87 LRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----TTST 159 (258)
T ss_pred HHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCcc----cccc
Confidence 9999988888999999999999999999999998 99999999999999999999999999876654321 1233
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA---VQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
.++..|+|||.+....++.++|+||+|+++|+|++|..||..... ........ ...+..+..+|..+.++|++||
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l 237 (258)
T cd05578 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE--TADVLYPATWSTEAIDAINKLL 237 (258)
T ss_pred CCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc--cccccCcccCcHHHHHHHHHHc
Confidence 578899999999888899999999999999999999999987663 33222222 1445566678899999999999
Q ss_pred ccCCCCCCCH--HHHHH
Q 042314 333 HKNPDRRPTF--EEIIF 347 (370)
Q Consensus 333 ~~~p~~Rp~~--~~ll~ 347 (370)
..||++||++ +++++
T Consensus 238 ~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 238 ERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cCChhHcCCccHHHHhc
Confidence 9999999999 66653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=282.20 Aligned_cols=242 Identities=30% Similarity=0.495 Sum_probs=197.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|+|+||.||++... +..+++|.+... .......+.+|+.+++.++|+||+++++++...+..++++||+.+++
T Consensus 15 ~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 91 (268)
T cd06624 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS 91 (268)
T ss_pred EEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence 3789999999999764 567889887653 23445678999999999999999999999999999999999999999
Q ss_pred HHHHHHhC-CCC--ChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC-CCcEEEeccccceeccccCcccee
Q 042314 176 LHDILKKK-GKL--DPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE-AGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 176 L~~~l~~~-~~~--~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
|.+++... ..+ +...+..++.|++.|+.|||+++ |+||||||+||+++. .+.++|+|||++........ .
T Consensus 92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~---~ 165 (268)
T cd06624 92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP---C 165 (268)
T ss_pred HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC---c
Confidence 99999864 445 78888999999999999999998 999999999999986 67899999999876543222 1
Q ss_pred ccCCCCCccccCcccccccC--CCchhhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRES--YGKSVDVFSFALIVHEMFQGGPSNRADTAVQ-VADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.....+++.|+|||.+.... ++.++|+||+|+++|+|++|++||....... ...........+..+..+++.+.+++
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHH
Confidence 12235788999999986543 7889999999999999999999997543221 11122222334556677889999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~ 348 (370)
++||+.+|++|||+.+++.+
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred HHHcCCCchhCCCHHHHHhC
Confidence 99999999999999999865
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=295.60 Aligned_cols=247 Identities=29% Similarity=0.510 Sum_probs=214.5
Q ss_pred ccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 96 RGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
...+|-|.||.||.+.|+ ...+|||.++. +.+....|..|+.+|+.++|||+|+++++|..+..+|||+|||..
T Consensus 272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKE----DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred eeccCCCcccceeeeeeeccceeeehhhhhh----cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 345899999999999997 56789998875 356788999999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 174 GSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 174 ~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
|+|.+++++.. .++.-..+.++.||.+||+||..++ +|||||..+|+||.++..+|++|||+++.+...... .
T Consensus 348 GNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT--A 422 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT--A 422 (1157)
T ss_pred ccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee--c
Confidence 99999999764 4566677889999999999999998 999999999999999999999999999988754321 1
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
-.+.-.++.|.|||.+....|+.++|||+||++|||+.| |-.||.+......+.. ...+.+..-|..+|+.+++||+.
T Consensus 423 HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~L-LEkgyRM~~PeGCPpkVYeLMra 501 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGL-LEKGYRMDGPEGCPPKVYELMRA 501 (1157)
T ss_pred ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH-HhccccccCCCCCCHHHHHHHHH
Confidence 223335789999999999999999999999999999997 4566666655554443 34788889999999999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
||+..|.+||+++|+-+.++.+
T Consensus 502 CW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 502 CWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HhcCCcccCccHHHHHHHHHHH
Confidence 9999999999999999999877
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=285.05 Aligned_cols=245 Identities=29% Similarity=0.443 Sum_probs=203.9
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|++|.||++... |..+++|.+.............+.+|+.++++++||||+++++.+......++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 478999999999885 888999998765444445677889999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc-----cee
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY-----SYK 251 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~ 251 (370)
.+++.+.+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 157 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence 999998778999999999999999999999998 999999999999999999999999998754432110 111
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
.....++..|+|||.+.....+.++|+||||+++|++++|..||.........................+..+.+++++|
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 237 (265)
T cd05579 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKL 237 (265)
T ss_pred ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHH
Confidence 22335788999999998888899999999999999999999999887776655554432222222222489999999999
Q ss_pred cccCCCCCCCHHHHH
Q 042314 332 WHKNPDRRPTFEEII 346 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll 346 (370)
|+.+|++|||+.++.
T Consensus 238 l~~~p~~Rpt~~~~~ 252 (265)
T cd05579 238 LVPDPEKRLGAKSIE 252 (265)
T ss_pred hcCCHhhcCCCccHH
Confidence 999999999994433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=282.24 Aligned_cols=234 Identities=21% Similarity=0.401 Sum_probs=189.2
Q ss_pred CCCCCcccEEEEEEcCce------------eEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEE
Q 042314 99 IDPGAYGEVYLVKWRGTE------------IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIF 166 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~------------vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~ 166 (370)
+|.|+||.||++...... +++|.+.... .....+.+|+.+++.++||||+++++++.. ...++
T Consensus 3 lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred ccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 789999999999886433 5666654432 115778899999999999999999999887 77899
Q ss_pred EEeecCCCCHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC-------cEEEecccc
Q 042314 167 LTEYLRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG-------HLKVTDFGL 238 (370)
Q Consensus 167 v~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~-------~~kl~Dfg~ 238 (370)
|+||+.+++|.+++...+ .++...+..++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999998765 7899999999999999999999988 99999999999999887 799999999
Q ss_pred ceeccccCccceeccCCCCCccccCccccccc--CCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCC
Q 042314 239 SKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE--SYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPA 315 (370)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 315 (370)
+....... ...++..|+|||.+.+. .++.++|+||||+++|+|++ |..||............. ....
T Consensus 155 a~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~ 224 (259)
T cd05037 155 PITVLSRE-------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHR 224 (259)
T ss_pred cccccccc-------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCC
Confidence 87654321 12356789999999876 78899999999999999999 577776654333222221 1111
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 316 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
.+......+.+++.+||..+|++||++.++++.|+
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 225 LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 22222378999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=316.80 Aligned_cols=245 Identities=22% Similarity=0.365 Sum_probs=195.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee--CCceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH--SERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~--~~~~~~v~e~~~g 173 (370)
.+|.|+||.||++... +..+++|.+..... .......+..|+.+++.++||||++++++|.. ...+++||||+.+
T Consensus 20 kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~g 98 (1021)
T PTZ00266 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDA 98 (1021)
T ss_pred EEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCC
Confidence 3789999999999875 56788898865432 33456778999999999999999999998854 3568999999999
Q ss_pred CCHHHHHHhC----CCCChHhHHHHHHHHHHHHHHHhhcCC----CceeecCCCCCCeeeCC-----------------C
Q 042314 174 GSLHDILKKK----GKLDPPTAVAYALDIARGMNYLHHHRP----HAIIHRDLTPSNVLQDE-----------------A 228 (370)
Q Consensus 174 ~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~----~~iiH~Dlk~~Nil~~~-----------------~ 228 (370)
++|.+++... +.+++..++.|+.||+.||.|||+.++ .+|+||||||+|||++. .
T Consensus 99 GSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~ 178 (1021)
T PTZ00266 99 GDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178 (1021)
T ss_pred CcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCC
Confidence 9999998752 579999999999999999999998531 34999999999999964 2
Q ss_pred CcEEEeccccceeccccCccceeccCCCCCccccCcccccc--cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Q 042314 229 GHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR--ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADR 306 (370)
Q Consensus 229 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~ 306 (370)
+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 179 ~iVKLsDFGlAr~l~~~s~----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~ 254 (1021)
T PTZ00266 179 PIAKIGDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLIS 254 (1021)
T ss_pred CceEEccCCcccccccccc----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHH
Confidence 3489999999976543321 123468999999999864 4578999999999999999999999976654433332
Q ss_pred hhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 307 RAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 307 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
........ .....|..+.+||..||..+|.+||++.+++.+
T Consensus 255 ~lk~~p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 255 ELKRGPDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHhcCCCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 22222222 223468899999999999999999999999864
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=284.27 Aligned_cols=241 Identities=30% Similarity=0.533 Sum_probs=202.9
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|++|.||++... +..+++|.+.... .......+.+|+.++++++||||+++++.+...+..++++||+.++
T Consensus 7 ~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence 34789999999999886 7889999887643 2356677889999999999999999999999999999999999999
Q ss_pred CHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhh-cCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 175 SLHDILKKK-GKLDPPTAVAYALDIARGMNYLHH-HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 175 ~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
+|.+++... ..+++..+..++.|++.++.|||+ .+ ++|+||||+||+++.++.++|+|||.+.........
T Consensus 85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~---- 157 (265)
T cd06605 85 SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---- 157 (265)
T ss_pred cHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh----
Confidence 999999876 788999999999999999999999 87 999999999999999999999999998665433211
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC-----cHHHHHHHhhccCCCCCCCCC-CcHHHHH
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRAD-----TAVQVADRRAYEDSRPALSSL-YPEPIKA 326 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~-~~~~l~~ 326 (370)
...++..|+|||.+.+..++.++|+||+|+++|+|++|+.||... .......... ....+..+.. +++.+.+
T Consensus 158 -~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06605 158 -TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPPPRLPSGKFSPDFQD 235 (265)
T ss_pred -cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCCCCCChhhcCHHHHH
Confidence 145788999999999989999999999999999999999998654 2222222222 2333344443 8889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 042314 327 LLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 327 li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+|.+||..+|++|||+.+++.+
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhC
Confidence 9999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=280.15 Aligned_cols=245 Identities=24% Similarity=0.400 Sum_probs=190.9
Q ss_pred CCCCCcccEEEEEEc-Cc---eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 99 IDPGAYGEVYLVKWR-GT---EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-g~---~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
+|+|+||.||++... +. .+++|.+... ........+.+|+..++.++||||+++++.+......++||||++++
T Consensus 3 lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKAN--ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CCCCcCceEEEEEEEcCCCcceEEEEEecCC--CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 789999999998653 32 3445554432 22345678899999999999999999999999999999999999999
Q ss_pred CHHHHHHhC----CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 175 SLHDILKKK----GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 175 ~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+|.+++.+. ...+...+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 156 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-IE 156 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh-hh
Confidence 999999764 24566678899999999999999998 99999999999999999999999998754322111 11
Q ss_pred eccCCCCCccccCcccccc-------cCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcc----CCCCCCCC
Q 042314 251 KMTGGTGSYRYMAPEVYRR-------ESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYE----DSRPALSS 318 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~----~~~~~~~~ 318 (370)
......++..|+|||.+.. ..++.++||||||+++|||++ |..||............... ..++..+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence 1223457889999998743 235789999999999999997 56788766655444432211 22344555
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 319 LYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 319 ~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
.+++.+.+++..|| .+|++||+++++++.|.
T Consensus 237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 237 PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 67889999999999 67999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=287.89 Aligned_cols=241 Identities=28% Similarity=0.445 Sum_probs=200.2
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..++.|++|.||++.. .+..+++|.+........+....+.+|+.+++.++||||+++++++...+..++|+||+.|
T Consensus 21 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g- 99 (307)
T cd06607 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG- 99 (307)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-
Confidence 4489999999999976 4788999988655444555667789999999999999999999999999999999999975
Q ss_pred CHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+|.+++.. .+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 100 ~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~------- 169 (307)
T cd06607 100 SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN------- 169 (307)
T ss_pred CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCCC-------
Confidence 77777654 457899999999999999999999998 9999999999999999999999999987554322
Q ss_pred CCCCCccccCccccc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 254 GGTGSYRYMAPEVYR---RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
...+++.|+|||.+. ...++.++||||||+++|+|++|.+||.....................+..++..+.+++.+
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 249 (307)
T cd06607 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDS 249 (307)
T ss_pred CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHH
Confidence 234688999999874 45678899999999999999999999987766554444332222222234578899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~ 348 (370)
||..+|++||++.+++.+
T Consensus 250 ~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 250 CLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HhcCChhhCcCHHHHhcC
Confidence 999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=280.01 Aligned_cols=243 Identities=23% Similarity=0.461 Sum_probs=206.3
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.+|.+.. .+..+++|.+...... ......+.+|+.+++.++||||+++++++...+..++|+||+.+++
T Consensus 7 ~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08218 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGD 85 (256)
T ss_pred EeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCc
Confidence 378999999999876 4788999988654322 3345678899999999999999999999999999999999999999
Q ss_pred HHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 176 LHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 176 L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|.+++.... .+++..++.++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~ 159 (256)
T cd08218 86 LYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---AR 159 (256)
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh---hh
Confidence 999987643 5788999999999999999999998 999999999999999999999999998766443211 11
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
...+++.|+|||.+.+..++.++|+||||+++++|++|+.||............. .+..+..+..++..+.++|.+||+
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPPVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHhh
Confidence 2347888999999998889999999999999999999999998777666555544 334445566788999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~ 348 (370)
.+|++||++.+++++
T Consensus 239 ~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 239 RNPRDRPSVNSILEK 253 (256)
T ss_pred CChhhCcCHHHHhhC
Confidence 999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=301.30 Aligned_cols=238 Identities=18% Similarity=0.318 Sum_probs=191.7
Q ss_pred CCCCCCcccEEEEEEc----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
.+|.|+||.||++... +..+++|.+... ....+|+.+++.++||||+++++++......+++||++.
T Consensus 99 ~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 169 (392)
T PHA03207 99 SLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK- 169 (392)
T ss_pred eecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-
Confidence 3799999999998754 356888877542 234579999999999999999999999999999999996
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++|+|||++.......... ...
T Consensus 170 ~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~-~~~ 245 (392)
T PHA03207 170 CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP-QCY 245 (392)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccc-ccc
Confidence 589999887788999999999999999999999998 9999999999999999999999999987665432211 223
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH----HHHHHh---h------------------
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAV----QVADRR---A------------------ 308 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~---~------------------ 308 (370)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .
T Consensus 246 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 325 (392)
T PHA03207 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHF 325 (392)
T ss_pred ccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHH
Confidence 446899999999999999999999999999999999999999654211 000000 0
Q ss_pred ---ccCCCCC--C-----CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 309 ---YEDSRPA--L-----SSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 309 ---~~~~~~~--~-----~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
....++. . ...++..++++|++||..||++||++.+++.+
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 326 KQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000110 1 12356789999999999999999999999887
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=285.80 Aligned_cols=242 Identities=29% Similarity=0.498 Sum_probs=200.9
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|++|.||++... +..+++|.++... .......+.+|+.++++++||||+++++.+...+..++|+||++++
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (286)
T cd06622 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAG 84 (286)
T ss_pred hhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCC
Confidence 34899999999999885 7889999886532 3344567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhC---CCCChHhHHHHHHHHHHHHHHHhh-cCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 175 SLHDILKKK---GKLDPPTAVAYALDIARGMNYLHH-HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 175 ~L~~~l~~~---~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+|.+++... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 157 (286)
T cd06622 85 SLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL---- 157 (286)
T ss_pred CHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----
Confidence 999998763 378999999999999999999997 46 9999999999999999999999999987553321
Q ss_pred eccCCCCCccccCcccccccC------CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh--hccCCCCCCCCCCcH
Q 042314 251 KMTGGTGSYRYMAPEVYRRES------YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRR--AYEDSRPALSSLYPE 322 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~------~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 322 (370)
.....+++.|+|||.+.+.. ++.++|+||+||++|+|++|+.||............ ......+..+..+++
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd06622 158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236 (286)
T ss_pred -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCH
Confidence 12235788999999986543 478999999999999999999999765543332221 112344556666899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 323 PIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 323 ~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+.+++++||..+|++||++.+++.+
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 237 DAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHHHHcccCcccCCCHHHHhcC
Confidence 99999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=287.66 Aligned_cols=241 Identities=27% Similarity=0.461 Sum_probs=200.7
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|++|.||++.. .+..+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++||||+++++
T Consensus 26 ~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (297)
T cd06656 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (297)
T ss_pred eeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCC
Confidence 378999999999976 488999998865322 234567899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.+. .++...+..++.|++.+|.|||+.+ ++||||||+||+++.++.++|+|||++........ .....
T Consensus 103 L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~ 175 (297)
T cd06656 103 LTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTM 175 (297)
T ss_pred HHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc---CcCcc
Confidence 99998764 6889999999999999999999998 99999999999999999999999999876543322 11223
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-CCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-DSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.+++.|+|||.+.+..++.++|+||+|+++|++++|..||............... ......+..++..+.+++.+||..
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 255 (297)
T cd06656 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEM 255 (297)
T ss_pred cCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccC
Confidence 5788999999999888999999999999999999999999776553332222111 112234556788999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042314 335 NPDRRPTFEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~ 348 (370)
+|++||++.+++++
T Consensus 256 ~p~~Rps~~~il~~ 269 (297)
T cd06656 256 DVDRRGSAKELLQH 269 (297)
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=282.86 Aligned_cols=248 Identities=27% Similarity=0.502 Sum_probs=204.0
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCC---ChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIAS---NPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~---~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|++|.||++.. .+..+++|.+...... .......+.+|+..++.++|+||+++++++...+..++|+||+.
T Consensus 7 ~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 86 (268)
T cd06630 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMA 86 (268)
T ss_pred eecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccC
Confidence 378999999999876 4788999998654321 23356789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC-cEEEeccccceeccccCccc-e
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG-HLKVTDFGLSKIAQEKDSYS-Y 250 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~-~ 250 (370)
|++|.+++.+.+++++..+..++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||++.......... .
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 163 (268)
T cd06630 87 GGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163 (268)
T ss_pred CCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCc
Confidence 9999999998888999999999999999999999998 99999999999998776 59999999987665432111 0
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhhccCCCCCCCCCCcHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA---VQVADRRAYEDSRPALSSLYPEPIKAL 327 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~l 327 (370)
......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||..... .............+..+..+++.+.++
T Consensus 164 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06630 164 FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243 (268)
T ss_pred cccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHH
Confidence 11223578899999999888889999999999999999999999965432 122222222233455666788999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 042314 328 LRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 328 i~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+.+||..+|++||++.+++++
T Consensus 244 i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 244 TLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred HHHHcCCCcccCcCHHHHhcC
Confidence 999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=287.77 Aligned_cols=242 Identities=25% Similarity=0.445 Sum_probs=201.0
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|+||.||++.. .+..+++|.+... .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 3489999999999976 4788999987543 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|.+++.. +.++...+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++........ ....
T Consensus 105 ~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~---~~~~ 177 (292)
T cd06658 105 ALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP---KRKS 177 (292)
T ss_pred cHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc---cCce
Confidence 99998865 47899999999999999999999998 99999999999999999999999999865433221 1122
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-cCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY-EDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..++..|+|||.+.+..++.++|+||+|+++|||++|+.||.............. ..........++..+.+++.+||.
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 257 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV 257 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHcc
Confidence 3578899999999888899999999999999999999999987665544333221 112222233578899999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~ 348 (370)
.||.+|||+++++++
T Consensus 258 ~~P~~Rpt~~~il~~ 272 (292)
T cd06658 258 REPSQRATAQELLQH 272 (292)
T ss_pred CChhHCcCHHHHhhC
Confidence 999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=282.35 Aligned_cols=248 Identities=31% Similarity=0.490 Sum_probs=200.7
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCC-------ChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEE
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIAS-------NPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFL 167 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~-------~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v 167 (370)
..+|.|++|.||++.. .+..+++|.++..... .....+.+..|+.+++.++|||++++++++...+..++|
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 86 (272)
T cd06629 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIF 86 (272)
T ss_pred ceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEE
Confidence 3489999999999965 4788999987542111 112345688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 168 TEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
+||+.+++|.+++.+.+.++...+..++.|++.||.|||+++ ++||||+|+||+++.++.++|+|||++........
T Consensus 87 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 163 (272)
T cd06629 87 LEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYD 163 (272)
T ss_pred EecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccccccccc
Confidence 999999999999998888999999999999999999999998 99999999999999999999999999875543211
Q ss_pred cceeccCCCCCccccCcccccccC--CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC----CCCCCCc
Q 042314 248 YSYKMTGGTGSYRYMAPEVYRRES--YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP----ALSSLYP 321 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 321 (370)
.. ......++..|+|||.+.... ++.++|+||||+++|++++|..||..................+ .....++
T Consensus 164 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (272)
T cd06629 164 ND-QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242 (272)
T ss_pred cc-ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCC
Confidence 11 122335788999999987654 7889999999999999999999997655543333222122222 2233568
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
..+.+++.+||..+|++||++.+++++
T Consensus 243 ~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 243 PVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=283.62 Aligned_cols=242 Identities=24% Similarity=0.447 Sum_probs=201.6
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|++|.||++... +..+++|.+... .......+.+|+.+++.++||||+++++++...+..++++||+.|+
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~ 101 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG 101 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCC
Confidence 35889999999999764 678999987542 2234566889999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|.+++.. ++++...+..++.|++.|+.|||+++ ++||||+|+||+++.++.++|+|||.+........ ....
T Consensus 102 ~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~ 174 (285)
T cd06648 102 ALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP---RRKS 174 (285)
T ss_pred CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc---cccc
Confidence 99999987 57899999999999999999999998 99999999999999999999999998765443221 1122
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC-CCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED-SRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||................ .....+..++..+.+++.+||.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 254 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLV 254 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence 357889999999988889999999999999999999999998776655444433221 1122233478899999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~ 348 (370)
.+|++||++.+++++
T Consensus 255 ~~p~~Rpt~~~il~~ 269 (285)
T cd06648 255 RDPAQRATAAELLNH 269 (285)
T ss_pred cChhhCcCHHHHccC
Confidence 999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=279.12 Aligned_cols=246 Identities=26% Similarity=0.492 Sum_probs=202.6
Q ss_pred CCCCCCcccEEEEEEc---CceeEEEEeccccC-------CChHHHHHHHHHHHHHHh-cCCCceeeeeeeEeeCCceEE
Q 042314 98 GIDPGAYGEVYLVKWR---GTEIAAKTIRSSIA-------SNPRVRNSFMKELGLWQK-LRHPNIVQFLGVLKHSERLIF 166 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~---g~~vavK~l~~~~~-------~~~~~~~~~~~e~~~l~~-l~hp~Iv~~~~~~~~~~~~~~ 166 (370)
.+|.|+||.||++... +..+++|.+..... ........+.+|+.++.+ ++||||+++++++...+..++
T Consensus 7 ~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 86 (269)
T cd08528 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYI 86 (269)
T ss_pred hhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEE
Confidence 4799999999999875 46789998754321 233445667788888765 789999999999999999999
Q ss_pred EEeecCCCCHHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhh-cCCCceeecCCCCCCeeeCCCCcEEEecccccee
Q 042314 167 LTEYLRNGSLHDILKK----KGKLDPPTAVAYALDIARGMNYLHH-HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI 241 (370)
Q Consensus 167 v~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~ 241 (370)
+|||++|++|.+++.. ...++...++.++.|++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||.+..
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 163 (269)
T cd08528 87 VMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQ 163 (269)
T ss_pred EEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccceee
Confidence 9999999999988743 3468999999999999999999996 55 99999999999999999999999999876
Q ss_pred ccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCc
Q 042314 242 AQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYP 321 (370)
Q Consensus 242 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (370)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|++||..................+.....++
T Consensus 164 ~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 164 KQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred ccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence 55432 12234578899999999988899999999999999999999999987766555444432223333334678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
+.+.+++.+||+.||++||++.++..+++
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 99999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=278.86 Aligned_cols=242 Identities=23% Similarity=0.402 Sum_probs=204.3
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|++|.||++.. .+..+++|.+..... .......+.+|+.+++.++||||+++++.+...+..++|+||+++++
T Consensus 7 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08220 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGT 85 (256)
T ss_pred EecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCC
Confidence 378999999999876 477899999875432 33456788999999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC-cEEEeccccceeccccCccceec
Q 042314 176 LHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG-HLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 176 L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|.+++... ..+++..+..++.+++.++.|||+++ ++|+||+|+||+++.++ .++|+|||++........ .
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~----~ 158 (256)
T cd08220 86 LAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK----A 158 (256)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc----c
Confidence 99999764 35889999999999999999999998 99999999999998654 579999999887654321 1
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||............. .......+..++..+.+++.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l 237 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM-SGTFAPISDRYSPDLRQLILSML 237 (256)
T ss_pred cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH-hcCCCCCCCCcCHHHHHHHHHHc
Confidence 22357889999999998888999999999999999999999998876655554443 23334456678899999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFR 348 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~ 348 (370)
..+|++|||+.+++.+
T Consensus 238 ~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 238 NLDPSKRPQLSQIMAQ 253 (256)
T ss_pred cCChhhCCCHHHHhhC
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=285.06 Aligned_cols=243 Identities=29% Similarity=0.411 Sum_probs=194.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|++|.||++... +..+++|.++... ........+.+|+.+++.++||||+++++++..++..++||||+. ++
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (285)
T cd07861 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MD 84 (285)
T ss_pred EecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CC
Confidence 3788999999999774 7889999886543 222344667889999999999999999999999999999999997 48
Q ss_pred HHHHHHhC---CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 176 LHDILKKK---GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 176 L~~~l~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........ ..
T Consensus 85 l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---~~ 158 (285)
T cd07861 85 LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR---VY 158 (285)
T ss_pred HHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc---cc
Confidence 98888643 46899999999999999999999998 99999999999999999999999999875543221 11
Q ss_pred cCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc---------------------
Q 042314 253 TGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE--------------------- 310 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~--------------------- 310 (370)
....+++.|+|||.+.+. .++.++|+||||+++|+|++|++||...............
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 223568899999988654 4688999999999999999999999876543322111000
Q ss_pred ------CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 311 ------DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 311 ------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.........+++++.++|++||..||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00001123468889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=284.83 Aligned_cols=244 Identities=25% Similarity=0.455 Sum_probs=197.8
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.++.|++|.||++... +..+++|.+.... ......+.+.+|+.+++.++|||++++++++......++||||+++++
T Consensus 8 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (286)
T cd07847 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESE-DDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTV 86 (286)
T ss_pred eecccCCeEEEEEEECCCCcEEEEEEEeecc-cCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccH
Confidence 3788999999999875 7889999886543 222344567899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|..++.....+++..+..++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++......... ....
T Consensus 87 l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~ 160 (286)
T cd07847 87 LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---YTDY 160 (286)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCccc---ccCc
Confidence 9888877778999999999999999999999998 999999999999999999999999999876543321 1223
Q ss_pred CCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc----------------------cCC
Q 042314 256 TGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY----------------------EDS 312 (370)
Q Consensus 256 ~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~----------------------~~~ 312 (370)
.++..|+|||.+.+ ..++.++|+||+|+++|+|++|++||......+....... ...
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP 240 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCC
Confidence 46789999999876 4578899999999999999999999986654332221100 000
Q ss_pred CCC-------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 313 RPA-------LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 313 ~~~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+. ....++..+.+|+.+||+.+|++||++.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 241 EPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred CcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 012457889999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=279.45 Aligned_cols=243 Identities=24% Similarity=0.461 Sum_probs=204.6
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee--CCceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH--SERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~--~~~~~~v~e~~~g 173 (370)
.+|.|++|.||++... +..+++|.+..... .....+.+..|+.+++.++||||+++++.+.. ....++++||+++
T Consensus 7 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~ 85 (265)
T cd08217 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG 85 (265)
T ss_pred eeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence 4788999999999764 67899998875432 34556778899999999999999999997754 4568999999999
Q ss_pred CCHHHHHHh----CCCCChHhHHHHHHHHHHHHHHHh-----hcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccc
Q 042314 174 GSLHDILKK----KGKLDPPTAVAYALDIARGMNYLH-----HHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQE 244 (370)
Q Consensus 174 ~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH-----~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 244 (370)
++|.+++.. ..++++..++.++.|++.||.||| +.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 86 GDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred CCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 999999875 357899999999999999999999 766 99999999999999999999999999887654
Q ss_pred cCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHH
Q 042314 245 KDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI 324 (370)
Q Consensus 245 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 324 (370)
.... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||............. ....+..+..++..+
T Consensus 163 ~~~~---~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 238 (265)
T cd08217 163 DSSF---AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-EGKFRRIPYRYSSEL 238 (265)
T ss_pred Cccc---ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-cCCCCCCccccCHHH
Confidence 3321 122357899999999998889999999999999999999999998876555444443 344455667788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 042314 325 KALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 325 ~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+++.+||+.+|++||++.+++++
T Consensus 239 ~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 239 NEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHccCCcccCCCHHHHhhC
Confidence 999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=279.47 Aligned_cols=249 Identities=26% Similarity=0.448 Sum_probs=201.6
Q ss_pred CCCCCCcccEEEEEEc-----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC------ceEE
Q 042314 98 GIDPGAYGEVYLVKWR-----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE------RLIF 166 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~------~~~~ 166 (370)
.+|.|+||.||++.+. +..+++|.+.... ......+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 6 ~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05074 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV 84 (273)
T ss_pred cccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEE
Confidence 4899999999999753 5779999987654 33445677889999999999999999999875432 3478
Q ss_pred EEeecCCCCHHHHHHhC------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccce
Q 042314 167 LTEYLRNGSLHDILKKK------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK 240 (370)
Q Consensus 167 v~e~~~g~~L~~~l~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~ 240 (370)
+++|+.+++|.+++... ..++...+..++.|++.|+.|||+++ |+||||||+||+++.++.+||+|||.++
T Consensus 85 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~ 161 (273)
T cd05074 85 ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSK 161 (273)
T ss_pred EEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccc
Confidence 99999999999887532 24788899999999999999999998 9999999999999999999999999987
Q ss_pred eccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCC
Q 042314 241 IAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSL 319 (370)
Q Consensus 241 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (370)
......... ......+++.|++||.+....++.++||||||+++|+|++ |++||............. .......+..
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (273)
T cd05074 162 KIYSGDYYR-QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLKQPPD 239 (273)
T ss_pred cccCCccee-cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCCCCCC
Confidence 654332111 1112235678999999998889999999999999999999 889998776655544433 2333344456
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042314 320 YPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 320 ~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
.+..+.+++.+||+.+|++||++.+++..|+.+
T Consensus 240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 788999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=278.92 Aligned_cols=240 Identities=25% Similarity=0.447 Sum_probs=201.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.++.|++|.||++... +..+++|.+.... ....+.+|+++++.++||||+++++.+......++++||+.+++
T Consensus 10 ~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 84 (256)
T cd06612 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84 (256)
T ss_pred hhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCc
Confidence 4788999999999876 6789999886532 26788999999999999999999999999999999999999999
Q ss_pred HHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 85 L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~---~~~~ 158 (256)
T cd06612 85 VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA---KRNT 158 (256)
T ss_pred HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc---cccc
Confidence 9999976 457899999999999999999999998 99999999999999999999999999876654321 1122
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-CCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-DSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..++..|+|||.+.+..++.++|+||+|+++|+|++|++||............... ......+..++..+.+++.+||+
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLV 238 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHh
Confidence 34788999999999888999999999999999999999999876554433322211 11222344577899999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~ 348 (370)
.+|++|||+.+++.+
T Consensus 239 ~~P~~Rps~~~il~~ 253 (256)
T cd06612 239 KDPEERPSAIQLLQH 253 (256)
T ss_pred cChhhCcCHHHHhcC
Confidence 999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=286.38 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=205.9
Q ss_pred eecccCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 93 LEDRGGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 93 L~~~~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
+.....++.|+||.||++.. .+..+++|.+........+....+.+|+.+++.++|||++++++++...+..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 33445589999999999986 4778999998765444555667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 171 LRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 171 ~~g~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+.| +|.+.+.. ..++++..+..++.+++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 976 77776654 457899999999999999999999998 999999999999999999999999987654322
Q ss_pred eeccCCCCCccccCccccc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYR---RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKA 326 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 326 (370)
....+++.|+|||.+. ...++.++|+||+|+++|+|++|.+||........................+++.+.+
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 255 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 255 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence 1235788999999974 4567899999999999999999999998776655555444333333344567889999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHH
Q 042314 327 LLRECWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 327 li~~~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
++.+||+.+|.+||++.+++++.-.+
T Consensus 256 li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 256 FVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred HHHHHccCCcccCcCHHHHHhChhhh
Confidence 99999999999999999999876544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=286.28 Aligned_cols=241 Identities=26% Similarity=0.450 Sum_probs=201.2
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++.. .+..+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++++||+++++
T Consensus 28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 489999999999976 478899999865322 234568899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.. ..+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++........ .....
T Consensus 105 L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~ 177 (297)
T cd06659 105 LTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP---KRKSL 177 (297)
T ss_pred HHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc---cccce
Confidence 9998766 47899999999999999999999998 99999999999999999999999998865433211 12234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-CCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-DSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.++..|+|||.+.+..++.++|+||+|+++|+|++|+.||............... .........++..+.+++++||..
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~ 257 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTR 257 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcC
Confidence 5789999999999888999999999999999999999999876655544433211 112223345788999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042314 335 NPDRRPTFEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~ 348 (370)
+|++||++.+++.+
T Consensus 258 ~P~~Rps~~~ll~~ 271 (297)
T cd06659 258 EPQERATAQELLDH 271 (297)
T ss_pred CcccCcCHHHHhhC
Confidence 99999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=291.23 Aligned_cols=242 Identities=25% Similarity=0.410 Sum_probs=183.5
Q ss_pred CCCCCCcccEEEEEEc----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee--CCceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKWR----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH--SERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~--~~~~~~v~e~~ 171 (370)
.+|.|+||.||++... +..+++|.+.... ....+.+|+.+++.++||||+++++++.. ....++|+||+
T Consensus 8 ~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred EeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 3899999999999864 3678999876432 22456789999999999999999998853 56789999999
Q ss_pred CCCCHHHHHHhC---------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee----CCCCcEEEecccc
Q 042314 172 RNGSLHDILKKK---------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ----DEAGHLKVTDFGL 238 (370)
Q Consensus 172 ~g~~L~~~l~~~---------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~----~~~~~~kl~Dfg~ 238 (370)
.+ +|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||++ +..+.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 65 888877522 24788889999999999999999998 9999999999999 4567899999999
Q ss_pred ceeccccCccceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH---------HHHH-h
Q 042314 239 SKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ---------VADR-R 307 (370)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---------~~~~-~ 307 (370)
++................+|+.|+|||.+.+. .++.++||||+||++|||++|++||....... .... .
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 98765433222222344678999999998764 57899999999999999999999996432110 0000 0
Q ss_pred hccC--------------C---------C------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 308 AYED--------------S---------R------------PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 308 ~~~~--------------~---------~------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
...+ . . .......+..+.+++.+||..||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 0 0 00011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=279.98 Aligned_cols=241 Identities=27% Similarity=0.484 Sum_probs=204.6
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++.. .+..+++|..... ........+.+|+..++.++||||+++++.+...+..++|+||+++++
T Consensus 11 ~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 88 (277)
T cd06641 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 88 (277)
T ss_pred eEeecCCeEEEEEEECCCCcEEEEEEeccc--cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCc
Confidence 478999999999976 4678999987543 223455678899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++... .++...+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 89 l~~~i~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~---~~~~~ 161 (277)
T cd06641 89 ALDLLEPG-PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---KRNTF 161 (277)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh---hhccc
Confidence 99998754 7899999999999999999999988 99999999999999999999999999876543321 11223
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.++..|+|||.+....++.++|+||+|+++|+|++|..||...........+. ....+..+..+|..+.+++.+||+.+
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~ 240 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACLNKE 240 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-cCCCCCCCcccCHHHHHHHHHHccCC
Confidence 57888999999988888999999999999999999999998766554444432 33445566678899999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042314 336 PDRRPTFEEIIFR 348 (370)
Q Consensus 336 p~~Rp~~~~ll~~ 348 (370)
|++||++.+++.+
T Consensus 241 p~~Rp~~~~~l~~ 253 (277)
T cd06641 241 PSFRPTAKELLKH 253 (277)
T ss_pred hhhCcCHHHHHhC
Confidence 9999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=293.83 Aligned_cols=240 Identities=26% Similarity=0.405 Sum_probs=190.9
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC------CceEEEE
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS------ERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~------~~~~~v~ 168 (370)
..+|.|+||.||++... +..+|+|.+..... .......+.+|+.+++.++||||+++++++... ...++++
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 99 (343)
T cd07878 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT 99 (343)
T ss_pred eecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence 34899999999999764 67899999865432 223445677899999999999999999987543 3578999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
+++ +++|.+++.. +.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 100 ~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 171 (343)
T cd07878 100 NLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE--- 171 (343)
T ss_pred ecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC---
Confidence 988 6799988764 47999999999999999999999998 999999999999999999999999998765432
Q ss_pred ceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC----------------
Q 042314 249 SYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED---------------- 311 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---------------- 311 (370)
.....+|+.|+|||.+.+ ..++.++|||||||++|+|++|+.||................
T Consensus 172 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07878 172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA 248 (343)
T ss_pred ---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence 123467999999999877 467899999999999999999999997655433222111000
Q ss_pred -----CCCC--------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 -----SRPA--------LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 -----~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
..+. .....++.+.+|+.+||..||.+|||+.+++.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 112345678999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=279.74 Aligned_cols=245 Identities=28% Similarity=0.465 Sum_probs=202.3
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|++|.||++.. .+..+++|.+...... .....+.+|+..++.++|+||+++++.+...+..++++|++++++
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (267)
T cd06610 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85 (267)
T ss_pred eecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence 378899999999976 4678999988654322 256778999999999999999999999999999999999999999
Q ss_pred HHHHHHhC---CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc-ee
Q 042314 176 LHDILKKK---GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS-YK 251 (370)
Q Consensus 176 L~~~l~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~ 251 (370)
|.+++... ..+++..+..++.|++.|+.+||+.+ ++|+||+|+||++++++.++|+|||++.......... ..
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~ 162 (267)
T cd06610 86 LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV 162 (267)
T ss_pred HHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccc
Confidence 99999764 45899999999999999999999998 9999999999999999999999999987665543221 11
Q ss_pred ccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCC-----CCCCcHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPAL-----SSLYPEPIK 325 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~ 325 (370)
.....++..|+|||.+... .++.++|+||||+++|+|++|+.||................ .+.. ...+++.+.
T Consensus 163 ~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06610 163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKKYSKSFR 241 (267)
T ss_pred cccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CCCcCCccccccccHHHH
Confidence 1223578899999998776 78899999999999999999999998776654444333221 1111 135788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 042314 326 ALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 326 ~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+++.+||..||++||++.+++.+
T Consensus 242 ~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 242 KMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HHHHHHcCCChhhCcCHHHHhhC
Confidence 99999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=278.83 Aligned_cols=242 Identities=29% Similarity=0.523 Sum_probs=206.9
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.++.|++|.+|++... +..+++|.+..... ......+.+|+..+++++|+|++++++++...+..++|+||+++++
T Consensus 8 ~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06623 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85 (264)
T ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence 4788999999999775 78899998876532 2556789999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhh-cCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHH-HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++.....+++..+..++.|++.++.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......... ..
T Consensus 86 L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~---~~ 159 (264)
T cd06623 86 LADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC---NT 159 (264)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCcc---cc
Confidence 99999988889999999999999999999999 88 9999999999999999999999999987665433211 12
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhccCCCCCCCCC-CcHHHHHHHHH
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT---AVQVADRRAYEDSRPALSSL-YPEPIKALLRE 330 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~ 330 (370)
..++..|+|||.+....++.++|+||||+++|+|++|..||.... ......... ....+..+.. +|..+.+++++
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~ 238 (264)
T cd06623 160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-DGPPPSLPAEEFSPEFRDFISA 238 (264)
T ss_pred eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-cCCCCCCCcccCCHHHHHHHHH
Confidence 346889999999998889999999999999999999999997763 333333333 3334445555 89999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~ 348 (370)
||..+|++||++.+++++
T Consensus 239 ~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 239 CLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HccCChhhCCCHHHHHhC
Confidence 999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=281.24 Aligned_cols=240 Identities=25% Similarity=0.410 Sum_probs=194.6
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHH---HHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELG---LWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~---~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|.|+||.||++... ++.+++|.+.............+..|.. .++...||+|+++++.+...+..++|+||+.|
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g 81 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 81 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence 689999999998764 7889999987643332222223334433 34445799999999999999999999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
++|.+++.+.+.+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++........ .
T Consensus 82 ~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-----~ 153 (278)
T cd05606 82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----H 153 (278)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-----c
Confidence 999999988888999999999999999999999998 99999999999999999999999999875543221 2
Q ss_pred CCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 254 GGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTA---VQVADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
...|+..|+|||.+.+. .++.++|+||+|+++|+|++|+.||..... ..... .. .......+..+|..+.+++.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~~-~~~~~~~~~~~s~~~~~li~ 231 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MT-LTMAVELPDSFSPELRSLLE 231 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-Hh-hccCCCCCCcCCHHHHHHHH
Confidence 23689999999998754 588999999999999999999999976522 22211 11 23345566677899999999
Q ss_pred HhcccCCCCCC-----CHHHHHHH
Q 042314 330 ECWHKNPDRRP-----TFEEIIFR 348 (370)
Q Consensus 330 ~~l~~~p~~Rp-----~~~~ll~~ 348 (370)
+||..+|.+|| ++.+++++
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 232 GLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHhhcCHHhccCCCCCCHHHHHhC
Confidence 99999999999 99999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=282.76 Aligned_cols=240 Identities=25% Similarity=0.405 Sum_probs=193.9
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEee------CCceEEEEe
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKH------SERLIFLTE 169 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~------~~~~~~v~e 169 (370)
+|.|+||.||++... +..+++|..... ......+..|+.+++++ +||||+++++++.. .+..+++||
T Consensus 24 lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 99 (282)
T cd06636 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME 99 (282)
T ss_pred eccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEE
Confidence 688999999999874 678899987543 23345678899999888 69999999998753 457899999
Q ss_pred ecCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 170 YLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 170 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
|+.+++|.+++... ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~ 176 (282)
T cd06636 100 FCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176 (282)
T ss_pred eCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc
Confidence 99999999999764 35788889999999999999999998 99999999999999999999999999875543221
Q ss_pred cceeccCCCCCccccCccccc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcH
Q 042314 248 YSYKMTGGTGSYRYMAPEVYR-----RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPE 322 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (370)
......+++.|+|||.+. ...++.++|+||||+++|+|++|..||........................+|.
T Consensus 177 ---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (282)
T cd06636 177 ---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSK 253 (282)
T ss_pred ---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCH
Confidence 112235788999999986 345788999999999999999999999766554443333222222333456889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 323 PIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 323 ~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+.++|++||..||.+||++.+++++
T Consensus 254 ~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 254 KFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred HHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 99999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=278.62 Aligned_cols=237 Identities=27% Similarity=0.397 Sum_probs=193.6
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHH-HhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLW-QKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l-~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
++.|++|.||++.. .+..+++|.++............+..|..++ ...+|+|++++++.+...+..++|+||+++++
T Consensus 4 l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 83 (260)
T cd05611 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGD 83 (260)
T ss_pred CCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCC
Confidence 78899999999987 4788999998654322222233445555444 44589999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.++++..+.+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 84 L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-------~~~ 153 (260)
T cd05611 84 CASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKF 153 (260)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecccc-------ccC
Confidence 9999998888999999999999999999999998 999999999999999999999999988754331 122
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC--CCCCCCCCCcHHHHHHHHHhcc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED--SRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~ 333 (370)
.+++.|+|||.+.+..++.++|+||+|+++|+|++|..||................ ........+|+.+.+++.+||.
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 233 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC 233 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence 47889999999988888999999999999999999999998777665544433221 1223344678999999999999
Q ss_pred cCCCCCCCHHHH
Q 042314 334 KNPDRRPTFEEI 345 (370)
Q Consensus 334 ~~p~~Rp~~~~l 345 (370)
.+|++||++.++
T Consensus 234 ~~p~~R~~~~~~ 245 (260)
T cd05611 234 MDPAKRLGANGY 245 (260)
T ss_pred CCHHHccCCCcH
Confidence 999999966433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=285.68 Aligned_cols=242 Identities=24% Similarity=0.386 Sum_probs=194.0
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|++|.||++... +..+++|.++.... ......+.+|+.+++.++||||+++++++...+..++|+||+.+ +
T Consensus 13 ~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~-~ 89 (301)
T cd07873 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-D 89 (301)
T ss_pred EeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecccc-C
Confidence 3789999999999775 67899998865422 22334567899999999999999999999999999999999975 8
Q ss_pred HHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++... ..++...+..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||++........ ....
T Consensus 90 l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~ 163 (301)
T cd07873 90 LKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK---TYSN 163 (301)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC---cccc
Confidence 98888754 46889999999999999999999998 99999999999999999999999999875443221 1122
Q ss_pred CCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC--------------------CC
Q 042314 255 GTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED--------------------SR 313 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--------------------~~ 313 (370)
..+++.|+|||.+.+. .++.++||||||+++|+|++|++||...+............ ..
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence 3468899999998654 47889999999999999999999998766543322111000 00
Q ss_pred C--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 P--------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 ~--------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+ .....+++.+.+||.+||..||.+|||+++++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 0123467889999999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=281.14 Aligned_cols=242 Identities=29% Similarity=0.546 Sum_probs=204.0
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..++.|++|.||.+... +..+++|.+..... ....+.+|+..++.++|+|++++++.+...+..++++||++++
T Consensus 25 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 25 EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred HhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 44889999999999886 78899999875432 4567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+|.+++.... .++...+..++.|++.+|.|||+.| ++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 101 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~ 174 (286)
T cd06614 101 SLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS---KRN 174 (286)
T ss_pred cHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh---hhc
Confidence 9999999876 8999999999999999999999988 99999999999999999999999998765543321 112
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC-CCCCCCcHHHHHHHHHhc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP-ALSSLYPEPIKALLRECW 332 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l 332 (370)
...+++.|+|||.+.+..++.++|+||||+++|+|++|..||................... ..+..+|..+.++|++||
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCL 254 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHh
Confidence 2246789999999988889999999999999999999999998776655444433222211 222347899999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFR 348 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~ 348 (370)
+.+|.+||++.+++++
T Consensus 255 ~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 255 VKDPEKRPSAEELLQH 270 (286)
T ss_pred ccChhhCcCHHHHhhC
Confidence 9999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=279.96 Aligned_cols=242 Identities=26% Similarity=0.460 Sum_probs=200.6
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC---CCceeeeeeeEeeCCceEEEEeec
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR---HPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~---hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
..++.|++|.||++.. .+..+++|.+.... .......+.+|+.+++.++ |||++++++++......++||||+
T Consensus 7 ~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06917 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA 84 (277)
T ss_pred hheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecC
Confidence 3478999999999986 47889999886542 2334567788999999986 999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
.+++|.++++.. .+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 85 ~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~---~ 157 (277)
T cd06917 85 EGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS---K 157 (277)
T ss_pred CCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc---c
Confidence 999999998764 7899999999999999999999998 99999999999999999999999999887654432 1
Q ss_pred ccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCC-CCcHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSS-LYPEPIKALLR 329 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~ 329 (370)
.....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.............. ...+.++. .++..+.+++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~ 236 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-SKPPRLEDNGYSKLLREFVA 236 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc-CCCCCCCcccCCHHHHHHHH
Confidence 2233578899999998654 468899999999999999999999987765544433221 12233333 37889999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~ 348 (370)
+||..||++||++.+++.+
T Consensus 237 ~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 237 ACLDEEPKERLSAEELLKS 255 (277)
T ss_pred HHcCCCcccCcCHHHHhhC
Confidence 9999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=288.20 Aligned_cols=245 Identities=23% Similarity=0.340 Sum_probs=197.2
Q ss_pred cCCCCCCcccEEEEEEcC-ceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g-~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
+.+|.||.+.||++...+ ..+++|.+.... .+......|.+|+..|.+++ |.+|++++++-..++.+|+|||+=+.
T Consensus 367 k~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~- 444 (677)
T KOG0596|consen 367 KQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDI- 444 (677)
T ss_pred HhhcCCCcceeeeeecCCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccc-
Confidence 349999999999998764 556777665443 55678899999999999995 89999999998889999999998755
Q ss_pred CHHHHHHhCCCCCh-HhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKKKGKLDP-PTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~~~~~~~-~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+|..+++++..... -.++.+..||+.++.++|..| |||.||||.|+|+-. |.+||+|||+|..+..... +....
T Consensus 445 DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT-sI~kd 519 (677)
T KOG0596|consen 445 DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT-SIVKD 519 (677)
T ss_pred cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcccc-ceeec
Confidence 99999998755433 578889999999999999999 999999999999887 8999999999988876543 23445
Q ss_pred CCCCCccccCccccccc-----------CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC-CCCCCCCCCc
Q 042314 254 GGTGSYRYMAPEVYRRE-----------SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED-SRPALSSLYP 321 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 321 (370)
.-+||+.||+||.+... ..++++||||||||+|+|+.|++||................ ...+++..-+
T Consensus 520 sQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~ 599 (677)
T KOG0596|consen 520 SQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE 599 (677)
T ss_pred cccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC
Confidence 56899999999998532 25688999999999999999999998776443333322222 2223333222
Q ss_pred H-HHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 322 E-PIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 322 ~-~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
. ++.++++.||..||++||+..+||.+
T Consensus 600 ~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 600 NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 3 39999999999999999999999875
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=280.95 Aligned_cols=242 Identities=24% Similarity=0.453 Sum_probs=194.1
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEe-----eCCceEEEEe
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLK-----HSERLIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~-----~~~~~~~v~e 169 (370)
.+|.|++|.||++... +..+++|.+.... .....+.+|+.+++.+ +||||+++++++. ..+..++|||
T Consensus 25 ~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 100 (286)
T cd06638 25 TIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100 (286)
T ss_pred eeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence 4789999999998764 7789999875432 2235677899999998 6999999999874 3456899999
Q ss_pred ecCCCCHHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceecccc
Q 042314 170 YLRNGSLHDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEK 245 (370)
Q Consensus 170 ~~~g~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 245 (370)
|++|++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 177 (286)
T cd06638 101 LCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177 (286)
T ss_pred ecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccC
Confidence 9999999998753 346888999999999999999999998 999999999999999999999999998766432
Q ss_pred CccceeccCCCCCccccCcccccc-----cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-CCCCCCCCC
Q 042314 246 DSYSYKMTGGTGSYRYMAPEVYRR-----ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-DSRPALSSL 319 (370)
Q Consensus 246 ~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 319 (370)
.. ......+++.|+|||.+.. ..++.++|+||+||++|+|++|+.||............... ......+..
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd06638 178 RL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPEL 254 (286)
T ss_pred CC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCC
Confidence 21 1223358899999999853 44788999999999999999999999877654433332211 112223455
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042314 320 YPEPIKALLRECWHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 320 ~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l 349 (370)
++..+.+++.+||+.||++|||+.+++++.
T Consensus 255 ~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 255 WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 778999999999999999999999998864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=301.91 Aligned_cols=237 Identities=17% Similarity=0.274 Sum_probs=184.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCC------CceeeeeeeEeeC-CceEEEE
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH------PNIVQFLGVLKHS-ERLIFLT 168 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h------p~Iv~~~~~~~~~-~~~~~v~ 168 (370)
.+|.|+||.||++... +..+|+|+++.. .........|+.+++.+.| ++++.+++++... ...++||
T Consensus 136 ~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~ 211 (467)
T PTZ00284 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNV----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVM 211 (467)
T ss_pred EEEeccCEEEEEEEEcCCCeEEEEEEEecc----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEE
Confidence 4899999999999764 678999998642 1233445667777776654 4588888888764 5789999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhh-cCCCceeecCCCCCCeeeCCCC----------------cE
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHH-HRPHAIIHRDLTPSNVLQDEAG----------------HL 231 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~iiH~Dlk~~Nil~~~~~----------------~~ 231 (370)
|++ |++|.+++.+.+.+++..+..++.|++.||.|||+ .+ ||||||||+|||++..+ .+
T Consensus 212 ~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~v 287 (467)
T PTZ00284 212 PKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287 (467)
T ss_pred ecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCceE
Confidence 988 67999999888899999999999999999999998 47 99999999999998765 49
Q ss_pred EEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC
Q 042314 232 KVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED 311 (370)
Q Consensus 232 kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 311 (370)
||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|++||......+....+....
T Consensus 288 kl~DfG~~~~~~~~------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 288 RICDLGGCCDERHS------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361 (467)
T ss_pred EECCCCccccCccc------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence 99999987543221 223468999999999999999999999999999999999999998766543222111000
Q ss_pred C-------------------------CCCC---------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 S-------------------------RPAL---------------SSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 ~-------------------------~~~~---------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
. .+.. .....+.+.+||++||..||++|||++|+++|
T Consensus 362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 0 0000 00113557899999999999999999999985
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=286.51 Aligned_cols=243 Identities=28% Similarity=0.434 Sum_probs=208.4
Q ss_pred eeecccCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEe
Q 042314 92 ILEDRGGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 92 ~L~~~~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
.+.....+|.|+||.|+.++. +|+.+|.|.+.+.......-.....+|-.++++++.+.||.+--.|+..+.+++|+.
T Consensus 186 ~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt 265 (591)
T KOG0986|consen 186 TFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT 265 (591)
T ss_pred ceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence 344455699999999998765 589999998866544444455667899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 170 YLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
.|+||+|.-.|.+.+ .+++..++.++.+|+.||++||+.+ ||.||+||+|||+|+.|+++|+|+|+|..+..+..
T Consensus 266 lMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 266 LMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred eecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence 999999998887765 8999999999999999999999998 99999999999999999999999999998877653
Q ss_pred cceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHhhccCCCCCCCCCCcHHH
Q 042314 248 YSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ---VADRRAYEDSRPALSSLYPEPI 324 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l 324 (370)
..+..||.+|||||++....|+.+.|.|||||++|||+.|+.||....... ...+.. ......++..+|++.
T Consensus 343 ----~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~-~~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 343 ----IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT-LEDPEEYSDKFSEEA 417 (591)
T ss_pred ----cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH-hcchhhcccccCHHH
Confidence 234589999999999999999999999999999999999999998654422 233333 345556778899999
Q ss_pred HHHHHHhcccCCCCCCCH
Q 042314 325 KALLRECWHKNPDRRPTF 342 (370)
Q Consensus 325 ~~li~~~l~~~p~~Rp~~ 342 (370)
+++++.+|.+||++|...
T Consensus 418 kslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHHHccCHHHhccC
Confidence 999999999999999643
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=293.18 Aligned_cols=247 Identities=24% Similarity=0.376 Sum_probs=224.8
Q ss_pred ccCCCCCCcccEEEEEEcCce--eEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 96 RGGIDPGAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~g~~--vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
...+|.|+||.|-++..++.. +|+|++++....+..+.+....|-.+|..++.|.||+++..|.++.++|+.||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 344899999999999887665 899999988777778888899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|.|+.++++++.|++.++..++.-+++|++|||++| ||.|||||+|++++.+|.+||.|||.++.++.+. ..+
T Consensus 505 GElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~----KTw 577 (732)
T KOG0614|consen 505 GELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR----KTW 577 (732)
T ss_pred chhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC----cee
Confidence 999999999999999999999999999999999999 9999999999999999999999999999887654 345
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
+.+|||.|.|||++.....+.++|.||||+++|||++|.+||....+...++.+...-....+|..++....+||+++-.
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr 657 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCR 657 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHh
Confidence 66899999999999999999999999999999999999999999999998888775555667788899999999999999
Q ss_pred cCCCCCCC-----HHHHHHHH
Q 042314 334 KNPDRRPT-----FEEIIFRL 349 (370)
Q Consensus 334 ~~p~~Rp~-----~~~ll~~l 349 (370)
.+|.+|.. ..++-+|.
T Consensus 658 ~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 658 DNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred cCcHhhhccccCChHHHHhhh
Confidence 99999976 55665553
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=324.81 Aligned_cols=246 Identities=26% Similarity=0.438 Sum_probs=212.9
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|.||.||.+.. +|...|+|-++..... ....+....|..++..++|||+|+++++-.+.+..+|.||||+||+|
T Consensus 1243 Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsL 1321 (1509)
T KOG4645|consen 1243 IGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSL 1321 (1509)
T ss_pred cCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcH
Confidence 89999999999865 4777899988766544 45667788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccC-ccceeccCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD-SYSYKMTGG 255 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~ 255 (370)
.+.++..+..++.....+..|++.|++|||+.| ||||||||+||+++.+|.+|++|||.|..+.... .........
T Consensus 1322 a~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~ 1398 (1509)
T KOG4645|consen 1322 ASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSM 1398 (1509)
T ss_pred HHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhh
Confidence 999999878888888999999999999999999 9999999999999999999999999998876553 222233456
Q ss_pred CCCccccCcccccccC---CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 256 TGSYRYMAPEVYRRES---YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
.||+.|||||++.+.. -..+.|||||||++.||+||+.||........+-.....+..|.+|..++.+-++|+..||
T Consensus 1399 ~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl 1478 (1509)
T KOG4645|consen 1399 MGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCL 1478 (1509)
T ss_pred cCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHH
Confidence 7999999999998754 4578999999999999999999998765544444444467888888889999999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFR 348 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~ 348 (370)
..||+.|-++.+|+++
T Consensus 1479 ~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1479 EQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hcCchhhhHHHHHHHh
Confidence 9999999999888765
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=297.02 Aligned_cols=238 Identities=24% Similarity=0.300 Sum_probs=187.0
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
+.+|.|+||.||++... +..+++|.... ..+.+|++++++++|+||+++++++...+..++|||++. +
T Consensus 175 ~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~ 244 (461)
T PHA03211 175 RALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-S 244 (461)
T ss_pred EEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-C
Confidence 34899999999999875 56788885321 235689999999999999999999999999999999995 5
Q ss_pred CHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......... ...
T Consensus 245 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~ 320 (461)
T PHA03211 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP-FHY 320 (461)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccc-ccc
Confidence 888887654 46999999999999999999999998 9999999999999999999999999998664332211 112
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHhhccC--------------
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT--------AVQVADRRAYED-------------- 311 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~--------~~~~~~~~~~~~-------------- 311 (370)
...||+.|+|||++.+..++.++|||||||++|||++|..|+.... .......+....
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 3468999999999999999999999999999999999876543211 111111111000
Q ss_pred -----------CCCC-----CC--CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 -----------SRPA-----LS--SLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 -----------~~~~-----~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
..+. +. ...+..+.+||.+||+.||.+|||+.|+|++
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 00 1244578999999999999999999999876
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=283.64 Aligned_cols=245 Identities=28% Similarity=0.501 Sum_probs=199.0
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|++|.||++.+. ++.+++|.+...... ....+.+.+|+++++.++||||+++++++...+..++|+||++++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (286)
T cd07846 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85 (286)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence 34789999999999874 788999988664332 245567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|.++......++...+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........ ....
T Consensus 86 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---~~~~ 159 (286)
T cd07846 86 VLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTD 159 (286)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc---ccCc
Confidence 99988877767999999999999999999999998 99999999999999999999999999876544321 1122
Q ss_pred CCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc--------------------CCC
Q 042314 255 GTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE--------------------DSR 313 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~--------------------~~~ 313 (370)
..++..|+|||.+.+. .++.++|+||||+++|+|++|++||............... ...
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 3578899999998753 4678999999999999999999999766543322111100 000
Q ss_pred C---------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 P---------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+ .....++..+.+++.+||..+|++||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 0123567889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=284.91 Aligned_cols=242 Identities=26% Similarity=0.436 Sum_probs=191.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|++|.||++... |..+++|.++... ........+.+|+.++++++||||+++++++......++++||+++ +|
T Consensus 8 l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l 85 (284)
T cd07839 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DL 85 (284)
T ss_pred ecccCCeEEEEEEECCCCcEEEEEEeeccc-ccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CH
Confidence 688999999999874 7889999986543 2223445677899999999999999999999999999999999975 88
Q ss_pred HHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 177 HDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 177 ~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
.+++.. .+.+++..++.++.|+++||.|||+++ ++||||||+||+++.++.+||+|||++........ .....
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~ 159 (284)
T cd07839 86 KKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR---CYSAE 159 (284)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC---CcCCC
Confidence 887764 567899999999999999999999998 99999999999999999999999999875543221 11223
Q ss_pred CCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhc------------------cCCCC-
Q 042314 256 TGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRA-DTAVQVADRRAY------------------EDSRP- 314 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~-~~~~~~~~~~~~------------------~~~~~- 314 (370)
.+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|+.. .+.......+.. ....+
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPM 239 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCC
Confidence 568899999998765 468999999999999999999888643 332222111100 00000
Q ss_pred --------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 315 --------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 315 --------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.....+++.+.++|.+||+.||.+|||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 240 YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 1112467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=272.27 Aligned_cols=239 Identities=27% Similarity=0.385 Sum_probs=194.3
Q ss_pred cccCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHh-cCCCceeeeeeeEee----CCceEEE
Q 042314 95 DRGGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQK-LRHPNIVQFLGVLKH----SERLIFL 167 (370)
Q Consensus 95 ~~~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~-l~hp~Iv~~~~~~~~----~~~~~~v 167 (370)
....+|.|-.|.|..+.. .+..+|+|++... ....+|++..-. -.|||||.++++|+. ...+.+|
T Consensus 66 s~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 66 SWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred hhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 335589999999988755 4888999998643 233467766433 369999999998865 3568899
Q ss_pred EeecCCCCHHHHHHhCCC--CChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC---CCcEEEeccccceec
Q 042314 168 TEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE---AGHLKVTDFGLSKIA 242 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~ 242 (370)
||.++||.|++.+++++. +++.++..|+.||..|+.|||+.+ |.||||||+|+|++. +..+||+|||.++.-
T Consensus 138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccccccc
Confidence 999999999999998865 999999999999999999999999 999999999999974 446899999999866
Q ss_pred cccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhccCCCCCC
Q 042314 243 QEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAV------QVADRRAYEDSRPAL 316 (370)
Q Consensus 243 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~ 316 (370)
.... ...+.+-||.|.|||++...+|+.+.|+||+|++||-|++|.+||...... .............+.
T Consensus 215 ~~~~----~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pE 290 (400)
T KOG0604|consen 215 QEPG----DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPE 290 (400)
T ss_pred CCCc----cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChh
Confidence 5432 334457799999999999999999999999999999999999999765321 111222222334445
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 317 SSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 317 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+...|+..+++|+++|..+|++|.|..+++.+
T Consensus 291 Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 291 WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 56788999999999999999999999999876
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=274.28 Aligned_cols=243 Identities=25% Similarity=0.503 Sum_probs=209.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.++.|++|.||++... +..+++|.+.... ........+..|+++++.++|||++++++.+...+..++++||+++++
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 85 (258)
T cd08215 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN-MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGD 85 (258)
T ss_pred eeccCCCeEEEEEEEcCCCcEEEEEEeeccc-CChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCc
Confidence 3788999999999886 7889999987643 234566778999999999999999999999999999999999999999
Q ss_pred HHHHHHhC----CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 176 LHDILKKK----GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 176 L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
|.+++.+. ..++...+..++.+++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~ 159 (258)
T cd08215 86 LSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD---L 159 (258)
T ss_pred HHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCcc---e
Confidence 99999864 67899999999999999999999998 99999999999999999999999999876654431 1
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
.....+++.|+|||.+.+..++.++|+||+|+++++|++|..||............. ....+..+..++..+.+++.+|
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~ 238 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-KGQYPPIPSQYSSELRNLVSSL 238 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHH
Confidence 222357889999999988889999999999999999999999998877665555443 3334556667899999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~ 348 (370)
|..+|++||++.+++++
T Consensus 239 l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 239 LQKDPEERPSIAQILQS 255 (258)
T ss_pred cCCChhhCcCHHHHhcC
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=273.75 Aligned_cols=246 Identities=32% Similarity=0.541 Sum_probs=209.0
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC--CceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS--ERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~--~~~~~v~e~~~g 173 (370)
.++.|++|.||++... +..+++|.+...... ......+.+|+.++++++||||+++++.+... ...++++||+++
T Consensus 7 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 85 (260)
T cd06606 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG 85 (260)
T ss_pred EeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCC
Confidence 3788999999999876 788999998765322 45678889999999999999999999999888 889999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
++|.+++.+...+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+......... ....
T Consensus 86 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~ 161 (260)
T cd06606 86 GSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-EGTG 161 (260)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc-cccc
Confidence 999999998889999999999999999999999988 999999999999999999999999998877654321 0122
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT-AVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..............+..+..++..+.+++.+||
T Consensus 162 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 241 (260)
T cd06606 162 SVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCL 241 (260)
T ss_pred CCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhC
Confidence 3357889999999988889999999999999999999999998765 222222332224455667778999999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFR 348 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~ 348 (370)
..+|++||++.+++.+
T Consensus 242 ~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 242 RRDPKKRPTADELLQH 257 (260)
T ss_pred cCChhhCCCHHHHhhC
Confidence 9999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=274.63 Aligned_cols=241 Identities=30% Similarity=0.499 Sum_probs=207.6
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|++|.||.+... +..+++|.+.............+..|+.+++.++||||+++++.+...+..+++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 578999999999875 788999998776555555677889999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.....+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~ 154 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFC 154 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC---cccCCc
Confidence 999998878999999999999999999999988 99999999999999999999999999877654321 122335
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
++..|+|||.+.+...+.++|+||||+++|++++|..||.............. .....+...|..+.+++++||..||
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p 232 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDP 232 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCH
Confidence 78899999999888889999999999999999999999987766554444432 4455667779999999999999999
Q ss_pred CCCCCH---HHHHH
Q 042314 337 DRRPTF---EEIIF 347 (370)
Q Consensus 337 ~~Rp~~---~~ll~ 347 (370)
++||++ .+++.
T Consensus 233 ~~R~~~~~~~~l~~ 246 (250)
T cd05123 233 TKRLGSGGAEEIKA 246 (250)
T ss_pred hhCCCcccHHHHHh
Confidence 999999 55544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=282.58 Aligned_cols=244 Identities=28% Similarity=0.449 Sum_probs=198.0
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCC--ChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIAS--NPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~--~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
.+|.|++|.||++... +..+++|.++..... .......+..|+.+++.++|+||+++++++...+..++||||+ +
T Consensus 7 ~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 85 (298)
T cd07841 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-E 85 (298)
T ss_pred eeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-C
Confidence 3788999999999864 789999998765432 2345566788999999999999999999999999999999999 8
Q ss_pred CCHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 174 GSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 174 ~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
++|.+++.... .+++..++.++.|+++||.|||+++ ++|+||+|+||+++.++.++|+|||++......... .
T Consensus 86 ~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~---~ 159 (298)
T cd07841 86 TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK---M 159 (298)
T ss_pred CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc---c
Confidence 89999998776 7999999999999999999999998 999999999999999999999999999776543221 1
Q ss_pred cCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC------------------
Q 042314 253 TGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR------------------ 313 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 313 (370)
....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||..........+.......
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 22245788999998865 45788999999999999999998888766554333222110000
Q ss_pred --------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 --------PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 --------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.......+..+.++|.+||..+|++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00113356789999999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=281.39 Aligned_cols=241 Identities=27% Similarity=0.439 Sum_probs=199.8
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|++|.||++.. .+..+++|.+.............+.+|+.+++.++|||++++++++...+..++||||+.+
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 105 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG- 105 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC-
Confidence 3488999999999976 4788999998765444445566788999999999999999999999999999999999965
Q ss_pred CHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+|.+++.. ...+++..+..++.|++.++.|||+++ ++|+||+|+||+++.++.++|+|||++...... .
T Consensus 106 ~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-------~ 175 (313)
T cd06633 106 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-------N 175 (313)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC-------C
Confidence 77777754 457899999999999999999999998 999999999999999999999999987543221 2
Q ss_pred CCCCCccccCccccc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 254 GGTGSYRYMAPEVYR---RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
...++..|+|||.+. ...++.++|+||||+++|+|++|.+||........................++..+.+++.+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 255 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY 255 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 235788999999984 45678899999999999999999999987766554444433333233344577889999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~ 348 (370)
||+.+|.+||++.+++.+
T Consensus 256 ~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 256 CLQKIPQERPASAELLRH 273 (313)
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=278.73 Aligned_cols=244 Identities=25% Similarity=0.419 Sum_probs=198.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|++|.||++.+. |..+++|.+..... .......+.+|+.++++++||||+++++++......++|+||+ +++
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~ 84 (286)
T cd07832 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSD 84 (286)
T ss_pred ecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCC
Confidence 3789999999999874 78899999876532 2344567889999999999999999999999999999999999 999
Q ss_pred HHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++... ..+++..++.++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++......... ....
T Consensus 85 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~ 159 (286)
T cd07832 85 LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR--LYSH 159 (286)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC--cccc
Confidence 99998653 56899999999999999999999998 999999999999999999999999998766543321 1223
Q ss_pred CCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--------------------
Q 042314 255 GTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR-------------------- 313 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------------- 313 (370)
..++..|+|||.+.+. .++.++||||+|+++|+|++|.+||..................
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence 3578899999998654 4688999999999999999998888776554433222110000
Q ss_pred --------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 --------PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 --------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.......+..+.+++++||..+|.+||++++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00112456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=272.25 Aligned_cols=240 Identities=30% Similarity=0.569 Sum_probs=203.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.++.|++|.||++... +..+++|.+..... .....+.+|+..++.++||+++++++.+......++++||+++++
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 83 (253)
T cd05122 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83 (253)
T ss_pred eeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence 3788999999999885 78899999876432 456788999999999999999999999999999999999999999
Q ss_pred HHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++... ..+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 84 L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----~~~ 156 (253)
T cd05122 84 LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA----RNT 156 (253)
T ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc----ccc
Confidence 99999876 68899999999999999999999988 99999999999999999999999999877655432 122
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCC--CCCCcHHHHHHHHHhc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPAL--SSLYPEPIKALLRECW 332 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l 332 (370)
..++..|+|||.+.+..++.++|+||||+++|+|++|+.||.............. ...+.. +..++..+.+++++||
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l 235 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCL 235 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHc
Confidence 3578899999999888889999999999999999999999987755444333332 222222 2234889999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFR 348 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~ 348 (370)
+.||++|||+.+++++
T Consensus 236 ~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 236 QKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCChhhCCCHHHHhcC
Confidence 9999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=280.08 Aligned_cols=244 Identities=27% Similarity=0.495 Sum_probs=198.9
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|++|.||++... +..+++|.+.... ........+.+|+.+++.++|+||+++++.+...+..++++||++++.+
T Consensus 9 i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l 87 (288)
T cd07833 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLL 87 (288)
T ss_pred ecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHH
Confidence 788999999999775 6789999886543 2334567889999999999999999999999999999999999999777
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
..+..+...++...+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.+||+|||++......... ......
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~ 162 (288)
T cd07833 88 ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPAS--PLTDYV 162 (288)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCccc--cccCcc
Confidence 777777677999999999999999999999998 999999999999999999999999998766544321 112235
Q ss_pred CCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-------------------C--C--
Q 042314 257 GSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-------------------D--S-- 312 (370)
Q Consensus 257 g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-------------------~--~-- 312 (370)
++..|+|||.+.+. .++.++|+||+|+++|+|++|++||............... . .
T Consensus 163 ~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07833 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPE 242 (288)
T ss_pred cccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCC
Confidence 68889999999888 7899999999999999999999999766543322111100 0 0
Q ss_pred -------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 313 -------RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 313 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
....+..+|..+.++|++||..+|++||++++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 243 PSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred CCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 001223358889999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=280.62 Aligned_cols=243 Identities=29% Similarity=0.427 Sum_probs=199.0
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|++|.||++... +..+++|.+.............+.+|+.+++.++|+|++++++++......++|+||+.|
T Consensus 21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 99 (308)
T cd06634 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG- 99 (308)
T ss_pred HheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccCC-
Confidence 44889999999999874 677999988654333445556788999999999999999999999999999999999975
Q ss_pred CHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+|.+++.. ...++...+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 100 ~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~------- 169 (308)
T cd06634 100 SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------- 169 (308)
T ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCcc-------
Confidence 78776653 456899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCCccccCccccc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 254 GGTGSYRYMAPEVYR---RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
...+++.|+|||.+. ...++.++||||||+++|+|++|..||........................++..+.++|++
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 249 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHH
Confidence 234788999999974 34578899999999999999999999877665444433332222222344688899999999
Q ss_pred hcccCCCCCCCHHHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~ 350 (370)
||..+|++||++.+++++-.
T Consensus 250 cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 250 CLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HhhCCcccCCCHHHHhhCcc
Confidence 99999999999999988744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=274.76 Aligned_cols=242 Identities=22% Similarity=0.453 Sum_probs=202.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
++.|++|.||++... |..+++|.+..... .....+.+.+|+.+++.++|+||+++++.+...+..++|+||+.+++|
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (257)
T cd08225 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDL 86 (257)
T ss_pred ecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcH
Confidence 788999999999874 67899998865422 223446778999999999999999999999999999999999999999
Q ss_pred HHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc-EEEeccccceeccccCccceecc
Q 042314 177 HDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH-LKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 177 ~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++. ++|+|||.+......... ..
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~---~~ 160 (257)
T cd08225 87 MKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL---AY 160 (257)
T ss_pred HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCccc---cc
Confidence 99987643 4789999999999999999999998 999999999999998764 699999998766543221 12
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
...+++.|+|||.+....++.++|+||+|+++|+|++|..||............. ..........++..+.+++++||.
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~ 239 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC-QGYFAPISPNFSRDLRSLISQLFK 239 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-cccCCCCCCCCCHHHHHHHHHHhc
Confidence 2357889999999988889999999999999999999999998776655554433 333444556688999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~ 348 (370)
.+|++|||+.+++++
T Consensus 240 ~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 240 VSPRDRPSITSILKR 254 (257)
T ss_pred cChhhCcCHHHHhhC
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=279.78 Aligned_cols=246 Identities=28% Similarity=0.451 Sum_probs=208.3
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|++|.||++.. .+..+++|++.............+..|..+++++. ||||+++++++...+..++|||++.++
T Consensus 8 ~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (280)
T cd05581 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNG 87 (280)
T ss_pred eecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCC
Confidence 378999999999987 47889999987654444455577889999999998 999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc-----
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS----- 249 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~----- 249 (370)
+|.+++.+.+.++...+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 88 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 164 (280)
T cd05581 88 ELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGD 164 (280)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCC
Confidence 99999998888999999999999999999999998 9999999999999999999999999987665432110
Q ss_pred ------------eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCC
Q 042314 250 ------------YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALS 317 (370)
Q Consensus 250 ------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 317 (370)
.......++..|+|||.+....++.++|+||||++++++++|+.||............. ......+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~ 242 (280)
T cd05581 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL--KLEYSFP 242 (280)
T ss_pred CccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--hcCCCCC
Confidence 11122346889999999988888999999999999999999999998777555444333 3344556
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 042314 318 SLYPEPIKALLRECWHKNPDRRPTF----EEIIFR 348 (370)
Q Consensus 318 ~~~~~~l~~li~~~l~~~p~~Rp~~----~~ll~~ 348 (370)
..+|+.+.+++.+||+.+|++||++ .+++.+
T Consensus 243 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 243 PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 6778999999999999999999999 787754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=289.44 Aligned_cols=234 Identities=21% Similarity=0.320 Sum_probs=182.8
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|..... ....|+.++++++||||+++++++...+..++|+|++.+ +
T Consensus 73 ~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 142 (357)
T PHA03209 73 TLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-D 142 (357)
T ss_pred EecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCC-c
Confidence 3789999999999886 457888875332 124689999999999999999999999999999999965 8
Q ss_pred HHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++..+.+||+|||++....... ...+
T Consensus 143 l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~~~~ 215 (357)
T PHA03209 143 LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP----AFLG 215 (357)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc----cccc
Confidence 8887765 457899999999999999999999998 9999999999999999999999999987543221 1123
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCC-CCCcH----------HHHHHHhhccCC-CCCC------
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSN-RADTA----------VQVADRRAYEDS-RPAL------ 316 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~-~~~~~----------~~~~~~~~~~~~-~~~~------ 316 (370)
..||+.|+|||++.+..++.++|||||||++|||+++..++ ..... ............ ...+
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 295 (357)
T PHA03209 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS 295 (357)
T ss_pred ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCcc
Confidence 45899999999999999999999999999999999865444 32110 000000000000 0000
Q ss_pred ------------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 317 ------------------------SSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 317 ------------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
...++..+.+||.+||+.||++|||+.|++++
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 296 RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 11356677889999999999999999999875
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=270.70 Aligned_cols=243 Identities=30% Similarity=0.526 Sum_probs=207.9
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.++.|++|.+|++... +..+++|.+..... .......+.+|++++++++|||++++++++...+..++++||+++++
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (254)
T cd06627 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGS 85 (254)
T ss_pred EEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCc
Confidence 3788999999999764 67899999876532 23456789999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++...+.+++..+..++.|++.++.+||+.+ ++||||+|+||+++.++.++|+|||.+......... ....
T Consensus 86 L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---~~~~ 159 (254)
T cd06627 86 LRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD---DASV 159 (254)
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc---cccc
Confidence 9999998888999999999999999999999998 999999999999999999999999999877654321 1223
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.++..|+|||...+..++.++|+||+|+++|+|++|..||............. ....+..+...++.+.+++.+||..+
T Consensus 160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-QDDHPPLPEGISPELKDFLMQCFQKD 238 (254)
T ss_pred ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence 57889999999988888999999999999999999999998766544333333 23445566778899999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042314 336 PDRRPTFEEIIFR 348 (370)
Q Consensus 336 p~~Rp~~~~ll~~ 348 (370)
|++||++.+++.+
T Consensus 239 p~~R~~~~~~l~~ 251 (254)
T cd06627 239 PNLRPTAKQLLKH 251 (254)
T ss_pred hhhCcCHHHHhcC
Confidence 9999999999753
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=273.55 Aligned_cols=241 Identities=24% Similarity=0.455 Sum_probs=205.8
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.++.|+++.+|++... +..+++|.+..... .......+..|+.+++.++|+||+++++++......++|+||+++++
T Consensus 7 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd08530 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGD 85 (256)
T ss_pred eecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCC
Confidence 4788999999998764 67899999876432 23445677899999999999999999999999999999999999999
Q ss_pred HHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 176 LHDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 176 L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
|.+++.+ ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----- 157 (256)
T cd08530 86 LSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----- 157 (256)
T ss_pred HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC-----
Confidence 9999876 356889999999999999999999998 9999999999999999999999999987665441
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
.....+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||............. ....+..+..++..+.+++.+|
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNFIRSM 236 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHHHHHH
Confidence 112357889999999999889999999999999999999999998877665544443 3344455567889999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~ 348 (370)
|..+|++||++.+++.+
T Consensus 237 l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 237 LQVKPKLRPNCDKILAS 253 (256)
T ss_pred cCCCcccCCCHHHHhcC
Confidence 99999999999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=278.03 Aligned_cols=242 Identities=27% Similarity=0.426 Sum_probs=192.6
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
..+|.|+||.||++... +..+++|.+..... ......+.+|+..+.++. ||||+++++++...+..+++|||+.+
T Consensus 10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 45899999999998774 68899998875432 245567889999999996 99999999999988899999999865
Q ss_pred CCHHHHHH-----hCCCCChHhHHHHHHHHHHHHHHHhhc-CCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 174 GSLHDILK-----KKGKLDPPTAVAYALDIARGMNYLHHH-RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 174 ~~L~~~l~-----~~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
++.++.. ....+++..+..++.+++.||+|||+. + ++||||||+||+++.++.++|+|||++........
T Consensus 88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 6655432 235789999999999999999999975 6 99999999999999999999999999876543221
Q ss_pred cceeccCCCCCccccCccccccc---CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCC----CCCCC
Q 042314 248 YSYKMTGGTGSYRYMAPEVYRRE---SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPA----LSSLY 320 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 320 (370)
.....+++.|+|||.+.+. .++.++|+||+|+++|+|++|++||..................+. .+..+
T Consensus 164 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd06616 164 ----KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREF 239 (288)
T ss_pred ----cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCcc
Confidence 1222578899999999776 688999999999999999999999976543211111111111222 22347
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 321 PEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 321 ~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+..+.+|+++||+.+|++|||+.+++.+
T Consensus 240 ~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 240 SPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 8899999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=276.47 Aligned_cols=241 Identities=26% Similarity=0.426 Sum_probs=194.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCC------ceEEEE
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSE------RLIFLT 168 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~------~~~~v~ 168 (370)
.++.|++|.||++... +..+++|.+.... .....+.+|+.+++++ +|+||+++++++.... ..++||
T Consensus 13 ~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 88 (275)
T cd06608 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVM 88 (275)
T ss_pred eecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEE
Confidence 3788999999999874 6779999876542 2346788999999998 6999999999986644 489999
Q ss_pred eecCCCCHHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccc
Q 042314 169 EYLRNGSLHDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQE 244 (370)
Q Consensus 169 e~~~g~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 244 (370)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 165 (275)
T cd06608 89 ELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS 165 (275)
T ss_pred EcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceeccc
Confidence 99999999998865 347899999999999999999999998 99999999999999999999999999876543
Q ss_pred cCccceeccCCCCCccccCcccccc-----cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC-CCCCCC
Q 042314 245 KDSYSYKMTGGTGSYRYMAPEVYRR-----ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS-RPALSS 318 (370)
Q Consensus 245 ~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~ 318 (370)
... ......++..|+|||.+.. ..++.++|+||||+++|+|++|.+||................. ....+.
T Consensus 166 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (275)
T cd06608 166 TLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPE 242 (275)
T ss_pred chh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchh
Confidence 221 1223457889999998753 3467899999999999999999999986655444443332111 112223
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 319 LYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 319 ~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.++..+.+++.+||..||++|||+.+++.+
T Consensus 243 ~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 243 NWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 477899999999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=279.60 Aligned_cols=240 Identities=27% Similarity=0.463 Sum_probs=199.0
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++.. .+..+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++|+||+++++|
T Consensus 27 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L 103 (293)
T cd06647 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103 (293)
T ss_pred ecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcH
Confidence 68899999999975 47789999875432 23346688999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.+. .++...+..++.|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 104 ~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~---~~~~~~ 176 (293)
T cd06647 104 TDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMV 176 (293)
T ss_pred HHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc---cccccc
Confidence 9998765 6788999999999999999999998 99999999999999999999999998875543322 112235
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-CCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-DSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
+++.|+|||.+....++.++|+||||+++|++++|+.||............... ......+..++..+.+++++||..+
T Consensus 177 ~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 256 (293)
T cd06647 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 256 (293)
T ss_pred CChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCC
Confidence 788999999998888899999999999999999999999876654432222111 1111233456788999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042314 336 PDRRPTFEEIIFR 348 (370)
Q Consensus 336 p~~Rp~~~~ll~~ 348 (370)
|++||++.+++.+
T Consensus 257 p~~Rp~~~~il~h 269 (293)
T cd06647 257 VEKRGSAKELLQH 269 (293)
T ss_pred hhhCcCHHHHhcC
Confidence 9999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=278.28 Aligned_cols=244 Identities=24% Similarity=0.389 Sum_probs=196.1
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC--CceEEEEeecC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS--ERLIFLTEYLR 172 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~--~~~~~v~e~~~ 172 (370)
..+|.|++|.||++.+. ++.+++|.++..... ......+.+|+.++++++||||+++++++... +..++|+||+.
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 89 (293)
T cd07843 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE 89 (293)
T ss_pred hhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence 34789999999999885 778999998754322 23345667899999999999999999998777 88999999997
Q ss_pred CCCHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 173 NGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 173 g~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
+ +|.+++.... .+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++........ .
T Consensus 90 ~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---~ 162 (293)
T cd07843 90 H-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK---P 162 (293)
T ss_pred c-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc---c
Confidence 5 9999887653 5899999999999999999999998 99999999999999999999999999886654321 1
Q ss_pred ccCCCCCccccCcccccccC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc--------------------
Q 042314 252 MTGGTGSYRYMAPEVYRRES-YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-------------------- 310 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-------------------- 310 (370)
.....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|.+||..........+....
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 12234688999999987644 688999999999999999999999876554433222110
Q ss_pred ---------CCCCCCCCC-CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 311 ---------DSRPALSSL-YPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 311 ---------~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
......+.. +++.+.++|++||+.+|++|||+.|++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 001112222 57889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=289.27 Aligned_cols=242 Identities=27% Similarity=0.445 Sum_probs=213.6
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|.|+.|.++... +..||+|.+.+...+. ..+..+.+|+++++.++|||||+++.+......+|+||||+.+|
T Consensus 62 ~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~g 140 (596)
T KOG0586|consen 62 KTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGG 140 (596)
T ss_pred eeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCc
Confidence 34889999999999764 8999999998765433 44455999999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++++.+.++..+..+..++.|+++|++|+|+++ |+|||||++|+|++.+.++||+|||++..+.... ....
T Consensus 141 e~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~----~lqt 213 (596)
T KOG0586|consen 141 ELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGL----MLQT 213 (596)
T ss_pred hhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccc----cccc
Confidence 99999999999999999999999999999999999 9999999999999999999999999998886432 3455
Q ss_pred CCCCccccCcccccccCCC-chhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYG-KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
.+|++.|.|||++.+..|+ +.+|+||+|+++|-|+.|..||++.+...+......... .++..++.+..++|+++|.
T Consensus 214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~--rIp~~ms~dce~lLrk~lv 291 (596)
T KOG0586|consen 214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY--RIPFYMSCDCEDLLRKFLV 291 (596)
T ss_pred cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee--cccceeechhHHHHHHhhc
Confidence 6899999999999998875 799999999999999999999998887776666553333 3445567889999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~ 348 (370)
.+|.+|++.+++.++
T Consensus 292 l~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 292 LNPSKRGPCDQIMKD 306 (596)
T ss_pred cCccccCCHHHhhhh
Confidence 999999999998765
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=276.79 Aligned_cols=242 Identities=23% Similarity=0.413 Sum_probs=200.5
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|++|.||++.. .+..+++|.+... .......+.+|+.+++.++|+||+++++.+...+..+++|||++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 3489999999999977 4788999987532 2345667889999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|.+++.. +.+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 103 ~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~---~~~~ 175 (292)
T cd06657 103 ALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---RRKS 175 (292)
T ss_pred cHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc---cccc
Confidence 99998765 46899999999999999999999998 99999999999999999999999998865543221 1122
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-CCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-DSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..+++.|+|||.+.+..++.++|+||+|+++|+|++|..||............... .........++..+.+++.+||.
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 35788999999998888899999999999999999999999876655443333211 11122234578899999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~ 348 (370)
.+|.+||++.+++.+
T Consensus 256 ~~P~~R~~~~~ll~~ 270 (292)
T cd06657 256 RDPAQRATAAELLKH 270 (292)
T ss_pred CCcccCcCHHHHhcC
Confidence 999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=285.06 Aligned_cols=241 Identities=26% Similarity=0.367 Sum_probs=192.6
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC------CceEEEE
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS------ERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~------~~~~~v~ 168 (370)
..+|.|++|.||++.. .+..+++|.+..... .......+.+|+.+++.++||||+++++++... ...++|+
T Consensus 22 ~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 100 (353)
T cd07850 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100 (353)
T ss_pred EEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence 3478999999999976 478899999865432 334456677899999999999999999987643 3579999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
||+.+ +|.+.+... ++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 101 e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 173 (353)
T cd07850 101 ELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM- 173 (353)
T ss_pred eccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC-
Confidence 99965 888888754 889999999999999999999998 99999999999999999999999999976644321
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC-----------------
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED----------------- 311 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~----------------- 311 (370)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||................
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 174 ---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred ---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 222357889999999999999999999999999999999999997654332221111000
Q ss_pred ---CCC---------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 ---SRP---------------------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 ---~~~---------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
..+ ..+...++.+.++|.+||+.||++|||+.+++.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0012346678999999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=275.67 Aligned_cols=240 Identities=27% Similarity=0.425 Sum_probs=192.6
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeC-----CceEEEEee
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHS-----ERLIFLTEY 170 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~-----~~~~~v~e~ 170 (370)
++.|++|.||++... +..+++|.+.... .....+.+|+.+++++ +|||++++++++... +..++|+||
T Consensus 30 l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey 105 (291)
T cd06639 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL 105 (291)
T ss_pred eecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence 688999999999774 7789999886432 2345667889999988 799999999988653 358999999
Q ss_pred cCCCCHHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccC
Q 042314 171 LRNGSLHDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD 246 (370)
Q Consensus 171 ~~g~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 246 (370)
+++++|.++++. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 106 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 182 (291)
T cd06639 106 CNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182 (291)
T ss_pred CCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhccccc
Confidence 999999998763 357899999999999999999999998 9999999999999999999999999987654322
Q ss_pred ccceeccCCCCCccccCccccccc-----CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-CCCCCCCCCC
Q 042314 247 SYSYKMTGGTGSYRYMAPEVYRRE-----SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-DSRPALSSLY 320 (370)
Q Consensus 247 ~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 320 (370)
.. .....++..|+|||.+... .++.++|+||+|+++|+|++|++||............... ......+..+
T Consensus 183 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (291)
T cd06639 183 LR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKW 259 (291)
T ss_pred cc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccccc
Confidence 11 1223578899999998643 3678999999999999999999999876654443333211 1111224456
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 321 PEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 321 ~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+..+.++|.+||+.+|++||++.+++.+
T Consensus 260 ~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 260 CRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 7889999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=277.09 Aligned_cols=242 Identities=27% Similarity=0.462 Sum_probs=193.8
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
++.|++|.||++... +..+++|.+.... ........+.+|++++++++||||+++++++...+..++||||+. ++|
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l 85 (284)
T cd07860 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDL 85 (284)
T ss_pred ecCCCceEEEEEEECCCCCEEEEEEccccc-cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCH
Confidence 688999999999774 7889999886543 223344678899999999999999999999999999999999996 589
Q ss_pred HHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......... ...
T Consensus 86 ~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~---~~~ 159 (284)
T cd07860 86 KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTH 159 (284)
T ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc---ccc
Confidence 8888653 46889999999999999999999998 999999999999999999999999998755432211 122
Q ss_pred CCCCccccCcccccccC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--------------------
Q 042314 255 GTGSYRYMAPEVYRRES-YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR-------------------- 313 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------------- 313 (370)
..+++.|+|||.+.+.. ++.++|+||||+++|+|+||+.||..................
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 24678899999887654 588999999999999999999999876554332221110000
Q ss_pred -------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 -------PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 -------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
......+++.+.++|.+||+.||++||++++++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00122467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=281.95 Aligned_cols=247 Identities=25% Similarity=0.383 Sum_probs=193.1
Q ss_pred CCCCCCcccEEEEEE----cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC--CceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKW----RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS--ERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~----~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~--~~~~~v~e~~ 171 (370)
.+|.|++|.||++.. .+..+++|.+.............+.+|+.+++.++||||+++++++... ..+++||||+
T Consensus 7 ~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 86 (316)
T cd07842 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYA 86 (316)
T ss_pred EeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCC
Confidence 378999999999987 4688999998874423334456678899999999999999999999887 7899999999
Q ss_pred CCCCHHHHHHhC-----CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC----CCcEEEeccccceec
Q 042314 172 RNGSLHDILKKK-----GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE----AGHLKVTDFGLSKIA 242 (370)
Q Consensus 172 ~g~~L~~~l~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~----~~~~kl~Dfg~~~~~ 242 (370)
++ +|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||++...
T Consensus 87 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~ 162 (316)
T cd07842 87 EH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162 (316)
T ss_pred Cc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCcccccc
Confidence 75 777766532 26889999999999999999999998 999999999999999 899999999998866
Q ss_pred cccCccceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH---------HHHHhhc---
Q 042314 243 QEKDSYSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ---------VADRRAY--- 309 (370)
Q Consensus 243 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---------~~~~~~~--- 309 (370)
..............+++.|+|||.+.+. .++.++|+||||+++|+|++|++||....... .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 242 (316)
T cd07842 163 NAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLG 242 (316)
T ss_pred CCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhC
Confidence 5433222223344678899999988764 57899999999999999999999997543221 0000000
Q ss_pred ---------------------cCCCCCCC-----------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 310 ---------------------EDSRPALS-----------SLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 310 ---------------------~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.......+ ...+..+.+++.+||+.||++|||+.+++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 243 TPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred CCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000111 1456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=272.86 Aligned_cols=232 Identities=23% Similarity=0.397 Sum_probs=188.2
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... +..+++|......... .|......+ +||||+++++.+...+..++||||+++++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 95 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGD 95 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCc
Confidence 699999999998764 6788888876542211 122222222 69999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC-cEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG-HLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++.....+++..+..++.|+++|+.|||+.+ ++||||||+||+++.++ .++|+|||++....... .
T Consensus 96 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-------~ 165 (267)
T PHA03390 96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-------C 165 (267)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-------c
Confidence 9999998888999999999999999999999998 99999999999999988 99999999987654332 1
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH--HHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQV--ADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
..++..|+|||.+.+..++.++|+||+|+++|+|++|..||........ .............+..+++.+.++|.+||
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 245 (267)
T PHA03390 166 YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSML 245 (267)
T ss_pred CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHh
Confidence 2478899999999998899999999999999999999999975433221 11111112333445578999999999999
Q ss_pred ccCCCCCCC-HHHHHHH
Q 042314 333 HKNPDRRPT-FEEIIFR 348 (370)
Q Consensus 333 ~~~p~~Rp~-~~~ll~~ 348 (370)
+.+|.+||+ +++++++
T Consensus 246 ~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 246 KYNINYRLTNYNEIIKH 262 (267)
T ss_pred ccChhhCCchHHHHhcC
Confidence 999999996 6998754
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=279.32 Aligned_cols=243 Identities=28% Similarity=0.408 Sum_probs=193.6
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC--CceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS--ERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~--~~~~~v~e~~~g 173 (370)
.+|.|++|.||++... |..+++|.++..... ......+.+|+.++++++|+||+++++++... +..++||||+.+
T Consensus 14 ~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 92 (309)
T cd07845 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ 92 (309)
T ss_pred eeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC
Confidence 4788999999999874 788999998654322 22233456799999999999999999998654 568999999975
Q ss_pred CCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 174 GSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 174 ~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ ..
T Consensus 93 -~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~---~~ 165 (309)
T cd07845 93 -DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK---PM 165 (309)
T ss_pred -CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccC---CC
Confidence 888888753 57899999999999999999999998 99999999999999999999999999887654321 11
Q ss_pred cCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC-----------------C
Q 042314 253 TGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR-----------------P 314 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-----------------~ 314 (370)
....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|++||...+.............. .
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (309)
T cd07845 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF 245 (309)
T ss_pred CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccc
Confidence 22245788999999865 45789999999999999999999999877665544332211000 0
Q ss_pred CC-----------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 315 AL-----------SSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 315 ~~-----------~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.. ....++.+.++|++||+.||++|||+.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 01247889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=275.50 Aligned_cols=240 Identities=28% Similarity=0.462 Sum_probs=189.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHH-HHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGL-WQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~-l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|+||.||++... |..+|+|.++..... .....+..|... ++..+||||+++++++...+..++++||++ +
T Consensus 8 ~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 3789999999999875 788999998764322 223345556664 566789999999999999999999999997 4
Q ss_pred CHHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhc-CCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 175 SLHDILKK----KGKLDPPTAVAYALDIARGMNYLHHH-RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 175 ~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+|.+++.. ...+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-- 159 (283)
T cd06617 85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA-- 159 (283)
T ss_pred cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccccc--
Confidence 88887764 24689999999999999999999997 7 99999999999999999999999999876543221
Q ss_pred eeccCCCCCccccCcccccc----cCCCchhhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhccCCCCCC-CCCCcHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRR----ESYGKSVDVFSFALIVHEMFQGGPSNRADTA-VQVADRRAYEDSRPAL-SSLYPEP 323 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 323 (370)
.....++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||..... ........ ....+.. ...+|..
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (283)
T cd06617 160 --KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFSPE 236 (283)
T ss_pred --cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccCHH
Confidence 122347888999998865 4468899999999999999999999975322 22222222 2222332 2357899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 324 IKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 324 l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+.++|.+||..+|++||++.+++++
T Consensus 237 l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 237 FQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=274.05 Aligned_cols=240 Identities=30% Similarity=0.495 Sum_probs=194.1
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee--CCceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH--SERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~--~~~~~~v~e~~~g 173 (370)
.+|.|++|.||++... +..+++|.+.... .......+.+|+++++.++||||+++++++.. .+.+++||||+++
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 3788999999999874 6789999887542 23456778999999999999999999998865 3468999999999
Q ss_pred CCHHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 174 GSLHDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 174 ~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
++|.+++.. ...++...+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-- 160 (287)
T cd06621 86 GSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-- 160 (287)
T ss_pred CCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccccc--
Confidence 999988653 346888999999999999999999998 99999999999999999999999999865543221
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc-----HHHHHHHhhccCCCCCCC------C
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT-----AVQVADRRAYEDSRPALS------S 318 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~------~ 318 (370)
....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.... ..+...... ....+..+ .
T Consensus 161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 236 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPELKDEPGNGI 236 (287)
T ss_pred ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchhhccCCCCCC
Confidence 12246788999999998889999999999999999999999997652 222222221 11111111 2
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 319 LYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 319 ~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+++.+.+++.+||..+|++|||+.+++++
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 356789999999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=279.39 Aligned_cols=245 Identities=20% Similarity=0.340 Sum_probs=191.6
Q ss_pred CCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 100 DPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 100 ~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
|.|+++.||.+.. .|+.+++|.+..... .....+.+.+|+.+++.++||||+++++++...+..++|+||+.+++|.
T Consensus 9 g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~ 87 (328)
T cd08226 9 GFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSAN 87 (328)
T ss_pred cccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHH
Confidence 4458999999987 589999999875432 3345578899999999999999999999999999999999999999999
Q ss_pred HHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc-c--cee-
Q 042314 178 DILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS-Y--SYK- 251 (370)
Q Consensus 178 ~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~--~~~- 251 (370)
+++.+. ..+++..+..++.|++.||+|||+++ ++||||||+||+++.++.++++||+.+........ . ...
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (328)
T cd08226 88 SLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDF 164 (328)
T ss_pred HHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccc
Confidence 998864 35888999999999999999999998 99999999999999999999999986533221110 0 000
Q ss_pred ccCCCCCccccCccccccc--CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC-----------------
Q 042314 252 MTGGTGSYRYMAPEVYRRE--SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS----------------- 312 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~----------------- 312 (370)
.....++..|+|||.+.+. .++.++||||+||++|+|++|.+||.................
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (328)
T cd08226 165 PQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMK 244 (328)
T ss_pred cccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhc
Confidence 0111245679999999764 478899999999999999999999977654333222111000
Q ss_pred ----------------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 313 ----------------------------RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 313 ----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
....+..+++.+.+|+++||..||++|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 245 NSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 011122356789999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=275.66 Aligned_cols=243 Identities=24% Similarity=0.395 Sum_probs=189.5
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|++|.||++... ++.+++|.+...... .....+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus 11 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 87 (291)
T cd07844 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT- 87 (291)
T ss_pred EEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-
Confidence 34788999999999774 788999998654321 2234467899999999999999999999999999999999975
Q ss_pred CHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+|.+++.+. ..++...+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........ ...
T Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~ 161 (291)
T cd07844 88 DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK---TYS 161 (291)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc---ccc
Confidence 999988764 46789999999999999999999998 99999999999999999999999999865432211 111
Q ss_pred CCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhc-cCC------------------
Q 042314 254 GGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTA-VQVADRRAY-EDS------------------ 312 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~-~~~------------------ 312 (370)
...++..|+|||.+.+ ..++.++|+||+|+++|+|++|++||..... .+....... ...
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY 241 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc
Confidence 2246788999999876 4578999999999999999999999976542 111111100 000
Q ss_pred ------CC---CCCCCCc--HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 313 ------RP---ALSSLYP--EPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 313 ------~~---~~~~~~~--~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.. .....++ ..+.+++.+||+.+|++||++.+++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 0001223 678899999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=298.18 Aligned_cols=247 Identities=17% Similarity=0.258 Sum_probs=182.3
Q ss_pred ccCCCCCCcccEEEEEEcCc---eeEEE--------------EeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeE
Q 042314 96 RGGIDPGAYGEVYLVKWRGT---EIAAK--------------TIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~g~---~vavK--------------~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~ 158 (370)
...+|.|+||.||++..+.. ..+.| .+.+...........+.+|+.++++++||||+++++++
T Consensus 153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 232 (501)
T PHA03210 153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232 (501)
T ss_pred EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEE
Confidence 34589999999999865321 11111 11111122334566788999999999999999999999
Q ss_pred eeCCceEEEEeecCCCCHHHHHHhC-----CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEE
Q 042314 159 KHSERLIFLTEYLRNGSLHDILKKK-----GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKV 233 (370)
Q Consensus 159 ~~~~~~~~v~e~~~g~~L~~~l~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl 233 (370)
...+..++|++++.+ +|.+++... .......+..++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 233 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vkL 308 (501)
T PHA03210 233 RSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVL 308 (501)
T ss_pred EECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 999999999999965 777766532 23345678889999999999999998 999999999999999999999
Q ss_pred eccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-Cc--H-HHHHHHhhc
Q 042314 234 TDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRA-DT--A-VQVADRRAY 309 (370)
Q Consensus 234 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~-~~--~-~~~~~~~~~ 309 (370)
+|||++......... ......||+.|+|||.+.+..++.++|||||||++|||++|..++.. .. . ......+..
T Consensus 309 ~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~ 386 (501)
T PHA03210 309 GDFGTAMPFEKEREA--FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS 386 (501)
T ss_pred EeCCCceecCccccc--ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHh
Confidence 999999876543221 12234689999999999999999999999999999999998754432 21 1 111111100
Q ss_pred cC-C----------------------C-CC-----CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 310 ED-S----------------------R-PA-----LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 310 ~~-~----------------------~-~~-----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.. . . .. ....++..+.+++.+||..||.+|||+.|++.+
T Consensus 387 ~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 387 LSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred cccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00 0 0 00 011356678889999999999999999999875
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=280.10 Aligned_cols=248 Identities=23% Similarity=0.354 Sum_probs=197.0
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChH-----------HHHHHHHHHHHHHhcCCCceeeeeeeEeeCCc
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPR-----------VRNSFMKELGLWQKLRHPNIVQFLGVLKHSER 163 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~-----------~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~ 163 (370)
..+|.|++|.||++... +..+++|.++........ ....+.+|+.+++.++||||+++++++...+.
T Consensus 15 ~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 94 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF 94 (335)
T ss_pred hcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCc
Confidence 34899999999999764 788999998654322111 12357789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceecc
Q 042314 164 LIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQ 243 (370)
Q Consensus 164 ~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 243 (370)
.++||||+.+ +|.+++.....++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 95 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~~~ 170 (335)
T PTZ00024 95 INLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYG 170 (335)
T ss_pred EEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceeecc
Confidence 9999999975 99999988888999999999999999999999998 9999999999999999999999999987665
Q ss_pred ccCc-----------cceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC
Q 042314 244 EKDS-----------YSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED 311 (370)
Q Consensus 244 ~~~~-----------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 311 (370)
.... .........+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...........+....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~ 250 (335)
T PTZ00024 171 YPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250 (335)
T ss_pred cccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 2110 00111223467889999998764 46889999999999999999999998776554333221100
Q ss_pred CCC--------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 SRP--------------------------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 ~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
..+ ......+..+.+++.+||+.+|++||++++++.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 000 0112357789999999999999999999999874
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=278.72 Aligned_cols=246 Identities=17% Similarity=0.294 Sum_probs=192.2
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHHH
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHD 178 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~~ 178 (370)
.+.|+++.++.....++.+++|.+.... ........+.+|+.+++.++||||+++++++...+..+++|||+.+++|.+
T Consensus 10 ~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 3445555555666678999999987643 233456789999999999999999999999999999999999999999999
Q ss_pred HHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc----ceec
Q 042314 179 ILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY----SYKM 252 (370)
Q Consensus 179 ~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~ 252 (370)
++.+. ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||.+......... ....
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~ 165 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence 99864 46889999999999999999999998 999999999999999999999999988655432111 0111
Q ss_pred cCCCCCccccCcccccc--cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC-------------------
Q 042314 253 TGGTGSYRYMAPEVYRR--ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED------------------- 311 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~------------------- 311 (370)
....++..|+|||.+.. ..++.++|+||+|+++|+|++|..||................
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (314)
T cd08216 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQ 245 (314)
T ss_pred ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCc
Confidence 22346778999999876 357889999999999999999999998665433222111000
Q ss_pred -------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 -------------SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 -------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
........++..+.+++.+||..||++|||+++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0001112234678899999999999999999999885
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=274.84 Aligned_cols=248 Identities=14% Similarity=0.120 Sum_probs=181.3
Q ss_pred CCCCCCcccEEEEEEcCc-----eeEEEEeccccCCC--hHH------HHHHHHHHHHHHhcCCCceeeeeeeEeeCC--
Q 042314 98 GIDPGAYGEVYLVKWRGT-----EIAAKTIRSSIASN--PRV------RNSFMKELGLWQKLRHPNIVQFLGVLKHSE-- 162 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~-----~vavK~l~~~~~~~--~~~------~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~-- 162 (370)
.+|+|+||.||++.+.+. .+++|......... +.. ......+...+..+.|++++++++.+....
T Consensus 19 ~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 98 (294)
T PHA02882 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCR 98 (294)
T ss_pred EEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCC
Confidence 379999999999987643 45555533221110 000 111223334455678999999998765543
Q ss_pred --ceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccce
Q 042314 163 --RLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK 240 (370)
Q Consensus 163 --~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~ 240 (370)
..+++++++.. ++.+.+......++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++
T Consensus 99 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l~DFGla~ 174 (294)
T PHA02882 99 MYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIAS 174 (294)
T ss_pred ceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEEEEcCCce
Confidence 34778888744 78888777666788889999999999999999998 9999999999999999999999999998
Q ss_pred eccccCccc----eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHH-----hhcc
Q 042314 241 IAQEKDSYS----YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA-VQVADR-----RAYE 310 (370)
Q Consensus 241 ~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~-----~~~~ 310 (370)
......... .......||+.|+|||.+.+..++.++|||||||++|||++|..||..... ...... ....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~ 254 (294)
T PHA02882 175 HFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRL 254 (294)
T ss_pred eeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHh
Confidence 664322111 111223589999999999999999999999999999999999999987632 111110 0000
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042314 311 DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 311 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l 349 (370)
..........|+.+.++++.||..+|++||+++++++.|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 255 HEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111112344688999999999999999999999999876
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=275.38 Aligned_cols=241 Identities=26% Similarity=0.429 Sum_probs=187.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|++|.||++... +..+++|.+..... ......+.+|+.+++.++|+||+++++++...+..++|+||+. ++|
T Consensus 13 ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l 89 (291)
T cd07870 13 LGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDL 89 (291)
T ss_pred EEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCH
Confidence 788999999999764 78899999865432 2233456789999999999999999999999999999999996 577
Q ss_pred HHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 177 HDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 177 ~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
.+++.. ...++...+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++....... .....
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~ 163 (291)
T cd07870 90 AQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ---TYSSE 163 (291)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC---CCCCc
Confidence 766654 356788889999999999999999998 99999999999999999999999999875433221 11223
Q ss_pred CCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHhhc-cC---------------CCCC--
Q 042314 256 TGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQV-ADRRAY-ED---------------SRPA-- 315 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~~~~-~~---------------~~~~-- 315 (370)
.+++.|+|||.+.+. .++.++|+||||+++|+|++|..||........ ...... .+ ..+.
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhc
Confidence 468899999998764 478899999999999999999999976543211 111000 00 0000
Q ss_pred ----------CC--CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 316 ----------LS--SLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 316 ----------~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.. -..+..+.+++.+|+..||++|||+.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 0135678999999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=273.94 Aligned_cols=243 Identities=29% Similarity=0.456 Sum_probs=195.3
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|++|.||++.. .|..+++|.+.... ........+.+|+.+++.++|||++++++++...+..++++||++ ++
T Consensus 6 ~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~ 83 (283)
T cd07835 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LD 83 (283)
T ss_pred EecCCCCeEEEEEEEcCCCCEEEEEEeeccc-ccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cC
Confidence 378899999999976 48899999887543 222344567889999999999999999999999999999999995 59
Q ss_pred HHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 176 LHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 176 L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|.+++.... .+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......... ..
T Consensus 84 l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~ 157 (283)
T cd07835 84 LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT---YT 157 (283)
T ss_pred HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc---cC
Confidence 999998765 6899999999999999999999988 999999999999999999999999998755432111 11
Q ss_pred CCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc----------------------
Q 042314 254 GGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE---------------------- 310 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~---------------------- 310 (370)
...+++.|+|||.+.+. .++.++|+||||+++|+|++|++||...............
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 22457889999988664 4688999999999999999999999776553322221100
Q ss_pred --C---CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 311 --D---SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 311 --~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
. ........++..+.+++.+||+.+|++||++++++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0011234567889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=281.85 Aligned_cols=247 Identities=26% Similarity=0.433 Sum_probs=192.6
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC-----CceEEEEeec
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS-----ERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~-----~~~~~v~e~~ 171 (370)
+|.|++|.||++... |..+++|.+... ........+..|+.+++.++||||+++++++... ...++++||+
T Consensus 13 lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 90 (336)
T cd07849 13 IGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELM 90 (336)
T ss_pred EEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhc
Confidence 688999999999764 788999988642 2234556678899999999999999999886543 3579999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
.+ +|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++............
T Consensus 91 ~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 165 (336)
T cd07849 91 ET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165 (336)
T ss_pred cc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCC
Confidence 65 88888765 47999999999999999999999998 999999999999999999999999998766543322212
Q ss_pred ccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc---------------------
Q 042314 252 MTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY--------------------- 309 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~--------------------- 309 (370)
.....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|++||..............
T Consensus 166 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (336)
T cd07849 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNY 245 (336)
T ss_pred cCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhH
Confidence 233467899999998754 5678999999999999999999999975443221110000
Q ss_pred ---cCCCCC-----CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHH
Q 042314 310 ---EDSRPA-----LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR--LEAI 352 (370)
Q Consensus 310 ---~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~--l~~~ 352 (370)
....+. .....++.+.+++++||+.+|++|||+.+++++ ++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 246 IKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 000000 112356789999999999999999999999988 5444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=297.33 Aligned_cols=250 Identities=31% Similarity=0.524 Sum_probs=214.6
Q ss_pred CCCCCCcccEEEEEEc---------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEE
Q 042314 98 GIDPGAYGEVYLVKWR---------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFL 167 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~---------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v 167 (370)
.+|.|.||.|+++... ...||||.++..... ...+.+..|+.+++.+. ||||+.+++++.....+++|
T Consensus 303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v 380 (609)
T KOG0200|consen 303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVI 380 (609)
T ss_pred eeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEE
Confidence 5899999999998653 345899998876433 67789999999999995 99999999999999999999
Q ss_pred EeecCCCCHHHHHHhCC----------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcE
Q 042314 168 TEYLRNGSLHDILKKKG----------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHL 231 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~ 231 (370)
+||+..|+|.++++.++ .++..+.+.++.||+.|++||++.. +|||||-.+|||++.+..+
T Consensus 381 ~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~ 457 (609)
T KOG0200|consen 381 VEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVI 457 (609)
T ss_pred EEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEE
Confidence 99999999999998765 3888999999999999999999998 9999999999999999999
Q ss_pred EEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCc-HHHHHHHhhc
Q 042314 232 KVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADT-AVQVADRRAY 309 (370)
Q Consensus 232 kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~-~~~~~~~~~~ 309 (370)
||+|||+++.......+........-+..|||||.+....|+.++||||+|++|||+++ |..||.+.. ..+. .....
T Consensus 458 kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l-~~~l~ 536 (609)
T KOG0200|consen 458 KIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL-LEFLK 536 (609)
T ss_pred EEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH-HHHHh
Confidence 99999999876665544322222124568999999999999999999999999999998 667777654 4444 33555
Q ss_pred cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042314 310 EDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQ 353 (370)
Q Consensus 310 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~ 353 (370)
.+.+...|..++++++++|+.||+.+|++||++.++.+.+....
T Consensus 537 ~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 537 EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 78888999999999999999999999999999999999999853
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=271.71 Aligned_cols=240 Identities=23% Similarity=0.344 Sum_probs=189.3
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeC--CceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHS--ERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~--~~~~~v~e~~~ 172 (370)
.+|.|++|.||++.. .+..+++|.++...... .. ....+|+..++++. |+|++++++++... +.+++|+||+.
T Consensus 6 ~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred eccccccceEEEEEEcCCCcEEEEEEehhccCCc-hh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 378899999999976 47889999887643222 22 23457888888885 99999999999887 88999999997
Q ss_pred CCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 173 NGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 173 g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
+ +|.+.+... ..+++..++.++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||++.........
T Consensus 84 ~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~--- 155 (282)
T cd07831 84 M-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY--- 155 (282)
T ss_pred c-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCc---
Confidence 5 888877653 57899999999999999999999998 999999999999999 99999999998766443221
Q ss_pred ccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC----------------CCC
Q 042314 252 MTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED----------------SRP 314 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~----------------~~~ 314 (370)
....++..|+|||.+.. ..++.++|+||+||++|+|++|.+||...+..+......... ...
T Consensus 156 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 156 -TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred -CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 12346889999997654 456889999999999999999999998765543222211000 000
Q ss_pred -----------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 315 -----------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 315 -----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.....+|..+.++|.+||.++|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0112467899999999999999999999999865
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=280.15 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=204.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC-----ceEEEEee
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE-----RLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~-----~~~~v~e~ 170 (370)
.+|.|++|.||++... +..+++|.+.... ......+.+.+|+.+++.++||||+++++++...+ ..+++|||
T Consensus 7 ~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~ 85 (330)
T cd07834 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL 85 (330)
T ss_pred eecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecc
Confidence 4789999999999875 6889999887543 22445577899999999999999999999987765 78999999
Q ss_pred cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 171 LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 171 ~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+.+ +|.+++.+...+++..+..++.|++.||.+||+.| |+|+||||.||+++.++.++|+|||++...........
T Consensus 86 ~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~ 161 (330)
T cd07834 86 MET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKG 161 (330)
T ss_pred hhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccc
Confidence 975 89999988788999999999999999999999998 99999999999999999999999999987655431111
Q ss_pred eccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC---------------
Q 042314 251 KMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP--------------- 314 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 314 (370)
......++..|+|||.+.+. .++.++|+||+|+++|+|++|++||...........+......+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 241 (330)
T cd07834 162 FLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARN 241 (330)
T ss_pred cccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhh
Confidence 12334578899999999887 78999999999999999999999998776544333222111000
Q ss_pred --------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHH
Q 042314 315 --------------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR--LEAIQE 354 (370)
Q Consensus 315 --------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~--l~~~~~ 354 (370)
.....+|..+.++|.+||+.+|++||++.+++.+ ++.+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 242 YLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred HHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0123367889999999999999999999999986 555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=280.87 Aligned_cols=251 Identities=26% Similarity=0.394 Sum_probs=198.6
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC-----CceEEEEee
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS-----ERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~-----~~~~~v~e~ 170 (370)
.+|.|++|.||.+... +..+++|.+..... .......+.+|+.+++.++||||+++++++... ...++|+||
T Consensus 12 ~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07858 12 PIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL 90 (337)
T ss_pred EeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeC
Confidence 4789999999999764 78899999875432 223345677899999999999999999987643 358999999
Q ss_pred cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 171 LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 171 ~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+. ++|.+++...+++++..+..++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........
T Consensus 91 ~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--- 163 (337)
T cd07858 91 MD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--- 163 (337)
T ss_pred CC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCcc---
Confidence 96 599999988888999999999999999999999998 99999999999999999999999999876644321
Q ss_pred eccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--------------------
Q 042314 251 KMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY-------------------- 309 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-------------------- 309 (370)
......++..|+|||.+.. ..++.++|+||||+++|+|++|++||..............
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07858 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARR 243 (337)
T ss_pred cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhH
Confidence 1223357889999998865 4588999999999999999999999976543221110000
Q ss_pred ------cCCCC---CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHHHh
Q 042314 310 ------EDSRP---ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR--LEAIQESF 356 (370)
Q Consensus 310 ------~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~--l~~~~~~~ 356 (370)
....+ .....+++.+.++|++||+.+|++|||+++++++ +..+...-
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 244 YIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred HHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 00000 1123578889999999999999999999999998 66654443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=264.71 Aligned_cols=243 Identities=24% Similarity=0.371 Sum_probs=198.9
Q ss_pred CCCCCCcccEEEEE--EcCceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVK--WRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~--~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|+|+|+.|-.+. .+|..+|||++.+. ....+.+..+|++++.++ .|+||++++++|+++..+|+|||.+.||
T Consensus 85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 38999999998764 46999999999775 346788999999999999 5999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC---cEEEeccccceeccccCccc--
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG---HLKVTDFGLSKIAQEKDSYS-- 249 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~-- 249 (370)
+|...|+++..+++.++.++..+|+.||.|||.+| |.||||||+|||-...+ -+|||||.+..-.......+
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 99999999999999999999999999999999999 99999999999987655 47999999875443222111
Q ss_pred --eeccCCCCCccccCccccc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCc---------------HHHHHHHh
Q 042314 250 --YKMTGGTGSYRYMAPEVYR-----RESYGKSVDVFSFALIVHEMFQGGPSNRADT---------------AVQVADRR 307 (370)
Q Consensus 250 --~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~---------------~~~~~~~~ 307 (370)
-...+.+|+..|||||+.. ...|+.+.|.||||+++|-|++|.+||.+.- ...+...+
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI 318 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 318 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence 1223456888999999873 2358999999999999999999999996531 11122222
Q ss_pred hccC---CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 042314 308 AYED---SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIF 347 (370)
Q Consensus 308 ~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~ 347 (370)
. ++ .....+..+|.+.+++++.+|..|+.+|.++.+++.
T Consensus 319 Q-EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 319 Q-EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred h-ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 2 22 222345568899999999999999999999999887
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=272.99 Aligned_cols=244 Identities=25% Similarity=0.429 Sum_probs=198.8
Q ss_pred CCCCCCcccEEEEEE-----cCceeEEEEeccccC-CChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEee
Q 042314 98 GIDPGAYGEVYLVKW-----RGTEIAAKTIRSSIA-SNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~-----~g~~vavK~l~~~~~-~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
.+|.|+||.||.+.. .|..+++|.++.... ........+.+|+.+++.+ +|++|+++++.+......++|+||
T Consensus 7 ~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (290)
T cd05613 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDY 86 (290)
T ss_pred eeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEec
Confidence 378999999999876 578899999875322 2233456778899999999 589999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 171 LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 171 ~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+++++|.+++.....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.........
T Consensus 87 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-- 161 (290)
T cd05613 87 INGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-- 161 (290)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccccccc--
Confidence 999999999988888999999999999999999999998 999999999999999999999999998765433211
Q ss_pred eccCCCCCccccCccccccc--CCCchhhHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHhhccCCCCCCCCCCcHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRE--SYGKSVDVFSFALIVHEMFQGGPSNRADTA----VQVADRRAYEDSRPALSSLYPEPI 324 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l 324 (370)
......++..|+|||.+... .++.++|+||||+++|+|++|..||..... ....... ....+..+..+++.+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 239 (290)
T cd05613 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh--hccCCCCCccCCHHH
Confidence 11223578899999998753 467899999999999999999999964322 2222221 123344566788999
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHHHH
Q 042314 325 KALLRECWHKNPDRRP-----TFEEIIFR 348 (370)
Q Consensus 325 ~~li~~~l~~~p~~Rp-----~~~~ll~~ 348 (370)
.+++++||+.||++|| ++.+++.+
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 9999999999999997 78888775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=267.17 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=199.8
Q ss_pred eeeEEeeecccCCCCCCcccEEEEEEc------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee
Q 042314 87 VVICKILEDRGGIDPGAYGEVYLVKWR------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160 (370)
Q Consensus 87 ~~~~~~L~~~~~l~~g~~~~v~~a~~~------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~ 160 (370)
++....+...+.+|.|.||.||+|... ...+|+|.++.... .........+|+..++.++||||+.+..+|..
T Consensus 20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 344444455566899999999999543 23678888876532 23445667899999999999999999998876
Q ss_pred -CCceEEEEeecCCCCHHHHHHhC-----CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC----Cc
Q 042314 161 -SERLIFLTEYLRNGSLHDILKKK-----GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA----GH 230 (370)
Q Consensus 161 -~~~~~~v~e~~~g~~L~~~l~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~----~~ 230 (370)
+..+++++||.+. +|+.+|.-. ..++...+.+|+.||+.|+.|||++. |+||||||.||||..+ |.
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCe
Confidence 7789999999977 999988632 46888999999999999999999998 9999999999999877 89
Q ss_pred EEEeccccceeccccCccceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH-------
Q 042314 231 LKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ------- 302 (370)
Q Consensus 231 ~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~------- 302 (370)
|||+|||+++.+..+-.........+-|.+|.|||.+.+. -||.+.|+|++|||+.||+|-.+.|.+.....
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 9999999999887664444344455679999999999886 48999999999999999999988775432211
Q ss_pred --HHHHhhcc--CC----CCC---C--------------------------CCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 042314 303 --VADRRAYE--DS----RPA---L--------------------------SSLYPEPIKALLRECWHKNPDRRPTFEEI 345 (370)
Q Consensus 303 --~~~~~~~~--~~----~~~---~--------------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~l 345 (370)
...++... .+ .|. + .+.-++...+|+.++|..||.+|.|+++.
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 11111100 00 000 0 01123457899999999999999999999
Q ss_pred HHHHH
Q 042314 346 IFRLE 350 (370)
Q Consensus 346 l~~l~ 350 (370)
+++.-
T Consensus 335 leh~y 339 (438)
T KOG0666|consen 335 LEHPY 339 (438)
T ss_pred hcccc
Confidence 88743
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=272.90 Aligned_cols=241 Identities=25% Similarity=0.464 Sum_probs=191.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.++.|++|.||++.+. ++.+++|.++... .......+..|+.++... +||||+++++++......+++|||+.+
T Consensus 22 ~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~- 98 (296)
T cd06618 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST- 98 (296)
T ss_pred EeeccCCeEEEEEEECCCCeEEEEEEEeccC--ChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc-
Confidence 4788999999999887 8889999987542 223445566677766666 499999999999999999999999954
Q ss_pred CHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhh-cCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 175 SLHDILKK-KGKLDPPTAVAYALDIARGMNYLHH-HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 175 ~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
+|.+++.. ...+++..+..++.|++.|+.|||+ .+ |+||||+|+||+++.++.+||+|||++.........
T Consensus 99 ~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~---- 171 (296)
T cd06618 99 CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---- 171 (296)
T ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCcc----
Confidence 88887765 3578899999999999999999997 46 999999999999999999999999998765432211
Q ss_pred cCCCCCccccCcccccccC----CCchhhHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHhhccCCCCC--CCCCCcHHHH
Q 042314 253 TGGTGSYRYMAPEVYRRES----YGKSVDVFSFALIVHEMFQGGPSNRADTAV-QVADRRAYEDSRPA--LSSLYPEPIK 325 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~l~ 325 (370)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... +...... ....+. ....++..+.
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~ 250 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL-QEEPPSLPPNEGFSPDFC 250 (296)
T ss_pred cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh-cCCCCCCCCCCCCCHHHH
Confidence 1224678999999987553 788999999999999999999999764332 2222222 122222 2234788999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHH
Q 042314 326 ALLRECWHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 326 ~li~~~l~~~p~~Rp~~~~ll~~l 349 (370)
+++.+||..||++||++.+++++-
T Consensus 251 ~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 251 SFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred HHHHHHccCChhhCCCHHHHhcCh
Confidence 999999999999999999998773
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=272.02 Aligned_cols=243 Identities=28% Similarity=0.428 Sum_probs=191.7
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|++|.||++... ++.+++|.+.... ........+.+|+.++++++||||+++++++...+..++||||+++ +
T Consensus 9 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 86 (294)
T PLN00009 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-D 86 (294)
T ss_pred EecCCCCEEEEEEEecCCCcEEEEEehhhcc-ccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-c
Confidence 4788999999999864 7789999886543 2223456688999999999999999999999999999999999965 8
Q ss_pred HHHHHHhCCC--CChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC-CCcEEEeccccceeccccCccceec
Q 042314 176 LHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE-AGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 176 L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|.+.+..... ++...+..++.|++.||.|||+++ ++|+||+|+||+++. ++.+||+|||++........ ..
T Consensus 87 l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~---~~ 160 (294)
T PLN00009 87 LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR---TF 160 (294)
T ss_pred HHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc---cc
Confidence 8888765443 577888899999999999999998 999999999999985 45799999999875543211 11
Q ss_pred cCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC-------------------
Q 042314 253 TGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS------------------- 312 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~------------------- 312 (370)
....+++.|+|||.+.+. .++.++|+||+|+++|+|++|.+||..........+......
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA 240 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence 223467899999988664 578899999999999999999999987655443332211000
Q ss_pred CCC--------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 313 RPA--------LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 313 ~~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+. ....+++.+.+++.+||+.+|++||++.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 241 FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 123467889999999999999999999999874
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=271.49 Aligned_cols=242 Identities=26% Similarity=0.452 Sum_probs=193.1
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.++.|++|.||++... |..+++|.++.... ......+.+|+.++++++||||+++++.+...+..++|+||+++ +
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 4788999999999874 78899998875432 22345567899999999999999999999999999999999986 8
Q ss_pred HHHHHHhC---CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 176 LHDILKKK---GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 176 L~~~l~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++........ ..
T Consensus 84 l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~ 157 (284)
T cd07836 84 LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN---TF 157 (284)
T ss_pred HHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc---cc
Confidence 88888754 35899999999999999999999998 99999999999999999999999999875543221 11
Q ss_pred cCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC----------------CCCC
Q 042314 253 TGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED----------------SRPA 315 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~----------------~~~~ 315 (370)
....+++.|++||.+.+. .++.++|+||||+++|+|++|.+||......+......... ....
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 223468889999988664 46889999999999999999999998665443322211000 0000
Q ss_pred -----------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 316 -----------LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 316 -----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.....+..+.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 112356789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=281.14 Aligned_cols=246 Identities=24% Similarity=0.391 Sum_probs=195.6
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee----CCceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH----SERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~----~~~~~~v~e~~ 171 (370)
.+|.|++|.||++... +..+++|.+..... .......+.+|+.+++.++||||+++++++.. ....++|+||+
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 90 (334)
T cd07855 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM 90 (334)
T ss_pred eeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehh
Confidence 3788999999999764 88899999875432 23445677889999999999999999998753 34689999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc-ce
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY-SY 250 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~ 250 (370)
. ++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ..
T Consensus 91 ~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 166 (334)
T cd07855 91 E-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166 (334)
T ss_pred h-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCc
Confidence 6 599999988878999999999999999999999998 999999999999999999999999998766443221 11
Q ss_pred eccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--------------------
Q 042314 251 KMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY-------------------- 309 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-------------------- 309 (370)
......++..|+|||.+.+ ..++.++|+||+|+++|+|++|++||..............
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~ 246 (334)
T cd07855 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRK 246 (334)
T ss_pred ccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHH
Confidence 1223467889999999865 4578999999999999999999999976543322111110
Q ss_pred ----cCCCCC-----CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 310 ----EDSRPA-----LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 310 ----~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
...... .....++.+.++|++||+.+|++||++.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 247 YIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 001111 123468899999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=273.79 Aligned_cols=235 Identities=29% Similarity=0.462 Sum_probs=206.6
Q ss_pred CCCCCCcccEEEEEEcCc--eeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
++|.|+||.|.++..+|. -+|+|++++...-..+..+--+.|-+++.... -|.+++++.+|+.-+++|+||||+.||
T Consensus 356 VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGG 435 (683)
T KOG0696|consen 356 VLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGG 435 (683)
T ss_pred EeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCc
Confidence 389999999999988865 48999998875544444455667888887764 578899999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|-..+++-+++.+..+..++.+|+-||.+||++| ||.||||.+|||++.+|.+||+|||+++.--.... ....
T Consensus 436 DLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~---TTkT 509 (683)
T KOG0696|consen 436 DLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV---TTKT 509 (683)
T ss_pred hhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccCCc---ceee
Confidence 99999999999999999999999999999999999 99999999999999999999999999875433322 3345
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.+|||.|+|||++.-.+|..++|.||+|++||||+.|++||.+....++...+. .....+|+.+|.+..++++..|.+
T Consensus 510 FCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~--ehnvsyPKslSkEAv~ickg~ltK 587 (683)
T KOG0696|consen 510 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM--EHNVSYPKSLSKEAVAICKGLLTK 587 (683)
T ss_pred ecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--HccCcCcccccHHHHHHHHHHhhc
Confidence 689999999999999999999999999999999999999999999988888776 445667888999999999999999
Q ss_pred CCCCCC
Q 042314 335 NPDRRP 340 (370)
Q Consensus 335 ~p~~Rp 340 (370)
.|.+|.
T Consensus 588 ~P~kRL 593 (683)
T KOG0696|consen 588 HPGKRL 593 (683)
T ss_pred CCcccc
Confidence 999994
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=272.88 Aligned_cols=243 Identities=26% Similarity=0.388 Sum_probs=190.8
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCc-----eEEEEe
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSER-----LIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~-----~~~v~e 169 (370)
.+|.|++|.||++... ++.+++|....... .......+.+|+.+++.++ ||||+++++++...+. .++|||
T Consensus 8 ~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e 86 (295)
T cd07837 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFE 86 (295)
T ss_pred EecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEee
Confidence 3788999999999874 78899998765432 2223456788999999995 6999999999877655 899999
Q ss_pred ecCCCCHHHHHHhC-----CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC-CCcEEEeccccceecc
Q 042314 170 YLRNGSLHDILKKK-----GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE-AGHLKVTDFGLSKIAQ 243 (370)
Q Consensus 170 ~~~g~~L~~~l~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~-~~~~kl~Dfg~~~~~~ 243 (370)
|+++ +|.+++... ..+++..++.++.|++.||.|||+++ ++||||+|+||+++. ++.+||+|||++....
T Consensus 87 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~ 162 (295)
T cd07837 87 YLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162 (295)
T ss_pred ccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecC
Confidence 9986 888887643 35799999999999999999999998 999999999999998 8899999999987654
Q ss_pred ccCccceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC----------
Q 042314 244 EKDSYSYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS---------- 312 (370)
Q Consensus 244 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---------- 312 (370)
.... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||.................
T Consensus 163 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 163 IPVK---SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred CCcc---ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 3221 1122246888999998865 4578999999999999999999999987665443322211000
Q ss_pred ------------CC----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 313 ------------RP----ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 313 ------------~~----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+ .....++..+.++|.+||..||.+||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0113467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=270.63 Aligned_cols=243 Identities=28% Similarity=0.475 Sum_probs=197.1
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC--CceEEEEeecCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS--ERLIFLTEYLRNG 174 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~--~~~~~v~e~~~g~ 174 (370)
+|.|++|.||++... +..+++|.+.... ........+.+|+.+++.++|||++++++++... +..++|+||+++
T Consensus 7 l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~- 84 (287)
T cd07840 7 IGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH- 84 (287)
T ss_pred eccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-
Confidence 688999999999875 5889999998754 3344556788999999999999999999999887 889999999975
Q ss_pred CHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+|.+++... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......... ..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~--~~ 159 (287)
T cd07840 85 DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD--YT 159 (287)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc--cc
Confidence 899888765 57899999999999999999999998 9999999999999999999999999988765543211 12
Q ss_pred CCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC------------------
Q 042314 254 GGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP------------------ 314 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------------ 314 (370)
...++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..................+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence 2346788999998765 457899999999999999999999998766544333221100000
Q ss_pred -----------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 315 -----------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 315 -----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.....+++.+.+++++||..+|++||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0111237889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=272.93 Aligned_cols=245 Identities=25% Similarity=0.408 Sum_probs=197.8
Q ss_pred CCCCCCcccEEEEEE-----cCceeEEEEeccccC-CChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEee
Q 042314 98 GIDPGAYGEVYLVKW-----RGTEIAAKTIRSSIA-SNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~-----~g~~vavK~l~~~~~-~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
.+|.|++|.||++.. .+..+++|.++.... ........+..|+.+++++ +||+|+++++.+......++||||
T Consensus 7 ~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (288)
T cd05583 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDY 86 (288)
T ss_pred EeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEec
Confidence 378999999999875 356799998865322 2234456788999999999 599999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 171 LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 171 ~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+.+++|.+++.....+++..+..++.|++++|.|||+.+ ++||||+|+||+++.++.++|+|||++.........
T Consensus 87 ~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-- 161 (288)
T cd05583 87 VNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-- 161 (288)
T ss_pred CCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccccccc--
Confidence 999999999988778999999999999999999999988 999999999999999999999999998765433211
Q ss_pred eccCCCCCccccCcccccccC--CCchhhHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHhhccCCCCCCCCCCcHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRES--YGKSVDVFSFALIVHEMFQGGPSNRADTA----VQVADRRAYEDSRPALSSLYPEPI 324 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l 324 (370)
......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||..... ....... ....+..+..++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 239 (288)
T cd05583 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI--LKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHH--HccCCCCCcccCHHH
Confidence 112235788999999987665 68899999999999999999999864321 1222221 123345566788999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHH
Q 042314 325 KALLRECWHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 325 ~~li~~~l~~~p~~Rp~~~~ll~~l 349 (370)
.+++.+||+.||++|||+.++...|
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l 264 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIK 264 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHh
Confidence 9999999999999999976665443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=274.29 Aligned_cols=247 Identities=21% Similarity=0.368 Sum_probs=190.1
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC--------ceEE
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE--------RLIF 166 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~--------~~~~ 166 (370)
..+|.|++|.||++... +..+++|.+..... .......+.+|+.++++++||||+++++++.... ..++
T Consensus 18 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 96 (310)
T cd07865 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL 96 (310)
T ss_pred EEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence 34788999999999874 78899998865432 2233345678999999999999999999876543 4599
Q ss_pred EEeecCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceecccc
Q 042314 167 LTEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEK 245 (370)
Q Consensus 167 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 245 (370)
|+||+.+ +|.+.+... ..+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......
T Consensus 97 v~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 172 (310)
T cd07865 97 VFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLS 172 (310)
T ss_pred EEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCC
Confidence 9999965 888887765 37899999999999999999999998 999999999999999999999999998766443
Q ss_pred Ccc-ceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC--CC-------
Q 042314 246 DSY-SYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS--RP------- 314 (370)
Q Consensus 246 ~~~-~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~------- 314 (370)
... ........++..|+|||.+.+. .++.++|+||+|+++|+|++|.+||................. .+
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (310)
T cd07865 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252 (310)
T ss_pred cccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 221 1112233568899999988664 368899999999999999999999987655433221111000 00
Q ss_pred --------CC-------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 315 --------AL-------------SSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 315 --------~~-------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.. +...++.+.++|.+||..||++|||+++++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 253 KLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred chhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 11234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=265.18 Aligned_cols=218 Identities=21% Similarity=0.283 Sum_probs=180.7
Q ss_pred CCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHHHH
Q 042314 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDI 179 (370)
Q Consensus 102 g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~~~ 179 (370)
|.++.||++... ++.+++|.++... .+..|...+....||||+++++++...+..+++|||++|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 889999999874 7889999986542 123344555556799999999999999999999999999999999
Q ss_pred HHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCCCCc
Q 042314 180 LKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSY 259 (370)
Q Consensus 180 l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~ 259 (370)
+.+...+++..+..++.|++.||.|||+++ ++||||||+||+++.++.++++|||.+....... ....++.
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~~ 146 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAVEN 146 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc------ccCCcCc
Confidence 988778999999999999999999999998 9999999999999999999999999876554321 1224567
Q ss_pred cccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCCCCC
Q 042314 260 RYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRR 339 (370)
Q Consensus 260 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 339 (370)
.|+|||.+.+..++.++|+||+|+++|+|++|..|+....... ........+..+++.+++++++||+.||++|
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 220 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------NTHTTLNIPEWVSEEARSLLQQLLQFNPTER 220 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------ccccccCCcccCCHHHHHHHHHHccCCHHHh
Confidence 8999999988888999999999999999999998876433211 0112223556688999999999999999999
Q ss_pred CCH
Q 042314 340 PTF 342 (370)
Q Consensus 340 p~~ 342 (370)
|++
T Consensus 221 ~~~ 223 (237)
T cd05576 221 LGA 223 (237)
T ss_pred cCC
Confidence 986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=266.82 Aligned_cols=244 Identities=27% Similarity=0.457 Sum_probs=198.6
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccC--CChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIA--SNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~--~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
..+|.|++|.||++.+. +..+++|+++.... ........+..|+.+++.++||||+++++++......++|+||+.
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (260)
T cd08222 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCE 85 (260)
T ss_pred eeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCC
Confidence 34899999999999776 34455666543221 122234456788999999999999999999998889999999999
Q ss_pred CCCHHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 173 NGSLHDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 173 g~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
+++|.+++.+ ...+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++. +.++|+|||.+.........
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~ 161 (260)
T cd08222 86 GRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDL 161 (260)
T ss_pred CCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCCccc
Confidence 9999998864 357899999999999999999999998 999999999999975 67999999998766433221
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||............. ....+..+..+|..+.++|
T Consensus 162 ---~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 237 (260)
T cd08222 162 ---ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQLNSIM 237 (260)
T ss_pred ---ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHHHHHH
Confidence 122357889999999988888999999999999999999999998766655444433 3445556677889999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+||..+|++||++.+++++
T Consensus 238 ~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 238 QSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHhcCChhhCcCHHHHhhC
Confidence 99999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=262.49 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=197.6
Q ss_pred eeecccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHH-HHhcCCCceeeeeeeEeeCCceEEEE
Q 042314 92 ILEDRGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGL-WQKLRHPNIVQFLGVLKHSERLIFLT 168 (370)
Q Consensus 92 ~L~~~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~-l~~l~hp~Iv~~~~~~~~~~~~~~v~ 168 (370)
-|...+.+|.|+||+|++...+ |+..|||.++... .+....++..|.+. ++.-++||||+++|....++..||.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 3555677999999999998765 8889999998763 34566778888876 45557999999999999999999999
Q ss_pred eecCCCCHHHHHH-----hCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceecc
Q 042314 169 EYLRNGSLHDILK-----KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQ 243 (370)
Q Consensus 169 e~~~g~~L~~~l~-----~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 243 (370)
|+|+- ||+.+.+ ++..+++.-.-.|..-.+.||.||.+.- .|||||+||+|||++..|.+||||||++..+.
T Consensus 143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 99965 8877654 2347888888888888999999998754 49999999999999999999999999986654
Q ss_pred ccCccceeccCCCCCccccCcccccc--cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCC----
Q 042314 244 EKDSYSYKMTGGTGSYRYMAPEVYRR--ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALS---- 317 (370)
Q Consensus 244 ~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 317 (370)
.+- ..+...|-..|||||.+.. ..|+.+||+||||++|||+.||..|+......-........+..|.+.
T Consensus 220 ~Si----AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~ 295 (361)
T KOG1006|consen 220 DSI----AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKE 295 (361)
T ss_pred HHH----HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccc
Confidence 432 1222346668999999964 458999999999999999999999998876643333333344444322
Q ss_pred -CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 318 -SLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 318 -~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
-.++..+..+|.-||.+|-+.||.+.+|++.
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2378899999999999999999999998764
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=275.33 Aligned_cols=246 Identities=27% Similarity=0.416 Sum_probs=194.0
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeC--CceEEEEeec
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHS--ERLIFLTEYL 171 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~--~~~~~v~e~~ 171 (370)
..+|.|++|.||++... +..+++|.+..... .......+.+|+.+++++ +||||+++++++... ...++|+||+
T Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~ 91 (337)
T cd07852 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM 91 (337)
T ss_pred HhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccc
Confidence 44899999999999774 77899998865432 223445677899999999 999999999988653 3689999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc--
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS-- 249 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-- 249 (370)
.+ +|..++... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..........
T Consensus 92 ~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~ 166 (337)
T cd07852 92 ET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166 (337)
T ss_pred cc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccC
Confidence 75 999998876 7888999999999999999999998 9999999999999999999999999987665432210
Q ss_pred eeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC-----------------
Q 042314 250 YKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED----------------- 311 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~----------------- 311 (370)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|++||................
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (337)
T cd07852 167 PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAA 246 (337)
T ss_pred cchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHH
Confidence 11122357889999998765 457889999999999999999999997655433222111000
Q ss_pred ---------C---CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 ---------S---RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 ---------~---~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
. .......+|..+.++|.+||+.+|++|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 247 TMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 011122368899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=272.33 Aligned_cols=244 Identities=26% Similarity=0.455 Sum_probs=192.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC----------ceE
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE----------RLI 165 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~----------~~~ 165 (370)
.+|.|++|.||++... +..+++|.++.... .......+.+|+.+++.++||||+++++++.... .++
T Consensus 14 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 92 (302)
T cd07864 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFY 92 (302)
T ss_pred eecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEE
Confidence 4788999999999874 78899999865432 2233456778999999999999999999887654 789
Q ss_pred EEEeecCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccc
Q 042314 166 FLTEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQE 244 (370)
Q Consensus 166 ~v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 244 (370)
+|+||+++ ++...+... ..+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++.....
T Consensus 93 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 168 (302)
T cd07864 93 LVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168 (302)
T ss_pred EEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccC
Confidence 99999987 777777654 47899999999999999999999998 99999999999999999999999999876654
Q ss_pred cCccceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc--CCCC-------
Q 042314 245 KDSYSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE--DSRP------- 314 (370)
Q Consensus 245 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~--~~~~------- 314 (370)
..... .....++..|+|||.+.+. .++.++||||+|+++|+|++|++||............... ...+
T Consensus 169 ~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (302)
T cd07864 169 EESRP--YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVI 246 (302)
T ss_pred Ccccc--cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccc
Confidence 33211 1122457789999988654 4688999999999999999999999876554433222111 0000
Q ss_pred -------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 315 -------------------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 315 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.....+|..+.+++.+||..+|++||++.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 247 KLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0122468899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=268.57 Aligned_cols=243 Identities=27% Similarity=0.453 Sum_probs=197.7
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.++.|++|.||++... +..+++|.+..... .+.....+..|+.++++++||+|+++++++...+..++|+||+.+ +
T Consensus 6 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~ 83 (283)
T cd05118 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D 83 (283)
T ss_pred eeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence 3788999999999764 78899998876542 234556788999999999999999999999999999999999976 8
Q ss_pred HHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 84 l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~---~~~~ 157 (283)
T cd05118 84 LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR---PYTH 157 (283)
T ss_pred HHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc---cccC
Confidence 88887764 58899999999999999999999998 99999999999999999999999999877654431 1122
Q ss_pred CCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--------------------
Q 042314 255 GTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR-------------------- 313 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------------- 313 (370)
..++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......+...........
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 3467889999998776 7889999999999999999999999776654433222111000
Q ss_pred --------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 --------PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 --------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
......++..+.++|.+||.+||.+||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 01122467889999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=276.06 Aligned_cols=242 Identities=25% Similarity=0.394 Sum_probs=188.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC--------------C
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS--------------E 162 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~--------------~ 162 (370)
+|.|++|.||++... +..+++|.+..... ...+.+.+|+.+++.++||||+++++.+... .
T Consensus 13 Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (342)
T cd07854 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89 (342)
T ss_pred ecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence 688999999999774 78899998865432 3456688899999999999999999876543 3
Q ss_pred ceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC-CCcEEEecccccee
Q 042314 163 RLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE-AGHLKVTDFGLSKI 241 (370)
Q Consensus 163 ~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~-~~~~kl~Dfg~~~~ 241 (370)
..++|+||+++ +|.+++.. +.+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.++|+|||++..
T Consensus 90 ~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~ 164 (342)
T cd07854 90 SVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI 164 (342)
T ss_pred eEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCccccee
Confidence 57899999975 99888865 47899999999999999999999998 999999999999984 45789999999876
Q ss_pred ccccCccceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC---------
Q 042314 242 AQEKDSYSYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED--------- 311 (370)
Q Consensus 242 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--------- 311 (370)
...............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07854 165 VDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRN 244 (342)
T ss_pred cCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 5432211111122356889999998754 457889999999999999999999997665443332221100
Q ss_pred --------------CCC-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 --------------SRP-----ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 --------------~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
..+ .....++..+.+|+.+||..||++|||+.+++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 245 ELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000 0123467889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=266.31 Aligned_cols=242 Identities=31% Similarity=0.471 Sum_probs=193.1
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc---CCCceeeeeeeEeeCCc-----eEEE
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL---RHPNIVQFLGVLKHSER-----LIFL 167 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l---~hp~Iv~~~~~~~~~~~-----~~~v 167 (370)
.++.|++|.||++... +..+++|.++..... ......+.+|+.+++++ +|||++++++++...+. .+++
T Consensus 6 ~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~ 84 (287)
T cd07838 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLV 84 (287)
T ss_pred EecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEE
Confidence 3788999999999875 788999998765432 23345566787777666 59999999999988776 9999
Q ss_pred EeecCCCCHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceecccc
Q 042314 168 TEYLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEK 245 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 245 (370)
|||+.+ +|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 85 FEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred ehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 999975 8998887643 5899999999999999999999998 999999999999999999999999998776433
Q ss_pred CccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC-------------
Q 042314 246 DSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS------------- 312 (370)
Q Consensus 246 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~------------- 312 (370)
.. .....++..|+|||.+.+..++.++|+||+|+++|+|++|.+||......+...++.....
T Consensus 161 ~~----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 161 MA----LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred cc----cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 21 1122468889999999988899999999999999999999999987765544333221000
Q ss_pred --------CC----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 313 --------RP----ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 313 --------~~----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.. ......++.+.+++.+||+.||++||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 0011245678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=293.30 Aligned_cols=140 Identities=35% Similarity=0.573 Sum_probs=129.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+|+|+++............+..|+.+++.++||||+++++.+...+.+++||||+.|++
T Consensus 11 ~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~ 90 (669)
T cd05610 11 PISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGD 90 (669)
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCC
Confidence 3789999999999886 88999999976555556667889999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccce
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK 240 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~ 240 (370)
|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 91 VKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999988888999999999999999999999998 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=280.21 Aligned_cols=233 Identities=26% Similarity=0.384 Sum_probs=194.2
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+|+++..+... +...++|++.....+ ..+|..++... +||||+++.+.+.+....|+|||.+.|+-
T Consensus 330 ~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~e 402 (612)
T KOG0603|consen 330 LGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGE 402 (612)
T ss_pred cCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceeeeeehhccccH
Confidence 889999999887654 778899998765222 23566555555 69999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee-CCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ-DEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~-~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+.+...+.+. ..+..|+.+|+.|+.|||++| ++||||||+|||+ ++.|+++|+|||.++..... ...
T Consensus 403 ll~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~------~~t 472 (612)
T KOG0603|consen 403 LLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS------CDT 472 (612)
T ss_pred HHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh------hcc
Confidence 988887775555 888899999999999999998 9999999999999 58999999999998876654 222
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.+-|..|.|||++....|++++|+||||++||+|++|+.||............. ..+.....+|+..++|++.||+.
T Consensus 473 p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i---~~~~~s~~vS~~AKdLl~~LL~~ 549 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI---QMPKFSECVSDEAKDLLQQLLQV 549 (612)
T ss_pred cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh---cCCccccccCHHHHHHHHHhccC
Confidence 356889999999999999999999999999999999999998877763322222 22333377899999999999999
Q ss_pred CCCCCCCHHHHHHHHHH
Q 042314 335 NPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~l~~ 351 (370)
||.+||++.++..+=-.
T Consensus 550 dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 550 DPALRLGADEIGAHPWF 566 (612)
T ss_pred ChhhCcChhhhccCcch
Confidence 99999999999876433
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=271.47 Aligned_cols=245 Identities=25% Similarity=0.367 Sum_probs=192.0
Q ss_pred CCCCCcccEEEEEEc----CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEee----CCceEEEEe
Q 042314 99 IDPGAYGEVYLVKWR----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKH----SERLIFLTE 169 (370)
Q Consensus 99 l~~g~~~~v~~a~~~----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~----~~~~~~v~e 169 (370)
+|.|+||.||++... +..+++|.+.... ........+.+|+.+++++ +||||+++++.+.. ....++++|
T Consensus 8 lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e 86 (332)
T cd07857 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEE 86 (332)
T ss_pred ccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEe
Confidence 788999999999876 4579999886543 2234456778899999999 59999999987532 245788999
Q ss_pred ecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc-
Q 042314 170 YLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY- 248 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 248 (370)
++. ++|.+++.....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.........
T Consensus 87 ~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (332)
T cd07857 87 LME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN 162 (332)
T ss_pred ccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccc
Confidence 986 599999988888999999999999999999999998 999999999999999999999999999866543221
Q ss_pred ceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc------------------
Q 042314 249 SYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY------------------ 309 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~------------------ 309 (370)
........|++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||..............
T Consensus 163 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (332)
T cd07857 163 AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKA 242 (332)
T ss_pred cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhH
Confidence 111223468899999998765 4678999999999999999999999976543222111000
Q ss_pred --------cCCC---CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 310 --------EDSR---PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 310 --------~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.... .......+..+.+++.+||+.||++|||+.+++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 243 QNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 11123357889999999999999999999999866
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=297.47 Aligned_cols=245 Identities=25% Similarity=0.368 Sum_probs=208.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.||.|+||.|..++.+ ++.+|+|++.+-..-.......|..|-.+|..-+.+=|+.++-.|.+.+++|+||||+.||+
T Consensus 82 vIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGD 161 (1317)
T KOG0612|consen 82 VIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGD 161 (1317)
T ss_pred HhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCch
Confidence 4899999999999775 67899999876322222334668888899998899999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|-.++.+.+++++..++.++.+|+-||..+|+.| +|||||||+|||+|..|++||+|||.+-.+...+. ......
T Consensus 162 lltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~--V~s~~a 236 (1317)
T KOG0612|consen 162 LLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT--VRSSVA 236 (1317)
T ss_pred HHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCc--EEeccc
Confidence 9999999989999999999999999999999999 99999999999999999999999998766654332 244566
Q ss_pred CCCccccCccccc----c-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCC--CCCcHHHHHHH
Q 042314 256 TGSYRYMAPEVYR----R-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALS--SLYPEPIKALL 328 (370)
Q Consensus 256 ~g~~~y~aPE~~~----~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li 328 (370)
+|||.|.|||++. + +.|+...|.||+||++|||+.|..||+.++....+.++........+| ..+|+..++||
T Consensus 237 VGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI 316 (1317)
T KOG0612|consen 237 VGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLI 316 (1317)
T ss_pred cCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHH
Confidence 8999999999985 2 568899999999999999999999999999988888876543333333 34899999999
Q ss_pred HHhcccCCCCCCC---HHHHHHH
Q 042314 329 RECWHKNPDRRPT---FEEIIFR 348 (370)
Q Consensus 329 ~~~l~~~p~~Rp~---~~~ll~~ 348 (370)
.+.+. +|+.|.. ++++-.|
T Consensus 317 ~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 317 EALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HHHhc-ChhhhcccccHHHHHhC
Confidence 99876 5778877 8887665
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=272.86 Aligned_cols=239 Identities=25% Similarity=0.388 Sum_probs=191.7
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC------ceEEEEe
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE------RLIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~------~~~~v~e 169 (370)
.+|.|++|.||++... +..+++|.+.... ........+.+|+.+++.++||||+++++++.... ..++|+|
T Consensus 22 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 100 (343)
T cd07880 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMP 100 (343)
T ss_pred EeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEe
Confidence 3789999999999764 7889999886532 33445567889999999999999999999886543 3589999
Q ss_pred ecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 170 YLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
|+ |++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 101 ~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~--- 172 (343)
T cd07880 101 FM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM--- 172 (343)
T ss_pred cC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccCc---
Confidence 99 6799988875 47899999999999999999999998 9999999999999999999999999987554321
Q ss_pred eeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC----------------
Q 042314 250 YKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS---------------- 312 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---------------- 312 (370)
....+++.|+|||.+.+ ..++.++|+||||+++|++++|++||.................
T Consensus 173 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 173 ---TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred ---cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 22356889999999876 4578899999999999999999999987654332222110000
Q ss_pred ----------C---CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 313 ----------R---PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 313 ----------~---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
. ......+++.+.++|.+||..||++|||+.+++.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 01123567789999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=263.72 Aligned_cols=252 Identities=29% Similarity=0.502 Sum_probs=200.7
Q ss_pred ccCCCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHh--cCCCceeeeeeeEeeCC----ceEEEEe
Q 042314 96 RGGIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQK--LRHPNIVQFLGVLKHSE----RLIFLTE 169 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~--l~hp~Iv~~~~~~~~~~----~~~~v~e 169 (370)
...+|+|.||.||++.|+|..||||++.... .....+|.++.+. ++|+||+.+++.-..++ ++|+|++
T Consensus 216 ~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred EEEecCccccceeeccccCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 3458999999999999999999999997642 2446678888776 49999999998754432 5899999
Q ss_pred ecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhh-----cCCCceeecCCCCCCeeeCCCCcEEEeccccceeccc
Q 042314 170 YLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHH-----HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQE 244 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-----~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 244 (370)
|.+.|||++++.+. .++....++++..+++||++||. +|.+.|.|||||+.||||..+|..-|+|+|+|-....
T Consensus 290 YHe~GSL~DyL~r~-tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~ 368 (513)
T KOG2052|consen 290 YHEHGSLYDYLNRN-TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 368 (513)
T ss_pred cccCCcHHHHHhhc-cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecc
Confidence 99999999999994 89999999999999999999993 4556799999999999999999999999999976655
Q ss_pred c-CccceeccCCCCCccccCcccccccC----CC--chhhHHHHHHHHHHHHhC----------CCCCCCCc-----HHH
Q 042314 245 K-DSYSYKMTGGTGSYRYMAPEVYRRES----YG--KSVDVFSFALIVHEMFQG----------GPSNRADT-----AVQ 302 (370)
Q Consensus 245 ~-~~~~~~~~~~~g~~~y~aPE~~~~~~----~~--~~~Di~slG~~l~el~~g----------~~p~~~~~-----~~~ 302 (370)
. +.........+||.+|||||++...- |+ ..+||||||.++||+... .+||.... ..+
T Consensus 369 ~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ee 448 (513)
T KOG2052|consen 369 DTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEE 448 (513)
T ss_pred cCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHH
Confidence 4 22333445567999999999997642 21 468999999999998743 47775432 233
Q ss_pred HHHHhhccCCCCCCCCCCc-----HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042314 303 VADRRAYEDSRPALSSLYP-----EPIKALLRECWHKNPDRRPTFEEIIFRLEAIQE 354 (370)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~ 354 (370)
+..-+.....+|.+|..+. ..+..+|+.||..||.-|.|+-.+-+.|.++.+
T Consensus 449 MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 449 MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 3333333455666655433 347789999999999999999999999988875
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=268.60 Aligned_cols=240 Identities=29% Similarity=0.443 Sum_probs=190.3
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee-CCceEEEEeecCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH-SERLIFLTEYLRN 173 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~-~~~~~~v~e~~~g 173 (370)
..++.|+||.||++... ++.+++|.+..... .......+..|+.+++.++||||+++++++.. ....++++||+ +
T Consensus 16 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~ 93 (328)
T cd07856 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G 93 (328)
T ss_pred EeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence 34788999999999764 78899998865432 23445677899999999999999999998865 56789999999 5
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
++|.+++... +++...+..++.|+++||.|||+++ ++||||+|.||+++.++.++|+|||++....... .
T Consensus 94 ~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~------~ 163 (328)
T cd07856 94 TDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQM------T 163 (328)
T ss_pred cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCCc------C
Confidence 5999888754 6888889999999999999999998 9999999999999999999999999987543221 2
Q ss_pred CCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh------------------------
Q 042314 254 GGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRA------------------------ 308 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~------------------------ 308 (370)
...+++.|+|||.+.+ ..++.++|+||||+++|+|++|++||.............
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence 2356888999998766 568899999999999999999999997654322111000
Q ss_pred ccCCCC-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 309 YEDSRP-----ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 309 ~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
...... .....+++.+.++|++||+.+|++||++.+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 1113467889999999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=264.80 Aligned_cols=241 Identities=25% Similarity=0.462 Sum_probs=192.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|++|.||++... +..+++|.+...... .......+|+..+++++ |||++++++++...+..++||||+ ++
T Consensus 6 ~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred eeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 3789999999999874 678999988654322 12234457889999998 999999999999999999999999 77
Q ss_pred CHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 175 SLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 175 ~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
+|.+++.... .++...+..++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~---- 155 (283)
T cd07830 83 NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY---- 155 (283)
T ss_pred CHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc----
Confidence 9999887764 7899999999999999999999998 999999999999999999999999998766543221
Q ss_pred cCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC------------------
Q 042314 253 TGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR------------------ 313 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------------------ 313 (370)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|++||..........+.......
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 22357889999998854 45789999999999999999999999766544332221100000
Q ss_pred ----------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 ----------PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.......+..+.+++++||..+|++||++.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00111235789999999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=266.03 Aligned_cols=244 Identities=30% Similarity=0.469 Sum_probs=198.2
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|++|.||.+... +..+++|.+.... ........+..|+.+++.++|+|++++++++...+..++|+||+.+
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM- 82 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-
Confidence 34789999999999775 7889999987654 2334456778899999999999999999999999999999999975
Q ss_pred CHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+|.+++.+. ..++...+..++.|++.+|.+||+++ |+|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 83 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~ 156 (282)
T cd07829 83 DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR---TYT 156 (282)
T ss_pred CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc---ccC
Confidence 999999876 57999999999999999999999998 99999999999999999999999999876544321 112
Q ss_pred CCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC-------------------CC
Q 042314 254 GGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED-------------------SR 313 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------------------~~ 313 (370)
...++..|+|||.+.+. .++.++|+||||+++|+|++|++||................ ..
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 23457789999998766 78899999999999999999999998766544332221100 00
Q ss_pred C--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 P--------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 ~--------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+ ......+..+.+++.+||..+|++||++.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0 0112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=293.24 Aligned_cols=247 Identities=26% Similarity=0.418 Sum_probs=191.3
Q ss_pred eecccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee----------
Q 042314 93 LEDRGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH---------- 160 (370)
Q Consensus 93 L~~~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~---------- 160 (370)
+++...+|+||||.||+++.+ |+.+|+|.+.... .......+.+|+..+.+++|||||+++..+..
T Consensus 481 FEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 481 FEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 334455999999999999875 9999999998765 45677889999999999999999998721100
Q ss_pred --------------------------------------------------------------------------------
Q 042314 161 -------------------------------------------------------------------------------- 160 (370)
Q Consensus 161 -------------------------------------------------------------------------------- 160 (370)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ---------------------C--------CceEEEEeecCCCCHHHHHHhCCCC-ChHhHHHHHHHHHHHHHHHhhcCC
Q 042314 161 ---------------------S--------ERLIFLTEYLRNGSLHDILKKKGKL-DPPTAVAYALDIARGMNYLHHHRP 210 (370)
Q Consensus 161 ---------------------~--------~~~~~v~e~~~g~~L~~~l~~~~~~-~~~~~~~i~~~l~~~l~~lH~~~~ 210 (370)
+ -.+||-||||+.-+|.+++.++... ....+++++++|+.||.|+|++|
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g- 717 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG- 717 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc-
Confidence 0 1257889999887777777776444 47789999999999999999999
Q ss_pred CceeecCCCCCCeeeCCCCcEEEeccccceecc----c-----------cCccceeccCCCCCccccCcccccccC---C
Q 042314 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQ----E-----------KDSYSYKMTGGTGSYRYMAPEVYRRES---Y 272 (370)
Q Consensus 211 ~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~----~-----------~~~~~~~~~~~~g~~~y~aPE~~~~~~---~ 272 (370)
||||||||.||++++++.|||+|||+++... . ........++.+||.-|+|||++.+.. |
T Consensus 718 --iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 718 --IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred --eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 9999999999999999999999999998722 0 011112345668999999999997765 9
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCC---CCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 042314 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPAL---SSLYPEPIKALLRECWHKNPDRRPTFEEIIF 347 (370)
Q Consensus 273 ~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~ 347 (370)
+.|+|+||||++++||+. ||.............-.+.-|.. ...--+.-..+|+.+++.||.+|||+.|||.
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 999999999999999985 47766655443333222222222 2222234578999999999999999999975
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=270.13 Aligned_cols=245 Identities=25% Similarity=0.402 Sum_probs=188.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC--------CceEEEE
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS--------ERLIFLT 168 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~--------~~~~~v~ 168 (370)
+|.|++|.||++.+. +..+++|.+......+ .....+.+|+++++.++||||+++++++... ..+++|+
T Consensus 16 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~ 94 (311)
T cd07866 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVT 94 (311)
T ss_pred eccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEE
Confidence 788999999999875 7889999886543222 2234567899999999999999999876443 3479999
Q ss_pred eecCCCCHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 169 EYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 169 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
||+.+ +|...+.. ...+++..+..++.|+++||.|||+++ ++|+||||+||++++++.++|+|||++........
T Consensus 95 ~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 170 (311)
T cd07866 95 PYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170 (311)
T ss_pred ecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCc
Confidence 99976 77776664 457999999999999999999999998 99999999999999999999999999876543322
Q ss_pred cce--------eccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC-----
Q 042314 248 YSY--------KMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR----- 313 (370)
Q Consensus 248 ~~~--------~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~----- 313 (370)
... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|++||...+..............
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (311)
T cd07866 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEET 250 (311)
T ss_pred ccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 111 11122467889999988654 5789999999999999999999999876654433322110000
Q ss_pred ----------------CCC-------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 ----------------PAL-------SSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 ----------------~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
... ...+++.+.+++.+||..||++|||+.+++.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 251 WPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred chhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000 01244678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=273.16 Aligned_cols=244 Identities=25% Similarity=0.409 Sum_probs=192.3
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC------ceEEEEe
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE------RLIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~------~~~~v~e 169 (370)
.+|.|++|.||++.. .|..+++|.+..... .......+.+|+.+++.++||||+++++++.... ..++|+|
T Consensus 22 ~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 100 (342)
T cd07879 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP 100 (342)
T ss_pred EeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEec
Confidence 378899999999976 478899999875432 2334556789999999999999999999886542 4689999
Q ss_pred ecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 170 YLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
|+.. +|..+.. ..++...+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~---- 170 (342)
T cd07879 101 YMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE---- 170 (342)
T ss_pred cccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC----
Confidence 9965 7877653 36899999999999999999999998 999999999999999999999999998754322
Q ss_pred eeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC-----------------
Q 042314 250 YKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED----------------- 311 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~----------------- 311 (370)
.....+++.|+|||.+.+ ..++.++|+||||+++|||++|+.||................
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 171 --MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred --CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 122356888999999876 457889999999999999999999998765433222211100
Q ss_pred ---------CCC---CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHHHH
Q 042314 312 ---------SRP---ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR--LEAIQE 354 (370)
Q Consensus 312 ---------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~--l~~~~~ 354 (370)
... ......+..+.++|.+||+.||++||++++++.+ ++.+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000 0112456789999999999999999999999976 666654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=273.52 Aligned_cols=239 Identities=27% Similarity=0.416 Sum_probs=192.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCc------eEEEEe
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSER------LIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~------~~~v~e 169 (370)
.+|.|++|.||++... +..+++|.+.... ........+.+|+.+++.++|||++++++++...+. .++|+|
T Consensus 22 ~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 100 (343)
T cd07851 22 PVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH 100 (343)
T ss_pred EeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEe
Confidence 3788999999999875 6789999886543 223445667889999999999999999998766544 899999
Q ss_pred ecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 170 YLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
|+ +++|.+++.. .++++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 101 ~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---- 171 (343)
T cd07851 101 LM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---- 171 (343)
T ss_pred cC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccc----
Confidence 99 5699998876 47999999999999999999999998 999999999999999999999999998765432
Q ss_pred eeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC---------------
Q 042314 250 YKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--------------- 313 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 313 (370)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+......
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 172 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred --ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 122356888999998865 35788999999999999999999999766554433322111000
Q ss_pred -----------C---CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 -----------P---ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 -----------~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
. .....+++.+.+++++||..+|++|||+.+++.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 1112357889999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=262.95 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=207.5
Q ss_pred cCCCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhc--CCCceeeeeeeEeeCC----ceEEEEee
Q 042314 97 GGIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL--RHPNIVQFLGVLKHSE----RLIFLTEY 170 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l--~hp~Iv~~~~~~~~~~----~~~~v~e~ 170 (370)
..+++|.||.||+|...++.||||++.. +..+.+.+|-++.+.. +|+||+++++.-.... .+++|++|
T Consensus 216 eli~~Grfg~V~KaqL~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQLDNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred HHhhcCccceeehhhccCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 4589999999999999999999999975 3467788898888765 7999999999865544 78999999
Q ss_pred cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCC------CceeecCCCCCCeeeCCCCcEEEeccccceeccc
Q 042314 171 LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRP------HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQE 244 (370)
Q Consensus 171 ~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~------~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 244 (370)
.+.|+|.+++..+ .+++....+++..+++||+|||+.-+ .+|+|||||+.||||.++++..|+|||+|..+..
T Consensus 290 h~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 290 HPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP 368 (534)
T ss_pred ccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence 9999999999987 78999999999999999999997542 3799999999999999999999999999988875
Q ss_pred cCccceeccCCCCCccccCcccccccC-CC-----chhhHHHHHHHHHHHHhCC------------CCCC-----CCcHH
Q 042314 245 KDSYSYKMTGGTGSYRYMAPEVYRRES-YG-----KSVDVFSFALIVHEMFQGG------------PSNR-----ADTAV 301 (370)
Q Consensus 245 ~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-----~~~Di~slG~~l~el~~g~------------~p~~-----~~~~~ 301 (370)
..... ..-+..||.+|||||++.+.- +. .+.||||+|.++|||++.- +||. ..+..
T Consensus 369 ~~~~~-d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 369 GKPQG-DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred CCCCc-chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 54322 334467999999999997652 22 4689999999999998752 2332 12334
Q ss_pred HHHHHhhccCCCCCCCCC-----CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhcc
Q 042314 302 QVADRRAYEDSRPALSSL-----YPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQK 358 (370)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~ 358 (370)
++......+..+|.++.. -...+++.+..||+.||+.|.|+.=+-+.+..+...-+.
T Consensus 448 ~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 448 EMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 455555556677776653 335689999999999999999999999999988776654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=282.15 Aligned_cols=259 Identities=28% Similarity=0.515 Sum_probs=223.1
Q ss_pred cccCCCCCCcccEEEEEEc------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEE
Q 042314 95 DRGGIDPGAYGEVYLVKWR------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLT 168 (370)
Q Consensus 95 ~~~~l~~g~~~~v~~a~~~------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~ 168 (370)
+...+|.|+||+||++.|- .-+|++|++... ........+..|+-+|.++.|||++++++++..+. +.+|+
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 3456999999999999873 346888888764 33455678899999999999999999999987765 88999
Q ss_pred eecCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 169 EYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 169 e~~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
+|+++|+|.++++.. .++.....+.|..||++||.|||.++ ++||||-.+||||.+...+|+.|||+++.......
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999864 57888999999999999999999988 99999999999999999999999999998876543
Q ss_pred cceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHH
Q 042314 248 YSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKA 326 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 326 (370)
.+...+.--.+.|+|-|.+....|+.++||||+||++||++| |..|+.+....++-.... .+.+..-|..++-+++.
T Consensus 854 -ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-~geRLsqPpiCtiDVy~ 931 (1177)
T KOG1025|consen 854 -EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-KGERLSQPPICTIDVYM 931 (1177)
T ss_pred -cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-ccccCCCCCCccHHHHH
Confidence 334445556889999999999999999999999999999997 778888888776655444 67778888889999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHhccCCC
Q 042314 327 LLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKTV 361 (370)
Q Consensus 327 li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~~ 361 (370)
++.+||..|++.||+++++...+.++.+..+..-.
T Consensus 932 ~mvkCwmid~~~rp~fkel~~~fs~~ardpqryl~ 966 (1177)
T KOG1025|consen 932 VMVKCWMIDADSRPTFKELAEEFSRMARDPQRYLV 966 (1177)
T ss_pred HHHHHhccCcccCccHHHHHHHHHHHhcCcceEee
Confidence 99999999999999999999999999776654433
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=271.55 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=215.6
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|.||+||-+.. .|+.||||++.+..... .....+.+|+.+++.+.||.||.+-..|+..+++++|||.+.|.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 4599999999998865 49999999997654332 33478899999999999999999999999999999999999886
Q ss_pred CHHHHHH-hCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC---CcEEEeccccceeccccCccce
Q 042314 175 SLHDILK-KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA---GHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 175 ~L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
-|+-++. +++++++.....++.||+.||.|||-++ |+|.||||+|||+.+. -++||||||.++.++....
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--- 722 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--- 722 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh---
Confidence 6666665 5689999999999999999999999999 9999999999999754 3799999999999987643
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
.....|||.|.|||++....|..+-|+||+|+|+|--++|..||..+.+.....+...--..+..+..+++...+||..
T Consensus 723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 2334799999999999999999999999999999999999999987655433333332234455667789999999999
Q ss_pred hcccCCCCCCCHHHHHH-----------HHHHHHHHhccCCCCCCc
Q 042314 331 CWHKNPDRRPTFEEIIF-----------RLEAIQESFQKKTVPSCC 365 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~-----------~l~~~~~~~~~~~~~~~~ 365 (370)
+|+..=.+|.|.+..+. .|+.+...+..+.+...+
T Consensus 802 LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~igeRyiThes 847 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGERYITHES 847 (888)
T ss_pred HHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCcceecCcc
Confidence 99999999999887654 455666666666554433
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=268.47 Aligned_cols=239 Identities=26% Similarity=0.400 Sum_probs=188.7
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC------CceEEEEe
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS------ERLIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~------~~~~~v~e 169 (370)
.+|.|+||.||++.. .+..+++|.+.... ........+.+|+.++++++||||+++++++... ...+++++
T Consensus 24 ~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~ 102 (345)
T cd07877 24 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 102 (345)
T ss_pred EeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEeh
Confidence 478899999999975 47889999886542 2233456678899999999999999999987543 34678888
Q ss_pred ecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 170 YLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
++ +++|.++++.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 103 ~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~---- 173 (345)
T cd07877 103 LM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 173 (345)
T ss_pred hc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccccccc----
Confidence 87 77999888754 6899999999999999999999998 999999999999999999999999998754322
Q ss_pred eeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc------------------
Q 042314 250 YKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE------------------ 310 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~------------------ 310 (370)
.....++..|+|||.+.+ ..++.++|+||+|+++|+|++|++||...............
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T cd07877 174 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251 (345)
T ss_pred --ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence 122357889999998866 46788999999999999999999999765443322111000
Q ss_pred ------CCCC-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 311 ------DSRP-----ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 311 ------~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
...+ ......++.+.++|.+||+.||.+||++.+++.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 0112357789999999999999999999999887
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=252.86 Aligned_cols=235 Identities=36% Similarity=0.630 Sum_probs=197.5
Q ss_pred CcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHHHHH
Q 042314 103 AYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDIL 180 (370)
Q Consensus 103 ~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~~~l 180 (370)
+||.||++... +..+++|.+........ ...+.+|+..+++++|++++++++.+......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 47899999885 58899999876532221 678899999999999999999999999889999999999999999999
Q ss_pred HhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCCCCcc
Q 042314 181 KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYR 260 (370)
Q Consensus 181 ~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~ 260 (370)
.....++...++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+....... ......++..
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~ 151 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTPE 151 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCcC
Confidence 88766899999999999999999999998 9999999999999999999999999988776542 1223357889
Q ss_pred ccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhccCCCCCCCCC--CcHHHHHHHHHhcccCCC
Q 042314 261 YMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRA-DTAVQVADRRAYEDSRPALSSL--YPEPIKALLRECWHKNPD 337 (370)
Q Consensus 261 y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~ 337 (370)
|+|||.+.+..++.++|+||+|++++++++|..||.. ........... .......... ++..+.+++.+||..+|+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 230 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG-KPKPPFPPPEWKISPEAKDLIRKLLVKDPE 230 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh-ccCCCCccccccCCHHHHHHHHHHccCCch
Confidence 9999999988889999999999999999999999987 44433333332 2222222221 889999999999999999
Q ss_pred CCCCHHHHHH
Q 042314 338 RRPTFEEIIF 347 (370)
Q Consensus 338 ~Rp~~~~ll~ 347 (370)
+||++.++++
T Consensus 231 ~Rp~~~~~~~ 240 (244)
T smart00220 231 KRLTAEEALQ 240 (244)
T ss_pred hccCHHHHhh
Confidence 9999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=277.90 Aligned_cols=247 Identities=25% Similarity=0.438 Sum_probs=191.8
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee------CCceEEEE
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH------SERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~------~~~~~~v~ 168 (370)
..+|+|+||.||+++.+ |..+|||.++... ....++...+|++++++++|||||+++++-+. .....+||
T Consensus 19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred hhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 44899999999999854 9999999998753 34456778999999999999999999997543 33578999
Q ss_pred eecCCCCHHHHHHhC---CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC--CCCc--EEEecccccee
Q 042314 169 EYLRNGSLHDILKKK---GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD--EAGH--LKVTDFGLSKI 241 (370)
Q Consensus 169 e~~~g~~L~~~l~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~--~~~~--~kl~Dfg~~~~ 241 (370)
|||.||||+.++++. ..+++.+.+.++.++..||.|||++| |+||||||.||++- .+|+ .||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999864 47999999999999999999999998 99999999999964 4453 59999999998
Q ss_pred ccccCccceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH-----HHHHhhcc-----
Q 042314 242 AQEKDSYSYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ-----VADRRAYE----- 310 (370)
Q Consensus 242 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-----~~~~~~~~----- 310 (370)
..+.. ...+..||..|.+||.... ..|+..+|.|||||++|++.||..||.+..... ........
T Consensus 174 l~d~s----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 174 LDDNS----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred CCCCC----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 87664 3455689999999999984 788999999999999999999999997654331 11111100
Q ss_pred -------CC------CCCCCCCCcH----HHHHHHHHhcccCCCCCC--CHHHHHHHHHHH
Q 042314 311 -------DS------RPALSSLYPE----PIKALLRECWHKNPDRRP--TFEEIIFRLEAI 352 (370)
Q Consensus 311 -------~~------~~~~~~~~~~----~l~~li~~~l~~~p~~Rp--~~~~ll~~l~~~ 352 (370)
.. ..+.+..++. .+-.++..+|..+|.+|- .+.+.-..+..+
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 00 0011222222 345667778888888886 555555554444
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=230.26 Aligned_cols=244 Identities=27% Similarity=0.460 Sum_probs=195.6
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|+|.||+|++++.+ +..|++|.++-.. +++.......+|+-+++.++|.|||++++...++..+-+|+|||+.
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq- 85 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence 45899999999999775 6678889887654 3445567788999999999999999999999999999999999966
Q ss_pred CHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+|..+... ++.++...+++++.|+++|+.++|+.+ ++|||+||.|.+|..+|.+|++|||+++..+.+... ..
T Consensus 86 dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrc---ys 159 (292)
T KOG0662|consen 86 DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC---YS 159 (292)
T ss_pred HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEe---ee
Confidence 89888875 578999999999999999999999998 999999999999999999999999999877755321 12
Q ss_pred CCCCCccccCcccccccC-CCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcc------CCCCC---CC-----
Q 042314 254 GGTGSYRYMAPEVYRRES-YGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYE------DSRPA---LS----- 317 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~------~~~~~---~~----- 317 (370)
...-|.+|.+|.++.+.. |+.+.|+||.||++.|+.. |++.|.+....+...++... ...|. ++
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 235689999999998865 7889999999999999986 55656666555444433211 00110 01
Q ss_pred -------------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 318 -------------SLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 318 -------------~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+.+...-+++++++|.-+|.+|.++++.+++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 0122346789999999999999999998764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=248.99 Aligned_cols=252 Identities=21% Similarity=0.381 Sum_probs=196.9
Q ss_pred eeecccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee--------C
Q 042314 92 ILEDRGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH--------S 161 (370)
Q Consensus 92 ~L~~~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~--------~ 161 (370)
..+....+|+|.||.||+|+.+ |+.|++|...... .....-....+|+.++..++|+|++.+++.+.. .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3444456999999999999765 6777877654422 222334556799999999999999998887643 2
Q ss_pred CceEEEEeecCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccce
Q 042314 162 ERLIFLTEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK 240 (370)
Q Consensus 162 ~~~~~v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~ 240 (370)
..+++||.+|+. +|.-++... .+++..++..++.++..||.|+|++. |+|||+|+.|+||+.+|.+||+|||+++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 348999999977 999999876 68999999999999999999999999 9999999999999999999999999997
Q ss_pred eccccCccc-eeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC--CCCC-
Q 042314 241 IAQEKDSYS-YKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED--SRPA- 315 (370)
Q Consensus 241 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~- 315 (370)
......... ...+...-|.+|.+||.+.+. .|+++.|||..||+|.||+|+.+.+.+.+.......+.... ..++
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 765543222 223445569999999999875 58999999999999999999999998887766444332110 0000
Q ss_pred -----------------CCC-------------CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 316 -----------------LSS-------------LYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 316 -----------------~~~-------------~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
++. .-.+...+|+.++|..||.+|+++++++.+
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 110 012367799999999999999999998876
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=248.30 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=218.8
Q ss_pred CCCCCcccEEEEEEcC-------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEe-eCCceEEEEee
Q 042314 99 IDPGAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK-HSERLIFLTEY 170 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g-------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~-~~~~~~~v~e~ 170 (370)
+-+|.||.||.+.|+. +.+.+|.++.. ..+-+...+..|...+....|||+..+.++.. +....++++.+
T Consensus 292 lqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~ 369 (563)
T KOG1024|consen 292 LQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPA 369 (563)
T ss_pred hhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEec
Confidence 6789999999997752 34667777665 34567788899999999999999999999865 45678999999
Q ss_pred cCCCCHHHHHHhC--------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceec
Q 042314 171 LRNGSLHDILKKK--------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIA 242 (370)
Q Consensus 171 ~~g~~L~~~l~~~--------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~ 242 (370)
..-|+|..+++.. +.++..+...++.|++.|++|||+.+ +||.||..+|.+|++.-++||+|=.+++.+
T Consensus 370 ~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 370 TGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDL 446 (563)
T ss_pred cCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhcccc
Confidence 9999999999832 24677788999999999999999998 999999999999999999999999999988
Q ss_pred cccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCc
Q 042314 243 QEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYP 321 (370)
Q Consensus 243 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (370)
.+.+. .........+..||+||.+....|+.++|+||||++||||+| |+.|+....+.+...... .+.+...|.++|
T Consensus 447 FP~DY-hcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk-dGyRlaQP~NCP 524 (563)
T KOG1024|consen 447 FPGDY-HCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK-DGYRLAQPFNCP 524 (563)
T ss_pred Ccccc-cccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh-ccceecCCCCCc
Confidence 77643 234455567889999999999999999999999999999997 789999888888777665 788888999999
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhcc
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQK 358 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~ 358 (370)
+++..+|..||..+|++||+++++...|.++...+..
T Consensus 525 DeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~ 561 (563)
T KOG1024|consen 525 DELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTR 561 (563)
T ss_pred HHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhh
Confidence 9999999999999999999999999999998776653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=272.17 Aligned_cols=239 Identities=26% Similarity=0.451 Sum_probs=200.3
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEee-----CCceEEEEee
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKH-----SERLIFLTEY 170 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~-----~~~~~~v~e~ 170 (370)
++.|.+|.||++.. .++..|+|++..... ....+..|.++++.. .|||++.++++|.. ++.+|+||||
T Consensus 27 ig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf 102 (953)
T KOG0587|consen 27 IGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF 102 (953)
T ss_pred EeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence 67788888888754 588899999876543 335566788888887 49999999999864 4689999999
Q ss_pred cCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 171 LRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 171 ~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
|.|||.-++++.. .++.+..+..|.+.++.|+.+||.+. ++|||||-.|||++.++.|||+|||.+..+.....
T Consensus 103 C~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g- 178 (953)
T KOG0587|consen 103 CGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG- 178 (953)
T ss_pred cCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeecccc-
Confidence 9999999998854 57889999999999999999999998 99999999999999999999999999977765432
Q ss_pred ceeccCCCCCccccCcccccc-----cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCC--CCCCc
Q 042314 249 SYKMTGGTGSYRYMAPEVYRR-----ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPAL--SSLYP 321 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 321 (370)
.....+|||.|||||++.. ..|+.++|+||||++..||-.|.+|+-...+......+. ..++|.+ |..++
T Consensus 179 --rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip-RNPPPkLkrp~kWs 255 (953)
T KOG0587|consen 179 --RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RNPPPKLKRPKKWS 255 (953)
T ss_pred --cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC-CCCCccccchhhHH
Confidence 3455689999999999954 347789999999999999999999998888776665554 2333332 56688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
..|-+||+.||.+|.++||+..+++++
T Consensus 256 ~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 256 KKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred HHHHHHHHHHHhhccccCcchhhhccC
Confidence 899999999999999999999998865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=257.33 Aligned_cols=251 Identities=23% Similarity=0.374 Sum_probs=201.5
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCC----ChHHHHHHHHHHHHHHhcCCCceeeeeeeEee-CCceEEEEe
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIAS----NPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH-SERLIFLTE 169 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~----~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~-~~~~~~v~e 169 (370)
..+|.|+|+.||+|.+ ..+.+|+|+-...... .+...+..++|.++.+.+.||.||+++++|.- .+.+|-|+|
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE 548 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE 548 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence 4489999999999865 4778999987544322 23455668899999999999999999999875 567899999
Q ss_pred ecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC---CCcEEEeccccceeccccC
Q 042314 170 YLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE---AGHLKVTDFGLSKIAQEKD 246 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~~~~~ 246 (370)
||+|.+|+-+++...-+++.+++.|+.||+.||.||.+.. .||||-||||.|||+.+ .|.+||.|||+++.+....
T Consensus 549 YceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddS 627 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDS 627 (775)
T ss_pred ecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhhccCCc
Confidence 9999999999999999999999999999999999999987 68999999999999864 4689999999999876543
Q ss_pred ccc----eeccCCCCCccccCccccccc----CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhccCC---CC
Q 042314 247 SYS----YKMTGGTGSYRYMAPEVYRRE----SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ-VADRRAYEDS---RP 314 (370)
Q Consensus 247 ~~~----~~~~~~~g~~~y~aPE~~~~~----~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~---~~ 314 (370)
... -......||.+|.+||.+.-+ ..+.++||||+|+|+|+.+.|+.||....... +......... ..
T Consensus 628 y~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqF 707 (775)
T KOG1151|consen 628 YNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQF 707 (775)
T ss_pred cCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccC
Confidence 221 112345699999999998543 46789999999999999999999998875543 2222211111 11
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 315 ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 315 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+..+..+.+.+.||++||.+--++|.+..+|..+
T Consensus 708 P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 708 PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 2234577889999999999999999988887653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=297.02 Aligned_cols=243 Identities=23% Similarity=0.369 Sum_probs=186.7
Q ss_pred ccCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 96 RGGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
...+|.|+||.||++.. .+..+++|.+...... ...|+..+++++||||+++++++...+..++||||+++
T Consensus 695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence 34589999999999985 4788999988643211 12457888999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|+|.++++ .+++..+..++.|+++|++|||.....+|+||||||+||+++.++..++. ||........ .
T Consensus 768 g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-------~ 836 (968)
T PLN00113 768 KNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-------T 836 (968)
T ss_pred CcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-------C
Confidence 99999996 47889999999999999999995433449999999999999998887765 5554332211 1
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHhhcc------CCCCCCC------
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA----VQVADRRAYE------DSRPALS------ 317 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~------~~~~~~~------ 317 (370)
...+++.|+|||.+.+..++.++|||||||++|||++|+.||..... .......... ..++...
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 22578999999999999999999999999999999999999854211 0000000000 0111111
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 318 SLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 318 ~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
......+.+++.+||+.||++||++.++++.|+++.+.-
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 112235778999999999999999999999999886643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=247.80 Aligned_cols=236 Identities=26% Similarity=0.426 Sum_probs=202.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
++|.|+|+.|..++.. .+.+|+|++++....+.+.......|..+..+- +||.+|.+..+|..+.++++|.||++||
T Consensus 257 vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~gg 336 (593)
T KOG0695|consen 257 VIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGG 336 (593)
T ss_pred eecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCc
Confidence 4899999999988664 677999999988877778888899999988877 6999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|--.++++.+++++.++.+..+|+-||.|||++| ||.||||.+|+|++..|.+||.|+|+.+.--.+.. ....
T Consensus 337 dlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~gd---~tst 410 (593)
T KOG0695|consen 337 DLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD---TTST 410 (593)
T ss_pred ceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCCc---cccc
Confidence 99888898889999999999999999999999999 99999999999999999999999999875433332 3345
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC-------cHHHHHHHhhccCCCCCCCCCCcHHHHHH
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRAD-------TAVQVADRRAYEDSRPALSSLYPEPIKAL 327 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 327 (370)
.+|||.|.|||.+.+..|..++|.|+||++|+||+.|+.||..- +..+...++. ......+|..++-....+
T Consensus 411 fcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi-lekqiriprslsvkas~v 489 (593)
T KOG0695|consen 411 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI-LEKQIRIPRSLSVKASHV 489 (593)
T ss_pred ccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH-hhhcccccceeehhhHHH
Confidence 68999999999999999999999999999999999999999632 1222222222 234455677777778899
Q ss_pred HHHhcccCCCCCC
Q 042314 328 LRECWHKNPDRRP 340 (370)
Q Consensus 328 i~~~l~~~p~~Rp 340 (370)
++.-|.+||.+|.
T Consensus 490 lkgflnkdp~erl 502 (593)
T KOG0695|consen 490 LKGFLNKDPKERL 502 (593)
T ss_pred HHHhhcCCcHHhc
Confidence 9999999999994
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=250.64 Aligned_cols=237 Identities=24% Similarity=0.348 Sum_probs=188.7
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC--CC----ceeeeeeeEeeCCceEEEEe
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR--HP----NIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~--hp----~Iv~~~~~~~~~~~~~~v~e 169 (370)
.+|+|.||.|-.+.++ +..+|+|+++.- ...++...-|+++++++. .| -++++.++|...++.|||+|
T Consensus 96 ~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfe 171 (415)
T KOG0671|consen 96 LLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFE 171 (415)
T ss_pred hhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEe
Confidence 4899999999988665 677999998753 456777889999999994 23 37888899999999999999
Q ss_pred ecCCCCHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC-------------------
Q 042314 170 YLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA------------------- 228 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~------------------- 228 (370)
.+ |.|+++++.++. +++..+++.++.|+++++.+||+.+ ++|-||||+||++.+.
T Consensus 172 ll-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~k 247 (415)
T KOG0671|consen 172 LL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLK 247 (415)
T ss_pred cc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCC
Confidence 99 669999998864 6889999999999999999999999 9999999999997422
Q ss_pred -CcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH---HH
Q 042314 229 -GHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ---VA 304 (370)
Q Consensus 229 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---~~ 304 (370)
-.++++|||.|+....... ..+.|..|.|||++.+-+++..+||||+||||+|+++|...|+.....+ +.
T Consensus 248 s~~I~vIDFGsAtf~~e~hs------~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMM 321 (415)
T KOG0671|consen 248 STAIKVIDFGSATFDHEHHS------TIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMM 321 (415)
T ss_pred CcceEEEecCCcceeccCcc------eeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHH
Confidence 2589999999987765432 2356889999999999999999999999999999999999887665333 11
Q ss_pred HHhhc----------------cCCCCCCCC-------------------------CCcHHHHHHHHHhcccCCCCCCCHH
Q 042314 305 DRRAY----------------EDSRPALSS-------------------------LYPEPIKALLRECWHKNPDRRPTFE 343 (370)
Q Consensus 305 ~~~~~----------------~~~~~~~~~-------------------------~~~~~l~~li~~~l~~~p~~Rp~~~ 343 (370)
+.+.- ...+..++. ..-..|.+|+++||..||.+|+|+.
T Consensus 322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~ 401 (415)
T KOG0671|consen 322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR 401 (415)
T ss_pred HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence 11110 000111000 0113588999999999999999999
Q ss_pred HHHHH
Q 042314 344 EIIFR 348 (370)
Q Consensus 344 ~ll~~ 348 (370)
|++.+
T Consensus 402 EAL~H 406 (415)
T KOG0671|consen 402 EALSH 406 (415)
T ss_pred HHhcC
Confidence 99865
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=258.55 Aligned_cols=240 Identities=26% Similarity=0.377 Sum_probs=197.7
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..||.|+||.|.+++.. ...+|.|.+++...-......-.+.|-.+|..-..+-||+++-.|.+++.+|+||+|+.||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 34899999999998764 5668999998766555666777889999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceec---------ccc
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIA---------QEK 245 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~---------~~~ 245 (370)
++-.++-+.+-|++..++.++.++..|+++.|.+| +|||||||+|||||.+|.+||.|||+.+-. ..+
T Consensus 715 DmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~g 791 (1034)
T KOG0608|consen 715 DMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEG 791 (1034)
T ss_pred cHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccccccCC
Confidence 99999999999999999999999999999999999 999999999999999999999999986422 111
Q ss_pred Cccc---------ee---------------------ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCC
Q 042314 246 DSYS---------YK---------------------MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSN 295 (370)
Q Consensus 246 ~~~~---------~~---------------------~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~ 295 (370)
+... +. .-..+||+.|+|||++....|+...|.||.|+|||||+.|++||
T Consensus 792 dH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf 871 (1034)
T KOG0608|consen 792 DHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPF 871 (1034)
T ss_pred CccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCc
Confidence 0000 00 00124999999999999999999999999999999999999999
Q ss_pred CCCcHHHHHHHhhccC--CCCCCCCCCcHHHHHHHHHhcccCCCCCC
Q 042314 296 RADTAVQVADRRAYED--SRPALSSLYPEPIKALLRECWHKNPDRRP 340 (370)
Q Consensus 296 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 340 (370)
-..++.....++.... ........++++..++|.++. .+++.|.
T Consensus 872 ~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 872 LADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred cCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 8887766655554322 233455678899888888743 3456664
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=268.56 Aligned_cols=241 Identities=25% Similarity=0.389 Sum_probs=191.5
Q ss_pred cCCCCCCccc-EEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGE-VYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~-v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|..|+ ||++.+.|+.||||.+... ......+|+..++.- .|||||++++.-.+....||+.|.|..
T Consensus 515 eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~- 587 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYEGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC- 587 (903)
T ss_pred HHcccCCCCcEEEEEeeCCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence 3477777655 6899999999999998653 345678999999888 599999999998889999999999988
Q ss_pred CHHHHHHhCC-C---CChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC---CC--cEEEeccccceecccc
Q 042314 175 SLHDILKKKG-K---LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE---AG--HLKVTDFGLSKIAQEK 245 (370)
Q Consensus 175 ~L~~~l~~~~-~---~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~---~~--~~kl~Dfg~~~~~~~~ 245 (370)
+|.+++.... . ......+..+.|+++||++||+.+ ||||||||.||||+. ++ +++|+|||+++....+
T Consensus 588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 9999998741 1 122456888999999999999999 999999999999986 34 6899999999988876
Q ss_pred CccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHH
Q 042314 246 DSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG-GPSNRADTAVQVADRRAYEDSRPALSSLYPEPI 324 (370)
Q Consensus 246 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 324 (370)
........+..||.+|+|||++.+...+.++||||+||++|+.++| ..||......+.......... ..+........
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L-~~L~~~~d~eA 743 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTL-VHLEPLPDCEA 743 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccce-eeeccCchHHH
Confidence 5544456677899999999999999888999999999999998887 788886655443222111111 11111111278
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 042314 325 KALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 325 ~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+||.+|+.++|..||++.+++.|
T Consensus 744 ~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 744 KDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred HHHHHHhcCCCcccCCCHHHHhCC
Confidence 999999999999999999998754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=222.56 Aligned_cols=211 Identities=27% Similarity=0.430 Sum_probs=169.8
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
..+|.|++|.|-+.+. +|...|+|.++... +.+..++..+|+.+..+. .+|.+|.++|........|+.||.++-
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t 129 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT 129 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence 3489999999877654 58899999998764 345667788888886665 699999999998889999999999966
Q ss_pred CCHHHHH----HhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 174 GSLHDIL----KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 174 ~~L~~~l----~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
||+.+. .+.+.+++..+-+|+..+..||.|||++= .+||||+||.|||++.+|++|+||||++..+.++--.+
T Consensus 130 -Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt 206 (282)
T KOG0984|consen 130 -SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT 206 (282)
T ss_pred -hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH
Confidence 887764 45578999999999999999999999975 49999999999999999999999999998776543211
Q ss_pred eeccCCCCCccccCcccccc----cCCCchhhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHhhccCCCCCCC
Q 042314 250 YKMTGGTGSYRYMAPEVYRR----ESYGKSVDVFSFALIVHEMFQGGPSNRADT-AVQVADRRAYEDSRPALS 317 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~----~~~~~~~Di~slG~~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~ 317 (370)
-..|--.|+|||.+.. ..|+.++||||||+++.||.+++.||.... +.+...++. +.+.|.++
T Consensus 207 ----~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV-eep~P~Lp 274 (282)
T KOG0984|consen 207 ----MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV-EEPSPQLP 274 (282)
T ss_pred ----HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh-cCCCCCCc
Confidence 1235567999999854 368899999999999999999999998764 444444444 44444443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=250.77 Aligned_cols=239 Identities=26% Similarity=0.394 Sum_probs=193.7
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCC------CceeeeeeeEeeCCceEEEE
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH------PNIVQFLGVLKHSERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h------p~Iv~~~~~~~~~~~~~~v~ 168 (370)
+..|+|-|++|..|... |..||||++.. ++...+.-..|+++|++|+. .|+++++..|.+.+++|+|+
T Consensus 438 ~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn----NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVF 513 (752)
T KOG0670|consen 438 GYTGKGVFSTVVRARDQARGQEVAIKIIRN----NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVF 513 (752)
T ss_pred eccccceeeeeeeccccCCCCeeEEEEeec----chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEe
Confidence 44899999999999774 78999999975 34566778899999999963 48999999999999999999
Q ss_pred eecCCCCHHHHHHhCC---CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC-cEEEeccccceeccc
Q 042314 169 EYLRNGSLHDILKKKG---KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG-HLKVTDFGLSKIAQE 244 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~ 244 (370)
|.+. .+|.+++++.+ .+....++.++.|+.-||..|...| |+|.||||+||||.+.. .+||||||.|...+.
T Consensus 514 E~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~e 589 (752)
T KOG0670|consen 514 EPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASE 589 (752)
T ss_pred hhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcccccccc
Confidence 9994 59999999865 4788899999999999999999999 99999999999999654 579999999988877
Q ss_pred cCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh-ccCCCCC--------
Q 042314 245 KDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRA-YEDSRPA-------- 315 (370)
Q Consensus 245 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~-------- 315 (370)
....++. -+..|.|||++.+.+|++..|+||+||+||||+||+..|.+.+...+..... ..+..|.
T Consensus 590 neitPYL-----VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF 664 (752)
T KOG0670|consen 590 NEITPYL-----VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQF 664 (752)
T ss_pred ccccHHH-----HHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcch
Confidence 6544332 3568999999999999999999999999999999999887765444321110 0000000
Q ss_pred ------------------------------------C------CCCCc-------HHHHHHHHHhcccCCCCCCCHHHHH
Q 042314 316 ------------------------------------L------SSLYP-------EPIKALLRECWHKNPDRRPTFEEII 346 (370)
Q Consensus 316 ------------------------------------~------~~~~~-------~~l~~li~~~l~~~p~~Rp~~~~ll 346 (370)
+ ...+| ..|.+|+.+||..||++|.|..+.|
T Consensus 665 ~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL 744 (752)
T KOG0670|consen 665 KDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQAL 744 (752)
T ss_pred hhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHh
Confidence 0 00122 3588999999999999999999988
Q ss_pred HH
Q 042314 347 FR 348 (370)
Q Consensus 347 ~~ 348 (370)
.|
T Consensus 745 ~H 746 (752)
T KOG0670|consen 745 KH 746 (752)
T ss_pred cC
Confidence 65
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=223.09 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=191.7
Q ss_pred cccccCceeeEEeeecccCCCCCCcccEEEEE--EcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeee
Q 042314 80 DARSFGHVVICKILEDRGGIDPGAYGEVYLVK--WRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLG 156 (370)
Q Consensus 80 ~A~~~g~~~~~~~L~~~~~l~~g~~~~v~~a~--~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~ 156 (370)
....+|+.+-.++. ..+|.|.++.||.+. .++..+++|+++.- -.+.+.+|+.+++.++ +|||+.+++
T Consensus 30 ~~i~wg~~ddYeiv---rk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~D 100 (338)
T KOG0668|consen 30 LVIDWGNQDDYEIV---RKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLD 100 (338)
T ss_pred eeeeccccchHHHH---HHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhh
Confidence 33445544433332 338999999999987 45788999998753 3577899999999996 999999999
Q ss_pred eEeeC--CceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC-CcEEE
Q 042314 157 VLKHS--ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA-GHLKV 233 (370)
Q Consensus 157 ~~~~~--~~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~-~~~kl 233 (370)
+..+. ..+.+++||++..+...+.. .++...++.++.++++||.|+|++| |.|||+||.|+||+.. -.++|
T Consensus 101 iV~Dp~SktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrl 174 (338)
T KOG0668|consen 101 IVKDPESKTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRL 174 (338)
T ss_pred hhcCccccCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeee
Confidence 98764 56789999998877666554 6788899999999999999999999 9999999999999954 46999
Q ss_pred eccccceeccccCccceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCC--cHHHHHHHhhc-
Q 042314 234 TDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRAD--TAVQVADRRAY- 309 (370)
Q Consensus 234 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~--~~~~~~~~~~~- 309 (370)
+|+|++.+..+...++.. ..+.-|.-||.+... .|+++-|+|||||++..|+..+.||... +..++. ++..
T Consensus 175 IDWGLAEFYHp~~eYnVR----VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV-kIakV 249 (338)
T KOG0668|consen 175 IDWGLAEFYHPGKEYNVR----VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV-KIAKV 249 (338)
T ss_pred eecchHhhcCCCceeeee----eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH-HHHHH
Confidence 999999988876554432 346678899999765 4799999999999999999999887543 222211 1100
Q ss_pred --------------------------cCCCC--------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 310 --------------------------EDSRP--------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 310 --------------------------~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
...+. .-....+++..+|+.++|..|-.+|||+.|.+.+
T Consensus 250 LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 250 LGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred hChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00000 0111245789999999999999999999998765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=262.02 Aligned_cols=240 Identities=20% Similarity=0.217 Sum_probs=158.3
Q ss_pred cCCCCCCcccEEEEEEc------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeee------EeeCCce
Q 042314 97 GGIDPGAYGEVYLVKWR------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV------LKHSERL 164 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~------~~~~~~~ 164 (370)
..+|+|+||.||++... +..+++|.+...... .....+ .++...+.++..+... .......
T Consensus 138 ~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (566)
T PLN03225 138 KKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEY 210 (566)
T ss_pred EEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCce
Confidence 34899999999999874 568999987543211 111111 1111122222222211 2345678
Q ss_pred EEEEeecCCCCHHHHHHhCCC--------------------CChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCee
Q 042314 165 IFLTEYLRNGSLHDILKKKGK--------------------LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVL 224 (370)
Q Consensus 165 ~~v~e~~~g~~L~~~l~~~~~--------------------~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil 224 (370)
++|+||+.+++|.+++..... .....+..++.|++.||.|||+++ |+||||||+|||
T Consensus 211 ~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NIL 287 (566)
T PLN03225 211 WLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNII 287 (566)
T ss_pred EEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEE
Confidence 999999999999999875421 112346679999999999999998 999999999999
Q ss_pred eCC-CCcEEEeccccceeccccCccceeccCCCCCccccCccccccc----------------------CCCchhhHHHH
Q 042314 225 QDE-AGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE----------------------SYGKSVDVFSF 281 (370)
Q Consensus 225 ~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~Di~sl 281 (370)
++. .+.+||+|||+++........ ......+++.|+|||.+... .++.++||||+
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~--~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINY--IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EeCCCCcEEEEeCCCcccccccccc--CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 985 578999999999765433221 22334689999999976432 23446699999
Q ss_pred HHHHHHHHhCCCCCCCCcHHHH--HHH----------hhccCCCCC------CCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 042314 282 ALIVHEMFQGGPSNRADTAVQV--ADR----------RAYEDSRPA------LSSLYPEPIKALLRECWHKNPDRRPTFE 343 (370)
Q Consensus 282 G~~l~el~~g~~p~~~~~~~~~--~~~----------~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rp~~~ 343 (370)
||++|||+++..++........ ... .......+. .....+....+||.+||+.||++|||+.
T Consensus 366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~ 445 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK 445 (566)
T ss_pred HHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence 9999999997766543211100 000 000000000 0111223456899999999999999999
Q ss_pred HHHHH
Q 042314 344 EIIFR 348 (370)
Q Consensus 344 ~ll~~ 348 (370)
++++|
T Consensus 446 e~L~H 450 (566)
T PLN03225 446 AALAH 450 (566)
T ss_pred HHhCC
Confidence 99886
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=231.28 Aligned_cols=240 Identities=25% Similarity=0.371 Sum_probs=189.0
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC------ceEEEE
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE------RLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~------~~~~v~ 168 (370)
..++.|.- .|..+-+ .++++++|.+.... .+....++..+|+..+..++|+||++++.+|.-.. ..|+||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence 34566665 4444433 48899999887663 33455677889999999999999999999986533 479999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
|+++. +|..++.. .++...+..++.|++.|+.|||+.| |+||||||+||++..++.+||.|||+++.....
T Consensus 101 e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--- 171 (369)
T KOG0665|consen 101 ELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--- 171 (369)
T ss_pred Hhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc---
Confidence 99966 99998884 6788899999999999999999999 999999999999999999999999999866544
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc------------------
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE------------------ 310 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~------------------ 310 (370)
..++..+.|.-|.|||++.+..+...+||||+||++.||++|+..|.+....+...++...
T Consensus 172 -~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 172 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred -cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 3455567888999999999999999999999999999999999888765433322111100
Q ss_pred --CCCC--------------CC------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 311 --DSRP--------------AL------SSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 311 --~~~~--------------~~------~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
...+ .. +..-+...++++.+||..||++|.|++++|+|
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000 00 01122458899999999999999999999876
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-31 Score=247.63 Aligned_cols=247 Identities=17% Similarity=0.184 Sum_probs=172.5
Q ss_pred cCCCCCCcccEEEEEE------------------cCceeEEEEeccccCCC-h----------HHHHHHHHHHHHHHhcC
Q 042314 97 GGIDPGAYGEVYLVKW------------------RGTEIAAKTIRSSIASN-P----------RVRNSFMKELGLWQKLR 147 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~------------------~g~~vavK~l~~~~~~~-~----------~~~~~~~~e~~~l~~l~ 147 (370)
..+|+|+||.||++.. .++.|++|.+....... . ...+....|+.++.+++
T Consensus 151 ~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~ 230 (507)
T PLN03224 151 DKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIK 230 (507)
T ss_pred eEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhh
Confidence 3479999999999853 24679999986432110 0 01122344666777776
Q ss_pred CCc-----eeeeeeeEee--------CCceEEEEeecCCCCHHHHHHhCC------------------------CCChHh
Q 042314 148 HPN-----IVQFLGVLKH--------SERLIFLTEYLRNGSLHDILKKKG------------------------KLDPPT 190 (370)
Q Consensus 148 hp~-----Iv~~~~~~~~--------~~~~~~v~e~~~g~~L~~~l~~~~------------------------~~~~~~ 190 (370)
|.+ ++++++++.. .+..++|+||+++++|.+++.... .++...
T Consensus 231 ~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~ 310 (507)
T PLN03224 231 RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINV 310 (507)
T ss_pred cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHH
Confidence 554 3666776543 356899999999999999886421 234567
Q ss_pred HHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCCCCccccCccccccc
Q 042314 191 AVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE 270 (370)
Q Consensus 191 ~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 270 (370)
+..++.|++.+|.|||+.+ |+||||||+||+++.++.+||+|||++......... ......+++.|+|||.+...
T Consensus 311 ~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~--~~~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 311 IKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF--NPLYGMLDPRYSPPEELVMP 385 (507)
T ss_pred HHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc--CccccCCCcceeChhhhcCC
Confidence 8889999999999999998 999999999999999999999999998765433211 11223458899999998543
Q ss_pred C--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCCcHHHHH-----------HHhhccCCCCCC
Q 042314 271 S--------------------Y--GKSVDVFSFALIVHEMFQGGP-SNRADTAVQVA-----------DRRAYEDSRPAL 316 (370)
Q Consensus 271 ~--------------------~--~~~~Di~slG~~l~el~~g~~-p~~~~~~~~~~-----------~~~~~~~~~~~~ 316 (370)
. + ..+.|+||+||++++|++|.. ||......... ............
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~ 465 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSL 465 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCccc
Confidence 2 1 124799999999999999875 66432211110 111111112223
Q ss_pred CCCCcHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 042314 317 SSLYPEPIKALLRECWHKNP---DRRPTFEEIIFR 348 (370)
Q Consensus 317 ~~~~~~~l~~li~~~l~~~p---~~Rp~~~~ll~~ 348 (370)
....++..++|+.++|..+| .+|+|++|+++|
T Consensus 466 ~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 466 LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 44578899999999999766 689999999876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-31 Score=222.14 Aligned_cols=209 Identities=37% Similarity=0.695 Sum_probs=184.0
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
++.|.+|.+|++... +..+++|.+....... ....+.+|+..++.++|++|+++++++......++++|++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 578999999999887 8899999987653221 457789999999999999999999999998999999999999999
Q ss_pred HHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC-CCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE-AGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++... ..++...++.++.++++++.+||+.+ ++|+||+|.||+++. .+.++|+|||.+........ ....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLKT 152 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhhc
Confidence 9999876 57899999999999999999999998 999999999999999 89999999999876655431 1122
Q ss_pred CCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..+...|++||.+... .++.++|+|++|++++++ ..+.+++.+|++
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhh
Confidence 3467889999999887 788999999999999999 579999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~ 348 (370)
.+|++||++.+++++
T Consensus 200 ~~p~~R~~~~~l~~~ 214 (215)
T cd00180 200 KDPEKRPSAKEILEH 214 (215)
T ss_pred CCcccCcCHHHHhhC
Confidence 999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-34 Score=235.04 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=198.3
Q ss_pred eecccCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC-----CceE
Q 042314 93 LEDRGGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS-----ERLI 165 (370)
Q Consensus 93 L~~~~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~-----~~~~ 165 (370)
+.-...+|.|+||.||.+.+ .|+.+++|.+..-. .+-...+++.+|+.++..++|.|++..+++..-. ..+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 33445699999999999876 48899999886543 4445678899999999999999999999876543 2468
Q ss_pred EEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceecccc
Q 042314 166 FLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEK 245 (370)
Q Consensus 166 ~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 245 (370)
+++|++.. +|..++-..+.++...+..+..||++||.|||+.+ |+||||||.|++|.++..+||||||+++.....
T Consensus 134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 89999955 99999988889999999999999999999999999 999999999999999999999999999877654
Q ss_pred CccceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc--------------
Q 042314 246 DSYSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-------------- 310 (370)
Q Consensus 246 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-------------- 310 (370)
... .++...-|--|.|||.+.+. .|+.+.||||+||++.||+..+..|..-++.+..+.+...
T Consensus 210 ~~~--hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 210 DRL--NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhh--hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 332 34444567789999999886 5899999999999999999998888766655433332210
Q ss_pred ---------CCC-CCCCC--------CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 311 ---------DSR-PALSS--------LYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 311 ---------~~~-~~~~~--------~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
..+ |..+. .-..+...++..++..||+.|.+.++.+.++.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 011 11110 11134667888999999999999999887754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-33 Score=252.04 Aligned_cols=241 Identities=26% Similarity=0.433 Sum_probs=204.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|.||.||++++. +...++|+++-....+ ..-..+|+-+++.++||||+.+++.+...+.+|++||||.||+
T Consensus 22 rvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs 98 (829)
T KOG0576|consen 22 RVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS 98 (829)
T ss_pred eecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence 4789999999999875 7889999988754433 4556789999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+...-.+++++.++....++.++++.|||++| -+|||||-.||++++.|.+|+.|||.+..+...- ......
T Consensus 99 lQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati---~Krksf 172 (829)
T KOG0576|consen 99 LQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI---AKRKSF 172 (829)
T ss_pred ccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh---hhhhcc
Confidence 9999999999999999999999999999999999 8999999999999999999999999987665432 234556
Q ss_pred CCCccccCcccc---cccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC---CCCCCCCCcHHHHHHHH
Q 042314 256 TGSYRYMAPEVY---RRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS---RPALSSLYPEPIKALLR 329 (370)
Q Consensus 256 ~g~~~y~aPE~~---~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~ 329 (370)
+||+.|||||+- ..+.|...+|||++|++..|+---++|.....+..........+. ....+..+++.|.+|++
T Consensus 173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK 252 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVK 252 (829)
T ss_pred cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHH
Confidence 899999999986 356688999999999999999888888665555444333332232 23345568899999999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIF 347 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~ 347 (370)
.+|.++|++||+++.+|.
T Consensus 253 ~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 253 GALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHhcCCCccCCChhhhee
Confidence 999999999999998875
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=245.25 Aligned_cols=193 Identities=25% Similarity=0.396 Sum_probs=166.5
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHH-----HHHHHHHHHHHHhcC---CCceeeeeeeEeeCCceEE
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRV-----RNSFMKELGLWQKLR---HPNIVQFLGVLKHSERLIF 166 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~-----~~~~~~e~~~l~~l~---hp~Iv~~~~~~~~~~~~~~ 166 (370)
..+|.|+||.|+.|..+ ...|++|.+.+...-...+ .-....|+.+|..++ |+||++++++|++++.+|+
T Consensus 567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl 646 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL 646 (772)
T ss_pred eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence 45899999999999775 5678999886643222221 122568999999887 9999999999999999999
Q ss_pred EEeec-CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceecccc
Q 042314 167 LTEYL-RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEK 245 (370)
Q Consensus 167 v~e~~-~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 245 (370)
+||.. +|.+|++++..++++++.++..|++|++.|+++||+.| |||||||-+|+.++.+|-+||+|||.+.....+
T Consensus 647 ~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ksg 723 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG 723 (772)
T ss_pred EecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhcCC
Confidence 99986 45689999999999999999999999999999999999 999999999999999999999999999877665
Q ss_pred CccceeccCCCCCccccCcccccccCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 042314 246 DSYSYKMTGGTGSYRYMAPEVYRRESY-GKSVDVFSFALIVHEMFQGGPSNRA 297 (370)
Q Consensus 246 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~ 297 (370)
+. ...+||..|.|||++.+.+| ....|||++|+++|.+.....||.+
T Consensus 724 pf-----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 724 PF-----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred Cc-----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 43 23468999999999999988 4678999999999999999999864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=222.61 Aligned_cols=121 Identities=27% Similarity=0.429 Sum_probs=103.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-----C---CceeeeeeeEee----CCc
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-----H---PNIVQFLGVLKH----SER 163 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-----h---p~Iv~~~~~~~~----~~~ 163 (370)
.+|.|.|++||++.+. .+.||+|+.+.. ....+....|+.++++++ + .+||++++.|.. ..+
T Consensus 85 KLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~H 160 (590)
T KOG1290|consen 85 KLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQH 160 (590)
T ss_pred eccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcE
Confidence 4799999999999775 567999998764 356677889999999983 2 469999999876 457
Q ss_pred eEEEEeecCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee
Q 042314 164 LIFLTEYLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ 225 (370)
Q Consensus 164 ~~~v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~ 225 (370)
+|||+|++ |.+|..+|... +.++...+.+|++|++.||.|||+.- +|||-||||+|||+
T Consensus 161 VCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 161 VCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred EEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 99999999 66999988865 57899999999999999999999854 59999999999997
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=206.39 Aligned_cols=163 Identities=20% Similarity=0.265 Sum_probs=129.2
Q ss_pred CCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 174 GSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 174 ~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|+|.+++..+ ..+++.+++.++.|++.||.|||+.+ ||+||+++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999874 46999999999999999999999864 999999999999999 99987664422
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCC------CCCCCcH--HH
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPA------LSSLYPE--PI 324 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~--~l 324 (370)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.................... .+..++. .+
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSF 141 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhH
Confidence 1578999999999999999999999999999999999999976543221111111111111 1122333 69
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042314 325 KALLRECWHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 325 ~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
.+++.+||..+|++||++.++++++..+..+
T Consensus 142 ~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 142 ADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999877544
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=208.09 Aligned_cols=204 Identities=33% Similarity=0.608 Sum_probs=171.9
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.++.|+++.||++... +..+++|.+...... ...+.+.+|+..++.++|+|++++++++......++++|++.+++
T Consensus 6 ~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 6 KLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred EeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 3688999999999885 588999998764322 356788999999999999999999999998899999999999999
Q ss_pred HHHHHHhCCC-CChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKKGK-LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~~~-~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++..... ++...+..++.+++.++.+||+.+ ++|+||+|.||+++..+.++|+|||.+......... ....
T Consensus 84 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~--~~~~ 158 (225)
T smart00221 84 LFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA--LLKT 158 (225)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc--cccc
Confidence 9999988766 899999999999999999999998 999999999999999999999999998877554200 1122
Q ss_pred CCCCccccCcccc-cccCCCchhhHHHHHHHHHHHHhCCCCCCC-CcHH-HHHHHhh
Q 042314 255 GTGSYRYMAPEVY-RRESYGKSVDVFSFALIVHEMFQGGPSNRA-DTAV-QVADRRA 308 (370)
Q Consensus 255 ~~g~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~g~~p~~~-~~~~-~~~~~~~ 308 (370)
..++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .... ...+.+.
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 3467889999998 666778899999999999999999999977 3433 4444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=256.16 Aligned_cols=197 Identities=17% Similarity=0.195 Sum_probs=141.2
Q ss_pred hcCC-CceeeeeeeE-------eeCCceEEEEeecCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceee
Q 042314 145 KLRH-PNIVQFLGVL-------KHSERLIFLTEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215 (370)
Q Consensus 145 ~l~h-p~Iv~~~~~~-------~~~~~~~~v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH 215 (370)
.++| +||+.++++| .....++.++|++ +++|.+++... ..++..++..++.||++||.|||++| |+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 3445 5777777776 2334678889988 55999999753 46899999999999999999999998 999
Q ss_pred cCCCCCCeeeCCCC-------------------cEEEeccccceeccccCc-------------cceeccCCCCCccccC
Q 042314 216 RDLTPSNVLQDEAG-------------------HLKVTDFGLSKIAQEKDS-------------YSYKMTGGTGSYRYMA 263 (370)
Q Consensus 216 ~Dlk~~Nil~~~~~-------------------~~kl~Dfg~~~~~~~~~~-------------~~~~~~~~~g~~~y~a 263 (370)
|||||+|||++..| .+|++|||+++....... .........||+.|+|
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999996544 456666666553221000 0000112357889999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHH
Q 042314 264 PEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFE 343 (370)
Q Consensus 264 PE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~ 343 (370)
||++.+..++.++|||||||++|||++|.+|+....... .........+.... ..+....++.+||.++|.+||++.
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~L~~~P~~Rps~~ 260 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTM--SSLRHRVLPPQILL-NWPKEASFCLWLLHPEPSCRPSMS 260 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHH--HHHHHhhcChhhhh-cCHHHHHHHHHhCCCChhhCcChH
Confidence 999999999999999999999999999988876432211 11111111111111 234567899999999999999999
Q ss_pred HHHHH
Q 042314 344 EIIFR 348 (370)
Q Consensus 344 ~ll~~ 348 (370)
+++++
T Consensus 261 eil~h 265 (793)
T PLN00181 261 ELLQS 265 (793)
T ss_pred HHhhc
Confidence 99875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-29 Score=203.51 Aligned_cols=234 Identities=19% Similarity=0.327 Sum_probs=179.6
Q ss_pred ccCCCCCCcccEEEEEEcC--ceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeee-EeeCCceEEEEeec
Q 042314 96 RGGIDPGAYGEVYLVKWRG--TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGV-LKHSERLIFLTEYL 171 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~g--~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~-~~~~~~~~~v~e~~ 171 (370)
...+|+|-||.+-++..++ ..+++|.+.... ...+.|.+|...--.++ |.||+.-++. |+..+..++++||+
T Consensus 29 ~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a 104 (378)
T KOG1345|consen 29 NKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA 104 (378)
T ss_pred HHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence 3458999999999998874 568888886643 34577888887765664 8999988874 67788899999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC--CCcEEEeccccceeccccCccc
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE--AGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+-|+|.+-+... .+.+.....++.|+++|+.|||+++ +||||||.+||||-. ..++||||||.++..+......
T Consensus 105 P~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~ 180 (378)
T KOG1345|consen 105 PRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYL 180 (378)
T ss_pred ccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCceehhh
Confidence 999999988775 5677888999999999999999999 999999999999853 3489999999987665443211
Q ss_pred eeccCCCCCccccCccccccc-----CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH-------HHHHhhccCCCCCCC
Q 042314 250 YKMTGGTGSYRYMAPEVYRRE-----SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ-------VADRRAYEDSRPALS 317 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~ 317 (370)
--+..|.+||..... ...+.+|+|.||++++.++||.+||....... ...+.. ....|...
T Consensus 181 ------~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk-~~~~P~~F 253 (378)
T KOG1345|consen 181 ------EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK-NPALPKKF 253 (378)
T ss_pred ------hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc-CccCchhh
Confidence 125579999987432 24688999999999999999999997543211 111111 12334444
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHH
Q 042314 318 SLYPEPIKALLRECWHKNPDRRPTFEE 344 (370)
Q Consensus 318 ~~~~~~l~~li~~~l~~~p~~Rp~~~~ 344 (370)
..+++.+..+.++-|.++|++|--..+
T Consensus 254 ~~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred cccCHHHHHHHHHhcCCcccccchhHH
Confidence 567888999999999999999943333
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=212.88 Aligned_cols=243 Identities=22% Similarity=0.373 Sum_probs=184.8
Q ss_pred cccCCCCCCcccEEEEEEc-----CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEE
Q 042314 95 DRGGIDPGAYGEVYLVKWR-----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLT 168 (370)
Q Consensus 95 ~~~~l~~g~~~~v~~a~~~-----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~ 168 (370)
....+|.|.|++||++... .+.+++|.+.... ...++.+|++++..+ .+.||+++.+++...+...+|+
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl 114 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL 114 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence 3445899999999998553 5678999886543 235688999999999 4999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC-CCcEEEeccccceecccc--
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE-AGHLKVTDFGLSKIAQEK-- 245 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~-- 245 (370)
||++.....++... ++...+..+++.++.||.++|.+| ||||||||.||+++. .+.-.|+|||++......
T Consensus 115 p~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 115 PYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred cccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 99999888888764 568899999999999999999999 999999999999984 467899999998721100
Q ss_pred -----C------------------------ccce----------eccCCCCCccccCccccccc-CCCchhhHHHHHHHH
Q 042314 246 -----D------------------------SYSY----------KMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIV 285 (370)
Q Consensus 246 -----~------------------------~~~~----------~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l 285 (370)
. ...+ ......||++|.|||++... ..+.++||||.|+++
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 0 0000 01123499999999999765 457899999999999
Q ss_pred HHHHhCCCCCCCCcHHH--------------HHH------H----------------hhccCC--------------CCC
Q 042314 286 HEMFQGGPSNRADTAVQ--------------VAD------R----------------RAYEDS--------------RPA 315 (370)
Q Consensus 286 ~el~~g~~p~~~~~~~~--------------~~~------~----------------~~~~~~--------------~~~ 315 (370)
+.+++++.||....... +.. . ..+... ...
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 99999999985432111 000 0 000000 001
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 316 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
....+|..+.+|+.+|+..||.+|.|+++.|++
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 112355689999999999999999999999875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-26 Score=206.41 Aligned_cols=253 Identities=22% Similarity=0.304 Sum_probs=196.2
Q ss_pred cCCCCCCcccEEEEEEcCc---eeEEEEeccccCCChHHHHHHHHHHHHHHhcC----CCceeeeeeeE-eeCCceEEEE
Q 042314 97 GGIDPGAYGEVYLVKWRGT---EIAAKTIRSSIASNPRVRNSFMKELGLWQKLR----HPNIVQFLGVL-KHSERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g~---~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~----hp~Iv~~~~~~-~~~~~~~~v~ 168 (370)
..+|+|+||.||.+..... .+|+|+......... ..+..|..++..+. .+++..+++.+ ......++||
T Consensus 24 ~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM 100 (322)
T KOG1164|consen 24 KKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVM 100 (322)
T ss_pred eeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEE
Confidence 4489999999999987653 578887665422221 15667888887775 36899999998 4777889999
Q ss_pred eecCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC-----CcEEEeccccce-
Q 042314 169 EYLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA-----GHLKVTDFGLSK- 240 (370)
Q Consensus 169 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~-----~~~kl~Dfg~~~- 240 (370)
+.+ |.+|.++.... +.++..++..++.|++.+|.+||+.| ++||||||.|+++... ..+.|.|||+++
T Consensus 101 ~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 101 SLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred ecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 998 77999988654 58999999999999999999999999 9999999999999865 358999999998
Q ss_pred -eccccCc----ccee-ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc---C
Q 042314 241 -IAQEKDS----YSYK-MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE---D 311 (370)
Q Consensus 241 -~~~~~~~----~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~ 311 (370)
....... .... .....||.+|++++.+.+...+++.|+||+++++.+++.|..||..........+.... .
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~ 256 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL 256 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence 3222211 1111 22345999999999999999999999999999999999999999766532222221111 1
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 312 SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 312 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
.........|..+.++...+-..+...+|.+..+...++.....-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 257 LTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 111134456788999999999999999999999999988887764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=192.54 Aligned_cols=251 Identities=18% Similarity=0.267 Sum_probs=209.2
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.||+|+||.++.+.. ++.+||+|.-.... ...++..|.+..+.|. .++|+..+-+.....+-.+|+|++ |.
T Consensus 35 KIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP 108 (449)
T KOG1165|consen 35 KIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP 108 (449)
T ss_pred ccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence 499999999999854 69999999865432 1345678899998885 799999999988888899999999 88
Q ss_pred CHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC-----cEEEeccccceeccccCcc
Q 042314 175 SLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG-----HLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 175 ~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~-----~~kl~Dfg~~~~~~~~~~~ 248 (370)
||++++.-++ +|+.+++..++.|++.-++++|++. +|.|||||+|+||...+ .+.++|||+++.+.++...
T Consensus 109 SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk 185 (449)
T KOG1165|consen 109 SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK 185 (449)
T ss_pred CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence 9999998764 7999999999999999999999998 99999999999998554 4899999999988765432
Q ss_pred c----eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhhccCCC---CCCCC
Q 042314 249 S----YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA---VQVADRRAYEDSR---PALSS 318 (370)
Q Consensus 249 ~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~---~~~~~ 318 (370)
. .......||.+||+-..+.+...+.+.|+-|||=++.+.+.|..||.+... .+..+++...... ..+..
T Consensus 186 qHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~ 265 (449)
T KOG1165|consen 186 QHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCE 265 (449)
T ss_pred ccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHh
Confidence 2 123345699999999999999999999999999999999999999987644 4444444432222 23567
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 319 LYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 319 ~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
++|.+|...++..-..+-.+-|+++-+...+.++.+...
T Consensus 266 g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 266 GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 799999999999999999999999999999988877665
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-25 Score=180.80 Aligned_cols=250 Identities=19% Similarity=0.285 Sum_probs=203.2
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.+|.+.. .|..||+|+-+.... ...+..|..+.+.++ ...|+.+..++.+..+-.+||+++ |.|
T Consensus 23 iGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPs 96 (341)
T KOG1163|consen 23 IGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPS 96 (341)
T ss_pred ecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Ccc
Confidence 89999999999865 589999999766532 234567888888886 477888888888888999999999 889
Q ss_pred HHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC---CCcEEEeccccceeccccCc---c
Q 042314 176 LHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE---AGHLKVTDFGLSKIAQEKDS---Y 248 (370)
Q Consensus 176 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~~~~~~---~ 248 (370)
|+++++-. .+++..+++-++-|++.-++|+|.++ +|||||||+|+|..- ...+.++|||+|+...+... .
T Consensus 97 LEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HI 173 (341)
T KOG1163|consen 97 LEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHI 173 (341)
T ss_pred HHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccC
Confidence 99998744 57999999999999999999999998 999999999999763 45799999999987754322 1
Q ss_pred ce-eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHH---HHhhcc---CCCCCCCCCCc
Q 042314 249 SY-KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVA---DRRAYE---DSRPALSSLYP 321 (370)
Q Consensus 249 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~---~~~~~~---~~~~~~~~~~~ 321 (370)
++ ......||.+|.+-..+.+...+.+.|+-|+|+++.++-.|..||.+....... .++... .....+...+|
T Consensus 174 pyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P 253 (341)
T KOG1163|consen 174 PYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFP 253 (341)
T ss_pred ccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCc
Confidence 11 223456999999999998888899999999999999999999999987654332 233322 22234678899
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
.+|.-.+..|-..--++-|++.-+-+.+..+...+.
T Consensus 254 ~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 254 AEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 999999999999999999999999888887766554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-23 Score=188.43 Aligned_cols=246 Identities=30% Similarity=0.489 Sum_probs=199.7
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCC-ceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHP-NIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp-~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
+|.|+|+.||.+... ..+++|.+.............+.+|..+++.+.|+ +++++.+.+......+++++++.++++.
T Consensus 8 l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~ 86 (384)
T COG0515 8 LGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLE 86 (384)
T ss_pred ecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHH
Confidence 568999999999888 88899998877655545678899999999999988 7999999997777789999999999999
Q ss_pred HHHHhCC---CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC-cEEEeccccceeccccCccce---
Q 042314 178 DILKKKG---KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG-HLKVTDFGLSKIAQEKDSYSY--- 250 (370)
Q Consensus 178 ~~l~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~--- 250 (370)
+++.... .++......++.|++.++.++|+.+ ++|||+||+||+++..+ .++++|||.+...........
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (384)
T COG0515 87 DLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPA 163 (384)
T ss_pred HHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccc
Confidence 8887765 7899999999999999999999999 99999999999999988 799999999986654432211
Q ss_pred eccCCCCCccccCcccccc---cCCCchhhHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHhhccCCC---CCCCCCC
Q 042314 251 KMTGGTGSYRYMAPEVYRR---ESYGKSVDVFSFALIVHEMFQGGPSNRADTA----VQVADRRAYEDSR---PALSSLY 320 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~---~~~~~~~ 320 (370)
......++..|++||.+.+ ..++...|+||+|++++++++|..||..... ............. .......
T Consensus 164 ~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (384)
T COG0515 164 LPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSN 243 (384)
T ss_pred cccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccc
Confidence 2345578999999999987 5778999999999999999999999876653 2333322222211 1122222
Q ss_pred ----cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 321 ----PEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 321 ----~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
...+.+++.+++..+|..|.+..+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 244 PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 2578999999999999999998887765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-25 Score=214.34 Aligned_cols=247 Identities=28% Similarity=0.433 Sum_probs=189.0
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEecc---ccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRS---SIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~---~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.++.|++|.++.+... ......|..+. ...........+..|+-+-..++|||++..+..+.+.....-.||||+
T Consensus 325 ~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~ 404 (601)
T KOG0590|consen 325 VLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCP 404 (601)
T ss_pred eeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhccc
Confidence 3778888877766543 33333333321 111222333337778888888999999988887776655555599999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc-ccee
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS-YSYK 251 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 251 (370)
+ +|+.++...+.+...++-.++.|++.|+.|+|+.| |.|||+|++|++++..|.+||+|||.+........ ....
T Consensus 405 ~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~ 480 (601)
T KOG0590|consen 405 Y-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHE 480 (601)
T ss_pred H-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhh
Confidence 9 99999999888999999999999999999999999 99999999999999999999999999876554322 2234
Q ss_pred ccCCCCCccccCcccccccCCCc-hhhHHHHHHHHHHHHhCCCCCCCCcHHHHH-HHhhc------cCCCCCCCCCCcHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGK-SVDVFSFALIVHEMFQGGPSNRADTAVQVA-DRRAY------EDSRPALSSLYPEP 323 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~g~~p~~~~~~~~~~-~~~~~------~~~~~~~~~~~~~~ 323 (370)
..+.+|+..|+|||.+.+..|++ ..||||.|++++.|.+|+.||......+.. ..... ......+...+|..
T Consensus 481 ~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~ 560 (601)
T KOG0590|consen 481 SSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRE 560 (601)
T ss_pred hcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhh
Confidence 56678999999999999999985 689999999999999999999765443321 11111 11112234457888
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 324 IKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 324 l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
-+.+|.++|+.+|.+|.|++++++.
T Consensus 561 ~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 561 TRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred HHHHHHHHccCChhheecHHHHhhC
Confidence 9999999999999999999999764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=190.82 Aligned_cols=160 Identities=21% Similarity=0.266 Sum_probs=122.1
Q ss_pred cCCCCCCcccEEEEEEc---CceeEEEEeccccC--CChHHHHHHHHHHHHHHhcCCCceee-eeeeEeeCCceEEEEee
Q 042314 97 GGIDPGAYGEVYLVKWR---GTEIAAKTIRSSIA--SNPRVRNSFMKELGLWQKLRHPNIVQ-FLGVLKHSERLIFLTEY 170 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~---g~~vavK~l~~~~~--~~~~~~~~~~~e~~~l~~l~hp~Iv~-~~~~~~~~~~~~~v~e~ 170 (370)
..+|.|+||.||++... +..+++|.+..... ........+.+|++++++++|+|+++ +++. +..++||||
T Consensus 24 ~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~ 99 (365)
T PRK09188 24 AVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGW 99 (365)
T ss_pred cEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEc
Confidence 44799999999999763 56678988653311 23345677999999999999999985 4432 457999999
Q ss_pred cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCC-CCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 171 LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL-TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 171 ~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dl-k~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
++|++|... .. .. ...++.+++++|.|||++| |+|||| ||+|||++.++.+||+|||+++.........
T Consensus 100 ~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~ 169 (365)
T PRK09188 100 TEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALY 169 (365)
T ss_pred cCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchh
Confidence 999999732 11 11 2467889999999999998 999999 9999999999999999999998776543111
Q ss_pred e-----eccCCCCCccccCccccccc
Q 042314 250 Y-----KMTGGTGSYRYMAPEVYRRE 270 (370)
Q Consensus 250 ~-----~~~~~~g~~~y~aPE~~~~~ 270 (370)
. ......+++.|+|||.+...
T Consensus 170 ~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 170 RIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred hhhhhhhhhhhhccCccCCcccCChh
Confidence 1 11234578889999998654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.1e-25 Score=210.85 Aligned_cols=246 Identities=18% Similarity=0.277 Sum_probs=181.3
Q ss_pred cCCCCCCcccEEEEEEcCceeEEEEeccccC-CChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 97 GGIDPGAYGEVYLVKWRGTEIAAKTIRSSIA-SNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g~~vavK~l~~~~~-~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
..+|.+.|-.+.+++.+...+++|++.+... -.-....+-..|++ ...+++||++++.-+-......|+|-+|+.. +
T Consensus 29 ~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-n 106 (1431)
T KOG1240|consen 29 ENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-N 106 (1431)
T ss_pred cccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-h
Confidence 3488899999999988877799999866532 11122222333444 5566899999998887777778899999977 9
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceec--c--ccCcccee
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIA--Q--EKDSYSYK 251 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~--~--~~~~~~~~ 251 (370)
|++.+.-++-+..-+...|+.|++.|+.-+|..| |+|||||.+||||+.-+.+.|+||..-+.. . .+..+.+-
T Consensus 107 LyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fF 183 (1431)
T KOG1240|consen 107 LYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFF 183 (1431)
T ss_pred hhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEE
Confidence 9999999888888999999999999999999999 999999999999999999999999865432 2 22233333
Q ss_pred ccCCCCCccccCcccccccC-----------CCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCC
Q 042314 252 MTGGTGSYRYMAPEVYRRES-----------YGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSL 319 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~-----------~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (370)
..+...-..|.|||.+.... .+++-||||+||++.||++ |+++|.-..-....... ......-+..-
T Consensus 184 FDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~-~~~~e~~Le~I 262 (1431)
T KOG1240|consen 184 FDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGN-ADDPEQLLEKI 262 (1431)
T ss_pred EecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccC-ccCHHHHHHhC
Confidence 44444556899999986521 5678999999999999987 57777532211111000 00000001111
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 320 YPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 320 ~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
....++.||..|++.||++|.+++++|+.
T Consensus 263 ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 263 EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 23469999999999999999999999887
|
|
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-25 Score=169.80 Aligned_cols=91 Identities=35% Similarity=0.453 Sum_probs=52.3
Q ss_pred CCChhhhHHhhcCCHHHHHHHH-HcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHc-CCCccCccccCCCcccccccc
Q 042314 7 EGPYRLLYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK-GADVNSLDRWGRTPLSDARSF 84 (370)
Q Consensus 7 ~g~t~l~~a~~~g~~~~~~~ll-~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~-gad~~~~~~~g~tpl~~A~~~ 84 (370)
+|+|||||||+.|+.++|.+|+ +.+..+|.+|..||||||+||..|+.|+|+.|+.. |+|+|..++.|.|+||+|+..
T Consensus 37 D~Rt~LHwa~S~g~~eiv~fLlsq~nv~~ddkDdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK 116 (226)
T KOG4412|consen 37 DGRTPLHWACSFGHVEIVYFLLSQPNVKPDDKDDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGK 116 (226)
T ss_pred cCCceeeeeeecCchhHHHHHHhcCCCCCCCccccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcC
Confidence 5555555555555555555555 33455555555555555555555555555555555 555555555555555555555
Q ss_pred CceeeEEeeeccc
Q 042314 85 GHVVICKILEDRG 97 (370)
Q Consensus 85 g~~~~~~~L~~~~ 97 (370)
|..+++++|.+.+
T Consensus 117 ~r~eIaqlLle~g 129 (226)
T KOG4412|consen 117 GRLEIAQLLLEKG 129 (226)
T ss_pred ChhhHHHHHHhcC
Confidence 5555555555444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-24 Score=197.62 Aligned_cols=225 Identities=26% Similarity=0.416 Sum_probs=187.2
Q ss_pred CCCCCcccEEEEEE-----cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKW-----RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~-----~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
+|+|.||.|++++. .|+-+++|++++......... ....|-.++...+ ||.++++.-.++.+...++++++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 57899999987643 366688888766433222222 5667778888886 9999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
||.|...+.+...+.+.....+..+++-+++++|+.+ ++|||+|++||+++.+|.+++.|||+++..-....
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----- 152 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh-----
Confidence 9999999999888999999999999999999999998 99999999999999999999999999876654322
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
.+||..|||||++. ....++|.||+|++++||++|..||... ....+. ......|..++...++++..++
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----~~~~Il--~~~~~~p~~l~~~a~~~~~~l~ 222 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----TMKRIL--KAELEMPRELSAEARSLFRQLF 222 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----HHHHHh--hhccCCchhhhHHHHHHHHHHH
Confidence 17899999999998 4578899999999999999999999982 222221 3345667778889999999999
Q ss_pred ccCCCCCCCH
Q 042314 333 HKNPDRRPTF 342 (370)
Q Consensus 333 ~~~p~~Rp~~ 342 (370)
..+|.+|.-.
T Consensus 223 ~r~p~nrLg~ 232 (612)
T KOG0603|consen 223 KRNPENRLGA 232 (612)
T ss_pred hhCHHHHhcc
Confidence 9999999654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=169.91 Aligned_cols=164 Identities=14% Similarity=0.218 Sum_probs=129.1
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHH------HHHHHHHHHhcCCCceeeeeeeEeeC--------Cce
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNS------FMKELGLWQKLRHPNIVQFLGVLKHS--------ERL 164 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~------~~~e~~~l~~l~hp~Iv~~~~~~~~~--------~~~ 164 (370)
++.|+||.||++...+..+++|++.......+..... +.+|+..+.++.||+|..+.+++... ...
T Consensus 39 l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~ 118 (232)
T PRK10359 39 FRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTY 118 (232)
T ss_pred ecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCe
Confidence 5679999999988788899999998776555555444 57999999999999999998886543 357
Q ss_pred EEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccc
Q 042314 165 IFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQE 244 (370)
Q Consensus 165 ~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 244 (370)
+++|||++|.+|.++.. +++ ....++..++..+|+.| ++|||++|.||+++++| ++|+|||.+.....
T Consensus 119 ~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e 186 (232)
T PRK10359 119 IMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQ 186 (232)
T ss_pred EEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccc
Confidence 89999999999988732 232 34569999999999999 99999999999999988 99999998754432
Q ss_pred cCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHH
Q 042314 245 KDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMF 289 (370)
Q Consensus 245 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 289 (370)
.... ...+....+..++|+||||+++..+.
T Consensus 187 ~~a~---------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 187 RKAK---------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hhhH---------------HHHHHHhHhcccccccceeEeehHHH
Confidence 2111 01334455678999999999887654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=175.25 Aligned_cols=231 Identities=19% Similarity=0.274 Sum_probs=148.5
Q ss_pred eecccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC----------CCceeeeeeeEe-
Q 042314 93 LEDRGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR----------HPNIVQFLGVLK- 159 (370)
Q Consensus 93 L~~~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~----------hp~Iv~~~~~~~- 159 (370)
|.....++.|+++.||.+.+. +.+.++|+............+.+.+|......+. |-.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 344455899999999999886 5899999987655333445566666665444432 223333333322
Q ss_pred --------eC---C-----ceEEEEeecCCCCHHHHHH---hCCC----CChHhHHHHHHHHHHHHHHHhhcCCCceeec
Q 042314 160 --------HS---E-----RLIFLTEYLRNGSLHDILK---KKGK----LDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216 (370)
Q Consensus 160 --------~~---~-----~~~~v~e~~~g~~L~~~l~---~~~~----~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~ 216 (370)
.. . ..+++|+-+.+ +|.+++. .... +.......+..|+++.+++||+.| ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 11 1 23667777755 8888765 2222 222334556689999999999999 9999
Q ss_pred CCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCCCCccccCccccccc--------CCCchhhHHHHHHHHHHH
Q 042314 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE--------SYGKSVDVFSFALIVHEM 288 (370)
Q Consensus 217 Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--------~~~~~~Di~slG~~l~el 288 (370)
||+|+|++++.+|.++|+||+.....+..... ...+..|.|||..... .++.+.|.|+||+++|.|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999887666543221 1245789999977442 478899999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCCCCC
Q 042314 289 FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRR 339 (370)
Q Consensus 289 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 339 (370)
++++.||........... ....+..+|+.++.||+.+|+.||.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999999986654332221 112233788999999999999999987
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=171.68 Aligned_cols=199 Identities=22% Similarity=0.323 Sum_probs=150.8
Q ss_pred CCCceeeeeeeEee---------------------------CCceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHH
Q 042314 147 RHPNIVQFLGVLKH---------------------------SERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIA 199 (370)
Q Consensus 147 ~hp~Iv~~~~~~~~---------------------------~~~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~ 199 (370)
+|||||+++.+|.+ ...+|+||...+. +|..++-.+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 59999999877633 2247899999977 999999876 456777888999999
Q ss_pred HHHHHHhhcCCCceeecCCCCCCeeeC--CCC--cEEEeccccceecccc---CccceeccCCCCCccccCcccccccC-
Q 042314 200 RGMNYLHHHRPHAIIHRDLTPSNVLQD--EAG--HLKVTDFGLSKIAQEK---DSYSYKMTGGTGSYRYMAPEVYRRES- 271 (370)
Q Consensus 200 ~~l~~lH~~~~~~iiH~Dlk~~Nil~~--~~~--~~kl~Dfg~~~~~~~~---~~~~~~~~~~~g~~~y~aPE~~~~~~- 271 (370)
+|+.|||.+| |.|||+|++|||+. +++ .+.++|||++---... -.+.......-|+-.-||||+....+
T Consensus 352 Eav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 9999999999 99999999999974 443 5799999976322221 11111222234788899999986432
Q ss_pred ----C-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 042314 272 ----Y-GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346 (370)
Q Consensus 272 ----~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll 346 (370)
. -.++|.|+.|.+.||++....||.......+....-.+...|.++..+|+.+++++...|+.||++|+++.-..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 1 25899999999999999999999874443332222224556788999999999999999999999999876655
Q ss_pred HHHH
Q 042314 347 FRLE 350 (370)
Q Consensus 347 ~~l~ 350 (370)
..|+
T Consensus 509 Nvl~ 512 (598)
T KOG4158|consen 509 NVLN 512 (598)
T ss_pred hHHH
Confidence 5443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=160.64 Aligned_cols=187 Identities=16% Similarity=0.132 Sum_probs=139.4
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCC-hHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASN-PRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~-~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
++.|+||+|+.+...+.+++.+.+....... .-....+.+|+++++++. ++++++++++ +..+++|||+.|.+|
T Consensus 10 l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L 85 (218)
T PRK12274 10 LKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAM 85 (218)
T ss_pred ecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccH
Confidence 6789999999888888888877765432211 122336889999999995 5889999886 446899999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCC-CCCCeeeCCCCcEEEeccccceeccccCccc---ee-
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL-TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS---YK- 251 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dl-k~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---~~- 251 (370)
.+..... ...++.|++.++.++|++| |+|||| ||+|||++.+|.++|+|||++.......... ..
T Consensus 86 ~~~~~~~-------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~r 155 (218)
T PRK12274 86 YQRPPRG-------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLARE 155 (218)
T ss_pred Hhhhhhh-------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHH
Confidence 7654321 2357789999999999999 999999 7999999999999999999998554432110 00
Q ss_pred ------ccCCCCCccccCccccccc-CCC-chhhHHHHHHHHHHHHhCCCCCCCCc
Q 042314 252 ------MTGGTGSYRYMAPEVYRRE-SYG-KSVDVFSFALIVHEMFQGGPSNRADT 299 (370)
Q Consensus 252 ------~~~~~g~~~y~aPE~~~~~-~~~-~~~Di~slG~~l~el~~g~~p~~~~~ 299 (370)
......++.|++|+...-- ..+ .+.+.++.|+-+|.++|++.++..+.
T Consensus 156 Dl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 156 DLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0011257778888765322 233 67889999999999999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-22 Score=165.13 Aligned_cols=141 Identities=25% Similarity=0.289 Sum_probs=108.9
Q ss_pred cCCCCCCcccEEEEEE-cCceeEEEEeccccCCChH-----------------------HHHHHHHHHHHHHhcCCCcee
Q 042314 97 GGIDPGAYGEVYLVKW-RGTEIAAKTIRSSIASNPR-----------------------VRNSFMKELGLWQKLRHPNIV 152 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~-~g~~vavK~l~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~hp~Iv 152 (370)
+.+|.|++|.||+|.. .|..+|+|+++........ .......|+..+..+.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 4589999999999986 4899999999764321111 112335699999999877764
Q ss_pred eeeeeEeeCCceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHH-hhcCCCceeecCCCCCCeeeCCCCcE
Q 042314 153 QFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYL-HHHRPHAIIHRDLTPSNVLQDEAGHL 231 (370)
Q Consensus 153 ~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~l-H~~~~~~iiH~Dlk~~Nil~~~~~~~ 231 (370)
....... ...++||||++|+++.......+.++...+..++.|++.+|.++ |+.| |+||||||+||++++ +.+
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~-~~v 156 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD-GKL 156 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC-CcE
Confidence 3333222 22389999999988766544456889999999999999999999 6888 999999999999984 789
Q ss_pred EEeccccceecc
Q 042314 232 KVTDFGLSKIAQ 243 (370)
Q Consensus 232 kl~Dfg~~~~~~ 243 (370)
+|+|||+|....
T Consensus 157 ~LiDFG~a~~~~ 168 (190)
T cd05147 157 YIIDVSQSVEHD 168 (190)
T ss_pred EEEEccccccCC
Confidence 999999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-23 Score=161.08 Aligned_cols=114 Identities=31% Similarity=0.395 Sum_probs=101.2
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHc-CCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEK-GVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~-ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
.+|+.||||||+||+.|+.++|+.|+.+ |+|+|..+..|+|+||+|+..|..||+++|+++|+.++.+|..|.||+|.|
T Consensus 67 dkDdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtplHRA 146 (226)
T KOG4412|consen 67 DKDDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTPLHRA 146 (226)
T ss_pred CccccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCchhHHH
Confidence 4688999999999999999999999998 999999999999999999999999999999999999999999999999999
Q ss_pred cccCceeeEEeeecccC----CCCCCcccEEEEEEcCce
Q 042314 82 RSFGHVVICKILEDRGG----IDPGAYGEVYLVKWRGTE 116 (370)
Q Consensus 82 ~~~g~~~~~~~L~~~~~----l~~g~~~~v~~a~~~g~~ 116 (370)
+.-|..+++++|...+. .+.-+|..++.+...|++
T Consensus 147 AavGklkvie~Li~~~a~~n~qDk~G~TpL~~al~e~~~ 185 (226)
T KOG4412|consen 147 AAVGKLKVIEYLISQGAPLNTQDKYGFTPLHHALAEGHP 185 (226)
T ss_pred HhccchhhHHHHHhcCCCCCcccccCccHHHHHHhccCc
Confidence 99999999999977654 344455555555444444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.9e-21 Score=158.09 Aligned_cols=142 Identities=20% Similarity=0.218 Sum_probs=110.4
Q ss_pred cCCCCCCcccEEEEEEc-CceeEEEEeccccCCC-----------------------hHHHHHHHHHHHHHHhcCCCcee
Q 042314 97 GGIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASN-----------------------PRVRNSFMKELGLWQKLRHPNIV 152 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~-----------------------~~~~~~~~~e~~~l~~l~hp~Iv 152 (370)
+.+|.|++|.||++... |..+|+|+++...... ......+..|...+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 34889999999999875 9999999987652110 01123456889999999988875
Q ss_pred eeeeeEeeCCceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhh-cCCCceeecCCCCCCeeeCCCCcE
Q 042314 153 QFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHH-HRPHAIIHRDLTPSNVLQDEAGHL 231 (370)
Q Consensus 153 ~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~iiH~Dlk~~Nil~~~~~~~ 231 (370)
....+... ..++||||++|+++........+++...+..++.|++.++.++|+ .| |+||||||+||+++ ++.+
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCE
Confidence 44433322 248999999988654433334578888999999999999999999 88 99999999999999 7899
Q ss_pred EEeccccceeccc
Q 042314 232 KVTDFGLSKIAQE 244 (370)
Q Consensus 232 kl~Dfg~~~~~~~ 244 (370)
+|+|||++.....
T Consensus 157 ~liDFG~a~~~~~ 169 (190)
T cd05145 157 YIIDVSQAVELDH 169 (190)
T ss_pred EEEEcccceecCC
Confidence 9999999876653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-20 Score=170.75 Aligned_cols=210 Identities=29% Similarity=0.450 Sum_probs=162.9
Q ss_pred HHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCC
Q 042314 143 WQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPS 221 (370)
Q Consensus 143 l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~ 221 (370)
++.+.|.|+.++++.+.+....++|.+||.-|+|.+.+.. ...++......++++++.||.|+|..- --.|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeeccc
Confidence 3567899999999999999999999999999999999987 457788888999999999999999865 1289999999
Q ss_pred CeeeCCCCcEEEeccccceeccccCccceeccCCCCCccccCcccccccC-------CCchhhHHHHHHHHHHHHhCCCC
Q 042314 222 NVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES-------YGKSVDVFSFALIVHEMFQGGPS 294 (370)
Q Consensus 222 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~el~~g~~p 294 (370)
|.+++....+||+|||+........... .........-|.|||.+.... .+.+.|+||+|++++|+++...|
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~-~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPE-AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred cceeeeeEEEEechhhhccccccccccc-ccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999987664311100 001112345799999987642 35679999999999999999999
Q ss_pred CCCC----cHHHHHHHhhc---cCCCCCCCC--CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042314 295 NRAD----TAVQVADRRAY---EDSRPALSS--LYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 295 ~~~~----~~~~~~~~~~~---~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
|... ...+....+.. ...+|.... ..++.+..++..||..+|..||+++.+-..++.+...
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9753 22233333222 123333321 4566799999999999999999999998888877654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-18 Score=147.37 Aligned_cols=136 Identities=26% Similarity=0.408 Sum_probs=114.4
Q ss_pred CCCCCCcccEEEEEEcCceeEEEEeccccCCChH-----HHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPR-----VRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~-----~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+++|++|.||++.+.|..+++|.........+. ....+.+|+.++..+.|++++....++...+..+++|||++
T Consensus 3 ~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 82 (211)
T PRK14879 3 LIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIE 82 (211)
T ss_pred ccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeC
Confidence 3789999999999999999999987654322222 23467889999999999988777766667778899999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecccccee
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI 241 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~ 241 (370)
|++|.+++..... ....++.+++.+|.++|+.+ ++|+|++|.||+++ .+.++|+|||++..
T Consensus 83 G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 83 GEPLKDLINSNGM----EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999876432 78899999999999999998 99999999999999 78899999998753
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=149.77 Aligned_cols=136 Identities=16% Similarity=0.230 Sum_probs=103.7
Q ss_pred eecccCCCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhc-----CCCceeeeeeeEeeCC---c-
Q 042314 93 LEDRGGIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-----RHPNIVQFLGVLKHSE---R- 163 (370)
Q Consensus 93 L~~~~~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~Iv~~~~~~~~~~---~- 163 (370)
|.....+|+|+++.||. .......++|+..... ....+.+.+|+.+++.+ .||||+++++++.++. .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQRCIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCeEEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34445699999999996 2222334678775532 22346789999999999 5799999999998863 3
Q ss_pred eEEEEee--cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHH-HHHhhcCCCceeecCCCCCCeeeCCC----CcEEEecc
Q 042314 164 LIFLTEY--LRNGSLHDILKKKGKLDPPTAVAYALDIARGM-NYLHHHRPHAIIHRDLTPSNVLQDEA----GHLKVTDF 236 (370)
Q Consensus 164 ~~~v~e~--~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l-~~lH~~~~~~iiH~Dlk~~Nil~~~~----~~~kl~Df 236 (370)
+.+|+|| +.+++|.+++++. .+++. ..++.+++.++ .|||+++ |+||||||+||+++.. +.++|+||
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 3478999 4479999999774 56655 35678888777 9999998 9999999999999743 37999995
Q ss_pred cc
Q 042314 237 GL 238 (370)
Q Consensus 237 g~ 238 (370)
+.
T Consensus 154 ~G 155 (210)
T PRK10345 154 IG 155 (210)
T ss_pred CC
Confidence 43
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.9e-19 Score=172.42 Aligned_cols=235 Identities=21% Similarity=0.301 Sum_probs=171.6
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC---CCceeeeeeeEeeCCceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR---HPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~---hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
-+|.|+||.||.|... |+.+|+|+-+......--.. .+++.+|+ -+.|..+...+...+.-++|+||.+.
T Consensus 705 e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~------~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~ 778 (974)
T KOG1166|consen 705 EIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYIC------LQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPY 778 (974)
T ss_pred eeccccceEEEEeecCCCcEEEEEeecCCCceeeeeh------HHHHHhhchhhhcchHHHHHHHccCCcceeeeecccc
Confidence 3899999999998654 88899999766543321111 22333343 23455555555556777899999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC-------CCcEEEeccccceeccccC
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE-------AGHLKVTDFGLSKIAQEKD 246 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~-------~~~~kl~Dfg~~~~~~~~~ 246 (370)
|+|.++++..+.+++..+..+..|++..+++||..+ |||+||||+|+|+.. .--++|+|||.+..+..-.
T Consensus 779 Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp 855 (974)
T KOG1166|consen 779 GTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFP 855 (974)
T ss_pred ccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcC
Confidence 999999998889999999999999999999999999 999999999999853 2258999999998776443
Q ss_pred ccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCc-----
Q 042314 247 SYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYP----- 321 (370)
Q Consensus 247 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 321 (370)
.. ....+.++|-.+-.+|+..+.++++..|.|.++-+++-|+.|+.- + ...+........++
T Consensus 856 ~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-------q-----~~~g~~~~~~~~~~Ry~~~ 922 (974)
T KOG1166|consen 856 DG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-------E-----VKNGSSWMVKTNFPRYWKR 922 (974)
T ss_pred CC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-------H-----hcCCcceeccccchhhhhH
Confidence 32 234455788899999999999999999999999999999999532 1 10111111111122
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFRLEAIQE 354 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~ 354 (370)
+....|+..+|..|-..=|...+|...++....
T Consensus 923 ~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 923 DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 235578888888554444777777777766533
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.3e-20 Score=142.20 Aligned_cols=86 Identities=26% Similarity=0.175 Sum_probs=80.5
Q ss_pred ccCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 2 ~~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
+.+|++|.||||.||++||.+||+.|+..|||++++-..|+||||-||...+.+|+-+||++|||||+..+..+||||.|
T Consensus 91 NtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va~~LLqhgaDVnA~t~g~ltpLhla 170 (228)
T KOG0512|consen 91 NTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVAGRLLQHGADVNAQTKGLLTPLHLA 170 (228)
T ss_pred cccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHHHHHHhccCcccccccccchhhHHh
Confidence 45789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCce
Q 042314 82 RSFGHV 87 (370)
Q Consensus 82 ~~~g~~ 87 (370)
+...+.
T Consensus 171 a~~rn~ 176 (228)
T KOG0512|consen 171 AGNRNS 176 (228)
T ss_pred hcccch
Confidence 887654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6e-20 Score=176.96 Aligned_cols=199 Identities=32% Similarity=0.523 Sum_probs=146.8
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+..|+||.||.++.+ -.++++|+=+... ..+ + ++..-..|.+| |+-
T Consensus 91 isngAygavylvrh~~trqrfa~kiNkq~l-----ilR---n---ilt~a~npfvv---------------------gDc 138 (1205)
T KOG0606|consen 91 ISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILR---N---ILTFAGNPFVV---------------------GDC 138 (1205)
T ss_pred eccCCCCceeeeeccccccchhhcccccch-----hhh---c---cccccCCccee---------------------chh
Confidence 566999999999776 5667764322211 100 0 22222333333 455
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceecccc-----------
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEK----------- 245 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~----------- 245 (370)
...++.-+.++.. ++.+++|+|+.+ |+|||+||+|.+|+.-|.+|+.|||+++..--.
T Consensus 139 ~tllk~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~ 207 (1205)
T KOG0606|consen 139 ATLLKNIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIE 207 (1205)
T ss_pred hhhcccCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchH
Confidence 5566665555543 278899999998 999999999999999999999999988643211
Q ss_pred -CccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC-CCCCCCCCCcHH
Q 042314 246 -DSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED-SRPALSSLYPEP 323 (370)
Q Consensus 246 -~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 323 (370)
....+.....+|||.|.|||++....|...+|.|++|+++||.+-|..||.++++.++........ ..++-...++++
T Consensus 208 k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~E 287 (1205)
T KOG0606|consen 208 KDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPE 287 (1205)
T ss_pred HHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHH
Confidence 111122334579999999999999999999999999999999999999999999988877655332 333444557889
Q ss_pred HHHHHHHhcccCCCCCC
Q 042314 324 IKALLRECWHKNPDRRP 340 (370)
Q Consensus 324 l~~li~~~l~~~p~~Rp 340 (370)
.++++.++|+.+|..|.
T Consensus 288 a~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 288 AQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred HHHHHHHHHHhChHhhc
Confidence 99999999999999995
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.6e-19 Score=147.03 Aligned_cols=133 Identities=25% Similarity=0.352 Sum_probs=108.5
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCCh-----HHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNP-----RVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~-----~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|+|++|.||++.+.+..+++|.........+ ....++.+|+.+++.+.++++.....++...+..++||||++|
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 68999999999999999999999654322221 1246678899999999887655444444556677899999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceec
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIA 242 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~ 242 (370)
++|.+++..... .++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++++|||++...
T Consensus 82 ~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 82 KPLKDVIEEGND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998765421 88999999999999998 99999999999999 789999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-20 Score=166.28 Aligned_cols=172 Identities=26% Similarity=0.423 Sum_probs=130.1
Q ss_pred ceEEEEeecCCCCHHHHHHhCC---CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccc
Q 042314 163 RLIFLTEYLRNGSLHDILKKKG---KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLS 239 (370)
Q Consensus 163 ~~~~v~e~~~g~~L~~~l~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~ 239 (370)
.++|.|++|+..+|.+++..+. ..+......++.|+..++.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 5889999999999999997553 45677889999999999999 66 999999999999999999999999998
Q ss_pred eeccccC---ccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCC
Q 042314 240 KIAQEKD---SYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPA 315 (370)
Q Consensus 240 ~~~~~~~---~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 315 (370)
....... ......+...||..||+||++.+..|+.++||||||++++|++. -...+............. ..+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~---ip~~ 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGI---IPPE 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCC---CChH
Confidence 7655433 11123345579999999999999999999999999999999987 333333222222221111 1112
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHH
Q 042314 316 LSSLYPEPIKALLRECWHKNPDRRPTFEE 344 (370)
Q Consensus 316 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 344 (370)
....+|. =..|+..++.+.|.+||++.+
T Consensus 481 ~~~d~p~-e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 481 FLQDYPE-EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred HhhcCcH-HHHHHHHhcCCCcccCchHHH
Confidence 2233444 368999999999999994443
|
|
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.6e-19 Score=144.37 Aligned_cols=95 Identities=18% Similarity=0.172 Sum_probs=85.2
Q ss_pred CCCCCChhhhHHhhcCCHHH---HHHHHHcCCCCCCCC-CCCCcHHHHHHHCCCHHHHHHHHH-cCCCccCccccCCCcc
Q 042314 4 IDSEGPYRLLYCSSKGDRAG---VLQELEKGVEPNLAD-YDKRTALHLASSEGRAEIVLLLLE-KGADVNSLDRWGRTPL 78 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~---~~~ll~~ga~~~~~~-~~g~t~l~~A~~~g~~~~~~~Ll~-~gad~~~~~~~g~tpl 78 (370)
+|.+|+||||+||..|+.+. +++|+++|+++|.+| ..|.||||+|+..|+.+++++|+. .|++++.++..|+||+
T Consensus 53 ~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~tpL 132 (166)
T PHA02743 53 YDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAINYQHETAY 132 (166)
T ss_pred cCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcCCCCCCHH
Confidence 57889999999999987654 889999999999998 589999999999999999999995 7999999999999999
Q ss_pred ccccccCceeeEEeeecccC
Q 042314 79 SDARSFGHVVICKILEDRGG 98 (370)
Q Consensus 79 ~~A~~~g~~~~~~~L~~~~~ 98 (370)
|.|...++.+++++|...+.
T Consensus 133 ~~A~~~~~~~iv~~Ll~~ga 152 (166)
T PHA02743 133 HIAYKMRDRRMMEILRANGA 152 (166)
T ss_pred HHHHHcCCHHHHHHHHHcCC
Confidence 99999999999888876553
|
|
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.5e-19 Score=144.50 Aligned_cols=96 Identities=21% Similarity=0.248 Sum_probs=89.0
Q ss_pred cCCCCCChhhhHHhhcCC----HHHHHHHHHcCCCCCCCCC-CCCcHHHHHHHCCCHHHHHHHHH-cCCCccCccccCCC
Q 042314 3 IIDSEGPYRLLYCSSKGD----RAGVLQELEKGVEPNLADY-DKRTALHLASSEGRAEIVLLLLE-KGADVNSLDRWGRT 76 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~----~~~~~~ll~~ga~~~~~~~-~g~t~l~~A~~~g~~~~~~~Ll~-~gad~~~~~~~g~t 76 (370)
.+|..|+||||+||..|+ .+++++|+++|+++|.+|. +|+||||+|+..++.+++++|+. .|++++..|..|+|
T Consensus 55 ~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~t 134 (169)
T PHA02741 55 ATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQEMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKS 134 (169)
T ss_pred ccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCCCcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCC
Confidence 468899999999999999 5899999999999999985 99999999999999999999998 59999999999999
Q ss_pred ccccccccCceeeEEeeecccC
Q 042314 77 PLSDARSFGHVVICKILEDRGG 98 (370)
Q Consensus 77 pl~~A~~~g~~~~~~~L~~~~~ 98 (370)
|++.|...++.++++.|.+.+.
T Consensus 135 pL~~A~~~~~~~iv~~L~~~~~ 156 (169)
T PHA02741 135 PFELAIDNEDVAMMQILREIVA 156 (169)
T ss_pred HHHHHHHCCCHHHHHHHHHHHH
Confidence 9999999999999988877543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.1e-18 Score=144.16 Aligned_cols=140 Identities=24% Similarity=0.256 Sum_probs=107.8
Q ss_pred CCCCCCcccEEEEE---EcCceeEEEEeccccCC-------------------Ch--HHHHHHHHHHHHHHhcCCC--ce
Q 042314 98 GIDPGAYGEVYLVK---WRGTEIAAKTIRSSIAS-------------------NP--RVRNSFMKELGLWQKLRHP--NI 151 (370)
Q Consensus 98 ~l~~g~~~~v~~a~---~~g~~vavK~l~~~~~~-------------------~~--~~~~~~~~e~~~l~~l~hp--~I 151 (370)
.+|.|++|.||+|. ..|..+++|.++..... ++ .....+..|+..++++.+. .+
T Consensus 35 ~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~ 114 (237)
T smart00090 35 CISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPV 114 (237)
T ss_pred eeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 38899999999997 35899999998754211 00 1224467899999999753 34
Q ss_pred eeeeeeEeeCCceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcE
Q 042314 152 VQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHL 231 (370)
Q Consensus 152 v~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~ 231 (370)
+++++. ...++||||++|.+|.........+....+..++.|++.++.+||+.| +++||||||+||+++ .+.+
T Consensus 115 p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~-~~~i 187 (237)
T smart00090 115 PKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH-DGKV 187 (237)
T ss_pred CeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-CCCE
Confidence 455543 234899999999888776544456667778899999999999999976 399999999999999 7899
Q ss_pred EEeccccceeccc
Q 042314 232 KVTDFGLSKIAQE 244 (370)
Q Consensus 232 kl~Dfg~~~~~~~ 244 (370)
+|+|||.+.....
T Consensus 188 ~LiDFg~a~~~~~ 200 (237)
T smart00090 188 VIIDVSQSVELDH 200 (237)
T ss_pred EEEEChhhhccCC
Confidence 9999998865443
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-19 Score=164.47 Aligned_cols=91 Identities=31% Similarity=0.364 Sum_probs=52.8
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLAD-YDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~-~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.|.+|.|+|||||.+++++++++||++|||||..+ .-|.||||+||.+|+..+|++|+++|||++.+|..|.+|+|.|+
T Consensus 74 ~D~~g~tlLHWAAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~~~lHla~ 153 (600)
T KOG0509|consen 74 PDREGVTLLHWAAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGLTPLHLAA 153 (600)
T ss_pred CCcCCccceeHHHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCCcHHHHHH
Confidence 34456666666666666666666666666666555 44556666666666666666666666666655555555555555
Q ss_pred ccCceeeEEeee
Q 042314 83 SFGHVVICKILE 94 (370)
Q Consensus 83 ~~g~~~~~~~L~ 94 (370)
.+|+.-++-+++
T Consensus 154 ~~~~~~~vayll 165 (600)
T KOG0509|consen 154 QFGHTALVAYLL 165 (600)
T ss_pred HhCchHHHHHHH
Confidence 555554444443
|
|
| >PHA02736 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=4e-19 Score=142.78 Aligned_cols=94 Identities=20% Similarity=0.193 Sum_probs=86.0
Q ss_pred CCCCCChhhhHHhhcCCH---HHHHHHHHcCCCCCCCC-CCCCcHHHHHHHCCCHHHHHHHHHc-CCCccCccccCCCcc
Q 042314 4 IDSEGPYRLLYCSSKGDR---AGVLQELEKGVEPNLAD-YDKRTALHLASSEGRAEIVLLLLEK-GADVNSLDRWGRTPL 78 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~---~~~~~ll~~ga~~~~~~-~~g~t~l~~A~~~g~~~~~~~Ll~~-gad~~~~~~~g~tpl 78 (370)
+|.+|+||||+||..|+. +++++|+++|+++|.+| .+|+||||+|+..|+.+++++|+.+ |++++.+|..|+||+
T Consensus 51 ~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~tpL 130 (154)
T PHA02736 51 YNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKTPY 130 (154)
T ss_pred hcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCCHH
Confidence 477899999999999976 46899999999999998 5999999999999999999999984 999999999999999
Q ss_pred ccccccCceeeEEeeeccc
Q 042314 79 SDARSFGHVVICKILEDRG 97 (370)
Q Consensus 79 ~~A~~~g~~~~~~~L~~~~ 97 (370)
+.|+..|+.++++.|...+
T Consensus 131 ~~A~~~~~~~i~~~Ll~~g 149 (154)
T PHA02736 131 YVACERHDAKMMNILRAKG 149 (154)
T ss_pred HHHHHcCCHHHHHHHHHcC
Confidence 9999999999998887654
|
|
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-18 Score=152.51 Aligned_cols=93 Identities=27% Similarity=0.313 Sum_probs=87.7
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|.+|+||||+||..|+.++++.|+++|+++|..| |.||||+|+..|+.+++++|+++|++++..|..|+||||.|+
T Consensus 25 ~~D~~G~TpLh~Aa~~g~~eiv~~Ll~~ga~~n~~d--~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~Aa 102 (284)
T PHA02791 25 KADVHGHSALYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYAV 102 (284)
T ss_pred CCCCCCCcHHHHHHHcCCHHHHHHHHHCcCCCcCCC--CCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence 468899999999999999999999999999999874 789999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeeccc
Q 042314 83 SFGHVVICKILEDRG 97 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~ 97 (370)
..|+.++++.|...+
T Consensus 103 ~~g~~eivk~Ll~~g 117 (284)
T PHA02791 103 DSGNMQTVKLFVKKN 117 (284)
T ss_pred HcCCHHHHHHHHHCC
Confidence 999999999987755
|
|
| >KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.9e-19 Score=160.33 Aligned_cols=119 Identities=30% Similarity=0.338 Sum_probs=100.4
Q ss_pred CCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccC
Q 042314 6 SEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFG 85 (370)
Q Consensus 6 ~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g 85 (370)
.-|.|||||||++|++.+|++|+++|||++.+|..|.||||.||+.||.-+|-+|+.+|+|+|.+|..|+||+++|+..|
T Consensus 110 ~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~D~~grTpLmwAaykg 189 (600)
T KOG0509|consen 110 VLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLRDNNGRTPLMWAAYKG 189 (600)
T ss_pred CCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCcCCCCCCHHHHHHHhc
Confidence 45799999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeeEEeeecccC-----CCCCCcccEEEEEEcCceeEEEEecc
Q 042314 86 HVVICKILEDRGG-----IDPGAYGEVYLVKWRGTEIAAKTIRS 124 (370)
Q Consensus 86 ~~~~~~~L~~~~~-----l~~g~~~~v~~a~~~g~~vavK~l~~ 124 (370)
+...+..|+..+. -..-++..++.+...|..-+++++.+
T Consensus 190 ~~~~v~~LL~f~a~~~~~d~~~g~TpLHwa~~~gN~~~v~Ll~~ 233 (600)
T KOG0509|consen 190 FALFVRRLLKFGASLLLTDDNHGNTPLHWAVVGGNLTAVKLLLE 233 (600)
T ss_pred ccHHHHHHHHhcccccccccccCCchHHHHHhcCCcceEehhhh
Confidence 9886666666543 11334444555555666677774433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-17 Score=158.77 Aligned_cols=134 Identities=22% Similarity=0.235 Sum_probs=110.8
Q ss_pred ccCCCCCCcccEEEEEEcCceeEEEEeccccCC-----ChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 96 RGGIDPGAYGEVYLVKWRGTEIAAKTIRSSIAS-----NPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
...+|+|+||.||++.+.+..+++|........ ......++.+|+.+++.++|++++....++......++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 345899999999999988887777664332111 112346788999999999999998877777777778999999
Q ss_pred cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecccccee
Q 042314 171 LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI 241 (370)
Q Consensus 171 ~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~ 241 (370)
++|++|.+++. ....++.+++.+|.+||+.+ ++||||||+||++ .++.++|+|||+++.
T Consensus 418 ~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 418 IGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred cCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999886 35678999999999999998 9999999999999 568899999999864
|
|
| >PHA02791 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-18 Score=150.34 Aligned_cols=90 Identities=22% Similarity=0.194 Sum_probs=86.1
Q ss_pred CCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCC-CccccccccC
Q 042314 7 EGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGR-TPLSDARSFG 85 (370)
Q Consensus 7 ~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~-tpl~~A~~~g 85 (370)
+|+||||+|+..|+.++|+.|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++..+..|+ ||+|.|+..|
T Consensus 60 d~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~Aa~~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g 139 (284)
T PHA02791 60 ENEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLN 139 (284)
T ss_pred CCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcC
Confidence 589999999999999999999999999999999999999999999999999999999999999999885 8999999999
Q ss_pred ceeeEEeeecc
Q 042314 86 HVVICKILEDR 96 (370)
Q Consensus 86 ~~~~~~~L~~~ 96 (370)
+.++++.|...
T Consensus 140 ~~eivk~LL~~ 150 (284)
T PHA02791 140 DVSIVSYFLSE 150 (284)
T ss_pred CHHHHHHHHhc
Confidence 99999988764
|
|
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9e-19 Score=154.24 Aligned_cols=93 Identities=31% Similarity=0.407 Sum_probs=84.2
Q ss_pred CCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccC
Q 042314 6 SEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFG 85 (370)
Q Consensus 6 ~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g 85 (370)
....|||--||..||.++|++|+++|||++..|..|+|.||+||..||.+|+++|++.|||+|.++..|+|+||.++..|
T Consensus 115 ~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~kGNTALH~caEsG 194 (615)
T KOG0508|consen 115 RTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYKGNTALHDCAESG 194 (615)
T ss_pred ccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcccCchHHHhhhhcc
Confidence 45679999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeeEEeeecccC
Q 042314 86 HVVICKILEDRGG 98 (370)
Q Consensus 86 ~~~~~~~L~~~~~ 98 (370)
+.++++.|...+.
T Consensus 195 ~vdivq~Ll~~ga 207 (615)
T KOG0508|consen 195 SVDIVQLLLKHGA 207 (615)
T ss_pred cHHHHHHHHhCCc
Confidence 9999998887664
|
|
| >KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-18 Score=137.40 Aligned_cols=96 Identities=33% Similarity=0.391 Sum_probs=91.4
Q ss_pred ccCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 2 ~~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
+..|+.|.|||+|||.+|++++|++||+.|||++...+...|+|.+|+..|..++|++||..+.|+|..|..|.|||-+|
T Consensus 154 N~~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgTpLlyA 233 (296)
T KOG0502|consen 154 NACDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGTPLLYA 233 (296)
T ss_pred cCccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCceeeee
Confidence 34689999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCceeeEEeeeccc
Q 042314 82 RSFGHVVICKILEDRG 97 (370)
Q Consensus 82 ~~~g~~~~~~~L~~~~ 97 (370)
+..+|.++++.|+..+
T Consensus 234 vrgnhvkcve~Ll~sG 249 (296)
T KOG0502|consen 234 VRGNHVKCVESLLNSG 249 (296)
T ss_pred ecCChHHHHHHHHhcC
Confidence 9999999999886644
|
|
| >KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.1e-18 Score=167.18 Aligned_cols=97 Identities=32% Similarity=0.332 Sum_probs=91.9
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
+++.+|+||||.||.+|+.++|++||++|||+|.+|+.|+||||.||..|+.+|+++|+++||++|..|.+|.|||+.|.
T Consensus 535 ~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLlk~GA~vna~d~~g~TpL~iA~ 614 (1143)
T KOG4177|consen 535 LRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLLKHGASVNAADLDGFTPLHIAV 614 (1143)
T ss_pred hhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHHHcCCCCCcccccCcchhHHHH
Confidence 46778999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecccCC
Q 042314 83 SFGHVVICKILEDRGGI 99 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~l 99 (370)
..|+..+++.+...+..
T Consensus 615 ~lg~~~~~k~l~~~~~~ 631 (1143)
T KOG4177|consen 615 RLGYLSVVKLLKVVTAT 631 (1143)
T ss_pred HhcccchhhHHHhccCc
Confidence 99999999988775543
|
|
| >PHA02741 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.7e-18 Score=138.51 Aligned_cols=93 Identities=24% Similarity=0.174 Sum_probs=85.9
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHH------cCCCCCCCCCCCCcHHHHHHHCCC----HHHHHHHHHcCCCccCccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELE------KGVEPNLADYDKRTALHLASSEGR----AEIVLLLLEKGADVNSLDR 72 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~------~ga~~~~~~~~g~t~l~~A~~~g~----~~~~~~Ll~~gad~~~~~~ 72 (370)
.+|..|.||||+||..|+.++++.|+. .|+++|.+|..|+||||+|+..|+ .+++++|+++|+++|.++.
T Consensus 16 ~~~~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~~~ 95 (169)
T PHA02741 16 EKNSEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQEM 95 (169)
T ss_pred ccccCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCCCc
Confidence 467899999999999999999999854 479999999999999999999999 5899999999999999985
Q ss_pred -cCCCccccccccCceeeEEeeec
Q 042314 73 -WGRTPLSDARSFGHVVICKILED 95 (370)
Q Consensus 73 -~g~tpl~~A~~~g~~~~~~~L~~ 95 (370)
.|+||||.|+..++.++++.|+.
T Consensus 96 ~~g~TpLh~A~~~~~~~iv~~Ll~ 119 (169)
T PHA02741 96 LEGDTALHLAAHRRDHDLAEWLCC 119 (169)
T ss_pred CCCCCHHHHHHHcCCHHHHHHHHh
Confidence 89999999999999999998865
|
|
| >PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.1e-18 Score=122.59 Aligned_cols=82 Identities=44% Similarity=0.565 Sum_probs=68.9
Q ss_pred hhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccCceeeEE
Q 042314 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICK 91 (370)
Q Consensus 12 l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~~~~~~ 91 (370)
||+||..|+.+++++|++.|++++. |+||||+|+..|+.+++++|+++|++++..|..|+||+|.|+..|+.++++
T Consensus 1 L~~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~ 76 (89)
T PF12796_consen 1 LHIAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVK 76 (89)
T ss_dssp HHHHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHH
T ss_pred CHHHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHH
Confidence 7888888888888888888888877 888888888888888888888888888888888888888888888888888
Q ss_pred eeeccc
Q 042314 92 ILEDRG 97 (370)
Q Consensus 92 ~L~~~~ 97 (370)
+|.+.+
T Consensus 77 ~Ll~~g 82 (89)
T PF12796_consen 77 LLLEHG 82 (89)
T ss_dssp HHHHTT
T ss_pred HHHHcC
Confidence 777653
|
These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B .... |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.9e-19 Score=168.06 Aligned_cols=245 Identities=25% Similarity=0.377 Sum_probs=190.7
Q ss_pred CCCCCcccEEEEEEcC---ceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 99 IDPGAYGEVYLVKWRG---TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g---~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
+|+|+++.+-.....+ ..+++|.+.... ...........|..+-+.++ |+|++.+++.....+..++.+++..|+
T Consensus 28 ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~ 106 (601)
T KOG0590|consen 28 IGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGG 106 (601)
T ss_pred ccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccccccCccccc
Confidence 6789999988776542 234444443332 23445556667888878887 999999999999999999999999999
Q ss_pred CHHHHH-HhCC-CCChHhHHHHHHHHHHHHHHHh-hcCCCceeecCCCCCCeeeCCCC-cEEEeccccceeccccCccce
Q 042314 175 SLHDIL-KKKG-KLDPPTAVAYALDIARGMNYLH-HHRPHAIIHRDLTPSNVLQDEAG-HLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 175 ~L~~~l-~~~~-~~~~~~~~~i~~~l~~~l~~lH-~~~~~~iiH~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
++.+.+ .... ..+...+-.++.|+..++.|+| ..+ +.|+|+||+|.+++..+ .+++.|||+|...........
T Consensus 107 ~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~ 183 (601)
T KOG0590|consen 107 SLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAER 183 (601)
T ss_pred ccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccCCcce
Confidence 999988 4433 6778889999999999999999 777 99999999999999999 999999999988776333333
Q ss_pred eccCCCC-CccccCcccccccCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-hhcc--CCCCCCCCCCcHHHH
Q 042314 251 KMTGGTG-SYRYMAPEVYRRESY-GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADR-RAYE--DSRPALSSLYPEPIK 325 (370)
Q Consensus 251 ~~~~~~g-~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~l~ 325 (370)
.....+| ++.|+|||...+..+ ....|+||.|+++.-+++|..||........... .... ......+...+....
T Consensus 184 ~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (601)
T KOG0590|consen 184 SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAH 263 (601)
T ss_pred eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhh
Confidence 4455567 999999999988544 5789999999999999999999876544332211 1111 112445667888899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 042314 326 ALLRECWHKNPDRRPTFEEIIF 347 (370)
Q Consensus 326 ~li~~~l~~~p~~Rp~~~~ll~ 347 (370)
+++.+++..+|..|.+.+++-.
T Consensus 264 ~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 264 DLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred hcccccccCCchhccccccccc
Confidence 9999999999999999887644
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=134.06 Aligned_cols=134 Identities=22% Similarity=0.202 Sum_probs=103.3
Q ss_pred CCCCCCcccEEEEEE-cCceeEEEEeccccCCC-------------------hHHHHHHHHHHHHHHhcCCC--ceeeee
Q 042314 98 GIDPGAYGEVYLVKW-RGTEIAAKTIRSSIASN-------------------PRVRNSFMKELGLWQKLRHP--NIVQFL 155 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~-~g~~vavK~l~~~~~~~-------------------~~~~~~~~~e~~~l~~l~hp--~Iv~~~ 155 (370)
.++.|++|.||++.. .|..+++|++....... .........|...+..+.++ .++..+
T Consensus 22 ~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~ 101 (198)
T cd05144 22 QIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPI 101 (198)
T ss_pred ccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCcee
Confidence 388999999999977 48899999876432110 01122367788888888776 445554
Q ss_pred eeEeeCCceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEec
Q 042314 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTD 235 (370)
Q Consensus 156 ~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~D 235 (370)
+. ...++||||++|++|..+... .....++.+++.++.++|+.+ ++||||+|.||+++.++.++|+|
T Consensus 102 ~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liD 168 (198)
T cd05144 102 DW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIID 168 (198)
T ss_pred ec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEE
Confidence 42 355899999999999775431 345678899999999999988 99999999999999999999999
Q ss_pred cccceeccc
Q 042314 236 FGLSKIAQE 244 (370)
Q Consensus 236 fg~~~~~~~ 244 (370)
||++.....
T Consensus 169 fg~~~~~~~ 177 (198)
T cd05144 169 WPQMVSTDH 177 (198)
T ss_pred CCccccCCC
Confidence 999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-17 Score=145.54 Aligned_cols=95 Identities=21% Similarity=0.137 Sum_probs=61.7
Q ss_pred CCCCCChhh-hHHhhcCCHHHHHHHHHcCCCCCCCC----CCCCcHHHHHHHCCCHHHHHHHHHcCCCccCc-cccCCCc
Q 042314 4 IDSEGPYRL-LYCSSKGDRAGVLQELEKGVEPNLAD----YDKRTALHLASSEGRAEIVLLLLEKGADVNSL-DRWGRTP 77 (370)
Q Consensus 4 ~~~~g~t~l-~~a~~~g~~~~~~~ll~~ga~~~~~~----~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~-~~~g~tp 77 (370)
+|..|+|++ |.|+..|+.+++++|+++|||+|.++ ..|.||||+|+..|+.+++++|+++|||+|.. +..|.||
T Consensus 28 ~d~~~~~~lL~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~Tp 107 (300)
T PHA02884 28 KNKICIANILYSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITP 107 (300)
T ss_pred cCcCCCCHHHHHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCH
Confidence 455565544 34444466777777777777777653 46777777777777777777777777777764 3456777
Q ss_pred cccccccCceeeEEeeecccC
Q 042314 78 LSDARSFGHVVICKILEDRGG 98 (370)
Q Consensus 78 l~~A~~~g~~~~~~~L~~~~~ 98 (370)
+|.|+..|+.++++.|...++
T Consensus 108 Lh~Aa~~~~~eivklLL~~GA 128 (300)
T PHA02884 108 LYISVLHGCLKCLEILLSYGA 128 (300)
T ss_pred HHHHHHcCCHHHHHHHHHCCC
Confidence 777777777776666665553
|
|
| >PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.3e-17 Score=118.07 Aligned_cols=64 Identities=44% Similarity=0.547 Sum_probs=60.0
Q ss_pred CChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCcc
Q 042314 8 GPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71 (370)
Q Consensus 8 g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~ 71 (370)
|+||||+||.+|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++.+|
T Consensus 26 ~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~n 89 (89)
T PF12796_consen 26 GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVKLLLEHGADVNIRN 89 (89)
T ss_dssp SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHHHHHHTTT-TTSS-
T ss_pred CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence 8999999999999999999999999999999999999999999999999999999999999875
|
These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B .... |
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-17 Score=156.65 Aligned_cols=95 Identities=28% Similarity=0.380 Sum_probs=87.6
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARS 83 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~ 83 (370)
.+.+|+||||+||..|+.+++++|+++|||+|.+|.+|.||||+|+..|+.+++++|+++|++++..|..|+||||.|+.
T Consensus 98 ~~~~g~tpL~~A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~ 177 (413)
T PHA02875 98 FYKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMA 177 (413)
T ss_pred ccCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Confidence 35679999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCceeeEEeeecccC
Q 042314 84 FGHVVICKILEDRGG 98 (370)
Q Consensus 84 ~g~~~~~~~L~~~~~ 98 (370)
.|+.++++.|.+.++
T Consensus 178 ~g~~eiv~~Ll~~ga 192 (413)
T PHA02875 178 KGDIAICKMLLDSGA 192 (413)
T ss_pred cCCHHHHHHHHhCCC
Confidence 999999998877653
|
|
| >PF13637 Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A 3B7B_A 3F6Q_A 2KBX_A 3IXE_A 2DWZ_C 2DVW_A 3AJI_A 1S70_B 2HE0_A | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.2e-17 Score=106.32 Aligned_cols=54 Identities=37% Similarity=0.487 Sum_probs=47.0
Q ss_pred CChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHH
Q 042314 8 GPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLL 61 (370)
Q Consensus 8 g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll 61 (370)
|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+
T Consensus 1 g~t~lh~A~~~g~~~~~~~Ll~~~~din~~d~~g~t~lh~A~~~g~~~~~~~Ll 54 (54)
T PF13637_consen 1 GRTPLHWAARSGNLEIVKLLLEHGADINAQDEDGRTPLHYAAKNGNIDIVKFLL 54 (54)
T ss_dssp SSBHHHHHHHTT-HHHHHHHHHTTSGTT-B-TTS--HHHHHHHTT-HHHHHHHH
T ss_pred CChHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHccCHHHHHHHC
Confidence 799999999999999999999999999999999999999999999999999986
|
... |
| >KOG0508 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4e-18 Score=150.20 Aligned_cols=93 Identities=34% Similarity=0.439 Sum_probs=87.7
Q ss_pred ccCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 2 ~~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
++.|..|.|.||+||++||.+|+++|+++|||+|.++..|+|+||.++..||.|++++|+++|+.+.. |..|.|||..|
T Consensus 144 ~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~kGNTALH~caEsG~vdivq~Ll~~ga~i~~-d~~GmtPL~~A 222 (615)
T KOG0508|consen 144 EIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYKGNTALHDCAESGSVDIVQLLLKHGAKIDV-DGHGMTPLLLA 222 (615)
T ss_pred cccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcccCchHHHhhhhcccHHHHHHHHhCCceeee-cCCCCchHHHH
Confidence 46789999999999999999999999999999999999999999999999999999999999998865 55699999999
Q ss_pred cccCceeeEEeeec
Q 042314 82 RSFGHVVICKILED 95 (370)
Q Consensus 82 ~~~g~~~~~~~L~~ 95 (370)
+..|+.++++.|..
T Consensus 223 a~tG~~~iVe~L~~ 236 (615)
T KOG0508|consen 223 AVTGHTDIVERLLQ 236 (615)
T ss_pred hhhcchHHHHHHhc
Confidence 99999999998874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.7e-16 Score=134.24 Aligned_cols=136 Identities=18% Similarity=0.242 Sum_probs=105.9
Q ss_pred CC-CCCcccEEEEEEcCceeEEEEeccccC----------CChHHHHHHHHHHHHHHhcCCCce--eeeeeeEeeC-C--
Q 042314 99 ID-PGAYGEVYLVKWRGTEIAAKTIRSSIA----------SNPRVRNSFMKELGLWQKLRHPNI--VQFLGVLKHS-E-- 162 (370)
Q Consensus 99 l~-~g~~~~v~~a~~~g~~vavK~l~~~~~----------~~~~~~~~~~~e~~~l~~l~hp~I--v~~~~~~~~~-~-- 162 (370)
+| .|+.|++|.+...+..+++|....... .......++.+|+.++..+.|++| ++.+++.... .
T Consensus 39 lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~ 118 (239)
T PRK01723 39 VGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLF 118 (239)
T ss_pred eecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcc
Confidence 55 789999999998899999998753210 112345678899999999988774 6677664332 2
Q ss_pred -ceEEEEeecCC-CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccce
Q 042314 163 -RLIFLTEYLRN-GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK 240 (370)
Q Consensus 163 -~~~~v~e~~~g-~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~ 240 (370)
..++|+|+++| .+|.+++... .++.. .+.+++.++.+||+.| |+||||||.|||++.++.++|+|||.+.
T Consensus 119 ~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 119 YRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred eeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 23599999997 6999988653 45543 3568999999999999 9999999999999998999999999875
Q ss_pred ec
Q 042314 241 IA 242 (370)
Q Consensus 241 ~~ 242 (370)
..
T Consensus 191 ~~ 192 (239)
T PRK01723 191 LR 192 (239)
T ss_pred cC
Confidence 43
|
|
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-17 Score=139.68 Aligned_cols=96 Identities=21% Similarity=0.226 Sum_probs=83.1
Q ss_pred ccCCCCCChhhhHHhhcC--CHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHC---CCHHHHHHHHHcCCCccCccccCC
Q 042314 2 QIIDSEGPYRLLYCSSKG--DRAGVLQELEKGVEPNLAD-YDKRTALHLASSE---GRAEIVLLLLEKGADVNSLDRWGR 75 (370)
Q Consensus 2 ~~~~~~g~t~l~~a~~~g--~~~~~~~ll~~ga~~~~~~-~~g~t~l~~A~~~---g~~~~~~~Ll~~gad~~~~~~~g~ 75 (370)
+..|..|.||||+|+..+ +.+++++|+++|||+|.++ ..|.||||+|+.. ++.+++++|+++|+++|.+|..|.
T Consensus 45 n~~~~~g~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~ 124 (209)
T PHA02859 45 NDCNDLYETPIFSCLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDGK 124 (209)
T ss_pred hccCccCCCHHHHHHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCCC
Confidence 457889999999999754 8999999999999999997 5899999998763 579999999999999999999999
Q ss_pred Cccccccc--cCceeeEEeeeccc
Q 042314 76 TPLSDARS--FGHVVICKILEDRG 97 (370)
Q Consensus 76 tpl~~A~~--~g~~~~~~~L~~~~ 97 (370)
||+|.|.. .++.+++++|...+
T Consensus 125 TpLh~a~~~~~~~~~iv~~Li~~g 148 (209)
T PHA02859 125 NLLHMYMCNFNVRINVIKLLIDSG 148 (209)
T ss_pred CHHHHHHHhccCCHHHHHHHHHcC
Confidence 99998865 46788888887654
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.5e-18 Score=144.32 Aligned_cols=95 Identities=37% Similarity=0.409 Sum_probs=78.7
Q ss_pred ccCCCCCChhhhHHhhcCCHHHHHHHHHcC-CCCCCCCCC--------------------------------------CC
Q 042314 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKG-VEPNLADYD--------------------------------------KR 42 (370)
Q Consensus 2 ~~~~~~g~t~l~~a~~~g~~~~~~~ll~~g-a~~~~~~~~--------------------------------------g~ 42 (370)
++.|.+|+|+||||++++|.++|+.||+.| +|||.+|.- |.
T Consensus 262 NlaDsNGNTALHYsVSHaNF~VV~~LLDSgvC~VD~qNrAGYtpiMLaALA~lk~~~d~~vV~~LF~mgnVNaKAsQ~gQ 341 (452)
T KOG0514|consen 262 NLADSNGNTALHYAVSHANFDVVSILLDSGVCDVDQQNRAGYTPVMLAALAKLKQPADRTVVERLFKMGDVNAKASQHGQ 341 (452)
T ss_pred hhhcCCCCeeeeeeecccchHHHHHHhccCcccccccccccccHHHHHHHHhhcchhhHHHHHHHHhccCcchhhhhhcc
Confidence 356888999999999999999999998877 455555544 56
Q ss_pred cHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccCceeeEEeeecc
Q 042314 43 TALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDR 96 (370)
Q Consensus 43 t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~~~~~~~L~~~ 96 (370)
|+||+|+..|+.++|+.||.-|||||.+|.+|.|+|+.|+..||++++++|+..
T Consensus 342 TALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~ 395 (452)
T KOG0514|consen 342 TALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAV 395 (452)
T ss_pred hhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhcc
Confidence 778888888999999999999999999999999999999999999998887654
|
|
| >KOG4214 consensus Myotrophin and similar proteins [Transcription] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.2e-17 Score=111.32 Aligned_cols=75 Identities=25% Similarity=0.200 Sum_probs=64.4
Q ss_pred CCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 7 EGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 7 ~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
.|+|||||||-.|.++++++|+..||+|+.+|+.|-|||..|+..||.++|++|+++|||-.....+|.+.+..+
T Consensus 33 ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVklLL~~GAdrt~~~PdG~~~~eat 107 (117)
T KOG4214|consen 33 GGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVKLLLQNGADRTIHAPDGTALIEAT 107 (117)
T ss_pred CCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHHHHHHcCcccceeCCCchhHHhhc
Confidence 588999999999999999999999999999999999999999999999999999999998887777776655443
|
|
| >KOG0510 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.7e-18 Score=158.91 Aligned_cols=117 Identities=28% Similarity=0.337 Sum_probs=102.7
Q ss_pred ccCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHH-cC-CCccCccccCCCccc
Q 042314 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLE-KG-ADVNSLDRWGRTPLS 79 (370)
Q Consensus 2 ~~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~-~g-ad~~~~~~~g~tpl~ 79 (370)
+..|++|.||||+||+.|+.+.|+.|+..||++|.++.++.||||.||..|+.++|+-||+ .| ..+|..|-.|.||+|
T Consensus 267 ~~~d~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLH 346 (929)
T KOG0510|consen 267 NDEDNDGCTPLHYAARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLH 346 (929)
T ss_pred hcccccCCchHHHHHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchh
Confidence 3579999999999999999999999999999999999999999999999999999999998 55 678999999999999
Q ss_pred cccccCceeeEEeeecccCC-------CCCCcccEEEEEEcCceeE
Q 042314 80 DARSFGHVVICKILEDRGGI-------DPGAYGEVYLVKWRGTEIA 118 (370)
Q Consensus 80 ~A~~~g~~~~~~~L~~~~~l-------~~g~~~~v~~a~~~g~~va 118 (370)
.|+..||.++++.|++.|++ +.+++.+++.|...|..-+
T Consensus 347 laa~~gH~~v~qlLl~~GA~~~~~~e~D~dg~TaLH~Aa~~g~~~a 392 (929)
T KOG0510|consen 347 LAAKSGHDRVVQLLLNKGALFLNMSEADSDGNTALHLAAKYGNTSA 392 (929)
T ss_pred hhhhcCHHHHHHHHHhcChhhhcccccccCCchhhhHHHHhccHHH
Confidence 99999999999999888762 5566767776655554433
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-17 Score=156.55 Aligned_cols=95 Identities=29% Similarity=0.382 Sum_probs=88.7
Q ss_pred CCCC-CChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 4 IDSE-GPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 4 ~~~~-g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.|.. |+||||+||..|+.+++++|+++||++|..|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||.|+
T Consensus 163 ~~~~~g~tpLh~A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~TpLh~A~ 242 (477)
T PHA02878 163 KDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISV 242 (477)
T ss_pred cCCCCCCCHHHHHHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH
Confidence 4556 999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cc-CceeeEEeeecccC
Q 042314 83 SF-GHVVICKILEDRGG 98 (370)
Q Consensus 83 ~~-g~~~~~~~L~~~~~ 98 (370)
.. ++.++++.|.+.+.
T Consensus 243 ~~~~~~~iv~~Ll~~ga 259 (477)
T PHA02878 243 GYCKDYDILKLLLEHGV 259 (477)
T ss_pred HhcCCHHHHHHHHHcCC
Confidence 75 68888888877654
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.5e-17 Score=153.97 Aligned_cols=95 Identities=35% Similarity=0.462 Sum_probs=91.1
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|..|+||||+||..|+.++|++|+++|+++|.+|.+|.||||+|+..|+.+++++|+++|++++..+..|.||+|.|+
T Consensus 119 ~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~g~tpL~~A~ 198 (434)
T PHA02874 119 IKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGESPLHNAA 198 (434)
T ss_pred CCCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence 35788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeeccc
Q 042314 83 SFGHVVICKILEDRG 97 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~ 97 (370)
..|+.++++.|.+.+
T Consensus 199 ~~g~~~iv~~Ll~~g 213 (434)
T PHA02874 199 EYGDYACIKLLIDHG 213 (434)
T ss_pred HcCCHHHHHHHHhCC
Confidence 999999999987754
|
|
| >PHA02884 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.4e-17 Score=143.10 Aligned_cols=89 Identities=19% Similarity=0.193 Sum_probs=82.0
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCC-CCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccc
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLA-DYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARS 83 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~-~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~ 83 (370)
|..|.||||+||..|+.+++++|+++|||+|.+ +..|.||||+|+..|+.+++++|+.+|++++.+|..|.||++.|+.
T Consensus 67 d~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~~~eivklLL~~GAdin~kd~~G~TpL~~A~~ 146 (300)
T PHA02884 67 ENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHGCLKCLEILLSYGADINIQTNDMVTPIELALM 146 (300)
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Confidence 458999999999999999999999999999996 5689999999999999999999999999999999999999999998
Q ss_pred cCceeeEEee
Q 042314 84 FGHVVICKIL 93 (370)
Q Consensus 84 ~g~~~~~~~L 93 (370)
.++..++..+
T Consensus 147 ~~~~~~~~~~ 156 (300)
T PHA02884 147 ICNNFLAFMI 156 (300)
T ss_pred hCChhHHHHh
Confidence 8877665433
|
|
| >KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.7e-17 Score=125.59 Aligned_cols=87 Identities=30% Similarity=0.365 Sum_probs=83.0
Q ss_pred hhHHhhcCCHHHHHHHHHcCCC-CCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccCceeeE
Q 042314 12 LLYCSSKGDRAGVLQELEKGVE-PNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVIC 90 (370)
Q Consensus 12 l~~a~~~g~~~~~~~ll~~ga~-~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~~~~~ 90 (370)
+.+|+..+.+..|+.||+..|+ ||.+|.+|.||||-|+.+||.++|+.|+..||+++++...||||||.|+.+.+.+++
T Consensus 67 ~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va 146 (228)
T KOG0512|consen 67 LLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVA 146 (228)
T ss_pred HHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHH
Confidence 5799999999999999999988 899999999999999999999999999999999999999999999999999999999
Q ss_pred EeeecccC
Q 042314 91 KILEDRGG 98 (370)
Q Consensus 91 ~~L~~~~~ 98 (370)
..|+..++
T Consensus 147 ~~LLqhga 154 (228)
T KOG0512|consen 147 GRLLQHGA 154 (228)
T ss_pred HHHHhccC
Confidence 99987764
|
|
| >PHA02795 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.9e-17 Score=149.27 Aligned_cols=91 Identities=26% Similarity=0.113 Sum_probs=83.1
Q ss_pred CCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccCc
Q 042314 7 EGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86 (370)
Q Consensus 7 ~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~ 86 (370)
.|.|++|.|+..|+.+++++|+++|||+|.+|.+|.||||+|+..|+.+++++|+++||++|.+|..|+||||.|+..|+
T Consensus 187 ~~~t~l~~a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa~~g~ 266 (437)
T PHA02795 187 IQYTRGFLVDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTCLDVAVDRGS 266 (437)
T ss_pred hccchhHHHHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCC
Confidence 47789999999999999999999999999999999999999999999999999999999999999999999999999884
Q ss_pred --------eeeEEeeeccc
Q 042314 87 --------VVICKILEDRG 97 (370)
Q Consensus 87 --------~~~~~~L~~~~ 97 (370)
.++++.|...+
T Consensus 267 ~~~~~~~~~eIvelLL~~g 285 (437)
T PHA02795 267 VIARRETHLKILEILLREP 285 (437)
T ss_pred cccccccHHHHHHHHHhCC
Confidence 47788776544
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.8e-17 Score=152.32 Aligned_cols=93 Identities=28% Similarity=0.320 Sum_probs=60.9
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCC--HHHHHHHHHcCCCccC-ccccCCCccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGR--AEIVLLLLEKGADVNS-LDRWGRTPLS 79 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~--~~~~~~Ll~~gad~~~-~~~~g~tpl~ 79 (370)
.+|..|+||||+||..|+.++|++||++|||+|.+|.+|+||||+|+..++ .+++++|+++|+++|. .|..|.||++
T Consensus 67 ~~d~~G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~~g~tpL~ 146 (446)
T PHA02946 67 ETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDEEGCGPLL 146 (446)
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCCCCCcHHH
Confidence 345667777777777777777777777777777777777777777666543 5667777777777764 4666677775
Q ss_pred cccccCceeeEEeeecc
Q 042314 80 DARSFGHVVICKILEDR 96 (370)
Q Consensus 80 ~A~~~g~~~~~~~L~~~ 96 (370)
|+..|+.++++.|...
T Consensus 147 -aa~~~~~~vv~~Ll~~ 162 (446)
T PHA02946 147 -ACTDPSERVFKKIMSI 162 (446)
T ss_pred -HHHCCChHHHHHHHhc
Confidence 4444566666655543
|
|
| >KOG0514 consensus Ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.8e-17 Score=139.03 Aligned_cols=89 Identities=36% Similarity=0.368 Sum_probs=84.2
Q ss_pred CCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHc-CCCccCccccCCCcccccccc
Q 042314 6 SEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK-GADVNSLDRWGRTPLSDARSF 84 (370)
Q Consensus 6 ~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~-gad~~~~~~~g~tpl~~A~~~ 84 (370)
..|+|+||+|+++|..++|+.||..|||||.+|.+|.|+||.||..||.|++++||.+ ++|+...|.+|.|+|..|...
T Consensus 338 Q~gQTALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgSTAl~IAlea 417 (452)
T KOG0514|consen 338 QHGQTALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGSTALSIALEA 417 (452)
T ss_pred hhcchhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCchhhhhHHhc
Confidence 4699999999999999999999999999999999999999999999999999999986 799999999999999999999
Q ss_pred CceeeEEeee
Q 042314 85 GHVVICKILE 94 (370)
Q Consensus 85 g~~~~~~~L~ 94 (370)
||.++.-+|-
T Consensus 418 gh~eIa~mlY 427 (452)
T KOG0514|consen 418 GHREIAVMLY 427 (452)
T ss_pred CchHHHHHHH
Confidence 9999866553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.2e-15 Score=122.05 Aligned_cols=132 Identities=20% Similarity=0.265 Sum_probs=111.5
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCC--CceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH--PNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h--p~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
++.|.++.||++...+..+++|....... ...+..|..+++.+.+ ..+++++.+....+..++++||+.|+++
T Consensus 6 i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 6 LKGGLTNRVYLLGTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred cccccccceEEEEecCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 78899999999999888999998865432 4568889999999976 5899999988877889999999999877
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceec
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIA 242 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~ 242 (370)
..+ +......++.++++++..+|.....+++|+|++|+||+++..+.++++|||.+...
T Consensus 81 ~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 654 45667788999999999999864345999999999999999899999999987643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.1e-17 Score=163.08 Aligned_cols=97 Identities=32% Similarity=0.326 Sum_probs=85.2
Q ss_pred ccCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHC------------------------------
Q 042314 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSE------------------------------ 51 (370)
Q Consensus 2 ~~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~------------------------------ 51 (370)
+..|..|+||||+||.+|+.+++++|+++|+|+|.+|.+|+||||+|+..
T Consensus 552 n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g~~~iv~~L~~~~~~~~~~~~~~~L~~Aa~ 631 (823)
T PLN03192 552 DIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHHKIFRILYHFASISDPHAAGDLLCTAAK 631 (823)
T ss_pred CCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHhcCcccCcccCchHHHHHHH
Confidence 35788999999999999999999999999999999999999998865554
Q ss_pred -CCHHHHHHHHHcCCCccCccccCCCccccccccCceeeEEeeecccC
Q 042314 52 -GRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGG 98 (370)
Q Consensus 52 -g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~~~~~~~L~~~~~ 98 (370)
|+.++++.|+++|+|+|..|..|+||||.|+..|+.++++.|.+.++
T Consensus 632 ~g~~~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GA 679 (823)
T PLN03192 632 RNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGA 679 (823)
T ss_pred hCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCC
Confidence 45556667788999999999999999999999999999999987653
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.1e-17 Score=157.26 Aligned_cols=122 Identities=20% Similarity=0.077 Sum_probs=97.8
Q ss_pred cCCCCCChhhhHHhhcC---CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCC--CHHHHHHHHHcCCC--ccCccccCC
Q 042314 3 IIDSEGPYRLLYCSSKG---DRAGVLQELEKGVEPNLADYDKRTALHLASSEG--RAEIVLLLLEKGAD--VNSLDRWGR 75 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g---~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g--~~~~~~~Ll~~gad--~~~~~~~g~ 75 (370)
.+|..|+||||+|+.+| +.++|++||++|||+|.+|.+|+||||+|+..| +.|+|++|+++|++ ++..+.-+.
T Consensus 36 ~kd~~G~TaLh~A~~~~~~~~~eivklLLs~GAdin~kD~~G~TPLh~Aa~~~~~~~eIv~~Ll~~~~~~~~~~~~~~~d 115 (672)
T PHA02730 36 HIDRRGNNALHCYVSNKCDTDIKIVRLLLSRGVERLCRNNEGLTPLGVYSKRKYVKSQIVHLLISSYSNASNELTSNIND 115 (672)
T ss_pred hcCCCCCcHHHHHHHcCCcCcHHHHHHHHhCCCCCcccCCCCCChHHHHHHcCCCcHHHHHHHHhcCCCCCcccccccCC
Confidence 56789999999999997 599999999999999999999999999999976 79999999999654 477787788
Q ss_pred Cccccccc--cCceeeEEeeecccCCC----------CCCcccEEEEEEcCceeEEEEecc
Q 042314 76 TPLSDARS--FGHVVICKILEDRGGID----------PGAYGEVYLVKWRGTEIAAKTIRS 124 (370)
Q Consensus 76 tpl~~A~~--~g~~~~~~~L~~~~~l~----------~g~~~~v~~a~~~g~~vavK~l~~ 124 (370)
+|++.+.. .++.+++++|...+... .-+.-..|.++..+...+||.+..
T Consensus 116 ~~l~~y~~s~n~~~~~vk~Li~~~~~~~~~~~~~~~~~~~~~~~yl~~~~~~~eIvklLi~ 176 (672)
T PHA02730 116 FDLYSYMSSDNIDLRLLKYLIVDKRIRPSKNTNYYIHCLGLVDIYVTTPNPRPEVLLWLLK 176 (672)
T ss_pred chHHHHHHhcCCcHHHHHHHHHhcCCChhhhhhhhccccchhhhhHhcCCCchHHHHHHHH
Confidence 99888887 78888888887533211 123445566666676666666543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=9e-16 Score=127.59 Aligned_cols=137 Identities=21% Similarity=0.267 Sum_probs=96.3
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHH---------------------HHHHHHHHHHhcCCC--ceee
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRN---------------------SFMKELGLWQKLRHP--NIVQ 153 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~---------------------~~~~e~~~l~~l~hp--~Iv~ 153 (370)
.+|+|++|.||.+... +..+++|++............ ....|...+..+.+. .+++
T Consensus 4 ~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~ 83 (187)
T cd05119 4 PIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPK 83 (187)
T ss_pred ccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCc
Confidence 3789999999999876 889999998654222111111 113555555555433 2445
Q ss_pred eeeeEeeCCceEEEEeecCCCCHHH-HHHhCCCCChHhHHHHHHHHHHHHHHHhh-cCCCceeecCCCCCCeeeCCCCcE
Q 042314 154 FLGVLKHSERLIFLTEYLRNGSLHD-ILKKKGKLDPPTAVAYALDIARGMNYLHH-HRPHAIIHRDLTPSNVLQDEAGHL 231 (370)
Q Consensus 154 ~~~~~~~~~~~~~v~e~~~g~~L~~-~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~iiH~Dlk~~Nil~~~~~~~ 231 (370)
+++. ...++||||++|+++.. .+... .. ...+..++.+++.++.++|+ .+ |+|+||||+||+++ ++.+
T Consensus 84 ~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 84 PIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred eEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcE
Confidence 5543 24589999999954321 11111 11 16788999999999999999 87 99999999999999 8899
Q ss_pred EEeccccceeccc
Q 042314 232 KVTDFGLSKIAQE 244 (370)
Q Consensus 232 kl~Dfg~~~~~~~ 244 (370)
+|+|||.+.....
T Consensus 154 ~liDfg~a~~~~~ 166 (187)
T cd05119 154 YIIDVPQAVEIDH 166 (187)
T ss_pred EEEECcccccccC
Confidence 9999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.8e-17 Score=105.54 Aligned_cols=55 Identities=45% Similarity=0.584 Sum_probs=30.8
Q ss_pred HHHcC-CCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 27 ELEKG-VEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 27 ll~~g-a~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
||++| +++|.+|..|.||||+||..|+.+++++|++.|+|++.+|..|+||+++|
T Consensus 1 LL~~~~~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A 56 (56)
T PF13857_consen 1 LLEHGPADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA 56 (56)
T ss_dssp -----T--TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred CCccCcCCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence 67888 88999999999999999999999999999988999999999999998876
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.7e-17 Score=153.26 Aligned_cols=91 Identities=24% Similarity=0.182 Sum_probs=49.6
Q ss_pred CCCCCChhhhHHhhcCCH--HHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 4 IDSEGPYRLLYCSSKGDR--AGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~--~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
+|..|+||||+||..|+. .+++.|++.|+++|.+|.+|+||||+|+..|+.+++++|+++|||++..|..|+||++.|
T Consensus 218 ~d~~g~tpLh~Aa~~~~~~~~~v~~ll~~g~din~~d~~g~TpLh~A~~~~~~~~v~~LL~~gad~n~~~~~g~tpl~~A 297 (471)
T PHA03095 218 TDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDGNTPLSLM 297 (471)
T ss_pred cCCCCCCHHHHHHhcCCchHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHH
Confidence 344555555555555542 345555555555555555555555555555555555555555555555555555555555
Q ss_pred cccCceeeEEeee
Q 042314 82 RSFGHVVICKILE 94 (370)
Q Consensus 82 ~~~g~~~~~~~L~ 94 (370)
+..|+.++++.|.
T Consensus 298 ~~~~~~~~v~~LL 310 (471)
T PHA03095 298 VRNNNGRAVRAAL 310 (471)
T ss_pred HHhCCHHHHHHHH
Confidence 5555555555443
|
|
| >PHA02859 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.3e-16 Score=131.91 Aligned_cols=93 Identities=17% Similarity=0.098 Sum_probs=83.3
Q ss_pred CCCChhhhHHhhc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH--CCCHHHHHHHHHcCCCccCccccCCCcccc
Q 042314 6 SEGPYRLLYCSSK---GDRAGVLQELEKGVEPNLADYDKRTALHLASS--EGRAEIVLLLLEKGADVNSLDRWGRTPLSD 80 (370)
Q Consensus 6 ~~g~t~l~~a~~~---g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~--~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~ 80 (370)
..|+||||+|+.. ++.+++++|+++|||+|.+|.+|.||||+|+. .++.+++++|+++|++++.+|..|.||+|.
T Consensus 85 ~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~~~~~~iv~~Li~~gadin~~d~~g~t~Lh~ 164 (209)
T PHA02859 85 DNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDGKNLLHMYMCNFNVRINVIKLLIDSGVSFLNKDFDNNNILYS 164 (209)
T ss_pred CCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCcccccCCCCcHHHH
Confidence 4799999998864 58999999999999999999999999999876 478999999999999999999999999995
Q ss_pred -ccccCceeeEEeeecccC
Q 042314 81 -ARSFGHVVICKILEDRGG 98 (370)
Q Consensus 81 -A~~~g~~~~~~~L~~~~~ 98 (370)
+...++.+++++|...++
T Consensus 165 ~a~~~~~~~iv~~Ll~~Ga 183 (209)
T PHA02859 165 YILFHSDKKIFDFLTSLGI 183 (209)
T ss_pred HHHhcCCHHHHHHHHHcCC
Confidence 566788899998887664
|
|
| >PHA02875 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.9e-16 Score=148.27 Aligned_cols=95 Identities=22% Similarity=0.301 Sum_probs=89.3
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCC-Cccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGR-TPLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~-tpl~~A 81 (370)
..|..|+||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++..+..|. ||++.|
T Consensus 130 ~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~eiv~~Ll~~ga~~n~~~~~~~~t~l~~A 209 (413)
T PHA02875 130 IPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGANIDYFGKNGCVAALCYA 209 (413)
T ss_pred CCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCchHHHHH
Confidence 4577899999999999999999999999999999999999999999999999999999999999999998874 788889
Q ss_pred cccCceeeEEeeeccc
Q 042314 82 RSFGHVVICKILEDRG 97 (370)
Q Consensus 82 ~~~g~~~~~~~L~~~~ 97 (370)
+..|+.++++.|...+
T Consensus 210 ~~~~~~~iv~~Ll~~g 225 (413)
T PHA02875 210 IENNKIDIVRLFIKRG 225 (413)
T ss_pred HHcCCHHHHHHHHHCC
Confidence 9999999999998765
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.5e-16 Score=152.78 Aligned_cols=77 Identities=22% Similarity=0.153 Sum_probs=57.5
Q ss_pred CCCCChhhhHHhh--cCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCC--HHHHHHHHHcCCCccCccccCCCcccc
Q 042314 5 DSEGPYRLLYCSS--KGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGR--AEIVLLLLEKGADVNSLDRWGRTPLSD 80 (370)
Q Consensus 5 ~~~g~t~l~~a~~--~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~--~~~~~~Ll~~gad~~~~~~~g~tpl~~ 80 (370)
|..|+||||+|+. +++.++|++|+++|||+|.+|.+|.||||+|+..|+ .++|++|+++|||+|.+|..|+||||.
T Consensus 174 d~~G~TpLH~A~~n~~~~~eIVklLLe~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~ 253 (764)
T PHA02716 174 KKTGYGILHAYLGNMYVDIDILEWLCNNGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMT 253 (764)
T ss_pred CCCCCcHHHHHHHhccCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHH
Confidence 5667788877653 356777888887788887777778888888777774 477777777788877777777777775
Q ss_pred c
Q 042314 81 A 81 (370)
Q Consensus 81 A 81 (370)
|
T Consensus 254 A 254 (764)
T PHA02716 254 Y 254 (764)
T ss_pred H
Confidence 3
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.5e-16 Score=129.84 Aligned_cols=80 Identities=28% Similarity=0.296 Sum_probs=76.3
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|....||||.||.+||.++|+.||+..||||+.|+.|+|||||||..|...+.+-|++.||.++.-++.|.||+..|.
T Consensus 62 ~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgntplhyacfwgydqiaedli~~ga~v~icnk~g~tpldkak 141 (448)
T KOG0195|consen 62 STNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTPLHYACFWGYDQIAEDLISCGAAVNICNKKGMTPLDKAK 141 (448)
T ss_pred cccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCchhhhhhhcHHHHHHHHHhccceeeecccCCCCchhhhc
Confidence 45667889999999999999999999999999999999999999999999999999999999999999999999998765
|
|
| >PHA02743 Viral ankyrin protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.1e-16 Score=128.19 Aligned_cols=92 Identities=24% Similarity=0.202 Sum_probs=83.4
Q ss_pred CCCCCChhhhHHhhcCCH----HHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHH---HHHHHHcCCCccCcc-ccCC
Q 042314 4 IDSEGPYRLLYCSSKGDR----AGVLQELEKGVEPNLADYDKRTALHLASSEGRAEI---VLLLLEKGADVNSLD-RWGR 75 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~----~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~---~~~Ll~~gad~~~~~-~~g~ 75 (370)
.+.++.++||.||+.|+. ++++.|++.|+++|.+|.+|+||||+|+..|+.++ +++|+++|+++|.++ ..|.
T Consensus 16 ~~~~~~~~l~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~ 95 (166)
T PHA02743 16 IDEDEQNTFLRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTGN 95 (166)
T ss_pred hccCCCcHHHHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCCC
Confidence 567789999999999998 67778889999999999999999999999998764 899999999999998 5899
Q ss_pred CccccccccCceeeEEeeec
Q 042314 76 TPLSDARSFGHVVICKILED 95 (370)
Q Consensus 76 tpl~~A~~~g~~~~~~~L~~ 95 (370)
||||.|+..|+.++++.|..
T Consensus 96 TpLh~A~~~g~~~iv~~Ll~ 115 (166)
T PHA02743 96 TLLHIAASTKNYELAEWLCR 115 (166)
T ss_pred cHHHHHHHhCCHHHHHHHHh
Confidence 99999999999999888763
|
|
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.7e-16 Score=150.02 Aligned_cols=96 Identities=31% Similarity=0.289 Sum_probs=87.0
Q ss_pred cCCCCCChhhhHHhhc-----CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCC---CHHHHHHHHHcCCCccCccccC
Q 042314 3 IIDSEGPYRLLYCSSK-----GDRAGVLQELEKGVEPNLADYDKRTALHLASSEG---RAEIVLLLLEKGADVNSLDRWG 74 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~-----g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g---~~~~~~~Ll~~gad~~~~~~~g 74 (370)
.+|..|.||||.|+.+ ++.+++++|+++|||+|.+|.+|+||||+|+..| +.+++++|+++|||++..|..|
T Consensus 66 ~~d~~g~TpL~~~~~n~~~~~~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g 145 (489)
T PHA02798 66 GLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADTTLLDKDG 145 (489)
T ss_pred CCCCCCCChHHHHHHhHHhHHhHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCccccCCCC
Confidence 3578999999999864 7799999999999999999999999999999876 7899999999999999999999
Q ss_pred CCccccccccCc---eeeEEeeecccC
Q 042314 75 RTPLSDARSFGH---VVICKILEDRGG 98 (370)
Q Consensus 75 ~tpl~~A~~~g~---~~~~~~L~~~~~ 98 (370)
.||+|.|...++ .++++.|.+.+.
T Consensus 146 ~tpL~~a~~~~~~~~~~vv~~Ll~~ga 172 (489)
T PHA02798 146 FTMLQVYLQSNHHIDIEIIKLLLEKGV 172 (489)
T ss_pred CcHHHHHHHcCCcchHHHHHHHHHhCC
Confidence 999999999887 788888877653
|
|
| >PHA03095 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.6e-16 Score=148.32 Aligned_cols=96 Identities=27% Similarity=0.269 Sum_probs=87.6
Q ss_pred cCCCCCChhhhHHhhcC---CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCC-CHHHHHHHHHcCCCccCccccCCCcc
Q 042314 3 IIDSEGPYRLLYCSSKG---DRAGVLQELEKGVEPNLADYDKRTALHLASSEG-RAEIVLLLLEKGADVNSLDRWGRTPL 78 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g---~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g-~~~~~~~Ll~~gad~~~~~~~g~tpl 78 (370)
..|..|+||||+|+..| +.++++.|+++|||+|.+|..|.||||+|+..| +.+++++|+++|+++|..+..|.|||
T Consensus 42 ~~~~~g~t~Lh~a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~iv~lLl~~ga~in~~~~~g~tpL 121 (471)
T PHA03095 42 FRGEYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAKDKVGRTPL 121 (471)
T ss_pred cCCCCCCCHHHHHHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHHHHHHHHcCCCCCCCCCCCCCHH
Confidence 35778999999999998 999999999999999999999999999999999 59999999999999999999999999
Q ss_pred cccc--ccCceeeEEeeecccC
Q 042314 79 SDAR--SFGHVVICKILEDRGG 98 (370)
Q Consensus 79 ~~A~--~~g~~~~~~~L~~~~~ 98 (370)
|.|+ ..++.++++.|.+.+.
T Consensus 122 h~a~~~~~~~~~iv~~Ll~~ga 143 (471)
T PHA03095 122 HVYLSGFNINPKVIRLLLRKGA 143 (471)
T ss_pred HHHhhCCcCCHHHHHHHHHcCC
Confidence 9999 5567788888877653
|
|
| >PHA02878 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.5e-16 Score=147.60 Aligned_cols=93 Identities=28% Similarity=0.282 Sum_probs=84.5
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHC-CCHHHHHHHHHcCCCccCccc-cCCCcccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSE-GRAEIVLLLLEKGADVNSLDR-WGRTPLSD 80 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~-g~~~~~~~Ll~~gad~~~~~~-~g~tpl~~ 80 (370)
..|..|+||||+|+..|+.+++++|+++|+++|.+|..|.||||+|+.. ++.+++++|+++|+++|..+. .|.||||.
T Consensus 196 ~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~~~~g~TpLh~ 275 (477)
T PHA02878 196 IPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILGLTALHS 275 (477)
T ss_pred CcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhcCCHHHHHHHHHcCCCCCccCCCCCCCHHHH
Confidence 4678899999999999999999999999999999999999999999975 799999999999999999886 79999999
Q ss_pred ccccCceeeEEeeeccc
Q 042314 81 ARSFGHVVICKILEDRG 97 (370)
Q Consensus 81 A~~~g~~~~~~~L~~~~ 97 (370)
| .++.++++.|.+.+
T Consensus 276 A--~~~~~~v~~Ll~~g 290 (477)
T PHA02878 276 S--IKSERKLKLLLEYG 290 (477)
T ss_pred H--ccCHHHHHHHHHCC
Confidence 9 45667777777654
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.2e-16 Score=148.26 Aligned_cols=96 Identities=32% Similarity=0.461 Sum_probs=76.7
Q ss_pred cCCCCCChhhhHHh--hcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCC--CHHHHHHHHHcCCCccCccccCCCcc
Q 042314 3 IIDSEGPYRLLYCS--SKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEG--RAEIVLLLLEKGADVNSLDRWGRTPL 78 (370)
Q Consensus 3 ~~~~~g~t~l~~a~--~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g--~~~~~~~Ll~~gad~~~~~~~g~tpl 78 (370)
..|..|+||||+|| ..|+.+++++|+++|+++|..|.+|.||||+|+..| +.+++++|+++|++++..+..|.|||
T Consensus 101 ~~d~~g~tpL~~A~~~~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~~d~~g~tpL 180 (480)
T PHA03100 101 APDNNGITPLLYAISKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRYGYTPL 180 (480)
T ss_pred CCCCCCCchhhHHHhcccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCcccccCCCCCHH
Confidence 35667888888888 888888888888888888888888888888888888 78888888888888888888888888
Q ss_pred ccccccCceeeEEeeecccC
Q 042314 79 SDARSFGHVVICKILEDRGG 98 (370)
Q Consensus 79 ~~A~~~g~~~~~~~L~~~~~ 98 (370)
|.|+..|+.++++.|.+.+.
T Consensus 181 ~~A~~~~~~~iv~~Ll~~ga 200 (480)
T PHA03100 181 HIAVEKGNIDVIKFLLDNGA 200 (480)
T ss_pred HHHHHhCCHHHHHHHHHcCC
Confidence 88888888888777766543
|
|
| >PHA02874 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.4e-17 Score=153.36 Aligned_cols=96 Identities=27% Similarity=0.233 Sum_probs=83.9
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCC-----------------
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGA----------------- 65 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~ga----------------- 65 (370)
..+..|.||||+|+..|+.++|++|+++|+++|..+..|.||||.|+..|+.+++++|+++|+
T Consensus 30 ~~~~~~~tpL~~A~~~g~~~iv~~Ll~~Ga~~n~~~~~~~t~L~~A~~~~~~~iv~~Ll~~g~~~~~~~~~~~~~~~i~~ 109 (434)
T PHA02874 30 ISVDETTTPLIDAIRSGDAKIVELFIKHGADINHINTKIPHPLLTAIKIGAHDIIKLLIDNGVDTSILPIPCIEKDMIKT 109 (434)
T ss_pred CcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcchhccCCHHHHHH
Confidence 346678999999999999999999999999999999999999999999999999988887764
Q ss_pred ------CccCccccCCCccccccccCceeeEEeeecccC
Q 042314 66 ------DVNSLDRWGRTPLSDARSFGHVVICKILEDRGG 98 (370)
Q Consensus 66 ------d~~~~~~~g~tpl~~A~~~g~~~~~~~L~~~~~ 98 (370)
+++..+..|.||||.|+..|+.++++.|.+.+.
T Consensus 110 ll~~g~d~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~ga 148 (434)
T PHA02874 110 ILDCGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGA 148 (434)
T ss_pred HHHCcCCCCCCCCCCccHHHHHHHCCCHHHHHHHHhCCC
Confidence 466778889999999999999999988877653
|
|
| >PHA02716 CPXV016; CPX019; EVM010; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.5e-16 Score=149.45 Aligned_cols=82 Identities=23% Similarity=0.185 Sum_probs=64.7
Q ss_pred hcCCHHHHHHHHHcC-CCCCCC-CCCCCcHHHHHHH--CCCHHHHHHHHHcCCCccCccccCCCccccccccCce--eeE
Q 042314 17 SKGDRAGVLQELEKG-VEPNLA-DYDKRTALHLASS--EGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV--VIC 90 (370)
Q Consensus 17 ~~g~~~~~~~ll~~g-a~~~~~-~~~g~t~l~~A~~--~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~~--~~~ 90 (370)
+.++.++|++|+++| ||+|.+ |..|.||||+|+. .++.+++++|+++|+|+|..|..|.||||.|+..|+. +++
T Consensus 151 ~~v~leiVk~LLe~G~ADIN~~~d~~G~TpLH~A~~n~~~~~eIVklLLe~GADVN~kD~~G~TPLH~Aa~~g~~~~eIV 230 (764)
T PHA02716 151 RGIDLDLIKYMVDVGIVNLNYVCKKTGYGILHAYLGNMYVDIDILEWLCNNGVNVNLQNNHLITPLHTYLITGNVCASVI 230 (764)
T ss_pred cCCCHHHHHHHHHCCCCCcccccCCCCCcHHHHHHHhccCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCCCHHHH
Confidence 457888888888888 888887 7888888888764 3567888888888888888888888888888888753 677
Q ss_pred EeeecccC
Q 042314 91 KILEDRGG 98 (370)
Q Consensus 91 ~~L~~~~~ 98 (370)
+.|.+.|+
T Consensus 231 klLLe~GA 238 (764)
T PHA02716 231 KKIIELGG 238 (764)
T ss_pred HHHHHcCC
Confidence 77776654
|
|
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=1e-15 Score=149.10 Aligned_cols=96 Identities=15% Similarity=0.122 Sum_probs=84.5
Q ss_pred cCCCCCChhhhHHhhc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCC---------------------------
Q 042314 3 IIDSEGPYRLLYCSSK---GDRAGVLQELEKGVEPNLADYDKRTALHLASSEG--------------------------- 52 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~---g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g--------------------------- 52 (370)
.+|.+|+||||+||.. |+.++|++||+.|||+|..|.+|+||||+|+..|
T Consensus 27 ~~d~~g~t~Lh~a~~~~~~~~~~~v~~Ll~~ga~v~~~~~~g~TpL~~Aa~~g~~~v~~~~~~~Ll~~~~~~n~~~~~~~ 106 (661)
T PHA02917 27 TRNQFKNNALHAYLFNEHCNNVEVVKLLLDSGTNPLHKNWRQLTPLEEYTNSRHVKVNKDIAMALLEATGYSNINDFNIF 106 (661)
T ss_pred ccCCCCCcHHHHHHHhhhcCcHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCChhHHHHHHHHHHhccCCCCCCCcchH
Confidence 3588999999998665 8899999999999999999999999999888654
Q ss_pred --------CHHHHHHHHHcCCCccCccccCCCccccc--cccCceeeEEeeecccC
Q 042314 53 --------RAEIVLLLLEKGADVNSLDRWGRTPLSDA--RSFGHVVICKILEDRGG 98 (370)
Q Consensus 53 --------~~~~~~~Ll~~gad~~~~~~~g~tpl~~A--~~~g~~~~~~~L~~~~~ 98 (370)
+.|+|++|+++|+|+|.+|..|+|||+.+ +..|+.+++++|.+.|+
T Consensus 107 ~~~a~~~~~~e~vk~Ll~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga 162 (661)
T PHA02917 107 SYMKSKNVDVDLIKVLVEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGC 162 (661)
T ss_pred HHHHhhcCCHHHHHHHHHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCC
Confidence 45778899999999999999999999953 46789999999988875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2e-15 Score=128.63 Aligned_cols=201 Identities=22% Similarity=0.324 Sum_probs=142.8
Q ss_pred HHHhcCCCceeeeeeeEeeC-----CceEEEEeecCCCCHHHHHHhC----CCCChHhHHHHHHHHHHHHHHHhhcCCCc
Q 042314 142 LWQKLRHPNIVQFLGVLKHS-----ERLIFLTEYLRNGSLHDILKKK----GKLDPPTAVAYALDIARGMNYLHHHRPHA 212 (370)
Q Consensus 142 ~l~~l~hp~Iv~~~~~~~~~-----~~~~~v~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~ 212 (370)
-+-++-|.|+++++.++.+. .+..++.||++.|+|.+++++. ..+......+|..||++||.|||+.. .+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 34455689999999987653 3578999999999999999864 35788889999999999999999998 68
Q ss_pred eeecCCCCCCeeeCCCCcEEEeccccceecc-ccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhC
Q 042314 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQ-EKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG 291 (370)
Q Consensus 213 iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~-~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g 291 (370)
|+|+++..+-|++..+|-+|+.--.-...-. .............+.+.|.+||.-.-...+-++|||++|++..+|.-+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999999988875322111000 000001112223467899999987777778899999999999999887
Q ss_pred CCCCCCC-cHHHHHHHhh--ccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 292 GPSNRAD-TAVQVADRRA--YEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 292 ~~p~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
..-.... +.......+. ..+.. ..-=+.++.+|++..|..||++.+++.|.-
T Consensus 279 Eiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred eeccCCCcceeehhhhhhhheeecc-------CccccCcCcccccCCCCCCcchhhhhcCce
Confidence 6543222 1111111111 01111 112357899999999999999999988753
|
|
| >PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.3e-15 Score=99.18 Aligned_cols=47 Identities=32% Similarity=0.408 Sum_probs=32.1
Q ss_pred ccCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHH
Q 042314 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLA 48 (370)
Q Consensus 2 ~~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A 48 (370)
+.+|..|+||||+||.+|+.++|++|++.|+|+|.+|.+|+||||+|
T Consensus 10 n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A 56 (56)
T PF13857_consen 10 NAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA 56 (56)
T ss_dssp T---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred cCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence 46789999999999999999999999999999999999999999998
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.6e-17 Score=162.00 Aligned_cols=93 Identities=33% Similarity=0.423 Sum_probs=88.0
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccccc
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSF 84 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~ 84 (370)
+..+.++||.||..|+.++++.|+++|+|+|..|.+|+||||+||..|+.+++++|+++|+|+|.+|..|+||+|.|+..
T Consensus 522 ~~~~~~~L~~Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~ 601 (823)
T PLN03192 522 DPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISA 601 (823)
T ss_pred CccchhHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHh
Confidence 34568999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CceeeEEeeeccc
Q 042314 85 GHVVICKILEDRG 97 (370)
Q Consensus 85 g~~~~~~~L~~~~ 97 (370)
|+.++++.|...+
T Consensus 602 g~~~iv~~L~~~~ 614 (823)
T PLN03192 602 KHHKIFRILYHFA 614 (823)
T ss_pred CCHHHHHHHHhcC
Confidence 9999999887543
|
|
| >PHA03100 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-15 Score=145.21 Aligned_cols=89 Identities=30% Similarity=0.309 Sum_probs=85.7
Q ss_pred ChhhhHHhhcCC--HHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccCc
Q 042314 9 PYRLLYCSSKGD--RAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86 (370)
Q Consensus 9 ~t~l~~a~~~g~--~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~ 86 (370)
.||||+|+..|+ .++++.|+++|+++|.+|..|.||||+|+..|+.+++++|+++|+|++..|..|.||++.|...++
T Consensus 216 ~t~l~~a~~~~~~~~~iv~~Ll~~g~din~~d~~g~TpL~~A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpl~~A~~~~~ 295 (480)
T PHA03100 216 ETPLHIAACYNEITLEVVNYLLSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIAILNNN 295 (480)
T ss_pred HhHHHHHHHhCcCcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHHHHhCC
Confidence 899999999999 999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeEEeeeccc
Q 042314 87 VVICKILEDRG 97 (370)
Q Consensus 87 ~~~~~~L~~~~ 97 (370)
.++++.|.+.+
T Consensus 296 ~~iv~~Ll~~g 306 (480)
T PHA03100 296 KEIFKLLLNNG 306 (480)
T ss_pred HHHHHHHHhcC
Confidence 99999887754
|
|
| >KOG4214 consensus Myotrophin and similar proteins [Transcription] | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.4e-16 Score=106.81 Aligned_cols=89 Identities=29% Similarity=0.421 Sum_probs=82.8
Q ss_pred ChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccCcee
Q 042314 9 PYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVV 88 (370)
Q Consensus 9 ~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~~~ 88 (370)
.-..+|+..+|.++-|+..+..|-|||..- .|+||||+||-.|+.+++++|+..||+++.+|++|-|||-.|...||.+
T Consensus 3 d~~~~W~vkNG~~DeVk~~v~~g~nVn~~~-ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~ 81 (117)
T KOG4214|consen 3 DMSVAWNVKNGEIDEVKQSVNEGLNVNEIY-GGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRD 81 (117)
T ss_pred chhHhhhhccCcHHHHHHHHHccccHHHHh-CCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHH
Confidence 345789999999999999999999998775 8999999999999999999999999999999999999999999999999
Q ss_pred eEEeeecccC
Q 042314 89 ICKILEDRGG 98 (370)
Q Consensus 89 ~~~~L~~~~~ 98 (370)
++++|++.++
T Consensus 82 cVklLL~~GA 91 (117)
T KOG4214|consen 82 CVKLLLQNGA 91 (117)
T ss_pred HHHHHHHcCc
Confidence 9999987653
|
|
| >PHA02946 ankyin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.1e-15 Score=140.21 Aligned_cols=91 Identities=30% Similarity=0.305 Sum_probs=80.7
Q ss_pred CChhhhHHhh--cCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccC
Q 042314 8 GPYRLLYCSS--KGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFG 85 (370)
Q Consensus 8 g~t~l~~a~~--~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g 85 (370)
+.++||.++. .++.++|++|+++|+++|.+|.+|+||||+||..|+.+++++|+++|||+|.+|..|+||||+|+..+
T Consensus 37 ~~~~Lh~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~ 116 (446)
T PHA02946 37 NYHILHAYCGIKGLDERFVEELLHRGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTD 116 (446)
T ss_pred CChHHHHHHHhcCCCHHHHHHHHHCcCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcC
Confidence 4699998764 45789999999999999999999999999999999999999999999999999999999999988765
Q ss_pred c--eeeEEeeecccC
Q 042314 86 H--VVICKILEDRGG 98 (370)
Q Consensus 86 ~--~~~~~~L~~~~~ 98 (370)
+ .+++++|...++
T Consensus 117 ~~~~e~v~lLl~~Ga 131 (446)
T PHA02946 117 DEVIERINLLVQYGA 131 (446)
T ss_pred CchHHHHHHHHHcCC
Confidence 4 566777776654
|
|
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.5e-15 Score=143.63 Aligned_cols=122 Identities=15% Similarity=0.114 Sum_probs=87.8
Q ss_pred cCCCCCChhhhHHhh--cCCHHHHHHHHHcCCCCCC-CCCCCCcHHHHHHHCC----CHHHHHHHHHcCCCccCc-----
Q 042314 3 IIDSEGPYRLLYCSS--KGDRAGVLQELEKGVEPNL-ADYDKRTALHLASSEG----RAEIVLLLLEKGADVNSL----- 70 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~--~g~~~~~~~ll~~ga~~~~-~~~~g~t~l~~A~~~g----~~~~~~~Ll~~gad~~~~----- 70 (370)
.+|..|+||||+|+. .++.++|++|+++|||+|. .|..|.||||+|+..+ +.+++++|+++|+++|..
T Consensus 140 ~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~~~~~~g~tpL~~a~~~~~~~~~~~iv~~Ll~~Ga~vn~~~~~~~ 219 (494)
T PHA02989 140 VKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFEKTSLYGLTPMNIYLRNDIDVISIKVIKYLIKKGVNIETNNNGSE 219 (494)
T ss_pred ccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccccccccCCChHHHHHhcccccccHHHHHHHHhCCCCccccCCccc
Confidence 467788888888765 4688888888888888888 5778888888887654 788888888888766543
Q ss_pred ---------------------------------cccCCCccccccccCceeeEEeeecccC----CCCCCcccEEEEEEc
Q 042314 71 ---------------------------------DRWGRTPLSDARSFGHVVICKILEDRGG----IDPGAYGEVYLVKWR 113 (370)
Q Consensus 71 ---------------------------------~~~g~tpl~~A~~~g~~~~~~~L~~~~~----l~~g~~~~v~~a~~~ 113 (370)
|..|+||||.|+..|+.++++.|.+.++ .+..+...+..|...
T Consensus 220 t~l~~~~~~~~~~~~~~~~il~~l~~~advn~~d~~G~TpL~~Aa~~~~~~~v~~LL~~Gadin~~d~~G~TpL~~A~~~ 299 (494)
T PHA02989 220 SVLESFLDNNKILSKKEFKVLNFILKYIKINKKDKKGFNPLLISAKVDNYEAFNYLLKLGDDIYNVSKDGDTVLTYAIKH 299 (494)
T ss_pred cHHHHHHHhchhhcccchHHHHHHHhCCCCCCCCCCCCCHHHHHHHhcCHHHHHHHHHcCCCccccCCCCCCHHHHHHHc
Confidence 4458888888888888888888877664 333344445555555
Q ss_pred CceeEEEEecc
Q 042314 114 GTEIAAKTIRS 124 (370)
Q Consensus 114 g~~vavK~l~~ 124 (370)
+...+++.+..
T Consensus 300 ~~~~iv~~LL~ 310 (494)
T PHA02989 300 GNIDMLNRILQ 310 (494)
T ss_pred CCHHHHHHHHh
Confidence 55555555443
|
|
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.7e-15 Score=149.06 Aligned_cols=94 Identities=24% Similarity=0.242 Sum_probs=59.8
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCC-HHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGR-AEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~-~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
+|..|+||||+||..|+.+++++|+++|++++..+..|.||||+|+..++ .+++++|+++|+++|.+|..|+||||.|+
T Consensus 371 ~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A~~~~~~~~~vk~Ll~~gadin~~d~~G~TpLh~Aa 450 (682)
T PHA02876 371 RDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNPYMSVKTLIDRGANVNSKNKDLSTPLHYAC 450 (682)
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCCCchHHHHHHcCCHHHHHHHHHhCCCCCCcCCCCCChHHHHHH
Confidence 45566666666666666666666666666666666666666666665444 34566666666666666666677777666
Q ss_pred ccC-ceeeEEeeeccc
Q 042314 83 SFG-HVVICKILEDRG 97 (370)
Q Consensus 83 ~~g-~~~~~~~L~~~~ 97 (370)
..| +.+++++|.+.+
T Consensus 451 ~~~~~~~iv~lLl~~G 466 (682)
T PHA02876 451 KKNCKLDVIEMLLDNG 466 (682)
T ss_pred HhCCcHHHHHHHHHCC
Confidence 654 456666665544
|
|
| >KOG1710 consensus MYND Zn-finger and ankyrin repeat protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.5e-15 Score=124.75 Aligned_cols=94 Identities=28% Similarity=0.276 Sum_probs=87.8
Q ss_pred ccCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCC-CCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccc
Q 042314 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLA-DYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSD 80 (370)
Q Consensus 2 ~~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~-~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~ 80 (370)
+.+|.+|.|+|..||+.|+.+.|+.||+.|||||.. +..+.||||+||..|+.++.++|++.|+.....|.-|+|+-..
T Consensus 39 n~~D~sGMs~LahAaykGnl~~v~lll~~gaDvN~~qhg~~YTpLmFAALSGn~dvcrllldaGa~~~~vNsvgrTAaqm 118 (396)
T KOG1710|consen 39 NQRDPSGMSVLAHAAYKGNLTLVELLLELGADVNDKQHGTLYTPLMFAALSGNQDVCRLLLDAGARMYLVNSVGRTAAQM 118 (396)
T ss_pred hccCCCcccHHHHHHhcCcHHHHHHHHHhCCCcCcccccccccHHHHHHHcCCchHHHHHHhccCccccccchhhhHHHH
Confidence 357899999999999999999999999999999974 7889999999999999999999999999999999999999999
Q ss_pred ccccCceeeEEeeec
Q 042314 81 ARSFGHVVICKILED 95 (370)
Q Consensus 81 A~~~g~~~~~~~L~~ 95 (370)
|+.-|+.+.+.++.+
T Consensus 119 AAFVG~H~CV~iINN 133 (396)
T KOG1710|consen 119 AAFVGHHECVAIINN 133 (396)
T ss_pred HHHhcchHHHHHHhc
Confidence 999999988876644
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.8e-13 Score=126.24 Aligned_cols=164 Identities=20% Similarity=0.334 Sum_probs=128.5
Q ss_pred cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHHHHHHhCCCCChHhHH
Q 042314 113 RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAV 192 (370)
Q Consensus 113 ~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~ 192 (370)
.+.++.|...+.... +......+.+..++.++||+|+++++.+..+..+|+|+|.+ ..|..++++.+ ...+.
T Consensus 36 ~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~---~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG---KEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH---HHHHH
Confidence 477777777765432 55566778889999999999999999999999999999998 47888887654 66777
Q ss_pred HHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCCCCccccCcccccccCC
Q 042314 193 AYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272 (370)
Q Consensus 193 ~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 272 (370)
..+.||+.||.|||..+ .++|++|.-..|+|+..|..||.+|.++........ .......--.|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcCccc-
Confidence 88999999999998655 399999999999999999999999998765543321 111112233566777654443
Q ss_pred CchhhHHHHHHHHHHHHhC
Q 042314 273 GKSVDVFSFALIVHEMFQG 291 (370)
Q Consensus 273 ~~~~Di~slG~~l~el~~g 291 (370)
-..|.|.|||+++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 457999999999999999
|
|
| >PHA02917 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.3e-15 Score=144.05 Aligned_cols=93 Identities=22% Similarity=0.117 Sum_probs=76.2
Q ss_pred cCCCCCChhhhHH--hhcCCHHHHHHHHHcCCCCCCCCC---CC-----------CcHHHHHHH-----------CCCHH
Q 042314 3 IIDSEGPYRLLYC--SSKGDRAGVLQELEKGVEPNLADY---DK-----------RTALHLASS-----------EGRAE 55 (370)
Q Consensus 3 ~~~~~g~t~l~~a--~~~g~~~~~~~ll~~ga~~~~~~~---~g-----------~t~l~~A~~-----------~g~~~ 55 (370)
.+|..|+||||+| +..|+.++|++||++|||+|..|. .| .||||+|+. .|+.+
T Consensus 131 ~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~~d~~~~~g~~~~~~~~~~~~t~L~~a~~~~~~~~~~~~~~~~~e 210 (661)
T PHA02917 131 VKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLYEDEDDEYGYAYDDYQPRNCGTVLHLYIISHLYSESDTRAYVRPE 210 (661)
T ss_pred ccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCccccccccccccccccccccccccHHHHHHhhcccccccccccCcHH
Confidence 4567899999854 357899999999999999986653 34 499999975 46889
Q ss_pred HHHHHHHcCCCccCccccCCCccccccccCce--eeEEeeec
Q 042314 56 IVLLLLEKGADVNSLDRWGRTPLSDARSFGHV--VICKILED 95 (370)
Q Consensus 56 ~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~~--~~~~~L~~ 95 (370)
++++|+++|||+|.+|..|.||||.|+..|+. ++++.|..
T Consensus 211 iv~~Li~~Gadvn~~d~~G~TpLh~A~~~g~~~~eivk~Li~ 252 (661)
T PHA02917 211 VVKCLINHGIKPSSIDKNYCTALQYYIKSSHIDIDIVKLLMK 252 (661)
T ss_pred HHHHHHHCCCCcccCCCCCCcHHHHHHHcCCCcHHHHHHHHh
Confidence 99999999999999999999999999998886 57887753
|
|
| >PHA02730 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.8e-15 Score=140.74 Aligned_cols=94 Identities=15% Similarity=0.110 Sum_probs=82.3
Q ss_pred CCCCChhhhHHhhcCC----HHHHHHHHHcCC--CCCCCCCCCCcHHHH---HHHCC---------CHHHHHHHHHcCCC
Q 042314 5 DSEGPYRLLYCSSKGD----RAGVLQELEKGV--EPNLADYDKRTALHL---ASSEG---------RAEIVLLLLEKGAD 66 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~----~~~~~~ll~~ga--~~~~~~~~g~t~l~~---A~~~g---------~~~~~~~Ll~~gad 66 (370)
+..|+||||+||..++ .+++++||++|| |+|.+|.+|.||||. |+..+ ..+++++|+++|||
T Consensus 375 k~~G~TpLH~Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~~~e~~~~~ivk~LIs~GAD 454 (672)
T PHA02730 375 TTDNNYPLHDYFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYHCYETILIDVFDILSKYMDD 454 (672)
T ss_pred CCCCCcHHHHHHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHHHHHhccccccccchhHHHHHHHHHhcccc
Confidence 3689999999998875 899999999998 699999999999994 44332 23579999999999
Q ss_pred ccCccccCCCccccccccCceeeEEeeecccC
Q 042314 67 VNSLDRWGRTPLSDARSFGHVVICKILEDRGG 98 (370)
Q Consensus 67 ~~~~~~~g~tpl~~A~~~g~~~~~~~L~~~~~ 98 (370)
+|.+|..|+||||.|+..++.++++.|...|+
T Consensus 455 INakD~~G~TPLh~Aa~~~~~eive~LI~~GA 486 (672)
T PHA02730 455 IDMIDNENKTLLYYAVDVNNIQFARRLLEYGA 486 (672)
T ss_pred hhccCCCCCCHHHHHHHhCCHHHHHHHHHCCC
Confidence 99999999999999999999999999987765
|
|
| >PHA02798 ankyrin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.4e-15 Score=140.22 Aligned_cols=96 Identities=29% Similarity=0.321 Sum_probs=84.7
Q ss_pred cCCCCCChhhhHHhhcC---CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCC---HHHHHHHHHcCCCccCcc-ccCC
Q 042314 3 IIDSEGPYRLLYCSSKG---DRAGVLQELEKGVEPNLADYDKRTALHLASSEGR---AEIVLLLLEKGADVNSLD-RWGR 75 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g---~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~---~~~~~~Ll~~gad~~~~~-~~g~ 75 (370)
.+|..|+||||+|+.+| +.+++++|+++|||+|.+|.+|.||||+|+..|+ .+++++|+++|+|++..+ ..|.
T Consensus 104 ~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~~~~~~~ 183 (489)
T PHA02798 104 KKNSDGETPLYCLLSNGYINNLEILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTHNNKEKY 183 (489)
T ss_pred CCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCcccccCcCCC
Confidence 46789999999999876 7899999999999999999999999999999998 999999999999999985 5689
Q ss_pred Ccccccccc----CceeeEEeeecccC
Q 042314 76 TPLSDARSF----GHVVICKILEDRGG 98 (370)
Q Consensus 76 tpl~~A~~~----g~~~~~~~L~~~~~ 98 (370)
||+|.+... ++.++++.|.+.++
T Consensus 184 t~Lh~~~~~~~~~~~~~ivk~Li~~Ga 210 (489)
T PHA02798 184 DTLHCYFKYNIDRIDADILKLFVDNGF 210 (489)
T ss_pred cHHHHHHHhccccCCHHHHHHHHHCCC
Confidence 999987543 46778888876653
|
|
| >PHA02989 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.2e-15 Score=139.74 Aligned_cols=94 Identities=16% Similarity=0.199 Sum_probs=53.0
Q ss_pred CCCCCChhhhHHhhc---CCHHHHHHHHHcCCCC-CCCCCCCCcHHHHHHHC--CCHHHHHHHHHcCCCccC-ccccCCC
Q 042314 4 IDSEGPYRLLYCSSK---GDRAGVLQELEKGVEP-NLADYDKRTALHLASSE--GRAEIVLLLLEKGADVNS-LDRWGRT 76 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~---g~~~~~~~ll~~ga~~-~~~~~~g~t~l~~A~~~--g~~~~~~~Ll~~gad~~~-~~~~g~t 76 (370)
+|..|+||||.|+.. |+.++|++|+++|||+ +.+|..|+||||+|+.. ++.+++++|+++|+|++. .+..|.|
T Consensus 104 ~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~~~~~~g~t 183 (494)
T PHA02989 104 KTFNGVSPIVCFIYNSNINNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFEKTSLYGLT 183 (494)
T ss_pred CCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccccccccCCC
Confidence 455566666655433 4556666666666666 55666666666665432 455666666666666665 4555666
Q ss_pred cccccccc----CceeeEEeeeccc
Q 042314 77 PLSDARSF----GHVVICKILEDRG 97 (370)
Q Consensus 77 pl~~A~~~----g~~~~~~~L~~~~ 97 (370)
|++.|... ++.++++.|.+.|
T Consensus 184 pL~~a~~~~~~~~~~~iv~~Ll~~G 208 (494)
T PHA02989 184 PMNIYLRNDIDVISIKVIKYLIKKG 208 (494)
T ss_pred hHHHHHhcccccccHHHHHHHHhCC
Confidence 66554432 3455555555443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.9e-14 Score=132.50 Aligned_cols=240 Identities=20% Similarity=0.230 Sum_probs=178.7
Q ss_pred CCC--CCcccEEEEEE----cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeec
Q 042314 99 IDP--GAYGEVYLVKW----RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 99 l~~--g~~~~v~~a~~----~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
+|. |.++.+|.+.. .+..+++|.-+... ..+....+-.+|+...+.++ |++.++....+...+.+++-+|++
T Consensus 122 ~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~ 200 (524)
T KOG0601|consen 122 TGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC 200 (524)
T ss_pred cccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCCcceeeeccc
Confidence 677 99999998876 36677777743332 22233344456666666664 899999888899999999999999
Q ss_pred CCCCHHHHHHhCCC-CChHhHHHHHHHHHH----HHHHHhhcCCCceeecCCCCCCeeeCCC-CcEEEeccccceecccc
Q 042314 172 RNGSLHDILKKKGK-LDPPTAVAYALDIAR----GMNYLHHHRPHAIIHRDLTPSNVLQDEA-GHLKVTDFGLSKIAQEK 245 (370)
Q Consensus 172 ~g~~L~~~l~~~~~-~~~~~~~~i~~~l~~----~l~~lH~~~~~~iiH~Dlk~~Nil~~~~-~~~kl~Dfg~~~~~~~~ 245 (370)
. .+|..+...... ++...++....+... |+.++|+.+ ++|-|+||.||+...+ ...+++|||+...++..
T Consensus 201 ~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~ 276 (524)
T KOG0601|consen 201 G-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDG 276 (524)
T ss_pred c-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEccCC
Confidence 5 588888776655 788899999999999 999999998 9999999999999998 78899999999888776
Q ss_pred Cccc-eec-cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC--cHHHHHHHhhccCCCCCCCCCCc
Q 042314 246 DSYS-YKM-TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRAD--TAVQVADRRAYEDSRPALSSLYP 321 (370)
Q Consensus 246 ~~~~-~~~-~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 321 (370)
.... ... ....+...|++||...+. ++.++|+|++|.+..+-.++-.++... ..+...... ....++....+
T Consensus 277 ~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~---~ip~e~~~~~s 352 (524)
T KOG0601|consen 277 NFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG---YIPLEFCEGGS 352 (524)
T ss_pred ccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc---cCchhhhcCcc
Confidence 5222 111 122578899999987654 688999999999999988776554333 222111111 12233444456
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIF 347 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~ 347 (370)
..+...+..+++.+|-.|++++.+..
T Consensus 353 ~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 353 SSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 67788999999999999999887654
|
|
| >PTZ00322 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-14 Score=142.45 Aligned_cols=87 Identities=38% Similarity=0.567 Sum_probs=83.6
Q ss_pred hhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccCceee
Q 042314 10 YRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVI 89 (370)
Q Consensus 10 t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~~~~ 89 (370)
++||.||..|+.++|+.|+++|+|+|.+|.+|+||||+||..|+.+++++|+++|+|+|.+|..|.||||.|+..|+.++
T Consensus 84 ~~L~~aa~~G~~~~vk~LL~~Gadin~~d~~G~TpLh~Aa~~g~~eiv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~i 163 (664)
T PTZ00322 84 VELCQLAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREV 163 (664)
T ss_pred HHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHH
Confidence 45889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEeeecc
Q 042314 90 CKILEDR 96 (370)
Q Consensus 90 ~~~L~~~ 96 (370)
+++|...
T Consensus 164 v~~Ll~~ 170 (664)
T PTZ00322 164 VQLLSRH 170 (664)
T ss_pred HHHHHhC
Confidence 9998776
|
|
| >cd00204 ANK ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.5e-14 Score=110.23 Aligned_cols=95 Identities=44% Similarity=0.559 Sum_probs=89.4
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|.+|+||||+|+..|+.+++++|++.|++++..|..|.||||.|+..+..+++++|+++|++++..+..|.||+|.|.
T Consensus 2 ~~~~~g~t~l~~a~~~~~~~~i~~li~~~~~~~~~~~~g~~~l~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~l~~a~ 81 (126)
T cd00204 2 ARDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAA 81 (126)
T ss_pred CcCcCCCCHHHHHHHcCcHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHH
Confidence 46788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeeccc
Q 042314 83 SFGHVVICKILEDRG 97 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~ 97 (370)
..++.++++.|...+
T Consensus 82 ~~~~~~~~~~L~~~~ 96 (126)
T cd00204 82 RNGNLDVVKLLLKHG 96 (126)
T ss_pred HcCcHHHHHHHHHcC
Confidence 999999988886643
|
The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. |
| >KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.7e-15 Score=118.02 Aligned_cols=96 Identities=24% Similarity=0.177 Sum_probs=87.2
Q ss_pred CccCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccc
Q 042314 1 GQIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSD 80 (370)
Q Consensus 1 ~~~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~ 80 (370)
|+..+--+++|++++....+++.+..|.++ .||..|+.|.|||+||+..||.++|++||+.|||++...++-.++|..
T Consensus 122 gnevs~~p~s~~slsVhql~L~~~~~~~~n--~VN~~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsL 199 (296)
T KOG0502|consen 122 GNEVSLMPWSPLSLSVHQLHLDVVDLLVNN--KVNACDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSL 199 (296)
T ss_pred CCccccccCChhhHHHHHHHHHHHHHHhhc--cccCccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhH
Confidence 456677899999999999988888777665 689999999999999999999999999999999999999999999999
Q ss_pred ccccCceeeEEeeecccC
Q 042314 81 ARSFGHVVICKILEDRGG 98 (370)
Q Consensus 81 A~~~g~~~~~~~L~~~~~ 98 (370)
|.+.|..+++++|+..+.
T Consensus 200 At~ggytdiV~lLL~r~v 217 (296)
T KOG0502|consen 200 ATRGGYTDIVELLLTREV 217 (296)
T ss_pred HhcCChHHHHHHHHhcCC
Confidence 999999999999987654
|
|
| >PHA02876 ankyrin repeat protein; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.4e-14 Score=142.37 Aligned_cols=94 Identities=34% Similarity=0.389 Sum_probs=52.7
Q ss_pred CCCCCChhhhHHhhcC-CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHC-CCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 4 IDSEGPYRLLYCSSKG-DRAGVLQELEKGVEPNLADYDKRTALHLASSE-GRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g-~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~-g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
.|.+|+||||+||..| +.++++.|+..|+++|..|..|.||||+|+.. ++.+++++|+++|+++|.+|..|.||||.|
T Consensus 303 ~d~~g~TpLh~Aa~~g~~~~~v~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~iv~lLl~~gadin~~d~~G~TpLh~A 382 (682)
T PHA02876 303 KNIKGETPLYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNARDYCDKTPIHYA 382 (682)
T ss_pred cCCCCCCHHHHHHHhCCCHHHHHHHHHcCCCCCCcccCCCcHHHHHHHhCCcHHHHHHHHHcCCCCccCCCCCCCHHHHH
Confidence 3445555555555555 35555555555555555555555555555543 345555566666666666666666666666
Q ss_pred cccCceeeEEeeeccc
Q 042314 82 RSFGHVVICKILEDRG 97 (370)
Q Consensus 82 ~~~g~~~~~~~L~~~~ 97 (370)
+..|+.++++.|.+.+
T Consensus 383 a~~~~~~iv~~Ll~~g 398 (682)
T PHA02876 383 AVRNNVVIINTLLDYG 398 (682)
T ss_pred HHcCCHHHHHHHHHCC
Confidence 6666666666555443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 370 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-36 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-36 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-35 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-35 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-35 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-30 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-29 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-28 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-28 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-28 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-28 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-28 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-28 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-28 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-28 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-27 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-27 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-27 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-27 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-27 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-27 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-27 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-27 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-27 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-27 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-26 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-26 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-26 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-26 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-26 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-26 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-26 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-26 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-26 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-25 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-25 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-25 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-25 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-25 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-25 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-25 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-25 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-25 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-25 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-25 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-25 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-25 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-25 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-25 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-25 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-25 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-25 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-25 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-25 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-25 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-25 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-25 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-25 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-25 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-25 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-25 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-25 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-25 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-25 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-25 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-25 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-25 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-25 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-25 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-25 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-25 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-25 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-25 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-25 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-24 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-24 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-24 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-24 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-24 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-24 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-24 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-24 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-24 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-24 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-24 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-24 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-24 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-24 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-24 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-24 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-24 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-24 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-24 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-24 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-24 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-24 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-24 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-24 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-24 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-24 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-24 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-24 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-24 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-24 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-24 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-24 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-24 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-23 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-23 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-23 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-23 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-23 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-23 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-23 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-23 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-23 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-23 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-23 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-23 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-23 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-23 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-23 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-23 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-23 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-23 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-23 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-23 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-23 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-23 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-23 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-23 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-23 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-23 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-23 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-23 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-23 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-23 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-23 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-23 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-23 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-23 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-23 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-23 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-23 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-23 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-23 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-23 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-22 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-22 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-22 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-22 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-22 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-22 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-22 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-22 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-22 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-22 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-22 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-22 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-22 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-22 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-22 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-22 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-22 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-22 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-22 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-22 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-22 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-22 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-22 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-22 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-22 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-22 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-22 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-22 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-22 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-22 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-22 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-22 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-22 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-21 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-21 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-21 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-21 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-21 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-21 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-21 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-21 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-21 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-21 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-21 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-21 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-21 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-21 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-21 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-21 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-21 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-21 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-21 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-21 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-21 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-21 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-21 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-21 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-21 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-21 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-21 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-21 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-21 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-21 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-21 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-21 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-21 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-21 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-21 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-21 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-21 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-21 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-21 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-21 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-21 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-21 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-21 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-21 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-21 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-21 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-21 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-21 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-21 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-20 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-20 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-20 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-20 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-20 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-20 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-20 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-20 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-20 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-20 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-20 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-20 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-20 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-20 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-20 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-20 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-20 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-20 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-20 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-20 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-20 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-20 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-20 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-20 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-20 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-20 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-20 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-20 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-20 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-20 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-20 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-20 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-20 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-20 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-20 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-20 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-20 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-20 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-20 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-20 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-20 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-20 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-20 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-20 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-20 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-20 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-20 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-20 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-20 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-20 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-20 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-20 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-20 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-20 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-20 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-20 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-20 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-20 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-20 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-20 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-20 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-20 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-20 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-20 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-20 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-20 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-20 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-19 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-19 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-19 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-19 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-19 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-19 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-19 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-19 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-19 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-19 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-19 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-19 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-19 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-19 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-19 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-19 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-19 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-19 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-19 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-19 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-19 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-19 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-19 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-19 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-19 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-19 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-19 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-19 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-19 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-19 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-19 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-19 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-19 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-19 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-19 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-19 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-19 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-19 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-19 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-19 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-19 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-19 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-19 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-19 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-19 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-19 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-19 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-19 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-19 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-19 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-19 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-19 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-19 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-18 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-18 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-18 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-18 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-18 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-18 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-18 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-18 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-18 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-18 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-18 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-18 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-18 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-18 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-18 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-18 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-18 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-18 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-18 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-18 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-18 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-18 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-18 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-18 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-18 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-18 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-18 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-18 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-18 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-18 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-18 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-18 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-18 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-18 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-18 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-18 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-18 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-18 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-18 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-18 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-18 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-18 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-18 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-18 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-18 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-17 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-17 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-17 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-17 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-17 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-17 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-17 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-17 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-17 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-17 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-17 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-17 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-17 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-17 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-17 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-17 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-17 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-17 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-17 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-17 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-17 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-17 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-17 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-17 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-17 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-17 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-17 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-17 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-16 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-16 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-16 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-16 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-16 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-16 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-15 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-15 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-15 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-15 | ||
| 4hb5_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 3e-15 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-15 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-15 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-15 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-15 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-15 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-15 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-15 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-15 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-15 | ||
| 4hqd_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 5e-15 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-15 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-15 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-15 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-15 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-15 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-15 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-15 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-14 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-14 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-14 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-14 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-14 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-14 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-14 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-14 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-14 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-14 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-14 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-14 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-14 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-14 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-14 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-14 | ||
| 4gmr_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 8e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-13 | ||
| 4gpm_A | 169 | Crystal Structure Of Engineered Protein. Northeast | 2e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 1n0r_A | 126 | 4ank: A Designed Ankyrin Repeat Protein With Four I | 1e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-11 | ||
| 1n0q_A | 93 | 3ank: A Designed Ankyrin Repeat Protein With Three | 3e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-10 | ||
| 2xzt_G | 136 | Caspase-3 In Complex With Darpin-3.4_i78s Length = | 5e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-10 | ||
| 2xzd_G | 136 | Caspase-3 In Complex With An Inhibitory Darpin-3.4 | 8e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-10 | ||
| 2y0b_G | 136 | Caspase-3 In Complex With An Inhibitory Darpin-3.4_ | 9e-10 | ||
| 4atz_D | 154 | Ad5 Knob In Complex With A Designed Ankyrin Repeat | 1e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-09 | ||
| 1mj0_A | 166 | Sank E3_5: An Artificial Ankyrin Repeat Protein Len | 1e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-09 | ||
| 2l6b_A | 115 | Nrc Consensus Ankyrin Repeat Protein Solution Struc | 1e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 4dui_A | 169 | Darpin D1 Binding To Tubulin Beta Chain (not In Com | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-09 | ||
| 4drx_E | 169 | Gtp-Tubulin In Complex With A Darpin Length = 169 | 3e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-09 | ||
| 2xeh_A | 157 | Structural Determinants For Improved Thermal Stabil | 4e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-09 | ||
| 4f6r_D | 169 | Tubulin:stathmin-Like Domain Complex Length = 169 | 6e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-09 | ||
| 2xee_A | 157 | Structural Determinants For Improved Thermal Stabil | 1e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-08 | ||
| 2qyj_A | 166 | Crystal Structure Of A Designed Full Consensus Anky | 1e-08 | ||
| 2p2c_P | 169 | Inhibition Of Caspase-2 By A Designed Ankyrin Repea | 1e-08 | ||
| 3v2o_A | 183 | Crystal Structure Of The Peptide Bound Complex Of T | 1e-08 | ||
| 2j8s_D | 169 | Drug Export Pathway Of Multidrug Exporter Acrb Reve | 1e-08 | ||
| 1s70_B | 299 | Complex Between Protein Ser/thr Phosphatase-1 (delt | 1e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-08 | ||
| 3so8_A | 162 | Crystal Structure Of Ankra Length = 162 | 1e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-08 | ||
| 3v2x_A | 167 | Crystal Structure Of The Peptide Bound Complex Of T | 1e-08 | ||
| 2y1l_E | 169 | Caspase-8 In Complex With Darpin-8.4 Length = 169 | 2e-08 | ||
| 3q9u_C | 158 | In Silico And In Vitro Co-Evolution Of A High Affin | 2e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 3zu7_B | 169 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-08 | ||
| 1n11_A | 437 | D34 Region Of Human Ankyrin-R And Linker Length = 4 | 3e-08 | ||
| 2bkg_A | 166 | Crystal Structure Of E3_19 An Designed Ankyrin Repe | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4HB5|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or267. Length = 169 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4HQD|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or265. Length = 169 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4GMR|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or266. Length = 169 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4GPM|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or264. Length = 169 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1N0R|A Chain A, 4ank: A Designed Ankyrin Repeat Protein With Four Identical Consensus Repeats Length = 126 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1N0Q|A Chain A, 3ank: A Designed Ankyrin Repeat Protein With Three Identical Consensus Repeats Length = 93 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2XZT|G Chain G, Caspase-3 In Complex With Darpin-3.4_i78s Length = 136 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2XZD|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4 Length = 136 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2Y0B|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4_s76r Length = 136 | Back alignment and structure |
|
| >pdb|4ATZ|D Chain D, Ad5 Knob In Complex With A Designed Ankyrin Repeat Protein Length = 154 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1MJ0|A Chain A, Sank E3_5: An Artificial Ankyrin Repeat Protein Length = 166 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2L6B|A Chain A, Nrc Consensus Ankyrin Repeat Protein Solution Structure Length = 115 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4DUI|A Chain A, Darpin D1 Binding To Tubulin Beta Chain (not In Complex) Length = 169 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4DRX|E Chain E, Gtp-Tubulin In Complex With A Darpin Length = 169 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2XEH|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4F6R|D Chain D, Tubulin:stathmin-Like Domain Complex Length = 169 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2XEE|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2QYJ|A Chain A, Crystal Structure Of A Designed Full Consensus Ankyrin Length = 166 | Back alignment and structure |
|
| >pdb|2P2C|P Chain P, Inhibition Of Caspase-2 By A Designed Ankyrin Repeat Protein (Darpin) Length = 169 | Back alignment and structure |
|
| >pdb|3V2O|A Chain A, Crystal Structure Of The Peptide Bound Complex Of The Ankyrin Repeat Domains Of Human Ankra2 Length = 183 | Back alignment and structure |
|
| >pdb|2J8S|D Chain D, Drug Export Pathway Of Multidrug Exporter Acrb Revealed By Darpin Inhibitors Length = 169 | Back alignment and structure |
|
| >pdb|1S70|B Chain B, Complex Between Protein Ser/thr Phosphatase-1 (delta) And The Myosin Phosphatase Targeting Subunit 1 (mypt1) Length = 299 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3SO8|A Chain A, Crystal Structure Of Ankra Length = 162 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3V2X|A Chain A, Crystal Structure Of The Peptide Bound Complex Of The Ankyrin Repeat Domains Of Human Ankra2 Length = 167 | Back alignment and structure |
|
| >pdb|2Y1L|E Chain E, Caspase-8 In Complex With Darpin-8.4 Length = 169 | Back alignment and structure |
|
| >pdb|3Q9U|C Chain C, In Silico And In Vitro Co-Evolution Of A High Affinity Complementary Protein-Protein Interface Length = 158 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ZU7|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 169 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1N11|A Chain A, D34 Region Of Human Ankyrin-R And Linker Length = 437 | Back alignment and structure |
|
| >pdb|2BKG|A Chain A, Crystal Structure Of E3_19 An Designed Ankyrin Repeat Protein Length = 166 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 1e-99
Identities = 86/266 (32%), Positives = 131/266 (49%), Gaps = 18/266 (6%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
GA+G V KWR ++A K I S R +F+ EL ++ HPNIV+ G +
Sbjct: 19 GAFGVVCKAKWRAKDVAIKQIES-----ESERKAFIVELRQLSRVNHPNIVKLYGACLNP 73
Query: 162 ERLIFLTEYLRNGSLHDILKKKG---KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
L+ EY GSL+++L A+++ L ++G+ YLH +P A+IHRDL
Sbjct: 74 VCLV--MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDL 131
Query: 219 TPSNVLQDEAG-HLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVD 277
P N+L G LK+ DFG + Q MT GS +MAPEV+ +Y + D
Sbjct: 132 KPPNLLLVAGGTVLKICDFGTACDIQT------HMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 278 VFSFALIVHEMFQG-GPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336
VFS+ +I+ E+ P + + +RP L P+PI++L+ CW K+P
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDP 245
Query: 337 DRRPTFEEIIFRLEAIQESFQKKTVP 362
+RP+ EEI+ + + F P
Sbjct: 246 SQRPSMEEIVKIMTHLMRYFPGADEP 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 8e-98
Identities = 85/261 (32%), Positives = 136/261 (52%), Gaps = 8/261 (3%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
G++G V+ +W G+++A K + + N F++E+ + ++LRHPNIV F+G +
Sbjct: 48 GSFGTVHRAEWHGSDVAVKILMEQ-DFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106
Query: 162 ERLIFLTEYLRNGSLHDILKKKG---KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
L +TEYL GSL+ +L K G +LD ++ A D+A+GMNYLH+ P I+HR+L
Sbjct: 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNL 165
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
N+L D+ +KV DFGLS++ K S G+ +MAPEV R E + DV
Sbjct: 166 KSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDV 222
Query: 279 FSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDR 338
+SF +I+ E+ QV ++ R + + A++ CW P +
Sbjct: 223 YSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWK 282
Query: 339 RPTFEEIIFRLEAIQESFQKK 359
RP+F I+ L + +S
Sbjct: 283 RPSFATIMDLLRPLIKSAVPP 303
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 6e-94
Identities = 86/260 (33%), Positives = 127/260 (48%), Gaps = 15/260 (5%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNP-RVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +G+VY W G E+A K R + + + +E L+ L+HPNI+ GV
Sbjct: 18 GGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK 77
Query: 161 SERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTP 220
L + E+ R G L+ +L K ++ P V +A+ IARGMNYLH IIHRDL
Sbjct: 78 EPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKS 136
Query: 221 SNVLQDEAGH--------LKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
SN+L + LK+TDFGL++ G+Y +MAPEV R +
Sbjct: 137 SNILILQKVENGDLSNKILKITDFGLAREWHRTT-----KMSAAGAYAWMAPEVIRASMF 191
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332
K DV+S+ +++ E+ G R + VA A + S PEP L+ +CW
Sbjct: 192 SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCW 251
Query: 333 HKNPDRRPTFEEIIFRLEAI 352
+ +P RP+F I+ +L I
Sbjct: 252 NPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 4e-89
Identities = 62/260 (23%), Positives = 124/260 (47%), Gaps = 17/260 (6%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH- 160
GE++ +W+G +I K ++ + R F +E + HPN++ LG +
Sbjct: 21 NHSGELWKGRWQGNDIVVKVLKVR-DWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79
Query: 161 -SERLIFLTEYLRNGSLHDIL--KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+ +T ++ GSL+++L +D AV +ALD+ARGM +LH P I
Sbjct: 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHA 138
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG---K 274
L +V+ DE +++ + S++ G + ++APE +++ +
Sbjct: 139 LNSRSVMIDEDMTARISMADVKF--------SFQSPGRMYAPAWVAPEALQKKPEDTNRR 190
Query: 275 SVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
S D++SFA+++ E+ + +++ + A E RP + + L++ C ++
Sbjct: 191 SADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNE 250
Query: 335 NPDRRPTFEEIIFRLEAIQE 354
+P +RP F+ I+ LE +Q+
Sbjct: 251 DPAKRPKFDMIVPILEKMQD 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 9e-89
Identities = 66/267 (24%), Positives = 120/267 (44%), Gaps = 25/267 (9%)
Query: 102 GAYGEVYLVKW--RGTEIAAKTIR----SSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G +G V+ + + +A K++ F +E+ + L HPNIV+
Sbjct: 30 GGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89
Query: 156 GVLKHSERLIFLTEYLRNGSLHDIL-KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
G++ + R++ E++ G L+ L K + + LDIA G+ Y+ + P I+
Sbjct: 90 GLMHNPPRMV--MEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP-PIV 146
Query: 215 HRDLTPSNVLQDEAG-----HLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
HRDL N+ KV DFGLS+ + + ++G G++++MAPE
Sbjct: 147 HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS------VHSVSGLLGNFQWMAPETIGA 200
Query: 270 ES--YGKSVDVFSFALIVHEMFQGGP--SNRADTAVQVADRRAYEDSRPALSSLYPEPIK 325
E Y + D +SFA+I++ + G + ++ + E RP + P ++
Sbjct: 201 EEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLR 260
Query: 326 ALLRECWHKNPDRRPTFEEIIFRLEAI 352
++ CW +P +RP F I+ L +
Sbjct: 261 NVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 4e-84
Identities = 74/269 (27%), Positives = 126/269 (46%), Gaps = 17/269 (6%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
G +G+ V R T ++ I + + +F+KE+ + + L HPN+++F+GVL
Sbjct: 21 GCFGQAIKVTHRETGEVMV-MKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79
Query: 162 ERLIFLTEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTP 220
+RL F+TEY++ G+L I+K + V++A DIA GM YLH IIHRDL
Sbjct: 80 KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNS 136
Query: 221 SNVLQDEAGHLKVTDFGLSKIAQEKDSYSY-----------KMTGGTGSYRYMAPEVYRR 269
N L E ++ V DFGL+++ ++ + K G+ +MAPE+
Sbjct: 137 HNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING 196
Query: 270 ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS-RPALSSLYPEPIKALL 328
SY + VDVFSF +++ E+ ++ + P +
Sbjct: 197 RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPIT 256
Query: 329 RECWHKNPDRRPTFEEIIFRLEAIQESFQ 357
C +P++RP+F ++ LE ++
Sbjct: 257 VRCCDLDPEKRPSFVKLEHWLETLRMHLA 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 1e-82
Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 26/278 (9%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
G +G+VY +W G E+A + I N +F +E+ +++ RH N+V F+G
Sbjct: 44 GRFGQVYHGRWHG-EVAIRLIDIE-RDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101
Query: 162 ERLIFLTEYLRNGSLHDIL-KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTP 220
L +T + +L+ ++ K LD A +I +GM YLH I+H+DL
Sbjct: 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKS 158
Query: 221 SNVLQDEAGHLKVTDFGLSKIAQ--EKDSYSYKMTGGTGSYRYMAPEVYR---------R 269
NV D G + +TDFGL I+ + K+ G ++APE+ R +
Sbjct: 159 KNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDK 217
Query: 270 ESYGKSVDVFSFALIVHEMFQGG---PSNRADTAVQVADRRAYEDSRPALSSL-YPEPIK 325
+ K DVF+ I +E+ + A+ + +P LS + + I
Sbjct: 218 LPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT----GMKPNLSQIGMGKEIS 273
Query: 326 ALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKTVPS 363
+L CW + RPTF +++ LE + + ++ + P
Sbjct: 274 DILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPG 311
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 7e-80
Identities = 80/261 (30%), Positives = 135/261 (51%), Gaps = 17/261 (6%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
G++G VY KW G ++A K + + A P+ +F E+G+ +K RH NI+ F+G +
Sbjct: 35 GSFGTVYKGKWHG-DVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-A 91
Query: 162 ERLIFLTEYLRNGSLHDIL-KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTP 220
+L +T++ SL+ L + K + + A ARGM+YLH IIHRDL
Sbjct: 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKS 148
Query: 221 SNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES---YGKSVD 277
+N+ E +K+ DFGL+ + + S S++ +GS +MAPEV R + Y D
Sbjct: 149 NNIFLHEDNTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 278 VFSFALIVHEMFQG-----GPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332
V++F ++++E+ G +N D +++ R + + S P+ +K L+ EC
Sbjct: 208 VYAFGIVLYELMTGQLPYSNINN-RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECL 266
Query: 333 HKNPDRRPTFEEIIFRLEAIQ 353
K D RP+F I+ +E +
Sbjct: 267 KKKRDERPSFPRILAEIEELA 287
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 7e-76
Identities = 80/289 (27%), Positives = 120/289 (41%), Gaps = 45/289 (15%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQ--KLRHPNIVQFLGVLK 159
G YGEV+ W+G +A K S R S+ +E L+ LRH NI+ F+
Sbjct: 19 GRYGEVWRGSWQGENVAVKIFSS------RDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 160 HSE----RLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLH-----HHRP 210
S +L +T Y GSL+D L+ LD + + L IA G+ +LH
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI-AQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
AI HRDL N+L + G + D GL+ + +Q + G+ RYMAPEV
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191
Query: 270 E------SYGKSVDVFSFALIVHEMFQGGPSNRAD---------------TAVQVADRRA 308
K VD+++F L++ E+ + SN + +
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVC 251
Query: 309 YEDSRPAL-----SSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
+ RP + S + L++ECW++NP R T I L I
Sbjct: 252 VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 8e-76
Identities = 77/297 (25%), Positives = 120/297 (40%), Gaps = 47/297 (15%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQ--KLRHPNIVQFLGVLK 159
G YGEV++ KWRG ++A K + S+ +E ++Q +RH NI+ F+
Sbjct: 48 GRYGEVWMGKWRGEKVAVKVFFT------TEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 160 HSE----RLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLH------HHR 209
+L +T+Y NGSL+D LK LD + + A G+ +LH +
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI-AQEKDSYSYKMTGGTGSYRYMAPEV-- 266
P AI HRDL N+L + G + D GL+ + + G+ RYM PEV
Sbjct: 161 P-AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219
Query: 267 ----YRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ---------------VADRR 307
D++SF LI+ E+ + S Q + +
Sbjct: 220 ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIV 279
Query: 308 AYEDSRPALSSLY-----PEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359
+ RP+ + + + L+ ECW NP R T + L + ES K
Sbjct: 280 CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIK 336
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 3e-73
Identities = 72/296 (24%), Positives = 116/296 (39%), Gaps = 45/296 (15%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQ--KLRHPNIVQFLGVLK 159
G +GEV+ KWRG E+A K S R S+ +E ++Q LRH NI+ F+
Sbjct: 53 GRFGEVWRGKWRGEEVAVKIFSS------REERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 160 HSE----RLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPH---- 211
+L +++Y +GSL D L + + + AL A G+ +LH
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165
Query: 212 -AIIHRDLTPSNVLQDEAGHLKVTDFGLSKI-AQEKDSYSYKMTGGTGSYRYMAPEV--- 266
AI HRDL N+L + G + D GL+ D+ G+ RYMAPEV
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225
Query: 267 ---YRRESYGKSVDVFSFALIVHEMFQGGPSNRAD---------------TAVQVADRRA 308
+ K D+++ L+ E+ + + ++
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 285
Query: 309 YEDSRPALSSL-----YPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359
+ RP + + + ++RECW+ N R T I L + + K
Sbjct: 286 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 341
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 3e-65
Identities = 76/316 (24%), Positives = 116/316 (36%), Gaps = 58/316 (18%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQ--KLRHPNIVQFLG--- 156
G YG VY +A K R +F+ E +++ + H NI +F+
Sbjct: 24 GRYGAVYKGSLDERPVAVKVFSF------ANRQNFINEKNIYRVPLMEHDNIARFIVGDE 77
Query: 157 --VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLH-------H 207
+ + EY NGSL L D ++ A + RG+ YLH H
Sbjct: 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDH 136
Query: 208 HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI-----AQEKDSYSYKMTGGTGSYRYM 262
++P AI HRDL NVL G ++DFGLS G+ RYM
Sbjct: 137 YKP-AISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYM 195
Query: 263 APEVYR-------RESYGKSVDVFSFALIVHEMF---QGGPSNRADTAVQVA-------- 304
APEV ES K VD+++ LI E+F + Q+A
Sbjct: 196 APEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNH 255
Query: 305 -------DRRAYEDSRPAL------SSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEA 351
+ E RP +SL +K + +CW ++ + R T + R+
Sbjct: 256 PTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315
Query: 352 IQESFQKKTVPSCCDC 367
+ +++ S
Sbjct: 316 LMMIWERNKSVSPTAH 331
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-64
Identities = 66/296 (22%), Positives = 109/296 (36%), Gaps = 47/296 (15%)
Query: 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFM--KELGLWQKLRHPNIVQFLG 156
G +G V+ + +A K + + S+ E+ ++H NI+QF+G
Sbjct: 32 KARGRFGCVWKAQLLNEYVAVKIF------PIQDKQSWQNEYEVYSLPGMKHENILQFIG 85
Query: 157 VLKHSE----RLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPH- 211
K L +T + GSL D LK + A +ARG+ YLH P
Sbjct: 86 AEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 212 ------AIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPE 265
AI HRD+ NVL + DFGL+ E + G G+ RYMAPE
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHGQVGTRRYMAPE 203
Query: 266 VYR-----RESYGKSVDVFSFALIVHEMFQG-------GPSNRADTAVQVADRRAYED-- 311
V + +D+++ L++ E+ ++ + ED
Sbjct: 204 VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ 263
Query: 312 -------SRPALSSLYPE-----PIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
RP L + + + + ECW + + R + + R+ +Q
Sbjct: 264 EVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 3e-56
Identities = 78/266 (29%), Positives = 127/266 (47%), Gaps = 27/266 (10%)
Query: 102 GAYGEVYLVKWRG--TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +GEV+ + R T +A K+ R + P ++ F++E + ++ HPNIV+ +GV
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182
Query: 160 HSERLIFLTEYLRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ + + E ++ G L+ +G +L T + D A GM YL IHRDL
Sbjct: 183 QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDL 239
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS--YRYMAPEVYRRESY-GKS 275
N L E LK++DFG+S+ + Y +GG ++ APE Y +S
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEADGV---YAASGGLRQVPVKWTAPEALNYGRYSSES 296
Query: 276 VDVFSFALIVHEMFQGG--P----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329
DV+SF +++ E F G P SN+ T V + P L P+ + L+
Sbjct: 297 -DVWSFGILLWETFSLGASPYPNLSNQ-QTREFV--EKGGRLPCPELC---PDAVFRLME 349
Query: 330 ECWHKNPDRRPTFEEIIFRLEAIQES 355
+CW P +RP+F I L++I++
Sbjct: 350 QCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 1e-55
Identities = 72/266 (27%), Positives = 115/266 (43%), Gaps = 21/266 (7%)
Query: 102 GAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G++G V +W +A K ++ + S P + F++E+ L H N+++ G
Sbjct: 29 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
V+ + + +TE GSL D L+K +G T YA+ +A GM YL R IH
Sbjct: 89 VVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIH 144
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESYG 273
RDL N+L +K+ DFGL + + D + + + APE R S+
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH- 203
Query: 274 KSVDVFSFALIVHEMFQGG----PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329
S D + F + + EMF G + D+ RP P+ I ++
Sbjct: 204 AS-DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC---PQDIYNVMV 259
Query: 330 ECWHKNPDRRPTFEEIIFRLEAIQES 355
+CW P+ RPTF + L Q +
Sbjct: 260 QCWAHKPEDRPTFVALRDFLLEAQPT 285
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-55
Identities = 62/251 (24%), Positives = 114/251 (45%), Gaps = 16/251 (6%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG--- 156
G++ VY E+A ++ + R F +E + + L+HPNIV+F
Sbjct: 37 GSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWE 95
Query: 157 -VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+K + ++ +TE + +G+L LK+ + ++ I +G+ +LH P IIH
Sbjct: 96 STVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIH 154
Query: 216 RDLTPSNVL-QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
RDL N+ G +K+ D GL+ + + + + G+ +MAPE+Y E Y +
Sbjct: 155 RDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI-----GTPEFMAPEMY-EEKYDE 208
Query: 275 SVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP-ALSSLYPEPIKALLRECWH 333
SVDV++F + + EM RR +P + + +K ++ C
Sbjct: 209 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268
Query: 334 KNPDRRPTFEE 344
+N D R + ++
Sbjct: 269 QNKDERYSIKD 279
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-55
Identities = 75/286 (26%), Positives = 131/286 (45%), Gaps = 42/286 (14%)
Query: 102 GAYGEVYLVKWRG------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G +G V + ++ +A K ++ S F +E+ + + L+H NIV++
Sbjct: 21 GNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 156 GV-LKHSERLIFL-TEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
GV R + L EYL GSL D L+K K ++D + Y I +GM YL R
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 134
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS-YRYMAPEV--YRR 269
IHRDL N+L + +K+ DFGL+K+ + + +K+ S + APE +
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF-FKVKEPGESPIFWYAPESLTESK 193
Query: 270 ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVAD--RRAYED---------------- 311
S S DV+SF ++++E+F +++ A +
Sbjct: 194 FSV-AS-DVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 251
Query: 312 SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357
RP P+ I ++ ECW+ N ++RP+F ++ R++ I+++
Sbjct: 252 PRPDGC---PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-54
Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 42/286 (14%)
Query: 102 GAYGEVYLVKWRG------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G +G V + ++ +A K ++ S F +E+ + + L+H NIV++
Sbjct: 52 GNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 156 GVLKHSER--LIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
GV + R L + EYL GSL D L+K K ++D + Y I +GM YL R
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--- 165
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS-YRYMAPEV--YRR 269
IHRDL N+L + +K+ DFGL+K+ + Y YK+ S + APE +
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY-YKVKEPGESPIFWYAPESLTESK 224
Query: 270 ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVAD------------------RRAYED 311
S S DV+SF ++++E+F +++ A + +
Sbjct: 225 FSV-AS-DVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 282
Query: 312 SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357
RP P+ I ++ ECW+ N ++RP+F ++ R++ I++
Sbjct: 283 PRPDGC---PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-54
Identities = 74/277 (26%), Positives = 126/277 (45%), Gaps = 34/277 (12%)
Query: 102 GAYGEVYLVKWR------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G +G+V L ++ G ++A K+++ S KE+ + + L H NIV++
Sbjct: 32 GHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYK 89
Query: 156 GV-LKHSERLIFL-TEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
G+ + I L E+L +GSL + L K K K++ + YA+ I +GM+YL +
Sbjct: 90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--- 146
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS-YRYMAPE--VYRR 269
+HRDL NVL + +K+ DFGL+K + Y Y + S + APE + +
Sbjct: 147 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY-YTVKDDRDSPVFWYAPECLMQSK 205
Query: 270 ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY------EDSRPALSSLY--- 320
S DV+SF + +HE+ S+ + A+ + L
Sbjct: 206 FYI-AS-DVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP 263
Query: 321 -----PEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
P+ + L+R+CW P R +F+ +I EA+
Sbjct: 264 CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-54
Identities = 68/268 (25%), Positives = 126/268 (47%), Gaps = 34/268 (12%)
Query: 102 GAYGEVYLVKWRG------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
GA+G VY W +A K +R + ++P+ + E + + +P++ + L
Sbjct: 26 GAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
G+ S + +T+ + G L D +++ K + + + + IA+GMNYL R ++
Sbjct: 84 GICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LV 139
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESY 272
HRDL NVL H+K+TDFGL+K+ ++ Y GG ++MA E +R ++
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YHAEGGKVPIKWMALESILHRIYTH 198
Query: 273 GKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVADR--RAYEDSRPALSSLYPEPI 324
+S DV+S+ + V E+ G P +++ + +P + +
Sbjct: 199 -QS-DVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILEKGERLPQPPIC---TIDV 248
Query: 325 KALLRECWHKNPDRRPTFEEIIFRLEAI 352
++R+CW + D RP F E+I +
Sbjct: 249 YMIMRKCWMIDADSRPKFRELIIEFSKM 276
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 6e-54
Identities = 65/266 (24%), Positives = 117/266 (43%), Gaps = 25/266 (9%)
Query: 102 GAYGEVYLVKWRG----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
G +G V ++ +A K +++ A++P +++ + E + Q+L +P IV+ +G+
Sbjct: 28 GNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLDNPYIVRMIGI 86
Query: 158 LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+ ++ + E G L+ L++ + + ++ GM YL +HRD
Sbjct: 87 CEAESWML-VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRD 142
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESYGKS 275
L NVL + K++DFGLSK + ++Y T G ++ APE Y + S KS
Sbjct: 143 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS-KS 201
Query: 276 VDVFSFALIVHEMFQGG--P----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329
DV+SF +++ E F G P + + + PA P + L+
Sbjct: 202 -DVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAML--EKGERMGCPAGC---PREMYDLMN 254
Query: 330 ECWHKNPDRRPTFEEIIFRLEAIQES 355
CW + + RP F + RL
Sbjct: 255 LCWTYDVENRPGFAAVELRLRNYYYD 280
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 7e-54
Identities = 81/264 (30%), Positives = 127/264 (48%), Gaps = 27/264 (10%)
Query: 102 GAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +G V+L W ++A KTIR S F++E + KL HP +VQ GV
Sbjct: 19 GQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 161 SERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ +TE++ +G L D L+ +G T + LD+ GM YL +IHRDL
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 131
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESYGKSVD 277
N L E +KV+DFG+++ + D Y TG ++ +PEV + R S KS D
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVLD-DQY-TSSTGTKFPVKWASPEVFSFSRYS-SKS-D 187
Query: 278 VFSFALIVHEMFQGG--P----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331
V+SF +++ E+F G P SN + + + +P L+ + ++ C
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENRSNS-EVVEDI--STGFRLYKPRLA---STHVYQIMNHC 241
Query: 332 WHKNPDRRPTFEEIIFRLEAIQES 355
W + P+ RP F ++ +L I ES
Sbjct: 242 WRERPEDRPAFSRLLRQLAEIAES 265
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-53
Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 35/280 (12%)
Query: 102 GAYGEVYLVKWRG------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G +G V L ++ +A K ++ S P + F +E+ + + L IV++
Sbjct: 34 GNFGSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 156 GVLKHSER--LIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
GV R L + EYL +G L D L++ + +LD + Y+ I +GM YL R
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--- 147
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS-YRYMAPE--VYRR 269
+HRDL N+L + H+K+ DFGL+K+ Y Y + S + APE
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY-YVVREPGQSPIFWYAPESLSDNI 206
Query: 270 ESYGKSVDVFSFALIVHEMF------QGGPSNRADTAVQVADRRAYEDSRPALSSLY--- 320
S +S DV+SF ++++E+F + D A L
Sbjct: 207 FSR-QS-DVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLP 264
Query: 321 -----PEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
P + L++ CW +P RP+F + +L+ +
Sbjct: 265 APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 4e-53
Identities = 83/265 (31%), Positives = 136/265 (51%), Gaps = 31/265 (11%)
Query: 102 GAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +G V L KW+G ++A K I+ S + F +E KL HP +V+F GV
Sbjct: 19 GQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 161 SERLIFLTEYLRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ +TEY+ NG L + L+ G L+P + D+ GM +L H+ IHRDL
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLA 131
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESYGKSVD 277
N L D +KV+DFG+++ + D Y G ++ APEV Y + S KS D
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVLD-DQY-VSSVGTKFPVKWSAPEVFHYFKYS-SKS-D 187
Query: 278 VFSFALIVHEMFQGG--P----SNRADTAVQVADR--RAYEDSRPALSSLYPEPIKALLR 329
V++F +++ E+F G P +N +V + + + RP L+ + I ++
Sbjct: 188 VWAFGILMWEVFSLGKMPYDLYTNS-----EVVLKVSQGHRLYRPHLA---SDTIYQIMY 239
Query: 330 ECWHKNPDRRPTFEEIIFRLEAIQE 354
CWH+ P++RPTF++++ +E ++E
Sbjct: 240 SCWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-53
Identities = 83/268 (30%), Positives = 124/268 (46%), Gaps = 27/268 (10%)
Query: 102 GAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G GEV + R +A K +++ R R F+ E + + HPNI++ G
Sbjct: 60 GDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNIIRLEG 117
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
V+ + +TEY+ NGSL L+ G+ V + GM YL +H
Sbjct: 118 VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVH 174
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESYG 273
RDL NVL D KV+DFGLS++ ++ +Y TGG R+ APE +R S
Sbjct: 175 RDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-S 233
Query: 274 KSVDVFSFALIVHEMFQGG--P----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKAL 327
S DV+SF +++ E+ G P +NR D V Y P P + L
Sbjct: 234 AS-DVWSFGVVMWEVLAYGERPYWNMTNR-DVISSV--EEGYRLPAPMGC---PHALHQL 286
Query: 328 LRECWHKNPDRRPTFEEIIFRLEAIQES 355
+ +CWHK+ +RP F +I+ L+A+ S
Sbjct: 287 MLDCWHKDRAQRPRFSQIVSVLDALIRS 314
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 6e-53
Identities = 77/271 (28%), Positives = 128/271 (47%), Gaps = 32/271 (11%)
Query: 102 GAYGEVYLVKWRG------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G +GEVY + +A KT+++ + R F+ E G+ + H NI++
Sbjct: 55 GEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFSHHNIIRLE 112
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
GV+ + ++ +TEY+ NG+L L++ G+ V IA GM YL + +
Sbjct: 113 GVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YV 169
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESY 272
HRDL N+L + KV+DFGLS++ ++ +Y +GG R+ APE YR+ +
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT- 228
Query: 273 GKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVADR--RAYEDSRPALSSLYPEPI 324
S DV+SF +++ E+ G P SN +V + P P I
Sbjct: 229 SAS-DVWSFGIVMWEVMTYGERPYWELSNH-----EVMKAINDGFRLPTPMDC---PSAI 279
Query: 325 KALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
L+ +CW + RRP F +I+ L+ + +
Sbjct: 280 YQLMMQCWQQERARRPKFADIVSILDKLIRA 310
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 7e-53
Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 31/266 (11%)
Query: 102 GAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +G V KWRG ++A K I+ S + F++E + L H +VQ GV
Sbjct: 35 GQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 161 SERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ +TEY+ NG L + L++ + + + D+ M YL + +HRDL
Sbjct: 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLA 147
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESYGKSVD 277
N L ++ G +KV+DFGLS+ + D Y G R+ PEV Y + S KS D
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLD-DEY-TSSVGSKFPVRWSPPEVLMYSKFS-SKS-D 203
Query: 278 VFSFALIVHEMFQGG--P----SNRADTAVQVADR--RAYEDSRPALSSLYPEPIKALLR 329
+++F +++ E++ G P +N + A+ + RP L+ E + ++
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERFTNS-----ETAEHIAQGLRLYRPHLA---SEKVYTIMY 255
Query: 330 ECWHKNPDRRPTFEEIIFRLEAIQES 355
CWH+ D RPTF+ ++ + + +
Sbjct: 256 SCWHEKADERPTFKILLSNILDVMDE 281
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-52
Identities = 76/287 (26%), Positives = 123/287 (42%), Gaps = 35/287 (12%)
Query: 102 GAYGEVYLVKWRG------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G +G+V L + +A K +++ + P+ R+ + +E+ + + L H +I+++
Sbjct: 42 GHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYK 99
Query: 156 GVLKHSER--LIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
G + + L + EY+ GSL D L + + + +A I GM YLH
Sbjct: 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---Y 155
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS-YRYMAPE--VYRRE 270
IHRDL NVL D +K+ DFGL+K E Y Y++ S + APE +
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY-YRVREDGDSPVFWYAPECLKEYKF 214
Query: 271 SYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAY-----EDSRPALSSLY---- 320
Y S DV+SF + ++E+ S T A L
Sbjct: 215 YY-AS-DVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR 272
Query: 321 ----PEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKTVPS 363
P + L++ CW RPTFE +I L+ + E +Q + PS
Sbjct: 273 PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQA-PS 318
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 3e-52
Identities = 78/267 (29%), Positives = 133/267 (49%), Gaps = 37/267 (13%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
G +G+V L +RG ++A K I++ + +F+ E + +LRH N+VQ LGV+
Sbjct: 32 GEFGDVMLGDYRGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLGVIVEE 86
Query: 162 ERLIFL-TEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ +++ TEY+ GSL D L+ +G+ L + ++LD+ M YL + +HRDL
Sbjct: 87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDL 143
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESYGKSV 276
NVL E KV+DFGL+K ++ G ++ APE ++ S KS
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTK-----EAS-STQDTGKLPVKWTAPEALREKKFS-TKS- 195
Query: 277 DVFSFALIVHEMFQGG--P----SNRADTAVQVADR--RAYEDSRPALSSLYPEPIKALL 328
DV+SF +++ E++ G P + V R + Y+ P P + ++
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVEKGYKMDAPDGC---PPAVYEVM 247
Query: 329 RECWHKNPDRRPTFEEIIFRLEAIQES 355
+ CWH + RP+F ++ +LE I+
Sbjct: 248 KNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 6e-52
Identities = 66/272 (24%), Positives = 111/272 (40%), Gaps = 27/272 (9%)
Query: 102 GAYGEVYLVKWRG----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
G +G V +R ++A K ++ + M+E + +L +P IV+ +GV
Sbjct: 21 GNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 158 LKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ ++ + E G LH L + ++ ++ GM YL +HR
Sbjct: 79 CQAEALML-VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHR 134
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESYGK 274
DL NVL + K++DFGLSK DSY + G ++ APE +R+ S +
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 193
Query: 275 SVDVFSFALIVHEMFQGG--P----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328
S DV+S+ + + E G P + + + P P + AL+
Sbjct: 194 S-DVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFI--EQGKRMECPPEC---PPELYALM 246
Query: 329 RECWHKNPDRRPTFEEIIFRLEAIQESFQKKT 360
+CW + RP F + R+ A S K
Sbjct: 247 SDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 7e-52
Identities = 77/268 (28%), Positives = 127/268 (47%), Gaps = 27/268 (10%)
Query: 102 GAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G +GEV + + +A KT++ + R F+ E + + HPNI++ G
Sbjct: 56 GEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIRLEG 113
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
V+ S+ ++ +TEY+ NGSL L+K + V IA GM YL +H
Sbjct: 114 VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVH 170
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESYG 273
RDL N+L + KV+DFGL ++ ++ +Y GG R+ +PE YR+ +
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT-S 229
Query: 274 KSVDVFSFALIVHEMFQGG--P----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKAL 327
S DV+S+ +++ E+ G P SN+ D V Y P P + L
Sbjct: 230 AS-DVWSYGIVLWEVMSYGERPYWEMSNQ-DVIKAV--DEGYRLPPPMDC---PAALYQL 282
Query: 328 LRECWHKNPDRRPTFEEIIFRLEAIQES 355
+ +CW K+ + RP FE+I+ L+ + +
Sbjct: 283 MLDCWQKDRNNRPKFEQIVSILDKLIRN 310
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-51
Identities = 76/261 (29%), Positives = 118/261 (45%), Gaps = 19/261 (7%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G YGEVY W+ + A KT++ F+KE + ++++HPN+VQ LGV
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+TE++ G+L D L++ + + + A I+ M YL IHR+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRN 343
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVD 277
L N L E +KV DFGLS++ D+Y G ++ APE + D
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTG-DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 278 VFSFALIVHEMFQGGPS---NRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
V++F +++ E+ G S + V + Y RP PE + L+R CW
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGC---PEKVYELMRACWQW 458
Query: 335 NPDRRPTFEEIIFRLEAIQES 355
NP RP+F EI E + +
Sbjct: 459 NPSDRPSFAEIHQAFETMFQE 479
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-51
Identities = 63/271 (23%), Positives = 117/271 (43%), Gaps = 34/271 (12%)
Query: 102 GAYGEVYLVKWRG------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G +G V+ W + K I S + + + L H +IV+ L
Sbjct: 24 GVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTDHMLAIGSLDHAHIVRLL 81
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
G+ S + +T+YL GSL D +++ +G L P + + + IA+GM YL H ++
Sbjct: 82 GLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MV 137
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESY 272
HR+L NVL ++V DFG++ + D + ++MA E + + ++
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ-LLYSEAKTPIKWMALESIHFGKYTH 196
Query: 273 GKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVAD--RRAYEDSRPALSSLYPEPI 324
+S DV+S+ + V E+ G P +V D + ++P + +
Sbjct: 197 -QS-DVWSYGVTVWELMTFGAEPYAGLRLA-----EVPDLLEKGERLAQPQIC---TIDV 246
Query: 325 KALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
++ +CW + + RPTF+E+ +
Sbjct: 247 YMVMVKCWMIDENIRPTFKELANEFTRMARD 277
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 4e-51
Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 34/272 (12%)
Query: 102 GAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G +GEVY + +A KT + + FM E + + L HP+IV+ +G
Sbjct: 23 GFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+++ I + E G L L++ K L T V Y+L I + M YL +H
Sbjct: 81 IIEEEPTWI-IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVH 136
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESYG 273
RD+ N+L +K+ DFGLS+ +++D Y YK + ++M+PE +RR +
Sbjct: 137 RDIAVRNILVASPECVKLGDFGLSRYIEDED-Y-YKASVTRLPIKWMSPESINFRRFTT- 193
Query: 274 KSVDVFSFALIVHEMFQGG--P----SNRADTAVQVADR--RAYEDSRPALSSLYPEPIK 325
S DV+ FA+ + E+ G P N+ V + +P L P +
Sbjct: 194 AS-DVWMFAVCMWEILSFGKQPFFWLENK-----DVIGVLEKGDRLPKPDLC---PPVLY 244
Query: 326 ALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357
L+ CW +P RP F E++ L + + +
Sbjct: 245 TLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-51
Identities = 80/263 (30%), Positives = 121/263 (46%), Gaps = 29/263 (11%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G YGEVY W+ + A KT++ F+KE + ++++HPN+VQ LGV
Sbjct: 24 GQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 160 HSERLIFLTEYLRNGSLHDILKK--KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+TE++ G+L D L++ + ++ + A I+ M YL IHRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 136
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESYGKS 275
L N L E +KV DFGLS++ D+Y G ++ APE Y + S KS
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTY-TAHAGAKFPIKWTAPESLAYNKFS-IKS 193
Query: 276 VDVFSFALIVHEMFQGG--P----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329
DV++F +++ E+ G P + + Y RP PE + L+R
Sbjct: 194 -DVWAFGVLLWEIATYGMSPYPGIDLS-QVYELL--EKDYRMERPEGC---PEKVYELMR 246
Query: 330 ECWHKNPDRRPTFEEIIFRLEAI 352
CW NP RP+F EI E +
Sbjct: 247 ACWQWNPSDRPSFAEIHQAFETM 269
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-51
Identities = 79/264 (29%), Positives = 134/264 (50%), Gaps = 31/264 (11%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
G +G+V L +RG ++A K I++ + +F+ E + +LRH N+VQ LGV+
Sbjct: 204 GEFGDVMLGDYRGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 162 ERLIFL-TEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ +++ TEY+ GSL D L+ +G+ L + ++LD+ M YL + +HRDL
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDL 315
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY-GKSVD 277
NVL E KV+DFGL+ K++ G ++ APE R + + KS D
Sbjct: 316 AARNVLVSEDNVAKVSDFGLT-----KEAS-STQDTGKLPVKWTAPEALREKKFSTKS-D 368
Query: 278 VFSFALIVHEMFQGG--P----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331
V+SF +++ E++ G P + D +V + Y+ P P + +++ C
Sbjct: 369 VWSFGILLWEIYSFGRVPYPRIPLK-DVVPRV--EKGYKMDAPDGC---PPAVYDVMKNC 422
Query: 332 WHKNPDRRPTFEEIIFRLEAIQES 355
WH + RPTF ++ +LE I+
Sbjct: 423 WHLDAATRPTFLQLREQLEHIRTH 446
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 6e-51
Identities = 67/271 (24%), Positives = 125/271 (46%), Gaps = 34/271 (12%)
Query: 102 GAYGEVYLVKWRG------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
GA+G VY W +A K +R + ++P+ + E + + +P++ + L
Sbjct: 26 GAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
G+ S + +T+ + G L D +++ K + + + + IA+GMNYL R ++
Sbjct: 84 GICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LV 139
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESY 272
HRDL NVL H+K+TDFGL+K+ ++ Y GG ++MA E +R ++
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YHAEGGKVPIKWMALESILHRIYTH 198
Query: 273 GKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVADR--RAYEDSRPALSSLYPEPI 324
+S DV+S+ + V E+ G P +++ + +P + +
Sbjct: 199 -QS-DVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILEKGERLPQPPIC---TIDV 248
Query: 325 KALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
++ +CW + D RP F E+I +
Sbjct: 249 YMIMVKCWMIDADSRPKFRELIIEFSKMARD 279
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-50
Identities = 54/266 (20%), Positives = 118/266 (44%), Gaps = 13/266 (4%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++G+ LVK G + K I S S + R +E+ + ++HPNIVQ+ +
Sbjct: 35 GSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFE 93
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+ L + +Y G L + + + + + I + ++H + I+HRD
Sbjct: 94 ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRD 150
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVD 277
+ N+ + G +++ DFG++++ + G+ Y++PE+ + Y D
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC---IGTPYYLSPEICENKPYNNKSD 207
Query: 278 VFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPD 337
+++ +++E+ + A + + + S P +S Y +++L+ + + +NP
Sbjct: 208 IWALGCVLYELCTLKHAFEAGSMKNLV-LKIISGSFPPVSLHYSYDLRSLVSQLFKRNPR 266
Query: 338 RRPTFEEIIFRLEAIQESFQKKTVPS 363
RP+ I+ I + +K P
Sbjct: 267 DRPSVNSIL-EKGFIAKRIEKFLSPQ 291
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 3e-50
Identities = 74/270 (27%), Positives = 123/270 (45%), Gaps = 34/270 (12%)
Query: 102 GAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G +G+V+ + +A KT ++ ++ VR F++E ++ HP+IV+ +G
Sbjct: 26 GQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIG 83
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
V+ + I + E G L L+ K LD + + YA ++ + YL R +H
Sbjct: 84 VITENPVWI-IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVH 139
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESYG 273
RD+ NVL +K+ DFGLS+ ++ +Y YK + G ++MAPE +RR +
Sbjct: 140 RDIAARNVLVSSNDCVKLGDFGLSRYMED-STY-YKASKGKLPIKWMAPESINFRRFTS- 196
Query: 274 KSVDVFSFALIVHEMFQGG--P----SNRADTAVQVAD--RRAYEDSRPALSSLYPEPIK 325
S DV+ F + + E+ G P N V P P +
Sbjct: 197 AS-DVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIENGERLPMPPNC---PPTLY 247
Query: 326 ALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
+L+ +CW +P RRP F E+ +L I E
Sbjct: 248 SLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 8e-50
Identities = 81/257 (31%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 102 GAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +GEV++ W G T +A KT++ S +F++E + +KLRH +VQ V+
Sbjct: 195 GCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 161 SERLIFLTEYLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
I +TEY+ GSL D LK + L P V A IA GM Y+ +HRDL
Sbjct: 251 EPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 306
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
+N+L E KV DFGL+++ ++ + Y G ++ APE + DV
Sbjct: 307 RAANILVGENLVCKVADFGLARLIED-NEY-TARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 279 FSFALIVHEMFQGGPS---NRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335
+SF +++ E+ G + V R Y P PE + L+ +CW K
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHDLMCQCWRKE 421
Query: 336 PDRRPTFEEIIFRLEAI 352
P+ RPTFE + LE
Sbjct: 422 PEERPTFEYLQAFLEDY 438
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-49
Identities = 79/265 (29%), Positives = 130/265 (49%), Gaps = 29/265 (10%)
Query: 102 GAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +GEV++ + G T++A K+++ S ++F+ E L ++L+H +V+ V+
Sbjct: 24 GQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 161 SERLIFLTEYLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
I +TEY+ NGSL D LK KL + A IA GM ++ IHRDL
Sbjct: 80 EPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESYGKSV 276
+N+L + K+ DFGL+++ ++ + Y G ++ APE Y + KS
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIED-NEY-TAREGAKFPIKWTAPEAINYGTFTI-KS- 191
Query: 277 DVFSFALIVHEMFQGG--P----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330
DV+SF +++ E+ G P +N + + R Y RP PE + L+R
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNL--ERGYRMVRPDNC---PEELYQLMRL 245
Query: 331 CWHKNPDRRPTFEEIIFRLEAIQES 355
CW + P+ RPTF+ + LE +
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-49
Identities = 59/269 (21%), Positives = 114/269 (42%), Gaps = 15/269 (5%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G + EVY G +A K ++ + + R +KE+ L ++L HPN++++
Sbjct: 43 GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGK----LDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
L + E G L ++K K + T Y + + + ++H R ++H
Sbjct: 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMH 159
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RD+ P+NV G +K+ D GL + K + ++ + GT Y YM+PE Y
Sbjct: 160 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GT-PY-YMSPERIHENGYNFK 216
Query: 276 VDVFSFALIVHEMFQGGP--SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333
D++S +++EM + + D P S Y E ++ L+ C +
Sbjct: 217 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCIN 276
Query: 334 KNPDRRPTFEEIIFRLEAIQESFQKKTVP 362
+P++RP ++ + + ++
Sbjct: 277 PDPEKRPDVTY-VYDVAKRMHACTASSLE 304
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-49
Identities = 64/275 (23%), Positives = 124/275 (45%), Gaps = 33/275 (12%)
Query: 102 GAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G +G VY ++ + A K++ + + +F++E L + L HPN++ +G
Sbjct: 32 GHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIG 89
Query: 157 VLKHSERLIFL-TEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
++ E L + Y+ +G L ++ + +++ L +ARGM YL + +
Sbjct: 90 IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FV 146
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS-YKMTGGTGSYRYMAPE--VYRRES 271
HRDL N + DE+ +KV DFGL++ +++ YS + ++ A E R +
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFT 206
Query: 272 YGKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVAD--RRAYEDSRPALSSLYPEP 323
KS DV+SF +++ E+ G P + + +P P+
Sbjct: 207 T-KS-DVWSFGVLLWELLTRGAPPYRHIDPF-----DLTHFLAQGRRLPQPEYC---PDS 256
Query: 324 IKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQK 358
+ ++++CW +P RPTF ++ +E I +
Sbjct: 257 LYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-49
Identities = 81/257 (31%), Positives = 121/257 (47%), Gaps = 19/257 (7%)
Query: 102 GAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +GEV++ W G T +A KT++ S +F++E + +KLRH +VQ V+
Sbjct: 278 GCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 161 SERLIFLTEYLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
I +TEY+ GSL D LK + L P V A IA GM Y+ +HRDL
Sbjct: 334 EPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 389
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
+N+L E KV DFGL+++ ++ + Y G ++ APE + DV
Sbjct: 390 RAANILVGENLVCKVADFGLARLIED-NEY-TARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 279 FSFALIVHEMFQGGPS---NRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335
+SF +++ E+ G + V R Y P PE + L+ +CW K
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC---PESLHDLMCQCWRKE 504
Query: 336 PDRRPTFEEIIFRLEAI 352
P+ RPTFE + LE
Sbjct: 505 PEERPTFEYLQAFLEDY 521
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-49
Identities = 68/284 (23%), Positives = 118/284 (41%), Gaps = 47/284 (16%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG--- 156
G +G+V+ K R G K ++ + +E+ KL H NIV + G
Sbjct: 22 GGFGQVFKAKHRIDGKTYVIKRVKYN-------NEKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 157 -------------VLKHSERLIFLTEYLRNGSLHDILKKK--GKLDPPTAVAYALDIARG 201
++ L E+ G+L ++K+ KLD A+ I +G
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKG 134
Query: 202 MNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRY 261
++Y+H + +I+RDL PSN+ + +K+ DFGL + K T G+ RY
Sbjct: 135 VDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG----KRTRSKGTLRY 187
Query: 262 MAPEVYRRESYGKSVDVFSFALIVHEMFQGG--PSNRADTAVQVADRRAYEDSRPALSSL 319
M+PE + YGK VD+++ LI+ E+ + + +S +
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL--------RDGIISDI 239
Query: 320 YPEPIKALLRECWHKNPDRRPTFEEII---FRLEAIQESFQKKT 360
+ + K LL++ K P+ RP EI+ + E ++ T
Sbjct: 240 FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHT 283
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-48
Identities = 62/247 (25%), Positives = 98/247 (39%), Gaps = 19/247 (7%)
Query: 102 GAYGEVYL-VKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++GEV+ + G + A K +R + ++EL L P IV G ++
Sbjct: 69 GSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSPRIVPLYGAVR 120
Query: 160 HSERL-IFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ IF+ E L GSL ++K+ G L A+ Y G+ YLH R I+H D+
Sbjct: 121 EGPWVNIFM-ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDV 176
Query: 219 TPSNVLQDEAG-HLKVTDFGLSKIAQEKDSYSYKMTGGT--GSYRYMAPEVYRRESYGKS 275
NVL G + DFG + Q +TG G+ +MAPEV +
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 236
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED-SRPALSSLYPEPIKALLRECWHK 334
VD++S ++ M G + + A E + ++E K
Sbjct: 237 VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRK 296
Query: 335 NPDRRPT 341
P R +
Sbjct: 297 EPVHRAS 303
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-48
Identities = 68/275 (24%), Positives = 125/275 (45%), Gaps = 33/275 (12%)
Query: 102 GAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G +G VY A K++ ++ + F+ E + + HPN++ LG
Sbjct: 36 GHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLG 93
Query: 157 VLKHSERLIF-LTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ SE + Y+++G L + ++ + + L +A+GM YL + +
Sbjct: 94 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FV 150
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS-YKMTGGTGSYRYMAPE--VYRRES 271
HRDL N + DE +KV DFGL++ +K+ YS + TG ++MA E ++ +
Sbjct: 151 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 210
Query: 272 YGKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVAD--RRAYEDSRPALSSLYPEP 323
KS DV+SF +++ E+ G P + + + +P P+P
Sbjct: 211 T-KS-DVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQGRRLLQPEYC---PDP 260
Query: 324 IKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQK 358
+ ++ +CWH + RP+F E++ R+ AI +F
Sbjct: 261 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-48
Identities = 62/268 (23%), Positives = 117/268 (43%), Gaps = 16/268 (5%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG--V 157
G+YG ++ + G + K + + + + E+ L ++L+HPNIV++ +
Sbjct: 17 GSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRII 75
Query: 158 LKHSERLIFLTEYLRNGSLHDILKKKGK----LDPPTAVAYALDIARGMNYLHHHR--PH 211
+ + L + EY G L ++ K K LD + + + H H
Sbjct: 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135
Query: 212 AIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES 271
++HRDL P+NV D ++K+ DFGL++I S++ G+ YM+PE R S
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF---VGTPYYMSPEQMNRMS 192
Query: 272 YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331
Y + D++S +++E+ P A + ++A + E + Y + + ++
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGKFRRIPYRYSDELNEIITRM 251
Query: 332 WHKNPDRRPTFEEIIFRLEAIQESFQKK 359
+ RP+ EEI+ I E
Sbjct: 252 LNLKDYHRPSVEEIL-ENPLILEHHHHH 278
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-48
Identities = 57/282 (20%), Positives = 108/282 (38%), Gaps = 52/282 (18%)
Query: 102 GAYGEVYLVKWRG---------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIV 152
G + +++ R TE+ K + + + SF + + KL H ++V
Sbjct: 19 GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLV 75
Query: 153 QFLGVLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPH 211
GV + I + E+++ GSL LKK K ++ + A +A M++L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT-- 133
Query: 212 AIIHRDLTPSNVL--------QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMA 263
+IH ++ N+L +K++D G+S KD ++ ++
Sbjct: 134 -LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI-------PWVP 185
Query: 264 PEV--YRRESYGKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVADR--RAYEDSR 313
PE + + D +SF + E+ GG P ++ + ++
Sbjct: 186 PECIENPKNLNLAT-DKWSFGTTLWEICSGGDKPLSALDSQ-----RKLQFYEDRHQLPA 239
Query: 314 PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
P + L L+ C PD RP+F II L ++
Sbjct: 240 PKAAELA-----NLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-48
Identities = 57/247 (23%), Positives = 89/247 (36%), Gaps = 15/247 (6%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G+YGEV+ V+ + G A K S + + +HP V+ +
Sbjct: 68 GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE 127
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGK-LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
L TE SL + G L Y D + +LH ++H D+
Sbjct: 128 EGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDV 183
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
P+N+ G K+ DFGL G RYMAPE+ + SYG + DV
Sbjct: 184 KPANIFLGPRGRCKLGDFGLLVELGTAG----AGEVQEGDPRYMAPELL-QGSYGTAADV 238
Query: 279 FSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDR 338
FS L + E+ Q + P ++ ++++L +P
Sbjct: 239 FSLGLTILEVACNMELPHGGEGWQQLRQG---YLPPEFTAGLSSELRSVLVMMLEPDPKL 295
Query: 339 RPTFEEI 345
R T E +
Sbjct: 296 RATAEAL 302
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-48
Identities = 65/273 (23%), Positives = 103/273 (37%), Gaps = 38/273 (13%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV-- 157
G +G V+ K + A K IR + + R M+E+ KL HP IV++
Sbjct: 16 GGFGVVFEAKNKVDDCNYAIKRIR--LPNRELAREKVMREVKALAKLEHPGIVRYFNAWL 73
Query: 158 ----------LKHSERLIFLTEYLRNGSLHDILKKKGKLDPP---TAVAYALDIARGMNY 204
L + R +L D + + ++ + L IA + +
Sbjct: 74 EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEF 133
Query: 205 LHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY---------KMTGG 255
LH ++HRDL PSN+ +KV DFGL + + + TG
Sbjct: 134 LHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQ 190
Query: 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ--GGPSNRADTAVQVADRRAYEDSR 313
G+ YM+PE SY VD+FS LI+ E+ R T V + +
Sbjct: 191 VGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRNLK-----F 245
Query: 314 PALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346
P L + ++++ +P RP II
Sbjct: 246 PPLFTQKYPCEYVMVQDMLSPSPMERPEAINII 278
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 4e-48
Identities = 75/261 (28%), Positives = 124/261 (47%), Gaps = 27/261 (10%)
Query: 102 GAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +GEV++ + T++A KT++ S +F+ E + + L+H +V+ V+
Sbjct: 199 GQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 161 SERLIFLTEYLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
I +TE++ GSL D LK K P + ++ IA GM ++ IHRDL
Sbjct: 255 EPIYI-ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDL 310
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG-KSVD 277
+N+L + K+ DFGL+++ ++ + Y G ++ APE S+ KS D
Sbjct: 311 RAANILVSASLVCKIADFGLARVIED-NEY-TAREGAKFPIKWTAPEAINFGSFTIKS-D 367
Query: 278 VFSFALIVHEMFQGG--P----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331
V+SF +++ E+ G P SN + + R Y RP PE + ++ C
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMSNP-EVIRAL--ERGYRMPRPENC---PEELYNIMMRC 421
Query: 332 WHKNPDRRPTFEEIIFRLEAI 352
W P+ RPTFE I L+
Sbjct: 422 WKNRPEERPTFEYIQSVLDDF 442
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-48
Identities = 66/275 (24%), Positives = 123/275 (44%), Gaps = 33/275 (12%)
Query: 102 GAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G +G VY A K++ ++ + F+ E + + HPN++ LG
Sbjct: 100 GHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLG 157
Query: 157 VLKHSERLIFL-TEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ SE + Y+++G L + ++ + + L +A+GM +L + +
Sbjct: 158 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FV 214
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY-KMTGGTGSYRYMAPE--VYRRES 271
HRDL N + DE +KV DFGL++ +K+ S TG ++MA E ++ +
Sbjct: 215 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 274
Query: 272 YGKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVAD--RRAYEDSRPALSSLYPEP 323
KS DV+SF +++ E+ G P + + + +P P+P
Sbjct: 275 T-KS-DVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQGRRLLQPEYC---PDP 324
Query: 324 IKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQK 358
+ ++ +CWH + RP+F E++ R+ AI +F
Sbjct: 325 LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-47
Identities = 68/309 (22%), Positives = 118/309 (38%), Gaps = 31/309 (10%)
Query: 62 EKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGGIDPGAYGEVYLVKWRG----TEI 117
D + + P + +L + G +G V +R ++
Sbjct: 307 PMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDV 366
Query: 118 AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177
A K ++ + M+E + +L +P IV+ +GV + ++ + E G LH
Sbjct: 367 AIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALML-VMEMAGGGPLH 423
Query: 178 DILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDF 236
L + ++ ++ GM YL +HR+L NVL + K++DF
Sbjct: 424 KFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDF 480
Query: 237 GLSKIAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESYGKSVDVFSFALIVHEMFQGG-- 292
GLSK DSY + G ++ APE +R+ S +S DV+S+ + + E G
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS-RS-DVWSYGVTMWEALSYGQK 538
Query: 293 P----SNRADTAVQVADR--RAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346
P +V + P P + AL+ +CW + RP F +
Sbjct: 539 PYKKMKGP-----EVMAFIEQGKRMECPPEC---PPELYALMSDCWIYKWEDRPDFLTVE 590
Query: 347 FRLEAIQES 355
R+ A S
Sbjct: 591 QRMRACYYS 599
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-47
Identities = 73/272 (26%), Positives = 123/272 (45%), Gaps = 32/272 (11%)
Query: 102 GAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G +G+V+ + +A KT ++ ++ VR F++E ++ HP+IV+ +G
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIG 458
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
V+ + I + E G L L+ K LD + + YA ++ + YL R +H
Sbjct: 459 VITENPVWI-IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVH 514
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RD+ NVL +K+ DFGLS+ ++ +Y YK + G ++MAPE + +
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYMED-STY-YKASKGKLPIKWMAPESINFRRFTSA 572
Query: 276 VDVFSFALIVHEMFQGG--P----SNRADTAVQVADR--RAYEDSRPALSSLYPEPIKAL 327
DV+ F + + E+ G P N V R P P + +L
Sbjct: 573 SDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIENGERLPMPPNC---PPTLYSL 624
Query: 328 LRECWHKNPDRRPTFEEIIFRLEAI--QESFQ 357
+ +CW +P RRP F E+ +L I +E Q
Sbjct: 625 MTKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-47
Identities = 57/259 (22%), Positives = 106/259 (40%), Gaps = 22/259 (8%)
Query: 102 GAYGEVYLVKWRGTEI-AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN--IVQFLGVL 158
G +V+ V +I A K + A + +S+ E+ KL+ + I++
Sbjct: 39 GGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ + + E N L+ LKKK +DP +Y ++ ++ +H H I+H DL
Sbjct: 98 ITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDL 153
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV-----------Y 267
P+N L + G LK+ DFG++ Q D+ S G+ YM PE
Sbjct: 154 KPANFLIVD-GMLKLIDFGIANQMQP-DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 211
Query: 268 RRESYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKA 326
+ DV+S I++ M G P + + + + + ++
Sbjct: 212 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 271
Query: 327 LLRECWHKNPDRRPTFEEI 345
+L+ C ++P +R + E+
Sbjct: 272 VLKCCLKRDPKQRISIPEL 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 7e-47
Identities = 57/259 (22%), Positives = 107/259 (41%), Gaps = 22/259 (8%)
Query: 102 GAYGEVYLVKWRGTEI-AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN--IVQFLGVL 158
G +V+ V +I A K + A + + +S+ E+ KL+ + I++
Sbjct: 20 GGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ + + E N L+ LKKK +DP +Y ++ ++ +H H I+H DL
Sbjct: 79 ITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDL 134
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV-----------Y 267
P+N L + G LK+ DFG++ Q D+ S G+ YM PE
Sbjct: 135 KPANFLIVD-GMLKLIDFGIANQMQP-DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGK 192
Query: 268 RRESYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKA 326
+ DV+S I++ M G P + + + + + ++
Sbjct: 193 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 252
Query: 327 LLRECWHKNPDRRPTFEEI 345
+L+ C ++P +R + E+
Sbjct: 253 VLKCCLKRDPKQRISIPEL 271
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 7e-47
Identities = 78/287 (27%), Positives = 126/287 (43%), Gaps = 50/287 (17%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA+G+V+L + +A K ++ R F +E L L+H +IV+F
Sbjct: 26 GAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKF 82
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKK----------------KGKLDPPTAVAYALDI 198
GV + LI + EY+++G L+ L+ KG+L + A I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 199 ARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS 258
A GM YL +HRDL N L +K+ DFG+S+ D Y
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-VGGHTMLP 198
Query: 259 YRYMAPE--VYRRESYGKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVAD--RRA 308
R+M PE +YR+ + +S DV+SF +I+ E+F G P SN +V + +
Sbjct: 199 IRWMPPESIMYRKFTT-ES-DVWSFGVILWEIFTYGKQPWFQLSNT-----EVIECITQG 251
Query: 309 YEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
RP + P+ + ++ CW + P +R +EI L A+ ++
Sbjct: 252 RVLERPRVC---PKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-46
Identities = 67/282 (23%), Positives = 117/282 (41%), Gaps = 41/282 (14%)
Query: 102 GAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G +G V + ++A KT++ +S R F+ E + HPN+++ LG
Sbjct: 45 GEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLG 103
Query: 157 V-----LKHSERLIFLTEYLRNGSLHDILKK------KGKLDPPTAVAYALDIARGMNYL 205
V + + + + +++ G LH L + T + + +DIA GM YL
Sbjct: 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL 163
Query: 206 HHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPE 265
+ +HRDL N + + + V DFGLSK D Y + +++A E
Sbjct: 164 SNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR-QGRIAKMPVKWIAIE 219
Query: 266 --VYRRESYGKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVAD--RRAYEDSRPA 315
R + KS DV++F + + E+ G P N ++ D + +P
Sbjct: 220 SLADRVYTS-KS-DVWAFGVTMWEIATRGMTPYPGVQNH-----EMYDYLLHGHRLKQPE 272
Query: 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357
+ + ++ CW +P RPTF + +LE + ES
Sbjct: 273 DC---LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-46
Identities = 82/285 (28%), Positives = 126/285 (44%), Gaps = 49/285 (17%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
+G+VY G +A KT++ + +R F E L +L+HPN+V
Sbjct: 20 DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--AEGPLREEFRHEAMLRARLQHPNVVCL 77
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKK----------------KGKLDPPTAVAYALDI 198
LGV+ + L + Y +G LH+ L K L+PP V I
Sbjct: 78 LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 137
Query: 199 ARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS 258
A GM YL H ++H+DL NVL + ++K++D GL + D Y +
Sbjct: 138 AAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY-KLLGNSLLP 193
Query: 259 YRYMAPE--VYRRESYGKSVDVFSFALIVHEMFQ------GGPSNRADTAVQVAD--RRA 308
R+MAPE +Y + S S D++S+ +++ E+F G SN+ V + R
Sbjct: 194 IRWMAPEAIMYGKFSI-DS-DIWSYGVVLWEVFSYGLQPYCGYSNQ-----DVVEMIRNR 246
Query: 309 YEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQ 353
P P + AL+ ECW++ P RRP F++I RL A
Sbjct: 247 QVLPCPDDC---PAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-46
Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 59/294 (20%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQ 153
GA+G+V G +A K ++ S ++ R + M EL + L H NIV
Sbjct: 34 GAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 154 FLGVLKHSERLIFLTEYLRNGSLHDILKKK------------------GKLDPPTAVAYA 195
LG + +TEY G L + L++K LD ++++
Sbjct: 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151
Query: 196 LDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255
+A+GM +L IHRDL N+L K+ DFGL++ + +Y
Sbjct: 152 YQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY-VVKGNA 207
Query: 256 TGSYRYMAPE-----VYRRESYGKSVDVFSFALIVHEMF-------QGGPSNRADTAVQV 303
++MAPE VY ES DV+S+ + + E+F G P + +
Sbjct: 208 RLPVKWMAPESIFNCVYTFES-----DVWSYGIFLWELFSLGSSPYPGMPVDS-----KF 257
Query: 304 AD--RRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
+ + P + P + +++ CW +P +RPTF++I+ +E
Sbjct: 258 YKMIKEGFRMLSPEHA---PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-46
Identities = 63/288 (21%), Positives = 113/288 (39%), Gaps = 42/288 (14%)
Query: 102 GAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G +G V + + ++A K +++ I + F++E ++ HP++ + +G
Sbjct: 34 GEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVG 92
Query: 157 V------LKHSERLIFLTEYLRNGSLHDILKK------KGKLDPPTAVAYALDIARGMNY 204
V + + ++++G LH L L T V + +DIA GM Y
Sbjct: 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEY 152
Query: 205 LHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAP 264
L IHRDL N + E + V DFGLS+ D Y + +++A
Sbjct: 153 LSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR-QGCASKLPVKWLAL 208
Query: 265 E--VYRRESYGKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVAD--RRAYEDSRP 314
E + S DV++F + + E+ G P N ++ + +P
Sbjct: 209 ESLADNLYTV-HS-DVWAFGVTMWEIMTRGQTPYAGIENA-----EIYNYLIGGNRLKQP 261
Query: 315 ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKTVP 362
E + L+ +CW +P +RP+F + LE I +
Sbjct: 262 PEC---MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-45
Identities = 57/259 (22%), Positives = 107/259 (41%), Gaps = 22/259 (8%)
Query: 102 GAYGEVYLVKWRGTEI-AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN--IVQFLGVL 158
G +V+ V +I A K + A + + +S+ E+ KL+ + I++
Sbjct: 67 GGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ + + E N L+ LKKK +DP +Y ++ ++ +H H I+H DL
Sbjct: 126 ITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDL 181
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV-----------Y 267
P+N L + G LK+ DFG++ Q D+ S G+ YM PE
Sbjct: 182 KPANFLIVD-GMLKLIDFGIANQMQP-DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGK 239
Query: 268 RRESYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKA 326
+ DV+S I++ M G P + + + + + ++
Sbjct: 240 SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQD 299
Query: 327 LLRECWHKNPDRRPTFEEI 345
+L+ C ++P +R + E+
Sbjct: 300 VLKCCLKRDPKQRISIPEL 318
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-45
Identities = 73/295 (24%), Positives = 130/295 (44%), Gaps = 56/295 (18%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQ 153
GA+G+V G ++A K ++S+ ++ + + M EL + L +H NIV
Sbjct: 57 GAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHLGQHENIVN 114
Query: 154 FLGVLKHSERLIFLTEYLRNGSLHDILKKKGK--------------LDPPTAVAYALDIA 199
LG H ++ +TEY G L + L++K + + ++ +A
Sbjct: 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVA 174
Query: 200 RGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSY 259
+GM +L IHRD+ NVL K+ DFGL++ +Y
Sbjct: 175 QGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-VKGNARLPV 230
Query: 260 RYMAPE-----VYRRESYGKSVDVFSFALIVHEMF-------QGGPSNRADTAVQVAD-- 305
++MAPE VY +S DV+S+ +++ E+F G N +
Sbjct: 231 KWMAPESIFDCVYTVQS-----DVWSYGILLWEIFSLGLNPYPGILVNS-----KFYKLV 280
Query: 306 RRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEA-IQESFQKK 359
+ Y+ ++PA + P+ I ++++ CW P RPTF++I L+ QE +++
Sbjct: 281 KDGYQMAQPAFA---PKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRRER 332
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-45
Identities = 74/254 (29%), Positives = 114/254 (44%), Gaps = 22/254 (8%)
Query: 102 GAYGEVYL-VKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G YG VY IA K I + R +E+ L + L+H NIVQ+LG
Sbjct: 33 GTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 160 HSERL-IFLTEYLRNGSLHDILKKKG---KLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ + IF+ E + GSL +L+ K K + T Y I G+ YLH ++ I+H
Sbjct: 90 ENGFIKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVH 145
Query: 216 RDLTPSNVLQD-EAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES--Y 272
RD+ NVL + +G LK++DFG SK + + TG+ +YMAPE+ + Y
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF---TGTLQYMAPEIIDKGPRGY 202
Query: 273 GKSVDVFSFALIVHEMFQGGP--SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330
GK+ D++S + EM G P + P + KA + +
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYE-LGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILK 261
Query: 331 CWHKNPDRRPTFEE 344
C+ +PD+R +
Sbjct: 262 CFEPDPDKRACAND 275
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-45
Identities = 74/284 (26%), Positives = 122/284 (42%), Gaps = 49/284 (17%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
G++G VY +G T +A KT+ + ++ R R F+ E + ++ ++V+
Sbjct: 36 GSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRL 93
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKK----------GKLDPPTAVAYALDIARGMNY 204
LGV+ + + + E + G L L+ + A +IA GM Y
Sbjct: 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY 153
Query: 205 LHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAP 264
L+ ++ +HRDL N + E +K+ DFG+++ E D Y K G R+M+P
Sbjct: 154 LNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSP 209
Query: 265 E-----VYRRESYGKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVAD--RRAYED 311
E V+ S DV+SF +++ E+ P SN QV
Sbjct: 210 ESLKDGVFTTYS-----DVWSFGVVLWEIATLAEQPYQGLSNE-----QVLRFVMEGGLL 259
Query: 312 SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
+P P+ + L+R CW NP RP+F EII ++ E
Sbjct: 260 DKPDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-45
Identities = 76/286 (26%), Positives = 128/286 (44%), Gaps = 49/286 (17%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA+G+V+L + +A K ++ + + R F +E L L+H +IV+F
Sbjct: 52 GAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRF 108
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKK---------------KGKLDPPTAVAYALDIA 199
GV L+ + EY+R+G L+ L+ G L +A A +A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 200 RGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSY 259
GM YL +HRDL N L + +K+ DFG+S+ D Y
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-VGGRTMLPI 224
Query: 260 RYMAPE--VYRRESYGKSVDVFSFALIVHEMFQ------GGPSNRADTAVQVAD--RRAY 309
R+M PE +YR+ + +S DV+SF +++ E+F SN + D +
Sbjct: 225 RWMPPESILYRKFTT-ES-DVWSFGVVLWEIFTYGKQPWYQLSNT-----EAIDCITQGR 277
Query: 310 EDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
E RP P + A++R CW + P +R + +++ RL+A+ ++
Sbjct: 278 ELERPRAC---PPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-44
Identities = 59/275 (21%), Positives = 103/275 (37%), Gaps = 39/275 (14%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+G+V + A K IR + + + E+ L L H +V++
Sbjct: 17 GAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS----EVMLLASLNHQYVVRYYAAWL 72
Query: 160 HSER-------------LIFLTEYLRNGSLHDILKKKGKLDPPTAVA-YALDIARGMNYL 205
L EY NG+L+D++ + I ++Y+
Sbjct: 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYI 132
Query: 206 HHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY-----------KMTG 254
H IIHRDL P N+ DE+ ++K+ DFGL+K +T
Sbjct: 133 HSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189
Query: 255 GTGSYRYMAPEV-YRRESYGKSVDVFSFALIVHEMFQG--GPSNRADTAVQVADRRAYED 311
G+ Y+A EV Y + +D++S +I EM R + ++ R +
Sbjct: 190 AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKL--RSVSIE 247
Query: 312 SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346
P + K ++R +P++RP ++
Sbjct: 248 FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-44
Identities = 64/290 (22%), Positives = 115/290 (39%), Gaps = 52/290 (17%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQ 153
GA+G+V G +A K ++ + + M EL + + H N+V
Sbjct: 38 GAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 154 FLGVLKHSERLIFL-TEYLRNGSLHDILKK----------------KGKLDPPTAVAYAL 196
LG + + E+ + G+L L+ K L + Y+
Sbjct: 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 197 DIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256
+A+GM +L + IHRDL N+L E +K+ DFGL++ + Y +
Sbjct: 156 QVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDAR 211
Query: 257 GSYRYMAPE--VYRRESYGKSVDVFSFALIVHEMF-------QGGPSNRADTAVQVAD-- 305
++MAPE R + +S DV+SF +++ E+F G + +
Sbjct: 212 LPLKWMAPETIFDRVYTI-QS-DVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRL 264
Query: 306 RRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
+ P + + + +CWH P +RPTF E++ L + ++
Sbjct: 265 KEGTRMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-43
Identities = 72/281 (25%), Positives = 114/281 (40%), Gaps = 43/281 (15%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA+GEVY + G ++A KT+ + + F+ E + K H NIV+
Sbjct: 41 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRC 98
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKK-------KGKLDPPTAVAYALDIARGMNYLHH 207
+GV S L E + G L L++ L + A DIA G YL
Sbjct: 99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 158
Query: 208 HRPHAIIHRDLTPSNVLQDEAGH---LKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAP 264
+ IHRD+ N L G K+ DFG+++ Y K ++M P
Sbjct: 159 NH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR-KGGCAMLPVKWMPP 214
Query: 265 E--VYRRESYGKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVAD--RRAYEDSRP 314
E + + K+ D +SF +++ E+F G P SN+ +V + P
Sbjct: 215 EAFMEGIFT-SKT-DTWSFGVLLWEIFSLGYMPYPSKSNQ-----EVLEFVTSGGRMDPP 267
Query: 315 ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
P P+ ++ +CW P+ RP F I+ R+E +
Sbjct: 268 KNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-43
Identities = 72/290 (24%), Positives = 128/290 (44%), Gaps = 52/290 (17%)
Query: 102 GAYGEVYLVKWRG---------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNI 151
GA+G+V + + G +A K ++ + + + + E+ + + + +H NI
Sbjct: 46 GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 152 VQFLGVLKHSERLIFLTEYLRNGSLHDILKKK----------------GKLDPPTAVAYA 195
+ LG L + EY G+L + L+ + ++ V+
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 196 LDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255
+ARGM YL + IHRDL NVL E +K+ DFGL++ D Y K T G
Sbjct: 164 YQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK-KTTNG 219
Query: 256 TGSYRYMAPE--VYRRESYGKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVAD-- 305
++MAPE R ++ +S DV+SF +++ E+F G P ++
Sbjct: 220 RLPVKWMAPEALFDRVYTH-QS-DVWSFGVLMWEIFTLGGSPYPGIPVE-----ELFKLL 272
Query: 306 RRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
+ + +PA + ++R+CWH P +RPTF++++ L+ I
Sbjct: 273 KEGHRMDKPANC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-43
Identities = 74/295 (25%), Positives = 120/295 (40%), Gaps = 57/295 (19%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA+G V+ + G T +A K ++ ++ ++ F +E L + +PNIV+
Sbjct: 58 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKL 115
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKK------------------------GKLDPPT 190
LGV + + L EY+ G L++ L+ L
Sbjct: 116 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 175
Query: 191 AVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250
+ A +A GM YL + +HRDL N L E +K+ DFGLS+ D Y
Sbjct: 176 QLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK- 231
Query: 251 KMTGGTGSYRYMAPE--VYRRESYGKSVDVFSFALIVHEMFQ------GGPSNRADTAVQ 302
R+M PE Y R + +S DV+++ +++ E+F G ++ +
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTT-ES-DVWAYGVVLWEIFSYGLQPYYGMAHE-----E 284
Query: 303 VAD--RRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
V R + P P + L+R CW K P RP+F I L+ + E
Sbjct: 285 VIYYVRDGNILACPENC---PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-43
Identities = 52/284 (18%), Positives = 100/284 (35%), Gaps = 43/284 (15%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVL 158
G +G V+ R G A K + +A + ++E+ L +H ++V++
Sbjct: 22 GEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAW 80
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGK----LDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ ++ EY GSL D + + + L + RG+ Y+H ++
Sbjct: 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LV 137
Query: 215 HRDLTPSNVLQDEAGHL-------------------KVTDFGLSKIAQEKDSYSYKMTGG 255
H D+ PSN+ K+ D G
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE------- 190
Query: 256 TGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP 314
G R++A EV + ++ D+F+ AL V P R + P
Sbjct: 191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH----EIRQGRLP 246
Query: 315 ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQK 358
+ + + LL+ H +P+RRP+ ++ + + + +K
Sbjct: 247 RIPQVLSQEFTELLKVMIHPDPERRPSAMALV-KHSVLLSASRK 289
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 5e-43
Identities = 69/292 (23%), Positives = 127/292 (43%), Gaps = 57/292 (19%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
G +G+V T +A K ++ + ++P + E + +++ HP++++
Sbjct: 34 GEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKL 91
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKK------------------------GKLDPPT 190
G L+ + EY + GSL L++ L
Sbjct: 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151
Query: 191 AVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250
+++A I++GM YL + ++HRDL N+L E +K++DFGLS+ E+DSY
Sbjct: 152 LISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY-V 207
Query: 251 KMTGGTGSYRYMAPE--VYRRESYGKSVDVFSFALIVHEMFQGG--P----SNRADTAVQ 302
K + G ++MA E + +S DV+SF +++ E+ G P +
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTT-QS-DVWSFGVLLWEIVTLGGNPYPGIPPE-----R 260
Query: 303 VAD--RRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
+ + + + RP E + L+ +CW + PD+RP F +I LE +
Sbjct: 261 LFNLLKTGHRMERPDNC---SEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-42
Identities = 77/285 (27%), Positives = 125/285 (43%), Gaps = 50/285 (17%)
Query: 102 GAYGEVYLVKWRG----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLG 156
G +G+V + + + A K ++ ++ F EL + KL HPNI+ LG
Sbjct: 36 GNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLG 93
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKK----------------GKLDPPTAVAYALDIAR 200
+H L EY +G+L D L+K L + +A D+AR
Sbjct: 94 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 153
Query: 201 GMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYR 260
GM+YL + IHRDL N+L E K+ DFGLS+ ++ Y K T G R
Sbjct: 154 GMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQEVY-VKKTMGRLPVR 206
Query: 261 YMAPE--VYRRESYGKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVAD--RRAYE 310
+MA E Y + S DV+S+ +++ E+ G P + ++ + + Y
Sbjct: 207 WMAIESLNYSVYTT-NS-DVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEKLPQGYR 259
Query: 311 DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
+P + + L+R+CW + P RP+F +I+ L + E
Sbjct: 260 LEKPLNC---DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-42
Identities = 72/281 (25%), Positives = 114/281 (40%), Gaps = 43/281 (15%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA+GEVY + G ++A KT+ + + F+ E + K H NIV+
Sbjct: 82 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRC 139
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKK-------KGKLDPPTAVAYALDIARGMNYLHH 207
+GV S L E + G L L++ L + A DIA G YL
Sbjct: 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 199
Query: 208 HRPHAIIHRDLTPSNVLQDEAGH---LKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAP 264
+ IHRD+ N L G K+ DFG+++ Y K ++M P
Sbjct: 200 NH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-KGGCAMLPVKWMPP 255
Query: 265 E--VYRRESYGKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVAD--RRAYEDSRP 314
E + + K+ D +SF +++ E+F G P SN+ +V + P
Sbjct: 256 EAFMEGIFT-SKT-DTWSFGVLLWEIFSLGYMPYPSKSNQ-----EVLEFVTSGGRMDPP 308
Query: 315 ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
P P+ ++ +CW P+ RP F I+ R+E +
Sbjct: 309 KNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-42
Identities = 66/296 (22%), Positives = 115/296 (38%), Gaps = 64/296 (21%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQ 153
GA+G+V G ++A K ++ ++ R + M EL + +L H NIV
Sbjct: 56 GAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQLGSHENIVN 113
Query: 154 FLGVLKHSERLIFLTEYLRNGSLHDILKKK-----------------------GKLDPPT 190
LG S + + EY G L + L+ K L
Sbjct: 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173
Query: 191 AVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250
+ +A +A+GM +L +HRDL NVL +K+ DFGL++ +Y
Sbjct: 174 LLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY-V 229
Query: 251 KMTGGTGSYRYMAPE-----VYRRESYGKSVDVFSFALIVHEMF-------QGGPSNRAD 298
++MAPE +Y +S DV+S+ +++ E+F G P +
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKS-----DVWSYGILLWEIFSLGVNPYPGIPVDA-- 282
Query: 299 TAVQVAD--RRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
+ ++ +P + E I +++ CW + +RP+F + L
Sbjct: 283 ---NFYKLIQNGFKMDQPFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-42
Identities = 66/249 (26%), Positives = 115/249 (46%), Gaps = 16/249 (6%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +G VYL + + + +A K + + V + +E+ + LRHPNI++ G
Sbjct: 20 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ R+ + EY G+++ L+K K D Y ++A ++Y H R +IHRD+
Sbjct: 80 DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIK 136
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
P N+L AG LK+ DFG S A G+ Y+ PE+ + + VD++
Sbjct: 137 PENLLLGSAGELKIADFGWSVHAPSSRRTDL-----CGTLDYLPPEMIEGRMHDEKVDLW 191
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PALSSLYPEPIKALLRECWHKNPD 337
S ++ +E G P A+T + R + + ++ + I LL+ NP
Sbjct: 192 SLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK----HNPS 247
Query: 338 RRPTFEEII 346
+RP E++
Sbjct: 248 QRPMLREVL 256
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-42
Identities = 57/281 (20%), Positives = 101/281 (35%), Gaps = 32/281 (11%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV-- 157
G + V LV+ G A K I + + R +E + + HPNI++ +
Sbjct: 40 GGFSYVDLVEGLHDGHFYALKRI---LCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 158 --LKHSERLIFLTEYLRNGSLHDILK----KKGKLDPPTAVAYALDIARGMNYLHHHRPH 211
L + + G+L + ++ K L + L I RG+ +H
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG-- 154
Query: 212 AIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG------TGSYRYMAPE 265
HRDL P+N+L + G + D G A S + + Y APE
Sbjct: 155 -YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 266 V---YRRESYGKSVDVFSFALIVHEMFQGGP----SNRADTAVQVADRRAYEDSRPALSS 318
+ + DV+S +++ M G + +V +A + S
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL---SIPQSP 270
Query: 319 LYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359
+ + LL +P +RP ++ +LEA+Q +
Sbjct: 271 RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 4e-42
Identities = 64/261 (24%), Positives = 109/261 (41%), Gaps = 38/261 (14%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G + + + + T A K + S+ P R E+ + + L H ++V F G +
Sbjct: 52 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
++ + + E R SL ++ K++ L P A Y I G YLH +R +IHRDL
Sbjct: 112 DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLK 168
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
N+ +E +K+ DFGL+ + K G+ Y+APEV ++ + VDV+
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLC-GTPNYIAPEVLSKKGHSFEVDVW 225
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLY--------------PEPIK 325
S I++ + G P +E S L Y
Sbjct: 226 SIGCIMYTLLVGKP--------------PFETS--CLKETYLRIKKNEYSIPKHINPVAA 269
Query: 326 ALLRECWHKNPDRRPTFEEII 346
+L+++ +P RPT E++
Sbjct: 270 SLIQKMLQTDPTARPTINELL 290
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 5e-42
Identities = 71/287 (24%), Positives = 127/287 (44%), Gaps = 52/287 (18%)
Query: 102 GAYGEVYLVKWRG---------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNI 151
G +G+V + + G +A K ++ + + + + E+ + + + +H NI
Sbjct: 92 GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 152 VQFLGVLKHSERLIFLTEYLRNGSLHDILKKK----------------GKLDPPTAVAYA 195
+ LG L + EY G+L + L+ + ++ V+
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209
Query: 196 LDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255
+ARGM YL + IHRDL NVL E +K+ DFGL++ D Y K T G
Sbjct: 210 YQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-KKTTNG 265
Query: 256 TGSYRYMAPE--VYRRESYGKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVAD-- 305
++MAPE R ++ +S DV+SF +++ E+F G P ++
Sbjct: 266 RLPVKWMAPEALFDRVYTH-QS-DVWSFGVLMWEIFTLGGSPYPGIPVE-----ELFKLL 318
Query: 306 RRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
+ + +PA + ++R+CWH P +RPTF++++ L+ I
Sbjct: 319 KEGHRMDKPANC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-42
Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 52/290 (17%)
Query: 102 GAYGEVYLVKWRG---------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNI 151
GA+G+V L + G T++A K ++S + + + + E+ + + + +H NI
Sbjct: 80 GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNI 137
Query: 152 VQFLGVLKHSERLIFLTEYLRNGSLHDILKKK----------------GKLDPPTAVAYA 195
+ LG L + EY G+L + L+ + +L V+ A
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197
Query: 196 LDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255
+ARGM YL + IHRDL NVL E +K+ DFGL++ D Y K T G
Sbjct: 198 YQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK-KTTNG 253
Query: 256 TGSYRYMAPE--VYRRESYGKSVDVFSFALIVHEMFQGG--P----SNRADTAVQVAD-- 305
++MAPE R ++ +S DV+SF +++ E+F G P ++
Sbjct: 254 RLPVKWMAPEALFDRIYTH-QS-DVWSFGVLLWEIFTLGGSPYPGVPVE-----ELFKLL 306
Query: 306 RRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
+ + +P+ + ++R+CWH P +RPTF++++ L+ I
Sbjct: 307 KEGHRMDKPSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-42
Identities = 64/261 (24%), Positives = 109/261 (41%), Gaps = 38/261 (14%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G + + + + T A K + S+ P R E+ + + L H ++V F G +
Sbjct: 26 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 85
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
++ + + E R SL ++ K++ L P A Y I G YLH +R +IHRDL
Sbjct: 86 DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLK 142
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
N+ +E +K+ DFGL+ + K G+ Y+APEV ++ + VDV+
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLC-GTPNYIAPEVLSKKGHSFEVDVW 199
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLY--------------PEPIK 325
S I++ + G P +E S L Y
Sbjct: 200 SIGCIMYTLLVGKP--------------PFETS--CLKETYLRIKKNEYSIPKHINPVAA 243
Query: 326 ALLRECWHKNPDRRPTFEEII 346
+L+++ +P RPT E++
Sbjct: 244 SLIQKMLQTDPTARPTINELL 264
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-42
Identities = 58/306 (18%), Positives = 115/306 (37%), Gaps = 58/306 (18%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL- 158
GA V+ + + G A K + S R + M+E + +KL H NIV+ +
Sbjct: 20 GATANVFRGRHKKTGDLFAIKVFNNI--SFLRPVDVQMREFEVLKKLNHKNIVKLFAIEE 77
Query: 159 KHSERLIFL-TEYLRNGSLHDILKKKGK---LDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ + R L E+ GSL+ +L++ L + D+ GMN+L + I+
Sbjct: 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IV 134
Query: 215 HRDLTPSNVL----QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR- 269
HR++ P N++ +D K+TDFG ++ ++ + + G+ Y+ P++Y R
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEYLHPDMYERA 190
Query: 270 -------ESYGKSVDVFSFALIVHEM------FQGGPSNRADTAV--------------- 301
+ YG +VD++S + + F+ R + V
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 302 ---QVADRRAYEDSRPA---LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
+ P LS + +L + ++ F++ +
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF---FAETSDI 307
Query: 356 FQKKTV 361
+ +
Sbjct: 308 LHRMVI 313
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-41
Identities = 58/290 (20%), Positives = 112/290 (38%), Gaps = 55/290 (18%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL- 158
GA V+ + + G A K + S R + M+E + +KL H NIV+ +
Sbjct: 20 GATANVFRGRHKKTGDLFAIKVFNNI--SFLRPVDVQMREFEVLKKLNHKNIVKLFAIEE 77
Query: 159 KHSERLIFL-TEYLRNGSLHDILKKKGK---LDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ + R L E+ GSL+ +L++ L + D+ GMN+L + I+
Sbjct: 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IV 134
Query: 215 HRDLTPSNVL----QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR- 269
HR++ P N++ +D K+TDFG ++ ++ + + G+ Y+ P++Y R
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEYLHPDMYERA 190
Query: 270 -------ESYGKSVDVFSFALIVHEM------FQGGPSNRADTAV--------------- 301
+ YG +VD++S + + F+ R + V
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 302 ---QVADRRAYEDSRPA---LSSLYPEPIKALLRECWHKNPDRRPTFEEI 345
+ P LS + +L + ++ F++
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-41
Identities = 63/248 (25%), Positives = 114/248 (45%), Gaps = 16/248 (6%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +G VYL + + +A K + S V + +E+ + LRHPNI++
Sbjct: 25 GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+R+ + E+ G L+ L+K G+ D + + ++A ++Y H + +IHRD+
Sbjct: 85 DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIK 141
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
P N+L G LK+ DFG S A S + G+ Y+ PE+ +++ + VD++
Sbjct: 142 PENLLMGYKGELKIADFGWSVHAP-----SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLW 196
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PALSSLYPEPIKALLRECWHKNPD 337
++ +E G P + + + R D + P LS + I LLR +P
Sbjct: 197 CAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLR----YHPP 252
Query: 338 RRPTFEEI 345
+R + +
Sbjct: 253 QRLPLKGV 260
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-40
Identities = 69/308 (22%), Positives = 116/308 (37%), Gaps = 51/308 (16%)
Query: 74 GRTPLSDARSFGHVVICKILEDRGGIDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPR 131
GR+P ++ G + + L G G +G V + G ++A K R +P+
Sbjct: 3 GRSPSLPTQTCGPWEMKERL----GT--GGFGYVLRWIHQDTGEQVAIKQCRQE--LSPK 54
Query: 132 VRNSFMKELGLWQKLRHPNIVQFLGVLK-----HSERLIFL-TEYLRNGSLHDILKKKGK 185
R + E+ + +KL HPN+V V L L EY G L L +
Sbjct: 55 NRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN 114
Query: 186 ---LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVL---QDEAGHLKVTDFGLS 239
L DI+ + YLH +R IIHRDL P N++ + K+ D G +
Sbjct: 115 CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
Query: 240 KIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG----GPSN 295
K + + T G+ +Y+APE+ ++ Y +VD +SF + E G P+
Sbjct: 172 KELDQGE----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW 227
Query: 296 RADTAVQVADRRAYEDSRPA------------------LSSLYPEPIKALLRECWHKNPD 337
+ ++ E LS + ++ L+ +
Sbjct: 228 QPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQR 287
Query: 338 RRPTFEEI 345
+R T +
Sbjct: 288 QRGTDPQN 295
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-40
Identities = 66/254 (25%), Positives = 108/254 (42%), Gaps = 23/254 (9%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++ VY + T E+A K I + E+ + +L+HP+I++ +
Sbjct: 22 GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGK-LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
S + + E NG ++ LK + K A + I GM YLH H I+HRDL
Sbjct: 82 DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDL 138
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
T SN+L ++K+ DFGL+ + T G+ Y++PE+ R ++G DV
Sbjct: 139 TLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYT-LCGTPNYISPEIATRSAHGLESDV 195
Query: 279 FSFALIVHEMFQGGP----SNRADT--AVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332
+S + + + G P +T V +AD L I LLR
Sbjct: 196 WSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDL----IHQLLR--- 248
Query: 333 HKNPDRRPTFEEII 346
+NP R + ++
Sbjct: 249 -RNPADRLSLSSVL 261
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 48/258 (18%), Positives = 94/258 (36%), Gaps = 25/258 (9%)
Query: 102 GAYGEVYLV-KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLK 159
GA G + + ++A K I P + +E+ L ++ HPN++++ K
Sbjct: 35 GAEGTIVYRGMFDNRDVAVKRI------LPECFSFADREVQLLRESDEHPNVIRYFCTEK 88
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYAL-DIARGMNYLHHHRPHAIIHRDL 218
+ E +L + +++K L G+ +LH I+HRDL
Sbjct: 89 DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDL 144
Query: 219 TPSNVLQDEAGH-----LKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES-- 271
P N+L ++DFGL K + +G G+ ++APE+ +
Sbjct: 145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKE 204
Query: 272 -YGKSVDVFSFALIVHEMFQGGP---SNRADTAVQVADRRAYEDSRPALSSLYPEPIKAL 327
+VD+FS + + + G + A + L
Sbjct: 205 NPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL-LGACSLDCLHPEKHEDVIAREL 263
Query: 328 LRECWHKNPDRRPTFEEI 345
+ + +P +RP+ + +
Sbjct: 264 IEKMIAMDPQKRPSAKHV 281
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 7e-39
Identities = 55/286 (19%), Positives = 103/286 (36%), Gaps = 49/286 (17%)
Query: 102 GAYGEVYLVKWRGTEIAAKTI--------------RSSIASNPRVRNSFMKELGLWQKLR 147
G + ++ L + A K + S + F EL + ++
Sbjct: 42 GKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101
Query: 148 HPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDP--------PTAVAYALDIA 199
+ + G++ + + + + EY+ N S+ + LD +
Sbjct: 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVL 161
Query: 200 RGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSY 259
+Y+H+ + I HRD+ PSN+L D+ G +K++DFG S+ +K K+ G G+Y
Sbjct: 162 NSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTY 214
Query: 260 RYMAPEVYRRES--YGKSVDVFSFALIVHEMFQGGP-----SNRADT------------- 299
+M PE + ES G VD++S + ++ MF + +
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPL 274
Query: 300 AVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345
++ L+ KNP R T E+
Sbjct: 275 DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 17/252 (6%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++GEV L K + T E A K I + S ++E+ L ++L HPNI++ +
Sbjct: 37 GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 96
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ E G L D + + + A + G+ Y+H ++ I+HRDL
Sbjct: 97 DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLK 153
Query: 220 PSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
P N+L + + ++++ DFGLS + KM G+ Y+APEV +Y +
Sbjct: 154 PENLLLESKSKDANIRIIDFGLSTHFEASK----KMKDKIGTAYYIAPEVLHG-TYDEKC 208
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVAD---RRAYEDSRPALSSLYPEPIKALLRECWH 333
DV+S +I++ + G P + + Y P + K L+R+
Sbjct: 209 DVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES-AKDLIRKMLT 267
Query: 334 KNPDRRPTFEEI 345
P R + +
Sbjct: 268 YVPSMRISARDA 279
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-38
Identities = 67/267 (25%), Positives = 117/267 (43%), Gaps = 18/267 (6%)
Query: 85 GHVVICKILEDR----GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMK 138
G +I KI+ +R + G VYL + ++A K I F +
Sbjct: 1 GSHMIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFER 60
Query: 139 ELGLWQKLRHPNIVQFLGVLKHSERLIFLT-EYLRNGSLHDILKKKGKLDPPTAVAYALD 197
E+ +L H NIV + V + +L EY+ +L + ++ G L TA+ +
Sbjct: 61 EVHNSSQLSHQNIVSMIDV-DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQ 119
Query: 198 IARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT- 256
I G+ + H R I+HRD+ P N+L D LK+ DFG IA+ S T
Sbjct: 120 ILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFG---IAKALSETSLTQTNHVL 173
Query: 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPAL 316
G+ +Y +PE + E+ + D++S ++++EM G P +TAV +A + +
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVT 233
Query: 317 SSLY---PEPIKALLRECWHKNPDRRP 340
+ + P+ + ++ K+ R
Sbjct: 234 TDVRKDIPQSLSNVILRATEKDKANRY 260
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-38
Identities = 65/285 (22%), Positives = 110/285 (38%), Gaps = 45/285 (15%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLG-- 156
G + VY + G E A K + +++ + ++E+ +KL HPNIVQF
Sbjct: 39 GGFAFVYEAQDVGSGREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 157 -----VLKHSERLIFLTEYLRNGSLHDILKK---KGKLDPPTAVAYALDIARGMNYLHHH 208
+ L L G L + LKK +G L T + R + ++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 209 RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT---------GSY 259
+P IIHRDL N+L G +K+ DFG + YS+ +
Sbjct: 156 KP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 260 RYMAPEV---YRRESYGKSVDVFSFALIVHEM------FQGGPSNRADTAVQVADRRAYE 310
Y PE+ Y G+ D+++ I++ + F+ G A + Y
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG----AKLRIV---NGKYS 267
Query: 311 DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
P + +L+R NP+ R + E++ +L+ I +
Sbjct: 268 I--PPHDT-QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-38
Identities = 67/254 (26%), Positives = 106/254 (41%), Gaps = 12/254 (4%)
Query: 93 LEDRGGIDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN 150
E + G G V+ V K G +A K I I P +RN ++EL + + P
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPY 92
Query: 151 IVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRP 210
IV F G + E++ GSL +LKK G++ ++ + +G+ YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK-- 150
Query: 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE 270
H I+HRD+ PSN+L + G +K+ DFG+S + + S+ G+ YM+PE +
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----VGTRSYMSPERLQGT 205
Query: 271 SYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329
Y D++S L + EM G P D + A + P L
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265
Query: 330 ECWHKNPDRRPTFE 343
+ + FE
Sbjct: 266 KFGMDSRPPMAIFE 279
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 51/233 (21%), Positives = 87/233 (37%), Gaps = 22/233 (9%)
Query: 128 SNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLD 187
S+P ++ ++ N V L L + R +L D + ++ L+
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159
Query: 188 PP---TAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQE 244
+ + IA + +LH ++HRDL PSN+ +KV DFGL +
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 245 KDSYSY---------KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG--GP 293
+ TG G+ YM+PE +Y VD+FS LI+ E+
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276
Query: 294 SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346
R V + + P L + ++++ +P RP +II
Sbjct: 277 MERVRIITDVRNLK-----FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 17/55 (30%), Positives = 26/55 (47%), Gaps = 4/55 (7%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
G +G V+ K + A K IR + + R M+E+ KL HP IV++
Sbjct: 17 GGFGVVFEAKNKVDDCNYAIKRIR--LPNRELAREKVMREVKALAKLEHPGIVRY 69
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-37
Identities = 69/255 (27%), Positives = 117/255 (45%), Gaps = 24/255 (9%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTI---RSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
GAYGEV L + + T E A K I S +SN ++ E+ + + L HPNI++
Sbjct: 48 GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE----EVAVLKLLDHPNIMKLYD 103
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ + E + G L D + + K + A + G+ YLH H I+HR
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHR 160
Query: 217 DLTPSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG 273
DL P N+L +++ +K+ DFGLS + + + KM G+ Y+APEV R+ Y
Sbjct: 161 DLKPENLLLESKEKDALIKIVDFGLSAVFENQK----KMKERLGTAYYIAPEVLRK-KYD 215
Query: 274 KSVDVFSFALIVHEMFQGGPSNRADTAVQVAD---RRAYEDSRPALSSLYPEPIKALLRE 330
+ DV+S +I+ + G P T ++ + Y P ++ K L+++
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG-AKDLIKQ 274
Query: 331 CWHKNPDRRPTFEEI 345
+ RR + ++
Sbjct: 275 MLQFDSQRRISAQQA 289
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-37
Identities = 40/282 (14%), Positives = 90/282 (31%), Gaps = 36/282 (12%)
Query: 102 GAYGEVYLVKWRGT-------EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA+ +VY + K + + + M+ L + ++F
Sbjct: 76 GAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERL---KPSMQHMFMKF 132
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGK-----LDPPTAVAYALDIARGMNYLHHHR 209
+ + E G+L + + + +++A+ + + +H
Sbjct: 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE 192
Query: 210 PHAIIHRDLTPSNVL-----------QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS 258
IIH D+ P N + D + L + D G S I + T +
Sbjct: 193 ---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS-IDMKLFPKGTIFTAKCET 248
Query: 259 YRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSS 318
+ E+ + + +D F A V+ M G + + + R
Sbjct: 249 SGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF--RRLPHLD 306
Query: 319 LYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI-QESFQKK 359
++ E +L + P+ + + +L+ + Q+ + K
Sbjct: 307 MWNEFFHVMLNI---PDCHHLPSLDLLRQKLKKVFQQHYTNK 345
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-36
Identities = 61/263 (23%), Positives = 110/263 (41%), Gaps = 20/263 (7%)
Query: 93 LEDRGGIDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHP 149
LE+ G + G G+V+ + + G IA K +R S N + +L + + P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84
Query: 150 NIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAY-ALDIARGMNYLHHH 208
IVQ G + + E + + K+ P + + I + + YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 209 RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV-- 266
H +IHRD+ PSN+L DE G +K+ DFG+S + D + + G + YMAPE
Sbjct: 144 --HGVIHRDVKPSNILLDERGQIKLCDFGIS--GRLVDDKAKDRSAGCAA--YMAPERID 197
Query: 267 ---YRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSS--LYP 321
+ Y DV+S + + E+ G + + ++ P L +
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS 257
Query: 322 EPIKALLRECWHKNPDRRPTFEE 344
++ +++C K+ +RP + +
Sbjct: 258 GDFQSFVKDCLTKDHRKRPKYNK 280
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 21/264 (7%)
Query: 93 LEDRGGIDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHP 149
LE + GAYG V + G +A K IR++ N + + + +L + + P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCP 66
Query: 150 NIVQFLGVLKHSERLIFLTEYLRNGSLHDILK---KKGKLDPPTAVAY-ALDIARGMNYL 205
V F G L + E + + SL K KG+ P + A+ I + + +L
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 206 HHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPE 265
H ++IHRD+ PSNVL + G +K+ DFG+S D + G YMAPE
Sbjct: 126 HSK--LSVIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDDVA--KDIDAGCKPYMAPE 179
Query: 266 V----YRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPAL-SSLY 320
++ Y D++S + + E+ + ++ E+ P L + +
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF 239
Query: 321 PEPIKALLRECWHKNPDRRPTFEE 344
+C KN RPT+ E
Sbjct: 240 SAEFVDFTSQCLKKNSKERPTYPE 263
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 60/242 (24%), Positives = 106/242 (43%), Gaps = 12/242 (4%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++ V L + T A K + I +V +E + +L HP V+
Sbjct: 41 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV-TRERDVMSRLDHPFFVKLYFTF 99
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ E+L F Y +NG L ++K G D Y +I + YLH IIHRDL
Sbjct: 100 QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDL 156
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG-GTGSYRYMAPEVYRRESYGKSVD 277
P N+L +E H+++TDFG +K+ + + + GT Y++PE+ +S KS D
Sbjct: 157 KPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ--YVSPELLTEKSACKSSD 214
Query: 278 VFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPD 337
+++ I++++ G P RA + + + + + L+ + +
Sbjct: 215 LWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD--FPEKFFPKARDLVEKLLVLDAT 272
Query: 338 RR 339
+R
Sbjct: 273 KR 274
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 72/252 (28%), Positives = 116/252 (46%), Gaps = 18/252 (7%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++GEV K R T E A K I + A N + ++E+ L +KL HPNI++ +L+
Sbjct: 33 GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLFEILE 91
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
S + E G L D + K+ + A + G+ Y+H H I+HRDL
Sbjct: 92 DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLK 148
Query: 220 PSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
P N+L +++ +K+ DFGLS Q+ KM G+ Y+APEV R +Y +
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYYIAPEVLRG-TYDEKC 203
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVAD---RRAYEDSRPALSSLYPEPIKALLRECWH 333
DV+S +I++ + G P + Y P ++ + K L+R+
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD-AKDLIRKMLT 262
Query: 334 KNPDRRPTFEEI 345
+P R T +
Sbjct: 263 FHPSLRITATQC 274
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 66/257 (25%), Positives = 118/257 (45%), Gaps = 26/257 (10%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++G+V +V+ T+ A K + VRN KEL + Q L HP +V L
Sbjct: 26 GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV-FKELQIMQGLEHPFLVN----L 80
Query: 159 KHS----ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+S E + + + L G L L++ T + ++ ++YL + R II
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---II 137
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES--- 271
HRD+ P N+L DE GH+ +TDF ++ + + ++T G+ YMAPE++
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTMAGTKPYMAPEMFSSRKGAG 193
Query: 272 YGKSVDVFSFALIVHEMFQGGP--SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329
Y +VD +S + +E+ +G R+ T+ + S + + + +LL+
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-VVTYPSAWSQEMVSLLK 252
Query: 330 ECWHKNPDRR-PTFEEI 345
+ NPD+R ++
Sbjct: 253 KLLEPNPDQRFSQLSDV 269
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-36
Identities = 60/297 (20%), Positives = 114/297 (38%), Gaps = 50/297 (16%)
Query: 102 GAYGEVYLV-KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLK 159
G+ G V ++G +A K + + + E+ L + HPN++++
Sbjct: 26 GSSGTVVFQGSFQGRPVAVKRM------LIDFCDIALMEIKLLTESDDHPNVIRYYCSET 79
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPT-------AVAYALDIARGMNYLHHHRPHA 212
L E N +L D+++ K D ++ IA G+ +LH +
Sbjct: 80 TDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--- 135
Query: 213 IIHRDLTPSNVL-------------QDEAGHLKVTDFGLSK-IAQEKDSYSYKMTGGTGS 258
IIHRDL P N+L E + ++DFGL K + + S+ + +G+
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195
Query: 259 YRYMAPEV-------YRRESYGKSVDVFSFALIVHEMFQGG-----PSNRADTAVQVADR 306
+ APE+ + +S+D+FS + + + G ++ +
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 255
Query: 307 RAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEII----FRLEAIQESFQKK 359
E SL E L+ + +P +RPT +++ F ++ + F K
Sbjct: 256 SLDEMKCLHDRSLIAEA-TDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLK 311
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-36
Identities = 71/268 (26%), Positives = 114/268 (42%), Gaps = 25/268 (9%)
Query: 93 LEDRGGIDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHP 149
L+D G I GAYG V + K G +A K IRS+ + + + + +L + + P
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCP 81
Query: 150 NIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPT----AVAY-ALDIARGMNY 204
IVQF G L E + + S K + + L + +N+
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 205 LHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAP 264
L + IIHRD+ PSN+L D +G++K+ DFG+S Q DS + G YMAP
Sbjct: 141 LKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDSIAKTRDAGCRP--YMAP 194
Query: 265 EV----YRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSL- 319
E R+ Y DV+S + ++E+ G +V + + P LS+
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSE 254
Query: 320 ---YPEPIKALLRECWHKNPDRRPTFEE 344
+ + C K+ +RP ++E
Sbjct: 255 EREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-35
Identities = 68/245 (27%), Positives = 113/245 (46%), Gaps = 19/245 (7%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G +G+V LVK + T A K ++ I + V ++ + E + Q RHP +
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHPFLTALKYSF 217
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ +RL F+ EY G L L ++ A Y +I ++YLH +++RDL
Sbjct: 218 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDL 275
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
N++ D+ GH+K+TDFGL K E M G+ Y+APEV YG++VD
Sbjct: 276 KLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 332
Query: 279 FSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI----KALLRECWHK 334
+ ++++EM G ++ + E+ R +P + K+LL K
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR------FPRTLGPEAKSLLSGLLKK 386
Query: 335 NPDRR 339
+P +R
Sbjct: 387 DPKQR 391
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 68/262 (25%), Positives = 113/262 (43%), Gaps = 27/262 (10%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIR----------SSIASNPRVRNSFMKELGLWQKLRHP 149
GAYGEV L K + E A K I+ + + E+ L + L HP
Sbjct: 47 GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHP 106
Query: 150 NIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHR 209
NI++ V + + +TE+ G L + + + K D A I G+ YLH H
Sbjct: 107 NIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN 166
Query: 210 PHAIIHRDLTPSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV 266
I+HRD+ P N+L ++ ++K+ DFGLS + K+ G+ Y+APEV
Sbjct: 167 ---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEV 219
Query: 267 YRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVAD---RRAYEDSRPALSSLYPEP 323
++ Y + DV+S +I++ + G P + + Y ++ E
Sbjct: 220 LKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDE- 277
Query: 324 IKALLRECWHKNPDRRPTFEEI 345
K L++ + ++R T EE
Sbjct: 278 AKELIKLMLTYDYNKRCTAEEA 299
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 54/249 (21%), Positives = 99/249 (39%), Gaps = 20/249 (8%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G +GEV+ + + T A K + + + + M E + K+ IV
Sbjct: 196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA-MVEKKILAKVHSRFIVSLAYAF 254
Query: 159 KHSERLIFLTEYLRNGSL----HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ L + + G + +++ + P A+ Y I G+ +LH II
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---II 311
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
+RDL P NVL D+ G+++++D GL+ + + + G G +MAPE+ E Y
Sbjct: 312 YRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG---FMAPELLLGEEYDF 368
Query: 275 SVDVFSFALIVHEMFQGGP----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330
SVD F+ + ++EM ++ R + + K
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA--VTYPDKFSPASKDFCEA 426
Query: 331 CWHKNPDRR 339
K+P++R
Sbjct: 427 LLQKDPEKR 435
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 63/235 (26%), Positives = 109/235 (46%), Gaps = 17/235 (7%)
Query: 116 EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV---LKHSERLIFLT-EYL 171
++A K +R+ +A +P F +E L HP IV + L ++ EY+
Sbjct: 39 DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHL 231
+L DI+ +G + P A+ D + +N+ H + IIHRD+ P+N++ +
Sbjct: 99 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAV 155
Query: 232 KVTDFGLSKIAQEKDSYSYKMTGGT---GSYRYMAPEVYRRESYGKSVDVFSFALIVHEM 288
KV DFG IA+ +T G+ +Y++PE R +S DV+S +++E+
Sbjct: 156 KVMDFG---IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 289 FQGGPSNRADTAVQVADRRAYEDSRPALSSLY---PEPIKALLRECWHKNPDRRP 340
G P D+ V VA + ED S+ + + A++ + KNP+ R
Sbjct: 213 LTGEPPFTGDSPVSVAYQHVREDP-IPPSARHEGLSADLDAVVLKALAKNPENRY 266
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 71/251 (28%), Positives = 115/251 (45%), Gaps = 32/251 (12%)
Query: 102 GAYGEVYLVKWRGT-EI-AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G +G+V LV+ + T A K +R I + V + E + Q RHP + L
Sbjct: 16 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEV-AHTVTESRVLQNTRHPFLTA----L 70
Query: 159 KHS----ERLIFLTEYLRNGSL--HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
K++ +RL F+ EY G L H L ++ A Y +I + YLH
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFH--LSRERVFTEERARFYGAEIVSALEYLHSRD--- 125
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
+++RD+ N++ D+ GH+K+TDFGL K E S M G+ Y+APEV Y
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI----KALL 328
G++VD + ++++EM G ++ + E+ R +P + K+LL
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR------FPRTLSPEAKSLL 236
Query: 329 RECWHKNPDRR 339
K+P +R
Sbjct: 237 AGLLKKDPKQR 247
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 65/247 (26%), Positives = 116/247 (46%), Gaps = 23/247 (9%)
Query: 102 GAYGEVYLVKWRGT-EI-AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++G+V+L +++ T + A K ++ + + V + +++ L HP +
Sbjct: 28 GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ E L F+ EYL G L ++ K D A YA +I G+ +LH I++RDL
Sbjct: 88 QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDL 144
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT--GSYRYMAPEVYRRESYGKSV 276
N+L D+ GH+K+ DFG+ K D+ T G+ Y+APE+ + Y SV
Sbjct: 145 KLDNILLDKDGHIKIADFGMCKENMLGDA-----KTNTFCGTPDYIAPEILLGQKYNHSV 199
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI----KALLRECW 332
D +SF ++++EM G ++ ++ YP + K LL + +
Sbjct: 200 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF------YPRWLEKEAKDLLVKLF 253
Query: 333 HKNPDRR 339
+ P++R
Sbjct: 254 VREPEKR 260
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-35
Identities = 73/255 (28%), Positives = 120/255 (47%), Gaps = 26/255 (10%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+ EV+LVK R T A K I+ S A +S E+ + +K++H NIV + +
Sbjct: 20 GAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ + + + G L D + ++G A + + YLH + I+HRDL
Sbjct: 77 STTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLK 133
Query: 220 PSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
P N+L +E + +TDFGLSK+ Q M+ G+ Y+APEV ++ Y K+V
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVAPEVLAQKPYSKAV 188
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVAD---RRAYE-DSRP--ALSSLYPEPIKALLRE 330
D +S +I + + G P +T ++ + YE +S +S E K +
Sbjct: 189 DCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDIS----ESAKDFICH 244
Query: 331 CWHKNPDRRPTFEEI 345
K+P+ R T E+
Sbjct: 245 LLEKDPNERYTCEKA 259
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 60/247 (24%), Positives = 101/247 (40%), Gaps = 19/247 (7%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G +GEV + R T A K + I + + E + +K+ +V
Sbjct: 195 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSRFVVSLAYAY 253
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ + L + + G L + G+ AV YA +I G+ LH R I++R
Sbjct: 254 ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYR 310
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
DL P N+L D+ GH++++D GL+ E + G G+ YMAPEV + E Y S
Sbjct: 311 DLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSP 366
Query: 277 DVFSFALIVHEMFQGGP----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332
D ++ +++EM G + +V S + ++L +
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--EEYSERFSPQARSLCSQLL 424
Query: 333 HKNPDRR 339
K+P R
Sbjct: 425 CKDPAER 431
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 60/252 (23%), Positives = 113/252 (44%), Gaps = 17/252 (6%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+ V + T E AAK I + + R +E + +KL+HPNIV+ ++
Sbjct: 17 GAFSVVRRCVHKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ + + G L + + + A I + Y H + I+HR+L
Sbjct: 76 EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLK 132
Query: 220 PSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
P N+L + + +K+ DFGL+ + + G G+ Y++PEV +++ Y K V
Sbjct: 133 PENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPV 188
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVAD---RRAYEDSRPALSSLYPEPIKALLRECWH 333
D+++ +I++ + G P + ++ AY+ P ++ PE K+L+
Sbjct: 189 DIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA-KSLIDSMLT 247
Query: 334 KNPDRRPTFEEI 345
NP +R T ++
Sbjct: 248 VNPKKRITADQA 259
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 62/253 (24%), Positives = 104/253 (41%), Gaps = 23/253 (9%)
Query: 96 RGGIDPGAYGEVYL----VKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNI 151
RGG+ G+VY V+ R +A K + +++S+P R +E +L+ P++
Sbjct: 44 RGGM-----GDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 152 VQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPH 211
V + +L + L +L+++G L PP AVA I ++ H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG-- 154
Query: 212 AIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT-GSYRYMAPEVYRRE 270
HRD+ P N+L + DFG IA G T G+ YMAPE +
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFG---IASATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 271 SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPE---PIKAL 327
D+++ +++E G P + D + V + P S++ P A+
Sbjct: 211 HATYRADIYALTCVLYECLTGSPPYQGDQ-LSVMGAHINQA-IPRPSTVRPGIPVAFDAV 268
Query: 328 LRECWHKNPDRRP 340
+ KNP+ R
Sbjct: 269 IARGMAKNPEDRY 281
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 61/256 (23%), Positives = 110/256 (42%), Gaps = 22/256 (8%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRV---RNSFMKELGLWQKLRHPNIVQFLG 156
G + V + + T E AAK I+ + R R +E+ + +++ HPNI+
Sbjct: 23 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD 82
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
V ++ ++ + E + G L D L +K L A ++ I G+NYLH + I H
Sbjct: 83 VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHF 139
Query: 217 DLTPSNVL----QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
DL P N++ H+K+ DFGL+ ++ + G+ ++APE+ E
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPL 195
Query: 273 GKSVDVFSFALIVHEMFQGGP----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328
G D++S +I + + G + +T + +Y+ S K +
Sbjct: 196 GLEADMWSIGVITYILLSGASPFLGDTKQETLANIT-AVSYDFDEEFFSQTSELA-KDFI 253
Query: 329 RECWHKNPDRRPTFEE 344
R+ K +R T +E
Sbjct: 254 RKLLVKETRKRLTIQE 269
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-34
Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 22/256 (8%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRV---RNSFMKELGLWQKLRHPNIVQFLG 156
G + V + + T E AAK I+ + R R +E+ + +++ H N++
Sbjct: 23 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
V ++ ++ + E + G L D L +K L A ++ I G+NYLH + I H
Sbjct: 83 VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHF 139
Query: 217 DLTPSNVL----QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
DL P N++ H+K+ DFGL+ ++ + G+ ++APE+ E
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPL 195
Query: 273 GKSVDVFSFALIVHEMFQGGP----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328
G D++S +I + + G + +T + +Y+ S K +
Sbjct: 196 GLEADMWSIGVITYILLSGASPFLGDTKQETLANIT-SVSYDFDEEFFSHTSELA-KDFI 253
Query: 329 RECWHKNPDRRPTFEE 344
R+ K +R T +E
Sbjct: 254 RKLLVKETRKRLTIQE 269
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 69/256 (26%), Positives = 115/256 (44%), Gaps = 24/256 (9%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTI-RSSIASNP-RVRNSFMKELGLWQKLRHPNIVQFLGV 157
GAYGEV L R T +A K + P ++ KE+ + + L H N+V+F G
Sbjct: 18 GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK----KEICINKMLNHENVVKFYGH 73
Query: 158 LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+ EY G L D ++ + P A + + G+ YLH I HRD
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRD 130
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY-GKSV 276
+ P N+L DE +LK++DFGL+ + + + G+ Y+APE+ +R + + V
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLKRREFHAEPV 189
Query: 277 DVFS-----FALIVHEM-FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330
DV+S A++ E+ + +D+ + +D + + + P ALL +
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQ----PSDSCQEYSDWKEKKTYLNPWKKIDSAP-LALLHK 244
Query: 331 CWHKNPDRRPTFEEII 346
+NP R T +I
Sbjct: 245 ILVENPSARITIPDIK 260
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 70/253 (27%), Positives = 124/253 (49%), Gaps = 35/253 (13%)
Query: 102 GAYGEVYLVKWRGT-EI-AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++G+V L + +GT E+ A K ++ + + V + +++ L + P + Q L
Sbjct: 31 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ----L 86
Query: 159 KHS----ERLIFLTEYLRNGSL--HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
+RL F+ EY+ G L H +++ G+ P AV YA +IA G+ +L
Sbjct: 87 HSCFQTMDRLYFVMEYVNGGDLMYH--IQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--- 141
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT--GSYRYMAPEVYRRE 270
II+RDL NV+ D GH+K+ DFG+ K++ +T T G+ Y+APE+ +
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMC-----KENIWDGVTTKTFCGTPDYIAPEIIAYQ 196
Query: 271 SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI----KA 326
YGKSVD ++F ++++EM G + ++ + YP+ + A
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA------YPKSMSKEAVA 250
Query: 327 LLRECWHKNPDRR 339
+ + K+P +R
Sbjct: 251 ICKGLMTKHPGKR 263
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 63/249 (25%), Positives = 108/249 (43%), Gaps = 23/249 (9%)
Query: 102 GAYGEVYLVKWRGT-EI-AAKTIR-SSIASNPRVRNSFMKE---LGLWQKLRHPNIVQFL 155
G +GEVY + T ++ A K + I + + E L L P IV
Sbjct: 200 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA-LNERIMLSLVSTGDCPFIVCMS 258
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
++L F+ + + G LH L + G YA +I G+ ++H+ +++
Sbjct: 259 YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVY 315
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES-YGK 274
RDL P+N+L DE GH++++D GL+ +K ++ T G YMAPEV ++ Y
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG-----YMAPEVLQKGVAYDS 370
Query: 275 SVDVFSFALIVHEMFQGGP----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330
S D FS ++ ++ +G D DR L + +++LL
Sbjct: 371 SADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTM-AVELPDSFSPELRSLLEG 427
Query: 331 CWHKNPDRR 339
++ +RR
Sbjct: 428 LLQRDVNRR 436
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 66/254 (25%), Positives = 117/254 (46%), Gaps = 34/254 (13%)
Query: 102 GAYGEVYLVK---WRGT-EI-AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G YG+V+ V+ T +I A K ++ + I N + E + ++++HP IV
Sbjct: 28 GGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVD-- 85
Query: 156 GVLKHS----ERLIFLTEYLRNGSL--HDILKKKGKLDPPTAVAYALDIARGMNYLHHHR 209
L ++ +L + EYL G L L+++G TA Y +I+ + +LH
Sbjct: 86 --LIYAFQTGGKLYLILEYLSGGELFMQ--LEREGIFMEDTACFYLAEISMALGHLHQK- 140
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
II+RDL P N++ + GH+K+TDFGL K + + ++ G YMAPE+ R
Sbjct: 141 --GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTI---EYMAPEILMR 195
Query: 270 ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI----K 325
+ ++VD +S ++++M G P + + D+ P + +
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN------LPPYLTQEAR 249
Query: 326 ALLRECWHKNPDRR 339
LL++ +N R
Sbjct: 250 DLLKKLLKRNAASR 263
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-34
Identities = 59/253 (23%), Positives = 104/253 (41%), Gaps = 22/253 (8%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTI-RSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++GEV + +GT AAK I + + R + E+ + + L HPNI++
Sbjct: 20 GSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ----EIEIMKSLDHPNIIRLYETF 75
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ + + + E G L + + K A D+ + Y H + HRDL
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDL 132
Query: 219 TPSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
P N L LK+ DFGL+ + M G+ Y++P+V YG
Sbjct: 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMRTKVGTPYYVSPQVLEG-LYGPE 187
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVAD---RRAYEDSRPALSSLYPEPIKALLRECW 332
D +S ++++ + G P A T +V + ++ P+ ++L+R
Sbjct: 188 CDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ-AESLIRRLL 246
Query: 333 HKNPDRRPTFEEI 345
K+P +R T +
Sbjct: 247 TKSPKQRITSLQA 259
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-34
Identities = 66/251 (26%), Positives = 114/251 (45%), Gaps = 31/251 (12%)
Query: 102 GAYGEVYLVKWRGT-EI-AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++G+V L + + T ++ A K ++ I + V + ++ L HP + Q L
Sbjct: 34 GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ----L 89
Query: 159 KHS----ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+RL F+ E++ G L ++K + D A YA +I + +LH II
Sbjct: 90 FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---II 146
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT--GSYRYMAPEVYRRESY 272
+RDL NVL D GH K+ DFG+ K+ +T T G+ Y+APE+ + Y
Sbjct: 147 YRDLKLDNVLLDHEGHCKLADFGMC-----KEGICNGVTTATFCGTPDYIAPEILQEMLY 201
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI----KALL 328
G +VD ++ ++++EM G A+ + + ++ YP + +L
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV------YPTWLHEDATGIL 255
Query: 329 RECWHKNPDRR 339
+ KNP R
Sbjct: 256 KSFMTKNPTMR 266
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 70/263 (26%), Positives = 122/263 (46%), Gaps = 39/263 (14%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++G+V L + + E+ A K ++ +I ++ + L + ++HP +V L
Sbjct: 49 GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG----L 104
Query: 159 KHS----ERLIFLTEYLRNGSL--HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
S ++L F+ +Y+ G L H L+++ P A YA +IA + YLH
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYH--LQRERCFLEPRARFYAAEIASALGYLHSL---N 159
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT--GSYRYMAPEVYRRE 270
I++RDL P N+L D GH+ +TDFGL K++ + T T G+ Y+APEV ++
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLC-----KENIEHNSTTSTFCGTPEYLAPEVLHKQ 214
Query: 271 SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI----KA 326
Y ++VD + +++EM G P + ++ D + + I +
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ------LKPNITNSARH 268
Query: 327 LLRECWHKNPDRR----PTFEEI 345
LL K+ +R F EI
Sbjct: 269 LLEGLLQKDRTKRLGAKDDFMEI 291
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-34
Identities = 68/256 (26%), Positives = 114/256 (44%), Gaps = 24/256 (9%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTI-RSSIASNP-RVRNSFMKELGLWQKLRHPNIVQFLGV 157
GAYGEV L R +A K + P ++ KE+ + + L H N+V+F G
Sbjct: 18 GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK----KEICINKMLNHENVVKFYGH 73
Query: 158 LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+ EY G L D ++ + P A + + G+ YLH I HRD
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRD 130
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY-GKSV 276
+ P N+L DE +LK++DFGL+ + + + G+ Y+APE+ +R + + V
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLKRREFHAEPV 189
Query: 277 DVFS-----FALIVHEM-FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330
DV+S A++ E+ + +D+ + +D + + + P ALL +
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQ----PSDSCQEYSDWKEKKTYLNPWKKIDSAP-LALLHK 244
Query: 331 CWHKNPDRRPTFEEII 346
+NP R T +I
Sbjct: 245 ILVENPSARITIPDIK 260
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-34
Identities = 71/266 (26%), Positives = 105/266 (39%), Gaps = 36/266 (13%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTI-----RSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA GEV L R T ++A + I A + E+ + +KL HP I++
Sbjct: 146 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 205
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+E + E + G L D + +L T Y + + YLH + II
Sbjct: 206 KNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---II 261
Query: 215 HRDLTPSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV---YR 268
HRDL P NVL Q+E +K+TDFG SKI E M G+ Y+APEV
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVG 317
Query: 269 RESYGKSVDVFSFALIVHEMFQGGP-----SNRADTAVQVADRRAYEDSRPALSSLYPEP 323
Y ++VD +S +I+ G P + Q+ Y
Sbjct: 318 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SGKYN-----FIPEVWAE 371
Query: 324 I----KALLRECWHKNPDRRPTFEEI 345
+ L+++ +P R T EE
Sbjct: 372 VSEKALDLVKKLLVVDPKARFTTEEA 397
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-34
Identities = 70/259 (27%), Positives = 121/259 (46%), Gaps = 17/259 (6%)
Query: 91 KILEDRGGIDPGAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH 148
K I GA G VY T E+A + + ++ P+ + + E+ + ++ ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPK-KELIINEILVMRENKN 76
Query: 149 PNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH 208
PNIV +L + L + EYL GSL D++ + +D A + + + +LH +
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN 135
Query: 209 RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT-GGTGSYRYMAPEVY 267
+ +IHRD+ N+L G +K+TDFG AQ S + T GT Y +MAPEV
Sbjct: 136 Q---VIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGT-PY-WMAPEVV 188
Query: 268 RRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALS--SLYPEPIK 325
R++YG VD++S ++ EM +G P + ++ A + P L +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFR 247
Query: 326 ALLRECWHKNPDRRPTFEE 344
L C + ++R + +E
Sbjct: 248 DFLNRCLEMDVEKRGSAKE 266
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-34
Identities = 37/184 (20%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +G V+ + AK ++ V+ E+ + RH NI+ +
Sbjct: 16 GEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK----EISILNIARHRNILHLHESFE 71
Query: 160 HSERLIFLTEYLRNGSLHD-ILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
E L+ + E++ + + I +L+ V+Y + + +LH H I H D+
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDI 128
Query: 219 TPSNVL--QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
P N++ + +K+ +FG ++ + D + Y APEV++ + +
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 277 DVFS 280
D++S
Sbjct: 185 DMWS 188
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-34
Identities = 50/188 (26%), Positives = 87/188 (46%), Gaps = 16/188 (8%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTI---RSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G + V + +GT E AAK I R S + R +E+ + +++RHPNI+
Sbjct: 16 GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD 75
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+ ++ ++ + E + G L D L +K L A + I G++YLH R I H
Sbjct: 76 IFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHF 132
Query: 217 DLTPSNVL----QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
DL P N++ +K+ DFG++ + + + G+ ++APE+ E
Sbjct: 133 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFKNIFGTPEFVAPEIVNYEPL 188
Query: 273 GKSVDVFS 280
G D++S
Sbjct: 189 GLEADMWS 196
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 72/252 (28%), Positives = 117/252 (46%), Gaps = 18/252 (7%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++GEV K R T E A K I + A N ++ ++E+ L +KL HPNI++ +L+
Sbjct: 33 GSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STILREVELLKKLDHPNIMKLFEILE 91
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
S + E G L D + K+ + A + G+ Y+H H I+HRDL
Sbjct: 92 DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLK 148
Query: 220 PSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
P N+L +++ +K+ DFGLS Q+ KM G+ Y+APEV R +Y +
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYYIAPEVLRG-TYDEKC 203
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVAD---RRAYEDSRPALSSLYPEPIKALLRECWH 333
DV+S +I++ + G P + Y P ++ + K L+R+
Sbjct: 204 DVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA-KDLIRKMLT 262
Query: 334 KNPDRRPTFEEI 345
+P R T +
Sbjct: 263 FHPSLRITATQC 274
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 69/259 (26%), Positives = 113/259 (43%), Gaps = 17/259 (6%)
Query: 91 KILEDRGGIDPGAYGEVY--LVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH 148
+L+ I G+ G V K G ++A K + + R R E+ + + +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQR-RELLFNEVVIMRDYQH 101
Query: 149 PNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH 208
N+V+ E L L E+L+ G+L DI+ + +L+ + + + YLH
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 209 RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT-GGTGSYRYMAPEVY 267
+IHRD+ ++L G +K++DFG AQ + + GT Y +MAPEV
Sbjct: 161 G---VIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGT-PY-WMAPEVI 213
Query: 268 RRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALS--SLYPEPIK 325
R Y VD++S ++V EM G P +D+ VQ R P L ++
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKLKNSHKVSPVLR 272
Query: 326 ALLRECWHKNPDRRPTFEE 344
L ++P R T +E
Sbjct: 273 DFLERMLVRDPQERATAQE 291
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 70/256 (27%), Positives = 109/256 (42%), Gaps = 28/256 (10%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA VY K +GT A K ++ + + E+G+ +L HPNI++ + +
Sbjct: 64 GATSIVYRCKQKGTQKPYALKVLKKT-----VDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ + E + G L D + +KG A I + YLH + I+HRDL
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLK 175
Query: 220 PSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
P N+L LK+ DFGLSKI + + M G+ Y APE+ R +YG V
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQV----LMKTVCGTPGYCAPEILRGCAYGPEV 231
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADRR----AYE-DSRP--ALSSLYPEPIKALLR 329
D++S +I + + G + Q RR Y S +S K L+R
Sbjct: 232 DMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS----LNAKDLVR 287
Query: 330 ECWHKNPDRRPTFEEI 345
+ +P +R T +
Sbjct: 288 KLIVLDPKKRLTTFQA 303
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 67/248 (27%), Positives = 117/248 (47%), Gaps = 29/248 (11%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++G V LVK + + A K + + ++ ++ + E + Q + P +V+
Sbjct: 52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLEFSF 110
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
K + L + EY+ G + L++ G+ P A YA I YLH +I+RDL
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDL 167
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT----GSYRYMAPEVYRRESYGK 274
P N+L D+ G+++VTDFG +K ++ G T G+ +APE+ + Y K
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK----------RVKGRTWTLCGTPEALAPEIILSKGYNK 217
Query: 275 SVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE---DSRPALSSLYPEPIKALLREC 331
+VD ++ ++++EM G P AD +Q+ YE + S + +K LLR
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQI-----YEKIVSGKVRFPSHFSSDLKDLLRNL 272
Query: 332 WHKNPDRR 339
+ +R
Sbjct: 273 LQVDLTKR 280
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 60/252 (23%), Positives = 112/252 (44%), Gaps = 17/252 (6%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+ V + T E AAK I + S +E + +KL+HPNIV+ ++
Sbjct: 40 GAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHPNIVRLHDSIQ 98
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ + + G L + + + A I + Y H + I+HR+L
Sbjct: 99 EESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLK 155
Query: 220 PSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
P N+L + + +K+ DFGL+ + + G G+ Y++PEV +++ Y K V
Sbjct: 156 PENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPV 211
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVAD---RRAYEDSRPALSSLYPEPIKALLRECWH 333
D+++ +I++ + G P + ++ AY+ P ++ PE K+L+
Sbjct: 212 DIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA-KSLIDSMLT 270
Query: 334 KNPDRRPTFEEI 345
NP +R T ++
Sbjct: 271 VNPKKRITADQA 282
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 67/245 (27%), Positives = 121/245 (49%), Gaps = 19/245 (7%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++G+V L + +GT+ A K ++ + + V + +++ L + P + Q
Sbjct: 352 GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ +RL F+ EY+ G L +++ G+ P AV YA +IA G+ +L II+RDL
Sbjct: 412 QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDL 468
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT--GSYRYMAPEVYRRESYGKSV 276
NV+ D GH+K+ DFG+ K++ +T T G+ Y+APE+ + YGKSV
Sbjct: 469 KLDNVMLDSEGHIKIADFGMC-----KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV 523
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PALSSLYPEPIKALLRECWHK 334
D ++F ++++EM G + ++ + ++S K L+ K
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT----K 579
Query: 335 NPDRR 339
+P +R
Sbjct: 580 HPGKR 584
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 60/256 (23%), Positives = 109/256 (42%), Gaps = 22/256 (8%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRV---RNSFMKELGLWQKLRHPNIVQFLG 156
G + V + + T + AAK I+ + R R +E+ + ++++HPN++
Sbjct: 22 GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
V ++ +I + E + G L D L +K L A + I G+ YLH + I H
Sbjct: 82 VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHF 138
Query: 217 DLTPSNVL----QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
DL P N++ +K+ DFGL+ + + G+ ++APE+ E
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPL 194
Query: 273 GKSVDVFSFALIVHEMFQGGP----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328
G D++S +I + + G + +T V+ YE S+ K +
Sbjct: 195 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVS-AVNYEFEDEYFSNTSALA-KDFI 252
Query: 329 RECWHKNPDRRPTFEE 344
R K+P +R T ++
Sbjct: 253 RRLLVKDPKKRMTIQD 268
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 70/248 (28%), Positives = 117/248 (47%), Gaps = 24/248 (9%)
Query: 102 GAYGEVYLVKWRGTEI-----AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G++G+V+LVK A K ++ +++ RVR E + ++ HP IV+
Sbjct: 35 GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPFIVK-- 90
Query: 156 GVLKHS----ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPH 211
L ++ +L + ++LR G L L K+ Y ++A +++LH
Sbjct: 91 --LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL--- 145
Query: 212 AIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES 271
II+RDL P N+L DE GH+K+TDFGLSK + + + +Y G+ YMAPEV R
Sbjct: 146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF---CGTVEYMAPEVVNRRG 202
Query: 272 YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331
+ +S D +SF +++ EM G + + + ++LLR
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--LGMPQFLSPEAQSLLRML 260
Query: 332 WHKNPDRR 339
+ +NP R
Sbjct: 261 FKRNPANR 268
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-33
Identities = 61/192 (31%), Positives = 85/192 (44%), Gaps = 21/192 (10%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTI-----RSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA GEV L R T ++A K I A + E+ + +KL HP I++
Sbjct: 21 GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+E + E + G L D + +L T Y + + YLH + II
Sbjct: 81 KNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---II 136
Query: 215 HRDLTPSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV---YR 268
HRDL P NVL Q+E +K+TDFG SKI E M G+ Y+APEV
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVG 192
Query: 269 RESYGKSVDVFS 280
Y ++VD +S
Sbjct: 193 TAGYNRAVDCWS 204
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 68/258 (26%), Positives = 116/258 (44%), Gaps = 36/258 (13%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G+Y +V LV+ + T+ A K ++ + + + ++ Q HP +V L
Sbjct: 20 GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG----L 75
Query: 159 KHS----ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
RL F+ EY+ G L ++++ KL A Y+ +I+ +NYLH II
Sbjct: 76 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---II 132
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT--GSYRYMAPEVYRRESY 272
+RDL NVL D GH+K+TD+G+ K+ T T G+ Y+APE+ R E Y
Sbjct: 133 YRDLKLDNVLLDSEGHIKLTDYGMC-----KEGLRPGDTTSTFCGTPNYIAPEILRGEDY 187
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSL-------YPEPI- 324
G SVD ++ +++ EM G + +++ L + P +
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVG----SSDNPDQNTEDYLFQVILEKQIRIPRSLS 243
Query: 325 ---KALLRECWHKNPDRR 339
++L+ +K+P R
Sbjct: 244 VKAASVLKSFLNKDPKER 261
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 31/287 (10%), Positives = 69/287 (24%), Gaps = 52/287 (18%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G V+LV+ + A K ++ + +L + + +
Sbjct: 73 GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132
Query: 160 HSERL-------------------------IFLTEYLRNGSL-------HDILKKKGKLD 187
L + L + +G
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192
Query: 188 PPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247
+ R L ++H TP N+ G L + D
Sbjct: 193 ILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT--- 246
Query: 248 YSYKMTGGTGSYRYMAPEVYRRES--YGKSVDVFSFALIVHEMFQGGP-----SNRADTA 300
+ + Y E + + +++ + L ++ ++ + +
Sbjct: 247 ---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
Query: 301 VQVADRRAYEDSRPALSSLY--PEPIKALLRECWHKNPDRRPTFEEI 345
+ R A S P+ +K L+ + + RR E
Sbjct: 304 WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-33
Identities = 71/261 (27%), Positives = 115/261 (44%), Gaps = 39/261 (14%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTI-RSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G + +V L + G E+A K I ++ + NP +E+ + + L HPNIV+ V+
Sbjct: 26 GNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ + L + EY G + D L G++ A + I + Y H R I+HRDL
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDL 140
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY-GKSVD 277
N+L D ++K+ DFG S K+ G+ Y APE+++ + Y G VD
Sbjct: 141 KAENLLLDADMNIKIADFGFSNEFTVGG----KLDAFCGAPPYAAPELFQGKKYDGPEVD 196
Query: 278 VFSFALIVHEM------FQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEP------IK 325
V+S +I++ + F G N + +V L Y P +
Sbjct: 197 VWSLGVILYTLVSGSLPFDG--QNLKELRERV------------LRGKYRIPFYMSTDCE 242
Query: 326 ALLRECWHKNPDRRPTFEEII 346
LL+ NP +R T E+I+
Sbjct: 243 NLLKRFLVLNPIKRGTLEQIM 263
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-33
Identities = 58/257 (22%), Positives = 109/257 (42%), Gaps = 26/257 (10%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+G+V+LV+ R + E KTI + P E+ + + L HPNI++ V +
Sbjct: 33 GAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAEIEVLKSLDHPNIIKIFEVFE 90
Query: 160 HSERLIFLTEYLRNGSLHD----ILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ + E G L + + L + + Y H ++H
Sbjct: 91 DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVH 147
Query: 216 RDLTPSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
+DL P N+L +K+ DFGL+++ + + T G+ YMAPEV++R
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE----HSTNAAGTALYMAPEVFKR-DV 202
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI----KALL 328
D++S ++++ + G + +V + P + P+ LL
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ--QKATYKEPNYAV-ECRPLTPQAVDLL 259
Query: 329 RECWHKNPDRRPTFEEI 345
++ K+P+RRP+ ++
Sbjct: 260 KQMLTKDPERRPSAAQV 276
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 67/258 (25%), Positives = 115/258 (44%), Gaps = 36/258 (13%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G+Y +V LV+ + T+ A + ++ + + + ++ Q HP +V L
Sbjct: 63 GSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG----L 118
Query: 159 KHS----ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
RL F+ EY+ G L ++++ KL A Y+ +I+ +NYLH II
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---II 175
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT--GSYRYMAPEVYRRESY 272
+RDL NVL D GH+K+TD+G+ K+ T T G+ Y+APE+ R E Y
Sbjct: 176 YRDLKLDNVLLDSEGHIKLTDYGMC-----KEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSS-------LYPEPI- 324
G SVD ++ +++ EM G + +++ L P +
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVG----SSDNPDQNTEDYLFQVILEKQIRIPRSLS 286
Query: 325 ---KALLRECWHKNPDRR 339
++L+ +K+P R
Sbjct: 287 VKAASVLKSFLNKDPKER 304
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 58/252 (23%), Positives = 107/252 (42%), Gaps = 21/252 (8%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+G V+ V R T AAK + + + + KE+ LRHP +V +
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVM---TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 160 HSERLIFLTEYLRNGSLHD-ILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
++ + E++ G L + + + K+ AV Y + +G+ ++H + +H DL
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDL 281
Query: 219 TPSNVL--QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
P N++ + LK+ DFGL+ K + TG+ + APEV + G
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYT 337
Query: 277 DVFSFALIVHEMFQGGP----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332
D++S ++ + + G N +T V + A S + + K +R+
Sbjct: 338 DMWSVGVLSYILLSGLSPFGGENDDETLRNVK-SCDWNMDDSAFSGISEDG-KDFIRKLL 395
Query: 333 HKNPDRRPTFEE 344
+P+ R T +
Sbjct: 396 LADPNTRMTIHQ 407
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 58/252 (23%), Positives = 107/252 (42%), Gaps = 16/252 (6%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+ V E AA I + S + +E + + L+HPNIV+ +
Sbjct: 22 GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ-KLEREARICRLLKHPNIVRLHDSIS 80
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ + + G L + + + A I + + H ++HR+L
Sbjct: 81 EEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLK 137
Query: 220 PSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
P N+L + + +K+ DFGL+ + + G G+ Y++PEV R++ YGK V
Sbjct: 138 PENLLLASKLKGAAVKLADFGLAIEVEGEQQ---AWFGFAGTPGYLSPEVLRKDPYGKPV 194
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVAD---RRAYEDSRPALSSLYPEPIKALLRECWH 333
D+++ +I++ + G P + ++ AY+ P ++ PE K L+ +
Sbjct: 195 DLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA-KDLINKMLT 253
Query: 334 KNPDRRPTFEEI 345
NP +R T E
Sbjct: 254 INPSKRITAAEA 265
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 58/252 (23%), Positives = 107/252 (42%), Gaps = 21/252 (8%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+G V+ + T AK I P + + E+ + +L HP ++ +
Sbjct: 62 GAFGVVHRCVEKATGRVFVAKFIN---TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 160 HSERLIFLTEYLRNGSLHD-ILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
++ + E+L G L D I + K+ + Y G+ ++H H I+H D+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDI 175
Query: 219 TPSNVL--QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
P N++ +A +K+ DFGL+ + + T + + APE+ RE G
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYT 231
Query: 277 DVFSFALIVHEMFQGGP----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332
D+++ ++ + + G + +T V R +E A SS+ PE K ++
Sbjct: 232 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK-RCDWEFDEDAFSSVSPEA-KDFIKNLL 289
Query: 333 HKNPDRRPTFEE 344
K P +R T +
Sbjct: 290 QKEPRKRLTVHD 301
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 50/190 (26%), Positives = 78/190 (41%), Gaps = 17/190 (8%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTI--RSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
G + V R T + A K + +S +E + L+HP+IV+ L
Sbjct: 35 GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 94
Query: 158 LKHSERLIFLTEYLRNGSLHDILKKKGKLDPP----TAVAYALDIARGMNYLHHHRPHAI 213
L + E++ L + K+ A Y I + Y H + I
Sbjct: 95 YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---I 151
Query: 214 IHRDLTPSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE 270
IHRD+ P VL ++ + +K+ FG++ E G G+ +MAPEV +RE
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL---VAGGRVGTPHFMAPEVVKRE 208
Query: 271 SYGKSVDVFS 280
YGK VDV+
Sbjct: 209 PYGKPVDVWG 218
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 52/260 (20%), Positives = 105/260 (40%), Gaps = 29/260 (11%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVL 158
G++ + + A K I + +N + KE+ + HPNIV+ V
Sbjct: 22 GSFSICRKCVHKKSNQAFAVKIISKRMEANTQ------KEITALKLCEGHPNIVKLHEVF 75
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ E L G L + +KKK A + ++++H ++HRDL
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDL 132
Query: 219 TPSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
P N+L +++ +K+ DFG +++ + + + Y APE+ + Y +S
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQ---PLKTPCFTLHYAAPELLNQNGYDES 189
Query: 276 VDVFSFALIVHEM------FQGGPSNRADTAVQVADRR----AYEDSRPALSSLYPEPIK 325
D++S +I++ M FQ + T+ ++ + A ++ E K
Sbjct: 190 CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEA-K 248
Query: 326 ALLRECWHKNPDRRPTFEEI 345
L++ +P++R +
Sbjct: 249 DLIQGLLTVDPNKRLKMSGL 268
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 68/250 (27%), Positives = 120/250 (48%), Gaps = 33/250 (13%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G++G V+L++ R A K ++ + +V ++ E + + HP I++ G
Sbjct: 17 GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSIVTHPFIIRMWGTF 75
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ ++++ + +Y+ G L +L+K + P A YA ++ + YLH II+RDL
Sbjct: 76 QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDL 132
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT--GSYRYMAPEVYRRESYGKSV 276
P N+L D+ GH+K+TDFG +K + T G+ Y+APEV + Y KS+
Sbjct: 133 KPENILLDKNGHIKITDFGFAKYVPDVTY--------TLCGTPDYIAPEVVSTKPYNKSI 184
Query: 277 DVFSFALIVHEMFQGGP----SNRADTAVQVADRRAYE---DSRPALSSLYPEPIKALLR 329
D +SF ++++EM G SN T YE ++ + E +K LL
Sbjct: 185 DWWSFGILIYEMLAGYTPFYDSNTMKT---------YEKILNAELRFPPFFNEDVKDLLS 235
Query: 330 ECWHKNPDRR 339
++ +R
Sbjct: 236 RLITRDLSQR 245
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-32
Identities = 64/296 (21%), Positives = 99/296 (33%), Gaps = 56/296 (18%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTI--RSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
G+YG V + T A K + NP+ E+ L +KL HPNI + V
Sbjct: 37 GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96
Query: 158 LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPT--------------------------- 190
+ + + + E G L D L
Sbjct: 97 YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHG 156
Query: 191 -------------AVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVL--QDEAGHLKVTD 235
I ++YLH+ I HRD+ P N L +++ +K+ D
Sbjct: 157 FRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 236 FGLSK-IAQEKDSYSYKMTGGTGSYRYMAPEV--YRRESYGKSVDVFSFALIVHEMFQGG 292
FGLSK + + Y MT G+ ++APEV ESYG D +S +++H + G
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 293 PSNRADTAVQVAD---RRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345
+ P + L + LL ++N D R
Sbjct: 274 VPFPGVNDADTISQVLNKKLCFENPNYNVL-SPLARDLLSNLLNRNVDERFDAMRA 328
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 59/257 (22%), Positives = 110/257 (42%), Gaps = 27/257 (10%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFLGVL 158
G+Y + T E A K I S + +E+ L + +HPNI+ V
Sbjct: 33 GSYSVCKRCIHKATNMEFAVKIIDKS-------KRDPTEEIEILLRYGQHPNIITLKDVY 85
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ + +TE ++ G L D + ++ A A I + + YLH ++HRDL
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDL 142
Query: 219 TPSNVL----QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
PSN+L +++ DFG +K + ++ + + ++APEV R+ Y
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQLRAENG---LLMTPCYTANFVAPEVLERQGYDA 199
Query: 275 SVDVFSFALIVHEMFQGGP---SNRADTAVQVADR---RAYEDSRPALSSLYPEPIKALL 328
+ D++S ++++ M G + DT ++ R + S +S+ K L+
Sbjct: 200 ACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA-KDLV 258
Query: 329 RECWHKNPDRRPTFEEI 345
+ H +P +R T +
Sbjct: 259 SKMLHVDPHQRLTAALV 275
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 67/245 (27%), Positives = 116/245 (47%), Gaps = 12/245 (4%)
Query: 102 GAYGEVY--LVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++GEV+ + +A K I + +E+ + + P + ++ G
Sbjct: 33 GSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL 90
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+L + EYL GS D+L + G LD +I +G++YLH + IHRD+
Sbjct: 91 KDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEK---KIHRDIK 146
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
+NVL E G +K+ DFG++ Q D+ + T G+ +MAPEV ++ +Y D++
Sbjct: 147 AANVLLSEHGEVKLADFGVA--GQLTDTQIKRNT-FVGTPFWMAPEVIKQSAYDSKADIW 203
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRR 339
S + E+ +G P + ++V + P L Y +P+K + C +K P R
Sbjct: 204 SLGITAIELARGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACLNKEPSFR 262
Query: 340 PTFEE 344
PT +E
Sbjct: 263 PTAKE 267
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-32
Identities = 64/262 (24%), Positives = 104/262 (39%), Gaps = 26/262 (9%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTI------RSSIASNPRVRNSFMKELGLWQKL-RHPNIV 152
G V + T E A K I S +R + +KE+ + +K+ HPNI+
Sbjct: 28 GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87
Query: 153 QFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
Q + + + + ++ G L D L +K L + + LH
Sbjct: 88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--- 144
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV------ 266
I+HRDL P N+L D+ ++K+TDFG S + K+ G+ Y+APE+
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMN 200
Query: 267 YRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVAD---RRAYEDSRPALSSLYPEP 323
YGK VD++S +I++ + G P + + Y+ P
Sbjct: 201 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV 260
Query: 324 IKALLRECWHKNPDRRPTFEEI 345
K L+ P +R T EE
Sbjct: 261 -KDLVSRFLVVQPQKRYTAEEA 281
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-32
Identities = 44/184 (23%), Positives = 87/184 (47%), Gaps = 15/184 (8%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +G+V+ + T ++AAK I+ + + E+ + +L H N++Q +
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIK---TRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 160 HSERLIFLTEYLRNGSLHD-ILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
++ + EY+ G L D I+ + L + + I G+ ++H I+H DL
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDL 213
Query: 219 TPSNVL--QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
P N+L +A +K+ DFGL++ + ++ K+ G+ ++APEV +
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPRE----KLKVNFGTPEFLAPEVVNYDFVSFPT 269
Query: 277 DVFS 280
D++S
Sbjct: 270 DMWS 273
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 67/252 (26%), Positives = 118/252 (46%), Gaps = 19/252 (7%)
Query: 99 IDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
+ G+YG VY K G +A K + + S+ + +KE+ + Q+ P++V++ G
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQ---EIIKEISIMQQCDSPHVVKYYG 91
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYAL-DIARGMNYLHHHRPHAIIH 215
+ L + EY GS+ DI++ + K +A L +G+ YLH R IH
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIH 148
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG-GTGSYRYMAPEVYRRESYGK 274
RD+ N+L + GH K+ DFG++ Q D+ + + T GT + +MAPEV + Y
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVA--GQLTDTMAKRNTVIGT-PF-WMAPEVIQEIGYNC 204
Query: 275 SVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPAL--SSLYPEPIKALLRECW 332
D++S + EM +G P ++ P L+ + +++C
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-PTFRKPELWSDNFTDFVKQCL 263
Query: 333 HKNPDRRPTFEE 344
K+P++R T +
Sbjct: 264 VKSPEQRATATQ 275
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 58/260 (22%), Positives = 101/260 (38%), Gaps = 37/260 (14%)
Query: 102 GAYGEVYLVKWRGT-EI-AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
GA+ EV +VK + T ++ A K + + V F +E + I Q L
Sbjct: 72 GAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVS-CFREERDVLVNGDRRWITQ----L 126
Query: 159 KHS----ERLIFLTEYLRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAI 213
+ L + EY G L +L K G ++ A Y +I ++ +H
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GY 183
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES-- 271
+HRD+ P N+L D GH+++ DFG + + + GT Y++PE+ +
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT--PDYLSPEILQAVGGG 241
Query: 272 -----YGKSVDVFSFALIVHEMFQGGPSNRADTAVQV-------ADRRAYEDSRPALSSL 319
YG D ++ + +EMF G AD+ + + + +
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEE 301
Query: 320 YPEPIKALLRECWHKNPDRR 339
+ I+ LL P+ R
Sbjct: 302 ARDFIQRLLC-----PPETR 316
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 51/265 (19%), Positives = 102/265 (38%), Gaps = 46/265 (17%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTI-RSSIASNPRVRNSFMK----ELGLWQKLRHPNIVQF 154
GA+G V+ + E+ K I + + + + + + E+ + ++ H NI++
Sbjct: 35 GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV 94
Query: 155 LGVLKHSERLIFLTEYLRNGS-LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
L + ++ + E +G L + + +LD P A + + YL I
Sbjct: 95 LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---I 151
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY- 272
IHRD+ N++ E +K+ DFG + + G+ Y APEV Y
Sbjct: 152 IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK----LFYTFCGTIEYCAPEVLMGNPYR 207
Query: 273 GKSVDVFS-----FALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEP---- 323
G ++++S + L+ E P + + + + P
Sbjct: 208 GPELEMWSLGVTLYTLVFEEN----P---------------FCELEETVEAAIHPPYLVS 248
Query: 324 --IKALLRECWHKNPDRRPTFEEII 346
+ +L+ P+RR T E+++
Sbjct: 249 KELMSLVSGLLQPVPERRTTLEKLV 273
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-31
Identities = 68/292 (23%), Positives = 119/292 (40%), Gaps = 64/292 (21%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNS------FMKELGLWQKLRHPNIVQFL 155
G +G VY T +A K + + + F +E+ + K +H N+V+ L
Sbjct: 42 GGFGVVYKGYVNNTTVAVKKL-----AAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 156 GV-LKHSER-LIFLTEYLRNGSLHDIL---KKKGKLDPPTAVAYALDIARGMNYLHHHRP 210
G + L++ Y+ NGSL D L L A A G+N+LH +
Sbjct: 97 GFSSDGDDLCLVY--VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN-- 152
Query: 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE 270
IHRD+ +N+L DEA K++DFGL++ +++ + + G+ YMAPE R E
Sbjct: 153 -HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ-TVMTSRIVGTTAYMAPEALRGE 210
Query: 271 SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALS------SLYPE-- 322
KS D++SF +++ E+ G A ++ R + E
Sbjct: 211 ITPKS-DIYSFGVVLLEIITG--------------LPAVDEHREPQLLLDIKEEIEDEEK 255
Query: 323 -------------PIKALLR------ECWHKNPDRRPTFEEIIFRLEAIQES 355
++ +C H+ ++RP +++ L+ + S
Sbjct: 256 TIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 70/254 (27%), Positives = 115/254 (45%), Gaps = 22/254 (8%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+G+VY K + T AAK I S + ++ E+ + HP IV+ LG
Sbjct: 30 GAFGKVYKAKNKETGALAAAKVI--ETKSEEEL-EDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYAL-DIARGMNYLHHHRPHAIIHRDL 218
H +L + E+ G++ I+ + + + + +N+LH R IIHRDL
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDL 143
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT-GGTGSYRYMAPEV-----YRRESY 272
NVL G +++ DFG+S A+ + + + GT Y +MAPEV + Y
Sbjct: 144 KAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGT-PY-WMAPEVVMCETMKDTPY 199
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALS--SLYPEPIKALLRE 330
D++S + + EM Q P + ++V + A D P L S + + L+
Sbjct: 200 DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP-PTLLTPSKWSVEFRDFLKI 258
Query: 331 CWHKNPDRRPTFEE 344
KNP+ RP+ +
Sbjct: 259 ALDKNPETRPSAAQ 272
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 56/248 (22%), Positives = 97/248 (39%), Gaps = 16/248 (6%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+GEV +VK + + A K + F +E + I +
Sbjct: 85 GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144
Query: 160 HSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
L + +Y G L +L K + +L A Y ++ ++ +H +HRD+
Sbjct: 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDI 201
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYR-----RESYG 273
P N+L D GH+++ DFG E + + GT Y++PE+ + + YG
Sbjct: 202 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT--PDYISPEILQAMEGGKGRYG 259
Query: 274 KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR---PALSSLYPEPIKALLRE 330
D +S + ++EM G A++ V+ + R P + E K L+R
Sbjct: 260 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRR 319
Query: 331 CWHKNPDR 338
R
Sbjct: 320 LICSREHR 327
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 39/187 (20%), Positives = 78/187 (41%), Gaps = 16/187 (8%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH-PNIVQFLGVL 158
G + V + T E AAK ++ R + E+ + + + P ++ V
Sbjct: 40 GKFAVVRQCISKSTGQEYAAKFLKKR-RRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98
Query: 159 KHSERLIFLTEYLRNGSLHD--ILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+++ +I + EY G + + + + + I G+ YLH + I+H
Sbjct: 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHL 155
Query: 217 DLTPSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG 273
DL P N+L G +K+ DFG+S+ ++ G+ Y+APE+ +
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC----ELREIMGTPEYLAPEILNYDPIT 211
Query: 274 KSVDVFS 280
+ D+++
Sbjct: 212 TATDMWN 218
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 66/262 (25%), Positives = 110/262 (41%), Gaps = 34/262 (12%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFLGV- 157
G G+V R T + A K + S P+ R +E+ WQ P+IV L V
Sbjct: 40 GVNGKVLECFHRRTGQKCALKLLYDS----PKAR----QEVDHHWQASGGPHIVCILDVY 91
Query: 158 --LKHSERLIFL-TEYLRNGSLHD-ILKKKGK-LDPPTAVAYALDIARGMNYLHHHRPHA 212
+ H +R + + E + G L I ++ + A DI + +LH H
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--- 148
Query: 213 IIHRDLTPSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
I HRD+ P N+L +++ LK+TDFG +K + + + Y+APEV
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-----ALQTPCYTPYYVAPEVLGP 203
Query: 270 ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADR--RAYEDSRPALSSLYPEPI--- 324
E Y KS D++S +I++ + G P ++T ++ R + + +
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSED 263
Query: 325 -KALLRECWHKNPDRRPTFEEI 345
K L+R +P R T +
Sbjct: 264 AKQLIRLLLKTDPTERLTITQF 285
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 59/263 (22%), Positives = 102/263 (38%), Gaps = 42/263 (15%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTI-RSSIASNPRVRNSFM--KELGLWQKLRH--PNIVQF 154
G +G VY +A K + + I+ + N E+ L +K+ +++
Sbjct: 54 GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113
Query: 155 LGVLKHSERLIFLTEYLRN-GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
L + + + + E L D + ++G L A ++ + + + H+ +
Sbjct: 114 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---V 170
Query: 214 IHRDLTPSNVLQD-EAGHLKVTDFGLSKIAQEKDSYSYKMTGGT--GSYRYMAPEVYRRE 270
+HRD+ N+L D G LK+ DFG A KD+ Y G+ Y PE R
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFGSG--ALLKDTV-YT----DFDGTRVYSPPEWIRYH 223
Query: 271 SY-GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEP------ 323
Y G+S V+S +++++M V +E +
Sbjct: 224 RYHGRSAAVWSLGILLYDM--------------VCGDIPFEHDEEIIRGQVFFRQRVSSE 269
Query: 324 IKALLRECWHKNPDRRPTFEEII 346
+ L+R C P RPTFEEI
Sbjct: 270 CQHLIRWCLALRPSDRPTFEEIQ 292
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 34/286 (11%), Positives = 75/286 (26%), Gaps = 53/286 (18%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR------------ 147
+ G + +E+ + LR
Sbjct: 89 EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148
Query: 148 ----------HPNIVQFLGVLKHSERLIFLTEYL-----------RNGSLHDILKKKGKL 186
P + + V + L+ + L L
Sbjct: 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 208
Query: 187 DPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD 246
+ L + R + LHH+ ++H L P +++ D+ G + +T F
Sbjct: 209 VHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFE---HLVRDG 262
Query: 247 SYSYKMTGGT-GSYRYMAPEVYRRE-----SYGKSVDVFSFALIVHEMFQGGPSNRADTA 300
+ + G A + + D ++ L ++ ++ N D A
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA 322
Query: 301 VQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346
+ ++ P+P++ALL + R + +
Sbjct: 323 LGGSEWIFRSCKNI------PQPVRALLEGFLRYPKEDRLLPLQAM 362
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 56/265 (21%), Positives = 99/265 (37%), Gaps = 44/265 (16%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTI-RSSIASNPRVRN--------SFMKELGLWQKLRHPN 150
G +G V+ ++A K I R+ + + + + + ++G HP
Sbjct: 42 GGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG--AGGGHPG 99
Query: 151 IVQFLGVLKHSERLIFLTEYLRNGS-LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHR 209
+++ L + E + + E L D + +KG L + + + + + H
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG 159
Query: 210 PHAIIHRDLTPSNVLQD-EAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYR 268
++HRD+ N+L D G K+ DFG A D T G+ Y PE
Sbjct: 160 ---VVHRDIKDENILIDLRRGCAKLIDFGSG--ALLHDE---PYTDFDGTRVYSPPEWIS 211
Query: 269 RESY-GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEP---- 323
R Y V+S +++++M V +E + L + P
Sbjct: 212 RHQYHALPATVWSLGILLYDM--------------VCGDIPFERDQEILEAELHFPAHVS 257
Query: 324 --IKALLRECWHKNPDRRPTFEEII 346
AL+R C P RP+ EEI+
Sbjct: 258 PDCCALIRRCLAPKPSSRPSLEEIL 282
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-30
Identities = 79/277 (28%), Positives = 119/277 (42%), Gaps = 38/277 (13%)
Query: 102 GAYGEVYL-VKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +G+VY GT +A K R F E+ + H N+++ G
Sbjct: 41 GGFGKVYKGRLADGTLVAVK--RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98
Query: 161 SERLIFLTEYLRNGS----LHDILKKKGKLDPPTAVAYALDIARGMNYLHHH-RPHAIIH 215
+ + Y+ NGS L + + + LD P AL ARG+ YLH H P IIH
Sbjct: 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK-IIH 157
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RD+ +N+L DE V DFGL+K+ KD++ T G+ ++APE Y S GKS
Sbjct: 158 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT--TAVRGTIGHIAPE-YL--STGKS 212
Query: 276 ---VDVFSFALIVHEMFQG-GPSNRADTAVQVAD------RRAYEDSR------PALSSL 319
DVF + +++ E+ G + A A + ++ + L
Sbjct: 213 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGN 272
Query: 320 YPEP-----IK-ALLRECWHKNPDRRPTFEEIIFRLE 350
Y + I+ ALL C +P RP E++ LE
Sbjct: 273 YKDEEVEQLIQVALL--CTQSSPMERPKMSEVVRMLE 307
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 102 GAYGEVYLVKWRGTEI--AAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
GA+GEV LV+ + T A K + + F +E + P +VQ L
Sbjct: 80 GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWVVQ----L 134
Query: 159 KHS----ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
++ L + EY+ G L +++ + A Y ++ ++ +H I
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSM---GFI 190
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE---- 270
HRD+ P N+L D++GHLK+ DFG ++ GT Y++PEV + +
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD--YISPEVLKSQGGDG 248
Query: 271 SYGKSVDVFSFALIVHEMFQGGP 293
YG+ D +S + ++EM G
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDT 271
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 3e-30
Identities = 36/291 (12%), Positives = 78/291 (26%), Gaps = 62/291 (21%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR------------ 147
+ G + +E+ + LR
Sbjct: 84 EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 143
Query: 148 -------------HPNIVQFLGVLKHSERL-IFLTEYLRNGS-------LHDILKKKGKL 186
+++ + L F + L L
Sbjct: 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 203
Query: 187 DPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD 246
+ L + R + LHH+ ++H L P +++ D+ G + +T F +
Sbjct: 204 VHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV 260
Query: 247 SYSYKMTGGTGSYRYMAPEV-----------YRRESYGKSVDVFSFALIVHEMFQGGPSN 295
+ S + PE+ RR S D ++ L+++ ++
Sbjct: 261 VS-------SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313
Query: 296 RADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346
D A+ ++ P+P++ALL + R + +
Sbjct: 314 TKDAALGGSEWIFRSCKN------IPQPVRALLEGFLRYPKEDRLLPLQAM 358
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-30
Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 21/193 (10%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTI-----RSSIASNPRVRNSFMKELGLWQKLR-HPNIVQ 153
G V R T E A K + R S VR + +E + +++ HP+I+
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164
Query: 154 FLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
+ + S + + + +R G L D L +K L + + +++LH + I
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---I 221
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV------Y 267
+HRDL P N+L D+ ++++DFG S + + K+ G+ Y+APE+
Sbjct: 222 VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE----KLRELCGTPGYLAPEILKCSMDE 277
Query: 268 RRESYGKSVDVFS 280
YGK VD+++
Sbjct: 278 THPGYGKEVDLWA 290
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 53/247 (21%), Positives = 95/247 (38%), Gaps = 32/247 (12%)
Query: 102 GAYGEVYL---VKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G G +YL G + K + + + + M E ++ HP+IVQ +
Sbjct: 91 GGLGWIYLALDRNVNGRPVVLKGLVH--SGDAEAQAMAMAERQFLAEVVHPSIVQIFNFV 148
Query: 159 KHSERLIFLT-----EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
+H++R EY+ SL KL A+AY L+I ++YLH +
Sbjct: 149 EHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSIG---L 203
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG 273
++ DL P N++ E LK+ D G +S+ Y G+ + APE+ R
Sbjct: 204 VYNDLKPENIMLTE-EQLKLIDLG---AVSRINSFGYLY----GTPGFQAPEIVRTGPTV 255
Query: 274 KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333
+ D+++ + + P+ + + +D + LLR
Sbjct: 256 AT-DIYTVGRTLAALTLDLPTRNGRYVDGLPE----DDPVLKT----YDSYGRLLRRAID 306
Query: 334 KNPDRRP 340
+P +R
Sbjct: 307 PDPRQRF 313
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-29
Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 27/198 (13%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +G+V + + + G ++A K + + V +E+ + RHP+I++ V+
Sbjct: 22 GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ EY+ G L D + K G+++ A I ++Y H H ++HRDL
Sbjct: 82 TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLK 138
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT------GSYRYMAPEVYRRESY- 272
P NVL D + K+ DFGLS + M+ G GS Y APEV Y
Sbjct: 139 PENVLLDAHMNAKIADFGLSNM----------MSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 273 GKSVDVFS-----FALIV 285
G VD++S +AL+
Sbjct: 189 GPEVDIWSCGVILYALLC 206
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 42/222 (18%)
Query: 144 QKLRHPNIVQFLGVLKHSER--LIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARG 201
+KL HPN+V+ + VL L + E + G + ++ L A Y D+ +G
Sbjct: 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKG 149
Query: 202 MNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRY 261
+ YLH+ + IIHRD+ PSN+L E GH+K+ DFG+S + D+ ++ G+ +
Sbjct: 150 IEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL---LSNTVGTPAF 203
Query: 262 MAPEV--YRRESY-GKSVDVFS-----FALI----------VHEMFQGGPSNRADTAVQV 303
MAPE R+ + GK++DV++ + + + + ++
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS---------KIKS 254
Query: 304 ADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345
P + + +K L+ KNP+ R EI
Sbjct: 255 QALEF-----PDQPDIAED-LKDLITRMLDKNPESRIVVPEI 290
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 60/257 (23%), Positives = 112/257 (43%), Gaps = 32/257 (12%)
Query: 102 GAYGEVYLVKWRGT----EI-AAKTIR-SSIASNPRVRNSFMKELGLWQKLRH-PNIVQF 154
GAYG+V+LV+ ++ A K ++ ++I + E + + +R P +V
Sbjct: 65 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVT- 123
Query: 155 LGVLKHS----ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRP 210
L ++ +L + +Y+ G L L ++ + Y +I + +LH
Sbjct: 124 ---LHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL-- 178
Query: 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT--GSYRYMAPEVYR 268
II+RD+ N+L D GH+ +TDFGLSK + G+ YMAP++ R
Sbjct: 179 -GIIYRDIKLENILLDSNGHVVLTDFGLSK----EFVADETERAYDFCGTIEYMAPDIVR 233
Query: 269 RESYG--KSVDVFSFALIVHEMFQGGP----SNRADTAVQVADRRAYEDSRPALSSLYPE 322
G K+VD +S ++++E+ G ++ +++ R + P
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQEMSA 291
Query: 323 PIKALLRECWHKNPDRR 339
K L++ K+P +R
Sbjct: 292 LAKDLIQRLLMKDPKKR 308
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 48/194 (24%), Positives = 82/194 (42%), Gaps = 21/194 (10%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVL 158
GA+ V T E A K I R+ +E+ + + + H N+++ +
Sbjct: 24 GAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ +R + E +R GS+ + K+ + A D+A +++LH+ I HRDL
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDL 137
Query: 219 TPSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSY----KMTGGTGSYRYMAPEVYRR-- 269
P N+L ++ +K+ DF L + S ++ GS YMAPEV
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 270 ---ESYGKSVDVFS 280
Y K D++S
Sbjct: 198 EEASIYDKRCDLWS 211
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 78/285 (27%), Positives = 131/285 (45%), Gaps = 46/285 (16%)
Query: 102 GAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +G+VY R G ++A K R + S+ + F E+ RHP++V +G
Sbjct: 50 GVFGKVYKGVLRDGAKVALK--RRTPESSQGIE-EFETEIETLSFCRHPHLVSLIGFCDE 106
Query: 161 SERLIFLTEYLRNGSLHDIL----KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+I + +Y+ NG+L L + + + ARG++YLH AIIHR
Sbjct: 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHR 163
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG--- 273
D+ N+L DE K+TDFG+SK E D ++ T G+ Y+ PE + + G
Sbjct: 164 DVKSINILLDENFVPKITDFGISKKGTELDQ-THLSTVVKGTLGYIDPEYFIK---GRLT 219
Query: 274 -KSVDVFSFALIVHEMFQG----------GPSNRADTAVQVADRRAYE---DSRPALSSL 319
KS DV+SF +++ E+ N A+ AV+ + E D P L+
Sbjct: 220 EKS-DVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD--PNLADK 276
Query: 320 YPEPIKALLR------ECWHKNPDRRPTFEEIIFRLE---AIQES 355
++L + +C + + RP+ +++++LE +QES
Sbjct: 277 IRP--ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 67/266 (25%), Positives = 110/266 (41%), Gaps = 41/266 (15%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFLGV- 157
G G+V + + T + A K ++ P+ R +E+ W+ + P+IV+ + V
Sbjct: 73 GINGKVLQIFNKRTQEKFALKMLQDC----PKAR----REVELHWRASQCPHIVRIVDVY 124
Query: 158 --LKHSERLIFL-TEYLRNGSLHD-ILKKKGKL----DPPTAVAYALDIARGMNYLHHHR 209
L + + + E L G L I + + + A I + YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE---ASEIMKSIGEAIQYLHSIN 181
Query: 210 PHAIIHRDLTPSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV 266
I HRD+ P N+L + LK+TDFG +K + +T + Y+APEV
Sbjct: 182 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTPYYVAPEV 234
Query: 267 YRRESYGKSVDVFSFALIVHEMFQGGP----SNRADTAVQVADR---RAYEDSRPALSSL 319
E Y KS D++S +I++ + G P ++ + + R YE P S +
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294
Query: 320 YPEPIKALLRECWHKNPDRRPTFEEI 345
E K L+R P +R T E
Sbjct: 295 SEEV-KMLIRNLLKTEPTQRMTITEF 319
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-28
Identities = 66/200 (33%), Positives = 99/200 (49%), Gaps = 20/200 (10%)
Query: 102 GAYGEVYLVKWRGT-EIAA-KTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G+YG V + + T I A K S + V+ M+E+ L ++LRH N+V L V K
Sbjct: 36 GSYGMVMKCRNKDTGRIVAIKKFLES-DDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK 94
Query: 160 HSERLIFLTEYLRNGSLHDILK----KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+R + E++ H IL LD Y I G+ + H H IIH
Sbjct: 95 KKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIH 147
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSK-IAQEKDSYSYKMTGGTGSYRYMAPEV-YRRESYG 273
RD+ P N+L ++G +K+ DFG ++ +A + Y ++ T YR APE+ YG
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYR--APELLVGDVKYG 203
Query: 274 KSVDVFSFALIVHEMFQGGP 293
K+VDV++ +V EMF G P
Sbjct: 204 KAVDVWAIGCLVTEMFMGEP 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 27/198 (13%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +G+V + K G ++A K + + V +E+ + RHP+I++ V+
Sbjct: 27 GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ + EY+ G L D + K G+LD + I G++Y H H ++HRDL
Sbjct: 87 TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLK 143
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT------GSYRYMAPEVYRRESY- 272
P NVL D + K+ DFGLS + M+ G GS Y APEV Y
Sbjct: 144 PENVLLDAHMNAKIADFGLSNM----------MSDGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 273 GKSVDVFS-----FALIV 285
G VD++S +AL+
Sbjct: 194 GPEVDIWSSGVILYALLC 211
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 28/198 (14%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++G+V L ++A K I + + +E+ + LRHP+I++ V+
Sbjct: 20 GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
++ + EY G L D + +K ++ + I + Y H H+ I+HRDL
Sbjct: 80 TPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLK 135
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT------GSYRYMAPEVYRRESY- 272
P N+L D+ ++K+ DFGLS I MT G GS Y APEV + Y
Sbjct: 136 PENLLLDDNLNVKIADFGLSNI----------MTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 273 GKSVDVFS-----FALIV 285
G VDV+S + ++V
Sbjct: 186 GPEVDVWSCGIVLYVMLV 203
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-28
Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 102 GAYGEVYLVKWRGT-EIAA-KTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G+YG V+ + R T +I A K S +P ++ ++E+ + ++L+HPN+V L V +
Sbjct: 14 GSYGVVFKCRNRDTGQIVAIKKFLES-EDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR 72
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
RL + EY + LH++ + + + + + +N+ H H IHRD+
Sbjct: 73 RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVK 129
Query: 220 PSNVLQDEAGHLKVTDFGLSK-IAQEKDSYSYKMTGGTGSYRYMAPEV-YRRESYGKSVD 277
P N+L + +K+ DFG ++ + D Y ++ T YR +PE+ YG VD
Sbjct: 130 PENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA--TRWYR--SPELLVGDTQYGPPVD 185
Query: 278 VFSFALIVHEMFQGGP 293
V++ + E+ G P
Sbjct: 186 VWAIGCVFAELLSGVP 201
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-28
Identities = 59/194 (30%), Positives = 89/194 (45%), Gaps = 21/194 (10%)
Query: 102 GAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +G L+ K +A K I A + V+ +E+ + LRHPNIV+F V+
Sbjct: 31 GNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ----REIINHRSLRHPNIVRFKEVIL 86
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
L + EY G L++ + G+ A + + G++Y H + I HRDL
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLK 143
Query: 220 PSNVLQDE--AGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY-GKSV 276
N L D A LK+ DFG SK + + G+ Y+APEV R+ Y GK
Sbjct: 144 LENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRQEYDGKIA 199
Query: 277 DVFS-----FALIV 285
DV+S + ++V
Sbjct: 200 DVWSCGVTLYVMLV 213
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 73/250 (29%), Positives = 107/250 (42%), Gaps = 19/250 (7%)
Query: 102 GAYGEVY--LVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++G VY +A K + S + +KE+ QKLRHPN +Q+ G
Sbjct: 65 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYAL-DIARGMNYLHHHRPHAIIHRDL 218
+ EY GS D+L+ K +A +G+ YLH H +IHRD+
Sbjct: 125 REHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDV 180
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV---YRRESYGKS 275
N+L E G +K+ DFG + I +S+ G+ +MAPEV Y
Sbjct: 181 KAGNILLSEPGLVKLGDFGSASIMAPANSF-------VGTPYWMAPEVILAMDEGQYDGK 233
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPAL-SSLYPEPIKALLRECWHK 334
VDV+S + E+ + P A+ A +S PAL S + E + + C K
Sbjct: 234 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-PALQSGHWSEYFRNFVDSCLQK 292
Query: 335 NPDRRPTFEE 344
P RPT E
Sbjct: 293 IPQDRPTSEV 302
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-27
Identities = 60/264 (22%), Positives = 104/264 (39%), Gaps = 26/264 (9%)
Query: 102 GAYGEVY--LVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA V + ++A K I + + +KE+ + HPNIV +
Sbjct: 26 GATAVVQAAYCAPKKEKVAIKRINLE-KCQTSM-DELLKEIQAMSQCHHPNIVSYYTSFV 83
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTA-------VAYAL-DIARGMNYLHHHRPH 211
+ L + + L GS+ DI+K + +A L ++ G+ YLH +
Sbjct: 84 VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG-- 141
Query: 212 AIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT--GSYRYMAPEVYRR 269
IHRD+ N+L E G +++ DFG+S + T G+ +MAPEV +
Sbjct: 142 -QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200
Query: 270 ES-YGKSVDVFSFALIVHEMFQGGPSNRADTAVQV--------ADRRAYEDSRPALSSLY 320
Y D++SF + E+ G ++V + Y
Sbjct: 201 VRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKY 260
Query: 321 PEPIKALLRECWHKNPDRRPTFEE 344
+ + ++ C K+P++RPT E
Sbjct: 261 GKSFRKMISLCLQKDPEKRPTAAE 284
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-27
Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 19/198 (9%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTI-RSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G+YG+V V A K + + + P + KE+ L ++LRH N++Q + VL
Sbjct: 16 GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVL 75
Query: 159 KH-SERLIFL-TEYLRNGS--LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ ++ +++ EY G + D + + + A Y + G+ YLH I+
Sbjct: 76 YNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQG---IV 131
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYR-RESY- 272
H+D+ P N+L G LK++ G+++ + T GS + PE+ +++
Sbjct: 132 HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPPEIANGLDTFS 190
Query: 273 GKSVDVFS-----FALIV 285
G VD++S + +
Sbjct: 191 GFKVDIWSAGVTLYNITT 208
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-27
Identities = 67/263 (25%), Positives = 115/263 (43%), Gaps = 30/263 (11%)
Query: 102 GAYGEVY--LVKWRGTEIAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFLG-- 156
G YG+VY G A K + + + +E+ L + H NI + G
Sbjct: 35 GTYGQVYKGRHVKTGQLAAIKVM--DVTGDEE--EEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 157 ----VLKHSERLIFLTEYLRNGSLHDILK--KKGKLDPPTAVAYAL-DIARGMNYLHHHR 209
++L + E+ GS+ D++K K L +AY +I RG+++LH H+
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE-WIAYICREILRGLSHLHQHK 149
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
+IHRD+ NVL E +K+ DFG+S AQ + + G+ +MAPEV
Sbjct: 150 ---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVG-RRNTFIGTPYWMAPEVIAC 203
Query: 270 E-----SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPAL-SSLYPEP 323
+ +Y D++S + EM +G P ++ + P L S + +
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-PRLKSKKWSKK 262
Query: 324 IKALLRECWHKNPDRRPTFEEII 346
++ + C KN +RP E+++
Sbjct: 263 FQSFIESCLVKNHSQRPATEQLM 285
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 36/204 (17%), Positives = 71/204 (34%), Gaps = 18/204 (8%)
Query: 102 GAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
V L K G + + I SN V EL + + HPNIV +
Sbjct: 38 EDLMTVNLARYKPTGEYVTVRRINLEACSNEMV-TFLQGELHVSKLFNHPNIVPYRATFI 96
Query: 160 HSERLIFLTEYLRNGSLHDILK--KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
L +T ++ GS D++ ++ + + ++Y+HH +HR
Sbjct: 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRS 153
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRY------MAPEVYRR-- 269
+ S++L G + ++ + + ++PEV ++
Sbjct: 154 VKASHILISVDGKVYLSGLRSN--LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL 211
Query: 270 ESYGKSVDVFSFALIVHEMFQGGP 293
+ Y D++S + E+ G
Sbjct: 212 QGYDAKSDIYSVGITACELANGHV 235
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 12/186 (6%)
Query: 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDF 236
K L + Y+ +A+GM +L + IHRDL N+L E +K+ DF
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDF 237
Query: 237 GLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGG---- 292
GL++ + Y + ++MAPE Y DV+SF +++ E+F G
Sbjct: 238 GLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 296
Query: 293 PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
P + D + P + + + +CWH P +RPTF E++ L +
Sbjct: 297 PGVKIDEEFCRRLKEGTRMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
Query: 353 -QESFQ 357
Q + Q
Sbjct: 354 LQANAQ 359
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 30/158 (18%), Positives = 53/158 (33%), Gaps = 18/158 (11%)
Query: 102 GAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQ 153
GA+G+V G +A K ++ + + M EL + + H N+V
Sbjct: 33 GAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVN 90
Query: 154 FLGV-LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
LG K L+ + E+ + G+L L+ K P +G +Y+
Sbjct: 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY-KTKGARFRQGKDYV------G 143
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250
I DL + + F K + +
Sbjct: 144 AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-26
Identities = 64/202 (31%), Positives = 102/202 (50%), Gaps = 25/202 (12%)
Query: 102 GAYGEVYLVKWRGTEIAA-KTIRSSIASN--PRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G YG VY + E A K IR P + ++E+ + ++L+H NIV+ V+
Sbjct: 13 GTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS---TTIREISILKELKHSNIVKLYDVI 69
Query: 159 KHSERLIFLTEYLRNGSLHDILKK-----KGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
+RL+ + E+L D LKK +G L+ TA ++ L + G+ Y H R +
Sbjct: 70 HTKKRLVLVFEHLD----QD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---V 121
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKI-AQEKDSYSYKMTGGTGSYRYMAPEV-YRRES 271
+HRDL P N+L + G LK+ DFGL++ Y++++ T YR AP+V +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYR--APDVLMGSKK 177
Query: 272 YGKSVDVFSFALIVHEMFQGGP 293
Y ++D++S I EM G P
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTP 199
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 63/206 (30%), Positives = 97/206 (47%), Gaps = 29/206 (14%)
Query: 102 GAYGEVYLVKWRGT-EIAA-KTIRSSIASNPRVRNSF----MKELGLWQKLRHPNIVQFL 155
G + VY + + T +I A K I+ + ++ ++E+ L Q+L HPNI+ L
Sbjct: 21 GQFATVYKARDKNTNQIVAIKKIK--LGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKK-----KGKLDPPTAVAYALDIARGMNYLHHHRP 210
H + + +++ D L+ L P AY L +G+ YLH H
Sbjct: 79 DAFGHKSNISLVFDFM----ETD-LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 132
Query: 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG--TGSYRYMAPEV-Y 267
I+HRDL P+N+L DE G LK+ DFGL A+ S + T T YR APE+ +
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGL---AKSFGSPNRAYTHQVVTRWYR--APELLF 185
Query: 268 RRESYGKSVDVFSFALIVHEMFQGGP 293
YG VD+++ I+ E+ P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVP 211
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 68/202 (33%), Positives = 96/202 (47%), Gaps = 25/202 (12%)
Query: 102 GAYGEVYLVKWRGTEIAA-KTIRSSIASN--PRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G YG VY K I A K IR P + ++E+ L ++L HPNIV + V+
Sbjct: 32 GTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPS---TAIREISLLKELHHPNIVSLIDVI 88
Query: 159 KHSERLIFLTEYLRNGSLHDILKK-----KGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
L + E++ D LKK K L Y + RG+ + H HR I
Sbjct: 89 HSERCLTLVFEFME----KD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---I 140
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKI-AQEKDSYSYKMTGGTGSYRYMAPEV-YRRES 271
+HRDL P N+L + G LK+ DFGL++ SY++++ T YR AP+V +
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYR--APDVLMGSKK 196
Query: 272 YGKSVDVFSFALIVHEMFQGGP 293
Y SVD++S I EM G P
Sbjct: 197 YSTSVDIWSIGCIFAEMITGKP 218
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 23/201 (11%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G Y VY K + T+ +A K IR + + ++E+ L + L+H NIV ++
Sbjct: 13 GTYATVYKGKSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH 70
Query: 160 HSERLIFLTEYLRNGSLHDILKK-----KGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ L + EYL D LK+ ++ + + RG+ Y H + ++
Sbjct: 71 TEKSLTLVFEYLD----KD-LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VL 122
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKI-AQEKDSYSYKMTGGTGSYRYMAPEV-YRRESY 272
HRDL P N+L +E G LK+ DFGL++ + +Y ++ T YR P++ Y
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYR--PPDILLGSTDY 178
Query: 273 GKSVDVFSFALIVHEMFQGGP 293
+D++ I +EM G P
Sbjct: 179 STQIDMWGVGCIFYEMATGRP 199
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-25
Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 26/202 (12%)
Query: 102 GAYGEVYLVKWRGT-EIAA-KTIRSSIASN--PRVRNSFMKELGLWQKLRHPNIVQFLGV 157
G YG V+ K R T EI A K +R P S ++E+ L ++L+H NIV+ V
Sbjct: 13 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS---SALREICLLKELKHKNIVRLHDV 69
Query: 158 LKHSERLIFLTEYLRNGSLHDILKK-----KGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
L ++L + E+ D LKK G LDP ++ + +G+ + H
Sbjct: 70 LHSDKKLTLVFEFCD----QD-LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKI-AQEKDSYSYKMTGGTGSYRYMAPEV-YRRE 270
++HRDL P N+L + G LK+ +FGL++ YS ++ T YR P+V + +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYR--PPDVLFGAK 177
Query: 271 SYGKSVDVFSFALIVHEMFQGG 292
Y S+D++S I E+ G
Sbjct: 178 LYSTSIDMWSAGCIFAELANAG 199
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 37/237 (15%)
Query: 99 IDPGAYGEVYLVKWR----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
+ G YG VY K + + A K I + S R E+ L ++L+HPN++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-----EIALLRELKHPNVISL 83
Query: 155 LGV-LKHSER---LIF------LTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNY 204
V L H++R L+F L ++ KK +L + I G++Y
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 205 LHHHRPHAIIHRDLTPSNVL----QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS-- 258
LH + ++HRDL P+N+L E G +K+ D G A+ +S +
Sbjct: 144 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF---ARLFNSPLKPLADLDPVVV 197
Query: 259 ---YRYMAPEV-YRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED 311
YR APE+ Y K++D+++ I E+ P + D
Sbjct: 198 TFWYR--APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 9e-24
Identities = 60/203 (29%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 102 GAYGEVYLVKWRGT-EIAA-KTIRSSIASN--PRVRNSFMKELGLWQKLRHPNIVQFLGV 157
G YGEVY T E A K IR P + ++E+ L ++L+H NI++ V
Sbjct: 45 GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPG---TAIREVSLLKELQHRNIIELKSV 101
Query: 158 LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+ H+ RL + EY L + K + ++ + G+N+ H R +HRD
Sbjct: 102 IHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRD 157
Query: 218 LTPSNVL-----QDEAGHLKVTDFGLSKI-AQEKDSYSYKMTGGTGSYRYMAPEV-YRRE 270
L P N+L E LK+ DFGL++ +++++ T YR PE+
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWYR--PPEILLGSR 213
Query: 271 SYGKSVDVFSFALIVHEMFQGGP 293
Y SVD++S A I EM P
Sbjct: 214 HYSTSVDIWSIACIWAEMLMKTP 236
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-23
Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 46/215 (21%)
Query: 102 GAYGEVYLVKWRGTE--IAAKTIR---------SSIASNPRVRNSFMKELGLWQKLRHPN 150
G Y VY + T +A K ++ ++I +E+ L ++L+H N
Sbjct: 16 GTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-----------REISLMKELKHEN 64
Query: 151 IVQFLGVLKHSERLIFLTEYLRNGSLHDILKK----------KGKLDPPTAVAYALDIAR 200
IV+ V+ +L + E++ +D LKK L+ + + +
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMD----ND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 201 GMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK-IAQEKDSYSYKMTGGTGSY 259
G+ + H ++ I+HRDL P N+L ++ G LK+ DFGL++ +++S ++ T Y
Sbjct: 120 GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWY 174
Query: 260 RYMAPEV-YRRESYGKSVDVFSFALIVHEMFQGGP 293
R AP+V +Y S+D++S I+ EM G P
Sbjct: 175 R--APDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-23
Identities = 61/215 (28%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 102 GAYGEVYLVKWRGT-EIAA-KTIR-----SSIASNPR--VRN-SFMKELGLWQKLRHPNI 151
GAYG VY + + A K++R P VR + ++ L + HPN+
Sbjct: 20 GAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL---EAFEHPNV 76
Query: 152 VQFLGVLKHSER-------LIFLTEYLRNGSLHDILKK------KGKLDPPTAVAYALDI 198
V+ + V S L+F E++ D L+ L T
Sbjct: 77 VRLMDVCATSRTDREIKVTLVF--EHVD----QD-LRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 199 ARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS 258
RG+++LH + I+HRDL P N+L G +K+ DFGL++I + + + + T
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLW 184
Query: 259 YRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGP 293
YR APEV + +Y VD++S I EMF+ P
Sbjct: 185 YR--APEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-23
Identities = 27/250 (10%), Positives = 61/250 (24%), Gaps = 50/250 (20%)
Query: 102 GAYGEVYLVKWRGT------EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
+ W+ ++A + V + ++ P + + L
Sbjct: 42 VPPLQF----WQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
V+ + + E++R GSL ++ P A+ +A + H +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAADAAHRA---GVAL 152
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
PS V G + + M +
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPA-----------------------TMPDANPQD------ 183
Query: 276 VDVFSFALIVHEMFQGGP---SNRADTAVQVADRRAYEDSRP--ALSSLYPEPIKALLRE 330
D+ ++ + + + A+R + P I A+
Sbjct: 184 -DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR 242
Query: 331 CWHKNPDRRP 340
+ R
Sbjct: 243 SVQGDGGIRS 252
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-23
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 46/217 (21%)
Query: 102 GAYGEVYL---VKWRGTEIAAKTIR----------SSIASNPRVRN-SFMKELGLWQKLR 147
GAYG+V+ +K G +A K +R S+I R + ++ L +
Sbjct: 22 GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI------REVAVLRHL---ETFE 72
Query: 148 HPNIVQFLGVL----KHSERLIFL-TEYLRNGSLHDILKK------KGKLDPPTAVAYAL 196
HPN+V+ V E + L E++ D L + + T
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QD-LTTYLDKVPEPGVPTETIKDMMF 127
Query: 197 DIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256
+ RG+++LH HR ++HRDL P N+L +G +K+ DFGL++I + + + + T
Sbjct: 128 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--T 182
Query: 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGP 293
YR APEV + SY VD++S I EMF+ P
Sbjct: 183 LWYR--APEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 32/207 (15%)
Query: 102 GAYGEVYLVKWRGT-EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G++G V+ K + E+A K + + R +N +EL + + ++HPN+V
Sbjct: 51 GSFGVVFQAKLVESDEVAIKKVLQ----DKRFKN---RELQIMRIVKHPNVVDLKAFFYS 103
Query: 161 SER------LIFLTEYLRNGSLHDIL----KKKGKLDPPTAVAYALDIARGMNYLHHHRP 210
+ L + EY+ +++ K K + Y + R + Y+H
Sbjct: 104 NGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG- 161
Query: 211 HAIIHRDLTPSNVLQDEA-GHLKVTDFGLSKIAQEKDSY-SYKMTGGTGSYR-YMAPEV- 266
I HRD+ P N+L D G LK+ DFG +KI + SY + R Y APE+
Sbjct: 162 --ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICS------RYYRAPELI 213
Query: 267 YRRESYGKSVDVFSFALIVHEMFQGGP 293
+ +Y ++D++S ++ E+ QG P
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 35/212 (16%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRN---SFMKELGLWQKLRHPNIVQFLG 156
G +G V L K + G +A K + +PR RN M++L L HPNIVQ
Sbjct: 34 GTFGTVQLGKEKSTGMSVAIKKVIQ----DPRFRNRELQIMQDL---AVLHHPNIVQLQS 86
Query: 157 VLKHSER-------LIFLTEYLRNGSLHDILK----KKGKLDPPTAVAYALDIARGMNYL 205
L + EY+ +LH + ++ P + + R + L
Sbjct: 87 YFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCL 145
Query: 206 HHHRPHAIIHRDLTPSNVLQDEA-GHLKVTDFGLSKIAQEKDSY-SYKMTGGTGSYR-YM 262
H + HRD+ P NVL +EA G LK+ DFG +K + +Y + R Y
Sbjct: 146 HLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS------RYYR 198
Query: 263 APEV-YRRESYGKSVDVFSFALIVHEMFQGGP 293
APE+ + + Y +VD++S I EM G P
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 40/216 (18%)
Query: 102 GAYGEVYLVKWRGT-EIAA-KTIRSSIASNPRVRNSF----MKELGLWQKLRHPNIVQFL 155
G +GEV+ + R T + A K + + F ++E+ + Q L+H N+V +
Sbjct: 28 GTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 156 GVLKHSERL--------IFL-TEYLRNGSLHDILKK-----KGKLDPPTAVAYALDIARG 201
+ ++ I+L ++ HD L K + G
Sbjct: 83 EIC-RTKASPYNRCKGSIYLVFDFCE----HD-LAGLLSNVLVKFTLSEIKRVMQMLLNG 136
Query: 202 MNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLS-KIAQEKDSYSYKMTGG--TGS 258
+ Y+H ++ I+HRD+ +NVL G LK+ DFGL+ + K+S + T T
Sbjct: 137 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193
Query: 259 YRYMAPEV-YRRESYGKSVDVFSFALIVHEMFQGGP 293
YR PE+ YG +D++ I+ EM+ P
Sbjct: 194 YR--PPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 73/289 (25%), Positives = 113/289 (39%), Gaps = 61/289 (21%)
Query: 99 IDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMK----ELGLWQKLRHPNIV 152
+ GAYG V K G ++A K + S P F K EL L + ++H N++
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKL-----SRPFQSEIFAKRAYRELLLLKHMQHENVI 86
Query: 153 QFLGVLKHSERL-----IFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHH 207
L V + L +L L I+ K + +G+ Y+H
Sbjct: 87 GLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKYIH- 143
Query: 208 HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG--GTGSYRYMAPE 265
++HRDL P N+ +E LK+ DFGL++ A + MTG T YR APE
Sbjct: 144 --SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYR--APE 193
Query: 266 V-YRRESYGKSVDVFSFALIVHEM------FQGG---------------PSNRADTAVQV 303
V Y ++VD++S I+ EM F+G P +
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 304 ADRRAYEDSRPA-----LSSLYPE-PIKA--LLRECWHKNPDRRPTFEE 344
++Y S P + L+P +A LL + + D+R T +
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQ 302
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 87.5 bits (218), Expect = 2e-21
Identities = 31/86 (36%), Positives = 43/86 (50%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
++ GD V + KG + N R LH A+ G+ EI+ LL KGAD+N+ D
Sbjct: 11 FMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPD 70
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
+ TPL A GHV K+L +G
Sbjct: 71 KHHITPLLSAVYEGHVSCVKLLLSKG 96
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 77.4 bits (192), Expect = 1e-17
Identities = 22/80 (27%), Positives = 32/80 (40%), Gaps = 1/80 (1%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L+ ++ + +L+ L KG + N D T L A EG V LLL KGAD
Sbjct: 44 LHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKG 103
Query: 72 RWGRTPLSDARSFGHVVICK 91
G T + + +
Sbjct: 104 PDGLTAFEATDNQAIKALLQ 123
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123 | Back alignment and structure |
|---|
Score = 70.9 bits (175), Expect = 3e-15
Identities = 17/58 (29%), Positives = 22/58 (37%)
Query: 40 DKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
A G + V + KG DVN GR PL A G + I + L +G
Sbjct: 6 MCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKG 63
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 33/208 (15%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++G VY K G +A K + + R +N +EL + +KL H NIV+
Sbjct: 65 GSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKN---RELQIMRKLDHCNIVRLRYFFY 117
Query: 160 HSER------LIFLTEYLRNGSLHDILKKKGKLD---PPTAVAYAL-DIARGMNYLHHHR 209
S L + +Y+ +++ + + + P V + + R + Y+H
Sbjct: 118 SSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 210 PHAIIHRDLTPSNVLQD-EAGHLKVTDFGLSKIAQEKDSY-SYKMTGGTGSYR-YMAPEV 266
I HRD+ P N+L D + LK+ DFG +K + SY + R Y APE+
Sbjct: 177 ---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS------RYYRAPEL 227
Query: 267 -YRRESYGKSVDVFSFALIVHEMFQGGP 293
+ Y S+DV+S ++ E+ G P
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 87.9 bits (219), Expect = 3e-21
Identities = 28/70 (40%), Positives = 39/70 (55%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ G +PN+ D+ T LH A + G ++V LLL+ A VN+ +PL DA GHV
Sbjct: 30 LQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGHV 89
Query: 88 VICKILEDRG 97
I K+L G
Sbjct: 90 DIVKLLLSYG 99
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 82.1 bits (204), Expect = 3e-19
Identities = 18/70 (25%), Positives = 29/70 (41%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ N Y + LH A+ G +IV LLL GA N+++ +G P+
Sbjct: 63 LQHKALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMK 122
Query: 88 VICKILEDRG 97
+ + E
Sbjct: 123 SLLLLPEKNE 132
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 75.2 bits (186), Expect = 1e-16
Identities = 23/67 (34%), Positives = 37/67 (55%), Gaps = 1/67 (1%)
Query: 31 GVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVIC 90
G++P ++ T LH+AS +G V LL+ G+D N D G TPL +A + GH+ +
Sbjct: 1 GIDPF-TNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVV 59
Query: 91 KILEDRG 97
++L
Sbjct: 60 ELLLQHK 66
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137 | Back alignment and structure |
|---|
Score = 50.5 bits (122), Expect = 5e-08
Identities = 8/42 (19%), Positives = 14/42 (33%), Gaps = 1/42 (2%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNS 69
L G N + + E ++ LL EK ++
Sbjct: 96 LSYGASRNAVNIFGLRPVDYTDDESMKSLL-LLPEKNESSSA 136
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-21
Identities = 65/292 (22%), Positives = 108/292 (36%), Gaps = 60/292 (20%)
Query: 102 GAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMK---------ELGLWQKLRHPNI 151
G+YG V G +A K + + S+ R N E+ L HPNI
Sbjct: 33 GSYGAVCAGVDSEGIPVAIKRV-FNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91
Query: 152 VQFLGVLKHSERLIF-----LTEYLRNGSLHDILKKKGKLDPPTAVAYAL-DIARGMNYL 205
+ + H E +TE +R L ++ + + P + Y + I G++ L
Sbjct: 92 LGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVL 150
Query: 206 HHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG--GTGSYRYMA 263
H ++HRDL P N+L + + + DF L++ T YR A
Sbjct: 151 HEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA----NKTHYVTHRWYR--A 201
Query: 264 PEV-YRRESYGKSVDVFSFALIVHEM------FQGG---------------PSNRADTAV 301
PE+ + + + K VD++S ++ EM F+G P
Sbjct: 202 PELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMF 261
Query: 302 QVADRRAY-EDSRP-----ALSSLYPE-PIKA--LLRECWHKNPDRRPTFEE 344
R Y +S A +++ P A L+ + NP RR + E+
Sbjct: 262 SSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-21
Identities = 62/266 (23%), Positives = 100/266 (37%), Gaps = 62/266 (23%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFLGV- 157
G G+V + + T + A K ++ P+ R +E+ W+ + P+IV+ + V
Sbjct: 29 GINGKVLQIFNKRTQEKFALKMLQDC----PKAR----REVELHWRASQCPHIVRIVDVY 80
Query: 158 --LKHSERLIFL-TEYLRNGSLHD-ILKKKGKL----DPPTAVAYALDIARGMNYLHHHR 209
L + + + E L G L I + + + A I + YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE---ASEIMKSIGEAIQYLHSIN 137
Query: 210 PHAIIHRDLTPSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV 266
I HRD+ P N+L + LK+TDFG A E
Sbjct: 138 ---IAHRDVKPENLLYTSKRPNAILKLTDFGF------------------------AKET 170
Query: 267 YRRESYGKSVDVFSFALIVHEMFQGGP----SNRADTAVQVADR---RAYEDSRPALSSL 319
E Y KS D++S +I++ + G P ++ + + R YE P S +
Sbjct: 171 -TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229
Query: 320 YPEPIKALLRECWHKNPDRRPTFEEI 345
E K L+R P +R T E
Sbjct: 230 SEEV-KMLIRNLLKTEPTQRMTITEF 254
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 72/287 (25%), Positives = 114/287 (39%), Gaps = 52/287 (18%)
Query: 99 IDPGAYGEVYLV--KWRGTEIAAKTIR--SSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
I GAYG V +A K I R ++E+ + + RH NI+
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT----LREIKILLRFRHENIIGI 90
Query: 155 LGVLKHSERLIF-----LTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHR 209
+++ + + + L+ +LK + L + I RG+ Y+H
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN 148
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG--GTGSYRYMAPEV- 266
++HRDL PSN+L + LK+ DFGL+++A ++ +T T YR APE+
Sbjct: 149 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR--APEIM 203
Query: 267 YRRESYGKSVDVFSFALIVHEM------FQGG---------------PSNRADTAVQVAD 305
+ Y KS+D++S I+ EM F G PS +
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263
Query: 306 RRAYEDSRP-----ALSSLYPE-PIKA--LLRECWHKNPDRRPTFEE 344
R Y S P + L+P KA LL + NP +R E+
Sbjct: 264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 86.7 bits (216), Expect = 2e-20
Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 1/86 (1%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L +S ++ L E G +P++ ++ +AL LAS+ G +IV LLLE+ D+N D
Sbjct: 40 LIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYD 99
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
G TPL A HV + L RG
Sbjct: 100 WNGGTPLLYAVRGNHVKCVEALLARG 125
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 85.9 bits (214), Expect = 3e-20
Identities = 23/86 (26%), Positives = 43/86 (50%), Gaps = 1/86 (1%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L +S G ++ L E+ V+ N+ D++ T L A + V LL +GAD+ +
Sbjct: 73 LSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTTEA 132
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
G TP+ A + G+ + +++E+
Sbjct: 133 DSGYTPMDLAVALGYRKVQQVIENHI 158
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 82.5 bits (205), Expect = 6e-19
Identities = 27/87 (31%), Positives = 42/87 (48%), Gaps = 1/87 (1%)
Query: 12 LLYCSSKGDRAGVLQELEKG-VEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSL 70
+ +++G+ + + L KG N D T L AS+ G E V LLE GAD + L
Sbjct: 6 IHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHIL 65
Query: 71 DRWGRTPLSDARSFGHVVICKILEDRG 97
+ + LS A + G+ I +L +R
Sbjct: 66 AKERESALSLASTGGYTDIVGLLLERD 92
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 69.0 bits (170), Expect = 3e-14
Identities = 9/66 (13%), Positives = 24/66 (36%), Gaps = 1/66 (1%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L + +G+ ++ L +G + T + LA + G ++ ++ + +
Sbjct: 106 LLYAVRGNHVKCVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVIENHILKLFQSN 165
Query: 72 RWGRTP 77
P
Sbjct: 166 LVPADP 171
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172 | Back alignment and structure |
|---|
Score = 67.4 bits (166), Expect = 1e-13
Identities = 17/57 (29%), Positives = 29/57 (50%), Gaps = 1/57 (1%)
Query: 42 RTALHLASSEGRAEIVLLLLEKGAD-VNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
++H +++G + + L KG + VN D G TPL A +FG + + L + G
Sbjct: 3 SLSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWG 59
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 86.3 bits (215), Expect = 2e-20
Identities = 29/70 (41%), Positives = 39/70 (55%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ G +P L + +AL LA S+G +IV +LL+ G DVN D G TPL A HV
Sbjct: 56 LQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHV 115
Query: 88 VICKILEDRG 97
K+L + G
Sbjct: 116 KCVKMLLESG 125
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 85.9 bits (214), Expect = 3e-20
Identities = 20/86 (23%), Positives = 37/86 (43%), Gaps = 1/86 (1%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L + +++ L + GV+ N D++ T L A + V +LLE GAD
Sbjct: 73 LSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADPTIET 132
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
G + A + G+ + +++E
Sbjct: 133 DSGYNSMDLAVALGYRSVQQVIESHL 158
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 85.1 bits (212), Expect = 5e-20
Identities = 24/70 (34%), Positives = 36/70 (51%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+E+ N D + T L A++ G+ +V LL+ GAD L + + LS A S G+
Sbjct: 23 IEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYT 82
Query: 88 VICKILEDRG 97
I K+L D G
Sbjct: 83 DIVKMLLDCG 92
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 72.0 bits (178), Expect = 2e-15
Identities = 13/56 (23%), Positives = 26/56 (46%)
Query: 42 RTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
++H +++G + +E+ +N D G TPL A + G + + + L G
Sbjct: 4 SLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNG 59
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167 | Back alignment and structure |
|---|
Score = 59.3 bits (145), Expect = 6e-11
Identities = 7/45 (15%), Positives = 17/45 (37%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDR 72
LE G +P + ++ LA + G + ++ + +
Sbjct: 122 LESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHLLKLLQNIK 166
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 83.9 bits (209), Expect = 2e-20
Identities = 39/93 (41%), Positives = 56/93 (60%), Gaps = 6/93 (6%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L+ +++ V++ L E G + N D + RT LHLA+ G E+V LLLE GADVN+ D
Sbjct: 6 LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKD 65
Query: 72 RWGRTPLSDARSFGHVVICKILEDRGGIDPGAY 104
+ GRTPL A GH+ + K+L ++ GAY
Sbjct: 66 KNGRTPLHLAARNGHLEVVKLL-----LEAGAY 93
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93 | Back alignment and structure |
|---|
Score = 72.4 bits (179), Expect = 3e-16
Identities = 30/58 (51%), Positives = 39/58 (67%)
Query: 40 DKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
+ RT LHLA+ G E+V LLLE GADVN+ D+ GRTPL A GH+ + K+L + G
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAG 58
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 45/202 (22%), Positives = 89/202 (44%), Gaps = 28/202 (13%)
Query: 102 GAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVL 158
G Y EV+ ++ K ++ P + +E+ + + LR PNI+ ++
Sbjct: 47 GKYSEVFEAINITNNEKVVVKILK------PVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 159 K--HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
K S + E++ N + + L Y +I + ++Y H I+HR
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHR 154
Query: 217 DLTPSNVLQD-EAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV---YRRESY 272
D+ P NV+ D E L++ D+GL++ Y+ ++ + ++ PE+ Y+ Y
Sbjct: 155 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFK--GPELLVDYQM--Y 208
Query: 273 GKSVDVFSFALIVHEM-FQGGP 293
S+D++S ++ M F+ P
Sbjct: 209 DYSLDMWSLGCMLASMIFRKEP 230
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 4e-20
Identities = 33/86 (38%), Positives = 47/86 (54%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L S GD VL+ LE+G + N A+ D TALH A + ++V L+E GA++N D
Sbjct: 44 FLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPD 103
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
G PL A S G++ I + L +G
Sbjct: 104 NEGWIPLHAAASCGYLDIAEYLISQG 129
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 4e-17
Identities = 25/89 (28%), Positives = 42/89 (47%), Gaps = 1/89 (1%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L+ + D +++ L E G N D + LH A+S G +I L+ +GA V +++
Sbjct: 77 LHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVN 136
Query: 72 RWGRTPLSDARSFGHVVICKILEDRGGID 100
G TPL A + + +R G+D
Sbjct: 137 SEGDTPLDIAEEEAMEELLQNEVNRQGVD 165
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 77.5 bits (192), Expect = 3e-16
Identities = 22/70 (31%), Positives = 34/70 (48%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+ TALH+A+++G E++ LL++ DVN D G TPL A +G
Sbjct: 186 NSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKE 245
Query: 88 VICKILEDRG 97
C+IL +
Sbjct: 246 EACRILVENL 255
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 3e-15
Identities = 16/73 (21%), Positives = 36/73 (49%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
++ + N+ DYD T LH A+ G+ E +L+E D+ ++++ G+T A
Sbjct: 219 IQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADEDILG 278
Query: 88 VICKILEDRGGID 100
+ ++ + + +
Sbjct: 279 YLEELQKKQNLLH 291
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 5e-13
Identities = 23/70 (32%), Positives = 32/70 (45%), Gaps = 1/70 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+ K + +D A S G E VL LLE+GAD+N + G T L A +V
Sbjct: 28 VVKRKKTK-VKFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNV 86
Query: 88 VICKILEDRG 97
+ K L + G
Sbjct: 87 DMVKFLVENG 96
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 2e-10
Identities = 12/86 (13%), Positives = 23/86 (26%), Gaps = 6/86 (6%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L + + E+ + D A + L +
Sbjct: 143 LDIAEEEAMEELLQNEVNRQ------GVDIEAARKEEERIMLRDARQWLNSGHINDVRHA 196
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
+ G T L A + G+ + K+L
Sbjct: 197 KSGGTALHVAAAKGYTEVLKLLIQAR 222
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 57.5 bits (140), Expect = 1e-09
Identities = 13/63 (20%), Positives = 19/63 (30%), Gaps = 1/63 (1%)
Query: 35 NLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILE 94
+AD ++ L G + + K G L A S G L
Sbjct: 2 KMADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFL-AACSSGDTEEVLRLL 60
Query: 95 DRG 97
+RG
Sbjct: 61 ERG 63
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 2e-06
Identities = 5/41 (12%), Positives = 15/41 (36%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVN 68
+E + + +TA +A + + L ++ +
Sbjct: 252 VENLCDMEAVNKVGQTAFDVADEDILGYLEELQKKQNLLHS 292
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 86.3 bits (215), Expect = 4e-20
Identities = 21/90 (23%), Positives = 39/90 (43%), Gaps = 1/90 (1%)
Query: 12 LLYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSL 70
LL +++ D V + L + + + D + T L++A EI L+++GAD+N
Sbjct: 9 LLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQ 68
Query: 71 DRWGRTPLSDARSFGHVVICKILEDRGGID 100
+ +P A + G I + D
Sbjct: 69 NSISDSPYLYAGAQGRTEILAYMLKHATPD 98
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 79.0 bits (196), Expect = 1e-17
Identities = 21/74 (28%), Positives = 38/74 (51%), Gaps = 1/74 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGA-DVNSLDRWGRTPLSDARSFGH 86
+++G + NL + + A ++GR EI+ +L+ D+N +R+G L A GH
Sbjct: 59 IDRGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGH 118
Query: 87 VVICKILEDRGGID 100
+ K+L + G D
Sbjct: 119 IDNVKLLLEDGRED 132
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 72.9 bits (180), Expect = 2e-15
Identities = 25/72 (34%), Positives = 35/72 (48%), Gaps = 6/72 (8%)
Query: 28 LEKG-VEPNLADYDKRTALHLA-----SSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81
LE G + + + TAL A ++ +IV LL+E GAD + D GRT + A
Sbjct: 126 LEDGREDIDFQNDFGYTALIEAVGLREGNQLYQDIVKLLMENGADQSIKDNSGRTAMDYA 185
Query: 82 RSFGHVVICKIL 93
G+ I KIL
Sbjct: 186 NQKGYTEISKIL 197
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 72.1 bits (178), Expect = 4e-15
Identities = 17/60 (28%), Positives = 27/60 (45%)
Query: 38 DYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
Y+ L A+ ++ +L + V+ +D G TPL+ A + I K L DRG
Sbjct: 3 TYEVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRG 62
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 65.5 bits (161), Expect = 8e-13
Identities = 21/77 (27%), Positives = 36/77 (46%), Gaps = 7/77 (9%)
Query: 28 LEKG-VEPNLADYDKRTALHLASSEGRAEIVLLLLEKG-ADVNSLDRWGRTPLSDA---- 81
L+ + N + AL A+ +G + V LLLE G D++ + +G T L +A
Sbjct: 92 LKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLR 151
Query: 82 -RSFGHVVICKILEDRG 97
+ + I K+L + G
Sbjct: 152 EGNQLYQDIVKLLMENG 168
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201 | Back alignment and structure |
|---|
Score = 47.1 bits (113), Expect = 2e-06
Identities = 11/35 (31%), Positives = 20/35 (57%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLE 62
+E G + ++ D RTA+ A+ +G EI +L +
Sbjct: 165 MENGADQSIKDNSGRTAMDYANQKGYTEISKILAQ 199
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 84.0 bits (209), Expect = 5e-20
Identities = 28/88 (31%), Positives = 40/88 (45%), Gaps = 5/88 (5%)
Query: 13 LYCSSKG--DRAGVLQELEKGVEPNLADYDKRT-ALHLASSEGRAEIVLLLLEKGADVNS 69
+ G A +L L G EPN AD T +H A+ EG + +++L GA ++
Sbjct: 49 IQVMMMGSAQVAELL--LLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDV 106
Query: 70 LDRWGRTPLSDARSFGHVVICKILEDRG 97
D WGR P+ A GH I + L
Sbjct: 107 CDAWGRLPVDLAEEQGHRDIARYLHAAT 134
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 81.7 bits (203), Expect = 4e-19
Identities = 20/67 (29%), Positives = 32/67 (47%), Gaps = 1/67 (1%)
Query: 31 GVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVIC 90
++ L A++ G+ E V LLE GAD N+L+R+GR P+ G +
Sbjct: 2 SPGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVM-MMGSAQVA 60
Query: 91 KILEDRG 97
++L G
Sbjct: 61 ELLLLHG 67
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 7e-17
Identities = 22/71 (30%), Positives = 32/71 (45%), Gaps = 2/71 (2%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRT-PLSDARSFGH 86
LE G +PN + R + + G A++ LLL GA+ N D T P+ DA G
Sbjct: 32 LEAGADPNALNRFGRRPIQVM-MMGSAQVAELLLLHGAEPNCADPATLTRPVHDAAREGF 90
Query: 87 VVICKILEDRG 97
+ +L G
Sbjct: 91 LDTLVVLHRAG 101
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136 | Back alignment and structure |
|---|
Score = 57.1 bits (139), Expect = 2e-10
Identities = 9/39 (23%), Positives = 14/39 (35%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGAD 66
G ++ D R + LA +G +I L D
Sbjct: 98 HRAGARLDVCDAWGRLPVDLAEEQGHRDIARYLHAATGD 136
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 75/289 (25%), Positives = 112/289 (38%), Gaps = 60/289 (20%)
Query: 99 IDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMK----ELGLWQKLRHPNIV 152
+ GAYG V G ++A K + P F K EL L + +RH N++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKL-----YRPFQSELFAKRAYRELRLLKHMRHENVI 87
Query: 153 QFLGVLKHSERL-----IFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHH 207
L V E L +L L ++K + KL + +G+ Y+H
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHA 146
Query: 208 HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG--GTGSYRYMAPE 265
IIHRDL P N+ +E LK+ DFGL++ A + MTG T YR APE
Sbjct: 147 AG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYR--APE 195
Query: 266 V-YRRESYGKSVDVFSFALIVHEM------FQGG---------------PSNRADTAVQV 303
V Y ++VD++S I+ EM F+G P +Q
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255
Query: 304 ADRRAYEDSRP-----ALSSLYPE-PIKA--LLRECWHKNPDRRPTFEE 344
+ + Y P +S+ A LL + + ++R T E
Sbjct: 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 29/208 (13%)
Query: 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMK----ELGLWQKLRHPNIV 152
I GA G V +A K + S P + K EL L + + H NI+
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKL-----SRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 153 QFLGVLKHSERL-----IFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHH 207
L V + L ++L L + +L +++ + LD + G+ +LH
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLH- 181
Query: 208 HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG--GTGSYRYMAPE 265
IIHRDL PSN++ LK+ DFGL++ A MT T YR APE
Sbjct: 182 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTPYVVTRYYR--APE 233
Query: 266 VYRRESYGKSVDVFSFALIVHEMFQGGP 293
V Y ++VD++S I+ EM +
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 7e-20
Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 99 IDPGAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMK----ELGLWQKLRHPNIV 152
I GA G V +A K + S P + K EL L + + H NI+
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKL-----SRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 153 QFLGVLKHSERL-----IFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHH 207
L V + L +++ L + +L +++ + LD + G+ +LH
Sbjct: 88 GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS 145
Query: 208 HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG--GTGSYRYMAPE 265
IIHRDL PSN++ LK+ DFGL++ A MT T YR APE
Sbjct: 146 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM----MTPYVVTRYYR--APE 196
Query: 266 VYRRESYGKSVDVFSFALIVHEMFQGGP 293
V Y ++VD++S I+ EM +GG
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 7e-20
Identities = 24/71 (33%), Positives = 35/71 (49%), Gaps = 1/71 (1%)
Query: 28 LEKGVEPNLADYDKRT-ALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
L G EPN AD T +H A+ EG + +++L GA ++ D WGR P+ A GH
Sbjct: 64 LLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGH 123
Query: 87 VVICKILEDRG 97
+ + L
Sbjct: 124 RDVARYLRAAA 134
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 9e-18
Identities = 19/70 (27%), Positives = 31/70 (44%), Gaps = 3/70 (4%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+E + L A++ GR E V LLE GA+ N+ + +GR P+ G
Sbjct: 1 MEPAAGSS--MEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVM-MMGSA 57
Query: 88 VICKILEDRG 97
+ ++L G
Sbjct: 58 RVAELLLLHG 67
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 77.1 bits (191), Expect = 3e-17
Identities = 22/71 (30%), Positives = 30/71 (42%), Gaps = 2/71 (2%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRT-PLSDARSFGH 86
LE G PN + R + + G A + LLL GA+ N D T P+ DA G
Sbjct: 32 LEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGF 90
Query: 87 VVICKILEDRG 97
+ +L G
Sbjct: 91 LDTLVVLHRAG 101
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 6e-14
Identities = 13/83 (15%), Positives = 24/83 (28%), Gaps = 6/83 (7%)
Query: 5 DSEGPYRLLYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK 63
D R ++ +++ L L G ++ D R + LA G ++ L
Sbjct: 74 DPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVARYLRAA 133
Query: 64 GADVNSLDRWGRTPLSDARSFGH 86
G + G
Sbjct: 134 AGGTR-----GSNHARIDAAEGP 151
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 83.2 bits (207), Expect = 8e-20
Identities = 37/77 (48%), Positives = 48/77 (62%), Gaps = 5/77 (6%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
LE G + N D + RT LHLA+ G E+V LLLE GADVN+ D+ GRTPL A GH+
Sbjct: 55 LEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHL 114
Query: 88 VICKILEDRGGIDPGAY 104
+ K+L ++ GAY
Sbjct: 115 EVVKLL-----LEAGAY 126
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 80.5 bits (200), Expect = 7e-19
Identities = 36/76 (47%), Positives = 47/76 (61%), Gaps = 5/76 (6%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
LE G + N D + RT LHLA+ G E+V LLLE GADVN+ D+ GRTPL A GH+
Sbjct: 22 LEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHL 81
Query: 88 VICKILEDRGGIDPGA 103
+ K+L ++ GA
Sbjct: 82 EVVKLL-----LEAGA 92
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 68.1 bits (168), Expect = 2e-14
Identities = 30/58 (51%), Positives = 39/58 (67%)
Query: 40 DKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
+ RT LHLA+ G E+V LLLE GADVN+ D+ GRTPL A GH+ + K+L + G
Sbjct: 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAG 58
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-19
Identities = 31/86 (36%), Positives = 42/86 (48%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
LL + G+ V Q +++ +P+ + + TALH A IV L+ GA+VNS D
Sbjct: 25 LLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPD 84
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
G TPL A S VIC L G
Sbjct: 85 SHGWTPLHCAASCNDTVICMALVQHG 110
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-13
Identities = 17/73 (23%), Positives = 26/73 (35%), Gaps = 3/73 (4%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDR-WGRTPLSDARSF-- 84
+ G N D T LH A+S I + L++ GA + + G T +
Sbjct: 74 ITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGATAFEKCDPYRE 133
Query: 85 GHVVICKILEDRG 97
G+ L D
Sbjct: 134 GYADCATYLADVE 146
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-13
Identities = 19/79 (24%), Positives = 29/79 (36%), Gaps = 8/79 (10%)
Query: 28 LEKGVEPNLAD---YDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSF 84
L K P A + L A+ G E+V +++ D + + G T L +A
Sbjct: 5 LRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICG 64
Query: 85 GHVVICKILEDRGGIDPGA 103
+ I L I GA
Sbjct: 65 ANYSIVDFL-----ITAGA 78
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-10
Identities = 12/73 (16%), Positives = 19/73 (26%), Gaps = 4/73 (5%)
Query: 28 LEKGVEPNLAD-YDKRTALHLASS--EGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSF 84
++ G D TA EG A+ L + + ++ L D S
Sbjct: 107 VQHGAAIFATTLSDGATAFEKCDPYREGYADCATYLADVEQSMGLMNSGAVYALWDY-SA 165
Query: 85 GHVVICKILEDRG 97
E
Sbjct: 166 EFGDELSFREGES 178
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 11/59 (18%), Positives = 16/59 (27%), Gaps = 1/59 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
+ L + AL S+E E + + V D T A G
Sbjct: 143 ADVEQSMGLMNSGAVYALWDYSAEFGDE-LSFREGESVTVLRRDGPEETDWWWAALHGQ 200
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 6e-04
Identities = 9/69 (13%), Positives = 16/69 (23%), Gaps = 1/69 (1%)
Query: 13 LYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVL-LLLEKGADVNSLD 71
L+ S + + V D + T A+ G+ V V
Sbjct: 160 LWDYSAEFGDELSFREGESVTVLRRDGPEETDWWWAALHGQEGYVPRNYFGLFPRVKPQR 219
Query: 72 RWGRTPLSD 80
+
Sbjct: 220 SKVKHHHHH 228
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 74/289 (25%), Positives = 115/289 (39%), Gaps = 60/289 (20%)
Query: 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMK----ELGLWQKLRHPNIV 152
+ GAYG V G +A K + S P K EL L + ++H N++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKL-----SRPFQSIIHAKRTYRELRLLKHMKHENVI 91
Query: 153 QFLGVLKHSERL-----IFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHH 207
L V + L ++L +L L++I+K + KL I RG+ Y+H
Sbjct: 92 GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS 150
Query: 208 HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG--GTGSYRYMAPE 265
IIHRDL PSN+ +E LK+ DFGL++ + +MTG T YR APE
Sbjct: 151 AD---IIHRDLKPSNLAVNEDCELKILDFGLAR------HTADEMTGYVATRWYR--APE 199
Query: 266 V-YRRESYGKSVDVFSFALIVHEM------FQGG---------------PSNRADTAVQV 303
+ Y ++VD++S I+ E+ F G P +
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 304 ADRRAYEDSRPA-----LSSLYPE-PIKA--LLRECWHKNPDRRPTFEE 344
R Y S ++++ A LL + + D+R T +
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 308
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 83.2 bits (207), Expect = 2e-19
Identities = 22/66 (33%), Positives = 34/66 (51%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L++G PN+ D + +H A+ G + + +L+E GADVN D G P+ A GH
Sbjct: 55 LKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHT 114
Query: 88 VICKIL 93
+ L
Sbjct: 115 AVVSFL 120
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 81.7 bits (203), Expect = 6e-19
Identities = 26/88 (29%), Positives = 43/88 (48%), Gaps = 4/88 (4%)
Query: 12 LLYCSSKGDRAGVLQEL--EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNS 69
L +++GD ++ L + V P+ + +TAL + G I L LL++GA N
Sbjct: 6 LSGAAARGDVQ-EVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNV 63
Query: 70 LDRWGRTPLSDARSFGHVVICKILEDRG 97
D G +P+ DA G + K+L + G
Sbjct: 64 QDTSGTSPVHDAARTGFLDTLKVLVEHG 91
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 76.3 bits (189), Expect = 5e-17
Identities = 21/66 (31%), Positives = 30/66 (45%), Gaps = 1/66 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+E G + N+ D +HLA EG +V L +D++ D G TPL A G
Sbjct: 88 VEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLA-AESDLHRRDARGLTPLELALQRGAQ 146
Query: 88 VICKIL 93
+ IL
Sbjct: 147 DLVDIL 152
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 61.3 bits (150), Expect = 1e-11
Identities = 16/56 (28%), Positives = 26/56 (46%), Gaps = 2/56 (3%)
Query: 43 TALHLASSEGRAEIV-LLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
L A++ G + V LL + ++L+R+G+T L FG I L +G
Sbjct: 4 DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVM-MFGSTAIALELLKQG 58
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156 | Back alignment and structure |
|---|
Score = 45.5 bits (109), Expect = 4e-06
Identities = 10/50 (20%), Positives = 20/50 (40%)
Query: 13 LYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLE 62
++ + + V+ L + + D T L LA G ++V +L
Sbjct: 105 IHLAVQEGHTAVVSFLAAESDLHRRDARGLTPLELALQRGAQDLVDILQG 154
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 4e-19
Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 1/86 (1%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L+ ++K + V + L E+ PN A + T LH+A +IV LLL +G +S
Sbjct: 150 LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPA 209
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
G TPL A V + + L G
Sbjct: 210 WNGYTPLHIAAKQNQVEVARSLLQYG 235
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 4e-19
Identities = 29/88 (32%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 12 LLYCSSKG--DRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNS 69
L + +G A VL ++ GV + T LH+AS G ++V LL+ ADVN+
Sbjct: 282 LHLVAQEGHVPVADVL--IKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNA 339
Query: 70 LDRWGRTPLSDARSFGHVVICKILEDRG 97
+ G +PL A GH I +L G
Sbjct: 340 KTKLGYSPLHQAAQQGHTDIVTLLLKNG 367
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 1e-18
Identities = 29/70 (41%), Positives = 38/70 (54%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
LE PNLA T LH+A+ EG E VL LLEK A + + G TPL A +G V
Sbjct: 100 LENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKV 159
Query: 88 VICKILEDRG 97
+ ++L +R
Sbjct: 160 RVAELLLERD 169
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 1e-18
Identities = 21/86 (24%), Positives = 41/86 (47%), Gaps = 1/86 (1%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L+ + + +++ L +G P+ ++ T LH+A+ + + E+ LL+ G N+
Sbjct: 183 LHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAES 242
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
G TPL A GH + +L +
Sbjct: 243 VQGVTPLHLAAQEGHAEMVALLLSKQ 268
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 4e-18
Identities = 21/70 (30%), Positives = 36/70 (51%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ + N + LH A+ +G +IV LLL+ GA N + G TPL+ A+ G++
Sbjct: 331 LQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYI 390
Query: 88 VICKILEDRG 97
+ +L+
Sbjct: 391 SVTDVLKVVT 400
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 4e-18
Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 1/86 (1%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L+ +S +++ L ++G PN+++ T LH+A+ G E+ LL+ A VN+
Sbjct: 18 LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKA 77
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
+ +TPL A GH + K+L +
Sbjct: 78 KDDQTPLHCAARIGHTNMVKLLLENN 103
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 5e-18
Identities = 24/70 (34%), Positives = 34/70 (48%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
LEK T LH+A+ G+ + LLLE+ A N+ + G TPL A ++
Sbjct: 133 LEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNL 192
Query: 88 VICKILEDRG 97
I K+L RG
Sbjct: 193 DIVKLLLPRG 202
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 82.5 bits (205), Expect = 1e-17
Identities = 24/70 (34%), Positives = 32/70 (45%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ + N D +T LH A+ G +V LLLE A+ N G TPL A GHV
Sbjct: 67 LQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHV 126
Query: 88 VICKILEDRG 97
L ++
Sbjct: 127 ETVLALLEKE 136
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 82.5 bits (205), Expect = 1e-17
Identities = 22/68 (32%), Positives = 28/68 (41%)
Query: 30 KGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVI 89
G+ T LH+AS G IV LL++GA N + TPL A GH +
Sbjct: 3 PGISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEV 62
Query: 90 CKILEDRG 97
K L
Sbjct: 63 AKYLLQNK 70
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 22/70 (31%), Positives = 34/70 (48%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L K NL + T LHL + EG + +L++ G V++ R G TPL A +G++
Sbjct: 265 LSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNI 324
Query: 88 VICKILEDRG 97
+ K L
Sbjct: 325 KLVKFLLQHQ 334
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 3e-17
Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 1/86 (1%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L+ ++K ++ V + L + G N T LHLA+ EG AE+V LLL K A+ N +
Sbjct: 216 LHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGN 275
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
+ G TPL GHV + +L G
Sbjct: 276 KSGLTPLHLVAQEGHVPVADVLIKHG 301
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437 | Back alignment and structure |
|---|
Score = 57.1 bits (139), Expect = 3e-09
Identities = 13/70 (18%), Positives = 28/70 (40%), Gaps = 4/70 (5%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLL---LEKGADVN 68
L+ +++ ++ L + G PN D T L +A G + +L ++ + V
Sbjct: 348 LHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVL 407
Query: 69 SLDRWGRTPL 78
D+ +
Sbjct: 408 VSDKHRMSFP 417
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 85.2 bits (212), Expect = 4e-19
Identities = 23/86 (26%), Positives = 36/86 (41%), Gaps = 1/86 (1%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
++ ++ L+ L +G N+ D + LH A G V +LL+ GA VN +
Sbjct: 63 MHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVT 122
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
TPL +A G +L G
Sbjct: 123 ADWHTPLFNACVSGSWDCVNLLLQHG 148
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 8e-17
Identities = 20/86 (23%), Positives = 33/86 (38%), Gaps = 2/86 (2%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
++ +++ + L G + T L+LA + V LLE GADVN
Sbjct: 161 IHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVNQ-G 219
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
+ +PL + +L D G
Sbjct: 220 KGQDSPLHAVVRTASEELACLLMDFG 245
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 77.1 bits (191), Expect = 3e-16
Identities = 17/70 (24%), Positives = 27/70 (38%), Gaps = 1/70 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ G + D + +H A+ G E V L+ G +++ TPL A
Sbjct: 145 LQHGASVQ-PESDLASPIHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQR 203
Query: 88 VICKILEDRG 97
K L + G
Sbjct: 204 ACVKKLLESG 213
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 1e-15
Identities = 17/70 (24%), Positives = 28/70 (40%), Gaps = 2/70 (2%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
LE G + N + + LH E+ LL++ GAD + + G+ P+ +
Sbjct: 210 LESGADVN-QGKGQDSPLHAVVRTASEELACLLMDFGADTQAKNAEGKRPVELVPPESPL 268
Query: 88 VICKILEDRG 97
LE G
Sbjct: 269 AQL-FLEREG 277
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 74.8 bits (185), Expect = 2e-15
Identities = 22/70 (31%), Positives = 30/70 (42%), Gaps = 1/70 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ G + N D T L A G + V LLL+ GA V + +P+ +A GHV
Sbjct: 112 LKHGAQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQP-ESDLASPIHEAARRGHV 170
Query: 88 VICKILEDRG 97
L G
Sbjct: 171 ECVNSLIAYG 180
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 72.9 bits (180), Expect = 8e-15
Identities = 19/78 (24%), Positives = 32/78 (41%), Gaps = 3/78 (3%)
Query: 20 DRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLS 79
D G+ L + + + +H A+ G + L+ +G VN + +PL
Sbjct: 41 DFPGIR-LLSNPLMGD--AVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLH 97
Query: 80 DARSFGHVVICKILEDRG 97
+A GH+ KIL G
Sbjct: 98 EACLGGHLSCVKILLKHG 115
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 51.3 bits (124), Expect = 1e-07
Identities = 7/41 (17%), Positives = 16/41 (39%), Gaps = 1/41 (2%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVN 68
++ G + + + + + L E L L +GA +
Sbjct: 242 MDFGADTQAKNAEGKRPVELVPPESP-LAQLFLEREGASLP 281
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285 | Back alignment and structure |
|---|
Score = 49.0 bits (118), Expect = 8e-07
Identities = 12/71 (16%), Positives = 28/71 (39%), Gaps = 4/71 (5%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIV-LLLLEKGADVNSLDRWGRTPLSDARSFGH 86
+ +G D K+ + + G + + LL +++ +P+ +A GH
Sbjct: 15 VPRGSHMASMD-GKQGGMDGSKPAGPRDFPGIRLLSNPLMGDAVS--DWSPMHEAAIHGH 71
Query: 87 VVICKILEDRG 97
+ + L +G
Sbjct: 72 QLSLRNLISQG 82
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 82.9 bits (206), Expect = 5e-19
Identities = 24/76 (31%), Positives = 39/76 (51%), Gaps = 5/76 (6%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+ +G N+ + T LHLA+S G +IV LL+ AD+N+++ G PL A +G
Sbjct: 59 IMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQD 118
Query: 88 VICKILEDRGGIDPGA 103
+ + L + GA
Sbjct: 119 QVAEDL-----VANGA 129
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 80.9 bits (201), Expect = 2e-18
Identities = 15/70 (21%), Positives = 32/70 (45%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ + N + LH A G+ ++ L+ GA V+ +++G P+ A++
Sbjct: 92 LQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAKAPLRE 151
Query: 88 VICKILEDRG 97
++ + E G
Sbjct: 152 LLRERAEKMG 161
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 77.1 bits (191), Expect = 6e-17
Identities = 24/67 (35%), Positives = 36/67 (53%), Gaps = 1/67 (1%)
Query: 28 LEKG-VEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
L+ + N D + LH A EGR+ +V +L+ +GA +N ++R TPL A S GH
Sbjct: 25 LDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGH 84
Query: 87 VVICKIL 93
I + L
Sbjct: 85 RDIVQKL 91
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 65.9 bits (162), Expect = 4e-13
Identities = 17/62 (27%), Positives = 25/62 (40%), Gaps = 1/62 (1%)
Query: 37 ADYDKRTALHLASSEGRAEIVLLLLEKGA-DVNSLDRWGRTPLSDARSFGHVVICKILED 95
+ + EG A V L L+ D+N D G +PL A G + ++L
Sbjct: 1 GSPEFMDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIM 60
Query: 96 RG 97
RG
Sbjct: 61 RG 62
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179 | Back alignment and structure |
|---|
Score = 63.2 bits (155), Expect = 4e-12
Identities = 9/59 (15%), Positives = 19/59 (32%), Gaps = 6/59 (10%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
+ G ++ + + A + R + + G ++N R P D G
Sbjct: 125 VANGALVSICNKYGEMPVDKAKAPLRELLRERAEKMGQNLN------RIPYKDTFWKGT 177
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 82.9 bits (206), Expect = 5e-19
Identities = 27/95 (28%), Positives = 42/95 (44%), Gaps = 2/95 (2%)
Query: 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK 63
+ SE + K D L +L + + + D + RTAL + G + V LL E
Sbjct: 40 VVSEYETPWWTAARKADEQ-ALSQLLEDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEA 98
Query: 64 GADVNSLD-RWGRTPLSDARSFGHVVICKILEDRG 97
GAD++ D R G T L A + + + L + G
Sbjct: 99 GADLDHRDMRGGLTALHMAAGYVRPEVVEALVELG 133
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 2e-18
Identities = 23/71 (32%), Positives = 30/71 (42%), Gaps = 1/71 (1%)
Query: 28 LEKGVEPNLAD-YDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
E G + + D TALH+A+ R E+V L+E GAD+ D G T L AR
Sbjct: 96 AEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILK 155
Query: 87 VVICKILEDRG 97
G
Sbjct: 156 TTPKGNPMQFG 166
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 59.0 bits (144), Expect = 1e-10
Identities = 9/59 (15%), Positives = 15/59 (25%), Gaps = 3/59 (5%)
Query: 35 NLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKIL 93
+ + + +G + + ADV S TP A L
Sbjct: 8 SRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVS---EYETPWWTAARKADEQALSQL 63
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183 | Back alignment and structure |
|---|
Score = 57.5 bits (140), Expect = 5e-10
Identities = 9/44 (20%), Positives = 16/44 (36%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
+E G + + D TAL LA + ++ G +
Sbjct: 130 VELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEK 173
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-19
Identities = 31/82 (37%), Positives = 46/82 (56%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
LL S +G+ V + + + +P+L + + TALH A G EIV L++ G +VN+ D
Sbjct: 41 LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 100
Query: 72 RWGRTPLSDARSFGHVVICKIL 93
G TPL A S +V +CK L
Sbjct: 101 SDGWTPLHCAASCNNVQVCKFL 122
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 19/86 (22%), Positives = 32/86 (37%), Gaps = 2/86 (2%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L + + E G+ + L +S EG ++V ++ + D + +
Sbjct: 9 LPPGKRTNLRKTGSERIAHGMRVK-FNPLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPN 67
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
G T L +A GH I K L G
Sbjct: 68 DEGITALHNAVCAGHTEIVKFLVQFG 93
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-14
Identities = 19/73 (26%), Positives = 30/73 (41%), Gaps = 3/73 (4%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSL---DRWGRTPLSDARSF 84
++ GV N AD D T LH A+S ++ L+E GA V ++ D +
Sbjct: 90 VQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEE 149
Query: 85 GHVVICKILEDRG 97
G+ + L
Sbjct: 150 GYTQCSQFLYGVQ 162
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 2e-10
Identities = 6/60 (10%), Positives = 16/60 (26%), Gaps = 1/60 (1%)
Query: 38 DYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
+ + +L + + G V + L D+ G + + +
Sbjct: 2 EITGQVSLPPGKRTNLRKTGSERIAHGMRVKF-NPLPLALLLDSSLEGEFDLVQRIIYEV 60
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 8/57 (14%), Positives = 15/57 (26%), Gaps = 3/57 (5%)
Query: 28 LEKGVEPN---LADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81
+E G +D EG + L + +++ L D
Sbjct: 123 VESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKMGIMNKGVIYALWDY 179
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 8/61 (13%), Positives = 17/61 (27%), Gaps = 5/61 (8%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDR--WGRTPLSDARSFG 85
+ + + AL + E L +++G + + R AR
Sbjct: 159 YGVQEKMGIMNKGVIYALWDYEPQNDDE---LPMKEGDCMTIIHREDEDEIEWWWARLND 215
Query: 86 H 86
Sbjct: 216 K 216
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 84.0 bits (209), Expect = 5e-19
Identities = 26/88 (29%), Positives = 43/88 (48%), Gaps = 2/88 (2%)
Query: 12 LLYCSSKGDRAGVLQEL-EKGVEPNLAD-YDKRTALHLASSEGRAEIVLLLLEKGADVNS 69
L++ + + + L V NL D Y K TALH A G ++ LLLE GA+V++
Sbjct: 146 LMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDA 205
Query: 70 LDRWGRTPLSDARSFGHVVICKILEDRG 97
+ G + L A+ +V + L++
Sbjct: 206 QNIKGESALDLAKQRKNVWMINHLQEAR 233
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 1e-17
Identities = 24/87 (27%), Positives = 38/87 (43%), Gaps = 2/87 (2%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
+ +++ +EL E G + D + T LH A+ R ++V + KGA V+ L
Sbjct: 13 IVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLG 72
Query: 72 R-WGRTPLSDARSFGHVVICKILEDRG 97
TPL A GH+ + L G
Sbjct: 73 GDLNSTPLHWATRQGHLSMVVQLMKYG 99
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 78.6 bits (195), Expect = 5e-17
Identities = 24/71 (33%), Positives = 38/71 (53%), Gaps = 1/71 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
++ G +P+L D + + +HLA+ G IV L+ KG DV+ +D+ G TPL A H
Sbjct: 96 MKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHS 155
Query: 88 V-ICKILEDRG 97
V ++L
Sbjct: 156 VDPTRLLLTFN 166
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 75.5 bits (187), Expect = 6e-16
Identities = 22/71 (30%), Positives = 35/71 (49%), Gaps = 1/71 (1%)
Query: 28 LEKGVEPNLADYDK-RTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
+ KG + D T LH A+ +G +V+ L++ GAD + +D G + + A FGH
Sbjct: 62 ISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGH 121
Query: 87 VVICKILEDRG 97
I L +G
Sbjct: 122 TSIVAYLIAKG 132
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 71.7 bits (177), Expect = 1e-14
Identities = 15/63 (23%), Positives = 22/63 (34%)
Query: 35 NLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILE 94
D + A+ G E L+E G DV D+ T L A + + K
Sbjct: 3 THIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYI 62
Query: 95 DRG 97
+G
Sbjct: 63 SKG 65
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240 | Back alignment and structure |
|---|
Score = 51.7 bits (125), Expect = 8e-08
Identities = 9/41 (21%), Positives = 14/41 (34%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVN 68
LE G + + +AL LA ++ L E
Sbjct: 197 LEAGANVDAQNIKGESALDLAKQRKNVWMINHLQEARQAKG 237
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 6e-19
Identities = 30/86 (34%), Positives = 46/86 (53%), Gaps = 1/86 (1%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L+ ++ +R ++Q L + G + + D LH A S G E+ LLL+ GA VN++D
Sbjct: 62 LHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMD 121
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
W TPL +A S V +C +L G
Sbjct: 122 LWQFTPLHEAASKNRVEVCSLLLSHG 147
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 12 LLYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSL 70
LL + G+ ++ L V + +D K T LHLA+ R IV LLL+ GADV++
Sbjct: 28 LLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAK 87
Query: 71 DRWGRTPLSDARSFGHVVICKILEDRGGIDPGA 103
D+ G PL +A S+GH + ++L + GA
Sbjct: 88 DKGGLVPLHNACSYGHYEVTELL-----LKHGA 115
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 24/70 (34%), Positives = 38/70 (54%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L KG N + D T LH+A+ +++ +L + GA +N+LD G+T L A GH+
Sbjct: 234 LRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTALHRAALAGHL 293
Query: 88 VICKILEDRG 97
C++L G
Sbjct: 294 QTCRLLLSYG 303
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 1e-16
Identities = 19/70 (27%), Positives = 30/70 (42%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ G N D + T LH A+S+ R E+ LLL GAD ++ G++ + A +
Sbjct: 111 LKHGACVNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELR 170
Query: 88 VICKILEDRG 97
Sbjct: 171 ERLTYEFKGH 180
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 77.5 bits (192), Expect = 5e-16
Identities = 27/89 (30%), Positives = 40/89 (44%), Gaps = 3/89 (3%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEG---RAEIVLLLLEKGADVN 68
LL + + D A V + L + TALH A + R ++ LLL KGA+VN
Sbjct: 182 LLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVN 241
Query: 69 SLDRWGRTPLSDARSFGHVVICKILEDRG 97
++ TPL A H + ++L G
Sbjct: 242 EKNKDFMTPLHVAAERAHNDVMEVLHKHG 270
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 9e-14
Identities = 16/71 (22%), Positives = 29/71 (40%), Gaps = 1/71 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEG-RAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
+ + L K+ L A+ G +++ LL + ++ D TPL A +
Sbjct: 11 ADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNR 70
Query: 87 VVICKILEDRG 97
V I ++L G
Sbjct: 71 VRIVQLLLQHG 81
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 3e-13
Identities = 16/54 (29%), Positives = 24/54 (44%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81
+ G + N D +TALH A+ G + LLL G+D + + G T
Sbjct: 267 HKHGAKMNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMG 320
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 59.4 bits (145), Expect = 4e-10
Identities = 17/110 (15%), Positives = 35/110 (31%), Gaps = 25/110 (22%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLL------------ 59
L+ ++ +R V L G +P L + ++A+ +A + E +
Sbjct: 128 LHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFKGHSLLQAAR 187
Query: 60 ---------LLEKGADVNSLDRWGRTPLSDARSFGHVV---ICKILEDRG 97
L + T L A + H + ++L +G
Sbjct: 188 EADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKG 237
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 8e-08
Identities = 10/49 (20%), Positives = 18/49 (36%), Gaps = 5/49 (10%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRT 76
L G +P++ TA + E V +L + + + D R
Sbjct: 300 LSYGSDPSIISLQGFTAAQMG-----NEAVQQILSESTPMRTSDVDYRL 343
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351 | Back alignment and structure |
|---|
Score = 42.1 bits (100), Expect = 2e-04
Identities = 8/44 (18%), Positives = 15/44 (34%), Gaps = 1/44 (2%)
Query: 55 EIVLLLLEKGADVNSLDRWGRTPLSD-ARSFGHVVICKILEDRG 97
+ L L + A + + L + ARS + +L
Sbjct: 5 KSALDLADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLN 48
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-19
Identities = 73/293 (24%), Positives = 114/293 (38%), Gaps = 62/293 (21%)
Query: 102 GAYGEVYLV--KWRGTEIAAKTIR--SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
GAYG V K G +A K I R ++E+ + + +H NI+ +
Sbjct: 22 GAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT----LREIKILKHFKHENIITIFNI 77
Query: 158 LKHSERLIF-----LTEYLRNGSLHDILKKKGKLDPPTAVAYAL-DIARGMNYLHHHRPH 211
+ F + E + LH ++ + L + Y + R + LH
Sbjct: 78 QRPDSFENFNEVYIIQELM-QTDLHRVISTQ-MLSD-DHIQYFIYQTLRAVKVLHGSN-- 132
Query: 212 AIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGS---------YRYM 262
+IHRDL PSN+L + LKV DFGL++I E + + + TG YR
Sbjct: 133 -VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR-- 189
Query: 263 APEV-YRRESYGKSVDVFSFALIVHEMFQ---------------------GGPSNRAD-T 299
APEV Y +++DV+S I+ E+F G P + D
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249
Query: 300 AVQVADRRAYEDSRP-----ALSSLYPE-PIKA--LLRECWHKNPDRRPTFEE 344
++ R Y S P L ++P K LL+ +P +R T +E
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKE 302
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 79.7 bits (198), Expect = 1e-18
Identities = 34/70 (48%), Positives = 42/70 (60%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L KG + N D T LHLA+ G AEIV LLL KGADVN+ + G TP A+ GH
Sbjct: 29 LSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGHH 88
Query: 88 VICKILEDRG 97
I K+L+ +G
Sbjct: 89 EIVKLLDAKG 98
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 75.1 bits (186), Expect = 5e-17
Identities = 29/69 (42%), Positives = 34/69 (49%), Gaps = 5/69 (7%)
Query: 35 NLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILE 94
D T LH A+ G AE V LL KGADVN+ + G TPL A GH I K+L
Sbjct: 3 MWGSKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLL- 61
Query: 95 DRGGIDPGA 103
+ GA
Sbjct: 62 ----LAKGA 66
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115 | Back alignment and structure |
|---|
Score = 68.6 bits (169), Expect = 1e-14
Identities = 21/51 (41%), Positives = 23/51 (45%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPL 78
L KG + N D T HLA G EIV LL KGADVN+
Sbjct: 62 LAKGADVNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADVNARSWGSSHHH 112
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 46/231 (19%), Positives = 90/231 (38%), Gaps = 37/231 (16%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G+YG V + +A K I + + ++E+ + +L H ++V+ L ++
Sbjct: 64 GSYGHVCEAYDKLEKRVVAIKKILR-VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122
Query: 160 HSERLIF-----LTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ F + E + + + L ++ G+ Y+H I+
Sbjct: 123 PKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---IL 178
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYR-------------- 260
HRDL P+N L ++ +KV DFGL++ ++ + ++
Sbjct: 179 HRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238
Query: 261 ----------YMAPEV-YRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA 300
Y APE+ +E+Y +++DV+S I E+ N A A
Sbjct: 239 QLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 80.9 bits (201), Expect = 1e-18
Identities = 24/76 (31%), Positives = 34/76 (44%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L +G P+L D +H A+ G + + LLE ADVN D G PL A GH+
Sbjct: 57 LLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHL 116
Query: 88 VICKILEDRGGIDPGA 103
+ + L + G
Sbjct: 117 RVVEFLVKHTASNVGH 132
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 73.2 bits (181), Expect = 8e-16
Identities = 21/66 (31%), Positives = 30/66 (45%), Gaps = 1/66 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ V N + RTAL + G EI LL +GA+ + DR G + DA G +
Sbjct: 25 LQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFL 83
Query: 88 VICKIL 93
+ L
Sbjct: 84 DTLQTL 89
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 73.2 bits (181), Expect = 8e-16
Identities = 20/71 (28%), Positives = 34/71 (47%), Gaps = 1/71 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGA-DVNSLDRWGRTPLSDARSFGH 86
LE + N+ D + LHLA+ EG +V L++ A +V + G T AR +G
Sbjct: 90 LEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGR 149
Query: 87 VVICKILEDRG 97
+ +++ G
Sbjct: 150 NEVVSLMQANG 160
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 66.6 bits (164), Expect = 2e-13
Identities = 18/62 (29%), Positives = 30/62 (48%), Gaps = 2/62 (3%)
Query: 36 LADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILED 95
+A+ L A++ G E + LL+ +VN+ + +GRT L G+ I + L
Sbjct: 1 MAE-PWGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVM-KLGNPEIARRLLL 58
Query: 96 RG 97
RG
Sbjct: 59 RG 60
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162 | Back alignment and structure |
|---|
Score = 45.8 bits (110), Expect = 3e-06
Identities = 11/39 (28%), Positives = 17/39 (43%), Gaps = 1/39 (2%)
Query: 28 LEKG-VEPNLADYDKRTALHLASSEGRAEIVLLLLEKGA 65
++ ++ TA LA GR E+V L+ GA
Sbjct: 123 VKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANGA 161
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-18
Identities = 27/95 (28%), Positives = 42/95 (44%), Gaps = 2/95 (2%)
Query: 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK 63
+ SE + K D L +L + + + D + RTAL + G + V LL E
Sbjct: 41 VVSEYETPWWTAARKADEQ-ALSQLLEDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEA 99
Query: 64 GADVNSLD-RWGRTPLSDARSFGHVVICKILEDRG 97
GAD++ D R G T L A + + + L + G
Sbjct: 100 GADLDHRDMRGGLTALHMAAGYVRPEVVEALVELG 134
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-18
Identities = 23/71 (32%), Positives = 30/71 (42%), Gaps = 1/71 (1%)
Query: 28 LEKGVEPNLAD-YDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
E G + + D TALH+A+ R E+V L+E GAD+ D G T L AR
Sbjct: 97 AEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILK 156
Query: 87 VVICKILEDRG 97
G
Sbjct: 157 TTPKGNPMQFG 167
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 19/94 (20%), Positives = 37/94 (39%), Gaps = 12/94 (12%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+E G + + D TAL LA + ++ G + + + + F +
Sbjct: 131 VELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEK---VINVLEGQVFEYA 187
Query: 88 VICKILEDRGGIDPGAYGEV--YLVKWRG-TEIA 118
+ +I+E RG G+ YLV+W+ +
Sbjct: 188 EVDEIVEKRG------KGKDVEYLVRWKDGGDCE 215
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 9e-10
Identities = 9/59 (15%), Positives = 15/59 (25%), Gaps = 3/59 (5%)
Query: 35 NLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKIL 93
+ + + +G + + ADV S TP A L
Sbjct: 9 SRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVS---EYETPWWTAARKADEQALSQL 64
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 1e-05
Identities = 7/61 (11%), Positives = 17/61 (27%), Gaps = 2/61 (3%)
Query: 27 ELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
E + E + +L + + + A+ + D L A +
Sbjct: 185 EYAEVDEIVEKRGKGKDVEYLVRWKDGGDCEWVKGVHVAEDVAKD--YEDGLEYAVAESV 242
Query: 87 V 87
+
Sbjct: 243 I 243
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 62/291 (21%), Positives = 109/291 (37%), Gaps = 58/291 (19%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIR-SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL 158
G G V+ +A K I + S ++E+ + ++L H NIV+ +L
Sbjct: 22 GGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA----LREIKIIRRLDHDNIVKVFEIL 77
Query: 159 KHSERLIFLTEYLRNGS-------------LHDILKKKGKLDPPTAVAYALDIARGMNYL 205
S + L ++L++ G L A + + RG+ Y+
Sbjct: 78 GPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYI 136
Query: 206 HHHRPHAIIHRDLTPSNVLQDEAG-HLKVTDFGLSKIAQEKDSYSYKMTG--GTGSYRYM 262
H ++HRDL P+N+ + LK+ DFGL++I S+ ++ T YR
Sbjct: 137 HSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR-- 191
Query: 263 APEV-YRRESYGKSVDVFSFALIVHEM------FQG--------------GPSNRADTAV 301
+P + +Y K++D+++ I EM F G + D
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQE 251
Query: 302 QVADRRAYEDSRPA-----LSSLYPE-PIKA--LLRECWHKNPDRRPTFEE 344
++ Y + L+ L P +A L + +P R T EE
Sbjct: 252 LLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE 302
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-18
Identities = 23/87 (26%), Positives = 39/87 (44%), Gaps = 2/87 (2%)
Query: 13 LYCSSKGDRAGVLQEL--EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSL 70
LY + G +++ L + +E N + TALH A+ +G A+IV LLL KGA +
Sbjct: 110 LYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGARTDLR 169
Query: 71 DRWGRTPLSDARSFGHVVICKILEDRG 97
+ + A + + K +
Sbjct: 170 NIEKKLAFDMATNAACASLLKKKQGTD 196
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 22/89 (24%), Positives = 31/89 (34%), Gaps = 5/89 (5%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
+SKG L LH A+ G + L+ VN LD
Sbjct: 49 WWKGTSKGR-----TGLIPSNYVAEQAESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLD 103
Query: 72 RWGRTPLSDARSFGHVVICKILEDRGGID 100
+ G T L A GH I ++L + I+
Sbjct: 104 KAGSTALYWACHGGHKDIVEMLFTQPNIE 132
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-15
Identities = 11/60 (18%), Positives = 22/60 (36%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L KG +L + +K+ A +A++ A ++ A + D+ H
Sbjct: 160 LAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSNAEDYLDDEDSDLEHHH 219
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 8e-12
Identities = 7/58 (12%), Positives = 13/58 (22%)
Query: 34 PNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICK 91
P + + A L + D+ + T S G +
Sbjct: 5 PPKPVKPGQVKVFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLIP 62
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 10/86 (11%), Positives = 23/86 (26%), Gaps = 5/86 (5%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
+ + + + + T +S+GR ++ V
Sbjct: 16 VFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLI-----PSNYVAEQA 70
Query: 72 RWGRTPLSDARSFGHVVICKILEDRG 97
PL +A G++ + D
Sbjct: 71 ESIDNPLHEAAKRGNLSWLRECLDNR 96
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 81.7 bits (203), Expect = 3e-18
Identities = 18/75 (24%), Positives = 32/75 (42%), Gaps = 1/75 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L + + + + LH+A+ E R + V+L L + +DV ++ G TPL A V
Sbjct: 164 LAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASLNSQV 223
Query: 88 VICKILEDRGGIDPG 102
+ + D
Sbjct: 224 WSALQM-SKALQDSA 237
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 80.5 bits (200), Expect = 8e-18
Identities = 22/73 (30%), Positives = 33/73 (45%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
++ G + D+RT L A+ E V L++ GA V+ D G T L A GH
Sbjct: 31 VQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHY 90
Query: 88 VICKILEDRGGID 100
+ + L G +D
Sbjct: 91 EVVQYLLSNGQMD 103
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 78.6 bits (195), Expect = 4e-17
Identities = 18/70 (25%), Positives = 32/70 (45%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L KG + N+ D ++ LH A+ G +I +LL D+++++ G +PL A
Sbjct: 131 LSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAARENRY 190
Query: 88 VICKILEDRG 97
+ R
Sbjct: 191 DCVVLFLSRD 200
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 75.9 bits (188), Expect = 4e-16
Identities = 19/66 (28%), Positives = 34/66 (51%)
Query: 32 VEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICK 91
+ + +KR+ LH A+ G +I +L++ GA++++ RTPL +A H+ K
Sbjct: 2 MNFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVK 61
Query: 92 ILEDRG 97
L G
Sbjct: 62 YLIKAG 67
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 74.8 bits (185), Expect = 1e-15
Identities = 22/71 (30%), Positives = 31/71 (43%), Gaps = 1/71 (1%)
Query: 28 LEKG-VEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
L G ++ N D T + A+ ++V LLL KG+D+N D L A G
Sbjct: 97 LSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGC 156
Query: 87 VVICKILEDRG 97
V I +IL
Sbjct: 157 VDIAEILLAAK 167
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237 | Back alignment and structure |
|---|
Score = 70.5 bits (174), Expect = 3e-14
Identities = 26/71 (36%), Positives = 38/71 (53%), Gaps = 1/71 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGA-DVNSLDRWGRTPLSDARSFGH 86
++ G + D + T LHLA+ +G E+V LL G DVN D G TP+ A + H
Sbjct: 64 IKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKH 123
Query: 87 VVICKILEDRG 97
V + K+L +G
Sbjct: 124 VDLVKLLLSKG 134
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 79.7 bits (198), Expect = 3e-18
Identities = 28/70 (40%), Positives = 37/70 (52%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L GV + RT LH+A+SEG A IV +LL+ GADVN+ D T L A H
Sbjct: 54 LRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQ 113
Query: 88 VICKILEDRG 97
+ ++L G
Sbjct: 114 EVVELLIKYG 123
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 78.6 bits (195), Expect = 7e-18
Identities = 22/67 (32%), Positives = 38/67 (56%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ G + N D K TALH A+ E+V LL++ GADV++ ++ +T + G+
Sbjct: 87 LKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNE 146
Query: 88 VICKILE 94
+ +IL+
Sbjct: 147 DLAEILQ 153
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 72.8 bits (180), Expect = 8e-16
Identities = 21/70 (30%), Positives = 31/70 (44%), Gaps = 1/70 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+ G D+ + LHLA+ G +LL G ++ + RTPL A S GH
Sbjct: 22 MANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHA 80
Query: 88 VICKILEDRG 97
I ++L G
Sbjct: 81 NIVEVLLKHG 90
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153 | Back alignment and structure |
|---|
Score = 62.0 bits (152), Expect = 5e-12
Identities = 17/58 (29%), Positives = 27/58 (46%), Gaps = 1/58 (1%)
Query: 40 DKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
D L A+ G+ + V +L+ GA + D G +PL A +GH ++L G
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPFTT-DWLGTSPLHLAAQYGHFSTTEVLLRAG 57
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-18
Identities = 14/77 (18%), Positives = 26/77 (33%), Gaps = 7/77 (9%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIV-------LLLLEKGADVNSLDRWGRTPLSD 80
LEKG + + + + L+ + G + D+WG T L
Sbjct: 101 LEKGADITALYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEF 160
Query: 81 ARSFGHVVICKILEDRG 97
+ + K++ED
Sbjct: 161 VKRCQKPIALKMMEDYI 177
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-17
Identities = 24/96 (25%), Positives = 37/96 (38%), Gaps = 11/96 (11%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLA----SSEGRAEIVLLLLEKGADV 67
+ + G L+ EKG E K L+ + E R +I + L+ KGAD+
Sbjct: 10 VSAAAMLGTYEDFLELFEKGYEDK-ESVLKSNILYDVLRNNNDEARYKISMFLINKGADI 68
Query: 68 NSLDRWGRTPLSDARSFGH------VVICKILEDRG 97
S + G T G +CKI ++G
Sbjct: 69 KSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKG 104
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-16
Identities = 15/85 (17%), Positives = 30/85 (35%), Gaps = 12/85 (14%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGR------AEIVLLLLEKGADVNSLDRWGRTPLSDA 81
+ KG + + T G E+ + LEKGAD+ +L + + +
Sbjct: 62 INKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFKN 121
Query: 82 RSFGHV------VICKILEDRGGID 100
V + K++ + G+
Sbjct: 122 IFNYFVDENEMIPLYKLIFSQSGLQ 146
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-10
Identities = 6/44 (13%), Positives = 16/44 (36%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
+ G++ + D TAL + + ++ + N +
Sbjct: 141 SQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKKYNLKE 184
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 12/62 (19%), Positives = 19/62 (30%), Gaps = 3/62 (4%)
Query: 39 YDKRTALHLASSEGRAEIVLLLLEKGADVNSL---DRWGRTPLSDARSFGHVVICKILED 95
+ + A+ G E L L EKG + L + I L +
Sbjct: 4 MSEYRTVSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFLIN 63
Query: 96 RG 97
+G
Sbjct: 64 KG 65
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 79.3 bits (197), Expect = 6e-18
Identities = 31/70 (44%), Positives = 41/70 (58%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+ G + N D T LHLA+ G EIV +LL+ GADVN++D G TPL A FGH+
Sbjct: 34 MANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHL 93
Query: 88 VICKILEDRG 97
I ++L G
Sbjct: 94 EIVEVLLKNG 103
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 78.6 bits (195), Expect = 1e-17
Identities = 31/70 (44%), Positives = 41/70 (58%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ G + N D+ T L LA+ G EIV +LL+ GADVN+ D G TPL A FGH+
Sbjct: 67 LKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHL 126
Query: 88 VICKILEDRG 97
I ++L G
Sbjct: 127 EIVEVLLKNG 136
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 77.4 bits (192), Expect = 3e-17
Identities = 26/66 (39%), Positives = 40/66 (60%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ G + N D + T LHLA+ G EIV +LL+ GADVN+ D++G+T + G+
Sbjct: 100 LKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKFGKTAFDISIDNGNE 159
Query: 88 VICKIL 93
+ +IL
Sbjct: 160 DLAEIL 165
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 70.5 bits (174), Expect = 8e-15
Identities = 24/69 (34%), Positives = 34/69 (49%), Gaps = 1/69 (1%)
Query: 30 KGVEPNLA-DYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVV 88
+G + D L A+ GR + V +L+ GADVN+ D G TPL A GH+
Sbjct: 2 RGSHHHHHHGSDLGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLE 61
Query: 89 ICKILEDRG 97
I ++L G
Sbjct: 62 IVEVLLKNG 70
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169 | Back alignment and structure |
|---|
Score = 44.7 bits (107), Expect = 9e-06
Identities = 8/36 (22%), Positives = 17/36 (47%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK 63
L+ G + N D +TA ++ G ++ +L +
Sbjct: 133 LKNGADVNAQDKFGKTAFDISIDNGNEDLAEILQKL 168
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 81.7 bits (203), Expect = 8e-18
Identities = 26/70 (37%), Positives = 35/70 (50%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L G +P L + T LA+ G +++ L L KGADVN D +G T +A +G V
Sbjct: 59 LRHGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKV 118
Query: 88 VICKILEDRG 97
K L RG
Sbjct: 119 KALKFLYKRG 128
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 77.5 bits (192), Expect = 3e-16
Identities = 29/87 (33%), Positives = 36/87 (41%), Gaps = 1/87 (1%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLAD-YDKRTALHLASSEGRAEIVLLLLEKGADVNSL 70
L+ D V Q LE G N + T LH A R +IV LLL GAD
Sbjct: 9 LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLR 68
Query: 71 DRWGRTPLSDARSFGHVVICKILEDRG 97
+ G TP A G V + K+ +G
Sbjct: 69 KKNGATPFLLAAIAGSVKLLKLFLSKG 95
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 76.7 bits (190), Expect = 4e-16
Identities = 21/71 (29%), Positives = 33/71 (46%), Gaps = 1/71 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK-GADVNSLDRWGRTPLSDARSFGH 86
L+ G + N+ +T L LA + +V LLE+ ++N D G+T L A
Sbjct: 206 LDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKL 265
Query: 87 VVICKILEDRG 97
I ++L RG
Sbjct: 266 KKIAELLCKRG 276
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 8e-16
Identities = 28/83 (33%), Positives = 39/83 (46%), Gaps = 10/83 (12%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD----------RWGRTP 77
L KG + N D+ TA A+ G+ + + L ++GA+VN + G T
Sbjct: 92 LSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGATA 151
Query: 78 LSDARSFGHVVICKILEDRGGID 100
L DA GHV + KIL D G D
Sbjct: 152 LMDAAEKGHVEVLKILLDEMGAD 174
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 74.4 bits (184), Expect = 2e-15
Identities = 25/76 (32%), Positives = 34/76 (44%), Gaps = 4/76 (5%)
Query: 29 EKGVEPNLADYDKRTALHLASSEGR----AEIVLLLLEKGADVNSLDRWGRTPLSDARSF 84
E G + N D R AL A I LLL+ GADVN G+TPL A
Sbjct: 170 EMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEK 229
Query: 85 GHVVICKILEDRGGID 100
H+ + + L ++ I+
Sbjct: 230 KHLGLVQRLLEQEHIE 245
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 67.9 bits (167), Expect = 4e-13
Identities = 19/62 (30%), Positives = 27/62 (43%), Gaps = 1/62 (1%)
Query: 37 ADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDR-WGRTPLSDARSFGHVVICKILED 95
A + L A ++V LLE GA+VN + G TPL +A I ++L
Sbjct: 1 AAVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLR 60
Query: 96 RG 97
G
Sbjct: 61 HG 62
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 65.2 bits (160), Expect = 4e-12
Identities = 22/76 (28%), Positives = 32/76 (42%), Gaps = 3/76 (3%)
Query: 17 SKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIV-LLLLEKGADVNSLDRWGR 75
+G A V + + TAL A+ +G E++ +LL E GADVN+ D GR
Sbjct: 126 KRG--ANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGR 183
Query: 76 TPLSDARSFGHVVICK 91
L A +
Sbjct: 184 NALIHALLSSDDSDVE 199
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285 | Back alignment and structure |
|---|
Score = 59.4 bits (145), Expect = 3e-10
Identities = 19/61 (31%), Positives = 31/61 (50%), Gaps = 2/61 (3%)
Query: 13 LYCSSKGDRAGVLQEL--EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSL 70
L + + G++Q L ++ +E N D D +TAL LA +I LL ++GA +
Sbjct: 223 LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG 282
Query: 71 D 71
D
Sbjct: 283 D 283
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 78.6 bits (195), Expect = 9e-18
Identities = 26/66 (39%), Positives = 35/66 (53%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ G + + D LH A S G E+ LL++ GA VN D W TPL +A + G
Sbjct: 62 LQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKY 121
Query: 88 VICKIL 93
ICK+L
Sbjct: 122 EICKLL 127
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 74.3 bits (184), Expect = 3e-16
Identities = 32/105 (30%), Positives = 54/105 (51%), Gaps = 8/105 (7%)
Query: 1 GQIIDSEGPYRLLYCSSKGDRAGVLQEL--EKGVEPNLADYDKRTALHLASSEGRAEIVL 58
G + +SE +LL + GD +++L + V + + T LH A+ R +V
Sbjct: 1 GAMGNSEADRQLLEAAKAGDVE-TVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVE 59
Query: 59 LLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGGIDPGA 103
LL+ GADV++ D+ G PL +A S+GH + ++L + GA
Sbjct: 60 YLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELL-----VKHGA 99
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 72.8 bits (180), Expect = 1e-15
Identities = 26/66 (39%), Positives = 37/66 (56%), Gaps = 1/66 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
++ G N+AD K T LH A+++G+ EI LLL+ GAD +R G TPL + G
Sbjct: 95 VKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLVKD-GDT 153
Query: 88 VICKIL 93
I +L
Sbjct: 154 DIQDLL 159
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165 | Back alignment and structure |
|---|
Score = 42.8 bits (102), Expect = 3e-05
Identities = 12/38 (31%), Positives = 17/38 (44%), Gaps = 1/38 (2%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGA 65
L+ G +P + D T L L +G +I LL A
Sbjct: 128 LQHGADPTKKNRDGNTPLDLVK-DGDTDIQDLLRGDAA 164
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 23/71 (32%), Positives = 35/71 (49%), Gaps = 1/71 (1%)
Query: 28 LEKGVEPNLADYDK-RTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
+ G + N + RT LHLA A ++ LLL+ GAD + GRTPL A +
Sbjct: 178 RDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPN 237
Query: 87 VVICKILEDRG 97
++ ++L G
Sbjct: 238 PILARLLRAHG 248
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-17
Identities = 23/87 (26%), Positives = 39/87 (44%), Gaps = 1/87 (1%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
+ + ++ + ++ +YD T LH+A AE+V LL + GAD+N +
Sbjct: 129 AVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPE 188
Query: 72 R-WGRTPLSDARSFGHVVICKILEDRG 97
GRTPL A + ++L G
Sbjct: 189 PTCGRTPLHLAVEAQAASVLELLLKAG 215
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 21/69 (30%), Positives = 28/69 (40%), Gaps = 5/69 (7%)
Query: 35 NLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILE 94
+L + +TALHLA+ G A V L GA V +R G T L A +L
Sbjct: 39 DLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVL- 97
Query: 95 DRGGIDPGA 103
+ P
Sbjct: 98 ----LQPRP 102
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 5e-16
Identities = 15/59 (25%), Positives = 20/59 (33%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
L+ G +P Y RT L A + LL GA +P S + S
Sbjct: 212 LKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSSSGSDSD 270
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 1e-11
Identities = 17/66 (25%), Positives = 23/66 (34%), Gaps = 3/66 (4%)
Query: 35 NLADYDKRTALHLASSEGRAEIVLLLLEKGAD---VNSLDRWGRTPLSDARSFGHVVICK 91
D TALHLA + LL A ++ + G+T L A G +
Sbjct: 3 GYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVE 62
Query: 92 ILEDRG 97
L G
Sbjct: 63 KLYAAG 68
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 13/84 (15%), Positives = 19/84 (22%), Gaps = 14/84 (16%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSD------- 80
G +A+ TALHLA +LL+ S
Sbjct: 65 YAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTS 124
Query: 81 -------ARSFGHVVICKILEDRG 97
++ ED
Sbjct: 125 HAPAAVDSQPNPENEEEPRDEDWR 148
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 2e-09
Identities = 10/66 (15%), Positives = 19/66 (28%), Gaps = 1/66 (1%)
Query: 33 EPNLADYDKRTALHLASSE-GRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICK 91
+ + S E + + + + G TPL A + +
Sbjct: 116 SQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLHVAVIHKDAEMVR 175
Query: 92 ILEDRG 97
+L D G
Sbjct: 176 LLRDAG 181
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 6e-05
Identities = 5/37 (13%), Positives = 10/37 (27%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKG 64
G DK + + S+ ++ E
Sbjct: 245 RAHGAPEPEDGGDKLSPCSSSGSDSDSDNRDEGDEYD 281
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-17
Identities = 34/149 (22%), Positives = 53/149 (35%), Gaps = 5/149 (3%)
Query: 12 LLYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSL 70
+ + G + + + D D RTALH A S G EIV LL+ G VN
Sbjct: 10 ICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 69
Query: 71 DRWGRTPLSDARSFGHVVICKILEDRGG----IDPGAYGEVYLVKWRGTEIAAKTIRSSI 126
D G +PL A S G I K L +G ++ ++ + A +
Sbjct: 70 DDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGG 129
Query: 127 ASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
A+ + + + +V L
Sbjct: 130 ANPDAKDHYDATAMHRAAAKGNLKMVHIL 158
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 1e-11
Identities = 16/58 (27%), Positives = 22/58 (37%)
Query: 40 DKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
+LA S E+ +L + D+ RT L A S GH I + L G
Sbjct: 6 SNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLG 63
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 30/94 (31%), Positives = 43/94 (45%)
Query: 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKG 64
+ G L Y +SK + LE G P+ D+ TA+H A+++G ++V +LL
Sbjct: 103 NQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYK 162
Query: 65 ADVNSLDRWGRTPLSDARSFGHVVICKILEDRGG 98
A N D G TPL A V K L +G
Sbjct: 163 ASTNIQDTEGNTPLHLACDEERVEEAKFLVTQGA 196
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 5e-11
Identities = 33/148 (22%), Positives = 60/148 (40%), Gaps = 6/148 (4%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L +S G V L KG N + + T LH A+S+ R EI ++LLE GA+ ++ D
Sbjct: 77 LHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKD 136
Query: 72 RWGRTPLSDARSFGHVVICKILEDRGG----IDPGAYGEVYLVKWRGTEIAAKTIRSSIA 127
+ T + A + G++ + IL D ++L AK + +
Sbjct: 137 HYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQ-G 195
Query: 128 SNPRVRNSFMKELGLWQKLRHPNIVQFL 155
++ + N ++ L ++
Sbjct: 196 ASIYIENKE-EKTPLQVAKGGLGLILKR 222
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 7e-10
Identities = 23/89 (25%), Positives = 38/89 (42%), Gaps = 2/89 (2%)
Query: 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKG 64
D + ++KG+ V L N+ D + T LHLA E R E L+ +G
Sbjct: 136 DHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQG 195
Query: 65 ADVNSLDRWGRTPLSDARSFGHVVICKIL 93
A + ++ +TPL A+ G + +
Sbjct: 196 ASIYIENKEEKTPLQVAK--GGLGLILKR 222
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 12/64 (18%), Positives = 27/64 (42%), Gaps = 2/64 (3%)
Query: 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKG 64
D+EG L + + +G + + +++T L +A G ++L L +G
Sbjct: 169 DTEGNTPLHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAK--GGLGLILKRLAEG 226
Query: 65 ADVN 68
+ +
Sbjct: 227 EEAS 230
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 79.8 bits (198), Expect = 2e-17
Identities = 19/71 (26%), Positives = 33/71 (46%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ G ++ + + T L LA+ EG E +LL+ A+ + D R P A+ H
Sbjct: 177 LKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHH 236
Query: 88 VICKILEDRGG 98
I ++L+
Sbjct: 237 DIVRLLDLEHH 247
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 79.8 bits (198), Expect = 2e-17
Identities = 23/92 (25%), Positives = 43/92 (46%), Gaps = 6/92 (6%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L +++ G+L++L + N D ++ALH A++ + ++LL+ GA+ + +
Sbjct: 128 LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 187
Query: 72 RWGRTPLSDARSFGHVVICKILEDRGGIDPGA 103
TPL A G K+L +D A
Sbjct: 188 NREETPLFLAAREGSYETAKVL-----LDHFA 214
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 6e-16
Identities = 27/74 (36%), Positives = 34/74 (45%), Gaps = 1/74 (1%)
Query: 28 LEKGVE-PNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
+ +G N D TALHLA+ R++ LLE AD N D GRTPL A S
Sbjct: 43 IYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADA 102
Query: 87 VVICKILEDRGGID 100
+ +IL D
Sbjct: 103 QGVFQILIRNRATD 116
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 4e-15
Identities = 22/83 (26%), Positives = 39/83 (46%), Gaps = 2/83 (2%)
Query: 13 LYCSSKGDRAGVLQEL--EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSL 70
L+ + D GV Q L + + + +D T L LA+ ++ L+ ADVN++
Sbjct: 94 LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAV 153
Query: 71 DRWGRTPLSDARSFGHVVICKIL 93
D G++ L A + +V +L
Sbjct: 154 DDLGKSALHWAAAVNNVDAAVVL 176
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 59.4 bits (145), Expect = 2e-10
Identities = 18/80 (22%), Positives = 29/80 (36%), Gaps = 14/80 (17%)
Query: 32 VEPNLADYDKRTALHLASSEG-------------RAEIVLLLLEKGADV-NSLDRWGRTP 77
++ N+ D T L +AS G ++ + +GA + N DR G T
Sbjct: 1 MDVNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETA 60
Query: 78 LSDARSFGHVVICKILEDRG 97
L A + K L +
Sbjct: 61 LHLAARYSRSDAAKRLLEAS 80
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 4e-08
Identities = 8/41 (19%), Positives = 16/41 (39%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVN 68
L+ ++ D+ R +A +IV LL + +
Sbjct: 210 LDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDLEHHHHH 250
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 3e-17
Identities = 52/231 (22%), Positives = 89/231 (38%), Gaps = 42/231 (18%)
Query: 102 GAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMK----ELGLWQKLRHPNIVQFL 155
G+YG VYL K +A K + + K E+ + +L+ I++
Sbjct: 37 GSYGYVYLAYDKNTEKNVAIKKV-----NRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 156 GVLKHSERLIF-----LTEYLRNGSLHDILKKKGKLDPPTAVAYAL-DIARGMNYLHHHR 209
++ + L F + E + L + K L + L ++ G N++H
Sbjct: 92 DLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEH-IKTILYNLLLGENFIHESG 149
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYR--------- 260
IIHRDL P+N L ++ +KV DFGL++ + +
Sbjct: 150 ---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
Query: 261 ----------YMAPEV-YRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA 300
Y APE+ +E+Y KS+D++S I E+ S+ D
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 78.6 bits (195), Expect = 4e-17
Identities = 18/70 (25%), Positives = 32/70 (45%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+ + N D ++ALH A++ + ++LL+ GA+ + + TPL A G
Sbjct: 112 INSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSY 171
Query: 88 VICKILEDRG 97
K+L D
Sbjct: 172 ETAKVLLDHF 181
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 78.2 bits (194), Expect = 5e-17
Identities = 19/79 (24%), Positives = 33/79 (41%), Gaps = 5/79 (6%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ G ++ + + T L LA+ EG E +LL+ A+ + D R P A+ H
Sbjct: 145 LKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHH 204
Query: 88 VICKILEDRGGIDPGAYGE 106
I ++L +
Sbjct: 205 DIVRLL-----DEYNLVRS 218
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 73.2 bits (181), Expect = 3e-15
Identities = 27/74 (36%), Positives = 34/74 (45%), Gaps = 1/74 (1%)
Query: 28 LEKGVE-PNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
+ +G N D TALHLA+ R++ LLE AD N D GRTPL A S
Sbjct: 11 IYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADA 70
Query: 87 VVICKILEDRGGID 100
+ +IL D
Sbjct: 71 QGVFQILIRNRATD 84
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 71.3 bits (176), Expect = 1e-14
Identities = 22/83 (26%), Positives = 39/83 (46%), Gaps = 2/83 (2%)
Query: 13 LYCSSKGDRAGVLQEL--EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSL 70
L+ + D GV Q L + + + +D T L LA+ ++ L+ ADVN++
Sbjct: 62 LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAV 121
Query: 71 DRWGRTPLSDARSFGHVVICKIL 93
D G++ L A + +V +L
Sbjct: 122 DDLGKSALHWAAAVNNVDAAVVL 144
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 70.5 bits (174), Expect = 3e-14
Identities = 19/71 (26%), Positives = 30/71 (42%), Gaps = 1/71 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGA-DVNSLDRWGRTPLSDARSFGH 86
LE + N+ D RT LH A S + +L+ A D+++ G TPL A
Sbjct: 45 LEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAV 104
Query: 87 VVICKILEDRG 97
+ + L +
Sbjct: 105 EGMLEDLINSH 115
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223 | Back alignment and structure |
|---|
Score = 42.8 bits (102), Expect = 6e-05
Identities = 11/47 (23%), Positives = 18/47 (38%), Gaps = 1/47 (2%)
Query: 52 GRAEIVLLLLEKGADV-NSLDRWGRTPLSDARSFGHVVICKILEDRG 97
++ + +GA + N DR G T L A + K L +
Sbjct: 2 DAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEAS 48
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 76.3 bits (189), Expect = 4e-17
Identities = 25/66 (37%), Positives = 38/66 (57%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ G + N D T LHLA+ G EI +LL+ GADVN+ D++G+T + G+
Sbjct: 67 LKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGKTAFDISIGNGNE 126
Query: 88 VICKIL 93
+ +IL
Sbjct: 127 DLAEIL 132
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 75.9 bits (188), Expect = 4e-17
Identities = 28/66 (42%), Positives = 40/66 (60%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+ G + N D T L+LA++ G EIV +LL+ GADVN++D G TPL A GH+
Sbjct: 34 MANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHL 93
Query: 88 VICKIL 93
I ++L
Sbjct: 94 EIAEVL 99
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 65.9 bits (162), Expect = 2e-13
Identities = 22/65 (33%), Positives = 35/65 (53%), Gaps = 1/65 (1%)
Query: 30 KGVEPNLAD-YDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVV 88
+G + D L A+ G+ + V +L+ GADVN+ D +G TPL A + GH+
Sbjct: 2 RGSHHHHHHGSDLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLE 61
Query: 89 ICKIL 93
I ++L
Sbjct: 62 IVEVL 66
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136 | Back alignment and structure |
|---|
Score = 41.2 bits (98), Expect = 6e-05
Identities = 8/35 (22%), Positives = 17/35 (48%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLE 62
L+ G + N D +TA ++ G ++ +L +
Sbjct: 100 LKHGADVNAQDKFGKTAFDISIGNGNEDLAEILQK 134
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 4e-17
Identities = 20/74 (27%), Positives = 29/74 (39%), Gaps = 2/74 (2%)
Query: 24 VLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARS 83
L+ + AD +A + A ++ +V LL GA N L+ PL A +
Sbjct: 14 QLKSFLSSKDTFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAAT 71
Query: 84 FGHVVICKILEDRG 97
I KIL G
Sbjct: 72 LEDTKIVKILLFSG 85
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 19/70 (27%), Positives = 29/70 (41%), Gaps = 2/70 (2%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L G N + LH A++ +IV +LL G D + D G T L A G++
Sbjct: 51 LNAGALKN--LLENEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNM 108
Query: 88 VICKILEDRG 97
K+ +
Sbjct: 109 QTVKLFVKKN 118
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 3e-15
Identities = 16/74 (21%), Positives = 26/74 (35%), Gaps = 1/74 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWG-RTPLSDARSFGH 86
L G++ + D TAL+ A G + V L ++K + + G +T A
Sbjct: 82 LFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLND 141
Query: 87 VVICKILEDRGGID 100
V I
Sbjct: 142 VSIVSYFLSEIPST 155
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 5e-14
Identities = 10/86 (11%), Positives = 29/86 (33%), Gaps = 1/86 (1%)
Query: 13 LYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDR 72
Y + + ++ + + +H+ G ++++LLL+ N+ +
Sbjct: 133 FYHAVMLNDVSIVSYFLSEIPSTFDLAILLSCIHITIKNGHVDMMILLLDYMTSTNTNNS 192
Query: 73 WGRTP-LSDARSFGHVVICKILEDRG 97
P + A + + + L
Sbjct: 193 LLFIPDIKLAIDNKDIEMLQALFKYD 218
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 2e-13
Identities = 11/71 (15%), Positives = 21/71 (29%), Gaps = 2/71 (2%)
Query: 28 LEKGVEPNLAD-YDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
++K +T+ + A IV L + + + GH
Sbjct: 115 VKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPSTFD-LAILLSCIHITIKNGH 173
Query: 87 VVICKILEDRG 97
V + +L D
Sbjct: 174 VDMMILLLDYM 184
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 1e-11
Identities = 8/71 (11%), Positives = 22/71 (30%), Gaps = 8/71 (11%)
Query: 28 LEKGVEPNLADYDKRT-ALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
L+ N + + LA E++ L + ++ + +
Sbjct: 181 LDYMTSTNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDINIY-------SANLENVLLDD 233
Query: 87 VVICKILEDRG 97
I K++ ++
Sbjct: 234 AEIAKMIIEKH 244
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285 | Back alignment and structure |
|---|
Score = 57.5 bits (140), Expect = 1e-09
Identities = 10/79 (12%), Positives = 23/79 (29%), Gaps = 8/79 (10%)
Query: 12 LLYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSL 70
+ + +LQ L + + +A AEI +++EK + S
Sbjct: 198 DIKLAIDNKDIEMLQALFKYDINIY-------SANLENVLLDDAEIAKMIIEKHVEYKSD 250
Query: 71 DRWGRTPLSDARSFGHVVI 89
+ ++
Sbjct: 251 SYTKDLDIVKNNKLDEIIS 269
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-17
Identities = 24/67 (35%), Positives = 38/67 (56%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+ G + D + T LHLA+ G E+V LLLE GADV + D++G+T + G+
Sbjct: 44 MANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDISIDNGNE 103
Query: 88 VICKILE 94
+ +IL+
Sbjct: 104 DLAEILQ 110
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 6e-17
Identities = 22/70 (31%), Positives = 35/70 (50%), Gaps = 3/70 (4%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+ +G D L A+ G+ + V +L+ GADV + D+ G TPL A GH+
Sbjct: 14 VPRGSHMG---SDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHL 70
Query: 88 VICKILEDRG 97
+ K+L + G
Sbjct: 71 EVVKLLLEAG 80
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-08
Identities = 12/50 (24%), Positives = 18/50 (36%), Gaps = 3/50 (6%)
Query: 48 ASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
SS L+ +G+ + S D L +A G +IL G
Sbjct: 1 GSSHHHHHHSSGLVPRGSHMGS-D--LGKKLLEAARAGQDDEVRILMANG 47
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 78.6 bits (195), Expect = 5e-17
Identities = 23/70 (32%), Positives = 31/70 (44%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L+ G N Y +ALH AS G +V L+ GAD + + TPL ARS +
Sbjct: 170 LQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVI 229
Query: 88 VICKILEDRG 97
I + R
Sbjct: 230 DILRGKATRP 239
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 6e-17
Identities = 22/80 (27%), Positives = 35/80 (43%), Gaps = 5/80 (6%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+ G E ++ + ++T LHLA +V LL+ GA +LDR G+T A
Sbjct: 33 QQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLACEHRSP 92
Query: 88 VICKILEDRGGIDPGAYGEV 107
+ L +D A G +
Sbjct: 93 TCLRAL-----LDSAAPGTL 107
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 74.8 bits (185), Expect = 1e-15
Identities = 21/71 (29%), Positives = 33/71 (46%), Gaps = 1/71 (1%)
Query: 28 LEKGVEPNLADY-DKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
LE+G + + D R+ L A +V LLL+ GA+VN+ G + L A G
Sbjct: 136 LERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGL 195
Query: 87 VVICKILEDRG 97
+ + + L G
Sbjct: 196 LPLVRTLVRSG 206
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 4e-14
Identities = 26/91 (28%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 13 LYCSSKGDRAGVLQEL-----EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADV 67
+ + + L+ L ++ +YD TALH+A + E V LLLE+GAD+
Sbjct: 83 AHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADI 142
Query: 68 NSLDR-WGRTPLSDARSFGHVVICKILEDRG 97
+++D GR+PL A + + ++L G
Sbjct: 143 DAVDIKSGRSPLIHAVENNSLSMVQLLLQHG 173
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 67.1 bits (165), Expect = 5e-13
Identities = 17/67 (25%), Positives = 28/67 (41%), Gaps = 4/67 (5%)
Query: 35 NLADYDKRTALHLASSEGRAEIVLLLLE----KGADVNSLDRWGRTPLSDARSFGHVVIC 90
AD D T LH+A +G V L+ G +++ + +TPL A +
Sbjct: 3 TRADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVV 62
Query: 91 KILEDRG 97
++L G
Sbjct: 63 RLLVTAG 69
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241 | Back alignment and structure |
|---|
Score = 51.3 bits (124), Expect = 1e-07
Identities = 8/38 (21%), Positives = 16/38 (42%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGA 65
+ G + +L + T L +A S +I+ + A
Sbjct: 203 VRSGADSSLKNCHNDTPLMVARSRRVIDILRGKATRPA 240
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 57/222 (25%), Positives = 89/222 (40%), Gaps = 44/222 (19%)
Query: 83 SFGHVVICKILEDRGGIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGL 142
SFG VV + +A K +R+ R +E+ +
Sbjct: 109 SFGQVVKAYDHK------------------VHQHVALKMVRN----EKRFHRQAAEEIRI 146
Query: 143 WQKLRH------PNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKK---KGKLDPPTAVA 193
+ LR N++ L + E L +L++++KK +G P
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQG-FSLPLVRK 204
Query: 194 YALDIARGMNYLHHHRPHAIIHRDLTPSNVL--QDEAGHLKVTDFGLSKIAQEKDSYSYK 251
+A I + ++ LH +R IIH DL P N+L Q +KV DFG S ++ Y+Y
Sbjct: 205 FAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-VYTY- 259
Query: 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGP 293
S Y APEV YG +D++S I+ E+ G P
Sbjct: 260 ----IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 6e-17
Identities = 20/70 (28%), Positives = 31/70 (44%)
Query: 31 GVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVIC 90
+ N T LHLA + E+ L+E GA V D++ + PL A S G + +
Sbjct: 97 KPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLI 156
Query: 91 KILEDRGGID 100
++L G
Sbjct: 157 ELLCGLGKSA 166
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 4e-16
Identities = 23/75 (30%), Positives = 37/75 (49%), Gaps = 1/75 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKG-ADVNSLDRWGRTPLSDARSFGH 86
+E G + D + LH A+S G +++ LL G + VN D+ G TPL A + GH
Sbjct: 127 IENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGH 186
Query: 87 VVICKILEDRGGIDP 101
+L ++ G +
Sbjct: 187 GDAAVLLVEKYGAEY 201
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 74.4 bits (184), Expect = 1e-15
Identities = 23/69 (33%), Positives = 28/69 (40%), Gaps = 3/69 (4%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVN---SLDRWGRTPLSDARSF 84
K D D R LH + S EI LL K +VN D G TP A S
Sbjct: 23 HSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLDDYPDDSGWTPFHIACSV 82
Query: 85 GHVVICKIL 93
G++ + K L
Sbjct: 83 GNLEVVKSL 91
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 67.1 bits (165), Expect = 4e-13
Identities = 24/81 (29%), Positives = 33/81 (40%), Gaps = 10/81 (12%)
Query: 28 LEKGVEPNLADY---DKRTALHLASSEGRAEIVLLLLEK--GADVNSLDRWGRTPLSDAR 82
L K NL DY T H+A S G E+V L ++ D+N + G T L A
Sbjct: 56 LSKMENVNLDDYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAV 115
Query: 83 SFGHVVICKILEDRGGIDPGA 103
+ + L I+ GA
Sbjct: 116 GKKWFEVSQFL-----IENGA 131
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 63.2 bits (155), Expect = 9e-12
Identities = 16/57 (28%), Positives = 23/57 (40%), Gaps = 1/57 (1%)
Query: 42 RTALHLASSEGR-AEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
LH A E ++ LL K + + D+ GR PL + SF I L +
Sbjct: 3 NYPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKM 59
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228 | Back alignment and structure |
|---|
Score = 61.3 bits (150), Expect = 4e-11
Identities = 17/56 (30%), Positives = 24/56 (42%), Gaps = 2/56 (3%)
Query: 28 LEKGV-EPNLADYDKRTALHLASSEGRAEIVLLLLEK-GADVNSLDRWGRTPLSDA 81
G N D T L A +EG + +LL+EK GA+ + +D G A
Sbjct: 160 CGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVA 215
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 76.3 bits (189), Expect = 1e-16
Identities = 28/66 (42%), Positives = 37/66 (56%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
LE G N + + T L +AS GR+EIV LLE GAD+++ D G T + AR FG
Sbjct: 121 LEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARDLTGLTAEASARIFGRQ 180
Query: 88 VICKIL 93
+ KI
Sbjct: 181 EVIKIF 186
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 75.5 bits (187), Expect = 2e-16
Identities = 24/76 (31%), Positives = 36/76 (47%), Gaps = 5/76 (6%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+E + D + TAL A R I LL KG++VN+ D G+TPL + FG+
Sbjct: 55 VENFDKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYS 114
Query: 88 VICKILEDRGGIDPGA 103
+ L ++ GA
Sbjct: 115 EMSYFL-----LEHGA 125
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 74.0 bits (183), Expect = 7e-16
Identities = 25/66 (37%), Positives = 33/66 (50%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L KG N D+ +T L + G +E+ LLE GA+VN + G TPL A +G
Sbjct: 88 LSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRS 147
Query: 88 VICKIL 93
I K L
Sbjct: 148 EIVKKL 153
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 71.3 bits (176), Expect = 7e-15
Identities = 20/93 (21%), Positives = 28/93 (30%), Gaps = 6/93 (6%)
Query: 1 GQIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLL 60
G +D G K + N D RT L +A G + L
Sbjct: 1 GSHMDKNGEIVEKIKDEKSINQNL------DFLRNYRDSYNRTPLMVACMLGMENAIDKL 54
Query: 61 LEKGADVNSLDRWGRTPLSDARSFGHVVICKIL 93
+E + D G T L A + I + L
Sbjct: 55 VENFDKLEDKDIEGSTALIWAVKNNRLGIAEKL 87
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (104), Expect = 3e-05
Identities = 11/63 (17%), Positives = 19/63 (30%), Gaps = 6/63 (9%)
Query: 35 NLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILE 94
+ D + + + + + L N D + RTPL A G L
Sbjct: 2 SHMDKNGEIVEKIKDEKSINQNLDFL------RNYRDSYNRTPLMVACMLGMENAIDKLV 55
Query: 95 DRG 97
+
Sbjct: 56 ENF 58
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192 | Back alignment and structure |
|---|
Score = 41.6 bits (99), Expect = 1e-04
Identities = 11/35 (31%), Positives = 16/35 (45%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLE 62
LE G + + D TA A GR E++ + E
Sbjct: 154 LELGADISARDLTGLTAEASARIFGRQEVIKIFTE 188
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 47/239 (19%), Positives = 81/239 (33%), Gaps = 63/239 (26%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++G V V G A K + +PR +N +EL + + L H NI++ +
Sbjct: 18 GSFGIVCEVFDIESGKRFALKKVLQ----DPRYKN---RELDIMKVLDHVNIIKLVDYFY 70
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALD---------------------- 197
+ + K G + +V
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 198 -------------------IARGMNYLHHHRPHAIIHRDLTPSNVLQD-EAGHLKVTDFG 237
+ R + ++H I HRD+ P N+L + + LK+ DFG
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 238 LSKIAQEKDSY-SYKMTGGTGSYR-YMAPEV-YRRESYGKSVDVFSFALIVHEMFQGGP 293
+K + +Y + R Y APE+ Y S+D++S + E+ G P
Sbjct: 188 SAKKLIPSEPSVAYICS------RFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 24/204 (11%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHP------NIVQ 153
G++G+V R +A K I++ N E+ L + + IV
Sbjct: 65 GSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120
Query: 154 FLGVLKHSERLIFLTEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPH 211
L + E L +L+D+L+ + +A + + +L
Sbjct: 121 LKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS 179
Query: 212 AIIHRDLTPSNVL--QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
IIH DL P N+L + +K+ DFG S ++ Y Y + YR +PEV
Sbjct: 180 -IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-IYQYIQSR---FYR--SPEVLLG 232
Query: 270 ESYGKSVDVFSFALIVHEMFQGGP 293
Y ++D++S I+ EM G P
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEP 256
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 17/66 (25%), Positives = 29/66 (43%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+ G + N D D+ T L LA R +V L++ GAD ++ R+ L A +
Sbjct: 153 IAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRDF 212
Query: 88 VICKIL 93
+ +
Sbjct: 213 GMMVYM 218
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 25/87 (28%), Positives = 46/87 (52%), Gaps = 2/87 (2%)
Query: 13 LYCSSKGDRAGVLQEL--EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSL 70
L+ +++ +++ L EKG + D D +T + LA+ EGR E+V+ L+++GA V ++
Sbjct: 283 LHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAV 342
Query: 71 DRWGRTPLSDARSFGHVVICKILEDRG 97
D T A++ H I I +
Sbjct: 343 DATDHTARQLAQANNHHNIVDIFDRCR 369
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 26/85 (30%), Positives = 38/85 (44%), Gaps = 14/85 (16%)
Query: 28 LEKGVEPNLA--------DYDKRTALHLASSEGRAEIV-LLLLEKGADVNSLDRWGRTPL 78
+EKG + + Y RTALH A+ IV L+ EKG++ + D G+TP+
Sbjct: 258 VEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPI 317
Query: 79 SDARSFGHVVICKILEDRGGIDPGA 103
A G + + L I GA
Sbjct: 318 MLAAQEGRIEVVMYL-----IQQGA 337
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 8e-13
Identities = 19/76 (25%), Positives = 36/76 (47%), Gaps = 6/76 (7%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK---GADVNSLDRWGRTPLSDARSF 84
++ G +P + + +R+ALH A++ +++ +L D+ LDR G T L
Sbjct: 186 MKAGADPTIYNKSERSALHQAAANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHN 245
Query: 85 GH---VVICKILEDRG 97
V K+L ++G
Sbjct: 246 EGRDQVASAKLLVEKG 261
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 17/103 (16%), Positives = 29/103 (28%), Gaps = 5/103 (4%)
Query: 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK 63
+ Y G+ P + + LH ++ G I + +
Sbjct: 57 LQHYSLYPNPQGYGNGNDFLGDFNHTNLQIPTEPEPESPIKLHTEAA-GSYAITEPITRE 115
Query: 64 GADVNSLDRWGRTPLSDARSFGHVVICKIL---EDRGGIDPGA 103
++ R RT L S + L E + I GA
Sbjct: 116 SVNIID-PRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGA 157
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 25/99 (25%), Positives = 34/99 (34%), Gaps = 14/99 (14%)
Query: 13 LYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLL--------EKG 64
L+ + G A + V RT LH +S AE L+ G
Sbjct: 98 LHTEAAGSYAITEPITRESVNII-DPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAG 156
Query: 65 ADVNSLDRWGRTPLSDARSFGHVVICKILEDRGGIDPGA 103
ADVN++D TPL A + L + GA
Sbjct: 157 ADVNAMDCDENTPLMLAVLARRRRLVAYL-----MKAGA 190
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 4e-12
Identities = 5/63 (7%), Positives = 11/63 (17%), Gaps = 1/63 (1%)
Query: 35 NLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILE 94
N + G + + L + G I + +
Sbjct: 55 NELQHYSLYPNPQGYGNGNDFLGDFNHTNLQIPTEPEPESPIKLHTE-AAGSYAITEPIT 113
Query: 95 DRG 97
Sbjct: 114 RES 116
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 22/103 (21%), Positives = 39/103 (37%), Gaps = 15/103 (14%)
Query: 13 LYCSSKGDRAGVLQEL----EKGVEPNLADYDKRTALHLASSEGRAE---IVLLLLEKGA 65
L+ ++ G++ + + + D + TAL + + + LL+EKGA
Sbjct: 203 LHQAAANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGA 262
Query: 66 DVNSL--------DRWGRTPLSDARSFGHVVICKILEDRGGID 100
V+ GRT L A ++ I K L G +
Sbjct: 263 KVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSN 305
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 8/40 (20%), Positives = 14/40 (35%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADV 67
+++G D TA LA + IV + +
Sbjct: 333 IQQGASVEAVDATDHTARQLAQANNHHNIVDIFDRCRPER 372
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 10/73 (13%), Positives = 22/73 (30%), Gaps = 9/73 (12%)
Query: 25 LQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSF 84
++ EK + + + + +L AS +G + N L + P
Sbjct: 21 MENEEKNRKNHQSITSSQHSLLEASYDGYIKRQ---------RNELQHYSLYPNPQGYGN 71
Query: 85 GHVVICKILEDRG 97
G+ +
Sbjct: 72 GNDFLGDFNHTNL 84
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 15/68 (22%), Positives = 27/68 (39%)
Query: 30 KGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVI 89
+ + A+ + LH A ++ + +E G DVN D PL + V++
Sbjct: 200 SSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGIDVNMEDNEHTVPLYLSVRAAMVLL 259
Query: 90 CKILEDRG 97
K L +
Sbjct: 260 TKELLQKT 267
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 13/88 (14%), Positives = 25/88 (28%), Gaps = 6/88 (6%)
Query: 17 SKGDRAGVLQELEK-GVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGR 75
K D + G + A+ + E++ LL EK +V G
Sbjct: 265 QKTDVFLIQACPYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTGA 324
Query: 76 TPLSDARSFGHVVICKILEDRGGIDPGA 103
+ + ++ + P A
Sbjct: 325 GGAVKRKKKAAPAVKRMK-----LAPSA 347
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 21/75 (28%), Positives = 35/75 (46%), Gaps = 1/75 (1%)
Query: 23 GVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82
G + + K + +D + +H+A+ +G+ + V L+E G +R+G T L A
Sbjct: 3 GSMTDFPK-LNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLAC 61
Query: 83 SFGHVVICKILEDRG 97
FG V K L G
Sbjct: 62 KFGCVDTAKYLASVG 76
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 17/66 (25%), Positives = 25/66 (37%), Gaps = 2/66 (3%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
+E GV P + + TALHLA G + L G + G+ P+ A
Sbjct: 40 IETGVSPTIQNRFGCTALHLACKFGCVDTAKYLASVGEVHSLWH--GQKPIHLAVMANKT 97
Query: 88 VICKIL 93
+ L
Sbjct: 98 DLVVAL 103
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 4e-15
Identities = 12/75 (16%), Positives = 25/75 (33%), Gaps = 5/75 (6%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLE-----KGADVNSLDRWGRTPLSDAR 82
++ G P D T L A E + L+++ ++ ++ G + L A
Sbjct: 160 VQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAI 219
Query: 83 SFGHVVICKILEDRG 97
+ + G
Sbjct: 220 LINWEDVAMRFVEMG 234
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 4e-14
Identities = 16/75 (21%), Positives = 30/75 (40%), Gaps = 2/75 (2%)
Query: 31 GVEPNLADYDKRTALHLASSEG--RAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVV 88
+ ++ +TALH G E++ +L++ GA + D+ TPL A F +
Sbjct: 128 EIGSHVKHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNRE 187
Query: 89 ICKILEDRGGIDPGA 103
++ D
Sbjct: 188 ALDLMMDTVPSKSSL 202
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 4e-13
Identities = 11/71 (15%), Positives = 23/71 (32%), Gaps = 1/71 (1%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
+ ++ + VLQ L EK E + + + + L A V +
Sbjct: 294 VPAAADPSKQEVLQLLQEKLDEVVRSLNTGAGGAVKRKKKAAPAVKRMKLAPSAPVRTRS 353
Query: 72 RWGRTPLSDAR 82
R + ++
Sbjct: 354 RSRARSSAVSK 364
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 12/83 (14%), Positives = 28/83 (33%), Gaps = 13/83 (15%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGA-------------DVNSLDRWG 74
+E G++ N+ D + L+L+ + LL+K V
Sbjct: 231 VEMGIDVNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQACPYHNGTTVLPDRVVW 290
Query: 75 RTPLSDARSFGHVVICKILEDRG 97
+ A + ++L+++
Sbjct: 291 LDFVPAAADPSKQEVLQLLQEKL 313
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 11/65 (16%), Positives = 24/65 (36%), Gaps = 8/65 (12%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
G + + + +HLA + ++V+ L+E + G+ P S
Sbjct: 73 ASVGEVHS--LWHGQKPIHLAVMANKTDLVVALVEGAKER------GQMPESLLNECDER 124
Query: 88 VICKI 92
+ +I
Sbjct: 125 EVNEI 129
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 5e-16
Identities = 20/76 (26%), Positives = 26/76 (34%), Gaps = 5/76 (6%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
N + ++T LHLA + EI LL G D D G TPL A G +
Sbjct: 32 KGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCL 91
Query: 88 VICKILEDRGGIDPGA 103
+L
Sbjct: 92 ASVGVL-----TQSCT 102
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-15
Identities = 22/71 (30%), Positives = 32/71 (45%), Gaps = 1/71 (1%)
Query: 28 LEKGVEPNLAD-YDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
+ G + N + + RTALHLA ++V LLL+ GADVN + G +P
Sbjct: 137 VSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPS 196
Query: 87 VVICKILEDRG 97
I + L
Sbjct: 197 TRIQQQLGQLT 207
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 2e-13
Identities = 21/76 (27%), Positives = 33/76 (43%), Gaps = 6/76 (7%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGAD------VNSLDRWGRTPLSDA 81
L G +P L D+ T LHLA +G V +L + + + + G T L A
Sbjct: 65 LGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLA 124
Query: 82 RSFGHVVICKILEDRG 97
G++ I ++L G
Sbjct: 125 SIHGYLGIVELLVSLG 140
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 4e-13
Identities = 24/64 (37%), Positives = 32/64 (50%), Gaps = 1/64 (1%)
Query: 35 NLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRW-GRTPLSDARSFGHVVICKIL 93
+Y+ T LHLAS G IV LL+ GADVN+ + GRT L A + + +L
Sbjct: 111 KATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLL 170
Query: 94 EDRG 97
G
Sbjct: 171 LKCG 174
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 5e-11
Identities = 8/54 (14%), Positives = 14/54 (25%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81
L+ G + N Y + L I L + + + S
Sbjct: 171 LKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLENLQMLPESEDEESYD 224
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 1e-09
Identities = 14/60 (23%), Positives = 22/60 (36%), Gaps = 4/60 (6%)
Query: 38 DYDKRTALHLASSEGR----AEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKIL 93
D + LHLA E++ + A +N + +TPL A I + L
Sbjct: 5 TEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEAL 64
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 44/217 (20%), Positives = 84/217 (38%), Gaps = 38/217 (17%)
Query: 102 GAYGEVYLVK--WRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-----------H 148
G + V+L K T +A K +R + + E+ L Q++
Sbjct: 30 GHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 149 PNIVQFLGVLKHSER----LIFLTEYLRNGSLHDILKKKG--KLDPPTAVAYALDIARGM 202
+I++ L H ++ + E L +L ++KK + + + G+
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLGL 144
Query: 203 NYLHHHRPHAIIHRDLTPSNVL------QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256
+Y+H R IIH D+ P NVL + +K+ D G + ++ +
Sbjct: 145 DYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWYDEHYTNSIQ---- 197
Query: 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGP 293
+ Y +PEV +G D++S A ++ E+ G
Sbjct: 198 -TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 7e-14
Identities = 23/96 (23%), Positives = 34/96 (35%), Gaps = 15/96 (15%)
Query: 17 SKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDR---- 72
+ L++ + Y +TALH+A +V LL+E GADV +
Sbjct: 78 DVARKTDSLKQFV-NASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFF 136
Query: 73 ----------WGRTPLSDARSFGHVVICKILEDRGG 98
+G PLS A + I K L
Sbjct: 137 KKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSW 172
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 5e-10
Identities = 15/62 (24%), Positives = 22/62 (35%), Gaps = 3/62 (4%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKG---ADVNSLDRWGRTPLSDARSF 84
K + Y L LA+ + IV LL+ AD+++ D G T L
Sbjct: 135 FFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEV 194
Query: 85 GH 86
Sbjct: 195 AD 196
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 9/58 (15%), Positives = 18/58 (31%), Gaps = 7/58 (12%)
Query: 29 EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
+ + T L LA+S G+ ++ +L++ A H
Sbjct: 221 PTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIH-------EPECRHAAAHHHH 271
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 18/109 (16%), Positives = 39/109 (35%), Gaps = 22/109 (20%)
Query: 11 RLLYCSSKGDRA---GVLQEL----EKGVEPNLADYDK-RTALHLAS---SEGRAEIVLL 59
+ ++ + +L L ++ + D + +T L A G+ + + L
Sbjct: 16 SIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIAL 75
Query: 60 LLEKGADVNSL-----------DRWGRTPLSDARSFGHVVICKILEDRG 97
LL+ +SL G+T L A ++ + +L + G
Sbjct: 76 LLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENG 124
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 8e-08
Identities = 17/98 (17%), Positives = 31/98 (31%), Gaps = 21/98 (21%)
Query: 25 LQELEKGVEPNLADYDKRTALHLASSEGRAEIVL---------LLLEKGADVNSL----- 70
LQ + + + D T LH + +L GA ++
Sbjct: 168 LQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEE 227
Query: 71 --DRWGRTPLSDARSFGHVVICKILEDRGGIDPGAYGE 106
+R G TPL+ A S G + + + + +
Sbjct: 228 ITNRKGLTPLALAASSGKIGVLAYI-----LQREIHEP 260
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 5e-06
Identities = 16/76 (21%), Positives = 25/76 (32%), Gaps = 12/76 (15%)
Query: 33 EPNLADYDKRTALHLASSEGRAEIVLLLLE-------KGADVNSLDR-WGRTPLSDA--- 81
E YD R ++ A ++ + + LL + D D G+T L A
Sbjct: 6 EKPPRLYD-RRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLN 64
Query: 82 RSFGHVVICKILEDRG 97
G +L D
Sbjct: 65 LHNGQNDTIALLLDVA 80
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 36/219 (16%)
Query: 102 GAYGEVYLV--KWRGTEIAAKTIRSSIASNPRVRNSFMK----ELGLWQKLR-HPNIVQF 154
GAYG V+ + G +A K I + ++ + E+ + +L H NIV
Sbjct: 20 GAYGIVWKSIDRRTGEVVAVKKI-----FDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 155 LGVLKHSE-RLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
L VL+ R ++L LH +++ L+P + + + YLH +
Sbjct: 75 LNVLRADNDRDVYLVFDYMETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGG---L 130
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYR------------- 260
+HRD+ PSN+L + H+KV DFGLS+ + +
Sbjct: 131 LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDY 190
Query: 261 -----YMAPEV-YRRESYGKSVDVFSFALIVHEMFQGGP 293
Y APE+ Y K +D++S I+ E+ G P
Sbjct: 191 VATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-13
Identities = 24/93 (25%), Positives = 40/93 (43%), Gaps = 8/93 (8%)
Query: 12 LLYCSSKGDRAGVLQEL--EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADV-- 67
LL + + D L +L +G E + TALH+A+ E ++L+E ++
Sbjct: 7 LLLAAKENDV-QALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVF 65
Query: 68 ---NSLDRWGRTPLSDARSFGHVVICKILEDRG 97
S G+T L A +V + + L RG
Sbjct: 66 EPMTSELYEGQTALHIAVINQNVNLVRALLARG 98
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-12
Identities = 16/80 (20%), Positives = 27/80 (33%), Gaps = 10/80 (12%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVL----LLLEKGADVN------SLDRWGRTP 77
+E G + D T LH+ + LLL + + G TP
Sbjct: 141 IEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDHLKSLELVPNNQGLTP 200
Query: 78 LSDARSFGHVVICKILEDRG 97
A G++V+ + L +
Sbjct: 201 FKLAGVEGNIVMFQHLMQKR 220
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 21/77 (27%), Positives = 32/77 (41%), Gaps = 13/77 (16%)
Query: 34 PNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDR-------------WGRTPLSD 80
Y+ +TALH+A +V LL +GA V++ +G PLS
Sbjct: 68 MTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSF 127
Query: 81 ARSFGHVVICKILEDRG 97
A G I ++L + G
Sbjct: 128 AACVGSEEIVRLLIEHG 144
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-11
Identities = 18/61 (29%), Positives = 25/61 (40%)
Query: 33 EPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKI 92
P+ Y L A+ G EIV LL+E GAD+ + D G T L +
Sbjct: 113 RPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQ 172
Query: 93 L 93
+
Sbjct: 173 M 173
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-09
Identities = 13/56 (23%), Positives = 25/56 (44%), Gaps = 1/56 (1%)
Query: 43 TALHLASSEGRAEIVL-LLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
+ L LA+ E + + LL +G +V+ G T L A + ++ +L +
Sbjct: 5 SPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAA 60
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 15/69 (21%), Positives = 25/69 (36%), Gaps = 1/69 (1%)
Query: 28 LEKGVEPNLA-DYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86
+ N+ D T LH +S E+V L++ G++ D G + L A +
Sbjct: 117 PNTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVN 176
Query: 87 VVICKILED 95
E
Sbjct: 177 NYDSGTFEA 185
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 16/71 (22%), Positives = 26/71 (36%)
Query: 8 GPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADV 67
P + + N D + T L++A+ G IV LL+ GAD
Sbjct: 250 KPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADP 309
Query: 68 NSLDRWGRTPL 78
++ G P+
Sbjct: 310 FIANKSGLRPV 320
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 10/55 (18%), Positives = 14/55 (25%), Gaps = 4/55 (7%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEG----RAEIVLLLLEKGADVNSLDRWGRTPL 78
++ G D + L A LL + D RT L
Sbjct: 151 VKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTIL 205
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 8e-05
Identities = 15/74 (20%), Positives = 29/74 (39%), Gaps = 4/74 (5%)
Query: 28 LEKGVEPNLADYDKRTALHLA----SSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARS 83
++K P + +++ + + E + L +N+ D G T L+ A
Sbjct: 233 VKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAAR 292
Query: 84 FGHVVICKILEDRG 97
G++ I L D G
Sbjct: 293 LGNISIVDALLDYG 306
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 13/76 (17%), Positives = 22/76 (28%), Gaps = 7/76 (9%)
Query: 30 KGVEPNLADYDKRTALHLAS-SEGRAEIVLLLLEKGADVNS-LDRWGRTPLSDARSFGHV 87
N S E+ ++N +D G TPL S ++
Sbjct: 85 DSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANL 144
Query: 88 VICKILEDRGGIDPGA 103
+ K L + G+
Sbjct: 145 ELVKHL-----VKHGS 155
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 20/65 (30%), Positives = 31/65 (47%)
Query: 31 GVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVIC 90
G + D TALH A+ + + + LLL+ A V +++ G T L AR H
Sbjct: 216 GGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECE 275
Query: 91 KILED 95
++LE
Sbjct: 276 ELLEQ 280
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 21/108 (19%), Positives = 35/108 (32%), Gaps = 10/108 (9%)
Query: 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADY------DKRTALHLASSEGRA---E 55
+ P RL D VL+ G + + LHLA
Sbjct: 148 CTPEPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLP 207
Query: 56 IVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGGIDPGA 103
+V +++ G +++ G T L A + K+L +G G
Sbjct: 208 LVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLL-KGRALVGT 254
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-12
Identities = 54/238 (22%), Positives = 89/238 (37%), Gaps = 58/238 (24%)
Query: 83 SFGHVVICKILEDRGGIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGL 142
+FG VV C D K G +A K +++ R + E+ +
Sbjct: 26 AFGKVVECI---DH--------------KAGGRHVAVKIVKN----VDRYCEAARSEIQV 64
Query: 143 WQKLRHP------NIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLD-PPTAV-AY 194
+ L VQ L +H + + E L S +D +K+ G L +
Sbjct: 65 LEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKM 123
Query: 195 ALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH-------------------LKVTD 235
A I + +N+LH ++ + H DL P N+L ++ + +KV D
Sbjct: 124 AYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 236 FGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGP 293
FG S ++ + T YR APEV + + DV+S I+ E + G
Sbjct: 181 FG-SATYDDEHHSTLVSTR---HYR--APEVILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 19/85 (22%), Positives = 30/85 (35%), Gaps = 13/85 (15%)
Query: 27 ELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDR-------------W 73
+ + Y +ALH+A + + V LL+E GADV+ +
Sbjct: 76 KPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYF 135
Query: 74 GRTPLSDARSFGHVVICKILEDRGG 98
G PLS A + L +
Sbjct: 136 GELPLSLAACTKQWDVVTYLLENPH 160
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 9e-11
Identities = 12/60 (20%), Positives = 23/60 (38%)
Query: 38 DYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
+ + +AL + +G ++ L + G TPL A G + I + + R
Sbjct: 185 NSPENSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQRE 244
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 5e-09
Identities = 13/49 (26%), Positives = 19/49 (38%), Gaps = 3/49 (6%)
Query: 33 EPNLADYDKRTALHLASSEGRAEIVLLLLEKG---ADVNSLDRWGRTPL 78
Y L LA+ + ++V LLE A + + D G T L
Sbjct: 128 HQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVL 176
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 9e-08
Identities = 9/42 (21%), Positives = 19/42 (45%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNS 69
++++ T L LA+ EG+ EI +L++ +
Sbjct: 208 CPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGAA 249
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 20/109 (18%), Positives = 32/109 (29%), Gaps = 22/109 (20%)
Query: 11 RLLYCSSKGD---RAGVLQELEKGVEPNLADYDKR-----TALHLA---SSEGRAEIVLL 59
RL S+G G+L+ L + T L A +G ++
Sbjct: 5 RLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNACIMP 64
Query: 60 LLEKG-----------ADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
LL+ A G + L A + K+L + G
Sbjct: 65 LLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENG 113
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 21/91 (23%), Positives = 31/91 (34%), Gaps = 1/91 (1%)
Query: 5 DSEGPYRLLYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK 63
E L S ++ L + + TALH AE + LLL
Sbjct: 168 PDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRG 227
Query: 64 GADVNSLDRWGRTPLSDARSFGHVVICKILE 94
A + + G TPL A+ H ++L
Sbjct: 228 KASIEIANESGETPLDIAKRLKHEHCEELLT 258
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 14/61 (22%), Positives = 21/61 (34%), Gaps = 3/61 (4%)
Query: 40 DKRTALHLASSEG---RAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDR 96
TALHLA IV L++ +++ G T L + K+L
Sbjct: 168 PDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRG 227
Query: 97 G 97
Sbjct: 228 K 228
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 16/103 (15%), Positives = 27/103 (26%), Gaps = 3/103 (2%)
Query: 4 IDSEGPYRLLYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLE 62
I SE + + L L + + A LA+ G ++ L E
Sbjct: 90 IKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCE 149
Query: 63 KGADVNSLD--RWGRTPLSDARSFGHVVICKILEDRGGIDPGA 103
A GH+ + L + + A
Sbjct: 150 LAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATA 192
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 9e-10
Identities = 21/121 (17%), Positives = 35/121 (28%), Gaps = 12/121 (9%)
Query: 13 LYCSSKGDRAGVLQEL-EKGVEPNLAD--YDKRTALHLASSEGRAEIVLLLLEKGADVNS 69
+++ VL L E +A + A LA+ G ++ L E +
Sbjct: 132 FRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEAT 191
Query: 70 --LDRWGRTPLSD-ARSFGHVVICKILEDRGG------IDPGAYGEVYLVKWRGTEIAAK 120
+ A GH + L D I YGE Y+ + +
Sbjct: 192 AMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEIHEFEYGEKYVNPFIARHVNRL 251
Query: 121 T 121
Sbjct: 252 K 252
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 9/71 (12%), Positives = 19/71 (26%), Gaps = 3/71 (4%)
Query: 25 LQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSF 84
+ ++ D L LA G LLL + + +
Sbjct: 303 IPGIKALAPTATIPGDANELLRLALRLGNQGACALLLSIPSVLALTK---ANNYYINETG 359
Query: 85 GHVVICKILED 95
G + + + +
Sbjct: 360 GRLDLRAVALE 370
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 12/94 (12%), Positives = 23/94 (24%)
Query: 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK 63
+ E +LL Q + + + + + LLL
Sbjct: 58 KNMEQVRQLLCLYYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTS 117
Query: 64 GADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
V + A GH+ + L +
Sbjct: 118 DEIVKVIQAENYQAFRLAAENGHLHVLNRLCELA 151
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 10/90 (11%), Positives = 22/90 (24%), Gaps = 13/90 (14%)
Query: 19 GDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLL--------LEKGADVNSL 70
+ GV + K L ++ + ++ A ++
Sbjct: 261 SNPDGVFDLVTKS-----ECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATI 315
Query: 71 DRWGRTPLSDARSFGHVVICKILEDRGGID 100
L A G+ C +L +
Sbjct: 316 PGDANELLRLALRLGNQGACALLLSIPSVL 345
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 9e-12
Identities = 24/77 (31%), Positives = 31/77 (40%), Gaps = 14/77 (18%)
Query: 35 NLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDR--------------WGRTPLSD 80
Y +TALH+A V LL+EKGADV++ R +G PLS
Sbjct: 87 RDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSL 146
Query: 81 ARSFGHVVICKILEDRG 97
A I L + G
Sbjct: 147 AACTNQPHIVHYLTENG 163
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 4e-09
Identities = 15/57 (26%), Positives = 20/57 (35%), Gaps = 3/57 (5%)
Query: 33 EPNLADYDKRTALHLASSEGRAEIVLLLLEKG---ADVNSLDRWGRTPLSDARSFGH 86
+ Y L LA+ + IV L E G AD+ D G T L +
Sbjct: 132 DEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIAD 188
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 21/95 (22%), Positives = 32/95 (33%), Gaps = 19/95 (20%)
Query: 28 LEKGVE---PNLADYDKRTALHLAS---------SEGRAEIVLLLLEKGADVNS------ 69
E G + D T LH ++ ++ LLL K A +
Sbjct: 160 TENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLFPDTNLEA 219
Query: 70 -LDRWGRTPLSDARSFGHVVICKILEDRGGIDPGA 103
L+ G +PL A G + I + + R D A
Sbjct: 220 LLNNDGLSPLMMAAKTGKIGIFQHIIRREIADAAA 254
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 4e-07
Identities = 19/109 (17%), Positives = 35/109 (32%), Gaps = 22/109 (20%)
Query: 11 RLLYCSSKGDRAGVLQELE----KGVEPNLADYDK----RTALHLA---SSEGRAEIVLL 59
L S+G G+ L ++ + +T L A S GR + + +
Sbjct: 8 ILFDIVSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDTIPI 67
Query: 60 LLEKGAD-----------VNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
LL+ + G+T L A ++L ++G
Sbjct: 68 LLDIAEKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKG 116
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 13/72 (18%), Positives = 24/72 (33%), Gaps = 10/72 (13%)
Query: 36 LADYDKRT---ALHLASSEGRAEIVLLLLEKGADVNSLDRW----GRTPLSDA---RSFG 85
+ +++ + S +G ++ LL + + G+T L A S G
Sbjct: 1 MKVFNRPILFDIVSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAG 60
Query: 86 HVVICKILEDRG 97
IL D
Sbjct: 61 RNDTIPILLDIA 72
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 45/238 (18%), Positives = 79/238 (33%), Gaps = 58/238 (24%)
Query: 83 SFGHVVICKILEDRGGIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGL 142
+FG VV C D +++A K IR+ + R + E+ +
Sbjct: 31 TFGKVVECL---DH--------------ARGKSQVALKIIRN----VGKYREAARLEINV 69
Query: 143 WQKLRHP------NIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAV--AY 194
+K++ V + E L + + LK+ P
Sbjct: 70 LKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHM 128
Query: 195 ALDIARGMNYLHHHRPHAIIHRDLTPSNVL-------------------QDEAGHLKVTD 235
A + + +LH ++ + H DL P N+L + ++V D
Sbjct: 129 AYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 236 FGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGP 293
FG S + + T YR PEV + + DV+S I+ E ++G
Sbjct: 186 FG-SATFDHEHHTTIVATR---HYR--PPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 48/244 (19%), Positives = 92/244 (37%), Gaps = 66/244 (27%)
Query: 83 SFGHVVICKILEDRGGIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGL 142
+FG V++C+ ++ A K +R+ + S E +
Sbjct: 47 TFGRVLLCQHID------------------NKKYYAVKVVRN----IKKYTRSAKIEADI 84
Query: 143 WQKLRH-----PNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLD-PPTAV-AYA 195
+K+++ NIV++ G + + + + E L SL++I+ + + Y
Sbjct: 85 LKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYC 143
Query: 196 LDIARGMNYLHHHRPHAIIHRDLTPSNVL-------------------------QDEAGH 230
++I + +NYL + H DL P N+L + ++
Sbjct: 144 IEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 231 LKVTDFGLSKIAQEKDSYSYKMTGGTGSYR-YMAPEVYRRESYGKSVDVFSFALIVHEMF 289
+K+ DFG + S T R Y APEV + S D++SF ++ E++
Sbjct: 201 IKLIDFG-CATFKSDYHGSIINT------RQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253
Query: 290 QGGP 293
G
Sbjct: 254 TGSL 257
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 7e-11
Identities = 24/92 (26%), Positives = 39/92 (42%), Gaps = 1/92 (1%)
Query: 5 DSEGPYRLLYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK 63
+ L ++ + + L + G N AD R LH A+ G + L L++
Sbjct: 231 GGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLKR 290
Query: 64 GADVNSLDRWGRTPLSDARSFGHVVICKILED 95
GAD+ + D GR PL+ A + I +L
Sbjct: 291 GADLGARDSEGRDPLTIAMETANADIVTLLRL 322
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 6e-08
Identities = 24/94 (25%), Positives = 32/94 (34%), Gaps = 2/94 (2%)
Query: 6 SEGPYRLLYCSSKGDRAGVLQELEKGVEPNLA--DYDKRTALHLASSEGRAEIVLLLLEK 63
G + L G + N D T L A++ LL+
Sbjct: 198 HPGALLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQN 257
Query: 64 GADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
GA+VN D GR PL A GH + + RG
Sbjct: 258 GANVNQADSAGRGPLHHATILGHTGLACLFLKRG 291
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 9e-11
Identities = 69/423 (16%), Positives = 124/423 (29%), Gaps = 113/423 (26%)
Query: 14 YCSSKGDRAGVLQELEKGVEPNLADY-DKRTALHLASSEGRAEIVLLLLEKGADVNSL-- 70
C+S +LQ+L ++PN D + + L +AE+ LL K N L
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY-ENCLLV 249
Query: 71 --DRWGRTPLSDARSFGHVVICKIL---EDRGGID---PGAYGEVYLVKWRGT------- 115
+ +A + CKIL + D + L T
Sbjct: 250 LLNVQNAKAW-NAFNLS----CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK 304
Query: 116 EIAAKTIRSSIAS--------NPRVRNSF---MKE-LGLWQKLRHPNIVQFLGVLKHSER 163
+ K + NPR + +++ L W +H N + +++ S
Sbjct: 305 SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS-- 362
Query: 164 LIFLTEYLRNGSLHD--ILKKKGKLDPPTAV---------------------AYAL---D 197
L L + + PT + Y+L
Sbjct: 363 LNVLEPAEYRKMFDRLSVFPPSAHI--PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420
Query: 198 IARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTD-FGLSK-------IAQEKDSYS 249
+ I+ +L + + A H + D + + K I D Y
Sbjct: 421 PKESTISIPS------IYLELKV-KLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYF 473
Query: 250 YKMTGGTGSYRYMAPEVYRRESYGKSV--DVFSF--ALIVHE-MFQGGPSNRADTAVQVA 304
Y G + E R + + V D F F I H+ + +T +
Sbjct: 474 YSHIG----HHLKNIEHPERMTLFRMVFLD-FRFLEQKIRHDSTAWNASGSILNT---LQ 525
Query: 305 DRRAYE----DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR---LEAIQESFQ 357
+ Y+ D+ P L + A+L D P EE + + ++ +
Sbjct: 526 QLKFYKPYICDNDPKYERL----VNAIL--------DFLPKIEENLICSKYTDLLRIALM 573
Query: 358 KKT 360
+
Sbjct: 574 AED 576
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 2e-09
Identities = 42/314 (13%), Positives = 91/314 (28%), Gaps = 62/314 (19%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIR-----SSIASNPRVRNSFMKELGLWQKL---------R 147
G +GEV+ T +A K I S+ + + E+ + ++L R
Sbjct: 31 GVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNR 90
Query: 148 HPNIVQFLGV------------------------------LKHSERLIFLTEYLRNGSLH 177
+ V ++L + E+ G
Sbjct: 91 TEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDL 150
Query: 178 DILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFG 237
+ ++ K TA + + + HRDL NVL + K+
Sbjct: 151 EQMRTK-LSSLATAKSILHQLTASL--AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTL 207
Query: 238 LSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRA 297
K T + + + + VF + ++F G +
Sbjct: 208 NGK----------SSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQF 257
Query: 298 DT--AVQVADRRAYEDSRPALSSLYPEPI-KALLRECWHKNPDRRPTFEEIIFRLEAIQE 354
D ++ + + + P + L+ + +L++ K P ++I +++
Sbjct: 258 DIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHR 317
Query: 355 SFQKKTVPSCCDCM 368
+ S D +
Sbjct: 318 TML--NFSSATDLL 329
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 22/104 (21%), Positives = 38/104 (36%), Gaps = 10/104 (9%)
Query: 9 PYRLLYCSSKGDRAGVLQELEKGVEPNL------ADYDKRTALHLA---SSEGRAEIVLL 59
P RL D VL+ G + A + LHLA +++ +V
Sbjct: 133 PQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDF 192
Query: 60 LLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGGIDPGA 103
+++ G +++ G T L A + K+L +G G
Sbjct: 193 IIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLL-KGRALVGT 235
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 20/64 (31%), Positives = 31/64 (48%)
Query: 31 GVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVIC 90
G + D TALH A+ + + + LLL+ A V +++ G T L AR H
Sbjct: 197 GGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECE 256
Query: 91 KILE 94
++LE
Sbjct: 257 ELLE 260
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 37/204 (18%), Positives = 71/204 (34%), Gaps = 37/204 (18%)
Query: 91 KILEDRGG--------IDPGAYGEVYLVK--WRGTEIAAKTIRSSIASNPRVRN--SFMK 138
K+L+D G I G +G +YL + + A ++ N + + F +
Sbjct: 29 KVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQ 88
Query: 139 ELG---------LWQKLRHPNIVQFL--GVLKHSERL--IFLTEYLRNG-SLHDILKKKG 184
+ ++L + I F G+ + R + E L G L I + G
Sbjct: 89 RVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNG 146
Query: 185 KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVL--QDEAGHLKVTDFGLSKI- 241
T + + + + Y+H + +H D+ +N+L + + D+GLS
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 242 --AQEKDSYSYKMTGG-TGSYRYM 262
Y G G+ +
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEFT 227
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 4e-07
Identities = 48/257 (18%), Positives = 80/257 (31%), Gaps = 78/257 (30%)
Query: 102 GAYGEVYLVK--WRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-----HPN---I 151
G + V+L +A K ++S + + E+ L + +R PN +
Sbjct: 48 GHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 152 VQFLGVLKHS----ERLIFLTEYLRNGSLHDILKK--KGKLDPPTAVAYALDIARGMNYL 205
VQ L K S + + E L + L + K L P + +G++YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162
Query: 206 HHHRPHAIIHRDLTPSNVL----------------------------------------- 224
H IIH D+ P N+L
Sbjct: 163 HTK--CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220
Query: 225 --------QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
E +K+ D G + + + + T YR + EV Y
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYR--SLEVLIGSGYNTPA 274
Query: 277 DVFSFALIVHEMFQGGP 293
D++S A + E+ G
Sbjct: 275 DIWSTACMAFELATGDY 291
|
| >3uo9_A Glutaminase kidney isoform, mitochondrial; hydrolase-hydrolase inhibitor complex; HET: 04A; 2.30A {Homo sapiens} PDB: 3unw_A* 3ss3_A 3ss4_A 3ss5_A* Length = 534 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 2e-05
Identities = 9/49 (18%), Positives = 16/49 (32%)
Query: 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGR 53
D + L S + + + K V P + T ++ S G
Sbjct: 478 DQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGE 526
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 30/186 (16%), Positives = 57/186 (30%), Gaps = 28/186 (15%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
G +G +YL +E + P EL +Q+ P +Q +
Sbjct: 46 GGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL 105
Query: 162 ERL-I-----FLTEYLRNG------------SLHDILKKKG-KLDPPTAVAYALDIARGM 202
+ L + L I + + T + +L I +
Sbjct: 106 KYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDIL 165
Query: 203 NYLHHHRPHAIIHRDLTPSNVL--QDEAGHLKVTDFGLSKI---AQEKDSYSYK-MTGGT 256
Y+H H +H D+ SN+L + + D+GL+ +Y+
Sbjct: 166 EYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHD 222
Query: 257 GSYRYM 262
G+ +
Sbjct: 223 GTIEFT 228
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 39/178 (21%), Positives = 68/178 (38%), Gaps = 26/178 (14%)
Query: 99 IDPGAYGEVYLVK--WRGTEIAAKT-IRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
I G++G++YL G E+A K + + + K + I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG-----VGIPTIR 71
Query: 156 GVLKHSERLIFLTEYLRNG-SLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAI 213
+ + + E L G SL D+ K T + A + + Y+H
Sbjct: 72 WCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---F 126
Query: 214 IHRDLTPSNVLQ---DEAGHLKVTDFGLSKIAQEKDSYSYKM------TGGTGSYRYM 262
IHRD+ P N L + + + DFGL+K + +D+ +++ TG+ RY
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK--KYRDARTHQHIPYRENKNLTGTARYA 182
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 7e-04
Identities = 29/160 (18%), Positives = 53/160 (33%), Gaps = 24/160 (15%)
Query: 102 GAYGEVYLV----------KWRGTEIAAK----TIRSSIASNPRVRNSFMKELGLWQKLR 147
G +Y + + + K R N R + ++ W+KL
Sbjct: 53 DNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLY 112
Query: 148 ---HPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKK--KGKLDPPTAVAYALDIARGM 202
I +G H ++ FL SL L K L + + A + +
Sbjct: 113 STPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDAL 172
Query: 203 NYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVT--DFGLSK 240
+LH + +H ++T N+ D +VT +G +
Sbjct: 173 EFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 370 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 4gpm_A | 169 | Engineered protein OR264; de novo protein, structu | 99.9 | |
| 1n0q_A | 93 | 3ANK, 3 ankyrin repeats; structural protein; 1.26A | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 4gpm_A | 169 | Engineered protein OR264; de novo protein, structu | 99.87 | |
| 3c5r_A | 137 | BARD-1, BRCA1-associated ring domain protein 1; an | 99.84 | |
| 2jab_A | 136 | H10-2-G3; HER2, darpin, ankyrin repeat protein, me | 99.84 | |
| 2zgd_A | 110 | 3 repeat synthetic ankyrin; ankyrin repeat, hydrox | 99.84 | |
| 2l6b_A | 115 | NR1C; ankyrin, consensus, repeat protein, ising mo | 99.84 | |
| 1d9s_A | 136 | Cyclin-dependent kinase 4 inhibitor B; helix-turn- | 99.83 | |
| 3aaa_C | 123 | Myotrophin, protein V-1; actin capping protein, ba | 99.83 | |
| 4b93_B | 269 | Ankyrin repeat domain-containing protein 27; endoc | 99.83 | |
| 3c5r_A | 137 | BARD-1, BRCA1-associated ring domain protein 1; an | 99.82 | |
| 1dcq_A | 278 | PYK2-associated protein beta; zinc-binding module, | 99.82 | |
| 3aaa_C | 123 | Myotrophin, protein V-1; actin capping protein, ba | 99.82 | |
| 3twr_A | 165 | Tankyrase-2; ankyrin repeat, protein-protein inter | 99.82 | |
| 1d9s_A | 136 | Cyclin-dependent kinase 4 inhibitor B; helix-turn- | 99.82 | |
| 1awc_B | 153 | Protein (GA binding protein beta 1); complex (tran | 99.82 | |
| 2vge_A | 229 | RELA-associated inhibitor; iaspp, nucleus, apoptos | 99.82 | |
| 1awc_B | 153 | Protein (GA binding protein beta 1); complex (tran | 99.81 | |
| 1bi7_B | 156 | P16INK4A, MTS1, multiple tumor suppressor; cyclin | 99.81 | |
| 3t8k_A | 186 | Uncharacterized protein; structural genomics, PSI- | 99.81 | |
| 3twr_A | 165 | Tankyrase-2; ankyrin repeat, protein-protein inter | 99.81 | |
| 3f6q_A | 179 | Integrin-linked protein kinase; ILK, integrin-link | 99.81 | |
| 1ihb_A | 162 | P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit | 99.81 | |
| 3v30_A | 172 | DNA-binding protein rfxank; structural genomics co | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 2y1l_E | 169 | Darpin-8.4; hydrolase-inhibitor complex, DEVD darp | 99.8 | |
| 1n0r_A | 126 | 4ANK, 4 ankyrin repeats; structural protein; 1.50A | 99.8 | |
| 1bd8_A | 156 | P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr | 99.8 | |
| 2y1l_E | 169 | Darpin-8.4; hydrolase-inhibitor complex, DEVD darp | 99.8 | |
| 3f6q_A | 179 | Integrin-linked protein kinase; ILK, integrin-link | 99.8 | |
| 2jab_A | 136 | H10-2-G3; HER2, darpin, ankyrin repeat protein, me | 99.79 | |
| 3v31_A | 167 | Ankyrin repeat family A protein 2; structural geno | 99.79 | |
| 3v30_A | 172 | DNA-binding protein rfxank; structural genomics co | 99.79 | |
| 4hbd_A | 276 | KN motif and ankyrin repeat domain-containing Pro; | 99.79 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 99.79 | |
| 2rfm_A | 192 | Putative ankyrin repeat protein TV1425; ANK repeat | 99.79 | |
| 1ikn_D | 236 | Protein (I-kappa-B-alpha), protein (NF-kappa-B P50 | 99.79 | |
| 1bd8_A | 156 | P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr | 99.79 | |
| 1ihb_A | 162 | P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit | 99.79 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 99.78 | |
| 3deo_A | 183 | Signal recognition particle 43 kDa protein; chloro | 99.78 | |
| 2rfm_A | 192 | Putative ankyrin repeat protein TV1425; ANK repeat | 99.78 | |
| 3v31_A | 167 | Ankyrin repeat family A protein 2; structural geno | 99.78 | |
| 1bi7_B | 156 | P16INK4A, MTS1, multiple tumor suppressor; cyclin | 99.78 | |
| 4b93_B | 269 | Ankyrin repeat domain-containing protein 27; endoc | 99.78 | |
| 3lvq_E | 497 | ARF-GAP with SH3 domain, ANK repeat and PH domain | 99.77 | |
| 1oy3_D | 282 | Transcription factor inhibitor I-kappa-B-beta; pro | 99.77 | |
| 2vge_A | 229 | RELA-associated inhibitor; iaspp, nucleus, apoptos | 99.77 | |
| 2b0o_E | 301 | UPLC1; arfgap, structural genomics, structural gen | 99.77 | |
| 3t8k_A | 186 | Uncharacterized protein; structural genomics, PSI- | 99.77 | |
| 1n0r_A | 126 | 4ANK, 4 ankyrin repeats; structural protein; 1.50A | 99.77 | |
| 3jxi_A | 260 | Vanilloid receptor-related osmotically activated p | 99.77 | |
| 3deo_A | 183 | Signal recognition particle 43 kDa protein; chloro | 99.77 | |
| 1yyh_A | 253 | HN1;, notch 1, ankyrin domain; ankyrin repeats, ce | 99.77 | |
| 1ycs_B | 239 | 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres | 99.77 | |
| 3ehr_A | 222 | Osteoclast-stimulating factor 1; beta barrel, heli | 99.76 | |
| 1oy3_D | 282 | Transcription factor inhibitor I-kappa-B-beta; pro | 99.76 | |
| 1yyh_A | 253 | HN1;, notch 1, ankyrin domain; ankyrin repeats, ce | 99.76 | |
| 1k1a_A | 241 | B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa | 99.76 | |
| 2f8y_A | 223 | Notch homolog 1, translocation-associated (drosoph | 99.76 | |
| 2etb_A | 256 | Transient receptor potential cation channel subfam | 99.76 | |
| 3ui2_A | 244 | Signal recognition particle 43 kDa protein, chlor; | 99.76 | |
| 3ui2_A | 244 | Signal recognition particle 43 kDa protein, chlor; | 99.75 | |
| 2rfa_A | 232 | Transient receptor potential cation channel subfa | 99.75 | |
| 2rfa_A | 232 | Transient receptor potential cation channel subfa | 99.75 | |
| 3hra_A | 201 | Ankyrin repeat family protein; structural protein; | 99.75 | |
| 2xai_A | 261 | ASB-9, ankyrin repeat and SOCS box protein 9; tran | 99.75 | |
| 4hbd_A | 276 | KN motif and ankyrin repeat domain-containing Pro; | 99.75 | |
| 3jue_A | 368 | Arfgap with coiled-coil, ANK repeat and PH domain | 99.75 | |
| 2pnn_A | 273 | Transient receptor potential cation channel subfa | 99.74 | |
| 3d9h_A | 285 | CDNA FLJ77766, highly similar to HOMO sapiens anky | 99.74 | |
| 3utm_A | 351 | Tankyrase-1; tankyrase, TNKS, ankryin repeat clust | 99.74 | |
| 2dzn_A | 228 | Probable 26S proteasome regulatory subunit P28; an | 99.74 | |
| 2etb_A | 256 | Transient receptor potential cation channel subfam | 99.74 | |
| 3jxi_A | 260 | Vanilloid receptor-related osmotically activated p | 99.74 | |
| 3ljn_A | 364 | Hypothetical protein; ankyrin, structural genomics | 99.74 | |
| 1k1a_A | 241 | B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa | 99.73 | |
| 2pnn_A | 273 | Transient receptor potential cation channel subfa | 99.73 | |
| 3hra_A | 201 | Ankyrin repeat family protein; structural protein; | 99.73 | |
| 3kea_A | 285 | K1L; tropism, ANK repeat, viral protein; 2.30A {Va | 99.73 | |
| 2f8y_A | 223 | Notch homolog 1, translocation-associated (drosoph | 99.73 | |
| 3aji_A | 231 | 26S proteasome non-ATPase regulatory subunit 10; g | 99.73 | |
| 3ljn_A | 364 | Hypothetical protein; ankyrin, structural genomics | 99.73 | |
| 2fo1_E | 373 | LIN-12 protein; beta-barrel, protein-DNA complex, | 99.73 | |
| 1ikn_D | 236 | Protein (I-kappa-B-alpha), protein (NF-kappa-B P50 | 99.73 | |
| 3b7b_A | 237 | Euchromatic histone-lysine N-methyltransferase 1; | 99.72 | |
| 3aji_A | 231 | 26S proteasome non-ATPase regulatory subunit 10; g | 99.72 | |
| 3kea_A | 285 | K1L; tropism, ANK repeat, viral protein; 2.30A {Va | 99.72 | |
| 1n0q_A | 93 | 3ANK, 3 ankyrin repeats; structural protein; 1.26A | 99.72 | |
| 3b7b_A | 237 | Euchromatic histone-lysine N-methyltransferase 1; | 99.71 | |
| 2xai_A | 261 | ASB-9, ankyrin repeat and SOCS box protein 9; tran | 99.71 | |
| 2l6b_A | 115 | NR1C; ankyrin, consensus, repeat protein, ising mo | 99.71 | |
| 1s70_B | 299 | 130 kDa myosin-binding subunit of smooth muscle my | 99.71 | |
| 2dzn_A | 228 | Probable 26S proteasome regulatory subunit P28; an | 99.71 | |
| 1n11_A | 437 | Ankyrin; clathrin, BAND 3, anion exchanger, struct | 99.7 | |
| 1s70_B | 299 | 130 kDa myosin-binding subunit of smooth muscle my | 99.7 | |
| 1n11_A | 437 | Ankyrin; clathrin, BAND 3, anion exchanger, struct | 99.7 | |
| 4g8k_A | 337 | 2-5A-dependent ribonuclease; ankyrin-repeat domain | 99.69 | |
| 1wdy_A | 285 | 2-5A-dependent ribonuclease; hydrolase, RNA-bindin | 99.69 | |
| 1sw6_A | 327 | Regulatory protein SWI6; transcription regulation, | 99.69 | |
| 4g8k_A | 337 | 2-5A-dependent ribonuclease; ankyrin-repeat domain | 99.69 | |
| 1sw6_A | 327 | Regulatory protein SWI6; transcription regulation, | 99.68 | |
| 3d9h_A | 285 | CDNA FLJ77766, highly similar to HOMO sapiens anky | 99.68 | |
| 1wdy_A | 285 | 2-5A-dependent ribonuclease; hydrolase, RNA-bindin | 99.68 | |
| 2fo1_E | 373 | LIN-12 protein; beta-barrel, protein-DNA complex, | 99.67 | |
| 3utm_A | 351 | Tankyrase-1; tankyrase, TNKS, ankryin repeat clust | 99.66 | |
| 2b0o_E | 301 | UPLC1; arfgap, structural genomics, structural gen | 99.65 | |
| 3jue_A | 368 | Arfgap with coiled-coil, ANK repeat and PH domain | 99.64 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3eu9_A | 240 | Huntingtin-interacting protein 14; epigenetics, an | 99.61 | |
| 3eu9_A | 240 | Huntingtin-interacting protein 14; epigenetics, an | 99.61 | |
| 3lvq_E | 497 | ARF-GAP with SH3 domain, ANK repeat and PH domain | 99.6 | |
| 2aja_A | 376 | Ankyrin repeat family protein; NESG, Q5ZSV0, struc | 99.59 | |
| 1dcq_A | 278 | PYK2-associated protein beta; zinc-binding module, | 99.56 | |
| 2zgd_A | 110 | 3 repeat synthetic ankyrin; ankyrin repeat, hydrox | 99.5 | |
| 2aja_A | 376 | Ankyrin repeat family protein; NESG, Q5ZSV0, struc | 99.48 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.05 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.77 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.63 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.59 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.52 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.19 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.12 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.08 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.07 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.99 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.97 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.48 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.34 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.25 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.18 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.17 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.08 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.07 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.04 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.99 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.73 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.15 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.03 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.72 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.8 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.47 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=409.09 Aligned_cols=250 Identities=27% Similarity=0.472 Sum_probs=218.5
Q ss_pred CCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 98 GIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
.+|+|+||.||++.+. +..||+|.++. ......+.|.+|+.++++++|||||++++++.+.+.+++||||
T Consensus 20 ~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~---~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 20 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEC--CCCEEEEEECSCC----CEEEEEEEECS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC---CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEc
Confidence 3899999999999863 56799999875 3456678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC-------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccc
Q 042314 171 LRNGSLHDILKKK-------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFG 237 (370)
Q Consensus 171 ~~g~~L~~~l~~~-------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg 237 (370)
+++|+|.+++.+. ..+++.+++.++.|+++||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFG 173 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFG 173 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCS
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcc
Confidence 9999999999764 36899999999999999999999998 9999999999999999999999999
Q ss_pred cceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCC
Q 042314 238 LSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPAL 316 (370)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 316 (370)
+|+......... ......||+.|+|||++.+..|+.++|||||||++|||+| |++||...+..+....+. .+.++..
T Consensus 174 la~~~~~~~~~~-~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~ 251 (299)
T 4asz_A 174 MSRDVYSTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-QGRVLQR 251 (299)
T ss_dssp CHHHHTGGGCEE-ETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-HTCCCCC
T ss_pred cceecCCCCcee-ecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCCCC
Confidence 998765443221 2223358999999999999999999999999999999998 899999988877766655 4556677
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042314 317 SSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 317 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
|..+|+.+.+||.+||+.||++|||++++++.|+++.+.
T Consensus 252 p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 252 PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 888999999999999999999999999999999988764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-58 Score=404.85 Aligned_cols=253 Identities=28% Similarity=0.484 Sum_probs=209.2
Q ss_pred CCCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 98 GIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
.+|.|+||.||++.+.+ .+|||+++... .+.+..+.|.+|+.++++++|||||++++++.. +.+++||||++||+|.
T Consensus 43 ~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~ 119 (307)
T 3omv_A 43 RIGSGSFGTVYKGKWHG-DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLY 119 (307)
T ss_dssp ECCCCSSSEEEEEESSS-EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHH
T ss_pred EEeeCCCcEEEEEEECC-cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHH
Confidence 38999999999998765 58999987543 455677889999999999999999999998754 5689999999999999
Q ss_pred HHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 178 DILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 178 ~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
+++... +++++.++..|+.|++.||+|||+++ ||||||||+|||+++++.+||+|||+|+........ .......
T Consensus 120 ~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~-~~~~~~~ 195 (307)
T 3omv_A 120 KHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS-QQVEQPT 195 (307)
T ss_dssp HHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-------------CC
T ss_pred HHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc-eeecccc
Confidence 999764 57999999999999999999999998 999999999999999999999999999876543221 1234457
Q ss_pred CCccccCcccccc---cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC----CCCCCCCCcHHHHHHHH
Q 042314 257 GSYRYMAPEVYRR---ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS----RPALSSLYPEPIKALLR 329 (370)
Q Consensus 257 g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~ 329 (370)
||+.|+|||++.+ ..|+.++|||||||++|||+||+.||...+............. .+..+..+|+.+.+||.
T Consensus 196 GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~ 275 (307)
T 3omv_A 196 GSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVA 275 (307)
T ss_dssp CCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHH
T ss_pred cCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHH
Confidence 9999999999864 3589999999999999999999999987654443333322221 23456678999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 330 ECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
+||+.||++|||+.++++.|+.++.+++
T Consensus 276 ~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 276 DCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp HHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 9999999999999999999999987664
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-58 Score=410.75 Aligned_cols=250 Identities=28% Similarity=0.509 Sum_probs=213.5
Q ss_pred CCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 98 GIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
.+|+|+||.||++.+. +..||||.++. .+....+.|.+|+.++++++|||||++++++.+.+.+++||||
T Consensus 48 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~---~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEECSSEEEEEEEESSSCC---CEEEEEEEESC---CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEccCCCcEEEEEEECCcccCCCCeEEEEEEECc---CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4899999999999864 56799999965 3456678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC---------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEec
Q 042314 171 LRNGSLHDILKKK---------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTD 235 (370)
Q Consensus 171 ~~g~~L~~~l~~~---------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~D 235 (370)
+++|+|.+++.+. +++++.+++.|+.|++.||.|||+++ ||||||||+|||++.++.+||+|
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcc
Confidence 9999999999754 35899999999999999999999998 99999999999999999999999
Q ss_pred cccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCC
Q 042314 236 FGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRP 314 (370)
Q Consensus 236 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 314 (370)
||+|+......... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+....+. .+.++
T Consensus 202 FGla~~~~~~~~~~-~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~-~g~~~ 279 (329)
T 4aoj_A 202 FGMSRDIYSTDYYR-VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT-QGREL 279 (329)
T ss_dssp CC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH-HTCCC
T ss_pred cccceeccCCCcce-ecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 99998765443221 2233468999999999999999999999999999999999 899999888877766654 45667
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042314 315 ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 315 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
+.|..+|+.+.+|+.+||+.||++|||+++++++|+.+.+.
T Consensus 280 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 280 ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 77888999999999999999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-58 Score=407.97 Aligned_cols=247 Identities=30% Similarity=0.516 Sum_probs=216.5
Q ss_pred CCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 99 IDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
+|+|+||.||+|.+. +..||||.++... .....+.|.+|+.++++++|||||++++++...+.+++||||+
T Consensus 34 lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~ 111 (308)
T 4gt4_A 34 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYC 111 (308)
T ss_dssp EEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcC
Confidence 899999999999863 4679999997542 3345678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC----------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEec
Q 042314 172 RNGSLHDILKKK----------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTD 235 (370)
Q Consensus 172 ~g~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~D 235 (370)
++|+|.+++..+ ..+++..+..++.|++.||.|||+++ ||||||||+|||+++++.+||+|
T Consensus 112 ~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~D 188 (308)
T 4gt4_A 112 SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISD 188 (308)
T ss_dssp SSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred CCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECC
Confidence 999999999653 35889999999999999999999998 99999999999999999999999
Q ss_pred cccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCC
Q 042314 236 FGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRP 314 (370)
Q Consensus 236 fg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~ 314 (370)
||+++......... ......||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+..+....+. .+.++
T Consensus 189 FGlar~~~~~~~~~-~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~-~~~~~ 266 (308)
T 4gt4_A 189 LGLFREVYAADYYK-LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR-NRQVL 266 (308)
T ss_dssp SCCBCGGGGGGCBC-SSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH-TTCCC
T ss_pred cccceeccCCCcee-EecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 99998765443221 2334578999999999999999999999999999999998 899999988877776655 45566
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042314 315 ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 315 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
+.|..+|+.+.+|+.+||+.||++|||+++|+++|+++
T Consensus 267 ~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 267 PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 77888999999999999999999999999999998754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-58 Score=397.84 Aligned_cols=240 Identities=28% Similarity=0.475 Sum_probs=199.5
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|+|+||.||++... |+.+|+|++.............+.+|+.++++++||||+++++++.+.+.+++||||+ +|+|
T Consensus 21 lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L 99 (275)
T 3hyh_A 21 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNEL 99 (275)
T ss_dssp EEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEH
T ss_pred EecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCH
Confidence 789999999999874 8899999998765555566788999999999999999999999999999999999999 6799
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.+++++++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....... ....+
T Consensus 100 ~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~----~~~~~ 172 (275)
T 3hyh_A 100 FDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF----LKTSC 172 (275)
T ss_dssp HHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----------------
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCCc----cCCee
Confidence 999999999999999999999999999999998 99999999999999999999999999987654322 23457
Q ss_pred CCccccCcccccccCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 257 GSYRYMAPEVYRRESY-GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
||+.|+|||++.+..+ +.++||||+||++|+|++|++||...+.......+.. ....++..+|+.+++||++||+.|
T Consensus 173 GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~~L~~d 250 (275)
T 3hyh_A 173 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN--GVYTLPKFLSPGAAGLIKRMLIVN 250 (275)
T ss_dssp --CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTSCHHHHHHHHHHSCSS
T ss_pred ECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccCC
Confidence 9999999999998886 5799999999999999999999998887776666542 334566789999999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042314 336 PDRRPTFEEIIFR 348 (370)
Q Consensus 336 p~~Rp~~~~ll~~ 348 (370)
|++|||++|++++
T Consensus 251 P~~R~s~~eil~h 263 (275)
T 3hyh_A 251 PLNRISIHEIMQD 263 (275)
T ss_dssp GGGSCCHHHHHHC
T ss_pred hhHCcCHHHHHcC
Confidence 9999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-58 Score=413.01 Aligned_cols=243 Identities=21% Similarity=0.433 Sum_probs=209.5
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|+|+||.||++... |+.+|+|++.... ......+.+.+|+.++++++|||||++++++.+.+.+|+||||++||+
T Consensus 31 ~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~ 109 (350)
T 4b9d_A 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGD 109 (350)
T ss_dssp EC------CEEEEEETTTCCEEEEEEEECTT-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEehHH-CCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 3899999999999875 8899999997654 344567889999999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 176 LHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 176 L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|+....... ...
T Consensus 110 L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~ 183 (350)
T 4b9d_A 110 LFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE---LAR 183 (350)
T ss_dssp HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH---HHH
T ss_pred HHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCcc---ccc
Confidence 99999754 35789999999999999999999998 99999999999999999999999999987654321 122
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..+||+.|+|||++.+..|+.++|||||||++|||++|++||...+..+...++.. ...+..+..+|+++.+||.+||+
T Consensus 184 ~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-~~~~~~~~~~s~~~~~li~~~L~ 262 (350)
T 4b9d_A 184 ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-GSFPPVSLHYSYDLRSLVSQLFK 262 (350)
T ss_dssp HHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-TCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-CCCCCCCccCCHHHHHHHHHHcc
Confidence 34699999999999999999999999999999999999999999888877776653 44456677899999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~ 348 (370)
.||++|||++|++++
T Consensus 263 ~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 263 RNPRDRPSVNSILEK 277 (350)
T ss_dssp SSGGGSCCHHHHHTS
T ss_pred CChhHCcCHHHHhcC
Confidence 999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-59 Score=410.67 Aligned_cols=244 Identities=24% Similarity=0.380 Sum_probs=216.5
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|+|+||.||++... |+.+|+|++.+....+....+.+.+|+.++++++|||||++++++.+.+.+|+||||++||+|
T Consensus 40 lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L 119 (311)
T 4aw0_A 40 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL 119 (311)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred EecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCH
Confidence 799999999999875 889999999764333334567899999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+........ ......+
T Consensus 120 ~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~-~~~~~~~ 195 (311)
T 4aw0_A 120 LKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ-ARANSFV 195 (311)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC-CCBCCCC
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc-ccccCcc
Confidence 999999899999999999999999999999999 999999999999999999999999999887543322 1334568
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
||+.|+|||++.+..|+.++||||+||++|+|++|++||...+......++... ...++..+|+.+++||++||..||
T Consensus 196 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli~~lL~~dp 273 (311)
T 4aw0_A 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL--EYDFPEKFFPKARDLVEKLLVLDA 273 (311)
T ss_dssp SCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTCCHHHHHHHHHHSCSSG
T ss_pred cCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCcccCHHHHHHHHHHccCCH
Confidence 999999999999999999999999999999999999999998888777766532 345667899999999999999999
Q ss_pred CCCCCHHHHHHH
Q 042314 337 DRRPTFEEIIFR 348 (370)
Q Consensus 337 ~~Rp~~~~ll~~ 348 (370)
++|||++|++.+
T Consensus 274 ~~R~t~~e~~~~ 285 (311)
T 4aw0_A 274 TKRLGCEEMEGY 285 (311)
T ss_dssp GGSTTSGGGTCH
T ss_pred hHCcChHHHcCC
Confidence 999999987543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-58 Score=409.15 Aligned_cols=255 Identities=24% Similarity=0.307 Sum_probs=215.7
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|+|+||.||++.+. |..||+|+++.... ..+|+.+++.++|||||++++++.+.+.+|+||||++||
T Consensus 64 ~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg 135 (336)
T 4g3f_A 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred cEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 34899999999999875 88999999976432 236999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC-cEEEeccccceeccccCccc--ee
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG-HLKVTDFGLSKIAQEKDSYS--YK 251 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~--~~ 251 (370)
+|.+++++.+++++..+..++.|++.||.|||+++ ||||||||+|||++.+| .+||+|||+|+......... ..
T Consensus 136 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~ 212 (336)
T 4g3f_A 136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212 (336)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence 99999999889999999999999999999999998 99999999999999987 69999999998776443211 12
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC-CCCCCCCCcHHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS-RPALSSLYPEPIKALLRE 330 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 330 (370)
....+||+.|+|||++.+..|+.++|||||||++|||++|++||...........+..... ....+..+|+.+.+||.+
T Consensus 213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~ 292 (336)
T 4g3f_A 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQE 292 (336)
T ss_dssp -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHH
T ss_pred CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHH
Confidence 2334799999999999999999999999999999999999999987665544444433222 234677899999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHHhccCCCC
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAIQESFQKKTVP 362 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~~~ 362 (370)
||+.||++|||+.|++++|.........-..|
T Consensus 293 ~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hP 324 (336)
T 4g3f_A 293 GLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324 (336)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSC
T ss_pred HccCCHhHCcCHHHHHHHHHHHHhhhhhccCC
Confidence 99999999999999999999988876654433
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-57 Score=397.75 Aligned_cols=243 Identities=24% Similarity=0.425 Sum_probs=205.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee----CCceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH----SERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~----~~~~~~v~e~~ 171 (370)
.+|.|+||.||+|.+. +..+|+|.+.... ......+.+.+|+.++++++|||||++++++.. .+.+++||||+
T Consensus 33 ~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred EEecCcCcEEEEEEECCCCeEEEEEEEchhh-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence 3899999999999876 6789999987653 344567889999999999999999999999865 35689999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC-CCcEEEeccccceeccccCccce
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE-AGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+||+|.+++.+.+.+++..+..++.||+.||.|||+++ .+|+||||||+|||++. +|.+||+|||+|+.....
T Consensus 112 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----- 185 (290)
T 3fpq_A 112 TSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----- 185 (290)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-----
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-----
Confidence 99999999999889999999999999999999999986 45999999999999984 789999999999754332
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA-VQVADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
.....+||+.|+|||++.+ .|+.++|||||||++|||+||++||..... ......+......+..+...++.+.+||.
T Consensus 186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~ 264 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHH
Confidence 1233579999999999865 599999999999999999999999976544 33434443222333456678899999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~ 348 (370)
+||..||++|||++++++|
T Consensus 265 ~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 265 GCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHSCSSGGGSCCHHHHHTS
T ss_pred HHccCChhHCcCHHHHhcC
Confidence 9999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-57 Score=406.09 Aligned_cols=240 Identities=24% Similarity=0.426 Sum_probs=211.3
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|+|+||.||+|... |+.+|+|++....... .+.+.+|+.+++.++|||||++++++.+.+.+|+||||++||+|
T Consensus 82 iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred eecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 899999999999885 8899999997543322 34578999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.+. ++++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+....... .....+
T Consensus 159 ~~~l~~~-~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~~ 231 (346)
T 4fih_A 159 TDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---RRKSLV 231 (346)
T ss_dssp HHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC---CBCCCC
T ss_pred HHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC---cccccc
Confidence 9999874 7999999999999999999999999 99999999999999999999999999987754432 234457
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC-CCCCCCCCCcHHHHHHHHHhcccC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED-SRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
||+.|+|||++.+..|+.++|||||||++|||++|++||...+..+....+.... .....+..+|+++++||.+||..|
T Consensus 232 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~d 311 (346)
T 4fih_A 232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRD 311 (346)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSS
T ss_pred cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCC
Confidence 9999999999999999999999999999999999999999988877766654322 233344568999999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042314 336 PDRRPTFEEIIFR 348 (370)
Q Consensus 336 p~~Rp~~~~ll~~ 348 (370)
|++|||++|+++|
T Consensus 312 P~~R~ta~e~l~H 324 (346)
T 4fih_A 312 PAQRATAAELLKH 324 (346)
T ss_dssp TTTSCCHHHHTTC
T ss_pred hhHCcCHHHHhcC
Confidence 9999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=407.83 Aligned_cols=241 Identities=24% Similarity=0.420 Sum_probs=212.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|+|+||.||+|... |+.||+|.+...... ..+.+.+|+.+++.++|||||+++++|.+.+.+|+|||||+||+
T Consensus 158 ~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~ 234 (423)
T 4fie_A 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 234 (423)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCc
Confidence 3899999999999885 889999999754322 24567899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++... ++++..+..++.||+.||.|||++| ||||||||+|||++.+|.+||+|||+|+....... .....
T Consensus 235 L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~~~ 307 (423)
T 4fie_A 235 LTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---RRKSL 307 (423)
T ss_dssp HHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC---CBCCC
T ss_pred HHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc---ccccc
Confidence 99999764 7999999999999999999999999 99999999999999999999999999987754432 23345
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC-CCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED-SRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
+||+.|||||++.+..|+.++|||||||++|||++|++||...+.......+.... .....+..+|+.+++||.+||..
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~ 387 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 387 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCC
Confidence 79999999999999999999999999999999999999999988877766654322 23344567899999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042314 335 NPDRRPTFEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~ 348 (370)
||++|||++|+++|
T Consensus 388 dP~~R~ta~ell~H 401 (423)
T 4fie_A 388 DPAQRATAAELLKH 401 (423)
T ss_dssp STTTSCCHHHHTTC
T ss_pred ChhHCcCHHHHhcC
Confidence 99999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-57 Score=399.78 Aligned_cols=241 Identities=29% Similarity=0.449 Sum_probs=203.5
Q ss_pred CCCCCcccEEEEEE-----cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKW-----RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~-----~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|+|+||.||+|.. .++.+|+|++....... .....+.+|+.++++++|||||++++++.+.+.+|+||||++|
T Consensus 32 lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~g 110 (304)
T 3ubd_A 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRG 110 (304)
T ss_dssp EECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTT
T ss_pred EecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCC
Confidence 79999999999976 35679999987543221 1223578899999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|+|.+++.+.+.+++..+..++.|++.||.|||++| |+||||||+|||++.+|.+||+|||+|+....... ...
T Consensus 111 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~---~~~ 184 (304)
T 3ubd_A 111 GDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAY 184 (304)
T ss_dssp CEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----C---CCC
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCCc---ccc
Confidence 999999999899999999999999999999999999 99999999999999999999999999986544322 233
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..+||+.|+|||++.+..|+.++||||+||++|||++|++||...+..+....+.. ..+..+..+|+.+.+||++||+
T Consensus 185 ~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~~L~ 262 (304)
T 3ubd_A 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKLGMPQFLSPEAQSLLRMLFK 262 (304)
T ss_dssp SCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCCcCCHHHHHHHHHHcc
Confidence 45799999999999999999999999999999999999999999888877776653 3345677899999999999999
Q ss_pred cCCCCCCCH-----HHHHHH
Q 042314 334 KNPDRRPTF-----EEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~-----~~ll~~ 348 (370)
.||++|||+ +|+++|
T Consensus 263 ~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 263 RNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp SSGGGSTTCSTTTHHHHHTS
T ss_pred cCHHHCCCCCcCCHHHHHcC
Confidence 999999984 677754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-56 Score=402.73 Aligned_cols=253 Identities=26% Similarity=0.486 Sum_probs=216.7
Q ss_pred CCCCCCcccEEEEEEcC-------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCC-CceeeeeeeEee-CCceEEEE
Q 042314 98 GIDPGAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH-PNIVQFLGVLKH-SERLIFLT 168 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g-------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h-p~Iv~~~~~~~~-~~~~~~v~ 168 (370)
.+|.|+||.||+|.+.+ +.||+|.+... ......+.+.+|+.++++++| ||||++++++.. .+.+++||
T Consensus 71 ~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~--~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~ 148 (353)
T 4ase_A 71 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 148 (353)
T ss_dssp EEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred EEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc--cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEE
Confidence 37999999999998764 46899998754 334556789999999999975 899999999866 45789999
Q ss_pred eecCCCCHHHHHHhC----------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEE
Q 042314 169 EYLRNGSLHDILKKK----------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLK 232 (370)
Q Consensus 169 e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~k 232 (370)
|||++|+|.++++.. ..+++..++.++.|+++||.|||+++ ||||||||+|||++.++.+|
T Consensus 149 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vK 225 (353)
T 4ase_A 149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 225 (353)
T ss_dssp ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEE
Confidence 999999999999753 34789999999999999999999998 99999999999999999999
Q ss_pred EeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccC
Q 042314 233 VTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYED 311 (370)
Q Consensus 233 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 311 (370)
|+|||+|+......... ......||+.|+|||++.+..|+.++|||||||++|||+| |++||...............+
T Consensus 226 i~DFGlar~~~~~~~~~-~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g 304 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 304 (353)
T ss_dssp ECCCGGGSCTTTCTTSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred ECcchhhhhcccCCCce-eeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcC
Confidence 99999998765443322 2334468999999999999999999999999999999998 899998766544444444466
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 312 SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 312 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
.++..|..+|+.+.++|.+||+.||++|||+++++++|+++.+.-
T Consensus 305 ~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 305 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 778888889999999999999999999999999999999987653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=384.09 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=199.2
Q ss_pred cCCCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC----ceEEEEeecC
Q 042314 97 GGIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE----RLIFLTEYLR 172 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~----~~~~v~e~~~ 172 (370)
..+|+|+||.||++.++|+.||||++.... .....+..|+..+.+++|||||++++++...+ .+++||||++
T Consensus 9 ~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~ 84 (303)
T 3hmm_A 9 ESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEECSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEeeCCCeEEEEEEECCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCC
Confidence 348999999999999999999999986532 22223345666667889999999999987654 5799999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcC-----CCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHR-----PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~-----~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
+|+|.++++.. ++++..+.+++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 163 (303)
T 3hmm_A 85 HGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163 (303)
T ss_dssp TCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred CCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCC
Confidence 99999999875 7899999999999999999999861 12399999999999999999999999999987765432
Q ss_pred cc-eeccCCCCCccccCccccccc------CCCchhhHHHHHHHHHHHHhCCCCCCCC---------------cHHHHHH
Q 042314 248 YS-YKMTGGTGSYRYMAPEVYRRE------SYGKSVDVFSFALIVHEMFQGGPSNRAD---------------TAVQVAD 305 (370)
Q Consensus 248 ~~-~~~~~~~g~~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~g~~p~~~~---------------~~~~~~~ 305 (370)
.. .......||+.|+|||++.+. .++.++|||||||++|||+||.+||... .......
T Consensus 164 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 243 (303)
T 3hmm_A 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243 (303)
T ss_dssp EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHH
Confidence 21 122345799999999999764 3677999999999999999997765321 1223333
Q ss_pred HhhccCCCCCCCCC-----CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042314 306 RRAYEDSRPALSSL-----YPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 306 ~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
.......++.++.. .++.+.+|+.+||+.||++|||+.++++.|+++.+.
T Consensus 244 ~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 33334445555433 235789999999999999999999999999998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=381.41 Aligned_cols=243 Identities=26% Similarity=0.397 Sum_probs=187.9
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC------------c
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE------------R 163 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~------------~ 163 (370)
.+|+|+||.||++.+. |+.+|+|.++.. ......+.+.+|+.++++++|||||++++++...+ .
T Consensus 12 ~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~ 89 (299)
T 4g31_A 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLP--NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89 (299)
T ss_dssp EEEECC--EEEEEEETTTCCEEEEEEEEEC--SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence 3789999999999875 889999998754 34556778999999999999999999999987544 3
Q ss_pred eEEEEeecCCCCHHHHHHhCCCC---ChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccce
Q 042314 164 LIFLTEYLRNGSLHDILKKKGKL---DPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK 240 (370)
Q Consensus 164 ~~~v~e~~~g~~L~~~l~~~~~~---~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~ 240 (370)
+|+||||++||+|.+++..+..+ +...++.++.|+++||+|||+++ |+||||||+|||++.+|.+||+|||+|+
T Consensus 90 l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~ 166 (299)
T 4g31_A 90 LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVT 166 (299)
T ss_dssp EEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC-
T ss_pred EEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccce
Confidence 79999999999999999977544 44568899999999999999998 9999999999999999999999999998
Q ss_pred eccccCccc---------eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC
Q 042314 241 IAQEKDSYS---------YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED 311 (370)
Q Consensus 241 ~~~~~~~~~---------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 311 (370)
......... ....+.+||+.|+|||++.+..|+.++|||||||++|||++ ||................
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~ 243 (299)
T 4g31_A 167 AMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNL 243 (299)
T ss_dssp -------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTT
T ss_pred ecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcC
Confidence 765432211 12234579999999999999999999999999999999996 776543322222212122
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
..++.....++.+.+||++||+.||++|||+.+++++
T Consensus 244 ~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 244 KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 3333333345668899999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=379.26 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=204.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee------CCceEEEEe
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH------SERLIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~------~~~~~~v~e 169 (370)
.+|.|+||.||+|... |+.||+|+++... ......+.+.+|+.+++.++|||||++++++.. .+.+|+|||
T Consensus 61 ~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE 139 (398)
T 4b99_A 61 TIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLD 139 (398)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEE
T ss_pred EEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEe
Confidence 3799999999999875 8899999997653 344556788999999999999999999998754 357899999
Q ss_pred ecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc-c
Q 042314 170 YLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS-Y 248 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 248 (370)
|++ |+|.+++.+.+++++..+..++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+|+....... .
T Consensus 140 ~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~ 215 (398)
T 4b99_A 140 LME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 215 (398)
T ss_dssp CCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------
T ss_pred CCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecccCcccc
Confidence 996 589999999899999999999999999999999999 99999999999999999999999999987654322 1
Q ss_pred ceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCC------------
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPA------------ 315 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 315 (370)
.......+||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+.......+......+.
T Consensus 216 ~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~ 295 (398)
T 4b99_A 216 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERV 295 (398)
T ss_dssp CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CH
T ss_pred ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhh
Confidence 2234456899999999998875 468999999999999999999999998877665554432111110
Q ss_pred -----------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 316 -----------------LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 316 -----------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
....+++.+.+||++||..||++|||++|+++|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 296 RAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 113467889999999999999999999999876
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=386.70 Aligned_cols=241 Identities=25% Similarity=0.399 Sum_probs=203.0
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccC---CChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIA---SNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~---~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|+||.||++... |+.+|+|++.+... ...........++.+++.++|||||+++++|.+.+.+|+||||++
T Consensus 196 ~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~ 275 (689)
T 3v5w_A 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 275 (689)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCC
Confidence 3799999999999875 88999999965421 222233334455667777899999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
||+|.+++.+.+.+++..++.++.||+.||.|||++| ||||||||+|||++.+|.+||+|||+|+...... .
T Consensus 276 GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~-----~ 347 (689)
T 3v5w_A 276 GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----P 347 (689)
T ss_dssp SCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-----C
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCCC-----C
Confidence 9999999999999999999999999999999999999 9999999999999999999999999998765432 2
Q ss_pred cCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 253 TGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTA---VQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
...+||+.|+|||++.+ ..|+.++|+|||||++|||++|++||..... ......+. ......+..+|+.+++||
T Consensus 348 ~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~--~~~~~~p~~~S~~a~dLI 425 (689)
T 3v5w_A 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPELRSLL 425 (689)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH--HCCCCCCTTSCHHHHHHH
T ss_pred CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc--CCCCCCCccCCHHHHHHH
Confidence 34589999999999964 5799999999999999999999999976432 22222222 344556778999999999
Q ss_pred HHhcccCCCCCCC-----HHHHHHH
Q 042314 329 RECWHKNPDRRPT-----FEEIIFR 348 (370)
Q Consensus 329 ~~~l~~~p~~Rp~-----~~~ll~~ 348 (370)
++||..||.+|++ ++++++|
T Consensus 426 ~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 426 EGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred HHHccCCHhHCCCCCCCCHHHHhcC
Confidence 9999999999998 6888765
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=363.08 Aligned_cols=239 Identities=21% Similarity=0.331 Sum_probs=190.9
Q ss_pred CCCCCcccEEEEEEc-----CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKWR-----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
+|+|+||.||+|..+ +..+|+|.+.... ...++.+|+.+++.+ +||||+++++++.+.+.+++||||++
T Consensus 29 lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~ 103 (361)
T 4f9c_A 29 IGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLE 103 (361)
T ss_dssp EEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCC
T ss_pred EecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCC
Confidence 789999999999763 5679999886532 234678999999988 69999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC-CcEEEeccccceeccccCcc---
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA-GHLKVTDFGLSKIAQEKDSY--- 248 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~--- 248 (370)
||+|.++++ .+++.++..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||+|+........
T Consensus 104 g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~ 177 (361)
T 4f9c_A 104 HESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177 (361)
T ss_dssp CCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGG
T ss_pred cccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccc
Confidence 999999984 6899999999999999999999999 9999999999999876 79999999999865432211
Q ss_pred ----------------------ceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcH-HHHH
Q 042314 249 ----------------------SYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTA-VQVA 304 (370)
Q Consensus 249 ----------------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~ 304 (370)
.......+||+.|+|||++.+. .++.++||||+||++|||++|++||..... ....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l 257 (361)
T 4f9c_A 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTAL 257 (361)
T ss_dssp GC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 0112335799999999999875 489999999999999999999999964432 2111
Q ss_pred HHhhc---------------------------------------c-------------CCCCCCCCCCcHHHHHHHHHhc
Q 042314 305 DRRAY---------------------------------------E-------------DSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 305 ~~~~~---------------------------------------~-------------~~~~~~~~~~~~~l~~li~~~l 332 (370)
..+.. . .........+|+++.+||++||
T Consensus 258 ~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL 337 (361)
T 4f9c_A 258 AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLL 337 (361)
T ss_dssp HHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHT
T ss_pred HHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHC
Confidence 11100 0 0001123457889999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFR 348 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~ 348 (370)
..||++|||++|+++|
T Consensus 338 ~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 338 DLNPASRITAEEALLH 353 (361)
T ss_dssp CSCTTTSCCHHHHHTS
T ss_pred cCChhHCcCHHHHhcC
Confidence 9999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=381.62 Aligned_cols=241 Identities=24% Similarity=0.388 Sum_probs=211.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... |+.+|+|.+... .....+.+.+|+.+++.++||||++++++|.+.+.+++||||++||+
T Consensus 164 ~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~ 240 (573)
T 3uto_A 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240 (573)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 3799999999999875 889999998653 33456778899999999999999999999999999999999999999
Q ss_pred HHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC--CcEEEeccccceeccccCccceec
Q 042314 176 LHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA--GHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 176 L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~--~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|.+++.+ .+.+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++....... .
T Consensus 241 L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~----~ 313 (573)
T 3uto_A 241 LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS----V 313 (573)
T ss_dssp HHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE----E
T ss_pred HHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCc----e
Confidence 9999864 468999999999999999999999999 9999999999999854 8999999999988765432 2
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC--CCCCCCCCcHHHHHHHHH
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS--RPALSSLYPEPIKALLRE 330 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~ 330 (370)
...+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+..+....+..... ....+..+|+.+++||++
T Consensus 314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ 393 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 393 (573)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHT
T ss_pred eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence 234799999999999999999999999999999999999999999888877766653332 233446789999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~ 348 (370)
||..||.+|||+.|+++|
T Consensus 394 ~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 394 LLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TSCSSGGGSCCHHHHHHS
T ss_pred HccCChhHCcCHHHHhcC
Confidence 999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=351.62 Aligned_cols=257 Identities=32% Similarity=0.569 Sum_probs=215.7
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHHH
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHD 178 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~~ 178 (370)
+|.|+||.||++.+.+..+|+|++.... ......+.+.+|+.++++++||||+++++++...+..++||||+++++|.+
T Consensus 45 lG~G~~g~V~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 123 (309)
T 3p86_A 45 IGAGSFGTVHRAEWHGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123 (309)
T ss_dssp EEECSSEEEEEEEETTEEEEEEEECCCC-CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHH
T ss_pred eecCCCeEEEEEEECCCcEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHH
Confidence 7889999999999999999999987653 345566789999999999999999999999999999999999999999999
Q ss_pred HHHhCCC---CChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 179 ILKKKGK---LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 179 ~l~~~~~---~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
++.+.+. +++..++.++.|++.||.|||+++ .+|+||||||+||+++.++.+||+|||+++....... .....
T Consensus 124 ~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~ 199 (309)
T 3p86_A 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL---SSKSA 199 (309)
T ss_dssp HHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------------------
T ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc---ccccC
Confidence 9987653 899999999999999999999976 3599999999999999999999999999975543321 12334
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||++.+..++.++||||||+++|+|++|+.||.....................+..+|+.+.++|.+||+.|
T Consensus 200 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 279 (309)
T 3p86_A 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNE 279 (309)
T ss_dssp --CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred CCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCC
Confidence 68999999999999999999999999999999999999999988887777766666777788889999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHHhccCC
Q 042314 336 PDRRPTFEEIIFRLEAIQESFQKKT 360 (370)
Q Consensus 336 p~~Rp~~~~ll~~l~~~~~~~~~~~ 360 (370)
|++|||++++++.|+.+.+...+.+
T Consensus 280 P~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 280 PWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp GGGSCCHHHHHHHHHHHHC------
T ss_pred hhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999987655433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=347.10 Aligned_cols=256 Identities=30% Similarity=0.532 Sum_probs=219.4
Q ss_pred CCCCCcccEEEEEEc-----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWR-----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|.|+||.||++... +..+|+|.++.. ......+.+.+|+.+++.++||||+++++++...+..++||||++|
T Consensus 57 lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 134 (325)
T 3kul_A 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN 134 (325)
T ss_dssp EEETTTEEEEEEEECCTTSCCEEEEEEEECTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTT
T ss_pred EEeCCCcEEEEEEEecCCCCCceEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCC
Confidence 788999999999874 345999998754 3456677899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 174 GSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 174 ~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
++|.+++... +.++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.............
T Consensus 135 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 211 (325)
T 3kul_A 135 GSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT 211 (325)
T ss_dssp CBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEEC
T ss_pred CcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeec
Confidence 9999999755 57999999999999999999999998 9999999999999999999999999998876554433344
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||............. .......+..+|+.+.+++.+|
T Consensus 212 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~ 290 (325)
T 3kul_A 212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGCPHALHQLMLDC 290 (325)
T ss_dssp C---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCCCcCHHHHHHHHHH
Confidence 44567889999999998899999999999999999999 999999888877666655 3455666778999999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHHhccCC
Q 042314 332 WHKNPDRRPTFEEIIFRLEAIQESFQKKT 360 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~ 360 (370)
|..||++|||+.++++.|+.+.+...+..
T Consensus 291 l~~dp~~Rps~~eil~~L~~l~~~~~~~~ 319 (325)
T 3kul_A 291 WHKDRAQRPRFSQIVSVLDALIRSPESLR 319 (325)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHSCC---
T ss_pred ccCChhhCcCHHHHHHHHHHHHhCccccc
Confidence 99999999999999999999988766543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=345.48 Aligned_cols=240 Identities=28% Similarity=0.472 Sum_probs=212.8
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++.. .|..+|+|++.... .+......+.+|+.+++.++||||+++++++...+..++||||++|++|
T Consensus 23 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L 101 (328)
T 3fe3_A 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEV 101 (328)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBH
T ss_pred EeeCCCEEEEEEEECCCCCEEEEEEEEhhc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcH
Confidence 68899999999986 48899999997654 3455677889999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++...+++++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... ......
T Consensus 102 ~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~----~~~~~~ 174 (328)
T 3fe3_A 102 FDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG----KLDAFC 174 (328)
T ss_dssp HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC----GGGTTS
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC----cccccc
Confidence 999998889999999999999999999999998 9999999999999999999999999997665432 223457
Q ss_pred CCccccCcccccccCCC-chhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 257 GSYRYMAPEVYRRESYG-KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
||+.|+|||.+.+..++ .++||||+||++|+|++|+.||...........+.. .....+..+|+.+.+|+++||..|
T Consensus 175 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~~L~~d 252 (328)
T 3fe3_A 175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFYMSTDCENLLKRFLVLN 252 (328)
T ss_dssp SSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHCCSS
T ss_pred CCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHCCCC
Confidence 89999999999888875 799999999999999999999999888776666553 233456678999999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042314 336 PDRRPTFEEIIFR 348 (370)
Q Consensus 336 p~~Rp~~~~ll~~ 348 (370)
|.+|||+++++++
T Consensus 253 P~~R~t~~eil~h 265 (328)
T 3fe3_A 253 PIKRGTLEQIMKD 265 (328)
T ss_dssp TTTSCCHHHHTTC
T ss_pred hhHCcCHHHHhcC
Confidence 9999999999876
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=347.96 Aligned_cols=253 Identities=27% Similarity=0.527 Sum_probs=217.4
Q ss_pred CCCCCCcccEEEEEEc---------CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEE
Q 042314 98 GIDPGAYGEVYLVKWR---------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFL 167 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~---------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v 167 (370)
.+|.|+||.||++.+. +..+|+|.++.. ........+.+|+.+++.+ +||||+++++++...+.+++|
T Consensus 88 ~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 165 (370)
T 2psq_A 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165 (370)
T ss_dssp EESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence 3799999999999863 345999998754 3345667899999999999 899999999999999999999
Q ss_pred EeecCCCCHHHHHHhCC----------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcE
Q 042314 168 TEYLRNGSLHDILKKKG----------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHL 231 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~ 231 (370)
|||+++|+|.+++...+ .++...++.++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 242 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVM 242 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCE
Confidence 99999999999998753 4788999999999999999999998 9999999999999999999
Q ss_pred EEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcc
Q 042314 232 KVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYE 310 (370)
Q Consensus 232 kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 310 (370)
||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||............. .
T Consensus 243 kl~DFG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~-~ 320 (370)
T 2psq_A 243 KIADFGLARDINNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-E 320 (370)
T ss_dssp EECCCSSCEETTCCCTTC-TTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-T
T ss_pred EEccccCCcccCccccee-cccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-c
Confidence 999999998765443221 2233457889999999999999999999999999999999 999998776655444433 4
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 311 DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 311 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
...+..+..+++.+.++|.+||+.||++||++.++++.|+++.....
T Consensus 321 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 321 GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 45566777899999999999999999999999999999999977654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=344.16 Aligned_cols=242 Identities=26% Similarity=0.425 Sum_probs=211.2
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... |+.+|+|+++............+.+|..+++.++||||+++++++...+.+++||||++||+|
T Consensus 13 lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L 92 (337)
T 1o6l_A 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL 92 (337)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcH
Confidence 788999999999875 788999999764322223456788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+||+++.+|.+||+|||+++....... ......
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~~ 166 (337)
T 1o6l_A 93 FFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFC 166 (337)
T ss_dssp HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC---CBCCCE
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCCC---cccccc
Confidence 999998889999999999999999999999998 99999999999999999999999999875433221 223446
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
||+.|+|||++.+..++.++|+||||+++|||++|++||...........+.. .....+..+|+.+.++|++||+.||
T Consensus 167 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~lL~~dP 244 (337)
T 1o6l_A 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSLLAGLLKKDP 244 (337)
T ss_dssp ECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSST
T ss_pred cChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 89999999999999999999999999999999999999998877776665543 2344567789999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 042314 337 DRRP-----TFEEIIFR 348 (370)
Q Consensus 337 ~~Rp-----~~~~ll~~ 348 (370)
++|| ++++++++
T Consensus 245 ~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 245 KQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTSTTCSTTTHHHHHTS
T ss_pred HHhcCCCCCCHHHHHcC
Confidence 9999 89999876
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=337.31 Aligned_cols=254 Identities=24% Similarity=0.412 Sum_probs=215.1
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+++|.+...........+.+.+|+.++++++||||+++++++...+..++||||++|++|
T Consensus 19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L 98 (294)
T 4eqm_A 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTL 98 (294)
T ss_dssp EEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCH
Confidence 688999999999864 788999998776666777888999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++...+++++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ......
T Consensus 99 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~ 173 (294)
T 4eqm_A 99 SEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT--QTNHVL 173 (294)
T ss_dssp HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccccc--ccCccc
Confidence 999998889999999999999999999999998 999999999999999999999999999766543221 222346
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC---CCCCCCCcHHHHHHHHHhcc
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR---PALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~ 333 (370)
||+.|+|||.+.+..++.++||||||+++|+|++|+.||.................. ...+..+|+.+.++|.+||+
T Consensus 174 gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 253 (294)
T 4eqm_A 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATE 253 (294)
T ss_dssp -CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSC
T ss_pred cCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhc
Confidence 899999999999999999999999999999999999999988876655444322222 12456789999999999999
Q ss_pred cCCCCCC-CHHHHHHHHHHHHHHhc
Q 042314 334 KNPDRRP-TFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 334 ~~p~~Rp-~~~~ll~~l~~~~~~~~ 357 (370)
.||.+|| +++++.+.|..+.....
T Consensus 254 ~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 254 KDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp SSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred CCHhHccccHHHHHHHHHHHHhhcc
Confidence 9999998 89999999887654433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=334.89 Aligned_cols=240 Identities=26% Similarity=0.461 Sum_probs=208.1
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++.. .+..+|+|.+....... .+.+.+|+.+++.++||||+++++++...+..++||||++|++|
T Consensus 28 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (297)
T 3fxz_A 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (297)
T ss_dssp EEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence 78899999999975 47889999987653332 45688999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.+. .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ......
T Consensus 105 ~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~ 177 (297)
T 3fxz_A 105 TDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMV 177 (297)
T ss_dssp HHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC---CBCCCC
T ss_pred HHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc---ccCCcc
Confidence 9999876 7999999999999999999999998 99999999999999999999999999987654432 223456
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-cCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY-EDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
||+.|+|||.+.+..++.++||||||+++|+|++|+.||.............. .......+..+|+.+.++|.+||+.|
T Consensus 178 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 257 (297)
T 3fxz_A 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 257 (297)
T ss_dssp SCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSS
T ss_pred CCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCC
Confidence 89999999999999999999999999999999999999988776655444332 22334445678999999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042314 336 PDRRPTFEEIIFR 348 (370)
Q Consensus 336 p~~Rp~~~~ll~~ 348 (370)
|++|||+++++++
T Consensus 258 p~~Rps~~ell~h 270 (297)
T 3fxz_A 258 VEKRGSAKELLQH 270 (297)
T ss_dssp TTTSCCHHHHTTC
T ss_pred hhHCcCHHHHhhC
Confidence 9999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=346.69 Aligned_cols=254 Identities=28% Similarity=0.513 Sum_probs=206.0
Q ss_pred CCCCCCcccEEEEEEc-----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWR-----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|+||.||++... +..+|+|.++.. ........+.+|+.++++++||||+++++++...+..++||||++
T Consensus 52 ~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 129 (373)
T 2qol_A 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129 (373)
T ss_dssp EEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence 3789999999999764 667999998764 345667889999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 173 NGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 173 g~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
+++|.+++.+.+ .++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...........
T Consensus 130 ~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 206 (373)
T 2qol_A 130 NGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206 (373)
T ss_dssp TCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------------
T ss_pred CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCcccee
Confidence 999999998754 6999999999999999999999998 999999999999999999999999999877654332222
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||............. .......+..+|..+.+++.+
T Consensus 207 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~ 285 (373)
T 2qol_A 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-EGYRLPPPMDCPAALYQLMLD 285 (373)
T ss_dssp -------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH-TTEECCCCTTCBHHHHHHHHH
T ss_pred ccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccccHHHHHHHHH
Confidence 333346788999999999999999999999999999998 999998887766655544 333445566789999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
||+.||++||++.++++.|+++.+...
T Consensus 286 cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 286 CWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred HhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=343.87 Aligned_cols=257 Identities=30% Similarity=0.554 Sum_probs=222.4
Q ss_pred CCCCCCcccEEEEEEcC---------ceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEE
Q 042314 98 GIDPGAYGEVYLVKWRG---------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFL 167 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g---------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v 167 (370)
.+|.|+||.||++...+ ..+|+|+++.. ........+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 76 ~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 153 (382)
T 3tt0_A 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 153 (382)
T ss_dssp EEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence 37889999999998642 46999998764 3455668899999999999 899999999999999999999
Q ss_pred EeecCCCCHHHHHHhCC----------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcE
Q 042314 168 TEYLRNGSLHDILKKKG----------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHL 231 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~ 231 (370)
|||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+
T Consensus 154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 230 (382)
T 3tt0_A 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM 230 (382)
T ss_dssp EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcE
Confidence 99999999999998753 4899999999999999999999998 9999999999999999999
Q ss_pred EEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcc
Q 042314 232 KVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYE 310 (370)
Q Consensus 232 kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 310 (370)
||+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||............. .
T Consensus 231 kL~DFG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~-~ 308 (382)
T 3tt0_A 231 KIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-E 308 (382)
T ss_dssp EECSCSCCCCSSCCCTTC-CCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-T
T ss_pred EEcccCcccccccccccc-cccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 999999998765443221 2334467889999999999999999999999999999999 999999887766655544 4
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccCCC
Q 042314 311 DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKTV 361 (370)
Q Consensus 311 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~~ 361 (370)
......+..+++.+.+++.+||+.||++|||+.+++++|+++.........
T Consensus 309 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 309 GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence 455666778999999999999999999999999999999999887765554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=341.16 Aligned_cols=243 Identities=25% Similarity=0.412 Sum_probs=210.7
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCC---hHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASN---PRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~---~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|.|+||.||++... |..+|+|.+....... ......+.+|+.+++.++||||+++++++...+.+++||||++|
T Consensus 20 LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~g 99 (361)
T 2yab_A 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSG 99 (361)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCC
Confidence 788999999999875 7889999987653321 12456789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC----cEEEeccccceeccccCccc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG----HLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~ 249 (370)
|+|.+++...+.+++..+..++.|++.||.|||++| |+||||||+||+++.++ .+||+|||++........
T Consensus 100 g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~-- 174 (361)
T 2yab_A 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-- 174 (361)
T ss_dssp CBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC--
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc--
Confidence 999999998889999999999999999999999998 99999999999998777 799999999987654322
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--CCCCCCCcHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PALSSLYPEPIKAL 327 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l 327 (370)
.....||+.|+|||++.+..++.++||||||+++|+|++|.+||...........+...... +..+..+|+.+.+|
T Consensus 175 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 252 (361)
T 2yab_A 175 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDF 252 (361)
T ss_dssp --CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHH
T ss_pred --cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHH
Confidence 23346899999999999999999999999999999999999999988877766665432221 22345688999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 042314 328 LRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 328 i~~~l~~~p~~Rp~~~~ll~~ 348 (370)
|++||..||++|||+.+++++
T Consensus 253 i~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 253 IRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHCCCChhHCcCHHHHhcC
Confidence 999999999999999999863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=349.33 Aligned_cols=252 Identities=28% Similarity=0.505 Sum_probs=216.9
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++.+. +..+|+|.++.. ........+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 121 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 198 (377)
T 3cbl_A 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 198 (377)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCC
Confidence 3789999999999885 788999998754 344566778999999999999999999999999999999999999999
Q ss_pred HHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++... ..++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......... ....
T Consensus 199 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~-~~~~ 274 (377)
T 3cbl_A 199 FLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA-SGGL 274 (377)
T ss_dssp HHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC-CSSC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee-cCCC
Confidence 99999865 36899999999999999999999998 9999999999999999999999999998654332110 1111
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..+++.|+|||.+.+..++.++||||||+++|||++ |..||............. ...+.+.+..+|+.+.++|.+||+
T Consensus 275 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~ 353 (377)
T 3cbl_A 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDAVFRLMEQCWA 353 (377)
T ss_dssp CEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcC
Confidence 235778999999998889999999999999999998 999998887766555443 455666777899999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHh
Q 042314 334 KNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
.||++|||++++++.|+++.+..
T Consensus 354 ~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 354 YEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCchhCcCHHHHHHHHHHHHhhc
Confidence 99999999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=331.81 Aligned_cols=248 Identities=35% Similarity=0.625 Sum_probs=205.1
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCC-hHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASN-PRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~-~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
+|.|+||.||++.+.+..+++|+++...... ....+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 15 lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (271)
T 3dtc_A 15 IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLN 94 (271)
T ss_dssp EEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHH
T ss_pred eccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHH
Confidence 6889999999999999999999987643222 344577899999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC--------CCcEEEeccccceeccccCccc
Q 042314 178 DILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE--------AGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 178 ~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~--------~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+++.. +++++..++.++.|++.||.|||+++..+|+||||||+||+++. ++.+||+|||++........
T Consensus 95 ~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-- 171 (271)
T 3dtc_A 95 RVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-- 171 (271)
T ss_dssp HHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------
T ss_pred HHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc--
Confidence 99865 48999999999999999999999987444889999999999986 67899999999976654322
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....................+..+|+.+.+++.
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 248 (271)
T 3dtc_A 172 ---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLME 248 (271)
T ss_dssp -------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHH
T ss_pred ---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHH
Confidence 12368999999999999999999999999999999999999999888777766666566666777889999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
+||+.||++|||+.+++++|+++
T Consensus 249 ~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 249 DCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHhcCCcccCcCHHHHHHHHhcC
Confidence 99999999999999999999754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=347.30 Aligned_cols=243 Identities=26% Similarity=0.413 Sum_probs=208.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|+||.||++... +..+|+|+++............+..|..+++.+ +||||+++++++...+.+++||||++||
T Consensus 30 ~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg 109 (353)
T 3txo_A 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGG 109 (353)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCC
Confidence 3788999999999875 788999999764333334456788999999988 6999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++....... ....
T Consensus 110 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~---~~~~ 183 (353)
T 3txo_A 110 DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---TTAT 183 (353)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----------
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCCc---cccc
Confidence 99999998889999999999999999999999998 99999999999999999999999999875433221 2234
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.+||+.|+|||++.+..++.++|+|||||++|||++|++||...+.......+.. .....+..+++.+.++|++||..
T Consensus 184 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~lL~~ 261 (353)
T 3txo_A 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEVVYPTWLHEDATGILKSFMTK 261 (353)
T ss_dssp --CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCS
T ss_pred cCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHhhh
Confidence 4789999999999999999999999999999999999999999888777776653 33445667899999999999999
Q ss_pred CCCCCCCH------HHHHHH
Q 042314 335 NPDRRPTF------EEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~------~~ll~~ 348 (370)
||++||++ .++++|
T Consensus 262 dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 262 NPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp SGGGSTTSGGGTCTHHHHTS
T ss_pred CHHHccCCcccCCHHHHhhC
Confidence 99999998 777653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=338.11 Aligned_cols=239 Identities=27% Similarity=0.505 Sum_probs=210.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... |+.+|+|++.............+.+|..+++.++||||+++++++.+.+.+++||||++||+|
T Consensus 14 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L 93 (318)
T 1fot_A 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL 93 (318)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCH
Confidence 788999999999875 888999999764322223456778999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+||+++.+|.+||+|||+++...... ....
T Consensus 94 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~------~~~~ 164 (318)
T 1fot_A 94 FSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT------YTLC 164 (318)
T ss_dssp HHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB------CCCC
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCcc------cccc
Confidence 999999889999999999999999999999998 9999999999999999999999999998654321 2346
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
||+.|+|||++.+..++.++|+||||+++|||++|++||...........+... ....+..+++.+.++|++||..||
T Consensus 165 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~lL~~dp 242 (318)
T 1fot_A 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRDL 242 (318)
T ss_dssp SCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCT
T ss_pred CCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHhccCH
Confidence 899999999999999999999999999999999999999988877766665532 344567789999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 042314 337 DRRP-----TFEEIIFR 348 (370)
Q Consensus 337 ~~Rp-----~~~~ll~~ 348 (370)
++|| ++++++++
T Consensus 243 ~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 243 SQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp TTCTTSSTTTTHHHHTS
T ss_pred HHcCCCcCCCHHHHhcC
Confidence 9999 88998865
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=335.73 Aligned_cols=257 Identities=28% Similarity=0.522 Sum_probs=212.8
Q ss_pred CCCCCCcccEEEEEEcC------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKWRG------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
.+|.|+||.||++.... ..+++|.+... ........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 51 ~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EEecCCCeEEEEEEEecCCCCccccEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 37889999999997652 24899998754 34556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 172 RNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 172 ~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
++++|.+++... +.++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...........
T Consensus 129 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 205 (333)
T 1mqb_A 129 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205 (333)
T ss_dssp TTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------------
T ss_pred CCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcccccccc
Confidence 999999999865 57999999999999999999999998 99999999999999999999999999987765433222
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||............. .......+..+|+.+.+++.
T Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~ 284 (333)
T 1mqb_A 206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDCPSAIYQLMM 284 (333)
T ss_dssp -----CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTCBHHHHHHHH
T ss_pred ccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CCCcCCCcccCCHHHHHHHH
Confidence 3333456889999999998899999999999999999999 999998887766655544 34455566778999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHHHhccCC
Q 042314 330 ECWHKNPDRRPTFEEIIFRLEAIQESFQKKT 360 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~ 360 (370)
+||+.||++||++.++++.|+++........
T Consensus 285 ~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~ 315 (333)
T 1mqb_A 285 QCWQQERARRPKFADIVSILDKLIRAPDSLK 315 (333)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred HHcCCChhhCcCHHHHHHHHHHHHhcchhhh
Confidence 9999999999999999999999987766543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=337.18 Aligned_cols=257 Identities=29% Similarity=0.490 Sum_probs=211.8
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|.+.. .+....+.+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 17 ~lG~G~~g~V~~~~~~~~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 93 (310)
T 3s95_A 17 VLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGT 93 (310)
T ss_dssp EEECCSSEEEEEEEETTTCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred eecCCCCEEEEEEEECCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCc
Confidence 3789999999999875 78899998754 345677889999999999999999999999999999999999999999
Q ss_pred HHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce----
Q 042314 176 LHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY---- 250 (370)
Q Consensus 176 L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~---- 250 (370)
|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...........
T Consensus 94 L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 170 (310)
T 3s95_A 94 LRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170 (310)
T ss_dssp HHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----------
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccccccccc
Confidence 9999987 467999999999999999999999998 99999999999999999999999999987654322110
Q ss_pred -------eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh-hccCCCCCCCCCCcH
Q 042314 251 -------KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRR-AYEDSRPALSSLYPE 322 (370)
Q Consensus 251 -------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 322 (370)
......||+.|+|||.+.+..++.++||||||+++|+|++|..||............ .........+..+|+
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T 3s95_A 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPP 250 (310)
T ss_dssp ---------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCT
T ss_pred ccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCH
Confidence 111346899999999999999999999999999999999999988653221100000 000001123456788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccCC
Q 042314 323 PIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKT 360 (370)
Q Consensus 323 ~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~ 360 (370)
.+.+++.+||+.||++|||+.++++.|++++..+....
T Consensus 251 ~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~ 288 (310)
T 3s95_A 251 SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHL 288 (310)
T ss_dssp THHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcc
Confidence 99999999999999999999999999999998887543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=335.08 Aligned_cols=253 Identities=28% Similarity=0.538 Sum_probs=206.6
Q ss_pred CCCCCcccEEEEEE------cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee--CCceEEEEee
Q 042314 99 IDPGAYGEVYLVKW------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH--SERLIFLTEY 170 (370)
Q Consensus 99 l~~g~~~~v~~a~~------~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~--~~~~~~v~e~ 170 (370)
+|.|+||.||++.+ .+..+|+|.+.. ......+.+.+|+.++++++||||+++++++.. ...+++||||
T Consensus 18 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 94 (295)
T 3ugc_A 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 94 (295)
T ss_dssp EEECSSEEEEEEEECTTCSSCCEEEEEEEESC---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEEC
T ss_pred eeccCCEEEEEEEEecccCCCCcEEEEEEccc---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEe
Confidence 68899999999984 477899999865 345666789999999999999999999999855 3568999999
Q ss_pred cCCCCHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 171 LRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 171 ~~g~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+++++|.+++...+ ++++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..........
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (295)
T 3ugc_A 95 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF 171 (295)
T ss_dssp CTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC---------
T ss_pred CCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCccee
Confidence 99999999998754 5999999999999999999999998 9999999999999999999999999998776543322
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH---------------HHHHhhccCCCC
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ---------------VADRRAYEDSRP 314 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---------------~~~~~~~~~~~~ 314 (370)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..||....... ............
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (295)
T 3ugc_A 172 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 251 (295)
T ss_dssp ----CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCC
T ss_pred eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcC
Confidence 23333457788999999999999999999999999999999999987543321 111122234455
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 315 ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 315 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
..+..+|+.+.+++.+||+.||++|||+.++++.|+++.+.+.
T Consensus 252 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 252 PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 6677899999999999999999999999999999999988764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=329.34 Aligned_cols=259 Identities=25% Similarity=0.427 Sum_probs=222.5
Q ss_pred CCCCCCcccEEEEEE----cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKW----RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~----~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
.+|.|+||.||++.+ .+..+++|.++.. ......+.+.+|+.+++.++||||+++++++ ..+..++||||+++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~ 93 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGG 93 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence 378999999999975 3677999998764 3456678899999999999999999999998 55679999999999
Q ss_pred CCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 174 GSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 174 ~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.............
T Consensus 94 ~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 170 (287)
T 1u59_A 94 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170 (287)
T ss_dssp EEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred CCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecc
Confidence 9999999754 46999999999999999999999998 9999999999999999999999999998776544332233
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+. ....+..+..+|+.+.++|.+|
T Consensus 171 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~ 249 (287)
T 1u59_A 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPELYALMSDC 249 (287)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHT
T ss_pred ccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHh-cCCcCCCCCCcCHHHHHHHHHH
Confidence 34457899999999998889999999999999999998 999998877665554443 3455667778999999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHHhccCCCCC
Q 042314 332 WHKNPDRRPTFEEIIFRLEAIQESFQKKTVPS 363 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~~~~ 363 (370)
|..||++||++.+++++|+.+..+......+.
T Consensus 250 l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~ 281 (287)
T 1u59_A 250 WIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281 (287)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSC
T ss_pred cCCChhhCcCHHHHHHHHHHHHHhcCCcccCC
Confidence 99999999999999999999988887665543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=341.08 Aligned_cols=252 Identities=29% Similarity=0.477 Sum_probs=216.4
Q ss_pred CCCCCcccEEEEEEcC-------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 99 IDPGAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g-------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
+|.|+||.||++...+ ..+++|.++.. ........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 55 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 132 (343)
T 1luf_A 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 132 (343)
T ss_dssp EEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeecCCeeEEEEEecCcCCCCCceeEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecC
Confidence 6889999999998864 77999998754 34566788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC------------------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC
Q 042314 172 RNGSLHDILKKK------------------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE 227 (370)
Q Consensus 172 ~g~~L~~~l~~~------------------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~ 227 (370)
++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.
T Consensus 133 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~ 209 (343)
T 1luf_A 133 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 209 (343)
T ss_dssp TTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred CCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECC
Confidence 999999999864 56899999999999999999999998 999999999999999
Q ss_pred CCcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 042314 228 AGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADR 306 (370)
Q Consensus 228 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~ 306 (370)
++.+||+|||++.......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus 210 ~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 288 (343)
T 1luf_A 210 NMVVKIADFGLSRNIYSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 288 (343)
T ss_dssp GGCEEECCCSCHHHHTGGGCBC-----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred CCeEEEeecCCCcccccCcccc-ccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHH
Confidence 9999999999997665432211 2233457899999999998899999999999999999999 9999998877666555
Q ss_pred hhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 307 RAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 307 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
+. ....+..+..+|+.+.+++.+||+.||++|||+.++++.|+++.+...
T Consensus 289 ~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 289 VR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp HH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred Hh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 44 344556677899999999999999999999999999999999876655
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=328.77 Aligned_cols=247 Identities=30% Similarity=0.560 Sum_probs=214.9
Q ss_pred CCCCCcccEEEEEE-cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 99 IDPGAYGEVYLVKW-RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 99 l~~g~~~~v~~a~~-~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
+|.|+||.||++.+ .+..+++|.+..... ..+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 18 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (269)
T 4hcu_A 18 IGSGQFGLVHLGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93 (269)
T ss_dssp EEECSSCEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred ecCCCccEEEEEEecCCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHH
Confidence 78899999999988 477899999876432 2356889999999999999999999999999999999999999999
Q ss_pred HHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 178 DILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 178 ~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
+++... +.++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ......
T Consensus 94 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~ 168 (269)
T 4hcu_A 94 DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT--SSTGTK 168 (269)
T ss_dssp HHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH--STTSTT
T ss_pred HHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc--cccCcc
Confidence 999754 46899999999999999999999998 999999999999999999999999999766443211 223345
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||............. .......+..+|+.+.+++.+||+.|
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~ 247 (269)
T 4hcu_A 169 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMNHCWRER 247 (269)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCccCCCCCcCCHHHHHHHHHHccCC
Confidence 6889999999998999999999999999999999 999999888777666554 34455666778999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHH
Q 042314 336 PDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 336 p~~Rp~~~~ll~~l~~~~~~ 355 (370)
|++|||+.+++++|+++.++
T Consensus 248 p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 248 PEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp GGGSCCHHHHHHHHHHHHHC
T ss_pred cccCcCHHHHHHHHHHHHHc
Confidence 99999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=347.39 Aligned_cols=243 Identities=22% Similarity=0.344 Sum_probs=209.5
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... |..+|+|.+.... ........+.+|+.+++.++||||+++++++...+..++||||+.||+|
T Consensus 19 LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 97 (444)
T 3soa_A 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKK-LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL 97 (444)
T ss_dssp EEEC--CEEEEEEETTTTEEEEEEEEESCS-CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBH
T ss_pred eccCCCeEEEEEEECCCCcEEEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCH
Confidence 788999999999764 8889999987653 2334567789999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC---CCCcEEEeccccceeccccCccceecc
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD---EAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
.+.+...+.+++..+..++.|++.||.|||++| |+||||||+||+++ .++.+||+|||++........ ...
T Consensus 98 ~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~---~~~ 171 (444)
T 3soa_A 98 FEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ---AWF 171 (444)
T ss_dssp HHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC---BCC
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc---eee
Confidence 999999889999999999999999999999998 99999999999998 457899999999976654322 223
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--CCCCCCCcHHHHHHHHHh
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PALSSLYPEPIKALLREC 331 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~ 331 (370)
...||+.|+|||++.+..++.++||||+||++|+|++|.+||...........+...... .+....+|+.+.+||.+|
T Consensus 172 ~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 251 (444)
T 3soa_A 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKM 251 (444)
T ss_dssp CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHH
T ss_pred cccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHH
Confidence 457899999999999999999999999999999999999999988877766665533322 233457899999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~ 348 (370)
|+.||++|||+.+++++
T Consensus 252 L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 252 LTINPSKRITAAEALKH 268 (444)
T ss_dssp SCSSTTTSCCHHHHHHS
T ss_pred cCCChhHCCCHHHHhcC
Confidence 99999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=340.72 Aligned_cols=239 Identities=27% Similarity=0.453 Sum_probs=210.9
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... |..+|+|++.............+.+|+.+++.++||||+++++++...+.+++||||++||+|
T Consensus 49 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L 128 (350)
T 1rdq_E 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128 (350)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred eecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcH
Confidence 688999999999875 789999998764322223456788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+||+++.+|.+||+|||+++...... ....
T Consensus 129 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~------~~~~ 199 (350)
T 1rdq_E 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT------WTLC 199 (350)
T ss_dssp HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB------CCCE
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCCc------cccc
Confidence 999998889999999999999999999999998 9999999999999999999999999998765432 2346
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
||+.|+|||++.+..++.++|+|||||++|+|++|.+||...........+... ....+..+|+.+.++|.+||+.||
T Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~lL~~dp 277 (350)
T 1rdq_E 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDL 277 (350)
T ss_dssp ECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHHHHHSCSCT
T ss_pred CCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhcCH
Confidence 899999999999999999999999999999999999999988887776665532 345567789999999999999999
Q ss_pred CCCCC-----HHHHHHH
Q 042314 337 DRRPT-----FEEIIFR 348 (370)
Q Consensus 337 ~~Rp~-----~~~ll~~ 348 (370)
.+||+ +++++++
T Consensus 278 ~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 278 TKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp TTCTTSSTTTTHHHHTS
T ss_pred HhccCCccCCHHHHHhC
Confidence 99998 8888765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=343.19 Aligned_cols=253 Identities=27% Similarity=0.453 Sum_probs=215.8
Q ss_pred CCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 98 GIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
.+|.|+||.||++.+. +..+|+|.++.. ........+.+|+.++++++||||+++++++......++||||
T Consensus 78 ~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 155 (367)
T 3l9p_A 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155 (367)
T ss_dssp ECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEe
Confidence 3899999999999853 457999998643 3445566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCC-------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC---cEEEeccccce
Q 042314 171 LRNGSLHDILKKKG-------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG---HLKVTDFGLSK 240 (370)
Q Consensus 171 ~~g~~L~~~l~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~---~~kl~Dfg~~~ 240 (370)
++||+|.+++...+ .++...++.++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+++
T Consensus 156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~ 232 (367)
T 3l9p_A 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232 (367)
T ss_dssp CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCcccc
Confidence 99999999998653 5889999999999999999999998 99999999999999555 59999999997
Q ss_pred eccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCC
Q 042314 241 IAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSL 319 (370)
Q Consensus 241 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (370)
......... ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...........+. .......+..
T Consensus 233 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~ 310 (367)
T 3l9p_A 233 DIYRAGYYR-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SGGRMDPPKN 310 (367)
T ss_dssp HHHHHSSCT-TCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TTCCCCCCTT
T ss_pred ccccccccc-cCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcc
Confidence 654332211 1222357899999999999999999999999999999998 999999888777666555 3445566778
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 320 YPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 320 ~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
+|+.+.+++.+||+.||++|||+.+++++|+.+.+...
T Consensus 311 ~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 311 CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 89999999999999999999999999999999976554
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=331.92 Aligned_cols=256 Identities=24% Similarity=0.456 Sum_probs=217.3
Q ss_pred CCCCCCcccEEEEEEc----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
.+|.|+||.||++.+. +..+++|.+.... ......+.+.+|+.+++.++||||+++++++ ..+..++||||+.+
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~ 101 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAEL 101 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCC
Confidence 3788999999999653 5779999987653 3345577899999999999999999999998 56778999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..............
T Consensus 102 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 178 (291)
T 1xbb_A 102 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 178 (291)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccc
Confidence 999999999888999999999999999999999998 99999999999999999999999999987765443332333
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
...+++.|+|||.+.+..++.++||||||+++|+|++ |+.||............. ....+..+..+|+.+.+++.+||
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l 257 (291)
T 1xbb_A 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCW 257 (291)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHT
T ss_pred cCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHc
Confidence 3456789999999998889999999999999999999 999999887766555544 34556667789999999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHhccC
Q 042314 333 HKNPDRRPTFEEIIFRLEAIQESFQKK 359 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~l~~~~~~~~~~ 359 (370)
+.||++||++.++++.|+.+.......
T Consensus 258 ~~dp~~Rps~~~l~~~L~~~~~~~~~~ 284 (291)
T 1xbb_A 258 TYDVENRPGFAAVELRLRNYYYDVVNE 284 (291)
T ss_dssp CSSTTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred CCChhhCcCHHHHHHHHHHHHHHHhhc
Confidence 999999999999999999997765543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=337.20 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=203.9
Q ss_pred CCCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC----ceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE----RLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~----~~~~v~e~~~g 173 (370)
.+|.|+||.||++.+.++.+|+|++... .........|+.++++++||||+++++++.... .+++||||+++
T Consensus 31 ~lg~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 31 VKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEECSTTCEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred eecccCceEEEEEEECCCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 3789999999999999999999998653 233455667899999999999999999988744 37999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhc----------CCCceeecCCCCCCeeeCCCCcEEEeccccceecc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH----------RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQ 243 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~----------~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 243 (370)
|+|.+++... .+++..++.++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 107 g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~ 182 (322)
T 3soc_A 107 GSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFE 182 (322)
T ss_dssp CBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEEC
T ss_pred CCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccc
Confidence 9999999875 699999999999999999999998 7 9999999999999999999999999998776
Q ss_pred ccCccceeccCCCCCccccCcccccc-----cCCCchhhHHHHHHHHHHHHhCCCCCCCCc----------------HHH
Q 042314 244 EKDSYSYKMTGGTGSYRYMAPEVYRR-----ESYGKSVDVFSFALIVHEMFQGGPSNRADT----------------AVQ 302 (370)
Q Consensus 244 ~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~----------------~~~ 302 (370)
...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ...
T Consensus 183 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (322)
T 3soc_A 183 AGKSAG-DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261 (322)
T ss_dssp TTSCCC-CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHH
T ss_pred cccCcc-ccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhh
Confidence 543221 2334578999999999986 345678999999999999999999986532 122
Q ss_pred HHHHhhccCCCCCCCCC-----CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 303 VADRRAYEDSRPALSSL-----YPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 303 ~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
...........+..+.. .++.+.++|.+||+.||++|||+.++++.|+++++..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 262 MQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 22222222333333322 2456999999999999999999999999999998753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=344.37 Aligned_cols=243 Identities=26% Similarity=0.427 Sum_probs=204.1
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|+||.||++... ++.+|+|+++............+..|..+++++ +||||+++++++...+.+++||||++||
T Consensus 59 ~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg 138 (396)
T 4dc2_A 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 138 (396)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCC
Confidence 3788999999999875 678999999876555555566788999999877 8999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++....... ....
T Consensus 139 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~---~~~~ 212 (396)
T 4dc2_A 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTST 212 (396)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC---CBCC
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCCC---cccc
Confidence 99999998889999999999999999999999998 99999999999999999999999999975332221 2334
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc---------HHHHHHHhhccCCCCCCCCCCcHHHH
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT---------AVQVADRRAYEDSRPALSSLYPEPIK 325 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~ 325 (370)
.+||+.|+|||++.+..++.++|+|||||++|||++|++||.... .......+. ......+..+++.+.
T Consensus 213 ~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~--~~~~~~p~~~s~~~~ 290 (396)
T 4dc2_A 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQIRIPRSLSVKAA 290 (396)
T ss_dssp CCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH--HCCCCCCTTSCHHHH
T ss_pred ccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh--ccccCCCCcCCHHHH
Confidence 579999999999999999999999999999999999999996431 122222222 334556777999999
Q ss_pred HHHHHhcccCCCCCCCH------HHHHHH
Q 042314 326 ALLRECWHKNPDRRPTF------EEIIFR 348 (370)
Q Consensus 326 ~li~~~l~~~p~~Rp~~------~~ll~~ 348 (370)
+||++||+.||++||++ ++++++
T Consensus 291 ~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 291 SVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred HHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 99999999999999985 566554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=328.93 Aligned_cols=246 Identities=25% Similarity=0.447 Sum_probs=216.2
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC--CceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS--ERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~--~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++.+++..+++|++.... ......+.+.+|+.++++++||||+++++++... +..++||||+++++|
T Consensus 18 lg~G~~g~V~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L 96 (271)
T 3kmu_A 18 LNENHSGELWKGRWQGNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSL 96 (271)
T ss_dssp EEEETTEEEEEEEETTEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBH
T ss_pred hcCCCcceEEEEEECCeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcH
Confidence 7889999999999999999999997653 3445667899999999999999999999999876 788999999999999
Q ss_pred HHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++...+ .+++..++.++.|++.||.|||+++ .+++||||||+||+++.++.++|+|||++..... ..
T Consensus 97 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~--------~~ 167 (271)
T 3kmu_A 97 YNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--------PG 167 (271)
T ss_dssp HHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--------TT
T ss_pred HHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc--------cC
Confidence 99998765 4899999999999999999999976 4599999999999999999999999887654322 22
Q ss_pred CCCCccccCcccccccCCC---chhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 255 GTGSYRYMAPEVYRRESYG---KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~---~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
..+|+.|+|||.+.+..++ .++||||||+++|+|++|+.||..................+..+..+|+.+.+++.+|
T Consensus 168 ~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 247 (271)
T 3kmu_A 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKIC 247 (271)
T ss_dssp CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHH
T ss_pred ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 3579999999999876544 3899999999999999999999988887777766666777788888999999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFRLEAIQE 354 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~l~~~~~ 354 (370)
|+.||++|||++++++.|+++.+
T Consensus 248 l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 248 MNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHCC
T ss_pred cCCChhhCcCHHHHHHHHHHhhc
Confidence 99999999999999999998754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=337.35 Aligned_cols=242 Identities=27% Similarity=0.439 Sum_probs=207.9
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... ++.+|+|++.............+.+|..+++++ +||||+++++++...+.+++||||++||+
T Consensus 17 lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~ 96 (345)
T 3a8x_A 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD 96 (345)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCc
Confidence 788999999999875 788999999877666667778899999999988 89999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+||+++.+|.+||+|||+++....... .....
T Consensus 97 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~---~~~~~ 170 (345)
T 3a8x_A 97 LMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTF 170 (345)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC---CBCCC
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCCC---ccccc
Confidence 9999998889999999999999999999999998 99999999999999999999999999975432221 22345
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC---------cHHHHHHHhhccCCCCCCCCCCcHHHHH
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRAD---------TAVQVADRRAYEDSRPALSSLYPEPIKA 326 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 326 (370)
.||+.|+|||++.+..++.++|+|||||++|||++|++||... ........+. ......+..+|..+.+
T Consensus 171 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~ 248 (345)
T 3a8x_A 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL--EKQIRIPRSLSVKAAS 248 (345)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH--HCCCCCCTTSCHHHHH
T ss_pred CCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH--cCCCCCCCCCCHHHHH
Confidence 7899999999999999999999999999999999999999652 2222222222 2344566778999999
Q ss_pred HHHHhcccCCCCCCCH------HHHHHH
Q 042314 327 LLRECWHKNPDRRPTF------EEIIFR 348 (370)
Q Consensus 327 li~~~l~~~p~~Rp~~------~~ll~~ 348 (370)
+|++||..||++||++ .+++++
T Consensus 249 li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 249 VLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 9999999999999995 666654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=343.24 Aligned_cols=252 Identities=26% Similarity=0.485 Sum_probs=213.7
Q ss_pred CCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCC-ceEEEEe
Q 042314 99 IDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSE-RLIFLTE 169 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~-~~~~v~e 169 (370)
+|.|+||.||++.+. ++.+|+|.++.. ......+.+.+|+.+++++ +||||+++++++...+ ..++|||
T Consensus 30 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e 107 (359)
T 3vhe_A 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 107 (359)
T ss_dssp EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEE
T ss_pred ecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEE
Confidence 788999999999853 367999999754 3445567899999999999 7899999999987754 4899999
Q ss_pred ecCCCCHHHHHHhCCC----------------------------------------------------------------
Q 042314 170 YLRNGSLHDILKKKGK---------------------------------------------------------------- 185 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~---------------------------------------------------------------- 185 (370)
|+++|+|.+++.....
T Consensus 108 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (359)
T 3vhe_A 108 FCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYK 187 (359)
T ss_dssp CCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTTT
T ss_pred ecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhc
Confidence 9999999999986543
Q ss_pred --CChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCCCCccccC
Q 042314 186 --LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMA 263 (370)
Q Consensus 186 --~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~a 263 (370)
+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... .......+|+.|+|
T Consensus 188 ~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~t~~y~a 263 (359)
T 3vhe_A 188 DFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMA 263 (359)
T ss_dssp TCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC-EEC--CEECGGGCC
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc-hhccccCCCceeEC
Confidence 889999999999999999999998 999999999999999999999999999876543322 12333457889999
Q ss_pred cccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCH
Q 042314 264 PEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTF 342 (370)
Q Consensus 264 PE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~ 342 (370)
||++.+..++.++||||||+++|+|++ |..||.....................+..+++.+.+++.+||+.||++|||+
T Consensus 264 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 343 (359)
T 3vhe_A 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTF 343 (359)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 999999999999999999999999998 9999987654444444444555666777899999999999999999999999
Q ss_pred HHHHHHHHHHHHHh
Q 042314 343 EEIIFRLEAIQESF 356 (370)
Q Consensus 343 ~~ll~~l~~~~~~~ 356 (370)
.+++++|+.+....
T Consensus 344 ~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 344 SELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHh
Confidence 99999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=350.32 Aligned_cols=243 Identities=32% Similarity=0.594 Sum_probs=210.8
Q ss_pred CCCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC-ceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE-RLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~-~~~~v~e~~~g~~L 176 (370)
.+|.|+||.||++.+.+..+|+|.++... ..+.+.+|+.++++++||||+++++++.... .+++||||+++|+|
T Consensus 200 ~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 200 TIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEECSSEEEEEEEETTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred eecCcCCeeEEEEEecCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 37899999999999999999999997542 3467889999999999999999999977654 79999999999999
Q ss_pred HHHHHhCCC--CChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++...+. ++...++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 275 ~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~------~~ 345 (450)
T 1k9a_A 275 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DT 345 (450)
T ss_dssp HHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----------
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc------cC
Confidence 999987643 789999999999999999999998 9999999999999999999999999998543321 12
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. .+.+...+..+|+.+.++|.+||+
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~ 424 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYDVMKNCWH 424 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcC
Confidence 256889999999999999999999999999999998 999998776555544443 455667778899999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
.||++|||+.++++.|+.+...
T Consensus 425 ~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 425 LDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHT
T ss_pred CChhHCcCHHHHHHHHHHHHHh
Confidence 9999999999999999988653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=342.53 Aligned_cols=241 Identities=27% Similarity=0.457 Sum_probs=208.5
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... ++.+|+|.++............+..|..+++.+ +||||+++++++...+.+++||||++||+
T Consensus 25 lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~ 104 (345)
T 1xjd_A 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGD 104 (345)
T ss_dssp EEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCc
Confidence 788999999999875 788999999764322223345677889988876 89999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.+.+.+++..++.++.|++.||.|||++| |+||||||+||+++.+|.+||+|||+++....... .....
T Consensus 105 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~ 178 (345)
T 1xjd_A 105 LMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNTF 178 (345)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC---CBCCC
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC---cccCC
Confidence 9999998889999999999999999999999998 99999999999999999999999999975433221 22345
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||++.+..++.++|+|||||++|||++|++||...........+.. ..+..+..+|+.+.++|.+||..|
T Consensus 179 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~lL~~d 256 (345)
T 1xjd_A 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEAKDLLVKLFVRE 256 (345)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHSCSS
T ss_pred CCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh--CCCCCCcccCHHHHHHHHHHhcCC
Confidence 789999999999999999999999999999999999999998888777666553 234556778999999999999999
Q ss_pred CCCCCCHH-HHHH
Q 042314 336 PDRRPTFE-EIIF 347 (370)
Q Consensus 336 p~~Rp~~~-~ll~ 347 (370)
|++||++. ++++
T Consensus 257 p~~R~~~~~~i~~ 269 (345)
T 1xjd_A 257 PEKRLGVRGDIRQ 269 (345)
T ss_dssp GGGSBTTBSCGGG
T ss_pred HhHcCCChHHHHc
Confidence 99999997 6654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=327.83 Aligned_cols=250 Identities=27% Similarity=0.512 Sum_probs=202.1
Q ss_pred CCCCCcccEEEEEEc-----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWR-----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|.|+||.||++... +..+++|.+... ......+.+.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 23 lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~ 99 (281)
T 1mp8_A 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTL 99 (281)
T ss_dssp EEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTT
T ss_pred eeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCC
Confidence 688999999999874 345888887653 34566788999999999999999999999974 5678999999999
Q ss_pred CCHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 174 GSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 174 ~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
++|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ..
T Consensus 100 ~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~ 174 (281)
T 1mp8_A 100 GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY--KA 174 (281)
T ss_dssp EEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----------------
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCccccc--cc
Confidence 99999998654 6899999999999999999999998 999999999999999999999999999876543221 22
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
....+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...........+. .......+..+|+.+.+++.+|
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~ 253 (281)
T 1mp8_A 175 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLMTKC 253 (281)
T ss_dssp ----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHH
Confidence 23356789999999998899999999999999999996 999998776655444443 3445566778999999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 332 WHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
|+.||++|||+.++++.|+++.+.-.
T Consensus 254 l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 254 WAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 99999999999999999999976543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=333.20 Aligned_cols=250 Identities=28% Similarity=0.526 Sum_probs=215.7
Q ss_pred CCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 99 IDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
+|.|+||.||++... +..+++|.+... ......+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 31 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 108 (314)
T 2ivs_A 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYA 108 (314)
T ss_dssp EEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred ecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeec
Confidence 688999999999762 367999998754 34566788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCC------------------------CChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC
Q 042314 172 RNGSLHDILKKKGK------------------------LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE 227 (370)
Q Consensus 172 ~g~~L~~~l~~~~~------------------------~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~ 227 (370)
++++|.+++..... +++..++.++.|++.||.|||+++ |+||||||+||+++.
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~ 185 (314)
T 2ivs_A 109 KYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAE 185 (314)
T ss_dssp TTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred CCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcC
Confidence 99999999987543 788999999999999999999998 999999999999999
Q ss_pred CCcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 042314 228 AGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADR 306 (370)
Q Consensus 228 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~ 306 (370)
++.+||+|||++.......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus 186 ~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 264 (314)
T 2ivs_A 186 GRKMKISDFGLSRDVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL 264 (314)
T ss_dssp TTEEEECCCTTCEECTTTSCEE-CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCEEEccccccccccccccce-eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999998765443221 2334457889999999998889999999999999999999 9999987766554444
Q ss_pred hhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042314 307 RAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 307 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
.. .......+..+|+.+.+++.+||+.||++|||+.+++++|+++..+
T Consensus 265 ~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 265 LK-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hh-cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 33 3445566778999999999999999999999999999999998664
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=333.24 Aligned_cols=257 Identities=27% Similarity=0.500 Sum_probs=216.4
Q ss_pred CCCCCcccEEEEEE------cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC--CceEEEEee
Q 042314 99 IDPGAYGEVYLVKW------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS--ERLIFLTEY 170 (370)
Q Consensus 99 l~~g~~~~v~~a~~------~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~--~~~~~v~e~ 170 (370)
+|.|+||.||++.+ .+..+|+|++... ........+.+|+.+++.++||||+++++++... ..+++||||
T Consensus 39 lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (318)
T 3lxp_A 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116 (318)
T ss_dssp EEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECC
T ss_pred ecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEec
Confidence 78899999998865 4778999999764 3456678899999999999999999999999874 678999999
Q ss_pred cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 171 LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 171 ~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+++++|.+++... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...........
T Consensus 117 ~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~ 192 (318)
T 3lxp_A 117 VPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 192 (318)
T ss_dssp CTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEE
T ss_pred ccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccccccc
Confidence 9999999999876 5999999999999999999999998 99999999999999999999999999988765543333
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH--------------HHHHhhccCCCCCC
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ--------------VADRRAYEDSRPAL 316 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~~ 316 (370)
......+|+.|+|||.+.+..++.++||||||+++|+|++|..||....... ..............
T Consensus 193 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (318)
T 3lxp_A 193 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR 272 (318)
T ss_dssp C---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCC
T ss_pred cccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCC
Confidence 3344567889999999999889999999999999999999999987643221 11222223445666
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccCCC
Q 042314 317 SSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKTV 361 (370)
Q Consensus 317 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~~ 361 (370)
+..+|+.+.++|++||+.||++|||+.++++.|+.+.+.+++..+
T Consensus 273 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 273 PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 778999999999999999999999999999999999999985543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=327.36 Aligned_cols=247 Identities=30% Similarity=0.600 Sum_probs=213.6
Q ss_pred CCCCCcccEEEEEEcC-ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 99 IDPGAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g-~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
+|.|+||.||++...+ ..+++|.+..... ....+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 16 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (268)
T 3sxs_A 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91 (268)
T ss_dssp EEEETTEEEEEEEETTTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eccCCCceEEEEEecCceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence 6889999999998874 4799999876432 2356889999999999999999999999999999999999999999
Q ss_pred HHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 178 DILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 178 ~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
+++...+ .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......... ......
T Consensus 92 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~ 166 (268)
T 3sxs_A 92 NYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV--SSVGTK 166 (268)
T ss_dssp HHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE--ECCSCC
T ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh--cccCCC
Confidence 9998754 5999999999999999999999998 999999999999999999999999999876554322 233445
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||............. .......+...|+.+.+++.+||+.|
T Consensus 167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~ 245 (268)
T 3sxs_A 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASDTIYQIMYSCWHEL 245 (268)
T ss_dssp CCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHTTCSS
T ss_pred cCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChHHHHHHHHHHcCCC
Confidence 6788999999998889999999999999999999 999999887776665554 34455556778999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHH
Q 042314 336 PDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 336 p~~Rp~~~~ll~~l~~~~~~ 355 (370)
|++|||+.+++++|+.+++.
T Consensus 246 p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 246 PEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp GGGSCCHHHHHHHHGGGCC-
T ss_pred hhhCcCHHHHHHHHHHhhhc
Confidence 99999999999999887543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=333.51 Aligned_cols=244 Identities=23% Similarity=0.395 Sum_probs=209.8
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCC---hHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASN---PRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~---~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|+||.||++... +..+|+|.+....... ......+.+|+.+++.++||||+++++++......++||||++
T Consensus 18 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 97 (326)
T 2y0a_A 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97 (326)
T ss_dssp EEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCC
Confidence 3789999999999875 7889999987643221 1245778999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC----cEEEeccccceeccccCcc
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG----HLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~ 248 (370)
|++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||++........
T Consensus 98 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~- 173 (326)
T 2y0a_A 98 GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 173 (326)
T ss_dssp SCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC-
T ss_pred CCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc-
Confidence 9999999998889999999999999999999999998 99999999999999877 799999999987654322
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--CCCCCCCcHHHHH
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PALSSLYPEPIKA 326 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ 326 (370)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||.................. ...+..+|+.+.+
T Consensus 174 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (326)
T 2y0a_A 174 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 250 (326)
T ss_dssp ---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred ---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHH
Confidence 22346899999999999999999999999999999999999999888776655554422222 1223567899999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 042314 327 LLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 327 li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
||++||..||++|||+.+++++
T Consensus 251 li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 251 FIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhhCCCHHHHhcC
Confidence 9999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=327.06 Aligned_cols=248 Identities=27% Similarity=0.544 Sum_probs=212.6
Q ss_pred CCCCCCcccEEEEEEcC-ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g-~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|+||.||++.+.+ ..+++|++...... .+.+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 31 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 106 (283)
T 3gen_A 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 106 (283)
T ss_dssp ECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBH
T ss_pred hcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcH
Confidence 37999999999998874 57999998754322 35688999999999999999999999999999999999999999
Q ss_pred HHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 177 HDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 177 ~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... .....
T Consensus 107 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~ 181 (283)
T 3gen_A 107 LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVGS 181 (283)
T ss_dssp HHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH--STTST
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc--cccCC
Confidence 999986 467999999999999999999999998 999999999999999999999999999766443211 22334
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||............. .......+...|+.+.+++.+||+.
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~ 260 (283)
T 3gen_A 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHE 260 (283)
T ss_dssp TSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred ccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCCcCCHHHHHHHHHHccC
Confidence 56889999999998899999999999999999998 999999888776666554 3445556677899999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHH
Q 042314 335 NPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
||++|||+.+++++|+++.++
T Consensus 261 ~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 261 KADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp SGGGSCCHHHHHHHHHHHHHH
T ss_pred ChhHCcCHHHHHHHHHHHhhc
Confidence 999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=335.92 Aligned_cols=254 Identities=25% Similarity=0.425 Sum_probs=205.6
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCc----eEEEEeecC
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSER----LIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~----~~~v~e~~~ 172 (370)
+|.|+||.||++.. .++.+|+|++......+......+.+|+.++++++||||+++++++..... .++||||++
T Consensus 20 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~ 99 (311)
T 3ork_A 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99 (311)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCC
Confidence 68899999999986 478899999988766677778889999999999999999999999876543 499999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.............
T Consensus 100 g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 176 (311)
T 3ork_A 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176 (311)
T ss_dssp EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-------------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccc
Confidence 9999999998889999999999999999999999998 9999999999999999999999999998766543332233
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCC--CCCCCcHHHHHHHHH
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPA--LSSLYPEPIKALLRE 330 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~ 330 (370)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||..................+. ....+|+.+.++|.+
T Consensus 177 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 256 (311)
T 3ork_A 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLK 256 (311)
T ss_dssp -----CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHH
T ss_pred cccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHH
Confidence 345689999999999999999999999999999999999999998887665554443332222 245688999999999
Q ss_pred hcccCCCCCCCHHH-HHHHHHHHHHH
Q 042314 331 CWHKNPDRRPTFEE-IIFRLEAIQES 355 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~-ll~~l~~~~~~ 355 (370)
||+.||++||+..+ +...+.++...
T Consensus 257 ~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 257 ALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp HTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred HHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 99999999996554 55555555433
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=338.25 Aligned_cols=242 Identities=23% Similarity=0.373 Sum_probs=209.7
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+|+|++..... .......+.+|+.+++.++||||+++++++...+..++||||+.|++|
T Consensus 37 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L 115 (362)
T 2bdw_A 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 115 (362)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCH
Confidence 788999999999875 78899999976532 345567789999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC---cEEEeccccceeccccCccceecc
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG---HLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||++........ ..
T Consensus 116 ~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~----~~ 188 (362)
T 2bdw_A 116 FEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA----WH 188 (362)
T ss_dssp HHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS----CC
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc----cc
Confidence 999998888999999999999999999999998 99999999999998654 599999999987654322 22
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--CCCCCCCcHHHHHHHHHh
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PALSSLYPEPIKALLREC 331 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~ 331 (370)
...||+.|+|||++.+..++.++|||||||++|+|++|.+||...........+...... ......+|+.+.+||.+|
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 268 (362)
T 2bdw_A 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 268 (362)
T ss_dssp CSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHH
T ss_pred cCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 346899999999999999999999999999999999999999988777666655433222 222346789999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~ 348 (370)
|..||++||++.+++++
T Consensus 269 L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 269 LTVNPKKRITADQALKV 285 (362)
T ss_dssp SCSSGGGSCCHHHHTTS
T ss_pred cCCChhhCcCHHHHhcC
Confidence 99999999999999876
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=339.73 Aligned_cols=242 Identities=26% Similarity=0.414 Sum_probs=209.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... ++.+|+|++.............+..|..+++.+ +||+|+++++++...+.+++||||++||+
T Consensus 28 lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~ 107 (353)
T 2i0e_A 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 107 (353)
T ss_dssp EEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred EeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCc
Confidence 688999999999886 678999999764322223456778999999887 79999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.+.+.+++..++.++.|++.||.|||++| |+||||||+|||++.+|.+||+|||+++....... .....
T Consensus 108 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~ 181 (353)
T 2i0e_A 108 LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTF 181 (353)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC---CBCCC
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc---ccccc
Confidence 9999998889999999999999999999999998 99999999999999999999999999975432221 23345
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||++.+..++.++|+|||||++|||++|++||...........+.. .....+..+|+.+.+||++||..|
T Consensus 182 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~lL~~d 259 (353)
T 2i0e_A 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAVAICKGLMTKH 259 (353)
T ss_dssp CSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSC
T ss_pred cCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHhhcC
Confidence 789999999999999999999999999999999999999998888777666653 234456778999999999999999
Q ss_pred CCCCCC-----HHHHHHH
Q 042314 336 PDRRPT-----FEEIIFR 348 (370)
Q Consensus 336 p~~Rp~-----~~~ll~~ 348 (370)
|++||+ +++++++
T Consensus 260 P~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 260 PGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp TTSCTTCSTTHHHHHHTS
T ss_pred HHHcCCCCCCCHHHHhcC
Confidence 999995 5777765
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=339.08 Aligned_cols=255 Identities=24% Similarity=0.406 Sum_probs=210.4
Q ss_pred CCCCCcccEEEEEE-------cCceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEee
Q 042314 99 IDPGAYGEVYLVKW-------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 99 l~~g~~~~v~~a~~-------~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
+|.|+||.||++.. .+..+++|.+.... .......+.+|+.+++++ +||||+++++++...+..++||||
T Consensus 53 lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 130 (344)
T 1rjb_A 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEY 130 (344)
T ss_dssp EEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred ecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEec
Confidence 78899999999986 24579999987542 234457889999999999 899999999999999999999999
Q ss_pred cCCCCHHHHHHhCC-----------------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC
Q 042314 171 LRNGSLHDILKKKG-----------------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE 227 (370)
Q Consensus 171 ~~g~~L~~~l~~~~-----------------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~ 227 (370)
+++|+|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||+++.
T Consensus 131 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~ 207 (344)
T 1rjb_A 131 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTH 207 (344)
T ss_dssp CTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEET
T ss_pred CCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcC
Confidence 99999999998653 2788999999999999999999998 999999999999999
Q ss_pred CCcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 042314 228 AGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADR 306 (370)
Q Consensus 228 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~ 306 (370)
++.+||+|||++.......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus 208 ~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 286 (344)
T 1rjb_A 208 GKVVKICDFGLARDIMSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 286 (344)
T ss_dssp TTEEEECCCGGGSCGGGCTTSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEeCCCccCcccccCccce-eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHH
Confidence 9999999999998765443221 2223346889999999999999999999999999999998 9999987665444444
Q ss_pred hhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccC
Q 042314 307 RAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359 (370)
Q Consensus 307 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~ 359 (370)
.......+..+..+|+.+.+++.+||..||.+|||+.+++++|+.+.......
T Consensus 287 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 287 LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339 (344)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence 44345566667778999999999999999999999999999999987765543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=332.30 Aligned_cols=253 Identities=26% Similarity=0.449 Sum_probs=216.1
Q ss_pred CCCCCcccEEEEEE-------cCceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEee
Q 042314 99 IDPGAYGEVYLVKW-------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 99 l~~g~~~~v~~a~~-------~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
+|.|+||.||++.+ .+..+++|.+... ......+.+.+|+.+++++ +||||+++++++...+..++||||
T Consensus 31 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 108 (313)
T 1t46_A 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 108 (313)
T ss_dssp EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred hCccCCcceEEEEEeeccccchhhhhHHHhcCcc--hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEec
Confidence 78899999999985 2567999998754 3345567899999999999 899999999999999999999999
Q ss_pred cCCCCHHHHHHhCC------------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEE
Q 042314 171 LRNGSLHDILKKKG------------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLK 232 (370)
Q Consensus 171 ~~g~~L~~~l~~~~------------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~k 232 (370)
+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+|
T Consensus 109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k 185 (313)
T 1t46_A 109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITK 185 (313)
T ss_dssp CTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEE
T ss_pred CCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEE
Confidence 99999999998754 3899999999999999999999998 99999999999999999999
Q ss_pred EeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccC
Q 042314 233 VTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYED 311 (370)
Q Consensus 233 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 311 (370)
|+|||++.......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||................
T Consensus 186 l~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 264 (313)
T 1t46_A 186 ICDFGLARDIKNDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264 (313)
T ss_dssp ECCCGGGSCTTSCTTSE-ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHT
T ss_pred Eccccccccccccccce-eccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccC
Confidence 99999998776543321 2223346889999999999999999999999999999999 999998765444333333344
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 312 SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 312 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
.....+..+|+.+.+++.+||+.||.+|||+.++++.|+++.++..
T Consensus 265 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 265 FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 5555667789999999999999999999999999999999887654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=341.68 Aligned_cols=240 Identities=26% Similarity=0.465 Sum_probs=204.9
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++.. .+..+|+|++.............+.+|+.+++.++||||+++++++...+..++||||+ +|+|
T Consensus 17 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l 95 (336)
T 3h4j_B 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGEL 95 (336)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEH
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcH
Confidence 68899999999987 47899999987543222233467889999999999999999999999999999999999 6799
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++...+++++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++........ .....
T Consensus 96 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~----~~~~~ 168 (336)
T 3h4j_B 96 FDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF----LKTSC 168 (336)
T ss_dssp HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT----TCCCT
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCcc----ccccc
Confidence 999988889999999999999999999999999 99999999999999999999999999976654332 23346
Q ss_pred CCccccCcccccccCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 257 GSYRYMAPEVYRRESY-GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
||+.|+|||++.+..+ +.++||||||+++|+|++|+.||............ .......+..+|+.+.+||++||..|
T Consensus 169 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~~~L~~d 246 (336)
T 3h4j_B 169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIRRMIVAD 246 (336)
T ss_dssp TSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHHHTTSCSS
T ss_pred CCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHHHHHcCCC
Confidence 8999999999988776 68999999999999999999999876543332222 12234456678999999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042314 336 PDRRPTFEEIIFR 348 (370)
Q Consensus 336 p~~Rp~~~~ll~~ 348 (370)
|.+|||+++++++
T Consensus 247 P~~Rpt~~eil~h 259 (336)
T 3h4j_B 247 PMQRITIQEIRRD 259 (336)
T ss_dssp GGGSCCHHHHTTC
T ss_pred hhHCcCHHHHHhC
Confidence 9999999999886
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=331.48 Aligned_cols=254 Identities=28% Similarity=0.532 Sum_probs=217.6
Q ss_pred CCCCCcccEEEEEEc---------CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEE
Q 042314 99 IDPGAYGEVYLVKWR---------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLT 168 (370)
Q Consensus 99 l~~g~~~~v~~a~~~---------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~ 168 (370)
+|.|+||.||++... +..+++|.+... ........+.+|+.+++.+ +||||+++++++...+..++||
T Consensus 43 lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 120 (334)
T 2pvf_A 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 120 (334)
T ss_dssp EEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEE
T ss_pred EeecCceeEEEeEeccccccccccceEEEEeeeccC--CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEE
Confidence 688999999999863 467999998754 3455677899999999999 8999999999999999999999
Q ss_pred eecCCCCHHHHHHhCC----------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEE
Q 042314 169 EYLRNGSLHDILKKKG----------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLK 232 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~k 232 (370)
||+++++|.+++.... .++...++.++.|++.||.|||+++ |+||||||+||+++.++.+|
T Consensus 121 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~k 197 (334)
T 2pvf_A 121 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMK 197 (334)
T ss_dssp ECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred ECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEE
Confidence 9999999999998653 3889999999999999999999998 99999999999999999999
Q ss_pred EeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccC
Q 042314 233 VTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYED 311 (370)
Q Consensus 233 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~ 311 (370)
|+|||++.......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||............. ..
T Consensus 198 L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~ 275 (334)
T 2pvf_A 198 IADFGLARDINNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EG 275 (334)
T ss_dssp ECCCTTCEECTTTSSEE-CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HT
T ss_pred Ecccccccccccccccc-ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHh-cC
Confidence 99999998766543221 2233457889999999998889999999999999999999 999998887766555443 34
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccC
Q 042314 312 SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359 (370)
Q Consensus 312 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~ 359 (370)
.....+..+|..+.+++.+||..||.+|||+.++++.|+++.......
T Consensus 276 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 276 HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 455667788999999999999999999999999999999998766543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=338.88 Aligned_cols=240 Identities=25% Similarity=0.461 Sum_probs=204.2
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+|+|++.............+.+|+.+++.++||||+++++++...+.+++||||+.||+|
T Consensus 23 LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L 102 (384)
T 4fr4_A 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL 102 (384)
T ss_dssp EECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcH
Confidence 789999999999875 677999998754322233456788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++...+.+++..++.++.|++.||.|||++| |+||||||+|||++.+|.+||+|||++....... ......
T Consensus 103 ~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~----~~~~~~ 175 (384)
T 4fr4_A 103 RYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTMA 175 (384)
T ss_dssp HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC----CBCCCC
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC----ceeccC
Confidence 999999889999999999999999999999998 9999999999999999999999999998765432 223457
Q ss_pred CCccccCcccccc---cCCCchhhHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 257 GSYRYMAPEVYRR---ESYGKSVDVFSFALIVHEMFQGGPSNRAD---TAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 257 g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
||+.|+|||++.. ..++.++|+|||||++|+|++|+.||... .......... ......+..+|+.+.+||.+
T Consensus 176 gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~p~~~s~~~~~li~~ 253 (384)
T 4fr4_A 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--TTVVTYPSAWSQEMVSLLKK 253 (384)
T ss_dssp SCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH--HCCCCCCTTSCHHHHHHHHH
T ss_pred CCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--hcccCCCCcCCHHHHHHHHH
Confidence 9999999999974 45889999999999999999999999743 2233333222 33455667789999999999
Q ss_pred hcccCCCCCCC-HHHHHH
Q 042314 331 CWHKNPDRRPT-FEEIIF 347 (370)
Q Consensus 331 ~l~~~p~~Rp~-~~~ll~ 347 (370)
||..||++||+ ++++++
T Consensus 254 lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 254 LLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HSCSSGGGSCCSHHHHHT
T ss_pred HhcCCHhHhcccHHHHHc
Confidence 99999999998 777664
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=359.61 Aligned_cols=253 Identities=24% Similarity=0.459 Sum_probs=215.6
Q ss_pred CCCCCCcccEEEEEEc----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
.+|.|+||.||++.+. +..+|+|+++... .+....+.+.+|+.++++++||||+++++++.. +..++||||+.+
T Consensus 376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4899999999999653 5679999997653 344567889999999999999999999999864 568899999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.............
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 999999999889999999999999999999999998 99999999999999999999999999987755433222333
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
...+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+. .......+..+|+.+.++|.+||
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl 609 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCW 609 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHc
Confidence 3457889999999999999999999999999999998 999999888776665554 45566677889999999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 333 HKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
+.||++||++.++++.|+++...+
T Consensus 610 ~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 610 TYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp CSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999999999999987655
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=328.47 Aligned_cols=257 Identities=21% Similarity=0.354 Sum_probs=207.6
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... ++.+++|++...........+.+.+|+.+++.++||||+++++++...+..++|+||++|++|
T Consensus 42 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 121 (309)
T 2h34_A 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDL 121 (309)
T ss_dssp EEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEH
T ss_pred EcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCH
Confidence 678999999999864 788999999876666667778899999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ......
T Consensus 122 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~ 196 (309)
T 2h34_A 122 AAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT--QLGNTV 196 (309)
T ss_dssp HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------------------
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccccc--cccccC
Confidence 999998888999999999999999999999998 999999999999999999999999998766543221 122346
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC-CCCCCCCCcHHHHHHHHHhcccC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS-RPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
+++.|+|||.+.+..++.++||||||+++|+|++|+.||................. ....+..+|+.+.++|.+||..|
T Consensus 197 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 276 (309)
T 2h34_A 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKN 276 (309)
T ss_dssp CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSS
T ss_pred CCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCC
Confidence 89999999999999999999999999999999999999998776644443332222 22345678999999999999999
Q ss_pred CCCCC-CHHHHHHHHHHHHHHhccCC
Q 042314 336 PDRRP-TFEEIIFRLEAIQESFQKKT 360 (370)
Q Consensus 336 p~~Rp-~~~~ll~~l~~~~~~~~~~~ 360 (370)
|++|| +++++++.|+++........
T Consensus 277 P~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 277 PEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp GGGSCSSHHHHHHHHHHTCC------
T ss_pred HHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 99999 99999999988765554333
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=348.29 Aligned_cols=242 Identities=26% Similarity=0.450 Sum_probs=210.8
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... |..+|+|++.............+.+|+.+++.++||||+++++++...+..++||||++|++
T Consensus 23 ~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~ 102 (476)
T 2y94_A 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGE 102 (476)
T ss_dssp EEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEE
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 3789999999999875 88999999875432222345678999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 103 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~----~~~~ 175 (476)
T 2y94_A 103 LFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF----LRTS 175 (476)
T ss_dssp HHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC----BCCC
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccccc----cccc
Confidence 9999998889999999999999999999999998 99999999999999999999999999987654322 2334
Q ss_pred CCCccccCcccccccCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESY-GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||...........+.. .....+..+++.+.+||++||..
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~Li~~~L~~ 253 (476)
T 2y94_A 176 CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD--GIFYTPQYLNPSVISLLKHMLQV 253 (476)
T ss_dssp CSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT--TCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCcCCCccCCHHHHHHHHHHcCC
Confidence 78999999999988765 6899999999999999999999988776666555542 23345667899999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042314 335 NPDRRPTFEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~ 348 (370)
||++|||+.+++++
T Consensus 254 dP~~Rpt~~eil~h 267 (476)
T 2y94_A 254 DPMKRATIKDIREH 267 (476)
T ss_dssp STTTSCCHHHHHTC
T ss_pred CchhCcCHHHHHhC
Confidence 99999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=331.99 Aligned_cols=242 Identities=26% Similarity=0.466 Sum_probs=199.0
Q ss_pred CCCCCcccEEEEEE-----cCceeEEEEeccccC-CChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKW-----RGTEIAAKTIRSSIA-SNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~-----~g~~vavK~l~~~~~-~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
+|.|+||.||++.. .+..+|+|+++.... ........+.+|+.+++.++||||+++++++...+.+++||||++
T Consensus 25 lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 104 (327)
T 3a62_A 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLS 104 (327)
T ss_dssp EEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCT
T ss_pred EEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCC
Confidence 78899999999986 478899999976432 223345667899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ..
T Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~ 178 (327)
T 3a62_A 105 GGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT---VT 178 (327)
T ss_dssp TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-------------
T ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccCCc---cc
Confidence 9999999998888999999999999999999999998 99999999999999999999999999875433221 12
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.. .....+..+++.+.++|.+||
T Consensus 179 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~~p~~~~~~~~~li~~~L 256 (327)
T 3a62_A 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--CKLNLPPYLTQEARDLLKKLL 256 (327)
T ss_dssp CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--TCCCCCTTSCHHHHHHHHHHS
T ss_pred cccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHH
Confidence 334689999999999999999999999999999999999999998877766655542 234456678999999999999
Q ss_pred ccCCCCCC-----CHHHHHHH
Q 042314 333 HKNPDRRP-----TFEEIIFR 348 (370)
Q Consensus 333 ~~~p~~Rp-----~~~~ll~~ 348 (370)
..||++|| ++.+++++
T Consensus 257 ~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 257 KRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp CSCGGGSTTSSTTTHHHHHHS
T ss_pred hcCHhhccCCCCCCHHHHHcC
Confidence 99999999 78888764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=327.62 Aligned_cols=251 Identities=33% Similarity=0.607 Sum_probs=205.2
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHHH
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHD 178 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~~ 178 (370)
+|.|+||.||++.+.++.+++|.+... ...+.+.+|+.++++++||||+++++++. +..++||||+++++|.+
T Consensus 16 lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~ 88 (307)
T 2eva_A 16 VGRGAFGVVCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYN 88 (307)
T ss_dssp EECCSSSEEEEEEETTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHH
T ss_pred eecCCCceEEEEEECCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHH
Confidence 788999999999999999999998542 34577899999999999999999999876 45899999999999999
Q ss_pred HHHhCC---CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc-EEEeccccceeccccCccceeccC
Q 042314 179 ILKKKG---KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH-LKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 179 ~l~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~-~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
++.... .++...++.++.|+++||.|||+.++++|+||||||+||+++.++. +||+|||++....... ..
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~------~~ 162 (307)
T 2eva_A 89 VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM------TN 162 (307)
T ss_dssp HHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------------
T ss_pred HHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc------cc
Confidence 998764 3688899999999999999999932223999999999999998886 7999999987654321 22
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA--VQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
..||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ...... ......+..+..+|+.+.+++.+||
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l 241 (307)
T 2eva_A 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA-VHNGTRPPLIKNLPKPIESLMTRCW 241 (307)
T ss_dssp --CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH-HHTTCCCCCBTTCCHHHHHHHHHHT
T ss_pred CCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH-HhcCCCCCcccccCHHHHHHHHHHh
Confidence 3589999999999999999999999999999999999999975432 222222 2234556667789999999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHhccCCCCC
Q 042314 333 HKNPDRRPTFEEIIFRLEAIQESFQKKTVPS 363 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~l~~~~~~~~~~~~~~ 363 (370)
+.||++|||++++++.|+.+.+.+.....|.
T Consensus 242 ~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 242 SKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp CSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred cCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 9999999999999999999988876554443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=332.37 Aligned_cols=240 Identities=19% Similarity=0.276 Sum_probs=207.3
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+++|.+... ......+.+|+.+++.++||||+++++++...+..++||||++|++|
T Consensus 13 lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L 88 (321)
T 1tki_A 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred EecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCH
Confidence 788999999999875 778999988643 23456788999999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC--CCcEEEeccccceeccccCccceecc
Q 042314 177 HDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE--AGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 177 ~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||++......... .
T Consensus 89 ~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~----~ 161 (321)
T 1tki_A 89 FERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF----R 161 (321)
T ss_dssp HHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE----E
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc----c
Confidence 9999865 47999999999999999999999998 999999999999997 789999999999877544321 2
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC--CCCCCCcHHHHHHHHHh
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP--ALSSLYPEPIKALLREC 331 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~ 331 (370)
...||+.|+|||++.+..++.++||||||+++|+|++|.+||...........+....... .....+|+.+.+++.+|
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 241 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHH
Confidence 2357999999999999888999999999999999999999999888777666554332222 12346889999999999
Q ss_pred cccCCCCCCCHHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~l 349 (370)
|..||++|||+.+++++-
T Consensus 242 L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 242 LVKERKSRMTASEALQHP 259 (321)
T ss_dssp SCSSGGGSCCHHHHHHSH
T ss_pred cCCChhHCcCHHHHhcCh
Confidence 999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=328.14 Aligned_cols=244 Identities=27% Similarity=0.431 Sum_probs=200.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCC-----------------------hHHHHHHHHHHHHHHhcCCCcee
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASN-----------------------PRVRNSFMKELGLWQKLRHPNIV 152 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~-----------------------~~~~~~~~~e~~~l~~l~hp~Iv 152 (370)
.+|.|+||.||++... +..+|+|++....... ....+.+.+|+.+++.++||||+
T Consensus 20 ~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 99 (298)
T 2zv2_A 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVV 99 (298)
T ss_dssp EEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBC
T ss_pred EEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 3789999999999764 7889999986543211 12245688999999999999999
Q ss_pred eeeeeEee--CCceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc
Q 042314 153 QFLGVLKH--SERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH 230 (370)
Q Consensus 153 ~~~~~~~~--~~~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~ 230 (370)
++++++.. .+..++||||+++++|.+++.. +.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.
T Consensus 100 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~ 175 (298)
T 2zv2_A 100 KLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGH 175 (298)
T ss_dssp CEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSC
T ss_pred eEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCC
Confidence 99999886 5679999999999999886543 47999999999999999999999998 999999999999999999
Q ss_pred EEEeccccceeccccCccceeccCCCCCccccCcccccccC---CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Q 042314 231 LKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES---YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRR 307 (370)
Q Consensus 231 ~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~ 307 (370)
+||+|||++........ ......||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||...........+
T Consensus 176 ~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 252 (298)
T 2zv2_A 176 IKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI 252 (298)
T ss_dssp EEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHH
Confidence 99999999987654332 223447899999999998765 378899999999999999999999988776665555
Q ss_pred hccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 308 AYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 308 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.......+....+|+.+.++|.+||+.||++|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 253 KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred hcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 43333444455789999999999999999999999999865
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=338.70 Aligned_cols=268 Identities=16% Similarity=0.294 Sum_probs=213.0
Q ss_pred cccCCCccccccccCceeeEEeeecccCCCCC--CcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc
Q 042314 71 DRWGRTPLSDARSFGHVVICKILEDRGGIDPG--AYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL 146 (370)
Q Consensus 71 ~~~g~tpl~~A~~~g~~~~~~~L~~~~~l~~g--~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l 146 (370)
+..+.++-......+..++.+. +|.| +||.||++... +..+|+|.+.... ........+.+|+.+++.+
T Consensus 11 ~~~~~~~s~~~~~~~~y~~~~~------lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l 83 (389)
T 3gni_B 11 NLYFQGMSSFLPEGGCYELLTV------IGKGFEDLMTVNLARYKPTGEYVTVRRINLEA-CSNEMVTFLQGELHVSKLF 83 (389)
T ss_dssp HSCCC--CCCCCCGGGEEEEEE------EEEETTTTEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHHHC
T ss_pred hhhhhhhhcccCCCCcEEEEec------ccCCcCCceEEEEEEEcCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhC
Confidence 3445555555566677777765 4668 99999999886 8889999997654 3456778899999999999
Q ss_pred CCCceeeeeeeEeeCCceEEEEeecCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCee
Q 042314 147 RHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVL 224 (370)
Q Consensus 147 ~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil 224 (370)
+||||+++++++...+.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||
T Consensus 84 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIl 160 (389)
T 3gni_B 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHIL 160 (389)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEE
T ss_pred CCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 9999999999999999999999999999999999876 67999999999999999999999998 999999999999
Q ss_pred eCCCCcEEEeccccceeccccCccc----eeccCCCCCccccCcccccc--cCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 042314 225 QDEAGHLKVTDFGLSKIAQEKDSYS----YKMTGGTGSYRYMAPEVYRR--ESYGKSVDVFSFALIVHEMFQGGPSNRAD 298 (370)
Q Consensus 225 ~~~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~ 298 (370)
++.++.+||+|||.+.......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...
T Consensus 161 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 161 ISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp ECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999887554322111 11223468999999999987 57899999999999999999999999765
Q ss_pred cHHHHHHHhhcc--------------------------------------------CCCCCCCCCCcHHHHHHHHHhccc
Q 042314 299 TAVQVADRRAYE--------------------------------------------DSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 299 ~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
............ ......+..+++.+.+||++||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 320 (389)
T 3gni_B 241 PATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320 (389)
T ss_dssp CSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHTCS
T ss_pred CHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhc
Confidence 433222211100 001123455788999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042314 335 NPDRRPTFEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~ 348 (370)
||++|||+.+++++
T Consensus 321 dP~~Rpta~ell~h 334 (389)
T 3gni_B 321 NPDARPSASTLLNH 334 (389)
T ss_dssp CTTTSCCHHHHTTS
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999876
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=338.66 Aligned_cols=238 Identities=27% Similarity=0.463 Sum_probs=198.0
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHH-HHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGL-WQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~-l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... +..+|+|++.............+..|..+ ++.++||||+++++++...+.+++||||++||+
T Consensus 46 lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~ 125 (373)
T 2r5t_A 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGE 125 (373)
T ss_dssp EECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred EeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCc
Confidence 789999999999875 67799999987654444455666777776 567899999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.+.+.+++..++.++.|++.||.|||++| |+||||||+|||++.+|.+||+|||+++....... .....
T Consensus 126 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~---~~~~~ 199 (373)
T 2r5t_A 126 LFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTSTF 199 (373)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC---CCCSB
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCCC---ccccc
Confidence 9999998889999999999999999999999998 99999999999999999999999999876433221 22344
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||++.+..++.++|+|||||++|||++|.+||...........+... ....+..++..+.++|++||+.|
T Consensus 200 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~lL~~d 277 (373)
T 2r5t_A 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHLLEGLLQKD 277 (373)
T ss_dssp SCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--CCCCCSSSCHHHHHHHHHHTCSS
T ss_pred cCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHHHHHHHHHHcccC
Confidence 6899999999999999999999999999999999999999988887777666532 33455678999999999999999
Q ss_pred CCCCCCHHH
Q 042314 336 PDRRPTFEE 344 (370)
Q Consensus 336 p~~Rp~~~~ 344 (370)
|++||++.+
T Consensus 278 p~~R~~~~~ 286 (373)
T 2r5t_A 278 RTKRLGAKD 286 (373)
T ss_dssp GGGSTTTTT
T ss_pred HHhCCCCCC
Confidence 999999753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=333.60 Aligned_cols=255 Identities=24% Similarity=0.442 Sum_probs=200.0
Q ss_pred CCCCCcccEEEEEEcCc-----eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCce------EEE
Q 042314 99 IDPGAYGEVYLVKWRGT-----EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERL------IFL 167 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~-----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~------~~v 167 (370)
+|.|+||.||++..... .+|+|.++..... ....+.+.+|+.++++++||||+++++++...... ++|
T Consensus 31 lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v 109 (323)
T 3qup_A 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVI 109 (323)
T ss_dssp EEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEE
T ss_pred ecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEE
Confidence 78899999999987532 6899998765433 34567899999999999999999999998876554 999
Q ss_pred EeecCCCCHHHHHHhCC------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecccccee
Q 042314 168 TEYLRNGSLHDILKKKG------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI 241 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~ 241 (370)
|||+.+++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~ 186 (323)
T 3qup_A 110 LPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRK 186 (323)
T ss_dssp EECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred EEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeecccccc
Confidence 99999999999986542 5899999999999999999999998 99999999999999999999999999987
Q ss_pred ccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCC
Q 042314 242 AQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLY 320 (370)
Q Consensus 242 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (370)
........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||............. .......+..+
T Consensus 187 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 264 (323)
T 3qup_A 187 IYSGDYYR-QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-GGNRLKQPPEC 264 (323)
T ss_dssp ---------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTC
T ss_pred cccccccc-ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh-cCCCCCCCCcc
Confidence 65443221 2223356889999999999999999999999999999999 899998877665555444 34455566778
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccC
Q 042314 321 PEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359 (370)
Q Consensus 321 ~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~ 359 (370)
|+.+.+++.+||+.||++|||+.++++.|+++.......
T Consensus 265 ~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 265 MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 999999999999999999999999999999997765533
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=326.24 Aligned_cols=253 Identities=28% Similarity=0.495 Sum_probs=206.7
Q ss_pred CCCCCcccEEEEEEc---Cc--eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWR---GT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~---g~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|.|+||.||++.+. +. .+++|.+...........+.+.+|+.+++.++||||+++++++.... .++|+||+.+
T Consensus 26 lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~ 104 (291)
T 1u46_A 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPL 104 (291)
T ss_dssp CC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTT
T ss_pred ecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccC
Confidence 789999999999863 22 58999987665455567788999999999999999999999987754 8899999999
Q ss_pred CCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 174 GSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 174 ~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
++|.+++... +.+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++.............
T Consensus 105 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 181 (291)
T 1u46_A 105 GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 181 (291)
T ss_dssp CBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-
T ss_pred CCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccccchhhh
Confidence 9999998764 57899999999999999999999998 9999999999999999999999999998776544332233
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.....................+..+|+.+.+++.+|
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 261 (291)
T 1u46_A 182 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQC 261 (291)
T ss_dssp ----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHH
T ss_pred ccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHH
Confidence 33457889999999998888999999999999999999 99999988887777766655556666778999999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
|..||++|||+.++++.|+++...
T Consensus 262 l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 262 WAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCcccCcCHHHHHHHHHHhCcc
Confidence 999999999999999999887543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=356.02 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=214.4
Q ss_pred CCCCCCcccEEEEEEc----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
.+|.|+||.||++.+. +..+|+|.++... .....+.+.+|+.++++++||||+++++++.. +.+++||||+.+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence 3899999999999764 4569999997642 23456789999999999999999999999876 569999999999
Q ss_pred CCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 174 GSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 174 ~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++............
T Consensus 420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 9999999754 46999999999999999999999998 9999999999999999999999999998765433222222
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+....+. .+.+...+..+|+.+.++|.+|
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~c 575 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPELYALMSDC 575 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHT
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHH
Confidence 23346789999999999999999999999999999998 999999877766655544 4556677788999999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHHhccCC
Q 042314 332 WHKNPDRRPTFEEIIFRLEAIQESFQKKT 360 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~ 360 (370)
|..||++||++.++++.|+.+......+.
T Consensus 576 l~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 576 WIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp TCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred cCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 99999999999999999999988876544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=332.82 Aligned_cols=250 Identities=26% Similarity=0.547 Sum_probs=204.4
Q ss_pred CCCCCcccEEEEEEc--Cce----eEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKWR--GTE----IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~----vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
+|.|+||.||++.+. +.. +++|.+... ........+.+|+.++++++||||+++++++.... .++|+||+.
T Consensus 23 lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~ 99 (327)
T 3poz_A 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMP 99 (327)
T ss_dssp EEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCT
T ss_pred EeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecC
Confidence 788999999999874 444 466666543 23345678899999999999999999999988754 788999999
Q ss_pred CCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 173 NGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 173 g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
+|+|.+++... +.++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++........ ..
T Consensus 100 ~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~ 175 (327)
T 3poz_A 100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YH 175 (327)
T ss_dssp TCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC----
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCccc-cc
Confidence 99999999874 57999999999999999999999998 999999999999999999999999999876544322 12
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||............. .......+..++..+.+++.+
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 254 (327)
T 3poz_A 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDVYMIMVK 254 (327)
T ss_dssp ----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCHHHHHHHHH
T ss_pred ccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHH
Confidence 334457889999999999999999999999999999999 999998776655444433 344555667789999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
||+.||++||++.+++++|+.+....
T Consensus 255 ~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 255 CWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp HTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred HcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 99999999999999999999987643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=332.88 Aligned_cols=241 Identities=29% Similarity=0.443 Sum_probs=207.6
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++.. .+..+|+|.+.............+.+|+.+++.++||||+++++++...+..++||||+.| +
T Consensus 61 ~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g-~ 139 (348)
T 1u5q_A 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-S 139 (348)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred EEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCCC-C
Confidence 378999999999986 4888999999766545556667899999999999999999999999999999999999975 8
Q ss_pred HHHHHH-hCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILK-KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 140 l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-------~~ 209 (348)
T 1u5q_A 140 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NS 209 (348)
T ss_dssp HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------CC
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-------Cc
Confidence 887775 4568999999999999999999999998 999999999999999999999999998765432 22
Q ss_pred CCCCccccCccccc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 255 GTGSYRYMAPEVYR---RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 255 ~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
..||+.|+|||++. ...++.++||||||+++|||++|++||.....................+..+|+.+.++|.+|
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 289 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 289 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 36899999999984 567899999999999999999999999888776655555433444444567899999999999
Q ss_pred cccCCCCCCCHHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~l 349 (370)
|+.||++|||+++++++-
T Consensus 290 l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 290 LQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp TCSSGGGSCCHHHHTTCH
T ss_pred cccChhhCcCHHHHhhCh
Confidence 999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=327.22 Aligned_cols=241 Identities=26% Similarity=0.439 Sum_probs=207.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... |+.+|+|++..... ...+.+.+|+.+++.++||||+++++++...+..++||||++|++
T Consensus 52 ~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 128 (321)
T 2c30_A 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128 (321)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred EeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCC
Confidence 4789999999999874 88999999875432 235668899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++... ++++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 129 L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 201 (321)
T 2c30_A 129 LTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP---KRKSL 201 (321)
T ss_dssp HHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC---CBCCC
T ss_pred HHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc---ccccc
Confidence 99998764 7999999999999999999999998 99999999999999999999999999987654322 12344
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC-CCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS-RPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.||+.|+|||.+.+..++.++||||||+++|+|++|+.||................. ....+..+|+.+.+++.+||+.
T Consensus 202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 281 (321)
T 2c30_A 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR 281 (321)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCS
T ss_pred cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccC
Confidence 689999999999999999999999999999999999999988877665554442221 2223345789999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042314 335 NPDRRPTFEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~ 348 (370)
||++|||+.+++++
T Consensus 282 dp~~Rps~~ell~h 295 (321)
T 2c30_A 282 DPQERATAQELLDH 295 (321)
T ss_dssp STTTSCCHHHHHTS
T ss_pred ChhhCcCHHHHhcC
Confidence 99999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=348.78 Aligned_cols=243 Identities=27% Similarity=0.426 Sum_probs=201.9
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... |..+|+|++.............+.+|+.+++.++||||+++++++...+.+++||||++|++
T Consensus 155 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~ 234 (446)
T 4ejn_A 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 234 (446)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCB
T ss_pred EEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCc
Confidence 3788999999999875 78899999976543344455677899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhh-cCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHH-HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++...+.+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 235 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~ 308 (446)
T 4ejn_A 235 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKT 308 (446)
T ss_dssp HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--------CC
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCCc---cccc
Confidence 99999988899999999999999999999998 88 99999999999999999999999999875433221 2334
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... ....+..+|+.+.+||.+||+.
T Consensus 309 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~ 386 (446)
T 4ejn_A 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLGPEAKSLLSGLLKK 386 (446)
T ss_dssp SSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCS
T ss_pred ccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHccc
Confidence 57899999999999999999999999999999999999999988877766665532 3445667899999999999999
Q ss_pred CCCCCC-----CHHHHHHH
Q 042314 335 NPDRRP-----TFEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp-----~~~~ll~~ 348 (370)
||.+|| ++++++++
T Consensus 387 dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 387 DPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp STTTSTTCSTTTHHHHHTS
T ss_pred CHHHhCCCCCCCHHHHHhC
Confidence 999999 99999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=326.17 Aligned_cols=250 Identities=28% Similarity=0.521 Sum_probs=208.4
Q ss_pred CCCCCcccEEEEEE------cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC--CceEEEEee
Q 042314 99 IDPGAYGEVYLVKW------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS--ERLIFLTEY 170 (370)
Q Consensus 99 l~~g~~~~v~~a~~------~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~--~~~~~v~e~ 170 (370)
+|.|+||.||++.+ .+..+|+|.+.... .......+.+|+.+++.++||||+++++++... +..++||||
T Consensus 29 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 106 (302)
T 4e5w_A 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 106 (302)
T ss_dssp EEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEEC
T ss_pred cCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEe
Confidence 78899999999984 47889999987543 233456789999999999999999999998876 678999999
Q ss_pred cCCCCHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 171 LRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 171 ~~g~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+++++|.+++.. ...++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 107 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 183 (302)
T 4e5w_A 107 LPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY 183 (302)
T ss_dssp CTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEE
T ss_pred CCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCCCcce
Confidence 999999999954 457999999999999999999999998 9999999999999999999999999998876554433
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc--------------HHHHHHHhhccCCCCC
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT--------------AVQVADRRAYEDSRPA 315 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~--------------~~~~~~~~~~~~~~~~ 315 (370)
.......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+.... ................
T Consensus 184 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (302)
T 4e5w_A 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLP 263 (302)
T ss_dssp ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCC
T ss_pred eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCC
Confidence 33444568889999999999889999999999999999999998764322 2222222333445566
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042314 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQ 353 (370)
Q Consensus 316 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~ 353 (370)
.+..+|+.+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 264 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 264 CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 67789999999999999999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=324.28 Aligned_cols=258 Identities=25% Similarity=0.489 Sum_probs=214.5
Q ss_pred CCCCCCcccEEEEEEc--Cc---eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCce-EEEEeec
Q 042314 98 GIDPGAYGEVYLVKWR--GT---EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERL-IFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~---~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~-~~v~e~~ 171 (370)
.+|.|+||.||++.+. +. .+++|.+... ......+.+.+|+.+++.++||||+++++++...+.. ++|+||+
T Consensus 28 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred eeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 3789999999999763 22 5888888653 4455678899999999999999999999999776554 9999999
Q ss_pred CCCCHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc-
Q 042314 172 RNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS- 249 (370)
Q Consensus 172 ~g~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~- 249 (370)
.+++|.+++.. ...++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (298)
T 3pls_A 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182 (298)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence 99999999987 357889999999999999999999998 9999999999999999999999999998665432211
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCC-CCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.......+|+.|+|||.+.+..++.++||||||+++|+|++|. +||............. .......+..+|+.+.+++
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li 261 (298)
T 3pls_A 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYCPDSLYQVM 261 (298)
T ss_dssp CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCCCTTCCHHHHHHH
T ss_pred ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCCCccchHHHHHHH
Confidence 1223345788999999999999999999999999999999955 5555554444433333 4445566777899999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHhccCCC
Q 042314 329 RECWHKNPDRRPTFEEIIFRLEAIQESFQKKTV 361 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~~ 361 (370)
.+||+.||.+|||+.++++.|+++.+.+.+...
T Consensus 262 ~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~~ 294 (298)
T 3pls_A 262 QQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294 (298)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCCB
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHHHHhccch
Confidence 999999999999999999999999998876654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=331.40 Aligned_cols=256 Identities=27% Similarity=0.510 Sum_probs=211.7
Q ss_pred CCCCCcccEEEEEE------cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEe--eCCceEEEEee
Q 042314 99 IDPGAYGEVYLVKW------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK--HSERLIFLTEY 170 (370)
Q Consensus 99 l~~g~~~~v~~a~~------~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~--~~~~~~~v~e~ 170 (370)
+|.|+||.||++.+ .+..+++|.+... .....+.+.+|+.++++++||||+++++++. .....++||||
T Consensus 31 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 107 (327)
T 3lxl_A 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107 (327)
T ss_dssp EEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred ccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence 78899999999984 4778999998753 4556678999999999999999999999876 45668999999
Q ss_pred cCCCCHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 171 LRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 171 ~~g~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 184 (327)
T 3lxl_A 108 LPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY 184 (327)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEE
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCCccc
Confidence 999999999986 456999999999999999999999998 9999999999999999999999999998776554433
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH--------------HHHHhhccCCCCC
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ--------------VADRRAYEDSRPA 315 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~ 315 (370)
.......+|+.|+|||.+.+..++.++||||||+++|+|++|..||....... .............
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (327)
T 3lxl_A 185 VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLP 264 (327)
T ss_dssp ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCC
T ss_pred eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCC
Confidence 33444568889999999999889999999999999999999999986544321 1222222445556
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccCC
Q 042314 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKT 360 (370)
Q Consensus 316 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~ 360 (370)
.+..+|+.+.+++.+||+.||++|||+.+++++|+.+........
T Consensus 265 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 265 APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 677899999999999999999999999999999999866555433
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=324.77 Aligned_cols=241 Identities=27% Similarity=0.493 Sum_probs=207.9
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|++|.||++... +..+++|++.............+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 96 (279)
T 3fdn_A 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 96 (279)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred EecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcH
Confidence 788999999999876 567999998654333334457789999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... .....
T Consensus 97 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-----~~~~~ 168 (279)
T 3fdn_A 97 YRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RTDLC 168 (279)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-------------C
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCccc-----ccccC
Confidence 999998889999999999999999999999998 9999999999999999999999999886544332 12346
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
+++.|+|||.+.+..++.++||||||+++|+|++|..||.............. .....+..+++.+.+|+.+||+.||
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p 246 (279)
T 3fdn_A 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--VEFTFPDFVTEGARDLISRLLKHNP 246 (279)
T ss_dssp CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCCCTTSCHHHHHHHHHHCCSSG
T ss_pred CCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh--CCCCCCCcCCHHHHHHHHHHhccCh
Confidence 89999999999999999999999999999999999999998887766655542 3344566789999999999999999
Q ss_pred CCCCCHHHHHHHH
Q 042314 337 DRRPTFEEIIFRL 349 (370)
Q Consensus 337 ~~Rp~~~~ll~~l 349 (370)
++|||+.+++++-
T Consensus 247 ~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 247 SQRPMLREVLEHP 259 (279)
T ss_dssp GGSCCHHHHHHCH
T ss_pred hhCCCHHHHhhCc
Confidence 9999999999873
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=327.34 Aligned_cols=244 Identities=27% Similarity=0.446 Sum_probs=197.3
Q ss_pred cCCCCCCcccEEEEEE-cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 97 GGIDPGAYGEVYLVKW-RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~-~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
..+|.|+||.||++.. .++.+|+|.+.... ........+.+|+.+++.++||||+++++++...+..++||||+++ +
T Consensus 27 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~ 104 (311)
T 3niz_A 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-D 104 (311)
T ss_dssp EEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-E
T ss_pred hhccCCCCeEEEEEEECCCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-C
Confidence 3478999999999987 47889999987643 3334567788999999999999999999999999999999999986 8
Q ss_pred HHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 105 l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~~ 178 (311)
T 3niz_A 105 LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR---SYTH 178 (311)
T ss_dssp HHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC------C
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcc---cccC
Confidence 88877664 46999999999999999999999998 99999999999999999999999999987654322 2233
Q ss_pred CCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc--CCCC-----------------
Q 042314 255 GTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE--DSRP----------------- 314 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~--~~~~----------------- 314 (370)
..+|+.|+|||.+.+ ..++.++||||||+++|+|++|++||...........+... ...+
T Consensus 179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (311)
T 3niz_A 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258 (311)
T ss_dssp CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC
T ss_pred CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccc
Confidence 468999999999876 56899999999999999999999999776544333222110 0000
Q ss_pred ---------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 315 ---------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 315 ---------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.....+++.+.+||++||..||++|||+++++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0123467889999999999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=326.81 Aligned_cols=243 Identities=24% Similarity=0.398 Sum_probs=209.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCC---hHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASN---PRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~---~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|.|+||.||++... |..+++|.+....... ....+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 20 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (321)
T 2a2a_A 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSG 99 (321)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCC
Confidence 788999999999875 7889999987653322 12467789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC----cEEEeccccceeccccCccc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG----HLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~ 249 (370)
++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||++........
T Consensus 100 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~-- 174 (321)
T 2a2a_A 100 GELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-- 174 (321)
T ss_dssp CBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC--
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc--
Confidence 999999998888999999999999999999999998 99999999999999888 799999999987654322
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--CCCCCCCcHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PALSSLYPEPIKAL 327 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l 327 (370)
.....||+.|+|||.+.+..++.++||||||+++|+|++|..||...........+...... +..+..+|+.+.++
T Consensus 175 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 252 (321)
T 2a2a_A 175 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDF 252 (321)
T ss_dssp --CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHH
T ss_pred --ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHH
Confidence 22346899999999999999999999999999999999999999988776665554422221 12235688999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 042314 328 LRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 328 i~~~l~~~p~~Rp~~~~ll~~ 348 (370)
|++||..||++|||+.+++++
T Consensus 253 i~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 253 IRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=334.23 Aligned_cols=244 Identities=27% Similarity=0.397 Sum_probs=201.8
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+|+|++..... ....+.+.+|+.+++.++||||+++++++...+..++||||++|++|
T Consensus 15 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 92 (323)
T 3tki_A 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92 (323)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEG
T ss_pred EecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcH
Confidence 688999999999875 78899999865422 23346688999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.....+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++......... .......
T Consensus 93 ~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~ 168 (323)
T 3tki_A 93 FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMC 168 (323)
T ss_dssp GGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE-CCBCSCC
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc-cccCCCc
Confidence 999988888999999999999999999999998 999999999999999999999999999876543221 1233457
Q ss_pred CCccccCcccccccCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 257 GSYRYMAPEVYRRESY-GKSVDVFSFALIVHEMFQGGPSNRADTAVQ-VADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....... .................+++.+.+|+.+||..
T Consensus 169 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 248 (323)
T 3tki_A 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE 248 (323)
T ss_dssp SCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCS
T ss_pred cCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccC
Confidence 8999999999988765 678999999999999999999997654421 12222212222333456889999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042314 335 NPDRRPTFEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~ 348 (370)
||++|||+.+++++
T Consensus 249 dP~~R~t~~eil~h 262 (323)
T 3tki_A 249 NPSARITIPDIKKD 262 (323)
T ss_dssp STTTSCCHHHHTTC
T ss_pred ChhhCcCHHHHhhC
Confidence 99999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=322.32 Aligned_cols=254 Identities=23% Similarity=0.426 Sum_probs=203.6
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++.. .|..+++|.+......+......+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 40 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 119 (310)
T 2wqm_A 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL 119 (310)
T ss_dssp EECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBH
T ss_pred ecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCH
Confidence 68899999999986 4889999999875555667788899999999999999999999999999999999999999999
Q ss_pred HHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 177 HDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 177 ~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........ ..
T Consensus 120 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~ 193 (310)
T 2wqm_A 120 SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT---AA 193 (310)
T ss_dssp HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC----------------
T ss_pred HHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc---cc
Confidence 999874 456899999999999999999999998 99999999999999999999999999876654322 12
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT--AVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..............+.....+|+.+.+++.+
T Consensus 194 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 273 (310)
T 2wqm_A 194 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 273 (310)
T ss_dssp -----CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHH
T ss_pred cccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHH
Confidence 23358999999999999999999999999999999999999997542 2233333332222333346789999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHHhcc
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAIQESFQK 358 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~~~~~~~ 358 (370)
||..||++|||+.++++.|+++.....+
T Consensus 274 ~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 274 CINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999887664
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=319.98 Aligned_cols=247 Identities=30% Similarity=0.563 Sum_probs=213.4
Q ss_pred CCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 99 IDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
+|.|+||.||++.+. +..+++|.+..... ..+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 16 lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (267)
T 3t9t_A 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91 (267)
T ss_dssp EEEETTEEEEEEEETTTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred ecCCCceeEEEEEecCCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence 688999999999884 67899999876432 2357889999999999999999999999999999999999999999
Q ss_pred HHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 178 DILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 178 ~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
+++... +.++...++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........ .......
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~ 166 (267)
T 3t9t_A 92 DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTK 166 (267)
T ss_dssp HHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH--HSTTSTT
T ss_pred HHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc--ccccccc
Confidence 999875 56899999999999999999999998 99999999999999999999999999876543221 1222345
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||...........+. .......+..+|+.+.+++.+||+.|
T Consensus 167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~~l~~~ 245 (267)
T 3t9t_A 167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMNHCWRER 245 (267)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred ccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-cCCcCCCCccCcHHHHHHHHHHccCC
Confidence 6889999999998889999999999999999999 899999887766655544 33445556778999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHH
Q 042314 336 PDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 336 p~~Rp~~~~ll~~l~~~~~~ 355 (370)
|++|||+.+++++|+++.++
T Consensus 246 p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 246 PEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp GGGSCCHHHHHHHHHHHHHC
T ss_pred hhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999998763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=322.19 Aligned_cols=244 Identities=25% Similarity=0.381 Sum_probs=198.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+|+|.+.... ........+.+|+.++++++||||+++++++...+..++||||++++.
T Consensus 9 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l 87 (292)
T 3o0g_A 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL 87 (292)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred EecCCCCeEEEEEEECCCCceEEEEeeeccC-CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCCCH
Confidence 3788999999999885 7889999997654 334556778899999999999999999999999999999999998744
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
+..+....+.+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++........ .....
T Consensus 88 ~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 161 (292)
T 3o0g_A 88 KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR---CYSAE 161 (292)
T ss_dssp HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS---CCCSC
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCccc---cccCC
Confidence 4444444678999999999999999999999998 99999999999999999999999999987654322 22334
Q ss_pred CCCccccCcccccccC-CCchhhHHHHHHHHHHHHhCCCCC-CCCcHHHHHHHhhccC----------------------
Q 042314 256 TGSYRYMAPEVYRRES-YGKSVDVFSFALIVHEMFQGGPSN-RADTAVQVADRRAYED---------------------- 311 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~-~~~~~~~~~~~~~~~~---------------------- 311 (370)
.+|+.|+|||.+.+.. ++.++||||+|+++|+|++|..|| ...........+....
T Consensus 162 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T 3o0g_A 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred ccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccccc
Confidence 6899999999998766 799999999999999999887774 4444443333221100
Q ss_pred -----CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 -----SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
........+++.+.+|+++||+.||++|||+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0011223478899999999999999999999999875
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=330.93 Aligned_cols=239 Identities=26% Similarity=0.365 Sum_probs=192.9
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+|+|++...... ...+.+|+.+++.++||||+++++++...+..++||||++||+|
T Consensus 28 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103 (361)
T ss_dssp ESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred eccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence 789999999999885 788999998764332 25577999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc--EEEeccccceeccccCccceeccC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH--LKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++...+++++..++.++.|++.||.|||++| |+||||||+||+++.++. +||+|||+++...... ....
T Consensus 104 ~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~----~~~~ 176 (361)
T 3uc3_A 104 YERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKS 176 (361)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---------------
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccC----CCCC
Confidence 999988889999999999999999999999998 999999999999987665 9999999987443222 1223
Q ss_pred CCCCccccCcccccccCCCch-hhHHHHHHHHHHHHhCCCCCCCCcH----HHHHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 255 GTGSYRYMAPEVYRRESYGKS-VDVFSFALIVHEMFQGGPSNRADTA----VQVADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
..||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..... ..............+....+|+.+.+||+
T Consensus 177 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 256 (361)
T 3uc3_A 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLIS 256 (361)
T ss_dssp ----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHH
T ss_pred CcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHH
Confidence 468999999999988887655 8999999999999999999976433 23333333223333334468899999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~ 348 (370)
+||..||++|||+.+++++
T Consensus 257 ~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 257 RIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHSCSCTTTSCCHHHHHTS
T ss_pred HHccCChhHCcCHHHHHhC
Confidence 9999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=331.63 Aligned_cols=253 Identities=26% Similarity=0.457 Sum_probs=214.0
Q ss_pred CCCCCcccEEEEEEcC-------ceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEee
Q 042314 99 IDPGAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g-------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
+|.|+||.||++...+ ..+++|.+... ........+.+|+.+++.+ +||||+++++++...+..++||||
T Consensus 54 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 131 (333)
T 2i1m_A 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131 (333)
T ss_dssp EEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eccCCCcceEEEEecCCCcccchhHHHHHhcccc--cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEec
Confidence 7889999999998753 36899988754 3445667899999999999 899999999999999999999999
Q ss_pred cCCCCHHHHHHhC--------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 042314 171 LRNGSLHDILKKK--------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDF 236 (370)
Q Consensus 171 ~~g~~L~~~l~~~--------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Df 236 (370)
+++|+|.+++... ..++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+||
T Consensus 132 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 208 (333)
T 2i1m_A 132 CCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDF 208 (333)
T ss_dssp CTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCC
T ss_pred CCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECcc
Confidence 9999999998753 35799999999999999999999998 999999999999999999999999
Q ss_pred ccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCC
Q 042314 237 GLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPA 315 (370)
Q Consensus 237 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 315 (370)
|++.......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....................
T Consensus 209 g~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 287 (333)
T 2i1m_A 209 GLARDIMNDSNYI-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA 287 (333)
T ss_dssp GGGCCGGGCTTSE-ECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC
T ss_pred cccccccccccee-ecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC
Confidence 9998765443221 2223346889999999999899999999999999999998 8999987654443333333445555
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 316 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
.+...|+.+.+++.+||+.||.+|||+.++++.|+++.....
T Consensus 288 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 288 QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 667789999999999999999999999999999999876644
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=336.41 Aligned_cols=258 Identities=24% Similarity=0.483 Sum_probs=204.5
Q ss_pred CCCCCCcccEEEEEEcC-----ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEe-eCCceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK-HSERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g-----~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~-~~~~~~~v~e~~ 171 (370)
.+|.|+||.||++.+.. ..+++|.+... ......+.+.+|+.++++++||||+++++++. ..+..++||||+
T Consensus 96 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred EeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 48999999999997642 34788887643 34456788999999999999999999999864 456789999999
Q ss_pred CCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc-
Q 042314 172 RNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS- 249 (370)
Q Consensus 172 ~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~- 249 (370)
++++|.+++... ..++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.........
T Consensus 174 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 250 (373)
T 3c1x_A 174 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 250 (373)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred CCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccccccc
Confidence 999999999865 45888999999999999999999998 9999999999999999999999999998665432211
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||............. ...+...+..+|+.+.+++
T Consensus 251 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-~~~~~~~p~~~~~~l~~li 329 (373)
T 3c1x_A 251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVM 329 (373)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-TTCCCCCCTTCCHHHHHHH
T ss_pred cccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHH
Confidence 12233457889999999999999999999999999999999 677887655443333332 3445556677899999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHhccCCC
Q 042314 329 RECWHKNPDRRPTFEEIIFRLEAIQESFQKKTV 361 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~~ 361 (370)
.+||..||++|||+.++++.|+++...+.+...
T Consensus 330 ~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~ 362 (373)
T 3c1x_A 330 LKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 362 (373)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHHHhccccce
Confidence 999999999999999999999999988876553
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=325.84 Aligned_cols=247 Identities=27% Similarity=0.459 Sum_probs=212.3
Q ss_pred CCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 99 IDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
+|.|+||.||++... +..+++|.+... ........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 33 lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 110 (322)
T 1p4o_A 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 110 (322)
T ss_dssp EEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeC
Confidence 688999999999764 577999998753 34455677899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC----------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecccccee
Q 042314 172 RNGSLHDILKKK----------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI 241 (370)
Q Consensus 172 ~g~~L~~~l~~~----------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~ 241 (370)
++++|.+++... ..++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 111 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~ 187 (322)
T 1p4o_A 111 TRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRD 187 (322)
T ss_dssp TTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCG
T ss_pred CCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCccccc
Confidence 999999998753 35689999999999999999999998 99999999999999999999999999986
Q ss_pred ccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCC
Q 042314 242 AQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLY 320 (370)
Q Consensus 242 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (370)
........ ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||............. .......+..+
T Consensus 188 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 265 (322)
T 1p4o_A 188 IYETDYYR-KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-EGGLLDKPDNC 265 (322)
T ss_dssp GGGGGCEE-GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTC
T ss_pred cccccccc-cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH-cCCcCCCCCCC
Confidence 65433211 2233356889999999999899999999999999999999 899998887766655544 34445566788
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042314 321 PEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 321 ~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
|+.+.+++.+||+.||++|||+.+++++|+++
T Consensus 266 ~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 266 PDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 99999999999999999999999999999876
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=320.90 Aligned_cols=244 Identities=27% Similarity=0.497 Sum_probs=204.1
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHH----HHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVR----NSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~----~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
+|.|+||.||++... +..+|+|.+........... +.+.+|+.+++.++||||+++++++.... ++||||++
T Consensus 27 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~ 104 (287)
T 4f0f_A 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVP 104 (287)
T ss_dssp CCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCT
T ss_pred cccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecC
Confidence 789999999999874 78899999876543332222 67899999999999999999999986554 79999999
Q ss_pred CCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc-----EEEeccccceeccccC
Q 042314 173 NGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH-----LKVTDFGLSKIAQEKD 246 (370)
Q Consensus 173 g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~-----~kl~Dfg~~~~~~~~~ 246 (370)
+++|.+.+.+. ..+++..++.++.|++.||.|||+++ .+|+||||||+||+++.++. +||+|||+++.....
T Consensus 105 ~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~- 182 (287)
T 4f0f_A 105 CGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS- 182 (287)
T ss_dssp TCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC-
T ss_pred CCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc-
Confidence 99998887654 47999999999999999999999976 45999999999999998776 999999998744332
Q ss_pred ccceeccCCCCCccccCccccc--ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH--HHHHHHhhccCCCCCCCCCCcH
Q 042314 247 SYSYKMTGGTGSYRYMAPEVYR--RESYGKSVDVFSFALIVHEMFQGGPSNRADTA--VQVADRRAYEDSRPALSSLYPE 322 (370)
Q Consensus 247 ~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 322 (370)
.....||+.|+|||.+. ...++.++||||||+++|+|++|+.||..... .............+..+..+|+
T Consensus 183 -----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (287)
T 4f0f_A 183 -----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPP 257 (287)
T ss_dssp -----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred -----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCH
Confidence 22346899999999984 45578999999999999999999999976543 2223444445566777888999
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042314 323 PIKALLRECWHKNPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 323 ~l~~li~~~l~~~p~~Rp~~~~ll~~l~~ 351 (370)
.+.+++.+||+.||++|||++++++.|++
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 258 RLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 99999999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=323.30 Aligned_cols=242 Identities=31% Similarity=0.593 Sum_probs=202.7
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee-CCceEEEEeecCCCCHH
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH-SERLIFLTEYLRNGSLH 177 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~-~~~~~~v~e~~~g~~L~ 177 (370)
+|.|++|.||++...|..+++|.+.... ..+.+.+|+.++++++||||+++++++.. .+..++||||+++++|.
T Consensus 29 lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (278)
T 1byg_A 29 IGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 103 (278)
T ss_dssp EEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred EecCCCceEEEEEEcCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHH
Confidence 6789999999999999999999986532 35678899999999999999999998654 45789999999999999
Q ss_pred HHHHhCCC--CChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 178 DILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 178 ~~l~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
+++.+.+. +++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........ ..
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~------~~ 174 (278)
T 1byg_A 104 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------TG 174 (278)
T ss_dssp HHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------
T ss_pred HHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccccc------CC
Confidence 99986543 889999999999999999999998 99999999999999999999999999876543321 22
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.+++.|+|||.+.+..++.++||||||+++|+|++ |+.||............. ....+..+..+|+.+.+++.+||+.
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~ 253 (278)
T 1byg_A 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYEVMKNCWHL 253 (278)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHhcC
Confidence 46889999999998899999999999999999998 999998776555444433 3445666778999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHH
Q 042314 335 NPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
||++|||+.++++.|+.++..
T Consensus 254 ~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 254 DAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp SGGGSCCHHHHHHHHHHHHHH
T ss_pred ChhhCCCHHHHHHHHHHHHhh
Confidence 999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=346.06 Aligned_cols=248 Identities=27% Similarity=0.504 Sum_probs=213.0
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|+||.||++.+. +..+|+|.++... ...+.+.+|+.+++.++||||+++++++. .+..++||||+.+|+|
T Consensus 195 ~lG~G~fg~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L 269 (454)
T 1qcf_A 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSL 269 (454)
T ss_dssp EEECCSSEEEEEEEETTTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred EcccCCceEEEEEEECCccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcH
Confidence 4899999999999886 6789999987543 23567899999999999999999999986 5678999999999999
Q ss_pred HHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++... ..++...++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ....
T Consensus 270 ~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~--~~~~ 344 (454)
T 1qcf_A 270 LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT--AREG 344 (454)
T ss_dssp HHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH--TTCS
T ss_pred HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee--ccCC
Confidence 9999754 36889999999999999999999998 999999999999999999999999999866433211 1223
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..+|+.|+|||.+....++.++||||||+++|||++ |+.||......+....+. ...+.+.+..+|+.+.++|.+||.
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~ 423 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELYNIMMRCWK 423 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcc
Confidence 346789999999998899999999999999999999 999999887766665544 345566677899999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHh
Q 042314 334 KNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
.||++|||++++++.|+.+....
T Consensus 424 ~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 424 NRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp SSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CChhHCcCHHHHHHHHHHHHhcc
Confidence 99999999999999998875543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=323.83 Aligned_cols=256 Identities=25% Similarity=0.514 Sum_probs=211.0
Q ss_pred CCCCCCcccEEEEEEcC-----ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeE-eeCCceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL-KHSERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g-----~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~-~~~~~~~~v~e~~ 171 (370)
.+|.|+||.||++.... ..+++|.+... ........+.+|+.++++++||||+++++++ ...+..++||||+
T Consensus 32 ~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 109 (298)
T 3f66_A 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 109 (298)
T ss_dssp EEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred eeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence 37889999999998642 24778877653 4456678899999999999999999999985 4566889999999
Q ss_pred CCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc-
Q 042314 172 RNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS- 249 (370)
Q Consensus 172 ~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~- 249 (370)
++++|.+++... ..++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 110 ~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~ 186 (298)
T 3f66_A 110 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 186 (298)
T ss_dssp TTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccchhcc
Confidence 999999999764 46899999999999999999999998 9999999999999999999999999998765443221
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.......+|+.|+|||.+.+..++.++||||||+++|+|++ +.+||............. .......+..+|+.+.+++
T Consensus 187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li 265 (298)
T 3f66_A 187 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCPDPLYEVM 265 (298)
T ss_dssp -----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHHHHHH
T ss_pred ccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccCCHHHHHHH
Confidence 12334457889999999999999999999999999999999 566676655544443333 3445555677899999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHhccC
Q 042314 329 RECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~ 359 (370)
.+||+.||++|||+.++++.|+++...+..+
T Consensus 266 ~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 266 LKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred HHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 9999999999999999999999998877654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=325.29 Aligned_cols=253 Identities=25% Similarity=0.429 Sum_probs=203.1
Q ss_pred CCCCCcccEEEEEEc-----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC-----ceEEEE
Q 042314 99 IDPGAYGEVYLVKWR-----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE-----RLIFLT 168 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~-----~~~~v~ 168 (370)
+|.|+||.||++... +..+++|.+.... ......+.+.+|+.++++++||||+++++++...+ ..++||
T Consensus 42 lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~ 120 (313)
T 3brb_A 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120 (313)
T ss_dssp EEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEE
T ss_pred eeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEE
Confidence 788999999999764 3369999987653 34455678999999999999999999999987654 459999
Q ss_pred eecCCCCHHHHHHh------CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceec
Q 042314 169 EYLRNGSLHDILKK------KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIA 242 (370)
Q Consensus 169 e~~~g~~L~~~l~~------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~ 242 (370)
||+.+++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 121 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~ 197 (313)
T 3brb_A 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKI 197 (313)
T ss_dssp ECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC---
T ss_pred ecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceec
Confidence 99999999999843 356899999999999999999999998 999999999999999999999999999876
Q ss_pred cccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCc
Q 042314 243 QEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYP 321 (370)
Q Consensus 243 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (370)
....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||............. ....+..+..+|
T Consensus 198 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 275 (313)
T 3brb_A 198 YSGDYYR-QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL-HGHRLKQPEDCL 275 (313)
T ss_dssp --------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCBTTCC
T ss_pred ccccccC-cccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH-cCCCCCCCcccc
Confidence 5432211 2223356889999999999999999999999999999999 889998776655544443 344556677889
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
+.+.+++.+||..||++|||+.+++++|+++.+.++
T Consensus 276 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 276 DELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 999999999999999999999999999999988765
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=343.53 Aligned_cols=244 Identities=25% Similarity=0.371 Sum_probs=206.5
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+|+|++.............+.+|..+++.++||||+++++++.+.+.+++||||++||+|
T Consensus 77 LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L 156 (410)
T 3v8s_A 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL 156 (410)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred EEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 788999999999875 778999998653211111223477899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.++++.. .+++..++.++.|++.||.|||+++ |+||||||+|||++.+|.+||+|||+++....... .......
T Consensus 157 ~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~--~~~~~~~ 230 (410)
T 3v8s_A 157 VNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM--VRCDTAV 230 (410)
T ss_dssp HHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE--EECCSCC
T ss_pred HHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCc--ccccCCc
Confidence 9999865 7999999999999999999999998 99999999999999999999999999987654332 1233557
Q ss_pred CCccccCcccccccC----CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC--CCCCCCCCCcHHHHHHHHH
Q 042314 257 GSYRYMAPEVYRRES----YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED--SRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 257 g~~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~ 330 (370)
||+.|+|||++.+.. ++.++|+|||||++|||++|++||...+.......+.... ...+....+|+.+++||++
T Consensus 231 gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~ 310 (410)
T 3v8s_A 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA 310 (410)
T ss_dssp SCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred CCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHH
Confidence 999999999998765 7889999999999999999999999888777666654322 2223334689999999999
Q ss_pred hcccCCCC--CCCHHHHHHH
Q 042314 331 CWHKNPDR--RPTFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~--Rp~~~~ll~~ 348 (370)
||..+|.+ ||+++++++|
T Consensus 311 lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 311 FLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HSSCGGGCTTSSCHHHHHTS
T ss_pred HccChhhhCCCCCHHHHhcC
Confidence 99999988 9999999876
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=320.68 Aligned_cols=248 Identities=27% Similarity=0.490 Sum_probs=206.4
Q ss_pred CCCCCcccEEEEEEcC-----ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g-----~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|.|+||.||++.+.+ ..+++|.+... ......+.+.+|+.+++.++||||+++++++.. +..++||||+.+
T Consensus 20 lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 96 (281)
T 3cc6_A 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPY 96 (281)
T ss_dssp EEECSSSEEEEEEEECTTCCEEEEEEEECCTT--SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred EEecCCeeEEEeEEcCCCCCcceEEEEecccc--cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCC
Confidence 6889999999998653 24899988754 345567889999999999999999999999765 456899999999
Q ss_pred CCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 174 GSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 174 ~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
++|.+++... ..++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ..
T Consensus 97 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~ 171 (281)
T 3cc6_A 97 GELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY--KA 171 (281)
T ss_dssp CBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC----------
T ss_pred CCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccccccc--cc
Confidence 9999999765 46999999999999999999999998 999999999999999999999999999866543221 22
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||............. .......+..+|+.+.+++.+|
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~ 250 (281)
T 3cc6_A 172 SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCPPVLYTLMTRC 250 (281)
T ss_dssp -CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHH
Confidence 33456889999999998899999999999999999998 999997665544443333 2344556677899999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
|..||++|||+.+++++|+++...
T Consensus 251 l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 251 WDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCchhCcCHHHHHHHHHHHHHh
Confidence 999999999999999999998654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=319.61 Aligned_cols=253 Identities=28% Similarity=0.527 Sum_probs=212.5
Q ss_pred CCCCCcccEEEEEEcC-ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 99 IDPGAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g-~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
+|.|+||.||++...+ ..+++|.+..... ..+.+.+|+.+++.++||||+++++++. .+..++||||+.+++|.
T Consensus 21 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 95 (279)
T 1qpc_A 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (279)
T ss_dssp EEEETTEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred ecCCCCeEEEEEEEcCCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHH
Confidence 6889999999998764 5799999865432 2467889999999999999999999876 45689999999999999
Q ss_pred HHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 178 DILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 178 ~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
+++.... .++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... .....
T Consensus 96 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~ 170 (279)
T 1qpc_A 96 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT--AREGA 170 (279)
T ss_dssp HHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE--CCTTC
T ss_pred HHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc--cccCC
Confidence 9997543 6899999999999999999999998 999999999999999999999999999877543221 22334
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.+++.|+|||.+.+..++.++||||||+++|+|++ |+.||............. .......+..+|+.+.+++.+||..
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~ 249 (279)
T 1qpc_A 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQLMRLCWKE 249 (279)
T ss_dssp CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCCcccccHHHHHHHHHHhcc
Confidence 56889999999998889999999999999999999 899998877766555443 3445556678899999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHHhccCCCC
Q 042314 335 NPDRRPTFEEIIFRLEAIQESFQKKTVP 362 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~l~~~~~~~~~~~~~ 362 (370)
||++|||+.++++.|+++.........|
T Consensus 250 ~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 277 (279)
T 1qpc_A 250 RPEDRPTFDYLRSVLEDFFTATEGQYQP 277 (279)
T ss_dssp SGGGSCCHHHHHHHHHHHHHHC------
T ss_pred ChhhCCCHHHHHHHHHHHHHhccCCCCC
Confidence 9999999999999999998887665544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=321.43 Aligned_cols=243 Identities=24% Similarity=0.409 Sum_probs=214.8
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|++...........+.+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 22 ~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 101 (294)
T 2rku_A 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 101 (294)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCC
Confidence 3788999999999886 67899999887665666778889999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 102 L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~ 175 (294)
T 2rku_A 102 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVL 175 (294)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC---CBCCC
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc---ccccc
Confidence 9999998889999999999999999999999998 99999999999999999999999999987653322 12334
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.+|+.|+|||.+.+..++.++|+||||+++|+|++|+.||............. ......+..+++.+.+++.+||+.|
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~ 253 (294)
T 2rku_A 176 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--KNEYSIPKHINPVAASLIQKMLQTD 253 (294)
T ss_dssp CSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--hccCCCccccCHHHHHHHHHHcccC
Confidence 68999999999999889999999999999999999999999887766555443 2334556678999999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042314 336 PDRRPTFEEIIFR 348 (370)
Q Consensus 336 p~~Rp~~~~ll~~ 348 (370)
|++|||+++++++
T Consensus 254 p~~Rps~~~ll~~ 266 (294)
T 2rku_A 254 PTARPTINELLND 266 (294)
T ss_dssp GGGSCCGGGGGGS
T ss_pred hhhCcCHHHHhhC
Confidence 9999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=318.62 Aligned_cols=242 Identities=23% Similarity=0.374 Sum_probs=210.2
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+++|++.... ........+.+|+.++++++||||+++++++...+..++||||+.+++|
T Consensus 14 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l 92 (284)
T 3kk8_A 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92 (284)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEGGG-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred hcCcCCeEEEEEEEcCCCceEEEEEeeccc-CCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCH
Confidence 688999999999875 7889999987654 3445567889999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc---EEEeccccceeccccCccceecc
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH---LKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
.+.+...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++........ ..
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~ 165 (284)
T 3kk8_A 93 FEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA----WH 165 (284)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB----CC
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc----cc
Confidence 999988888999999999999999999999998 999999999999986655 99999999977654432 22
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--CCCCCCCcHHHHHHHHHh
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PALSSLYPEPIKALLREC 331 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~ 331 (370)
...||+.|+|||.+.+..++.++||||||+++|+|++|+.||.................. ......+|+.+.+++.+|
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (284)
T 3kk8_A 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 245 (284)
T ss_dssp CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHH
T ss_pred CCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHH
Confidence 346899999999999999999999999999999999999999988777666655433322 223356899999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~ 348 (370)
|+.||++|||+.+++++
T Consensus 246 l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 246 LTVNPKKRITADQALKV 262 (284)
T ss_dssp SCSSTTTSCCHHHHTTS
T ss_pred cccChhhCCCHHHHhcC
Confidence 99999999999999886
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=345.67 Aligned_cols=246 Identities=23% Similarity=0.351 Sum_probs=207.7
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... ++.+|+|++.............+..|..++..++||||+++++++.+.+.+++||||+.||+
T Consensus 81 ~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~ 160 (437)
T 4aw2_A 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGD 160 (437)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred EEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCc
Confidence 3789999999999876 67899999865321111223347889999999999999999999999999999999999999
Q ss_pred HHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++.+ .+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .....
T Consensus 161 L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~ 235 (437)
T 4aw2_A 161 LLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--VQSSV 235 (437)
T ss_dssp HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC--EECCS
T ss_pred HHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC--ccccc
Confidence 9999987 468999999999999999999999998 99999999999999999999999999977654332 12334
Q ss_pred CCCCccccCccccc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc---CCCCCCCCCCcHHHHH
Q 042314 255 GTGSYRYMAPEVYR-----RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE---DSRPALSSLYPEPIKA 326 (370)
Q Consensus 255 ~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~ 326 (370)
..||+.|+|||++. ...++.++|||||||++|||++|++||...+..+....+... ...+.....+|+.+++
T Consensus 236 ~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~d 315 (437)
T 4aw2_A 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315 (437)
T ss_dssp CCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHH
T ss_pred ccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHH
Confidence 57999999999997 456899999999999999999999999988877766655432 2333444568999999
Q ss_pred HHHHhcccCCCC--CCCHHHHHHH
Q 042314 327 LLRECWHKNPDR--RPTFEEIIFR 348 (370)
Q Consensus 327 li~~~l~~~p~~--Rp~~~~ll~~ 348 (370)
||++||..+|++ ||++++++++
T Consensus 316 Li~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 316 LIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred HHHHHhcccccccCCCCHHHHhCC
Confidence 999999888888 9999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=328.53 Aligned_cols=253 Identities=26% Similarity=0.483 Sum_probs=212.8
Q ss_pred CCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCC-ceEEEEe
Q 042314 99 IDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSE-RLIFLTE 169 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~-~~~~v~e 169 (370)
+|.|+||.||++.+. +..+++|.+... ........+.+|+.+++++ +||||+++++++...+ ..++|||
T Consensus 35 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e 112 (316)
T 2xir_A 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 112 (316)
T ss_dssp EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEE
T ss_pred EcCCCceeEEEEEEecCCccccceEEEEEecccC--CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEE
Confidence 688999999999753 477999998764 3345567889999999999 6899999999987654 5899999
Q ss_pred ecCCCCHHHHHHhCCC----------------CChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEE
Q 042314 170 YLRNGSLHDILKKKGK----------------LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKV 233 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~----------------~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl 233 (370)
|+++++|.+++..... ++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl 189 (316)
T 2xir_A 113 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKI 189 (316)
T ss_dssp CCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred cCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEE
Confidence 9999999999987643 789999999999999999999998 999999999999999999999
Q ss_pred eccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCC
Q 042314 234 TDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDS 312 (370)
Q Consensus 234 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~ 312 (370)
+|||++.......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.................
T Consensus 190 ~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~ 268 (316)
T 2xir_A 190 CDFGLARDIYKDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT 268 (316)
T ss_dssp CCCGGGSCTTTCTTSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTC
T ss_pred CCCccccccccCccce-eccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCc
Confidence 9999998765433221 2223356889999999999999999999999999999998 9999987654333333333445
Q ss_pred CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 313 RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 313 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
....+..+++.+.+++.+||+.||.+|||+.+++++|+.+.+.-.
T Consensus 269 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 269 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 566677789999999999999999999999999999999977654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=331.94 Aligned_cols=242 Identities=21% Similarity=0.340 Sum_probs=203.1
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|+||.||++... |..+|+|+++... ....+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 34899999999999874 7889999987632 345678899999999999999999999999999999999999999
Q ss_pred CHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee--CCCCcEEEeccccceeccccCcccee
Q 042314 175 SLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ--DEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 175 ~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
+|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+ +..+.+||+|||++........
T Consensus 172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---- 244 (373)
T 2x4f_A 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---- 244 (373)
T ss_dssp EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB----
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc----
Confidence 999988654 46999999999999999999999998 9999999999999 5677899999999987754432
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--CCCCCCCcHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PALSSLYPEPIKALLR 329 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~ 329 (370)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...... ......+|+.+.+||.
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 324 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFIS 324 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHH
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHH
Confidence 22346899999999999999999999999999999999999999988877665555432222 2233568899999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~ 348 (370)
+||+.||.+|||+.+++++
T Consensus 325 ~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 325 KLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TTSCSSGGGSCCHHHHHHS
T ss_pred HHcCCChhhCCCHHHHhcC
Confidence 9999999999999999984
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=320.83 Aligned_cols=254 Identities=22% Similarity=0.443 Sum_probs=215.6
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|++|.||++... +..+++|.+.............+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 22 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 101 (284)
T 2vgo_A 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 101 (284)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred ecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcH
Confidence 688999999999875 667999998654322233456788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....... .....
T Consensus 102 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~ 173 (284)
T 2vgo_A 102 YKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-----RRTMC 173 (284)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-----BCCCC
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc-----ccccc
Confidence 999998888999999999999999999999998 9999999999999999999999999987654322 22346
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+. ......+..+|+.+.++|.+||..||
T Consensus 174 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p 251 (284)
T 2vgo_A 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPPFLSDGSKDLISKLLRYHP 251 (284)
T ss_dssp SCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHHHHSCSSG
T ss_pred CCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh--ccccCCCCcCCHHHHHHHHHHhhcCH
Confidence 8999999999999889999999999999999999999999887766555443 23345567789999999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHhccCCCCCC
Q 042314 337 DRRPTFEEIIFRLEAIQESFQKKTVPSC 364 (370)
Q Consensus 337 ~~Rp~~~~ll~~l~~~~~~~~~~~~~~~ 364 (370)
.+|||+.+++++ ........+..|..
T Consensus 252 ~~Rps~~~ll~h--~~~~~~~~~~~p~~ 277 (284)
T 2vgo_A 252 PQRLPLKGVMEH--PWVKANSRRVLPPV 277 (284)
T ss_dssp GGSCCHHHHHTC--HHHHHHCCCCCCCC
T ss_pred hhCCCHHHHhhC--HHHHhhccccCCCc
Confidence 999999999986 33344444554443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=332.93 Aligned_cols=250 Identities=25% Similarity=0.460 Sum_probs=205.8
Q ss_pred CCCCCcccEEEEEEc--Cce----eEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKWR--GTE----IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~----vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
+|.|+||.||++.+. +.. +++|.+.... .......+.+|+.+++.++||||+++++++. .+..++|+||+.
T Consensus 21 lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 97 (325)
T 3kex_A 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLP 97 (325)
T ss_dssp EECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCT
T ss_pred eeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCC
Confidence 789999999999874 444 6666664332 1222345678999999999999999999886 567899999999
Q ss_pred CCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 173 NGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 173 g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
+|+|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......... .
T Consensus 98 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~-~ 173 (325)
T 3kex_A 98 LGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL-L 173 (325)
T ss_dssp TCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCC-C
T ss_pred CCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccccc-c
Confidence 99999999865 57899999999999999999999998 9999999999999999999999999998765443221 2
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
.....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||............. .......+..++..+.+++.+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~ 252 (325)
T 3kex_A 174 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICTIDVYMVMVK 252 (325)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTTBCTTTTHHHHH
T ss_pred ccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCcCcHHHHHHHHH
Confidence 233457889999999999999999999999999999999 999998876655444443 344555666788899999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
||..||.+|||+.+++++|+++....
T Consensus 253 ~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 253 CWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp HTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred HcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 99999999999999999999986544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=333.00 Aligned_cols=244 Identities=26% Similarity=0.360 Sum_probs=201.6
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccC--CChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIA--SNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~--~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
.+|.|+||.||++... ++.+|+|++..... ......+.+.+|+.+++.++||||+++++++...+.+++||||++|
T Consensus 31 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 110 (351)
T 3c0i_A 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG 110 (351)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSS
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCC
Confidence 3788999999999875 78999999864321 1122356789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhC----CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc---EEEeccccceeccccC
Q 042314 174 GSLHDILKKK----GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH---LKVTDFGLSKIAQEKD 246 (370)
Q Consensus 174 ~~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~---~kl~Dfg~~~~~~~~~ 246 (370)
++|.+.+.+. ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++.......
T Consensus 111 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~ 187 (351)
T 3c0i_A 111 ADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187 (351)
T ss_dssp CBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS
T ss_pred CCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC
Confidence 9998877643 35899999999999999999999998 999999999999987654 9999999998776543
Q ss_pred ccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC--CCCCCCCCcHHH
Q 042314 247 SYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS--RPALSSLYPEPI 324 (370)
Q Consensus 247 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l 324 (370)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+..... .+..+..+|+.+
T Consensus 188 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~ 263 (351)
T 3c0i_A 188 L---VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHISESA 263 (351)
T ss_dssp C---BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-HHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred e---eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-HHHHHHcCCCCCCccccccCCHHH
Confidence 2 123446899999999999999999999999999999999999999876543 2222221111 112235688999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 042314 325 KALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 325 ~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+||++||..||++|||+.+++++
T Consensus 264 ~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 264 KDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHCCCChhHCcCHHHHhcC
Confidence 999999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=345.86 Aligned_cols=245 Identities=30% Similarity=0.524 Sum_probs=212.1
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++.+. +..+|+|.++... ...+.+.+|+.++++++||||+++++++...+..++||||+++|+
T Consensus 227 ~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~ 302 (495)
T 1opk_A 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 302 (495)
T ss_dssp ESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCC
Confidence 4899999999999886 6789999987543 235678999999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 176 LHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 176 L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|.+++... ..++...++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 303 L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~ 377 (495)
T 1opk_A 303 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHA 377 (495)
T ss_dssp HHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE--ECCT
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce--eecC
Confidence 99999864 45899999999999999999999998 99999999999999999999999999987654321 1223
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
...+++.|+|||.+....++.++||||||+++|||++ |..||............. ...+...+..+|+.+.+||.+||
T Consensus 378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl 456 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKVYELMRACW 456 (495)
T ss_dssp TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHc
Confidence 3456789999999998899999999999999999999 999998776554444333 44556667789999999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~l~~~ 352 (370)
+.||++|||+.++++.|+.+
T Consensus 457 ~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 457 QWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp CSSGGGSCCHHHHHHHHHTS
T ss_pred CcChhHCcCHHHHHHHHHHH
Confidence 99999999999999998875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=321.38 Aligned_cols=249 Identities=30% Similarity=0.515 Sum_probs=214.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++.+. +..+++|.+... ....+.+.+|+.+++.++||||+++++++...+..++||||++|++
T Consensus 20 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 95 (288)
T 3kfa_A 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 95 (288)
T ss_dssp ESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEE
T ss_pred ecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCc
Confidence 3789999999999886 778999998653 2345778899999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 176 LHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 176 L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ...
T Consensus 96 L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~ 170 (288)
T 3kfa_A 96 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT--AHA 170 (288)
T ss_dssp HHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE--EET
T ss_pred HHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCccc--ccc
Confidence 99999874 35899999999999999999999999 999999999999999999999999999866543321 222
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
...+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||............. .......+..+|+.+.+++.+||
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l 249 (288)
T 3kfa_A 171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKVYELMRACW 249 (288)
T ss_dssp TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHHHh
Confidence 3346789999999999999999999999999999999 999998766554444333 34455666788999999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 333 HKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
..||++|||+.++++.|+.+....
T Consensus 250 ~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 250 QWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCChhhCcCHHHHHHHHHHHHHhc
Confidence 999999999999999999986654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=342.98 Aligned_cols=252 Identities=31% Similarity=0.538 Sum_probs=210.1
Q ss_pred CCCCCCcccEEEEEEcC-ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g-~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|+||.||++.+.+ ..+|+|.++.... ..+.+.+|+.++++++||||+++++++.. +..++||||+++|+|
T Consensus 191 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL 265 (452)
T 1fmk_A 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 265 (452)
T ss_dssp EEEECSSCEEEEEEETTTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBH
T ss_pred eecCCCCeEEEEEEECCCceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCH
Confidence 37899999999999875 5699999876432 24578999999999999999999999876 678999999999999
Q ss_pred HHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++... ..++...++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ....
T Consensus 266 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~ 340 (452)
T 1fmk_A 266 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQG 340 (452)
T ss_dssp HHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------------
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee--cccC
Confidence 9999743 46899999999999999999999998 999999999999999999999999999876543211 1223
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. .+.+.+.+..+|+.+.++|.+||+
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~ 419 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWR 419 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcc
Confidence 346889999999999999999999999999999999 999999887766665554 455666677899999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHhccCC
Q 042314 334 KNPDRRPTFEEIIFRLEAIQESFQKKT 360 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~~~~~~~~~~ 360 (370)
.||++|||++++++.|+.+.....+..
T Consensus 420 ~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 420 KEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp SSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred CChhhCcCHHHHHHHHHHHhccCCccc
Confidence 999999999999999988766555433
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=327.56 Aligned_cols=243 Identities=24% Similarity=0.405 Sum_probs=214.5
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|++.............+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 48 ~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 127 (335)
T 2owb_A 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127 (335)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCC
Confidence 3789999999999875 67899999887665666778889999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ .....
T Consensus 128 L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 201 (335)
T 2owb_A 128 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE---RKKVL 201 (335)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC---CBCCC
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc---ccccc
Confidence 9999998889999999999999999999999998 99999999999999999999999999987653322 12334
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||.+.+..++.++||||||+++|+|++|+.||.............. .....+..+++.+.++|++||+.|
T Consensus 202 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~d 279 (335)
T 2owb_A 202 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK--NEYSIPKHINPVAASLIQKMLQTD 279 (335)
T ss_dssp CSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--TCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc--CCCCCCccCCHHHHHHHHHHccCC
Confidence 689999999999998899999999999999999999999998776665554432 233456678899999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042314 336 PDRRPTFEEIIFR 348 (370)
Q Consensus 336 p~~Rp~~~~ll~~ 348 (370)
|++|||+.+++++
T Consensus 280 p~~Rps~~ell~~ 292 (335)
T 2owb_A 280 PTARPTINELLND 292 (335)
T ss_dssp GGGSCCGGGGGGS
T ss_pred hhHCcCHHHHhcC
Confidence 9999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=340.87 Aligned_cols=244 Identities=23% Similarity=0.358 Sum_probs=204.5
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... |+.+|+|++.............+..|..++..++||||+++++++.+.+.+++||||+.||+|
T Consensus 69 lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L 148 (412)
T 2vd5_A 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL 148 (412)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcH
Confidence 788999999999874 889999998653222222344578899999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 177 HDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 177 ~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
.+++.+. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.+|.+||+|||+++....... ......
T Consensus 149 ~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~--~~~~~~ 223 (412)
T 2vd5_A 149 LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT--VRSLVA 223 (412)
T ss_dssp HHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC--EECSSC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCc--ccccee
Confidence 9999875 47999999999999999999999998 99999999999999999999999999987654332 122345
Q ss_pred CCCccccCccccc-------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc---CCCCCCCCCCcHHHH
Q 042314 256 TGSYRYMAPEVYR-------RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE---DSRPALSSLYPEPIK 325 (370)
Q Consensus 256 ~g~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~ 325 (370)
.||+.|+|||++. ...++.++|+|||||++|||++|++||...+.......+... ...+..+..+|+.++
T Consensus 224 ~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~ 303 (412)
T 2vd5_A 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEAR 303 (412)
T ss_dssp CSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHH
T ss_pred ccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHH
Confidence 7999999999997 356899999999999999999999999988877766555421 223334567899999
Q ss_pred HHHHHhcccCCCCC---CCHHHHHHH
Q 042314 326 ALLRECWHKNPDRR---PTFEEIIFR 348 (370)
Q Consensus 326 ~li~~~l~~~p~~R---p~~~~ll~~ 348 (370)
+||++||. +|.+| |+++++++|
T Consensus 304 dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 304 DFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 99999999 99998 689998765
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=324.84 Aligned_cols=252 Identities=26% Similarity=0.438 Sum_probs=207.0
Q ss_pred CCCCCCcccEEEEEEcCceeEEEEeccccC-CChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWRGTEIAAKTIRSSIA-SNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~~vavK~l~~~~~-~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|+||.||++...+..+++|.+..... ......+.+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 38 ~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 117 (307)
T 2nru_A 38 KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117 (307)
T ss_dssp EEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred ccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcH
Confidence 378999999999999999999999875432 3445678899999999999999999999999999999999999999999
Q ss_pred HHHHHh---CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 177 HDILKK---KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 177 ~~~l~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......... ....
T Consensus 118 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~ 193 (307)
T 2nru_A 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT-VMTS 193 (307)
T ss_dssp HHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC-EECS
T ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeeccccccccccccc-cccc
Confidence 999874 346899999999999999999999998 999999999999999999999999999876543222 1223
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH----HHHHhhc---------cCCCCCCCCCC
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ----VADRRAY---------EDSRPALSSLY 320 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~~---------~~~~~~~~~~~ 320 (370)
...||+.|+|||.+.+ .++.++||||||+++|+|++|.+||....... ....... .......+...
T Consensus 194 ~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (307)
T 2nru_A 194 RIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS 272 (307)
T ss_dssp SCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHH
T ss_pred ccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHH
Confidence 3468999999998875 47899999999999999999999997653221 1111100 01112223345
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042314 321 PEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQE 354 (370)
Q Consensus 321 ~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~ 354 (370)
++.+.+++.+||+.||.+|||+.+++++|+++..
T Consensus 273 ~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 273 VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 6789999999999999999999999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=332.45 Aligned_cols=240 Identities=21% Similarity=0.396 Sum_probs=206.6
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+++|.+... .......+.+|+.+++.++||||+++++++......++||||+.|++|
T Consensus 59 LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L 135 (387)
T 1kob_A 59 LGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135 (387)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EecCCCEEEEEEEECCCCCEEEEEEeccc---chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcH
Confidence 788999999999875 778999998653 234456789999999999999999999999999999999999999999
Q ss_pred HHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC--CCcEEEeccccceeccccCccceecc
Q 042314 177 HDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE--AGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 177 ~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+||+++. .+.+||+|||++......... .
T Consensus 136 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~----~ 208 (387)
T 1kob_A 136 FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----K 208 (387)
T ss_dssp HHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE----E
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcce----e
Confidence 99987653 7999999999999999999999998 999999999999984 467999999999877544321 1
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC--CCCCCCCCCcHHHHHHHHHh
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED--SRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~ 331 (370)
...||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.... ........+|+.+.+||++|
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 288 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 288 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHH
Confidence 2368999999999999999999999999999999999999999887766655544322 22334457899999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~ 348 (370)
|..||++|||+.+++++
T Consensus 289 L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 289 LQKEPRKRLTVHDALEH 305 (387)
T ss_dssp SCSSGGGSCCHHHHHTS
T ss_pred cCCChhHCcCHHHHhhC
Confidence 99999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=319.78 Aligned_cols=252 Identities=17% Similarity=0.227 Sum_probs=209.4
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++.. .+..+|+|++..... ...+.+|+.+++.+ +|++++++++++......++||||+ +++
T Consensus 18 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 91 (298)
T 1csn_A 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 91 (298)
T ss_dssp EEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCC
Confidence 68899999999985 588999999865422 23467899999999 7999999999999999999999999 889
Q ss_pred HHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc-----EEEeccccceeccccCccc
Q 042314 176 LHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH-----LKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 176 L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~-----~kl~Dfg~~~~~~~~~~~~ 249 (370)
|.+++...+ +++...++.++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++..........
T Consensus 92 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (298)
T 1csn_A 92 LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 168 (298)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC
T ss_pred HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccc
Confidence 999998754 5999999999999999999999998 999999999999987776 9999999998776543211
Q ss_pred ----eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhh---ccCCCCCCCCC
Q 042314 250 ----YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT---AVQVADRRA---YEDSRPALSSL 319 (370)
Q Consensus 250 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~---~~~~~~~~~---~~~~~~~~~~~ 319 (370)
.......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ......... .....+.....
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1csn_A 169 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 248 (298)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTT
T ss_pred cccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhh
Confidence 12234568999999999999999999999999999999999999998742 222222221 11222334457
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccC
Q 042314 320 YPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359 (370)
Q Consensus 320 ~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~ 359 (370)
+|+.+.+++.+||+.||++|||++++++.|+++.+.....
T Consensus 249 ~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 249 FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 8999999999999999999999999999999999887643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=325.73 Aligned_cols=250 Identities=18% Similarity=0.229 Sum_probs=206.3
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|+||.||++.. .+..+|+|++...... ..+.+|+.+++.+ +||||+++++++...+..++||||+ ++
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (330)
T 2izr_A 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP 89 (330)
T ss_dssp ECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred EeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence 379999999999985 5889999998754322 3477899999999 8999999999999999999999999 88
Q ss_pred CHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc-----EEEeccccceeccccCcc
Q 042314 175 SLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH-----LKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 175 ~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~-----~kl~Dfg~~~~~~~~~~~ 248 (370)
+|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++.........
T Consensus 90 ~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~ 166 (330)
T 2izr_A 90 SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166 (330)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence 999999864 68999999999999999999999998 999999999999998887 999999999876543321
Q ss_pred c----eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhc---cCCCCCCCC
Q 042314 249 S----YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT---AVQVADRRAY---EDSRPALSS 318 (370)
Q Consensus 249 ~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~---~~~~~~~~~~---~~~~~~~~~ 318 (370)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .......+.. .........
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 246 (330)
T 2izr_A 167 KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCE 246 (330)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTT
T ss_pred ccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhc
Confidence 1 11234578999999999999999999999999999999999999998642 2222222211 111112234
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 319 LYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 319 ~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
.+| .+.+++.+||+.||.+||+++++.+.|+++.+...
T Consensus 247 ~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 247 NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 466 89999999999999999999999999999987763
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=321.88 Aligned_cols=248 Identities=30% Similarity=0.527 Sum_probs=195.7
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHHH
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLHD 178 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~~ 178 (370)
+|.|+||.||++...+ .+++|+++... ......+.+.+|+.+++.++||||++++++. .....++||||+++++|.+
T Consensus 32 lG~G~~g~Vy~~~~~~-~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~ 108 (289)
T 3og7_A 32 IGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYH 108 (289)
T ss_dssp EEECSSEEEEEEESSS-EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHH
T ss_pred ecCCCCeEEEEEEEcC-ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHH
Confidence 6889999999998765 58999987653 4456678899999999999999999999964 5567899999999999999
Q ss_pred HHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCCC
Q 042314 179 ILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTG 257 (370)
Q Consensus 179 ~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g 257 (370)
++... ..++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... .......|
T Consensus 109 ~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~g 184 (289)
T 3og7_A 109 HLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS-HQFEQLSG 184 (289)
T ss_dssp HHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------------------C
T ss_pred HHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccccc-ccccccCC
Confidence 99644 57899999999999999999999998 999999999999999999999999999765532221 12233468
Q ss_pred CccccCccccc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc----CCCCCCCCCCcHHHHHHHHH
Q 042314 258 SYRYMAPEVYR---RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE----DSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 258 ~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~ 330 (370)
|+.|+|||.+. +..++.++||||||+++|+|++|+.||............... .........+|+.+.+++.+
T Consensus 185 t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 264 (289)
T 3og7_A 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAE 264 (289)
T ss_dssp CCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHH
T ss_pred CccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHH
Confidence 99999999986 566888999999999999999999999875543333222211 12233455789999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAIQ 353 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~~ 353 (370)
||+.||++|||+.++++.|+++.
T Consensus 265 ~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 265 CLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HccCChhhCCCHHHHHHHHHHHh
Confidence 99999999999999999998864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=330.54 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=206.2
Q ss_pred ccCCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 96 RGGIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
...+|.|+||.||++... +..+++|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 345899999999999875 7889999876542 344677899999999999999999999999999999999999999
Q ss_pred CHHHHHHhCC----CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 175 SLHDILKKKG----KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 175 ~L~~~l~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~- 196 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH- 196 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC-
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccc-
Confidence 9999987543 5899999999999999999999998 9999999999999999999999999998654332211
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHH------HHHhhc-----cCCCC----C
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQV------ADRRAY-----EDSRP----A 315 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~------~~~~~~-----~~~~~----~ 315 (370)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ ...... ....+ .
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (321)
T 2qkw_B 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADK 276 (321)
T ss_dssp CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccc
Confidence 12233579999999999988999999999999999999999999975432110 000000 00111 1
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042314 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 316 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
.+...+..+.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 2233456799999999999999999999999999988764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=325.18 Aligned_cols=253 Identities=28% Similarity=0.542 Sum_probs=211.3
Q ss_pred CCCCCcccEEEEEE------cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC--ceEEEEee
Q 042314 99 IDPGAYGEVYLVKW------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE--RLIFLTEY 170 (370)
Q Consensus 99 l~~g~~~~v~~a~~------~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~--~~~~v~e~ 170 (370)
+|.|+||.||++.+ .+..+++|.+... .....+.+.+|+.+++.++||||+++++++...+ ..++||||
T Consensus 49 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 125 (326)
T 2w1i_A 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125 (326)
T ss_dssp EECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECC
T ss_pred eccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEEC
Confidence 78899999999984 4778999998753 3456678999999999999999999999886543 78999999
Q ss_pred cCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 171 LRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 171 ~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+++++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 126 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~ 202 (326)
T 2w1i_A 126 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY 202 (326)
T ss_dssp CTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEE
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcccccccc
Confidence 9999999999876 46899999999999999999999998 9999999999999999999999999998776543322
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH---------------HHHHhhccCCCC
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ---------------VADRRAYEDSRP 314 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---------------~~~~~~~~~~~~ 314 (370)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||....... ............
T Consensus 203 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (326)
T 2w1i_A 203 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL 282 (326)
T ss_dssp ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCC
T ss_pred ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCC
Confidence 22233457788999999998889999999999999999999999886432111 111112233445
Q ss_pred CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 315 ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 315 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
..+..+|+.+.++|++||+.||++|||+.++++.|+++.+.+.
T Consensus 283 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 283 PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 5677899999999999999999999999999999999998765
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=328.01 Aligned_cols=251 Identities=27% Similarity=0.557 Sum_probs=203.6
Q ss_pred CCCCCcccEEEEEEc--Ccee----EEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKWR--GTEI----AAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~v----avK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
+|.|+||.||++.+. +..+ ++|.+... ........+.+|+.+++.++||||+++++++.... .++|+|++.
T Consensus 23 lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~ 99 (327)
T 3lzb_A 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMP 99 (327)
T ss_dssp EEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCS
T ss_pred eeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecC
Confidence 788999999999874 5554 55555432 23345677899999999999999999999988654 788999999
Q ss_pred CCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 173 NGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 173 g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
+|+|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++........ ..
T Consensus 100 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~-~~ 175 (327)
T 3lzb_A 100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YH 175 (327)
T ss_dssp SCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-------------
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCcccc-cc
Confidence 99999999864 57999999999999999999999998 999999999999999999999999999876544322 12
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
.....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||............. .......+..+|..+.+++.+
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~ 254 (327)
T 3lzb_A 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDVYMIMRK 254 (327)
T ss_dssp ----CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCHHHHHHHHH
T ss_pred ccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHH
Confidence 334457889999999999999999999999999999999 999998876655544443 344556677789999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
||..||.+|||+.++++.|+++.....
T Consensus 255 ~l~~dp~~Rps~~ell~~L~~~~~~~~ 281 (327)
T 3lzb_A 255 CWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred HcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence 999999999999999999999975543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=322.41 Aligned_cols=244 Identities=31% Similarity=0.502 Sum_probs=196.5
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHh--cCCCceeeeeeeEee----CCceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQK--LRHPNIVQFLGVLKH----SERLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~--l~hp~Iv~~~~~~~~----~~~~~~v~e~~~ 172 (370)
+|.|+||.||++.+++..+|+|++... ....+..|.+++.. ++||||+++++++.. ....++||||++
T Consensus 16 lg~G~~g~V~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~ 89 (301)
T 3q4u_A 16 VGKGRYGEVWRGSWQGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 89 (301)
T ss_dssp EEECSSEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCT
T ss_pred eccCCCcEEEEEEECCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhcc
Confidence 788999999999999999999998653 23445667777666 789999999998654 346899999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHh--------hcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccc
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLH--------HHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQE 244 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH--------~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 244 (370)
+|+|.++++. ..+++..++.++.|++.||.||| +.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 165 (301)
T 3q4u_A 90 MGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165 (301)
T ss_dssp TCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeeccc
Confidence 9999999965 47999999999999999999999 777 99999999999999999999999999987655
Q ss_pred cCccc-eeccCCCCCccccCccccccc------CCCchhhHHHHHHHHHHHHhC----------CCCCCCCc-----HHH
Q 042314 245 KDSYS-YKMTGGTGSYRYMAPEVYRRE------SYGKSVDVFSFALIVHEMFQG----------GPSNRADT-----AVQ 302 (370)
Q Consensus 245 ~~~~~-~~~~~~~g~~~y~aPE~~~~~------~~~~~~Di~slG~~l~el~~g----------~~p~~~~~-----~~~ 302 (370)
..... .......||+.|+|||.+.+. .++.++||||||+++|||++| ..||.... ...
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~ 245 (301)
T 3q4u_A 166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245 (301)
T ss_dssp TTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred ccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhh
Confidence 43321 112334689999999999876 455799999999999999999 88885431 222
Q ss_pred HHHHhhccCCCCCCCC-----CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042314 303 VADRRAYEDSRPALSS-----LYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 303 ~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
...........+..+. ..++.+.+++.+||+.||++|||+.++++.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 2222222333333332 2557899999999999999999999999999876
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=323.04 Aligned_cols=244 Identities=25% Similarity=0.465 Sum_probs=200.5
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... |..+|+|.+.... ......+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 10 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (311)
T 4agu_A 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTV 88 (311)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred EEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCch
Confidence 3788999999999885 7889999886653 445667788999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++...+.+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++......... ....
T Consensus 89 l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~ 162 (311)
T 4agu_A 89 LHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY---YDDE 162 (311)
T ss_dssp HHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC------------
T ss_pred HHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc---cCCC
Confidence 9999988888999999999999999999999998 999999999999999999999999999876543221 2234
Q ss_pred CCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-------------------CCCCC
Q 042314 256 TGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-------------------DSRPA 315 (370)
Q Consensus 256 ~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-------------------~~~~~ 315 (370)
.+|+.|+|||.+.+ ..++.++||||||+++|+|++|.+||............... .....
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
T 4agu_A 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIP 242 (311)
T ss_dssp ---GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCC
T ss_pred cCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCC
Confidence 68999999999976 56799999999999999999999999887665543322110 00000
Q ss_pred ----------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 316 ----------LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 316 ----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
....+|+.+.+|+.+||+.||++|||+++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 243 DPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 013578889999999999999999999999865
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=321.63 Aligned_cols=242 Identities=28% Similarity=0.455 Sum_probs=197.8
Q ss_pred CCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 99 IDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
+|.|+||.||++... +..+|+|.+.... ........+.+|+.+++.++||||+++++++...+..++||||+++ +|.
T Consensus 10 lg~G~~g~V~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~ 87 (288)
T 1ob3_A 10 IGEGTYGVVYKAQNNYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLK 87 (288)
T ss_dssp EEEETTEEEEEEEETTSCEEEEEEECCSS-GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHH
T ss_pred cccCCCEEEEEEEcCCCCEEEEEEEeccc-cccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHH
Confidence 788999999999875 7889999986543 2223346678999999999999999999999999999999999986 999
Q ss_pred HHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 178 DILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 178 ~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
+++... +.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ......
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~ 161 (288)
T 1ob3_A 88 KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---KYTHEI 161 (288)
T ss_dssp HHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------------
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc---cccccc
Confidence 988864 67999999999999999999999998 99999999999999999999999999876643321 122346
Q ss_pred CCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc---CC-------------C------
Q 042314 257 GSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE---DS-------------R------ 313 (370)
Q Consensus 257 g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~-------------~------ 313 (370)
+|+.|+|||++.+. .++.++||||||+++|+|++|++||............... .. .
T Consensus 162 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T 1ob3_A 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241 (288)
T ss_dssp CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCC
T ss_pred ccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccc
Confidence 79999999999764 5899999999999999999999999887665544332110 00 0
Q ss_pred -----CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 -----PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 -----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
......+++.+.+||++||+.||++|||+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01124578999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=326.69 Aligned_cols=241 Identities=20% Similarity=0.367 Sum_probs=184.1
Q ss_pred ccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecC
Q 042314 96 RGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
...+|.|+||.||++... +..+|+|.+... ....+.+|+.+++.+. ||||+++++++.+....++||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 345999999999999875 788999998653 3456778999999997 9999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC---cEEEeccccceeccccCccc
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG---HLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~~ 249 (370)
|++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||++........
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 9999999999889999999999999999999999998 99999999999998766 799999999986654322
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHhhccCCC--CCCCCCC
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA-------VQVADRRAYEDSR--PALSSLY 320 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-------~~~~~~~~~~~~~--~~~~~~~ 320 (370)
......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+...... ...+..+
T Consensus 165 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (325)
T 3kn6_A 165 -PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTS
T ss_pred -cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCC
Confidence 22334679999999999999999999999999999999999999976433 2333333211111 1112357
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 321 PEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 321 ~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
|+.+.+||++||..||++|||+++++++
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 8999999999999999999999998754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=323.95 Aligned_cols=252 Identities=26% Similarity=0.438 Sum_probs=210.1
Q ss_pred CCCCCcccEEEEEE-------cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 99 IDPGAYGEVYLVKW-------RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~-------~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
+|.|+||.||++.+ .+..+++|.+... ........+.+|+.++++++||||+++++++......++||||+
T Consensus 38 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 115 (327)
T 2yfx_A 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELM 115 (327)
T ss_dssp CC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecC
Confidence 78999999999984 3567999998643 34456678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCC-------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC---CcEEEecccccee
Q 042314 172 RNGSLHDILKKKG-------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA---GHLKVTDFGLSKI 241 (370)
Q Consensus 172 ~g~~L~~~l~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~---~~~kl~Dfg~~~~ 241 (370)
++++|.+++.... .++...++.++.|++.||.|||+++ |+||||||+||+++.+ ..+||+|||++..
T Consensus 116 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~ 192 (327)
T 2yfx_A 116 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192 (327)
T ss_dssp TTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred CCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECccccccc
Confidence 9999999998753 4888999999999999999999998 9999999999999944 4699999999876
Q ss_pred ccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCC
Q 042314 242 AQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLY 320 (370)
Q Consensus 242 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (370)
........ ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||............. ....+..+..+
T Consensus 193 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 270 (327)
T 2yfx_A 193 IYRASYYR-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-SGGRMDPPKNC 270 (327)
T ss_dssp HHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-TTCCCCCCTTC
T ss_pred cccccccc-cCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh-cCCCCCCCCCC
Confidence 54332211 1222357889999999998899999999999999999998 999998887766555544 34455667788
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 321 PEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 321 ~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
|+.+.+++.+||+.||.+||++.+++++|+.+.....
T Consensus 271 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 271 PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 9999999999999999999999999999999876543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=324.53 Aligned_cols=249 Identities=31% Similarity=0.532 Sum_probs=209.5
Q ss_pred CCCCCcccEEEEEEc--Cce--eEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWR--GTE--IAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~--vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|.|+||.||++... +.. +++|.+... ........+.+|+.+++++ +||||+++++++...+..++||||+++
T Consensus 33 lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 110 (327)
T 1fvr_A 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 110 (327)
T ss_dssp EECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCC
Confidence 688999999999865 443 488887643 2334456788999999999 899999999999999999999999999
Q ss_pred CCHHHHHHhCC----------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccc
Q 042314 174 GSLHDILKKKG----------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFG 237 (370)
Q Consensus 174 ~~L~~~l~~~~----------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg 237 (370)
++|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 111 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg 187 (327)
T 1fvr_A 111 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 187 (327)
T ss_dssp CBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTT
T ss_pred CCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccC
Confidence 99999998754 6899999999999999999999998 9999999999999999999999999
Q ss_pred cceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCC
Q 042314 238 LSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPAL 316 (370)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 316 (370)
++....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||............. .......
T Consensus 188 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~ 262 (327)
T 1fvr_A 188 LSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEK 262 (327)
T ss_dssp CEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-GTCCCCC
T ss_pred cCccccccc----cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh-cCCCCCC
Confidence 987443221 1122346889999999998889999999999999999998 999999888776665554 3445556
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 317 SSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 317 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
+..+|+.+.+++.+||..||++|||+.+++++|+++.+...
T Consensus 263 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 263 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 67789999999999999999999999999999999987654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=325.59 Aligned_cols=244 Identities=23% Similarity=0.369 Sum_probs=201.1
Q ss_pred CCCCCcccEEEEEEcC---------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEe
Q 042314 99 IDPGAYGEVYLVKWRG---------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g---------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
+|.|+||.||++.... ..+++|.+... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 16 lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 92 (289)
T 4fvq_A 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE 92 (289)
T ss_dssp EEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEE
T ss_pred eccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEE
Confidence 7889999999997653 45899988653 23456778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCC-CChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc--------EEEeccccce
Q 042314 170 YLRNGSLHDILKKKGK-LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH--------LKVTDFGLSK 240 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~-~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~--------~kl~Dfg~~~ 240 (370)
|++|++|.+++...+. ++...++.++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++.
T Consensus 93 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~ 169 (289)
T 4fvq_A 93 FVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169 (289)
T ss_dssp CCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCT
T ss_pred CCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCcccc
Confidence 9999999999987654 999999999999999999999998 999999999999998887 9999999986
Q ss_pred eccccCccceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCC-CCCCCCcHHHHHHHhhccCCCCCCCC
Q 042314 241 IAQEKDSYSYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALSS 318 (370)
Q Consensus 241 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 318 (370)
....... ..+|+.|+|||.+.+ ..++.++||||||+++|+|++|. +||............. .....+.
T Consensus 170 ~~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~---~~~~~~~ 239 (289)
T 4fvq_A 170 TVLPKDI-------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE---DRHQLPA 239 (289)
T ss_dssp TTSCHHH-------HHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---TTCCCCC
T ss_pred cccCccc-------cCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh---ccCCCCC
Confidence 5543221 136888999999987 67899999999999999999954 5555555444333222 2344455
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhcc
Q 042314 319 LYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQK 358 (370)
Q Consensus 319 ~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~ 358 (370)
..++.+.+++.+||+.||++|||+.+++++|+++...-..
T Consensus 240 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 240 PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 5678899999999999999999999999999988664443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=323.30 Aligned_cols=243 Identities=23% Similarity=0.411 Sum_probs=194.5
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|+||.||++... +..+|+|.++... .......+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~- 87 (317)
T 2pmi_A 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN- 87 (317)
T ss_dssp --------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCC-
T ss_pred eEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCC-
Confidence 34899999999999765 7889999987543 222345678999999999999999999999999999999999985
Q ss_pred CHHHHHHhC------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 175 SLHDILKKK------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 175 ~L~~~l~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
+|.+++... ..++...+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++........
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 163 (317)
T 2pmi_A 88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN- 163 (317)
T ss_dssp BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC-
T ss_pred CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCcc-
Confidence 999988754 35899999999999999999999998 99999999999999999999999999987654322
Q ss_pred ceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC---------------
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS--------------- 312 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--------------- 312 (370)
......+|+.|+|||++.+. .++.++|||||||++|+|++|++||...........+.....
T Consensus 164 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 164 --TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp --CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred --cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 12334689999999999764 689999999999999999999999988776654443321000
Q ss_pred -----------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 313 -----------------RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 313 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+..+..+++.+.+||.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 001123578899999999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=325.62 Aligned_cols=244 Identities=22% Similarity=0.340 Sum_probs=200.2
Q ss_pred CCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCC--CceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH--PNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h--p~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... +..+|+|.+.... ........+.+|+.+++.++| |||+++++++...+..++|||+ .+++
T Consensus 17 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~ 94 (343)
T 3dbq_A 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNID 94 (343)
T ss_dssp ESCCSSEEEEEEECTTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEE
T ss_pred EecCCCeEEEEEEeCCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCC
Confidence 789999999999765 6779999987653 345666889999999999986 9999999999999999999995 5779
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++ ++.+||+|||++......... ......
T Consensus 95 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~-~~~~~~ 169 (343)
T 3dbq_A 95 LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS-VVKDSQ 169 (343)
T ss_dssp HHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccccc-ccCCCC
Confidence 9999999989999999999999999999999998 99999999999997 588999999999876543221 122344
Q ss_pred CCCccccCcccccc-----------cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHhhccCCCCCCCCCCcHH
Q 042314 256 TGSYRYMAPEVYRR-----------ESYGKSVDVFSFALIVHEMFQGGPSNRADTAV-QVADRRAYEDSRPALSSLYPEP 323 (370)
Q Consensus 256 ~g~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 323 (370)
.||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ...............+...++.
T Consensus 170 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T 3dbq_A 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 249 (343)
T ss_dssp CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHH
T ss_pred cCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHH
Confidence 68999999999865 66889999999999999999999999864332 3333333334455666778889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHH
Q 042314 324 IKALLRECWHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 324 l~~li~~~l~~~p~~Rp~~~~ll~~l 349 (370)
+.+++.+||+.||.+|||+.+++++-
T Consensus 250 l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 250 LQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 99999999999999999999998863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=322.06 Aligned_cols=242 Identities=25% Similarity=0.415 Sum_probs=184.2
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++.. .+..+++|.+.............+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 19 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (278)
T 3cok_A 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEM 98 (278)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEH
T ss_pred ecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcH
Confidence 68899999999986 5889999998654322223457789999999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 177 HDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 177 ~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......... ....
T Consensus 99 ~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~---~~~~ 172 (278)
T 3cok_A 99 NRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK---HYTL 172 (278)
T ss_dssp HHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC------------
T ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc---ceec
Confidence 9999875 57899999999999999999999998 999999999999999999999999999876533221 1223
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.+|+.|+|||.+.+..++.++||||||+++|+|++|+.||............. ......+..+|..+.++|.+||+.|
T Consensus 173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~d 250 (278)
T 3cok_A 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV--LADYEMPSFLSIEAKDLIHQLLRRN 250 (278)
T ss_dssp -------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC--SSCCCCCTTSCHHHHHHHHHHSCSS
T ss_pred cCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh--hcccCCccccCHHHHHHHHHHcccC
Confidence 58999999999999889999999999999999999999998765443333322 2233456678999999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042314 336 PDRRPTFEEIIFR 348 (370)
Q Consensus 336 p~~Rp~~~~ll~~ 348 (370)
|++|||+++++++
T Consensus 251 p~~Rps~~~~l~h 263 (278)
T 3cok_A 251 PADRLSLSSVLDH 263 (278)
T ss_dssp GGGSCCHHHHTTS
T ss_pred HhhCCCHHHHhcC
Confidence 9999999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=329.20 Aligned_cols=239 Identities=27% Similarity=0.392 Sum_probs=189.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+|+|++.... ..+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 60 ~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134 (349)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence 3788999999999886 6779999987542 23567889999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC---CCcEEEeccccceeccccCccceec
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE---AGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||+++....... .
T Consensus 135 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~----~ 207 (349)
T 2w4o_A 135 LFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL----M 207 (349)
T ss_dssp HHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC---------------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcccc----c
Confidence 9999998888999999999999999999999998 999999999999975 78999999999986644321 2
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhccC--CCCCCCCCCcHHHHHHHH
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ-VADRRAYED--SRPALSSLYPEPIKALLR 329 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~l~~li~ 329 (370)
....||+.|+|||.+.+..++.++|||||||++|+|++|..||....... ....+.... ........+|..+.+||+
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 287 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287 (349)
T ss_dssp -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHH
Confidence 23468999999999999999999999999999999999999997665443 333322111 122334568899999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~ 348 (370)
+||..||++|||+.+++++
T Consensus 288 ~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 288 KLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTSCSSGGGSCCHHHHHHS
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=353.52 Aligned_cols=243 Identities=26% Similarity=0.413 Sum_probs=211.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|+||.||++... ++.+|+|+++............+..|..++..+ +||+|+++++++...+.+++||||++||
T Consensus 348 ~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg 427 (674)
T 3pfq_A 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427 (674)
T ss_dssp ESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSC
T ss_pred EEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCC
Confidence 4899999999999875 667999999764322223446678899998887 6999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|.++++..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++....... ....
T Consensus 428 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~---~~~~ 501 (674)
T 3pfq_A 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKT 501 (674)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC---CBCC
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCCc---cccc
Confidence 99999998889999999999999999999999998 99999999999999999999999999986433222 2334
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
..||+.|+|||++.+..++.++|+||||+++|||++|++||......+....+.. ....++..+++.+.+||++||..
T Consensus 502 ~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~lL~~ 579 (674)
T 3pfq_A 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAVAICKGLMTK 579 (674)
T ss_dssp CCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS--SCCCCCTTSCHHHHHHHHHHSCS
T ss_pred ccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHHHccC
Confidence 5799999999999999999999999999999999999999999888877777653 34556678999999999999999
Q ss_pred CCCCCCCH-----HHHHHH
Q 042314 335 NPDRRPTF-----EEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~-----~~ll~~ 348 (370)
||++||++ ++++++
T Consensus 580 dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 580 HPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp SSTTCTTCSTTHHHHHHSS
T ss_pred CHHHCCCCCCCcHHHHhcC
Confidence 99999997 677653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=315.03 Aligned_cols=240 Identities=24% Similarity=0.343 Sum_probs=205.9
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|.+....... .+.+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (277)
T 3f3z_A 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE 92 (277)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred EEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCc
Confidence 3788999999999886 5578999887654332 5678899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee---CCCCcEEEeccccceeccccCccceec
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ---DEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++........ .
T Consensus 93 L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~----~ 165 (277)
T 3f3z_A 93 LFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM----M 165 (277)
T ss_dssp HHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC----B
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc----h
Confidence 9999988888999999999999999999999998 9999999999999 7788999999999987654332 2
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCC--CCCCCcHHHHHHHHH
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPA--LSSLYPEPIKALLRE 330 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~ 330 (370)
....+|+.|+|||.+.+. ++.++||||||+++|+|++|+.||...................+ ....+|+.+.+++.+
T Consensus 166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHH
T ss_pred hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHH
Confidence 334689999999998765 89999999999999999999999998887766665543322221 123678999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~ 348 (370)
||+.||++|||+.+++++
T Consensus 245 ~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 245 LLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HTCSSTTTSCCHHHHTTS
T ss_pred HccCChhhCcCHHHHhcC
Confidence 999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=323.19 Aligned_cols=246 Identities=22% Similarity=0.369 Sum_probs=199.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC--ceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE--RLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~--~~~~v~e~~~g 173 (370)
.+|.|+||.||++... +..+|+|++...... ...+.+.+|+.++++++||||+++++++.... ..++||||+++
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 3788999999999886 788999998754322 23566789999999999999999999987655 78999999999
Q ss_pred CCHHHHHHhCC---CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee----CCCCcEEEeccccceeccccC
Q 042314 174 GSLHDILKKKG---KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ----DEAGHLKVTDFGLSKIAQEKD 246 (370)
Q Consensus 174 ~~L~~~l~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~----~~~~~~kl~Dfg~~~~~~~~~ 246 (370)
++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||++ +..+.+||+|||+++......
T Consensus 94 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~ 170 (319)
T 4euu_A 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170 (319)
T ss_dssp CBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC
T ss_pred CCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC
Confidence 99999998653 3899999999999999999999998 9999999999999 777889999999998765543
Q ss_pred ccceeccCCCCCccccCccccc--------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHhhccCC--
Q 042314 247 SYSYKMTGGTGSYRYMAPEVYR--------RESYGKSVDVFSFALIVHEMFQGGPSNRADT----AVQVADRRAYEDS-- 312 (370)
Q Consensus 247 ~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~el~~g~~p~~~~~----~~~~~~~~~~~~~-- 312 (370)
. .....||+.|+|||++. +..++.++|||||||++|||++|+.||.... ............+
T Consensus 171 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (319)
T 4euu_A 171 Q----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (319)
T ss_dssp C----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTT
T ss_pred c----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcc
Confidence 2 22346899999999986 4678899999999999999999999996432 1222222221111
Q ss_pred ---------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 042314 313 ---------------------RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 313 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
....+..+++.+.+++++||+.||++|||++|++++...-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 0112223456799999999999999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=332.36 Aligned_cols=259 Identities=14% Similarity=0.180 Sum_probs=200.8
Q ss_pred cCCCCCCcccEEEEEEc-------CceeEEEEeccccCCChH--------HHHHHHHHHHHHHhcCCCceeeeeeeEeeC
Q 042314 97 GGIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPR--------VRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~--------~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~ 161 (370)
..+|.|+||.||++.+. +..+|+|++......... ....+..|+..++.++||||+++++++...
T Consensus 41 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 120 (364)
T 3op5_A 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120 (364)
T ss_dssp EECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEE
T ss_pred EEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeec
Confidence 34899999999999774 367999998654211000 011234455566777899999999998764
Q ss_pred ----CceEEEEeecCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC--CCCcEEEe
Q 042314 162 ----ERLIFLTEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD--EAGHLKVT 234 (370)
Q Consensus 162 ----~~~~~v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~--~~~~~kl~ 234 (370)
...++||||+ |++|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 121 ~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~kl~ 196 (364)
T 3op5_A 121 KNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLV 196 (364)
T ss_dssp ETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEEEC
T ss_pred cCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEEEE
Confidence 4589999999 88999999876 67999999999999999999999998 99999999999999 88999999
Q ss_pred ccccceeccccCccc----eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHH---Hh
Q 042314 235 DFGLSKIAQEKDSYS----YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVAD---RR 307 (370)
Q Consensus 235 Dfg~~~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~---~~ 307 (370)
|||+++......... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ..
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~ 276 (364)
T 3op5_A 197 DYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKI 276 (364)
T ss_dssp CCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHH
T ss_pred ECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHH
Confidence 999998765432211 11123458999999999999999999999999999999999999998532111110 00
Q ss_pred hccCCC------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccC
Q 042314 308 AYEDSR------PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359 (370)
Q Consensus 308 ~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~ 359 (370)
...... ......+|+.+.+++..||..||++||++.++++.|+++.+....+
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 277 RYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 000000 0112567899999999999999999999999999999998876543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=325.70 Aligned_cols=236 Identities=20% Similarity=0.343 Sum_probs=201.8
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCCh-----HHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNP-----RVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~-----~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
.+|.|+||.||++.. .+..+|+|.+........ .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 31 ~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 110 (335)
T 3dls_A 31 PLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEK 110 (335)
T ss_dssp ECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 489999999999976 478899999876532221 1334567899999999999999999999999999999999
Q ss_pred cCCC-CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 171 LRNG-SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 171 ~~g~-~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+.+| +|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 111 ~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~- 186 (335)
T 3dls_A 111 HGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF- 186 (335)
T ss_dssp CTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCB-
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECCCCCce-
Confidence 9766 99999999889999999999999999999999998 999999999999999999999999999877554322
Q ss_pred eeccCCCCCccccCcccccccCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESY-GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ........+..+|+.+.+||
T Consensus 187 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~~l~~li 255 (335)
T 3dls_A 187 ---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEAAIHPPYLVSKELMSLV 255 (335)
T ss_dssp ---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTTCCCCSSCCCHHHHHHH
T ss_pred ---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhhccCCCcccCHHHHHHH
Confidence 22358999999999988876 7899999999999999999999976322 11223344556899999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+||+.||++|||+.+++++
T Consensus 256 ~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 256 SGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp HHHTCSSGGGSCCHHHHHHC
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=328.85 Aligned_cols=244 Identities=22% Similarity=0.344 Sum_probs=200.5
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC--CCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR--HPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~--hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|+||.||++... +..+|+|++.... ........+.+|+.+++.++ ||||+++++++...+.+++||| +.++
T Consensus 63 ~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~ 140 (390)
T 2zmd_A 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 140 (390)
T ss_dssp EEECCSSEEEEEEECTTCCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSE
T ss_pred EEccCCCeEEEEEEcCCCCEEEEEEEeccc-ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCC
Confidence 4799999999999765 7789999987653 34566788999999999996 5999999999999999999999 5577
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||+++........ .....
T Consensus 141 ~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~-~~~~~ 215 (390)
T 2zmd_A 141 DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS-VVKDS 215 (390)
T ss_dssp EHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----------CC
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc-ccCCC
Confidence 99999999889999999999999999999999998 99999999999996 588999999999876543221 12234
Q ss_pred CCCCccccCcccccc-----------cCCCchhhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhccCCCCCCCCCCcH
Q 042314 255 GTGSYRYMAPEVYRR-----------ESYGKSVDVFSFALIVHEMFQGGPSNRADTA-VQVADRRAYEDSRPALSSLYPE 322 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 322 (370)
..||+.|+|||++.+ ..++.++|||||||++|+|++|++||..... ................+...++
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (390)
T 2zmd_A 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 295 (390)
T ss_dssp SCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCH
T ss_pred CCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchH
Confidence 468999999999865 3688999999999999999999999986533 2333333323344455666788
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 323 PIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 323 ~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+.+||.+||..||++|||+.+++++
T Consensus 296 ~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 296 DLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHcccChhhCCCHHHHhhC
Confidence 99999999999999999999999876
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=315.95 Aligned_cols=242 Identities=24% Similarity=0.425 Sum_probs=202.2
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee----CCceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH----SERLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~----~~~~~~v~e~~~ 172 (370)
+|.|+||.||++... +..+++|.+.... ........+.+|+.+++.++||||+++++++.. ...+++||||++
T Consensus 34 lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 112 (290)
T 1t4h_A 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112 (290)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCC
T ss_pred ccCCCCeEEEEeEecCCceEEEEEEecchh-hCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecC
Confidence 789999999999875 6678888887653 345567889999999999999999999998865 356899999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC-CCCcEEEeccccceeccccCcccee
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD-EAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
+++|.+++...+.++...++.++.|++.||.|||+.+ .+|+||||||+||+++ .++.+||+|||++........
T Consensus 113 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~---- 187 (290)
T 1t4h_A 113 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---- 187 (290)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSB----
T ss_pred CCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccccc----
Confidence 9999999998889999999999999999999999976 3599999999999998 788999999999865443321
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ-VADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||....... ..............+...++.+.++|.+
T Consensus 188 -~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 265 (290)
T 1t4h_A 188 -KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265 (290)
T ss_dssp -EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHH
T ss_pred -ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHH
Confidence 22358999999998864 58999999999999999999999998754433 3333332223334556678899999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~ 348 (370)
||+.||++|||+++++++
T Consensus 266 ~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 266 CIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HSCSSGGGSCCHHHHHTS
T ss_pred HccCChhhCCCHHHHhhC
Confidence 999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=325.17 Aligned_cols=242 Identities=27% Similarity=0.407 Sum_probs=192.3
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+|+|.+.... ........+.+|+.++++++||||+++++++...+..++||||++| +|
T Consensus 42 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L 119 (329)
T 3gbz_A 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DL 119 (329)
T ss_dssp EEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EH
T ss_pred EEecCCeEEEEEEECCCCceEEEEEEcccc-cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CH
Confidence 788999999999764 7889999997653 3334556778999999999999999999999999999999999986 99
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC-----CCCcEEEeccccceeccccCcccee
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD-----EAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~-----~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++ ..+.+||+|||++........ .
T Consensus 120 ~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~---~ 193 (329)
T 3gbz_A 120 KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR---Q 193 (329)
T ss_dssp HHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--------
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc---c
Confidence 999999889999999999999999999999998 99999999999994 445699999999976653322 2
Q ss_pred ccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCC---C-----------
Q 042314 252 MTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPA---L----------- 316 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~----------- 316 (370)
.....+|+.|+|||++.+. .++.++|||||||++|+|++|++||...........+......+. .
T Consensus 194 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (329)
T 3gbz_A 194 FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQ 273 (329)
T ss_dssp ------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhh
Confidence 2334679999999999875 479999999999999999999999988877655444321111000 0
Q ss_pred --------------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 317 --------------SSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 317 --------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+..+++.+.+||.+||+.||++|||+.+++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 274 SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 01167889999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=324.92 Aligned_cols=238 Identities=24% Similarity=0.402 Sum_probs=199.5
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|+||.||++... +..+|+|++...... ..+|++++.++ +||||+++++++.+.+..++||||++||
T Consensus 29 ~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg 101 (342)
T 2qr7_A 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGG 101 (342)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCC
Confidence 3788999999999875 788999999765322 24677888777 7999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC-C---cEEEeccccceeccccCccce
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA-G---HLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~-~---~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+|.+++.+.+.+++..+..++.|++.||.|||++| |+||||||+||++... + .+||+|||++........
T Consensus 102 ~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--- 175 (342)
T 2qr7_A 102 ELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--- 175 (342)
T ss_dssp BHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC---
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC---
Confidence 99999998889999999999999999999999998 9999999999998543 2 599999999987654432
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHhhccCC--CCCCCCCCcHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRAD---TAVQVADRRAYEDS--RPALSSLYPEPIK 325 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~~l~ 325 (370)
......||+.|+|||++.+..++.++||||||+++|+|++|.+||... ........+..... ....+..+|+.+.
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 255 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHH
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHH
Confidence 123346899999999999888999999999999999999999999753 34444444432222 2233467899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 042314 326 ALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 326 ~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+||++||..||++||++.+++++
T Consensus 256 ~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 256 DLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHCCCChhHCcCHHHHhcC
Confidence 99999999999999999999876
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=344.23 Aligned_cols=243 Identities=25% Similarity=0.431 Sum_probs=211.0
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+|+|++.............+.+|+.++++++||||+++++++...+..++||||+.|++
T Consensus 33 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~ 112 (484)
T 3nyv_A 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE 112 (484)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCC
Confidence 3788999999999875 78999999876544444556788999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee---CCCCcEEEeccccceeccccCccceec
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ---DEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++........ .
T Consensus 113 L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~----~ 185 (484)
T 3nyv_A 113 LFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK----M 185 (484)
T ss_dssp HHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS----H
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc----c
Confidence 9999998889999999999999999999999998 9999999999999 4678999999999976654332 1
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC--CCCCCCcHHHHHHHHH
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP--ALSSLYPEPIKALLRE 330 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~ 330 (370)
....||+.|+|||++.+ .++.++||||+||++|+|++|.+||...........+....... +.+..+|+.+.+||++
T Consensus 186 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 264 (484)
T 3nyv_A 186 KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264 (484)
T ss_dssp HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHH
T ss_pred ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHH
Confidence 22368999999999876 68999999999999999999999999988877766655433332 2335688999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~ 348 (370)
||..||++|||+.+++++
T Consensus 265 ~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 265 MLTYVPSMRISARDALDH 282 (484)
T ss_dssp HTCSSGGGSCCHHHHHTS
T ss_pred HCCCChhHCcCHHHHhhC
Confidence 999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=339.90 Aligned_cols=246 Identities=26% Similarity=0.469 Sum_probs=205.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+|+|++....... .....+.+|+.+++.++||||+++++++......++||||+.||+
T Consensus 44 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 122 (494)
T 3lij_A 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122 (494)
T ss_dssp EEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred EEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCc
Confidence 4789999999999885 7789999987653222 234678899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC---CcEEEeccccceeccccCccceec
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA---GHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|.+.+.....+++..+..++.|++.||.|||+++ |+||||||+||+++.. +.+||+|||++........ .
T Consensus 123 L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~----~ 195 (494)
T 3lij_A 123 LFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK----M 195 (494)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC----B
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc----c
Confidence 9999988889999999999999999999999998 9999999999999864 4599999999987654332 2
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--CCCCCCCcHHHHHHHHH
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PALSSLYPEPIKALLRE 330 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~ 330 (370)
....||+.|+|||++. ..++.++||||+||++|+|++|.+||...........+...... .+.+..+|+.+.+||++
T Consensus 196 ~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 274 (494)
T 3lij_A 196 KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274 (494)
T ss_dssp CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHH
T ss_pred cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHH
Confidence 3446899999999986 45899999999999999999999999998887766665533322 23345689999999999
Q ss_pred hcccCCCCCCCHHHHHHH--HHHH
Q 042314 331 CWHKNPDRRPTFEEIIFR--LEAI 352 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~--l~~~ 352 (370)
||+.||.+|||+.+++++ ++..
T Consensus 275 ~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 275 MLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HCCCChhhCccHHHHhcCcccccC
Confidence 999999999999999976 4444
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=315.35 Aligned_cols=241 Identities=23% Similarity=0.438 Sum_probs=199.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|.+..... ....+.+.+|+.+++.++||||+++++++......++||||+++++
T Consensus 29 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 106 (285)
T 3is5_A 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE 106 (285)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCB
T ss_pred eeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCc
Confidence 3788999999999875 77899999876532 2335678899999999999999999999999999999999999999
Q ss_pred HHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee---CCCCcEEEeccccceeccccCcc
Q 042314 176 LHDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ---DEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 176 L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++........
T Consensus 107 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~- 182 (285)
T 3is5_A 107 LLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH- 182 (285)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------
T ss_pred HHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc-
Confidence 9998854 367999999999999999999999998 9999999999999 4567899999999976554322
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC-CCCCCCcHHHHHH
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP-ALSSLYPEPIKAL 327 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 327 (370)
.....+|+.|+|||.+. ..++.++||||||+++|+|++|+.||................... .....+++.+.++
T Consensus 183 ---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 258 (285)
T 3is5_A 183 ---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258 (285)
T ss_dssp -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHH
T ss_pred ---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHH
Confidence 22346899999999986 468899999999999999999999999888776666554333322 2234578999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 042314 328 LRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 328 i~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+.+||+.||++|||+.+++++
T Consensus 259 i~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 259 LKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=326.67 Aligned_cols=244 Identities=23% Similarity=0.393 Sum_probs=207.5
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCC-----ChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEe
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIAS-----NPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~-----~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
.+|.|++|.||++... |..+|+|++...... .......+.+|+.+++++ +||||+++++++......++|||
T Consensus 101 ~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 180 (365)
T 2y7j_A 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180 (365)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEEC
T ss_pred EEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEE
Confidence 3788999999999875 889999998765322 123466788999999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 170 YLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
|++|++|.+++.....+++..+..++.|++.||.|||+.| |+|+||||+||+++.++.+||+|||++........
T Consensus 181 ~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~-- 255 (365)
T 2y7j_A 181 LMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-- 255 (365)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC--
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccCCCcc--
Confidence 9999999999998888999999999999999999999998 99999999999999999999999999987664432
Q ss_pred eeccCCCCCccccCcccccc------cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCC--CCCCCc
Q 042314 250 YKMTGGTGSYRYMAPEVYRR------ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPA--LSSLYP 321 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 321 (370)
.....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+........ .+..+|
T Consensus 256 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 333 (365)
T 2y7j_A 256 --LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 333 (365)
T ss_dssp --BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSC
T ss_pred --cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCC
Confidence 233468999999999863 3578899999999999999999999988777665554443222221 224678
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
..+.++|.+||..||++|||+.+++++
T Consensus 334 ~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 334 STVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 899999999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=327.40 Aligned_cols=240 Identities=26% Similarity=0.466 Sum_probs=204.8
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+++|++... ........+.+|+.+++.++||||+++++++...+..++||||++|++|
T Consensus 41 lg~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 118 (360)
T 3eqc_A 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 118 (360)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred ecCCCCeEEEEEEECCCCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCH
Confidence 688999999999886 788999998764 3456678899999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhc-CCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHH-RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
.+++...+.+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++....... ....
T Consensus 119 ~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~ 190 (360)
T 3eqc_A 119 DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANSF 190 (360)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---------
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccccc-----ccCC
Confidence 99999888999999999999999999999996 7 9999999999999999999999999987654332 1234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-----------------------------
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADR----------------------------- 306 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~----------------------------- 306 (370)
.||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........
T Consensus 191 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (360)
T 3eqc_A 191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270 (360)
T ss_dssp CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------------
T ss_pred CCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccC
Confidence 689999999999999999999999999999999999999987655432211
Q ss_pred -------------hhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 307 -------------RAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 307 -------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.............+|..+.+||++||..||++|||+.+++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 111111222234578899999999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=316.88 Aligned_cols=241 Identities=25% Similarity=0.436 Sum_probs=201.7
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|++|.||++... ++.+++|.+.............+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (276)
T 2h6d_A 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGEL 98 (276)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred ecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcH
Confidence 688999999999875 889999998654322234456789999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++...+.+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++........ .....
T Consensus 99 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~ 171 (276)
T 2h6d_A 99 FDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF----LRTSC 171 (276)
T ss_dssp HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------------
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCcc----eeccc
Confidence 999998888999999999999999999999999 99999999999999999999999999876654321 12335
Q ss_pred CCccccCcccccccCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 257 GSYRYMAPEVYRRESY-GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
+++.|+|||.+.+..+ +.++|+||||+++|+|++|+.||...........+.. .....+..++..+.+++.+||+.|
T Consensus 172 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~ 249 (276)
T 2h6d_A 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG--GVFYIPEYLNRSVATLLMHMLQVD 249 (276)
T ss_dssp -----CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred CCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--CcccCchhcCHHHHHHHHHHccCC
Confidence 7999999999988765 5899999999999999999999988777665555432 233456678999999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042314 336 PDRRPTFEEIIFR 348 (370)
Q Consensus 336 p~~Rp~~~~ll~~ 348 (370)
|++|||+.+++++
T Consensus 250 p~~Rps~~~~l~h 262 (276)
T 2h6d_A 250 PLKRATIKDIREH 262 (276)
T ss_dssp GGGSCCHHHHHHS
T ss_pred hhhCCCHHHHHhC
Confidence 9999999999886
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=344.67 Aligned_cols=242 Identities=25% Similarity=0.404 Sum_probs=206.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... |..+|+|.+.............+.+|+.+++.++||||+++++++...+.+++||||++||+
T Consensus 191 ~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~ 270 (576)
T 2acx_A 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGD 270 (576)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 3789999999999874 88999999865432222335668899999999999999999999999999999999999999
Q ss_pred HHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 176 LHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 176 L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++........ ..
T Consensus 271 L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~----~~ 343 (576)
T 2acx_A 271 LKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT----IK 343 (576)
T ss_dssp HHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC----EE
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCcc----cc
Confidence 999998754 4999999999999999999999998 99999999999999999999999999987654322 23
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT----AVQVADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
...||+.|+|||++.+..++.++|+|||||++|||++|++||.... .......+. ......+..+|+.+.+||+
T Consensus 344 ~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~--~~~~~~p~~~s~~~~dLI~ 421 (576)
T 2acx_A 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EVPEEYSERFSPQARSLCS 421 (576)
T ss_dssp CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHH--HCCCCCCTTSCHHHHHHHH
T ss_pred ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhh--cccccCCccCCHHHHHHHH
Confidence 3479999999999999899999999999999999999999998653 233333222 2334456778999999999
Q ss_pred HhcccCCCCCC-----CHHHHHHH
Q 042314 330 ECWHKNPDRRP-----TFEEIIFR 348 (370)
Q Consensus 330 ~~l~~~p~~Rp-----~~~~ll~~ 348 (370)
+||..||++|| +++++++|
T Consensus 422 ~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 422 QLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HhccCCHHHcCCCCCCCHHHHHhC
Confidence 99999999999 78998875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=328.41 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=193.3
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCC--ceEEEEeec
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSE--RLIFLTEYL 171 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~--~~~~v~e~~ 171 (370)
..+|.|+||.||++... |..+|+|.+.... ........+.+|+.+++.+. ||||+++++++...+ .+++||||+
T Consensus 15 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 34899999999999764 8889999986543 44556677889999999997 999999999987544 789999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc----
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS---- 247 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 247 (370)
++ +|.+++... .+++..+..++.|++.||.|||+.| |+||||||+|||++.++.+||+|||+++.......
T Consensus 94 ~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 168 (388)
T 3oz6_A 94 ET-DLHAVIRAN-ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168 (388)
T ss_dssp SE-EHHHHHHHT-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCC
T ss_pred Cc-CHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccccccccccc
Confidence 75 999999874 7999999999999999999999998 99999999999999999999999999986543110
Q ss_pred --------------cceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC
Q 042314 248 --------------YSYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS 312 (370)
Q Consensus 248 --------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 312 (370)
.........||+.|+|||++.+ ..++.++|||||||++|||++|++||...........+.....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 248 (388)
T 3oz6_A 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVID 248 (388)
T ss_dssp GGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 0112234579999999999987 5789999999999999999999999988776655444321111
Q ss_pred CC---------------------------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 042314 313 RP---------------------------------------------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIF 347 (370)
Q Consensus 313 ~~---------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~ 347 (370)
.+ ..+..+++.+.+|+++||..||++|||++++++
T Consensus 249 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 249 FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK 328 (388)
T ss_dssp CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhC
Confidence 10 012256889999999999999999999999998
Q ss_pred H
Q 042314 348 R 348 (370)
Q Consensus 348 ~ 348 (370)
|
T Consensus 329 H 329 (388)
T 3oz6_A 329 H 329 (388)
T ss_dssp S
T ss_pred C
Confidence 7
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=341.98 Aligned_cols=242 Identities=24% Similarity=0.401 Sum_probs=205.1
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... |+.+|+|++.............+.+|..+++.++||||+++++++.....+++||||++||+
T Consensus 192 ~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~ 271 (543)
T 3c4z_A 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGD 271 (543)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred EEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCC
Confidence 3789999999999874 88999999976432222345678899999999999999999999999999999999999999
Q ss_pred HHHHHHhC----CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 176 LHDILKKK----GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 176 L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++.+|.+||+|||+++....... .
T Consensus 272 L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~---~ 345 (543)
T 3c4z_A 272 IRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT---K 345 (543)
T ss_dssp HHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---C
T ss_pred HHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCc---c
Confidence 99999764 36999999999999999999999998 99999999999999999999999999987654432 1
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHhhccCCCCCCCCCCcHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT----AVQVADRRAYEDSRPALSSLYPEPIKAL 327 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~l 327 (370)
.....||+.|+|||++.+..++.++|+|||||++|||++|++||.... .......+. ......+..+|+.+.++
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~l 423 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL--EQAVTYPDKFSPASKDF 423 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH--HCCCCCCTTSCHHHHHH
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh--hcccCCCcccCHHHHHH
Confidence 233478999999999999999999999999999999999999997652 333333333 23345567789999999
Q ss_pred HHHhcccCCCCCCCH-----HHHHH
Q 042314 328 LRECWHKNPDRRPTF-----EEIIF 347 (370)
Q Consensus 328 i~~~l~~~p~~Rp~~-----~~ll~ 347 (370)
|++||..||++||++ +++++
T Consensus 424 i~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 424 CEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HHHhccCCHhHCCCCcccCHHHHHc
Confidence 999999999999965 66665
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=320.97 Aligned_cols=245 Identities=21% Similarity=0.340 Sum_probs=195.5
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|+||.||++.. .+..+|+|++.... ......+.+|+.+++++ +||||+++++++...+..++||||++|+
T Consensus 20 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 96 (316)
T 2ac3_A 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGG 96 (316)
T ss_dssp CCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCC
Confidence 489999999999976 48899999987643 23456788999999885 7999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc---EEEeccccceeccccCcc---
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH---LKVTDFGLSKIAQEKDSY--- 248 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~--- 248 (370)
+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++.........
T Consensus 97 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 173 (316)
T 2ac3_A 97 SILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173 (316)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------
T ss_pred cHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccc
Confidence 99999998888999999999999999999999998 999999999999998776 999999998765432211
Q ss_pred -ceeccCCCCCccccCcccccc-----cCCCchhhHHHHHHHHHHHHhCCCCCCCCcH---------------HHHHHHh
Q 042314 249 -SYKMTGGTGSYRYMAPEVYRR-----ESYGKSVDVFSFALIVHEMFQGGPSNRADTA---------------VQVADRR 307 (370)
Q Consensus 249 -~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---------------~~~~~~~ 307 (370)
........||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ......+
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 253 (316)
T 2ac3_A 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253 (316)
T ss_dssp --------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHH
T ss_pred cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHH
Confidence 111223458999999999875 5578999999999999999999999976431 1222222
Q ss_pred hccCCCCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 308 AYEDSRPA--LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 308 ~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.......+ ....+|+.+.+||++||..||++|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 254 QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 21111111 124578999999999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=339.51 Aligned_cols=243 Identities=28% Similarity=0.463 Sum_probs=205.6
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCC----------hHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceE
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASN----------PRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLI 165 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~----------~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~ 165 (370)
.+|.|+||.||++... +..+|+|++....... ......+.+|+.+++.++||||+++++++......+
T Consensus 43 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 122 (504)
T 3q5i_A 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY 122 (504)
T ss_dssp EEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred EecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 4789999999999875 6789999987643221 134577899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC---cEEEeccccceec
Q 042314 166 FLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG---HLKVTDFGLSKIA 242 (370)
Q Consensus 166 ~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~---~~kl~Dfg~~~~~ 242 (370)
+||||++||+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||++...
T Consensus 123 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 199 (504)
T 3q5i_A 123 LVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199 (504)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEECCCCEEc
Confidence 99999999999999988889999999999999999999999998 99999999999999776 6999999999876
Q ss_pred cccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCC--CCCCC
Q 042314 243 QEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPA--LSSLY 320 (370)
Q Consensus 243 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~ 320 (370)
.... ......||+.|+|||++.+ .++.++||||+||++|+|++|.+||...........+........ .+..+
T Consensus 200 ~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (504)
T 3q5i_A 200 SKDY----KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI 274 (504)
T ss_dssp CTTS----CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTS
T ss_pred CCCC----ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCC
Confidence 5432 2233468999999999874 589999999999999999999999999888777666653332222 23568
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 321 PEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 321 ~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
|+.+.+||++||..||.+|||+.+++++
T Consensus 275 s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 275 SDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 8999999999999999999999999876
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=339.15 Aligned_cols=242 Identities=29% Similarity=0.472 Sum_probs=206.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+|+|++....... .....+.+|+.++++++||||+++++++......++||||+.|++
T Consensus 29 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~ 107 (486)
T 3mwu_A 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107 (486)
T ss_dssp EEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCc
Confidence 3789999999999875 8889999986543222 234678899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC---CCCcEEEeccccceeccccCccceec
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD---EAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|.+.+...+.+++..+..++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++....... ..
T Consensus 108 L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~ 180 (486)
T 3mwu_A 108 LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KM 180 (486)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC----cc
Confidence 9999988889999999999999999999999998 99999999999995 45679999999997665432 22
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC--CCCCCCcHHHHHHHHH
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP--ALSSLYPEPIKALLRE 330 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~ 330 (370)
....||+.|+|||++.+ .++.++||||+||++|+|++|.+||...........+....... +.+..+|+.+.+||++
T Consensus 181 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 259 (486)
T 3mwu_A 181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259 (486)
T ss_dssp -CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHH
T ss_pred CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHH
Confidence 34468999999999876 58999999999999999999999999888877666655333222 2335688999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~ 348 (370)
||..||++|||+.+++++
T Consensus 260 ~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 260 MLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HTCSSTTTSCCHHHHHHC
T ss_pred HcCCChhhCcCHHHHhcC
Confidence 999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=316.62 Aligned_cols=243 Identities=28% Similarity=0.483 Sum_probs=211.5
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|++..... ......+.+|+.+++.++||||+++++++......++||||+++++
T Consensus 29 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 106 (303)
T 3a7i_A 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106 (303)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence 3788999999999764 78899999876532 2346778999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.. ++++...+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........ .....
T Consensus 107 L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 179 (303)
T 3a7i_A 107 ALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI---KRNTF 179 (303)
T ss_dssp HHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC---CBCCC
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc---ccCcc
Confidence 9999876 47999999999999999999999998 99999999999999999999999999987654322 22334
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.+|+.|+|||.+.+..++.++||||||+++|+|++|+.||............. ....+..+..+|..+.+++.+||..|
T Consensus 180 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~d 258 (303)
T 3a7i_A 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPPTLEGNYSKPLKEFVEACLNKE 258 (303)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCCSSCCHHHHHHHHHHCCSS
T ss_pred CCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh-cCCCCCCccccCHHHHHHHHHHcCCC
Confidence 68999999999999999999999999999999999999998877766554443 34455667788999999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 042314 336 PDRRPTFEEIIFRLE 350 (370)
Q Consensus 336 p~~Rp~~~~ll~~l~ 350 (370)
|++|||+.+++++.-
T Consensus 259 p~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 259 PSFRPTAKELLKHKF 273 (303)
T ss_dssp GGGSCCHHHHTTCHH
T ss_pred hhhCcCHHHHhhChh
Confidence 999999999998743
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=313.96 Aligned_cols=243 Identities=25% Similarity=0.424 Sum_probs=206.2
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCC---hHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASN---PRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~---~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|.|+||.||++... +..+++|.+....... ....+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 13 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 92 (283)
T 3bhy_A 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSG 92 (283)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred hcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCC
Confidence 688999999999885 7899999987653222 22467789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC----cEEEeccccceeccccCccc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG----HLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~~ 249 (370)
++|.+++.+.+.+++..++.++.|++.||.|||+++ ++||||||+||+++.++ .+||+|||++........
T Consensus 93 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~-- 167 (283)
T 3bhy_A 93 GELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-- 167 (283)
T ss_dssp CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC------
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc--
Confidence 999999998888999999999999999999999998 99999999999999877 899999999987654322
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--CCCCCCCcHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PALSSLYPEPIKAL 327 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l 327 (370)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||.................. ......+|+.+.++
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 245 (283)
T 3bhy_A 168 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDF 245 (283)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHH
T ss_pred --ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHH
Confidence 12335899999999999999999999999999999999999999988776655554322221 12235678999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 042314 328 LRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 328 i~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+++||..||++|||+.+++++
T Consensus 246 i~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 246 IRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHTTSCSSGGGSCCHHHHHHC
T ss_pred HHHHccCCHhHCcCHHHHHhC
Confidence 999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=316.77 Aligned_cols=239 Identities=28% Similarity=0.458 Sum_probs=204.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... |+.+++|.+..... .....+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 17 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (304)
T 2jam_A 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93 (304)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred ccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccH
Confidence 788999999999875 88899999875422 2345688999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee---CCCCcEEEeccccceeccccCccceecc
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ---DEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++........ .
T Consensus 94 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~-----~ 165 (304)
T 2jam_A 94 FDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM-----S 165 (304)
T ss_dssp HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT-----H
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc-----c
Confidence 999988889999999999999999999999998 9999999999999 7788999999999875543211 1
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC--CCCCCCCCcHHHHHHHHHh
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS--RPALSSLYPEPIKALLREC 331 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~ 331 (370)
...||+.|+|||.+.+..++.++||||||+++|+|++|..||...........+..... ....+..+|+.+.++|.+|
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (304)
T 2jam_A 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHL 245 (304)
T ss_dssp HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHH
T ss_pred cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHH
Confidence 12479999999999999999999999999999999999999998877666555443222 2334467899999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~ 348 (370)
|..||++|||+.+++++
T Consensus 246 l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 246 LEKDPNERYTCEKALSH 262 (304)
T ss_dssp HCSSTTTSCCHHHHHTS
T ss_pred cCCChhHCcCHHHHhcC
Confidence 99999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=331.62 Aligned_cols=257 Identities=17% Similarity=0.200 Sum_probs=197.8
Q ss_pred cCCCCCCcccEEEEEE-----cCceeEEEEeccccCCCh--------HHHHHHHHHHHHHHhcCCCceeeeeeeEee---
Q 042314 97 GGIDPGAYGEVYLVKW-----RGTEIAAKTIRSSIASNP--------RVRNSFMKELGLWQKLRHPNIVQFLGVLKH--- 160 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~-----~g~~vavK~l~~~~~~~~--------~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~--- 160 (370)
..+|.|+||.||++.. .+..+++|.......... .....+.+|+..++.++||||+++++++..
T Consensus 43 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~ 122 (345)
T 2v62_A 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFK 122 (345)
T ss_dssp EEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESS
T ss_pred eeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccC
Confidence 3489999999999988 467799998875421110 012336678888999999999999999887
Q ss_pred -CCceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC--cEEEeccc
Q 042314 161 -SERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG--HLKVTDFG 237 (370)
Q Consensus 161 -~~~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~--~~kl~Dfg 237 (370)
....++||||+ |++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||
T Consensus 123 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg 198 (345)
T 2v62_A 123 GRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYG 198 (345)
T ss_dssp SCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECCCT
T ss_pred CCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEeCC
Confidence 67899999999 8899999988878999999999999999999999998 99999999999999877 99999999
Q ss_pred cceeccccCccc----eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC--cHHHHHHH-hhcc
Q 042314 238 LSKIAQEKDSYS----YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRAD--TAVQVADR-RAYE 310 (370)
Q Consensus 238 ~~~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~--~~~~~~~~-~~~~ 310 (370)
+++......... .......||+.|+|||++.+..++.++||||||+++|||++|+.||... ........ ....
T Consensus 199 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 278 (345)
T 2v62_A 199 LSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLL 278 (345)
T ss_dssp TCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHH
T ss_pred CceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhc
Confidence 998765432111 1123456899999999999999999999999999999999999999642 22111111 1101
Q ss_pred CCCC------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 311 DSRP------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 311 ~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
...+ .....+|+.+.+++.+||..||++|||++++++.|+++.....
T Consensus 279 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 331 (345)
T 2v62_A 279 DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLG 331 (345)
T ss_dssp HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCC
T ss_pred ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCccc
Confidence 1111 0122688999999999999999999999999999987654443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=318.41 Aligned_cols=238 Identities=26% Similarity=0.365 Sum_probs=192.6
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|+||.||++... ++.+|+|.+...... .........|+..+..+ +||||+++++++...+.+++||||+ ++
T Consensus 64 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~ 141 (311)
T 3p1a_A 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG-PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GP 141 (311)
T ss_dssp EEEEETTEEEEEEEETTTSCEEEEEEESSSCCS-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CC
T ss_pred eeccCCCeEEEEEEECCCCeEEEEEEecccccC-hHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CC
Confidence 3789999999999885 889999998665433 33444555566555554 8999999999999999999999999 56
Q ss_pred CHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 142 ~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~----~~ 214 (311)
T 3p1a_A 142 SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA----GE 214 (311)
T ss_dssp BHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC----------
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCCC----Cc
Confidence 998887754 46999999999999999999999998 99999999999999999999999999877654322 22
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
...||+.|+|||++.+ .++.++||||||+++|||++|..|+........... ....+..+..+|+.+.++|.+||+
T Consensus 215 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~L~ 290 (311)
T 3p1a_A 215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ---GYLPPEFTAGLSSELRSVLVMMLE 290 (311)
T ss_dssp CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTT---TCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhc---cCCCcccccCCCHHHHHHHHHHcC
Confidence 3458999999999876 689999999999999999999777665443322221 222333456688999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~ 348 (370)
.||++|||+.+++++
T Consensus 291 ~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 291 PDPKLRATAEALLAL 305 (311)
T ss_dssp SSTTTSCCHHHHHTS
T ss_pred CChhhCcCHHHHHhC
Confidence 999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=326.23 Aligned_cols=248 Identities=25% Similarity=0.333 Sum_probs=201.0
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccC--CChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIA--SNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~--~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
.+|.|+||.||++... +..+|+|++..... ........+.+|+.+++.++||||+++++++...+..++||||++|
T Consensus 33 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g 112 (345)
T 3hko_A 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHG 112 (345)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred eeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCC
Confidence 3788999999999875 67899999865421 2334567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhC----------------------------------------CCCChHhHHHHHHHHHHHHHHHhhcCCCce
Q 042314 174 GSLHDILKKK----------------------------------------GKLDPPTAVAYALDIARGMNYLHHHRPHAI 213 (370)
Q Consensus 174 ~~L~~~l~~~----------------------------------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i 213 (370)
|+|.+++... ..+++..++.++.|++.||.|||+++ |
T Consensus 113 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i 189 (345)
T 3hko_A 113 GHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---I 189 (345)
T ss_dssp CBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred CcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---c
Confidence 9999988521 12356778899999999999999998 9
Q ss_pred eecCCCCCCeeeCCCC--cEEEeccccceeccccCc-cceeccCCCCCccccCcccccc--cCCCchhhHHHHHHHHHHH
Q 042314 214 IHRDLTPSNVLQDEAG--HLKVTDFGLSKIAQEKDS-YSYKMTGGTGSYRYMAPEVYRR--ESYGKSVDVFSFALIVHEM 288 (370)
Q Consensus 214 iH~Dlk~~Nil~~~~~--~~kl~Dfg~~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el 288 (370)
+||||||+||+++.++ .+||+|||++........ .........||+.|+|||.+.+ ..++.++||||||+++|+|
T Consensus 190 vH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el 269 (345)
T 3hko_A 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269 (345)
T ss_dssp ECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHH
T ss_pred cccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999998776 899999999987654322 1122344568999999999975 6788999999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHhhccCCCCC--CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 289 FQGGPSNRADTAVQVADRRAYEDSRPA--LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 289 ~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
++|+.||.................... ....+++.+.++|.+||..||++||++.+++++
T Consensus 270 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 270 LMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 999999998887766665543333222 223478999999999999999999999999875
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=323.68 Aligned_cols=240 Identities=25% Similarity=0.394 Sum_probs=196.2
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC------ceEEEE
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE------RLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~------~~~~v~ 168 (370)
..+|.|+||.||++... |..+|+|.+.... ......+.+.+|+.+++.++||||+++++++.... .+++||
T Consensus 31 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 109 (367)
T 1cm8_A 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 109 (367)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence 34899999999999874 8889999986543 44566788999999999999999999999987653 469999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
||+ +++|.++++. +.+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||+++.....
T Consensus 110 e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~--- 181 (367)
T 1cm8_A 110 PFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE--- 181 (367)
T ss_dssp ECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS---
T ss_pred ecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc---
Confidence 999 7799999987 47999999999999999999999998 999999999999999999999999999875432
Q ss_pred ceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC----------------
Q 042314 249 SYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED---------------- 311 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---------------- 311 (370)
.....+|+.|+|||++.+ ..++.++||||+||++|+|++|++||...........+....
T Consensus 182 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 258 (367)
T 1cm8_A 182 ---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258 (367)
T ss_dssp ---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred ---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence 233468999999999887 678999999999999999999999998876654433322110
Q ss_pred -------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 -------------SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 -------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.........++.+.+|+++||..||++|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0112234578899999999999999999999999885
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=318.58 Aligned_cols=242 Identities=28% Similarity=0.413 Sum_probs=196.3
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCC--ChHHHHHHHHHHHHHHhc---CCCceeeeeeeEeeCC-----ceEE
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIAS--NPRVRNSFMKELGLWQKL---RHPNIVQFLGVLKHSE-----RLIF 166 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~--~~~~~~~~~~e~~~l~~l---~hp~Iv~~~~~~~~~~-----~~~~ 166 (370)
+|.|+||.||++.. .++.+|+|.+...... .......+.+|+.+++.+ +||||+++++++.... ..++
T Consensus 17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~l 96 (308)
T 3g33_A 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTL 96 (308)
T ss_dssp ECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEE
T ss_pred EecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEE
Confidence 78999999999985 4788999998754321 112234455677766666 4999999999987754 5899
Q ss_pred EEeecCCCCHHHHHHhCCC--CChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccc
Q 042314 167 LTEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQE 244 (370)
Q Consensus 167 v~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 244 (370)
||||+.+ +|.+++..... +++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 97 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 172 (308)
T 3g33_A 97 VFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY 172 (308)
T ss_dssp EEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTSTT
T ss_pred Eehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccccccCC
Confidence 9999975 99999987654 899999999999999999999998 99999999999999999999999999976543
Q ss_pred cCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC---CCCC------
Q 042314 245 KDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED---SRPA------ 315 (370)
Q Consensus 245 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~~~------ 315 (370)
... .....||+.|+|||++.+..++.++|||||||++|+|++|++||...........+.... ....
T Consensus 173 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (308)
T 3g33_A 173 QMA----LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVS 248 (308)
T ss_dssp CCC----SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCS
T ss_pred Ccc----cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhh
Confidence 322 223357999999999999999999999999999999999999999887766554432210 0000
Q ss_pred ----------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 316 ----------------LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 316 ----------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
....+++.+.+||.+||+.||++|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 249 LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp SCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 113577899999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=327.83 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=199.4
Q ss_pred cCCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 97 GGIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
..+|.|+||.||++... +..+|+|.+...... .....+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 36 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 113 (326)
T 3uim_A 36 NILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 113 (326)
T ss_dssp TEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCB
T ss_pred eeEecCCCcEEEEEEecCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCC
Confidence 34789999999999764 788999998764322 122358899999999999999999999999999999999999999
Q ss_pred HHHHHHhCC----CCChHhHHHHHHHHHHHHHHHhhc---CCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 176 LHDILKKKG----KLDPPTAVAYALDIARGMNYLHHH---RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 176 L~~~l~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++.........
T Consensus 114 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (326)
T 3uim_A 114 VASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190 (326)
T ss_dssp HHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSC
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEeccCccccccCccccc
Confidence 999998653 489999999999999999999999 7 999999999999999999999999999876544322
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH--------HHHHHHhhccC---------
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA--------VQVADRRAYED--------- 311 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--------~~~~~~~~~~~--------- 311 (370)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ...........
T Consensus 191 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 3uim_A 191 --VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVD 268 (326)
T ss_dssp --EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTT
T ss_pred --ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChh
Confidence 22334589999999999988899999999999999999999999952211 11111110000
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 042314 312 SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 312 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~ 351 (370)
.....+...++.+.+++.+||+.||++|||+.+++++|+.
T Consensus 269 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 269 LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0111122234679999999999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=323.19 Aligned_cols=245 Identities=29% Similarity=0.505 Sum_probs=201.6
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|+||.||++... +..+++|.+.... ......+.+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 109 (331)
T 4aaa_A 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT 109 (331)
T ss_dssp EEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence 34899999999999886 7889999986653 44566777899999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 110 ~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 183 (331)
T 4aaa_A 110 ILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYDD 183 (331)
T ss_dssp HHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------------
T ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc---ccCC
Confidence 99998888888999999999999999999999998 99999999999999999999999999976654322 1233
Q ss_pred CCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-------------------CC-C
Q 042314 255 GTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-------------------DS-R 313 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-------------------~~-~ 313 (370)
..+|+.|+|||.+.+. .++.++||||||+++|+|++|++||............... .. .
T Consensus 184 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
T 4aaa_A 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263 (331)
T ss_dssp CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCC
T ss_pred CcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccC
Confidence 4689999999999875 6899999999999999999999999887765543322110 00 0
Q ss_pred CC---------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 PA---------LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 ~~---------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+. ....+|+.+.+||.+||+.||++|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 113478899999999999999999999999875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=314.25 Aligned_cols=244 Identities=27% Similarity=0.397 Sum_probs=203.6
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|++|.||++... +..+++|.+..... ......+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 15 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 92 (276)
T 2yex_A 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92 (276)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEG
T ss_pred eecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcH
Confidence 788999999999875 78899999875432 24557789999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++......... .......
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~ 168 (276)
T 2yex_A 93 FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMC 168 (276)
T ss_dssp GGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE-CCBCCCC
T ss_pred HHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcch-hcccCCc
Confidence 999988778999999999999999999999998 999999999999999999999999999866543221 1223456
Q ss_pred CCccccCcccccccCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 257 GSYRYMAPEVYRRESY-GKSVDVFSFALIVHEMFQGGPSNRADTAVQ-VADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||....... .................+|+.+.+++.+||+.
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 248 (276)
T 2yex_A 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE 248 (276)
T ss_dssp SCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCS
T ss_pred cccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCC
Confidence 8999999999987765 679999999999999999999997654321 11122211222223346789999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042314 335 NPDRRPTFEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~ 348 (370)
||++|||+.+++++
T Consensus 249 ~p~~Rps~~~il~~ 262 (276)
T 2yex_A 249 NPSARITIPDIKKD 262 (276)
T ss_dssp STTTSCCHHHHTTC
T ss_pred CchhCCCHHHHhcC
Confidence 99999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=323.37 Aligned_cols=243 Identities=25% Similarity=0.406 Sum_probs=193.5
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC-------------
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE------------- 162 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~------------- 162 (370)
.+|.|+||.||++... |..+|+|+++... .....+.+.+|+.++++++||||+++++++....
T Consensus 13 ~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~ 90 (332)
T 3qd2_B 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL 90 (332)
T ss_dssp EEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred EecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence 3789999999999875 8889999997643 3446678999999999999999999999885543
Q ss_pred --------------------------------------------ceEEEEeecCCCCHHHHHHhCCC---CChHhHHHHH
Q 042314 163 --------------------------------------------RLIFLTEYLRNGSLHDILKKKGK---LDPPTAVAYA 195 (370)
Q Consensus 163 --------------------------------------------~~~~v~e~~~g~~L~~~l~~~~~---~~~~~~~~i~ 195 (370)
..++||||++|++|.+++..... .+...++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~ 170 (332)
T 3qd2_B 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170 (332)
T ss_dssp -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHH
T ss_pred ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHH
Confidence 37999999999999999987643 3455689999
Q ss_pred HHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc---------eeccCCCCCccccCccc
Q 042314 196 LDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS---------YKMTGGTGSYRYMAPEV 266 (370)
Q Consensus 196 ~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~---------~~~~~~~g~~~y~aPE~ 266 (370)
.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.......... .......||+.|+|||.
T Consensus 171 ~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 247 (332)
T 3qd2_B 171 IQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247 (332)
T ss_dssp HHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHH
T ss_pred HHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHH
Confidence 99999999999998 9999999999999999999999999998776542111 12233468999999999
Q ss_pred ccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 042314 267 YRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346 (370)
Q Consensus 267 ~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll 346 (370)
+.+..++.++||||||+++|+|++|..|+..... ...... ....+......++.+.++|.+||+.||++|||+.+++
T Consensus 248 ~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 324 (332)
T 3qd2_B 248 IHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR--IITDVR-NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324 (332)
T ss_dssp HHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH--HHHHHH-TTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHH
T ss_pred hcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH--HHHHhh-ccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHh
Confidence 9999999999999999999999998776432211 111111 2222333334567889999999999999999999998
Q ss_pred HH
Q 042314 347 FR 348 (370)
Q Consensus 347 ~~ 348 (370)
++
T Consensus 325 ~~ 326 (332)
T 3qd2_B 325 EN 326 (332)
T ss_dssp HS
T ss_pred hc
Confidence 74
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=317.74 Aligned_cols=246 Identities=24% Similarity=0.428 Sum_probs=204.7
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEe--eCCceEEEEeecCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK--HSERLIFLTEYLRNG 174 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~--~~~~~~~v~e~~~g~ 174 (370)
+|.|+||.||++... +..+++|.+.... ......+.+.+|+.++++++||||+++++++. .....++||||++++
T Consensus 14 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 92 (279)
T 2w5a_A 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 92 (279)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTE
T ss_pred ccCCCCcEEEEEEECCCCcEEEEEEEEccc-CCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCC
Confidence 688999999999875 7889999987653 34556788999999999999999999999874 356899999999999
Q ss_pred CHHHHHHhC----CCCChHhHHHHHHHHHHHHHHHhhcC--CCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 175 SLHDILKKK----GKLDPPTAVAYALDIARGMNYLHHHR--PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 175 ~L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~--~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
+|.+++... ..+++..++.++.|++.||.|||+.+ ..+|+||||||+||+++.++.+||+|||++.........
T Consensus 93 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~ 172 (279)
T 2w5a_A 93 DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172 (279)
T ss_dssp EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHH
T ss_pred CHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccccc
Confidence 999998753 34899999999999999999999975 123999999999999999999999999998765543211
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+. ....+..+..+|+.+.+++
T Consensus 173 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li 248 (279)
T 2w5a_A 173 ---AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDELNEII 248 (279)
T ss_dssp ---HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTCCCCCCTTSCHHHHHHH
T ss_pred ---ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh-hcccccCCcccCHHHHHHH
Confidence 112247899999999999899999999999999999999999999887766555444 3445566778899999999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l 349 (370)
.+||+.||++|||+.++++++
T Consensus 249 ~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 249 TRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHHTCSSGGGSCCHHHHHTST
T ss_pred HHHcCCCcccCCCHHHHHhCh
Confidence 999999999999999998864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=328.37 Aligned_cols=237 Identities=26% Similarity=0.399 Sum_probs=189.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHH-HhcCCCceeeeeeeEee----CCceEEEEee
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLW-QKLRHPNIVQFLGVLKH----SERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l-~~l~hp~Iv~~~~~~~~----~~~~~~v~e~ 170 (370)
.+|.|+||.||++... +..+|+|++... ..+.+|+.++ +..+||||+++++++.. ...+++||||
T Consensus 69 ~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~ 140 (400)
T 1nxk_A 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140 (400)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence 3789999999999875 788999998632 3456788876 44589999999998875 5678999999
Q ss_pred cCCCCHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC---CCcEEEeccccceecccc
Q 042314 171 LRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE---AGHLKVTDFGLSKIAQEK 245 (370)
Q Consensus 171 ~~g~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~~~~ 245 (370)
++||+|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 141 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp CCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred CCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 99999999998753 5999999999999999999999998 999999999999997 788999999999866533
Q ss_pred CccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH----HHHHhhcc--CCCCCCCCC
Q 042314 246 DSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ----VADRRAYE--DSRPALSSL 319 (370)
Q Consensus 246 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~~~--~~~~~~~~~ 319 (370)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+... .........
T Consensus 218 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 293 (400)
T 1nxk_A 218 NS----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293 (400)
T ss_dssp -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTT
T ss_pred Cc----cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccccc
Confidence 21 233468999999999999999999999999999999999999997653211 11111111 112223356
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042314 320 YPEPIKALLRECWHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 320 ~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l 349 (370)
+|+.+.+||++||..||++|||+.+++++-
T Consensus 294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 899999999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=344.33 Aligned_cols=250 Identities=32% Similarity=0.543 Sum_probs=213.3
Q ss_pred CCCCCCcccEEEEEEcC-ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWRG-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g-~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|.|+||.||++.+.+ ..+|+|.++.... ..+.+.+|+.++++++||||+++++++.. +..++||||+.+|+|
T Consensus 274 ~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL 348 (535)
T 2h8h_A 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL 348 (535)
T ss_dssp EEEECSSEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEH
T ss_pred ecccCCCeEEEEEEECCCceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcH
Confidence 37899999999999875 5699999876432 24578999999999999999999999866 678999999999999
Q ss_pred HHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 177 HDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 177 ~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
.+++... ..++...++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .....
T Consensus 349 ~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~ 423 (535)
T 2h8h_A 349 LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY--TARQG 423 (535)
T ss_dssp HHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH--HTTCS
T ss_pred HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce--ecccC
Confidence 9999753 46899999999999999999999998 99999999999999999999999999976643211 11223
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..+++.|+|||.+....++.++||||||+++|||++ |+.||......+....+. ...+...+..+|+.+.+||.+||+
T Consensus 424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~ 502 (535)
T 2h8h_A 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWR 502 (535)
T ss_dssp TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcC
Confidence 356789999999999999999999999999999999 899999887766665554 455566677899999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHhcc
Q 042314 334 KNPDRRPTFEEIIFRLEAIQESFQK 358 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~~~~~~~~ 358 (370)
.||++|||+++|++.|+.+......
T Consensus 503 ~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 503 KEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp SSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CChhHCcCHHHHHHHHHHHhhccCc
Confidence 9999999999999999887654443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=311.96 Aligned_cols=235 Identities=22% Similarity=0.414 Sum_probs=200.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++... +..+++|.+....... .....+.+|+..+..+ +||||+++++++...+..++||||++|++
T Consensus 19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 97 (289)
T 1x8b_A 19 IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGS 97 (289)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred hcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCc
Confidence 688999999999885 8899999987654333 4456788999999999 89999999999999999999999999999
Q ss_pred HHHHHHhC----CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC-------------------CcEE
Q 042314 176 LHDILKKK----GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA-------------------GHLK 232 (370)
Q Consensus 176 L~~~l~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~-------------------~~~k 232 (370)
|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+||+++.+ ..+|
T Consensus 98 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~k 174 (289)
T 1x8b_A 98 LADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174 (289)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CCCEE
T ss_pred HHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEE
Confidence 99999864 67999999999999999999999998 9999999999999844 4799
Q ss_pred EeccccceeccccCccceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC
Q 042314 233 VTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED 311 (370)
Q Consensus 233 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 311 (370)
|+|||++........ ..||+.|+|||.+.+. .++.++||||||+++|+|++|.+++.......... ..
T Consensus 175 l~Dfg~~~~~~~~~~-------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~----~~ 243 (289)
T 1x8b_A 175 IGDLGHVTRISSPQV-------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR----QG 243 (289)
T ss_dssp ECCCTTCEETTCSCC-------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHH----TT
T ss_pred EcccccccccCCccc-------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHH----cC
Confidence 999999987654322 2489999999999876 56689999999999999999998876655433222 23
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
..+..+..+|+.+.+++.+||+.||++|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 4456677899999999999999999999999999875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=334.31 Aligned_cols=243 Identities=14% Similarity=0.175 Sum_probs=193.3
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHH---HHHhcCCCceeeee-------eeEeeCC--
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELG---LWQKLRHPNIVQFL-------GVLKHSE-- 162 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~---~l~~l~hp~Iv~~~-------~~~~~~~-- 162 (370)
..+|.|+||.||++... |..+|+|++...........+.+.+|+. .++.++||||++++ +++...+
T Consensus 79 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 158 (377)
T 3byv_A 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158 (377)
T ss_dssp EEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSC
T ss_pred ceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCc
Confidence 34789999999999864 8899999998665555567788999995 45555799999998 6555443
Q ss_pred ---------------ceEEEEeecCCCCHHHHHHhCCCCCh-------HhHHHHHHHHHHHHHHHhhcCCCceeecCCCC
Q 042314 163 ---------------RLIFLTEYLRNGSLHDILKKKGKLDP-------PTAVAYALDIARGMNYLHHHRPHAIIHRDLTP 220 (370)
Q Consensus 163 ---------------~~~~v~e~~~g~~L~~~l~~~~~~~~-------~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~ 220 (370)
..++||||+ +|+|.+++...+.+++ ..++.++.|++.||.|||+++ |+||||||
T Consensus 159 ~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp 234 (377)
T 3byv_A 159 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRP 234 (377)
T ss_dssp SEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCG
T ss_pred cccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 278999999 5699999987655655 778889999999999999998 99999999
Q ss_pred CCeeeCCCCcEEEeccccceeccccCccceeccCCCCCccccCccccccc-----------CCCchhhHHHHHHHHHHHH
Q 042314 221 SNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE-----------SYGKSVDVFSFALIVHEMF 289 (370)
Q Consensus 221 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~el~ 289 (370)
+|||++.++.+||+|||+++..... .....| +.|+|||++.+. .++.++|||||||++|||+
T Consensus 235 ~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 235 VDIVLDQRGGVFLTGFEHLVRDGAR------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp GGEEECTTCCEEECCGGGCEETTCE------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred HHEEEcCCCCEEEEechhheecCCc------ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 9999999999999999999864331 223456 999999999887 8999999999999999999
Q ss_pred hCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH--HHHHHHHHh
Q 042314 290 QGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIF--RLEAIQESF 356 (370)
Q Consensus 290 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~--~l~~~~~~~ 356 (370)
+|+.||............. .....+|+.+.+||.+||+.||++|||+.++++ .++.+.+..
T Consensus 308 tg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~ 370 (377)
T 3byv_A 308 CADLPITKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 370 (377)
T ss_dssp HSSCCC------CCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred HCCCCCcccccccchhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence 9999997655433322221 123567899999999999999999999999997 455554443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=319.38 Aligned_cols=249 Identities=29% Similarity=0.484 Sum_probs=197.6
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHh--cCCCceeeeeeeEeeC----CceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQK--LRHPNIVQFLGVLKHS----ERLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~--l~hp~Iv~~~~~~~~~----~~~~~v~e~~~ 172 (370)
+|.|+||.||++..++..+|+|++.... ......|.+++.. ++||||+++++++... ...++||||++
T Consensus 45 lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 118 (337)
T 3mdy_A 45 IGKGRYGEVWMGKWRGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHE 118 (337)
T ss_dssp EEEETTEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCT
T ss_pred eecCCCeEEEEEEECCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccC
Confidence 6889999999999999999999986431 2334455555544 4899999999998876 67999999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhc--------CCCceeecCCCCCCeeeCCCCcEEEeccccceeccc
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH--------RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQE 244 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~--------~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 244 (370)
+++|.++++.. .+++..++.++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++.....
T Consensus 119 ~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 194 (337)
T 3mdy_A 119 NGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFIS 194 (337)
T ss_dssp TCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred CCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCCCceeecc
Confidence 99999999775 799999999999999999999998 7 99999999999999999999999999976654
Q ss_pred cCcc-ceeccCCCCCccccCcccccccCCCch------hhHHHHHHHHHHHHhC----------CCCCCCC-----cHHH
Q 042314 245 KDSY-SYKMTGGTGSYRYMAPEVYRRESYGKS------VDVFSFALIVHEMFQG----------GPSNRAD-----TAVQ 302 (370)
Q Consensus 245 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~------~Di~slG~~l~el~~g----------~~p~~~~-----~~~~ 302 (370)
.... ........||+.|+|||++.+...+.. +||||||+++|||++| ..||... ....
T Consensus 195 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 274 (337)
T 3mdy_A 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274 (337)
T ss_dssp --------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred ccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhh
Confidence 3321 112234568999999999987766554 9999999999999999 6676542 1222
Q ss_pred HHHHhhccCCCCCCCC-----CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 303 VADRRAYEDSRPALSS-----LYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 303 ~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
...........+..+. .+++.+.+++.+||+.||++|||+.+++++|+++.++.+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 2222222333333332 456779999999999999999999999999999988765
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=313.39 Aligned_cols=242 Identities=29% Similarity=0.507 Sum_probs=201.0
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee----------------
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH---------------- 160 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~---------------- 160 (370)
+|.|+||.||++... +..+++|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 19 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (284)
T 2a19_B 19 IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91 (284)
T ss_dssp EECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCE
T ss_pred eccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccC
Confidence 788999999999885 8899999987542 245689999999999999999998754
Q ss_pred CCceEEEEeecCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecccc
Q 042314 161 SERLIFLTEYLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGL 238 (370)
Q Consensus 161 ~~~~~~v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~ 238 (370)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 168 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGL 168 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTT
T ss_pred cceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchh
Confidence 44589999999999999999754 57899999999999999999999998 99999999999999999999999999
Q ss_pred ceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCC
Q 042314 239 SKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSS 318 (370)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 318 (370)
+........ .....+|+.|+|||.+.+..++.++||||||+++|+|++|..|+..... ...... ....+.
T Consensus 169 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--~~~~~~----~~~~~~ 238 (284)
T 2a19_B 169 VTSLKNDGK----RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--FFTDLR----DGIISD 238 (284)
T ss_dssp CEESSCCSC----CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--HHHHHH----TTCCCT
T ss_pred heecccccc----ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH--HHHHhh----cccccc
Confidence 987654432 2234689999999999999999999999999999999999988753222 111111 123456
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccCC
Q 042314 319 LYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKT 360 (370)
Q Consensus 319 ~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~ 360 (370)
.+|+.+.+++.+||+.||++|||+.+++++|..++.......
T Consensus 239 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 688999999999999999999999999999999987666443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=321.73 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=194.2
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHH--HHhcCCCceeeeeeeEee-----CCceEEEEeec
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGL--WQKLRHPNIVQFLGVLKH-----SERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~--l~~l~hp~Iv~~~~~~~~-----~~~~~~v~e~~ 171 (370)
+|.|+||.||++...+..+|+|++.... ...+..|.++ +..++||||+++++.+.. ...+++||||+
T Consensus 21 lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 94 (336)
T 3g2f_A 21 IGRGRYGAVYKGSLDERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYY 94 (336)
T ss_dssp EEECSSEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCC
T ss_pred cccCCCeEEEEEEECCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecC
Confidence 6889999999999999999999986532 2333344444 455899999999985532 33578999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhc---------CCCceeecCCCCCCeeeCCCCcEEEeccccceec
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH---------RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIA 242 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~---------~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~ 242 (370)
++|+|.+++... ..+...++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++...
T Consensus 95 ~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~ 170 (336)
T 3g2f_A 95 PNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170 (336)
T ss_dssp TTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccceeec
Confidence 999999999876 558899999999999999999998 7 999999999999999999999999999876
Q ss_pred cccCcc-----ceeccCCCCCccccCcccccc-------cCCCchhhHHHHHHHHHHHHhCCCCCCCCc-----------
Q 042314 243 QEKDSY-----SYKMTGGTGSYRYMAPEVYRR-------ESYGKSVDVFSFALIVHEMFQGGPSNRADT----------- 299 (370)
Q Consensus 243 ~~~~~~-----~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~g~~p~~~~~----------- 299 (370)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~ 250 (336)
T 3g2f_A 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQT 250 (336)
T ss_dssp SSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHH
T ss_pred ccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhc
Confidence 543211 112233468999999999987 456678999999999999999976653221
Q ss_pred -------HHHHHHHhhccCCCCCCCCC------CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccCC
Q 042314 300 -------AVQVADRRAYEDSRPALSSL------YPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKT 360 (370)
Q Consensus 300 -------~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~ 360 (370)
.............++..+.. +++.+.++|.+||+.||++|||++++++.|+++.+.+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 251 EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp HHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred ccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 11111112222333444333 34579999999999999999999999999999988776543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=330.41 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=185.9
Q ss_pred ccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee-----CCceEEEE
Q 042314 96 RGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH-----SERLIFLT 168 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~-----~~~~~~v~ 168 (370)
...+|.|+||.||++... +..+|+|.+.... .+....+.+.+|+.+++.++||||+++++++.. ...+++||
T Consensus 58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 136 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136 (458)
T ss_dssp CCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred eeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEE
Confidence 445899999999999764 7889999986543 445567889999999999999999999999843 35689999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
||+. ++|.+++.....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 137 e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 212 (458)
T 3rp9_A 137 EIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212 (458)
T ss_dssp CCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTC
T ss_pred eccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCcccc
Confidence 9985 599999998888999999999999999999999998 999999999999999999999999999876532211
Q ss_pred ------------------------ceeccCCCCCccccCcccc-cccCCCchhhHHHHHHHHHHHHh-----------CC
Q 042314 249 ------------------------SYKMTGGTGSYRYMAPEVY-RRESYGKSVDVFSFALIVHEMFQ-----------GG 292 (370)
Q Consensus 249 ------------------------~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~-----------g~ 292 (370)
.......+||+.|+|||++ .+..++.++|||||||++|||++ |+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~ 292 (458)
T 3rp9_A 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRG 292 (458)
T ss_dssp CCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCC
T ss_pred ccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccccc
Confidence 0123345689999999986 55679999999999999999999 66
Q ss_pred CCCCCCcHH--------------------HHHHHhhc------------------------cCC-----CCCCCCCCcHH
Q 042314 293 PSNRADTAV--------------------QVADRRAY------------------------EDS-----RPALSSLYPEP 323 (370)
Q Consensus 293 ~p~~~~~~~--------------------~~~~~~~~------------------------~~~-----~~~~~~~~~~~ 323 (370)
++|.+.... .....+.. ... ........++.
T Consensus 293 p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 372 (458)
T 3rp9_A 293 PLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSAD 372 (458)
T ss_dssp CSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHH
T ss_pred ccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHH
Confidence 777553310 00000000 000 01112346889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 324 IKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 324 l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+.+||++||..||++|||++|+++|
T Consensus 373 ~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 373 AIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhccCccccCCHHHHhcC
Confidence 9999999999999999999999886
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=321.55 Aligned_cols=236 Identities=23% Similarity=0.376 Sum_probs=197.0
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-----CCceeeeeeeEeeCCceEEEEeec
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-----HPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-----hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
+|.|+||.||++.. .+..+|+|++.. .......+..|+.+++.+. ||||+++++++...+..++||||+
T Consensus 43 lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 118 (360)
T 3llt_A 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL 118 (360)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC
T ss_pred EcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC
Confidence 68899999999988 478899999864 2355667788999999986 999999999999999999999999
Q ss_pred CCCCHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC----------------------
Q 042314 172 RNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE---------------------- 227 (370)
Q Consensus 172 ~g~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~---------------------- 227 (370)
+++|.+++.... .++...++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 119 -~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~ 194 (360)
T 3llt_A 119 -GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194 (360)
T ss_dssp -CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEE
T ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccccccccccc
Confidence 889999998764 5899999999999999999999998 999999999999975
Q ss_pred ---CCcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHH
Q 042314 228 ---AGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVA 304 (370)
Q Consensus 228 ---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~ 304 (370)
.+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.........
T Consensus 195 ~~~~~~~kl~DFG~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~ 268 (360)
T 3llt_A 195 RTKSTGIKLIDFGCATFKSDYH------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268 (360)
T ss_dssp EESCCCEEECCCTTCEETTSCC------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccCCCCEEEEeccCceecCCCC------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence 7889999999998654332 2346899999999999999999999999999999999999999887665543
Q ss_pred HHhhccCCC-C-------------------------------------------CCCCCCcHHHHHHHHHhcccCCCCCC
Q 042314 305 DRRAYEDSR-P-------------------------------------------ALSSLYPEPIKALLRECWHKNPDRRP 340 (370)
Q Consensus 305 ~~~~~~~~~-~-------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp 340 (370)
......... + ......++.+.+||.+||+.||++||
T Consensus 269 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 348 (360)
T 3llt_A 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP 348 (360)
T ss_dssp HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC
Confidence 332211100 0 00011236788999999999999999
Q ss_pred CHHHHHHH
Q 042314 341 TFEEIIFR 348 (370)
Q Consensus 341 ~~~~ll~~ 348 (370)
|+++++++
T Consensus 349 ta~elL~h 356 (360)
T 3llt_A 349 SPAELLKH 356 (360)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=310.73 Aligned_cols=253 Identities=19% Similarity=0.256 Sum_probs=203.7
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeE-eeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL-KHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~-~~~~~~~~v~e~~~g~ 174 (370)
.+|.|+||.||++.. .+..+|+|++...... ..+.+|+.+++.++|++++..+..+ ...+..++||||+ ++
T Consensus 16 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 4hgt_A 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred eecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CC
Confidence 378899999999985 4888999987554322 3467899999999988776666554 6677889999999 88
Q ss_pred CHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee---CCCCcEEEeccccceeccccCccc-
Q 042314 175 SLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ---DEAGHLKVTDFGLSKIAQEKDSYS- 249 (370)
Q Consensus 175 ~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~- 249 (370)
+|.+++.. .+.+++..++.++.|++.||.|||+++ |+||||||+||++ +.++.+||+|||++..........
T Consensus 90 ~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~ 166 (296)
T 4hgt_A 90 SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 166 (296)
T ss_dssp BHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCB
T ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCcc
Confidence 99999985 457999999999999999999999998 9999999999999 788999999999998776543211
Q ss_pred ---eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHhhccCCCCCCCCCC
Q 042314 250 ---YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA------VQVADRRAYEDSRPALSSLY 320 (370)
Q Consensus 250 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~ 320 (370)
.......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ...................+
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T 4hgt_A 167 IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 246 (296)
T ss_dssp CCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTS
T ss_pred CCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccC
Confidence 122344689999999999999999999999999999999999999976422 11111111122222334667
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccC
Q 042314 321 PEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359 (370)
Q Consensus 321 ~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~ 359 (370)
|+.+.+++.+||+.||++|||++++++.|+++..+...+
T Consensus 247 ~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~ 285 (296)
T 4hgt_A 247 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence 899999999999999999999999999999998887643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=312.06 Aligned_cols=241 Identities=25% Similarity=0.375 Sum_probs=186.6
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++.. .++.+|+|.+.... ........+..+...++.++||||+++++++...+..++||||++| +|
T Consensus 15 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l 92 (290)
T 3fme_A 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SL 92 (290)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EH
T ss_pred cCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-ch
Confidence 78899999999988 58889999987643 2223344455555567888999999999999999999999999976 88
Q ss_pred HHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhc-CCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 177 HDILKK----KGKLDPPTAVAYALDIARGMNYLHHH-RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 177 ~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
.+++.. .+.+++..++.++.|++.||.|||++ + |+||||||+||+++.++.+||+|||++........
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 165 (290)
T 3fme_A 93 DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---- 165 (290)
T ss_dssp HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC---------------
T ss_pred HHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccccccc----
Confidence 777653 46899999999999999999999998 8 99999999999999999999999999976654322
Q ss_pred ccCCCCCccccCcccc----cccCCCchhhHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhhccCCCCCCCCCCcHHHHH
Q 042314 252 MTGGTGSYRYMAPEVY----RRESYGKSVDVFSFALIVHEMFQGGPSNRAD-TAVQVADRRAYEDSRPALSSLYPEPIKA 326 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~----~~~~~~~~~Di~slG~~l~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 326 (370)
.....||+.|+|||.+ .+..++.++||||+|+++|+|++|+.||... ..................+..+|+.+.+
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (290)
T 3fme_A 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 245 (290)
T ss_dssp ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHH
T ss_pred ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHH
Confidence 1223589999999996 5567889999999999999999999999863 3333333333333333444578999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 042314 327 LLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 327 li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
++.+||+.||++|||+.+++++
T Consensus 246 li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 246 FTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHhhcChhhCcCHHHHHhC
Confidence 9999999999999999999884
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=316.35 Aligned_cols=253 Identities=24% Similarity=0.388 Sum_probs=189.1
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEe--------eCCceEE
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLK--------HSERLIF 166 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~--------~~~~~~~ 166 (370)
.+|.|+||.||++.+ .+..+|+|.+... .......+.+|+.+++++. ||||+++++++. ....+++
T Consensus 35 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~l 111 (337)
T 3ll6_A 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111 (337)
T ss_dssp EEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEE
T ss_pred EEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEE
Confidence 478999999999988 5789999988543 3456678899999999996 999999999984 3445899
Q ss_pred EEeecCCCCHHHHHHh---CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceecc
Q 042314 167 LTEYLRNGSLHDILKK---KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQ 243 (370)
Q Consensus 167 v~e~~~g~~L~~~l~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 243 (370)
||||+. |+|.+++.. .+.+++..++.++.|++.||.|||+.+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 112 v~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 189 (337)
T 3ll6_A 112 LTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189 (337)
T ss_dssp EEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCS
T ss_pred EEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceecc
Confidence 999996 599988865 457999999999999999999999975 359999999999999999999999999998765
Q ss_pred ccCccce---------eccCCCCCccccCcccc---cccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC
Q 042314 244 EKDSYSY---------KMTGGTGSYRYMAPEVY---RRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED 311 (370)
Q Consensus 244 ~~~~~~~---------~~~~~~g~~~y~aPE~~---~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 311 (370)
....... ......+|+.|+|||++ .+..++.++||||||+++|+|++|+.||........... .
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~ 265 (337)
T 3ll6_A 190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG----K 265 (337)
T ss_dssp SCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred ccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC----c
Confidence 4332211 11133589999999998 566788999999999999999999999976554433222 2
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccC
Q 042314 312 SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359 (370)
Q Consensus 312 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~ 359 (370)
.....+...+..+.+++.+||+.||++|||+.+++++|+.+.......
T Consensus 266 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 266 YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 223344567788999999999999999999999999999998776543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=312.27 Aligned_cols=243 Identities=25% Similarity=0.381 Sum_probs=206.1
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCC------ChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEe
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIAS------NPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~------~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
+|.|++|.||++... +..+++|++...... .......+.+|+.+++++. ||||+++++++...+..++|||
T Consensus 25 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 104 (298)
T 1phk_A 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFD 104 (298)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred ecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEe
Confidence 688999999999874 788999998754321 1234567889999999995 9999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 170 YLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
|+++++|.+++.....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 179 (298)
T 1phk_A 105 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-- 179 (298)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC--
T ss_pred ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcCCCcc--
Confidence 9999999999998889999999999999999999999998 99999999999999999999999999987654322
Q ss_pred eeccCCCCCccccCccccc------ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC--CCCCCCc
Q 042314 250 YKMTGGTGSYRYMAPEVYR------RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP--ALSSLYP 321 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~------~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 321 (370)
.....+++.|+|||.+. ...++.++||||||+++|+|++|..||................... .....+|
T Consensus 180 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (298)
T 1phk_A 180 --LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 257 (298)
T ss_dssp --BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSC
T ss_pred --cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccC
Confidence 22346899999999985 4457889999999999999999999998887766555444332222 2224588
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+.+.+++.+||..||++|||+.+++++
T Consensus 258 ~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 258 DTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 999999999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=311.14 Aligned_cols=242 Identities=30% Similarity=0.483 Sum_probs=200.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+++|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 105 (295)
T 2clq_A 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS 105 (295)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred EEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence 4899999999999874 6789999987542 3455778999999999999999999999999999999999999999
Q ss_pred HHHHHHhCC---CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC-CCcEEEeccccceeccccCcccee
Q 042314 176 LHDILKKKG---KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE-AGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 176 L~~~l~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
|.+++.... .+++..+..++.|++.||.|||+++ |+|+||||+||+++. ++.+||+|||++........ .
T Consensus 106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~---~ 179 (295)
T 2clq_A 106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP---C 179 (295)
T ss_dssp HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------
T ss_pred HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC---c
Confidence 999998652 4568889999999999999999998 999999999999987 89999999999987654322 1
Q ss_pred ccCCCCCccccCcccccccC--CCchhhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRES--YGKSVDVFSFALIVHEMFQGGPSNRADTA-VQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.....|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .............+..+..+|+.+.+++
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence 22346899999999997653 78999999999999999999999975432 2222222223455667778999999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+||..||++||++.+++++
T Consensus 260 ~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 260 LKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHTTCSSTTTSCCHHHHHTS
T ss_pred HHHccCChhhCCCHHHHhcC
Confidence 99999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=320.24 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=200.8
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee----CCceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH----SERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~----~~~~~~v~e~~ 171 (370)
.+|.|+||.||++.. .+..+|+|.+.. ........+.+|+.+++.++||||+++++++.. ....++||||+
T Consensus 36 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 112 (317)
T 2buj_A 36 KLGEGGFSYVDLVEGLHDGHFYALKRILC---HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112 (317)
T ss_dssp EEEC--CEEEEEEEETTTCCEEEEEEEEE---SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred EecCCCCeEEEEEEecCCCcEEEEEEEec---CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence 378999999999986 488999998865 334567788999999999999999999999863 34789999999
Q ss_pred CCCCHHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 172 RNGSLHDILKK----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 172 ~g~~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
.+++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~ 189 (317)
T 2buj_A 113 KRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189 (317)
T ss_dssp TTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEE
T ss_pred CCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccc
Confidence 99999999876 467999999999999999999999998 99999999999999999999999999876543211
Q ss_pred cc------eeccCCCCCccccCcccccccC---CCchhhHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhccCCCCCC
Q 042314 248 YS------YKMTGGTGSYRYMAPEVYRRES---YGKSVDVFSFALIVHEMFQGGPSNRADTAV--QVADRRAYEDSRPAL 316 (370)
Q Consensus 248 ~~------~~~~~~~g~~~y~aPE~~~~~~---~~~~~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~ 316 (370)
.. .......||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ....... .....+.
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 268 (317)
T 2buj_A 190 GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-NQLSIPQ 268 (317)
T ss_dssp SHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH-CC--CCC
T ss_pred cccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh-ccCCCCc
Confidence 10 0011224689999999987654 688999999999999999999999542111 0111111 1223334
Q ss_pred CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 317 SSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 317 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
+..+|+.+.++|.+||+.||.+|||+.+++++|+.+....+
T Consensus 269 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 269 SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 45688999999999999999999999999999988754333
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=341.54 Aligned_cols=249 Identities=27% Similarity=0.516 Sum_probs=210.5
Q ss_pred CCCCCCcccEEEEEEc-----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWR-----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|+||.||++.+. +..+++|.+... ........+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 397 ~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~ 473 (656)
T 2j0j_A 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 473 (656)
T ss_dssp EEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred EEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCC
Confidence 3799999999999874 345788887643 34566788999999999999999999999985 466899999999
Q ss_pred CCCHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 173 NGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 173 g~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
+|+|.++++..+ .++...++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........ .
T Consensus 474 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~--~ 548 (656)
T 2j0j_A 474 LGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY--K 548 (656)
T ss_dssp TCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-------
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCcce--e
Confidence 999999998654 6899999999999999999999998 999999999999999999999999999876543221 2
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...........+. .......+..+|+.+.++|.+
T Consensus 549 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~ 627 (656)
T 2j0j_A 549 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLMTK 627 (656)
T ss_dssp -----CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCCCCCCccccHHHHHHHHH
Confidence 233456889999999998899999999999999999997 999999887776665554 345556777899999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
||..||++|||+.++++.|+++.+.
T Consensus 628 ~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 628 CWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCChhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999998665
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=322.17 Aligned_cols=242 Identities=23% Similarity=0.364 Sum_probs=192.5
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... +..+|+|.+..... ......+.+|+.+++.++||||+++++++...+..++||||+++ +
T Consensus 9 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (324)
T 3mtl_A 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-D 85 (324)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred EEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-C
Confidence 3788999999999875 78899999865421 11222345799999999999999999999999999999999975 9
Q ss_pred HHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++... ..++...+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++........ ....
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---~~~~ 159 (324)
T 3mtl_A 86 LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK---TYDN 159 (324)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------------
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc---cccc
Confidence 98888765 45899999999999999999999998 99999999999999999999999999976553322 2233
Q ss_pred CCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC---CCC---------------
Q 042314 255 GTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS---RPA--------------- 315 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~--------------- 315 (370)
..+|+.|+|||.+.+ ..++.++||||||+++|+|++|++||...........+..... ...
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence 467999999999876 5689999999999999999999999998877665443322110 000
Q ss_pred ----------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 316 ----------LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 316 ----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
....+++.+.+||++||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 112467889999999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=322.71 Aligned_cols=250 Identities=13% Similarity=0.191 Sum_probs=203.4
Q ss_pred CCCCCCcccEEEEEEc----------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceee--------------
Q 042314 98 GIDPGAYGEVYLVKWR----------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQ-------------- 153 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~----------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~-------------- 153 (370)
.+|.|+||.||++... +..+|+|.+... ..+.+|+.++++++||||++
T Consensus 49 ~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp EEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred EecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 3788999999999874 678999998653 35778999999999999887
Q ss_pred -eeeeEee-CCceEEEEeecCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC
Q 042314 154 -FLGVLKH-SERLIFLTEYLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG 229 (370)
Q Consensus 154 -~~~~~~~-~~~~~~v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~ 229 (370)
+++++.. ....++||||+ +++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~ 196 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPED 196 (352)
T ss_dssp CCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTE
T ss_pred chhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCC
Confidence 5666665 67889999999 88999999976 68999999999999999999999998 99999999999999988
Q ss_pred --cEEEeccccceeccccCccc----eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc--HH
Q 042314 230 --HLKVTDFGLSKIAQEKDSYS----YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT--AV 301 (370)
Q Consensus 230 --~~kl~Dfg~~~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~--~~ 301 (370)
.+||+|||+++......... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... ..
T Consensus 197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 276 (352)
T 2jii_A 197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE 276 (352)
T ss_dssp EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHH
Confidence 89999999998765432211 11133468999999999999999999999999999999999999998653 22
Q ss_pred HHHHHhh-ccCCCCCC------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccC
Q 042314 302 QVADRRA-YEDSRPAL------SSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359 (370)
Q Consensus 302 ~~~~~~~-~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~ 359 (370)
....... ........ ...+|+.+.+++.+||..||++|||++++++.|+++.+.....
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 277 DIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp HHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 2221111 11111111 1256899999999999999999999999999999998887643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=319.14 Aligned_cols=243 Identities=20% Similarity=0.358 Sum_probs=205.1
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|+||.||++... ++.+|+|++..... .......+.+|+.+++.+. ||||+++++++...+..++||||+.++
T Consensus 36 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 3789999999999875 88999999876532 2344577889999999995 699999999999999999999999999
Q ss_pred CHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC---CCcEEEeccccceeccccCccc
Q 042314 175 SLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE---AGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 175 ~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
+|.+++... +.+++..++.++.|++.||.|||+++ |+||||||+||+++. .+.+||+|||++........
T Consensus 115 ~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~-- 189 (327)
T 3lm5_A 115 EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-- 189 (327)
T ss_dssp EGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-------
T ss_pred cHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc--
Confidence 999998653 67999999999999999999999998 999999999999997 78999999999987654322
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC--CCCCCCCCCcHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED--SRPALSSLYPEPIKAL 327 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l 327 (370)
.....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+.... ........+++.+.++
T Consensus 190 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l 267 (327)
T 3lm5_A 190 --LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDF 267 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred --cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHH
Confidence 223468999999999999999999999999999999999999998887766555443322 2334445789999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 042314 328 LRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 328 i~~~l~~~p~~Rp~~~~ll~~ 348 (370)
|.+||+.||++|||+++++++
T Consensus 268 i~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 268 IQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHcCCChhhCcCHHHHhCC
Confidence 999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=318.41 Aligned_cols=249 Identities=28% Similarity=0.441 Sum_probs=203.9
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHh--cCCCceeeeeeeEeeCC----ceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQK--LRHPNIVQFLGVLKHSE----RLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~--l~hp~Iv~~~~~~~~~~----~~~~v~e~~~ 172 (370)
+|.|+||.||++..+++.+|+|.+... ....+.+|.++++. ++||||+++++++.... ..++||||++
T Consensus 50 lg~G~~g~Vy~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~ 123 (342)
T 1b6c_B 50 IGKGRFGEVWRGKWRGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 123 (342)
T ss_dssp EEEETTEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCT
T ss_pred ecCCCCcEEEEEEEcCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecC
Confidence 688999999999999999999998643 23567788888887 78999999999998765 7899999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHh--------hcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccc
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLH--------HHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQE 244 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH--------~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 244 (370)
+++|.+++.+. ++++..++.++.|++.||.||| +.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 124 ~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 199 (342)
T 1b6c_B 124 HGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199 (342)
T ss_dssp TCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccc
Confidence 99999999875 7899999999999999999999 777 99999999999999999999999999987765
Q ss_pred cCccc-eeccCCCCCccccCcccccccC------CCchhhHHHHHHHHHHHHhC----------CCCCCCCc-----HHH
Q 042314 245 KDSYS-YKMTGGTGSYRYMAPEVYRRES------YGKSVDVFSFALIVHEMFQG----------GPSNRADT-----AVQ 302 (370)
Q Consensus 245 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~------~~~~~Di~slG~~l~el~~g----------~~p~~~~~-----~~~ 302 (370)
..... .......||+.|+|||.+.+.. ++.++||||||+++|+|++| ..||.... ...
T Consensus 200 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 279 (342)
T 1b6c_B 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279 (342)
T ss_dssp TTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred cccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHH
Confidence 43221 1223446899999999997752 34689999999999999999 77886542 233
Q ss_pred HHHHhhccCCCCCCCC-----CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 303 VADRRAYEDSRPALSS-----LYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 303 ~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
..........++..+. ..++.+.+++.+||+.||++|||+.+++++|+++.+...
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp HHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence 3333332333344332 344679999999999999999999999999999987654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=321.54 Aligned_cols=243 Identities=24% Similarity=0.392 Sum_probs=199.9
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC-----CceEEEEeec
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS-----ERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~-----~~~~~v~e~~ 171 (370)
+|.|+||.||++... +..+|+|.+... ........+.+|+.++++++||||+++++++... ...++||||+
T Consensus 35 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~ 112 (364)
T 3qyz_A 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112 (364)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred eecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEccc
Confidence 788999999999765 778999998753 3455667899999999999999999999998654 3689999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
.+ +|.+++... .+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++............
T Consensus 113 ~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 187 (364)
T 3qyz_A 113 ET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187 (364)
T ss_dssp SE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCT
T ss_pred Cc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCcccc
Confidence 75 999999775 7999999999999999999999998 999999999999999999999999999877654333322
Q ss_pred ccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc--------------------
Q 042314 252 MTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-------------------- 310 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-------------------- 310 (370)
.....||+.|+|||++.+ ..++.++||||||+++|+|++|++||...........+...
T Consensus 188 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 267 (364)
T 3qyz_A 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267 (364)
T ss_dssp TCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHH
T ss_pred ccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHH
Confidence 344578999999998754 45899999999999999999999999876543333222110
Q ss_pred ----CCC-----CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 311 ----DSR-----PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 311 ----~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
... ......+++.+.+||.+||..||++|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 268 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 01124578899999999999999999999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=334.80 Aligned_cols=241 Identities=25% Similarity=0.343 Sum_probs=193.3
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC------CceEEEE
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS------ERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~------~~~~~v~ 168 (370)
..+|.|+||.||++... +..+|+|++.... ........+.+|+.+++.++||||+++++++... ..+++||
T Consensus 68 ~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 146 (464)
T 3ttj_A 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146 (464)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEE
Confidence 44899999999999765 7889999997653 3456677889999999999999999999998654 3579999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
||+++ +|.+.+.. .+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||+++......
T Consensus 147 E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 218 (464)
T 3ttj_A 147 ELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-- 218 (464)
T ss_dssp ECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----CC--
T ss_pred eCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc--
Confidence 99977 57776654 5899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC----------------
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS---------------- 312 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---------------- 312 (370)
......||+.|+|||++.+..++.++|||||||++|||++|++||.+.........+.....
T Consensus 219 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~ 296 (464)
T 3ttj_A 219 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296 (464)
T ss_dssp --CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred --ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence 22345789999999999999999999999999999999999999998776554443321100
Q ss_pred ----CCCCCC-----C---------------CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 313 ----RPALSS-----L---------------YPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 313 ----~~~~~~-----~---------------~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+.... . .++.+.+||++||..||++|||++|+++|
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0 14578999999999999999999999886
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=321.86 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=204.6
Q ss_pred ccCCCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 96 RGGIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
...+|.|+||.||++...+ .+++|.+..... .....+.+.+|+.++++++||||+++++++...+..++||||++|++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 115 (319)
T 2y4i_B 38 GELIGKGRFGQVYHGRWHG-EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115 (319)
T ss_dssp CCBCCCSSSSEEEEEEESS-SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred eeEeccCCceEEEEEEEcC-eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence 3458999999999998866 589999875432 22334557789999999999999999999999999999999999999
Q ss_pred HHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc--cceec
Q 042314 176 LHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS--YSYKM 252 (370)
Q Consensus 176 L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~ 252 (370)
|.+++...+ .+++..++.++.|++.||.|||+++ |+||||||+||+++ ++.+||+|||++........ .....
T Consensus 116 L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 191 (319)
T 2y4i_B 116 LYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKL 191 (319)
T ss_dssp HHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccccccccccc
Confidence 999998764 6899999999999999999999998 99999999999998 68999999999876542211 11122
Q ss_pred cCCCCCccccCcccccc---------cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHH
Q 042314 253 TGGTGSYRYMAPEVYRR---------ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEP 323 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~---------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (370)
....|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.....................+..+|..
T Consensus 192 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (319)
T 2y4i_B 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKE 271 (319)
T ss_dssp BCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTT
T ss_pred ccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHH
Confidence 23458999999999875 347889999999999999999999999888776665554333333334468889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhcc
Q 042314 324 IKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQK 358 (370)
Q Consensus 324 l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~ 358 (370)
+.+++.+||..||++|||+.++++.|+++.+....
T Consensus 272 l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 272 ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 99999999999999999999999999998776554
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=315.34 Aligned_cols=240 Identities=25% Similarity=0.429 Sum_probs=196.6
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEee------CCceEEEEe
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKH------SERLIFLTE 169 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~------~~~~~~v~e 169 (370)
+|.|+||.||++.. .+..+++|++..... ....+.+|+.+++++ +||||+++++++.. .+..++|||
T Consensus 32 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 107 (326)
T 2x7f_A 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107 (326)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEE
T ss_pred eccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEE
Confidence 67899999999988 588999999875432 235678899999998 79999999999876 467899999
Q ss_pred ecCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 170 YLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 170 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
|+++++|.+++... ..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.+||+|||++........
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 184 (326)
T 2x7f_A 108 FCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184 (326)
T ss_dssp CCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC-------
T ss_pred cCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc
Confidence 99999999999864 47899999999999999999999998 99999999999999999999999999876643321
Q ss_pred cceeccCCCCCccccCccccc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcH
Q 042314 248 YSYKMTGGTGSYRYMAPEVYR-----RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPE 322 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (370)
......||+.|+|||.+. +..++.++||||||+++|+|++|..||.....................+..+|+
T Consensus 185 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 2x7f_A 185 ---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK 261 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCH
T ss_pred ---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCH
Confidence 122346899999999987 556889999999999999999999999887776655544433333344567899
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 323 PIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 323 ~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+.++|.+||..||.+||++.+++++
T Consensus 262 ~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 262 KFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHhccChhhCCCHHHHhhC
Confidence 99999999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=308.88 Aligned_cols=252 Identities=19% Similarity=0.258 Sum_probs=204.2
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeE-eeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL-KHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~-~~~~~~~~v~e~~~g~~ 175 (370)
+|.|+||.||++.. .+..+|+|++...... ..+.+|+.+++.++|++++..+..+ ...+..++||||+ +++
T Consensus 17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 68899999999985 5889999998654322 3578899999999988766656554 5677889999999 889
Q ss_pred HHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC---CCCcEEEeccccceeccccCccc--
Q 042314 176 LHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD---EAGHLKVTDFGLSKIAQEKDSYS-- 249 (370)
Q Consensus 176 L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~-- 249 (370)
|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++..........
T Consensus 91 L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (296)
T 3uzp_A 91 LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167 (296)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccc
Confidence 9999984 457999999999999999999999998 99999999999994 78899999999998776543211
Q ss_pred --eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHhhccCCCCCCCCCCc
Q 042314 250 --YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA------VQVADRRAYEDSRPALSSLYP 321 (370)
Q Consensus 250 --~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 321 (370)
.......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... .............+..+..+|
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T 3uzp_A 168 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 247 (296)
T ss_dssp CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSC
T ss_pred ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCC
Confidence 112344689999999999999999999999999999999999999976321 111111111222223446688
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccC
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~ 359 (370)
+.+.+++.+||+.||++|||+.++++.|+++......+
T Consensus 248 ~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 248 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 99999999999999999999999999999998887643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=324.65 Aligned_cols=245 Identities=25% Similarity=0.428 Sum_probs=201.6
Q ss_pred CCCCCCcccEEEEEE-----cCceeEEEEeccccC-CChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEee
Q 042314 98 GIDPGAYGEVYLVKW-----RGTEIAAKTIRSSIA-SNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~-----~g~~vavK~l~~~~~-~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
.+|.|+||.||++.. .+..+|+|+++.... ........+.+|+.+++.+ +||||+++++++...+..++||||
T Consensus 61 ~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 140 (355)
T 1vzo_A 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDY 140 (355)
T ss_dssp EEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECC
T ss_pred EeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeec
Confidence 378899999999987 578899999865321 1122334567889999999 699999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 171 LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 171 ~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 141 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 215 (355)
T 1vzo_A 141 INGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-- 215 (355)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG--
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC--
Confidence 999999999998889999999999999999999999998 999999999999999999999999999866433221
Q ss_pred eccCCCCCccccCcccccc--cCCCchhhHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHhhccCCCCCCCCCCcHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRR--ESYGKSVDVFSFALIVHEMFQGGPSNRADT----AVQVADRRAYEDSRPALSSLYPEPI 324 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l 324 (370)
......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ......... ...+..+..++..+
T Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 293 (355)
T 1vzo_A 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KSEPPYPQEMSALA 293 (355)
T ss_dssp GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH--HCCCCCCTTSCHHH
T ss_pred cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh--ccCCCCCcccCHHH
Confidence 1223358999999999986 347899999999999999999999996432 222222222 23455667789999
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHHHHH
Q 042314 325 KALLRECWHKNPDRRP-----TFEEIIFRL 349 (370)
Q Consensus 325 ~~li~~~l~~~p~~Rp-----~~~~ll~~l 349 (370)
.+||.+||..||.+|| ++++++++.
T Consensus 294 ~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 9999999999999999 999998864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=317.54 Aligned_cols=246 Identities=21% Similarity=0.364 Sum_probs=198.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee--------CCceEEE
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH--------SERLIFL 167 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~--------~~~~~~v 167 (370)
.+|.|+||.||++... |..+|+|.+..... .......+.+|+.+++.++||||+++++++.. .+..++|
T Consensus 24 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 102 (351)
T 3mi9_A 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 102 (351)
T ss_dssp ECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEE
T ss_pred EEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEE
Confidence 3799999999999874 78899999866532 22334567799999999999999999999876 3468999
Q ss_pred EeecCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccC
Q 042314 168 TEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD 246 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 246 (370)
|||+++ +|.+.+... ..+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++.......
T Consensus 103 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 178 (351)
T 3mi9_A 103 FDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178 (351)
T ss_dssp EECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCS
T ss_pred EeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccccccc
Confidence 999986 777766654 67999999999999999999999998 9999999999999999999999999998765332
Q ss_pred c-cceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc--CCCCCCCCC---
Q 042314 247 S-YSYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE--DSRPALSSL--- 319 (370)
Q Consensus 247 ~-~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~--- 319 (370)
. .........||+.|+|||++.+ ..++.++||||||+++|+|++|.+||...........+... ...+.....
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 258 (351)
T 3mi9_A 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 258 (351)
T ss_dssp SSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccc
Confidence 2 1122344568999999999876 45799999999999999999999999988776554433221 111111111
Q ss_pred -------------------------CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 320 -------------------------YPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 320 -------------------------~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.++.+.+||.+||+.||++|||+++++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 259 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 26779999999999999999999999886
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=310.72 Aligned_cols=240 Identities=25% Similarity=0.447 Sum_probs=201.5
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... |..+++|.+.... ....+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 36 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (314)
T 3com_A 36 KLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110 (314)
T ss_dssp ECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCC
Confidence 3889999999999876 7889999987542 23567899999999999999999999999999999999999999
Q ss_pred HHHHHH-hCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILK-KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++. ....++...++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........ ....
T Consensus 111 L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~ 184 (314)
T 3com_A 111 VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA---KRNT 184 (314)
T ss_dssp HHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS---CBCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc---ccCc
Confidence 999997 4568999999999999999999999998 99999999999999999999999999977654322 1233
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-CCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-DSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..+++.|+|||.+.+..++.++||||||+++|+|++|+.||............... ......+..+|+.+.++|.+||.
T Consensus 185 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 264 (314)
T 3com_A 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLV 264 (314)
T ss_dssp CCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTC
T ss_pred cCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHcc
Confidence 46899999999999988999999999999999999999999887665544433222 12223345678999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~ 348 (370)
.||.+|||+.+++++
T Consensus 265 ~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 265 KSPEQRATATQLLQH 279 (314)
T ss_dssp SCTTTSCCHHHHTTS
T ss_pred CChhhCcCHHHHHhC
Confidence 999999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=325.54 Aligned_cols=245 Identities=23% Similarity=0.349 Sum_probs=192.5
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC-----CceEEEEeec
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS-----ERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~-----~~~~~v~e~~ 171 (370)
+|.|+||.||++... +..+|+|.+.... ......+.+.+|+.+++.++||||+++++++... ..+++||||+
T Consensus 34 lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~ 112 (432)
T 3n9x_A 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA 112 (432)
T ss_dssp EEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECC
T ss_pred EeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecC
Confidence 788999999999875 6789999997543 4456678899999999999999999999998765 5789999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc--
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS-- 249 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-- 249 (370)
++ +|.+++.....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 113 ~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 188 (432)
T 3n9x_A 113 DS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188 (432)
T ss_dssp SE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC---------
T ss_pred Cc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccccccccccccc
Confidence 65 99999998888999999999999999999999998 9999999999999999999999999998765432110
Q ss_pred -----------------eeccCCCCCccccCcccc-cccCCCchhhHHHHHHHHHHHHhC-----------CCCCCCCcH
Q 042314 250 -----------------YKMTGGTGSYRYMAPEVY-RRESYGKSVDVFSFALIVHEMFQG-----------GPSNRADTA 300 (370)
Q Consensus 250 -----------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Di~slG~~l~el~~g-----------~~p~~~~~~ 300 (370)
.......||+.|+|||++ ....++.++||||+||++|||++| .++|.+...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~ 268 (432)
T 3n9x_A 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSC 268 (432)
T ss_dssp ----------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCS
T ss_pred ccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccc
Confidence 123455789999999986 556699999999999999999984 344433210
Q ss_pred -----------------HHHHHH------------------------hhccCCCCC-----CCCCCcHHHHHHHHHhccc
Q 042314 301 -----------------VQVADR------------------------RAYEDSRPA-----LSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 301 -----------------~~~~~~------------------------~~~~~~~~~-----~~~~~~~~l~~li~~~l~~ 334 (370)
...... ......... ....+++.+.+||++||..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~ 348 (432)
T 3n9x_A 269 FPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKF 348 (432)
T ss_dssp CC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCS
T ss_pred cccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcC
Confidence 000000 000011111 1135789999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042314 335 NPDRRPTFEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~ 348 (370)
||++|||+++++++
T Consensus 349 dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 349 NPNKRITIDQALDH 362 (432)
T ss_dssp STTTSCCHHHHHTC
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=319.82 Aligned_cols=243 Identities=28% Similarity=0.432 Sum_probs=197.3
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCC--hHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASN--PRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~--~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
+|.|+||.||++... |..+|+|.+....... ......+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 18 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 96 (346)
T 1ua2_A 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET- 96 (346)
T ss_dssp EEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-
T ss_pred EeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-
Confidence 688999999999875 7889999987543221 22335678999999999999999999999999999999999987
Q ss_pred CHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++........ ...
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~ 170 (346)
T 1ua2_A 97 DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR---AYT 170 (346)
T ss_dssp EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC---CCC
T ss_pred CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCcc---cCC
Confidence 898888765 46899999999999999999999998 99999999999999999999999999987654322 223
Q ss_pred CCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC---CC--------------
Q 042314 254 GGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR---PA-------------- 315 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~-------------- 315 (370)
...+|+.|+|||.+.+. .++.++||||||+++|+|++|.+||...........+...... ..
T Consensus 171 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T 1ua2_A 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 250 (346)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred cccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccccccc
Confidence 34689999999999764 4789999999999999999999999888776554443211000 00
Q ss_pred ---------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 316 ---------LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 316 ---------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
....+++.+.+||++||..||++|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 251 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 014467899999999999999999999999876
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=310.31 Aligned_cols=245 Identities=22% Similarity=0.374 Sum_probs=202.2
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccC-CChHHHHHHHHHHHHHHhcCCCceeeeeeeE--eeCCceEEEEeec
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIA-SNPRVRNSFMKELGLWQKLRHPNIVQFLGVL--KHSERLIFLTEYL 171 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~-~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~--~~~~~~~~v~e~~ 171 (370)
..+|.|+||.||++... +..+++|++..... ........+.+|+.+++.++||||+++++++ ......++||||+
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (305)
T 2wtk_C 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC 90 (305)
T ss_dssp CEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECC
T ss_pred eEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhc
Confidence 34788999999999874 77899999875421 1234567889999999999999999999998 4456889999999
Q ss_pred CCCCHHHHHHh--CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 172 RNGSLHDILKK--KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 172 ~g~~L~~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
.++ |.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..........
T Consensus 91 ~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~ 166 (305)
T 2wtk_C 91 VCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166 (305)
T ss_dssp SEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSC
T ss_pred cCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCcccccc
Confidence 885 7777765 357899999999999999999999998 9999999999999999999999999998765432211
Q ss_pred eeccCCCCCccccCcccccccC--CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRES--YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKAL 327 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 327 (370)
......||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||...........+.. .....+..+++.+.++
T Consensus 167 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~--~~~~~~~~~~~~l~~l 243 (305)
T 2wtk_C 167 -TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK--GSYAIPGDCGPPLSDL 243 (305)
T ss_dssp -EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--CCCCCCSSSCHHHHHH
T ss_pred -ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc--CCCCCCCccCHHHHHH
Confidence 223446899999999997654 37899999999999999999999998877666555442 2344566789999999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 042314 328 LRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 328 i~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+.+||..||++|||+.+++++
T Consensus 244 i~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 244 LKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHccCChhhCCCHHHHhcC
Confidence 999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=322.33 Aligned_cols=241 Identities=24% Similarity=0.425 Sum_probs=203.2
Q ss_pred CCCCCCcccEEEEEEcCceeEEEEeccccCCChH--------------HHHHHHHHHHHHHhcCCCceeeeeeeEeeCCc
Q 042314 98 GIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPR--------------VRNSFMKELGLWQKLRHPNIVQFLGVLKHSER 163 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~--------------~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~ 163 (370)
.+|.|+||.||++...+..+++|.+......... ....+.+|+.+++.++||||+++++++...+.
T Consensus 38 ~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 117 (348)
T 2pml_X 38 TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE 117 (348)
T ss_dssp EEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSE
T ss_pred EEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCe
Confidence 3788999999999999999999998754322211 12778999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHH------HHh--CCCCChHhHHHHHHHHHHHHHHHhh-cCCCceeecCCCCCCeeeCCCCcEEEe
Q 042314 164 LIFLTEYLRNGSLHDI------LKK--KGKLDPPTAVAYALDIARGMNYLHH-HRPHAIIHRDLTPSNVLQDEAGHLKVT 234 (370)
Q Consensus 164 ~~~v~e~~~g~~L~~~------l~~--~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~iiH~Dlk~~Nil~~~~~~~kl~ 234 (370)
.++||||+++++|.++ +.. ...+++..++.++.|++.||.|||+ .| |+||||||+||+++.++.+||+
T Consensus 118 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~kl~ 194 (348)
T 2pml_X 118 VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLS 194 (348)
T ss_dssp EEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcEEEe
Confidence 9999999999999998 665 5689999999999999999999999 88 9999999999999999999999
Q ss_pred ccccceeccccCccceeccCCCCCccccCccccccc-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhccC
Q 042314 235 DFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE-SYGK-SVDVFSFALIVHEMFQGGPSNRADTA-VQVADRRAYED 311 (370)
Q Consensus 235 Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~ 311 (370)
|||++...... ......+++.|+|||.+.+. .++. ++||||||+++|+|++|..||..... ...........
T Consensus 195 dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~ 269 (348)
T 2pml_X 195 DFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN 269 (348)
T ss_dssp CCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCC
T ss_pred ccccccccccc-----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC
Confidence 99999876543 22334689999999999887 5665 99999999999999999999987665 44444333221
Q ss_pred CCCCCC-------------------CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 SRPALS-------------------SLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 ~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
...+ ..+|+.+.+++.+||+.||.+|||+.+++++
T Consensus 270 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 270 --IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp --CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1222 5688999999999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=330.42 Aligned_cols=242 Identities=28% Similarity=0.404 Sum_probs=189.5
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCC-----ChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIAS-----NPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
+|.|+||.||++... +..+|+|++...... .......+.+|+.++++++||||+++++++.. +..++||||+
T Consensus 143 LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~ 221 (419)
T 3i6u_A 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELM 221 (419)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECC
T ss_pred EeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcC
Confidence 899999999999875 678999998754321 12233457899999999999999999999754 5589999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC---cEEEeccccceeccccCcc
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG---HLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~ 248 (370)
++++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||++..+ .+||+|||+++......
T Consensus 222 ~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~-- 296 (419)
T 3i6u_A 222 EGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-- 296 (419)
T ss_dssp TTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----
T ss_pred CCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccceecCCCc--
Confidence 99999999988889999999999999999999999998 99999999999997554 59999999998765432
Q ss_pred ceeccCCCCCccccCcccccc---cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhc--cCCCCCCCCCCcH
Q 042314 249 SYKMTGGTGSYRYMAPEVYRR---ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ-VADRRAY--EDSRPALSSLYPE 322 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~ 322 (370)
......||+.|+|||++.+ ..++.++||||||+++|+|++|++||....... ....... ....+..+..+|+
T Consensus 297 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 374 (419)
T 3i6u_A 297 --LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 374 (419)
T ss_dssp ----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCH
T ss_pred --cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCH
Confidence 1233468999999999864 567889999999999999999999997643321 1111111 1112223356889
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 323 PIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 323 ~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+.+||.+||+.||++|||+++++++
T Consensus 375 ~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 375 KALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHccCChhHCcCHHHHhCC
Confidence 99999999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=312.29 Aligned_cols=241 Identities=28% Similarity=0.464 Sum_probs=199.0
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... +..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 27 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 103 (302)
T 2j7t_A 27 LGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 103 (302)
T ss_dssp EECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEH
T ss_pred eccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcH
Confidence 788999999999886 7789999986542 23456788999999999999999999999999999999999999999
Q ss_pred HHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 177 HDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 177 ~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........ .....
T Consensus 104 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~ 177 (302)
T 2j7t_A 104 DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ---KRDSF 177 (302)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH---C----
T ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccccc---ccccc
Confidence 998875 457999999999999999999999998 99999999999999999999999998754332211 11233
Q ss_pred CCCccccCcccc-----cccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC-CCCCCCCCcHHHHHHHH
Q 042314 256 TGSYRYMAPEVY-----RRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS-RPALSSLYPEPIKALLR 329 (370)
Q Consensus 256 ~g~~~y~aPE~~-----~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~ 329 (370)
.||+.|+|||.+ .+..++.++||||||+++|+|++|..||................. ....+..+|..+.+++.
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 257 (302)
T 2j7t_A 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLK 257 (302)
T ss_dssp -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHH
Confidence 689999999998 356788999999999999999999999998877665554432222 22345568899999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 042314 330 ECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~ 348 (370)
+||..||++|||+.+++++
T Consensus 258 ~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 258 IALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHSCSCTTTSCCHHHHTTS
T ss_pred HHcccChhhCCCHHHHhcC
Confidence 9999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=313.45 Aligned_cols=245 Identities=26% Similarity=0.444 Sum_probs=183.9
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|++|.||++.. .+..+++|.+..... ......+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 23 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 100 (303)
T 2vwi_A 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 100 (303)
T ss_dssp CC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBH
T ss_pred eccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCch
Confidence 78999999999976 588999999865422 23456788999999999999999999999999999999999999999
Q ss_pred HHHHHh--------CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 177 HDILKK--------KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 177 ~~~l~~--------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
.+++.. .+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.........
T Consensus 101 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 177 (303)
T 2vwi_A 101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177 (303)
T ss_dssp HHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC-----
T ss_pred HHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCc
Confidence 999874 356899999999999999999999998 999999999999999999999999998765443211
Q ss_pred c--eeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC--------CCCCC
Q 042314 249 S--YKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS--------RPALS 317 (370)
Q Consensus 249 ~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 317 (370)
. .......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||................. .....
T Consensus 178 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (303)
T 2vwi_A 178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEML 257 (303)
T ss_dssp ----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCC
T ss_pred cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhh
Confidence 1 11223468999999999876 5689999999999999999999999987655443322221111 12234
Q ss_pred CCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 318 SLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 318 ~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
..+|+.+.+++.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 258 KKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 5678999999999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=324.36 Aligned_cols=242 Identities=12% Similarity=0.088 Sum_probs=182.0
Q ss_pred ccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc--CCCceeeee-------eeEeeC---
Q 042314 96 RGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL--RHPNIVQFL-------GVLKHS--- 161 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l--~hp~Iv~~~-------~~~~~~--- 161 (370)
...+|.|+||.||++.+. +..+|+|++.............+..|+.+++.+ +||||++++ +++...
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~ 146 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSC
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCC
Confidence 344899999999999864 788999999886554556677788886555555 599988755 444332
Q ss_pred --------------CceEEEEeecCCCCHHHHHHhCC-CCChHhH------HHHHHHHHHHHHHHhhcCCCceeecCCCC
Q 042314 162 --------------ERLIFLTEYLRNGSLHDILKKKG-KLDPPTA------VAYALDIARGMNYLHHHRPHAIIHRDLTP 220 (370)
Q Consensus 162 --------------~~~~~v~e~~~g~~L~~~l~~~~-~~~~~~~------~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~ 220 (370)
...++||||++ ++|.+++...+ .++...+ ..++.|++.||.|||+++ |+||||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp 222 (371)
T 3q60_A 147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTP 222 (371)
T ss_dssp SSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred CeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCcCCH
Confidence 33799999998 79999998642 3444455 577799999999999998 99999999
Q ss_pred CCeeeCCCCcEEEeccccceeccccCccceeccCCCCCccccCcccccc--cCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 042314 221 SNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR--ESYGKSVDVFSFALIVHEMFQGGPSNRAD 298 (370)
Q Consensus 221 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~ 298 (370)
+|||++.++.+||+|||+++....... ...+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 223 ~NIll~~~~~~kL~DFG~a~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 223 DNLFIMPDGRLMLGDVSALWKVGTRGP------ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp GGEEECTTSCEEECCGGGEEETTCEEE------GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred HHEEECCCCCEEEEecceeeecCCCcc------CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999987653321 2246799999999987 67999999999999999999999999876
Q ss_pred cHHHHHHH-----h--hccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 042314 299 TAVQVADR-----R--AYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIF 347 (370)
Q Consensus 299 ~~~~~~~~-----~--~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~ 347 (370)
........ . .........+..+|+.+.+||.+||+.||++|||+.++++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 43211100 0 0011122233478999999999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=321.54 Aligned_cols=237 Identities=25% Similarity=0.361 Sum_probs=196.7
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhc------CCCceeeeeeeEeeCCceEEEEe
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL------RHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l------~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
.+|.|+||.||++... +..+|+|++... ......+.+|+.+++.+ +|+||+++++++...+..++|||
T Consensus 104 ~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 179 (429)
T 3kvw_A 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE 179 (429)
T ss_dssp EEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEEC
T ss_pred EcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEe
Confidence 4789999999999775 688999998643 34556778888888877 56799999999999999999999
Q ss_pred ecCCCCHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc--EEEeccccceecccc
Q 042314 170 YLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH--LKVTDFGLSKIAQEK 245 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~--~kl~Dfg~~~~~~~~ 245 (370)
|+. ++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 180 ~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~ 255 (429)
T 3kvw_A 180 LLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255 (429)
T ss_dssp CCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred ccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCc
Confidence 996 59999988753 5899999999999999999999998 999999999999999887 999999999765433
Q ss_pred CccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC------------
Q 042314 246 DSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR------------ 313 (370)
Q Consensus 246 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------------ 313 (370)
. ....||+.|+|||++.+..++.++|||||||++|||++|.+||...........+......
T Consensus 256 ~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~ 329 (429)
T 3kvw_A 256 V------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA 329 (429)
T ss_dssp C------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTH
T ss_pred c------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhh
Confidence 2 2346899999999999999999999999999999999999999887765543322110000
Q ss_pred ---------C------------------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 ---------P------------------------------------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 ---------~------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+ .++...++.+.+||++||+.||++|||++|++++
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRH 409 (429)
T ss_dssp HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence 0 0112346789999999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=320.10 Aligned_cols=241 Identities=26% Similarity=0.385 Sum_probs=183.2
Q ss_pred ccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC------CceEEE
Q 042314 96 RGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS------ERLIFL 167 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~------~~~~~v 167 (370)
...+|.|+||.||++... |..+|+|.+.... ........+.+|+.+++.++||||+++++++... ...++|
T Consensus 34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv 112 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112 (367)
T ss_dssp EEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred eeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEE
Confidence 344899999999999764 7889999987543 3455677889999999999999999999998653 567999
Q ss_pred EeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 168 TEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
+|++ +++|.+++.. +.+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||+++.....
T Consensus 113 ~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-- 185 (367)
T 2fst_X 113 THLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-- 185 (367)
T ss_dssp EECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC------------
T ss_pred eccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccccc--
Confidence 9999 6799998876 57999999999999999999999998 999999999999999999999999999765432
Q ss_pred cceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC---------------
Q 042314 248 YSYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED--------------- 311 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--------------- 311 (370)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+....
T Consensus 186 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 186 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred ----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 223468999999999887 678999999999999999999999998877654433322100
Q ss_pred ---------CCC-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 ---------SRP-----ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 ---------~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
..+ ......++.+.+||++||..||++|||+.+++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 0113467889999999999999999999999876
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=307.85 Aligned_cols=241 Identities=28% Similarity=0.458 Sum_probs=204.3
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|++|.||++... +..+++|++...... ......+.+|+.++++++||||+++++++...+..++|+||+.+++|
T Consensus 30 lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 108 (287)
T 2wei_A 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108 (287)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCH
Confidence 688999999999874 788999998765332 23456788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC---CcEEEeccccceeccccCccceecc
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA---GHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~---~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
.+++...+.+++..++.++.|++.||.|||+++ ++|+||||+||+++.. +.+||+|||++......... .
T Consensus 109 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~----~ 181 (287)
T 2wei_A 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM----K 181 (287)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC----S
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc----c
Confidence 999988889999999999999999999999998 9999999999999764 46999999998765443221 1
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC--CCCCCCcHHHHHHHHHh
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP--ALSSLYPEPIKALLREC 331 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~ 331 (370)
...+|+.|+|||.+.+. ++.++||||||+++|+|++|..||................... +....+|+.+.+++.+|
T Consensus 182 ~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 260 (287)
T 2wei_A 182 DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM 260 (287)
T ss_dssp CHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHH
T ss_pred cccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHH
Confidence 22468899999998764 8899999999999999999999999887766655544332222 22356889999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~ 348 (370)
|..||++|||+.+++++
T Consensus 261 l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 261 LTFHPSLRITATQCLEH 277 (287)
T ss_dssp TCSSGGGSCCHHHHHHS
T ss_pred cccChhhCcCHHHHhcC
Confidence 99999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=319.28 Aligned_cols=241 Identities=25% Similarity=0.350 Sum_probs=191.3
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC------ceEEEE
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE------RLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~------~~~~v~ 168 (370)
..+|.|+||.||++... +..+|+|.+.... ........+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 31 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~ 109 (371)
T 2xrw_A 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 109 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred eeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence 34789999999999764 7889999987643 34566678899999999999999999999987654 689999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
||+++ +|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 110 e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~-- 181 (371)
T 2xrw_A 110 ELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-- 181 (371)
T ss_dssp ECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----------
T ss_pred EcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccccccc--
Confidence 99976 88888864 6899999999999999999999998 9999999999999999999999999997665332
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC---------------
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--------------- 313 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 313 (370)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+......
T Consensus 182 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 182 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred --ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 122346899999999999999999999999999999999999999887765554443321110
Q ss_pred -----CCC--------------CC------CCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 -----PAL--------------SS------LYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 -----~~~--------------~~------~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+.. +. ..++.+.+||++||..||++|||+++++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000 00 015679999999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=324.89 Aligned_cols=249 Identities=22% Similarity=0.367 Sum_probs=200.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC--ceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE--RLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~--~~~~v~e~~~g 173 (370)
.+|.|+||.||++... +..+|+|++..... ......+.+|+.++++++||||+++++++...+ ..++||||++|
T Consensus 16 ~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 93 (396)
T 4eut_A 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (396)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred EEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence 3788999999999886 78999999875432 223566789999999999999999999988755 78999999999
Q ss_pred CCHHHHHHhCC---CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee----CCCCcEEEeccccceeccccC
Q 042314 174 GSLHDILKKKG---KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ----DEAGHLKVTDFGLSKIAQEKD 246 (370)
Q Consensus 174 ~~L~~~l~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~----~~~~~~kl~Dfg~~~~~~~~~ 246 (370)
++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||++ +..+.+||+|||+++......
T Consensus 94 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~ 170 (396)
T 4eut_A 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170 (396)
T ss_dssp EEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG
T ss_pred CCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC
Confidence 99999998653 3899999999999999999999998 9999999999999 777789999999998765443
Q ss_pred ccceeccCCCCCccccCcccccc--------cCCCchhhHHHHHHHHHHHHhCCCCCCCCc----HHHHHHHhhccCCC-
Q 042314 247 SYSYKMTGGTGSYRYMAPEVYRR--------ESYGKSVDVFSFALIVHEMFQGGPSNRADT----AVQVADRRAYEDSR- 313 (370)
Q Consensus 247 ~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~- 313 (370)
. .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.... ............+.
T Consensus 171 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (396)
T 4eut_A 171 Q----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (396)
T ss_dssp G----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTT
T ss_pred c----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcc
Confidence 2 223468999999999865 567789999999999999999999996422 12222222211110
Q ss_pred ----------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042314 314 ----------------------PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 314 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
..++..+++.+.+++++||+.||++||++.++++.++.+.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 011223456789999999999999999999999998887543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=314.16 Aligned_cols=244 Identities=14% Similarity=0.188 Sum_probs=199.8
Q ss_pred CCCCCCcccEEEEE-------EcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC---CCceeeeeeeEeeCCceEEE
Q 042314 98 GIDPGAYGEVYLVK-------WRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR---HPNIVQFLGVLKHSERLIFL 167 (370)
Q Consensus 98 ~l~~g~~~~v~~a~-------~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~---hp~Iv~~~~~~~~~~~~~~v 167 (370)
.+|.|+||.||++. ..++.+|+|++.... ...+..|..+++.++ |+||+++++++...+..++|
T Consensus 72 ~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv 145 (365)
T 3e7e_A 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145 (365)
T ss_dssp EEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEE
T ss_pred EeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEE
Confidence 48999999999993 347889999986532 345677777777776 89999999999999999999
Q ss_pred EeecCCCCHHHHHHh-----CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC-----------CCcE
Q 042314 168 TEYLRNGSLHDILKK-----KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE-----------AGHL 231 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~-----------~~~~ 231 (370)
|||++||+|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+
T Consensus 146 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~ 222 (365)
T 3e7e_A 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222 (365)
T ss_dssp ECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTE
T ss_pred EeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCE
Confidence 999999999999974 457999999999999999999999998 999999999999998 8999
Q ss_pred EEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC
Q 042314 232 KVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED 311 (370)
Q Consensus 232 kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 311 (370)
||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...
T Consensus 223 kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~ 297 (365)
T 3e7e_A 223 ALIDLGQSIDMKLFPKG-TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK----PEG 297 (365)
T ss_dssp EECCCTTCEEGGGSCTT-EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE----ECS
T ss_pred EEeeCchhhhhhccCCC-ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee----ech
Confidence 99999999876533221 2334457999999999999999999999999999999999999998654331110 001
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHHHHHhc
Q 042314 312 SRPALSSLYPEPIKALLRECWHKNPDRR-PTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 312 ~~~~~~~~~~~~l~~li~~~l~~~p~~R-p~~~~ll~~l~~~~~~~~ 357 (370)
... ....++.+.+++..||..+|.+| |+++++.+.|+++.....
T Consensus 298 ~~~--~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 298 LFR--RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp CCT--TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hcc--ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 111 11246789999999999999988 678899998888866644
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=307.30 Aligned_cols=245 Identities=22% Similarity=0.344 Sum_probs=198.8
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC--CCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR--HPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~--hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|.|+||.||++... +..+++|.+.... ........+.+|+.++++++ ||||+++++++...+..++||| +.++
T Consensus 35 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~ 112 (313)
T 3cek_A 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 112 (313)
T ss_dssp EEECCSSEEEEEEECTTCCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSE
T ss_pred EecCCCCEEEEEEEcCCCcEEEEEEecccc-ccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCC
Confidence 3789999999999775 7789999987643 34566788999999999997 5999999999999999999999 5577
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|.+++...+.++...++.++.|++.||.|||+++ |+||||||+||++++ +.+||+|||++.......... ....
T Consensus 113 ~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~-~~~~ 187 (313)
T 3cek_A 113 DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV-VKDS 187 (313)
T ss_dssp EHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-------------
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccc-cccC
Confidence 99999999889999999999999999999999998 999999999999975 899999999998765432211 1223
Q ss_pred CCCCccccCcccccc-----------cCCCchhhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhccCCCCCCCCCCcH
Q 042314 255 GTGSYRYMAPEVYRR-----------ESYGKSVDVFSFALIVHEMFQGGPSNRADTA-VQVADRRAYEDSRPALSSLYPE 322 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 322 (370)
..||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ................+...++
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (313)
T 3cek_A 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 267 (313)
T ss_dssp --CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCH
T ss_pred CCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchH
Confidence 468999999999875 4678899999999999999999999976543 2233333333344556667789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042314 323 PIKALLRECWHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 323 ~l~~li~~~l~~~p~~Rp~~~~ll~~l 349 (370)
.+.+++.+||..||++||++.+++++-
T Consensus 268 ~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 268 DLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 999999999999999999999998763
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=317.88 Aligned_cols=241 Identities=24% Similarity=0.350 Sum_probs=194.2
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee----------------
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH---------------- 160 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~---------------- 160 (370)
+|.|+||.||++.. .|..+|+|.+...... ..+|+.+++.++||||+++++++..
T Consensus 15 lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp EECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC---------------
T ss_pred EEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccc
Confidence 78999999999977 4789999998654222 2369999999999999999999843
Q ss_pred ----------------------CCceEEEEeecCCCCHHHHHH----hCCCCChHhHHHHHHHHHHHHHHHhhcCCCcee
Q 042314 161 ----------------------SERLIFLTEYLRNGSLHDILK----KKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214 (370)
Q Consensus 161 ----------------------~~~~~~v~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~ii 214 (370)
...+++||||+++ +|.+.+. ..+.+++..++.++.|++.||.|||++| |+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~ 163 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---IC 163 (383)
T ss_dssp ----------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EE
T ss_pred cccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---Cc
Confidence 3348899999986 8776664 4568999999999999999999999998 99
Q ss_pred ecCCCCCCeeeC-CCCcEEEeccccceeccccCccceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCC
Q 042314 215 HRDLTPSNVLQD-EAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGG 292 (370)
Q Consensus 215 H~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~ 292 (370)
||||||+||+++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||+||++|+|++|+
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 239 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCC
Confidence 999999999998 678999999999987654432 2234679999999998875 4899999999999999999999
Q ss_pred CCCCCCcHHHHHHHhhccCCC---------------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 042314 293 PSNRADTAVQVADRRAYEDSR---------------------------PALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345 (370)
Q Consensus 293 ~p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~l 345 (370)
+||......+....+...... ...+..+|+.+.+||++||..||++|||+.++
T Consensus 240 ~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (383)
T 3eb0_A 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319 (383)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 999988766554443211000 01345578899999999999999999999999
Q ss_pred HHH--HHHHHH
Q 042314 346 IFR--LEAIQE 354 (370)
Q Consensus 346 l~~--l~~~~~ 354 (370)
+++ ++.+.+
T Consensus 320 l~hp~f~~~~~ 330 (383)
T 3eb0_A 320 MAHPFFDHLRN 330 (383)
T ss_dssp HTSGGGHHHHH
T ss_pred hcCHHHHHHHh
Confidence 864 444443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=314.83 Aligned_cols=241 Identities=28% Similarity=0.406 Sum_probs=192.3
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccC-----CChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIA-----SNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~-----~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
+|.|+||.||++... +..+|+|.+..... ........+.+|+.+++.++||||+++++++...+ .++||||+
T Consensus 18 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~ 96 (322)
T 2ycf_A 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELM 96 (322)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECC
T ss_pred EecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecC
Confidence 788999999999875 67899999865421 12233456889999999999999999999987654 89999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc---EEEeccccceeccccCcc
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH---LKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~---~kl~Dfg~~~~~~~~~~~ 248 (370)
++++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++. +||+|||++........
T Consensus 97 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~- 172 (322)
T 2ycf_A 97 EGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL- 172 (322)
T ss_dssp TTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH-
T ss_pred CCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccceecccccc-
Confidence 99999999998889999999999999999999999998 999999999999987664 99999999987654321
Q ss_pred ceeccCCCCCccccCccccc---ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhc--cCCCCCCCCCCcH
Q 042314 249 SYKMTGGTGSYRYMAPEVYR---RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ-VADRRAY--EDSRPALSSLYPE 322 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~ 322 (370)
.....||+.|+|||.+. ...++.++||||||+++|+|++|..||....... ....... ....+..+..+|+
T Consensus 173 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (322)
T 2ycf_A 173 ---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249 (322)
T ss_dssp ---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCH
T ss_pred ---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCH
Confidence 11224799999999974 4568899999999999999999999997543221 1111111 1112223356789
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 042314 323 PIKALLRECWHKNPDRRPTFEEIIF 347 (370)
Q Consensus 323 ~l~~li~~~l~~~p~~Rp~~~~ll~ 347 (370)
.+.+++.+||..||++||++.++++
T Consensus 250 ~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 250 KALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHcccCHhhCCCHHHHhh
Confidence 9999999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=316.26 Aligned_cols=239 Identities=24% Similarity=0.395 Sum_probs=196.5
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCce------EEEE
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERL------IFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~------~~v~ 168 (370)
..+|.|+||.||++... |..+|+|.+.... ........+.+|+.+++.++||||+++++++...+.. ++||
T Consensus 48 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 126 (371)
T 4exu_A 48 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 126 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence 44899999999999765 7899999987653 4456678899999999999999999999999876654 9999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
||+.+ +|.+++.. .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 127 e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--- 197 (371)
T 4exu_A 127 PFMQT-DLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE--- 197 (371)
T ss_dssp ECCCE-EHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC---------
T ss_pred ccccc-cHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC---
Confidence 99975 88888754 5999999999999999999999998 999999999999999999999999999765432
Q ss_pred ceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--------------
Q 042314 249 SYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR-------------- 313 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 313 (370)
.....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+......
T Consensus 198 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 274 (371)
T 4exu_A 198 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 274 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred ---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence 223468999999999987 67899999999999999999999999887665544333211000
Q ss_pred ---------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 ---------------PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
......+++.+.+||.+||+.||++|||+.+++++
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 01123568899999999999999999999999876
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=312.65 Aligned_cols=243 Identities=25% Similarity=0.367 Sum_probs=197.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC-----CceEEEEeec
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS-----ERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~-----~~~~~v~e~~ 171 (370)
+|.|+||.||++... |..+|+|.+... ........+.+|+.+++.++||||+++++++... ...++||||+
T Consensus 19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 96 (353)
T 2b9h_A 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM 96 (353)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCC
T ss_pred EcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEecc
Confidence 688999999999876 888999998643 4456677888999999999999999999987654 6789999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce-
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY- 250 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~- 250 (370)
.+ +|.+++... .++...+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...........
T Consensus 97 ~~-~L~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 171 (353)
T 2b9h_A 97 QT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171 (353)
T ss_dssp SE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred Cc-cHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccC
Confidence 75 999998874 7999999999999999999999998 99999999999999999999999999987654322111
Q ss_pred ------eccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC----------
Q 042314 251 ------KMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR---------- 313 (370)
Q Consensus 251 ------~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~---------- 313 (370)
......||+.|+|||++.+ ..++.++||||||+++|+|++|++||..................
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (353)
T 2b9h_A 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCI 251 (353)
T ss_dssp --------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTC
T ss_pred ccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcccccc
Confidence 1223468999999998764 67899999999999999999999999887654433222110000
Q ss_pred ---------------C-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 ---------------P-----ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 ---------------~-----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+ .....+|+.+.+||.+||..||++|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 1124578899999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=309.24 Aligned_cols=243 Identities=23% Similarity=0.374 Sum_probs=191.7
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEe--------------eC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK--------------HS 161 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~--------------~~ 161 (370)
.+|.|+||.||++... ++.+++|.+... +....+.+.+|+.+++.++||||+++++++. ..
T Consensus 18 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 94 (320)
T 2i6l_A 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94 (320)
T ss_dssp ECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred EeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccccc
Confidence 3789999999999886 788999988653 4566778999999999999999999999873 34
Q ss_pred CceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC-CCCcEEEeccccce
Q 042314 162 ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD-EAGHLKVTDFGLSK 240 (370)
Q Consensus 162 ~~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~-~~~~~kl~Dfg~~~ 240 (370)
...++||||++| +|.+++.. +++++..++.++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++.
T Consensus 95 ~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~ 169 (320)
T 2i6l_A 95 NSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169 (320)
T ss_dssp SEEEEEEECCSE-EHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCB
T ss_pred CceeEEeeccCC-CHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCcccc
Confidence 678999999985 99999875 47999999999999999999999998 99999999999997 56789999999998
Q ss_pred eccccCccceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC------
Q 042314 241 IAQEKDSYSYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR------ 313 (370)
Q Consensus 241 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------ 313 (370)
................+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||..................
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (320)
T 2i6l_A 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249 (320)
T ss_dssp CC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHH
T ss_pred ccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhh
Confidence 76543222212223357889999998865 67899999999999999999999999887765544333211100
Q ss_pred ----------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 ----------------------PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
......+|+.+.++|++||+.||++|||+++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 250 QELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 01234578999999999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=320.42 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=204.3
Q ss_pred ccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCC-CceeeeeeeEeeCCceEEEEeecC
Q 042314 96 RGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH-PNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h-p~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
...+|.|+||.||++.+. +..+|+|++...... ..+..|+.+++.+.| +++..+..++...+..++||||+
T Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~- 85 (483)
T 3sv0_A 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (483)
T ss_dssp CCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence 345899999999999864 889999987654322 246789999999987 55666666667788899999999
Q ss_pred CCCHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee---CCCCcEEEeccccceeccccCcc
Q 042314 173 NGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ---DEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 173 g~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
+++|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++........
T Consensus 86 g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 8899999985 468999999999999999999999998 9999999999999 57889999999999877654321
Q ss_pred c----eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhh---ccCCCCCCCC
Q 042314 249 S----YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA---VQVADRRA---YEDSRPALSS 318 (370)
Q Consensus 249 ~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~~---~~~~~~~~~~ 318 (370)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ......+. .......++.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCR 242 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHT
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhc
Confidence 1 112245689999999999999999999999999999999999999976432 22222111 1122223345
Q ss_pred CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 319 LYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 319 ~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
.+|+.+.+++.+||..+|++||++.+|++.|+.+....
T Consensus 243 ~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 243 GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 68899999999999999999999999999999996654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=322.72 Aligned_cols=242 Identities=24% Similarity=0.380 Sum_probs=178.4
Q ss_pred CCCCCCcccEEEEEEc----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee--CCceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKWR----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH--SERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~--~~~~~~v~e~~ 171 (370)
.+|.|+||.||++... +..+|+|.+..... ...+.+|+.+++.++||||+++++++.. ...+++||||+
T Consensus 28 ~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~ 102 (405)
T 3rgf_A 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 102 (405)
T ss_dssp CCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECC
T ss_pred EeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCC
Confidence 4899999999999864 67899999865421 2457789999999999999999999854 67899999999
Q ss_pred CCCCHHHHHHhC---------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee----CCCCcEEEecccc
Q 042314 172 RNGSLHDILKKK---------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ----DEAGHLKVTDFGL 238 (370)
Q Consensus 172 ~g~~L~~~l~~~---------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~----~~~~~~kl~Dfg~ 238 (370)
.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+ +..+.+||+|||+
T Consensus 103 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 103 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp SE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred CC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 76 888877532 24899999999999999999999998 9999999999999 6778999999999
Q ss_pred ceeccccCccceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHH---------HHHHHhh
Q 042314 239 SKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAV---------QVADRRA 308 (370)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---------~~~~~~~ 308 (370)
++................||+.|+|||++.+. .++.++|||||||++|+|++|++||...... .....+.
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~ 258 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence 98775443222233445789999999999874 5899999999999999999999999755431 1111110
Q ss_pred c-cCCC-CC----------------------------------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 309 Y-EDSR-PA----------------------------------LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 309 ~-~~~~-~~----------------------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
. .+.. .. .....++.+.+||++||..||.+|||+++++++
T Consensus 259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 0000 00 011126788999999999999999999999876
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=309.24 Aligned_cols=242 Identities=27% Similarity=0.448 Sum_probs=177.9
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHH-HHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~-~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
..+|.|+||.||++... +..+++|.+.... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (327)
T 3aln_A 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST 105 (327)
T ss_dssp CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred heeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC
Confidence 34789999999999886 8899999987642 3344455566665 67778999999999999999999999999986
Q ss_pred CCHHHHHHh-----CCCCChHhHHHHHHHHHHHHHHHhhc-CCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 174 GSLHDILKK-----KGKLDPPTAVAYALDIARGMNYLHHH-RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 174 ~~L~~~l~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
+|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++........
T Consensus 106 -~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 181 (327)
T 3aln_A 106 -SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181 (327)
T ss_dssp -EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred -ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence 88888763 56789999999999999999999998 8 99999999999999999999999999976654322
Q ss_pred cceeccCCCCCccccCcccc----cccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCC----CCC
Q 042314 248 YSYKMTGGTGSYRYMAPEVY----RRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPAL----SSL 319 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~ 319 (370)
.....||+.|+|||.+ .+..++.++||||||+++|+|++|+.||..................+.+ ...
T Consensus 182 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3aln_A 182 ----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE 257 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCC
T ss_pred ----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccccc
Confidence 1223589999999998 4566899999999999999999999999875433222211112222222 245
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 320 YPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 320 ~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+++.+.+++.+||..||++|||+.+++++
T Consensus 258 ~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 258 FSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 88999999999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=316.30 Aligned_cols=238 Identities=26% Similarity=0.322 Sum_probs=190.7
Q ss_pred ccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC------CceEEE
Q 042314 96 RGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS------ERLIFL 167 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~------~~~~~v 167 (370)
...+|.|+||.||++... |..+|+|.+..... ...+|+.+++.++||||+++++++... ..+++|
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 345899999999999884 78899999865321 123699999999999999999987542 236799
Q ss_pred EeecCCCCHHHHHH----hCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC-CcEEEeccccceec
Q 042314 168 TEYLRNGSLHDILK----KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA-GHLKVTDFGLSKIA 242 (370)
Q Consensus 168 ~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~-~~~kl~Dfg~~~~~ 242 (370)
|||+.+ +|.+++. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.+ +.+||+|||+++..
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999987 6766554 3468999999999999999999999998 9999999999999965 56899999999876
Q ss_pred cccCccceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-----------
Q 042314 243 QEKDSYSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE----------- 310 (370)
Q Consensus 243 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~----------- 310 (370)
..... .....+|+.|+|||++.+. .++.++|||||||++|||++|++||......+....+...
T Consensus 208 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 208 VRGEP----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CTTCC----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred ccCCC----ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54322 2234689999999999765 6899999999999999999999999887765443332210
Q ss_pred -------CCCCC---------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 311 -------DSRPA---------LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 311 -------~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
...+. .+...|+.+.+||++||..||.+||++.+++++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00000 234568899999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=309.52 Aligned_cols=236 Identities=23% Similarity=0.334 Sum_probs=195.3
Q ss_pred CCCCCcccEEEEEE---cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCc------eeeeeeeEeeCCceEEEEe
Q 042314 99 IDPGAYGEVYLVKW---RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN------IVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 99 l~~g~~~~v~~a~~---~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~------Iv~~~~~~~~~~~~~~v~e 169 (370)
+|.|+||.||++.. .+..+|+|+++.. ......+.+|+.+++.++|++ ++++++++...+..++|||
T Consensus 22 lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 97 (339)
T 1z57_A 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97 (339)
T ss_dssp EEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred EecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEc
Confidence 68899999999976 4788999998642 355677889999999887654 9999999999999999999
Q ss_pred ecCCCCHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC-------------------C
Q 042314 170 YLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE-------------------A 228 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~-------------------~ 228 (370)
|+ +++|.+++...+ .++...++.++.|++.||.|||+++ |+||||||+||+++. +
T Consensus 98 ~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~ 173 (339)
T 1z57_A 98 LL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173 (339)
T ss_dssp CC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESC
T ss_pred CC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccC
Confidence 99 789999998765 6889999999999999999999998 999999999999987 6
Q ss_pred CcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Q 042314 229 GHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRA 308 (370)
Q Consensus 229 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~ 308 (370)
+.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 174 ~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 247 (339)
T 1z57_A 174 PDIKVVDFGSATYDDEHH------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247 (339)
T ss_dssp CCEEECCCSSCEETTSCC------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHH
T ss_pred CCceEeeCcccccCcccc------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 689999999997654322 23468999999999999999999999999999999999999998776654332221
Q ss_pred cc-CCC-----------------------------------------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 042314 309 YE-DSR-----------------------------------------PALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346 (370)
Q Consensus 309 ~~-~~~-----------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll 346 (370)
.. ... .......++.+.+||.+||+.||++|||+.+++
T Consensus 248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 327 (339)
T 1z57_A 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL 327 (339)
T ss_dssp HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHh
Confidence 10 000 011122357799999999999999999999998
Q ss_pred HH
Q 042314 347 FR 348 (370)
Q Consensus 347 ~~ 348 (370)
++
T Consensus 328 ~h 329 (339)
T 1z57_A 328 KH 329 (339)
T ss_dssp TS
T ss_pred cC
Confidence 65
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=311.06 Aligned_cols=239 Identities=24% Similarity=0.394 Sum_probs=195.8
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCc------eEEEE
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSER------LIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~------~~~v~ 168 (370)
..+|.|+||.||++... |..+|+|.+.... ........+.+|+.+++.++||||+++++++..... .++||
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence 34789999999999874 8899999987643 445667788999999999999999999999877654 49999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
||+.+ +|.+++.. .+++..+..++.|++.||.|||++| |+||||||+||+++.++.+||+|||++......
T Consensus 109 e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--- 179 (353)
T 3coi_A 109 PFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE--- 179 (353)
T ss_dssp ECCSE-EGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-------
T ss_pred ccccC-CHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC---
Confidence 99975 88887754 5899999999999999999999998 999999999999999999999999998765432
Q ss_pred ceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-----------------
Q 042314 249 SYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE----------------- 310 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~----------------- 310 (370)
.....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+...
T Consensus 180 ---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 3coi_A 180 ---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256 (353)
T ss_dssp -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred ---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence 223467999999999877 67899999999999999999999999887654433322110
Q ss_pred ------------CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 311 ------------DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 311 ------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.........+++.+.+||.+||..||++|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01112334678999999999999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=307.81 Aligned_cols=241 Identities=29% Similarity=0.458 Sum_probs=195.6
Q ss_pred CCCCCcccEEEEEE---cCceeEEEEeccccCCChHHHHHHHHHHHHHHhc---CCCceeeeeeeEe-----eCCceEEE
Q 042314 99 IDPGAYGEVYLVKW---RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL---RHPNIVQFLGVLK-----HSERLIFL 167 (370)
Q Consensus 99 l~~g~~~~v~~a~~---~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l---~hp~Iv~~~~~~~-----~~~~~~~v 167 (370)
+|.|+||.||++.. .+..+++|.+....... .....+.+|+.+++.+ +||||+++++++. .....++|
T Consensus 19 lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 97 (326)
T 1blx_A 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLV 97 (326)
T ss_dssp EEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEE
T ss_pred ecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEE
Confidence 68899999999987 36789999987543221 1223445667666655 8999999999987 45678999
Q ss_pred EeecCCCCHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceecccc
Q 042314 168 TEYLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEK 245 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 245 (370)
|||+.| +|.+++.... .+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++......
T Consensus 98 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (326)
T 1blx_A 98 FEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173 (326)
T ss_dssp EECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG
T ss_pred EecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccccccCC
Confidence 999984 9999998753 4899999999999999999999998 999999999999999999999999999766533
Q ss_pred CccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC--------------
Q 042314 246 DSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED-------------- 311 (370)
Q Consensus 246 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-------------- 311 (370)
. ......+|+.|+|||.+.+..++.++||||||+++|+|++|++||...........+....
T Consensus 174 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (326)
T 1blx_A 174 M----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249 (326)
T ss_dssp G----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred C----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccccc
Confidence 2 2233468999999999999999999999999999999999999999877655444332100
Q ss_pred -----------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 -----------SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
........+|+.+.+|+.+||..||++|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 250 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0011235678999999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=313.58 Aligned_cols=239 Identities=24% Similarity=0.346 Sum_probs=189.9
Q ss_pred ccCCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC------ceEEEE
Q 042314 96 RGGIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE------RLIFLT 168 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~------~~~~v~ 168 (370)
...+|.|+||.||++... +..+++|.+...... ..+|+.+++.++||||+++++++.... .+++||
T Consensus 45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 345899999999999884 556888887543221 136999999999999999999986543 388999
Q ss_pred eecCCCCHHHHH---HhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC-CCCcEEEeccccceeccc
Q 042314 169 EYLRNGSLHDIL---KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD-EAGHLKVTDFGLSKIAQE 244 (370)
Q Consensus 169 e~~~g~~L~~~l---~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~ 244 (370)
||++++.+.... ...+.+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||+++....
T Consensus 118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194 (394)
T ss_dssp ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence 999874433322 23568999999999999999999999998 99999999999999 789999999999987644
Q ss_pred cCccceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-------------
Q 042314 245 KDSYSYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE------------- 310 (370)
Q Consensus 245 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~------------- 310 (370)
... .....+|+.|+|||.+.+. .++.++||||+||++|+|++|++||...........+...
T Consensus 195 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 195 GEP----NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp TCC----CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred CCC----CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 332 2234679999999998765 5899999999999999999999999987765544332210
Q ss_pred -----CCCC---------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 311 -----DSRP---------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 311 -----~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
...+ ..+...|+.+.+||.+||..||++|||+.++++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000 1233478899999999999999999999999876
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=313.65 Aligned_cols=242 Identities=24% Similarity=0.395 Sum_probs=190.6
Q ss_pred CCCCCcccEEEEEEc-CceeEEEEeccccC--------CChHHHHHHHHHHHHHHhcCCCceeeeeeeEee-----CCce
Q 042314 99 IDPGAYGEVYLVKWR-GTEIAAKTIRSSIA--------SNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH-----SERL 164 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-g~~vavK~l~~~~~--------~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~-----~~~~ 164 (370)
+|.|+||.||++... |..+|+|.+..... .+....+.+.+|+.++++++||||+++++++.. ....
T Consensus 30 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 109 (362)
T 3pg1_A 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKL 109 (362)
T ss_dssp EEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEE
T ss_pred eccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceE
Confidence 688999999999664 88899999865432 233456889999999999999999999999854 3368
Q ss_pred EEEEeecCCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceecc
Q 042314 165 IFLTEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQ 243 (370)
Q Consensus 165 ~~v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 243 (370)
++||||+.| +|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 110 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (362)
T 3pg1_A 110 YLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDT 185 (362)
T ss_dssp EEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTTC-----
T ss_pred EEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecCcccccc
Confidence 999999985 888877654 47999999999999999999999998 9999999999999999999999999997554
Q ss_pred ccCccceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC--------
Q 042314 244 EKDSYSYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP-------- 314 (370)
Q Consensus 244 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 314 (370)
.... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||..................+
T Consensus 186 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 261 (362)
T 3pg1_A 186 ADAN----KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMF 261 (362)
T ss_dssp --------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHT
T ss_pred cccc----cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhc
Confidence 3322 223468999999999877 678999999999999999999999999877655444332110000
Q ss_pred ----------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 315 ----------------------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 315 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
......++.+.+||.+||+.||++|||+.+++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 262 SSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp SCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1123467889999999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=305.71 Aligned_cols=234 Identities=20% Similarity=0.322 Sum_probs=191.2
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEee--CCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKH--SERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~--~~~~~~v~e~~~g 173 (370)
+|.|+||.||++.. .+..+|+|++... ..+.+.+|+.+++.++ ||||+++++++.. ....++||||+++
T Consensus 44 lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 44 LGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred ecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 78899999999976 4788999998643 2466889999999997 9999999999987 6678999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC-cEEEeccccceeccccCccceec
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG-HLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
++|.++++ .+++..++.++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||++........ .
T Consensus 118 ~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~ 187 (330)
T 3nsz_A 118 TDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE----Y 187 (330)
T ss_dssp CCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC----C
T ss_pred hhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc----c
Confidence 99999885 4889999999999999999999998 99999999999999777 899999999987654432 2
Q ss_pred cCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHh-------------hccC------
Q 042314 253 TGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADT-AVQVADRR-------------AYED------ 311 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~-~~~~~~~~-------------~~~~------ 311 (370)
....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.... ........ ....
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTH
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccc
Confidence 23468999999999977 668999999999999999999999985432 11111100 0000
Q ss_pred ----------------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 ----------------SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 ----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.....+..+++.+.+||.+||+.||++|||+++++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0111122378999999999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=308.27 Aligned_cols=236 Identities=28% Similarity=0.418 Sum_probs=169.8
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee----CCceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH----SERLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~----~~~~~~v~e~~~ 172 (370)
+|.|+||.||++... +..+|+|++... ..... .....++.++||||+++++++.. ....++||||++
T Consensus 37 lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 37 LGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 788999999999886 889999998642 22222 22234566799999999999876 455899999999
Q ss_pred CCCHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC---CcEEEeccccceeccccCc
Q 042314 173 NGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA---GHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 173 g~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~---~~~kl~Dfg~~~~~~~~~~ 247 (370)
||+|.+++.+.+ .+++..++.++.|++.||.|||+++ |+||||||+||+++.+ +.+||+|||++.......
T Consensus 110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~- 185 (336)
T 3fhr_A 110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA- 185 (336)
T ss_dssp TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccccc-
Confidence 999999998764 6999999999999999999999998 9999999999999864 459999999998665332
Q ss_pred cceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHH----Hhh--ccCCCCCCCCCCc
Q 042314 248 YSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVAD----RRA--YEDSRPALSSLYP 321 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~----~~~--~~~~~~~~~~~~~ 321 (370)
.....+|+.|+|||.+.+..++.++||||||+++|+|++|..||.......... ... ...........+|
T Consensus 186 ----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (336)
T 3fhr_A 186 ----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCC
T ss_pred ----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCC
Confidence 123357999999999988889999999999999999999999997665433211 111 1112223335689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFRL 349 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~l 349 (370)
+.+.+||.+||+.||++|||+.+++++-
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 262 EDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 9999999999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=301.99 Aligned_cols=241 Identities=23% Similarity=0.439 Sum_probs=180.6
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... |..+++|.+.... ........+..+..+++.++||||+++++++...+..++||||+ ++.
T Consensus 32 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 109 (318)
T 2dyl_A 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTC 109 (318)
T ss_dssp EC------CEEEEEETTTCCEEEEEEEETTS-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEE
T ss_pred eeeecCCeeEEEEEEecCCeEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCc
Confidence 4899999999999885 8899999987643 22233344455556788889999999999999999999999999 556
Q ss_pred HHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhc-CCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 176 LHDILKK-KGKLDPPTAVAYALDIARGMNYLHHH-RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 176 L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+..+... .+.+++..++.++.|++.||.|||++ + |+|+||||+||+++.++.+||+|||++........ ..
T Consensus 110 ~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~----~~ 182 (318)
T 2dyl_A 110 AEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA----KD 182 (318)
T ss_dssp HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--------------
T ss_pred HHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc----cc
Confidence 7666654 46899999999999999999999995 8 99999999999999999999999999876654322 12
Q ss_pred CCCCCccccCccccc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCc-HHHHHHHhhccCCCCC--CCCCCcHHHH
Q 042314 254 GGTGSYRYMAPEVYR-----RESYGKSVDVFSFALIVHEMFQGGPSNRADT-AVQVADRRAYEDSRPA--LSSLYPEPIK 325 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~ 325 (370)
...+|+.|+|||.+. ...++.++||||||+++|+|++|+.||.... ......... ....+. ....+|+.+.
T Consensus 183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~ 261 (318)
T 2dyl_A 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL-QEEPPLLPGHMGFSGDFQ 261 (318)
T ss_dssp ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH-HSCCCCCCSSSCCCHHHH
T ss_pred ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh-ccCCCCCCccCCCCHHHH
Confidence 235899999999994 4568899999999999999999999998743 333333322 222222 2345899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 042314 326 ALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 326 ~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
++|.+||..||.+||++.+++++
T Consensus 262 ~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 262 SFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHccCChhHCcCHHHHhhC
Confidence 99999999999999999999875
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=309.32 Aligned_cols=240 Identities=26% Similarity=0.337 Sum_probs=183.6
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCc-------eEEE
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSER-------LIFL 167 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~-------~~~v 167 (370)
..+|.|+||.||++... +..+|+|.+..... .......++..++.++||||+++++++..... .++|
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv 104 (360)
T 3e3p_A 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR----FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVV 104 (360)
T ss_dssp ----------CEEEEETTTCCEEEEEEEECCTT----CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEecCcc----ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEE
Confidence 34899999999999875 78899998865432 22345677888888999999999999865433 8899
Q ss_pred EeecCCCCHHHHH----HhCCCCChHhHHHHHHHHHHHHHHHh--hcCCCceeecCCCCCCeeeCC-CCcEEEeccccce
Q 042314 168 TEYLRNGSLHDIL----KKKGKLDPPTAVAYALDIARGMNYLH--HHRPHAIIHRDLTPSNVLQDE-AGHLKVTDFGLSK 240 (370)
Q Consensus 168 ~e~~~g~~L~~~l----~~~~~~~~~~~~~i~~~l~~~l~~lH--~~~~~~iiH~Dlk~~Nil~~~-~~~~kl~Dfg~~~ 240 (370)
|||+.+ +|...+ .....++...+..++.|++.||.||| +++ |+||||||+||+++. ++.+||+|||++.
T Consensus 105 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 105 MEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred eecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 999987 554443 34567899999999999999999999 887 999999999999996 8999999999998
Q ss_pred eccccCccceeccCCCCCccccCcccccccC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC-------
Q 042314 241 IAQEKDSYSYKMTGGTGSYRYMAPEVYRRES-YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS------- 312 (370)
Q Consensus 241 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~------- 312 (370)
....... .....||+.|+|||.+.+.. ++.++||||||+++|+|++|++||...........+.....
T Consensus 181 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 181 KLSPSEP----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CCCTTSC----CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ecCCCCC----cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 7654432 22346899999999987654 89999999999999999999999998876554443321100
Q ss_pred -----------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 313 -----------------------RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 313 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+......++.+.+||.+||+.||++|||+.+++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 011222357889999999999999999999999876
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=301.64 Aligned_cols=240 Identities=25% Similarity=0.414 Sum_probs=189.2
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee-------------CCc
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH-------------SER 163 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~-------------~~~ 163 (370)
+|.|+||.||++.. .+..+++|.+... ......+.+|+.+++.++||||+++++++.. .+.
T Consensus 14 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (303)
T 1zy4_A 14 LGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89 (303)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred eccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence 68899999999986 4888999998642 3456788999999999999999999998754 456
Q ss_pred eEEEEeecCCCCHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceec
Q 042314 164 LIFLTEYLRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIA 242 (370)
Q Consensus 164 ~~~v~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~ 242 (370)
.++||||+++++|.+++...+ .++...++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 166 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCT
T ss_pred eEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhc
Confidence 899999999999999998653 5788899999999999999999998 999999999999999999999999998766
Q ss_pred cccCcc-----------ceeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhc
Q 042314 243 QEKDSY-----------SYKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTA-VQVADRRAY 309 (370)
Q Consensus 243 ~~~~~~-----------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~ 309 (370)
...... ........||+.|+|||.+.+. .++.++||||||+++|+|++ ||..... .........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~ 243 (303)
T 1zy4_A 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRS 243 (303)
T ss_dssp TC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHS
T ss_pred ccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccc
Confidence 432110 1112334689999999999865 68999999999999999998 5543322 222222221
Q ss_pred --cCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 310 --EDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 310 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
....+..+...++.+.+++.+||+.||++|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 244 VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 122334556678889999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=308.49 Aligned_cols=234 Identities=24% Similarity=0.404 Sum_probs=197.7
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCCh---HHHHHHHHHHHHHHhcC--CCceeeeeeeEeeCCceEEEEeec
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNP---RVRNSFMKELGLWQKLR--HPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~---~~~~~~~~e~~~l~~l~--hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
+|.|+||.||++.. .+..+|+|.+........ .....+.+|+.++++++ ||||+++++++...+..++|+|++
T Consensus 51 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~ 130 (320)
T 3a99_A 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 130 (320)
T ss_dssp CSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECC
T ss_pred EeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcC
Confidence 78999999999976 478899999876532221 12244667899999996 599999999999999999999999
Q ss_pred CC-CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC-CCCcEEEeccccceeccccCccc
Q 042314 172 RN-GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD-EAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 172 ~g-~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
.+ ++|.+++...+.+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++.......
T Consensus 131 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~--- 204 (320)
T 3a99_A 131 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 204 (320)
T ss_dssp SSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC---
T ss_pred CCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc---
Confidence 76 899999998889999999999999999999999998 99999999999999 78899999999998765432
Q ss_pred eeccCCCCCccccCcccccccCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESY-GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||....... ......+..+|+.+.++|
T Consensus 205 --~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~li 274 (320)
T 3a99_A 205 --YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------RGQVFFRQRVSSECQHLI 274 (320)
T ss_dssp --BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------HCCCCCSSCCCHHHHHHH
T ss_pred --ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh--------cccccccccCCHHHHHHH
Confidence 123468999999999987665 688999999999999999999997643211 112334567899999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+||..||++|||+++++++
T Consensus 275 ~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 275 RWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HHHTCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhhCcCHHHHhcC
Confidence 99999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=315.15 Aligned_cols=236 Identities=21% Similarity=0.283 Sum_probs=188.6
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC--------CCceeeeeeeEe----eCCce
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR--------HPNIVQFLGVLK----HSERL 164 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~--------hp~Iv~~~~~~~----~~~~~ 164 (370)
+|.|+||.||++... +..+|+|++... ......+.+|+.+++.++ |+||+++++++. .....
T Consensus 45 lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~ 120 (397)
T 1wak_A 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI 120 (397)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEE
T ss_pred eeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceE
Confidence 688999999999764 788999998643 455677889999999985 788999999987 45679
Q ss_pred EEEEeecCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhc-CCCceeecCCCCCCeeeCCCC------------
Q 042314 165 IFLTEYLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHH-RPHAIIHRDLTPSNVLQDEAG------------ 229 (370)
Q Consensus 165 ~~v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~iiH~Dlk~~Nil~~~~~------------ 229 (370)
++||||+ +++|.+.+... +.+++..++.++.||+.||.|||++ | |+||||||+|||++.++
T Consensus 121 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~ 196 (397)
T 1wak_A 121 CMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATE 196 (397)
T ss_dssp EEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC-
T ss_pred EEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHH
Confidence 9999999 45666666543 4699999999999999999999998 8 99999999999999775
Q ss_pred -------------------------------------cEEEeccccceeccccCccceeccCCCCCccccCcccccccCC
Q 042314 230 -------------------------------------HLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272 (370)
Q Consensus 230 -------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 272 (370)
.+||+|||++...... .....||+.|+|||++.+..+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp --------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHHHTSCC
T ss_pred HhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhhcCCCC
Confidence 7999999999876543 223468999999999999999
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHhhc-cCCC--------------------------------
Q 042314 273 GKSVDVFSFALIVHEMFQGGPSNRADT------AVQVADRRAY-EDSR-------------------------------- 313 (370)
Q Consensus 273 ~~~~Di~slG~~l~el~~g~~p~~~~~------~~~~~~~~~~-~~~~-------------------------------- 313 (370)
+.++|||||||++|+|++|+.||.... .......... .+..
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL 350 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence 999999999999999999999997543 1111111100 0000
Q ss_pred -------CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 -------PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 -------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
...+...++.+.+||.+||+.||++|||+++++++
T Consensus 351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 01122234678999999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=313.15 Aligned_cols=242 Identities=20% Similarity=0.270 Sum_probs=184.1
Q ss_pred cCCCCCCcccE-EEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 97 GGIDPGAYGEV-YLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 97 ~~l~~g~~~~v-~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
..+|.|+||.| +.+...++.||+|.+..... ..+.+|+.+++.+ +||||+++++++......++||||+.|
T Consensus 30 ~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g- 102 (432)
T 3p23_A 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA- 102 (432)
T ss_dssp EEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred CeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCC-
Confidence 34899999995 45566799999999865322 1245799999999 799999999999999999999999975
Q ss_pred CHHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC-----CcEEEeccccceeccccCcc
Q 042314 175 SLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA-----GHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 175 ~L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~-----~~~kl~Dfg~~~~~~~~~~~ 248 (370)
+|.+++.... ..+...++.++.|++.||.|||+++ |+||||||+||+++.. ..+||+|||+++........
T Consensus 103 ~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 103 TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 9999998663 4566678899999999999999998 9999999999999532 25889999999877644322
Q ss_pred ceeccCCCCCccccCccccc---ccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCC-CCCCCCCcHH
Q 042314 249 SYKMTGGTGSYRYMAPEVYR---RESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSR-PALSSLYPEP 323 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 323 (370)
........||+.|+|||++. ...++.++|||||||++|||++ |..||.................. .......+..
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVI 259 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHH
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHH
Confidence 22334457999999999997 4567889999999999999999 88998765544433322211111 1112234566
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 324 IKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 324 l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+.+||.+||+.||++|||+.+++++
T Consensus 260 ~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 260 ARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 8999999999999999999999853
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=301.88 Aligned_cols=236 Identities=22% Similarity=0.342 Sum_probs=191.8
Q ss_pred CCCCCcccEEEEEEc--C-ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCc------eeeeeeeEeeCCceEEEEe
Q 042314 99 IDPGAYGEVYLVKWR--G-TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN------IVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g-~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~------Iv~~~~~~~~~~~~~~v~e 169 (370)
+|.|+||.||++... + ..+|+|+++.. ......+.+|+.+++.++|++ ++.+++++...+..++|||
T Consensus 27 lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T 2eu9_A 27 LGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE 102 (355)
T ss_dssp EEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEE
T ss_pred eeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEe
Confidence 688999999999874 3 67999998642 355677889999999987665 8999999999999999999
Q ss_pred ecCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee-------------------CCC
Q 042314 170 YLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ-------------------DEA 228 (370)
Q Consensus 170 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~-------------------~~~ 228 (370)
|+ +++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+||++ +..
T Consensus 103 ~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 178 (355)
T 2eu9_A 103 LL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178 (355)
T ss_dssp CC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESC
T ss_pred cc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCC
Confidence 99 55777777654 36999999999999999999999998 9999999999999 567
Q ss_pred CcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Q 042314 229 GHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRA 308 (370)
Q Consensus 229 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~ 308 (370)
+.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 179 ~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 252 (355)
T 2eu9_A 179 TSIRVADFGSATFDHEHH------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME 252 (355)
T ss_dssp CCEEECCCTTCEETTSCC------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CcEEEeecCccccccccc------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 889999999997654332 23468999999999999999999999999999999999999998876654332221
Q ss_pred cc-CCCC-----------------------------------------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 042314 309 YE-DSRP-----------------------------------------ALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346 (370)
Q Consensus 309 ~~-~~~~-----------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll 346 (370)
.. ...+ ......+..+.+||++||+.||++|||+.+++
T Consensus 253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL 332 (355)
T ss_dssp HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 10 0000 00112245789999999999999999999998
Q ss_pred HH
Q 042314 347 FR 348 (370)
Q Consensus 347 ~~ 348 (370)
++
T Consensus 333 ~h 334 (355)
T 2eu9_A 333 LH 334 (355)
T ss_dssp TS
T ss_pred cC
Confidence 64
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=302.47 Aligned_cols=235 Identities=23% Similarity=0.397 Sum_probs=192.5
Q ss_pred CCCCCCcccEEEEEE--cCceeEEEEeccccCCCh---HHHHHHHHHHHHHHhc----CCCceeeeeeeEeeCCceEEEE
Q 042314 98 GIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNP---RVRNSFMKELGLWQKL----RHPNIVQFLGVLKHSERLIFLT 168 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~---~~~~~~~~e~~~l~~l----~hp~Iv~~~~~~~~~~~~~~v~ 168 (370)
.+|.|+||.||++.. .+..+++|.+........ .....+.+|+.+++++ +||||+++++++...+..++|+
T Consensus 38 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~ 117 (312)
T 2iwi_A 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL 117 (312)
T ss_dssp EEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEE
T ss_pred EEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEE
Confidence 478899999999977 478899999865432211 1233456788988888 8999999999999989999999
Q ss_pred ee-cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC-CCCcEEEeccccceeccccC
Q 042314 169 EY-LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD-EAGHLKVTDFGLSKIAQEKD 246 (370)
Q Consensus 169 e~-~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~ 246 (370)
|+ +.+++|.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+||+++ .++.+||+|||++.......
T Consensus 118 e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~ 194 (312)
T 2iwi_A 118 ERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP 194 (312)
T ss_dssp ECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc
Confidence 99 789999999998888999999999999999999999998 99999999999999 78999999999998765432
Q ss_pred ccceeccCCCCCccccCcccccccCCC-chhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHH
Q 042314 247 SYSYKMTGGTGSYRYMAPEVYRRESYG-KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIK 325 (370)
Q Consensus 247 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 325 (370)
.....+++.|+|||.+.+..+. .++||||||+++|+|++|+.||....... ......+..++..+.
T Consensus 195 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~ 261 (312)
T 2iwi_A 195 -----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL--------EAELHFPAHVSPDCC 261 (312)
T ss_dssp -----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------HTCCCCCTTSCHHHH
T ss_pred -----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh--------hhccCCcccCCHHHH
Confidence 2234589999999999877664 58999999999999999999997643211 122345567899999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 042314 326 ALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 326 ~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
++|.+||..||++|||+.+++++
T Consensus 262 ~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 262 ALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHHHHccCChhhCcCHHHHhcC
Confidence 99999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=307.45 Aligned_cols=239 Identities=23% Similarity=0.257 Sum_probs=192.1
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CC-----ceeeeeeeEeeCCceEEEEe
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HP-----NIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp-----~Iv~~~~~~~~~~~~~~v~e 169 (370)
.+|.|+||.||++... +..+|+|+++.. ......+..|+.+++.++ |+ +|+++++++...+..++|||
T Consensus 61 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 136 (382)
T 2vx3_A 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE 136 (382)
T ss_dssp EEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEE
T ss_pred EEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEe
Confidence 3788999999999875 778999998643 345667788888888875 44 49999999999999999999
Q ss_pred ecCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC--CCCcEEEeccccceecccc
Q 042314 170 YLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD--EAGHLKVTDFGLSKIAQEK 245 (370)
Q Consensus 170 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~--~~~~~kl~Dfg~~~~~~~~ 245 (370)
|+.+ +|.+++... +.++...++.++.|++.||.|||+.. .+|+||||||+|||++ .++.+||+|||+++.....
T Consensus 137 ~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~ 214 (382)
T 2vx3_A 137 MLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214 (382)
T ss_dssp CCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred cCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc
Confidence 9965 999999875 46899999999999999999999521 2399999999999995 4778999999999876543
Q ss_pred CccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCC----------
Q 042314 246 DSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPA---------- 315 (370)
Q Consensus 246 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------- 315 (370)
. ....+|+.|+|||++.+..++.++|||||||++|||++|++||...........+......++
T Consensus 215 ~------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (382)
T 2vx3_A 215 I------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288 (382)
T ss_dssp C------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred c------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence 2 234689999999999999999999999999999999999999998776554433321100000
Q ss_pred ------------------------CCCC----------------------------CcHHHHHHHHHhcccCCCCCCCHH
Q 042314 316 ------------------------LSSL----------------------------YPEPIKALLRECWHKNPDRRPTFE 343 (370)
Q Consensus 316 ------------------------~~~~----------------------------~~~~l~~li~~~l~~~p~~Rp~~~ 343 (370)
.+.. .++.+.+||++||+.||++|||++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~ 368 (382)
T 2vx3_A 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY 368 (382)
T ss_dssp HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence 0000 013789999999999999999999
Q ss_pred HHHHH
Q 042314 344 EIIFR 348 (370)
Q Consensus 344 ~ll~~ 348 (370)
+++++
T Consensus 369 e~L~h 373 (382)
T 2vx3_A 369 YALQH 373 (382)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.79 Aligned_cols=240 Identities=22% Similarity=0.331 Sum_probs=181.6
Q ss_pred CCCCCCcccEEEE-EEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLV-KWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a-~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||+||.+ ...|+.+|+|.+... ....+.+|+.+++++ +||||+++++++...+..++||||++| +
T Consensus 22 ~LG~G~~g~V~~~~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~g-s 94 (434)
T 2rio_A 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNL-N 94 (434)
T ss_dssp EEEECSTTCEEEEEESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSE-E
T ss_pred eEeeCCCeEEEEEEEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCC-C
Confidence 3789999999754 556899999998653 234577899999876 899999999999999999999999965 9
Q ss_pred HHHHHHhCCCC-------ChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC-------------CcEEEec
Q 042314 176 LHDILKKKGKL-------DPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA-------------GHLKVTD 235 (370)
Q Consensus 176 L~~~l~~~~~~-------~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~-------------~~~kl~D 235 (370)
|.+++...... ++..++.++.|++.||.|||+++ |+||||||+||+++.. +.+||+|
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 99999876432 23356789999999999999998 9999999999999754 4799999
Q ss_pred cccceeccccCcc-ceeccCCCCCccccCcccccc-------cCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHH
Q 042314 236 FGLSKIAQEKDSY-SYKMTGGTGSYRYMAPEVYRR-------ESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADR 306 (370)
Q Consensus 236 fg~~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~ 306 (370)
||++......... ........||+.|+|||++.+ ..++.++|||||||++|||++ |..||...........
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~ 251 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHHH
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHHh
Confidence 9999877654321 112234468999999999976 568899999999999999999 8999976543332111
Q ss_pred hhccCCCCCC----CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 307 RAYEDSRPAL----SSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 307 ~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.. ....+.. ...+++.+.++|.+||+.||++|||+.+++++
T Consensus 252 ~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 252 RG-IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HT-CCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cC-CCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 11 1111111 12345789999999999999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=307.42 Aligned_cols=236 Identities=22% Similarity=0.337 Sum_probs=188.1
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-----------CCceeeeeeeEeeCC---
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-----------HPNIVQFLGVLKHSE--- 162 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-----------hp~Iv~~~~~~~~~~--- 162 (370)
+|.|+||.||++.. .+..+|+|++... ......+.+|+.++++++ ||||+++++++...+
T Consensus 27 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 102 (373)
T 1q8y_A 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 102 (373)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred eeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCC
Confidence 68899999999986 4788999998642 345667888999988876 789999999987654
Q ss_pred -ceEEEEeecCCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhc-CCCceeecCCCCCCeeeC------CCCcEE
Q 042314 163 -RLIFLTEYLRNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHH-RPHAIIHRDLTPSNVLQD------EAGHLK 232 (370)
Q Consensus 163 -~~~~v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~iiH~Dlk~~Nil~~------~~~~~k 232 (370)
..++|||++ +++|.+++... ..++...+..++.|++.||.|||++ + |+||||||+||+++ ..+.+|
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~k 178 (373)
T 1q8y_A 103 VHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIK 178 (373)
T ss_dssp EEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred ceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEE
Confidence 789999999 88999999864 4599999999999999999999998 8 99999999999995 344799
Q ss_pred EeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHH------HHHHH
Q 042314 233 VTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAV------QVADR 306 (370)
Q Consensus 233 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~~~ 306 (370)
|+|||++....... ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||...... .....
T Consensus 179 l~Dfg~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 252 (373)
T 1q8y_A 179 IADLGNACWYDEHY------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252 (373)
T ss_dssp ECCCTTCEETTBCC------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred EcccccccccCCCC------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence 99999998765432 2336899999999999999999999999999999999999999865421 11111
Q ss_pred hh-ccCC---------------------------------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 042314 307 RA-YEDS---------------------------------------RPALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346 (370)
Q Consensus 307 ~~-~~~~---------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll 346 (370)
.. ..+. ....+..+++.+.+||++||+.||++|||+++++
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 332 (373)
T 1q8y_A 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332 (373)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence 10 0000 0112233467899999999999999999999998
Q ss_pred HH
Q 042314 347 FR 348 (370)
Q Consensus 347 ~~ 348 (370)
++
T Consensus 333 ~h 334 (373)
T 1q8y_A 333 NH 334 (373)
T ss_dssp TC
T ss_pred hC
Confidence 75
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=290.74 Aligned_cols=223 Identities=11% Similarity=0.080 Sum_probs=186.0
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++.+. ++.+|+|++.............+.+|+..++.++||||+++++++...+..++||||++|++|
T Consensus 39 lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L 118 (286)
T 3uqc_A 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSL 118 (286)
T ss_dssp EEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEH
T ss_pred EcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCH
Confidence 688999999999886 789999999887666677788899999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.++++.. ....++..++.|++.||.|||++| |+||||||+||+++.+|.+||++++
T Consensus 119 ~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------------------- 174 (286)
T 3uqc_A 119 QEVADTS--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------------------- 174 (286)
T ss_dssp HHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------------------
T ss_pred HHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------------------
Confidence 9999653 466678999999999999999998 9999999999999999999998543
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHH---HhhccCCC--CCCCCCCcHHHHHHHHHh
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVAD---RRAYEDSR--PALSSLYPEPIKALLREC 331 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~---~~~~~~~~--~~~~~~~~~~l~~li~~~ 331 (370)
|++ .++.++||||||+++|+|++|+.||.......... ........ ......+|+.+.++|.+|
T Consensus 175 ----~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 243 (286)
T 3uqc_A 175 ----TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARS 243 (286)
T ss_dssp ----CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHH
T ss_pred ----ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHH
Confidence 222 26889999999999999999999998765432110 00000111 123456889999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 332 WHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
|+.||++| |+.++++.|+++...-.
T Consensus 244 l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 244 VQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred cccCCccC-CHHHHHHHHHHHhccCC
Confidence 99999999 99999999999865544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=318.54 Aligned_cols=241 Identities=25% Similarity=0.378 Sum_probs=195.0
Q ss_pred cCCCCCCcccEEEEEE--cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee------CCceEEEE
Q 042314 97 GGIDPGAYGEVYLVKW--RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH------SERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~------~~~~~~v~ 168 (370)
..+|.|+||.||++.. .|..+|+|.+... ........+.+|+.+++.++||||+++++++.. .+..++||
T Consensus 20 ~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVm 97 (676)
T 3qa8_A 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 97 (676)
T ss_dssp CCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEE
Confidence 4489999999999976 4788999998754 345667889999999999999999999998755 67789999
Q ss_pred eecCCCCHHHHHHhCC---CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCc---EEEeccccceec
Q 042314 169 EYLRNGSLHDILKKKG---KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGH---LKVTDFGLSKIA 242 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~---~kl~Dfg~~~~~ 242 (370)
||++|++|.+++.... .+++..++.++.|++.||.|||+.| |+||||||+||+++.++. +||+|||++...
T Consensus 98 Ey~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~ 174 (676)
T 3qa8_A 98 EYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL 174 (676)
T ss_dssp ECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred EeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence 9999999999998754 6899999999999999999999998 999999999999997765 899999999876
Q ss_pred cccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh----------cc--
Q 042314 243 QEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRA----------YE-- 310 (370)
Q Consensus 243 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~----------~~-- 310 (370)
..... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||............. ..
T Consensus 175 ~~~~~----~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 175 DQGEL----CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp TSCCC----CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred ccccc----cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence 54432 233468999999999999999999999999999999999999997654332211000 00
Q ss_pred ----------CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHH
Q 042314 311 ----------DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346 (370)
Q Consensus 311 ----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll 346 (370)
.........+|+.+.+++.+||..||++|||+.+++
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 000112233678899999999999999999998854
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=285.60 Aligned_cols=214 Identities=25% Similarity=0.415 Sum_probs=174.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHH-HhcCCCceeeeeeeEee----CCceEEEEeec
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLW-QKLRHPNIVQFLGVLKH----SERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l-~~l~hp~Iv~~~~~~~~----~~~~~~v~e~~ 171 (370)
+|.|+||.||++... +..+|+|.+... ..+.+|+.++ +..+||||+++++++.. ....++||||+
T Consensus 26 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 26 LGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred cccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 788999999999874 788999998642 3456788887 56689999999999876 67789999999
Q ss_pred CCCCHHHHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC---CCcEEEeccccceeccccC
Q 042314 172 RNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE---AGHLKVTDFGLSKIAQEKD 246 (370)
Q Consensus 172 ~g~~L~~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~~~~~ 246 (370)
+|++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||+++. ++.+||+|||++....
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 171 (299)
T 3m2w_A 98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--- 171 (299)
T ss_dssp CSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence 9999999998764 6999999999999999999999998 999999999999998 7889999999985432
Q ss_pred ccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc--CCCCCCC----CCC
Q 042314 247 SYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE--DSRPALS----SLY 320 (370)
Q Consensus 247 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~----~~~ 320 (370)
+..++.++||||||+++|+|++|+.||............... ......+ ..+
T Consensus 172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (299)
T 3m2w_A 172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229 (299)
T ss_dssp ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTS
T ss_pred ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccC
Confidence 234678999999999999999999999876554432221111 1111122 467
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 321 PEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 321 ~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
|+.+.+++.+||+.||++|||+.+++++
T Consensus 230 ~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 230 SEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 8999999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=305.71 Aligned_cols=236 Identities=15% Similarity=0.140 Sum_probs=180.4
Q ss_pred ccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCC-Cce---------eeee--------
Q 042314 96 RGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH-PNI---------VQFL-------- 155 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h-p~I---------v~~~-------- 155 (370)
...+|.|+||.||++.+. |..+|+|++...........+.+.+|+.+++.++| ++. +..+
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 345899999999999976 89999999885544444556778999999999976 211 1111
Q ss_pred ----eeEee-----CCceEEEEeecCCCCHHHHHHh-------CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCC
Q 042314 156 ----GVLKH-----SERLIFLTEYLRNGSLHDILKK-------KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219 (370)
Q Consensus 156 ----~~~~~-----~~~~~~v~e~~~g~~L~~~l~~-------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk 219 (370)
.++.. ....+++|+++ +++|.++++. ...+++..++.++.|++.||.|||+++ |+|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiK 238 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLR 238 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcc
Confidence 11111 12356777766 5699998852 234677788999999999999999998 9999999
Q ss_pred CCCeeeCCCCcEEEeccccceeccccCccceeccCCCCCccccCcccc----------cccCCCchhhHHHHHHHHHHHH
Q 042314 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVY----------RRESYGKSVDVFSFALIVHEMF 289 (370)
Q Consensus 220 ~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Di~slG~~l~el~ 289 (370)
|+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||+
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999998765543 233457 999999999 5556889999999999999999
Q ss_pred hCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 290 QGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 290 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+|+.||............. .....+|+.+.+||.+||+.||++||++.+++++
T Consensus 312 tg~~Pf~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HSSCCCCTTGGGSCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HCCCCCCCcchhhhHHHHH------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999998765433222221 1223578999999999999999999998887654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=318.40 Aligned_cols=234 Identities=24% Similarity=0.342 Sum_probs=189.4
Q ss_pred CCCCCCcccEEEEEEc---CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCc-----eEEEEe
Q 042314 98 GIDPGAYGEVYLVKWR---GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSER-----LIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~---g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~-----~~~v~e 169 (370)
.+|.|+||.||++.+. ++.+++|.+... ........+.+|+.++++++||||+++++++...+. .++|||
T Consensus 87 ~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E 164 (681)
T 2pzi_A 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164 (681)
T ss_dssp EEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEE
T ss_pred EEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEE
Confidence 3788999999999874 688999988653 345667788999999999999999999999987665 799999
Q ss_pred ecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 170 YLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
|++|++|.+++.. .+++..++.++.|++.||.|||++| |+||||||+|||++.+ .+||+|||+++.....
T Consensus 165 ~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~---- 234 (681)
T 2pzi_A 165 YVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF---- 234 (681)
T ss_dssp CCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC----
T ss_pred eCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC----
Confidence 9999999988765 7999999999999999999999998 9999999999999984 8999999999876543
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
....||+.|+|||++.+. ++.++||||||+++|+|++|.+||....... ..........++.+.++|.
T Consensus 235 ---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~ 302 (681)
T 2pzi_A 235 ---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------LPEDDPVLKTYDSYGRLLR 302 (681)
T ss_dssp ---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS--------CCTTCHHHHHCHHHHHHHH
T ss_pred ---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc--------ccccccccccCHHHHHHHh
Confidence 233689999999998765 4899999999999999999998876422100 0000001113578999999
Q ss_pred HhcccCCCCCCC-HHHHHHHHHHHHHH
Q 042314 330 ECWHKNPDRRPT-FEEIIFRLEAIQES 355 (370)
Q Consensus 330 ~~l~~~p~~Rp~-~~~ll~~l~~~~~~ 355 (370)
+||+.||++||+ ++++.+.|..+...
T Consensus 303 ~~l~~dP~~R~~~~~~l~~~l~~~~~~ 329 (681)
T 2pzi_A 303 RAIDPDPRQRFTTAEEMSAQLTGVLRE 329 (681)
T ss_dssp HHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred hhccCChhhCCCHHHHHHHHHHHHHHH
Confidence 999999999995 77777777766443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=297.97 Aligned_cols=233 Identities=14% Similarity=0.191 Sum_probs=179.6
Q ss_pred CCCCCCcccEEEEEEcCceeEEEEeccccCC-----ChHHHHHHHHHHHHHHhcC---------CCceeeeeee------
Q 042314 98 GIDPGAYGEVYLVKWRGTEIAAKTIRSSIAS-----NPRVRNSFMKELGLWQKLR---------HPNIVQFLGV------ 157 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~-----~~~~~~~~~~e~~~l~~l~---------hp~Iv~~~~~------ 157 (370)
.+|.|+||.||++.++|..+|+|++...... .....+.+.+|+.+++.++ ||||+++.+.
T Consensus 27 ~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~ 106 (336)
T 2vuw_A 27 KIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGS 106 (336)
T ss_dssp EEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESS
T ss_pred eecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCC
Confidence 3788999999999999999999999765321 2334577889999988886 6666555554
Q ss_pred -----------Eee-------------CCceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHh-hcCCCc
Q 042314 158 -----------LKH-------------SERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLH-HHRPHA 212 (370)
Q Consensus 158 -----------~~~-------------~~~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH-~~~~~~ 212 (370)
+.. .+.+++||||+++|++.+.+.+ +.+++..++.++.|++.||.||| +++
T Consensus 107 ~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~--- 182 (336)
T 2vuw_A 107 YPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLR--- 182 (336)
T ss_dssp CCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHC---
T ss_pred CcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCC---
Confidence 333 6789999999999976665544 57899999999999999999999 898
Q ss_pred eeecCCCCCCeeeCCCC--------------------cEEEeccccceeccccCccceeccCCCCCccccCcccccccCC
Q 042314 213 IIHRDLTPSNVLQDEAG--------------------HLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272 (370)
Q Consensus 213 iiH~Dlk~~Nil~~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 272 (370)
|+||||||+|||++.++ .+||+|||+++...... ..||+.|+|||++.+..
T Consensus 183 ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~--------~~gt~~y~aPE~~~g~~- 253 (336)
T 2vuw_A 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGI--------VVFCDVSMDEDLFTGDG- 253 (336)
T ss_dssp CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTE--------EECCCCTTCSGGGCCCS-
T ss_pred EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCc--------EEEeecccChhhhcCCC-
Confidence 99999999999999887 89999999998765431 25899999999998776
Q ss_pred CchhhHHHHHHH-HHHHHhCCCCCCCCcH-HHHHHHhh----ccC-CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHH
Q 042314 273 GKSVDVFSFALI-VHEMFQGGPSNRADTA-VQVADRRA----YED-SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345 (370)
Q Consensus 273 ~~~~Di~slG~~-l~el~~g~~p~~~~~~-~~~~~~~~----~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~l 345 (370)
+.++||||++++ .+++++|..||..... ........ ... .....+..+|+.+.+||++||+.| |++++
T Consensus 254 ~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~ 328 (336)
T 2vuw_A 254 DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDL 328 (336)
T ss_dssp SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHH
T ss_pred ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHH
Confidence 899999998777 7788999999854321 11111111 111 111122346788999999999976 89998
Q ss_pred H-HH
Q 042314 346 I-FR 348 (370)
Q Consensus 346 l-~~ 348 (370)
+ ++
T Consensus 329 l~~H 332 (336)
T 2vuw_A 329 LCQH 332 (336)
T ss_dssp HHHC
T ss_pred HhcC
Confidence 8 53
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=273.15 Aligned_cols=183 Identities=17% Similarity=0.124 Sum_probs=130.3
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCC-------ChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEE
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIAS-------NPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLT 168 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~-------~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~ 168 (370)
.+.|+.+.+..++. .|..+++|.+...... .+...+++.+|+++|+++ .|+||++++++++++..+||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 34555555554433 4889999998764321 133456799999999999 6999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
||++|++|.+++.+.++++.. +|+.||+.||.|+|++| ||||||||+|||++.+|.+||+|||+++.......
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~- 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS- 394 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C-
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-
Confidence 999999999999998888764 58899999999999999 99999999999999999999999999987654332
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhC
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG 291 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g 291 (370)
.....+||+.|+|||++.+. +..++|+||+|++++++.++
T Consensus 395 --~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 395 --WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp --CSHHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred --cccCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence 12234689999999999764 56789999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=235.69 Aligned_cols=186 Identities=18% Similarity=0.211 Sum_probs=148.1
Q ss_pred cCCCCCCcccEEEEEEcCceeEEEEeccccCCChH-----HHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 97 GGIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPR-----VRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~-----~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
..+|+|+||.||++...+..+++|........... ..+++.+|+.++++++||||+++..++...+..++||||+
T Consensus 342 ~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~ 421 (540)
T 3en9_A 342 HLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYI 421 (540)
T ss_dssp ------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECC
T ss_pred CEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECC
Confidence 45899999999999888999999987554333222 2456899999999999999996655555777789999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce-
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY- 250 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~- 250 (370)
+|++|.+++.+ +..++.|++++|.|||+++ |+||||||+|||++. .+||+|||+++..........
T Consensus 422 ~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~ 488 (540)
T 3en9_A 422 NGKLAKDVIED--------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD 488 (540)
T ss_dssp CSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred CCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence 99999999876 5689999999999999998 999999999999999 999999999988765322110
Q ss_pred ---eccCCCCCccccCcccccc--cCCCchhhHHHHHHHHHHHHhCCCCC
Q 042314 251 ---KMTGGTGSYRYMAPEVYRR--ESYGKSVDVFSFALIVHEMFQGGPSN 295 (370)
Q Consensus 251 ---~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~ 295 (370)
......||+.|+|||++.. ..|+..+|+||..+-..+...++.+|
T Consensus 489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1123358999999999987 56788899999999888887776665
|
| >4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-24 Score=175.01 Aligned_cols=93 Identities=41% Similarity=0.554 Sum_probs=46.4
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARS 83 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~ 83 (370)
+|.+|+||||+|+..|+.++++.|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|+|+|.+|..|+||||.|+.
T Consensus 33 ~d~~g~t~l~~a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G~TpLh~A~~ 112 (169)
T 4gpm_A 33 SDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAE 112 (169)
T ss_dssp CCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHH
T ss_pred cCCCCCCHHHHHHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHH
Confidence 34445555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred cCceeeEEeeecc
Q 042314 84 FGHVVICKILEDR 96 (370)
Q Consensus 84 ~g~~~~~~~L~~~ 96 (370)
.|+.++++.|.+.
T Consensus 113 ~g~~~~v~~Ll~~ 125 (169)
T 4gpm_A 113 NGHKEVVKLLISK 125 (169)
T ss_dssp TTCHHHHHHHHHT
T ss_pred cCCHHHHHHHHHc
Confidence 5555444444443
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-24 Score=157.00 Aligned_cols=91 Identities=43% Similarity=0.576 Sum_probs=86.3
Q ss_pred CCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccCc
Q 042314 7 EGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86 (370)
Q Consensus 7 ~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~ 86 (370)
+|+||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|+||+|.|+..|+
T Consensus 1 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~ 80 (93)
T 1n0q_A 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH 80 (93)
T ss_dssp --CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred CCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC
Confidence 58999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeEEeeeccc
Q 042314 87 VVICKILEDRG 97 (370)
Q Consensus 87 ~~~~~~L~~~~ 97 (370)
.++++.|.+.+
T Consensus 81 ~~~~~~Ll~~g 91 (93)
T 1n0q_A 81 LEVVKLLLEAG 91 (93)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHcC
Confidence 99999887654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=183.65 Aligned_cols=140 Identities=20% Similarity=0.099 Sum_probs=111.2
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCCh---------------HHHHHHHHHHHHHHhcCCCceeeeeeeEeeC
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNP---------------RVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~---------------~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~ 161 (370)
.+|.|++|.||++.+. |..+|+|.++....... .....+.+|+.+++.++ | +++.+++..
T Consensus 97 ~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~- 172 (282)
T 1zar_A 97 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW- 172 (282)
T ss_dssp EEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-
T ss_pred EeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-
Confidence 3789999999999884 78899999865321111 24567899999999998 4 566665443
Q ss_pred CceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecccccee
Q 042314 162 ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI 241 (370)
Q Consensus 162 ~~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~ 241 (370)
+..++||||++|++|.+ +. ......++.|++.||.|||++| |+||||||+|||++ ++.+||+|||+++.
T Consensus 173 ~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 173 EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVE 241 (282)
T ss_dssp ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence 56799999999999988 42 2345689999999999999998 99999999999999 99999999999852
Q ss_pred ccccCccceeccCCCCCccccCccccc
Q 042314 242 AQEKDSYSYKMTGGTGSYRYMAPEVYR 268 (370)
Q Consensus 242 ~~~~~~~~~~~~~~~g~~~y~aPE~~~ 268 (370)
+..+.|||.+.
T Consensus 242 ----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 242 ----------------VGEEGWREILE 252 (282)
T ss_dssp ----------------TTSTTHHHHHH
T ss_pred ----------------CCCCCHHHHHH
Confidence 33467888874
|
| >4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A | Back alignment and structure |
|---|
Probab=99.87 E-value=4.2e-24 Score=173.20 Aligned_cols=96 Identities=43% Similarity=0.596 Sum_probs=88.7
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|.+|+||||+||..|+.++|++|+++|||||.+|.+|+||||+|+..|+.+++++|+++|+|++.+|..|+|||+.|+
T Consensus 65 ~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~ 144 (169)
T 4gpm_A 65 AKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNTSDSDGRTPLDLAR 144 (169)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred hhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHH
Confidence 46788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecccC
Q 042314 83 SFGHVVICKILEDRGG 98 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~ 98 (370)
..|+.+++++|.+.|+
T Consensus 145 ~~g~~~iv~~Ll~~GA 160 (169)
T 4gpm_A 145 EHGNEEVVKLLEKQGG 160 (169)
T ss_dssp HTTCHHHHHHHHTC--
T ss_pred HcCCHHHHHHHHHCCC
Confidence 9999999998877653
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-22 Score=158.91 Aligned_cols=96 Identities=36% Similarity=0.449 Sum_probs=91.4
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++..|..|.||||.|+
T Consensus 5 ~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~ 84 (137)
T 3c5r_A 5 FTNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAA 84 (137)
T ss_dssp CCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHHHH
T ss_pred CcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHHHH
Confidence 46889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecccC
Q 042314 83 SFGHVVICKILEDRGG 98 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~ 98 (370)
..|+.++++.|.+.+.
T Consensus 85 ~~~~~~~v~~Ll~~ga 100 (137)
T 3c5r_A 85 KNGHVDIVKLLLSYGA 100 (137)
T ss_dssp HTTCHHHHHHHHHTTC
T ss_pred HcCCHHHHHHHHHcCC
Confidence 9999999999887643
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C | Back alignment and structure |
|---|
Probab=99.84 E-value=6.7e-22 Score=154.58 Aligned_cols=90 Identities=33% Similarity=0.414 Sum_probs=48.8
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccccc
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSF 84 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~ 84 (370)
|..|+||||+||..|+.+++++|+++|+++|..|.+|.||||+|+..|+.+++++|+++|++++..|..|+||++.|+..
T Consensus 44 ~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A~~~ 123 (136)
T 2jab_A 44 DEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGKTAFDISIGN 123 (136)
T ss_dssp CTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcCcCCCCCCHHHHHHHC
Confidence 44455555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred CceeeEEeee
Q 042314 85 GHVVICKILE 94 (370)
Q Consensus 85 g~~~~~~~L~ 94 (370)
|+.++++.|.
T Consensus 124 ~~~~~~~~Ll 133 (136)
T 2jab_A 124 GNEDLAEILQ 133 (136)
T ss_dssp TCHHHHHHHH
T ss_pred CCHHHHHHHH
Confidence 5555544443
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A | Back alignment and structure |
|---|
Probab=99.84 E-value=5e-22 Score=149.27 Aligned_cols=91 Identities=32% Similarity=0.446 Sum_probs=84.9
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
-.|.+|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++..|..|+||++.|+
T Consensus 19 ~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~ 98 (110)
T 2zgd_A 19 HMGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDISI 98 (110)
T ss_dssp ---CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred ccCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcHHHHHH
Confidence 35788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEee
Q 042314 83 SFGHVVICKIL 93 (370)
Q Consensus 83 ~~g~~~~~~~L 93 (370)
..|+.+++++|
T Consensus 99 ~~~~~~~~~~L 109 (110)
T 2zgd_A 99 DNGNEDLAEIL 109 (110)
T ss_dssp HHTCHHHHHHH
T ss_pred HcCCHHHHHHh
Confidence 99998877654
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.84 E-value=5.6e-22 Score=150.22 Aligned_cols=96 Identities=40% Similarity=0.514 Sum_probs=92.2
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|.+|+||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++..|..|+||++.|+
T Consensus 4 ~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~ 83 (115)
T 2l6b_A 4 WGSKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAK 83 (115)
T ss_dssp CCSCSSCCHHHHHHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHH
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHH
Confidence 47899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecccC
Q 042314 83 SFGHVVICKILEDRGG 98 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~ 98 (370)
..|+.++++.|.+.++
T Consensus 84 ~~~~~~~~~~Ll~~ga 99 (115)
T 2l6b_A 84 KNGHHEIVKLLDAKGA 99 (115)
T ss_dssp TTTCHHHHHHHHTTSS
T ss_pred HCCCHHHHHHHHHcCC
Confidence 9999999999887654
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=5.9e-22 Score=154.87 Aligned_cols=96 Identities=26% Similarity=0.344 Sum_probs=80.3
Q ss_pred ccCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCcccc-CCCcccc
Q 042314 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRW-GRTPLSD 80 (370)
Q Consensus 2 ~~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~-g~tpl~~ 80 (370)
+..|..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+. |+.+++++|+++|++++..|.. |+||||.
T Consensus 6 ~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~ 84 (136)
T 1d9s_A 6 HMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTRPVHD 84 (136)
T ss_dssp SCCCCCCSCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBCHHHH
T ss_pred cCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCCHHHH
Confidence 3567788888888888888888888888888888888888888888888 8888888888888888888888 8888888
Q ss_pred ccccCceeeEEeeecccC
Q 042314 81 ARSFGHVVICKILEDRGG 98 (370)
Q Consensus 81 A~~~g~~~~~~~L~~~~~ 98 (370)
|+..|+.++++.|.+.+.
T Consensus 85 A~~~~~~~~v~~Ll~~ga 102 (136)
T 1d9s_A 85 AAREGFLDTLVVLHRAGA 102 (136)
T ss_dssp HHHHTCHHHHHHHHHTCC
T ss_pred HHHcCCHHHHHHHHHcCC
Confidence 888888888888776653
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A | Back alignment and structure |
|---|
Probab=99.83 E-value=2.9e-21 Score=148.11 Aligned_cols=94 Identities=34% Similarity=0.417 Sum_probs=80.2
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccccc
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSF 84 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~ 84 (370)
+..|.||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++..|..|+||||.|+..
T Consensus 4 ~~~~~~~l~~A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~ 83 (123)
T 3aaa_C 4 GSMCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYE 83 (123)
T ss_dssp ---CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHH
T ss_pred ccccchHHHHHHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHc
Confidence 45688899999999999999999999999988888899999999999999999999988999988888899999999988
Q ss_pred CceeeEEeeecccC
Q 042314 85 GHVVICKILEDRGG 98 (370)
Q Consensus 85 g~~~~~~~L~~~~~ 98 (370)
|+.++++.|.+.+.
T Consensus 84 ~~~~~v~~Ll~~ga 97 (123)
T 3aaa_C 84 GHVSCVKLLLSKGA 97 (123)
T ss_dssp TCHHHHHHHHHTTC
T ss_pred CCHHHHHHHHHcCC
Confidence 88888888877653
|
| >4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.2e-21 Score=167.20 Aligned_cols=84 Identities=32% Similarity=0.337 Sum_probs=65.4
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|..|+||||+||..|+.++|++||++|+|||.+|..|+||||+|+..|+.++|++|+++|||+|.+|..|+|||+.|+
T Consensus 147 ~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gadvn~~~~~g~t~Lh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL~~A~ 226 (269)
T 4b93_B 147 KKDLSGNTPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEAVIEKHVFVVELLLLHGASVQVLNKRQRTAVDCAE 226 (269)
T ss_dssp CCCTTCCCHHHHHHHTTCGGGHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCSGGGSC
T ss_pred CCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCccccCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHH
Confidence 45677778888888777878888888778888777777788888888778888888887778887777777788887777
Q ss_pred ccCc
Q 042314 83 SFGH 86 (370)
Q Consensus 83 ~~g~ 86 (370)
..++
T Consensus 227 ~~~~ 230 (269)
T 4b93_B 227 QNSK 230 (269)
T ss_dssp TTCH
T ss_pred hCCc
Confidence 6664
|
| >3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.82 E-value=6.7e-21 Score=148.99 Aligned_cols=94 Identities=24% Similarity=0.286 Sum_probs=87.6
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|..|+||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||++.|.
T Consensus 38 ~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~ 117 (137)
T 3c5r_A 38 VKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTD 117 (137)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCGGGGCC
T ss_pred cCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHh
Confidence 46788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecc
Q 042314 83 SFGHVVICKILEDR 96 (370)
Q Consensus 83 ~~g~~~~~~~L~~~ 96 (370)
..+..+++.++.+.
T Consensus 118 ~~~~~~~l~~l~~~ 131 (137)
T 3c5r_A 118 DESMKSLLLLPEKN 131 (137)
T ss_dssp CHHHHHHHSCC---
T ss_pred hccHHHHHhhcccc
Confidence 99988888777653
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 | Back alignment and structure |
|---|
Probab=99.82 E-value=3.6e-21 Score=168.98 Aligned_cols=95 Identities=20% Similarity=0.117 Sum_probs=91.0
Q ss_pred CCCCCChhhhHHhhc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccc
Q 042314 4 IDSEGPYRLLYCSSK---GDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSD 80 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~---g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~ 80 (370)
.|..|+||||+||.. |+.+++++|+++||++|.+|.+|+||||+|+..|+.+++++|+++|||++.+|..|.||||.
T Consensus 165 ~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tpL~~ 244 (278)
T 1dcq_A 165 GHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDI 244 (278)
T ss_dssp CSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred cccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCccCCCCCHHHH
Confidence 367899999999999 89999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCceeeEEeeecccC
Q 042314 81 ARSFGHVVICKILEDRGG 98 (370)
Q Consensus 81 A~~~g~~~~~~~L~~~~~ 98 (370)
|+..|+.+++++|.+.+.
T Consensus 245 A~~~~~~~~v~~Ll~~ga 262 (278)
T 1dcq_A 245 AKRLKHEHCEELLTQALS 262 (278)
T ss_dssp HHHTTCHHHHHHHHHHHT
T ss_pred HHHcCCHHHHHHHHHcCC
Confidence 999999999999987654
|
| >3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.6e-21 Score=147.59 Aligned_cols=85 Identities=28% Similarity=0.201 Sum_probs=80.2
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|..|+||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++..|..|+||++.|.
T Consensus 35 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~ 114 (123)
T 3aaa_C 35 RTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLTAFEATD 114 (123)
T ss_dssp SCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHCC
T ss_pred ccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHhC
Confidence 46788999999999999999999999999999999999999999999999999999999999999999999999999996
Q ss_pred ccCce
Q 042314 83 SFGHV 87 (370)
Q Consensus 83 ~~g~~ 87 (370)
..+..
T Consensus 115 ~~~~~ 119 (123)
T 3aaa_C 115 NQAIK 119 (123)
T ss_dssp CHHHH
T ss_pred CHHHH
Confidence 65443
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-20 Score=152.20 Aligned_cols=96 Identities=31% Similarity=0.409 Sum_probs=86.4
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++..|..|+||+|.|+
T Consensus 37 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~ 116 (165)
T 3twr_A 37 DIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAA 116 (165)
T ss_dssp CTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHH
T ss_pred ccccCCCCHHHHHHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCCCHHHHHH
Confidence 45677889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecccC
Q 042314 83 SFGHVVICKILEDRGG 98 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~ 98 (370)
..|+.++++.|.+.+.
T Consensus 117 ~~~~~~~v~~Ll~~ga 132 (165)
T 3twr_A 117 AKGKYEICKLLLQHGA 132 (165)
T ss_dssp HTTCHHHHHHHHHTTC
T ss_pred HcCCHHHHHHHHHcCC
Confidence 9999999988887654
|
| >1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 | Back alignment and structure |
|---|
Probab=99.82 E-value=1.8e-21 Score=152.12 Aligned_cols=94 Identities=28% Similarity=0.366 Sum_probs=89.6
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCC-CCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYD-KRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~-g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
.+|..|+||||+||. |+.+++++|+++|+++|.+|.. |+||||+|+..|+.+++++|+++|++++..|..|+||++.|
T Consensus 40 ~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A 118 (136)
T 1d9s_A 40 ALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLA 118 (136)
T ss_dssp CCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBCHHHHHHHHTCHHHHHHHHHTCCCCCCCSSSSSCHHHHH
T ss_pred CcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHH
Confidence 467899999999999 9999999999999999999999 99999999999999999999999999999999999999999
Q ss_pred cccCceeeEEeeeccc
Q 042314 82 RSFGHVVICKILEDRG 97 (370)
Q Consensus 82 ~~~g~~~~~~~L~~~~ 97 (370)
+..|+.+++++|.+.+
T Consensus 119 ~~~~~~~~~~~Ll~~G 134 (136)
T 1d9s_A 119 EEQGHRDIARYLHAAT 134 (136)
T ss_dssp HHHTCHHHHHHHHHHH
T ss_pred HHcCCHHHHHHHHHcC
Confidence 9999999998887654
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.82 E-value=5e-22 Score=158.57 Aligned_cols=94 Identities=34% Similarity=0.376 Sum_probs=89.1
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARS 83 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~ 83 (370)
.|..|+||||+||..|+.+++++|+++|+++|..|..|.||||+|+..|+.+++++|+++|++++..|..|+||+|.|+.
T Consensus 30 ~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~ 109 (153)
T 1awc_B 30 TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATE 109 (153)
T ss_dssp CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHH
T ss_pred cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHH
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCceeeEEeeeccc
Q 042314 84 FGHVVICKILEDRG 97 (370)
Q Consensus 84 ~g~~~~~~~L~~~~ 97 (370)
.|+.++++.|.+.+
T Consensus 110 ~~~~~~v~~Ll~~g 123 (153)
T 1awc_B 110 HNHQEVVELLIKYG 123 (153)
T ss_dssp TTCHHHHHHHHHTT
T ss_pred cCCHHHHHHHHHcC
Confidence 99999999988764
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.5e-20 Score=158.93 Aligned_cols=95 Identities=22% Similarity=0.162 Sum_probs=88.5
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCcc-ccCCCccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD-RWGRTPLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~-~~g~tpl~~A 81 (370)
..|..|+||||+||..|+.++|++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++..+ ..|+||++.|
T Consensus 49 ~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A 128 (229)
T 2vge_A 49 QPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGATAFEKC 128 (229)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCSSTTCCTGGGC
T ss_pred CCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCCCCCCHHHHH
Confidence 467899999999999999999999999999999999999999999999999999999999999999987 6999999999
Q ss_pred --cccCceeeEEeeeccc
Q 042314 82 --RSFGHVVICKILEDRG 97 (370)
Q Consensus 82 --~~~g~~~~~~~L~~~~ 97 (370)
+..|+.+++++|.+.+
T Consensus 129 ~a~~~~~~~~v~~Ll~~g 146 (229)
T 2vge_A 129 DPYREGYADCATYLADVE 146 (229)
T ss_dssp CTTSTTHHHHHHHHHHHH
T ss_pred HHHhcChHHHHHHHHHcC
Confidence 8889888888776653
|
| >1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.81 E-value=9.6e-21 Score=151.06 Aligned_cols=91 Identities=29% Similarity=0.329 Sum_probs=87.0
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+||..|+.+++++|+++|+++|.+|.+|.||||+|+..|+.+++++|+++|++++..|..|.||++.|+
T Consensus 62 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~ 141 (153)
T 1awc_B 62 ARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISI 141 (153)
T ss_dssp CCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHH
Confidence 46788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEee
Q 042314 83 SFGHVVICKIL 93 (370)
Q Consensus 83 ~~g~~~~~~~L 93 (370)
..|+.+++++|
T Consensus 142 ~~~~~~i~~~L 152 (153)
T 1awc_B 142 DNGNEDLAEIL 152 (153)
T ss_dssp HTTCHHHHHHH
T ss_pred HcCCHHHHHHh
Confidence 99998887654
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A | Back alignment and structure |
|---|
Probab=99.81 E-value=4.8e-21 Score=153.39 Aligned_cols=92 Identities=29% Similarity=0.394 Sum_probs=57.1
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCc-HHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRT-ALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t-~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.|..|+||||+|+ .|+.+++++|+++|+++|.+|..|+| |||+|+..|+.+++++|+++|++++..|..|+||+|.|+
T Consensus 41 ~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~ 119 (156)
T 1bi7_B 41 PNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAE 119 (156)
T ss_dssp CCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTCCCHHHHHH
T ss_pred CCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHHCCCHHHHHHHHHcCCCCcccCCCCCCHHHHHH
Confidence 3455666666654 56666666666666666666666666 666666666666666666666666666666666666666
Q ss_pred ccCceeeEEeeecc
Q 042314 83 SFGHVVICKILEDR 96 (370)
Q Consensus 83 ~~g~~~~~~~L~~~ 96 (370)
..|+.+++++|.+.
T Consensus 120 ~~~~~~~v~~Ll~~ 133 (156)
T 1bi7_B 120 ELGHRDVARYLRAA 133 (156)
T ss_dssp HHTCHHHHHHHSSC
T ss_pred HhCHHHHHHHHHHc
Confidence 66666666655543
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=99.81 E-value=5e-22 Score=163.67 Aligned_cols=90 Identities=16% Similarity=0.154 Sum_probs=81.2
Q ss_pred CCCChhhhHHhhcCCH----HHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCC------HHHHHHHHHcCCCccCccccCC
Q 042314 6 SEGPYRLLYCSSKGDR----AGVLQELEKGVEPNLADYDKRTALHLASSEGR------AEIVLLLLEKGADVNSLDRWGR 75 (370)
Q Consensus 6 ~~g~t~l~~a~~~g~~----~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~------~~~~~~Ll~~gad~~~~~~~g~ 75 (370)
..|+||||+|+.+|+. +++++||++|||||.+|.+|+||||+|+..|+ .+++++|+++|||+|.+|..|+
T Consensus 36 ~~g~T~Lh~A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~ 115 (186)
T 3t8k_A 36 VLKSNILYDVLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYK 115 (186)
T ss_dssp HHTTTHHHHHTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSSCBGGGT
T ss_pred cCCCCHHHHHHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCccCCCcC
Confidence 5699999999999985 59999999999999999999999999999997 5789999999999999999999
Q ss_pred -CccccccccCc-----eeeEEeeec
Q 042314 76 -TPLSDARSFGH-----VVICKILED 95 (370)
Q Consensus 76 -tpl~~A~~~g~-----~~~~~~L~~ 95 (370)
||+|.|+..+. .+++++|..
T Consensus 116 ttpLh~A~~~~~~~~~~~~iv~~Ll~ 141 (186)
T 3t8k_A 116 IVVFKNIFNYFVDENEMIPLYKLIFS 141 (186)
T ss_dssp BCTTGGGGGCCSCHHHHHHHHHHHHT
T ss_pred chHHHHHHHcCCChhhHHHHHHHHHH
Confidence 99999998554 346677765
|
| >3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.4e-20 Score=152.09 Aligned_cols=94 Identities=33% Similarity=0.367 Sum_probs=77.7
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|.||++.|.
T Consensus 70 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~a~ 149 (165)
T 3twr_A 70 AKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLVK 149 (165)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTGGGSC
T ss_pred ccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCChhHhHh
Confidence 45677888888888888888888888888888888888888888888888888888888888888888888888888877
Q ss_pred ccCceeeEEeeeccc
Q 042314 83 SFGHVVICKILEDRG 97 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~ 97 (370)
. |+.+++++|...+
T Consensus 150 ~-~~~~i~~~L~~~g 163 (165)
T 3twr_A 150 D-GDTDIQDLLRGDA 163 (165)
T ss_dssp T-TCHHHHHHHHTC-
T ss_pred c-CChHHHHHHhhcc
Confidence 6 7777777776543
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-20 Score=154.12 Aligned_cols=95 Identities=31% Similarity=0.399 Sum_probs=91.1
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+||..|+.+++++|+++|+++|.+|.+|.||||+|+..|+.+++++|+++|++++..|..|.||+|.|+
T Consensus 34 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~ 113 (179)
T 3f6q_A 34 QGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYAC 113 (179)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred ccCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHH
Confidence 46788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeeccc
Q 042314 83 SFGHVVICKILEDRG 97 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~ 97 (370)
..|+.++++.|.+.+
T Consensus 114 ~~~~~~~v~~Ll~~g 128 (179)
T 3f6q_A 114 FWGQDQVAEDLVANG 128 (179)
T ss_dssp HTTCHHHHHHHHHTT
T ss_pred HcCCHHHHHHHHHCC
Confidence 999999999998765
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.7e-20 Score=151.05 Aligned_cols=95 Identities=27% Similarity=0.290 Sum_probs=74.9
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+|+. |+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++..|..|+||+|.|+
T Consensus 33 ~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~ 111 (162)
T 1ihb_A 33 AQNGFGRTALQVMKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAA 111 (162)
T ss_dssp CCCTTSCCHHHHCCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred ccCccCccHHHHHHc-CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHH
Confidence 356678888888877 8888888888888888888888888888888888888888888888888888888888888888
Q ss_pred ccCceeeEEeeecccC
Q 042314 83 SFGHVVICKILEDRGG 98 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~ 98 (370)
..|+.++++.|.+.+.
T Consensus 112 ~~~~~~~v~~Ll~~g~ 127 (162)
T 1ihb_A 112 KEGHLRVVEFLVKHTA 127 (162)
T ss_dssp HTTCHHHHHHHHHHSC
T ss_pred HcCCHHHHHHHHHccC
Confidence 8888887777776554
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-20 Score=152.04 Aligned_cols=95 Identities=37% Similarity=0.444 Sum_probs=90.6
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+||..|+.++|++|+++|+++|..|..|.||||+|+..|+.+++++|+++|++++..|..|+||+|.|+
T Consensus 31 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~ 110 (172)
T 3v30_A 31 KPDERGFTPLIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAV 110 (172)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeeccc
Q 042314 83 SFGHVVICKILEDRG 97 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~ 97 (370)
..|+.++++.|.+.+
T Consensus 111 ~~~~~~~v~~Ll~~g 125 (172)
T 3v30_A 111 RGNHVKCVEALLARG 125 (172)
T ss_dssp HTTCHHHHHHHHHTT
T ss_pred HcCCHHHHHHHHHcC
Confidence 999999999988754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.6e-19 Score=156.79 Aligned_cols=133 Identities=17% Similarity=0.241 Sum_probs=103.2
Q ss_pred CCCCCCcccEEEEEE--cCce--eEEEEeccccCC---------------------ChHHHHHHHHHHHHHHhcCCCce-
Q 042314 98 GIDPGAYGEVYLVKW--RGTE--IAAKTIRSSIAS---------------------NPRVRNSFMKELGLWQKLRHPNI- 151 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~--~g~~--vavK~l~~~~~~---------------------~~~~~~~~~~e~~~l~~l~hp~I- 151 (370)
.+|.|+||.||++.. .|.. +|+|+++..... .......+.+|+.+++.+.|+++
T Consensus 54 ~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 133 (258)
T 1zth_A 54 VISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVS 133 (258)
T ss_dssp EEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 478999999999987 6888 999987543211 01223468899999999987753
Q ss_pred -eeeeeeEeeCCceEEEEeecCC-C----CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHh-hcCCCceeecCCCCCCee
Q 042314 152 -VQFLGVLKHSERLIFLTEYLRN-G----SLHDILKKKGKLDPPTAVAYALDIARGMNYLH-HHRPHAIIHRDLTPSNVL 224 (370)
Q Consensus 152 -v~~~~~~~~~~~~~~v~e~~~g-~----~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH-~~~~~~iiH~Dlk~~Nil 224 (370)
+.+++. +..++||||+.+ | +|.++... .++..+..++.|++.+|.||| +.| |+||||||+|||
T Consensus 134 ~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NIL 203 (258)
T 1zth_A 134 VPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIM 203 (258)
T ss_dssp CCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEE
T ss_pred CCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEE
Confidence 444442 356899999942 3 77776433 235678899999999999999 888 999999999999
Q ss_pred eCCCCcEEEeccccceec
Q 042314 225 QDEAGHLKVTDFGLSKIA 242 (370)
Q Consensus 225 ~~~~~~~kl~Dfg~~~~~ 242 (370)
++. .++|+|||+|...
T Consensus 204 l~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 204 YID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ESS--SEEECCCTTCEET
T ss_pred EcC--cEEEEECcccccC
Confidence 998 8999999998754
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.9e-20 Score=150.91 Aligned_cols=96 Identities=38% Similarity=0.426 Sum_probs=89.3
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|..|+||||+||..|+.+++++|+++|+++|..|..|.||||+|+..|+.+++++|+++|++++..|..|.||+|.|+
T Consensus 42 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~ 121 (169)
T 2y1l_E 42 AEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAA 121 (169)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH
Confidence 46788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecccC
Q 042314 83 SFGHVVICKILEDRGG 98 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~ 98 (370)
..|+.++++.|.+.+.
T Consensus 122 ~~~~~~~v~~Ll~~g~ 137 (169)
T 2y1l_E 122 MFGHLEIVEVLLKNGA 137 (169)
T ss_dssp HTTCHHHHHHHHHTTC
T ss_pred HcCCHHHHHHHHHcCC
Confidence 9999999998887654
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.80 E-value=2.9e-20 Score=142.83 Aligned_cols=91 Identities=43% Similarity=0.571 Sum_probs=49.8
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccccc
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSF 84 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~ 84 (370)
|..|+||||+|+..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++..|..|.||++.|...
T Consensus 32 ~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~ 111 (126)
T 1n0r_A 32 DKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 111 (126)
T ss_dssp CTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred CCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCcccCCCCCCHHHHHHHc
Confidence 44455555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred CceeeEEeeec
Q 042314 85 GHVVICKILED 95 (370)
Q Consensus 85 g~~~~~~~L~~ 95 (370)
|+.++++.|.+
T Consensus 112 ~~~~~~~~Ll~ 122 (126)
T 1n0r_A 112 GHLEVVKLLLE 122 (126)
T ss_dssp TCHHHHHHHHH
T ss_pred CcHHHHHHHHH
Confidence 55555554443
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B | Back alignment and structure |
|---|
Probab=99.80 E-value=2.2e-20 Score=149.38 Aligned_cols=93 Identities=29% Similarity=0.382 Sum_probs=85.1
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+ |..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++..|..|+||+|.|+
T Consensus 31 ~~~~~g~t~L~~-~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~ 109 (156)
T 1bd8_A 31 ALNRFGKTALQV-MMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAV 109 (156)
T ss_dssp CCCTTSCCHHHH-SCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHH
T ss_pred ccCCCCCcHHHH-HHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHH
Confidence 467889999999 8899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecc
Q 042314 83 SFGHVVICKILEDR 96 (370)
Q Consensus 83 ~~g~~~~~~~L~~~ 96 (370)
..|+.++++.|.+.
T Consensus 110 ~~~~~~~v~~Ll~~ 123 (156)
T 1bd8_A 110 QEGHTAVVSFLAAE 123 (156)
T ss_dssp HHTCHHHHHHHHTT
T ss_pred HhChHHHHHHHHhc
Confidence 99999998888765
|
| >2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.7e-20 Score=150.21 Aligned_cols=120 Identities=33% Similarity=0.388 Sum_probs=97.7
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccccc
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSF 84 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~ 84 (370)
...+.|+||+||..|+.++|++|+++|+++|.+|.+|.||||+|+..|+.+++++|+++|++++..|..|.||||.|+..
T Consensus 11 ~~~~~~~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~ 90 (169)
T 2y1l_E 11 GSDLGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALF 90 (169)
T ss_dssp --CHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred CCcccchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHc
Confidence 34578899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CceeeEEeeecccC----CCCCCcccEEEEEEcCceeEEEEecc
Q 042314 85 GHVVICKILEDRGG----IDPGAYGEVYLVKWRGTEIAAKTIRS 124 (370)
Q Consensus 85 g~~~~~~~L~~~~~----l~~g~~~~v~~a~~~g~~vavK~l~~ 124 (370)
|+.++++.|.+.+. .+..+...++.+...+...+++.+..
T Consensus 91 ~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~ 134 (169)
T 2y1l_E 91 GHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLK 134 (169)
T ss_dssp TCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHH
Confidence 99999998877654 23334445555555566666666543
|
| >3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A | Back alignment and structure |
|---|
Probab=99.80 E-value=3.9e-20 Score=151.54 Aligned_cols=96 Identities=21% Similarity=0.267 Sum_probs=91.6
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|..|+||||+||..|+.+++++|+++|+++|.+|.+|.||||+|+..|+.+++++|+++|++++..|..|.||++.|.
T Consensus 67 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~ 146 (179)
T 3f6q_A 67 VMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAK 146 (179)
T ss_dssp CCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSSBCCTTSCCGGGGSC
T ss_pred CcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcchhccCCCCcHHHHH
Confidence 46788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecccC
Q 042314 83 SFGHVVICKILEDRGG 98 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~ 98 (370)
..++.++++.|.+.+.
T Consensus 147 ~~~~~~~~~~L~~~g~ 162 (179)
T 3f6q_A 147 APLRELLRERAEKMGQ 162 (179)
T ss_dssp HHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhhc
Confidence 9999999998877654
|
| >2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C | Back alignment and structure |
|---|
Probab=99.79 E-value=1.6e-20 Score=146.71 Aligned_cols=93 Identities=37% Similarity=0.458 Sum_probs=88.5
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccccc
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSF 84 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~ 84 (370)
...|.||||+||..|+.+++++|+++|+++|..|..|+||||+|+..|+.+++++|+++|++++..|..|.||||.|+..
T Consensus 11 ~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~ 90 (136)
T 2jab_A 11 GSDLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFI 90 (136)
T ss_dssp -CHHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHH
T ss_pred cccccHHHHHHHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHc
Confidence 34689999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CceeeEEeeeccc
Q 042314 85 GHVVICKILEDRG 97 (370)
Q Consensus 85 g~~~~~~~L~~~~ 97 (370)
|+.++++.|.+.+
T Consensus 91 ~~~~~v~~Ll~~g 103 (136)
T 2jab_A 91 GHLEIAEVLLKHG 103 (136)
T ss_dssp TCHHHHHHHHHTT
T ss_pred CCHHHHHHHHHcC
Confidence 9999999988754
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.2e-20 Score=149.56 Aligned_cols=95 Identities=38% Similarity=0.493 Sum_probs=77.9
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+||..|+.+++++|+++|+++|..|..|.||||+|+..|+.+++++|+++|++++..|..|.||+|.|+
T Consensus 31 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~ 110 (167)
T 3v31_A 31 HTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAV 110 (167)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCCCCHHHHHH
Confidence 35677888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred ccCceeeEEeeeccc
Q 042314 83 SFGHVVICKILEDRG 97 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~ 97 (370)
..|+.++++.|.+.+
T Consensus 111 ~~~~~~~v~~Ll~~g 125 (167)
T 3v31_A 111 HGNHVKCVKMLLESG 125 (167)
T ss_dssp HTTCHHHHHHHHHTT
T ss_pred HcCCHHHHHHHHHcC
Confidence 888888888776643
|
| >3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=3.2e-20 Score=150.97 Aligned_cols=95 Identities=27% Similarity=0.309 Sum_probs=91.1
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++..|..|.||++.|+
T Consensus 64 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~ 143 (172)
T 3v30_A 64 ILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTTEADSGYTPMDLAV 143 (172)
T ss_dssp CCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred hhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHH
Confidence 46788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeeccc
Q 042314 83 SFGHVVICKILEDRG 97 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~ 97 (370)
..|+.++++.|.+.+
T Consensus 144 ~~~~~~~~~~L~~~~ 158 (172)
T 3v30_A 144 ALGYRKVQQVIENHI 158 (172)
T ss_dssp HHTCHHHHHHHHHHH
T ss_pred HhCcHHHHHHHHHHH
Confidence 999999999887654
|
| >4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.3e-20 Score=162.89 Aligned_cols=95 Identities=32% Similarity=0.301 Sum_probs=87.5
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHH-cCCCccCccccCCCccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLE-KGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~-~gad~~~~~~~g~tpl~~A 81 (370)
..|..|+||||+||..|+.++|++|+++|+|+|.+|.+|+||||+|+..|+.+++++|++ .|+|++..|..|+||++.|
T Consensus 178 ~~~~~g~tpLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~TpL~~A 257 (276)
T 4hbd_A 178 KASQAGQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGSTALMVA 257 (276)
T ss_dssp CCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTTSCCHHHHH
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCCCCCHHHHH
Confidence 346679999999999999999999999999999999999999999999999999999999 8999999999999999999
Q ss_pred cccCceeeEEeeeccc
Q 042314 82 RSFGHVVICKILEDRG 97 (370)
Q Consensus 82 ~~~g~~~~~~~L~~~~ 97 (370)
+..|+.++++.|.+..
T Consensus 258 ~~~g~~~iv~~Ll~~~ 273 (276)
T 4hbd_A 258 LDAGQSEIASMLYSRM 273 (276)
T ss_dssp HHHTCHHHHHHHHHHC
T ss_pred HHcCCHHHHHHHHhcc
Confidence 9999999998887654
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=99.79 E-value=5.3e-20 Score=158.06 Aligned_cols=91 Identities=35% Similarity=0.407 Sum_probs=52.0
Q ss_pred CCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccCc
Q 042314 7 EGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86 (370)
Q Consensus 7 ~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~ 86 (370)
.|.||||+||..|+.++|++|+++|+++|.+|.+|+||||+||..|+.+++++|+++|+++|..|..|+||||.|+..|+
T Consensus 36 ~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~ 115 (239)
T 1ycs_B 36 LPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNN 115 (239)
T ss_dssp -CHHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTC
T ss_pred hhhHHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC
Confidence 34555555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred eeeEEeeeccc
Q 042314 87 VVICKILEDRG 97 (370)
Q Consensus 87 ~~~~~~L~~~~ 97 (370)
.+++++|.+.+
T Consensus 116 ~~~v~~Ll~~g 126 (239)
T 1ycs_B 116 VQVCKFLVESG 126 (239)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHcC
Confidence 55555555443
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.7e-20 Score=153.47 Aligned_cols=96 Identities=31% Similarity=0.385 Sum_probs=86.9
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+||..|+.+++++|+++|+++|..|..|.||||+|+..|+.+++++|+++|++++..|..|.||+|.|+
T Consensus 63 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~ 142 (192)
T 2rfm_A 63 DKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVAS 142 (192)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHH
T ss_pred cccccCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence 45778999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecccC
Q 042314 83 SFGHVVICKILEDRGG 98 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~ 98 (370)
..|+.++++.|.+.+.
T Consensus 143 ~~~~~~~v~~Ll~~ga 158 (192)
T 2rfm_A 143 KYGRSEIVKKLLELGA 158 (192)
T ss_dssp HHTCHHHHHHHHHTTC
T ss_pred HcCCHHHHHHHHHCCC
Confidence 9999999988877654
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=155.72 Aligned_cols=96 Identities=28% Similarity=0.234 Sum_probs=85.8
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCC-CCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADY-DKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~-~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
..|..|+||||+||..|+.++|++|+++|+++|.+|. .|.||||+|+..|+.+++++|+++|++++..|..|+||++.|
T Consensus 112 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A 191 (236)
T 1ikn_D 112 ATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLT 191 (236)
T ss_dssp CCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGC
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCCCCHHHHH
Confidence 3567799999999999999999999999999999987 899999999999999999999999999999999999999999
Q ss_pred cccCceeeEEeeecccC
Q 042314 82 RSFGHVVICKILEDRGG 98 (370)
Q Consensus 82 ~~~g~~~~~~~L~~~~~ 98 (370)
+..|+.+++++|.+.++
T Consensus 192 ~~~~~~~~~~~Ll~~ga 208 (236)
T 1ikn_D 192 WGRPSTRIQQQLGQLTL 208 (236)
T ss_dssp TTSSCHHHHHHHHTTSC
T ss_pred HccCchHHHHHHHHcch
Confidence 99999999988877654
|
| >1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B | Back alignment and structure |
|---|
Probab=99.79 E-value=5.6e-20 Score=147.01 Aligned_cols=92 Identities=26% Similarity=0.338 Sum_probs=76.6
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++ ++++..|..|.||++.|+
T Consensus 63 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~-~~~~~~~~~g~t~l~~A~ 141 (156)
T 1bd8_A 63 VQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRDARGLTPLELAL 141 (156)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTT-SCTTCCCTTSCCHHHHHH
T ss_pred CcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHhChHHHHHHHHhc-cCCCCcCCCCCCHHHHHH
Confidence 4567788888888888888888888888888888888888888888888888888888888 888888888888888888
Q ss_pred ccCceeeEEeeec
Q 042314 83 SFGHVVICKILED 95 (370)
Q Consensus 83 ~~g~~~~~~~L~~ 95 (370)
..|+.++++.|.+
T Consensus 142 ~~~~~~~v~~Ll~ 154 (156)
T 1bd8_A 142 QRGAQDLVDILQG 154 (156)
T ss_dssp HSCCHHHHHHHHT
T ss_pred HcCcHHHHHHHHh
Confidence 8888887776643
|
| >1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.6e-20 Score=148.44 Aligned_cols=93 Identities=24% Similarity=0.296 Sum_probs=64.0
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCC-ccCccccCCCcccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGAD-VNSLDRWGRTPLSDAR 82 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad-~~~~~~~g~tpl~~A~ 82 (370)
+|..|+||||+|+..|+.+++++|+++|+++|.+|.+|.||||+|+..|+.+++++|+++|++ ++..+..|.||++.|+
T Consensus 66 ~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~t~l~~A~ 145 (162)
T 1ihb_A 66 KDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLAR 145 (162)
T ss_dssp CCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHccCCCCCCcCCCCCcHHHHHH
Confidence 455667777777777777777777777777777777777777777777777777777777766 4666666777777777
Q ss_pred ccCceeeEEeeecc
Q 042314 83 SFGHVVICKILEDR 96 (370)
Q Consensus 83 ~~g~~~~~~~L~~~ 96 (370)
..|+.++++.|.+.
T Consensus 146 ~~~~~~~~~~Ll~~ 159 (162)
T 1ihb_A 146 LYGRNEVVSLMQAN 159 (162)
T ss_dssp HTTCHHHHHHHHHT
T ss_pred HcCCHHHHHHHHHh
Confidence 77766666666544
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.7e-20 Score=156.00 Aligned_cols=119 Identities=20% Similarity=0.160 Sum_probs=82.3
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHc-CCCccCccccCCCcccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK-GADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~-gad~~~~~~~g~tpl~~A~ 82 (370)
.|..|+||||+||..|+.++|++|++.|+++|.+|..|+||||+||..|+.+++++|+++ |++++..|..|+||||.|+
T Consensus 69 ~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~ 148 (222)
T 3ehr_A 69 QAESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAA 148 (222)
T ss_dssp HEEEESCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHH
T ss_pred cccccccccccccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHH
Confidence 355677788888888888888888877777777777788888888888888888877777 7777777777778888877
Q ss_pred ccCceeeEEeeecccC----CCCCCcccEEEEEEcCceeEEEEe
Q 042314 83 SFGHVVICKILEDRGG----IDPGAYGEVYLVKWRGTEIAAKTI 122 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~----l~~g~~~~v~~a~~~g~~vavK~l 122 (370)
..|+.+++++|++.++ .+..+...+..|...+...+++.+
T Consensus 149 ~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~l~~l 192 (222)
T 3ehr_A 149 WKGYADIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKK 192 (222)
T ss_dssp HHTCHHHHHHHHHHTCCSCCCCTTSCCHHHHCCSHHHHHHHC--
T ss_pred HcCCHHHHHHHHHcCCCCccccCCCCCHHHHhcchhHHHHHHHH
Confidence 7777777777766654 223333444444444444444443
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A | Back alignment and structure |
|---|
Probab=99.78 E-value=7.2e-20 Score=150.58 Aligned_cols=92 Identities=30% Similarity=0.311 Sum_probs=64.2
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCcc-ccCCCccccccc
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD-RWGRTPLSDARS 83 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~-~~g~tpl~~A~~ 83 (370)
|..|+||||+||..|+.++++.|++ |+++|.+|.+|+||||+|+..|+.+++++|+++|+++|..+ ..|+||||.|+.
T Consensus 41 ~~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~ 119 (183)
T 3deo_A 41 VSEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAG 119 (183)
T ss_dssp HHHHHHHHHHHHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHh
Confidence 4456677777777777777777777 77777777777777777777777777777777777777666 667777777777
Q ss_pred cCceeeEEeeeccc
Q 042314 84 FGHVVICKILEDRG 97 (370)
Q Consensus 84 ~g~~~~~~~L~~~~ 97 (370)
.|+.++++.|.+.+
T Consensus 120 ~~~~~~v~~Ll~~g 133 (183)
T 3deo_A 120 YVRPEVVEALVELG 133 (183)
T ss_dssp TTCHHHHHHHHHHT
T ss_pred cCcHHHHHHHHHcC
Confidence 77777766666554
|
| >2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.9e-20 Score=152.26 Aligned_cols=123 Identities=24% Similarity=0.198 Sum_probs=106.3
Q ss_pred ccCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 2 ~~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
+.+|..|+||||+||..|+.+++++|+++|+++|..|..|+||||+|+..|+.+++++|+++|++++..|..|.||||.|
T Consensus 29 n~~d~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A 108 (192)
T 2rfm_A 29 NYRDSYNRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWS 108 (192)
T ss_dssp TCCCTTCCCHHHHHHHHTCGGGHHHHHHHHCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHH
T ss_pred hCcCCCCCCHHHHHHHcCCHHHHHHHHHhccccccccccCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHH
Confidence 35788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCceeeEEeeecccC----CCCCCcccEEEEEEcCceeEEEEecc
Q 042314 82 RSFGHVVICKILEDRGG----IDPGAYGEVYLVKWRGTEIAAKTIRS 124 (370)
Q Consensus 82 ~~~g~~~~~~~L~~~~~----l~~g~~~~v~~a~~~g~~vavK~l~~ 124 (370)
+..|+.++++.|.+.+. .+..+...++.|...+...+++.+..
T Consensus 109 ~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~ 155 (192)
T 2rfm_A 109 IIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLE 155 (192)
T ss_dssp HHHTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHH
T ss_pred HHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHH
Confidence 99999999999887654 23344455555555666666666543
|
| >3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A | Back alignment and structure |
|---|
Probab=99.78 E-value=7.2e-20 Score=148.13 Aligned_cols=94 Identities=26% Similarity=0.274 Sum_probs=89.8
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+|+..|+.+++++|+++|+++|.+|.+|.||||+|+..|+.+++++|+++|++++..|..|.||++.|+
T Consensus 64 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~ 143 (167)
T 3v31_A 64 LLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADPTIETDSGYNSMDLAV 143 (167)
T ss_dssp CCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred CcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHH
Confidence 46788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecc
Q 042314 83 SFGHVVICKILEDR 96 (370)
Q Consensus 83 ~~g~~~~~~~L~~~ 96 (370)
..|+.++++.|.+.
T Consensus 144 ~~~~~~~~~~L~~~ 157 (167)
T 3v31_A 144 ALGYRSVQQVIESH 157 (167)
T ss_dssp HHTCHHHHHHHHHH
T ss_pred HcCcHHHHHHHHHH
Confidence 99999998887654
|
| >1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.9e-21 Score=155.71 Aligned_cols=94 Identities=27% Similarity=0.297 Sum_probs=87.9
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCC-ccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRT-PLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~t-pl~~A 81 (370)
..+..|.||||+||..|+.++|++|+++|+++|..|..|+||||+|+ .|+.+++++|+++|++++..|..|+| |||.|
T Consensus 7 ~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A 85 (156)
T 1bi7_B 7 SSMEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDA 85 (156)
T ss_dssp ---CCSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHH
T ss_pred CCCccchHHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHH
Confidence 35678999999999999999999999999999999999999999996 99999999999999999999999999 99999
Q ss_pred cccCceeeEEeeeccc
Q 042314 82 RSFGHVVICKILEDRG 97 (370)
Q Consensus 82 ~~~g~~~~~~~L~~~~ 97 (370)
+..|+.+++++|.+.+
T Consensus 86 ~~~~~~~~v~~Ll~~g 101 (156)
T 1bi7_B 86 AREGFLDTLVVLHRAG 101 (156)
T ss_dssp HHHTCHHHHHHHHHHT
T ss_pred HHCCCHHHHHHHHHcC
Confidence 9999999999998765
|
| >4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=9.8e-21 Score=165.46 Aligned_cols=95 Identities=28% Similarity=0.369 Sum_probs=80.3
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|.+|+||||+||..|+.++|++|+++|++++..+.+|.||+|+|+..++.+++++|+++|+++|..|..|+||||.|+
T Consensus 81 ~~d~~G~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~TpL~~A~ 160 (269)
T 4b93_B 81 VTSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQAVPLHLACQQGHFQVVKCLLDSNAKPNKKDLSGNTPLIYAC 160 (269)
T ss_dssp CCCTTSCCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHH
T ss_pred CcCCCCCCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCCCccccccccChHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence 46788999999999999999999988888888888888888888888888888888888888888888888888888888
Q ss_pred ccCceeeEEeeeccc
Q 042314 83 SFGHVVICKILEDRG 97 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~ 97 (370)
..|+.++++.|++.+
T Consensus 161 ~~g~~~~v~~Ll~~g 175 (269)
T 4b93_B 161 SGGHHELVALLLQHG 175 (269)
T ss_dssp HTTCGGGHHHHHHTT
T ss_pred HCCCHHHHHHHHHCC
Confidence 888888888777654
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* | Back alignment and structure |
|---|
Probab=99.77 E-value=8.7e-20 Score=173.45 Aligned_cols=95 Identities=23% Similarity=0.190 Sum_probs=90.5
Q ss_pred CCCCCChhhhHHhh---cCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccc
Q 042314 4 IDSEGPYRLLYCSS---KGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSD 80 (370)
Q Consensus 4 ~~~~g~t~l~~a~~---~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~ 80 (370)
.|..|+||||+||. .|+.++|++||++|||+|.+|.+|+||||+||..|+.++|++|+++|||+|..|..|+||||.
T Consensus 167 ~~~~g~t~Lh~A~~~a~~g~~~~v~~Ll~~ga~vn~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~ 246 (497)
T 3lvq_E 167 AQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDI 246 (497)
T ss_dssp SCCSCBCHHHHHHHTCCTTTHHHHHHHHHHSCCTTCCCSSSCCHHHHHTTTTCHHHHHHHHHTCCCCSCCCTTCCCHHHH
T ss_pred cccccchHHHHHHHhcccccHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHH
Confidence 37789999999955 999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCceeeEEeeecccC
Q 042314 81 ARSFGHVVICKILEDRGG 98 (370)
Q Consensus 81 A~~~g~~~~~~~L~~~~~ 98 (370)
|+..|+.+++++|.+.++
T Consensus 247 A~~~~~~~~~~~Ll~~ga 264 (497)
T 3lvq_E 247 ARKKHHKECEELLEQAQA 264 (497)
T ss_dssp HHHTTCHHHHHHHHHTCC
T ss_pred HHHcCCHHHHHHHHHhCC
Confidence 999999999999988664
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-19 Score=159.02 Aligned_cols=96 Identities=28% Similarity=0.313 Sum_probs=91.3
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCC-CCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYD-KRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~-g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
..|..|+||||+||..|+.++|++|+++|+++|..+.. |+||||+|+..|+.+++++|+++|++++.+|..|+||+|.|
T Consensus 153 ~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A 232 (282)
T 1oy3_D 153 AENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSA 232 (282)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred CcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCcccccCCCCHHHHH
Confidence 46788999999999999999999999999999999854 99999999999999999999999999999999999999999
Q ss_pred cccCceeeEEeeecccC
Q 042314 82 RSFGHVVICKILEDRGG 98 (370)
Q Consensus 82 ~~~g~~~~~~~L~~~~~ 98 (370)
+..|+.+++++|.+.++
T Consensus 233 ~~~~~~~~v~~Ll~~ga 249 (282)
T 1oy3_D 233 LLRPNPILARLLRAHGA 249 (282)
T ss_dssp HTSSCHHHHHHHHHTTC
T ss_pred HHcCCcHHHHHHHHcCC
Confidence 99999999999988764
|
| >2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=1e-19 Score=155.17 Aligned_cols=95 Identities=33% Similarity=0.360 Sum_probs=90.5
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARS 83 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~ 83 (370)
.+.+|.||||+||..|+.++|++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|+++|..|..|+||||.|+.
T Consensus 17 ~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~~ 96 (229)
T 2vge_A 17 ARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAAS 96 (229)
T ss_dssp TTSCHHHHHHHHHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHH
T ss_pred cccchhHHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Confidence 45678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCceeeEEeeecccC
Q 042314 84 FGHVVICKILEDRGG 98 (370)
Q Consensus 84 ~g~~~~~~~L~~~~~ 98 (370)
.|+.++++.|.+.+.
T Consensus 97 ~g~~~~v~~Ll~~ga 111 (229)
T 2vge_A 97 CNDTVICMALVQHGA 111 (229)
T ss_dssp TTCHHHHHHHHTTTC
T ss_pred cCCHHHHHHHHHcCC
Confidence 999999999987653
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=7.4e-20 Score=162.38 Aligned_cols=95 Identities=23% Similarity=0.178 Sum_probs=90.9
Q ss_pred CCCCCChhhhHHhhc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccc
Q 042314 4 IDSEGPYRLLYCSSK---GDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSD 80 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~---g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~ 80 (370)
.|..|+||||+||.. |+.++|++||++|+|+|.+|.+|+||||+|+..|+.+++++|+++|+|++.+|..|.|||+.
T Consensus 186 ~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~ 265 (301)
T 2b0o_E 186 AQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDI 265 (301)
T ss_dssp SCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCCSCCCTTSCCHHHH
T ss_pred cCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHH
Confidence 578999999999997 89999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCceeeEEeeecccC
Q 042314 81 ARSFGHVVICKILEDRGG 98 (370)
Q Consensus 81 A~~~g~~~~~~~L~~~~~ 98 (370)
|+..|+.+++++|...+.
T Consensus 266 A~~~~~~~iv~~Ll~~ga 283 (301)
T 2b0o_E 266 ARKKHHKECEELLEQAQA 283 (301)
T ss_dssp HHHHTCHHHHHHHHHHHH
T ss_pred HHHcCCHHHHHHHHHhcC
Confidence 999999999999887653
|
| >3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.8e-20 Score=154.36 Aligned_cols=94 Identities=18% Similarity=0.153 Sum_probs=86.0
Q ss_pred cCCCCCChhhhHHhhcCC------HHHHHHHHHcCCCCCCCCCCCC-cHHHHHHHCC-----CHHHHHHHHH-cCCCccC
Q 042314 3 IIDSEGPYRLLYCSSKGD------RAGVLQELEKGVEPNLADYDKR-TALHLASSEG-----RAEIVLLLLE-KGADVNS 69 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~------~~~~~~ll~~ga~~~~~~~~g~-t~l~~A~~~g-----~~~~~~~Ll~-~gad~~~ 69 (370)
.+|..|+||||+|+..|+ .+++++||++|||||.+|.+|+ ||||+|+..| +.+++++|++ +|+|++.
T Consensus 70 ~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~ 149 (186)
T 3t8k_A 70 SRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLI 149 (186)
T ss_dssp CCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSSCBGGGTBCTTGGGGGCCSCHHHHHHHHHHHHTSTTCCTTC
T ss_pred CCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCccCCCcCchHHHHHHHcCCChhhHHHHHHHHHHhcCCCCcc
Confidence 568899999999999987 6899999999999999999999 9999999955 4569999999 9999999
Q ss_pred ccccCCCccccccccCceeeEEeeecc
Q 042314 70 LDRWGRTPLSDARSFGHVVICKILEDR 96 (370)
Q Consensus 70 ~~~~g~tpl~~A~~~g~~~~~~~L~~~ 96 (370)
+|..|+||+|+|+..|+.+++++|...
T Consensus 150 ~d~~G~TpL~~A~~~~~~~~v~~L~~~ 176 (186)
T 3t8k_A 150 KDKWGLTALEFVKRCQKPIALKMMEDY 176 (186)
T ss_dssp CCTTSCCHHHHHHTTTCHHHHHHHHHH
T ss_pred cCCCCCCHHHHHHHcCCHHHHHHHHHH
Confidence 999999999999999999988877643
|
| >1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-19 Score=138.93 Aligned_cols=91 Identities=43% Similarity=0.576 Sum_probs=87.9
Q ss_pred CCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccCc
Q 042314 7 EGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86 (370)
Q Consensus 7 ~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~ 86 (370)
+|+||||+||..|+.+++++|+++|+++|..|..|.||||+|+..|+.+++++|+++|++++..+..|.||+|.|+..|+
T Consensus 1 ~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~ 80 (126)
T 1n0r_A 1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH 80 (126)
T ss_dssp CCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred CCccHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCh
Confidence 59999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeEEeeeccc
Q 042314 87 VVICKILEDRG 97 (370)
Q Consensus 87 ~~~~~~L~~~~ 97 (370)
.++++.|.+.+
T Consensus 81 ~~~~~~Ll~~g 91 (126)
T 1n0r_A 81 LEVVKLLLEAG 91 (126)
T ss_dssp HHHHHHHHHTT
T ss_pred HHHHHHHHHcC
Confidence 99999987754
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-20 Score=163.72 Aligned_cols=94 Identities=23% Similarity=0.228 Sum_probs=86.2
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCC--------------CCCCcHHHHHHHCCCHHHHHHHHH---cCCC
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLAD--------------YDKRTALHLASSEGRAEIVLLLLE---KGAD 66 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~--------------~~g~t~l~~A~~~g~~~~~~~Ll~---~gad 66 (370)
.|..|+||||+||..|+.++|++|+++|+++|..| ..|.||||+|+..|+.+++++|++ +|++
T Consensus 89 ~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~ 168 (260)
T 3jxi_A 89 VYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQAD 168 (260)
T ss_dssp SSEESBCHHHHHHHTTCHHHHHHHHHTTCCTTCCCEECCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCC
T ss_pred cccCCCCHHHHHHHcCCHHHHHHHHhCCCCcCccccccccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCC
Confidence 34589999999999999999999999999999999 689999999999999999999999 9999
Q ss_pred ccCccccCCCccccccccCc---------eeeEEeeeccc
Q 042314 67 VNSLDRWGRTPLSDARSFGH---------VVICKILEDRG 97 (370)
Q Consensus 67 ~~~~~~~g~tpl~~A~~~g~---------~~~~~~L~~~~ 97 (370)
+|..|..|+||||.|+..|+ .++++.|...+
T Consensus 169 ~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~g 208 (260)
T 3jxi_A 169 LRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKC 208 (260)
T ss_dssp TTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHH
T ss_pred CcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhC
Confidence 99999999999999998776 57777777654
|
| >3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.9e-20 Score=152.98 Aligned_cols=86 Identities=33% Similarity=0.377 Sum_probs=81.7
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLAD-YDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~-~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
.+|..|+||||+||..|+.+++++|+++|+++|.+| .+|+||||+|+..|+.+++++|+++|++++.+|..|+||++.|
T Consensus 71 ~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A 150 (183)
T 3deo_A 71 AVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERGLTALELA 150 (183)
T ss_dssp CCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHH
T ss_pred CcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHhcCcHHHHHHHHHcCCCCcCCCCCCCCHHHHH
Confidence 568899999999999999999999999999999998 8999999999999999999999999999999999999999999
Q ss_pred cccCcee
Q 042314 82 RSFGHVV 88 (370)
Q Consensus 82 ~~~g~~~ 88 (370)
+..++..
T Consensus 151 ~~~~~~~ 157 (183)
T 3deo_A 151 REILKTT 157 (183)
T ss_dssp HHHHHTC
T ss_pred HHhccCc
Confidence 8876554
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-19 Score=156.23 Aligned_cols=122 Identities=18% Similarity=0.134 Sum_probs=83.8
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+|+..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++..|..|.||+|.|+
T Consensus 119 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~ 198 (253)
T 1yyh_A 119 ARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAA 198 (253)
T ss_dssp CCCTTCCCHHHHHHHHTCSSHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred ccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHH
Confidence 34566777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred ccCceeeEEeeecccC----CCCCCcccEEEEEEcCceeEEEEecc
Q 042314 83 SFGHVVICKILEDRGG----IDPGAYGEVYLVKWRGTEIAAKTIRS 124 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~----l~~g~~~~v~~a~~~g~~vavK~l~~ 124 (370)
..|+.++++.|.+.+. .+..+...+..|...|...+++.+..
T Consensus 199 ~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~g~~~i~~~l~~ 244 (253)
T 1yyh_A 199 REGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDL 244 (253)
T ss_dssp HHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHC
T ss_pred HCCCHHHHHHHHHcCCCccccccCCCCHHHHHHHcCCHHHHHHHHH
Confidence 7777777777766653 22233344444445555555555443
|
| >1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B | Back alignment and structure |
|---|
Probab=99.77 E-value=9.4e-20 Score=156.51 Aligned_cols=96 Identities=25% Similarity=0.211 Sum_probs=90.1
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCC-Cccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGR-TPLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~-tpl~~A 81 (370)
.+|..|+||||+||..|+.++|++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++..+..|. ||++.|
T Consensus 65 ~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~~~t~l~~a 144 (239)
T 1ycs_B 65 LPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKC 144 (239)
T ss_dssp CCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHC
T ss_pred CcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcceecCCCCcchHHHH
Confidence 4688999999999999999999999999999999999999999999999999999999999999999998887 999999
Q ss_pred --cccCceeeEEeeecccC
Q 042314 82 --RSFGHVVICKILEDRGG 98 (370)
Q Consensus 82 --~~~g~~~~~~~L~~~~~ 98 (370)
...|+.+++++|...+.
T Consensus 145 ~~~~~g~~~~~~~Ll~~~a 163 (239)
T 1ycs_B 145 EEMEEGYTQCSQFLYGVQE 163 (239)
T ss_dssp CSSSTTCCCHHHHHHHHHH
T ss_pred HHhhhccHHHHHHHHHhhh
Confidence 77899999999887654
|
| >3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A | Back alignment and structure |
|---|
Probab=99.76 E-value=7.1e-20 Score=155.41 Aligned_cols=95 Identities=25% Similarity=0.250 Sum_probs=86.7
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHc-CCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEK-GVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~-ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
.+|..|+||||+||..|+.++|++|+++ |+++|.+|.+|+||||+|+..|+.+++++|+++|++++..|..|.||++.|
T Consensus 101 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A 180 (222)
T 3ehr_A 101 GLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGARTDLRNIEKKLAFDMA 180 (222)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCSCCCCTTSCCHHHHC
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccCCCCCHHHHh
Confidence 4678999999999999999999999999 999999999999999999999999999999999999999999999999999
Q ss_pred cccCceeeEEeeeccc
Q 042314 82 RSFGHVVICKILEDRG 97 (370)
Q Consensus 82 ~~~g~~~~~~~L~~~~ 97 (370)
+..|+.++++.+...+
T Consensus 181 ~~~~~~~~l~~l~~~~ 196 (222)
T 3ehr_A 181 TNAACASLLKKKQGTD 196 (222)
T ss_dssp CSHHHHHHHC------
T ss_pred cchhHHHHHHHHhccc
Confidence 9999999998887654
|
| >1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D | Back alignment and structure |
|---|
Probab=99.76 E-value=2.2e-19 Score=157.81 Aligned_cols=96 Identities=24% Similarity=0.139 Sum_probs=92.0
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCC---CCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVE---PNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLS 79 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~---~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~ 79 (370)
.+|.+|+||||+||..|+.++|++|+++|++ +|.+|..|+||||+|+..|+.+++++|+++|++++..+..|+||||
T Consensus 4 ~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~ 83 (282)
T 1oy3_D 4 YVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALH 83 (282)
T ss_dssp CCCTTCCCHHHHHHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHH
T ss_pred ccCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHH
Confidence 5789999999999999999999999999998 8999999999999999999999999999999999999999999999
Q ss_pred cccccCceeeEEeeecccC
Q 042314 80 DARSFGHVVICKILEDRGG 98 (370)
Q Consensus 80 ~A~~~g~~~~~~~L~~~~~ 98 (370)
.|+..|+.++++.|...+.
T Consensus 84 ~A~~~~~~~~v~~Ll~~~~ 102 (282)
T 1oy3_D 84 LACRVRAHTCACVLLQPRP 102 (282)
T ss_dssp HHTTTTCHHHHHHHSSSCC
T ss_pred HHHHcCCcchhHhhhccCC
Confidence 9999999999999887654
|
| >1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.8e-20 Score=162.42 Aligned_cols=122 Identities=21% Similarity=0.205 Sum_probs=97.9
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCC-CCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGV-EPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga-~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
..|..|+||||+|+..|+.+++++|+++|+ +++..|.+|.||||+|+..|+.+++++|+++|++++..|..|+||||.|
T Consensus 85 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A 164 (253)
T 1yyh_A 85 IQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWA 164 (253)
T ss_dssp CCCTTSCCHHHHHHHHTCHHHHHHHHHSTTSCTTCCCTTCCCHHHHHHHHTCSSHHHHHHHTTCCTTCBCTTSCBHHHHH
T ss_pred CCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCCCcCCCCCCHHHHH
Confidence 457788999999999999999999998887 8888888999999999999999999999999999999888899999999
Q ss_pred cccCceeeEEeeecccC----CCCCCcccEEEEEEcCceeEEEEecc
Q 042314 82 RSFGHVVICKILEDRGG----IDPGAYGEVYLVKWRGTEIAAKTIRS 124 (370)
Q Consensus 82 ~~~g~~~~~~~L~~~~~----l~~g~~~~v~~a~~~g~~vavK~l~~ 124 (370)
+..|+.++++.|.+.+. .+..+...++.|...|...+++.+..
T Consensus 165 ~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~ 211 (253)
T 1yyh_A 165 AAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLD 211 (253)
T ss_dssp HHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHH
T ss_pred HHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHH
Confidence 99998888888877654 23334455555555566666666543
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A | Back alignment and structure |
|---|
Probab=99.76 E-value=5e-19 Score=151.84 Aligned_cols=94 Identities=26% Similarity=0.300 Sum_probs=61.1
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLAD-YDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~-~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.|..|+||||+|+..|+.+++++|+++|+++|..| ..|.||||+|+..|+.+++++|+++|++++..|..|+||+|.|+
T Consensus 112 ~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~ 191 (241)
T 1k1a_A 112 RNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSAS 191 (241)
T ss_dssp CCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHH
T ss_pred cCcCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHH
Confidence 45566666666666666666666666666666666 56666666666666666666666666666666666666666666
Q ss_pred ccCceeeEEeeeccc
Q 042314 83 SFGHVVICKILEDRG 97 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~ 97 (370)
..|+.++++.|.+.+
T Consensus 192 ~~~~~~~v~~Ll~~g 206 (241)
T 1k1a_A 192 GRGLLPLVRTLVRSG 206 (241)
T ss_dssp HHTCHHHHHHHHHTT
T ss_pred HcCCHHHHHHHHhcC
Confidence 666666666665544
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.6e-19 Score=150.34 Aligned_cols=95 Identities=21% Similarity=0.222 Sum_probs=70.8
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARS 83 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~ 83 (370)
.|..|+||||+|+..|+.+++++|+++|+++|..|.+|.||||+|+..|+.+++++|+++|++++..|..|.||+|.|+.
T Consensus 88 ~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~ 167 (223)
T 2f8y_A 88 RMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAR 167 (223)
T ss_dssp CCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHhCcHHHHHHHHHcCCCCcCcCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCcCHHHHHHH
Confidence 45667777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred cCceeeEEeeecccC
Q 042314 84 FGHVVICKILEDRGG 98 (370)
Q Consensus 84 ~g~~~~~~~L~~~~~ 98 (370)
.|+.++++.|.+.+.
T Consensus 168 ~~~~~~v~~Ll~~ga 182 (223)
T 2f8y_A 168 EGSYETAKVLLDHFA 182 (223)
T ss_dssp HTCHHHHHHHHHTTC
T ss_pred cCCHHHHHHHHHcCC
Confidence 777777777766543
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.5e-19 Score=154.48 Aligned_cols=94 Identities=22% Similarity=0.170 Sum_probs=87.1
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCC-------------CCcHHHHHHHCCCHHHHHHHHH---cCCCc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYD-------------KRTALHLASSEGRAEIVLLLLE---KGADV 67 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~-------------g~t~l~~A~~~g~~~~~~~Ll~---~gad~ 67 (370)
.|..|+||||+||..|+.++|++|+++|+++|..|.. |.||||+|+..|+.+++++|++ +|+++
T Consensus 86 ~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~ 165 (256)
T 2etb_A 86 EFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASL 165 (256)
T ss_dssp TTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCT
T ss_pred ccccCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCc
Confidence 3577999999999999999999999999999999987 9999999999999999999999 99999
Q ss_pred cCccccCCCccccccc--cCcee-------eEEeeeccc
Q 042314 68 NSLDRWGRTPLSDARS--FGHVV-------ICKILEDRG 97 (370)
Q Consensus 68 ~~~~~~g~tpl~~A~~--~g~~~-------~~~~L~~~~ 97 (370)
|..|..|+||||.|+. .++.+ +++.|.+.+
T Consensus 166 n~~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~~g 204 (256)
T 2etb_A 166 EATDSLGNTVLHALVMIADNSPENSALVIHMYDGLLQMG 204 (256)
T ss_dssp TCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHH
T ss_pred CccCCCCCCHHHHHHHcccCCchhhHHHHHHHHHHHHcC
Confidence 9999999999999998 67776 888877653
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.9e-20 Score=158.77 Aligned_cols=92 Identities=30% Similarity=0.311 Sum_probs=82.9
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCcc-ccCCCccccccc
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD-RWGRTPLSDARS 83 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~-~~g~tpl~~A~~ 83 (370)
+..|+||||+||..|+.++|+.|++ |+++|.+|.+|+||||+||..|+.+++++|+++|+++|..+ ..|+||||.|+.
T Consensus 42 ~~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~ 120 (244)
T 3ui2_A 42 VSEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAG 120 (244)
T ss_dssp HHHHHHHHHHHHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHH
T ss_pred ccCCCCHHHHHHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHH
Confidence 4568899999999999999999999 99999999999999999999999999999999999999888 789999999999
Q ss_pred cCceeeEEeeeccc
Q 042314 84 FGHVVICKILEDRG 97 (370)
Q Consensus 84 ~g~~~~~~~L~~~~ 97 (370)
.|+.++++.|...+
T Consensus 121 ~g~~~~v~~Ll~~g 134 (244)
T 3ui2_A 121 YVRPEVVEALVELG 134 (244)
T ss_dssp TTCHHHHHHHHHTT
T ss_pred cCCHHHHHHHHHCC
Confidence 99999998887754
|
| >3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.4e-18 Score=149.71 Aligned_cols=83 Identities=34% Similarity=0.409 Sum_probs=78.8
Q ss_pred ccCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccc
Q 042314 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLAD-YDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSD 80 (370)
Q Consensus 2 ~~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~-~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~ 80 (370)
+.+|..|+||||+||..|+.++|++|+++|+++|.+| ..|+||||+|+..|+.+++++|+++|++++..|..|+||+|.
T Consensus 71 ~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~l~~ 150 (244)
T 3ui2_A 71 DAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERGLTALEL 150 (244)
T ss_dssp TCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHH
T ss_pred CCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHH
Confidence 3568899999999999999999999999999999998 889999999999999999999999999999999999999999
Q ss_pred cccc
Q 042314 81 ARSF 84 (370)
Q Consensus 81 A~~~ 84 (370)
|+..
T Consensus 151 A~~~ 154 (244)
T 3ui2_A 151 AREI 154 (244)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9853
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.7e-19 Score=150.74 Aligned_cols=93 Identities=25% Similarity=0.206 Sum_probs=60.8
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCC-------------CCCcHHHHHHHCCCHHHHHHHHHcCCCccCc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADY-------------DKRTALHLASSEGRAEIVLLLLEKGADVNSL 70 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~-------------~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~ 70 (370)
.|..|+||||+||..|+.+++++|+++|+++|..+. +|.||||+|+..|+.+++++|+++|+|+|..
T Consensus 71 ~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~ 150 (232)
T 2rfa_A 71 ELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQ 150 (232)
T ss_dssp TTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCC
T ss_pred cCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCcccCCcceeecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Confidence 345666666666666666666666666666666554 5666666666666666666666666666666
Q ss_pred cccCCCccccccccCceeeE----Eeeecc
Q 042314 71 DRWGRTPLSDARSFGHVVIC----KILEDR 96 (370)
Q Consensus 71 ~~~g~tpl~~A~~~g~~~~~----~~L~~~ 96 (370)
|..|+||||.|+..|+.+++ +.|...
T Consensus 151 d~~g~t~L~~A~~~~~~~~~~~i~~~Ll~~ 180 (232)
T 2rfa_A 151 DSLGNTVLHILILQPNKTFACQMYNLLLSY 180 (232)
T ss_dssp CTTSCCHHHHHHTCSCHHHHHHHHHHHHHT
T ss_pred CCCCCCHHHHHHHcCChHHHHHHHHHHHhc
Confidence 66666666666666666655 555443
|
| >2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.7e-19 Score=151.94 Aligned_cols=95 Identities=21% Similarity=0.186 Sum_probs=89.4
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHH----HHHHHcCCCc------cCcccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIV----LLLLEKGADV------NSLDRW 73 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~----~~Ll~~gad~------~~~~~~ 73 (370)
.|..|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++ ++|+++|++. +..|..
T Consensus 117 ~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~~~~~~~~~i~~~Ll~~g~~~~~~~~~~~~~~~ 196 (232)
T 2rfa_A 117 LIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDHLKSLELVPNNQ 196 (232)
T ss_dssp SCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHTCSCHHHHHHHHHHHHHTTCSCSSCCGGGCCCTT
T ss_pred cccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCChHHHHHHHHHHHhcCCchhhhhhhccCCCC
Confidence 355899999999999999999999999999999999999999999999999988 9999999998 589999
Q ss_pred CCCccccccccCceeeEEeeecccC
Q 042314 74 GRTPLSDARSFGHVVICKILEDRGG 98 (370)
Q Consensus 74 g~tpl~~A~~~g~~~~~~~L~~~~~ 98 (370)
|+||++.|+..|+.++++.|.+.+.
T Consensus 197 g~tpl~~A~~~g~~~~v~~Ll~~g~ 221 (232)
T 2rfa_A 197 GLTPFKLAGVEGNIVMFQHLMQKRK 221 (232)
T ss_dssp SCCHHHHHHHHTCHHHHHHHHHHHH
T ss_pred CCCHHHHHHHcCCHHHHHHHHhcCc
Confidence 9999999999999999999987653
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} | Back alignment and structure |
|---|
Probab=99.75 E-value=5e-19 Score=147.55 Aligned_cols=94 Identities=27% Similarity=0.317 Sum_probs=55.0
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHH-HcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcC-CCccCccccCCCccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKG-ADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll-~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~g-ad~~~~~~~g~tpl~~A 81 (370)
.|..|+||||+|+..|+.+++++|+ ..|+++|..|..|.||||+|+..|+.+++++|+++| ++++..|..|+||+|.|
T Consensus 68 ~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A 147 (201)
T 3hra_A 68 QNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEA 147 (201)
T ss_dssp CCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCSHHHHHHTTCHHHHHHHHHHCCCCTTCCCTTSCCHHHHH
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcCCCCCCCCCHHHHH
Confidence 4455566666666666666666666 444556666666666666666666666666666665 56666666666666666
Q ss_pred cccCc-----eeeEEeeeccc
Q 042314 82 RSFGH-----VVICKILEDRG 97 (370)
Q Consensus 82 ~~~g~-----~~~~~~L~~~~ 97 (370)
+..+. .++++.|.+.+
T Consensus 148 ~~~~~~~~~~~~~v~~Ll~~g 168 (201)
T 3hra_A 148 VGLREGNQLYQDIVKLLMENG 168 (201)
T ss_dssp HHSSCCSHHHHHHHHHHHHTT
T ss_pred HHhccchhhHHHHHHHHHHCC
Confidence 65554 55555555443
|
| >4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=7.7e-20 Score=160.52 Aligned_cols=93 Identities=39% Similarity=0.410 Sum_probs=78.3
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCC-CCCCCCC--------------------------------------CCCc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGV-EPNLADY--------------------------------------DKRT 43 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga-~~~~~~~--------------------------------------~g~t 43 (370)
..|.+|+||||+||..|+.++|++|+++|+ ++|..|. .|+|
T Consensus 106 ~~d~~g~T~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~a~~~~~~~~~~~~~v~~Ll~~g~~~~~~~~~g~t 185 (276)
T 4hbd_A 106 IADSNGNTALHYSVSHANFPVVQQLLDSGVCKVDKQNRAGYSPIMLTALATLKTQDDIETVLQLFRLGNINAKASQAGQT 185 (276)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHGGGCCCCSHHHHHHHHHHHHHSCTTCCCTTTCCC
T ss_pred CCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCcCCCCCCCCCCHHHHHHHHHhhhhhhHHHHHHHHHcCCCccccCCCCCC
Confidence 568889999999999999999999999987 6666554 4778
Q ss_pred HHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccCceeeEEeeec
Q 042314 44 ALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILED 95 (370)
Q Consensus 44 ~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~~~~~~~L~~ 95 (370)
|||+|+..|+.+++++|+++|+|+|..|..|+||||.|+..|+.++++.|..
T Consensus 186 pLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~ 237 (276)
T 4hbd_A 186 ALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLA 237 (276)
T ss_dssp HHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHT
T ss_pred HHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHh
Confidence 8888888888888888888888888888888888888888888888888776
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4.6e-19 Score=160.93 Aligned_cols=92 Identities=26% Similarity=0.324 Sum_probs=85.2
Q ss_pred CCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccC
Q 042314 6 SEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFG 85 (370)
Q Consensus 6 ~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g 85 (370)
..|+||||+||..|+.++|++||++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++..|..|.|||+.|+..|
T Consensus 233 ~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~LL~~Gad~~~~d~~G~TpL~~A~~~g 312 (368)
T 3jue_A 233 QDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLKRGADLGARDSEGRDPLTIAMETA 312 (368)
T ss_dssp TTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred cCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHCcCCCCCcCCCCCCHHHHHHHCC
Confidence 78999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeeEEeeeccc
Q 042314 86 HVVICKILEDRG 97 (370)
Q Consensus 86 ~~~~~~~L~~~~ 97 (370)
+.+++++|...+
T Consensus 313 ~~~iv~lLl~~~ 324 (368)
T 3jue_A 313 NADIVTLLRLAK 324 (368)
T ss_dssp CHHHHHHHHHHH
T ss_pred CHHHHHHHHHcC
Confidence 999998887654
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=5.2e-19 Score=154.92 Aligned_cols=94 Identities=21% Similarity=0.188 Sum_probs=87.4
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCC--------------CCCcHHHHHHHCCCHHHHHHHHH---cCCC
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADY--------------DKRTALHLASSEGRAEIVLLLLE---KGAD 66 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~--------------~g~t~l~~A~~~g~~~~~~~Ll~---~gad 66 (370)
.|..|+||||+||..|+.++|++|+++|+++|.+|. .|.||||+|+..|+.+++++|++ +|++
T Consensus 97 ~d~~g~tpL~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad 176 (273)
T 2pnn_A 97 SYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPAD 176 (273)
T ss_dssp TTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBCSGGGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCCCC
T ss_pred ccCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCCCC
Confidence 467899999999999999999999999999999997 79999999999999999999999 9999
Q ss_pred ccCccccCCCccccccccCc---------eeeEEeeeccc
Q 042314 67 VNSLDRWGRTPLSDARSFGH---------VVICKILEDRG 97 (370)
Q Consensus 67 ~~~~~~~g~tpl~~A~~~g~---------~~~~~~L~~~~ 97 (370)
++.+|..|+||||.|+..|+ .++++.|...+
T Consensus 177 ~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~g 216 (273)
T 2pnn_A 177 ISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILG 216 (273)
T ss_dssp TTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHH
T ss_pred ceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhh
Confidence 99999999999999999887 57777776654
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.7e-19 Score=155.75 Aligned_cols=95 Identities=23% Similarity=0.215 Sum_probs=91.2
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+||..|+.++|++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++..|..|+|||+.|+
T Consensus 54 ~~~~~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~A~ 133 (285)
T 3d9h_A 54 GDAVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNAC 133 (285)
T ss_dssp SSSCCSCCHHHHHHHTTCHHHHHHHHHTTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHH
T ss_pred CCCccCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence 36788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeeccc
Q 042314 83 SFGHVVICKILEDRG 97 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~ 97 (370)
..|+.++++.|.+.+
T Consensus 134 ~~~~~~~v~~Ll~~g 148 (285)
T 3d9h_A 134 VSGSWDCVNLLLQHG 148 (285)
T ss_dssp HHTCHHHHHHHHHTT
T ss_pred HcCHHHHHHHHHHCC
Confidence 999999999988754
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.74 E-value=9.5e-19 Score=158.55 Aligned_cols=95 Identities=32% Similarity=0.395 Sum_probs=91.4
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+||..|+.++|++|+++|+++|..|.+|.||||+|+..|+.+++++|+++|++++..+..|.||+|.|+
T Consensus 53 ~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~ 132 (351)
T 3utm_A 53 ASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAA 132 (351)
T ss_dssp CSSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHH
T ss_pred cCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence 46788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeeccc
Q 042314 83 SFGHVVICKILEDRG 97 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~ 97 (370)
..|+.++++.|.+.+
T Consensus 133 ~~~~~~~v~~Ll~~g 147 (351)
T 3utm_A 133 SKNRVEVCSLLLSHG 147 (351)
T ss_dssp HTTCHHHHHHHHHTT
T ss_pred HcCCHHHHHHHHHcC
Confidence 999999999998764
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A | Back alignment and structure |
|---|
Probab=99.74 E-value=9.8e-19 Score=148.76 Aligned_cols=90 Identities=28% Similarity=0.244 Sum_probs=44.8
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcC-CCccCccccCCCccccccc
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKG-ADVNSLDRWGRTPLSDARS 83 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~g-ad~~~~~~~g~tpl~~A~~ 83 (370)
|..|+||||+|+..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++| ++++..|..|+||+|.|+.
T Consensus 104 ~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~d~~g~t~L~~A~~ 183 (228)
T 2dzn_A 104 TNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALA 183 (228)
T ss_dssp CTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHH
T ss_pred CcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhcCcccccCcCCCCCCHHHHHHH
Confidence 344445555555555555555555555555555555555555555555555555555444 4455444455555555555
Q ss_pred cCceeeEEeee
Q 042314 84 FGHVVICKILE 94 (370)
Q Consensus 84 ~g~~~~~~~L~ 94 (370)
.|+.++++.|.
T Consensus 184 ~~~~~~v~~Ll 194 (228)
T 2dzn_A 184 EGHGDAAVLLV 194 (228)
T ss_dssp TTCHHHHHHHH
T ss_pred cCCHHHHHHHH
Confidence 55444444444
|
| >2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A | Back alignment and structure |
|---|
Probab=99.74 E-value=4e-19 Score=154.15 Aligned_cols=91 Identities=24% Similarity=0.200 Sum_probs=87.2
Q ss_pred CCChhhhHHhhcCCHHHHHHHHH---cCCCCCCCCCCCCcHHHHHHH--CCCHH-------HHHHHHHcCCCc-------
Q 042314 7 EGPYRLLYCSSKGDRAGVLQELE---KGVEPNLADYDKRTALHLASS--EGRAE-------IVLLLLEKGADV------- 67 (370)
Q Consensus 7 ~g~t~l~~a~~~g~~~~~~~ll~---~ga~~~~~~~~g~t~l~~A~~--~g~~~-------~~~~Ll~~gad~------- 67 (370)
.|+||||+||..|+.++|++|++ +|+|+|.+|.+|+||||+|+. .++.+ ++++|+++|+++
T Consensus 135 ~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~~ga~~~~~~~~~ 214 (256)
T 2etb_A 135 FGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENSALVIHMYDGLLQMGARLCPTVQLE 214 (256)
T ss_dssp SCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHSTTCCGG
T ss_pred CCCCHHHHHHHcCCHHHHHHHHhccccCCCcCccCCCCCCHHHHHHHcccCCchhhHHHHHHHHHHHHcCCCcccccccc
Confidence 49999999999999999999999 999999999999999999999 88988 999999999999
Q ss_pred cCccccCCCccccccccCceeeEEeeeccc
Q 042314 68 NSLDRWGRTPLSDARSFGHVVICKILEDRG 97 (370)
Q Consensus 68 ~~~~~~g~tpl~~A~~~g~~~~~~~L~~~~ 97 (370)
+.+|..|+||+|.|+..|+.++++.|.+.+
T Consensus 215 ~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g 244 (256)
T 2etb_A 215 EISNHQGLTPLKLAAKEGKIEIFRHILQRE 244 (256)
T ss_dssp GCCCTTSCCHHHHHHHTTCHHHHHHHHHHH
T ss_pred cccCCCCCCHHHHHHHhCCHHHHHHHHhCC
Confidence 999999999999999999999999887765
|
| >3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=3.6e-19 Score=154.76 Aligned_cols=93 Identities=24% Similarity=0.154 Sum_probs=88.0
Q ss_pred CCCChhhhHHhhcCCHHHHHHHHH---cCCCCCCCCCCCCcHHHHHHHCCC---------HHHHHHHHHcCCCc------
Q 042314 6 SEGPYRLLYCSSKGDRAGVLQELE---KGVEPNLADYDKRTALHLASSEGR---------AEIVLLLLEKGADV------ 67 (370)
Q Consensus 6 ~~g~t~l~~a~~~g~~~~~~~ll~---~ga~~~~~~~~g~t~l~~A~~~g~---------~~~~~~Ll~~gad~------ 67 (370)
..|+||||+||..|+.++|++|++ +|+++|.+|.+|+||||+|+..|+ .+++++|+++|+++
T Consensus 138 ~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~~ 217 (260)
T 3jxi_A 138 YFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLFPDTNL 217 (260)
T ss_dssp CSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHHHHHCTTCCG
T ss_pred cCCCCHHHHHHHcCCHHHHHHHHhccccCCCCcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhCcccccccch
Confidence 679999999999999999999999 999999999999999999999888 79999999999999
Q ss_pred -cCccccCCCccccccccCceeeEEeeecccC
Q 042314 68 -NSLDRWGRTPLSDARSFGHVVICKILEDRGG 98 (370)
Q Consensus 68 -~~~~~~g~tpl~~A~~~g~~~~~~~L~~~~~ 98 (370)
+..|..|+||||.|+..|+.++++.|++.+.
T Consensus 218 ~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~ 249 (260)
T 3jxi_A 218 EALLNNDGLSPLMMAAKTGKIGIFQHIIRREI 249 (260)
T ss_dssp GGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHH
T ss_pred hhcccCCCCCHHHHHHHcCCHHHHHHHHHhCC
Confidence 6799999999999999999999999887653
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.74 E-value=7.6e-19 Score=160.46 Aligned_cols=123 Identities=16% Similarity=0.154 Sum_probs=100.8
Q ss_pred cCCCCCChhhhHHhhcC--CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCC-----ccCccccCC
Q 042314 3 IIDSEGPYRLLYCSSKG--DRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGAD-----VNSLDRWGR 75 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g--~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad-----~~~~~~~g~ 75 (370)
..|..|+||||+||..| +.++|++|+++|+++|..|..|.||||+|+..|+.+++++|+++|++ +|..|..|+
T Consensus 133 ~~~~~g~t~L~~A~~~g~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~ 212 (364)
T 3ljn_A 133 VKHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGN 212 (364)
T ss_dssp EEEESCCCHHHHHHHSCGGGHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCC
T ss_pred cCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCCC
Confidence 35678899999999999 89999999999999999999999999999999999999999998888 888888999
Q ss_pred CccccccccCceeeEEeeecccC----CCCCCcccEEEEEEcCceeEEEEeccc
Q 042314 76 TPLSDARSFGHVVICKILEDRGG----IDPGAYGEVYLVKWRGTEIAAKTIRSS 125 (370)
Q Consensus 76 tpl~~A~~~g~~~~~~~L~~~~~----l~~g~~~~v~~a~~~g~~vavK~l~~~ 125 (370)
||||.|+..|+.+++++|.+.+. .+..+...++.|...|...+++.+...
T Consensus 213 t~L~~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~ 266 (364)
T 3ljn_A 213 SHLHWAILINWEDVAMRFVEMGIDVNMEDNEHTVPLYLSVRAAMVLLTKELLQK 266 (364)
T ss_dssp CTTHHHHTTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTCCHHHHHHHHHH
T ss_pred cHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhChHHHHHHHHHc
Confidence 99999999999999888887654 334445556666666777777776543
|
| >1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.9e-19 Score=154.47 Aligned_cols=90 Identities=28% Similarity=0.260 Sum_probs=55.1
Q ss_pred CCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccC
Q 042314 6 SEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFG 85 (370)
Q Consensus 6 ~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g 85 (370)
..|+||||+|+..|+.+++++|+++|+++|.+|.+|.||||+|+..|+.+++++|+++|++++.+|..|.||++.|+..|
T Consensus 148 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~~~~ 227 (241)
T 1k1a_A 148 KSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRR 227 (241)
T ss_dssp TTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTTCSSHH
T ss_pred cCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCcCCCCCCHHHHHHhcC
Confidence 45666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred ceeeEEeeec
Q 042314 86 HVVICKILED 95 (370)
Q Consensus 86 ~~~~~~~L~~ 95 (370)
+.++++.|..
T Consensus 228 ~~~i~~~l~~ 237 (241)
T 1k1a_A 228 VIDILRGKAT 237 (241)
T ss_dssp HHHHHTC---
T ss_pred cHHHHhhhcc
Confidence 6665555543
|
| >2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=4.7e-19 Score=155.20 Aligned_cols=94 Identities=22% Similarity=0.140 Sum_probs=89.0
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHH---cCCCCCCCCCCCCcHHHHHHHCCC---------HHHHHHHHHcCCCcc----
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELE---KGVEPNLADYDKRTALHLASSEGR---------AEIVLLLLEKGADVN---- 68 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~---~ga~~~~~~~~g~t~l~~A~~~g~---------~~~~~~Ll~~gad~~---- 68 (370)
|..|+||||+||..|+.++|++|++ +|+++|.+|.+|+||||+|+..|+ .+++++|+++|+++|
T Consensus 145 ~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n~~~~ 224 (273)
T 2pnn_A 145 FYFGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLK 224 (273)
T ss_dssp CCSCBSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHCTTCC
T ss_pred ccCCCCHHHHHHHcCCHHHHHHHHhcccCCCCceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhcccccc
Confidence 3479999999999999999999999 999999999999999999999998 899999999999997
Q ss_pred ---CccccCCCccccccccCceeeEEeeecccC
Q 042314 69 ---SLDRWGRTPLSDARSFGHVVICKILEDRGG 98 (370)
Q Consensus 69 ---~~~~~g~tpl~~A~~~g~~~~~~~L~~~~~ 98 (370)
..|..|+||||.|+..|+.+++++|++.++
T Consensus 225 ~~~~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga 257 (273)
T 2pnn_A 225 LEEITNRKGLTPLALAASSGKIGVLAYILQREI 257 (273)
T ss_dssp GGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHT
T ss_pred cccccCCCCCCHHHHHHHhChHHHHHHHHHCCC
Confidence 489999999999999999999999988775
|
| >3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.7e-18 Score=144.39 Aligned_cols=95 Identities=26% Similarity=0.385 Sum_probs=81.0
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHH-HcCCCccCccccCCCccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLL-EKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll-~~gad~~~~~~~g~tpl~~A 81 (370)
..|..|+||||+||..|+.++|++|+++|+++|..|..|.||||+|+..|+.+++++|+ ..+++++..+..|.||+|.|
T Consensus 34 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A 113 (201)
T 3hra_A 34 EVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPA 113 (201)
T ss_dssp CCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCSHHHH
T ss_pred CCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCcHHHHH
Confidence 45678888888888888888888888888888888888888888888888888888888 45678888888888888888
Q ss_pred cccCceeeEEeeeccc
Q 042314 82 RSFGHVVICKILEDRG 97 (370)
Q Consensus 82 ~~~g~~~~~~~L~~~~ 97 (370)
+..|+.++++.|.+.+
T Consensus 114 ~~~~~~~~v~~Ll~~g 129 (201)
T 3hra_A 114 AEKGHIDNVKLLLEDG 129 (201)
T ss_dssp HHTTCHHHHHHHHHHC
T ss_pred HHcCCHHHHHHHHHcC
Confidence 8888888888887655
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} | Back alignment and structure |
|---|
Probab=99.73 E-value=5e-19 Score=156.12 Aligned_cols=94 Identities=26% Similarity=0.272 Sum_probs=87.1
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|..|+||||+||..|+.++|++|+++|+++|..| |+||||+|+..|+.+++++|+++|++++..|..|+||||.|+
T Consensus 26 ~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~--g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~ 103 (285)
T 3kea_A 26 KADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAV 103 (285)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTGGGSCCT--TCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCC--CCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHH
Confidence 568899999999999999999999999999999884 999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecccC
Q 042314 83 SFGHVVICKILEDRGG 98 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~ 98 (370)
..|+.++++.|.+.+.
T Consensus 104 ~~g~~~~v~~Ll~~ga 119 (285)
T 3kea_A 104 DSGNMQTVKLFVKKNW 119 (285)
T ss_dssp HTTCHHHHHHHHHHCG
T ss_pred HcCCHHHHHHHHhcCC
Confidence 9999999998887643
|
| >2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-18 Score=147.53 Aligned_cols=122 Identities=21% Similarity=0.205 Sum_probs=101.1
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCC-CCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGV-EPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga-~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
..|..|+||||+|+..|+.+++++|+++|+ +++..|.+|.||||+|+..|+.+++++|+++|++++..+..|+||||.|
T Consensus 53 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A 132 (223)
T 2f8y_A 53 IQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWA 132 (223)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHBTTSCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSCBHHHHH
T ss_pred CcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCcHHHHHHHhCcHHHHHHHHHcCCCCcCcCCCCCcHHHHH
Confidence 467889999999999999999999999987 8999999999999999999999999999999999999999999999999
Q ss_pred cccCceeeEEeeecccC----CCCCCcccEEEEEEcCceeEEEEecc
Q 042314 82 RSFGHVVICKILEDRGG----IDPGAYGEVYLVKWRGTEIAAKTIRS 124 (370)
Q Consensus 82 ~~~g~~~~~~~L~~~~~----l~~g~~~~v~~a~~~g~~vavK~l~~ 124 (370)
+..|+.++++.|.+.+. .+..+...++.|...+...+++.+..
T Consensus 133 ~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~ 179 (223)
T 2f8y_A 133 AAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLD 179 (223)
T ss_dssp HHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHH
T ss_pred HHcCCHHHHHHHHHcCCCCCCcCCCCcCHHHHHHHcCCHHHHHHHHH
Confidence 99999999998887653 22334445555555566666666543
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A | Back alignment and structure |
|---|
Probab=99.73 E-value=9.5e-19 Score=149.18 Aligned_cols=96 Identities=31% Similarity=0.357 Sum_probs=86.2
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+|+..|+.+++++|+++|+++|..|..|.||||+|+..|+.+++++|+++|++++..|..|+||+|.|+
T Consensus 101 ~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~ 180 (231)
T 3aji_A 101 AVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLAC 180 (231)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccCCCCCCHHHHHH
Confidence 45778999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecccC
Q 042314 83 SFGHVVICKILEDRGG 98 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~ 98 (370)
..|+.++++.|.+.+.
T Consensus 181 ~~~~~~~v~~Ll~~ga 196 (231)
T 3aji_A 181 DEERVEEAKFLVTQGA 196 (231)
T ss_dssp HTTCHHHHHHHHHTTC
T ss_pred HCCCHHHHHHHHHCCC
Confidence 9999999888887654
|
| >3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-19 Score=165.06 Aligned_cols=96 Identities=19% Similarity=0.164 Sum_probs=92.3
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCC-----CCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVE-----PNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTP 77 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~-----~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tp 77 (370)
..|..|+||||+||..|+.++|++|+++|++ +|..|..|+||||+|+..|+.+++++|+++|+|+|..|..|+||
T Consensus 168 ~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tp 247 (364)
T 3ljn_A 168 AKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGIDVNMEDNEHTVP 247 (364)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTTCCTTCCCTTSCCH
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCH
Confidence 4678999999999999999999999999999 99999999999999999999999999999999999999999999
Q ss_pred cccccccCceeeEEeeecccC
Q 042314 78 LSDARSFGHVVICKILEDRGG 98 (370)
Q Consensus 78 l~~A~~~g~~~~~~~L~~~~~ 98 (370)
|+.|+..|+.++++.|++.+.
T Consensus 248 L~~A~~~g~~~~v~~Ll~~~~ 268 (364)
T 3ljn_A 248 LYLSVRAAMVLLTKELLQKTD 268 (364)
T ss_dssp HHHHHHTCCHHHHHHHHHHSC
T ss_pred HHHHHHhChHHHHHHHHHcCC
Confidence 999999999999999988753
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.73 E-value=1.6e-18 Score=158.84 Aligned_cols=94 Identities=26% Similarity=0.321 Sum_probs=89.7
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcC-CCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKG-VEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~g-a~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.|..|+||||+||..|+.++|++|+++| +++|.+|.+|+||||+|+..|+.++|++|+++|++++..|..|.||++.|+
T Consensus 275 ~d~~g~t~Lh~A~~~g~~~~v~~Ll~~~~~~~n~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gad~~~~d~~g~t~l~~A~ 354 (373)
T 2fo1_E 275 EKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQ 354 (373)
T ss_dssp SSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHHHHHH
T ss_pred ccccCCCHHHHHHHhCCHHHHHHHHHhcCCCccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccCCCCCCCCHHHHHH
Confidence 5678999999999999999999999886 999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeeccc
Q 042314 83 SFGHVVICKILEDRG 97 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~ 97 (370)
..|+.+++++|.+.+
T Consensus 355 ~~g~~~iv~~Ll~~~ 369 (373)
T 2fo1_E 355 ANNHHNIVDIFDRCR 369 (373)
T ss_dssp HTTCHHHHHHHHTTC
T ss_pred HcCCHHHHHHHHhcC
Confidence 999999999887654
|
| >1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E | Back alignment and structure |
|---|
Probab=99.73 E-value=3.2e-19 Score=152.75 Aligned_cols=92 Identities=32% Similarity=0.320 Sum_probs=50.6
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHHcCCC------CCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccc-cCCCc
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVE------PNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDR-WGRTP 77 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~~ga~------~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~-~g~tp 77 (370)
|..|+||||+||..|+.+++++|+++|++ ++..|..|.||||+|+..|+.+++++|+++|++++..+. .|+||
T Consensus 75 ~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~tp 154 (236)
T 1ikn_D 75 DFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTA 154 (236)
T ss_dssp CTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCH
T ss_pred CCCCCCHHHHHHHcCCHHHHHHHHhcccchhHHHHhhccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCCH
Confidence 44555555555555555555555555544 344455555555555555555555555555555555554 55555
Q ss_pred cccccccCceeeEEeeecc
Q 042314 78 LSDARSFGHVVICKILEDR 96 (370)
Q Consensus 78 l~~A~~~g~~~~~~~L~~~ 96 (370)
||.|+..|+.+++++|.+.
T Consensus 155 L~~A~~~~~~~~v~~Ll~~ 173 (236)
T 1ikn_D 155 LHLAVDLQNPDLVSLLLKC 173 (236)
T ss_dssp HHHHHHTTCHHHHHHHHTT
T ss_pred HHHHHHcCCHHHHHHHHHc
Confidence 5555555555555555543
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.4e-18 Score=147.28 Aligned_cols=96 Identities=24% Similarity=0.230 Sum_probs=92.0
Q ss_pred ccCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 2 ~~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
+..|..|+||||+||..|+.+++++|+++|+++|..|.+|.||||+|+..|+.+++++|+++|++++..+..|.||++.|
T Consensus 5 ~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A 84 (237)
T 3b7b_A 5 KMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLA 84 (237)
T ss_dssp CCSSCCSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCCCCCCTTSCCHHHHH
T ss_pred ccccCCCCCHHHHHHHcCcHHHHHHHHHcCCCcCccCCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCcHHHHH
Confidence 35788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCceeeEEeeeccc
Q 042314 82 RSFGHVVICKILEDRG 97 (370)
Q Consensus 82 ~~~g~~~~~~~L~~~~ 97 (370)
+..|+.++++.|.+.+
T Consensus 85 ~~~~~~~~~~~Ll~~~ 100 (237)
T 3b7b_A 85 AKKGHYEVVQYLLSNG 100 (237)
T ss_dssp HHTTCHHHHHHHHTTT
T ss_pred HHcCCHHHHHHHHhCC
Confidence 9999999999987755
|
| >3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A | Back alignment and structure |
|---|
Probab=99.72 E-value=2.7e-18 Score=146.39 Aligned_cols=121 Identities=27% Similarity=0.252 Sum_probs=104.6
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+|+..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++..+..|.||+|.|+
T Consensus 68 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~ 147 (231)
T 3aji_A 68 DKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAA 147 (231)
T ss_dssp CCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred CcCCCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHH
Confidence 46788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecccC----CCCCCcccEEEEEEcCceeEEEEec
Q 042314 83 SFGHVVICKILEDRGG----IDPGAYGEVYLVKWRGTEIAAKTIR 123 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~----l~~g~~~~v~~a~~~g~~vavK~l~ 123 (370)
..|+.++++.|...+. .+..+...++.+...+...+++.+.
T Consensus 148 ~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll 192 (231)
T 3aji_A 148 AKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLV 192 (231)
T ss_dssp HHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHH
T ss_pred HcCCHHHHHHHHhcCCCccccCCCCCCHHHHHHHCCCHHHHHHHH
Confidence 9999999999887654 2334445555555556655566554
|
| >3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.5e-18 Score=153.02 Aligned_cols=91 Identities=22% Similarity=0.192 Sum_probs=87.9
Q ss_pred CCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccC-CCccccccccC
Q 042314 7 EGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWG-RTPLSDARSFG 85 (370)
Q Consensus 7 ~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g-~tpl~~A~~~g 85 (370)
+|+||||+||..|+.++|++|+++|+++|.+|..|+||||+|+..|+.+++++|+++|++++..+..| .||+|.|+..|
T Consensus 61 ~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~~t~L~~A~~~~ 140 (285)
T 3kea_A 61 ENEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLN 140 (285)
T ss_dssp TTCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCSSSGGGSHHHHHHHTT
T ss_pred CCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCCCccCCCCCCCHHHHHHHcC
Confidence 59999999999999999999999999999999999999999999999999999999999999999999 79999999999
Q ss_pred ceeeEEeeeccc
Q 042314 86 HVVICKILEDRG 97 (370)
Q Consensus 86 ~~~~~~~L~~~~ 97 (370)
+.++++.|...+
T Consensus 141 ~~~~v~~Ll~~g 152 (285)
T 3kea_A 141 DVSIVSYFLSEI 152 (285)
T ss_dssp CHHHHHHHHTTS
T ss_pred CHHHHHHHHhCC
Confidence 999999987754
|
| >1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 | Back alignment and structure |
|---|
Probab=99.72 E-value=1.9e-17 Score=120.08 Aligned_cols=64 Identities=39% Similarity=0.471 Sum_probs=61.9
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCC
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGAD 66 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad 66 (370)
.+|..|+||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++||+
T Consensus 30 ~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~~~~Ll~~ga~ 93 (93)
T 1n0q_A 30 AKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGAY 93 (93)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCC
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence 5688999999999999999999999999999999999999999999999999999999999985
|
| >3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=3.9e-18 Score=145.97 Aligned_cols=93 Identities=23% Similarity=0.287 Sum_probs=54.8
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARS 83 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~ 83 (370)
.|..|+||||+|+..|+.+++++|+++|+++|.+|.+|.||||+|+..|+.+++++|+++|++++..|..|.||+|.|+.
T Consensus 107 ~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~ 186 (237)
T 3b7b_A 107 QDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAAR 186 (237)
T ss_dssp CCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHH
Confidence 34455566666666666666666666666666555566666666666666666666666666666555556666666666
Q ss_pred cCceeeEEeeecc
Q 042314 84 FGHVVICKILEDR 96 (370)
Q Consensus 84 ~g~~~~~~~L~~~ 96 (370)
.|+.++++.|.+.
T Consensus 187 ~~~~~~v~~Ll~~ 199 (237)
T 3b7b_A 187 ENRYDCVVLFLSR 199 (237)
T ss_dssp TTCHHHHHHHHTT
T ss_pred hCCHhHHHHHHHc
Confidence 5555555555443
|
| >2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} | Back alignment and structure |
|---|
Probab=99.71 E-value=6.9e-18 Score=127.50 Aligned_cols=77 Identities=32% Similarity=0.317 Sum_probs=70.9
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLS 79 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~ 79 (370)
.+|..|+||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|+++|..+..|.+|-.
T Consensus 37 ~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~~~~~~~~~~Ll~~ga~~n~~~~~~~~~~~ 113 (115)
T 2l6b_A 37 ARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADVNARSWGSSHHHH 113 (115)
T ss_dssp CCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTSSSHHHHSCCCC----
T ss_pred CcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCcccccccc
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999988753
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.71 E-value=2e-18 Score=153.19 Aligned_cols=93 Identities=35% Similarity=0.478 Sum_probs=88.6
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccccc
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSF 84 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~ 84 (370)
+..|.||||+||..|+.++|++|+++|+++|..|.+|.||||+||..|+.+++++|+++|++++..|..|+||||.|+..
T Consensus 37 ~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~ 116 (299)
T 1s70_B 37 KFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASC 116 (299)
T ss_dssp EECHHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHH
T ss_pred ccCCccHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHc
Confidence 45688999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CceeeEEeeeccc
Q 042314 85 GHVVICKILEDRG 97 (370)
Q Consensus 85 g~~~~~~~L~~~~ 97 (370)
|+.++++.|...+
T Consensus 117 g~~~~v~~Ll~~g 129 (299)
T 1s70_B 117 GYLDIAEYLISQG 129 (299)
T ss_dssp TCHHHHHHHHHTT
T ss_pred CCHHHHHHHHhCC
Confidence 9999999998765
|
| >2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A | Back alignment and structure |
|---|
Probab=99.71 E-value=2e-17 Score=140.53 Aligned_cols=84 Identities=24% Similarity=0.171 Sum_probs=80.0
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcC-CCCCCCCCCCCcHHHHHHHCCCHHHHHHHH-HcCCCccCccccCCCcccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKG-VEPNLADYDKRTALHLASSEGRAEIVLLLL-EKGADVNSLDRWGRTPLSD 80 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~g-a~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll-~~gad~~~~~~~g~tpl~~ 80 (370)
.+|..|+||||+||..|+.+++++|+++| +++|.+|.+|+||||+|+..|+.+++++|+ ++|+|++..|..|+||++.
T Consensus 135 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~~ga~~~~~~~~g~t~l~~ 214 (228)
T 2dzn_A 135 IKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDV 214 (228)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCBCTTSCBGGGG
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHhcCcccccCcCCCCCCHHHHHHHcCCHHHHHHHHHhcCCCCCccCCCCCcHHHH
Confidence 46788999999999999999999999999 999999999999999999999999999999 8999999999999999999
Q ss_pred ccccCc
Q 042314 81 ARSFGH 86 (370)
Q Consensus 81 A~~~g~ 86 (370)
|...+.
T Consensus 215 A~~~~~ 220 (228)
T 2dzn_A 215 ALNEQV 220 (228)
T ss_dssp CSSTTH
T ss_pred HHHHHH
Confidence 987653
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.70 E-value=3.2e-18 Score=160.14 Aligned_cols=96 Identities=29% Similarity=0.377 Sum_probs=82.9
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+||||+||..|+.++|++|+++|+++|..|..|.||||+|+..|+.+++++|+++|+++|..+..|+||||.|+
T Consensus 9 ~~~~~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~ 88 (437)
T 1n11_A 9 GGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAA 88 (437)
T ss_dssp ------CCHHHHHHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHHHHHH
T ss_pred ccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHH
Confidence 46778999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecccC
Q 042314 83 SFGHVVICKILEDRGG 98 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~ 98 (370)
..|+.++++.|.+.+.
T Consensus 89 ~~g~~~~v~~Ll~~ga 104 (437)
T 1n11_A 89 RIGHTNMVKLLLENNA 104 (437)
T ss_dssp HHTCHHHHHHHHHHTC
T ss_pred HCCCHHHHHHHHhCCC
Confidence 9999999998887653
|
| >1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.70 E-value=3e-17 Score=145.48 Aligned_cols=82 Identities=24% Similarity=0.295 Sum_probs=78.4
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARS 83 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~ 83 (370)
.+..|+||||+||..|+.++|++|+++|+|+|.+|.+|.||||+|+..|+.+++++|+++|+|++.+|..|.||++.|..
T Consensus 195 ~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~d~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~t~l~~A~~ 274 (299)
T 1s70_B 195 HAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADE 274 (299)
T ss_dssp CTTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTTTSCCS
T ss_pred hcCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHhcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHH
Confidence 45789999999999999999999999999999999999999999999999999999999999999999999999999976
Q ss_pred cC
Q 042314 84 FG 85 (370)
Q Consensus 84 ~g 85 (370)
..
T Consensus 275 ~~ 276 (299)
T 1s70_B 275 DI 276 (299)
T ss_dssp GG
T ss_pred HH
Confidence 43
|
| >1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.70 E-value=5.4e-18 Score=158.66 Aligned_cols=94 Identities=28% Similarity=0.390 Sum_probs=57.6
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARS 83 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~ 83 (370)
.|..|+||||+|+..|+.++|++|+++|+++|..|..|.||||+|+..|+.+++++|+++|++++..+..|+||||.|+.
T Consensus 241 ~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~ 320 (437)
T 1n11_A 241 ESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASH 320 (437)
T ss_dssp CCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCccCCCCCCCCCCHHHHHHH
Confidence 34556666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cCceeeEEeeeccc
Q 042314 84 FGHVVICKILEDRG 97 (370)
Q Consensus 84 ~g~~~~~~~L~~~~ 97 (370)
.|+.++++.|.+.+
T Consensus 321 ~g~~~~v~~Ll~~g 334 (437)
T 1n11_A 321 YGNIKLVKFLLQHQ 334 (437)
T ss_dssp SSCSHHHHHHHHTT
T ss_pred cCcHHHHHHHHhcC
Confidence 66666666555543
|
| >4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=4.1e-18 Score=153.92 Aligned_cols=93 Identities=34% Similarity=0.368 Sum_probs=77.8
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCC-CCCcHHHHHHHCCCHHHHHHHHHcCCCccC--------------
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADY-DKRTALHLASSEGRAEIVLLLLEKGADVNS-------------- 69 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~-~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~-------------- 69 (370)
+.+|+||||.||.+|++++|++||++|||||.+|. .|+||||+||..|+.++|++|+++|++++.
T Consensus 22 ~~~~~t~L~~Av~~g~~~~V~~LL~~Gadvn~~~~~~g~TpLh~A~~~g~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~~~ 101 (337)
T 4g8k_A 22 AVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFILAAI 101 (337)
T ss_dssp HHHHHHHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHH
T ss_pred CCCCChHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCcCHHHHHHHcCCHHHHHHHHHcCCchhhhccCCCchhHHHHh
Confidence 34589999999999999999999999999999875 599999999999999999999999987654
Q ss_pred -------------------ccccCCCccccccccCceeeEEeeeccc
Q 042314 70 -------------------LDRWGRTPLSDARSFGHVVICKILEDRG 97 (370)
Q Consensus 70 -------------------~~~~g~tpl~~A~~~g~~~~~~~L~~~~ 97 (370)
.|..|+||++.|+..|+.++++.+...+
T Consensus 102 ~~~~~~~~~~~~~~~~~~~~d~~g~t~l~~A~~~~~~~~~~~ll~~g 148 (337)
T 4g8k_A 102 AGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRG 148 (337)
T ss_dssp HTCHHHHHHHHTTTCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTT
T ss_pred cccchhhHHhhhccchhhhhccCCCCHHHHHHHcCcHHHHHHHHHcC
Confidence 4556667777777777777666665543
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-17 Score=146.58 Aligned_cols=93 Identities=31% Similarity=0.398 Sum_probs=75.3
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccccc
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSF 84 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~ 84 (370)
+..|+||||+||..|+.+++++|+++|++++..|.+|.||||+|+..|+.+++++|+++|++++..+..|+||++.|+..
T Consensus 36 ~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~ 115 (285)
T 1wdy_A 36 EEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVY 115 (285)
T ss_dssp TTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTCCBHHHHHHHT
T ss_pred CCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCcccCCHHHHHHHh
Confidence 56678888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CceeeEEeeeccc
Q 042314 85 GHVVICKILEDRG 97 (370)
Q Consensus 85 g~~~~~~~L~~~~ 97 (370)
|+.++++.|.+.+
T Consensus 116 ~~~~~~~~Ll~~g 128 (285)
T 1wdy_A 116 GKVKALKFLYKRG 128 (285)
T ss_dssp TCHHHHHHHHHTT
T ss_pred CCHHHHHHHHHhC
Confidence 8888777776643
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.69 E-value=3.4e-18 Score=153.82 Aligned_cols=93 Identities=19% Similarity=0.085 Sum_probs=86.7
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCC---HHHHHHHHHcC-CCccCccccCCCccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGR---AEIVLLLLEKG-ADVNSLDRWGRTPLS 79 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~---~~~~~~Ll~~g-ad~~~~~~~g~tpl~ 79 (370)
+|..|+||||+||..|+.++|++||++||++|.+|.+|+||||+|+..|+ .++++.|++.+ ++++..|..|+||||
T Consensus 127 ~d~~g~TpLh~Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~~~ll~~~~~~~~~~d~~g~tpLh 206 (327)
T 1sw6_A 127 VDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILH 206 (327)
T ss_dssp CSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEECTTCCCHHH
T ss_pred cCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHHHHHHHhhhccccCCCCCCCCHHH
Confidence 68899999999999999999999999999999999999999999999999 78888888887 889999999999999
Q ss_pred cccc----cCceeeEEeeecc
Q 042314 80 DARS----FGHVVICKILEDR 96 (370)
Q Consensus 80 ~A~~----~g~~~~~~~L~~~ 96 (370)
.|+. .|+.++++.|.+.
T Consensus 207 ~A~~~~~~~g~~~~v~~Ll~~ 227 (327)
T 1sw6_A 207 HIIITSGMTGCSAAAKYYLDI 227 (327)
T ss_dssp HHHHHHTSTTCHHHHHHHHHH
T ss_pred HHHHHccccccHHHHHHHHHH
Confidence 9998 8888888887654
|
| >4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=7.5e-18 Score=152.19 Aligned_cols=94 Identities=28% Similarity=0.288 Sum_probs=55.7
Q ss_pred CCCCCChhhhHHhhcCC----HHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHc-CCCccCccccCCCcc
Q 042314 4 IDSEGPYRLLYCSSKGD----RAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK-GADVNSLDRWGRTPL 78 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~----~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~-gad~~~~~~~g~tpl 78 (370)
+|..|+|+||+++..++ .+++++|+++|||+|.+|.+|+||||+|+..|+.++++.|+.. |+++|.+|..|+|||
T Consensus 198 ~d~~g~t~l~~~~~~~~~~~~~~i~~lLl~~gad~n~~d~~g~t~L~~a~~~~~~~~v~~Ll~~~~~~vn~~d~~G~TpL 277 (337)
T 4g8k_A 198 CDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTAL 277 (337)
T ss_dssp CCTTSCCHHHHHHHHSCTTTHHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHTSTTCCTTCBCTTSCBHH
T ss_pred cCCCCCcHHHHHHHHcCcccHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhhhhHHHHHHHHhcCCcccCcCCCCCCHH
Confidence 45556666665544332 2355566666666666666666666666666666666666653 566666666666666
Q ss_pred ccccccCceeeEEeeeccc
Q 042314 79 SDARSFGHVVICKILEDRG 97 (370)
Q Consensus 79 ~~A~~~g~~~~~~~L~~~~ 97 (370)
|.|+..|+.+++++|++.+
T Consensus 278 ~~A~~~g~~~iv~~Ll~~G 296 (337)
T 4g8k_A 278 LLAVELKLKKIAELLCKRG 296 (337)
T ss_dssp HHHHHTTCHHHHHHHHTTS
T ss_pred HHHHHcCCHHHHHHHHHCC
Confidence 6666666666666665544
|
| >1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.68 E-value=2.8e-17 Score=147.78 Aligned_cols=83 Identities=25% Similarity=0.186 Sum_probs=76.4
Q ss_pred cCCCCCChhhhHHhh----cCCHHHHHHHHHcCC---------------------------------------------C
Q 042314 3 IIDSEGPYRLLYCSS----KGDRAGVLQELEKGV---------------------------------------------E 33 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~----~g~~~~~~~ll~~ga---------------------------------------------~ 33 (370)
.+|..|+||||+||. .|+.+++++|++.|+ +
T Consensus 196 ~~d~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~Ll~~~ 275 (327)
T 1sw6_A 196 LEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANM 275 (327)
T ss_dssp EECTTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHT
T ss_pred CCCCCCCCHHHHHHHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHHHHhC
Confidence 568899999999999 999999999998854 6
Q ss_pred CCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccC
Q 042314 34 PNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFG 85 (370)
Q Consensus 34 ~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g 85 (370)
+|.+|.+|+||||+|+..|+.++|++|+++|||++.+|..|+||||+|+..|
T Consensus 276 ~n~~d~~G~TpLh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL~~A~~~g 327 (327)
T 1sw6_A 276 LNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGAGLE 327 (327)
T ss_dssp TTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTCC--
T ss_pred CCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHhcC
Confidence 8899999999999999999999999999999999999999999999998765
|
| >3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-17 Score=147.37 Aligned_cols=94 Identities=29% Similarity=0.254 Sum_probs=88.3
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|..|+||||+||..|+.++|++|+++|+++|.+|.+|.||||+|+..|+.+++++|+++|++++..+ .|.||++.|+
T Consensus 87 ~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~-~g~t~L~~A~ 165 (285)
T 3d9h_A 87 IITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPES-DLASPIHEAA 165 (285)
T ss_dssp EECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCSC-TTSCHHHHHH
T ss_pred CcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCHHHHHHHHHHCCCCCCCCC-CCCCHHHHHH
Confidence 467899999999999999999999999999999999999999999999999999999999999998755 4999999999
Q ss_pred ccCceeeEEeeeccc
Q 042314 83 SFGHVVICKILEDRG 97 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~ 97 (370)
..|+.++++.|.+.+
T Consensus 166 ~~g~~~~v~~Ll~~g 180 (285)
T 3d9h_A 166 RRGHVECVNSLIAYG 180 (285)
T ss_dssp HHTCHHHHHHHHHTT
T ss_pred HcCCHHHHHHHHHCC
Confidence 999999999987754
|
| >1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.68 E-value=1.6e-17 Score=145.76 Aligned_cols=91 Identities=31% Similarity=0.335 Sum_probs=47.4
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHHc-CCCCCCCCCCCCcHHHHHHHCCC----HHHHHHHHHcCCCccCccccCCCccc
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELEK-GVEPNLADYDKRTALHLASSEGR----AEIVLLLLEKGADVNSLDRWGRTPLS 79 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~~-ga~~~~~~~~g~t~l~~A~~~g~----~~~~~~Ll~~gad~~~~~~~g~tpl~ 79 (370)
+..|.||||+|+..|+.+++++|+++ |+++|..|..|.||||+|+..|+ .+++++|+++|++++..+..|.||+|
T Consensus 145 ~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~i~~~Ll~~g~~~~~~~~~g~t~L~ 224 (285)
T 1wdy_A 145 RKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLI 224 (285)
T ss_dssp TCCCCCHHHHHHHHTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHH
T ss_pred ccCCCcHHHHHHHcCCHHHHHHHHHhcCCCCCccCCCCCCHHHHHHHccccchHHHHHHHHHHcCCCCCCcCCCCCcHHH
Confidence 44455555555555555555555544 55555555555555555555555 45555555555555555555555555
Q ss_pred cccccCceeeEEeeec
Q 042314 80 DARSFGHVVICKILED 95 (370)
Q Consensus 80 ~A~~~g~~~~~~~L~~ 95 (370)
.|+..|+.++++.|.+
T Consensus 225 ~A~~~~~~~~v~~Ll~ 240 (285)
T 1wdy_A 225 LAVEKKHLGLVQRLLE 240 (285)
T ss_dssp HHHHTTCHHHHHHHHH
T ss_pred HHHHcCCHHHHHHHHh
Confidence 5555555555554444
|
| >2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 | Back alignment and structure |
|---|
Probab=99.67 E-value=5.6e-18 Score=155.23 Aligned_cols=94 Identities=22% Similarity=0.261 Sum_probs=88.0
Q ss_pred CC-CCCChhhhHHhhcCCHHHHHHHH--------HcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccC
Q 042314 4 ID-SEGPYRLLYCSSKGDRAGVLQEL--------EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWG 74 (370)
Q Consensus 4 ~~-~~g~t~l~~a~~~g~~~~~~~ll--------~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g 74 (370)
.| ..|+||||+||..|+.+++++|+ ++|+++|.+|.+|.||||+|+..|+.++|++|+++|++++..+..|
T Consensus 120 ~d~~~g~t~Lh~Aa~~g~~~~v~~Ll~~~~~~ll~~ga~vn~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g 199 (373)
T 2fo1_E 120 IDPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSE 199 (373)
T ss_dssp CCCSSCCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTC
T ss_pred cCCcCCCCHHHHHHHCCCHHHHHHHHHHHHHHHHhcCCCCcCCCCCCCCHHHHHHHcChHHHHHHHHHCCCCCcccCCCC
Confidence 45 68999999999999998888776 8999999999999999999999999999999999999999999999
Q ss_pred CCccccccccCceeeEEeeeccc
Q 042314 75 RTPLSDARSFGHVVICKILEDRG 97 (370)
Q Consensus 75 ~tpl~~A~~~g~~~~~~~L~~~~ 97 (370)
.||||.|+..|+.++++.|...+
T Consensus 200 ~t~L~~A~~~g~~~~v~~Ll~~~ 222 (373)
T 2fo1_E 200 RSALHQAAANRDFGMMVYMLNST 222 (373)
T ss_dssp CCHHHHHHHTTCHHHHHHHTTSH
T ss_pred CCHHHHHHHCCCHHHHHHHHhcC
Confidence 99999999999999999887654
|
| >3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.7e-17 Score=148.05 Aligned_cols=95 Identities=26% Similarity=0.359 Sum_probs=88.4
Q ss_pred CCCCCChhhhHHhhc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccc
Q 042314 4 IDSEGPYRLLYCSSK---GDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSD 80 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~---g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~ 80 (370)
.+..|+||||+|+.. +..+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|+++|..|..|+||||.
T Consensus 207 ~~~~~~t~L~~A~~~~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~t~L~~ 286 (351)
T 3utm_A 207 QPQSHETALHCAVASLHPKRKQVAELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTALHR 286 (351)
T ss_dssp CTTTCCCHHHHHHHCCSTTHHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHhCccHHHHHHHHHHcCCCcCCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHH
Confidence 467899999999999 55899999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCceeeEEeeecccC
Q 042314 81 ARSFGHVVICKILEDRGG 98 (370)
Q Consensus 81 A~~~g~~~~~~~L~~~~~ 98 (370)
|+..|+.+++++|.+.+.
T Consensus 287 A~~~~~~~~v~~Ll~~ga 304 (351)
T 3utm_A 287 AALAGHLQTCRLLLSYGS 304 (351)
T ss_dssp HHHHTCHHHHHHHHHTTC
T ss_pred HHHcCcHHHHHHHHHcCC
Confidence 999999999999987653
|
| >2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=9.7e-17 Score=142.28 Aligned_cols=79 Identities=19% Similarity=0.067 Sum_probs=68.1
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|..|+||||+||..|+.++|++||++|||+|.+|.+|.||||+|+..|+.+++++|+++|++ .|.||+|.|+
T Consensus 221 ~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~iv~~Ll~~ga~------~g~tpLh~A~ 294 (301)
T 2b0o_E 221 AKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELLEQAQAG------TFAFPLHVDY 294 (301)
T ss_dssp CCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCCSCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHH------TTSSCCC---
T ss_pred CCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHhcCC------CCCChhHHHH
Confidence 4688999999999999999999999999999999999999999999999999999999999986 5789999999
Q ss_pred ccCce
Q 042314 83 SFGHV 87 (370)
Q Consensus 83 ~~g~~ 87 (370)
.+|+.
T Consensus 295 ~~g~~ 299 (301)
T 2b0o_E 295 SWVIS 299 (301)
T ss_dssp -----
T ss_pred hcCCc
Confidence 98864
|
| >3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A | Back alignment and structure |
|---|
Probab=99.64 E-value=5.1e-17 Score=147.51 Aligned_cols=93 Identities=27% Similarity=0.347 Sum_probs=88.0
Q ss_pred CCCChhhhHHhhc-CCHHHHHHHHHcCCCCCCCC--CCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 6 SEGPYRLLYCSSK-GDRAGVLQELEKGVEPNLAD--YDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 6 ~~g~t~l~~a~~~-g~~~~~~~ll~~ga~~~~~~--~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..+.|+||+||.. |+.++++.||++|+|+|..| .+|.||||+|+..|+.+++++|+++|+++|..|..|+||||.|+
T Consensus 197 ~~~~t~L~~Aa~~~g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~ 276 (368)
T 3jue_A 197 LHPGALLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHAT 276 (368)
T ss_dssp CCHHHHHHHHTSSSCCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred CCCCcHHHHHHHccCCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH
Confidence 3567899999999 99999999999999999998 89999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecccC
Q 042314 83 SFGHVVICKILEDRGG 98 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~ 98 (370)
..|+.+++++|+..++
T Consensus 277 ~~g~~~~v~~LL~~Ga 292 (368)
T 3jue_A 277 ILGHTGLACLFLKRGA 292 (368)
T ss_dssp HHTCHHHHHHHHHTTC
T ss_pred HcCcHHHHHHHHHCcC
Confidence 9999999999987653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=6.5e-17 Score=145.99 Aligned_cols=133 Identities=17% Similarity=0.193 Sum_probs=95.1
Q ss_pred CCCCCCcccEEEEEE-cCceeEEEEeccccCC--------------C-----hHHHHHHHHHHHHHHhcCCCce--eeee
Q 042314 98 GIDPGAYGEVYLVKW-RGTEIAAKTIRSSIAS--------------N-----PRVRNSFMKELGLWQKLRHPNI--VQFL 155 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~-~g~~vavK~l~~~~~~--------------~-----~~~~~~~~~e~~~l~~l~hp~I--v~~~ 155 (370)
.+|.|++|.||+|.. .|+.+|+|+++..... . ...+.....|...+.++.+.++ ...+
T Consensus 102 ~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~ 181 (397)
T 4gyi_A 102 RIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPI 181 (397)
T ss_dssp EEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEE
T ss_pred EeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeee
Confidence 489999999999976 4889999997643111 0 0111223456667777654433 2233
Q ss_pred eeEeeCCceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC------
Q 042314 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG------ 229 (370)
Q Consensus 156 ~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~------ 229 (370)
+. ...++||||++|++|.++. .......++.|++.+|.+||+.| ||||||||.|||++++|
T Consensus 182 ~~----~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~ 248 (397)
T 4gyi_A 182 AQ----SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPS 248 (397)
T ss_dssp EE----ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTT
T ss_pred ec----cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCccccc
Confidence 22 2347999999998886542 22345678899999999999998 99999999999999776
Q ss_pred ----cEEEeccccceecc
Q 042314 230 ----HLKVTDFGLSKIAQ 243 (370)
Q Consensus 230 ----~~kl~Dfg~~~~~~ 243 (370)
.+.|+||+.+....
T Consensus 249 ~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 249 SITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SEEEEEEECCCTTCEETT
T ss_pred ccccceEEEEeCCcccCC
Confidence 38999999876543
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.4e-16 Score=136.17 Aligned_cols=120 Identities=23% Similarity=0.212 Sum_probs=83.0
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCC-HHHHHHHHHcCCCccCccc-cCCCcccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGR-AEIVLLLLEKGADVNSLDR-WGRTPLSD 80 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~-~~~~~~Ll~~gad~~~~~~-~g~tpl~~ 80 (370)
..|..|+||||+|+..|+.+++++|+++|++++..|.+|.||||+|+..++ .+++++|++.|++++..+. .|.||||.
T Consensus 104 ~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~~L~~~~~~~~~~~~~~g~t~L~~ 183 (240)
T 3eu9_A 104 LIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHW 183 (240)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCSSTTHHHHHHTTCCTTCCCTTTCCCHHHH
T ss_pred ccCCCCCCHHHHHHHcCHHHHHHHHHhcCCCccccCCCCCcHHHHHHHhCChHHHHHHHHhcCCCcchhhccCCCcHHHH
Confidence 356678888888888888888888888888888888888888888775555 6777777777777777776 77777777
Q ss_pred ccccCceeeEEeeecccC----CCCCCcccEEEEEEcCceeEEEEe
Q 042314 81 ARSFGHVVICKILEDRGG----IDPGAYGEVYLVKWRGTEIAAKTI 122 (370)
Q Consensus 81 A~~~g~~~~~~~L~~~~~----l~~g~~~~v~~a~~~g~~vavK~l 122 (370)
|+..|+.++++.|.+.+. .+..+...+..|...+...+++.+
T Consensus 184 A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~v~~L 229 (240)
T 3eu9_A 184 AVLAGNTTVISLLLEAGANVDAQNIKGESALDLAKQRKNVWMINHL 229 (240)
T ss_dssp HHHHTCHHHHHHHHHHTCCTTCBCTTSCBHHHHHHHTTCHHHHHHH
T ss_pred HHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHH
Confidence 777777777777766543 222333344444444444444444
|
| >3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=2.9e-16 Score=134.18 Aligned_cols=120 Identities=24% Similarity=0.282 Sum_probs=87.6
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccc-cCCCcccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDR-WGRTPLSDAR 82 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~-~g~tpl~~A~ 82 (370)
.|..|.||||+||..|+.+++++|++.|++++..|..|.||||+|+..|+.+++++|+++|++++..+. .|.||++.|+
T Consensus 5 ~d~~~~~~l~~A~~~g~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~ 84 (240)
T 3eu9_A 5 IDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWAT 84 (240)
T ss_dssp CSCGGGCCHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHH
T ss_pred cccccchHHHHHHHcCChHHHHHHHHcCCCcCCCCCCCCCHHHHHHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHH
Confidence 577788888888888888888888888888888888888888888888888888888888888775554 4788888888
Q ss_pred ccCceeeEEeeecccC----CCCCCcccEEEEEEcCceeEEEEec
Q 042314 83 SFGHVVICKILEDRGG----IDPGAYGEVYLVKWRGTEIAAKTIR 123 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~----l~~g~~~~v~~a~~~g~~vavK~l~ 123 (370)
..|+.++++.|.+.+. .+..+...++.+...+...+++.+.
T Consensus 85 ~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll 129 (240)
T 3eu9_A 85 RQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLI 129 (240)
T ss_dssp HHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHH
T ss_pred HcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCHHHHHHHHH
Confidence 8888888887776543 2223334444444445555555553
|
| >3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* | Back alignment and structure |
|---|
Probab=99.60 E-value=4.2e-17 Score=154.95 Aligned_cols=116 Identities=16% Similarity=0.231 Sum_probs=96.8
Q ss_pred CChhhhHHhhcCCHHHHHHHHHcCCCCCCC------CCCCCcHHHHHHH---CCCHHHHHHHHHcCCCccCccccCCCcc
Q 042314 8 GPYRLLYCSSKGDRAGVLQELEKGVEPNLA------DYDKRTALHLASS---EGRAEIVLLLLEKGADVNSLDRWGRTPL 78 (370)
Q Consensus 8 g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~------~~~g~t~l~~A~~---~g~~~~~~~Ll~~gad~~~~~~~g~tpl 78 (370)
..+.||.|+..|+.+.|+.||++|+|+|.. |.+|+||||+||. .|+.+++++|+++|+|+|..|..|+|||
T Consensus 132 ~~~~L~~A~~~g~~~~v~~ll~~g~~~n~~~~~~~~~~~g~t~Lh~A~~~a~~g~~~~v~~Ll~~ga~vn~~d~~g~TpL 211 (497)
T 3lvq_E 132 EPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTAL 211 (497)
T ss_dssp CHHHHHHHHHHTCHHHHHHHHHTTCCSSSCBCCSSSCCSCBCHHHHHHHTCCTTTHHHHHHHHHHSCCTTCCCSSSCCHH
T ss_pred cHHHHHHHHhccCHHHHHHHHhhcccccCCCCCcccccccchHHHHHHHhcccccHHHHHHHHHcCCCCCccCCCCCcHH
Confidence 457899999999999999999999999988 8999999999966 9999999999999999999999999999
Q ss_pred ccccccCceeeEEeeecccC----CCCCCcccEEEEEEcCceeEEEEec
Q 042314 79 SDARSFGHVVICKILEDRGG----IDPGAYGEVYLVKWRGTEIAAKTIR 123 (370)
Q Consensus 79 ~~A~~~g~~~~~~~L~~~~~----l~~g~~~~v~~a~~~g~~vavK~l~ 123 (370)
|.|+..|+.+++++|++.++ .+..+...++.|...|...+++.+.
T Consensus 212 h~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~Ll 260 (497)
T 3lvq_E 212 HYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELLE 260 (497)
T ss_dssp HHHTTTTCHHHHHHHHHTCCCCSCCCTTCCCHHHHHHHTTCHHHHHHHH
T ss_pred HHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHH
Confidence 99999999999999988764 2333334444444444444444443
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 | Back alignment and structure |
|---|
Probab=99.59 E-value=1e-17 Score=152.64 Aligned_cols=94 Identities=16% Similarity=0.121 Sum_probs=71.3
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCC---CCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccC--ccccCCCc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEP---NLADYDKRTALHLASSEGRAEIVLLLLEKGADVNS--LDRWGRTP 77 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~---~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~--~~~~g~tp 77 (370)
..|..|+||||+||.+|+.++|++|+++|+|+ +..+.+ .||||+||..|+.++|++|+++|++++. .|..|+||
T Consensus 123 ~~~~~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpLh~Aa~~G~~eiv~~Ll~~ga~~~~~~~d~~g~Tp 201 (376)
T 2aja_A 123 VIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYA 201 (376)
T ss_dssp --CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHHHHHHH
T ss_pred HhccCCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCHHHHHHHCCCHHHHHHHHHcCCccchhccCCCCCCH
Confidence 34556778888888888888888888888752 333333 7888888888888888888888888777 77778888
Q ss_pred ccccc-ccCceeeEEeeeccc
Q 042314 78 LSDAR-SFGHVVICKILEDRG 97 (370)
Q Consensus 78 l~~A~-~~g~~~~~~~L~~~~ 97 (370)
||.|+ ..|+.+++++|.+.+
T Consensus 202 L~~Aa~~~G~~eiv~~Ll~~g 222 (376)
T 2aja_A 202 FRWAAVGRGHHNVINFLLDCP 222 (376)
T ss_dssp HHHHHSTTCCHHHHHHHTTSH
T ss_pred HHHHHHHCCCHHHHHHHHhCC
Confidence 88888 888888888876643
|
| >1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 | Back alignment and structure |
|---|
Probab=99.56 E-value=1.6e-16 Score=139.20 Aligned_cols=90 Identities=23% Similarity=0.206 Sum_probs=83.8
Q ss_pred ChhhhHHhhcCCHHHHHHHHHcCCCCC------CCCCCCCcHHHHHHHC---CCHHHHHHHHHcCCCccCccccCCCccc
Q 042314 9 PYRLLYCSSKGDRAGVLQELEKGVEPN------LADYDKRTALHLASSE---GRAEIVLLLLEKGADVNSLDRWGRTPLS 79 (370)
Q Consensus 9 ~t~l~~a~~~g~~~~~~~ll~~ga~~~------~~~~~g~t~l~~A~~~---g~~~~~~~Ll~~gad~~~~~~~g~tpl~ 79 (370)
.++|+.|+..|+.+.++.|++.|++++ ..|..|+||||+|+.. |+.+++++|+++|+++|..|..|+||||
T Consensus 131 l~~l~~a~~~~d~~~~~~ll~~g~~~~~~~~l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh 210 (278)
T 1dcq_A 131 LHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALH 210 (278)
T ss_dssp HHHHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHH
T ss_pred hhhhhhHhhhcccHHHHHHHHhhcchhhhccccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHHH
Confidence 478999999999999999999999954 4589999999999999 9999999999999999999999999999
Q ss_pred cccccCceeeEEeeecccC
Q 042314 80 DARSFGHVVICKILEDRGG 98 (370)
Q Consensus 80 ~A~~~g~~~~~~~L~~~~~ 98 (370)
.|+..|+.+++++|.+.++
T Consensus 211 ~A~~~g~~~~v~~Ll~~ga 229 (278)
T 1dcq_A 211 YCCLTDNAECLKLLLRGKA 229 (278)
T ss_dssp HHHHTTCHHHHHHHHHTTC
T ss_pred HHHHcCCHHHHHHHHHcCC
Confidence 9999999999999987653
|
| >2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A | Back alignment and structure |
|---|
Probab=99.50 E-value=3.4e-14 Score=106.13 Aligned_cols=58 Identities=22% Similarity=0.288 Sum_probs=55.9
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHH
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLL 60 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~L 60 (370)
.+|..|+||||+||..|+.+++++|+++|+++|.+|..|+||||+|+..|+.+++++|
T Consensus 52 ~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L 109 (110)
T 2zgd_A 52 AKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDISIDNGNEDLAEIL 109 (110)
T ss_dssp CCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHH
T ss_pred ccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcHHHHHHHcCCHHHHHHh
Confidence 4678999999999999999999999999999999999999999999999999999987
|
| >2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 | Back alignment and structure |
|---|
Probab=99.48 E-value=8.8e-16 Score=139.87 Aligned_cols=92 Identities=12% Similarity=0.041 Sum_probs=76.1
Q ss_pred CCCCChhhhHHhhcCCHHHHHHHHHcCCCC---CCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCC---ccCccccCCCcc
Q 042314 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEP---NLADYDKRTALHLASSEGRAEIVLLLLEKGAD---VNSLDRWGRTPL 78 (370)
Q Consensus 5 ~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~---~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad---~~~~~~~g~tpl 78 (370)
+.+++||||+||..|+.++|++|+++|+.. +..|..|.||||+||..|+.++|++|+++|+| .+..+.. +|||
T Consensus 89 g~~~~T~Lh~Aa~~G~~e~v~~Ll~~ga~~~~~~~~~~~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpL 167 (376)
T 2aja_A 89 GIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAF 167 (376)
T ss_dssp TCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHH
T ss_pred CCCcCCHHHHHHHcCCHHHHHHHHHcCCcHHHHHHhccCCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCHH
Confidence 456789999999999999999999999832 34566789999999999999999999999986 2333333 8999
Q ss_pred ccccccCceeeEEeeeccc
Q 042314 79 SDARSFGHVVICKILEDRG 97 (370)
Q Consensus 79 ~~A~~~g~~~~~~~L~~~~ 97 (370)
|.|+..|+.++++.|.+.+
T Consensus 168 h~Aa~~G~~eiv~~Ll~~g 186 (376)
T 2aja_A 168 RLAAENGHLHVLNRLCELA 186 (376)
T ss_dssp HHHHHTTCHHHHHHHHHSC
T ss_pred HHHHHCCCHHHHHHHHHcC
Confidence 9999999999999998765
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=4.9e-12 Score=109.76 Aligned_cols=134 Identities=15% Similarity=0.098 Sum_probs=103.5
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
.+.|+.+.||++...+..+++|......... ...+.+|+.+++.+. +..++++++++...+..++||||++|.+|.
T Consensus 22 ~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 22 TEGMSPAKVYKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp CSCCSSSEEEEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred ccCCCCCeEEEEECCCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 4456678899998888999999987532111 234778999998884 677889999988888999999999999998
Q ss_pred HHHHhCCCCChHhHHHHHHHHHHHHHHHhhc-------------------------------------------------
Q 042314 178 DILKKKGKLDPPTAVAYALDIARGMNYLHHH------------------------------------------------- 208 (370)
Q Consensus 178 ~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~------------------------------------------------- 208 (370)
+... +......++.++..++..||+.
T Consensus 99 ~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 173 (263)
T 3tm0_A 99 EEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF 173 (263)
T ss_dssp HHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHH
T ss_pred hccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHH
Confidence 7631 2234457888999999999981
Q ss_pred -------CCCceeecCCCCCCeeeCCCCcEEEeccccce
Q 042314 209 -------RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK 240 (370)
Q Consensus 209 -------~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~ 240 (370)
.+..++|+|++|.||++++.+.+.|+||+.+.
T Consensus 174 l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11348999999999999875556799998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.22 E-value=5.6e-11 Score=107.99 Aligned_cols=140 Identities=16% Similarity=0.237 Sum_probs=103.9
Q ss_pred CCCCCcccEEEEEEcCceeEEEEec--cccCCChHHHHHHHHHHHHHHhcC--CCceeeeeeeEeeC---CceEEEEeec
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIR--SSIASNPRVRNSFMKELGLWQKLR--HPNIVQFLGVLKHS---ERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~--~~~~~~~~~~~~~~~e~~~l~~l~--hp~Iv~~~~~~~~~---~~~~~v~e~~ 171 (370)
++.|.++.+|++...+..+++|... ... .......+.+|..+++.+. +..+++++.++.+. +..++||||+
T Consensus 46 l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~--~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v 123 (359)
T 3dxp_A 46 FKGGQSNPTFKLVTPGQTYVMRAKPGPKSK--LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV 123 (359)
T ss_dssp CCC-CCSCEEEEECSSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred cCCcccceEEEEEECCceEEEEeCCCCCCC--CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence 5668889999998888888888876 321 1122346778999999886 34578888887766 4589999999
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHR------------------------------------------ 209 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~------------------------------------------ 209 (370)
+|.++.+. ....++......++.++...|..||+..
T Consensus 124 ~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (359)
T 3dxp_A 124 SGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLM 201 (359)
T ss_dssp CCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHH
T ss_pred CCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHH
Confidence 99877431 1234677888889999999999999731
Q ss_pred -------------CCceeecCCCCCCeeeCCCCc--EEEeccccceec
Q 042314 210 -------------PHAIIHRDLTPSNVLQDEAGH--LKVTDFGLSKIA 242 (370)
Q Consensus 210 -------------~~~iiH~Dlk~~Nil~~~~~~--~kl~Dfg~~~~~ 242 (370)
+..++|+|+++.||+++.++. +.|+||+.+..-
T Consensus 202 ~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 202 DWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 245999999999999997653 689999988654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=1.1e-10 Score=101.00 Aligned_cols=126 Identities=17% Similarity=0.121 Sum_probs=91.9
Q ss_pred CCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCc--eeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 101 PGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN--IVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 101 ~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~--Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
.|..+.||++... |..+++|...... ...+..|+.+++.+.+.+ +++++++....+..++||||++|.+|.
T Consensus 30 gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 30 GCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp TTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 4556889998764 5679999875431 134678888888885444 566888888778899999999998884
Q ss_pred HHHHhCCCCChHhHHHHHHHHHHHHHHHhhcC------------------------------------------------
Q 042314 178 DILKKKGKLDPPTAVAYALDIARGMNYLHHHR------------------------------------------------ 209 (370)
Q Consensus 178 ~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~------------------------------------------------ 209 (370)
.. ..+ ...++.++...+..||+..
T Consensus 104 --~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (264)
T 1nd4_A 104 --SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLK 175 (264)
T ss_dssp --TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHH
T ss_pred --cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHH
Confidence 11 111 2356677777777777643
Q ss_pred -------CCceeecCCCCCCeeeCCCCcEEEeccccce
Q 042314 210 -------PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK 240 (370)
Q Consensus 210 -------~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~ 240 (370)
+..++|+|++|.||++++++.+.|+||+.+.
T Consensus 176 ~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 176 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999876656799999865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.05 E-value=1.3e-10 Score=103.00 Aligned_cols=183 Identities=18% Similarity=0.181 Sum_probs=116.9
Q ss_pred CCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCc--eeeeeeeEeeCC---ceEEEEeecCC
Q 042314 100 DPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPN--IVQFLGVLKHSE---RLIFLTEYLRN 173 (370)
Q Consensus 100 ~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~--Iv~~~~~~~~~~---~~~~v~e~~~g 173 (370)
+.|....+|++. ..+++|+... ......+.+|..+++.+. +.. +++++......+ ..|+||++++|
T Consensus 29 ~~G~~n~v~~v~---~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 29 GEGNDCIAYEIN---RDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp EECSSEEEEEST---TSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred CCCCcceEEEEC---CEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 446666677653 5688887643 245677889999998873 322 455555543333 34889999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHR-------------------------------------------- 209 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~-------------------------------------------- 209 (370)
.+|...... .++..+...++.++...+..||+..
T Consensus 101 ~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 101 VPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp EECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred eECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 888754332 4667777788888888888888621
Q ss_pred -----------CCceeecCCCCCCeeeCC--CCcEEEeccccceeccccCccceeccCCCCCccccCcccccc----c--
Q 042314 210 -----------PHAIIHRDLTPSNVLQDE--AGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR----E-- 270 (370)
Q Consensus 210 -----------~~~iiH~Dlk~~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~-- 270 (370)
+..++|+|++|.||+++. .+.+.|+||+.+............. ....-..|+.... .
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~----~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLM----EDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTC----CTTTSCCHHHHHHHHHHHTC
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHH----hhccccCHHHHHHHHHHcCC
Confidence 134899999999999998 4567899999886543221110000 0000012221110 0
Q ss_pred --------CCCchhhHHHHHHHHHHHHhCCCCCC
Q 042314 271 --------SYGKSVDVFSFALIVHEMFQGGPSNR 296 (370)
Q Consensus 271 --------~~~~~~Di~slG~~l~el~~g~~p~~ 296 (370)
....-.+.|+++.++|.+.+|.++|.
T Consensus 255 ~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 255 KDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 01123689999999999999987753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=4.6e-07 Score=80.07 Aligned_cols=132 Identities=23% Similarity=0.205 Sum_probs=88.1
Q ss_pred CCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCC---ceeeeeeeEe-eCCceEEEEeecCCCCH
Q 042314 101 PGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHP---NIVQFLGVLK-HSERLIFLTEYLRNGSL 176 (370)
Q Consensus 101 ~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp---~Iv~~~~~~~-~~~~~~~v~e~~~g~~L 176 (370)
.|....+|.. +..+++|+.. .......+.+|..+++.+.+. .+++++.+.. ..+..++|||+++|.+|
T Consensus 29 ~G~~n~v~~v---g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 29 EGFRNYAILV---NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp ECSSEEEEEE---TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred CCcceeEEEE---CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 4666677777 6778888842 234567889999999998642 3566776664 44567899999999888
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhc------------------------------------------------
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHH------------------------------------------------ 208 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~------------------------------------------------ 208 (370)
....-. .++......+..++...|..||+.
T Consensus 101 ~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 178 (306)
T 3tdw_A 101 GEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQS 178 (306)
T ss_dssp HHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHH
T ss_pred chhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHH
Confidence 763211 233333444444444444444432
Q ss_pred ---------CCCceeecCCCCCCeeeCC---CCcE-EEeccccceec
Q 042314 209 ---------RPHAIIHRDLTPSNVLQDE---AGHL-KVTDFGLSKIA 242 (370)
Q Consensus 209 ---------~~~~iiH~Dlk~~Nil~~~---~~~~-kl~Dfg~~~~~ 242 (370)
.+..++|+|++|.||+++. ++.+ .|+||+.+..-
T Consensus 179 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 179 YMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2234799999999999997 4555 79999987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=1.2e-06 Score=75.80 Aligned_cols=126 Identities=18% Similarity=0.222 Sum_probs=91.2
Q ss_pred cEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecCCCCHHHHHHh
Q 042314 106 EVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKK 182 (370)
Q Consensus 106 ~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~ 182 (370)
.+|+.... +..+++|.-... ....+.+|...++.+. +--|+++++++.+.+..++|||+++|.++.+....
T Consensus 40 ~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~ 113 (272)
T 4gkh_A 40 TIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE 113 (272)
T ss_dssp EEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH
T ss_pred eEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccC
Confidence 57776543 567888876532 3456788999888874 33377888888888999999999999988876554
Q ss_pred CCCCChHhHHHHHHHHHHHHHHHhhcC-----------------------------------------------------
Q 042314 183 KGKLDPPTAVAYALDIARGMNYLHHHR----------------------------------------------------- 209 (370)
Q Consensus 183 ~~~~~~~~~~~i~~~l~~~l~~lH~~~----------------------------------------------------- 209 (370)
. ......+..++...+..||+..
T Consensus 114 ~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 189 (272)
T 4gkh_A 114 Y----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPF 189 (272)
T ss_dssp C----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCC
T ss_pred C----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccc
Confidence 2 2233455666666666666431
Q ss_pred --CCceeecCCCCCCeeeCCCCcEEEecccccee
Q 042314 210 --PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI 241 (370)
Q Consensus 210 --~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~ 241 (370)
+..++|+|+.+.||+++..+.+-|+||+.+..
T Consensus 190 ~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 190 SPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999876667999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=4.2e-06 Score=75.51 Aligned_cols=77 Identities=9% Similarity=0.094 Sum_probs=48.8
Q ss_pred CCCCcccEEEEEEc--------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCC---CceeeeeeeEeeC---CceE
Q 042314 100 DPGAYGEVYLVKWR--------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH---PNIVQFLGVLKHS---ERLI 165 (370)
Q Consensus 100 ~~g~~~~v~~a~~~--------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h---p~Iv~~~~~~~~~---~~~~ 165 (370)
+.|....+|+.... +..+++|...............+.+|..+++.+.. -.+++++.+.... +..+
T Consensus 30 ~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~ 109 (357)
T 3ats_A 30 STGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPF 109 (357)
T ss_dssp TTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCE
T ss_pred CCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCce
Confidence 45777888887655 67788887654320000001345677777777742 3467788776554 3568
Q ss_pred EEEeecCCCCH
Q 042314 166 FLTEYLRNGSL 176 (370)
Q Consensus 166 ~v~e~~~g~~L 176 (370)
+|||+++|.++
T Consensus 110 ~v~e~l~G~~l 120 (357)
T 3ats_A 110 FLMDYVEGVVP 120 (357)
T ss_dssp EEEECCCCBCC
T ss_pred EEEEecCCCCh
Confidence 99999998664
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.19 E-value=3.7e-05 Score=68.75 Aligned_cols=30 Identities=23% Similarity=0.319 Sum_probs=26.8
Q ss_pred CceeecCCCCCCeeeCCCCcEEEeccccce
Q 042314 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSK 240 (370)
Q Consensus 211 ~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~ 240 (370)
..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 459999999999999877889999999764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=1.2e-05 Score=73.74 Aligned_cols=74 Identities=14% Similarity=0.078 Sum_probs=46.2
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccC-CC---hHHHHHHHHHHHHHHhcCC--C-ceeeeeeeEeeCCceEEEEe
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIA-SN---PRVRNSFMKELGLWQKLRH--P-NIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~-~~---~~~~~~~~~e~~~l~~l~h--p-~Iv~~~~~~~~~~~~~~v~e 169 (370)
++.|..+.||++.. .+..+++|....... .. +....++..|.++++.+.. | .+++++.+ +.+..++|||
T Consensus 38 lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE 115 (397)
T 2olc_A 38 IGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVME 115 (397)
T ss_dssp CCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEEC
T ss_pred CCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEE
Confidence 67789999999954 467899998653221 00 1123456778888887742 3 34556644 3445689999
Q ss_pred ecCCC
Q 042314 170 YLRNG 174 (370)
Q Consensus 170 ~~~g~ 174 (370)
+++|.
T Consensus 116 ~l~g~ 120 (397)
T 2olc_A 116 DLSHL 120 (397)
T ss_dssp CCTTS
T ss_pred eCCCc
Confidence 99774
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.07 E-value=5e-05 Score=70.12 Aligned_cols=78 Identities=14% Similarity=0.092 Sum_probs=46.9
Q ss_pred CceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCCCCccccCccccccc---CCCchhhHHHHHHHHHH
Q 042314 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE---SYGKSVDVFSFALIVHE 287 (370)
Q Consensus 211 ~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Di~slG~~l~e 287 (370)
..++|+|++|.|||++.++ ++++||+.+..-...-....... .-...|.+|+..... .-....++..+...+|+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLG--NLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHH--HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHH--HHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 4599999999999999876 99999998875443211110000 001345665544311 11234556677777777
Q ss_pred HHhC
Q 042314 288 MFQG 291 (370)
Q Consensus 288 l~~g 291 (370)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.99 E-value=5.7e-05 Score=66.55 Aligned_cols=72 Identities=19% Similarity=0.207 Sum_probs=56.9
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC---CCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR---HPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~---hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
++.|....+|+....+..+++|..... ....+..|...++.+. ...+++++.+....+..++||||++|.+
T Consensus 44 l~gG~~n~~y~v~~~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 44 LYSGEMNEIWLINDEVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp ECCSSSSEEEEEESSSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eCCccceeeeEEEECCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 456888899999888888999987542 2566788988888874 3568888888877788999999999976
Q ss_pred H
Q 042314 176 L 176 (370)
Q Consensus 176 L 176 (370)
+
T Consensus 118 ~ 118 (312)
T 3jr1_A 118 N 118 (312)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.97 E-value=0.0002 Score=58.61 Aligned_cols=141 Identities=11% Similarity=0.126 Sum_probs=93.4
Q ss_pred CHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhh-cCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 175 SLHDILKKK-GKLDPPTAVAYALDIARGMNYLHH-HRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 175 ~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
||.++++.. .+++++++|.++.|.+.+|.-+-. .. -..+=+.|..|++..+|.|-+.+ ..+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~---~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ---PRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc---CCceecCCcceEEecCCceeccc-cccc------------
Confidence 799999854 689999999999999999877622 11 11233456888899999887653 1110
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
.....+.|||... ...+.+.=|||||+++|.-+--..| +..+..+|+.|.+||..|.
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL~~Mt 154 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLIDHMA 154 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHHHHHH
Confidence 0123466888763 3456888999999999988865433 3344567889999999987
Q ss_pred cc-------------------------CCCCCCCHHHHHHHHHHHHHHhc
Q 042314 333 HK-------------------------NPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 333 ~~-------------------------~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
.. .+..|++++++++. +...++
T Consensus 155 ~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~---C~~hl~ 201 (229)
T 2yle_A 155 NTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKL---CAAHLP 201 (229)
T ss_dssp TCCC--------------------CCSCCCCCCSHHHHHHH---HHTTSS
T ss_pred hcccccccccccccccccccccccccccccCcCCHHHHHHH---HHhhcc
Confidence 55 24578888888644 444444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00075 Score=60.01 Aligned_cols=34 Identities=26% Similarity=0.416 Sum_probs=28.3
Q ss_pred CCceeecCCCCCCeeeCCC----CcEEEeccccceecc
Q 042314 210 PHAIIHRDLTPSNVLQDEA----GHLKVTDFGLSKIAQ 243 (370)
Q Consensus 210 ~~~iiH~Dlk~~Nil~~~~----~~~kl~Dfg~~~~~~ 243 (370)
+..++|+|+.+.||+++.+ +.+.|+||+.+..-.
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 3459999999999999874 679999999876543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0012 Score=58.26 Aligned_cols=138 Identities=20% Similarity=0.171 Sum_probs=74.2
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCc--eeeeeee------EeeCCceEEEEee
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN--IVQFLGV------LKHSERLIFLTEY 170 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~--Iv~~~~~------~~~~~~~~~v~e~ 170 (370)
++.|....+|+....+..+++|....... ...+..|..+++.+.... +++++.. ....+..+++++|
T Consensus 30 i~~G~~n~~~~v~~~~g~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 30 IAEGVENSNFLLHTTKDPLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp ECC---EEEEEEEESSCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred cCCCcccceEEEEeCCccEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 34566678888877766888998765211 123445666666553211 3344321 1234567899999
Q ss_pred cCCCCHH---------------HHHHhCCCC--------ChHhHHH---------------HHHHHHHHHHHHhhc----
Q 042314 171 LRNGSLH---------------DILKKKGKL--------DPPTAVA---------------YALDIARGMNYLHHH---- 208 (370)
Q Consensus 171 ~~g~~L~---------------~~l~~~~~~--------~~~~~~~---------------i~~~l~~~l~~lH~~---- 208 (370)
++|.++. .+-.....+ ....... +...+...+..+...
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 9986531 111111111 1000000 001133344555421
Q ss_pred CCCceeecCCCCCCeeeCCCCcEEEecccccee
Q 042314 209 RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI 241 (370)
Q Consensus 209 ~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~ 241 (370)
.+..++|+|+.+.||++++++.+.++||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 234599999999999999866568999987653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0016 Score=56.91 Aligned_cols=32 Identities=25% Similarity=0.288 Sum_probs=26.2
Q ss_pred CceeecCCCCCCeeeCCCCcEEEeccccceecc
Q 042314 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQ 243 (370)
Q Consensus 211 ~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 243 (370)
..++|+|+.+.||+ ..++.+.++||..+..-.
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 45899999999999 556778999999876443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0013 Score=60.63 Aligned_cols=69 Identities=14% Similarity=0.254 Sum_probs=42.8
Q ss_pred CCCCCcccEEEEEEc---------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCc-eeeeeeeEeeCCceEEEE
Q 042314 99 IDPGAYGEVYLVKWR---------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN-IVQFLGVLKHSERLIFLT 168 (370)
Q Consensus 99 l~~g~~~~v~~a~~~---------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~-Iv~~~~~~~~~~~~~~v~ 168 (370)
++.|....+|++... +..+++|+.... .. ...+.+|..+++.+...+ .+++++.+.. .+|+
T Consensus 81 l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 81 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred eCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 345667788888764 367888877331 11 133457888888775333 3566665532 3899
Q ss_pred eecCCCCH
Q 042314 169 EYLRNGSL 176 (370)
Q Consensus 169 e~~~g~~L 176 (370)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0058 Score=54.39 Aligned_cols=33 Identities=21% Similarity=0.363 Sum_probs=28.3
Q ss_pred CceeecCCCCCCeeeCCCCcEEEeccccceecc
Q 042314 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQ 243 (370)
Q Consensus 211 ~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 243 (370)
..++|+|+.+.||+++.++.+.|+||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 459999999999999987889999998776443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0016 Score=58.91 Aligned_cols=134 Identities=19% Similarity=0.209 Sum_probs=75.0
Q ss_pred CCCcccEEEEEEc---------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEee
Q 042314 101 PGAYGEVYLVKWR---------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 101 ~g~~~~v~~a~~~---------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
.|-...+|++... +..+++++.-.. . .......+|..+++.+. +.-.+++++.+.. .+|+||
T Consensus 60 GG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 60 GGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp ----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred CcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 3556667776653 356777775221 1 12344568888888774 2223566666543 389999
Q ss_pred cCCCCHHH-----------H---HH---hC----C-CCC--hHhHHHHHHHHHH-------------------HHHHH--
Q 042314 171 LRNGSLHD-----------I---LK---KK----G-KLD--PPTAVAYALDIAR-------------------GMNYL-- 205 (370)
Q Consensus 171 ~~g~~L~~-----------~---l~---~~----~-~~~--~~~~~~i~~~l~~-------------------~l~~l-- 205 (370)
++|.+|.. + +. .. + ... ..++.++..++.. .+..|
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 99865421 1 11 11 1 111 2344444433321 12222
Q ss_pred --hh-cCCCceeecCCCCCCeeeCCC----CcEEEeccccceec
Q 042314 206 --HH-HRPHAIIHRDLTPSNVLQDEA----GHLKVTDFGLSKIA 242 (370)
Q Consensus 206 --H~-~~~~~iiH~Dlk~~Nil~~~~----~~~kl~Dfg~~~~~ 242 (370)
.. ..+..++|+|+.+.||+++.+ +.+.++||..+...
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 21 123458999999999999876 68999999987644
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0037 Score=58.00 Aligned_cols=70 Identities=14% Similarity=0.085 Sum_probs=42.8
Q ss_pred CCCCCcccEEEEEEcC--ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCce-eeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWRG--TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNI-VQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g--~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~I-v~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
++.|-...+|++...+ ..+++|+....... .. .-.+|..+++.+...++ +++++.+. + ..|+||++|.+
T Consensus 116 lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 116 INGGITNILIKVKDMSKQAKYLIRLYGPKTDE---II-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp ECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred cCCCeEeEEEEEEECCCCceEEEEECCCChhh---hc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4456778899988776 77888876432111 11 11478888888864444 56777663 2 35999998854
Q ss_pred H
Q 042314 176 L 176 (370)
Q Consensus 176 L 176 (370)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.0072 Score=53.36 Aligned_cols=70 Identities=11% Similarity=0.076 Sum_probs=41.5
Q ss_pred CCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCC--ceeeeeee-----EeeCCceEEEEeecCC
Q 042314 102 GAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHP--NIVQFLGV-----LKHSERLIFLTEYLRN 173 (370)
Q Consensus 102 g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp--~Iv~~~~~-----~~~~~~~~~v~e~~~g 173 (370)
|....+|.+... |..+++|....... . ...+..|..+++.+... .+++++.. ....+..++++++++|
T Consensus 36 g~~n~~y~v~~~~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 36 SYENRVYQFQDEDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred CcccceEEEEcCCCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 555677877654 55789998863321 1 23455677777666321 24444443 2234566889999988
Q ss_pred CC
Q 042314 174 GS 175 (370)
Q Consensus 174 ~~ 175 (370)
.+
T Consensus 112 ~~ 113 (328)
T 1zyl_A 112 RQ 113 (328)
T ss_dssp EE
T ss_pred CC
Confidence 54
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.01 Score=51.33 Aligned_cols=71 Identities=15% Similarity=0.104 Sum_probs=48.5
Q ss_pred CCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCC---CceeeeeeeEeeCCceEEEEeecCCC
Q 042314 99 IDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH---PNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h---p~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
++.|..+.||+.... |+.+++|+...... .....+..|...++.+.. --+++++++. .-++||||++++
T Consensus 23 ~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~ 95 (288)
T 3f7w_A 23 RGHSHRWHLYRVELADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDER 95 (288)
T ss_dssp EEEETTEEEEEEEETTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCC
T ss_pred cCCCCCeEEEEEEECCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeeccc
Confidence 566888999999864 78999998654322 223457789988888742 1345555542 347899999876
Q ss_pred CH
Q 042314 175 SL 176 (370)
Q Consensus 175 ~L 176 (370)
..
T Consensus 96 ~~ 97 (288)
T 3f7w_A 96 PP 97 (288)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0044 Score=55.86 Aligned_cols=31 Identities=26% Similarity=0.460 Sum_probs=25.3
Q ss_pred CceeecCCCCCCeeeCCCCcEEEeccccceec
Q 042314 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIA 242 (370)
Q Consensus 211 ~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~ 242 (370)
..++|+|+.+.||+++.++ +.++||..+..-
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~g 242 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGFN 242 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCCC
Confidence 3599999999999998654 899999877643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.03 E-value=0.23 Score=45.46 Aligned_cols=32 Identities=25% Similarity=0.459 Sum_probs=27.3
Q ss_pred CceeecCCCCCCeeeCCCCcEEEeccccceecc
Q 042314 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQ 243 (370)
Q Consensus 211 ~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 243 (370)
..++|+|+.+.||+ +.++.+.++||..+....
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~~ 293 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAINF 293 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEEEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCcCC
Confidence 45899999999999 777899999999886543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.72 E-value=0.95 Score=36.84 Aligned_cols=115 Identities=12% Similarity=0.152 Sum_probs=77.4
Q ss_pred CCCceeeeeeeEeeCCceEEEEeecC-CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeee
Q 042314 147 RHPNIVQFLGVLKHSERLIFLTEYLR-NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQ 225 (370)
Q Consensus 147 ~hp~Iv~~~~~~~~~~~~~~v~e~~~-g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~ 225 (370)
.+|++++. .+-...+.+.+.++.-+ +.++.. ++ ..+....++++.+|+....++++ -+|--|.|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 57888866 45566677666666554 223333 32 46788999999999998866554 4677899999999
Q ss_pred CCCCcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCC
Q 042314 226 DEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNR 296 (370)
Q Consensus 226 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~ 296 (370)
+.++.+++.-.|+...+ +|. ..+...=.-.+=+++..+++++..|.
T Consensus 113 ~~~~~p~i~~RGik~~l--------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVV--------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETTTB--------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCccCC--------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999877653211 222 12233334456678888888877764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.80 E-value=1.7 Score=35.54 Aligned_cols=115 Identities=10% Similarity=0.066 Sum_probs=76.7
Q ss_pred CCCceeeeeeeEeeCCceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHH-HHhhcCCCceeecCCCCCCeee
Q 042314 147 RHPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMN-YLHHHRPHAIIHRDLTPSNVLQ 225 (370)
Q Consensus 147 ~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~-~lH~~~~~~iiH~Dlk~~Nil~ 225 (370)
.||++ -..+-...+.+.+.++.-+++.=+..++ .++....++++.+|+.... ++++ -+|=-|.|+|+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEEE
Confidence 57877 3444466777777777664433333443 5688899999999998777 5554 5677899999999
Q ss_pred CCCCcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCC
Q 042314 226 DEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNR 296 (370)
Q Consensus 226 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~ 296 (370)
+.++.+++.-.|+-. -++|..+ +...=.-.+=+++..++.++..|.
T Consensus 118 ~~~~~p~i~hRGi~~--------------------~lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 118 NRALEPFFLHVGVKE--------------------SLPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CTTCCEEESCCEETT--------------------TBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eCCCcEEEEEcCCcc--------------------cCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999998777532 1223221 222223345678888888876654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.47 E-value=0.31 Score=44.25 Aligned_cols=31 Identities=29% Similarity=0.390 Sum_probs=25.9
Q ss_pred eeecCCCCCCeee------CCCCcEEEeccccceecc
Q 042314 213 IIHRDLTPSNVLQ------DEAGHLKVTDFGLSKIAQ 243 (370)
Q Consensus 213 iiH~Dlk~~Nil~------~~~~~~kl~Dfg~~~~~~ 243 (370)
++|+|+.+.||++ ++.+.++++||.+|..-.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n~ 282 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNY 282 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCCC
Confidence 5799999999999 445679999999887543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 370 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-68 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-67 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-64 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-63 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-63 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-59 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-58 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-56 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-56 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-55 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-52 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-51 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-50 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-48 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-48 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-46 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-23 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-18 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 3e-15 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 5e-13 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-11 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 3e-09 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 4e-08 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-07 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-06 | |
| d1n11a_ | 408 | d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta | 2e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-16 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 3e-15 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 3e-11 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 3e-09 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 1e-08 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 2e-05 | |
| d1wdya_ | 285 | d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas | 5e-04 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 3e-15 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 4e-08 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 4e-07 | |
| d2fo1e1 | 277 | d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele | 2e-05 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 6e-13 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 2e-07 | |
| d1ot8a_ | 209 | d.211.1.1 (A:) Neurogenic locus notch receptor dom | 4e-04 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 3e-12 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 9e-11 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 7e-08 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 2e-04 | |
| d1s70b_ | 291 | d.211.1.1 (B:) Myosin phosphatase targeting subuni | 0.002 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 7e-12 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 4e-09 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 7e-07 | |
| d1sw6a_ | 301 | d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker | 2e-04 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 6e-11 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 7e-11 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 1e-06 | |
| d1uoha_ | 223 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 5e-06 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 1e-10 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 5e-07 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 1e-06 | |
| d2ajaa1 | 346 | a.118.24.1 (A:3-348) Hypothetical protein LPG2416 | 0.003 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 3e-10 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 2e-09 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 1e-08 | |
| d1oy3d_ | 255 | d.211.1.1 (D:) Transcription factor inhibitor I-ka | 3e-04 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 4e-10 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 1e-08 | |
| d1k1aa_ | 228 | d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: | 2e-06 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 9e-10 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 1e-05 | |
| d1ixva_ | 229 | d.211.1.1 (A:) 26S proteasome non-ATPase regulator | 3e-05 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 3e-08 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 1e-07 | |
| d1iknd_ | 221 | d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien | 3e-06 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 3e-07 | |
| d1ihba_ | 156 | d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens | 4e-05 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 7e-07 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 2e-05 | |
| d1dcqa1 | 154 | d.211.1.1 (A:369-522) Pyk2-associated protein beta | 8e-04 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 1e-05 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 7e-05 | |
| d1awcb_ | 153 | d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 { | 8e-04 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 4e-04 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 6e-04 | |
| d1bd8a_ | 156 | d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma | 7e-04 | |
| d1bi7b_ | 125 | d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 2e-68
Identities = 80/262 (30%), Positives = 133/262 (50%), Gaps = 15/262 (5%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
G++G VY KW G +A K + + A P+ +F E+G+ +K RH NI+ F+G +
Sbjct: 19 GSFGTVYKGKWHGD-VAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STA 75
Query: 162 ERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTP 220
+L +T++ SL+ L + K + + A A+GM+YLH IIHRDL
Sbjct: 76 PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKS 132
Query: 221 SNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES---YGKSVD 277
+N+ E +K+ DFGL+ + + + S S++ +GS +MAPEV R + Y D
Sbjct: 133 NNIFLHEDLTVKIGDFGLATV-KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 278 VFSFALIVHEMFQGGP----SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333
V++F ++++E+ G N D + + R + S P+ +K L+ EC
Sbjct: 192 VYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLK 251
Query: 334 KNPDRRPTFEEIIFRLEAIQES 355
K D RP F +I+ +E + S
Sbjct: 252 KKRDERPLFPQILASIELLARS 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 4e-67
Identities = 75/255 (29%), Positives = 125/255 (49%), Gaps = 17/255 (6%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV-LKH 160
G +G+V L +RG ++A K I+ N +F+ E + +LRH N+VQ LGV ++
Sbjct: 18 GEFGDVMLGDYRGNKVAVKCIK-----NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72
Query: 161 SERLIFLTEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
L +TEY+ GSL D L+ +G+ L + ++LD+ M YL + +HRDL
Sbjct: 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDL 129
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
NVL E KV+DFGL+K S G ++ APE R + + DV
Sbjct: 130 AARNVLVSEDNVAKVSDFGLTKE------ASSTQDTGKLPVKWTAPEALREKKFSTKSDV 183
Query: 279 FSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDR 338
+SF +++ E++ G ++ R + + P + +++ CWH +
Sbjct: 184 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAM 243
Query: 339 RPTFEEIIFRLEAIQ 353
RP+F ++ +LE I+
Sbjct: 244 RPSFLQLREQLEHIK 258
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 3e-64
Identities = 65/247 (26%), Positives = 110/247 (44%), Gaps = 12/247 (4%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +G VYL + + +A K + + V + +E+ + LRHPNI++ G
Sbjct: 17 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ R+ + EY G+++ L+K K D Y ++A ++Y H R +IHRD+
Sbjct: 77 DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIK 133
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
P N+L AG LK+ DFG S A + G+ Y+ PE+ + + VD++
Sbjct: 134 PENLLLGSAGELKIADFGWSVHAPSSRRTTLC-----GTLDYLPPEMIEGRMHDEKVDLW 188
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRR 339
S ++ +E G P A+T + R E + L+ NP +R
Sbjct: 189 SLGVLCYEFLVGKPPFEANTYQETYKR--ISRVEFTFPDFVTEGARDLISRLLKHNPSQR 246
Query: 340 PTFEEII 346
P E++
Sbjct: 247 PMLREVL 253
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 9e-64
Identities = 62/254 (24%), Positives = 113/254 (44%), Gaps = 11/254 (4%)
Query: 102 GAYGEVYLVKWR----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
G +G V ++ +A K +++ A++P +++ + E + Q+L +P IV+ +G+
Sbjct: 18 GNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLDNPYIVRMIGI 76
Query: 158 LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+ E + + E G L+ L++ + + ++ GM YL +HRD
Sbjct: 77 CEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRD 132
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVD 277
L NVL + K++DFGLSK + ++Y T G ++ APE + D
Sbjct: 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD 192
Query: 278 VFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336
V+SF +++ E F G R +V + R + P + L+ CW +
Sbjct: 193 VWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCWTYDV 251
Query: 337 DRRPTFEEIIFRLE 350
+ RP F + RL
Sbjct: 252 ENRPGFAAVELRLR 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-63
Identities = 65/264 (24%), Positives = 105/264 (39%), Gaps = 11/264 (4%)
Query: 102 GAYGEVYLVKWR----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
G +G V +R ++A K ++ + M+E + +L +P IV+ +GV
Sbjct: 20 GNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGV 77
Query: 158 LKHSERLIFLTEYLRNGSLHDIL-KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
+E L+ + E G LH L K+ ++ ++ GM YL +HR
Sbjct: 78 C-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHR 133
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
DL NVL + K++DFGLSK DSY + G ++ APE +
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 193
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336
DV+S+ + + E G + R P + AL+ +CW
Sbjct: 194 DVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKW 253
Query: 337 DRRPTFEEIIFRLEAIQESFQKKT 360
+ RP F + R+ A S K
Sbjct: 254 EDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (515), Expect = 3e-63
Identities = 67/250 (26%), Positives = 103/250 (41%), Gaps = 15/250 (6%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++G VY + +A K + S + +KE+ QKLRHPN +Q+ G
Sbjct: 26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ EY + + K L A +G+ YLH H +IHRD+
Sbjct: 86 REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVK 142
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES---YGKSV 276
N+L E G +K+ DFG + I +S+ G+ +MAPEV Y V
Sbjct: 143 AGNILLSEPGLVKLGDFGSASIMAPANSF-------VGTPYWMAPEVILAMDEGQYDGKV 195
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336
DV+S + E+ + P A+ A +S S + E + + C K P
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 255
Query: 337 DRRPTFEEII 346
RPT E ++
Sbjct: 256 QDRPTSEVLL 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-61
Identities = 69/259 (26%), Positives = 114/259 (44%), Gaps = 11/259 (4%)
Query: 102 GAYGEVYLVKW-----RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G++G V +W + +A K ++ + S P + F++E+ L H N+++ G
Sbjct: 19 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 157 VLKHSERLIFLTEYLRNGSLHDIL-KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
V+ + + +TE GSL D L K +G T YA+ +A GM YL R IH
Sbjct: 79 VV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIH 134
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RDL N+L +K+ DFGL + + D + + + APE + ++ +
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA 194
Query: 276 VDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
D + F + + EMF G Q+ + E R P+ I ++ +CW
Sbjct: 195 SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAH 254
Query: 335 NPDRRPTFEEIIFRLEAIQ 353
P+ RPTF + L Q
Sbjct: 255 KPEDRPTFVALRDFLLEAQ 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 2e-61
Identities = 60/255 (23%), Positives = 114/255 (44%), Gaps = 15/255 (5%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL- 158
G+YG ++ + G + K + + + + E+ L ++L+HPNIV++ +
Sbjct: 15 GSYGRCQKIRRKSDGKILVWKELDYG-SMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 73
Query: 159 -KHSERLIFLTEYLRNGSLHDILKKKGK----LDPPTAVAYALDIARGMNYLHHH--RPH 211
+ + L + EY G L ++ K K LD + + + H H
Sbjct: 74 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 133
Query: 212 AIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES 271
++HRDL P+NV D ++K+ DFGL++I S+ G+ YM+PE R S
Sbjct: 134 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF---AKAFVGTPYYMSPEQMNRMS 190
Query: 272 YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331
Y + D++S +++E+ P A + ++A + E + Y + + ++
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELA-GKIREGKFRRIPYRYSDELNEIITRM 249
Query: 332 WHKNPDRRPTFEEII 346
+ RP+ EEI+
Sbjct: 250 LNLKDYHRPSVEEIL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 3e-61
Identities = 64/253 (25%), Positives = 111/253 (43%), Gaps = 11/253 (4%)
Query: 102 GAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +G V KWR ++A K I+ S + F++E + L H +VQ GV
Sbjct: 15 GQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 161 SERLIFLTEYLRNGSLHDILK-KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ +TEY+ NG L + L+ + + + D+ M YL + +HRDL
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLA 127
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
N L ++ G +KV+DFGLS+ + + S G R+ PEV + D++
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--SVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRR 339
+F +++ E++ G + R L E + ++ CWH+ D R
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADER 245
Query: 340 PTFEEIIFRLEAI 352
PTF+ ++ + +
Sbjct: 246 PTFKILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 3e-61
Identities = 72/256 (28%), Positives = 115/256 (44%), Gaps = 11/256 (4%)
Query: 102 GAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +G V+L W ++A KTIR S F++E + KL HP +VQ GV
Sbjct: 16 GQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 161 SERLIFLTEYLRNGSLHDILKKKGKL-DPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ + E++ +G L D L+ + L T + LD+ GM YL +IHRDL
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 128
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
N L E +KV+DFG+++ + S T ++ +PEV+ Y DV+
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFSRYSSKSDVW 186
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRR 339
SF +++ E+F G + + R L + ++ CW + P+ R
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 246
Query: 340 PTFEEIIFRLEAIQES 355
P F ++ +L I ES
Sbjct: 247 PAFSRLLRQLAEIAES 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 6e-61
Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 13/254 (5%)
Query: 102 GAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +GEV++ + T++A K+++ S ++F+ E L ++L+H +V+ V+
Sbjct: 24 GQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 161 SERLIFLTEYLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
I +TEY+ NGSL D LK KL + A IA GM ++ IHRDL
Sbjct: 80 EPIYI-ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
+N+L + K+ DFGL+++ + D+ G ++ APE ++ DV
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 279 FSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDR 338
+SF +++ E+ G + R PE + L+R CW + P+
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPED 253
Query: 339 RPTFEEIIFRLEAI 352
RPTF+ + LE
Sbjct: 254 RPTFDYLRSVLEDF 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-60
Identities = 67/288 (23%), Positives = 112/288 (38%), Gaps = 53/288 (18%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G G V+ V + G +A K I I P +RN ++EL + + P IV F G
Sbjct: 17 GNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 74
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ E++ GSL +LKK G++ ++ + +G+ YL H I+HRD+
Sbjct: 75 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVK 132
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
PSN+L + G +K+ DFG+S + + S+ G+ YM+PE + Y D++
Sbjct: 133 PSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----VGTRSYMSPERLQGTHYSVQSDIW 187
Query: 280 SFALIVHEMFQGGP------------------------------------------SNRA 297
S L + EM G S
Sbjct: 188 SMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPP 247
Query: 298 DTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345
++ D E S ++ + + +C KNP R +++
Sbjct: 248 MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 6e-60
Identities = 66/249 (26%), Positives = 113/249 (45%), Gaps = 12/249 (4%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GAYGEV L R +A K + + + KE+ + + L H N+V+F G +
Sbjct: 16 GAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 73
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
EY G L D ++ + P A + + G+ YLH I HRD+
Sbjct: 74 EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIK 130
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY-GKSVDV 278
P N+L DE +LK++DFGL+ + + ++ + G+ Y+APE+ +R + + VDV
Sbjct: 131 PENLLLDERDNLKISDFGLATVFRY-NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 189
Query: 279 FSFALIVHEMFQGGP--SNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336
+S +++ M G +D+ + +D + + + ALL + +NP
Sbjct: 190 WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI-DSAPLALLHKILVENP 248
Query: 337 DRRPTFEEI 345
R T +I
Sbjct: 249 SARITIPDI 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 7e-60
Identities = 63/253 (24%), Positives = 117/253 (46%), Gaps = 16/253 (6%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV-- 157
G++ VY T E+A ++ + R F +E + + L+HPNIV+F
Sbjct: 20 GSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWE 78
Query: 158 --LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+K + ++ +TE + +G+L LK+ + ++ I +G+ +LH P IIH
Sbjct: 79 STVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP-IIH 137
Query: 216 RDLTPSNVL-QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
RDL N+ G +K+ D GL+ + + + + G+ +MAPE+Y + Y +
Sbjct: 138 RDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-----IGTPEFMAPEMYEEK-YDE 191
Query: 275 SVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPA-LSSLYPEPIKALLRECWH 333
SVDV++F + + EM RR +PA + +K ++ C
Sbjct: 192 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 251
Query: 334 KNPDRRPTFEEII 346
+N D R + ++++
Sbjct: 252 QNKDERYSIKDLL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 3e-59
Identities = 71/261 (27%), Positives = 123/261 (47%), Gaps = 12/261 (4%)
Query: 102 GAYGEVYLVKWRGT------EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
G +GEVY + + +A KT+++ RV F+ E G+ + H NI++
Sbjct: 18 GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMGQFSHHNIIRLE 75
Query: 156 GVLKHSERLIFLTEYLRNGSLHDI-LKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
GV+ + ++ +TEY+ NG+L +K G+ V IA GM YL + +
Sbjct: 76 GVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YV 132
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
HRDL N+L + KV+DFGLS++ ++ +Y +GG R+ APE +
Sbjct: 133 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS 192
Query: 275 SVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
+ DV+SF +++ E+ G + + + + R P I L+ +CW +
Sbjct: 193 ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQ 252
Query: 335 NPDRRPTFEEIIFRLEAIQES 355
RRP F +I+ L+ + +
Sbjct: 253 ERARRPKFADIVSILDKLIRA 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 4e-59
Identities = 61/257 (23%), Positives = 107/257 (41%), Gaps = 8/257 (3%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++ V L + E A K + +E + +L HP V+ +
Sbjct: 19 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
E+L F Y +NG L ++K G D Y +I + YLH IIHRDL
Sbjct: 79 DDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLK 135
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
P N+L +E H+++TDFG +K+ +S + G+ +Y++PE+ +S KS D++
Sbjct: 136 PENILLNEDMHIQITDFGTAKV-LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW 194
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRR 339
+ I++++ G P RA + + + + L+ + + +R
Sbjct: 195 ALGCIIYQLVAGLPPFRAGNEYLIF--QKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 252
Query: 340 PTFEEIIFRLEAIQESF 356
EE+ F
Sbjct: 253 LGCEEMEGYGPLKAHPF 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-59
Identities = 65/254 (25%), Positives = 109/254 (42%), Gaps = 18/254 (7%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+G+VY + + AAK I + + +M E+ + HPNIV+ L
Sbjct: 23 GAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 160 HSERLIFLTEYLRNGSLHDIL-KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ L L E+ G++ ++ + + L +NYLH ++ IIHRDL
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDL 136
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEV-----YRRESYG 273
N+L G +K+ DFG+S + G+ +MAPEV + Y
Sbjct: 137 KAGNILFTLDGDIKLADFGVSAKNTRTIQ---RRDSFIGTPYWMAPEVVMCETSKDRPYD 193
Query: 274 KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED-SRPALSSLYPEPIKALLRECW 332
DV+S + + EM + P + ++V + A + A S + K L++C
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCL 253
Query: 333 HKNPDRRPTFEEII 346
KN D R T +++
Sbjct: 254 EKNVDARWTTSQLL 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-58
Identities = 80/265 (30%), Positives = 122/265 (46%), Gaps = 13/265 (4%)
Query: 102 GAYGEVYLVKWRGT-EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G +GEV++ W GT +A KT++ S +F++E + +KLRH +VQ V+
Sbjct: 28 GCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE 83
Query: 161 SERLIFLTEYLRNGSLHDILKKKGK--LDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
I +TEY+ GSL D LK + L P V A IA GM Y+ +HRDL
Sbjct: 84 EPIYI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 139
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
+N+L E KV DFGL+++ + D+ G ++ APE + DV
Sbjct: 140 RAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197
Query: 279 FSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDR 338
+SF +++ E+ G + + R PE + L+ +CW K P+
Sbjct: 198 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEE 257
Query: 339 RPTFEEIIFRLEAIQESFQKKTVPS 363
RPTFE + LE S + + P
Sbjct: 258 RPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 5e-58
Identities = 63/282 (22%), Positives = 106/282 (37%), Gaps = 38/282 (13%)
Query: 102 GAYGEVYLVKWRGT-------EIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQ 153
GA+G+V G ++A K ++ ++ R + M EL + +L H NIV
Sbjct: 48 GAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQLGSHENIVN 105
Query: 154 FLGVLKHSERLIFLTEYLRNGSLHDILKKK-----------------------GKLDPPT 190
LG S + + EY G L + L+ K L
Sbjct: 106 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 165
Query: 191 AVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250
+ +A +A+GM +L +HRDL NVL +K+ DFGL++ +Y
Sbjct: 166 LLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV- 221
Query: 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAY 309
++MAPE Y DV+S+ +++ E+F G +
Sbjct: 222 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ 281
Query: 310 EDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEA 351
+ E I +++ CW + +RP+F + L
Sbjct: 282 NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 1e-57
Identities = 66/248 (26%), Positives = 110/248 (44%), Gaps = 11/248 (4%)
Query: 102 GAYGEVYLVKWRGT--EIAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFLGVL 158
G++G+V+L +++ T A K ++ + M E L HP +
Sbjct: 13 GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ E L F+ EYL G L ++ K D A YA +I G+ +LH I++RDL
Sbjct: 73 QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDL 129
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDV 278
N+L D+ GH+K+ DFG+ K D+ K G+ Y+APE+ + Y SVD
Sbjct: 130 KLDNILLDKDGHIKIADFGMCKENMLGDA---KTNTFCGTPDYIAPEILLGQKYNHSVDW 186
Query: 279 FSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDR 338
+SF ++++EM G ++ + P + K LL + + + P++
Sbjct: 187 WSFGVLLYEMLIGQSPFHGQDEEELF--HSIRMDNPFYPRWLEKEAKDLLVKLFVREPEK 244
Query: 339 RPTFEEII 346
R I
Sbjct: 245 RLGVRGDI 252
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 1e-57
Identities = 70/284 (24%), Positives = 113/284 (39%), Gaps = 37/284 (13%)
Query: 102 GAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA+G V+ + T +A K ++ ++ ++ F +E L + +PNIV+
Sbjct: 24 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKL 81
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGK------------------------LDPPT 190
LGV + + L EY+ G L++ L+ L
Sbjct: 82 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 141
Query: 191 AVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250
+ A +A GM YL + +HRDL N L E +K+ DFGLS+ D Y
Sbjct: 142 QLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK- 197
Query: 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE 310
R+M PE Y DV+++ +++ E+F G A + +
Sbjct: 198 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257
Query: 311 DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQE 354
+ A P + L+R CW K P RP+F I L+ + E
Sbjct: 258 GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 4e-57
Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 12/268 (4%)
Query: 102 GAYGEVYLVKWRGT------EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFL 155
GA+G VY W +A K +R A++P+ + E + + +P++ + L
Sbjct: 20 GAFGTVYKGLWIPEGEKVKIPVAIKELRE--ATSPKANKEILDEAYVMASVDNPHVCRLL 77
Query: 156 GVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
G+ S + L + + K + + + + IA+GMNYL R ++H
Sbjct: 78 GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVH 134
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RDL NVL H+K+TDFGL+K+ + Y GG ++MA E Y
Sbjct: 135 RDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEYHAEGGKVPIKWMALESILHRIYTHQ 193
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335
DV+S+ + V E+ G + R + + ++ +CW +
Sbjct: 194 SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 253
Query: 336 PDRRPTFEEIIFRLEAIQESFQKKTVPS 363
D RP F E+I + Q+ V
Sbjct: 254 ADSRPKFRELIIEFSKMARDPQRYLVIQ 281
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 187 bits (476), Expect = 5e-57
Identities = 57/252 (22%), Positives = 108/252 (42%), Gaps = 17/252 (6%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+G V+ V R G AAK + + S+ + + KE+ LRHP +V +
Sbjct: 37 GAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 160 HSERLIFLTEYLRNGSLHDIL-KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
++ + E++ G L + + + K+ AV Y + +G+ ++H + +H DL
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDL 150
Query: 219 TPSNVL--QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
P N++ + LK+ DFGL+ K S + TG+ + APEV + G
Sbjct: 151 KPENIMFTTKRSNELKLIDFGLTAHLDPKQS----VKVTTGTAEFAAPEVAEGKPVGYYT 206
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADR--RAYEDSRPALSSLYPEPIKALLRECWHK 334
D++S ++ + + G + + + + S E K +R+
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA 266
Query: 335 NPDRRPTFEEII 346
+P+ R T + +
Sbjct: 267 DPNTRMTIHQAL 278
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (471), Expect = 6e-57
Identities = 71/262 (27%), Positives = 119/262 (45%), Gaps = 13/262 (4%)
Query: 102 GAYGEVYLVKWRGT-----EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G +GEV + +A KT++S + R F+ E + + HPN++ G
Sbjct: 37 GEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEG 94
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
V+ S ++ +TE++ NGSL L++ G+ V IA GM YL +H
Sbjct: 95 VVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVH 151
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY--KMTGGTGSYRYMAPEVYRRESYG 273
RDL N+L + KV+DFGLS+ ++ S GG R+ APE + +
Sbjct: 152 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT 211
Query: 274 KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333
+ DV+S+ +++ E+ G D Q +D R P + L+ +CW
Sbjct: 212 SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQ 271
Query: 334 KNPDRRPTFEEIIFRLEAIQES 355
K+ + RP F +I+ L+ + +
Sbjct: 272 KDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 184 bits (468), Expect = 1e-56
Identities = 73/258 (28%), Positives = 113/258 (43%), Gaps = 13/258 (5%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G YGEVY W+ +A KT++ + F+KE + ++++HPN+VQ LGV
Sbjct: 28 GQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 160 HSERLIFLTEYLRNGSLHDIL--KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
+TE++ G+L D L + ++ + A I+ M YL IHRD
Sbjct: 84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 140
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVD 277
L N L E +KV DFGLS++ G ++ APE + D
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 278 VFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPD 337
V++F +++ E+ G S + +D R PE + L+R CW NP
Sbjct: 199 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS 258
Query: 338 RRPTFEEIIFRLEAIQES 355
RP+F EI E + +
Sbjct: 259 DRPSFAEIHQAFETMFQE 276
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-56
Identities = 64/266 (24%), Positives = 123/266 (46%), Gaps = 13/266 (4%)
Query: 102 GAYGEVYLVKW-----RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G +G VY + A K++ ++ + F+ E + + HPN++ LG
Sbjct: 38 GHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLG 95
Query: 157 VLKHSE-RLIFLTEYLRNGSLHDILK-KKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ SE + + Y+++G L + ++ + + + L +A+GM +L + +
Sbjct: 96 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FV 152
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS-YKMTGGTGSYRYMAPEVYRRESYG 273
HRDL N + DE +KV DFGL++ +K+ S + TG ++MA E + + +
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 274 KSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333
DV+SF +++ E+ G D + R P+P+ ++ +CWH
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWH 272
Query: 334 KNPDRRPTFEEIIFRLEAIQESFQKK 359
+ RP+F E++ R+ AI +F +
Sbjct: 273 PKAEMRPSFSELVSRISAIFSTFIGE 298
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-56
Identities = 68/259 (26%), Positives = 117/259 (45%), Gaps = 14/259 (5%)
Query: 102 GAYGEVYLVKWRGTE-----IAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG 156
G +G+V+ + E +A KT ++ ++ VR F++E ++ HP+IV+ +G
Sbjct: 18 GQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIVKLIG 75
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
V+ + I E G L L+ + LD + + YA ++ + YL R +H
Sbjct: 76 VITENPVWII-MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVH 131
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RD+ NVL +K+ DFGLS+ ++ Y K + G ++MAPE + +
Sbjct: 132 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY--KASKGKLPIKWMAPESINFRRFTSA 189
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335
DV+ F + + E+ G R R + P + +L+ +CW +
Sbjct: 190 SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYD 249
Query: 336 PDRRPTFEEIIFRLEAIQE 354
P RRP F E+ +L I E
Sbjct: 250 PSRRPRFTELKAQLSTILE 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-56
Identities = 61/248 (24%), Positives = 112/248 (45%), Gaps = 13/248 (5%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA G VY G E+A + + + + E+ + ++ ++PNIV +L
Sbjct: 31 GASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ L + EYL GSL D++ + D A + + + +LH ++ +IHRD+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ---VIHRDIK 143
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
N+L G +K+TDFG + S K + G+ +MAPEV R++YG VD++
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAYEDS-RPALSSLYPEPIKALLRECWHKNPDR 338
S ++ EM +G P + ++ A + + L C + ++
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260
Query: 339 RPTFEEII 346
R + +E++
Sbjct: 261 RGSAKELL 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 182 bits (463), Expect = 5e-56
Identities = 67/261 (25%), Positives = 118/261 (45%), Gaps = 12/261 (4%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G EV+L + ++A K +R+ +A +P F +E L HP IV +
Sbjct: 18 GGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 77
Query: 160 HSE----RLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ EY+ +L DI+ +G + P A+ D + +N+ H + IIH
Sbjct: 78 AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIH 134
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKS 275
RD+ P+N++ +KV DFG+++ + + + G+ +Y++PE R +S
Sbjct: 135 RDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR 194
Query: 276 VDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP--ALSSLYPEPIKALLRECWH 333
DV+S +++E+ G P D+ V VA + ED P A + A++ +
Sbjct: 195 SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALA 254
Query: 334 KNPDRRP-TFEEIIFRLEAIQ 353
KNP+ R T E+ L +
Sbjct: 255 KNPENRYQTAAEMRADLVRVH 275
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-55
Identities = 68/290 (23%), Positives = 108/290 (37%), Gaps = 41/290 (14%)
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
G +GEV+ KWRG E+A K S + E+ LRH NI+ F+
Sbjct: 14 GRFGEVWRGKWRGEEVAVKIFSSREERSWF----REAEIYQTVMLRHENILGFIAADNKD 69
Query: 162 E----RLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHA----- 212
+L +++Y +GSL D L + + + AL A G+ +LH
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGL-SKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE- 270
I HRDL N+L + G + D GL + D+ G+ RYMAPEV
Sbjct: 129 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188
Query: 271 -----SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ---------------VADRRAYE 310
K D+++ L+ E+ + Q + +
Sbjct: 189 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 248
Query: 311 DSRPALSSLYPEP-----IKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
RP + + + + ++RECW+ N R T I L + +
Sbjct: 249 KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-55
Identities = 70/282 (24%), Positives = 115/282 (40%), Gaps = 34/282 (12%)
Query: 102 GAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQ 153
GA+G+V +A K ++ S ++ R + M EL + L H NIV
Sbjct: 34 GAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 154 FLGVLKHSERLIFLTEYLRNGSLHDILKKKG------------------KLDPPTAVAYA 195
LG + +TEY G L + L++K LD ++++
Sbjct: 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151
Query: 196 LDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255
+A+GM +L IHRDL N+L K+ DFGL++ + +Y
Sbjct: 152 YQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV-VKGNA 207
Query: 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRP 314
++MAPE Y DV+S+ + + E+F G + E R
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 267
Query: 315 ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE-AIQES 355
P + +++ CW +P +RPTF++I+ +E I ES
Sbjct: 268 LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 183 bits (466), Expect = 2e-55
Identities = 50/252 (19%), Positives = 103/252 (40%), Gaps = 17/252 (6%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+G V+ + G AK I + P + + E+ + +L HP ++ +
Sbjct: 40 GAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 160 HSERLIFLTEYLRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
++ + E+L G L D + + K+ + Y G+ ++H H I+H D+
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDI 153
Query: 219 TPSNVLQD--EAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
P N++ + +A +K+ DFGL+ + + T + + APE+ RE G
Sbjct: 154 KPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADR--RAYEDSRPALSSLYPEPIKALLRECWHK 334
D+++ ++ + + G + ++ R + S K ++ K
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK 269
Query: 335 NPDRRPTFEEII 346
P +R T + +
Sbjct: 270 EPRKRLTVHDAL 281
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (460), Expect = 4e-55
Identities = 63/252 (25%), Positives = 111/252 (44%), Gaps = 16/252 (6%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GA+ EV L + + +A K I E+ + K++HPNIV + +
Sbjct: 20 GAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS--MENEIAVLHKIKHPNIVALDDIYE 77
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
L + + + G L D + +KG A + + YLH I+HRDL
Sbjct: 78 SGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLK 134
Query: 220 PSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
P N+L DE + ++DFGLSK+ ++ G+ Y+APEV ++ Y K+V
Sbjct: 135 PENLLYYSLDEDSKIMISDFGLSKMEDPGS----VLSTACGTPGYVAPEVLAQKPYSKAV 190
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADR--RAYEDSRPALSSLYPEPIKALLRECWHK 334
D +S +I + + G P + ++ ++ +A + + K +R K
Sbjct: 191 DCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEK 250
Query: 335 NPDRRPTFEEII 346
+P++R T E+ +
Sbjct: 251 DPEKRFTCEQAL 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-54
Identities = 74/272 (27%), Positives = 116/272 (42%), Gaps = 26/272 (9%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVL 158
G +G+V + + G + A R ++ F EL + KL HPNI+ LG
Sbjct: 21 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80
Query: 159 KHSERLIFLTEYLRNGSLHDILKKK----------------GKLDPPTAVAYALDIARGM 202
+H L EY +G+L D L+K L + +A D+ARGM
Sbjct: 81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 140
Query: 203 NYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYM 262
+YL + IHRDL N+L E K+ DFGLS+ + K T G R+M
Sbjct: 141 DYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV----KKTMGRLPVRWM 193
Query: 263 APEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPE 322
A E Y + DV+S+ +++ E+ G + + + R +
Sbjct: 194 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD 253
Query: 323 PIKALLRECWHKNPDRRPTFEEIIFRLEAIQE 354
+ L+R+CW + P RP+F +I+ L + E
Sbjct: 254 EVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-52
Identities = 67/275 (24%), Positives = 119/275 (43%), Gaps = 23/275 (8%)
Query: 102 GAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
G++G VY + T +A KT+ + ++ R R F+ E + ++ ++V+
Sbjct: 31 GSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRL 88
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGK----------LDPPTAVAYALDIARGMNY 204
LGV+ + + + E + G L L+ + A +IA GM Y
Sbjct: 89 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY 148
Query: 205 LHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAP 264
L+ ++ +HRDL N + E +K+ DFG+++ E D Y K G R+M+P
Sbjct: 149 LNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSP 204
Query: 265 EVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPI 324
E + + DV+SF +++ E+ + + R E P+ +
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDML 264
Query: 325 KALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359
L+R CW NP RP+F EII ++ E ++
Sbjct: 265 FELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 172 bits (437), Expect = 5e-52
Identities = 62/262 (23%), Positives = 106/262 (40%), Gaps = 24/262 (9%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIR------SSIASNPRVRNSFMKELGLWQKLR-HPNIV 152
G V + E A K I S +R + +KE+ + +K+ HPNI+
Sbjct: 14 GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73
Query: 153 QFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHA 212
Q + + + + ++ G L D L +K L + + LH
Sbjct: 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--- 130
Query: 213 IIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYR---- 268
I+HRDL P N+L D+ ++K+TDFG S + K+ G+ Y+APE+
Sbjct: 131 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMN 186
Query: 269 --RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSL--YPEPI 324
YGK VD++S +I++ + G P + + + + Y + +
Sbjct: 187 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV 246
Query: 325 KALLRECWHKNPDRRPTFEEII 346
K L+ P +R T EE +
Sbjct: 247 KDLVSRFLVVQPQKRYTAEEAL 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 3e-51
Identities = 46/251 (18%), Positives = 94/251 (37%), Gaps = 18/251 (7%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +G V+ AK ++ + KE+ + RH NI+ +
Sbjct: 16 GEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFE 71
Query: 160 HSERLIFLTEYLRNGSLHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
E L+ + E++ + + + +L+ V+Y + + +LH H I H D+
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDI 128
Query: 219 TPSNVL--QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSV 276
P N++ + +K+ +FG ++ + D++ + Y APEV++ + +
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF----TAPEYYAPEVHQHDVVSTAT 184
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADR--RAYEDSRPALSSLYPEPIKALLRECWHK 334
D++S +V+ + G A+T Q+ + A + K
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK 244
Query: 335 NPDRRPTFEEI 345
R T E
Sbjct: 245 ERKSRMTASEA 255
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-51
Identities = 59/276 (21%), Positives = 112/276 (40%), Gaps = 22/276 (7%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPR---VRNSFMKELGLWQKLRHPNIVQFLG 156
G + V + + G + AAK I+ + R R +E+ + ++++HPN++
Sbjct: 21 GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
V ++ +I + E + G L D L +K L A + I G+ YLH + I H
Sbjct: 81 VYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHF 137
Query: 217 DLTPSNVLQDEAG----HLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
DL P N++ + +K+ DFGL+ + + G+ ++APE+ E
Sbjct: 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF----GTPEFVAPEIVNYEPL 193
Query: 273 GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADR--RAYEDSRPALSSLYPEPIKALLRE 330
G D++S +I + + G DT + + S K +R
Sbjct: 194 GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 253
Query: 331 CWHKNPDRRPTFEEII----FRLEAIQESFQKKTVP 362
K+P +R T ++ + + + Q++
Sbjct: 254 LLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSH 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 8e-51
Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 32/277 (11%)
Query: 102 GAYGEVYLVKWRGT---------EIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNI 151
GA+G+V L + G ++A K ++S + + + + E+ + + + +H NI
Sbjct: 24 GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNI 81
Query: 152 VQFLGVLKHSERLIFLTEYLRNGSLHDILK----------------KKGKLDPPTAVAYA 195
+ LG L + EY G+L + L+ + +L V+ A
Sbjct: 82 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 141
Query: 196 LDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255
+ARGM YL + IHRDL NVL E +K+ DFGL++ D Y K T G
Sbjct: 142 YQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-KKTTNG 197
Query: 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPA 315
++MAPE Y DV+SF +++ E+F G S V+ + E R
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 257
Query: 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAI 352
S + ++R+CWH P +RPTF++++ L+ I
Sbjct: 258 KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 169 bits (429), Expect = 7e-50
Identities = 62/247 (25%), Positives = 107/247 (43%), Gaps = 15/247 (6%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKE---LGLWQKLRHPNIVQFLG 156
G +GEVY + G A K + + + E L L P IV
Sbjct: 15 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74
Query: 157 VLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
++L F+ + + G LH L + G YA +I G+ ++H+ +++R
Sbjct: 75 AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYR 131
Query: 217 DLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR-ESYGKS 275
DL P+N+L DE GH++++D GL+ D K G++ YMAPEV ++ +Y S
Sbjct: 132 DLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSS 186
Query: 276 VDVFSFALIVHEMFQG-GPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334
D FS ++ ++ +G P + T + R L + +++LL +
Sbjct: 187 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 246
Query: 335 NPDRRPT 341
+ +RR
Sbjct: 247 DVNRRLG 253
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (425), Expect = 7e-50
Identities = 64/251 (25%), Positives = 119/251 (47%), Gaps = 18/251 (7%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++G V+L++ R G A K ++ I + E + + HP I++ G +
Sbjct: 15 GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
++++ + +Y+ G L +L+K + P A YA ++ + YLH II+RDL
Sbjct: 75 DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLK 131
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
P N+L D+ GH+K+TDFG +K + G+ Y+APEV + Y KS+D +
Sbjct: 132 PENILLDKNGHIKITDFGFAKYVPD------VTYTLCGTPDYIAPEVVSTKPYNKSIDWW 185
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRR 339
SF ++++EM G ++ ++ ++ + E +K LL ++ +R
Sbjct: 186 SFGILIYEMLAGYTPFYDSNTMKTYEKIL--NAELRFPPFFNEDVKDLLSRLITRDLSQR 243
Query: 340 -----PTFEEI 345
E++
Sbjct: 244 LGNLQNGTEDV 254
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-48
Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 30/279 (10%)
Query: 102 GAYGEVYLVKWRGT-------EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQF 154
GA+G+V G +A K ++ A++ R + L H N+V
Sbjct: 24 GAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNL 82
Query: 155 LGV-LKHSERLIFLTEYLRNGSLHDILKKKGK----------------LDPPTAVAYALD 197
LG K L+ + E+ + G+L L+ K L + Y+
Sbjct: 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 142
Query: 198 IARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTG 257
+A+GM +L + IHRDL N+L E +K+ DFGL++ + Y +
Sbjct: 143 VAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKGDARL 198
Query: 258 SYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPAL 316
++MAPE Y DV+SF +++ E+F G + RR E +R
Sbjct: 199 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 258
Query: 317 SSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355
+ + +CWH P +RPTF E++ L + ++
Sbjct: 259 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-48
Identities = 61/242 (25%), Positives = 103/242 (42%), Gaps = 10/242 (4%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +G+V LV+ + G A K +R + + E + Q RHP + +
Sbjct: 16 GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+RL F+ EY G L L ++ A Y +I + YLH +++RD+
Sbjct: 76 THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIK 132
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
N++ D+ GH+K+TDFGL K + G+ Y+APEV YG++VD +
Sbjct: 133 LENLMLDKDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEVLEDNDYGRAVDWW 189
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRR 339
++++EM G ++ + E+ K+LL K+P +R
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 340 PT 341
Sbjct: 248 LG 249
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 6e-48
Identities = 61/263 (23%), Positives = 108/263 (41%), Gaps = 33/263 (12%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELG-LWQKLRHPNIVQFLGVL 158
G G+V + + + A K ++ +E+ W+ + P+IV+ + V
Sbjct: 23 GINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVY 74
Query: 159 KHS----ERLIFLTEYLRNGSLHDILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHA 212
++ + L+ + E L G L ++ +G A I + YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--- 131
Query: 213 IIHRDLTPSNVL---QDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
I HRD+ P N+L + LK+TDFG +K +S + + Y+APEV
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY----TPYYVAPEVLGP 187
Query: 270 ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVAD------RRAYEDSRPALSSLYPEP 323
E Y KS D++S +I++ + G P ++ + ++ R + S E
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247
Query: 324 IKALLRECWHKNPDRRPTFEEII 346
+K L+R P +R T E +
Sbjct: 248 VKMLIRNLLKTEPTQRMTITEFM 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 4e-46
Identities = 44/274 (16%), Positives = 89/274 (32%), Gaps = 27/274 (9%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLG-VL 158
G++G++YL G E+A K E +++ ++ + +
Sbjct: 18 GSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ + + E L K T + A + + Y+H IHRD+
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDV 129
Query: 219 TPSNVL---QDEAGHLKVTDFGLSKIAQEKDSYS----YKMTGGTGSYRYMAPEVYRRES 271
P N L + + + DFGL+K ++ ++ + TG+ RY + +
Sbjct: 130 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 189
Query: 272 YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVAD------RRAYEDSRPALSSLYPEPIK 325
+ D+ S ++ G + A + L YP
Sbjct: 190 QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFA 249
Query: 326 ALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359
L C D +P + + + + F ++
Sbjct: 250 TYLNFCRSLRFDDKPDYSYLR---QLFRNLFHRQ 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-46
Identities = 54/255 (21%), Positives = 98/255 (38%), Gaps = 26/255 (10%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRV---RNSFMKELGLWQKLR--HPNIVQF 154
G +G VY +A K + S+ E+ L +K+ +++
Sbjct: 15 GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 74
Query: 155 LGVLKHSERLIFLTEYLRNGS-LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
L + + + + E L D + ++G L A ++ + + + H+ +
Sbjct: 75 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---V 131
Query: 214 IHRDLTPSNVLQD-EAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY 272
+HRD+ N+L D G LK+ DFG + ++ + G+ Y PE R Y
Sbjct: 132 LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-----DGTRVYSPPEWIRYHRY 186
Query: 273 -GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331
G+S V+S +++++M G D + + + L+R C
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--------QVFFRQRVSSECQHLIRWC 238
Query: 332 WHKNPDRRPTFEEII 346
P RPTFEEI
Sbjct: 239 LALRPSDRPTFEEIQ 253
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (400), Expect = 7e-46
Identities = 65/251 (25%), Positives = 110/251 (43%), Gaps = 18/251 (7%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G++G V LVK + G A K + + + E + Q + P +V+ K
Sbjct: 52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
+ L + EY+ G + L++ G+ P A YA I YLH +I+RDL
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLK 168
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
P N+L D+ G+++VTDFG +K + G+ +APE+ + Y K+VD +
Sbjct: 169 PENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWW 222
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNPDRR 339
+ ++++EM G P AD +Q+ + S + +K LLR + +R
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQIY--EKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKR 280
Query: 340 -----PTFEEI 345
+I
Sbjct: 281 FGNLKNGVNDI 291
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 4e-45
Identities = 68/276 (24%), Positives = 112/276 (40%), Gaps = 37/276 (13%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIR--SSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV 157
G + VY + + +A K I+ + + + ++E+ L Q+L HPNI+ L
Sbjct: 9 GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 68
Query: 158 LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRD 217
H + + +++ I L P AY L +G+ YLH H I+HRD
Sbjct: 69 FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRD 125
Query: 218 LTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR-ESYGKSV 276
L P+N+L DE G LK+ DFGL+K + T + Y APE+ YG V
Sbjct: 126 LKPNNLLLDENGVLKLADFGLAKSFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGV 182
Query: 277 DVFSFALIVHEMFQGGPSNRADTAVQVADR------RAYEDSRPALSSL----------- 319
D+++ I+ E+ P D+ + R E+ P + SL
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242
Query: 320 ---------YPEPIKALLRECWHKNPDRRPTFEEII 346
+ + L++ + NP R T + +
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-43
Identities = 61/281 (21%), Positives = 108/281 (38%), Gaps = 42/281 (14%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GAYG V +A K I + ++E+ + + RH NI+ +++
Sbjct: 19 GAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIR 76
Query: 160 HSE----RLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
+ ++L +L L+ +LK L + I RG+ Y+H ++H
Sbjct: 77 APTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN---VLH 132
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRE-SYGK 274
RDL PSN+L + LK+ DFGL+++A ++ +T + Y APE+ Y K
Sbjct: 133 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 192
Query: 275 SVDVFSFALIVHEMFQGGPSNRADTAVQVADR--------------------------RA 308
S+D++S I+ EM P + +
Sbjct: 193 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 252
Query: 309 YEDSRPALSSLYP---EPIKALLRECWHKNPDRRPTFEEII 346
++ + L+P LL + NP +R E+ +
Sbjct: 253 PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 150 bits (379), Expect = 2e-43
Identities = 36/276 (13%), Positives = 83/276 (30%), Gaps = 26/276 (9%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH-PNIVQFLGVL 158
G++G ++ ++A K + E ++ L I
Sbjct: 16 GSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----QLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 159 KHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+ + + + L + K T A + + +H +++RD+
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDI 127
Query: 219 TPSNVLQDE-----AGHLKVTDFGLSKIAQEKDS----YSYKMTGGTGSYRYMAPEVYRR 269
P N L A + V DFG+ K ++ + + +G+ RYM+ +
Sbjct: 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187
Query: 270 ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADR------RAYEDSRPALSSLYPEP 323
+ D+ + + +G + A + + L + +PE
Sbjct: 188 REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEE 247
Query: 324 IKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKK 359
+ + D P ++ + + E
Sbjct: 248 FYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (374), Expect = 9e-43
Identities = 63/274 (22%), Positives = 109/274 (39%), Gaps = 36/274 (13%)
Query: 102 GAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH 160
G YG VY + G A K IR + + ++ ++E+ + ++L+H NIV+ V+
Sbjct: 13 GTYGVVYKAQNNYGETFALKKIRLE-KEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71
Query: 161 SERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTP 220
+RL+ + E+L + +G L+ TA ++ L + G+ Y H R ++HRDL P
Sbjct: 72 KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKP 128
Query: 221 SNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRES-YGKSVDVF 279
N+L + G LK+ DFGL++ Y AP+V Y ++D++
Sbjct: 129 QNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW---YRAPDVLMGSKKYSTTIDIW 185
Query: 280 SFALIVHEMFQGGPSNRADTAVQVADR---------------------------RAYEDS 312
S I EM G P + R
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP 245
Query: 313 RPALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346
+ E LL + +P++R T ++ +
Sbjct: 246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-41
Identities = 63/276 (22%), Positives = 109/276 (39%), Gaps = 38/276 (13%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G YG VY + + G +A K IR V ++ ++E+ L ++L HPNIV+ L V+
Sbjct: 13 GTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIH 71
Query: 160 HSERLIFLTEYLRNGSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDL 218
+L + E+L + + P +Y + +G+ + H HR ++HRDL
Sbjct: 72 TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDL 128
Query: 219 TPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESY-GKSVD 277
P N+L + G +K+ DFGL++ Y APE+ Y +VD
Sbjct: 129 KPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW---YRAPEILLGCKYYSTAVD 185
Query: 278 VFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP----------------------- 314
++S I EM D+ + R P
Sbjct: 186 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWAR 245
Query: 315 ----ALSSLYPEPIKALLRECWHKNPDRRPTFEEII 346
+ E ++LL + H +P++R + + +
Sbjct: 246 QDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-41
Identities = 58/249 (23%), Positives = 99/249 (39%), Gaps = 12/249 (4%)
Query: 102 GAYGEVYLV-----KWRGTEIAAKTIR-SSIASNPRVRNSFMKELGLWQKLRH-PNIVQF 154
GAYG+V+LV G A K ++ ++I + E + + +R P +V
Sbjct: 35 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 94
Query: 155 LGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ +L + +Y+ G L L ++ + Y +I + +LH II
Sbjct: 95 HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---II 151
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGK 274
+RD+ N+L D GH+ +TDFGLSK ++ GT Y + K
Sbjct: 152 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDK 211
Query: 275 SVDVFSFALIVHEMFQGGPSNRADTAVQVADR--RAYEDSRPALSSLYPEPIKALLRECW 332
+VD +S ++++E+ G D R S P K L++
Sbjct: 212 AVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLL 271
Query: 333 HKNPDRRPT 341
K+P +R
Sbjct: 272 MKDPKKRLG 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 7e-41
Identities = 50/286 (17%), Positives = 105/286 (36%), Gaps = 46/286 (16%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G +GEV+ + R G ++A K + + ++E+ + Q L+H N+V + + +
Sbjct: 21 GTFGEVFKARHRKTGQKVALKKVLME-NEKEGFPITALREIKILQLLKHENVVNLIEICR 79
Query: 160 HSE--------RLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPH 211
+ + ++ + + K + G+ Y+H ++
Sbjct: 80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK-- 137
Query: 212 AIIHRDLTPSNVLQDEAGHLKVTDFGLSK-IAQEKDSYSYKMTGGTGSYRYMAPEVYRRE 270
I+HRD+ +NVL G LK+ DFGL++ + K+S + T + Y PE+ E
Sbjct: 138 -ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 196
Query: 271 -SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADR----------------------- 306
YG +D++ I+ EM+ P + +T
Sbjct: 197 RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 256
Query: 307 --RAYEDSRPALSSLYPEPI-----KALLRECWHKNPDRRPTFEEI 345
+ + + + L+ + +P +R ++
Sbjct: 257 KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 5e-39
Identities = 58/274 (21%), Positives = 102/274 (37%), Gaps = 36/274 (13%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
G YG V+ K R +A K +R + V +S ++E+ L ++L+H NIV+ VL
Sbjct: 13 GTYGTVFKAKNRETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKHKNIVRLHDVLH 71
Query: 160 HSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLT 219
++L + E+ G LDP ++ + +G+ + H ++HRDL
Sbjct: 72 SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLK 128
Query: 220 PSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVF 279
P N+L + G LK+ +FGL++ + ++ + Y S+D++
Sbjct: 129 PQNLLINRNGELKLANFGLARAFGIPVRCYSAE--VVTLWYRPPDVLFGAKLYSTSIDMW 186
Query: 280 SFALIVHEMFQGG----------------------------PSNRADTAVQVADRRAYED 311
S I E+ G PS +
Sbjct: 187 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATT 246
Query: 312 SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345
S + + LL+ NP +R + EE
Sbjct: 247 SLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 5e-38
Identities = 72/282 (25%), Positives = 118/282 (41%), Gaps = 45/282 (15%)
Query: 102 GAYGEVYLVKWR---GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL---RHPNIVQFL 155
GAYG+V+ + G +A K +R + S ++E+ + + L HPN+V+
Sbjct: 18 GAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLF 76
Query: 156 GVLKHSE-----RLIFLTEYLRNGSL-HDILKKKGKLDPPTAVAYALDIARGMNYLHHHR 209
V S +L + E++ + + + T + RG+++LH HR
Sbjct: 77 DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR 136
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
++HRDL P N+L +G +K+ DFGL++I + +T + Y APEV +
Sbjct: 137 ---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVVTLWYRAPEVLLQ 189
Query: 270 ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADR--------------RAYEDSRPA 315
SY VD++S I EMF+ P R + V + R R A
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 316 LSSLYPEPI-----------KALLRECWHKNPDRRPTFEEII 346
S +PI K LL +C NP +R + +
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 8e-37
Identities = 64/280 (22%), Positives = 101/280 (36%), Gaps = 46/280 (16%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GAYG V G ++A K + + +EL L + +RH N++ L V
Sbjct: 29 GAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFT 87
Query: 160 HSERLIFLTEYLRN----GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIH 215
E L T++ G+ L K KL + +G+ Y+H H
Sbjct: 88 PDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII---H 144
Query: 216 RDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYR-RESYGK 274
RDL P N+ +E LK+ DFGL++ A + MTG + Y APEV Y +
Sbjct: 145 RDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQ 198
Query: 275 SVDVFSFALIVHEMFQGGPSNRADTAVQVADR--------------------------RA 308
+VD++S I+ EM G + +
Sbjct: 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258
Query: 309 YEDSRPALSSLYP---EPIKALLRECWHKNPDRRPTFEEI 345
E + +S+ LL + + ++R T E
Sbjct: 259 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 8e-36
Identities = 56/284 (19%), Positives = 90/284 (31%), Gaps = 52/284 (18%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVL- 158
G++G VY K G +A K + + +EL + +KL H NIV+
Sbjct: 31 GSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 159 -----KHSERLIFLTEYLRNGSLHDIL---KKKGKLDPPTAVAYALDIARGMNYLHHHRP 210
K L + +Y+ + K L Y + R + Y+H
Sbjct: 84 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG- 142
Query: 211 HAIIHRDLTPSNV-LQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
I HRD+ P N+ L + LK+ DFG +K + ++ Y ++
Sbjct: 143 --ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGA 197
Query: 270 ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADR---------------RAYEDSRP 314
Y S+DV+S ++ E+ G P D+ V +
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257
Query: 315 ALSSLYPEPI------------KALLRECWHKNPDRRPTFEEII 346
+ P AL P R T E
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (318), Expect = 3e-34
Identities = 51/287 (17%), Positives = 98/287 (34%), Gaps = 59/287 (20%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVL 158
G Y EV+ ++ K ++ P + +E+ + + LR PNI+ ++
Sbjct: 46 GKYSEVFEAINITNNEKVVVKILK------PVKKKKIKREIKILENLRGGPNIITLADIV 99
Query: 159 KH--SERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHR 216
K S + E++ N + + L Y +I + ++Y H I+HR
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHR 153
Query: 217 DLTPSNVLQDEAG-HLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR-ESYGK 274
D+ P NV+ D L++ D+GL++ Y+ ++ S + PE+ + Y
Sbjct: 154 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV----ASRYFKGPELLVDYQMYDY 209
Query: 275 SVDVFSFALIVHEMFQGGP-----SNRADTAVQVAD------------------------ 305
S+D++S ++ M + D V++A
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269
Query: 306 -------RRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEI 345
+R L L + + R T E
Sbjct: 270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-31
Identities = 67/281 (23%), Positives = 105/281 (37%), Gaps = 48/281 (17%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLK 159
GAYG V G +A K + S +EL L + ++H N++ L V
Sbjct: 29 GAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFT 87
Query: 160 HSERL-----IFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAII 214
+ L ++L +L L++I K KL I RG+ Y+H II
Sbjct: 88 PARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSAD---II 143
Query: 215 HRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVY-RRESYG 273
HRDL PSN+ +E LK+ DFGL++ +MTG + Y APE+ Y
Sbjct: 144 HRDLKPSNLAVNEDCELKILDFGLARH------TDDEMTGYVATRWYRAPEIMLNWMHYN 197
Query: 274 KSVDVFSFALIVHEMFQGGPSNRADTAVQVADR---------------------RAYEDS 312
++VD++S I+ E+ G + R Y S
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257
Query: 313 RPALSSLYPEPI--------KALLRECWHKNPDRRPTFEEI 345
+ + + LL + + D+R T +
Sbjct: 258 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 7e-30
Identities = 62/293 (21%), Positives = 106/293 (36%), Gaps = 59/293 (20%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGV-- 157
GA G V +A K + N +EL L + + H NI+ L V
Sbjct: 28 GAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86
Query: 158 ----LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAI 213
L+ + + + E + I + D + G+ +LH
Sbjct: 87 PQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSAGI--- 140
Query: 214 IHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYG 273
IHRDL PSN++ LK+ DFGL++ A S+ MT + Y APEV Y
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVVTRYYRAPEVILGMGYK 196
Query: 274 KSVDVFSFALIVHEMFQGGPSNRADTAVQVADR--------------------RAYEDSR 313
++VD++S I+ EM + + ++ R Y ++R
Sbjct: 197 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256
Query: 314 P-----ALSSLYPEPI---------------KALLRECWHKNPDRRPTFEEII 346
P L+P+ + + LL + +P +R + ++ +
Sbjct: 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 96.6 bits (239), Expect = 5e-23
Identities = 53/308 (17%), Positives = 92/308 (29%), Gaps = 70/308 (22%)
Query: 102 GAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN--------- 150
G + V+L K T +A K +R + + E+ L Q++ +
Sbjct: 24 GHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 151 --IVQFLGVLKH----SERLIFLTEYLRNGSLHDILKKKGKLDP-PTAVAYALDIARGMN 203
I++ L H ++ + E L L I K + + P + + G++
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 204 YLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMA 263
Y+H IIH D+ P NVL + + Y T + Y +
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 264 PEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVAD------------------ 305
PEV +G D++S A ++ E+ G D
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257
Query: 306 -------RRAYEDSRPAL---------------------SSLYPEPIKALLRECWHKNPD 337
R + +SR L S + I L +P
Sbjct: 258 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317
Query: 338 RRPTFEEI 345
+R +
Sbjct: 318 KRADAGGL 325
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.5 bits (205), Expect = 2e-18
Identities = 34/148 (22%), Positives = 55/148 (37%), Gaps = 4/148 (2%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L S G V L++G PN+++ T LH+A+ G E+ LL+ A VN+
Sbjct: 4 LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKA 63
Query: 72 RWGRTPLSDARSFGHVVICKILEDRGGIDPGAYGEVYLV----KWRGTEIAAKTIRSSIA 127
+ +TPL A GH + K+L + A + G + A
Sbjct: 64 KDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEA 123
Query: 128 SNPRVRNSFMKELGLWQKLRHPNIVQFL 155
S + L + K + + L
Sbjct: 124 SQACMTKKGFTPLHVAAKYGKVRVAELL 151
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.2 bits (181), Expect = 3e-15
Identities = 25/83 (30%), Positives = 41/83 (49%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD 71
L S G+ V L+ + N + LH A+ +G +IV LLL+ GA N +
Sbjct: 301 LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVS 360
Query: 72 RWGRTPLSDARSFGHVVICKILE 94
G TPL+ A+ G++ + +L+
Sbjct: 361 SDGTTPLAIAKRLGYISVTDVLK 383
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.3 bits (163), Expect = 5e-13
Identities = 21/55 (38%), Positives = 26/55 (47%)
Query: 43 TALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
T LH+AS G IV LL++GA N + TPL A GH + K L
Sbjct: 2 TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNK 56
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.7 bits (151), Expect = 2e-11
Identities = 26/91 (28%), Positives = 37/91 (40%)
Query: 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLE 62
+ +G L + G LE+ PN A + T LH+A +IV LLL
Sbjct: 127 CMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLP 186
Query: 63 KGADVNSLDRWGRTPLSDARSFGHVVICKIL 93
+G +S G TPL A V + + L
Sbjct: 187 RGGSPHSPAWNGYTPLHIAAKQNQVEVARSL 217
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.1 bits (134), Expect = 3e-09
Identities = 24/70 (34%), Positives = 34/70 (48%)
Query: 29 EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVV 88
EK T LH+A+ G+ + LLLE+ A N+ + G TPL A ++
Sbjct: 120 EKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLD 179
Query: 89 ICKILEDRGG 98
I K+L RGG
Sbjct: 180 IVKLLLPRGG 189
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (124), Expect = 4e-08
Identities = 36/176 (20%), Positives = 69/176 (39%), Gaps = 6/176 (3%)
Query: 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLL 61
+G L + +G V L K NL + T LHL + EG + +L+
Sbjct: 225 NAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLI 284
Query: 62 EKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGGI----DPGAYGEVYLVKWRGTEI 117
+ G V++ R G TPL A +G++ + K L Y ++ +G
Sbjct: 285 KHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTD 344
Query: 118 AAKTIRSSIASNPRVRNSF-MKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172
+ + A +P +S L + ++L + ++ L V+ + +++ R
Sbjct: 345 IVTLLLKNGA-SPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSDKHR 399
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (119), Expect = 2e-07
Identities = 25/126 (19%), Positives = 40/126 (31%), Gaps = 33/126 (26%)
Query: 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK- 63
+ + L + G L+ + N D +T LH A+ G +V LLLE
Sbjct: 30 NVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENN 89
Query: 64 --------------------------------GADVNSLDRWGRTPLSDARSFGHVVICK 91
A + + G TPL A +G V + +
Sbjct: 90 ANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAE 149
Query: 92 ILEDRG 97
+L +R
Sbjct: 150 LLLERD 155
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 22/89 (24%), Positives = 35/89 (39%)
Query: 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLE 62
G L + V L +G P+ ++ T LH+A+ + + E+ LL+
Sbjct: 160 AAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQ 219
Query: 63 KGADVNSLDRWGRTPLSDARSFGHVVICK 91
G N+ G TPL A GH +
Sbjct: 220 YGGSANAESVQGVTPLHLAAQEGHAEMVA 248
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (110), Expect = 2e-06
Identities = 30/93 (32%), Positives = 40/93 (43%)
Query: 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKG 64
G L + + L+ G N T LHLA+ EG AE+V LLL K
Sbjct: 195 AWNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQ 254
Query: 65 ADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
A+ N ++ G TPL GHV + +L G
Sbjct: 255 ANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHG 287
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 74.8 bits (183), Expect = 2e-16
Identities = 32/198 (16%), Positives = 56/198 (28%), Gaps = 29/198 (14%)
Query: 102 GAYGEVYLVK-WRGTEIAAKTIRSSIASNPRVRN-------SFMKELGLWQKLRHPNIVQ 153
G V+ + E K + S +V+ F + + +
Sbjct: 11 GKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 70
Query: 154 FLGV----LKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHR 209
G+ + E L E + L+ + I + +H
Sbjct: 71 LQGLAVPKVYAWEGNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAKFYHRG 123
Query: 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRR 269
I+H DL+ NVL E G + + DF S E+ Y + R
Sbjct: 124 ---IVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITY-----FSR 174
Query: 270 ESYGKSVDVFSFALIVHE 287
Y D+ S + +
Sbjct: 175 T-YRTEKDINSAIDRILQ 191
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.1 bits (178), Expect = 3e-15
Identities = 21/71 (29%), Positives = 33/71 (46%), Gaps = 1/71 (1%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK-GADVNSLDRWGRTPLSDARSFGH 86
L+ G + N+ +T L LA + +V LLE+ ++N D G+T L A
Sbjct: 206 LDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKL 265
Query: 87 VVICKILEDRG 97
I ++L RG
Sbjct: 266 KKIAELLCKRG 276
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.1 bits (147), Expect = 3e-11
Identities = 21/70 (30%), Positives = 31/70 (44%), Gaps = 1/70 (1%)
Query: 3 IIDSEGPYRLLYCSSKGDRAGVLQELEK-GVEPNLADYDKRTALHLASSEGRAEIVLLLL 61
+ G L+ K V + LE+ +E N D D +TAL LA +I LL
Sbjct: 214 VRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLC 273
Query: 62 EKGADVNSLD 71
++GA + D
Sbjct: 274 KRGASTDCGD 283
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.0 bits (131), Expect = 3e-09
Identities = 17/57 (29%), Positives = 25/57 (43%), Gaps = 1/57 (1%)
Query: 37 ADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD-RWGRTPLSDARSFGHVVICKI 92
A + L A ++V LLE GA+VN + G TPL +A I ++
Sbjct: 1 AAVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVEL 57
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (127), Expect = 1e-08
Identities = 29/97 (29%), Positives = 42/97 (43%), Gaps = 6/97 (6%)
Query: 13 LYCSSKGDRAGVLQEL--EKGVEPNLADYDKRTALHLA----SSEGRAEIVLLLLEKGAD 66
L +++ VL+ L E G + N D R AL A I LLL+ GAD
Sbjct: 152 LMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGAD 211
Query: 67 VNSLDRWGRTPLSDARSFGHVVICKILEDRGGIDPGA 103
VN G+TPL A H+ + + L ++ I+
Sbjct: 212 VNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEIND 248
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (102), Expect = 2e-05
Identities = 30/92 (32%), Positives = 38/92 (41%), Gaps = 1/92 (1%)
Query: 7 EGPYRLLYCSSKGDRAGVLQELEKGVEPNLAD-YDKRTALHLASSEGRAEIVLLLLEKGA 65
E + L+ D V Q LE G N + T LH A R +IV LLL GA
Sbjct: 4 EDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGA 63
Query: 66 DVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
D + G TP A G V + K+ +G
Sbjct: 64 DPVLRKKNGATPFLLAAIAGSVKLLKLFLSKG 95
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 5e-04
Identities = 39/161 (24%), Positives = 61/161 (37%), Gaps = 19/161 (11%)
Query: 14 YCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRW 73
+ G + L KG + N D+ TA A+ G+ + + L ++GA+VN +
Sbjct: 78 LAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKT 137
Query: 74 ----------GRTPLSDARSFGHVVICKILEDRGGIDPGAYGEVYLVKWRGTEIAAKTIR 123
G T L DA GHV + KIL D G D A + +++
Sbjct: 138 KEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSD 197
Query: 124 S--------SIASNPRVRNSFMKE-LGLWQKLRHPNIVQFL 155
++ VR K L L + +H +VQ L
Sbjct: 198 VEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRL 238
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 72.8 bits (177), Expect = 3e-15
Identities = 21/64 (32%), Positives = 35/64 (54%)
Query: 31 GVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVIC 90
G + D D +T + LA+ EGR E+V+ L+++GA V ++D T A++ H I
Sbjct: 211 GSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIV 270
Query: 91 KILE 94
I +
Sbjct: 271 DIFD 274
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 51.7 bits (122), Expect = 4e-08
Identities = 26/93 (27%), Positives = 36/93 (38%), Gaps = 12/93 (12%)
Query: 7 EGPYRLLYCSSKGDRAGVLQELEKGVEPNLAD-YDKRTALHLASSEGRAEIVLLLL---- 61
E P +L + + G A + V N+ D RT LH +S AE L+
Sbjct: 1 ESPIKL-HTEAAGSYAITEPITRESV--NIIDPRHNRTVLHWIASNSSAEKSEDLIVHEA 57
Query: 62 ----EKGADVNSLDRWGRTPLSDARSFGHVVIC 90
GADVN++D TPL A +
Sbjct: 58 KECIAAGADVNAMDCDENTPLMLAVLARRRRLV 90
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 48.6 bits (114), Expect = 4e-07
Identities = 12/58 (20%), Positives = 23/58 (39%)
Query: 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLE 62
D +G ++ + +G V+ +++G D TA LA + IV +
Sbjct: 218 DEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDR 275
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Score = 43.2 bits (100), Expect = 2e-05
Identities = 14/181 (7%), Positives = 38/181 (20%), Gaps = 2/181 (1%)
Query: 43 TALHLA-SSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGGIDP 101
+ + L + G I + + ++ R RT L S + L +
Sbjct: 2 SPIKLHTEAAGSYAITEPITRESVNIID-PRHNRTVLHWIASNSSAEKSEDLIVHEAKEC 60
Query: 102 GAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161
A G + + + +
Sbjct: 61 IAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRDF 120
Query: 162 ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPS 221
++++ + + L + G L + + +
Sbjct: 121 GMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDYDGAARK 180
Query: 222 N 222
+
Sbjct: 181 D 181
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 65.2 bits (157), Expect = 6e-13
Identities = 23/90 (25%), Positives = 35/90 (38%)
Query: 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKG 64
D+ G L + ++ + V L + D T L LA+ EG E LL+
Sbjct: 120 DNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNF 179
Query: 65 ADVNSLDRWGRTPLSDARSFGHVVICKILE 94
A+ D R P A H I ++L+
Sbjct: 180 ANREITDHMDRLPRDVASERLHHDIVRLLD 209
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 49.0 bits (115), Expect = 2e-07
Identities = 14/41 (34%), Positives = 23/41 (56%), Gaps = 1/41 (2%)
Query: 54 AEIVLLLLEKGADVNS-LDRWGRTPLSDARSFGHVVICKIL 93
A+++ LL +GA++N+ +D+ G T L A F K L
Sbjct: 2 AQVISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRL 42
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.0 bits (89), Expect = 4e-04
Identities = 13/34 (38%), Positives = 17/34 (50%), Gaps = 1/34 (2%)
Query: 28 LEKGVEPNL-ADYDKRTALHLASSEGRAEIVLLL 60
L +G E N D T+LHLA+ RA+ L
Sbjct: 9 LAQGAELNATMDKTGETSLHLAARFARADAAKRL 42
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 64.4 bits (155), Expect = 3e-12
Identities = 20/79 (25%), Positives = 37/79 (46%)
Query: 5 DSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKG 64
G L ++KG + ++ + N+ DYD T LH A+ G+ E +L+E
Sbjct: 196 AKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENL 255
Query: 65 ADVNSLDRWGRTPLSDARS 83
D+ ++++ G+T A
Sbjct: 256 CDMEAVNKVGQTAFDVADE 274
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 59.7 bits (143), Expect = 9e-11
Identities = 19/53 (35%), Positives = 25/53 (47%)
Query: 38 DYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVIC 90
+D A S G E VL LLE+GAD+N + G T L A +V +
Sbjct: 37 KFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMV 89
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 50.9 bits (120), Expect = 7e-08
Identities = 22/69 (31%), Positives = 34/69 (49%)
Query: 29 EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVV 88
+ TALH+A+++G E++ LL++ DVN D G TPL A +G
Sbjct: 187 SGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEE 246
Query: 89 ICKILEDRG 97
C+IL +
Sbjct: 247 ACRILVENL 255
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 40.1 bits (92), Expect = 2e-04
Identities = 33/94 (35%), Positives = 49/94 (52%)
Query: 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK 63
+ + L S GD VL+ LE+G + N A+ D TALH A + ++V L+E
Sbjct: 36 VKFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVEN 95
Query: 64 GADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
GA++N D G PL A S G++ I + L +G
Sbjct: 96 GANINQPDNEGWIPLHAAASCGYLDIAEYLISQG 129
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 37.8 bits (86), Expect = 0.002
Identities = 14/68 (20%), Positives = 23/68 (33%), Gaps = 4/68 (5%)
Query: 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLE 62
I D +G L + G +E + + +TA +A +I+ L E
Sbjct: 227 IKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADE----DILGYLEE 282
Query: 63 KGADVNSL 70
N L
Sbjct: 283 LQKKQNLL 290
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 63.1 bits (152), Expect = 7e-12
Identities = 15/44 (34%), Positives = 23/44 (52%)
Query: 35 NLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPL 78
N D + T L++A+ G IV LL+ GAD ++ G P+
Sbjct: 253 NAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPV 296
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 54.7 bits (130), Expect = 4e-09
Identities = 17/79 (21%), Positives = 27/79 (34%), Gaps = 6/79 (7%)
Query: 23 GVLQELEKGVEPNLA------DYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRT 76
+LQE+ D T LH +S E+V L++ G++ D G +
Sbjct: 83 SLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGES 142
Query: 77 PLSDARSFGHVVICKILED 95
L A + E
Sbjct: 143 CLVKAVKSVNNYDSGTFEA 161
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 48.1 bits (113), Expect = 7e-07
Identities = 16/72 (22%), Positives = 29/72 (40%), Gaps = 3/72 (4%)
Query: 29 EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEK---GADVNSLDRWGRTPLSDARSFG 85
++ +K + + + E + I+ L K +N+ D G T L+ A G
Sbjct: 211 KQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARLG 270
Query: 86 HVVICKILEDRG 97
++ I L D G
Sbjct: 271 NISIVDALLDYG 282
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 40.4 bits (93), Expect = 2e-04
Identities = 12/58 (20%), Positives = 22/58 (37%), Gaps = 1/58 (1%)
Query: 41 KRTALHLASSEGRAEIVLLLLEKGADVN-SLDRWGRTPLSDARSFGHVVICKILEDRG 97
+ H++ E+ ++N +D G TPL S ++ + K L G
Sbjct: 73 NQQQQHVSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHG 130
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.6 bits (143), Expect = 6e-11
Identities = 28/124 (22%), Positives = 45/124 (36%), Gaps = 34/124 (27%)
Query: 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHL--------------- 47
++ G L Y +SK + LE G P+ D+ + TA+H
Sbjct: 98 AVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLY 157
Query: 48 ------------------ASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVI 89
A E R E LL+ +GA + ++ +TPL A+ G +I
Sbjct: 158 YKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVAKG-GLGLI 216
Query: 90 CKIL 93
K +
Sbjct: 217 LKRM 220
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.2 bits (142), Expect = 7e-11
Identities = 23/66 (34%), Positives = 39/66 (59%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHV 87
L KG + N + + T LH A+S+ R EI ++LLE GA+ ++ D + T + A + G++
Sbjct: 90 LGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNL 149
Query: 88 VICKIL 93
+ IL
Sbjct: 150 KMIHIL 155
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (109), Expect = 1e-06
Identities = 47/229 (20%), Positives = 68/229 (29%), Gaps = 63/229 (27%)
Query: 12 LLYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEG------------------ 52
+ + G + + + D D RTALH A S G
Sbjct: 7 VCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 66
Query: 53 ---------------RAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
R EIV LL KGA VN++++ G TPL A S I +L +
Sbjct: 67 DDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEG- 125
Query: 98 GIDPGA---YGEVYL--VKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIV 152
G +P A Y + +G + AS L L
Sbjct: 126 GANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEA 185
Query: 153 QFLGVLKHSERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARG 201
+ L + G+ I K+ K L +A+G
Sbjct: 186 KLL---------------VSQGASIYIENKEEKT--------PLQVAKG 211
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (105), Expect = 5e-06
Identities = 12/61 (19%), Positives = 25/61 (40%), Gaps = 1/61 (1%)
Query: 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLL 61
I D+EG L + + +G + + +++T L +A G I+ ++
Sbjct: 163 NIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVA-KGGLGLILKRMV 221
Query: 62 E 62
E
Sbjct: 222 E 222
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 59.9 bits (144), Expect = 1e-10
Identities = 13/102 (12%), Positives = 24/102 (23%), Gaps = 5/102 (4%)
Query: 5 DSEGPYRLLYCSSKG--DRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLL 61
+ + G L L + + A LA+ G ++ L
Sbjct: 87 GIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLC 146
Query: 62 EKGADVNSLDR--WGRTPLSDARSFGHVVICKILEDRGGIDP 101
E A GH+ + L + +
Sbjct: 147 ELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEA 188
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 48.7 bits (115), Expect = 5e-07
Identities = 10/72 (13%), Positives = 19/72 (26%), Gaps = 5/72 (6%)
Query: 33 EPNLADYDKRTALHLASSEGRAEIVLLLLEKGAD-----VNSLDRWGRTPLSDARSFGHV 87
L + L + E + + LL ++ L A G+
Sbjct: 271 SECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANELLRLALRLGNQ 330
Query: 88 VICKILEDRGGI 99
C +L +
Sbjct: 331 GACALLLSIPSV 342
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 47.2 bits (111), Expect = 1e-06
Identities = 21/121 (17%), Positives = 34/121 (28%), Gaps = 11/121 (9%)
Query: 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDK--RTALHLASSEGRAEIVLLL 60
+I +E + G + + E +A A LA+ G ++ L
Sbjct: 121 VIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRL 180
Query: 61 LEKGADVNSL---DRWGRTPLSDARSFGHVVICKILEDRGG------IDPGAYGEVYLVK 111
E + A GH + L D I YGE Y+
Sbjct: 181 CELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEIHEFEYGEKYVNP 240
Query: 112 W 112
+
Sbjct: 241 F 241
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Score = 36.8 bits (84), Expect = 0.003
Identities = 10/43 (23%), Positives = 13/43 (30%), Gaps = 1/43 (2%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSL 70
++ D L LA G LLL V +L
Sbjct: 304 IKALAPTATIPGDANELLRLALRLGNQGACALLLSIP-SVLAL 345
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 57.8 bits (138), Expect = 3e-10
Identities = 22/63 (34%), Positives = 32/63 (50%)
Query: 39 YDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGG 98
RT LHLA A ++ LLL+ GAD + GRTPL A + ++ ++L G
Sbjct: 190 TCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGA 249
Query: 99 IDP 101
+P
Sbjct: 250 PEP 252
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 55.1 bits (131), Expect = 2e-09
Identities = 15/56 (26%), Positives = 20/56 (35%), Gaps = 3/56 (5%)
Query: 38 DYDKRTALHLASSEGRAEIVLLLLEKGAD---VNSLDRWGRTPLSDARSFGHVVIC 90
D TALHLA + LL A ++ + G+T L A G
Sbjct: 6 TEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTV 61
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 52.8 bits (125), Expect = 1e-08
Identities = 12/41 (29%), Positives = 15/41 (36%)
Query: 28 LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVN 68
L+ G +P Y RT L A + LL GA
Sbjct: 212 LKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEP 252
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Score = 39.3 bits (90), Expect = 3e-04
Identities = 29/140 (20%), Positives = 44/140 (31%), Gaps = 3/140 (2%)
Query: 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEP---NLADYDKRTALHLASSEGRAEIVLLL 60
+ +G L + L +L + +TALHLA+ G A V L
Sbjct: 5 VTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKL 64
Query: 61 LEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGGIDPGAYGEVYLVKWRGTEIAAK 120
GA V +R G T L A +L P + YL + +
Sbjct: 65 YAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTS 124
Query: 121 TIRSSIASNPRVRNSFMKEL 140
+++ S P N
Sbjct: 125 HAPAAVDSQPNPENEEEPRD 144
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.2 bits (136), Expect = 4e-10
Identities = 21/63 (33%), Positives = 29/63 (46%)
Query: 29 EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVV 88
+ G N Y +ALH AS G +V L+ GAD + + TPL ARS +
Sbjct: 165 QHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVID 224
Query: 89 ICK 91
I +
Sbjct: 225 ILR 227
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.5 bits (124), Expect = 1e-08
Identities = 13/55 (23%), Positives = 23/55 (41%), Gaps = 4/55 (7%)
Query: 40 DKRTALHLASSEGRAEIVLLLL----EKGADVNSLDRWGRTPLSDARSFGHVVIC 90
D T LH+A +G V L+ + G +++ + +TPL A +
Sbjct: 2 DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVV 56
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (107), Expect = 2e-06
Identities = 12/51 (23%), Positives = 20/51 (39%)
Query: 7 EGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIV 57
G L S +G V + G + +L + T L +A S +I+
Sbjct: 176 SGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVIDIL 226
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 56.0 bits (133), Expect = 9e-10
Identities = 17/56 (30%), Positives = 22/56 (39%), Gaps = 1/56 (1%)
Query: 43 TALHLASSEGRAEIVLLLLE-KGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
LH A E V LL K + + D+ GR PL + SF I L +
Sbjct: 2 YPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKM 57
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 43.7 bits (101), Expect = 1e-05
Identities = 16/61 (26%), Positives = 26/61 (42%), Gaps = 4/61 (6%)
Query: 38 DYDKRTALHLASSEGRAEIVLLLLEK-GADVNSLDRWGRTPLSDARSFGHVVICKILEDR 96
D T L A +EG + +LL+EK GA+ + +D G A + + K +
Sbjct: 169 DKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKFFLNN 225
Query: 97 G 97
Sbjct: 226 V 226
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 42.5 bits (98), Expect = 3e-05
Identities = 15/63 (23%), Positives = 26/63 (41%), Gaps = 4/63 (6%)
Query: 5 DSEGPYRLLYCSSKGDRAGVLQELEK-GVEPNLADYDKRTALHLASSEGRAEIVLLLLEK 63
D +G L + ++G + +EK G E +L D A +A +E ++ L
Sbjct: 169 DKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALNE---QVKKFFLNN 225
Query: 64 GAD 66
D
Sbjct: 226 VVD 228
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.4 bits (121), Expect = 3e-08
Identities = 12/55 (21%), Positives = 19/55 (34%), Gaps = 4/55 (7%)
Query: 40 DKRTALHLASSEGRAEIVL----LLLEKGADVNSLDRWGRTPLSDARSFGHVVIC 90
D + LHLA + + + A +N + +TPL A I
Sbjct: 1 DGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIA 55
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.5 bits (116), Expect = 1e-07
Identities = 20/59 (33%), Positives = 27/59 (45%)
Query: 39 YDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRG 97
+ RTALHLA ++V LLL+ GADVN + G +P I + L
Sbjct: 143 CNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLT 201
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 3e-06
Identities = 9/55 (16%), Positives = 15/55 (27%)
Query: 12 LLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGAD 66
L + V L+ G + N Y + L I L + +
Sbjct: 149 LHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 203
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.6 bits (111), Expect = 3e-07
Identities = 10/33 (30%), Positives = 18/33 (54%)
Query: 43 TALHLASSEGRAEIVLLLLEKGADVNSLDRWGR 75
L A++ G E + LL+ +VN+ + +GR
Sbjct: 3 NELASAAARGDLEQLTSLLQNNVNVNAQNGFGR 35
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 4e-05
Identities = 10/30 (33%), Positives = 14/30 (46%)
Query: 35 NLADYDKRTALHLASSEGRAEIVLLLLEKG 64
++ TA LA GR E+V L+ G
Sbjct: 127 GHRNHKGDTACDLARLYGRNEVVSLMQANG 156
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 46.5 bits (109), Expect = 7e-07
Identities = 22/130 (16%), Positives = 34/130 (26%), Gaps = 42/130 (32%)
Query: 10 YRLLYCSSKGDRAGVLQELEKGVEPN------LADYDKRTALHL---ASSEGRAEIVLLL 60
+ L D G+LQ GV+ TALHL + IV L
Sbjct: 8 HSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFL 67
Query: 61 LEKGADV---------------------------------NSLDRWGRTPLSDARSFGHV 87
++ ++ + G TPL A+ H
Sbjct: 68 VQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHE 127
Query: 88 VICKILEDRG 97
++L
Sbjct: 128 HCEELLTQAL 137
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.3 bits (98), Expect = 2e-05
Identities = 6/36 (16%), Positives = 11/36 (30%)
Query: 31 GVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGAD 66
+A+ T L +A LL + +
Sbjct: 104 KASIEIANESGETPLDIAKRLKHEHCEELLTQALSG 139
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Score = 37.3 bits (85), Expect = 8e-04
Identities = 16/131 (12%), Positives = 30/131 (22%), Gaps = 13/131 (9%)
Query: 38 DYDKRTALHLASSEGRAEIVLLLLEKGADVNSL------DRWGRTPL---SDARSFGHVV 88
K +L A +L G D+ T L + +
Sbjct: 3 TAAKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLH 62
Query: 89 ICKILEDRGGIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKE----LGLWQ 144
I L G G+ + + L + +
Sbjct: 63 IVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAK 122
Query: 145 KLRHPNIVQFL 155
+L+H + + L
Sbjct: 123 RLKHEHCEELL 133
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 42.5 bits (98), Expect = 1e-05
Identities = 21/64 (32%), Positives = 36/64 (56%)
Query: 31 GVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVIC 90
G + N D K TALH A+ E+V LL++ GADV++ ++ +T + G+ +
Sbjct: 90 GADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLA 149
Query: 91 KILE 94
+IL+
Sbjct: 150 EILQ 153
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 40.6 bits (93), Expect = 7e-05
Identities = 11/38 (28%), Positives = 18/38 (47%), Gaps = 1/38 (2%)
Query: 40 DKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTP 77
D L A+ G+ + V +L+ GA + D G +P
Sbjct: 1 DLGKKLLEAARAGQDDEVRILMANGAPFTT-DWLGTSP 37
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 37.5 bits (85), Expect = 8e-04
Identities = 7/53 (13%), Positives = 20/53 (37%)
Query: 8 GPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLL 60
L + + + V ++ G + + +TA ++ G ++ +L
Sbjct: 100 KMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 4e-04
Identities = 10/36 (27%), Positives = 19/36 (52%), Gaps = 1/36 (2%)
Query: 43 TALHLASSEGRAEIVLLLLEK-GADVNSLDRWGRTP 77
L A++ G + V LL + ++L+R+G+T
Sbjct: 4 DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTA 39
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (86), Expect = 6e-04
Identities = 10/50 (20%), Positives = 20/50 (40%)
Query: 13 LYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLE 62
++ + + V+ L + + D T L LA G ++V +L
Sbjct: 105 IHLAVQEGHTAVVSFLAAESDLHRRDARGLTPLELALQRGAQDLVDILQG 154
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 7e-04
Identities = 20/65 (30%), Positives = 29/65 (44%), Gaps = 1/65 (1%)
Query: 31 GVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVIC 90
G + N+ D +HLA EG +V L +D++ D G TPL A G +
Sbjct: 91 GADVNVPDGTGALPIHLAVQEGHTAVVSFL-AAESDLHRRDARGLTPLELALQRGAQDLV 149
Query: 91 KILED 95
IL+
Sbjct: 150 DILQG 154
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.7 bits (80), Expect = 0.002
Identities = 21/117 (17%), Positives = 40/117 (34%), Gaps = 4/117 (3%)
Query: 43 TALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGGIDPG 102
L A++ GR E V LLE GA+ N+ + +GR P+ V +L +
Sbjct: 5 DWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMMMGSARVAELLLLHGAEPNCA 64
Query: 103 AYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKE----LGLWQKLRHPNIVQFL 155
+ + + + L ++L H ++ ++L
Sbjct: 65 DPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVARYL 121
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 370 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.86 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.85 | |
| d1myoa_ | 118 | Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116] | 99.85 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.83 | |
| d1ycsb1 | 130 | 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | 99.83 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.8 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 99.78 | |
| d1bi7b_ | 125 | Cell cycle inhibitor p16ink4A {Human (Homo sapiens | 99.78 | |
| d1oy3d_ | 255 | Transcription factor inhibitor I-kappa-B-beta, IKB | 99.77 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.75 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.74 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 99.73 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.72 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.72 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.72 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.71 | |
| d1uoha_ | 223 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.71 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.7 | |
| d1n11a_ | 408 | Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | 99.69 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.68 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.67 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.67 | |
| d1awcb_ | 153 | GA bindinig protein (GABP) beta 1 {Mouse (Mus musc | 99.67 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.66 | |
| d2ajaa1 | 346 | Hypothetical protein LPG2416 {Legionella pneumophi | 99.65 | |
| d1bd8a_ | 156 | Cell cycle inhibitor p19ink4D {Human (Homo sapiens | 99.65 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.64 | |
| d1dcqa1 | 154 | Pyk2-associated protein beta {Mouse (Mus musculus) | 99.63 | |
| d2fo1e1 | 277 | Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | 99.63 | |
| d1s70b_ | 291 | Myosin phosphatase targeting subunit 1, MYPT1 {Chi | 99.63 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 99.63 | |
| d1k1aa_ | 228 | bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | 99.62 | |
| d1iknd_ | 221 | I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606 | 99.62 | |
| d1wdya_ | 285 | RNase L, 2-5a-dependent ribonuclease {Human (Homo | 99.62 | |
| d1ot8a_ | 209 | Neurogenic locus notch receptor domain {Fruit fly | 99.53 | |
| d1ihba_ | 156 | p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606] | 99.52 | |
| d1ixva_ | 229 | 26S proteasome non-ATPase regulatory subunit 10, g | 99.41 | |
| d1sw6a_ | 301 | Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch | 99.15 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.5 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.14 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.92 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.03 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.92 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.59 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-57 Score=390.97 Aligned_cols=241 Identities=27% Similarity=0.494 Sum_probs=214.6
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|+|+||.||++... ++.+|+|++......+......+.+|+.+++.++||||+++++++.+++.+++||||++||+
T Consensus 13 ~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~ 92 (263)
T d2j4za1 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 92 (263)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 3789999999999875 77899999875433334456778999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... ....
T Consensus 93 L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-----~~~~ 164 (263)
T d2j4za1 93 VYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----RTTL 164 (263)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-----CEET
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc-----cccc
Confidence 9999998889999999999999999999999998 9999999999999999999999999997665432 2234
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccC
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKN 335 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 335 (370)
.||+.|+|||++.+..++.++|||||||++|+|++|++||...+.......+. ...+..+..+|+.+.+||.+||+.|
T Consensus 165 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~L~~d 242 (263)
T d2j4za1 165 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS--RVEFTFPDFVTEGARDLISRLLKHN 242 (263)
T ss_dssp TEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--TTCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred CCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH--cCCCCCCccCCHHHHHHHHHHccCC
Confidence 68999999999999999999999999999999999999999888877766654 3345567789999999999999999
Q ss_pred CCCCCCHHHHHHH
Q 042314 336 PDRRPTFEEIIFR 348 (370)
Q Consensus 336 p~~Rp~~~~ll~~ 348 (370)
|++|||++|++++
T Consensus 243 p~~R~t~~eil~h 255 (263)
T d2j4za1 243 PSQRPMLREVLEH 255 (263)
T ss_dssp GGGSCCHHHHHTC
T ss_pred HhHCcCHHHHHcC
Confidence 9999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-56 Score=387.01 Aligned_cols=251 Identities=24% Similarity=0.462 Sum_probs=215.8
Q ss_pred CCCCCCcccEEEEEEc----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
.+|+|+||.||++.++ ++.||+|+++... .++...+.+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 14 ~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 4899999999999764 3569999987653 345667889999999999999999999999865 467899999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|+|.+++.+...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.............
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 999999999889999999999999999999999998 99999999999999999999999999987765544333344
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
...||+.|+|||.+.+..++.++|||||||++|||+| |++||...+..+....+. .+.+++.+..+|+.+.+||.+||
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~~cl 247 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCW 247 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHHHHc
Confidence 4578999999999999999999999999999999998 899999888776655554 46677788889999999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFRLEAIQE 354 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~l~~~~~ 354 (370)
+.||++|||++++++.|+....
T Consensus 248 ~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 248 TYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999998877643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-56 Score=387.84 Aligned_cols=253 Identities=30% Similarity=0.499 Sum_probs=207.7
Q ss_pred CCCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 98 GIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
.+|+|+||.||++.+++ .+|||+++... .+....+.+.+|+.++++++||||+++++++. .+.+++||||++||+|.
T Consensus 15 ~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~ 91 (276)
T d1uwha_ 15 RIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLY 91 (276)
T ss_dssp EEEECSSCEEEEEESSS-EEEEEECCCSS-CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHH
T ss_pred EEeeCCCcEEEEEEECC-EEEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHH
Confidence 37999999999998765 59999987653 33456788999999999999999999999865 45689999999999999
Q ss_pred HHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 178 DILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 178 ~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
+++... .++++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+........ .......
T Consensus 92 ~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~ 167 (276)
T d1uwha_ 92 HHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS-HQFEQLS 167 (276)
T ss_dssp HHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------------CC
T ss_pred HHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCc-ccccccc
Confidence 999765 57999999999999999999999998 999999999999999999999999999876543221 1334457
Q ss_pred CCccccCcccccc---cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC----CCCCCCCCcHHHHHHHH
Q 042314 257 GSYRYMAPEVYRR---ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS----RPALSSLYPEPIKALLR 329 (370)
Q Consensus 257 g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~ 329 (370)
||+.|+|||++.+ ..++.++|||||||++|||+||+.||................. ....+..+|+.+.+||.
T Consensus 168 gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~ 247 (276)
T d1uwha_ 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMA 247 (276)
T ss_dssp CCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHH
T ss_pred cCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHH
Confidence 8999999999864 3578999999999999999999999987655443333222222 22456678999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 330 ECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
+||+.||++|||+++++++|+.++++++
T Consensus 248 ~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 248 ECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 9999999999999999999999988654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=386.88 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=222.0
Q ss_pred CCCCCcccEEEEEEc----CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 99 IDPGAYGEVYLVKWR----GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 99 l~~g~~~~v~~a~~~----g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
+|+|+||.||++.++ +..||||.++.. ......+.+.+|+.++++++|||||++++++.. +.+++||||+++|
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g 93 (285)
T d1u59a_ 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 93 (285)
T ss_dssp EECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred EecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCC
Confidence 799999999999764 346899998754 345667889999999999999999999999865 5689999999999
Q ss_pred CHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 175 SLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 175 ~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+|.+++.. ++.+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.............
T Consensus 94 ~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 170 (285)
T d1u59a_ 94 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170 (285)
T ss_dssp EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred cHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccccccccccc
Confidence 99998765 457999999999999999999999998 99999999999999999999999999998776544433444
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
...||+.|+|||.+.+..++.++|||||||++|||+| |++||......+....+. .+.+++.+..+|+.+.+||.+||
T Consensus 171 ~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl 249 (285)
T d1u59a_ 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPELYALMSDCW 249 (285)
T ss_dssp SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTT
T ss_pred ccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHc
Confidence 5578999999999999999999999999999999998 899998877666555544 56677788899999999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHhccCC
Q 042314 333 HKNPDRRPTFEEIIFRLEAIQESFQKKT 360 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~l~~~~~~~~~~~ 360 (370)
+.||++|||+.++++.|+.+..++..+.
T Consensus 250 ~~~p~~RPs~~~i~~~L~~~~~~~~~~~ 277 (285)
T d1u59a_ 250 IYKWEDRPDFLTVEQRMRACYYSLASKV 277 (285)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred CCCHhHCcCHHHHHHHHHHHHHHhhhcc
Confidence 9999999999999999998877766543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-55 Score=384.45 Aligned_cols=241 Identities=26% Similarity=0.454 Sum_probs=210.9
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|+|+||.||+|... |..+|+|.+...... ..+.+.+|+.+++.++||||+++++++...+.+++||||++||+
T Consensus 27 ~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 103 (293)
T d1yhwa1 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 103 (293)
T ss_dssp ECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCc
Confidence 3899999999999865 889999998765332 24678999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.++ .+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||+++....... .....
T Consensus 104 L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~---~~~~~ 176 (293)
T d1yhwa1 104 LTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTM 176 (293)
T ss_dssp HHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC---CBCCC
T ss_pred HHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc---ccccc
Confidence 99988765 7999999999999999999999998 99999999999999999999999999987754432 23345
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-CCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-DSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.||+.|+|||++.+..++.++||||+||++|+|++|++||...+........... ......+..+|+.+++||.+||+.
T Consensus 177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 256 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256 (293)
T ss_dssp CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCS
T ss_pred ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccC
Confidence 7999999999999999999999999999999999999999888776655544322 334455667899999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042314 335 NPDRRPTFEEIIFR 348 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~ 348 (370)
||++|||++|+++|
T Consensus 257 dP~~R~s~~eil~H 270 (293)
T d1yhwa1 257 DVEKRGSAKELLQH 270 (293)
T ss_dssp STTTSCCHHHHTTC
T ss_pred ChhHCcCHHHHhcC
Confidence 99999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-56 Score=389.32 Aligned_cols=244 Identities=24% Similarity=0.390 Sum_probs=212.1
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|+|+||.||+|... |+.+|+|++.............+.+|+.++++++||||+++++++.+.+.+++||||++||+|
T Consensus 16 lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L 95 (288)
T d1uu3a_ 16 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL 95 (288)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEH
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCH
Confidence 789999999999875 788999998754333334457789999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++...+.+++..++.++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++......... ......
T Consensus 96 ~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~-~~~~~~ 171 (288)
T d1uu3a_ 96 LKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFV 171 (288)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-----------CC
T ss_pred HHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCccc-cccccc
Confidence 999999899999999999999999999999999 9999999999999999999999999998775433221 233457
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
||+.|+|||++.+..++.++||||+||++|||++|++||...+.......+.. ....++..+|+.+.+||++||+.||
T Consensus 172 GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP 249 (288)
T d1uu3a_ 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--LEYDFPEKFFPKARDLVEKLLVLDA 249 (288)
T ss_dssp CCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT--TCCCCCTTCCHHHHHHHHTTSCSSG
T ss_pred CCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc--CCCCCCccCCHHHHHHHHHHccCCH
Confidence 99999999999999999999999999999999999999998888777766652 3345677899999999999999999
Q ss_pred CCCCCHHHHHHH
Q 042314 337 DRRPTFEEIIFR 348 (370)
Q Consensus 337 ~~Rp~~~~ll~~ 348 (370)
++|||++|++.+
T Consensus 250 ~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 250 TKRLGCEEMEGY 261 (288)
T ss_dssp GGSTTSGGGTCH
T ss_pred hHCcCHHHHcCC
Confidence 999999997654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-55 Score=385.85 Aligned_cols=254 Identities=29% Similarity=0.525 Sum_probs=207.7
Q ss_pred CCCCCCcccEEEEEEc--Cc---eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWR--GT---EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~---~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|+|+||.||++... ++ .+++|.+... ......+.+.+|+.++++++|||||++++++...+.+++||||++
T Consensus 33 ~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 33 VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 3799999999999874 32 3677776543 345667789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc--
Q 042314 173 NGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS-- 249 (370)
Q Consensus 173 g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-- 249 (370)
+|+|.+++... +.+++.++..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 111 ~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~ 187 (299)
T d1jpaa_ 111 NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 187 (299)
T ss_dssp TEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------------
T ss_pred CCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCccee
Confidence 99999988874 57899999999999999999999998 9999999999999999999999999998765433221
Q ss_pred eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
....+..+|+.|+|||.+.+..++.++|||||||++|||+| |++||...+..+....+. .+.+++.+..+|+.+.+|+
T Consensus 188 ~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li 266 (299)
T d1jpaa_ 188 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLPPPMDCPSALHQLM 266 (299)
T ss_dssp --------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHH
T ss_pred eecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCccchHHHHHHH
Confidence 12223457999999999999999999999999999999998 899999888877666654 4556667788999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 329 RECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
.+||+.||++|||++++++.|+++.+..+
T Consensus 267 ~~cl~~~P~~RPs~~ei~~~L~~~l~~p~ 295 (299)
T d1jpaa_ 267 LDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295 (299)
T ss_dssp HHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHhcChh
Confidence 99999999999999999999999876543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-56 Score=386.01 Aligned_cols=245 Identities=26% Similarity=0.393 Sum_probs=204.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|+|+||.||+|... |..+|+|++.... ..+..+.+.+|+.++++++||||+++++++.+.+.+++||||++||+
T Consensus 12 ~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 89 (271)
T d1nvra_ 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89 (271)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEehhh--cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence 3789999999999875 7889999987643 22344678999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|.+++.+.+.+++..++.++.|+++||.|||++| |+||||||+|||++.++.+||+|||+|+......... .....
T Consensus 90 L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~-~~~~~ 165 (271)
T d1nvra_ 90 LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER-LLNKM 165 (271)
T ss_dssp GGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC-CBCCC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccc-cccce
Confidence 9999988889999999999999999999999998 9999999999999999999999999998775443221 23445
Q ss_pred CCCccccCcccccccCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 256 TGSYRYMAPEVYRRESY-GKSVDVFSFALIVHEMFQGGPSNRADTAVQ-VADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
.||+.|+|||++.+..+ +.++||||+||++|||++|++||....... ..............+..+|+.+.+||++||+
T Consensus 166 ~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 245 (271)
T d1nvra_ 166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 245 (271)
T ss_dssp CSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSC
T ss_pred eeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcC
Confidence 79999999999988876 578999999999999999999997654322 2222222233333445688999999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFR 348 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~ 348 (370)
.||++|||++|++++
T Consensus 246 ~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 246 ENPSARITIPDIKKD 260 (271)
T ss_dssp SSTTTSCCHHHHTTC
T ss_pred CChhHCcCHHHHhcC
Confidence 999999999999764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-55 Score=379.04 Aligned_cols=248 Identities=29% Similarity=0.542 Sum_probs=205.9
Q ss_pred CCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 98 GIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
.+|+|+||.||++.+. +..||+|.++... ...+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 12 ~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L 87 (263)
T d1sm2a_ 12 EIGSGQFGLVHLGYWLNKDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 87 (263)
T ss_dssp EEECCSSCCEEEEEETTTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEeeCCCeEEEEEEECCCCEEEEEEECCCc----CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence 3799999999999885 6679999987532 2246789999999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 177 HDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 177 ~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........ .....
T Consensus 88 ~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~--~~~~~ 162 (263)
T d1sm2a_ 88 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT--SSTGT 162 (263)
T ss_dssp HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------------
T ss_pred HHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce--eecce
Confidence 9998755 56889999999999999999999998 999999999999999999999999999876544322 22334
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG-GPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.||+.|+|||.+.+..++.++|||||||++|||+|+ .+||...+..+....+. .+.++..+..+|+.+.+++.+||+.
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~ 241 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQIMNHCWKE 241 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-hcCCCCCccccCHHHHHHHHHHccC
Confidence 689999999999999999999999999999999995 66677666666555544 4566677788899999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHH
Q 042314 335 NPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
||++|||+++++++|+++.++
T Consensus 242 ~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 242 RPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp SGGGSCCHHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=382.18 Aligned_cols=245 Identities=24% Similarity=0.430 Sum_probs=200.7
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee--CCceEEEEeecCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH--SERLIFLTEYLRNG 174 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~--~~~~~~v~e~~~g~ 174 (370)
+|+|+||.||++... |+.+|+|.+.... .++...+.+.+|+.++++++||||+++++++.+ .+.+++||||++||
T Consensus 12 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g 90 (269)
T d2java1 12 IGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 90 (269)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEECCTT-SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTE
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEChhh-CCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCC
Confidence 789999999999875 7889999987653 345567789999999999999999999998864 46789999999999
Q ss_pred CHHHHHHh----CCCCChHhHHHHHHHHHHHHHHHhhcC--CCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 175 SLHDILKK----KGKLDPPTAVAYALDIARGMNYLHHHR--PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 175 ~L~~~l~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~--~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
+|.+++.+ .+.+++..++.++.|++.||.|||+++ ..+|+||||||+|||++.++.+||+|||+++.......
T Consensus 91 ~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~- 169 (269)
T d2java1 91 DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS- 169 (269)
T ss_dssp EHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC------
T ss_pred cHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC-
Confidence 99998864 457999999999999999999999864 13499999999999999999999999999987654322
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
......||+.|+|||++.+..++.++|||||||++|||++|++||...+..+....+. ....+.++..+|+++.+||
T Consensus 170 --~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~s~~l~~li 246 (269)
T d2java1 170 --FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR-EGKFRRIPYRYSDELNEII 246 (269)
T ss_dssp --------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HTCCCCCCTTSCHHHHHHH
T ss_pred --ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHH
Confidence 2234578999999999999999999999999999999999999999888877666654 3444567778999999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~ 348 (370)
++||+.||++|||++|++++
T Consensus 247 ~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 247 TRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHTCSSGGGSCCHHHHHTS
T ss_pred HHHcCCChhHCcCHHHHHhC
Confidence 99999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-55 Score=387.81 Aligned_cols=241 Identities=28% Similarity=0.415 Sum_probs=213.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|+|+||.||+|... |..+|+|.+...........+.+.+|+.++++++||||+++++++.+.+.+++||||+.+|+
T Consensus 22 ~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~ 101 (309)
T d1u5ra_ 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 101 (309)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCc
Confidence 3899999999999864 77899999987655556677889999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|..++..++++++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...... ...
T Consensus 102 l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-------~~~ 171 (309)
T d1u5ra_ 102 SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSF 171 (309)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------CCC
T ss_pred hHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-------Ccc
Confidence 9988888889999999999999999999999998 999999999999999999999999999765432 234
Q ss_pred CCCccccCcccccc---cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 256 TGSYRYMAPEVYRR---ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 256 ~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
.||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...........+.........+..+|+.+.+||++||
T Consensus 172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L 251 (309)
T d1u5ra_ 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251 (309)
T ss_dssp CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHT
T ss_pred ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHC
Confidence 69999999999864 458899999999999999999999999888777666665444444556678999999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFR 348 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~ 348 (370)
+.||++|||++++++|
T Consensus 252 ~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 252 QKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CSSGGGSCCHHHHTTC
T ss_pred cCChhHCcCHHHHHhC
Confidence 9999999999999863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=377.58 Aligned_cols=242 Identities=24% Similarity=0.427 Sum_probs=204.2
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee----CCceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH----SERLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~----~~~~~~v~e~~~ 172 (370)
+|+|+||.||++.+. +..+|+|.+.... ......+.+.+|++++++++||||+++++++.. ...+++||||++
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~ 95 (270)
T d1t4ha_ 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 95 (270)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEGGG-SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCC
T ss_pred EecCcCcEEEEEEECCCCeEEEEEEEchhh-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCC
Confidence 899999999999875 6789999987653 244556789999999999999999999999865 346899999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC-CCCcEEEeccccceeccccCcccee
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD-EAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
||+|.+++.+.+.+++..++.++.|+++||.|||+++ .+|+||||||+|||++ +++.+||+|||+++......
T Consensus 96 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~----- 169 (270)
T d1t4ha_ 96 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----- 169 (270)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS-----
T ss_pred CCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc-----
Confidence 9999999998889999999999999999999999976 4599999999999997 57899999999997544322
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTA-VQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
.....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... ......+......+..+...++.+.+||++
T Consensus 170 ~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~ 248 (270)
T d1t4ha_ 170 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 248 (270)
T ss_dssp BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHH
T ss_pred cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHH
Confidence 223479999999999876 599999999999999999999999976544 333344432233344566788999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~ 348 (370)
||+.||++|||++|+++|
T Consensus 249 ~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 249 CIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp HSCSSGGGSCCHHHHHTS
T ss_pred HccCCHhHCcCHHHHhCC
Confidence 999999999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=379.36 Aligned_cols=254 Identities=29% Similarity=0.525 Sum_probs=208.7
Q ss_pred CCCCCCcccEEEEEEcC------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKWRG------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
.+|+|+||.||+|.+++ ..||||.+... ........+.+|+.++++++|||||++++++...+..++||||+
T Consensus 14 ~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc--cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 47999999999998763 35899998654 34455677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 172 RNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 172 ~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
.++++.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..........
T Consensus 92 ~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~ 168 (283)
T d1mqba_ 92 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 168 (283)
T ss_dssp TTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------------
T ss_pred ccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCccce
Confidence 999999987755 57999999999999999999999998 99999999999999999999999999987765443333
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCC-CCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPS-NRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
......||+.|+|||.+.+..++.++|||||||++|||++++.| +......+....+ ..+.+++.+..+|+.+.++|.
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~ 247 (283)
T d1mqba_ 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRLPTPMDCPSAIYQLMM 247 (283)
T ss_dssp -----CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCTTCBHHHHHHHH
T ss_pred EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH-hccCCCCCchhhHHHHHHHHH
Confidence 44455689999999999999999999999999999999996555 5555555544443 356677778889999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 330 ECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
+||+.||++|||+.++++.|+++.+..+
T Consensus 248 ~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 248 QCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred HHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 9999999999999999999999887543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-54 Score=379.83 Aligned_cols=245 Identities=31% Similarity=0.519 Sum_probs=210.9
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||+|.+. +..+|+|.++... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++|+
T Consensus 24 ~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~ 99 (287)
T d1opja_ 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99 (287)
T ss_dssp ETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcc
Confidence 3899999999999885 7789999987543 234678999999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 176 LHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 176 L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|.+++.+. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........ ...
T Consensus 100 l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~--~~~ 174 (287)
T d1opja_ 100 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT--AHA 174 (287)
T ss_dssp HHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE--EET
T ss_pred hHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCce--eec
Confidence 99999764 57899999999999999999999998 999999999999999999999999999876544322 223
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCC-CCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhc
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNR-ADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECW 332 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 332 (370)
+..|++.|+|||.+.+..++.++|||||||++|||++|+.||. ........ .......++..+..+|+.+.+||.+||
T Consensus 175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~-~~i~~~~~~~~~~~~~~~l~~li~~cl 253 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPEGCPEKVYELMRACW 253 (287)
T ss_dssp TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-HHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH-HHHhcCCCCCCCccchHHHHHHHHHHc
Confidence 3357899999999999999999999999999999999766654 44444433 333356677788889999999999999
Q ss_pred ccCCCCCCCHHHHHHHHHHH
Q 042314 333 HKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 333 ~~~p~~Rp~~~~ll~~l~~~ 352 (370)
+.||++|||++++++.|+.+
T Consensus 254 ~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 254 QWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CSSGGGSCCHHHHHHHHHHT
T ss_pred CCCHhHCcCHHHHHHHHHHH
Confidence 99999999999999988776
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-54 Score=381.97 Aligned_cols=242 Identities=26% Similarity=0.438 Sum_probs=196.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... ++.+|+|++...... .....+.+|+.+++.++||||+++++++.+.+.+++||||++||+
T Consensus 16 ~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~ 93 (307)
T d1a06a_ 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE 93 (307)
T ss_dssp ESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 4899999999999875 788999998765332 234568899999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC---CCCcEEEeccccceeccccCccceec
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD---EAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+||++. .++.+||+|||+++....... .
T Consensus 94 L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~----~ 166 (307)
T d1a06a_ 94 LFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV----L 166 (307)
T ss_dssp HHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------------
T ss_pred HHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCCe----e
Confidence 9999999889999999999999999999999998 99999999999995 478999999999986654332 2
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--CCCCCCCcHHHHHHHHH
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PALSSLYPEPIKALLRE 330 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~ 330 (370)
....||+.|+|||++.+..++.++|||||||++|+|++|++||...........+...... .+.+..+|+.+.+||++
T Consensus 167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 246 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246 (307)
T ss_dssp ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence 3346999999999999999999999999999999999999999988877766665533322 33456789999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~ 348 (370)
||+.||++|||++|++++
T Consensus 247 ~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 247 LMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HSCSSGGGSCCHHHHHHS
T ss_pred HccCCHhHCcCHHHHhcC
Confidence 999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=381.65 Aligned_cols=242 Identities=27% Similarity=0.419 Sum_probs=207.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|+|+||.||++.+. +..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+.+++||||++||+
T Consensus 19 ~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~ 95 (288)
T d2jfla1 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 95 (288)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCc
Confidence 3799999999999875 7789999987542 3345678899999999999999999999999999999999999999
Q ss_pred HHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++.+ .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....... ....
T Consensus 96 L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~---~~~~ 169 (288)
T d2jfla1 96 VDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ---RRDS 169 (288)
T ss_dssp HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH---HHTC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc---cccc
Confidence 9998765 457999999999999999999999998 99999999999999999999999999976654321 2234
Q ss_pred CCCCccccCccccc-----ccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-CCCCCCCCCCcHHHHHHH
Q 042314 255 GTGSYRYMAPEVYR-----RESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-DSRPALSSLYPEPIKALL 328 (370)
Q Consensus 255 ~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li 328 (370)
..||+.|+|||++. +..|+.++|||||||++|||++|++||...+..+....+... ......+..+|+.+.+||
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li 249 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 249 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence 57999999999984 456889999999999999999999999887766655554432 223344567899999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~ 348 (370)
++||+.||++|||++|++++
T Consensus 250 ~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 250 KKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHSCSSTTTSCCHHHHTTS
T ss_pred HHHccCChhHCcCHHHHhcC
Confidence 99999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-53 Score=374.09 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=213.5
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC----ceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE----RLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~----~~~~v~e~~~ 172 (370)
+|+|+||.||++... |+.+|+|+++.....+......+.+|+.+++.++||||+++++++...+ .+++||||++
T Consensus 15 lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~ 94 (277)
T d1o6ya_ 15 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 94 (277)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCC
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCC
Confidence 688999999999864 8899999998877677788889999999999999999999999987654 3899999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|++|.+++...+++++.+++.++.|++.||.|||++| |+||||||+|||++.++..+++|||.+.............
T Consensus 95 g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~ 171 (277)
T d1o6ya_ 95 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171 (277)
T ss_dssp EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC---------
T ss_pred CCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhcccccccccc
Confidence 9999999999889999999999999999999999998 9999999999999999999999999987765544433344
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC--CCCCCCcHHHHHHHHH
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP--ALSSLYPEPIKALLRE 330 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~ 330 (370)
....||+.|+|||++.+..++.++||||+||++|||+||++||...+..+...........+ .....+|+.+.++|++
T Consensus 172 ~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~ 251 (277)
T d1o6ya_ 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLK 251 (277)
T ss_dssp -------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHH
T ss_pred ccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHH
Confidence 55679999999999999999999999999999999999999999888877666555444333 3456789999999999
Q ss_pred hcccCCCCCC-CHHHHHHHHHHHH
Q 042314 331 CWHKNPDRRP-TFEEIIFRLEAIQ 353 (370)
Q Consensus 331 ~l~~~p~~Rp-~~~~ll~~l~~~~ 353 (370)
||+.||++|| |++++++.|.++.
T Consensus 252 ~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 252 ALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HccCCHhHCHhHHHHHHHHHHHHh
Confidence 9999999999 8999999988875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=386.44 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=209.8
Q ss_pred CCCCCCcccEEEEEEcCc-------eeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEe
Q 042314 98 GIDPGAYGEVYLVKWRGT-------EIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~-------~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
.+|.|+||.||+|.+.+. .||+|.+.... .......+.+|+.+++++ +|||||++++++...+.+++|||
T Consensus 44 ~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (325)
T d1rjba_ 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121 (325)
T ss_dssp EEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEE
Confidence 379999999999987532 47888876542 334556789999999998 89999999999999999999999
Q ss_pred ecCCCCHHHHHHhCC-----------------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC
Q 042314 170 YLRNGSLHDILKKKG-----------------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD 226 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~-----------------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~ 226 (370)
|+++|+|.+++..+. .+++..++.++.|+++||.|||+++ |+||||||+||+++
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~ 198 (325)
T d1rjba_ 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVT 198 (325)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEE
T ss_pred cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccc
Confidence 999999999997642 4788999999999999999999998 99999999999999
Q ss_pred CCCcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHH
Q 042314 227 EAGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVAD 305 (370)
Q Consensus 227 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~ 305 (370)
.++.+||+|||+|+......... ......||+.|+|||.+.+..++.++|||||||++|||+| |++||...+......
T Consensus 199 ~~~~~Kl~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~ 277 (325)
T d1rjba_ 199 HGKVVKICDFGLARDIMSDSNYV-VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277 (325)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred cCCeEEEeeccccccccCCCcee-eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999998766543322 2233457999999999999999999999999999999998 899998766555555
Q ss_pred HhhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 042314 306 RRAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLE 350 (370)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~ 350 (370)
.......+++.+..+|+.+.+||.+||+.||++|||++||+++|.
T Consensus 278 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 278 KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 555566677788889999999999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=384.82 Aligned_cols=241 Identities=27% Similarity=0.493 Sum_probs=203.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|+|+||.||++... |..+|+|+++... .+.....+.+|+.++++++|||||++++++.+.+.+++||||++||+
T Consensus 13 ~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~ 90 (322)
T d1s9ja_ 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 90 (322)
T ss_dssp EEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence 3799999999999875 7889999987643 34556788999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhc-CCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHH-RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|.+++.+.+.+++..++.++.|++.||.|||++ + |+||||||+|||++.+|.+||+|||+|+...... ...
T Consensus 91 L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-----~~~ 162 (322)
T d1s9ja_ 91 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-----ANS 162 (322)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-----C--
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCc-----ccc
Confidence 999999888999999999999999999999974 7 9999999999999999999999999998765432 223
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----------------------------
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADR---------------------------- 306 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~---------------------------- 306 (370)
..||+.|+|||++.+..|+.++||||+||++|||++|+.||...........
T Consensus 163 ~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (322)
T d1s9ja_ 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242 (322)
T ss_dssp -CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------------
T ss_pred ccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccc
Confidence 4799999999999999999999999999999999999999976432211000
Q ss_pred -------------hhccCCCCCC-CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 307 -------------RAYEDSRPAL-SSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 307 -------------~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.......+.. ...+|.++.+||.+||..||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0001111112 23467899999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=369.04 Aligned_cols=245 Identities=27% Similarity=0.528 Sum_probs=216.4
Q ss_pred cCCCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 97 GGIDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
..+|+|+||.||++.++ ++.||+|.++.... ..+.+.+|+.++++++||||+++++++.+++.+++||||+++|+
T Consensus 10 ~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCEETTEEEEEEEETTTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred EEEecCCCeEEEEEEECCCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 34899999999999986 55799999876432 24578999999999999999999999999999999999999999
Q ss_pred HHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 176 LHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 176 L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
|..++.. ...+++..+.+++.|+++||.|||+++ |+||||||+||+++.++.+||+|||+++........ ....
T Consensus 86 l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~ 160 (258)
T d1k2pa_ 86 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSVG 160 (258)
T ss_dssp HHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC--CCCC
T ss_pred HHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce--eecc
Confidence 9998664 457899999999999999999999998 999999999999999999999999999876554322 2334
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWH 333 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 333 (370)
..+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...+..+....+. .+.++..|..+|+.+.+||++||+
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~ 239 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMYSCWH 239 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTC
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCcccccHHHHHHHHHHcc
Confidence 568999999999999999999999999999999998 899999988877776665 566777888999999999999999
Q ss_pred cCCCCCCCHHHHHHHHHH
Q 042314 334 KNPDRRPTFEEIIFRLEA 351 (370)
Q Consensus 334 ~~p~~Rp~~~~ll~~l~~ 351 (370)
.||++|||+++++++|.+
T Consensus 240 ~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 240 EKADERPTFKILLSNILD 257 (258)
T ss_dssp SSGGGSCCHHHHHHHHHC
T ss_pred CCHhHCcCHHHHHHHhhC
Confidence 999999999999999854
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=382.37 Aligned_cols=242 Identities=26% Similarity=0.424 Sum_probs=214.5
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||++... |+.+|+|++++...........+.+|+.+++.++||||+++++++.+.+.+++||||++||+|
T Consensus 13 lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L 92 (337)
T d1o6la_ 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL 92 (337)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred EecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCch
Confidence 789999999999874 889999999764322234467788999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
.+++.+.+.+++..++.++.|++.||+|||++| |+||||||+|||++.+|.+||+|||+|+....... .....+
T Consensus 93 ~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~---~~~~~~ 166 (337)
T d1o6la_ 93 FFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFC 166 (337)
T ss_dssp HHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC---CBCCCE
T ss_pred hhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc---ccccce
Confidence 999999999999999999999999999999999 99999999999999999999999999986654322 233456
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
||+.|+|||++.+..|+.++|+|||||++|||++|++||...+.......+.. .....|..+|+.+++||++||++||
T Consensus 167 GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~dli~~~L~~dP 244 (337)
T d1o6la_ 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--EEIRFPRTLSPEAKSLLAGLLKKDP 244 (337)
T ss_dssp ECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSST
T ss_pred eCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc--CCCCCCccCCHHHHHHHHhhccCCc
Confidence 89999999999999999999999999999999999999999888777766653 3356677899999999999999999
Q ss_pred CCCCC-----HHHHHHH
Q 042314 337 DRRPT-----FEEIIFR 348 (370)
Q Consensus 337 ~~Rp~-----~~~ll~~ 348 (370)
++||+ ++++++|
T Consensus 245 ~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 245 KQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTSTTCSTTTHHHHHTS
T ss_pred hhhcccccccHHHHHcC
Confidence 99995 8888875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=372.47 Aligned_cols=245 Identities=28% Similarity=0.509 Sum_probs=209.1
Q ss_pred CCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 99 IDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
+|.|+||.||++.++ +..||||.++... ...+.+.+|+.++++++||||+++++++.. +..++||||+++|+|.
T Consensus 21 iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~ 95 (272)
T d1qpca_ 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLV 95 (272)
T ss_dssp EEEETTEEEEEEEETTTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHH
T ss_pred EecCCCcEEEEEEECCCCEEEEEEEccCc----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHH
Confidence 799999999999987 4679999987542 224578999999999999999999998754 5679999999999999
Q ss_pred HHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 178 DILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 178 ~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
+++... .++++..++.++.|+++||.|||+++ |+||||||+|||+++++.+||+|||+|+....... ......
T Consensus 96 ~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~--~~~~~~ 170 (272)
T d1qpca_ 96 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGA 170 (272)
T ss_dssp HHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE--ECCTTC
T ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc--cccccc
Confidence 977543 36899999999999999999999998 99999999999999999999999999987764432 223445
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG-GPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.||+.|+|||.+.+..++.++|||||||++|||+|| .+|+......+....+. .+.++..+..+|+.+.+|+.+||+.
T Consensus 171 ~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~ 249 (272)
T d1qpca_ 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQLMRLCWKE 249 (272)
T ss_dssp CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCcccChHHHHHHHHHHcCC
Confidence 689999999999988999999999999999999996 45556666555555443 5667777888999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHH
Q 042314 335 NPDRRPTFEEIIFRLEAIQE 354 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~l~~~~~ 354 (370)
||++|||++++++.|+.+-.
T Consensus 250 ~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 250 RPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp SGGGSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999887654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=370.92 Aligned_cols=250 Identities=27% Similarity=0.487 Sum_probs=208.7
Q ss_pred CCCCCcccEEEEEEcC-----ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g-----~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|.|+||.||++.+.+ ..||+|.+...........+.+.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus 16 iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~ 94 (273)
T d1u46a_ 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPL 94 (273)
T ss_dssp CC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred EecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecC
Confidence 8999999999998642 2589999877665666777889999999999999999999999965 567899999999
Q ss_pred CCHHHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceec
Q 042314 174 GSLHDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 174 ~~L~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|++.+++.. .+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++............
T Consensus 95 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~ 171 (273)
T d1u46a_ 95 GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 171 (273)
T ss_dssp CBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-
T ss_pred cchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCCCcceec
Confidence 999987764 457999999999999999999999998 9999999999999999999999999999876654443333
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
....+++.|+|||.+.+..++.++||||||+++|||+| |++||...+..+....+...+.+++.+..+|+.+.+||.+|
T Consensus 172 ~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 251 (273)
T d1u46a_ 172 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQC 251 (273)
T ss_dssp ----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHH
T ss_pred CccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHH
Confidence 44457889999999999999999999999999999998 89999999888887777767777788888999999999999
Q ss_pred cccCCCCCCCHHHHHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFRLEAI 352 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~l~~~ 352 (370)
|+.||++|||++++++.|++.
T Consensus 252 l~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 252 WAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCChhHCcCHHHHHHHHHhc
Confidence 999999999999999988875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-53 Score=376.94 Aligned_cols=239 Identities=27% Similarity=0.505 Sum_probs=213.5
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||+|... |+.+|+|+++..........+.+.+|+.+++.++||||+++++++.+.+.+++||||++||+|
T Consensus 12 lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l 91 (316)
T d1fota_ 12 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL 91 (316)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccc
Confidence 789999999999875 889999998764333334467789999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
..++.....+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++...... ....
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~------~~~~ 162 (316)
T d1fota_ 92 FSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT------YTLC 162 (316)
T ss_dssp HHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB------CCCC
T ss_pred cccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecccc------cccc
Confidence 999999999999999999999999999999998 9999999999999999999999999998765432 2347
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+... ....+..+|+.+.+++++||..||
T Consensus 163 Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dp 240 (316)
T d1fota_ 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITRDL 240 (316)
T ss_dssp SCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSCT
T ss_pred CcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhhCH
Confidence 999999999999999999999999999999999999999998887777766532 345567789999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 042314 337 DRRP-----TFEEIIFR 348 (370)
Q Consensus 337 ~~Rp-----~~~~ll~~ 348 (370)
.+|+ |++++++|
T Consensus 241 ~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 241 SQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp TTCTTSSTTTTHHHHTS
T ss_pred HhccccchhhHHHHHcC
Confidence 9996 89999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-53 Score=371.44 Aligned_cols=244 Identities=23% Similarity=0.393 Sum_probs=212.5
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccC---CChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIA---SNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~---~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|+|+||.||+|... |..+|+|++..... ......+.+.+|+.++++++||||+++++++.+.+.+++||||++
T Consensus 17 ~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (293)
T d1jksa_ 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 96 (293)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 3789999999999875 88999999875432 222346789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC----cEEEeccccceeccccCcc
Q 042314 173 NGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG----HLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 173 g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~----~~kl~Dfg~~~~~~~~~~~ 248 (370)
||+|.+++.+.+.+++..++.++.|++.||.|||+++ |+||||||+||+++.++ .+||+|||++........
T Consensus 97 gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~- 172 (293)
T d1jksa_ 97 GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 172 (293)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB-
T ss_pred CccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhcCCCcc-
Confidence 9999999998889999999999999999999999998 99999999999999776 499999999987754432
Q ss_pred ceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--CCCCCCCcHHHHH
Q 042314 249 SYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PALSSLYPEPIKA 326 (370)
Q Consensus 249 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ 326 (370)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+...... ...+..+|+.+.+
T Consensus 173 ---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 249 (293)
T d1jksa_ 173 ---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 249 (293)
T ss_dssp ---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred ---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHH
Confidence 23346899999999999999999999999999999999999999988887776665433222 2234578999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 042314 327 LLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 327 li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
||++||+.||++|||+++++++
T Consensus 250 li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 250 FIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHccCChhHCcCHHHHhcC
Confidence 9999999999999999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-53 Score=366.24 Aligned_cols=242 Identities=31% Similarity=0.587 Sum_probs=205.5
Q ss_pred CCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee-CCceEEEEeecCCCCHH
Q 042314 99 IDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH-SERLIFLTEYLRNGSLH 177 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~-~~~~~~v~e~~~g~~L~ 177 (370)
+|.|+||.||++.++|..+|+|.++.. ...+.+.+|+.++++++||||+++++++.+ .+.+++||||+++|+|.
T Consensus 15 lG~G~fg~Vy~~~~~~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~ 89 (262)
T d1byga_ 15 IGKGEFGDVMLGDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 89 (262)
T ss_dssp EEECSSCEEEEEEETTEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred EecCCCeEEEEEEECCeEEEEEEECcH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHH
Confidence 789999999999999999999999653 234678899999999999999999998854 46689999999999999
Q ss_pred HHHHhCC--CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 178 DILKKKG--KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 178 ~~l~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
+++.+.+ .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....... ..
T Consensus 90 ~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~------~~ 160 (262)
T d1byga_ 90 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------TG 160 (262)
T ss_dssp HHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------
T ss_pred HHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCCc------cc
Confidence 9997643 5899999999999999999999998 99999999999999999999999999986544322 23
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.+|+.|+|||.+.+..++.++||||||+++|||+| |++||......+....+. .+.+++.+..+|+.+++||++||+.
T Consensus 161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~cl~~ 239 (262)
T d1byga_ 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYEVMKNCWHL 239 (262)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHHHHHccc
Confidence 57889999999999999999999999999999998 788888877666655554 4667778888999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHH
Q 042314 335 NPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
||.+|||+.+++++|++++..
T Consensus 240 dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 240 DAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp SGGGSCCHHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHHHHHHhC
Confidence 999999999999999998653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.2e-52 Score=378.05 Aligned_cols=241 Identities=24% Similarity=0.388 Sum_probs=209.7
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|+|+||.||++... |..+|+|++... .....+.+.+|+.++++++||||+++++++.+.+.+++||||++||+
T Consensus 33 ~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 109 (350)
T d1koaa2 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 109 (350)
T ss_dssp EEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCC
Confidence 3799999999999875 889999998653 23456778999999999999999999999999999999999999999
Q ss_pred HHHHHH-hCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC--CCcEEEeccccceeccccCccceec
Q 042314 176 LHDILK-KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE--AGHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 176 L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|.+++. ..+++++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+++........
T Consensus 110 L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~---- 182 (350)
T d1koaa2 110 LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---- 182 (350)
T ss_dssp HHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE----
T ss_pred HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccccc----
Confidence 999985 4467999999999999999999999999 999999999999964 578999999999877654322
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--CCCCCCCcHHHHHHHHH
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PALSSLYPEPIKALLRE 330 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~ 330 (370)
....||+.|+|||++.+..++.++|||||||++|+|++|++||...+..+....+...... ......+|+.+++||++
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 262 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 262 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHH
T ss_pred ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence 2346899999999999999999999999999999999999999988887766665533322 23345688999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~ 348 (370)
||..||++|||++|+++|
T Consensus 263 ~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 263 LLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HCCSSGGGSCCHHHHHHS
T ss_pred HccCChhHCcCHHHHhcC
Confidence 999999999999999885
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.8e-52 Score=376.08 Aligned_cols=240 Identities=21% Similarity=0.392 Sum_probs=209.7
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||+|... |..+|+|++.... ......+.+|+.++++++||||+++++++.+.+.+++||||++||+|
T Consensus 37 lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L 113 (352)
T d1koba_ 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 113 (352)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChH
Confidence 789999999999874 8899999987542 34456788999999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeC--CCCcEEEeccccceeccccCccceecc
Q 042314 177 HDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQD--EAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 177 ~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
.+.+... .++++.+++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++......... .
T Consensus 114 ~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~----~ 186 (352)
T d1koba_ 114 FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----K 186 (352)
T ss_dssp HHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE----E
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCce----e
Confidence 9887655 47999999999999999999999998 99999999999998 5789999999999887654322 2
Q ss_pred CCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC--CCCCCCCCcHHHHHHHHHh
Q 042314 254 GGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS--RPALSSLYPEPIKALLREC 331 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~ 331 (370)
...||+.|+|||++.+..++.++|||||||++|+|++|++||...........+..... ....+..+|+.+.+||++|
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 266 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 23689999999999999999999999999999999999999999888776666543332 2334567899999999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 042314 332 WHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp~~~~ll~~ 348 (370)
|+.||++|||++|+++|
T Consensus 267 L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 267 LQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SCSSGGGSCCHHHHHTS
T ss_pred ccCChhHCcCHHHHhcC
Confidence 99999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=365.99 Aligned_cols=250 Identities=27% Similarity=0.503 Sum_probs=204.2
Q ss_pred CCCCCCcccEEEEEEcC-----ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g-----~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|.|+||.||+|.+.. ..+++|.++.. ........+.+|+.++++++||||+++++++. .+.+++||||++
T Consensus 14 ~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~ 90 (273)
T d1mp8a_ 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 90 (273)
T ss_dssp EEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred EEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEecc
Confidence 37999999999997742 34677776543 45566788999999999999999999999985 567899999999
Q ss_pred CCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 173 NGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 173 g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
+|+|.+++... ..+++..++.++.|+++||.|||+++ |+||||||+||+++.++.+||+|||+++........ .
T Consensus 91 ~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~--~ 165 (273)
T d1mp8a_ 91 LGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY--K 165 (273)
T ss_dssp TEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------------
T ss_pred CCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcce--e
Confidence 99999987654 57899999999999999999999998 999999999999999999999999999876543321 2
Q ss_pred ccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 252 MTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
.....||+.|+|||.+.+..++.++|||||||++|||++ |.+||......+....+. .+.+++.+..+|+.+.+||.+
T Consensus 166 ~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~ 244 (273)
T d1mp8a_ 166 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLMTK 244 (273)
T ss_dssp -----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHH
T ss_pred ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHH
Confidence 333468999999999999999999999999999999998 899998887766665554 455667788899999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
||+.||++|||+.+++++|+++.+.-
T Consensus 245 cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 245 CWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999999986653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-52 Score=376.52 Aligned_cols=239 Identities=27% Similarity=0.453 Sum_probs=212.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|.|+||.||+|... |..+|+|++.............+.+|+.+++.++||||+++++++......++||||+.||+|
T Consensus 49 lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l 128 (350)
T d1rdqe_ 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128 (350)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBH
T ss_pred eecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccch
Confidence 789999999999875 889999998654323334456789999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCC
Q 042314 177 HDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGT 256 (370)
Q Consensus 177 ~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 256 (370)
..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++...... ....
T Consensus 129 ~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~------~~~~ 199 (350)
T d1rdqe_ 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT------WTLC 199 (350)
T ss_dssp HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB------CCCE
T ss_pred hhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccccc------cccc
Confidence 999998889999999999999999999999998 9999999999999999999999999998775432 2346
Q ss_pred CCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhcccCC
Q 042314 257 GSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHKNP 336 (370)
Q Consensus 257 g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 336 (370)
||+.|+|||++.+..++.++|||||||++|+|++|++||...+.......+... .+..+..+|+.+.+||++||..||
T Consensus 200 Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP 277 (350)
T d1rdqe_ 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLRNLLQVDL 277 (350)
T ss_dssp ECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHHHHHSCSCT
T ss_pred CccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHHHHHHHhhhCH
Confidence 899999999999999999999999999999999999999998887776666532 345567799999999999999999
Q ss_pred CCCC-----CHHHHHHH
Q 042314 337 DRRP-----TFEEIIFR 348 (370)
Q Consensus 337 ~~Rp-----~~~~ll~~ 348 (370)
.+|+ |++++++|
T Consensus 278 ~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 278 TKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp TTCTTSSTTTTHHHHTS
T ss_pred HhccccccccHHHHHcC
Confidence 9994 89999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-52 Score=369.67 Aligned_cols=248 Identities=29% Similarity=0.484 Sum_probs=215.5
Q ss_pred CCCCCcccEEEEEEcC-------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 99 IDPGAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g-------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
+|+|+||.||+|.+.+ ..||||.+... .......++.+|+.++++++||||+++++++...+..+++|||+
T Consensus 21 lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~ 98 (301)
T d1lufa_ 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 98 (301)
T ss_dssp EEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh--cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEec
Confidence 7899999999998764 57999998653 34566788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCC------------------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC
Q 042314 172 RNGSLHDILKKKG------------------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE 227 (370)
Q Consensus 172 ~g~~L~~~l~~~~------------------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~ 227 (370)
.+|+|.+++.... .++...++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 99 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~ 175 (301)
T d1lufa_ 99 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175 (301)
T ss_dssp TTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECG
T ss_pred CCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECC
Confidence 9999999997532 3788899999999999999999998 999999999999999
Q ss_pred CCcEEEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCC-CCCCCCcHHHHHHH
Q 042314 228 AGHLKVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADR 306 (370)
Q Consensus 228 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~-~p~~~~~~~~~~~~ 306 (370)
++.+||+|||+|+......... ......+|+.|+|||.+.+..++.++|||||||++|||++|. +||......+....
T Consensus 176 ~~~~Kl~DFGls~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~ 254 (301)
T d1lufa_ 176 NMVVKIADFGLSRNIYSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 254 (301)
T ss_dssp GGCEEECCCSCHHHHTGGGCBC-----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred CCcEEEccchhheeccCCcccc-ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHH
Confidence 9999999999998665443222 223446889999999999999999999999999999999995 67888887777666
Q ss_pred hhccCCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042314 307 RAYEDSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQ 353 (370)
Q Consensus 307 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~ 353 (370)
+. .+..++.+..+|+.+.+|+.+||+.||++|||+.++++.|+++.
T Consensus 255 v~-~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 255 VR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HH-cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 54 45567778889999999999999999999999999999998864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=366.29 Aligned_cols=254 Identities=31% Similarity=0.530 Sum_probs=207.6
Q ss_pred CCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 99 IDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
+|+|+||.||++.++ +..||+|.++.... ..+.+.+|+.++++++|||||++++++. .+..++||||+++|+|.
T Consensus 25 iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~ 99 (285)
T d1fmka3 25 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 99 (285)
T ss_dssp EEECSSCEEEEEEETTTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred EeeCCCeEEEEEEECCCCEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchh
Confidence 799999999999886 45799999875432 2367899999999999999999999985 45689999999999999
Q ss_pred HHHHh--CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 178 DILKK--KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 178 ~~l~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
.++.. .+.+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........ .....
T Consensus 100 ~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~--~~~~~ 174 (285)
T d1fmka3 100 DFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT--ARQGA 174 (285)
T ss_dssp HHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------
T ss_pred hhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce--eeccc
Confidence 88764 357999999999999999999999998 999999999999999999999999999876544321 23344
Q ss_pred CCCccccCcccccccCCCchhhHHHHHHHHHHHHhCC-CCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 256 TGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
.||+.|+|||.+....++.++||||||+++|||++|+ +|+......+....+. ...+++.+..+|+.+.++|.+||+.
T Consensus 175 ~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~ 253 (285)
T d1fmka3 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQCWRK 253 (285)
T ss_dssp -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred cccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCcccCHHHHHHHHHHccc
Confidence 6899999999999999999999999999999999965 5555566555555544 4556677888999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHHhccCCCCC
Q 042314 335 NPDRRPTFEEIIFRLEAIQESFQKKTVPS 363 (370)
Q Consensus 335 ~p~~Rp~~~~ll~~l~~~~~~~~~~~~~~ 363 (370)
||++|||++++++.|+....+..++..|+
T Consensus 254 dP~~Rps~~~i~~~L~~~~~~~~p~~~p~ 282 (285)
T d1fmka3 254 EPEERPTFEYLQAFLEDYFTSTEPQYQPG 282 (285)
T ss_dssp SGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred CHhHCcCHHHHHHHHhhhhcCCCCCCCCC
Confidence 99999999999988887666655554443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-51 Score=359.32 Aligned_cols=243 Identities=25% Similarity=0.383 Sum_probs=210.1
Q ss_pred CCCCCcccEEEEEE--cCceeEEEEeccccCCC------hHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEe
Q 042314 99 IDPGAYGEVYLVKW--RGTEIAAKTIRSSIASN------PRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 99 l~~g~~~~v~~a~~--~g~~vavK~l~~~~~~~------~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
+|+|+||.||++.. .|+.+|+|++....... ....+.+.+|+.++++++ ||||+++++++.+++.+|+|||
T Consensus 11 iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE 90 (277)
T d1phka_ 11 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFD 90 (277)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred EecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEE
Confidence 78999999999987 47899999987653222 234567899999999997 9999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 170 YLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
|++||+|.+++..++.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++.......
T Consensus 91 ~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-- 165 (277)
T d1phka_ 91 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-- 165 (277)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC--
T ss_pred cCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEccCCCc--
Confidence 9999999999998889999999999999999999999998 99999999999999999999999999987765432
Q ss_pred eeccCCCCCccccCcccccc------cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC--CCCCCCCc
Q 042314 250 YKMTGGTGSYRYMAPEVYRR------ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--PALSSLYP 321 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~------~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 321 (370)
.....||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||...........+...... ......+|
T Consensus 166 --~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 243 (277)
T d1phka_ 166 --LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 243 (277)
T ss_dssp --BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSC
T ss_pred --eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCC
Confidence 233578999999999853 34678999999999999999999999998887766655543332 22334689
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+.+.+|+.+||+.||++|||++|++++
T Consensus 244 ~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 244 DTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 999999999999999999999999765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=366.20 Aligned_cols=252 Identities=26% Similarity=0.480 Sum_probs=203.0
Q ss_pred CCCCCCcccEEEEEEcC-------ceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEee-CCceEEEE
Q 042314 98 GIDPGAYGEVYLVKWRG-------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKH-SERLIFLT 168 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g-------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~-~~~~~~v~ 168 (370)
.+|+|+||.||+|.+.+ +.+|+|.++.. ......+.+.+|...+.++ +|+||+.+++++.. ...+++||
T Consensus 20 ~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~ 97 (299)
T d1ywna1 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97 (299)
T ss_dssp EEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred EEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc--cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence 37999999999998742 46899998654 3345566778888887776 68999999998765 45689999
Q ss_pred eecCCCCHHHHHHhC----------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEE
Q 042314 169 EYLRNGSLHDILKKK----------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLK 232 (370)
Q Consensus 169 e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~k 232 (370)
||+++|+|.+++... ..+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+|
T Consensus 98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~K 174 (299)
T d1ywna1 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 174 (299)
T ss_dssp ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEE
Confidence 999999999999753 24789999999999999999999998 99999999999999999999
Q ss_pred EeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHhhccC
Q 042314 233 VTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG-GPSNRADTAVQVADRRAYED 311 (370)
Q Consensus 233 l~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~ 311 (370)
|+|||+|+......... ......||+.|+|||.+.+..++.++|||||||++|||++| .+||...............+
T Consensus 175 l~DFGla~~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~ 253 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYV-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 253 (299)
T ss_dssp ECC------CCSCTTSC-CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred EccCcchhhcccccccc-ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence 99999998765443221 23345789999999999999999999999999999999987 46787665444444444456
Q ss_pred CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042314 312 SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 312 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
.++..+..+|+.+.++|.+||+.||++|||+++++++|+++.++
T Consensus 254 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 254 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 67778888999999999999999999999999999999998654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=371.79 Aligned_cols=242 Identities=26% Similarity=0.453 Sum_probs=209.8
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHH-hcCCCceeeeeeeEeeCCceEEEEeecCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQ-KLRHPNIVQFLGVLKHSERLIFLTEYLRNG 174 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~-~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~ 174 (370)
.+|+|+||.||+|... |+.+|+|+++............+..|..++. .++||||+++++++.+.+.+++||||++||
T Consensus 9 ~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g 88 (320)
T d1xjda_ 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG 88 (320)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCC
Confidence 3789999999999884 8889999997543222233455667776654 689999999999999999999999999999
Q ss_pred CHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccC
Q 042314 175 SLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTG 254 (370)
Q Consensus 175 ~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 254 (370)
+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....... ....
T Consensus 89 ~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~---~~~~ 162 (320)
T d1xjda_ 89 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNT 162 (320)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC---CBCC
T ss_pred cHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccccc---cccc
Confidence 99999999889999999999999999999999998 99999999999999999999999999986654322 2334
Q ss_pred CCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHHhccc
Q 042314 255 GTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRECWHK 334 (370)
Q Consensus 255 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 334 (370)
..||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.......+.. ..+..+..+|+.+.+||++||..
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~~~s~~~~dli~~~L~~ 240 (320)
T d1xjda_ 163 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRWLEKEAKDLLVKLFVR 240 (320)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHSCS
T ss_pred cCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCccCCHHHHHHHHHhccc
Confidence 5799999999999999999999999999999999999999999888877766653 34566778999999999999999
Q ss_pred CCCCCCCHH-HHHH
Q 042314 335 NPDRRPTFE-EIIF 347 (370)
Q Consensus 335 ~p~~Rp~~~-~ll~ 347 (370)
||++||++. ++++
T Consensus 241 dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 241 EPEKRLGVRGDIRQ 254 (320)
T ss_dssp SGGGSBTTBSCGGG
T ss_pred CCCCCcCHHHHHHh
Confidence 999999995 6764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=368.48 Aligned_cols=251 Identities=26% Similarity=0.538 Sum_probs=207.0
Q ss_pred CCCCCCcccEEEEEEc--Cc----eeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKWR--GT----EIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~----~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
.+|+|+||.||++.+. |+ .||+|.++.. ......+.+.+|+.++++++||||+++++++.++ ..++++|++
T Consensus 16 ~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~ 92 (317)
T d1xkka_ 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 92 (317)
T ss_dssp EEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred EEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEec
Confidence 3789999999999874 33 4777777543 2334567899999999999999999999998764 567888999
Q ss_pred CCCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 172 RNGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 172 ~g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
.+++|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........ .
T Consensus 93 ~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~-~ 168 (317)
T d1xkka_ 93 PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-Y 168 (317)
T ss_dssp TTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC---
T ss_pred cCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccccccc-c
Confidence 999999877754 57999999999999999999999998 999999999999999999999999999876544322 1
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLR 329 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 329 (370)
......||+.|+|||.+.+..++.++|||||||++|||+| |.+||...+..+....+. .+.+++.+..+|+.+.+++.
T Consensus 169 ~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-~~~~~~~p~~~~~~~~~li~ 247 (317)
T d1xkka_ 169 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDVYMIMV 247 (317)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-HTCCCCCCTTBCHHHHHHHH
T ss_pred cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHH
Confidence 2334468999999999999999999999999999999998 788888776655444433 45667777889999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHHHh
Q 042314 330 ECWHKNPDRRPTFEEIIFRLEAIQESF 356 (370)
Q Consensus 330 ~~l~~~p~~Rp~~~~ll~~l~~~~~~~ 356 (370)
+||+.||++|||+.+++++|.++....
T Consensus 248 ~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 248 KCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred HhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence 999999999999999999999986543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=362.68 Aligned_cols=257 Identities=25% Similarity=0.479 Sum_probs=215.2
Q ss_pred CCCCCcccEEEEEEcC-----ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee-CCceEEEEeecC
Q 042314 99 IDPGAYGEVYLVKWRG-----TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH-SERLIFLTEYLR 172 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g-----~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~-~~~~~~v~e~~~ 172 (370)
+|+|+||.||+|.+.. ..+|||.++.. .+....+.+.+|++++++++||||+++++++.. +...++||||++
T Consensus 35 iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~ 112 (311)
T d1r0pa_ 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112 (311)
T ss_dssp EEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred EeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence 8999999999998742 24788988642 456677889999999999999999999999765 568999999999
Q ss_pred CCCHHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc-e
Q 042314 173 NGSLHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS-Y 250 (370)
Q Consensus 173 g~~L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~ 250 (370)
+|+|.+++... ...+...++.++.|++.||.|+|+.+ |+||||||+|||+++++.+||+|||+++......... .
T Consensus 113 ~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~ 189 (311)
T d1r0pa_ 113 HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189 (311)
T ss_dssp TCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred cCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence 99999988855 45778889999999999999999998 9999999999999999999999999998776543221 2
Q ss_pred eccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALLRE 330 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 330 (370)
......||+.|+|||.+....++.++||||||+++|||++|+.||...............+.++..+..+|+.+.+||.+
T Consensus 190 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~ 269 (311)
T d1r0pa_ 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK 269 (311)
T ss_dssp CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHH
Confidence 23334689999999999999999999999999999999998877766544433333334566777788899999999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHHhccCC
Q 042314 331 CWHKNPDRRPTFEEIIFRLEAIQESFQKKT 360 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~ 360 (370)
||+.||++||++.|++++|+++.+.+..+.
T Consensus 270 cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 270 CWHPKAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred HcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 999999999999999999999998877654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=359.22 Aligned_cols=250 Identities=31% Similarity=0.570 Sum_probs=213.0
Q ss_pred CCCCCCcccEEEEEEcC---------ceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEE
Q 042314 98 GIDPGAYGEVYLVKWRG---------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFL 167 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g---------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v 167 (370)
.+|.|+||.||++...+ ..||+|.++.. ........+.+|...+.++ +||||+++++++.+++..++|
T Consensus 20 ~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp ECC-----CEEEEEEECC----CCCEEEEEEECCCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc--cChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence 38999999999997643 35899998764 3345567889999998888 799999999999999999999
Q ss_pred EeecCCCCHHHHHHhC----------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcE
Q 042314 168 TEYLRNGSLHDILKKK----------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHL 231 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~ 231 (370)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~ 174 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM 174 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCE
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCe
Confidence 9999999999999754 25899999999999999999999998 9999999999999999999
Q ss_pred EEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcc
Q 042314 232 KVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYE 310 (370)
Q Consensus 232 kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 310 (370)
||+|||+++......... ......+|+.|+|||.+.+..|+.++||||||+++|||++ |.+||...+.......+. .
T Consensus 175 kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~-~ 252 (299)
T d1fgka_ 175 KIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK-E 252 (299)
T ss_dssp EECSTTCCCCGGGCCTTC-CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-T
T ss_pred Eeccchhhcccccccccc-ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHH-c
Confidence 999999998776544322 2344568999999999999999999999999999999998 688998888777665554 5
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 042314 311 DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQE 354 (370)
Q Consensus 311 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~ 354 (370)
+.++..+..+|+.+.+||.+||+.||++|||+.|+++.|+++..
T Consensus 253 ~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 253 GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 66777888899999999999999999999999999999988753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-51 Score=373.77 Aligned_cols=242 Identities=25% Similarity=0.402 Sum_probs=201.9
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCC---ChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIAS---NPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~---~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
+|.|+||.||+|... |..+|+|++...... ..........++.+++.++||||+++++++...+.+++||||++|
T Consensus 12 lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~g 91 (364)
T d1omwa3 12 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG 91 (364)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCC
Confidence 789999999999875 889999998643221 222223334456677777899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
|+|.+++.+...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+...... ..
T Consensus 92 g~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-----~~ 163 (364)
T d1omwa3 92 GDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-----PH 163 (364)
T ss_dssp CBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-----CC
T ss_pred CcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCc-----cc
Confidence 999999999889999999999999999999999999 9999999999999999999999999998765432 23
Q ss_pred CCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHH-HhhccCCCCCCCCCCcHHHHHHHHHh
Q 042314 254 GGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVAD-RRAYEDSRPALSSLYPEPIKALLREC 331 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~ 331 (370)
...||+.|+|||++.. ..++.++|||||||++|||++|++||.......... ...........+..+|+.+.+||.+|
T Consensus 164 ~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 243 (364)
T d1omwa3 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 243 (364)
T ss_dssp SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHH
T ss_pred ccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHH
Confidence 3479999999999965 568999999999999999999999998654322211 11223445566778999999999999
Q ss_pred cccCCCCCCC-----HHHHHHH
Q 042314 332 WHKNPDRRPT-----FEEIIFR 348 (370)
Q Consensus 332 l~~~p~~Rp~-----~~~ll~~ 348 (370)
|+.||++||| ++++++|
T Consensus 244 L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 244 LQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp TCSSTTTSTTTSSSTHHHHHTS
T ss_pred cccCHHHhCCCcccCHHHHHcC
Confidence 9999999999 7888875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=363.99 Aligned_cols=250 Identities=30% Similarity=0.501 Sum_probs=211.1
Q ss_pred CCCCCCcccEEEEEEcC--c--eeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEeecC
Q 042314 98 GIDPGAYGEVYLVKWRG--T--EIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTEYLR 172 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g--~--~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e~~~ 172 (370)
.+|+|+||.||++.+.+ . .++||.+... ...+..+.+.+|+.+++++ +||||+++++++...+.+++||||++
T Consensus 17 ~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 38999999999998753 3 4666766433 2334566799999999998 69999999999999999999999999
Q ss_pred CCCHHHHHHhC----------------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 042314 173 NGSLHDILKKK----------------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDF 236 (370)
Q Consensus 173 g~~L~~~l~~~----------------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Df 236 (370)
+|+|.+++++. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~Df 171 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 171 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEccc
Confidence 99999999754 57899999999999999999999998 999999999999999999999999
Q ss_pred ccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCC-CCCCCCcHHHHHHHhhccCCCCC
Q 042314 237 GLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGG-PSNRADTAVQVADRRAYEDSRPA 315 (370)
Q Consensus 237 g~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~ 315 (370)
|+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|. +||...+..+....+. .+.++.
T Consensus 172 G~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~-~~~~~~ 246 (309)
T d1fvra_ 172 GLSRGQEVYVK----KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLE 246 (309)
T ss_dssp TCEESSCEECC----C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-GTCCCC
T ss_pred ccccccccccc----ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH-hcCCCC
Confidence 99976543322 22335899999999999999999999999999999999975 6788777777666654 566777
Q ss_pred CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 316 LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 316 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
.+..+|+.+.+||.+||+.||++|||+++++++|+++.+...
T Consensus 247 ~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 888899999999999999999999999999999999976544
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=364.51 Aligned_cols=240 Identities=19% Similarity=0.281 Sum_probs=207.5
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|.|+||.||++... ++.+|+|+++... .....+.+|+.+++.++||||+++++++.+.+.+|+||||++||+
T Consensus 12 ~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~ 87 (321)
T d1tkia_ 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred EEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence 3799999999999875 7889999997542 334567899999999999999999999999999999999999999
Q ss_pred HHHHHHhCC-CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCC--CcEEEeccccceeccccCccceec
Q 042314 176 LHDILKKKG-KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEA--GHLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 176 L~~~l~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~--~~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
|.+++...+ ++++.+++.++.||+.||.|||++| |+||||||+|||++.+ ..+||+|||+++........
T Consensus 88 L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~---- 160 (321)
T d1tkia_ 88 IFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---- 160 (321)
T ss_dssp HHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE----
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCcc----
Confidence 999998765 7999999999999999999999998 9999999999999854 47999999999876543321
Q ss_pred cCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCC--CCCCCCcHHHHHHHHH
Q 042314 253 TGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRP--ALSSLYPEPIKALLRE 330 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~ 330 (370)
....+|+.|+|||.+.+..++.++||||+||++|+|++|.+||...+.......+....... ..+..+|+.+++||++
T Consensus 161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 240 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHH
Confidence 22357999999999999999999999999999999999999999988877766665333222 2234688999999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 042314 331 CWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 331 ~l~~~p~~Rp~~~~ll~~ 348 (370)
||..||++|||++|+++|
T Consensus 241 ~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 241 LLVKERKSRMTASEALQH 258 (321)
T ss_dssp TSCSSGGGSCCHHHHHHS
T ss_pred HccCChhHCcCHHHHhcC
Confidence 999999999999999885
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=362.78 Aligned_cols=245 Identities=27% Similarity=0.406 Sum_probs=200.4
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCC--ChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIAS--NPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~--~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g 173 (370)
.+|.|+||.||+|... |+.+|+|+++..... .......+.+|+.++++++||||+++++++...+.+++||||+.|
T Consensus 5 ~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~ 84 (299)
T d1ua2a_ 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 84 (299)
T ss_dssp EEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE
T ss_pred EeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcc
Confidence 3789999999999864 788999998754322 122345788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceecc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMT 253 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 253 (370)
+++..+...+..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 85 ~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~---~~~ 158 (299)
T d1ua2a_ 85 DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR---AYT 158 (299)
T ss_dssp EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC---CCC
T ss_pred hHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc---ccc
Confidence 888877777778999999999999999999999998 99999999999999999999999999976654432 223
Q ss_pred CCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC---C----------------
Q 042314 254 GGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS---R---------------- 313 (370)
Q Consensus 254 ~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~---------------- 313 (370)
...||+.|+|||++... .++.++||||+||++|||++|.+||...+..+....+..... .
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 34789999999998654 579999999999999999999999998877665544321100 0
Q ss_pred --CC-----CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 --PA-----LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 --~~-----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+. .....++.+.+||++||+.||++|||++|+++|
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 112467899999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=359.55 Aligned_cols=252 Identities=27% Similarity=0.451 Sum_probs=217.2
Q ss_pred CCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhc-CCCceeeeeeeEeeCCceEEEEe
Q 042314 98 GIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL-RHPNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l-~hp~Iv~~~~~~~~~~~~~~v~e 169 (370)
.+|.|+||.||+|.+. ++.+|||.++.. ........+.+|+.+++.+ +||||+++++++...+..++|||
T Consensus 30 ~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc--cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 3799999999999864 357999998754 3455677899999999999 69999999999999999999999
Q ss_pred ecCCCCHHHHHHhCC------------------CCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcE
Q 042314 170 YLRNGSLHDILKKKG------------------KLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHL 231 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~------------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~ 231 (370)
|+++|+|.+++.+.. .+++..+..++.||+.||.|||+++ ++||||||+||+++.++.+
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRIT 184 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcc
Confidence 999999999997643 5889999999999999999999998 9999999999999999999
Q ss_pred EEeccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcc
Q 042314 232 KVTDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQ-GGPSNRADTAVQVADRRAYE 310 (370)
Q Consensus 232 kl~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 310 (370)
|++|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||+| |.+||...............
T Consensus 185 ki~DfG~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~ 263 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263 (311)
T ss_dssp EECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHH
T ss_pred cccccchheeccCCCcc-eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 99999999877654332 23344568999999999999999999999999999999998 56667666555555555556
Q ss_pred CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042314 311 DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 311 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
+.++..+..+|+.+.+||.+||+.||++|||++++++.|+++..+
T Consensus 264 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 264 GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 677777888999999999999999999999999999999876554
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=354.03 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=215.5
Q ss_pred CCCCCCcccEEEEEEc-------CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEee
Q 042314 98 GIDPGAYGEVYLVKWR-------GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~-------g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
.+|+|+||.||+|.+. +..||||.++.. ........+.+|+.++++++||||+++++++...+..++||||
T Consensus 27 ~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 104 (308)
T d1p4oa_ 27 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 104 (308)
T ss_dssp EEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEee
Confidence 3799999999999875 467999998753 3455667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC----------CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccce
Q 042314 171 LRNGSLHDILKKK----------GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK 240 (370)
Q Consensus 171 ~~g~~L~~~l~~~----------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~ 240 (370)
+.+|+|.+++... ..++...+..++.|+++||.|||+++ |+||||||+|||++.++++||+|||+++
T Consensus 105 ~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~ 181 (308)
T d1p4oa_ 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR 181 (308)
T ss_dssp CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred cCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccce
Confidence 9999999988643 24688899999999999999999998 9999999999999999999999999998
Q ss_pred eccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhC-CCCCCCCcHHHHHHHhhccCCCCCCCCC
Q 042314 241 IAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQG-GPSNRADTAVQVADRRAYEDSRPALSSL 319 (370)
Q Consensus 241 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (370)
........ .......+|+.|+|||.+.+..++.++||||||+++|||+|| ++||...+..+....+. .+..+..+..
T Consensus 182 ~~~~~~~~-~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~-~~~~~~~p~~ 259 (308)
T d1p4oa_ 182 DIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM-EGGLLDKPDN 259 (308)
T ss_dssp GGGGGGCE-EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-TTCCCCCCTT
T ss_pred eccCCcce-eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-hCCCCCCccc
Confidence 76554332 223344689999999999999999999999999999999998 57888777777666554 5566777888
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 042314 320 YPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQ 353 (370)
Q Consensus 320 ~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~ 353 (370)
+|+.+.++|.+||+.||++|||+++++++|++..
T Consensus 260 ~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 260 CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 9999999999999999999999999999987753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-50 Score=358.85 Aligned_cols=235 Identities=26% Similarity=0.396 Sum_probs=192.6
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHh-cCCCceeeeeeeEee----CCceEEEEeec
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQK-LRHPNIVQFLGVLKH----SERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~-l~hp~Iv~~~~~~~~----~~~~~~v~e~~ 171 (370)
+|.|+||.||+|... ++.+|+|+++.. ..+.+|+.++.+ .+||||++++++|.+ ...+|+||||+
T Consensus 20 lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 789999999999874 789999998642 346689988655 489999999999875 46689999999
Q ss_pred CCCCHHHHHHhC--CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC---CCcEEEeccccceeccccC
Q 042314 172 RNGSLHDILKKK--GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE---AGHLKVTDFGLSKIAQEKD 246 (370)
Q Consensus 172 ~g~~L~~~l~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~~~~~ 246 (370)
+||+|.+++.++ .++++.+++.++.|++.||.|||++| |+||||||+|||++. .+.+||+|||+++......
T Consensus 92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred CCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCCC
Confidence 999999999875 36899999999999999999999998 999999999999985 4579999999998766543
Q ss_pred ccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--cCCCCCC----CCCC
Q 042314 247 SYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAY--EDSRPAL----SSLY 320 (370)
Q Consensus 247 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~----~~~~ 320 (370)
. .....||+.|+|||++.+..|+.++|||||||++|+|+||++||.............. ....... +..+
T Consensus 169 ~----~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 244 (335)
T d2ozaa1 169 S----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244 (335)
T ss_dssp C----CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred c----cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence 2 2334799999999999999999999999999999999999999976543322211110 1111111 2357
Q ss_pred cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 321 PEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 321 ~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
|+.+.+||++||+.||++|||+.+++++
T Consensus 245 s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 245 SEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 8899999999999999999999999885
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=351.96 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=198.6
Q ss_pred CCCCCCcccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC----ceEEEEeecCC
Q 042314 98 GIDPGAYGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE----RLIFLTEYLRN 173 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~----~~~~v~e~~~g 173 (370)
.+|+|+||.||++..+|..||+|+++... ........|+..++.++||||+++++++...+ .+++||||+++
T Consensus 10 ~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~ 85 (303)
T d1vjya_ 10 SIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEECCSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEeeCCCeEEEEEEECCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence 48999999999999999999999986432 22222334555666789999999999987643 58999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhc-----CCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHH-----RPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~-----~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
|+|.+++++. ++++..++.++.|++.||.|+|+. ..++|+||||||+|||++.++.+||+|||+++........
T Consensus 86 g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~ 164 (303)
T d1vjya_ 86 GSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164 (303)
T ss_dssp CBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTE
T ss_pred CCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcc
Confidence 9999999876 789999999999999999999974 1124999999999999999999999999999877654322
Q ss_pred -ceeccCCCCCccccCcccccccC------CCchhhHHHHHHHHHHHHhCCCCCCCC---------------cHHHHHHH
Q 042314 249 -SYKMTGGTGSYRYMAPEVYRRES------YGKSVDVFSFALIVHEMFQGGPSNRAD---------------TAVQVADR 306 (370)
Q Consensus 249 -~~~~~~~~g~~~y~aPE~~~~~~------~~~~~Di~slG~~l~el~~g~~p~~~~---------------~~~~~~~~ 306 (370)
........||+.|+|||.+.+.. ++.++|||||||++|||+||.+||... ........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (303)
T d1vjya_ 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244 (303)
T ss_dssp ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH
T ss_pred eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHH
Confidence 22334457999999999987643 567899999999999999998876432 12223333
Q ss_pred hhccCCCCCCCCC-----CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 307 RAYEDSRPALSSL-----YPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 307 ~~~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
......++..+.. .+..+.+++.+||+.||++|||+.|+++.|+++.+.-.
T Consensus 245 ~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 3323344444332 22458999999999999999999999999999986543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-50 Score=351.04 Aligned_cols=234 Identities=24% Similarity=0.398 Sum_probs=197.3
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCCh---HHHHHHHHHHHHHHhcC--CCceeeeeeeEeeCCceEEEEeec
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNP---RVRNSFMKELGLWQKLR--HPNIVQFLGVLKHSERLIFLTEYL 171 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~---~~~~~~~~e~~~l~~l~--hp~Iv~~~~~~~~~~~~~~v~e~~ 171 (370)
+|+|+||.||+|... |..+|+|.+........ ....++.+|+.++++++ ||||+++++++.+.+..++||||+
T Consensus 12 lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~ 91 (273)
T d1xwsa_ 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 91 (273)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECC
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEec
Confidence 688999999999875 78999999875432221 11234668999999986 899999999999999999999999
Q ss_pred CC-CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC-CCcEEEeccccceeccccCccc
Q 042314 172 RN-GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE-AGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 172 ~g-~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
.+ +++.+++.+++.+++..++.++.|++.||.|||+++ |+||||||+|||++. .+.+||+|||+++......
T Consensus 92 ~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~--- 165 (273)
T d1xwsa_ 92 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--- 165 (273)
T ss_dssp SSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC---
T ss_pred cCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceeccccc---
Confidence 76 688899988889999999999999999999999998 999999999999985 5789999999998654432
Q ss_pred eeccCCCCCccccCcccccccCC-CchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCCCCCCCCCcHHHHHHH
Q 042314 250 YKMTGGTGSYRYMAPEVYRRESY-GKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSRPALSSLYPEPIKALL 328 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 328 (370)
.....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...... . ......+..+|+++.+||
T Consensus 166 --~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i--~------~~~~~~~~~~s~~~~~li 235 (273)
T d1xwsa_ 166 --YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--I------RGQVFFRQRVSSECQHLI 235 (273)
T ss_dssp --BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--H------HCCCCCSSCCCHHHHHHH
T ss_pred --ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH--h------hcccCCCCCCCHHHHHHH
Confidence 233579999999999987765 57799999999999999999999864321 1 123345667899999999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 042314 329 RECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 329 ~~~l~~~p~~Rp~~~~ll~~ 348 (370)
++||..||++|||++|++++
T Consensus 236 ~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 236 RWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHHTCSSGGGSCCHHHHHTS
T ss_pred HHHccCCHhHCcCHHHHhcC
Confidence 99999999999999999875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-49 Score=346.59 Aligned_cols=243 Identities=27% Similarity=0.454 Sum_probs=196.0
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+|+|+||.||+|... |+.+|+|+++... ........+.+|+.++++++||||+++++++.+.+.+++||||+.++.+
T Consensus 10 lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~ 88 (298)
T d1gz8a_ 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK 88 (298)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHH
T ss_pred EecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchh
Confidence 789999999999875 8899999996543 2334457889999999999999999999999999999999999977444
Q ss_pred HHHHHh-CCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 177 HDILKK-KGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 177 ~~~l~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
...... ...+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||+|+....... .....
T Consensus 89 ~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~ 162 (298)
T d1gz8a_ 89 KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR---TYTHE 162 (298)
T ss_dssp HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB---CTTCC
T ss_pred hhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcc---cceee
Confidence 433333 357999999999999999999999998 99999999999999999999999999986654332 23334
Q ss_pred CCCccccCcccccccC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-C---------------CCCC---
Q 042314 256 TGSYRYMAPEVYRRES-YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-D---------------SRPA--- 315 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~---------------~~~~--- 315 (370)
.||+.|+|||.+.... ++.++||||+||++|+|++|+.||...+.......+... + ....
T Consensus 163 ~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T d1gz8a_ 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPK 242 (298)
T ss_dssp BCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCC
T ss_pred cccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccccc
Confidence 6899999999987765 478999999999999999999999887765544332110 0 0000
Q ss_pred --------CCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 316 --------LSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 316 --------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
....+++.+.+|+++||..||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 243 WARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 012456889999999999999999999999886
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7e-49 Score=345.82 Aligned_cols=243 Identities=27% Similarity=0.424 Sum_probs=200.7
Q ss_pred CCCCCcccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCCHH
Q 042314 99 IDPGAYGEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGSLH 177 (370)
Q Consensus 99 l~~g~~~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~ 177 (370)
+|+|+||.||++.+. |+.+|+|++..... +....+.+.+|+.++++++||||+++++++...+..++++|++.++.+.
T Consensus 10 iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~ 88 (286)
T d1ob3a_ 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKK 88 (286)
T ss_dssp EEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHH
T ss_pred EecCCCcEEEEEEeCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHH
Confidence 789999999999875 78899999866532 2344578899999999999999999999999999999999999998888
Q ss_pred HHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCCCC
Q 042314 178 DILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGGTG 257 (370)
Q Consensus 178 ~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~g 257 (370)
.+.+..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+........ ......+
T Consensus 89 ~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~ 162 (286)
T d1ob3a_ 89 LLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---KYTHEIV 162 (286)
T ss_dssp HHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------------C
T ss_pred HHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc---ccceecc
Confidence 88787889999999999999999999999998 99999999999999999999999999987654332 2233458
Q ss_pred CccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-C------------------------
Q 042314 258 SYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-D------------------------ 311 (370)
Q Consensus 258 ~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~------------------------ 311 (370)
++.|+|||.+.+. .++.++||||+||++|||++|++||...+..+...++... +
T Consensus 163 ~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T d1ob3a_ 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242 (286)
T ss_dssp CCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCC
T ss_pred cchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccccc
Confidence 9999999998765 5689999999999999999999999887665543332110 0
Q ss_pred --CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 --SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
........+++.+.+||++||+.||++|||++|+++|
T Consensus 243 ~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011234567899999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=344.45 Aligned_cols=242 Identities=28% Similarity=0.433 Sum_probs=193.7
Q ss_pred CCCCCcccEEEEEEc---CceeEEEEeccccCCChHHHHHHHHHHHHHHhc---CCCceeeeeeeEee-----CCceEEE
Q 042314 99 IDPGAYGEVYLVKWR---GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKL---RHPNIVQFLGVLKH-----SERLIFL 167 (370)
Q Consensus 99 l~~g~~~~v~~a~~~---g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l---~hp~Iv~~~~~~~~-----~~~~~~v 167 (370)
+|.|+||.||+|... ++.||+|+++...... .....+.+|+.+++.+ +||||+++++++.. ...++++
T Consensus 15 LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~ 93 (305)
T d1blxa_ 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLV 93 (305)
T ss_dssp EEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEE
T ss_pred EecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEE
Confidence 688999999999874 4568999987643222 2223345677666655 79999999998853 3468999
Q ss_pred EeecCCCCHHHHHH-hCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccC
Q 042314 168 TEYLRNGSLHDILK-KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKD 246 (370)
Q Consensus 168 ~e~~~g~~L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 246 (370)
+||++++++..... ....+++..++.++.|++.||+|||+++ |+||||||+|||++..+.+||+|||++.......
T Consensus 94 ~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~ 170 (305)
T d1blxa_ 94 FEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 170 (305)
T ss_dssp EECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG
T ss_pred EEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhhcccc
Confidence 99999877665444 3357899999999999999999999998 9999999999999999999999999987654332
Q ss_pred ccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccC---------------
Q 042314 247 SYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYED--------------- 311 (370)
Q Consensus 247 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--------------- 311 (370)
......||+.|+|||++.+..++.++||||+||++|||++|++||...+..+....+....
T Consensus 171 ----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 246 (305)
T d1blxa_ 171 ----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246 (305)
T ss_dssp ----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred ----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccch
Confidence 2344579999999999999999999999999999999999999999887765544332100
Q ss_pred ----------CCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 312 ----------SRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 312 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
........+++.+.+||++||+.||++|||++|+++|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0012234578899999999999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=343.54 Aligned_cols=245 Identities=25% Similarity=0.384 Sum_probs=197.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC----ceEEEEeec
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE----RLIFLTEYL 171 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~----~~~~v~e~~ 171 (370)
.+|+|+||.||+|... |..+|+|++... ......+.+.+|+.+++.++||||+++++++.... ..+++++++
T Consensus 15 ~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~ 92 (345)
T d1pmea_ 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL 92 (345)
T ss_dssp ECC---CCCEEEEEETTTCSEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEeeccCeEEEEEEECCCCcEEEEEEEehh--cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence 3899999999999875 889999998753 34566778999999999999999999999986543 234555666
Q ss_pred CCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcccee
Q 042314 172 RNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYK 251 (370)
Q Consensus 172 ~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 251 (370)
.||+|.++++.. ++++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||++............
T Consensus 93 ~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~ 168 (345)
T d1pmea_ 93 MGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168 (345)
T ss_dssp CCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCT
T ss_pred cCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCcccee
Confidence 788999999865 7999999999999999999999998 999999999999999999999999999877655443333
Q ss_pred ccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc--------------------
Q 042314 252 MTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE-------------------- 310 (370)
Q Consensus 252 ~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~-------------------- 310 (370)
.....||+.|+|||.+.. ..++.++||||+||++|+|++|++||...............
T Consensus 169 ~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (345)
T d1pmea_ 169 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 248 (345)
T ss_dssp TCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHH
T ss_pred eccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcc
Confidence 455679999999999854 45788999999999999999999999877654433222110
Q ss_pred ----CCC-----CCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 311 ----DSR-----PALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 311 ----~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
... ......+++.+.+|+++||..||++|||+++++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 249 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 01223567889999999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=339.38 Aligned_cols=243 Identities=26% Similarity=0.401 Sum_probs=196.2
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCC------ceEEEEe
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSE------RLIFLTE 169 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~------~~~~v~e 169 (370)
.+|.|+||.||+|.+. |+.+|+|+++... .+....+.+.+|+.+++.++||||+++++++...+ .+++|||
T Consensus 25 ~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 103 (346)
T d1cm8a_ 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 103 (346)
T ss_dssp EC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEe
Confidence 4899999999999875 8899999997643 45566788999999999999999999999987654 5799999
Q ss_pred ecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 170 YLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
|+ +.+|..+.+. +++++..++.++.|++.||.|||++| |+||||||+|||++.++.+|++|||+++.....
T Consensus 104 ~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~---- 174 (346)
T d1cm8a_ 104 FM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE---- 174 (346)
T ss_dssp CC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS----
T ss_pred cc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCc----
Confidence 99 5588887765 48999999999999999999999999 999999999999999999999999999866543
Q ss_pred eeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc------------------
Q 042314 250 YKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE------------------ 310 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~------------------ 310 (370)
.....||+.|+|||.+.+. .++.++||||+||++|+|++|++||...+...........
T Consensus 175 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 175 --MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp --CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred --cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 2344789999999998764 5689999999999999999999999887655433221110
Q ss_pred -----------CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH--HHHH
Q 042314 311 -----------DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR--LEAI 352 (370)
Q Consensus 311 -----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~--l~~~ 352 (370)
..........++.+.+||++||..||++|||++|+++| ++.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00112234578899999999999999999999999986 5444
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-46 Score=330.96 Aligned_cols=248 Identities=19% Similarity=0.265 Sum_probs=196.4
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCc-eeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN-IVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~-Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|+|+||.||+|.+. |+.||+|++...... ..+..|+++++.++|++ |+.+.+++...+..++||||+.+ +
T Consensus 15 iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~-~ 88 (299)
T d1ckia_ 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-S 88 (299)
T ss_dssp EEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCC-B
T ss_pred EeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCC-c
Confidence 789999999999875 789999998764322 24678999999998766 55556666778889999999955 6
Q ss_pred HHHHHH-hCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC---CCcEEEeccccceeccccCccc--
Q 042314 176 LHDILK-KKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE---AGHLKVTDFGLSKIAQEKDSYS-- 249 (370)
Q Consensus 176 L~~~l~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~-- 249 (370)
|...+. ..+.+++..+..++.|++.||+|||++| |+||||||+|||++. +..+||+|||+|+.........
T Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~ 165 (299)
T d1ckia_ 89 LEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165 (299)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBC
T ss_pred hhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccce
Confidence 666554 4568999999999999999999999999 999999999999864 4479999999998876543211
Q ss_pred --eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHH------hhccCCCCCCCCCCc
Q 042314 250 --YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADR------RAYEDSRPALSSLYP 321 (370)
Q Consensus 250 --~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 321 (370)
.......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... .......+.....+|
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p 245 (299)
T d1ckia_ 166 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245 (299)
T ss_dssp CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSC
T ss_pred eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCC
Confidence 123345799999999999999999999999999999999999999977554332211 111122333456789
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Q 042314 322 EPIKALLRECWHKNPDRRPTFEEIIFRLEAIQES 355 (370)
Q Consensus 322 ~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~ 355 (370)
+.+.++|.+||+.+|++||+++++.+.|+.+...
T Consensus 246 ~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999999988887543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=334.46 Aligned_cols=257 Identities=21% Similarity=0.350 Sum_probs=199.2
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee--------CCceEEEE
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH--------SERLIFLT 168 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~--------~~~~~~v~ 168 (370)
+|+|+||+||+|.+. |+.+|||++..... ......++.+|+.+++.++||||+++++++.. .+.+++||
T Consensus 18 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~ 96 (318)
T d3blha1 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 96 (318)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEE
T ss_pred EecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEE
Confidence 789999999999875 88999999866532 23445678899999999999999999998754 34689999
Q ss_pred eecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCcc
Q 042314 169 EYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSY 248 (370)
Q Consensus 169 e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 248 (370)
||+.++.+.........+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 97 e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~ 173 (318)
T d3blha1 97 DFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 173 (318)
T ss_dssp ECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC----
T ss_pred eccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeeccccccc
Confidence 99988777766667778999999999999999999999998 999999999999999999999999999876543321
Q ss_pred c-eeccCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc--CCCCCCCC------
Q 042314 249 S-YKMTGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE--DSRPALSS------ 318 (370)
Q Consensus 249 ~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~------ 318 (370)
. .......||+.|+|||++.+. .++.++||||+||++|||++|++||...........+... ...+....
T Consensus 174 ~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 253 (318)
T d3blha1 174 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253 (318)
T ss_dssp -CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-
T ss_pred ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhh
Confidence 1 122345689999999998765 6899999999999999999999999887765544332211 11111000
Q ss_pred ----------------------CCcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhccCCCCCC
Q 042314 319 ----------------------LYPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQKKTVPSC 364 (370)
Q Consensus 319 ----------------------~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~~~~~~~~ 364 (370)
..++.+.+||.+||+.||++|||++|+++| .-+...++|+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H-----pff~~~p~p~~ 316 (318)
T d3blha1 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH-----DFFWSDPMPSD 316 (318)
T ss_dssp ------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS-----GGGSSSSCCCC
T ss_pred hhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC-----hhhccCCCCCC
Confidence 024567899999999999999999999876 23344455543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.1e-46 Score=326.64 Aligned_cols=250 Identities=17% Similarity=0.220 Sum_probs=204.5
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCC-CceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH-PNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h-p~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
+|+|+||.||+|.+. |+.+|+|++...... ..+.+|++.++.++| +|++.+++++......++||||+ +++
T Consensus 13 iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~ 86 (293)
T d1csna_ 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 86 (293)
T ss_dssp EEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCC
Confidence 788999999999865 788999988654321 235678888888875 89999999999999999999999 679
Q ss_pred HHHHHHhC-CCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCC-----CCcEEEeccccceeccccCccc
Q 042314 176 LHDILKKK-GKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDE-----AGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 176 L~~~l~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~-----~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
|.++++.. ..++...+..++.|++.||+|||++| |+||||||+|||++. .+.+||+|||+|+.........
T Consensus 87 l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (293)
T d1csna_ 87 LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 163 (293)
T ss_dssp HHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC
T ss_pred HHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCcccc
Confidence 99998765 47999999999999999999999999 999999999999974 5689999999998875432211
Q ss_pred ----eeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhh---ccCCCCCCCCC
Q 042314 250 ----YKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADT---AVQVADRRA---YEDSRPALSSL 319 (370)
Q Consensus 250 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~---~~~~~~~~~---~~~~~~~~~~~ 319 (370)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+. .......++..
T Consensus 164 ~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (293)
T d1csna_ 164 HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243 (293)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTT
T ss_pred ceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCC
Confidence 12334569999999999999999999999999999999999999997542 222222111 11222334567
Q ss_pred CcHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHhc
Q 042314 320 YPEPIKALLRECWHKNPDRRPTFEEIIFRLEAIQESFQ 357 (370)
Q Consensus 320 ~~~~l~~li~~~l~~~p~~Rp~~~~ll~~l~~~~~~~~ 357 (370)
+|+++.+++..|+..+|++||+++.+.+.|+++.+...
T Consensus 244 ~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 244 FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 89999999999999999999999999999998876654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=340.10 Aligned_cols=244 Identities=25% Similarity=0.425 Sum_probs=202.8
Q ss_pred CCCCCCcccEEEEEE-----cCceeEEEEeccccC-CChHHHHHHHHHHHHHHhcCC-CceeeeeeeEeeCCceEEEEee
Q 042314 98 GIDPGAYGEVYLVKW-----RGTEIAAKTIRSSIA-SNPRVRNSFMKELGLWQKLRH-PNIVQFLGVLKHSERLIFLTEY 170 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~-----~g~~vavK~l~~~~~-~~~~~~~~~~~e~~~l~~l~h-p~Iv~~~~~~~~~~~~~~v~e~ 170 (370)
.+|+|+||.||+|.. +|+.+|+|.+..... .+....+.+.+|+.++++++| |||+++++++.+...++++|||
T Consensus 31 ~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~ 110 (322)
T d1vzoa_ 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDY 110 (322)
T ss_dssp EEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECC
T ss_pred EEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeec
Confidence 379999999999975 367899999865421 223345667899999999977 8999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccce
Q 042314 171 LRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSY 250 (370)
Q Consensus 171 ~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 250 (370)
+.+|+|.++++..+.+++..+..++.|++.||.|+|+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 111 ~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~-- 185 (322)
T d1vzoa_ 111 INGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-- 185 (322)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG--
T ss_pred ccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcccccc--
Confidence 999999999999889999999999999999999999998 999999999999999999999999999876543322
Q ss_pred eccCCCCCccccCccccccc--CCCchhhHHHHHHHHHHHHhCCCCCCCCcHH----HHHHHhhccCCCCCCCCCCcHHH
Q 042314 251 KMTGGTGSYRYMAPEVYRRE--SYGKSVDVFSFALIVHEMFQGGPSNRADTAV----QVADRRAYEDSRPALSSLYPEPI 324 (370)
Q Consensus 251 ~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l 324 (370)
......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...... ...... ....+..+..+|+.+
T Consensus 186 ~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~ 263 (322)
T d1vzoa_ 186 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQEMSALA 263 (322)
T ss_dssp GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHCCCCCCTTSCHHH
T ss_pred cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--ccCCCCCcccCCHHH
Confidence 12234689999999999764 4678999999999999999999999765332 222221 234556667899999
Q ss_pred HHHHHHhcccCCCCCC-----CHHHHHHH
Q 042314 325 KALLRECWHKNPDRRP-----TFEEIIFR 348 (370)
Q Consensus 325 ~~li~~~l~~~p~~Rp-----~~~~ll~~ 348 (370)
.+|+++||++||++|| |++|+++|
T Consensus 264 ~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 264 KDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 9999999999999999 48899874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=336.99 Aligned_cols=238 Identities=26% Similarity=0.306 Sum_probs=191.3
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC------CceEEEE
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS------ERLIFLT 168 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~------~~~~~v~ 168 (370)
..+|.|+||.||+|.+. |+.+|+|++...... ..+|+.++++++||||+++++++... .++++||
T Consensus 26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred eEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 34899999999999885 788999998764321 23799999999999999999998542 3579999
Q ss_pred eecCCCCHHHHH---HhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC-cEEEeccccceeccc
Q 042314 169 EYLRNGSLHDIL---KKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG-HLKVTDFGLSKIAQE 244 (370)
Q Consensus 169 e~~~g~~L~~~l---~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~ 244 (370)
||++++.+..+. .....+++.+++.++.|++.||+|||++| |+||||||+|||++.++ .+||+|||++.....
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 999875433332 34567999999999999999999999998 99999999999999775 899999999987654
Q ss_pred cCccceeccCCCCCccccCcccccc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcc-------------
Q 042314 245 KDSYSYKMTGGTGSYRYMAPEVYRR-ESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYE------------- 310 (370)
Q Consensus 245 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~------------- 310 (370)
... .....||+.|+|||.+.+ ..++.++||||+||++|||++|++||...........+...
T Consensus 176 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 176 GEP----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp TSC----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred Ccc----cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 432 233478999999998875 46899999999999999999999999887765544332110
Q ss_pred -----CCCC---------CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 311 -----DSRP---------ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 311 -----~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
...+ ......++.+.+||++||..||++|||++|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 1123468899999999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-46 Score=327.27 Aligned_cols=244 Identities=25% Similarity=0.386 Sum_probs=203.3
Q ss_pred CCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeCCceEEEEeecCCCC
Q 042314 98 GIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHSERLIFLTEYLRNGS 175 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~~~~~~v~e~~~g~~ 175 (370)
.+|+|+||.||+|.+. ++.+|+|+++... ........+.+|+.+++.++||||+++++++...+..++|+|++.|++
T Consensus 9 ~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~ 87 (292)
T d1unla_ 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL 87 (292)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEH
T ss_pred EEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccc
Confidence 3789999999999874 7789999997654 344567889999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccceeccCC
Q 042314 176 LHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYSYKMTGG 255 (370)
Q Consensus 176 L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 255 (370)
|..+++..+.+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++........ ....
T Consensus 88 l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~---~~~~ 161 (292)
T d1unla_ 88 KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC---YSAE 161 (292)
T ss_dssp HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC---CCSC
T ss_pred cccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc---ceee
Confidence 9999998889999999999999999999999998 999999999999999999999999999877654332 2233
Q ss_pred CCCccccCcccccccC-CCchhhHHHHHHHHHHHHhCCCCCC-CCcHHHHHHHhhcc-----------------------
Q 042314 256 TGSYRYMAPEVYRRES-YGKSVDVFSFALIVHEMFQGGPSNR-ADTAVQVADRRAYE----------------------- 310 (370)
Q Consensus 256 ~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~-~~~~~~~~~~~~~~----------------------- 310 (370)
.+++.|+|||.+.+.. ++.++||||+||++|||++|+.||. .....+........
T Consensus 162 ~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (292)
T d1unla_ 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241 (292)
T ss_dssp CSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCC
T ss_pred ccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccccc
Confidence 5788999999987765 6899999999999999999998864 33333332221110
Q ss_pred ----CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 311 ----DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 311 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.........+++.+.+|+++||+.||.+|||++|+++|
T Consensus 242 ~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112234467889999999999999999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=333.22 Aligned_cols=242 Identities=25% Similarity=0.333 Sum_probs=187.8
Q ss_pred ccCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEee------CCceEEE
Q 042314 96 RGGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKH------SERLIFL 167 (370)
Q Consensus 96 ~~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~------~~~~~~v 167 (370)
...+|.|+||+||+|.+. |..+|+|+++... .+.....++.+|+.++++++||||++++++|.. ...+|+|
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv 100 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 100 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEE
Confidence 345899999999999875 8899999997654 345566789999999999999999999999864 3678999
Q ss_pred EeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCc
Q 042314 168 TEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDS 247 (370)
Q Consensus 168 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 247 (370)
|||+.++ +.+.+. ..+++..++.++.|++.||.|||++| |+||||||+|||++.++.+|++|||+++.......
T Consensus 101 ~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~ 174 (355)
T d2b1pa1 101 MELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174 (355)
T ss_dssp EECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccccccc
Confidence 9999775 444443 47899999999999999999999999 99999999999999999999999999876654332
Q ss_pred cceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCC---------------
Q 042314 248 YSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDS--------------- 312 (370)
Q Consensus 248 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--------------- 312 (370)
.....+|+.|+|||++.+..++.++||||+||++|+|++|++||...+......++.....
T Consensus 175 ----~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 175 ----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred ----cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 2334689999999999999999999999999999999999999987765543332210000
Q ss_pred -----CCC--------------C------CCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 313 -----RPA--------------L------SSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 313 -----~~~--------------~------~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.+. . ....++.+.+||++||..||++|||++|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 0 01134678999999999999999999999876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=332.27 Aligned_cols=241 Identities=26% Similarity=0.382 Sum_probs=194.4
Q ss_pred cCCCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC-----CceEEEEe
Q 042314 97 GGIDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS-----ERLIFLTE 169 (370)
Q Consensus 97 ~~l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~-----~~~~~v~e 169 (370)
..+|.|+||+||+|... |+.||+|++.... .+....+.+.+|+.+++.++||||+++++++... ...+++++
T Consensus 24 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~ 102 (348)
T d2gfsa1 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102 (348)
T ss_dssp EECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence 34899999999999864 8899999997653 3445567789999999999999999999998643 23466677
Q ss_pred ecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEeccccceeccccCccc
Q 042314 170 YLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKIAQEKDSYS 249 (370)
Q Consensus 170 ~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 249 (370)
++.||+|.+++..+ ++++..++.++.||+.||.|||++| |+||||||+|||++.+|.+|++|||++......
T Consensus 103 ~~~gg~L~~~~~~~-~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~---- 174 (348)
T d2gfsa1 103 HLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---- 174 (348)
T ss_dssp ECCSEEHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTGG----
T ss_pred eecCCchhhhcccc-cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCcc----
Confidence 78899999998654 7999999999999999999999998 999999999999999999999999998765433
Q ss_pred eeccCCCCCccccCcccccccC-CCchhhHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhccCCC---------------
Q 042314 250 YKMTGGTGSYRYMAPEVYRRES-YGKSVDVFSFALIVHEMFQGGPSNRADTAVQVADRRAYEDSR--------------- 313 (370)
Q Consensus 250 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 313 (370)
.....||+.|+|||.+.+.. ++.++||||+||++|+|++|++||...+.......+......
T Consensus 175 --~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 252 (348)
T d2gfsa1 175 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252 (348)
T ss_dssp --GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred --cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence 23346899999999877654 588999999999999999999999887665443332211000
Q ss_pred ---------C-----CCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 314 ---------P-----ALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 314 ---------~-----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
+ ......++.+.+||++||..||++|||++|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0 0123478899999999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.5e-45 Score=326.64 Aligned_cols=234 Identities=20% Similarity=0.304 Sum_probs=189.1
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEee--CCceEEEEeecCC
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKH--SERLIFLTEYLRN 173 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~--~~~~~~v~e~~~g 173 (370)
+|.|+||.||+|... |+.+|+|+++... .+++.+|+.+++.++ ||||+++++++.. ...+++||||+++
T Consensus 43 LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~ 116 (328)
T d3bqca1 43 LGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116 (328)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCS
T ss_pred EecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCC
Confidence 789999999999875 8889999986532 456889999999995 9999999999874 4568999999999
Q ss_pred CCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCC-cEEEeccccceeccccCccceec
Q 042314 174 GSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAG-HLKVTDFGLSKIAQEKDSYSYKM 252 (370)
Q Consensus 174 ~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 252 (370)
++|..+. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+|+....... .
T Consensus 117 ~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~----~ 186 (328)
T d3bqca1 117 TDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE----Y 186 (328)
T ss_dssp CBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC----C
T ss_pred CcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCc----c
Confidence 9997653 47999999999999999999999999 99999999999998655 589999999987655432 2
Q ss_pred cCCCCCccccCccccccc-CCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHh----------------hcc----
Q 042314 253 TGGTGSYRYMAPEVYRRE-SYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ-VADRR----------------AYE---- 310 (370)
Q Consensus 253 ~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~----------------~~~---- 310 (370)
....+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||....... ..... ...
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 266 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence 334689999999998765 47999999999999999999999997543211 10000 000
Q ss_pred ---------------CCCCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 042314 311 ---------------DSRPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIFR 348 (370)
Q Consensus 311 ---------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~~ 348 (370)
.........+++++.+||++||..||++|||++|+++|
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111123367889999999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-38 Score=289.82 Aligned_cols=237 Identities=20% Similarity=0.302 Sum_probs=177.1
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-----------CCceeeeeeeEee--CCc
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-----------HPNIVQFLGVLKH--SER 163 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-----------hp~Iv~~~~~~~~--~~~ 163 (370)
+|.|+||.||+|... |..||||+++.. ....+.+.+|+.+++.++ |+||+++++++.. ...
T Consensus 21 LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~ 96 (362)
T d1q8ya_ 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 96 (362)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccc
Confidence 789999999999874 889999998653 344567788888887774 5789999998764 345
Q ss_pred eEEEEeecCCCCH-HHHH--HhCCCCChHhHHHHHHHHHHHHHHHhh-cCCCceeecCCCCCCeeeCCCC------cEEE
Q 042314 164 LIFLTEYLRNGSL-HDIL--KKKGKLDPPTAVAYALDIARGMNYLHH-HRPHAIIHRDLTPSNVLQDEAG------HLKV 233 (370)
Q Consensus 164 ~~~v~e~~~g~~L-~~~l--~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~iiH~Dlk~~Nil~~~~~------~~kl 233 (370)
.++++++...+.. .... .....+++..+..++.|++.||.|||+ .| |+||||||+|||++.++ .+++
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl 173 (362)
T d1q8ya_ 97 VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKI 173 (362)
T ss_dssp EEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred eeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeE
Confidence 5666666655443 2222 234578999999999999999999998 77 99999999999998655 3999
Q ss_pred eccccceeccccCccceeccCCCCCccccCcccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCcHHH------HH-HH
Q 042314 234 TDFGLSKIAQEKDSYSYKMTGGTGSYRYMAPEVYRRESYGKSVDVFSFALIVHEMFQGGPSNRADTAVQ------VA-DR 306 (370)
Q Consensus 234 ~Dfg~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~------~~-~~ 306 (370)
+|||.+....... ....||+.|+|||++....++.++|+||+||++++|++|+.||....... .. ..
T Consensus 174 ~dfg~s~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 174 ADLGNACWYDEHY------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp CCCTTCEETTBCC------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eeccccccccccc------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 9999987655432 23468999999999999999999999999999999999999997543211 00 00
Q ss_pred hhc------------------cC------C---------------CCCCCCCCcHHHHHHHHHhcccCCCCCCCHHHHHH
Q 042314 307 RAY------------------ED------S---------------RPALSSLYPEPIKALLRECWHKNPDRRPTFEEIIF 347 (370)
Q Consensus 307 ~~~------------------~~------~---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ll~ 347 (370)
... .. . ....+...++.+.+|+.+||..||++|||++|+|+
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 00 0 00111223567999999999999999999999987
Q ss_pred H
Q 042314 348 R 348 (370)
Q Consensus 348 ~ 348 (370)
|
T Consensus 328 H 328 (362)
T d1q8ya_ 328 H 328 (362)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=4.9e-24 Score=174.75 Aligned_cols=163 Identities=19% Similarity=0.123 Sum_probs=118.8
Q ss_pred CCCCCCcccEEEEEE-cCceeEEEEeccccCC---------------ChHHHHHHHHHHHHHHhcCCCceeeeeeeEeeC
Q 042314 98 GIDPGAYGEVYLVKW-RGTEIAAKTIRSSIAS---------------NPRVRNSFMKELGLWQKLRHPNIVQFLGVLKHS 161 (370)
Q Consensus 98 ~l~~g~~~~v~~a~~-~g~~vavK~l~~~~~~---------------~~~~~~~~~~e~~~l~~l~hp~Iv~~~~~~~~~ 161 (370)
.+|.|+||.||+|.. +|+.+|+|+++..... ..........|...+.++.|++++..+++.
T Consensus 7 ~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~--- 83 (191)
T d1zara2 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE--- 83 (191)
T ss_dssp EEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE---
T ss_pred EeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec---
Confidence 389999999999975 5889999987542111 012234456788899999999999888653
Q ss_pred CceEEEEeecCCCCHHHHHHhCCCCChHhHHHHHHHHHHHHHHHhhcCCCceeecCCCCCCeeeCCCCcEEEecccccee
Q 042314 162 ERLIFLTEYLRNGSLHDILKKKGKLDPPTAVAYALDIARGMNYLHHHRPHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI 241 (370)
Q Consensus 162 ~~~~~v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~ 241 (370)
..+++|||+++..+. .++...+..++.|++.++.|||++| |+||||||+|||++++ .++|+|||+|..
T Consensus 84 -~~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~~ 151 (191)
T d1zara2 84 -GNAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVE 151 (191)
T ss_dssp -TTEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCEE
T ss_pred -CCEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCccc
Confidence 237999999886543 3566677899999999999999998 9999999999999975 489999999876
Q ss_pred ccccCccceeccCCCCCccccCc--c---cccccCCCchhhHHHHHHHHH
Q 042314 242 AQEKDSYSYKMTGGTGSYRYMAP--E---VYRRESYGKSVDVFSFALIVH 286 (370)
Q Consensus 242 ~~~~~~~~~~~~~~~g~~~y~aP--E---~~~~~~~~~~~Di~slG~~l~ 286 (370)
...+.... |... + .+....|+.++|+||+.--+.
T Consensus 152 ~~~~~~~~-----------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 152 VGEEGWRE-----------ILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTSTTHHH-----------HHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred CCCCCcHH-----------HHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 64332111 1110 0 012356788999999875443
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.86 E-value=4.2e-23 Score=162.24 Aligned_cols=94 Identities=20% Similarity=0.117 Sum_probs=88.6
Q ss_pred CCCCCChhhhHHhhc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccc
Q 042314 4 IDSEGPYRLLYCSSK---GDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSD 80 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~---g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~ 80 (370)
.+..|+||||+|+.. |+.++|++|+++|+|+|.+|.+|+||||+||..|+.+++++|+++|+|++.+|..|+||+|.
T Consensus 41 ~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~ 120 (154)
T d1dcqa1 41 GHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDI 120 (154)
T ss_dssp CSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred CCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccccccccccccccccccCccccccCCCCCCHHHH
Confidence 367899999999974 68999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCceeeEEeeeccc
Q 042314 81 ARSFGHVVICKILEDRG 97 (370)
Q Consensus 81 A~~~g~~~~~~~L~~~~ 97 (370)
|+..|+.+++++|.+.+
T Consensus 121 A~~~~~~~i~~~L~~~~ 137 (154)
T d1dcqa1 121 AKRLKHEHCEELLTQAL 137 (154)
T ss_dssp HHHTTCHHHHHHHHHHH
T ss_pred HHHcCCHHHHHHHHHhC
Confidence 99999999999887754
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.85 E-value=3.2e-22 Score=150.26 Aligned_cols=90 Identities=34% Similarity=0.442 Sum_probs=80.5
Q ss_pred ChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccCcee
Q 042314 9 PYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVV 88 (370)
Q Consensus 9 ~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~~~ 88 (370)
.|||++||.+|+.++|++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|+|+|.+|..|+||||.|+..|+.+
T Consensus 3 ~tpL~~A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~ 82 (118)
T d1myoa_ 3 DKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVS 82 (118)
T ss_dssp HHHHHHHHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCH
T ss_pred ChHHHHHHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchh
Confidence 58999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eEEeeecccC
Q 042314 89 ICKILEDRGG 98 (370)
Q Consensus 89 ~~~~L~~~~~ 98 (370)
+++.|.+.++
T Consensus 83 ~v~~Ll~~Ga 92 (118)
T d1myoa_ 83 CVKLLLSKGA 92 (118)
T ss_dssp HHHHHHTTCC
T ss_pred hhhhhhcccc
Confidence 9888887664
|
| >d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myotrophin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.85 E-value=1.3e-22 Score=152.53 Aligned_cols=81 Identities=31% Similarity=0.243 Sum_probs=78.2
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|..|+||||+||..|+.+++++|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|+|++.+|..|+||++.|.
T Consensus 30 ~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~~v~~Ll~~Gad~~~~d~~G~t~l~~a~ 109 (118)
T d1myoa_ 30 RTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLTALEATD 109 (118)
T ss_dssp CCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCHHHHHHHTTCCCSSSSSSSTCCCCCTCS
T ss_pred cccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchhhhhhhhcccccceeeCCCCCCHHHHHh
Confidence 56889999999999999999999999999999999999999999999999999999999999999999999999999985
Q ss_pred c
Q 042314 83 S 83 (370)
Q Consensus 83 ~ 83 (370)
.
T Consensus 110 ~ 110 (118)
T d1myoa_ 110 N 110 (118)
T ss_dssp S
T ss_pred H
Confidence 4
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=1.7e-21 Score=148.91 Aligned_cols=88 Identities=36% Similarity=0.446 Sum_probs=65.5
Q ss_pred hhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccCceee
Q 042314 10 YRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVI 89 (370)
Q Consensus 10 t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~~~~ 89 (370)
+.||.||..|+.++|+.|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|+++|..|..|+||||.|+..|+.++
T Consensus 3 ~lL~~A~~~G~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~ 82 (130)
T d1ycsb1 3 ALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQV 82 (130)
T ss_dssp HHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHH
Confidence 56677777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred EEeeeccc
Q 042314 90 CKILEDRG 97 (370)
Q Consensus 90 ~~~L~~~~ 97 (370)
++.|.+.+
T Consensus 83 v~~Ll~~g 90 (130)
T d1ycsb1 83 CKFLVESG 90 (130)
T ss_dssp HHHHHHTT
T ss_pred HHHHHHcC
Confidence 77776654
|
| >d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 53BP2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=4.8e-22 Score=152.03 Aligned_cols=94 Identities=26% Similarity=0.227 Sum_probs=84.4
Q ss_pred ccCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccc-cCCCccc-
Q 042314 2 QIIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDR-WGRTPLS- 79 (370)
Q Consensus 2 ~~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~-~g~tpl~- 79 (370)
+.+|.+|+||||+||..|+.+++++|+++|+++|.+|.+|+||||+|+..|+.+++++|+++|++++..+. .|.||++
T Consensus 28 n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~v~~~~~~~~~~~~~~ 107 (130)
T d1ycsb1 28 SLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADK 107 (130)
T ss_dssp CCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSSSCCCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHHHHHHHHcCCCcccccCCCCCCHHHH
Confidence 35788999999999999999999999999999999999999999999999999999999999999998775 4777754
Q ss_pred -cccccCceeeEEeeec
Q 042314 80 -DARSFGHVVICKILED 95 (370)
Q Consensus 80 -~A~~~g~~~~~~~L~~ 95 (370)
.+...|+.+++++|..
T Consensus 108 ~~a~~~g~~eiv~~L~~ 124 (130)
T d1ycsb1 108 CEEMEEGYTQCSQFLYG 124 (130)
T ss_dssp CCSSSTTCCCHHHHHHH
T ss_pred HHHHHcChHHHHHHHHh
Confidence 5567788998887754
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=3.9e-21 Score=145.84 Aligned_cols=91 Identities=29% Similarity=0.389 Sum_probs=67.0
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCC-cHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKR-TALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~-t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
.+|..|+||||+|+ .|+.+++++|+++|+++|.+|..|. ||||+|+..|+.+++++|+++|+|++.+|..|+||+|.|
T Consensus 31 ~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~G~T~l~~A 109 (125)
T d1bi7b_ 31 APNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLA 109 (125)
T ss_dssp CCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTCCCHHHHH
T ss_pred cccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccCCCCCHHHHH
Confidence 45667777777554 5777777777777777777776665 577777777777777777777777777777777777777
Q ss_pred cccCceeeEEeee
Q 042314 82 RSFGHVVICKILE 94 (370)
Q Consensus 82 ~~~g~~~~~~~L~ 94 (370)
+..|+.+++++|.
T Consensus 110 ~~~g~~~~v~~Ll 122 (125)
T d1bi7b_ 110 EELGHRDVARYLR 122 (125)
T ss_dssp HHHTCHHHHHHHS
T ss_pred HHcCCHHHHHHHH
Confidence 7777777776654
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.78 E-value=2.7e-20 Score=159.25 Aligned_cols=94 Identities=24% Similarity=0.150 Sum_probs=88.7
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCC---CCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVE---PNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSD 80 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~---~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~ 80 (370)
+|++|+||||+||.+|+.+++++||++|++ +|.+|.+|.||||+|+..|+.+++++|+++|++++..|..|.||++.
T Consensus 5 i~~~G~t~Lh~A~~~~~~~~v~~Ll~~~a~~~~i~~~~~~g~TpL~~A~~~g~~~iv~~Ll~~ga~i~~~d~~g~tpL~~ 84 (255)
T d1oy3d_ 5 VTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHL 84 (255)
T ss_dssp CCTTCCCHHHHHHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHHH
T ss_pred CCcCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCcCCCCCCccchHHhhcccccccccccccccccccccccchhhhh
Confidence 588999999999999999999999999998 77889999999999999999999999999999999999999999999
Q ss_pred ccccCceeeEEeeeccc
Q 042314 81 ARSFGHVVICKILEDRG 97 (370)
Q Consensus 81 A~~~g~~~~~~~L~~~~ 97 (370)
|+..++.++++.|.+..
T Consensus 85 A~~~~~~~~~~~Ll~~~ 101 (255)
T d1oy3d_ 85 ACRVRAHTCACVLLQPR 101 (255)
T ss_dssp HTTTTCHHHHHHHSSSC
T ss_pred hhccCchHHHHHHHhhc
Confidence 99999999888876544
|
| >d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p16ink4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=7.9e-22 Score=149.76 Aligned_cols=90 Identities=27% Similarity=0.324 Sum_probs=84.1
Q ss_pred CCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCC-CccccccccC
Q 042314 7 EGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGR-TPLSDARSFG 85 (370)
Q Consensus 7 ~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~-tpl~~A~~~g 85 (370)
.+.++||+||.+|+.++|++|+++|+|+|.+|.+|.||||+|+ .|+.+++++|+++|+++|..+..|. ||+|.|+..|
T Consensus 2 p~~~~L~~Aa~~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g 80 (125)
T d1bi7b_ 2 PSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREG 80 (125)
T ss_dssp CSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHT
T ss_pred CChhHHHHHHHCCCHHHHHHHHHcCCccccccccccccccccc-cccccccccccccccccccccccccccccccccccc
Confidence 4679999999999999999999999999999999999999775 7999999999999999999998876 6999999999
Q ss_pred ceeeEEeeeccc
Q 042314 86 HVVICKILEDRG 97 (370)
Q Consensus 86 ~~~~~~~L~~~~ 97 (370)
+.++++.|.+.+
T Consensus 81 ~~~~v~~Ll~~g 92 (125)
T d1bi7b_ 81 FLDTLVVLHRAG 92 (125)
T ss_dssp CHHHHHHHHHHT
T ss_pred cccccccccccc
Confidence 999999998765
|
| >d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Transcription factor inhibitor I-kappa-B-beta, IKBB species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.77 E-value=9.2e-20 Score=155.88 Aligned_cols=96 Identities=28% Similarity=0.294 Sum_probs=90.8
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCC-CCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLA-DYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~-~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
.+|.+|+||||+||..|+.++|++|+++|++++.. +..|.||||+|+..|+.+++++|+++|+|++.+|..|.||||.|
T Consensus 153 ~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~TpL~~A~~~~~~~~v~~Ll~~gadin~~d~~g~t~L~~A 232 (255)
T d1oy3d_ 153 AENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSA 232 (255)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred cccccCcccccccccccccccccchhcccccccccccccccccccccccccHHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence 46889999999999999999999999999998865 67899999999999999999999999999999999999999999
Q ss_pred cccCceeeEEeeecccC
Q 042314 82 RSFGHVVICKILEDRGG 98 (370)
Q Consensus 82 ~~~g~~~~~~~L~~~~~ 98 (370)
+..++.+++++|.+.|+
T Consensus 233 ~~~~~~~i~~~Ll~~Ga 249 (255)
T d1oy3d_ 233 LLRPNPILARLLRAHGA 249 (255)
T ss_dssp HTSSCHHHHHHHHHTTC
T ss_pred HHCCCHHHHHHHHHcCC
Confidence 99999999999988764
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=4.1e-19 Score=147.01 Aligned_cols=91 Identities=25% Similarity=0.244 Sum_probs=87.8
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..|..|+|||++|+..|..++++.|++.++++|..|.+|.||||+||..|+.+++++|+++|+|++..|..|+||+|.|+
T Consensus 118 ~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gad~n~~d~~g~Tpl~~A~ 197 (209)
T d1ot8a_ 118 AADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITDHMDRLPRDVAS 197 (209)
T ss_dssp CBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred ccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHCCCCCCCcCCCCCCHHHHHH
Confidence 56788999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEee
Q 042314 83 SFGHVVICKIL 93 (370)
Q Consensus 83 ~~g~~~~~~~L 93 (370)
..|+.+++++|
T Consensus 198 ~~~~~~iv~lL 208 (209)
T d1ot8a_ 198 ERLHHDIVRLL 208 (209)
T ss_dssp HTTCHHHHHHH
T ss_pred HcCCHHHHhhc
Confidence 99999988765
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.74 E-value=8.9e-20 Score=157.77 Aligned_cols=90 Identities=21% Similarity=0.245 Sum_probs=82.7
Q ss_pred CCCChhhhHHhhcCCHHHHHHH--------HHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCc
Q 042314 6 SEGPYRLLYCSSKGDRAGVLQE--------LEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTP 77 (370)
Q Consensus 6 ~~g~t~l~~a~~~g~~~~~~~l--------l~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tp 77 (370)
.+|+||||+||.+|+.++|++| +++|||||.+|.+|+||||+|+..|+.+++++|+++|+|++..|..|.||
T Consensus 31 ~~g~T~Lh~A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~d~~G~TpLh~A~~~g~~~iv~~Ll~~Gad~n~~~~~g~t~ 110 (277)
T d2fo1e1 31 RHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSA 110 (277)
T ss_dssp SSCCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCH
T ss_pred CCCccHHHHHHHcCCHHHHHHHHhcchhHHHHcCCCccccCCCCCeeecccccccccccccccccccccccccccccccc
Confidence 4699999999999999988777 57799999999999999999999999999999999999999999999999
Q ss_pred cccccccCceeeEEeeec
Q 042314 78 LSDARSFGHVVICKILED 95 (370)
Q Consensus 78 l~~A~~~g~~~~~~~L~~ 95 (370)
++.|...++..+...+..
T Consensus 111 l~~a~~~~~~~~~~~l~~ 128 (277)
T d2fo1e1 111 LHQAAANRDFGMMVYMLN 128 (277)
T ss_dssp HHHHHHTTCHHHHHHHTT
T ss_pred ccchhhhcchhhhhhhhh
Confidence 999999998777665543
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=4.5e-19 Score=161.94 Aligned_cols=87 Identities=31% Similarity=0.428 Sum_probs=83.9
Q ss_pred hhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccCceee
Q 042314 10 YRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVI 89 (370)
Q Consensus 10 t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~~~~ 89 (370)
||||+||..|+.++|++||++|+|||..|.+|+||||+||..|+.+++++|+++|++++..+..|+||++.|+..|+.++
T Consensus 2 TpL~~Aa~~g~~~~v~~Ll~~g~~in~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gadi~~~~~~g~t~L~~A~~~g~~~~ 81 (408)
T d1n11a_ 2 TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNM 81 (408)
T ss_dssp CHHHHHHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHHHHHHHHTCHHH
T ss_pred ChHHHHHHCcCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred EEeeecc
Q 042314 90 CKILEDR 96 (370)
Q Consensus 90 ~~~L~~~ 96 (370)
++.|...
T Consensus 82 ~~~Ll~~ 88 (408)
T d1n11a_ 82 VKLLLEN 88 (408)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 8877654
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.6e-18 Score=136.76 Aligned_cols=90 Identities=30% Similarity=0.399 Sum_probs=51.5
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARS 83 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~ 83 (370)
.|..|+||||+|+ .|+.+++++|+++|+++|..+.+|.+||+.|+..++.++++.++++|+++|..|..|+||+|.|+.
T Consensus 32 ~d~~g~t~L~~A~-~~~~~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~t~L~~A~~ 110 (156)
T d1bd8a_ 32 LNRFGKTALQVMM-FGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQ 110 (156)
T ss_dssp CCTTSCCHHHHSC-TTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHH
T ss_pred cCCCCCccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccCCCCeeeccccc
Confidence 3455666666554 355555666665555555555555555555555555555555555555555555555555555555
Q ss_pred cCceeeEEeee
Q 042314 84 FGHVVICKILE 94 (370)
Q Consensus 84 ~g~~~~~~~L~ 94 (370)
.|+.+++++|.
T Consensus 111 ~~~~~i~~~L~ 121 (156)
T d1bd8a_ 111 EGHTAVVSFLA 121 (156)
T ss_dssp HTCHHHHHHHH
T ss_pred ccccccccccc
Confidence 55555555443
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.72 E-value=6.2e-18 Score=147.21 Aligned_cols=81 Identities=25% Similarity=0.326 Sum_probs=77.9
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..+..|.||||+||..|+.++++.|++.|+|+|.+|.+|+||||+|+..|+.++|++|+++|||++.+|..|+||||.|+
T Consensus 194 ~~~~~g~t~L~~a~~~~~~~~~~~Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~TaL~~A~ 273 (291)
T d1s70b_ 194 RHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVAD 273 (291)
T ss_dssp CCTTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTTTSCC
T ss_pred cccCCCCChhhHHHHcCChhhhcccccceecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHH
Confidence 35678999999999999999999999999999999999999999999999999999999999999999999999999997
Q ss_pred c
Q 042314 83 S 83 (370)
Q Consensus 83 ~ 83 (370)
.
T Consensus 274 e 274 (291)
T d1s70b_ 274 E 274 (291)
T ss_dssp S
T ss_pred H
Confidence 5
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.9e-18 Score=144.69 Aligned_cols=96 Identities=30% Similarity=0.370 Sum_probs=89.6
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|.+|+||||+||.+|+.+++++|+++|+|+|.+|.+|.||||+|+..|+.+++++|+.+|++++..|..|+||||.|+
T Consensus 98 ~~d~~g~tpL~~A~~~~~~e~~~~Ll~~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d~~g~TpL~~Aa 177 (223)
T d1uoha_ 98 AVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLAC 177 (223)
T ss_dssp CCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHH
T ss_pred eeCCCCCchhhHHHHcCCHHHHHHHHHCCCCCCCcCCCCCccchhhhhcCCcchhhhhccccceeeeccCCCCceecccc
Confidence 46889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecccC
Q 042314 83 SFGHVVICKILEDRGG 98 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~ 98 (370)
..|+.++++.|.+.++
T Consensus 178 ~~g~~~~v~~LL~~Ga 193 (223)
T d1uoha_ 178 DEERVEEAKLLVSQGA 193 (223)
T ss_dssp HTTCHHHHHHHHHTTC
T ss_pred ccCcHHHHHHHHHCCC
Confidence 9999999999877553
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.71 E-value=7.3e-18 Score=147.69 Aligned_cols=95 Identities=23% Similarity=0.249 Sum_probs=79.6
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCH-------HHHHHH----------------
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRA-------EIVLLL---------------- 60 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~-------~~~~~L---------------- 60 (370)
.|.+|+||||+||..|+.++|++||++|||+|.+|..|+||||.||..++. +++++|
T Consensus 103 ~D~~G~T~LH~Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~~~d~~g~t~lh 182 (301)
T d1sw6a_ 103 VDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILH 182 (301)
T ss_dssp CSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEECTTCCCHHH
T ss_pred cCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhhhcccccCCHHH
Confidence 388999999999999999999999999999999999999999999987652 333322
Q ss_pred --------------------------HHcCCC-------------------------------------ccCccccCCCc
Q 042314 61 --------------------------LEKGAD-------------------------------------VNSLDRWGRTP 77 (370)
Q Consensus 61 --------------------------l~~gad-------------------------------------~~~~~~~g~tp 77 (370)
+..+.. +|.+|..|+||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~~D~~G~Tp 262 (301)
T d1sw6a_ 183 HIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTC 262 (301)
T ss_dssp HHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTCCCTTSCCH
T ss_pred HHHHHhCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcCccCCCCCCCCH
Confidence 122211 57789999999
Q ss_pred cccccccCceeeEEeeecccC
Q 042314 78 LSDARSFGHVVICKILEDRGG 98 (370)
Q Consensus 78 l~~A~~~g~~~~~~~L~~~~~ 98 (370)
||+|+..|+.+++++|.+.++
T Consensus 263 Lh~A~~~g~~~iv~~Ll~~GA 283 (301)
T d1sw6a_ 263 LNIAARLGNISIVDALLDYGA 283 (301)
T ss_dssp HHHHHHHCCHHHHHHHHHTTC
T ss_pred HHHHHHcCCHHHHHHHHHCCC
Confidence 999999999999999988765
|
| >d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=2.7e-18 Score=143.76 Aligned_cols=91 Identities=27% Similarity=0.277 Sum_probs=85.2
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|..|.||||+|+..|+.+++++|++.|+++|.+|.+|+||||+|+..|+.+++++|+++|||++.+|.+|+||+|.|+
T Consensus 131 ~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d~~g~TpL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~g~tpl~~A~ 210 (223)
T d1uoha_ 131 AKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVAK 210 (223)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHCC
T ss_pred CcCCCCCccchhhhhcCCcchhhhhccccceeeeccCCCCceeccccccCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999999999985
Q ss_pred ccCceeeEEeee
Q 042314 83 SFGHVVICKILE 94 (370)
Q Consensus 83 ~~g~~~~~~~L~ 94 (370)
.|+.++++.|+
T Consensus 211 -~~~~~i~~~Ll 221 (223)
T d1uoha_ 211 -GGLGLILKRMV 221 (223)
T ss_dssp -TTHHHHHHHHH
T ss_pred -CCCHHHHhccc
Confidence 58877776654
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.70 E-value=1.1e-19 Score=162.52 Aligned_cols=94 Identities=13% Similarity=0.044 Sum_probs=82.5
Q ss_pred CCCCCChhhhHHhhcCCHHHHHH---HHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCcc--ccCCCcc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQ---ELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLD--RWGRTPL 78 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~---ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~--~~g~tpl 78 (370)
+|..|+||||+||.+||.+++++ |++.|++||.+|.+|+||||+||.+||.++|++|+++|++++..+ ..|+|||
T Consensus 86 ~~~~~~t~L~~Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~L 165 (346)
T d2ajaa1 86 KGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAF 165 (346)
T ss_dssp HTCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHH
T ss_pred ccCCCCcHHHHHHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCChh
Confidence 46789999999999999887765 789999999999999999999999999999999999999999876 4689999
Q ss_pred ccccccCceeeEEeeeccc
Q 042314 79 SDARSFGHVVICKILEDRG 97 (370)
Q Consensus 79 ~~A~~~g~~~~~~~L~~~~ 97 (370)
|.|+..|+.+++++|.+.+
T Consensus 166 ~~Aa~~g~~~iv~~Ll~~~ 184 (346)
T d2ajaa1 166 RLAAENGHLHVLNRLCELA 184 (346)
T ss_dssp HHHHHTTCHHHHHHHHHSC
T ss_pred HHHHHHhhHHHHHHHHHcC
Confidence 9999999999999987643
|
| >d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Ankyrin-R species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=5.5e-18 Score=154.61 Aligned_cols=91 Identities=29% Similarity=0.345 Sum_probs=84.6
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARS 83 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~ 83 (370)
.+..+.||||.|+..|+.++++.+++.|+++|.+|.+|+||||+|+..|+.++|++|+++|||+|.+|..|+||+|.|+.
T Consensus 293 ~~~~~~t~L~~~~~~~~~~~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g~~~iv~~Ll~~GAd~n~~d~~G~t~L~~A~~ 372 (408)
T d1n11a_ 293 TTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKR 372 (408)
T ss_dssp CCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCSSSCCHHHHHHH
T ss_pred ccccccccchhhcccCcceeeeeeccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Confidence 45678889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCceeeEEeee
Q 042314 84 FGHVVICKILE 94 (370)
Q Consensus 84 ~g~~~~~~~L~ 94 (370)
.|+.+++++|.
T Consensus 373 ~~~~~iv~~L~ 383 (408)
T d1n11a_ 373 LGYISVTDVLK 383 (408)
T ss_dssp TTCHHHHHHHH
T ss_pred cCCHHHHHHHH
Confidence 99999988763
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.68 E-value=1.2e-17 Score=140.11 Aligned_cols=92 Identities=24% Similarity=0.181 Sum_probs=82.1
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcC-CCCCCCCCCCCcHHHHHHHCCCHHHHHHHHH-cCCCccCccccCCCcccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKG-VEPNLADYDKRTALHLASSEGRAEIVLLLLE-KGADVNSLDRWGRTPLSD 80 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~g-a~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~-~gad~~~~~~~g~tpl~~ 80 (370)
..|..|+||||+|+..|+.+++++|++.| .++|.+|.+|+||||+|+..|+.++|++|++ .|+|++.+|..|+|||+.
T Consensus 133 ~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~gad~~~~d~~g~t~l~~ 212 (229)
T d1ixva_ 133 IKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDV 212 (229)
T ss_dssp CCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCCCTTSCCTGGG
T ss_pred ccCCCCCCccchhhhcccccccccccccccccccccccccCCchhhhcccccHHHHHHHHHhcCCCCCCcCCCCCCHHHH
Confidence 35788999999999999999999999997 7899999999999999999999999999996 599999999999999999
Q ss_pred ccccCceeeEEeeeccc
Q 042314 81 ARSFGHVVICKILEDRG 97 (370)
Q Consensus 81 A~~~g~~~~~~~L~~~~ 97 (370)
|... +++++|.+.+
T Consensus 213 A~~~---~~~~~Ll~~g 226 (229)
T d1ixva_ 213 ALNE---QVKKFFLNNV 226 (229)
T ss_dssp CSCH---HHHHHHHHHC
T ss_pred HhhH---HHHHHHHHcC
Confidence 9853 4556665543
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.67 E-value=1.6e-17 Score=130.21 Aligned_cols=90 Identities=30% Similarity=0.343 Sum_probs=79.9
Q ss_pred CCCCCChhhhHHhhcCCH---------------------------------HHHHHHHHcCCCCCCCCCCCCcHHHHHHH
Q 042314 4 IDSEGPYRLLYCSSKGDR---------------------------------AGVLQELEKGVEPNLADYDKRTALHLASS 50 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~---------------------------------~~~~~ll~~ga~~~~~~~~g~t~l~~A~~ 50 (370)
.|..|+||||+|+..++. +++++|+.+|++++.+|.+|+||||+|+.
T Consensus 30 ~~~~g~t~L~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~T~L~~A~~ 109 (153)
T d1awcb_ 30 TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATE 109 (153)
T ss_dssp CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHH
T ss_pred cccCCCccccccccccccccccccccccccccccccccccccccccccccceeeecccccCCccccccccCchHHHhhhh
Confidence 466677777777776655 57777778899999999999999999999
Q ss_pred CCCHHHHHHHHHcCCCccCccccCCCccccccccCceeeEEee
Q 042314 51 EGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVICKIL 93 (370)
Q Consensus 51 ~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~~~~~~~L 93 (370)
.|+.+++++|+++|+|++..|..|.||+++|+..|+.+++++|
T Consensus 110 ~g~~~iv~~ll~~gad~~~~d~~g~Tpl~~A~~~g~~eiv~lL 152 (153)
T d1awcb_ 110 HNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152 (153)
T ss_dssp TTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred cchhheeeeccccccCCcccCCCCCCHHHHHHHcCCHHHHHhC
Confidence 9999999999999999999999999999999999999988755
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=2.6e-17 Score=136.73 Aligned_cols=88 Identities=26% Similarity=0.300 Sum_probs=81.5
Q ss_pred CCCChhhhHHhhcCCHHHHHHHHH----cCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 6 SEGPYRLLYCSSKGDRAGVLQELE----KGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 6 ~~g~t~l~~a~~~g~~~~~~~ll~----~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
++|+||||+||.+|+.++|+.|++ .|+++|.+|.+|+||||+|+..|+.+++++|+++|++++..+..|.++++.|
T Consensus 1 ~dG~TpLh~A~~~g~~~~v~~Ll~~~~~~g~~in~~d~~g~TpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~a 80 (228)
T d1k1aa_ 1 EDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLA 80 (228)
T ss_dssp CTTCCHHHHHHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred CCCccHHHHHHHcCCHHHHHHHHHHHHHCCCCCCccCCCCCccceehhcccccccccccccccccccccccccccccccc
Confidence 479999999999999999999884 8999999999999999999999999999999999999999999999999999
Q ss_pred cccCceeeEEee
Q 042314 82 RSFGHVVICKIL 93 (370)
Q Consensus 82 ~~~g~~~~~~~L 93 (370)
...++.++++.+
T Consensus 81 ~~~~~~~~~~~~ 92 (228)
T d1k1aa_ 81 CEHRSPTCLRAL 92 (228)
T ss_dssp HHTTCHHHHHHH
T ss_pred cccccccchhhh
Confidence 988887665544
|
| >d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: GA bindinig protein (GABP) beta 1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.67 E-value=8.3e-19 Score=137.77 Aligned_cols=90 Identities=28% Similarity=0.315 Sum_probs=78.3
Q ss_pred CChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHH-----------------------------
Q 042314 8 GPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVL----------------------------- 58 (370)
Q Consensus 8 g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~----------------------------- 58 (370)
..||||.||..|+.++|+.||++||+++ .|..|+||||+|+..++.++++
T Consensus 2 ~~t~L~~Aa~~g~~~~v~~LL~~ga~~~-~~~~g~t~L~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (153)
T d1awcb_ 2 LGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHA 80 (153)
T ss_dssp HHHHHHHHHHHTCHHHHHHHHHHTCCCC-CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCH
T ss_pred CCHHHHHHHHCCCHHHHHHHHHcCCCcc-cccCCCccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4599999999999999999999999988 6999999999999988877665
Q ss_pred ----HHHHcCCCccCccccCCCccccccccCceeeEEeeecccC
Q 042314 59 ----LLLEKGADVNSLDRWGRTPLSDARSFGHVVICKILEDRGG 98 (370)
Q Consensus 59 ----~Ll~~gad~~~~~~~g~tpl~~A~~~g~~~~~~~L~~~~~ 98 (370)
+|+.+|++.+.++..|+||||+|+..|+.+++++|.+.++
T Consensus 81 ~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~ga 124 (153)
T d1awcb_ 81 NIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGA 124 (153)
T ss_dssp HHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTC
T ss_pred eeeecccccCCccccccccCchHHHhhhhcchhheeeecccccc
Confidence 4455566777888899999999999999999998877654
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=6.1e-18 Score=133.16 Aligned_cols=87 Identities=28% Similarity=0.282 Sum_probs=81.6
Q ss_pred hhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccCceee
Q 042314 10 YRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGHVVI 89 (370)
Q Consensus 10 t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~~~~ 89 (370)
+|||+||..|+.++|+.|+++|+|+|.+|.+|.||||+|+ .|+.+++++|+++|++++..+..|.++++.+...++...
T Consensus 3 ~~Lh~Aa~~g~~~~v~~Ll~~g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~ 81 (156)
T d1ihba_ 3 NELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDT 81 (156)
T ss_dssp HHHHHHHHHTCHHHHHHHTTSCCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHH
T ss_pred HHHHHHHHcCCHHHHHHHHHCCCCcCccCCcccccccccc-cccccccccccccccccccccccCccccccccccccccc
Confidence 8999999999999999999999999999999999999886 799999999999999999999999999999999999888
Q ss_pred EEeeeccc
Q 042314 90 CKILEDRG 97 (370)
Q Consensus 90 ~~~L~~~~ 97 (370)
+..+...+
T Consensus 82 ~~~l~~~~ 89 (156)
T d1ihba_ 82 LQTLLEFQ 89 (156)
T ss_dssp HHHHHHTT
T ss_pred cccccccc
Confidence 87776543
|
| >d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: Pseudo ankyrin repeat-like family: Pseudo ankyrin repeat domain: Hypothetical protein LPG2416 species: Legionella pneumophila [TaxId: 446]
Probab=99.65 E-value=5.4e-19 Score=157.94 Aligned_cols=95 Identities=17% Similarity=0.064 Sum_probs=83.0
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCC--CCCCcHHHHHHHCCCHHHHHHHHHcCCCcc---CccccCCCc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLAD--YDKRTALHLASSEGRAEIVLLLLEKGADVN---SLDRWGRTP 77 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~--~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~---~~~~~g~tp 77 (370)
.+|.+|+||||+||.+||.++|++|+++|+++|..| .+|+||||+||.+||.++|++|+++|++.. ..+..|.||
T Consensus 121 ~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~L~~Aa~~g~~~iv~~Ll~~~~~~~~~~~~~~~~~t~ 200 (346)
T d2ajaa1 121 VIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAF 200 (346)
T ss_dssp --CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHHHHHHHH
T ss_pred ccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCChhHHHHHHhhHHHHHHHHHcCCcccccccccCCCcch
Confidence 467789999999999999999999999999999876 469999999999999999999999998764 344567788
Q ss_pred cccccccCceeeEEeeeccc
Q 042314 78 LSDARSFGHVVICKILEDRG 97 (370)
Q Consensus 78 l~~A~~~g~~~~~~~L~~~~ 97 (370)
++.|+..|+.+++++|.+.+
T Consensus 201 l~~A~~~g~~~iv~~Ll~~g 220 (346)
T d2ajaa1 201 RWAAVGRGHHNVINFLLDCP 220 (346)
T ss_dssp HHHHSTTCCHHHHHHHTTSH
T ss_pred hhHHhhcCHHHHHHHHHhCC
Confidence 89999999999999987654
|
| >d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Cell cycle inhibitor p19ink4D species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=3.9e-18 Score=134.44 Aligned_cols=92 Identities=26% Similarity=0.330 Sum_probs=81.5
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
..+..|.+||++|+..++.++++.++++|+++|.+|.+|+||||+||..|+.+++++|+ .|++++.+|..|+||++.|+
T Consensus 63 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~~i~~~L~-~~~~~~~~d~~G~TpL~~A~ 141 (156)
T d1bd8a_ 63 VQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLA-AESDLHRRDARGLTPLELAL 141 (156)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHH-TTSCTTCCCTTSCCHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccCCCCeeecccccccccccccccc-ccccccccCCCCCCHHHHHH
Confidence 35667899999999999999999999999999999999999999999999999999777 68999999999999999999
Q ss_pred ccCceeeEEeeec
Q 042314 83 SFGHVVICKILED 95 (370)
Q Consensus 83 ~~g~~~~~~~L~~ 95 (370)
..|+.+++++|.+
T Consensus 142 ~~g~~~iv~~Ll~ 154 (156)
T d1bd8a_ 142 QRGAQDLVDILQG 154 (156)
T ss_dssp HSCCHHHHHHHHT
T ss_pred HcCCHHHHHHHHh
Confidence 9999988887754
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=9.2e-17 Score=133.99 Aligned_cols=93 Identities=29% Similarity=0.273 Sum_probs=86.5
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLAD-YDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~-~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
....|.||||+|+..|+.+.+++|++.|+++|..+ .+|.||||+|+..|+.+++++|+++|+|++.+|..|+||++.|+
T Consensus 107 ~~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl~~A~ 186 (221)
T d1iknd_ 107 TNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTW 186 (221)
T ss_dssp CCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGCT
T ss_pred cccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCHHHHHH
Confidence 34568999999999999999999999999999875 67999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeecc
Q 042314 83 SFGHVVICKILEDR 96 (370)
Q Consensus 83 ~~g~~~~~~~L~~~ 96 (370)
..++.++++.|.+.
T Consensus 187 ~~~~~~~~~~l~~~ 200 (221)
T d1iknd_ 187 GRPSTRIQQQLGQL 200 (221)
T ss_dssp TSSCHHHHHHHHTT
T ss_pred HCCCHHHHHHHHHc
Confidence 99999998877654
|
| >d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Pyk2-associated protein beta species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.63 E-value=3.3e-16 Score=122.35 Aligned_cols=64 Identities=17% Similarity=0.160 Sum_probs=61.2
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCC
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGAD 66 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad 66 (370)
.+|.+|+||||+||..|+.+++++|+++|+|+|.+|.+|.||||+|+..|+.+++++|++.++.
T Consensus 76 ~~d~~g~TpLh~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~~~~~~i~~~L~~~~~~ 139 (154)
T d1dcqa1 76 KQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEHCEELLTQALSG 139 (154)
T ss_dssp CCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTT
T ss_pred hhhhhhccccccccccccccccccccccCccccccCCCCCCHHHHHHHcCCHHHHHHHHHhCCC
Confidence 5788999999999999999999999999999999999999999999999999999999998754
|
| >d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Lin-12 species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.63 E-value=7.1e-17 Score=139.18 Aligned_cols=93 Identities=29% Similarity=0.379 Sum_probs=87.0
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHH-HcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQEL-EKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDA 81 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll-~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A 81 (370)
..+..|+||||+|+..|+.++++.++ ..|.+++.+|..|+||||+|+..|+.++|++|+++|+|+|.+|.+|+||||+|
T Consensus 182 ~~~~~g~t~L~~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~tpL~~A~~~g~~~iv~~Ll~~gadin~~d~~G~T~L~~A 261 (277)
T d2fo1e1 182 SEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLA 261 (277)
T ss_dssp SSSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHHHHH
T ss_pred ccccCCCCccccccccccccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCcCCCCCCHHHHH
Confidence 35678999999999999999999755 67899999999999999999999999999999999999999999999999999
Q ss_pred cccCceeeEEeeec
Q 042314 82 RSFGHVVICKILED 95 (370)
Q Consensus 82 ~~~g~~~~~~~L~~ 95 (370)
+..|+.+++++|.+
T Consensus 262 ~~~~~~~iv~lL~~ 275 (277)
T d2fo1e1 262 QANNHHNIVDIFDR 275 (277)
T ss_dssp HHTTCHHHHHHHHT
T ss_pred HHcCCHHHHHHHHH
Confidence 99999999988764
|
| >d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Myosin phosphatase targeting subunit 1, MYPT1 species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=99.63 E-value=3.2e-17 Score=142.58 Aligned_cols=92 Identities=36% Similarity=0.481 Sum_probs=87.0
Q ss_pred CCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccC
Q 042314 6 SEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFG 85 (370)
Q Consensus 6 ~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g 85 (370)
.+|.||||.||..|+.++|++||++|||||.+|.+|.||||+|+..|+.+++++|+++|++.+..+..+.+|++.++..+
T Consensus 38 ~~~~t~l~~A~~~G~~~~v~~Ll~~Gadvn~~d~~G~T~L~~A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~~ 117 (291)
T d1s70b_ 38 FDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCG 117 (291)
T ss_dssp ECHHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHT
T ss_pred CCCchHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCcHHHHHHhcCCceeeeeeccccccccccccccccccccccccc
Confidence 45679999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeeEEeeeccc
Q 042314 86 HVVICKILEDRG 97 (370)
Q Consensus 86 ~~~~~~~L~~~~ 97 (370)
+.++++.|...+
T Consensus 118 ~~~~~~~l~~~~ 129 (291)
T d1s70b_ 118 YLDIAEYLISQG 129 (291)
T ss_dssp CHHHHHHHHHTT
T ss_pred ccchhhcccccC
Confidence 999988887654
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=8e-17 Score=139.45 Aligned_cols=95 Identities=26% Similarity=0.314 Sum_probs=79.6
Q ss_pred CCCCCChhhhHHhhcCCHHHHH--------------------------------------HHHHcCCCCCCCCCCCCcHH
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVL--------------------------------------QELEKGVEPNLADYDKRTAL 45 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~--------------------------------------~ll~~ga~~~~~~~~g~t~l 45 (370)
.+..|.||||+||..|+.++++ +|+++|+++|.+|.+|.|||
T Consensus 144 ~~~~g~t~L~~A~~~~~~~~~~~Ll~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~i~~~Li~~ga~~n~~~~~g~t~L 223 (285)
T d1wdya_ 144 LRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPL 223 (285)
T ss_dssp TTCCCCCHHHHHHHHTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHH
T ss_pred hcccCchHHHHHHHcCCHHHHHHHHhccCCCcccccCCCCcccccccccccchHHHHHHHHHHHCCCCCCccCCCCCCcc
Confidence 3456788888888887665444 45556777788888999999
Q ss_pred HHHHHCCCHHHHHHHHHc-CCCccCccccCCCccccccccCceeeEEeeecccC
Q 042314 46 HLASSEGRAEIVLLLLEK-GADVNSLDRWGRTPLSDARSFGHVVICKILEDRGG 98 (370)
Q Consensus 46 ~~A~~~g~~~~~~~Ll~~-gad~~~~~~~g~tpl~~A~~~g~~~~~~~L~~~~~ 98 (370)
|+|+..|+.+++++|+++ |+|+|.+|.+|.||||.|+..|+.+++++|++.|+
T Consensus 224 ~~a~~~~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GA 277 (285)
T d1wdya_ 224 ILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGA 277 (285)
T ss_dssp HHHHHTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSS
T ss_pred chhhhcCcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCC
Confidence 999999999999999974 89999999999999999999999999999887764
|
| >d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: bcl-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=1.7e-16 Score=131.57 Aligned_cols=87 Identities=29% Similarity=0.255 Sum_probs=83.2
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARS 83 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~ 83 (370)
.+..|.++|+.|+..++..+++.++++|.+++.+|.+|.||||+|+..|+.+++++|+++|+|+|.+|..|+||||.|+.
T Consensus 140 ~~~~~~~~l~~a~~~~~~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~TpL~~A~~ 219 (228)
T d1k1aa_ 140 DIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARS 219 (228)
T ss_dssp CTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTTCSS
T ss_pred cccchhhHHHHHHHhhhhhhhhhhhhhccccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHh
Confidence 45679999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCceeeE
Q 042314 84 FGHVVIC 90 (370)
Q Consensus 84 ~g~~~~~ 90 (370)
.|+.+++
T Consensus 220 ~~~~div 226 (228)
T d1k1aa_ 220 RRVIDIL 226 (228)
T ss_dssp HHHHHHH
T ss_pred CCCcccc
Confidence 9987765
|
| >d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: I-kappa-B-alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=8.8e-18 Score=140.31 Aligned_cols=91 Identities=25% Similarity=0.217 Sum_probs=79.3
Q ss_pred CCChhhhHHhhcCCH----HHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 7 EGPYRLLYCSSKGDR----AGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 7 ~g~t~l~~a~~~g~~----~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
+|+||||+|+.+|+. ++++.|...|++||.+|.+|+||||+|+..|+.+++++|+++|+|++..|..|.||++.+.
T Consensus 1 dG~t~Lh~A~~~g~~~~~~~li~~~~~~~~~in~~d~~g~TpLh~A~~~~~~~iv~~L~~~g~d~~~~d~~g~t~l~~~~ 80 (221)
T d1iknd_ 1 DGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLAC 80 (221)
T ss_dssp CCCCTTHHHHHTTCSSSSSCCCC-----CCCCCCCCTTCCCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHH
T ss_pred CCChHHHHHHHcCCHHHHHHHHHHHHhCCCCcccCCCCCCcccccccccccccccccccccccccccccccccccccccc
Confidence 699999999999986 5566677889999999999999999999999999999999999999999999999999999
Q ss_pred ccCceeeEEeeeccc
Q 042314 83 SFGHVVICKILEDRG 97 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~ 97 (370)
..++.++++.+...+
T Consensus 81 ~~~~~~~~~~l~~~~ 95 (221)
T d1iknd_ 81 EQGCLASVGVLTQSC 95 (221)
T ss_dssp HHTCHHHHHHHHHST
T ss_pred ccccccccchhhhhc
Confidence 999988888776543
|
| >d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: RNase L, 2-5a-dependent ribonuclease species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=3.9e-16 Score=135.01 Aligned_cols=70 Identities=30% Similarity=0.277 Sum_probs=66.4
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHH-cCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELE-KGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDR 72 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~-~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~ 72 (370)
.+|..|+||||+||..|+.++|++||+ .|+|||.+|.+|.||||+|+..|+.++|++|+++|||+|.+|.
T Consensus 214 ~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d~ 284 (285)
T d1wdya_ 214 VRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGDL 284 (285)
T ss_dssp CCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSSC
T ss_pred ccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcccC
Confidence 467889999999999999999999997 4999999999999999999999999999999999999999874
|
| >d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Neurogenic locus notch receptor domain species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.53 E-value=6.6e-15 Score=121.18 Aligned_cols=58 Identities=21% Similarity=0.207 Sum_probs=55.9
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHH
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLL 60 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~L 60 (370)
..|..|+||||+||..|+.++|++||++|||+|.+|.+|+||||+|+.+|+.++|++|
T Consensus 151 ~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gad~n~~d~~g~Tpl~~A~~~~~~~iv~lL 208 (209)
T d1ot8a_ 151 AQDDKDETPLFLAAREGSYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLL 208 (209)
T ss_dssp CCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred ccccccccccchhccccHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCCHHHHhhc
Confidence 4688999999999999999999999999999999999999999999999999999976
|
| >d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: p18ink4C(ink6) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=3.7e-15 Score=116.85 Aligned_cols=95 Identities=27% Similarity=0.290 Sum_probs=81.6
Q ss_pred cCCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCcccccc
Q 042314 3 IIDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 3 ~~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~ 82 (370)
.+|.+|+||||+|+ .|+.+++++|+++|++++..+..|.|||+.|+..|+.++++.|++++.+++..+..|.+|++.|.
T Consensus 29 ~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~a~ 107 (156)
T d1ihba_ 29 AQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAA 107 (156)
T ss_dssp CCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred ccCCcccccccccc-cccccccccccccccccccccccCccccccccccccccccccccccccccccccccccccccccc
Confidence 46889999999886 78999999999999999999999888888888888888888888888888888888888888888
Q ss_pred ccCceeeEEeeecccC
Q 042314 83 SFGHVVICKILEDRGG 98 (370)
Q Consensus 83 ~~g~~~~~~~L~~~~~ 98 (370)
..++.++++.|.+.+.
T Consensus 108 ~~~~~~~~~~Ll~~~~ 123 (156)
T d1ihba_ 108 KEGHLRVVEFLVKHTA 123 (156)
T ss_dssp HTTCHHHHHHHHHHSC
T ss_pred cccccccccccccccc
Confidence 8888888877765543
|
| >d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.41 E-value=5e-14 Score=117.51 Aligned_cols=93 Identities=28% Similarity=0.269 Sum_probs=88.1
Q ss_pred CCCCCChhhhHHhhcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHCCCHHHHHHHHHcC-CCccCccccCCCcccccc
Q 042314 4 IDSEGPYRLLYCSSKGDRAGVLQELEKGVEPNLADYDKRTALHLASSEGRAEIVLLLLEKG-ADVNSLDRWGRTPLSDAR 82 (370)
Q Consensus 4 ~~~~g~t~l~~a~~~g~~~~~~~ll~~ga~~~~~~~~g~t~l~~A~~~g~~~~~~~Ll~~g-ad~~~~~~~g~tpl~~A~ 82 (370)
.+..+.|+|++++..++.+++++|++.|.+++..|.+|+||||+|+..|+.+++++|+++| .++|.+|..|+||||.|+
T Consensus 101 ~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A~ 180 (229)
T d1ixva_ 101 ITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHAL 180 (229)
T ss_dssp CCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHH
T ss_pred cccccccccccccccchhhhhhhhhhhcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCchhhhc
Confidence 4677899999999999999999999999999999999999999999999999999999987 789999999999999999
Q ss_pred ccCceeeEEeeecc
Q 042314 83 SFGHVVICKILEDR 96 (370)
Q Consensus 83 ~~g~~~~~~~L~~~ 96 (370)
..|+.++++.|...
T Consensus 181 ~~~~~~~v~~Ll~~ 194 (229)
T d1ixva_ 181 AEGHGDAAVLLVEK 194 (229)
T ss_dssp HTTCHHHHHHHHHH
T ss_pred ccccHHHHHHHHHh
Confidence 99999999988754
|
| >d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-hairpin-alpha-hairpin repeat superfamily: Ankyrin repeat family: Ankyrin repeat domain: Swi6 ankyrin-repeat fragment species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.15 E-value=5.9e-12 Score=109.43 Aligned_cols=58 Identities=24% Similarity=0.237 Sum_probs=54.2
Q ss_pred HcCCCCCCC-CCCCCcHHHHHHHCCCHHHHHHHHHcCCCccCccccCCCccccccccCc
Q 042314 29 EKGVEPNLA-DYDKRTALHLASSEGRAEIVLLLLEKGADVNSLDRWGRTPLSDARSFGH 86 (370)
Q Consensus 29 ~~ga~~~~~-~~~g~t~l~~A~~~g~~~~~~~Ll~~gad~~~~~~~g~tpl~~A~~~g~ 86 (370)
..++|+|.. |.+|+||||+||..|+.++|++|+++|||++.+|..|+||||.|+..++
T Consensus 94 ~~~~dvn~~~D~~G~T~LH~Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~ 152 (301)
T d1sw6a_ 94 NTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVN 152 (301)
T ss_dssp TSCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSH
T ss_pred ccCCCcCcCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhccc
Confidence 458899976 9999999999999999999999999999999999999999999998765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.50 E-value=5.2e-07 Score=75.68 Aligned_cols=130 Identities=15% Similarity=0.087 Sum_probs=87.6
Q ss_pred cccEEEEEEcCceeEEEEeccccCCChHHHHHHHHHHHHHHhcC-CCceeeeeeeEeeCCceEEEEeecCCCCHHHHHHh
Q 042314 104 YGEVYLVKWRGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLR-HPNIVQFLGVLKHSERLIFLTEYLRNGSLHDILKK 182 (370)
Q Consensus 104 ~~~v~~a~~~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~-hp~Iv~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~ 182 (370)
.+.||+....+..+++|......... ...+.+|...++.+. +--+++++.+....+..++||++++|.++.+....
T Consensus 27 ~~~v~rv~~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 27 PAKVYKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp SSEEEEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCcEEEEEeCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 46789888788888999876543222 223567777777664 33367788888888889999999999887654321
Q ss_pred CCCCChHhHHHHHHHHHHHHHHHhhcC-----------------------------------------------------
Q 042314 183 KGKLDPPTAVAYALDIARGMNYLHHHR----------------------------------------------------- 209 (370)
Q Consensus 183 ~~~~~~~~~~~i~~~l~~~l~~lH~~~----------------------------------------------------- 209 (370)
......+..++.+.+..||+..
T Consensus 104 -----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 178 (263)
T d1j7la_ 104 -----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEK 178 (263)
T ss_dssp -----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSC
T ss_pred -----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcC
Confidence 1122233444444455555321
Q ss_pred ---CCceeecCCCCCCeeeCCCCcEEEecccccee
Q 042314 210 ---PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI 241 (370)
Q Consensus 210 ---~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~ 241 (370)
+..++|+|+.|.||++++++.+-|+||+.+..
T Consensus 179 ~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 179 PEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999866567999997653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.14 E-value=8.1e-06 Score=67.74 Aligned_cols=66 Identities=18% Similarity=0.109 Sum_probs=45.4
Q ss_pred ccEEEEEEc-CceeEEEEeccccCCChHHHHHHHHHHHHHHhcCC--CceeeeeeeEeeCCceEEEEeecCCCCH
Q 042314 105 GEVYLVKWR-GTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRH--PNIVQFLGVLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 105 ~~v~~a~~~-g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~h--p~Iv~~~~~~~~~~~~~~v~e~~~g~~L 176 (370)
+.||+.... +..+++|....... ..+..|...++.+.. -.+++++.+..+.+..++||++++|.++
T Consensus 25 ~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 25 AAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CeEEEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 567888776 44577787654322 235566776666632 2367788888888889999999988665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.92 E-value=2.6e-05 Score=69.07 Aligned_cols=76 Identities=14% Similarity=0.077 Sum_probs=45.5
Q ss_pred CCCCCcccEEEEEEc--CceeEEEEecccc----CCChHHHHHHHHHHHHHHhcC-C--CceeeeeeeEeeCCceEEEEe
Q 042314 99 IDPGAYGEVYLVKWR--GTEIAAKTIRSSI----ASNPRVRNSFMKELGLWQKLR-H--PNIVQFLGVLKHSERLIFLTE 169 (370)
Q Consensus 99 l~~g~~~~v~~a~~~--g~~vavK~l~~~~----~~~~~~~~~~~~e~~~l~~l~-h--p~Iv~~~~~~~~~~~~~~v~e 169 (370)
+|.|....||++... ++.+++|.-.... ..-+....+...|.++++.+. + ..+++++.+ +.+..++|||
T Consensus 34 ig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvmE 111 (392)
T d2pula1 34 IGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVME 111 (392)
T ss_dssp CCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEEC
T ss_pred eCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEEe
Confidence 577888899998653 6678888643211 111122334456777777663 2 345666654 3455678999
Q ss_pred ecCCCCH
Q 042314 170 YLRNGSL 176 (370)
Q Consensus 170 ~~~g~~L 176 (370)
++++..+
T Consensus 112 ~L~~~~~ 118 (392)
T d2pula1 112 DLSHLKI 118 (392)
T ss_dssp CCTTSEE
T ss_pred ccCCccc
Confidence 9987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.03 E-value=0.0019 Score=55.11 Aligned_cols=131 Identities=12% Similarity=0.151 Sum_probs=73.0
Q ss_pred ccEEEEEE-cCceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCc--eeeeee-----eEeeCCceEEEEeecCCCCH
Q 042314 105 GEVYLVKW-RGTEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN--IVQFLG-----VLKHSERLIFLTEYLRNGSL 176 (370)
Q Consensus 105 ~~v~~a~~-~g~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~--Iv~~~~-----~~~~~~~~~~v~e~~~g~~L 176 (370)
..||.+.. +|..+++|+.+..... .+++..|...+..+.... ++..+. .+......+.+++++.|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 47888865 5778999998654322 344666777776664221 111111 23446678899999987432
Q ss_pred -----HHH------H-------HhC-----CC-------------------CChH---hHHHHHHHHHHHHHHH-hhcCC
Q 042314 177 -----HDI------L-------KKK-----GK-------------------LDPP---TAVAYALDIARGMNYL-HHHRP 210 (370)
Q Consensus 177 -----~~~------l-------~~~-----~~-------------------~~~~---~~~~i~~~l~~~l~~l-H~~~~ 210 (370)
..+ + ... .. ++.. .....+.++...+.-. .+..+
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 111 1 000 01 1111 1122233333333222 22334
Q ss_pred CceeecCCCCCCeeeCCCCcEEEecccccee
Q 042314 211 HAIIHRDLTPSNVLQDEAGHLKVTDFGLSKI 241 (370)
Q Consensus 211 ~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~~ 241 (370)
.++||+|+.+.|||+++ + ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 56999999999999974 3 45899997653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.92 E-value=0.0032 Score=53.22 Aligned_cols=31 Identities=29% Similarity=0.339 Sum_probs=27.1
Q ss_pred CCceeecCCCCCCeeeCCCCcEEEeccccce
Q 042314 210 PHAIIHRDLTPSNVLQDEAGHLKVTDFGLSK 240 (370)
Q Consensus 210 ~~~iiH~Dlk~~Nil~~~~~~~kl~Dfg~~~ 240 (370)
+.++||+|+.++||+++.+...-++||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4569999999999999987777899999874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.59 E-value=0.0032 Score=55.18 Aligned_cols=69 Identities=14% Similarity=0.258 Sum_probs=40.8
Q ss_pred CCCCCcccEEEEEEcC---------ceeEEEEeccccCCChHHHHHHHHHHHHHHhcCCCc-eeeeeeeEeeCCceEEEE
Q 042314 99 IDPGAYGEVYLVKWRG---------TEIAAKTIRSSIASNPRVRNSFMKELGLWQKLRHPN-IVQFLGVLKHSERLIFLT 168 (370)
Q Consensus 99 l~~g~~~~v~~a~~~g---------~~vavK~l~~~~~~~~~~~~~~~~e~~~l~~l~hp~-Iv~~~~~~~~~~~~~~v~ 168 (370)
++-|-.-.+|++.... ..+++++.-. ... . ....+|..+++.+.-.+ .+++++++.. ++|+
T Consensus 50 l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~-~--idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 50 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PET-E--SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCC-H--HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred cCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cch-h--hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3446667778776532 3355555431 111 1 23457888888875333 4577777643 6899
Q ss_pred eecCCCCH
Q 042314 169 EYLRNGSL 176 (370)
Q Consensus 169 e~~~g~~L 176 (370)
||++|.+|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99988544
|